Citrus Sinensis ID: 001057
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1170 | 2.2.26 [Sep-21-2011] | |||||||
| Q559T8 | 2102 | Probable serine/threonine | yes | no | 0.269 | 0.149 | 0.527 | 1e-98 | |
| Q6P0Q8 | 1798 | Microtubule-associated se | yes | no | 0.267 | 0.174 | 0.495 | 1e-87 | |
| Q60592 | 1734 | Microtubule-associated se | yes | no | 0.267 | 0.180 | 0.489 | 7e-87 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | no | 0.267 | 0.211 | 0.483 | 1e-86 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | no | 0.343 | 0.256 | 0.422 | 5e-86 | |
| Q811L6 | 2618 | Microtubule-associated se | no | no | 0.290 | 0.129 | 0.466 | 6e-86 | |
| O15021 | 2626 | Microtubule-associated se | no | no | 0.260 | 0.116 | 0.485 | 8e-86 | |
| Q810W7 | 1570 | Microtubule-associated se | no | no | 0.345 | 0.257 | 0.424 | 5e-85 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | no | 0.345 | 0.257 | 0.412 | 7e-85 | |
| Q3U214 | 1321 | Microtubule-associated se | no | no | 0.267 | 0.236 | 0.474 | 4e-84 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 362 bits (928), Expect = 1e-98, Method: Compositional matrix adjust.
Identities = 194/368 (52%), Positives = 237/368 (64%), Gaps = 53/368 (14%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
I DFEIIKPIS+GAFGRV+LA+K+ TGDL+AIKVLKK D IRKN V ++ ERNIL V+
Sbjct: 1524 IADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVERNILAMVQ 1583
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876
N FVV+ FY+F + LYLVMEYL GGD SLLR LGC +E MA+ YIAE VL LEYLH
Sbjct: 1584 NEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLHK 1643
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS------------------------ 912
++HRDLKPDN+LI GHIKLTDFGLSK+G+I
Sbjct: 1644 SAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDDKKMEDSGNTNTNTHFNFSTSPTNT 1703
Query: 913 --TDDLSA---PSLGSGGFLVNDELKD------------QPPLTREQRQKHSVAGTPDYL 955
DD S P+ G+G +N + + PL + ++ V GTPDYL
Sbjct: 1704 SMMDDSSTTGNPN-GNGNTSLNSSQTNILSPYPQRKNTLKTPLKKPVKK---VVGTPDYL 1759
Query: 956 APEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRD--IPWPNIPEE 1013
+PEILLG GHG T DWW++GIIL+E L G PPFN TP+ IF +I++RD + W PEE
Sbjct: 1760 SPEILLGTGHGQTVDWWALGIILYEFLTGSPPFNDDTPELIFQHILHRDREMEW---PEE 1816
Query: 1014 MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKA--MFIPAAE-SL 1070
+S EA DLI KLL +P +RLGA GA EVK HPFF N+NWDTL Q+ +F+P E +
Sbjct: 1817 ISSEAKDLILKLLNPDPYKRLGANGAYEVKTHPFFANVNWDTLIDQEMDNIFLPKPENNY 1876
Query: 1071 DTSYFVSR 1078
DT YF R
Sbjct: 1877 DTDYFWDR 1884
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 325 bits (834), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 163/329 (49%), Positives = 213/329 (64%), Gaps = 16/329 (4%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
SK S EDFE IK IS GA+G VFL R ++T FA+K + K ++I +N ++ ER+
Sbjct: 503 SKKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERD 562
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
IL NPFVV F SF + +L +VMEY+ GGD +LL+N+G L DM R+Y AE VLA
Sbjct: 563 ILTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLA 622
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
LEYLH+ ++HRDLKPDNLLI GHIKLTDFGLSK+GL+ T +L G + D
Sbjct: 623 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE------GHIEKD 676
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
RE K V GTP+Y+APE++L G+G DWW++GIIL+E L+G PF
Sbjct: 677 --------AREFLDKQ-VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 727
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
TP+++F +++ +I WP E + +A DL KLL +NP++RLG A EVKQHPFF
Sbjct: 728 DTPEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTG 787
Query: 1051 INWDTLARQKAMFIPAAESL-DTSYFVSR 1078
++W L RQKA FIP ES DTSYF +R
Sbjct: 788 LDWTGLLRQKAEFIPQLESEDDTSYFDTR 816
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 7e-87, Method: Compositional matrix adjust.
Identities = 161/329 (48%), Positives = 214/329 (65%), Gaps = 16/329 (4%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
S+ S EDFE IK IS GA+G VFL R ++T FA+K + K ++I +N ++ ER+
Sbjct: 444 SQKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERD 503
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
IL NPFVV F SF + +L +VMEY+ GGD +LL+N+G L DM R+Y AE VLA
Sbjct: 504 ILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLA 563
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
LEYLH+ ++HRDLKPDNLLI GHIKLTDFGLSK+GL+ T +L G + D
Sbjct: 564 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE------GHIEKD 617
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
RE K V GTP+Y+APE++L G+G DWW++GIIL+E L+G PF
Sbjct: 618 --------AREFLDKQ-VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 668
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
TP+++F +++ +I WP + + +A DL KLL +NP++RLG + A EVKQHPFF
Sbjct: 669 DTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNPLERLGTSSAYEVKQHPFFMG 728
Query: 1051 INWDTLARQKAMFIPAAESL-DTSYFVSR 1078
++W L RQKA FIP ES DTSYF +R
Sbjct: 729 LDWTGLLRQKAEFIPQLESEDDTSYFDTR 757
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 159/329 (48%), Positives = 217/329 (65%), Gaps = 16/329 (4%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
S+ + DFE IK IS GA+G V+L R + T FA+K + K ++I +N + + ER+
Sbjct: 390 SRKKPCESDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIHQVFVERD 449
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
IL NPFVV F SF R +L +VMEY+ GGD +LL+N+G L DM+R+Y AE VLA
Sbjct: 450 ILTFAENPFVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMSRMYFAETVLA 509
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
LEYLH+ ++HRDLKPDNLLI GHIKLTDFGLSKVGL++ T +L G + D
Sbjct: 510 LEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKVGLMNMTTNLYE------GHIEKD 563
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
TRE K V GTP+Y+APE++L G+G DWW++GIIL+E L+G PF
Sbjct: 564 --------TREFLDKQ-VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 614
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
TP+++F +++ DI WP E + ++ DLI +LL +N ++RLG GA+EVKQH FF +
Sbjct: 615 DTPEELFGQVISDDIIWPGGEEALPADSQDLITRLLRQNSLERLGTGGAQEVKQHTFFLS 674
Query: 1051 INWDTLARQKAMFIPAAES-LDTSYFVSR 1078
++W+ L RQKA F+P E+ DTSYF +R
Sbjct: 675 LDWNGLLRQKAEFVPQLEADDDTSYFDTR 703
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 320 bits (819), Expect = 5e-86, Method: Compositional matrix adjust.
Identities = 184/436 (42%), Positives = 253/436 (58%), Gaps = 34/436 (7%)
Query: 647 QQIKKLLDVSRSIASVNDC-DYNSLE--HMLDRLEELKYIIQDRKVDALFVETFGRRIEK 703
Q +KKLL + A + +C ++N E H+L+ E K D + + R
Sbjct: 273 QLVKKLLIIISRPARLLECLEFNPEEFYHLLEAAEGHAKEGHLVKTD---IPRYIIRQLG 329
Query: 704 LLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEII 763
L ++ + ++ + E+ DS + T E+ + E + P DF+ I
Sbjct: 330 LTRDPFPDV---VHLEEQDSGGSNTPEQDDLSEGRSSKAKKPPGE---------NDFDTI 377
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRF 823
K IS GA+G V+L R R T FA+K + K ++I +N ++ ER+IL NPFVV
Sbjct: 378 KLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVGM 437
Query: 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRD 883
F SF R +L +VMEY+ GGD +LL+N+G L +MAR+Y AE VLALEYLH+ ++HRD
Sbjct: 438 FCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNYGIVHRD 497
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
LKPDNLLI GHIKLTDFGLSK+GL+ T +L G + D RE
Sbjct: 498 LKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYE------GHIEKD--------AREFL 543
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003
K V GTP+Y+APE++L G+G DWW++GIIL+E L+G PF TP+++F +++
Sbjct: 544 DKQ-VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 602
Query: 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMF 1063
DI WP E + EA LI LL NP+ RLGA GA EVKQH FF++++W L RQKA F
Sbjct: 603 DILWPEGDEALPTEAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWTGLLRQKAEF 662
Query: 1064 IPAAESL-DTSYFVSR 1078
IP ES DTSYF +R
Sbjct: 663 IPHLESEDDTSYFDTR 678
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 320 bits (819), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 168/360 (46%), Positives = 230/360 (63%), Gaps = 20/360 (5%)
Query: 720 KLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARK 779
+L + ++ T E MDE +V S TS + K R S DFE IK IS GA+G V+ R
Sbjct: 532 QLGNYDSRTAETPEMDE-SVSSSNTS-LRLRRKPRES--DFETIKLISNGAYGAVYFVRH 587
Query: 780 RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839
+ + FA+K + K ++I +N ++ ER+IL NPFVV + SF R +L +VMEY
Sbjct: 588 KESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEY 647
Query: 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKL 899
+ GGD +L++N+G L DMAR+Y AE VLALEYLH+ ++HRDLKPDNLL+ GHIKL
Sbjct: 648 VEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKL 707
Query: 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEI 959
TDFGLSKVGL+ T +L G + D RE K V GTP+Y+APE+
Sbjct: 708 TDFGLSKVGLMSMTTNLYE------GHIEKD--------AREFLDKQ-VCGTPEYIAPEV 752
Query: 960 LLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEAC 1019
+L G+G DWW++GIIL+E L+G PF TP+++F +++ +I WP E +A
Sbjct: 753 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQ 812
Query: 1020 DLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAESL-DTSYFVSR 1078
+LI LL +NP++RLG GA EVKQH FF++++W++L RQKA FIP ES DTSYF +R
Sbjct: 813 ELITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTR 872
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 319 bits (818), Expect = 8e-86, Method: Compositional matrix adjust.
Identities = 156/321 (48%), Positives = 211/321 (65%), Gaps = 16/321 (4%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
DFE IK IS GA+G V+ R + + FA+K + K ++I +N ++ ER+IL NP
Sbjct: 572 DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 631
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN 878
FVV + SF R +L +VMEY+ GGD +L++N+G L DMAR+Y AE VLALEYLH+
Sbjct: 632 FVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYG 691
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
++HRDLKPDNLL+ GHIKLTDFGLSKVGL+ T +L G + D
Sbjct: 692 IVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNLYE------GHIEKD-------- 737
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998
RE K V GTP+Y+APE++L G+G DWW++GIIL+E L+G PF TP+++F
Sbjct: 738 AREFLDKQ-VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 796
Query: 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLAR 1058
+++ +I WP E +A DLI LL +NP++RLG GA EVKQH FF++++W++L R
Sbjct: 797 QVISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLR 856
Query: 1059 QKAMFIPAAESL-DTSYFVSR 1078
QKA FIP ES DTSYF +R
Sbjct: 857 QKAEFIPQLESEDDTSYFDTR 877
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q810W7|MAST1_RAT Microtubule-associated serine/threonine-protein kinase 1 OS=Rattus norvegicus GN=Mast1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 317 bits (811), Expect = 5e-85, Method: Compositional matrix adjust.
Identities = 185/436 (42%), Positives = 255/436 (58%), Gaps = 32/436 (7%)
Query: 647 QQIKKLLDVSRSIASVNDC-DYNSLE--HMLDRLEELKYIIQDRKVDALFVETFGRRIEK 703
Q +KKLL + A + +C ++N E H+L+ E K D + + R
Sbjct: 273 QLVKKLLIIISRPARLLECLEFNPEEFYHLLEAAEGHAKEGHLVKTD---IPRYIIRQLG 329
Query: 704 LLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEII 763
L ++ + ++ + E+ DS + T E+ E RS + P + DF+ I
Sbjct: 330 LTRDPFPDV---VRLEEQDSGGSNTPEQDDTSEG--RSSTSKAKKPPGES-----DFDTI 379
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRF 823
K IS GA+G V+L R R T FA+K + K ++I +N ++ ER+IL NPFVV
Sbjct: 380 KLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVGM 439
Query: 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRD 883
F SF R +L +VMEY+ GGD +LL+N+G L +MAR+Y AE VLALEYLH+ ++HRD
Sbjct: 440 FCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNYGIVHRD 499
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
LKPDNLLI GHIKLTDFGLSK+GL+ T +L G + D RE
Sbjct: 500 LKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYE------GHIEKD--------AREFL 545
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003
K V GTP+Y+APE++L G+G DWW++GIIL+E L+G PF TP+++F +++
Sbjct: 546 DKQ-VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 604
Query: 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMF 1063
DI WP E + +A LI LL NP+ RLGA GA EVKQH FF++++W L RQKA F
Sbjct: 605 DILWPEGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWTGLLRQKAEF 664
Query: 1064 IPAAESL-DTSYFVSR 1078
IP ES DTSYF +R
Sbjct: 665 IPHLESEDDTSYFDTR 680
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Isoform 2 may play a role in neuronal transcriptional regulation. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 180/436 (41%), Positives = 255/436 (58%), Gaps = 32/436 (7%)
Query: 647 QQIKKLLDVSRSIASVNDC-DYNSLE--HMLDRLEELKYIIQDRKVDALFVETFGRRIEK 703
Q +KKLL + A + +C ++N E H+L+ E K D + + R
Sbjct: 273 QLVKKLLIIISRPARLLECLEFNPEEFYHLLEAAEGHAKEGHLVKTD---IPRYIIRQLG 329
Query: 704 LLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEII 763
L ++ + ++ +++++ SN ++++S + + P DF+ I
Sbjct: 330 LTRDPFPDVV-RLEEQDSGGSNTPEQDDTSEGRSSTSKAKKPPGE---------SDFDTI 379
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRF 823
K IS GA+G V+L R R T FA+K + K ++I +N ++ ER+IL NPFVV
Sbjct: 380 KLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVGM 439
Query: 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRD 883
F SF R +L +VMEY+ GGD +LL+N+G L +MAR+Y AE VLALEYLH+ ++HRD
Sbjct: 440 FCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNYGIVHRD 499
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
LKPDNLLI GHIKLTDFGLSK+GL+ T +L G + D RE
Sbjct: 500 LKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNLYE------GHIEKD--------AREFL 545
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003
K V GTP+Y+APE++L G+G DWW++GIIL+E L+G PF TP+++F +++
Sbjct: 546 DKQ-VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD 604
Query: 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMF 1063
DI WP E + +A LI LL NP+ RLGA GA EVKQH FF++++W L RQKA F
Sbjct: 605 DILWPEGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWTGLLRQKAEF 664
Query: 1064 IPAAESL-DTSYFVSR 1078
IP ES DTSYF +R
Sbjct: 665 IPHLESEDDTSYFDTR 680
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 313 bits (803), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 156/329 (47%), Positives = 211/329 (64%), Gaps = 16/329 (4%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
S+ + DFE IK IS GA+G V+L R R T FAIK + K ++I +N ++ + ER+
Sbjct: 380 SRRKPCESDFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERD 439
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
IL NPFVV F SF R +L +VMEY+ GGD +LL+N+G L DMAR+Y AE VLA
Sbjct: 440 ILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLA 499
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
LEYLH+ ++HRDLKPDNLLI GHIKLTDFGLSK+GL+ +L G + D
Sbjct: 500 LEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLYE------GHIEKD 553
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
RE K V GTP+Y+APE++ G+G DWW++G+IL+E L+G PF
Sbjct: 554 --------AREFVDKQ-VCGTPEYIAPEVIFRQGYGKPVDWWAMGVILYEFLVGCVPFFG 604
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
TP+++F +++ +I WP E + ++A DLI +LL ++P+ RLG G EVKQHPFF
Sbjct: 605 DTPEELFGQVVSDEIMWPEGDEALPLDAQDLITRLLRQSPMDRLGTGGTHEVKQHPFFLA 664
Query: 1051 INWDTLARQKAMFIPAAESL-DTSYFVSR 1078
++W L R KA F+P E+ DTSYF +R
Sbjct: 665 LDWAGLLRHKAEFVPQLEAEDDTSYFDTR 693
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1170 | ||||||
| 255539727 | 1211 | kinase, putative [Ricinus communis] gi|2 | 0.987 | 0.953 | 0.703 | 0.0 | |
| 359490266 | 1222 | PREDICTED: uncharacterized protein LOC10 | 0.975 | 0.933 | 0.679 | 0.0 | |
| 356544254 | 1173 | PREDICTED: uncharacterized protein LOC10 | 0.965 | 0.963 | 0.668 | 0.0 | |
| 296084166 | 1099 | unnamed protein product [Vitis vinifera] | 0.917 | 0.976 | 0.661 | 0.0 | |
| 224136766 | 1218 | predicted protein [Populus trichocarpa] | 0.943 | 0.906 | 0.655 | 0.0 | |
| 356529891 | 1179 | PREDICTED: uncharacterized protein LOC10 | 0.970 | 0.962 | 0.666 | 0.0 | |
| 297793797 | 1166 | hypothetical protein ARALYDRAFT_332465 [ | 0.963 | 0.966 | 0.654 | 0.0 | |
| 15241795 | 1168 | AGC (cAMP-dependent, cGMP-dependent and | 0.945 | 0.946 | 0.660 | 0.0 | |
| 224120242 | 1055 | predicted protein [Populus trichocarpa] | 0.877 | 0.973 | 0.678 | 0.0 | |
| 449451934 | 1179 | PREDICTED: uncharacterized protein LOC10 | 0.958 | 0.951 | 0.628 | 0.0 |
| >gi|255539727|ref|XP_002510928.1| kinase, putative [Ricinus communis] gi|223550043|gb|EEF51530.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1670 bits (4324), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 856/1217 (70%), Positives = 988/1217 (81%), Gaps = 62/1217 (5%)
Query: 2 SSSAENQDPLSPTPASTPSPTTRTKLRKIPPIPIRRGKHDHSEG-----------ENQRR 50
SS+AE SP+ ASTP TR KLRKIPPIPIRR K ++G N+
Sbjct: 9 SSTAETT---SPSSASTP---TRFKLRKIPPIPIRRTKTHLNDGTVSSSPFDDDASNENE 62
Query: 51 HHDDSNV--EQARGDDESSILVASSLGLNHIRTKSVSSSPSPLRFFSAAGTPSSF-TNEA 107
+ DD+ + + A+ + + I++ASSLGLNHIRT+S + S SPLRF S AG S+ N
Sbjct: 63 NDDDNQLSNKSAKEEKNTPIIMASSLGLNHIRTQS-TPSLSPLRFSSNAGKLSNLGNNND 121
Query: 108 KKN-----KTETAAADVKPKFAVPPSNKPPSLESGKKGQWTQSKSLRFPS---PLNPELE 159
KKN ++ D+K K A+P + S E GK+ W QSKS ++PS PLNP +E
Sbjct: 122 KKNGLIKEDKGGSSVDMKLKCALP-LHSVSSTEPGKRIAWCQSKSSKYPSGPLPLNPAVE 180
Query: 160 VSHAAFAKEMQSPRFQAILRVTSGRKKKAPEIKSFSHELNSKGVRPFPVWKSRAFGHMEE 219
HAAFA+E+QSPRFQAILRVTSGRKKKAP++KSFSHELNSKGV+PFPVWKSRAFGH+EE
Sbjct: 181 SHHAAFARELQSPRFQAILRVTSGRKKKAPDVKSFSHELNSKGVKPFPVWKSRAFGHIEE 240
Query: 220 IMVAIRAKFDKLKEEVNCDLGVLAGDLVGILEKSSDSHPEWQESLEDLLVIARKCATMSP 279
+MVAIRAKFDKLKEEV+ DLG+ AGDLVGILEK+ DSHPEW+ESLEDLLVIAR+C+ MSP
Sbjct: 241 VMVAIRAKFDKLKEEVDSDLGIFAGDLVGILEKTCDSHPEWRESLEDLLVIARQCSKMSP 300
Query: 280 SEFWVKCEGIVLNLDDRRQELPMGILKQAYTRLLFILTRCTRLVQFQKESGYEEEHILGL 339
+EFWVK E IV LDD+RQELP+GI+KQA+TRLLFILTRCTRLVQFQKESG+E+ HILGL
Sbjct: 301 NEFWVKSEAIVQTLDDKRQELPIGIIKQAHTRLLFILTRCTRLVQFQKESGFEDYHILGL 360
Query: 340 HQLSDLGVYPEQILQIRQQDFSGPLTGGKVM-NEKQRKK-SHGQELGSLNLKEDQVDQHE 397
HQLSDLGVYPEQIL++ QDFSGPL G V +EKQRKK S+ QE SL ++++ VD
Sbjct: 361 HQLSDLGVYPEQILEVATQDFSGPLVAGNVTTSEKQRKKLSYDQEQDSLVIQQEHVDH-- 418
Query: 398 TENVEVGTAKSGDSTTSSYRMSSWKRLPSGSRRKKGSEAAADTPPKDKTEAFQNKDEPKI 457
VEV TAKS DSTTSSY+MSSWK+LPS + + + A DTP KDK+E+ NKD+ +I
Sbjct: 419 --TVEVSTAKSVDSTTSSYKMSSWKKLPSAAEKNRKCNDAVDTPTKDKSESPHNKDDTRI 476
Query: 458 GSDDGNDNLDGLYHHASSRITK-SWGFWGE-------NSMICRICEVEIPVVHVEEHSRI 509
DD ++ + H ASS + WG WGE NSMICRICEVEIP+VHVEEHS I
Sbjct: 477 VGDDNSEIIATPEHPASSETRRVPWGLWGEHHNVAYGNSMICRICEVEIPIVHVEEHSLI 536
Query: 510 CTIADRCDLKSLTVNERLERVAETLEKILDSWSPKK-------------HTKKRTHDDLN 556
CTI DRCDLK LT+NERLERV +TL+KIL+S +PK R H++L+
Sbjct: 537 CTIVDRCDLKGLTLNERLERVVDTLDKILESMTPKSTPGCDTPRQSLEVERMARVHEELD 596
Query: 557 LMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA-AKTSSAGS 615
+SPK+NS SR S++MLD +PD DNAF+IED+NV PE C+ + + A AKTSSAGS
Sbjct: 597 ELSPKRNSFSRHCSEDMLDLMPDADNAFLIEDINVSPENLCEGHSVLSPEADAKTSSAGS 656
Query: 616 LTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLD 675
LTPRSPLLTPRTSQIELL+ G RTI EL+N QQI KLL+++RS+AS+N+CDY++LE MLD
Sbjct: 657 LTPRSPLLTPRTSQIELLLTGRRTIMELENHQQISKLLEIARSVASINECDYSALECMLD 716
Query: 676 RLEELKYIIQDRKVDALFVETFGRRIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMD 735
RLE+LKY IQDRKVDAL VETFGRRIEKLLQEKYV+LC QIDDEKLD SN M +EESS++
Sbjct: 717 RLEDLKYAIQDRKVDALVVETFGRRIEKLLQEKYVHLCAQIDDEKLDLSNHMADEESSLE 776
Query: 736 EDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD 795
+D VRS R SPINP SKDRTSIEDFEIIKPIS+GAFGRVFLA+KRATGDLFAIKVLKKAD
Sbjct: 777 DDAVRSWRASPINP-SKDRTSIEDFEIIKPISRGAFGRVFLAKKRATGDLFAIKVLKKAD 835
Query: 796 MIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL 855
MIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL
Sbjct: 836 MIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL 895
Query: 856 DEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915
DEDMARVYIAE+VLALEYLHSL+VIHRDLKPDNLLIGQDGH+KLTDFGLSKVGLI+STDD
Sbjct: 896 DEDMARVYIAEVVLALEYLHSLSVIHRDLKPDNLLIGQDGHLKLTDFGLSKVGLINSTDD 955
Query: 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVG 975
LS PS S F + K Q REQRQKHSV GTPDYLAPEILLG GHG TADWWSVG
Sbjct: 956 LSGPSFNSSVFFDDGAQKGQNSSKREQRQKHSVVGTPDYLAPEILLGTGHGTTADWWSVG 1015
Query: 976 IILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG 1035
IILFELL+GIPPFNA+ PQQIFDNIMNRDIPWP +PEEMS EACDLIDKLLTENP+QRLG
Sbjct: 1016 IILFELLVGIPPFNAENPQQIFDNIMNRDIPWPRVPEEMSFEACDLIDKLLTENPLQRLG 1075
Query: 1036 ATGAREVKQHPFFKNINWDTLARQKAMFIPAAESLDTSYFVSRYVWNP--EDENVQGGSD 1093
ATG++EVKQH FF +INWDTLARQKAMFIPAA++ DTSYF+SRY+WNP E E++QGGSD
Sbjct: 1076 ATGSKEVKQHSFFGDINWDTLARQKAMFIPAADAHDTSYFMSRYIWNPEGEGEHLQGGSD 1135
Query: 1094 FDDLTDTCSSGSFSNTLDEEQADECGSLAEFSAPALAVQYSFSNFSFKNLSQLASINYDL 1153
FDDLTDTCS+GSFSNT DE+ DECGSLA+F+APALAV+YSFSNFSFKNLSQLAS+NYDL
Sbjct: 1136 FDDLTDTCSTGSFSNTHDED-GDECGSLADFNAPALAVKYSFSNFSFKNLSQLASMNYDL 1194
Query: 1154 VVKSAKESAEASKSSVP 1170
V++SAKE+A+ASK SVP
Sbjct: 1195 VIRSAKEAADASKPSVP 1211
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359490266|ref|XP_002265664.2| PREDICTED: uncharacterized protein LOC100252544 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1590 bits (4118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 821/1209 (67%), Positives = 944/1209 (78%), Gaps = 68/1209 (5%)
Query: 8 QDPLSP----TPASTPSPTTRTKLRKIPPIPIRRGKHDHS------EGENQRRHHDDSNV 57
DP P +P + PS + + KLRKIPPIP+RR D S EG+ + + D S
Sbjct: 36 HDPPPPAVDSSPTAAPSASLKAKLRKIPPIPVRRNPRDDSVDDKEEEGDGESENDDVS-- 93
Query: 58 EQARGDDESSILVASSLGLNHIRTKSVSSSPSPLRFFSAAGTPSSFTNEAKKNKTETAAA 117
DD+S ++ASSLGLN IRT+S SPSPLRF S AG P + N+AKKNK A
Sbjct: 94 -----DDDSEFILASSLGLNQIRTRS---SPSPLRFTSLAGEPPNLGNDAKKNKD---GA 142
Query: 118 DVKPKFAVPPSNKPPSLESGKKGQWTQSKSLRFPSPLNPELEVSHAAFAKEMQSPRFQAI 177
+ +PK P + S+E KK W Q KS R PSPLNP LE HA AKE+QSPRFQAI
Sbjct: 143 EARPK-RTSPLCRATSMEHSKKISWIQPKSFRVPSPLNPGLEAHHAILAKEIQSPRFQAI 201
Query: 178 LRVTSGRKKKAPEIKSFSHELNSKGVRPFPVWKSRAFGHMEEIMVAIRAKFDKLKEEVNC 237
LRVTSGR+K+ +IKSFSHELNSKGVR FP WKSRA GHMEEIMV IRAKFD+LKEEVN
Sbjct: 202 LRVTSGRRKRTSDIKSFSHELNSKGVRAFPFWKSRAVGHMEEIMVVIRAKFDRLKEEVNS 261
Query: 238 DLGVLAGDLVGILEKSSDSHPEWQESLEDLLVIARKCATMSPSEFWVKCEGIVLNLDDRR 297
DLG+ AGDLVGILEK++++ EW+E LEDLL++AR CA M P+EFW+KCEGIV NLDDRR
Sbjct: 262 DLGIFAGDLVGILEKTAETKLEWKEGLEDLLIVARHCAKMPPNEFWLKCEGIVQNLDDRR 321
Query: 298 QELPMGILKQAYTRLLFILTRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQILQIRQ 357
QELPMG LKQA+TRLLFILTRCTRLVQF KESGYEE+HILGLHQLSDLG+Y E IL Q
Sbjct: 322 QELPMGTLKQAHTRLLFILTRCTRLVQFHKESGYEEDHILGLHQLSDLGIYSEHILGAMQ 381
Query: 358 QDFSGPLTGGKVMNEKQRKKSHGQELGSLNLKEDQVDQ---HETENVEVGTAKSGDSTTS 414
Q+ GP+ +NEKQ KKSH QE SL K+DQVD E+ EVGTAKS DS TS
Sbjct: 382 QESGGPVD----VNEKQSKKSHAQEHSSLAPKQDQVDHDLDSGVEDHEVGTAKSADSITS 437
Query: 415 SYRMSSWKRLPSGSRR--KKGSEAAADTPPKDKTEAFQNKDEPKIGSDDGNDNL---DGL 469
SY+MSSWK+ PS + + +KG+EA D K K + KDE K G +D N+ L
Sbjct: 438 SYKMSSWKKYPSTAEKNHRKGNEAV-DMTSKVKLDPLPVKDENKTGINDNTGNMVTPSCL 496
Query: 470 YHHA--SSRITK-SWGFWG-------ENSMICRICEVEIPVVHVEEHSRICTIADRCDLK 519
+A +S++ + SWG W ENSMICRICEVEIP VHVE+HSRICTIADRCDLK
Sbjct: 497 SENAEATSKVHRVSWGCWSDQQQITYENSMICRICEVEIPTVHVEDHSRICTIADRCDLK 556
Query: 520 SLTVNERLERVAETLEKILDSWSPK------------KHTKKRTHDDLNLMSPKQNSLSR 567
LTVNERLERVAETLE+IL+ W+PK + + ++L+ SPK+N+LSR
Sbjct: 557 GLTVNERLERVAETLERILECWTPKSTDTSGGSPDIVRVSISSASEELDDFSPKKNTLSR 616
Query: 568 QGSKEMLDHVPDDDNAFVIEDLNVLPEISCD-KNPTAADIAAKTSSAGSLTPRSPLLTPR 626
S +MLD V + DN FV++DLNVLPE+SCD ++ D + SS+GSLTPRSPLLTPR
Sbjct: 617 SCSTDMLDCVNEADNEFVMDDLNVLPEMSCDTRSFLTTDQGTRASSSGSLTPRSPLLTPR 676
Query: 627 TSQIELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQD 686
T+QIELL++G R I+E +N QQI KLLD++RS+ +VN DY++LE+MLDRLE+LKY IQ
Sbjct: 677 TNQIELLLSGRRAISEHENFQQISKLLDIARSVVTVNSNDYSALEYMLDRLEDLKYAIQY 736
Query: 687 RKVDALFVETFGRRIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSP 746
RKVDAL V+TFGRRIEKLLQEKYV+LCGQI+DEK+DSSN M +E+S +++D VRSLR SP
Sbjct: 737 RKVDALIVQTFGRRIEKLLQEKYVHLCGQIEDEKIDSSNTMADEDSPVEDDAVRSLRASP 796
Query: 747 INPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESIL 806
INP KDRTSIEDFEI+KPIS+GAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESIL
Sbjct: 797 INPSCKDRTSIEDFEILKPISRGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESIL 856
Query: 807 AERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE 866
AERNILIS RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL+NLGCLDEDMAR YIAE
Sbjct: 857 AERNILISARNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLKNLGCLDEDMARAYIAE 916
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+VLALEYLHSLNVIHRDLKPDNLLIG DGHIKLTDFGLSKVGLI+ST+DLS PS+ G
Sbjct: 917 VVLALEYLHSLNVIHRDLKPDNLLIGHDGHIKLTDFGLSKVGLINSTEDLSGPSVLLGHD 976
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
N + Q PL REQRQKHSVAGTPDYLAPEILLGMGHG TADWWSVG+ILFELL+GIP
Sbjct: 977 EPNTTV--QKPLKREQRQKHSVAGTPDYLAPEILLGMGHGTTADWWSVGVILFELLVGIP 1034
Query: 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046
PFNA PQ+IFDNIMNRDIPWP +PEEMS EA DLI+KLL ENP QRLGATGA EVK+H
Sbjct: 1035 PFNAANPQKIFDNIMNRDIPWPKVPEEMSFEAHDLIEKLLIENPFQRLGATGASEVKKHV 1094
Query: 1047 FFKNINWDTLARQKAMFIPAAES-LDTSYFVSRYVWNPEDENVQGGSDFDDLTD----TC 1101
FFK INWDT ARQKAMFIP+AES DTSYF+SRY+WNPEDE+V G SD +D T+ TC
Sbjct: 1095 FFKGINWDTFARQKAMFIPSAESAYDTSYFMSRYIWNPEDEHVHGESDCEDTTETCSGTC 1154
Query: 1102 SSGSFSNTLDEEQADECGSLAEFSAPALAVQYSFSNFSFKNLSQLASINYDLVVKSAKES 1161
SSGSFSN DEE DECG+LA+FSAP LAV YSFSNFSFKNLSQLASINYDL+VK+ K+S
Sbjct: 1155 SSGSFSNVQDEE-GDECGNLADFSAPNLAVNYSFSNFSFKNLSQLASINYDLLVKTFKDS 1213
Query: 1162 AEASKSSVP 1170
E S+SS P
Sbjct: 1214 PETSRSSNP 1222
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356544254|ref|XP_003540569.1| PREDICTED: uncharacterized protein LOC100806311 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1539 bits (3985), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 794/1188 (66%), Positives = 933/1188 (78%), Gaps = 58/1188 (4%)
Query: 9 DPLSPTPASTPSPTTRTKLRKIPPIPIRRGKHDHSEGENQRRHHDDSNVEQARGDDESSI 68
D P P + SP R KL+KIPPIPIRR K + H +++ EQ +D SSI
Sbjct: 11 DQCDPVPGTPSSPAGRGKLQKIPPIPIRRSK---VSSSSTTTHAGNADEEQE--EDSSSI 65
Query: 69 LVASSLGLNHIRTKSVSSSPSPLRFFSAAGTPSSFTNEAKKNKTETAAADVKPKFAVPPS 128
L+ASSLGLNHIRT+S S PLR+ S+ G PS T +A A ++ K +
Sbjct: 66 LLASSLGLNHIRTRS---SSFPLRYSSSLGAPSFLTQDA----VTVNDARLRSK----SN 114
Query: 129 NKPPSLESGKKGQWTQSKSLRFPSPLNPELEVSHAAFAKEMQSPRFQAILRVTSGRKKKA 188
N P G K +SK+LR S L P LE HAAF KEMQSPRFQ ILR+TSGRKK+
Sbjct: 115 NSHPRKVLGGKVHLGKSKTLRPHSQLIPGLEGHHAAFTKEMQSPRFQEILRLTSGRKKRN 174
Query: 189 PEIKSFSHELNSKGVRPFPVWKSRAFGHMEEIMVAIRAKFDKLKEEVNCDLGVLAGDLVG 248
P+IKSFSHELNSKGVRPFP+WK RAFGHMEE+M AIR KF+KLKEEV+ DLG AGDLVG
Sbjct: 175 PDIKSFSHELNSKGVRPFPIWKHRAFGHMEEVMAAIRFKFEKLKEEVDSDLGGFAGDLVG 234
Query: 249 ILEKSSDSHPEWQESLEDLLVIARKCATMSPSEFWVKCEGIVLNLDDRRQELPMGILKQA 308
ILEK+ + EW+E LEDLLV+ ++CA M+P++FW+KCE IV NLDD+RQELP+GILKQ
Sbjct: 235 ILEKNLVADREWKERLEDLLVVTQQCAKMTPTQFWIKCESIVQNLDDKRQELPVGILKQT 294
Query: 309 YTRLLFILTRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQILQIRQQDFSGPLTGGK 368
+TRLLFILTRCTRLVQFQKESGYE++HILGLHQ SDLGVYPEQI + QQ S P + G
Sbjct: 295 HTRLLFILTRCTRLVQFQKESGYEQDHILGLHQFSDLGVYPEQIFKAVQQKSSIP-SAGH 353
Query: 369 VMNEKQRKKSHGQELGSLNLKEDQVDQHET---ENVEVGTAKSGDSTTSSYRMSSWKRLP 425
M EKQ K SHG+E ++ Q DQH + +N EV TAKS +ST +Y+MSSW++LP
Sbjct: 354 EMPEKQLKMSHGKEKDKPITEQSQADQHVSVAIDNEEVATAKSIESTPGTYKMSSWRKLP 413
Query: 426 SGSRRKKGSEAAADTPPKDKTEAFQNKDEPKIGSDDGNDNLDGLYHH-----ASSRITK- 479
S +K+ + A D P K + + KDE +NLD L H +SSR K
Sbjct: 414 SAGEKKRKDQDAVDFPSKGELDHLLVKDE-------NCENLDTLSCHPEHSQSSSRARKV 466
Query: 480 SWGFWG-------ENSMICRICEVEIPVVHVEEHSRICTIADRCDLKSLTVNERLERVAE 532
SWGFWG E+SMICRICEVEIP+VHVEEHSRICTIADRCDLK LTVNERLERV+E
Sbjct: 467 SWGFWGDQQNLTYEDSMICRICEVEIPIVHVEEHSRICTIADRCDLKGLTVNERLERVSE 526
Query: 533 TLEKILDSWSPKKHTKK----------------RTHDDLNLMSPKQNSLSRQGSKEMLDH 576
T+E+IL+SW+PK K H++ N +S ++N+L+ + S++MLD
Sbjct: 527 TIERILESWTPKSTPKSTDTSGESFELAAVSTSSVHEEFNDLSLERNNLTCRCSEDMLDS 586
Query: 577 VPDDDNAFVIEDLNVLPEISCDKNPT-AADIAAKTSSAGSLTPRSPLLTPRTSQIELLVN 635
+ DN F +EDLN+ ISC+ + D K SSAGSLTPRSPL+TPRT+QIE+L++
Sbjct: 587 GVEPDNTFAMEDLNLSSGISCEAHICLKTDHGTKLSSAGSLTPRSPLITPRTTQIEILLS 646
Query: 636 GHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVE 695
G RT++EL++ QI KL++++R++A+VN+CDY +LE+MLDRLE+LKY IQDRKVDAL VE
Sbjct: 647 GRRTLSELESCDQISKLVEIARAVANVNNCDYRALEYMLDRLEDLKYAIQDRKVDALIVE 706
Query: 696 TFGRRIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRT 755
TFGRRIEKLLQEKY++LCGQI+DEK+DSS +M +EESS+++DTVRSLR SPIN CSKDRT
Sbjct: 707 TFGRRIEKLLQEKYLSLCGQIEDEKVDSSTSMADEESSVEDDTVRSLRASPINACSKDRT 766
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
SIEDFEIIKPIS+GAFGRVFLARKRATGDLFAIKVLKKADMIRKNAV+SILAER+ILISV
Sbjct: 767 SIEDFEIIKPISRGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVQSILAERDILISV 826
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS+LRNLGCLDEDMARVYIAE+VLALEYLH
Sbjct: 827 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSILRNLGCLDEDMARVYIAEVVLALEYLH 886
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI+STDDLSAPS GFL +DE K +
Sbjct: 887 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLINSTDDLSAPSFSDNGFLGDDEPKSR 946
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
RE+RQK SV GTPDYLAPEILLGMGHGATADWWSVG+IL+ELL+GIPPFNA+ PQQ
Sbjct: 947 HSSKREERQKQSVVGTPDYLAPEILLGMGHGATADWWSVGVILYELLVGIPPFNAEHPQQ 1006
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055
IFDNI+NRDI WP IPEE+S EA DLI+KLL ENPVQRLGATGA EVK+H FFK+INWDT
Sbjct: 1007 IFDNIINRDIQWPKIPEEISFEAYDLINKLLNENPVQRLGATGATEVKRHAFFKDINWDT 1066
Query: 1056 LARQKAMFIPAAESLDTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSFSNTLDEEQA 1115
LARQKAMFIP AE+LDTSYF+SRY+WNPEDE+ GGSDFD++T+TCSSGS S+ LDE+
Sbjct: 1067 LARQKAMFIPMAEALDTSYFMSRYIWNPEDEHCLGGSDFDEITETCSSGSGSDLLDED-G 1125
Query: 1116 DECGSLAEFSAPALAVQYSFSNFSFKNLSQLASINYDLVVKSAKESAE 1163
DECGSLAEFS P L VQYSFSNFSFKNLSQLASINYDLV+KS+KES +
Sbjct: 1126 DECGSLAEFSGPPLEVQYSFSNFSFKNLSQLASINYDLVIKSSKESTQ 1173
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084166|emb|CBI24554.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1514 bits (3920), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 786/1188 (66%), Positives = 896/1188 (75%), Gaps = 115/1188 (9%)
Query: 8 QDPLSP----TPASTPSPTTRTKLRKIPPIPIRRGKHDHSEGENQRRHHDDSNVEQARGD 63
DP P +P + PS + + KLRKIPPIP+RR D S + + +S + D
Sbjct: 2 HDPPPPAVDSSPTAAPSASLKAKLRKIPPIPVRRNPRDDSVDDKEEEGDGESENDDV-SD 60
Query: 64 DESSILVASSLGLNHIRTKSVSSSPSPLRFFSAAGTPSSFTNEAKKNKTETAAADVKPKF 123
D+S ++ASSLGLN IRT+S SPSPLRF S AG P + N+AKKNK A+ +PK
Sbjct: 61 DDSEFILASSLGLNQIRTRS---SPSPLRFTSLAGEPPNLGNDAKKNKD---GAEARPK- 113
Query: 124 AVPPSNKPPSLE--SGKKGQWTQSKSLRFPSPLNPELEVSHAAFAKEMQSPRFQAILRVT 181
P + S+E GKK W Q KS R PSPLNP LE HA AKE+QSPRFQAILRVT
Sbjct: 114 RTSPLCRATSMEHSQGKKISWIQPKSFRVPSPLNPGLEAHHAILAKEIQSPRFQAILRVT 173
Query: 182 SGRKKKAPEIKSFSHELNSKGVRPFPVWKSRAFGHMEEIMVAIRAKFDKLKEEVNCDLGV 241
SGR+K+ +IKSFSHELNSKGVR FP WKSRA GHMEEIMV IRAKFD+LKEEVN DLG+
Sbjct: 174 SGRRKRTSDIKSFSHELNSKGVRAFPFWKSRAVGHMEEIMVVIRAKFDRLKEEVNSDLGI 233
Query: 242 LAGDLVGILEKSSDSHPEWQESLEDLLVIARKCATMSPSEFWVKCEGIVLNLDDRRQELP 301
AGDLVGILEK++++ EW+E LEDLL++AR CA M P+EFW+KCEGIV NLDDRRQELP
Sbjct: 234 FAGDLVGILEKTAETKLEWKEGLEDLLIVARHCAKMPPNEFWLKCEGIVQNLDDRRQELP 293
Query: 302 MGILKQAYTRLLFILTRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQILQIRQQDFS 361
MG LKQA+TRLLFILTRCTRLVQF KESGYEE+HILGLHQLSDLG+Y E IL QQ+
Sbjct: 294 MGTLKQAHTRLLFILTRCTRLVQFHKESGYEEDHILGLHQLSDLGIYSEHILGAMQQESG 353
Query: 362 GPLTGGKVMNEKQRKKSHGQELGSLNLKEDQVDQ---HETENVEVGTAKSGDSTTSSYRM 418
GP+ +NEKQ KKSH QE SL K+DQVD E+ EVGTAKS DS TSSY+M
Sbjct: 354 GPVD----VNEKQSKKSHAQEHSSLAPKQDQVDHDLDSGVEDHEVGTAKSADSITSSYKM 409
Query: 419 SSWKRLPSGSRR--KKGSEAAADTPPKDKTEAFQNKDEPKIGSDDGNDNLDGLYHHASSR 476
SSWK+ PS + + +KG+EA D K K + KDE K A+S+
Sbjct: 410 SSWKKYPSTAEKNHRKGNEAV-DMTSKVKLDPLPVKDENKT--------------EATSK 454
Query: 477 ITK-SWGFWG-------ENSMICRICEVEIPVVHVEEHSRICTIADRCDLKSLTVNERLE 528
+ + SWG W ENSMICRICEVEIP VHVE+HSRICTIADRCDLK LTVNERLE
Sbjct: 455 VHRVSWGCWSDQQQITYENSMICRICEVEIPTVHVEDHSRICTIADRCDLKGLTVNERLE 514
Query: 529 RVAETLEKILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED 588
RVAETLE+IL+ W+PK D DN FV++D
Sbjct: 515 RVAETLERILECWTPKS----------------------------TDTSGGTDNEFVMDD 546
Query: 589 LNVLPEISCD-KNPTAADIAAKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQ 647
LNVLPE+SCD ++ D + SS+GSLTPRSPLLTPRT+QIELL++G R I+E +N Q
Sbjct: 547 LNVLPEMSCDTRSFLTTDQGTRASSSGSLTPRSPLLTPRTNQIELLLSGRRAISEHENFQ 606
Query: 648 QIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVETFGRRIEKLLQE 707
QI KLLD++RS+ +VN DY++LE+MLDRLE+LKY IQ RKVDAL V+TFGRRIEKLLQE
Sbjct: 607 QISKLLDIARSVVTVNSNDYSALEYMLDRLEDLKYAIQYRKVDALIVQTFGRRIEKLLQE 666
Query: 708 KYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPIS 767
KYV+LCGQI+DEK+DSSN M +E+S +++D VRSLR SPINP KDRTSIEDFEI+KPIS
Sbjct: 667 KYVHLCGQIEDEKIDSSNTMADEDSPVEDDAVRSLRASPINPSCKDRTSIEDFEILKPIS 726
Query: 768 QGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSF 827
+GAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS RNPFVVRFFYSF
Sbjct: 727 RGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISARNPFVVRFFYSF 786
Query: 828 TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPD 887
TCRENLYLVMEYLNGGDLYSLL+NLGCLDEDMAR YIAE+VLALEYLHSLNVIHRDLKPD
Sbjct: 787 TCRENLYLVMEYLNGGDLYSLLKNLGCLDEDMARAYIAEVVLALEYLHSLNVIHRDLKPD 846
Query: 888 NLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHS 947
NLLIG DGHIKLTDFGLSKVGLI+ST+DL S
Sbjct: 847 NLLIGHDGHIKLTDFGLSKVGLINSTEDL------------------------------S 876
Query: 948 VAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPW 1007
VAGTPDYLAPEILLGMGHG TADWWSVG+ILFELL+GIPPFNA PQ+IFDNIMNRDIPW
Sbjct: 877 VAGTPDYLAPEILLGMGHGTTADWWSVGVILFELLVGIPPFNAANPQKIFDNIMNRDIPW 936
Query: 1008 PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAA 1067
P +PEEMS EA DLI+KLL ENP QRLGATGA EVK+H FFK INWDT ARQKAMFIP+A
Sbjct: 937 PKVPEEMSFEAHDLIEKLLIENPFQRLGATGASEVKKHVFFKGINWDTFARQKAMFIPSA 996
Query: 1068 ES-LDTSYFVSRYVWNPEDENVQGGSDFDDLTD----TCSSGSFSNTLDEEQADECGSLA 1122
ES DTSYF+SRY+WNPEDE+V G SD +D T+ TCSSGSFSN Q DECG+LA
Sbjct: 997 ESAYDTSYFMSRYIWNPEDEHVHGESDCEDTTETCSGTCSSGSFSN-----QGDECGNLA 1051
Query: 1123 EFSAPALAVQYSFSNFSFKNLSQLASINYDLVVKSAKESAEASKSSVP 1170
+FSAP LAV YSFSNFSFKNLSQLASINYDL+VK+ K+S E S+SS P
Sbjct: 1052 DFSAPNLAVNYSFSNFSFKNLSQLASINYDLLVKTFKDSPETSRSSNP 1099
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224136766|ref|XP_002322410.1| predicted protein [Populus trichocarpa] gi|222869406|gb|EEF06537.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1514 bits (3919), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 798/1218 (65%), Positives = 913/1218 (74%), Gaps = 114/1218 (9%)
Query: 26 KLRKIPPIPIRR--------------GKHDHSEGENQRRHHDDSNVEQ--ARGDDESSIL 69
KLRKIPPIPIRR D ++ + ++ D +E+ + D+ S I+
Sbjct: 40 KLRKIPPIPIRRIQKPEAPLNDTESINNDDGNDTDCGDKNDDKEKLEKRNYKADENSPII 99
Query: 70 VASSLGLNHIRTKSVSSSPSPLRFFSAAGTPSSFTNEAKKNKTETAAADVKPKFAVPPSN 129
+AS+LGLNHIRT+S+ PSPLRF S+A TPS N N D + K V
Sbjct: 100 MASALGLNHIRTRSLPI-PSPLRFSSSAATPSYLGNAQVNNNN-----DDEVKTGVDTRL 153
Query: 130 KPPSLESGKKGQWTQSKSLRFPSPLNPELEVSHAAF-AKEMQSPRFQAILRVTSGRKKKA 188
S E GKK W ++K R S LNP +E +HAAF AKE+QSPRFQAILRVTSGR KK+
Sbjct: 154 NGSSFEQGKKISWGEAKPFRAHSQLNPAMESNHAAFFAKEIQSPRFQAILRVTSGRMKKS 213
Query: 189 PEIKSFSHELNSKGVRPFPVWKSRAFGHMEEIMVAIRAKFDKLKEEVNCDLGVLAGDLVG 248
P+IKSFSHELNSKGVR FPVWKSRAFGHMEE+MVAIR KF +LKEEV+ DLG+ AGDLVG
Sbjct: 214 PDIKSFSHELNSKGVRAFPVWKSRAFGHMEEVMVAIRMKFIRLKEEVDSDLGIFAGDLVG 273
Query: 249 ILEKSSDSHPEWQESLEDLLVIARKCATMSPSEFWVKCEGIVLNLDDRRQELPMGILKQA 308
ILEK+SD+HP+W+ESLEDLLV+AR+CA MS +EFWVK EGIV NLDD+RQELPMGI+KQA
Sbjct: 274 ILEKTSDTHPKWRESLEDLLVVARQCAKMSSNEFWVKGEGIVQNLDDKRQELPMGIVKQA 333
Query: 309 YTRLLFILTRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQILQIRQQDFSGPLTGGK 368
+TRLLFILTRCTRLVQFQKESG +E+ ILG+HQ SDLGVY EQI++I QQDFSGPL G K
Sbjct: 334 HTRLLFILTRCTRLVQFQKESGCDEDKILGIHQCSDLGVYREQIIEIAQQDFSGPLVGWK 393
Query: 369 VMNEKQRKKSHGQELGSLNLKEDQVDQHETENVEVGTAKSGDSTTSSYRMSSWKRLPSGS 428
EKQRKKS G E + K+DQVDQ ++EVGTAKS DST SS++MSSW++LPS +
Sbjct: 394 TAGEKQRKKSCGIEQDTQVTKQDQVDQ----SLEVGTAKSVDSTASSFKMSSWRKLPSAA 449
Query: 429 RRKKGSEAAADTPPKDKTEAFQNKDEPKIGSDDGNDNLDGLYHHASSRITK-SWGFW--- 484
+ + TP F++K EP + DD ++NL+ H S + SWG W
Sbjct: 450 EKNRKDTDVVQTP-------FKDKSEPLLDRDDYSENLETPDHPPSPGTKRVSWGLWVDQ 502
Query: 485 ----GENSMICRICEVEIPVVHVEEHSRICTIADRCDLKSLTVNERLERVAETLEKILDS 540
ENSMICRICEVEIP+VHVEEHS ICTIADRCDLK TVNERLERVAETLEKIL S
Sbjct: 503 HNVAYENSMICRICEVEIPIVHVEEHSLICTIADRCDLKGFTVNERLERVAETLEKILRS 562
Query: 541 WSPK---KHTKKRT-----------------HDDLNLMSPKQNSLSRQGSKEMLDHVPDD 580
WS K K T KR H+ + +SPK+N+ S S+EMLD VPD
Sbjct: 563 WSQKTTPKSTPKRCDTPRVSPEVERVPTSGIHEVSDGLSPKRNNFSSCCSEEMLDVVPD- 621
Query: 581 DNAFVIEDLNVLPEISCDKNPTAADIAAK-TSSAGSLTPRSPLLTPRTSQIELLVNGHRT 639
+FV+ED+NV PEISC+ T A K TSS SLTPRSPLLTPRTSQI LL++G RT
Sbjct: 622 --SFVMEDINVFPEISCEARSTQTPDADKITSSRESLTPRSPLLTPRTSQIGLLLSGQRT 679
Query: 640 ITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVETFGR 699
ITEL+ QI KLLD++RS+AS+ND DY++LE MLD LE+LKY +QDRKVDAL VETFGR
Sbjct: 680 ITELEGCHQISKLLDIARSVASLNDNDYSALESMLDCLEDLKYSVQDRKVDALIVETFGR 739
Query: 700 RIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIED 759
RIEKLL EKYV+LC QIDDEK D SN M +E+SS + D VRSLRTSP+N SKDRTSI+D
Sbjct: 740 RIEKLLLEKYVHLCTQIDDEKSDPSNQMADEDSSEENDAVRSLRTSPVNMSSKDRTSIDD 799
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
FEIIKPIS+GAFGRVFLARKRATGDLFAIKVL+KADMI KNAVESIL ER ILISV NPF
Sbjct: 800 FEIIKPISRGAFGRVFLARKRATGDLFAIKVLRKADMICKNAVESILEERKILISVCNPF 859
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
VVRFFYSFTC ENLYLVMEYLNGGDLYSLLRNLGCLDEDMAR+YIAE+VLALEYLHS NV
Sbjct: 860 VVRFFYSFTCSENLYLVMEYLNGGDLYSLLRNLGCLDEDMARMYIAEVVLALEYLHSSNV 919
Query: 880 IHRDLKPDNLLIGQDGHI----------------------------KLTDFGLSKVGLIH 911
IHRDLKPDNLLI QDGHI KLTDFGLSKVGLI+
Sbjct: 920 IHRDLKPDNLLINQDGHIKLYATAYERSIERAKCSRDTVLESSLRLKLTDFGLSKVGLIN 979
Query: 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADW 971
STDDLS P + S GFL +DELK Q RE+RQKHSVAGTPDYLAPEILLGMGHGATADW
Sbjct: 980 STDDLSVPLVSSSGFLDDDELKGQSSSKREERQKHSVAGTPDYLAPEILLGMGHGATADW 1039
Query: 972 WSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPV 1031
WSVGIILFELL+GIPPFNA TPQ+IFDN+MNRDIPWP +PEEMS +ACDLIDKLLTENP+
Sbjct: 1040 WSVGIILFELLVGIPPFNADTPQKIFDNVMNRDIPWPRVPEEMSFDACDLIDKLLTENPL 1099
Query: 1032 QRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAESLDTSYFVSRYVWNPEDENVQGG 1091
QRLGA GARE AMFIP+ E+ DTSYF+SRY+WNPE ENV GG
Sbjct: 1100 QRLGAIGARE-------------------AMFIPSGEAHDTSYFLSRYIWNPEGENVHGG 1140
Query: 1092 SDFDDLTDTCSSGSFSNTLDEEQADECGSLAEFSAPALAVQYSFSNFSFKNLSQLASINY 1151
SDF+DLTDTCSSGSFSNT D++ D CG++A F AP L V+YSFSNFSFKNLSQLASIN+
Sbjct: 1141 SDFEDLTDTCSSGSFSNTHDDD-VDGCGTMAGFGAPTLDVKYSFSNFSFKNLSQLASINH 1199
Query: 1152 DLVVKSAKESAEASKSSV 1169
DLVVKS KE+A+ASK V
Sbjct: 1200 DLVVKSTKEAADASKPPV 1217
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529891|ref|XP_003533520.1| PREDICTED: uncharacterized protein LOC100817975 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1509 bits (3907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 795/1193 (66%), Positives = 931/1193 (78%), Gaps = 58/1193 (4%)
Query: 7 NQDPLSPTPASTPSPTTRTKLRKIPPIPIRRGK---HDHSEGENQRRHHDDSNVEQARGD 63
N D P P S SP+ + KL+KIPPIPIRR K + H + + EQ +
Sbjct: 9 NPDQCDPAPGSPSSPSGKGKLQKIPPIPIRRRKVSSSSSAAAAATTTHAGNGDEEQE--E 66
Query: 64 DESSILVASSLGLNHIRTKSVSSSPSPLRFFSAAGTPSSFTNEAKKNKTETAAADVKPKF 123
D SSIL+ASSLGLNHIRT+S SS S+ G PS T +A DV+
Sbjct: 67 DSSSILLASSLGLNHIRTRSSSSPLRYS---SSLGAPSFLTQDA------VTINDVR--L 115
Query: 124 AVPPSNKPPSLESGKKGQWTQSKSLRFPSPLNPELEVSHAAFAKEMQSPRFQAILRVTSG 183
+N P + G K QSKS+R S L P LE HAAF KEMQSPRFQ ILR+TSG
Sbjct: 116 RSKSNNSHPRKDLGGKTHLGQSKSMRPHSQLIPVLEGHHAAFTKEMQSPRFQEILRLTSG 175
Query: 184 RKKKAPEIKSFSHELNSKGVRPFPVWKSRAFGHMEEIMVAIRAKFDKLKEEVNCDLGVLA 243
RKK+ P+IKSFSHELNSKGV+PFP+WK RAFGHMEE+M AIRAKF+KLKEEV+ DLG A
Sbjct: 176 RKKRNPDIKSFSHELNSKGVKPFPIWKHRAFGHMEEVMAAIRAKFEKLKEEVDSDLGGFA 235
Query: 244 GDLVGILEKSSDSHPEWQESLEDLLVIARKCATMSPSEFWVKCEGIVLNLDDRRQELPMG 303
GDLVGILEK+ S EW+E LEDLLV+ ++CA M+P++FW+KCE IV NLDD+RQELP+G
Sbjct: 236 GDLVGILEKNLLSDREWKERLEDLLVVTQQCAKMTPTQFWIKCESIVQNLDDKRQELPVG 295
Query: 304 ILKQAYTRLLFILTRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQILQIRQQDFSGP 363
ILKQA+TRLLFILTRCTRLVQFQKESGYE++HIL LHQ SDLGVYPEQIL+ QQ S P
Sbjct: 296 ILKQAHTRLLFILTRCTRLVQFQKESGYEQDHILSLHQFSDLGVYPEQILKAAQQKSSIP 355
Query: 364 LTGGKVMNEKQRKKSHGQELGSLNLKEDQVDQHET---ENVEVGTAKSGDSTTSSYRMSS 420
G M EKQ K SHG+E ++ Q DQ + +N EV TAKS +ST SYRMSS
Sbjct: 356 -PAGHEMPEKQLKISHGKEKDKPITEQSQADQQVSVAIDNGEVSTAKSIESTPGSYRMSS 414
Query: 421 WKRLPSGSRRKKGSEAAADTPPKDKTEAFQNKDEPKIGSDDGNDNLDGLYHH-----ASS 475
W++LPS + +++ + A D P K + + KDE ++NLD L H +SS
Sbjct: 415 WRKLPSAADKRRKGQDAVDFPSKGELDHLLVKDE-------NSENLDTLSCHPEHLQSSS 467
Query: 476 RITK-SWGFWG-------ENSMICRICEVEIPVVHVEEHSRICTIADRCDLKSLTVNERL 527
R K SWG WG E+SMICRICEVEIP+VHVEEHSRICTIADRCDLK LTVNERL
Sbjct: 468 RAQKVSWGLWGDQQNLTYEDSMICRICEVEIPIVHVEEHSRICTIADRCDLKGLTVNERL 527
Query: 528 ERVAETLEKILDSWSPKKHTKK----------------RTHDDLNLMSPKQNSLSRQGSK 571
ERV+ET+EKIL+SW+PK K H++ N +S ++N+L+ + S+
Sbjct: 528 ERVSETIEKILESWTPKSTPKSTDTPGESFELAAVSTSSVHEEFNDLSLERNNLTCRCSE 587
Query: 572 EMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAA-DIAAKTSSAGSLTPRSPLLTPRTSQI 630
+MLD + DN FV+EDLN+ PEISC+ + D K SSAGSLTPRSPL+TPRT+QI
Sbjct: 588 DMLDSTAEHDNTFVMEDLNLSPEISCEVHICLKPDHGTKVSSAGSLTPRSPLVTPRTTQI 647
Query: 631 ELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVD 690
E+L+ G RT++EL++ QI KL++++R++A+VN+CDY++LE+MLDRLE+LKY IQDRKVD
Sbjct: 648 EILLGGRRTLSELESGDQISKLVEIARAVANVNNCDYSALEYMLDRLEDLKYSIQDRKVD 707
Query: 691 ALFVETFGRRIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPC 750
AL VETFGRRIEKLLQEKY++LCGQI++EK+DSS M +EESS+++DTVRSLR SPIN C
Sbjct: 708 ALIVETFGRRIEKLLQEKYISLCGQIEEEKVDSSIGMADEESSVEDDTVRSLRASPINAC 767
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
SKDRTSIEDFEIIKPIS+GAFGRVFL RKRATGDLFAIKVLKKADMIRKNAV+SILAER+
Sbjct: 768 SKDRTSIEDFEIIKPISRGAFGRVFLTRKRATGDLFAIKVLKKADMIRKNAVQSILAERD 827
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS+LRNLGCLDEDMARVYIAE+VLA
Sbjct: 828 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSMLRNLGCLDEDMARVYIAEVVLA 887
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI+STDDLSAPS + FL +D
Sbjct: 888 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLINSTDDLSAPSFSNNDFLGDD 947
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
E K + RE+RQK SV GTPDYLAPEILLGMGH ATADWWSVG+IL+ELL+GIPPFNA
Sbjct: 948 EPKPRHSSKREERQKQSVVGTPDYLAPEILLGMGHAATADWWSVGVILYELLVGIPPFNA 1007
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+ PQQIFDNI+NRDI WP IPEE+S EA DLI+KLL ENPVQRLGATGA EVK+H FFK+
Sbjct: 1008 EHPQQIFDNIINRDIQWPKIPEEISFEAYDLINKLLNENPVQRLGATGATEVKRHAFFKD 1067
Query: 1051 INWDTLARQKAMFIPAAESLDTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSFSNTL 1110
INWDTLARQKAMFIP AE+LDTSYF+SRY+WNPEDE+ GGSDFD++T+TCSSGS S+ L
Sbjct: 1068 INWDTLARQKAMFIPTAEALDTSYFMSRYIWNPEDEHCLGGSDFDEITETCSSGSGSDLL 1127
Query: 1111 DEEQADECGSLAEFSAPALAVQYSFSNFSFKNLSQLASINYDLVVKSAKESAE 1163
EE DECGSLAEFS P L VQYSFSNFSFKNLSQLASINYDLV+KS+KES +
Sbjct: 1128 -EEDGDECGSLAEFSGPPLEVQYSFSNFSFKNLSQLASINYDLVIKSSKESTQ 1179
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793797|ref|XP_002864783.1| hypothetical protein ARALYDRAFT_332465 [Arabidopsis lyrata subsp. lyrata] gi|297310618|gb|EFH41042.1| hypothetical protein ARALYDRAFT_332465 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1496 bits (3873), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 783/1196 (65%), Positives = 916/1196 (76%), Gaps = 69/1196 (5%)
Query: 4 SAENQDPLSPTPASTPSPTTRTKLRKIPPIPIRRGKHDHSEGENQRRHHDDSN----VEQ 59
S EN T ASTP+ T L+KIP IP R HSE + Q + D+ E
Sbjct: 7 SPENDRDPQKTTASTPTSTNAKLLKKIPAIPFR-----HSEKDEQAKTLDEVTPELAAEG 61
Query: 60 ARGDDESSILVASSLGLNHIRTKSVSSSPSPLRFFSAAG--TPSSFTNEAKKNKTET--- 114
+ D IL SSLGLNHIRTKS S +PSPLRF SA +P + K K
Sbjct: 62 STSHDSPEILAPSSLGLNHIRTKS-SPAPSPLRFSSATPLISPGQDDKDVAKEKPRLGVV 120
Query: 115 -AAADVKPKFAVPPSNKPPSLESGKKGQWTQSKSLRFPSPLNPELEVSHAAFAKEMQSPR 173
A AD + ++ +PP ++P + GKK QW+QSKS R P+ NP LE +H AKE QSPR
Sbjct: 121 DARADARARWPIPP-HQP---DQGKKVQWSQSKSQRVPANSNPGLESTHVGLAKETQSPR 176
Query: 174 FQAILRVTSGRKKKAPEIKSFSHELNSKGVRPFPVWKSRAFGHMEEIMVAIRAKFDKLKE 233
FQAILRVTSGRKKKA +IKSFSHELNSKGVRPFPVW+SRA GHMEEIM AIR KFDK KE
Sbjct: 177 FQAILRVTSGRKKKAHDIKSFSHELNSKGVRPFPVWRSRAVGHMEEIMAAIRTKFDKQKE 236
Query: 234 EVNCDLGVLAGDLVGILEKSSDSHPEWQESLEDLLVIARKCATMSPSEFWVKCEGIVLNL 293
+V+ DLGV AG LV LE + +S+ E + LEDLLV AR+CATM SEFW+KCEGIV L
Sbjct: 237 DVDADLGVFAGYLVTTLESTPESNKELRMGLEDLLVEARQCATMPASEFWLKCEGIVQKL 296
Query: 294 DDRRQELPMGILKQAYTRLLFILTRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQIL 353
DDRRQELPMG LKQA+ RLLFILTRC RLVQF+KESGY EEHILG+HQLSDLGVYPEQ++
Sbjct: 297 DDRRQELPMGGLKQAHNRLLFILTRCNRLVQFRKESGYVEEHILGMHQLSDLGVYPEQMV 356
Query: 354 QI-RQQDFSGPLTGGKVMNEKQRKKSHGQELGSLNLKEDQVDQHE---TENVEVGTAKSG 409
+I RQQD ++ EK+ +K + ++ NL Q DQ+ + EV TA+S
Sbjct: 357 EISRQQD---------LLREKEIQKINEKQ----NLAGKQDDQNSNSGADGAEVNTARST 403
Query: 410 DSTTSSYRMSSWKRLPSGSRRKKGSEAAADTPPKDKTEAFQNKDEPKIGSDDGNDNLDGL 469
DS +S++RMSSWK+LPS + + + + + PK K E+ K +PK+ D+ +NL
Sbjct: 404 DSASSNFRMSSWKKLPSAAEKNR----SVNNTPKAKGES---KLQPKVYGDEYTENLHSP 456
Query: 470 YHH-ASSRITKSWGFWGE-------NSMICRICEVEIPVVHVEEHSRICTIADRCDLKSL 521
AS+ + WGFW + NSMICRICEVEIPVVHVEEHSRICTIADRCDLK +
Sbjct: 457 SGQPASADKSALWGFWADHQCVTYDNSMICRICEVEIPVVHVEEHSRICTIADRCDLKGI 516
Query: 522 TVNERLERVAETLEKILDSWSPKKHTKKRTHDDLNLMSPKQ-----NSLSRQGSKEMLDH 576
VN RLERVAE+LEKIL+SW+PK R D +S + +S++ S +MLD
Sbjct: 517 NVNLRLERVAESLEKILESWTPKSSVTPRAVADSARLSNSSRQEDLDEISQRCSDDMLDC 576
Query: 577 VPDDDNAFVIEDLNVLPEISCDKNPTAADIAAKTSSAGSLTPRSPLLTPRTSQIELLVNG 636
VP + F +++LN+L E+S K SSAGSLTP SP TPR SQ++LL++G
Sbjct: 577 VPRSEKTFSLDELNILNEMSMAN-------GTKDSSAGSLTPPSPA-TPRNSQVDLLLSG 628
Query: 637 HRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVET 696
+TI+EL+N QQI KLL+++RS+A+VN C Y+SL+ M+++L+ELKY+IQDRK DAL VET
Sbjct: 629 RKTISELENYQQINKLLEIARSVANVNVCGYSSLDFMIEQLDELKYVIQDRKADALVVET 688
Query: 697 FGRRIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTS 756
FGRRIEKLLQEKY+ LCGQIDDEK+DSSNAM +EESS D+DTVRSLR SP+NP +KDRTS
Sbjct: 689 FGRRIEKLLQEKYIELCGQIDDEKVDSSNAMVDEESSADDDTVRSLRASPLNPRAKDRTS 748
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
IEDFEIIKPIS+GAFGRVFLA+KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR
Sbjct: 749 IEDFEIIKPISRGAFGRVFLAKKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 808
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876
NPFVVRFFYSFTCRENLYLVMEYLNGGDL+SLLRNLGCLDEDMAR+YIAE+VLALEYLHS
Sbjct: 809 NPFVVRFFYSFTCRENLYLVMEYLNGGDLFSLLRNLGCLDEDMARIYIAEVVLALEYLHS 868
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA-PSLGSGGFLVNDELKDQ 935
+N+IHRDLKPDNLLI QDGHIKLTDFGLSKVGLI+STDDLS SLG+ GF D Q
Sbjct: 869 VNIIHRDLKPDNLLINQDGHIKLTDFGLSKVGLINSTDDLSGESSLGNSGFFAEDGTNAQ 928
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
R+ R+KH+V GTPDYLAPEILLGMGHG TADWWSVG+ILFELL+GIPPFNA+TPQQ
Sbjct: 929 HSQGRDSRKKHAVVGTPDYLAPEILLGMGHGKTADWWSVGVILFELLVGIPPFNAETPQQ 988
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055
IF+NI+NRDIPWPN+PEE+S EA DLI+KLLTENPVQRLGATGA EVKQH FFK+INWDT
Sbjct: 989 IFENIINRDIPWPNVPEEISYEAHDLINKLLTENPVQRLGATGAGEVKQHHFFKDINWDT 1048
Query: 1056 LARQKAMFIPAAESLDTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSFSNTLDEEQA 1115
LARQKAMF+P+AE DTSYF+SRY+WNPEDENV GGSDFDDLTDTCSS SF NT DE+
Sbjct: 1049 LARQKAMFVPSAEPQDTSYFMSRYIWNPEDENVHGGSDFDDLTDTCSSSSF-NTQDED-G 1106
Query: 1116 DECGSLAEF-SAPALAVQYSFSNFSFKNLSQLASINYDLVVKSAKESAEASKSSVP 1170
DEC SLAEF + P LAV+YSFSNFSFKNLSQLASINYDLV+K+AKES EAS S P
Sbjct: 1107 DECSSLAEFGNGPNLAVKYSFSNFSFKNLSQLASINYDLVLKNAKESVEASNQSAP 1162
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15241795|ref|NP_201037.1| AGC (cAMP-dependent, cGMP-dependent and protein kinase C) kinase family protein [Arabidopsis thaliana] gi|6729346|dbj|BAA89783.1| IRE [Arabidopsis thaliana] gi|8809644|dbj|BAA97195.1| IRE [Arabidopsis thaliana] gi|332010212|gb|AED97595.1| AGC (cAMP-dependent, cGMP-dependent and protein kinase C) kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1493 bits (3866), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 775/1173 (66%), Positives = 908/1173 (77%), Gaps = 67/1173 (5%)
Query: 27 LRKIPPIPIRRGKHDHSEGENQRRHHDDSNVEQA----RGDDESSILVASSLGLNHIRTK 82
L+KIP IP R H EGE+++ D+ E A D IL SSLGLNHIRTK
Sbjct: 30 LKKIPAIPFR---HSDKEGEDEQAKTDEVTTELAGEGPMSHDSPEILAPSSLGLNHIRTK 86
Query: 83 SVSSSPSPLRFFSAAG--TPSSFTNEAKKNKTET----AAADVKPKFAVPPSNKPPSLES 136
S S +PSPLRF SA +P + K K A AD + ++ +PP ++P +
Sbjct: 87 S-SPAPSPLRFSSATPLISPGQDDKDVAKEKPRVGVVDARADARARWPIPP-HQP---DQ 141
Query: 137 GKKGQWTQSKSLRFPSPLNPELEVSHAAFAKEMQSPRFQAILRVTSGRKKKAPEIKSFSH 196
GKK QW+QSKS R P+ NP +E +H AKE QSPRFQAILRVTSGRKKKA +IKSFSH
Sbjct: 142 GKKVQWSQSKSQRVPANSNPGVESTHVGLAKETQSPRFQAILRVTSGRKKKAHDIKSFSH 201
Query: 197 ELNSKGVRPFPVWKSRAFGHMEEIMVAIRAKFDKLKEEVNCDLGVLAGDLVGILEKSSDS 256
ELNSKGVRPFPVW+SRA GHMEEIM AIR KFDK KE+V+ DLGV AG LV LE + +S
Sbjct: 202 ELNSKGVRPFPVWRSRAVGHMEEIMAAIRTKFDKQKEDVDADLGVFAGYLVTTLESTPES 261
Query: 257 HPEWQESLEDLLVIARKCATMSPSEFWVKCEGIVLNLDDRRQELPMGILKQAYTRLLFIL 316
+ E + LEDLLV AR+CATM SEFW+KCEGIV LDD+RQELPMG LKQA+ RLLFIL
Sbjct: 262 NKELRVGLEDLLVEARQCATMPASEFWLKCEGIVQKLDDKRQELPMGGLKQAHNRLLFIL 321
Query: 317 TRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQILQI-RQQDFSGPLTGGKVMNEKQR 375
TRC RLVQF+KESGY EEHILG+HQLSDLGVYPEQ+++I RQQD ++ EK+
Sbjct: 322 TRCNRLVQFRKESGYVEEHILGMHQLSDLGVYPEQMVEISRQQD---------LLREKEI 372
Query: 376 KKSHGQELGSLNLKEDQVDQHE---TENVEVGTAKSGDSTTSSYRMSSWKRLPSGSRRKK 432
+K + ++ NL Q DQ+ + VEV TA+S DST+S++RMSSWK+LPS + + +
Sbjct: 373 QKINEKQ----NLAGKQDDQNSNSGADGVEVNTARSTDSTSSNFRMSSWKKLPSAAEKNR 428
Query: 433 GSEAAADTPPKDKTEAFQNKDEPKIGSDDGNDNLDGLYHH-ASSRITKSWGFWGE----- 486
+ + PK K E+ K +PK+ D+ +NL AS+ + WGFW +
Sbjct: 429 ----SLNNTPKAKGES---KIQPKVYGDENAENLHSPSGQPASADRSALWGFWADHQCVT 481
Query: 487 --NSMICRICEVEIPVVHVEEHSRICTIADRCDLKSLTVNERLERVAETLEKILDSWSPK 544
NSMICRICEVEIPVVHVEEHSRICTIADRCDLK + VN RLERVAE+LEKIL+SW+PK
Sbjct: 482 YDNSMICRICEVEIPVVHVEEHSRICTIADRCDLKGINVNLRLERVAESLEKILESWTPK 541
Query: 545 KHTKKRTHDDLNLMSPKQ-----NSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDK 599
R D +S + +S++ S +MLD VP N F +++LN+L E+S
Sbjct: 542 SSVTPRAVADSARLSNSSRQEDLDEISQRCSDDMLDCVPRSQNTFSLDELNILNEMSMTN 601
Query: 600 NPTAADIAAKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKLLDVSRSI 659
K SSAGSLTP SP TPR SQ++LL++G +TI+EL+N QQI KLLD++RS+
Sbjct: 602 -------GTKDSSAGSLTPPSPA-TPRNSQVDLLLSGRKTISELENYQQINKLLDIARSV 653
Query: 660 ASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVETFGRRIEKLLQEKYVNLCGQIDDE 719
A+VN C Y+SL+ M+++L+ELKY+IQDRK DAL VETFGRRIEKLLQEKY+ LCG IDDE
Sbjct: 654 ANVNVCGYSSLDFMIEQLDELKYVIQDRKADALVVETFGRRIEKLLQEKYIELCGLIDDE 713
Query: 720 KLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARK 779
K+DSSNAM +EESS DEDTVRSLR SP+NP +KDRTSIEDFEIIKPIS+GAFGRVFLA+K
Sbjct: 714 KVDSSNAMPDEESSADEDTVRSLRASPLNPRAKDRTSIEDFEIIKPISRGAFGRVFLAKK 773
Query: 780 RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839
RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY
Sbjct: 774 RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 833
Query: 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKL 899
LNGGDL+SLLRNLGCLDEDMAR+YIAE+VLALEYLHS+N+IHRDLKPDNLLI QDGHIKL
Sbjct: 834 LNGGDLFSLLRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLLINQDGHIKL 893
Query: 900 TDFGLSKVGLIHSTDDLSA-PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPE 958
TDFGLSKVGLI+STDDLS SLG+ GF D K Q ++ R+KH+V GTPDYLAPE
Sbjct: 894 TDFGLSKVGLINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVVGTPDYLAPE 953
Query: 959 ILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEA 1018
ILLGMGHG TADWWSVG+ILFE+L+GIPPFNA+TPQQIF+NI+NRDIPWPN+PEE+S EA
Sbjct: 954 ILLGMGHGKTADWWSVGVILFEVLVGIPPFNAETPQQIFENIINRDIPWPNVPEEISYEA 1013
Query: 1019 CDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAESLDTSYFVSR 1078
DLI+KLLTENPVQRLGATGA EVKQH FFK+INWDTLARQKAMF+P+AE DTSYF+SR
Sbjct: 1014 HDLINKLLTENPVQRLGATGAGEVKQHHFFKDINWDTLARQKAMFVPSAEPQDTSYFMSR 1073
Query: 1079 YVWNPEDENVQGGSDFDDLTDTCSSGSFSNTLDEEQADECGSLAEF-SAPALAVQYSFSN 1137
Y+WNPEDENV GGSDFDDLTDTCSS SF+ EE DECGSLAEF + P LAV+YSFSN
Sbjct: 1074 YIWNPEDENVHGGSDFDDLTDTCSSSSFNTQ--EEDGDECGSLAEFGNGPNLAVKYSFSN 1131
Query: 1138 FSFKNLSQLASINYDLVVKSAKESAEASKSSVP 1170
FSFKNLSQLASINYDLV+K+AKES EAS S P
Sbjct: 1132 FSFKNLSQLASINYDLVLKNAKESVEASNQSAP 1164
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120242|ref|XP_002318281.1| predicted protein [Populus trichocarpa] gi|222858954|gb|EEE96501.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1489 bits (3856), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 766/1129 (67%), Positives = 870/1129 (77%), Gaps = 102/1129 (9%)
Query: 70 VASSLGLNHIRTKSVSSSPSPLRFFSAAGTPSSFTNEAKKNKTETAAADVKPKFAVPPSN 129
+AS+LGLNHIRT+S+ PSPLRF S+AG
Sbjct: 1 MASALGLNHIRTRSLPV-PSPLRFSSSAG------------------------------- 28
Query: 130 KPPSLESGKKGQWTQSKSLRFPSPLNPELEVSHAAFAKEMQSPRFQAILRVTSGRKKKAP 189
+K W+ SK R S LNP +E E+QSPRFQAILR+TSGR KK P
Sbjct: 29 --------EKVSWSHSKPRRTHSQLNPAME--------EIQSPRFQAILRLTSGRMKK-P 71
Query: 190 EIKSFSHELNSKGVRPFPVWKSRAFGHMEEIMVAIRAKFDKLKEEVNCDLGVLAGDLVGI 249
++KSFSHELNSKGVRPFPVWKSRAFGHMEE+MV IR KF +LKEEV+CDLG+ AGDLVGI
Sbjct: 72 DVKSFSHELNSKGVRPFPVWKSRAFGHMEEVMVVIRTKFIRLKEEVDCDLGIFAGDLVGI 131
Query: 250 LEKSSDSHPEWQESLEDLLVIARKCATMSPSEFWVKCEGIVLNLDDRRQELPMGILKQAY 309
LEK+SD+HPEW+ESLEDLLV+AR+CA MS +EFWVKCE IVLNLDD+RQELPMGI+KQA+
Sbjct: 132 LEKTSDAHPEWRESLEDLLVVARQCAKMSSNEFWVKCESIVLNLDDKRQELPMGIVKQAH 191
Query: 310 TRLLFILTRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQILQIRQQDFSGPLTGGKV 369
TRLLFILTRCTRLVQFQKE+GY+E+ ILG+HQ SDLGVYPEQI++I QQDFSGPL G K
Sbjct: 192 TRLLFILTRCTRLVQFQKENGYDEDKILGIHQCSDLGVYPEQIIEIAQQDFSGPLVGWKT 251
Query: 370 MNEKQRKKSHGQELGSLNLKEDQVDQHETENVEVGTAKSGDSTTSSYRMSSWKRLPSGSR 429
NEKQRKK H E S +K+D +DQ +EVGTAKS DST SS+RMSSWK+LPS +
Sbjct: 252 ANEKQRKKFHSHEQDSKVIKQDHLDQ----TLEVGTAKSFDSTGSSFRMSSWKKLPSAAE 307
Query: 430 RKKGSEAAADTPPKDKTEAFQNKDEPKIGSDDGNDNLDGLYHHASSRITK-SWGFWGE-- 486
+ + TP KDK+E NKD D ++NL+ H S SWG WGE
Sbjct: 308 KNRKGSDLVQTPSKDKSEPIHNKD-------DYSENLETPEHPLSPGTKGVSWGLWGEQH 360
Query: 487 -----NSMICRICEVEIPVVHVEEHSRICTIADRCDLKSLTVNERLERVAETLEKILDSW 541
NSMICRICEVEIP+VHVEEHS ICTIADRCDLK VNERLERVAETLEKILDSW
Sbjct: 361 NVAYENSMICRICEVEIPIVHVEEHSLICTIADRCDLKGFGVNERLERVAETLEKILDSW 420
Query: 542 SPKKHTKKR--------------------THDDLNLMSPKQNSLSRQGSKEMLDHVPDDD 581
SPK K H+ + +S K+NS S S+EMLD VPD
Sbjct: 421 SPKSTPKSTPKGCDTPRGSPEVERLPTSGIHEVSDGLSTKRNSFSSHCSEEMLDVVPD-- 478
Query: 582 NAFVIEDLNVLPEISCDKNPTAADIAAKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTIT 641
FV+EDLN P IS + T I LTPR+PLLTPRTSQI LL++G RTI
Sbjct: 479 -TFVMEDLNAFPGISSEACSTLNQI---------LTPRTPLLTPRTSQIGLLLSGQRTIA 528
Query: 642 ELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVETFGRRI 701
EL+N Q+ KLLD++RS+AS++ +Y++L+ MLD ++++KY IQDRKVDAL VETFGRRI
Sbjct: 529 ELENSHQVSKLLDIARSVASLSG-NYSALQSMLDLVQDVKYAIQDRKVDALIVETFGRRI 587
Query: 702 EKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFE 761
EKL+QEK V LC QIDDEK D SN M +E+SS + D VRSLRTSPIN SKDRTSIEDFE
Sbjct: 588 EKLVQEKCVLLCKQIDDEKSDPSNHMADEDSSEENDAVRSLRTSPINMSSKDRTSIEDFE 647
Query: 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVV 821
IIKPIS+GAFGRVFLARKRATGDLFAIKVLKKADMIRKNAV+SIL ER+ILI+V NPFVV
Sbjct: 648 IIKPISRGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVQSILEERDILITVSNPFVV 707
Query: 822 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIH 881
RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMAR+YIAE+VLALEYLHS NVIH
Sbjct: 708 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARMYIAEVVLALEYLHSSNVIH 767
Query: 882 RDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTRE 941
RDLKPDNLLI QDGHIKLTDFGLSKVGLI+STDDLS P + S GFL +DELK Q E
Sbjct: 768 RDLKPDNLLISQDGHIKLTDFGLSKVGLINSTDDLSVPLVSSSGFLDDDELKSQSSSKSE 827
Query: 942 QRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIM 1001
+RQKH V GTPDYLAPEILLGMGHGATADWWSVG+IL+E+L+GIPPFNA+TPQQIFDNIM
Sbjct: 828 ERQKHPVVGTPDYLAPEILLGMGHGATADWWSVGVILYEMLVGIPPFNAETPQQIFDNIM 887
Query: 1002 NRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKA 1061
NRDIPWP IPEEMS +ACDLIDKLL ENP+QRLGATGAREVK+H FF++INWDTLARQKA
Sbjct: 888 NRDIPWPRIPEEMSFDACDLIDKLLAENPLQRLGATGAREVKKHSFFRDINWDTLARQKA 947
Query: 1062 MFIPAAESLDTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSFSNTLDEEQADECGSL 1121
MFIP+ E+ DTSYF+SRY+WNPE ENV GGSDF+DLTD CSSGSFSN+ D + DEC SL
Sbjct: 948 MFIPSGEAHDTSYFMSRYIWNPEGENVHGGSDFEDLTDICSSGSFSNSHD-DNGDECDSL 1006
Query: 1122 AEFSAPALAVQYSFSNFSFKNLSQLASINYDLVVKSAKESAEASKSSVP 1170
AE AP L + YSFSNFSFKNL QL SINYDLV KS KE+A+ASK SVP
Sbjct: 1007 AEVGAPILDMTYSFSNFSFKNLPQLVSINYDLVGKSTKEAADASKPSVP 1055
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451934|ref|XP_004143715.1| PREDICTED: uncharacterized protein LOC101210442 [Cucumis sativus] gi|449488666|ref|XP_004158136.1| PREDICTED: uncharacterized LOC101210442 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1459 bits (3776), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 754/1199 (62%), Positives = 912/1199 (76%), Gaps = 77/1199 (6%)
Query: 19 PSPTTRTKLRKIPPIPIRRGKHDHSEGENQRRH-------HDDSNVEQARGDDESSILVA 71
PSP+ KLRKIPPIP+RR ++ + D E D+S I++A
Sbjct: 11 PSPSA-GKLRKIPPIPVRRDSKSNAGDSDSDSDADSDSDLEHDLTEEFPLQPDDSCIIMA 69
Query: 72 SSLGLNHIRTKSVSSSPSPLRFFSAAGTPSSFTNEAKKNKTETAAADVKPKFAVPPSNKP 131
SSLGLNHIRT+S +P PLR SA GTPS+ + ++ N TE + +PK +
Sbjct: 70 SSLGLNHIRTRS---APLPLRT-SAVGTPSNLGDNSRNNVTE--GTNSEPKVS------- 116
Query: 132 PSLESGKKGQWTQSKSLRFPSPLNPELEVSHAAFAKEMQSPRFQAILRVTSGRKKKAPEI 191
S E GK+ W+QSKS R P +N + E +H AF KE+QSPRF+AILRVTSGR+K+ P+I
Sbjct: 117 -STELGKRVLWSQSKSFRHPPSVNHDFEGNHVAFGKEIQSPRFRAILRVTSGRRKRTPDI 175
Query: 192 KSFSHELNSKGVRPFPVWKSRAFGHMEEIMVAIRAKFDKLKEEVNCDLGVLAGDLVGILE 251
KSFSHELNSKGVRPFP+WK RA GH+EEIMVAIR KFD+LK++VN +LG+ AGDLV +L+
Sbjct: 176 KSFSHELNSKGVRPFPLWKPRALGHLEEIMVAIREKFDRLKDDVNNELGIFAGDLVDLLD 235
Query: 252 KSSDSHPEWQESLEDLLVIARKCATMSPSEFWVKCEGIVLNLDDRRQELPMGILKQAYTR 311
K+ S PE ++ LEDLLV++RKCAT+SP++FW + EGIV +LDDRRQEL +G+LKQA+TR
Sbjct: 236 KTDHSQPELRKGLEDLLVMSRKCATISPADFWAEGEGIVQSLDDRRQELSLGVLKQAHTR 295
Query: 312 LLFILTRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQILQIRQQDFSGPLTGGKVMN 371
+LFILTRCTRL+QF+KESGYE++HILG HQLSDLG+YPE+I Q+ Q +F PL ++
Sbjct: 296 ILFILTRCTRLIQFRKESGYEDDHILGFHQLSDLGIYPEKIRQLEQLNFGDPL----IVK 351
Query: 372 EKQRKKSH--GQELGSLNLKED--QVDQHETENVEVGTAKSGDSTTSSYRMSSWKRLPSG 427
E+ R++ + ++ S +K+D Q + NVE+G+A S DS+TS RM+SWK+LPS
Sbjct: 352 EEIRQQLNLVAKDQASHIVKQDLGQNFINSAGNVELGSALSVDSSTS-MRMASWKKLPSA 410
Query: 428 SRRKKGSEAAADTPPKDKTEAFQNKDEPKIGSDDGNDNLDGLYHHAS------SRITKSW 481
+ + + + TP +DK E ++E K GS N+ LD +H + SW
Sbjct: 411 AEKNRKDADSTGTPSRDKLELLH-ENEAKTGS---NNQLDTPSNHVAHLEAPPKEQKLSW 466
Query: 482 GFWG-------ENSMICRICEVEIPVVHVEEHSRICTIADRCDLKSLTVNERLERVAETL 534
G WG EN MICRICEVEIP +HVEEHSRICTIADRCDLK LTVNERL+RVA L
Sbjct: 467 GIWGYHQNATFENLMICRICEVEIPTIHVEEHSRICTIADRCDLKGLTVNERLDRVATAL 526
Query: 535 EKILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQ-----------------GSKEMLDHV 577
EKIL+SW+PK + N + K ++ S Q S+++LD +
Sbjct: 527 EKILESWTPKSTPRSSDTSCGNFDTIKVSTSSMQEEVFVELSSRGVNSSCRNSEDLLDSL 586
Query: 578 PDDDNAFVIEDLNVLPEISCDKNPT-AADIAAKTSSAGSLTPRSPLLTPRTSQIELLVNG 636
P + IE ++ P+ S ++ D + K++SAG+LTPRSPLLTPR+SQIELL++G
Sbjct: 587 PVTGSNSFIESQDIFPDSSFNRQFIFTPDYSTKSTSAGTLTPRSPLLTPRSSQIELLLHG 646
Query: 637 HRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVET 696
+ I+EL+N QQI KLLD+ RSIA+VND Y +LE MLDRLE+LKY IQDRKVDAL VET
Sbjct: 647 RKAISELENYQQIFKLLDIVRSIANVNDSGYGALESMLDRLEDLKYAIQDRKVDALVVET 706
Query: 697 FGRRIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTS 756
FGRRIEKLLQEKYV+LCGQI+D+KL+SS+ M +EES +++DTVRSLR SP+N CSKDRTS
Sbjct: 707 FGRRIEKLLQEKYVHLCGQIEDDKLESSHGMVDEESPVEDDTVRSLRASPVNKCSKDRTS 766
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
I DFEIIKPIS+GA+GRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR
Sbjct: 767 IADFEIIKPISRGAYGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 826
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876
NPFVVRFFYSFTCRENLYLVMEYLNGGD+YSLLRNLGCLDEDMAR+YIAE+VLALEYLHS
Sbjct: 827 NPFVVRFFYSFTCRENLYLVMEYLNGGDIYSLLRNLGCLDEDMARIYIAEIVLALEYLHS 886
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
LNVIHRDLKPDNLLIGQDGHIKLTDFGLSK+GLI+STDD S PS+ D L D
Sbjct: 887 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKIGLINSTDDFSGPSISGP-----DSLGDNG 941
Query: 937 PLT---REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993
P + RE RQK SV GTPDYLAPEILLGMGHG TADWWSVG+ILFE+L+GIPPFN + P
Sbjct: 942 PASLPKREHRQKQSVVGTPDYLAPEILLGMGHGVTADWWSVGVILFEMLVGIPPFNEENP 1001
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053
QQIFDNI+NRDIPWP +P+EMS EA DLIDKLLT+N VQRLGATGAREVK+HPFFK++NW
Sbjct: 1002 QQIFDNIINRDIPWPRVPDEMSYEAHDLIDKLLTDNAVQRLGATGAREVKEHPFFKDVNW 1061
Query: 1054 DTLARQKAMFIPAAESLDTSYFVSRYVWNPEDENVQGGSDFD--DLTDTCSSGSFSNTLD 1111
+TL RQKAMFIP+AE DTSYF+SRY+WNPEDE+ GGSDFD DLTDTCSS SFSN L
Sbjct: 1062 ETLERQKAMFIPSAEPQDTSYFMSRYIWNPEDEDFNGGSDFDDHDLTDTCSSSSFSN-LQ 1120
Query: 1112 EEQADECGSLAEFSAPALAVQYSFSNFSFKNLSQLASINYDLVVKSAKESAEASKSSVP 1170
+E DECGSL +F AL+V+YSFSNFSFKNLSQLASINYDLVVKS++ S + SK SVP
Sbjct: 1121 DEDGDECGSLTDFCTSALSVKYSFSNFSFKNLSQLASINYDLVVKSSQNSPDVSKPSVP 1179
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1170 | ||||||
| TAIR|locus:2167953 | 1168 | IRE "INCOMPLETE ROOT HAIR ELON | 0.933 | 0.934 | 0.653 | 0.0 | |
| TAIR|locus:2088515 | 1296 | AT3G17850 [Arabidopsis thalian | 0.566 | 0.511 | 0.600 | 1.5e-296 | |
| TAIR|locus:2198012 | 1235 | AT1G48490 [Arabidopsis thalian | 0.570 | 0.540 | 0.566 | 2.2e-273 | |
| TAIR|locus:2028285 | 1067 | AT1G45160 [Arabidopsis thalian | 0.541 | 0.594 | 0.491 | 2.7e-178 | |
| DICTYBASE|DDB_G0276157 | 1367 | pkgA "MAST family protein kina | 0.132 | 0.113 | 0.638 | 7.9e-90 | |
| DICTYBASE|DDB_G0272282 | 2102 | DDB_G0272282 "MAST family prot | 0.165 | 0.092 | 0.575 | 1e-86 | |
| RGD|1310139 | 968 | Mast4 "microtubule associated | 0.304 | 0.367 | 0.452 | 1.8e-80 | |
| UNIPROTKB|F1S920 | 729 | MAST3 "Uncharacterized protein | 0.270 | 0.433 | 0.471 | 1.9e-79 | |
| UNIPROTKB|F1NAH4 | 1370 | MAST2 "Uncharacterized protein | 0.292 | 0.249 | 0.462 | 1e-77 | |
| UNIPROTKB|F1N8U5 | 1118 | MAST4 "Uncharacterized protein | 0.323 | 0.338 | 0.442 | 8.4e-77 |
| TAIR|locus:2167953 IRE "INCOMPLETE ROOT HAIR ELONGATION" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3604 (1273.7 bits), Expect = 0., P = 0.
Identities = 754/1153 (65%), Positives = 876/1153 (75%)
Query: 27 LRKIPPIPIRRGKHDHSEGENQRRHHDDSNVEQA-RGD---DESSILVASSLGLNHIRTK 82
L+KIP IP R H EGE+++ D+ E A G D IL SSLGLNHIRTK
Sbjct: 30 LKKIPAIPFR---HSDKEGEDEQAKTDEVTTELAGEGPMSHDSPEILAPSSLGLNHIRTK 86
Query: 83 SVSSSPSPLRFFSAAG--TPSS----FXXXXXXXXXXXXXXDVKPKFAVPPSNKPPSLES 136
S S +PSPLRF SA +P D + ++ +PP ++P +
Sbjct: 87 S-SPAPSPLRFSSATPLISPGQDDKDVAKEKPRVGVVDARADARARWPIPP-HQP---DQ 141
Query: 137 GKKGQWTQSKSLRFPSPLNPELEVSHAAFAKEMQSPRFQAILRVTSGRKKKAPEIKSFSH 196
GKK QW+QSKS R P+ NP +E +H AKE QSPRFQAILRVTSGRKKKA +IKSFSH
Sbjct: 142 GKKVQWSQSKSQRVPANSNPGVESTHVGLAKETQSPRFQAILRVTSGRKKKAHDIKSFSH 201
Query: 197 ELNSKGVRPFPVWKSRAFGHMEEIMVAIRAKFDKLKEEVNCDLGVLAGDLVGILEKSSDS 256
ELNSKGVRPFPVW+SRA GHMEEIM AIR KFDK KE+V+ DLGV AG LV LE + +S
Sbjct: 202 ELNSKGVRPFPVWRSRAVGHMEEIMAAIRTKFDKQKEDVDADLGVFAGYLVTTLESTPES 261
Query: 257 HPEWQESLEDLLVIARKCATMSPSEFWVKCEGIVLNLDDRRQELPMGILKQAYTRLLFIL 316
+ E + LEDLLV AR+CATM SEFW+KCEGIV LDD+RQELPMG LKQA+ RLLFIL
Sbjct: 262 NKELRVGLEDLLVEARQCATMPASEFWLKCEGIVQKLDDKRQELPMGGLKQAHNRLLFIL 321
Query: 317 TRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQILQI-RQQDFSGPLTGGKVMNEKQR 375
TRC RLVQF+KESGY EEHILG+HQLSDLGVYPEQ+++I RQQD K+ NEKQ
Sbjct: 322 TRCNRLVQFRKESGYVEEHILGMHQLSDLGVYPEQMVEISRQQDLLREKEIQKI-NEKQN 380
Query: 376 KKSHGQELGSLNLKEDQVDQHETENVEVGTAKSGDSTTSSYRMSSWKRLPSGSRRKKGSE 435
G++ +DQ + VEV TA+S DST+S++RMSSWK+LPS + + +
Sbjct: 381 LA--GKQ-------DDQNSNSGADGVEVNTARSTDSTSSNFRMSSWKKLPSAAEKNR--- 428
Query: 436 AAADTPPKDKTEAFQNKDEPKI-GSXXXXXXXXXXYHHASSRITKSWGFWGE-------N 487
+ + PK K E+ K +PK+ G AS+ + WGFW + N
Sbjct: 429 -SLNNTPKAKGES---KIQPKVYGDENAENLHSPSGQPASADRSALWGFWADHQCVTYDN 484
Query: 488 SMICRICXXXXXXXXXXXXSRICTIADRCDLKSLTVNERLERVAETLEKILDSWSPKKH- 546
SMICRIC SRICTIADRCDLK + VN RLERVAE+LEKIL+SW+PK
Sbjct: 485 SMICRICEVEIPVVHVEEHSRICTIADRCDLKGINVNLRLERVAESLEKILESWTPKSSV 544
Query: 547 TKKRTHDDLNLM-SPKQNSL---SRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPT 602
T + D L S +Q L S++ S +MLD VP N F +++LN+L E+S N T
Sbjct: 545 TPRAVADSARLSNSSRQEDLDEISQRCSDDMLDCVPRSQNTFSLDELNILNEMSMT-NGT 603
Query: 603 AADIAAKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKLLDVSRSIASV 662
K SSAGSLTP SP TPR SQ++LL++G +TI+EL+N QQI KLLD++RS+A+V
Sbjct: 604 ------KDSSAGSLTPPSPA-TPRNSQVDLLLSGRKTISELENYQQINKLLDIARSVANV 656
Query: 663 NDCDYNSLEHMLDRLEELKYIIQDRKVDALFVETFGRRIEKLLQEKYVNLCGQIDDEKLD 722
N C Y+SL+ M+++L+ELKY+IQDRK DAL VETFGRRIEKLLQEKY+ LCG IDDEK+D
Sbjct: 657 NVCGYSSLDFMIEQLDELKYVIQDRKADALVVETFGRRIEKLLQEKYIELCGLIDDEKVD 716
Query: 723 SSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRAT 782
SSNAM +EESS DEDTVRSLR SP+NP +KDRTSIEDFEIIKPIS+GAFGRVFLA+KRAT
Sbjct: 717 SSNAMPDEESSADEDTVRSLRASPLNPRAKDRTSIEDFEIIKPISRGAFGRVFLAKKRAT 776
Query: 783 GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842
GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNG
Sbjct: 777 GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 836
Query: 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902
GDL+SLLRNLGCLDEDMAR+YIAE+VLALEYLHS+N+IHRDLKPDNLLI QDGHIKLTDF
Sbjct: 837 GDLFSLLRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLLINQDGHIKLTDF 896
Query: 903 GLSKVGLIHSTDDLSAPS-LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL 961
GLSKVGLI+STDDLS S LG+ GF D K Q ++ R+KH+V GTPDYLAPEILL
Sbjct: 897 GLSKVGLINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVVGTPDYLAPEILL 956
Query: 962 GMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDL 1021
GMGHG TADWWSVG+ILFE+L+GIPPFNA+TPQQIF+NI+NRDIPWPN+PEE+S EA DL
Sbjct: 957 GMGHGKTADWWSVGVILFEVLVGIPPFNAETPQQIFENIINRDIPWPNVPEEISYEAHDL 1016
Query: 1022 IDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAESLDTSYFVSRYVW 1081
I+KLLTENPVQRLGATGA EVKQH FFK+INWDTLARQKAMF+P+AE DTSYF+SRY+W
Sbjct: 1017 INKLLTENPVQRLGATGAGEVKQHHFFKDINWDTLARQKAMFVPSAEPQDTSYFMSRYIW 1076
Query: 1082 NPEDENVQGGSDFDDLTDTCSSGSFSNTLDEEQADECGSLAEF-SAPALAVQYSFSNFSF 1140
NPEDENV GGSDFDDLTDTCSS SF NT EE DECGSLAEF + P LAV+YSFSNFSF
Sbjct: 1077 NPEDENVHGGSDFDDLTDTCSSSSF-NT-QEEDGDECGSLAEFGNGPNLAVKYSFSNFSF 1134
Query: 1141 KNLSQLASINYDL 1153
KNLSQLASINYDL
Sbjct: 1135 KNLSQLASINYDL 1147
|
|
| TAIR|locus:2088515 AT3G17850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2023 (717.2 bits), Expect = 1.5e-296, Sum P(3) = 1.5e-296
Identities = 414/689 (60%), Positives = 518/689 (75%)
Query: 486 ENSMICRICXXXXXXXXXXXXSRICTIADRCDLKSLTVNERLERVAETLEKILDSW---- 541
E+S++CRIC SR+CT+AD+ D K L+V+ERL VA TL+KI +++
Sbjct: 597 ESSIMCRICEEEVPTTHVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKD 656
Query: 542 ------SPKKHTKKRTH--DDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLP 593
SP +H ++ +++SP+ + SR+GS++MLD P+ DN+ ++DL LP
Sbjct: 657 SLAAAESPDGMKVSNSHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLP 716
Query: 594 EISC-DKNPTAADIAAKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKL 652
+SC + +D TSSA S+TPRSP+ TPR IE ++ G T + + Q+ +L
Sbjct: 717 LMSCRTRFGPKSDQGMTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSEL 776
Query: 653 LDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVETFGRRIEKLLQEKYVNL 712
D+++ A D S+ +L LE+L+ +I RK DAL VETFG RIEKL++EKYV++
Sbjct: 777 ADIAKCAADAIPGDDQSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHM 836
Query: 713 CGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFG 772
C +DDEK+D + + +E++ +++D VRSLRTSP++P +DRTSI+DFEIIKPIS+GAFG
Sbjct: 837 CELMDDEKVDLLSTVIDEDAPLEDDVVRSLRTSPVHP--RDRTSIDDFEIIKPISRGAFG 894
Query: 773 RVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832
RVFLA+KR TGDLFAIKVLKKADMIRKNAVESILAER+ILI+VRNPFVVRFFYSFTCR+N
Sbjct: 895 RVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDN 954
Query: 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG 892
LYLVMEYLNGGDLYSLLRNLGCL+ED+ RVYIAE+VLALEYLHS V+HRDLKPDNLLI
Sbjct: 955 LYLVMEYLNGGDLYSLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIA 1014
Query: 893 QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ---RQKHSVA 949
DGHIKLTDFGLSKVGLI+STDDL+ P++ SG L+++E + + + EQ R+K S
Sbjct: 1015 HDGHIKLTDFGLSKVGLINSTDDLAGPAV-SGTSLLDEE-ESRLAASEEQLERRKKRSAV 1072
Query: 950 GTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPN 1009
GTPDYLAPEILLG GHGATADWWSVGIILFEL++GIPPFNA+ PQQIFDNI+NR IPWP+
Sbjct: 1073 GTPDYLAPEILLGTGHGATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPH 1132
Query: 1010 IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES 1069
+PEEMS EA D+ID+ LTE+P QRLGA GA EVKQH FFK+INWDTLARQKA F+PA+ES
Sbjct: 1133 VPEEMSAEAHDIIDRFLTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASES 1192
Query: 1070 -LDTSYFVSRYVWNPEDENVQGGSDFDDLTD----TCSSGSFSNTLDEEQADECGSLAEF 1124
+DTSYF SRY WN DE + D +D T SSG SN +E +A+EC AEF
Sbjct: 1193 AIDTSYFRSRYSWNTSDEQFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEF 1252
Query: 1125 SAPALAVQYSFSNFSFKNLSQLASINYDL 1153
+ + V YSFSNFSFKNLSQLASINYDL
Sbjct: 1253 ES-GIPVDYSFSNFSFKNLSQLASINYDL 1280
|
|
| TAIR|locus:2198012 AT1G48490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1889 (670.0 bits), Expect = 2.2e-273, Sum P(2) = 2.2e-273
Identities = 403/711 (56%), Positives = 500/711 (70%)
Query: 471 HHASSRITKSWGFWG-------ENSMICRICXXXXXXXXXXXXSRICTIADRCDLKSLTV 523
H + +R SWG+WG E+S+ICRIC SRIC +AD+ D K + V
Sbjct: 525 HMSKNRHNISWGYWGHQSCISEESSIICRICEEEIPTTHVEDHSRICALADKYDQKGVGV 584
Query: 524 NERLERVAETLEKILDSW----------SPK--KHTKKRTHDDLNLMSPKQNSLSRQGSK 571
+ERL VA TLEKI D+ SP+ K + ++L+++SPK + SR+GS+
Sbjct: 585 DERLMAVAVTLEKITDNVIQKDSLAAVESPEGMKISNASLTEELDVLSPKLSDWSRRGSE 644
Query: 572 EMLDHVPDDDNAFVIEDLNVLPEISC-DKNPTAADIAAKTSSAGSLTPRSPLLTPRTSQI 630
+MLD P+ DN+ ++D+ LP +SC + +D TSSAGS+TPRSP+ TPR I
Sbjct: 645 DMLDCFPETDNSVFMDDMGCLPSMSCRTRFGPKSDQGMATSSAGSMTPRSPIPTPRPDPI 704
Query: 631 ELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVD 690
ELL+ G T + + Q+ +L D++R A+ D S++ +L LE+L+ +I RK D
Sbjct: 705 ELLLEGKGTFHDQDDFPQMSELADIARCAANAIPVDDQSIQLLLSCLEDLRVVIDRRKFD 764
Query: 691 ALFVETFGRRIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPC 750
AL VETFG RIEKL+QEKY+ LC +DDEK + +E++ +++D VRSLRTSP++
Sbjct: 765 ALIVETFGTRIEKLIQEKYLQLCELMDDEK----GTIIDEDAPLEDDVVRSLRTSPVH-- 818
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
+DR SI+DFE++K IS+GAFG V LARK TGDLFAIKVL+KADMIRKNAVESILAER+
Sbjct: 819 LRDRISIDDFEVMKSISRGAFGHVILARKNTTGDLFAIKVLRKADMIRKNAVESILAERD 878
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
ILI+ RNPFVVRFFYSFTC ENLYLVMEYLNGGD YS+LR +GCLDE ARVYIAE+VLA
Sbjct: 879 ILINARNPFVVRFFYSFTCSENLYLVMEYLNGGDFYSMLRKIGCLDEANARVYIAEVVLA 938
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
LEYLHS V+HRDLKPDNLLI DGH+KLTDFGLSKVGLI++TDDLS P + LV +
Sbjct: 939 LEYLHSEGVVHRDLKPDNLLIAHDGHVKLTDFGLSKVGLINNTDDLSGPVSSATSLLVEE 998
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
+ K P L K S GTPDYLAPEILLG GHGATADWWSVGIIL+E L+GIPPFNA
Sbjct: 999 KPK-LPTLDH----KRSAVGTPDYLAPEILLGTGHGATADWWSVGIILYEFLVGIPPFNA 1053
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
PQQIFDNI+NR+I WP +PE+MS EA DLID+LLTE+P QRLGA GA EVKQH FFK+
Sbjct: 1054 DHPQQIFDNILNRNIQWPPVPEDMSHEARDLIDRLLTEDPHQRLGARGAAEVKQHSFFKD 1113
Query: 1051 INWDTLARQKAMFIPAAES-LDTSYFVSRYVWN-------PEDENVQGGSDFDDLTDTCS 1102
I+W+TLA+QKA F+P +E+ DTSYF SRY WN P +EN + S+ D L S
Sbjct: 1114 IDWNTLAQQKAAFVPDSENAFDTSYFQSRYSWNYSGERCFPTNEN-EDSSEGDSLCG--S 1170
Query: 1103 SGSFSNTLDEEQADECGSLAEFSAPALAVQYSFSNFSFKNLSQLASINYDL 1153
SG SN DE CG AEF +++ Y F NFSFKNLSQLA INY+L
Sbjct: 1171 SGRLSNHHDEGVDIPCGP-AEFET-SVSENYPFDNFSFKNLSQLAYINYNL 1219
|
|
| TAIR|locus:2028285 AT1G45160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1490 (529.6 bits), Expect = 2.7e-178, Sum P(2) = 2.7e-178
Identities = 338/687 (49%), Positives = 441/687 (64%)
Query: 485 GENSMICRICXXXXXXXXXXXXSRICTIADRCDLKSLTVNERLERVAETLEKILDSWSPK 544
G + +ICRIC S IC AD+C++ + V+ERL ++ E LE+I+DS S
Sbjct: 396 GSDYVICRICEEEVPLFHLEPHSYICAYADKCEINCVDVDERLLKLEEILEQIIDSRSLN 455
Query: 545 KHTKKRTHDDLNLM---------SPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEI 595
T+ ++ L SPK N +G + M + + + D AF+ E +
Sbjct: 456 SFTQAGGLENSVLRKSGVASEGCSPKINEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHL 515
Query: 596 SCDKNPTAADIA--AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKLL 653
K+ A A +SS GS+T S TPRTS + R E ++ + + L
Sbjct: 516 ---KSHVGAKFCHHATSSSTGSITSVSSTNTPRTSHFDSYWL-ERHCPEQEDLRLMMDLS 571
Query: 654 DVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVETFGRRIEKLLQEKYVNLC 713
D++R AS + S ++++ +++++ +++ K+ AL ++TFG RIEKLL EKY++
Sbjct: 572 DIARCGASTDFSKEGSCDYIMACMQDIQAVLKQGKLKALVIDTFGGRIEKLLCEKYLH-A 630
Query: 714 GQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGR 773
++ +K N +ES ED + +P KDR SI+DFEIIKPIS+GAFG+
Sbjct: 631 RELTADKSSVGNI---KES---EDVLEHASATP-QLLLKDRISIDDFEIIKPISRGAFGK 683
Query: 774 VFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833
VFLARKR TGD FAIKVLKK DMIRKN +E IL ERNILI+VR PF+VRFFYSFTCR+NL
Sbjct: 684 VFLARKRTTGDFFAIKVLKKLDMIRKNDIERILQERNILITVRYPFLVRFFYSFTCRDNL 743
Query: 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ 893
YLVMEYLNGGDLYSLL+ +GCLDE++AR+YIAELVLALEYLHSL ++HRDLKPDNLLI
Sbjct: 744 YLVMEYLNGGDLYSLLQKVGCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAY 803
Query: 894 DGHIKLTDFGLSKVGLIHSTDDLS------APSLGSGGFLVNDELKDQPPLTREQRQKHS 947
+GHIKLTDFGLSK+GLI++T DLS +P S F N E E+R +HS
Sbjct: 804 NGHIKLTDFGLSKIGLINNTIDLSGHESDVSPRTNSHHFQKNQE---------EERIRHS 854
Query: 948 VAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPW 1007
GTPDYLAPEILLG HG ADWWS GI+LFELL GIPPF A P++IFDNI+N +PW
Sbjct: 855 AVGTPDYLAPEILLGTEHGYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPW 914
Query: 1008 PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAA 1067
P++P EMS EA DLI++LL P +RLGA GA EVK HPFF+ ++W+ LA QKA F+P
Sbjct: 915 PDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQP 974
Query: 1068 ESL-DTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSFSNTLDEEQADECGSLAEFSA 1126
ES+ DTSYFVSR+ S D T+T + S SN ++ DEC +L +F +
Sbjct: 975 ESINDTSYFVSRF----------SESSCSD-TET-GNNSGSNPDSGDELDECTNLEKFDS 1022
Query: 1127 PALAVQYSFSNFSFKNLSQLASINYDL 1153
P + S NFSFKNLSQLASIN+D+
Sbjct: 1023 PPYYL--SLINFSFKNLSQLASINHDV 1047
|
|
| DICTYBASE|DDB_G0276157 pkgA "MAST family protein kinase PkgA" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 7.9e-90, Sum P(4) = 7.9e-90
Identities = 99/155 (63%), Positives = 126/155 (81%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
+I DFE IKPI++G +G+VFLA+K TGD++AIK LKK+DMI+KN ++ + ERNIL
Sbjct: 806 TISDFEFIKPITKGGYGKVFLAKKIRTGDIYAIKRLKKSDMIKKNQLDHVKVERNILAYT 865
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
NPFVV+ +YSF +E YLVMEYL GGD +SLL+ LG +DE+MA++ IAE VLALEYLH
Sbjct: 866 SNPFVVKMYYSFQTKEYYYLVMEYLQGGDCFSLLQMLGSMDENMAKMIIAETVLALEYLH 925
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910
S ++HRD+KPDNLLI + GHIKLTDFGLSKVGL+
Sbjct: 926 SHGIVHRDVKPDNLLIDKKGHIKLTDFGLSKVGLL 960
|
|
| DICTYBASE|DDB_G0272282 DDB_G0272282 "MAST family protein kinase DDB_G0272282" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 544 (196.6 bits), Expect = 1.0e-86, Sum P(6) = 1.0e-86
Identities = 114/198 (57%), Positives = 135/198 (68%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
SI DFEIIKPIS+GAFGRV+LA+K+ TGDL+AIKVLKK D IRKN V ++ ERNIL V
Sbjct: 1523 SIADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVERNILAMV 1582
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
+N FVV+ FY+F + LYLVMEYL GGD SLLR LGC +E MA+ YIAE VL LEYLH
Sbjct: 1583 QNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLH 1642
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
++HRDLKPDN+LI GHIKLTDFGLSK+G+I DD G+ +
Sbjct: 1643 KSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGII---DDKKMEDSGNTNTNTHFNFSTS 1699
Query: 936 PPLTREQRQKHSVAGTPD 953
P T S G P+
Sbjct: 1700 PTNT-SMMDDSSTTGNPN 1716
|
|
| RGD|1310139 Mast4 "microtubule associated serine/threonine kinase family member 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 780 (279.6 bits), Expect = 1.8e-80, Sum P(2) = 1.8e-80
Identities = 172/380 (45%), Positives = 236/380 (62%)
Query: 720 KLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARK 779
+L + ++ T E DE +V S TS + K R S DFE IK IS GA+G V+ R
Sbjct: 285 QLGNYDSRTAETPETDE-SVSSSNTS-LRLRRKPRES--DFETIKLISNGAYGAVYFVRH 340
Query: 780 RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839
+ + FA+K + K ++I +N ++ ER+IL NPFVV + SF R +L +VMEY
Sbjct: 341 KESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEY 400
Query: 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKL 899
+ GGD +L++N+G L DMAR+Y AE VLALEYLH+ ++HRDLKPDNLL+ GHIKL
Sbjct: 401 VEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKL 460
Query: 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEI 959
TDFGLSKVGL+ T +L G + D RE K V GTP+Y+APE+
Sbjct: 461 TDFGLSKVGLMSMTTNLYE------GHIEKD--------AREFLDKQ-VCGTPEYIAPEV 505
Query: 960 LLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEAC 1019
+L G+G DWW++GIIL+E L+G PF TP+++F +++ +I WP E +A
Sbjct: 506 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQ 565
Query: 1020 DLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAESLD-TSYFVSR 1078
DLI LL +NP++RLG GA EVKQH FF++++W++L RQKA FIP ES D TSYF +R
Sbjct: 566 DLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTR 625
Query: 1079 ----YVWNPEDENVQGGSDF 1094
+ E+E+ DF
Sbjct: 626 SEKYHHMETEEEDDTNDEDF 645
|
|
| UNIPROTKB|F1S920 MAST3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 768 (275.4 bits), Expect = 1.9e-79, Sum P(2) = 1.9e-79
Identities = 157/333 (47%), Positives = 213/333 (63%)
Query: 747 INPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESIL 806
+ P S+ + DFE IK IS GA+G V+L R R T FAIK + K ++I +N ++ +
Sbjct: 365 VGP-SRRKPCESDFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVF 423
Query: 807 AERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE 866
ER+IL NPFVV F SF R +L +VMEY+ GGD +LL+N+G L DMAR+Y AE
Sbjct: 424 VERDILTFAENPFVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAE 483
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
VLALEYLH+ ++HRDLKPDNLLI GHIKLTDFGLSK+GL+ +L G
Sbjct: 484 TVLALEYLHNYGIVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLYE------GH 537
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
+ D TRE K V GTP+Y+APE++ G+G DWW++G++L+E L+G
Sbjct: 538 IEKD--------TREFVDKQ-VCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCV 588
Query: 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046
PF TP+++F +++ +I WP E + +A DLI +LL ++P+ RLG G EVKQHP
Sbjct: 589 PFFGDTPEELFGQVVSDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHP 648
Query: 1047 FFKNINWDTLARQKAMFIPAAESLD-TSYFVSR 1078
FF ++W L R KA F+P E+ D TSYF +R
Sbjct: 649 FFWTLDWAGLLRHKAEFVPQLEAEDDTSYFDTR 681
|
|
| UNIPROTKB|F1NAH4 MAST2 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 1.0e-77, Sum P(2) = 1.0e-77
Identities = 167/361 (46%), Positives = 232/361 (64%)
Query: 719 EKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLAR 778
E++ N+ ++ +D+V S R + + SK S E+FE IK IS GA+G V+L R
Sbjct: 309 EEMAQLNSYDSPDTPETDDSVES-RGATVQ--SKKTPSEEEFETIKLISNGAYGAVYLVR 365
Query: 779 KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838
+ T FA+K + K ++I +N ++ ER+IL NPFVV F SF + +L +VME
Sbjct: 366 HKTTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVME 425
Query: 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898
Y+ GGD +LL+N+G L DMAR+Y AE VLALEYLH+ ++HRDLKPDNLLI GHIK
Sbjct: 426 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIK 485
Query: 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPE 958
LTDFGLSK+GL+ T +L G + D TRE K V GTP+Y+APE
Sbjct: 486 LTDFGLSKIGLMSLTTNLYE------GHIEKD--------TREFLDKQ-VCGTPEYIAPE 530
Query: 959 ILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEA 1018
++L G+G DWW++G+IL+E L+G PF TP+++F +++ +I WP + + +A
Sbjct: 531 VILRQGYGKPVDWWAMGVILYEFLVGCVPFFGDTPEELFGQVISDEIAWPEGDDALPPDA 590
Query: 1019 CDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAESLD-TSYFVS 1077
DLI KLL +NP++R+G A EVKQH FFK+++W+ L RQKA FIP ES D TSYF +
Sbjct: 591 QDLISKLLRQNPLERMGTGSAFEVKQHRFFKDLDWNGLLRQKAEFIPQLESEDDTSYFDT 650
Query: 1078 R 1078
R
Sbjct: 651 R 651
|
|
| UNIPROTKB|F1N8U5 MAST4 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 789 (282.8 bits), Expect = 8.4e-77, P = 8.4e-77
Identities = 182/411 (44%), Positives = 252/411 (61%)
Query: 720 KLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARK 779
+L + ++ T E MDE +V S TS + K R S DFE IK IS GA+G V+ R
Sbjct: 48 QLANCDSGTAETLEMDE-SVTSSNTS-LQLRRKPRES--DFETIKLISNGAYGAVYFVRH 103
Query: 780 RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839
+ T FA+K + K ++I +N ++ ER+IL NPFVV + SF R +L +VMEY
Sbjct: 104 KETRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEY 163
Query: 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKL 899
+ GGD +L++N+G L DMAR+Y AE VLALEYLH+ ++HRDLKPDNLL+ GHIKL
Sbjct: 164 VEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKL 223
Query: 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEI 959
TDFGLSKVGL+ T +L G + D RE K V GTP+Y+APE+
Sbjct: 224 TDFGLSKVGLMSLTTNLYE------GHIEKD--------AREFLDKQ-VCGTPEYIAPEV 268
Query: 960 LLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEAC 1019
+L G+G DWW++GIIL+E L+G PF TP+++F +++ +I WP E +A
Sbjct: 269 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQ 328
Query: 1020 DLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAESLD-TSYFVSR 1078
DLI LL +NP++RLG GA EVKQH FF++++W++L RQKA FIP ES D TSYF +R
Sbjct: 329 DLITLLLRQNPLERLGTGGAYEVKQHKFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTR 388
Query: 1079 ----YVWNPEDENVQGGSDFD-DLTD--TCS---SGSFSNT--LDEEQADE 1117
+ E+E+ DF+ ++ +CS S FS+ + + Q DE
Sbjct: 389 SEKYHHMETEEEDDTNDEDFNLEIRQFSSCSHRFSKVFSSIDRVSQTQGDE 439
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1170 | |||
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-153 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-118 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-118 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-116 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-116 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-109 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-108 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-101 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-96 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-95 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-95 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-94 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-93 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-85 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-84 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-84 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-83 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-82 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-79 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-79 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-79 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-78 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-75 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-75 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-75 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-75 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-74 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-74 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-73 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-73 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-73 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-73 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-71 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-70 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-70 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-70 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-69 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-69 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-68 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-68 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-67 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-65 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-65 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-64 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-64 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-64 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-63 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-63 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-63 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-62 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-62 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-62 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-62 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-62 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-61 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-61 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-60 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-59 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-59 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-57 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-57 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-55 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-55 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-54 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-53 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-51 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-49 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-48 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-48 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-48 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-48 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-47 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-47 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-46 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-46 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-44 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-43 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-43 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-42 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-42 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-42 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-41 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-41 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-41 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-41 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-41 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-40 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-40 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-39 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-38 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-38 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-38 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-38 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-37 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-37 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-37 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-36 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-36 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-36 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-34 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-33 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-33 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-32 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-31 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-31 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-31 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-31 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-31 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-31 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-31 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-30 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-30 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-30 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-29 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-29 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-29 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-29 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-29 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-29 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-29 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-28 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-28 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-28 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-27 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-27 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-27 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-27 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-26 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-26 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-26 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-26 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-26 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-26 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-25 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-25 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-25 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-24 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-24 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-23 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-23 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-23 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-22 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-22 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-22 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-21 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-20 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-20 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-19 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-19 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-17 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-17 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-17 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-16 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-16 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-15 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-12 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-10 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-08 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-07 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 3e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 2e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.002 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.003 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 457 bits (1177), Expect = e-153
Identities = 163/288 (56%), Positives = 211/288 (73%), Gaps = 23/288 (7%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
IS+GA+GRVFLA+K++TGD++AIKV+KKADMIRKN V+ +L ER+IL ++P+VV+ +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLK 885
SF ++NLYLVMEYL GGDL SLL N+G LDED+AR+YIAE+VLALEYLHS +IHRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 886 PDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQK 945
PDN+LI +GH+KLTDFGLSKVGL+ +L+ ++
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE----------------------KED 158
Query: 946 HSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI 1005
+ GTPDY+APE++LG GH T DWWS+G IL+E L+GIPPF+ +TP++IF NI+N I
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI 218
Query: 1006 PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053
WP E+S EA DLI KLL +P +RLGA E+K HPFFK I+W
Sbjct: 219 EWPEDV-EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 366 bits (941), Expect = e-118
Identities = 130/283 (45%), Positives = 180/283 (63%), Gaps = 33/283 (11%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
+ +G+FG+V L RK+ TG L+A+KVLKK +I++ VE L ERNIL + +PF+V+ Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLK 885
+F E LYLV+EY GG+L+S L G E+ AR Y AE+VLALEYLHSL +I+RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 886 PDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQK 945
P+N+L+ DGHIKLTDFGL+K E +
Sbjct: 121 PENILLDADGHIKLTDFGLAKELS------------------------------SEGSRT 150
Query: 946 HSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI 1005
++ GTP+YLAPE+LLG G+G DWWS+G++L+E+L G PPF A+ ++I++ I+ +
Sbjct: 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL 210
Query: 1006 PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
PE +S EA DLI LL ++P +RLG+ GA E+K HPFF
Sbjct: 211 ---RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 365 bits (938), Expect = e-118
Identities = 152/294 (51%), Positives = 197/294 (67%), Gaps = 36/294 (12%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVV 821
+KPIS+GAFG V+LA+KR+TGD FAIKVLKK+DMI KN V ++ AER I++ +P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 822 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIH 881
+ +YSF ++ LYLVMEYLNGGD SL++ LG L ED A+ YIAE+VL +E LH +IH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 882 RDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTRE 941
RD+KP+NLLI Q GH+KLTDFGLS+ GL
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLE------------------------------- 149
Query: 942 QRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIM 1001
GTPDYLAPE +LG+G +DWWS+G ++FE L G PPF+A+TP +FDNI+
Sbjct: 150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL 206
Query: 1002 NRDIPWPNIPEE-MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054
+R I WP +E S EA DLI++LL +P +RLGA G +E+K HPFFK+INWD
Sbjct: 207 SRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 365 bits (939), Expect = e-116
Identities = 147/321 (45%), Positives = 207/321 (64%), Gaps = 8/321 (2%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DFE+IK I +GAFG V+L R + TG ++A+KVL+K+DMI++N + + AER+IL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P++V+ +YSF E+LYLVMEY+ GGDL +LL E+ AR YIAELVLAL+ +H L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
IHRD+KPDN+LI DGHIKL DFGL K + + D + ++ L +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK-KMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
+ + + +S GTPDY+APE+L G +G DWWS+G+IL+E+L G PPF + T Q+ +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 998 DNIMN--RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055
+ I+N + +P P +S EA DLI +LL + P RLG+ E+K HPFFK I+W+
Sbjct: 240 NKIINWKESLRFPPDP-PVSPEAIDLICRLLCD-PEDRLGS--FEEIKSHPFFKGIDWEN 295
Query: 1056 LARQKAMFIPAAES-LDTSYF 1075
L K F+P S LDTS F
Sbjct: 296 LRETKPPFVPELSSPLDTSNF 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 361 bits (928), Expect = e-116
Identities = 161/319 (50%), Positives = 212/319 (66%), Gaps = 16/319 (5%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
EDFE IK IS GA+G V+L R + T FA+K + K ++I +N ++ + ER+IL N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
PFVV F SF + +L +VMEY+ GGD +LL+N+G L DMAR+Y AE VLALEYLH+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
++HRDLKPDNLLI GHIKLTDFGLSK+GL+ T +L G + D
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYE------GHIEKD------- 167
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
TRE K V GTP+Y+APE++L G+G DWW++GIIL+E L+G PF TP+++F
Sbjct: 168 -TREFLDKQ-VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 225
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLA 1057
+++ DI WP E + +A DLI +LL +NP++RLG GA EVKQH FF ++W+ L
Sbjct: 226 GQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLL 285
Query: 1058 RQKAMFIPAAESL-DTSYF 1075
RQKA FIP ES DTSYF
Sbjct: 286 RQKAEFIPQLESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 343 bits (882), Expect = e-109
Identities = 134/323 (41%), Positives = 193/323 (59%), Gaps = 41/323 (12%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DFE IK + G+FGRV L R + +G +A+K+L KA +++ VE +L E+ IL S+R+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
PF+V + SF NLYLVMEY+ GG+L+S LR G E +AR Y A++VLALEYLHSL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
++++RDLKP+NLL+ DG+IK+TDFG +K
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAK------------------------------- 149
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
R + + +++ GTP+YLAPEI+L G+G DWW++GI+++E+L G PPF P QI+
Sbjct: 150 --RVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY 207
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDT 1055
+ I+ + P S +A DLI LL + +RLG G ++K HP+F I+W
Sbjct: 208 EKILEGKV---RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264
Query: 1056 LARQK--AMFIP-AAESLDTSYF 1075
L ++K A FIP DTS F
Sbjct: 265 LLQRKIEAPFIPKVKGPGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 342 bits (879), Expect = e-108
Identities = 141/333 (42%), Positives = 199/333 (59%), Gaps = 21/333 (6%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DFE IK I +GAFG V L +K+ TG ++A+K L+K++M+ K V + AER+IL N
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P+VV+ +YSF LYL+MEYL GGD+ +LL E+ R YIAE +LA++ +H L
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL--IHSTDD--LSAPSLGSGGFLVNDELK 933
IHRD+KPDNLL+ GHIKL+DFGL GL H T+ + + +L S +
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHALPSNFLDFISKPM 179
Query: 934 DQPPLT----REQRQK-HSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988
R +R +S GTPDY+APE+ L G+ DWWS+G+I++E+L+G PPF
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239
Query: 989 NAKTPQQIFDNIMNRDIPWPN---IPEEM--SVEACDLIDKLLTENPVQRLGATGAREVK 1043
+ PQ+ + I+N W P+E+ S EA DLI +L E +RLG G E+K
Sbjct: 240 CSDNPQETYRKIIN----WKETLQFPDEVPLSPEAKDLIKRLCCE-AERRLGNNGVNEIK 294
Query: 1044 QHPFFKNINWDTLARQKAMFIPAAES-LDTSYF 1075
HPFFK ++W+ + + A IP +S DTS F
Sbjct: 295 SHPFFKGVDWEHIRERPAPIIPELKSITDTSNF 327
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 321 bits (825), Expect = e-101
Identities = 123/290 (42%), Positives = 172/290 (59%), Gaps = 37/290 (12%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+EI++ + +G+FG+V+LAR + TG L AIKV+KK + + E IL E IL +++P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
+VR + F + LYLVMEY GGDL+ LL+ G L ED AR Y+ +++ ALEYLHS +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
+HRDLKP+N+L+ +DGH+KL DFGL++ L G L
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQ-------------LDPGEKL------------ 153
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK-TPQQIFD 998
+ GTP+Y+APE+LLG G+G D WS+G+IL+ELL G PPF ++F
Sbjct: 154 ------TTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFK 207
Query: 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
I P+P ++S EA DLI KLL ++P +RL A E QHPFF
Sbjct: 208 KIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 311 bits (798), Expect = 4e-96
Identities = 157/365 (43%), Positives = 208/365 (56%), Gaps = 39/365 (10%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F IK I GAFG V L RK T L+A+K L+KAD++ +N + AER+IL N +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
VV+ +YSF ++NLY VM+Y+ GGD+ SLL LG +ED+AR YIAEL A+E +H +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGL---------SKV---GLIHSTDDLSAPSLGSGGFL 927
IHRD+KPDN+LI +DGHIKLTDFGL SK G H D + S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE--- 179
Query: 928 VNDELKDQPPLTREQRQK-----HSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
D + +P R +RQ HS+ GTP+Y+APE+LL G+ DWWSVG+IL+E+L
Sbjct: 180 -IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 983 IGIPPFNAKTPQQIFDNIMNRDIPWPN---IPE--EMSVEACDLIDKLLTENPVQRLGAT 1037
+G PPF A TP + ++N W IP ++S EA DLI +L RLG
Sbjct: 239 VGQPPFLADTPAETQLKVIN----WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKN 293
Query: 1038 GAREVKQHPFFKNINWDTLAR-QKAMFIPA-AESLDTSYFVSRYVWNPEDENVQGGSDFD 1095
GA E+K HPFFK I++ +L R QKA +IP DTS F +P D D
Sbjct: 294 GADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNF------DPVDPEKLRSDDSG 347
Query: 1096 DLTDT 1100
+ +
Sbjct: 348 ESSPD 352
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 306 bits (785), Expect = 1e-95
Identities = 111/294 (37%), Positives = 169/294 (57%), Gaps = 17/294 (5%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-R 816
+DF+ K I +G+F V LA+++ T +AIK+L K +I++ V+ + E+ +L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876
+P +++ +Y+F ENLY V+EY G+L +R G LDE R Y AE++LALEYLHS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+IHRDLKP+N+L+ +D HIK+TDFG +KV L S + Q
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKV--------LDPNSSPESNKGDATNIDSQI 172
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
+ +R+ S GT +Y++PE+L G ++D W++G I++++L G PPF
Sbjct: 173 E--KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230
Query: 997 FDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGA-TGAREVKQHPFF 1048
F I+ + +P N P +A DLI+KLL +P RLG G E+K HPFF
Sbjct: 231 FQKILKLEYSFPPNFPP----DAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 306 bits (786), Expect = 5e-95
Identities = 133/323 (41%), Positives = 194/323 (60%), Gaps = 42/323 (13%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
DF+I+ + QG +G+VFLA+K+ TG++ A+K +KK+ + + N V +L ER+IL + ++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN 878
++V+ Y+F E LYL MEY+ GGD +LL NLG L ED AR Y+AE+ A++ LH L
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
IHRDLKP+N LI GHIKLTDFGLSK + ++
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYA-------------------------- 155
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998
+SV G+PDY+APE+L G G+ T D+WS+G +L+E L G PPF+ TP + ++
Sbjct: 156 -------NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208
Query: 999 NIMN--RDIPWP--NIPE-EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053
N+ + P + P +S EA DLI KL+ + P +R G+ ++K HPFFK ++W
Sbjct: 209 NLKYWKETLQRPVYDDPRFNLSDEAWDLITKLIND-PSRRFGSL--EDIKNHPFFKEVDW 265
Query: 1054 DTLARQKAMFIPAAES-LDTSYF 1075
+ L K F+P ES +DT YF
Sbjct: 266 NELRELKPPFVPELESEIDTGYF 288
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 304 bits (780), Expect = 2e-94
Identities = 131/314 (41%), Positives = 191/314 (60%), Gaps = 11/314 (3%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
F+ IK + +G GRVFL R + TG LFA+KVL K +MI++N V+ +L E+ IL ++ +P
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDMARVYIAELVLALEYLHS 876
F+ + SF L LVM+Y GG+L+ LL + CL E++AR Y AE++LALEYLH
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST---DDLSAPSLGSGGFLVNDELK 933
L +++RDLKP+N+L+ + GHI L+DF LSK + L S S + E
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993
+ P R +S GT +Y+APE++ G GHG+ DWW++GI+L+E+L G PF
Sbjct: 182 SEEPSFR----SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG-ATGAREVKQHPFFKNIN 1052
+ F NI+ +++ +P P +S A DLI KLL ++P +RLG GA E+KQHPFF+ +N
Sbjct: 238 DETFSNILKKEVTFPGSP-PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296
Query: 1053 WDTLARQKAMFIPA 1066
W + IP
Sbjct: 297 WALIRHTTPPIIPR 310
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 302 bits (774), Expect = 8e-93
Identities = 150/354 (42%), Positives = 209/354 (59%), Gaps = 33/354 (9%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
EDF +K I +GAFG V L +K+ TG ++A+K L K++M +K+ + + AER++L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P+VV +YSF + LYL+ME+L GGDL ++L ED+ R Y+AE VLA+E +H L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD-------LSAPSLGSGGFLVND 930
IHRD+KPDN+LI + GHIKL+DFGLS G H D L S + N
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLS-TGF-HKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 931 ELKDQPPLTREQRQK------------HSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978
D LT + + +S GTPDY+APEI L G+G DWWS+G I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 979 FELLIGIPPFNAKTPQQIFDNIMN--RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA 1036
FE LIG PPF ++ + + I+N + +P+ +SVEA DLI +L+T N RLG
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGR 296
Query: 1037 TGAREVKQHPFFKNINWDTLARQKAMFIPAAESL-DTSYFVSRYVWNPEDENVQ 1089
GA E+K HPFF+ ++WDT+ + +A FIP +S+ DTSYF P DE Q
Sbjct: 297 GGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYF-------PTDELEQ 343
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 3e-85
Identities = 108/292 (36%), Positives = 171/292 (58%), Gaps = 40/292 (13%)
Query: 769 GAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828
G FGRV L + ++ FA+K +KK ++ E I +E+ IL +PF+V+ + +F
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK 63
Query: 829 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDN 888
++ +Y++MEY GG+L+++LR+ G DE AR YIA +VLA EYLH+ +I+RDLKP+N
Sbjct: 64 DKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPEN 123
Query: 889 LLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSV 948
LL+ +G++KL DFG +K L SG ++ +
Sbjct: 124 LLLDSNGYVKLVDFGFAKK-------------LKSG------------------QKTWTF 152
Query: 949 AGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA--KTPQQIFDNI--MNRD 1004
GTP+Y+APEI+L G+ + D+WS+GI+L+ELL G PPF + P +I+++I N
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK 212
Query: 1005 IPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWD 1054
+ +PN + A DLI +LL NP +RLG G +++K+H +F +W+
Sbjct: 213 LEFPNY---IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 1e-84
Identities = 108/300 (36%), Positives = 169/300 (56%), Gaps = 36/300 (12%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVR 822
K + +G+FG+V LA + T +L+A+KVLKK +++ + VE + E+ +L PF+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
F ++ L+ VMEY+NGGDL ++ G DE AR Y AE+VL L++LH +I+R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLK DN+L+ +GHIK+ DFG+ K G+
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGI------------------------------LGG 150
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
+ GTPDY+APEIL +G DWW++G++L+E+L G PF ++F +I+
Sbjct: 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQK 1060
++ P +S EA ++ LT+NP +RLG TG +++K HPFF+ I+WD L R++
Sbjct: 211 DEV---RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKE 267
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 273 bits (700), Expect = 5e-84
Identities = 105/295 (35%), Positives = 156/295 (52%), Gaps = 41/295 (13%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+E+++ + G+FG V+ A+ + TG + A+K+LKK + ++ E IL + +P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
+VR +F +++LYLVMEY GGDL+ L G L ED A+ +++ LEYLHS +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
IHRDLKP+N+L+ ++G +K+ DFGL+K L S+
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS------------------------- 154
Query: 940 REQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLIGIPPF---NAKTPQQ 995
+ GTP Y+APE+LL G G+G D WS+G+IL+ELL G PPF N Q
Sbjct: 155 -----LTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQ 209
Query: 996 IFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
+ I+ P EA DLI K L ++P +R A E+ QHP+F
Sbjct: 210 LIRRILGPPLEFDEPKWSSGSE-EAKDLIKKCLNKDPSKRPTAE---EILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 272 bits (696), Expect = 6e-83
Identities = 111/305 (36%), Positives = 177/305 (58%), Gaps = 38/305 (12%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+D E IK + G FGRV L R R + +A+KV+ ++IR + + E+ +L V +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
PF++R F++ + LY++MEY+ GG+L+S LRN G Y +E+V ALEYLHS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+++RDLKP+N+L+ ++GHIKLTDFG +K +L+D+
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK------------------------KLRDR-- 154
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
++ GTP+YLAPE++ GH DWW++GI+++E+L+G PPF P I+
Sbjct: 155 -------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDT 1055
+ I+ + + P + + A DLI KLL + +RLG GA +VK H +FK+++WD
Sbjct: 208 EKILAGKLEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264
Query: 1056 LARQK 1060
+ ++K
Sbjct: 265 VPQRK 269
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 3e-82
Identities = 130/320 (40%), Positives = 184/320 (57%), Gaps = 45/320 (14%)
Query: 759 DFEIIKPISQGAFGRVFLARKRA---TGDLFAIKVLKKADMIRK-NAVESILAERNILIS 814
+FE+++ + GA+G+VFL RK G L+A+KVLKKA +++K E ER +L +
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 815 VR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
VR PF+V Y+F L+L+++Y+NGG+L++ L E RVYIAE+VLAL++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LH L +I+RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK------------------------EF- 155
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPFNAK 991
L E+ + +S GT +Y+APE++ G GH DWWS+G++ FELL G PF
Sbjct: 156 ----LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211
Query: 992 TPQ----QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
Q +I I+ P+P MS EA D I KLL ++P +RLGA GA E+K HPF
Sbjct: 212 GEQNSQSEISRRILKSKPPFPK---TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268
Query: 1048 FKNINWDTLA--RQKAMFIP 1065
F+ I+WD LA R A F P
Sbjct: 269 FQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 266 bits (680), Expect = 1e-79
Identities = 156/358 (43%), Positives = 209/358 (58%), Gaps = 38/358 (10%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F IK + GAFG V LARK T L+A+K L+K D++ +N V + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
VVR +YSF ++NLY VM+Y+ GGD+ SLL +G ED+AR YIAEL A+E +H +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGL--------------SKVGLIHSTDDLSAPSLGSGG 925
IHRD+KPDN+LI +DGHIKLTDFGL S + + D S
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 926 FLVNDELKDQPPLTR---EQRQK---HSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979
D LK PL R Q Q+ HS+ GTP+Y+APE+LL G+ DWWSVG+IL+
Sbjct: 183 CRCGDRLK---PLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 980 ELLIGIPPFNAKTPQQIFDNIMNRDIPWP---NIPEE--MSVEACDLIDKLLTENPVQRL 1034
E+L+G PPF A+TP + ++N W +IP + +S EA DLI K L P RL
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVIN----WQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRL 294
Query: 1035 GATGAREVKQHPFFKNINWDT-LARQKAMFIPA-AESLDTSYF---VSRYVWNPEDEN 1087
G GA E+K HPFFK I++ + L +Q A +IP DTS F +W+ +D+
Sbjct: 295 GKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKE 352
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 9e-79
Identities = 125/335 (37%), Positives = 192/335 (57%), Gaps = 38/335 (11%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI-SVRNPFVVR 822
K I +G+FG+V LA+ +A G +A+KVL+K +++K + I+AERN+L+ +V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
YSF + LY V++Y+NGG+L+ L+ E AR Y AE+ AL YLHSLN+I+R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLKP+N+L+ GH+ LTDFGL K G+ HS
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHS------------------------------ 150
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
+ + GTP+YLAPE+L + T DWW +G +L+E+L G+PPF ++ +++DNI+N
Sbjct: 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA-REVKQHPFFKNINWDTLARQK- 1060
+ + + +SV A L++ LL ++ +RLGA E+K H FF +INWD L +K
Sbjct: 211 KPL---RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKI 267
Query: 1061 -AMFIP-AAESLDTSYFVSRYVWNPEDENVQGGSD 1093
F P + +D +F + P +V D
Sbjct: 268 TPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPD 302
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 263 bits (674), Expect = 9e-79
Identities = 154/387 (39%), Positives = 212/387 (54%), Gaps = 49/387 (12%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F IK + GAFG V LA K T L+A+K L+K D++ +N V + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
VV+ +YSF ++NLY VM+Y+ GGD+ SLL + E +AR YIAEL LA+E +H +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGL-SKVGLIHST--------------------DDLSA 918
IHRD+KPDN+LI DGHIKLTDFGL + H++ DD+S
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 919 PSLGSGGFLVNDELKDQPPLTREQRQK---HSVAGTPDYLAPEILLGMGHGATADWWSVG 975
G D LK +Q Q+ HS+ GTP+Y+APE+LL G+ DWWSVG
Sbjct: 183 CRCG-------DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 976 IILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPN---IPEE--MSVEACDLIDKLLTENP 1030
+ILFE+L+G PPF A TP + ++N W N IP + +S EA DLI KL
Sbjct: 236 VILFEMLVGQPPFLAPTPTETQLKVIN----WENTLHIPPQVKLSPEAVDLITKLCCSAE 291
Query: 1031 VQRLGATGAREVKQHPFFKNINWDT-LARQKAMFIPA-AESLDTSYFVSRYVWNPEDENV 1088
+RLG GA ++K HPFF +++ + + Q A ++P + +DTS F +P +E
Sbjct: 292 -ERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNF------DPVEEES 344
Query: 1089 QGGSDFDDLTDTCSSGSFSNTLDEEQA 1115
D T T + N E A
Sbjct: 345 PWNDASGDSTRTWDTLCSPNGKHPEHA 371
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 259 bits (664), Expect = 6e-78
Identities = 121/334 (36%), Positives = 188/334 (56%), Gaps = 42/334 (12%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ DFE+ + + G+FGRV +A+ + TG+ +AIK LKK ++++ V+ + E++IL+ +
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876
+PF+V SF +Y ++E++ GG+L++ LR G D+A+ Y AELVLA EYLHS
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS 136
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
++I+RDLKP+NLL+ GH+K+TDFG +K
Sbjct: 137 KDIIYRDLKPENLLLDNKGHVKVTDFGFAK------------------------------ 166
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
+ + ++ GTP+YLAPE++ GHG DWW++G++L+E + G PPF TP +I
Sbjct: 167 ---KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223
Query: 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWD 1054
++ I+ + +PN + A DL+ LL + +RLG G +VK HP+F NWD
Sbjct: 224 YEKILAGRLKFPNWFDG---RARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280
Query: 1055 TL-ARQKAMFIP--AAESLDTSYFVSRYVWNPED 1085
L AR IP DTS F +Y +P D
Sbjct: 281 KLYARYYPAPIPVRVKSPGDTSNF-EKYPDSPVD 313
|
Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 252 bits (646), Expect = 1e-75
Identities = 135/341 (39%), Positives = 198/341 (58%), Gaps = 49/341 (14%)
Query: 763 IKPISQGAFGRVFLARK---RATGDLFAIKVLKKADMIRKNAVES--ILAERNILISVRN 817
+K + +G +G+VF RK TG +FA+KVLKKA ++R N ++ AERNIL +V++
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVR-NQKDTAHTKAERNILEAVKH 59
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
PF+V Y+F LYL++EYL+GG+L+ L G ED A Y++E+ LALE+LH
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+I+RDLKP+N+L+ GH+KLTDFGL K +
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--------------------------- 152
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
E H+ GT +Y+APEIL+ GHG DWWS+G +++++L G PPF A+ ++
Sbjct: 153 ---EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINW-D 1054
D I+ + N+P ++ EA DL+ KLL NP RLGA A EV+ HPFF+++NW D
Sbjct: 210 DKILKGKL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDD 266
Query: 1055 TLARQ-KAMFIPAAES-LDTSYFVSRY-----VWNPEDENV 1088
LAR+ + F P +S D S F S++ V +P+D +
Sbjct: 267 LLARKVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTL 307
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 251 bits (642), Expect = 3e-75
Identities = 121/317 (38%), Positives = 183/317 (57%), Gaps = 36/317 (11%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
I +G+FG+V RKR T ++A+K ++KA ++ ++ V LAER +L V PF+V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLK 885
SF E LYLV+ ++NGG+L+ L+ G D AR Y AEL+ ALE LH NVI+RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 886 PDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQK 945
P+N+L+ GHI L DFGL K+ + DD +
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNM--KDDD----------------------------KT 150
Query: 946 HSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI 1005
++ GTP+YLAPE+LLG G+ DWW++G++L+E+L G+PPF + +++ I+ +
Sbjct: 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL 210
Query: 1006 PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAM--F 1063
+P+ + +A DL+ LL+ +P +RLG GA+E+K HPFF ++W L + F
Sbjct: 211 RFPDGFDR---DAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPF 267
Query: 1064 IPAAES-LDTSYFVSRY 1079
PA S +DTS F +
Sbjct: 268 KPAVSSAIDTSNFDEEF 284
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 252 bits (645), Expect = 9e-75
Identities = 123/353 (34%), Positives = 185/353 (52%), Gaps = 57/353 (16%)
Query: 736 EDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD 795
E + R EDF++IK I +GAFG V L R +++ ++A+K+L K +
Sbjct: 29 EKAAEKITKL--------RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE 80
Query: 796 MIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL 855
MI+++ ER+I+ + ++V+ Y+F + LY+VMEY+ GGDL +L+ N +
Sbjct: 81 MIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-I 139
Query: 856 DEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFG----LSKVGLIH 911
E AR Y AE+VLAL+ +HS+ IHRD+KPDN+L+ + GH+KL DFG + G++
Sbjct: 140 PEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVR 199
Query: 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH----GA 967
+ GTPDY++PE+L G G
Sbjct: 200 CD---------------------------------TAVGTPDYISPEVLKSQGGDGYYGR 226
Query: 968 TADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR--DIPWPNIPEEMSVEACDLIDKL 1025
DWWSVG+ L+E+L+G PF A + + IM+ + +P+ E+S +A DLI
Sbjct: 227 ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI-EISKQAKDLICAF 285
Query: 1026 LTENPVQRLGATGAREVKQHPFFKN--INWDTLARQKAMFIPAAES-LDTSYF 1075
LT+ V RLG G E+K HPFFKN +D + A +P S +DTS F
Sbjct: 286 LTDREV-RLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 9e-75
Identities = 137/332 (41%), Positives = 204/332 (61%), Gaps = 22/332 (6%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DFE +K I +GAFG V L +K+ TG ++A+K+L+KADM+ K V I AER+IL+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
+VV+ FYSF + NLYL+ME+L GGD+ +LL L E+ + YIAE VLA++ +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL--IHSTD---DLSAPSLGSGGFLVNDEL 932
IHRD+KPDNLL+ GH+KL+DFGL GL H T+ +L+ F +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLC-TGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 933 KDQPPLTREQRQ-KHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991
+ + +RQ +S GTPDY+APE+ + G+ DWWS+G+I++E+LIG PPF ++
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 992 TPQQIFDNIMNRDIPW-------PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044
TPQ+ + +MN W P +P +S +A DLI + T++ R+G+ G E+K
Sbjct: 240 TPQETYRKVMN----WKETLVFPPEVP--ISEKAKDLILRFCTDSE-NRIGSNGVEEIKS 292
Query: 1045 HPFFKNINWDTLARQKAMFIPAAESL-DTSYF 1075
HPFF+ ++W + + A +S+ DTS F
Sbjct: 293 HPFFEGVDWGHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 5e-74
Identities = 115/324 (35%), Positives = 177/324 (54%), Gaps = 42/324 (12%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI---SVR 816
F + + +G FG+V LA + TG+L+AIK LKK D+I ++ VES++ E+ I S R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876
+PF+V F F +++ VMEY GGDL + E A Y A +VL L+YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+++RDLK DNLL+ +G +K+ DFGL K G+ D S
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG-DRTS------------------- 159
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
+ GTP++LAPE+L + DWW +G++++E+L+G PF +++
Sbjct: 160 ----------TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV 209
Query: 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWD 1054
FD+I+N ++ +P +S EA ++ +LL NP +RLG+ A +VK+ PFF++INWD
Sbjct: 210 FDSIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266
Query: 1055 TL--ARQKAMFIPAAESL-DTSYF 1075
L + K F+P + D S F
Sbjct: 267 DLLARKIKPPFVPTIKGPEDVSNF 290
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 244 bits (626), Expect = 9e-74
Identities = 104/290 (35%), Positives = 157/290 (54%), Gaps = 34/290 (11%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
FE+++ I +GAFG+V + +KR T +FA+K + K + K +V ++L ER IL + +PF
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDL-YSLLRNLGCLDEDMARVYIAELVLALEYLHSLN 878
+V +YSF EN+YLV++ L GGDL Y L + E+ + +I E+VLALEYLHS
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
+IHRD+KPDN+L+ + GH+ +TDF ++ T D
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIA----TKVTPD----------------------- 153
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998
S +GTP Y+APE+L G+ DWWS+G+ +E L G P+ +
Sbjct: 154 ----TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209
Query: 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
++ P S EA D I+KLL +P +RLG +++K HP+F
Sbjct: 210 IRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 247 bits (632), Expect = 1e-73
Identities = 128/328 (39%), Positives = 190/328 (57%), Gaps = 44/328 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DF++ + +G FG V + R++ATGD++A+KV+KK+ ++ + V ER+IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLALEYLHS 876
P++ + Y+F ++NLYLVMEY GGDL SLL R DEDMA+ Y+AELVLA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+ +HRD+KP+N+LI + GHIKL DFG SA L + +VN +L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFG-------------SAARLTANK-MVNSKL---- 162
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMG------HGATADWWSVGIILFELLIGIPPFNA 990
P+ GTPDY+APE+L M +G DWWS+G+I +E++ G PF+
Sbjct: 163 PV-----------GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
Query: 991 KTPQQIFDNIMN--RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
T + ++NIMN R + +P P ++S + DLI LL +RLG G + HPFF
Sbjct: 212 GTSAKTYNNIMNFQRFLKFPEDP-KVSSDFLDLIQSLLC-GQKERLGYEG---LCCHPFF 266
Query: 1049 KNINWDTLARQKAMFIPAAESL-DTSYF 1075
I+W+ + F+P +S DTS F
Sbjct: 267 SKIDWNNIRNSLPPFVPTLKSDDDTSNF 294
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 248 bits (634), Expect = 2e-73
Identities = 139/333 (41%), Positives = 204/333 (61%), Gaps = 24/333 (7%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
EDFE +K I +GAFG V L +K+ TG ++A+K+L+KADM+ K V I AER+IL+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
+VV+ FYSF + NLYL+ME+L GGD+ +LL L E+ + YIAE VLA++ +H L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGL-SKVGLIHSTD-----DLSAPSLGSGGFLVNDE 931
IHRD+KPDNLL+ GH+KL+DFGL + + H T+ + S PS F +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS--DFTFQNMNS 178
Query: 932 LKDQPPLTREQRQ-KHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
+ R +RQ S GTPDY+APE+ + G+ DWWS+G+I++E+LIG PPF +
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 991 KTPQQIFDNIMNRDIPW-------PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043
+TPQ+ + +MN W P +P +S +A DLI + E R+GA G E+K
Sbjct: 239 ETPQETYKKVMN----WKETLIFPPEVP--ISEKAKDLILRFCCEWE-HRIGAPGVEEIK 291
Query: 1044 QHPFFKNINWDTLARQKAMFIPAAESL-DTSYF 1075
+PFF+ ++W+ + + A +S+ DTS F
Sbjct: 292 TNPFFEGVDWEHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 8e-73
Identities = 126/325 (38%), Positives = 188/325 (57%), Gaps = 42/325 (12%)
Query: 763 IKPISQGAFGRVFLARK---RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+K + QG+FG+VFL RK G L+A+KVLKKA + ++ V + + ER+IL V +PF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPF 59
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
+V+ Y+F LYL++++L GGDL++ L E+ + Y+AEL LAL++LHSL +
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
I+RDLKP+N+L+ ++GHIKLTDFGLSK + H
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDH---------------------------- 151
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999
+++ +S GT +Y+APE++ GH +ADWWS G+++FE+L G PF K ++
Sbjct: 152 --EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209
Query: 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLA 1057
I+ + +P+ +S EA L+ L NP RLGA G E+K+HPFF I+W+ L
Sbjct: 210 ILKAKL---GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLY 266
Query: 1058 RQ--KAMFIPAAESL-DTSYFVSRY 1079
R+ K F PA DT YF +
Sbjct: 267 RREIKPPFKPAVGRPDDTFYFDPEF 291
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 8e-73
Identities = 119/316 (37%), Positives = 181/316 (57%), Gaps = 39/316 (12%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI-SVRNPFVVR 822
K + +G+FG+V LA + T + FAIK LKK ++ + VE + ER +L + +PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
F +F +E+L+ VMEYLNGGDL +++ G DE AR Y AE++ L++LH +I+R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLK DN+L+ +DGHIK+ DFG+ K +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEG----------------------------- 151
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
+ + GTPDY+APEIL G + + DWWS G++L+E+LIG PF+ + ++FD+I+N
Sbjct: 152 -KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQK-- 1060
D P P +S EA D + KL +P +RLG G +++QHPFF+ I+W+ L +++
Sbjct: 211 -DRPH--FPRWISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGIDWERLEKREIP 265
Query: 1061 AMFIPAAES-LDTSYF 1075
F P +S D S F
Sbjct: 266 PPFKPKVKSPSDASNF 281
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (613), Expect = 6e-71
Identities = 123/332 (37%), Positives = 185/332 (55%), Gaps = 49/332 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DFEI+K I +GAFG V + + + TG ++A+K+L K +M+++ ER++L++
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHS 876
++ Y+F NLYLVM+Y GGDL +LL L EDMAR Y+AE+VLA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFG----LSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
L +HRD+KPDN+L+ ++GHI+L DFG L G + S
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS-------------------- 160
Query: 933 KDQPPLTREQRQKHSVA-GTPDYLAPEILLGMG-----HGATADWWSVGIILFELLIGIP 986
+VA GTPDY++PEIL M +G DWWS+G+ ++E+L G
Sbjct: 161 --------------NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206
Query: 987 PFNAKTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044
PF A++ + + IMN +P ++S EA DLI +L+ +P RLG G ++ K
Sbjct: 207 PFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLIC-SPETRLGRNGLQDFKD 265
Query: 1045 HPFFKNINWDTLARQKAMFIPAAES-LDTSYF 1075
HPFF+ I+WD + A ++P S DTS F
Sbjct: 266 HPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 238 bits (608), Expect = 3e-70
Identities = 116/341 (34%), Positives = 190/341 (55%), Gaps = 44/341 (12%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL-ISVRN 817
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ + VE + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
PF+ + F + LY VMEY+NGGDL ++ +G E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+I+RDLK DN+++ +GHIK+ DFG+ K +
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF------------------------GGK 156
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
TR + GTPDY+APEI+ +G + DWW+ G++L+E+L G PPF+ + ++F
Sbjct: 157 TTR------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 210
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDT 1055
+IM ++ + P+ +S EA + LLT++P +RLG TG R++++H FF+ I+W+
Sbjct: 211 QSIMEHNVSY---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEK 267
Query: 1056 LARQKAM--FIP------AAESLDTSYFVSRYVWNPEDENV 1088
L R++ F P +AE+ D + V P D+ V
Sbjct: 268 LERREIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPDKLV 308
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 7e-70
Identities = 132/383 (34%), Positives = 204/383 (53%), Gaps = 70/383 (18%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI-SVRNPFVVR 822
K I +G+FG+V LA++++ G +A+KVL+K +++K I+AERN+L+ ++++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
YSF E LY V++Y+NGG+L+ L+ C E AR Y AE+ A+ YLHSLN+I+R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLKP+N+L+ GH+ LTDFGL K G+ +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGV------------------------------EPE 150
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
+ GTP+YLAPE+L + T DWW +G +L+E+L G+PPF ++ Q++DNI++
Sbjct: 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA-TGAREVKQHPFFKNINWDTLARQKA 1061
+ + +P +V ACDL+ LL ++ +RLGA E+K H FF INWD L ++
Sbjct: 211 KPL---QLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKR- 266
Query: 1062 MFIPAAESLDTSYFVSRYVWNPEDENVQGGSD---FD-DLTDTCSSGSFSNTLDEEQADE 1117
+ P + NV G +D FD + T S S T D
Sbjct: 267 ------------------ITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPD------ 302
Query: 1118 CGSLAEFSAPALAVQYSFSNFSF 1140
+A + + +F FS+
Sbjct: 303 ------LTASSSSASSAFLGFSY 319
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 8e-70
Identities = 120/318 (37%), Positives = 181/318 (56%), Gaps = 40/318 (12%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV---RNPFVVR 822
I +G FG+V+ RK+ T ++A+KVL K +++ K V + ERNIL+ +PF+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
+SF +LYLV +Y++GG+L+ L+ G ED A+ YIAELVLALE+LH ++++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLKP+N+L+ GHI L DFGLSK L + + +
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANL--TDNKTT------------------------- 153
Query: 943 RQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIM 1001
++ GT +YLAPE+LL G+ D+WS+G+++FE+ G PF A+ QQ++ NI
Sbjct: 154 ---NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210
Query: 1002 NRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT-GAREVKQHPFFKNINWDTLARQK 1060
+ +P +S E + LL NP RLGA A E+K+HPFF +I+WD L++++
Sbjct: 211 FGKVRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQ 268
Query: 1061 AM--FIPAAES-LDTSYF 1075
F P +S D S F
Sbjct: 269 ITPPFKPIVDSDEDVSNF 286
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 1e-69
Identities = 121/317 (38%), Positives = 177/317 (55%), Gaps = 38/317 (11%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRF 823
K + +G FG+V L R++ATG +A+K+LKK +I K+ V L E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRD 883
YSF + L VMEY NGG+L+ L ED AR Y AE+V AL YLHS +V++RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
LK +NL++ +DGHIK+TDFGL K G+ S G
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI----------SDG--------------------A 150
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003
+ GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F+ I+
Sbjct: 151 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
Query: 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQKA 1061
+I P +S EA L+ LL ++P QRLG A+E+ +H FF +INW + ++K
Sbjct: 211 EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKL 267
Query: 1062 M--FIPAAES-LDTSYF 1075
F P S DT YF
Sbjct: 268 EPPFKPQVTSETDTRYF 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 234 bits (597), Expect = 9e-69
Identities = 130/336 (38%), Positives = 198/336 (58%), Gaps = 47/336 (13%)
Query: 759 DFEIIKPISQGAFGRVFLARKRA---TGDLFAIKVLKKADMIRK-NAVESILAERNILIS 814
+FE++K + GA+G+VFL RK TG L+A+KVL+KA +++K VE ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 815 VR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
VR +PF+V Y+F L+L+++Y++GG++++ L ED R Y E++LALE+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LH L +++RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK------------------------EF- 155
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAK- 991
L+ E+ + +S GT +Y+APEI+ G GHG DWWS+GI++FELL G PF +
Sbjct: 156 ----LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211
Query: 992 ---TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHP 1046
T ++ I+ D P+P+ + EA DL+ KLL ++P +RLGA GA E+K+HP
Sbjct: 212 ERNTQSEVSRRILKCDPPFPSF---IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268
Query: 1047 FFKNINWDTLARQK--AMFIPAAES-LDTSYFVSRY 1079
FFK ++W+ LA +K F P+ + LD F +
Sbjct: 269 FFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEF 304
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 230 bits (590), Expect = 1e-68
Identities = 94/293 (32%), Positives = 150/293 (51%), Gaps = 36/293 (12%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
++ + + +G+FG V+LA + TG+L A+K ++ + + E++ E IL S+++P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59
Query: 819 FVVRFFYSFTCRE--NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876
+VR++ S E L + +EY++GG L SLL+ G L E + R Y +++ L YLHS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
++HRD+K N+L+ DG +KL DFG +K + +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKR--LGDIETGE------------------- 158
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
SV GTP ++APE++ G +G AD WS+G + E+ G PP++
Sbjct: 159 -------GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA 211
Query: 997 FDN-IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
I + P P IPE +S EA D + K L +P +R T A E+ QHPF
Sbjct: 212 ALYKIGSSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKR--PT-ADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 232 bits (592), Expect = 3e-68
Identities = 115/338 (34%), Positives = 183/338 (54%), Gaps = 46/338 (13%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL-ISVRNPFVVR 822
K + +G+FG+V LA + T +++AIKVLKK +++ + V+ + E+ IL ++ ++PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
F ++ L+ VMEY+NGGDL ++ DE +R Y AE+ LAL +LH VI+R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLK DN+L+ +GH KL DFG+ K G+ G
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGI-------------LNGVTTT------------- 154
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
+ GTPDY+APEIL + +G + DWW++G++++E++ G PPF A +F++I++
Sbjct: 155 ----TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR----EVKQHPFFKNINWDTL-A 1057
D+ + P +S EA ++ +T+NP +RLG ++ +KQHPFFK I+W L
Sbjct: 211 DDVLY---PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQ 267
Query: 1058 RQ-KAMFIPA------AESLDTSYFVSRYVWNPEDENV 1088
R+ K F P + D + V P D V
Sbjct: 268 RKIKPPFKPKIKTKRDVNNFDQDFTKEEPVLTPVDPAV 305
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 228 bits (582), Expect = 2e-67
Identities = 122/322 (37%), Positives = 187/322 (58%), Gaps = 47/322 (14%)
Query: 759 DFEIIKPISQGAFGRVFLARKRA---TGDLFAIKVLKKADMIRK-NAVESILAERNILIS 814
+FE++K + GA+G+VFL RK + +G L+A+KVLKKA +++K E ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 815 VR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
+R +PF+V Y+F L+L+++Y+NGG+L++ L E ++Y E+VLALE+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LH L +I+RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK------------------------EF- 155
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPFNA- 990
E + +S GT +Y+AP+I+ G GH DWWS+G++++ELL G PF
Sbjct: 156 ----HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211
Query: 991 ---KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQH 1045
+ +I I+ + P+P +EMS A D+I +LL ++P +RLG + A E+K+H
Sbjct: 212 GEKNSQAEISRRILKSEPPYP---QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 1046 PFFKNINWDTLARQK--AMFIP 1065
PFF+ INWD LA +K A F P
Sbjct: 269 PFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 224 bits (571), Expect = 2e-65
Identities = 107/299 (35%), Positives = 171/299 (57%), Gaps = 37/299 (12%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFF 824
+ +G+FG+V LAR + +G L+A+KVLKK +++ + VE + E+ IL RN PF+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 825 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDL 884
F + L+ VME++NGGDL ++ DE AR Y AE+ AL +LH +I+RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 885 KPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQ 944
K DN+L+ +GH KL DFG+ K G+ +
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGI------------------------------FNGKT 152
Query: 945 KHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRD 1004
+ GTPDY+APEIL M +G + DWW++G++L+E+L G PF A+ +F+ I+N +
Sbjct: 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212
Query: 1005 IPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT---GAREVKQHPFFKNINWDTLARQK 1060
+ +P +S +A D++ +T+NP RLG+ G + +HPFFK ++W+ L R++
Sbjct: 213 VVYPTW---LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQ 268
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 223 bits (569), Expect = 3e-65
Identities = 110/311 (35%), Positives = 174/311 (55%), Gaps = 38/311 (12%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL-ISVRNPFVVR 822
K + +G+FG+VFLA + T FAIK LKK ++ + VE + E+ +L ++ +PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
+ +F +ENL+ VMEYLNGGDL +++ D A Y AE++ L++LHS +++R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLK DN+L+ DGHIK+ DFG+ K ++
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDA----------------------------- 151
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
+ + GTPDY+APEILLG + + DWWS G++L+E+LIG PF+ +++F +I
Sbjct: 152 -KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAM 1062
+ P P ++ EA D++ KL P +RLG G +++QHPFF+ I+W L ++
Sbjct: 211 DN---PCYPRWLTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREIDWSALEEREIE 265
Query: 1063 --FIPAAESLD 1071
F P +S +
Sbjct: 266 PPFKPKVKSAN 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 3e-64
Identities = 115/312 (36%), Positives = 175/312 (56%), Gaps = 41/312 (13%)
Query: 749 PCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDL--FAIKVLKKADMIRKNAVESIL 806
P K++ EDF I+ + G+FGRV LA + D AIK +K+ +I++ V+ +
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYK-NEDFPPVAIKRFEKSKIIKQKQVDHVF 79
Query: 807 AERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE 866
+ER IL + +PF V + SF LYLV+E++ GG+ ++ LR D+ Y A+
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+VL EYL SLN+++RDLKP+NLL+ +DG IK+TDFG +KV
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV------------------- 180
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
+ +++ GTP+Y+APEILL +GHG ADWW++GI ++E+L+G P
Sbjct: 181 --------------VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226
Query: 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQ 1044
PF A P I+ I+ I +P + L+ KLL+ + +R G GA+ VK+
Sbjct: 227 PFYANEPLLIYQKILEGIIYFPKF---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283
Query: 1045 HPFFKNINWDTL 1056
HP+F NI+W +L
Sbjct: 284 HPWFGNIDWVSL 295
|
Length = 340 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 3e-64
Identities = 86/279 (30%), Positives = 144/279 (51%), Gaps = 37/279 (13%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
+EIIK I +G+FG+V+L R+++ G L+ +K + ++M K ++ L E IL + +P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDA-LNEVKILKKLNHP 59
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----LDEDMARVYIAELVLALEYL 874
+++++ SF + L +VMEY +GGDL ++ E+ + +L LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
HS ++HRD+KP N+ + +G +KL DFG+SKV L + D
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVD-------------------- 158
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994
+V GTP YL+PE+ + +D WS+G +L+EL PF +
Sbjct: 159 ---------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL 209
Query: 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
++ I+ P IP + S E +L+ LL ++P +R
Sbjct: 210 ELALKILKGQY--PPIPSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 220 bits (561), Expect = 5e-64
Identities = 126/370 (34%), Positives = 199/370 (53%), Gaps = 53/370 (14%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRF 823
K + +G FG+V L R++ATG +A+K+L+K +I K+ V + E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRD 883
Y+F + L VMEY NGG+L+ L E+ AR Y AE+V ALEYLHS +V++RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
+K +NL++ +DGHIK+TDFGL K G+ +D + +
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGI---SDGATMKTF---------------------- 155
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003
GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F+ I+
Sbjct: 156 -----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210
Query: 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQKA 1061
+I P +S EA L+ LL ++P QRLG + A+EV +H FF +INW + ++K
Sbjct: 211 EI---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKL 267
Query: 1062 M--FIPAAES-LDTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSFSNTLDEEQADEC 1118
+ F P S +DT YF +DE F + T + ++L + D+
Sbjct: 268 LPPFKPQVTSEVDTRYF--------DDE-------FTAQSITITPPDRYDSLGLLELDQR 312
Query: 1119 GSLAEFSAPA 1128
+FS A
Sbjct: 313 THFPQFSYSA 322
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 1e-63
Identities = 116/300 (38%), Positives = 177/300 (59%), Gaps = 37/300 (12%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI-SVRNPFVVR 822
K I +G+FG+V LAR +A +A+KVL+K +++K + I++ERN+L+ +V++PF+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
+SF + LY V++Y+NGG+L+ L+ C E AR Y AE+ AL YLHSLN+++R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLKP+N+L+ GHI LTDFGL K + H+
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNG----------------------------- 151
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
+ GTP+YLAPE+L + T DWW +G +L+E+L G+PPF ++ +++DNI+N
Sbjct: 152 -TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210
Query: 1003 RDIPW-PNIPEEMSVEACDLIDKLLTENPVQRLGATGA-REVKQHPFFKNINWDTLARQK 1060
+ + PNI + A L++ LL ++ +RLGA E+K H FF INWD L +K
Sbjct: 211 KPLQLKPNI----TNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKK 266
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 2e-63
Identities = 110/312 (35%), Positives = 185/312 (59%), Gaps = 37/312 (11%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI-SVRNPFVVR 822
K I +G+FG+V LA+++ G +A+KVL+K ++ + + I+AERN+L+ +V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
YSF E LY V++++NGG+L+ L+ E AR Y AE+ AL YLHS+N+++R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLKP+N+L+ GH+ LTDFGL K G+ + D +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGI--AQSDTTT------------------------ 154
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
+ GTP+YLAPE++ + T DWW +G +L+E+L G+PPF + +++DNI++
Sbjct: 155 ----TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH 210
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA-REVKQHPFFKNINWDTLARQK- 1060
+ + + S+ A ++++LL ++ +RLGA E+++HPFF++++W L ++K
Sbjct: 211 KPL---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKI 267
Query: 1061 -AMFIPAAESLD 1071
F P E D
Sbjct: 268 PPPFNPNVEGPD 279
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 6e-63
Identities = 123/331 (37%), Positives = 186/331 (56%), Gaps = 49/331 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
ED++++K I +GAFG V L R +++ ++A+K+L K +MI+++ ER+I+ +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P+VV+ F +F + LY+VMEY+ GGDL +L+ N + E A+ Y AE+VLAL+ +HS+
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFG----LSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
+IHRD+KPDN+L+ + GH+KL DFG + + G++
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD-------------------- 201
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMG----HGATADWWSVGIILFELLIGIPPFN 989
+ GTPDY++PE+L G +G DWWSVG+ LFE+L+G PF
Sbjct: 202 -------------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
Query: 990 AKTPQQIFDNIMNRDIPWPNIPE--EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
A + + IM+ N PE E+S A +LI LT+ V RLG G E+KQHPF
Sbjct: 249 ADSLVGTYSKIMDHKNSL-NFPEDVEISKHAKNLICAFLTDREV-RLGRNGVEEIKQHPF 306
Query: 1048 FKN--INWDTLARQKAMFIPA-AESLDTSYF 1075
FKN NWD + A +P + +D+S F
Sbjct: 307 FKNDQWNWDNIRETAAPVVPELSSDIDSSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 2e-62
Identities = 111/330 (33%), Positives = 184/330 (55%), Gaps = 38/330 (11%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL-ISVRN 817
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ + VE + E+ +L +S +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
PF+ + F + LY VMEY+NGGDL ++ +G E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+I+RDLK DN+++ +GHIK+ DFG+ K + D ++ +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW---DGVTTKTF---------------- 161
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
GTPDY+APEI+ +G + DWW+ G++L+E+L G PF + ++F
Sbjct: 162 -----------CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 210
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDT 1055
+IM ++ + P+ MS EA + L+T++P +RLG G R++K+H FF+ I+W+
Sbjct: 211 QSIMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 267
Query: 1056 LARQKAM--FIPAAESLDTSYFVSRYVWNP 1083
L R++ + P A D F + +P
Sbjct: 268 LERKEVQPPYKPKACGRDAENFDKFFTRHP 297
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 2e-62
Identities = 124/328 (37%), Positives = 185/328 (56%), Gaps = 41/328 (12%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DFEIIK I +GAFG V + + + T ++A+K+L K +M+++ ERN+L++
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHS 876
++ Y+F LYLVM+Y GGDL +LL L EDMAR YIAE+VLA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
L+ +HRD+KPDN+L+ +GHI+L DFG + D + S
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG----SCLKMNQDGTVQS---------------- 160
Query: 937 PLTREQRQKHSVA-GTPDYLAPEILL----GMG-HGATADWWSVGIILFELLIGIPPFNA 990
SVA GTPDY++PEIL GMG +G DWWS+G+ ++E+L G PF A
Sbjct: 161 ----------SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210
Query: 991 KTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
++ + + IMN + +P+ ++S EA DLI +L+ +RLG G + K+H FF
Sbjct: 211 ESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE-RRLGQNGIEDFKKHAFF 269
Query: 1049 KNINWDTLARQKAMFIPAAES-LDTSYF 1075
+ I+W+ + +A +IP S DTS F
Sbjct: 270 EGIDWENIRNLEAPYIPDVSSPSDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 4e-62
Identities = 129/342 (37%), Positives = 190/342 (55%), Gaps = 49/342 (14%)
Query: 747 INPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESIL 806
IN R ED+E++K I +GAFG V L R ++T ++A+K+L K +MI+++
Sbjct: 32 INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFW 91
Query: 807 AERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE 866
ER+I+ +P+VV+ FY+F LY+VMEY+ GGDL +L+ N + E AR Y AE
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAE 150
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFG----LSKVGLIHSTDDLSAPSLG 922
+VLAL+ +HS+ IHRD+KPDN+L+ + GH+KL DFG ++K G++
Sbjct: 151 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD--------- 201
Query: 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG----HGATADWWSVGIIL 978
+ GTPDY++PE+L G +G DWWSVG+ L
Sbjct: 202 ------------------------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 979 FELLIGIPPFNAKTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGA 1036
+E+L+G PF A + + IMN + +P+ ++S EA +LI LT+ V RLG
Sbjct: 238 YEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREV-RLGR 295
Query: 1037 TGAREVKQHPFFKNIN--WDTLARQKAMFIPAAES-LDTSYF 1075
G E+K+H FFKN W+TL A +P S +DTS F
Sbjct: 296 NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 6e-62
Identities = 98/290 (33%), Positives = 149/290 (51%), Gaps = 38/290 (13%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
FEI++ I +G FG V+ AR + TG AIKV+K +K E I+ E IL ++P
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSL 877
+V+++ S+ ++ L++VME+ +GG L LL++ L E EL+ LEYLHS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+IHRD+K N+L+ DG +KL DFGLS LS
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA--------QLS-------------------- 149
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
+ + ++++ GTP ++APE++ G + AD WS+GI EL G PP++ P +
Sbjct: 150 ---DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL 206
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
I P PE+ S E D + K L +NP +R A ++ +HPF
Sbjct: 207 FKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAE---QLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 6e-62
Identities = 96/169 (56%), Positives = 124/169 (73%), Gaps = 3/169 (1%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
SIE+F I+KPIS+GAFG+V+L RK+ L+A+KV+KKADMI KN V + AER+ L
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
++PF+V +YS N+YLVMEYL GGD+ SLL G DE+MA YI+E+ LAL+YLH
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL---IHSTDDLSAPSL 921
+IHRDLKPDN+LI +GHIKLTDFGLSKV L ++ D L+ PS+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSM 170
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 1e-61
Identities = 105/298 (35%), Positives = 172/298 (57%), Gaps = 36/298 (12%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL-ISVRNPFVVR 822
K + +G+FG+V LA + G+ FA+K LKK ++ + VE + E+ +L ++ NPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
+ +F +E+L+ VME+LNGGDL +++ G D A Y AE+V L++LHS +I+R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLK DN+++ +DGHIK+ DFG+ K +
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFG------------------------------D 150
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
+ + GTPDY+APEIL G+ + + DWWS G++L+E+LIG PF+ ++F++I
Sbjct: 151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR- 209
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQK 1060
+ P+ P ++ E+ D+++KL +P +RLG G ++ HPFFK INW L +++
Sbjct: 210 --VDTPHYPRWITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTINWTALEKRE 263
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 212 bits (540), Expect = 3e-61
Identities = 115/349 (32%), Positives = 190/349 (54%), Gaps = 43/349 (12%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL-ISVRN 817
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ + VE + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
PF+ + F + LY VMEY+NGGDL ++ +G E A Y AE+ + L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+I+RDLK DN+++ +GHIK+ DFG+ K ++
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV------------------------ 156
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
TR + GTPDY+APEI+ +G + DWW+ G++L+E+L G PPF+ + ++F
Sbjct: 157 TTR------TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF 210
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDT 1055
+IM ++ + P+ +S EA + L+T++P +RLG G R++++H FF+ I+WD
Sbjct: 211 QSIMEHNVSY---PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDK 267
Query: 1056 LARQKAM--FIP-----AAESLDTSYFVSRYVWNPEDENVQGGSDFDDL 1097
L ++ F P AE+ D + + V P D+ V D D
Sbjct: 268 LENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQADF 316
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 210 bits (535), Expect = 2e-60
Identities = 122/327 (37%), Positives = 180/327 (55%), Gaps = 39/327 (11%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
EDFEI+K I +GAFG V + + + +FA+K+L K +M+++ ER++L++ N
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHS 876
++ Y+F NLYLVM+Y GGDL +LL L EDMAR Y+AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
L+ +HRD+KPDN+L+ +GHI+L DFG S L G +
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-------------SCLKLMEDGTV--------- 158
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMG-----HGATADWWSVGIILFELLIGIPPFNAK 991
Q GTPDY++PEIL M +G DWWS+G+ ++E+L G PF A+
Sbjct: 159 -------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
Query: 992 TPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ + + IMN +P ++S +A DLI +L+ RLG G + KQHPFF
Sbjct: 212 SLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSRE-HRLGQNGIEDFKQHPFFT 270
Query: 1050 NINWDTLARQKAMFIPAAES-LDTSYF 1075
I+WD + +A +IP S DTS F
Sbjct: 271 GIDWDNIRNCEAPYIPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 3e-59
Identities = 116/317 (36%), Positives = 179/317 (56%), Gaps = 38/317 (11%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRF 823
K + +G FG+V L R++A+G +A+K+LKK +I K+ V L E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRD 883
YSF ++ L VMEY+NGG+L+ L ED R Y AE+V AL+YLHS +++RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
LK +NL++ +DGHIK+TDFGL K G+ TD + +
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---TDAATMKTF---------------------- 155
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003
GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F+ I+
Sbjct: 156 -----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210
Query: 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQKA 1061
DI + P +S +A L+ LL ++P +RLG A+E+ +H FF +NW + +K
Sbjct: 211 DIKF---PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKL 267
Query: 1062 M--FIPAAES-LDTSYF 1075
+ F P S DT YF
Sbjct: 268 VPPFKPQVTSETDTRYF 284
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 4e-59
Identities = 120/318 (37%), Positives = 177/318 (55%), Gaps = 39/318 (12%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRF 823
K + +G FG+V L +++ATG +A+K+LKK ++ K+ V L E +L + R+PF+
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHR 882
YSF + L VMEY NGG+L+ L ED AR Y AE+V AL+YLHS NV++R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLK +NL++ +DGHIK+TDFGL K G+ KD +
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGI-----------------------KDGATMK--- 154
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
+ GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F+ I+
Sbjct: 155 ----TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRL--GATGAREVKQHPFFKNINWDTLARQK 1060
+I P +S EA L+ LL ++P QRL G A+E+ QH FF I W + +K
Sbjct: 211 EEI---RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKK 267
Query: 1061 AM--FIPAAES-LDTSYF 1075
+ F P S DT YF
Sbjct: 268 LVPPFKPQVTSETDTRYF 285
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 3e-57
Identities = 112/354 (31%), Positives = 183/354 (51%), Gaps = 47/354 (13%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFF 824
I +G++ +V L + T ++A+KV+KK + ++ + E+++ + N PF+V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 825 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDL 884
F L+ V+E+++GGDL ++ L E+ AR Y AE+ LAL +LH +I+RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 885 KPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQ 944
K DN+L+ +GHIKLTD+G+ K G+ R
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCKEGI------------------------------RPGDT 152
Query: 945 KHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF----NAKTPQQ----- 995
+ GTP+Y+APEIL G +G + DWW++G+++FE++ G PF + P Q
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNIN 1052
+F I+ + I IP +SV+A ++ L ++P +RLG TG R++K HPFF+NI+
Sbjct: 213 LFQVILEKQI---RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269
Query: 1053 WDTLARQKAMFIPAAESLDTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSF 1106
WD L QK + P ++++ + + DE VQ D D+ F
Sbjct: 270 WDLL-EQKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDDPDVIARIDQSEF 322
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 8e-57
Identities = 97/284 (34%), Positives = 139/284 (48%), Gaps = 72/284 (25%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
+ +G FG V+LAR + TG AIK++KK D + +E +L E IL + +P +V+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 826 SFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDL 884
F +LYLVMEY GG L LL N G L ED + +++ LEYLHS +IHRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 885 KPDNLLIGQD-GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
KP+N+L+ D G +KL DFGLSK LT ++
Sbjct: 119 KPENILLDSDNGKVKLADFGLSK------------------------------LLTSDKS 148
Query: 944 QKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
++ GTP Y+APE+LLG G+ +D WS+G+IL+EL
Sbjct: 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------- 187
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046
E DLI K+L ++P +R A+E+ +H
Sbjct: 188 -------------PELKDLIRKMLQKDPEKRP---SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 9e-57
Identities = 98/307 (31%), Positives = 160/307 (52%), Gaps = 38/307 (12%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
+ +G FG V + +ATG ++A K L K + ++ + L E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALEYLHSLNVIHRD 883
+F +++L LVM +NGGDL + N+G E A Y A+++ LE+LH +++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
LKP+N+L+ G+++++D GL+ ELK +
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV------------------------ELKGGKKI----- 151
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003
AGTP Y+APE+L G + + DW+++G L+E++ G PF + + + + R
Sbjct: 152 --KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209
Query: 1004 DIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATG--AREVKQHPFFKNINWDTLARQK 1060
+ P++ S EA DL + LL ++P +RLG G A EV++HP FK++NW L
Sbjct: 210 TLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGM 269
Query: 1061 AM--FIP 1065
FIP
Sbjct: 270 LEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 2e-55
Identities = 100/293 (34%), Positives = 159/293 (54%), Gaps = 40/293 (13%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
++ ++ I +GA G V+ A RATG AIK ++ +RK E I+ E I+ ++P
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDED-MARVYIAELVLALEYLHSL 877
+V ++ S+ + L++VMEY++GG L ++ N ++E +A V E++ LEYLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
NVIHRD+K DN+L+ +DG +KL DF GF
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADF----------------------GFAAQ-------- 165
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
LT+E+ +++SV GTP ++APE++ +G D WS+GI+ E+ G PP+ + P +
Sbjct: 166 LTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
I + IP PE+ S E D ++K L ++P +R + A E+ QHPF K
Sbjct: 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKR--PS-AEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 3e-55
Identities = 91/302 (30%), Positives = 144/302 (47%), Gaps = 46/302 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD--MIRKNAVESILAERNILISV 815
D E +K + QG+ G V+ R + TG ++A+K + RK +L E L S
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK----QLLRELKTLRSC 56
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
+P+VV+ + +F + +V+EY++GG L LL+ +G + E + +++ L+YLH
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 876 S-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
+ ++IHRD+KP NLLI G +K+ DFG+SKV
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGISKV--------------------------- 149
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA---K 991
L Q ++ GT Y++PE + G + AD WS+G+ L E +G PF
Sbjct: 150 ---LENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP 206
Query: 992 TPQQIFDNIMNRDIP-WPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+ ++ I + P P EE S E D I L ++P +R A E+ QHPF K
Sbjct: 207 SFFELMQAICDGPPPSLP--AEEFSPEFRDFISACLQKDPKKRPSAA---ELLQHPFIKK 261
Query: 1051 IN 1052
+
Sbjct: 262 AD 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 192 bits (488), Expect = 3e-54
Identities = 113/354 (31%), Positives = 183/354 (51%), Gaps = 47/354 (13%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFF 824
I +G++ +V L R + T ++A+KV+KK + ++ + E+++ N PF+V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 825 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDL 884
F L+ V+EY+NGGDL ++ L E+ AR Y AE+ LAL YLH +I+RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 885 KPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQ 944
K DN+L+ +GHIKLTD+G+ K GL R
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCKEGL------------------------------RPGDT 152
Query: 945 KHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN----AKTPQQ----- 995
+ GTP+Y+APEIL G +G + DWW++G+++FE++ G PF+ + P Q
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNIN 1052
+F I+ + I IP +SV+A ++ L ++P +RLG TG +++ HPFF+N++
Sbjct: 213 LFQVILEKQI---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269
Query: 1053 WDTLARQKAMFIPAAESLDTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSF 1106
WD + QK + P ++ + + + +E VQ D DD+ F
Sbjct: 270 WDLM-EQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDDIVRKIDQSEF 322
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 4e-53
Identities = 110/342 (32%), Positives = 178/342 (52%), Gaps = 52/342 (15%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL-ISVRNPFVVRFF 824
I +G++ +V L R + ++A+KV+KK + ++ + E+++ + NPF+V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 825 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDL 884
F L+LV+EY+NGGDL ++ L E+ AR Y AE+ +AL +LH +I+RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 885 KPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQ 944
K DN+L+ DGHIKLTD+G+ K GL
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCKEGL------------------------------GPGDT 152
Query: 945 KHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF-------NAKTPQQIF 997
+ GTP+Y+APEIL G +G + DWW++G+++FE++ G PF + T +F
Sbjct: 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNINWD 1054
I+ + I IP +SV+A ++ L ++P +RLG TG ++K H FF++I+WD
Sbjct: 213 QVILEKPI---RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269
Query: 1055 TLARQKAM--FIP------AAESLDTSYFVSRYVWNPEDENV 1088
L +++ F P E+ DT + P+DE+V
Sbjct: 270 LLEKKQVTPPFKPQITDDYGLENFDTQFTSEPVQLTPDDEDV 311
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 6e-51
Identities = 86/290 (29%), Positives = 147/290 (50%), Gaps = 36/290 (12%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
++++ I +GAFG V+ TGD AIK + I++ A++SI+ E ++L ++++P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN 878
+V++ S ++LY+++EY G L +++ G E + VY+ +++ L YLH
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
VIHRD+K N+L +DG +KL DFG+ +T L
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGV-------ATK-----------------------L 149
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998
+ SV GTP ++APE++ G +D WS+G + ELL G PP+ P
Sbjct: 150 NDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF 209
Query: 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
I+ D P P +PE +S E D + + ++P R A+++ +HP+
Sbjct: 210 RIVQDDHP-P-LPEGISPELKDFLMQCFQKDPNLR---PTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 1e-49
Identities = 121/414 (29%), Positives = 185/414 (44%), Gaps = 54/414 (13%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-N 817
+ I++ + +G+FG V+LAR R L A+KVL K + VE L E IL S+
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---CLDEDMARVYIAELVLALEYL 874
P +V+ + F +LYLVMEY++GG L LL+ +G L E A +A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 875 HSLNVIHRDLKPDNLLIGQDGH-IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
HS +IHRD+KP+N+L+ +DG +KL DFGL+K L
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAK------------------------LLP 153
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT---ADWWSVGIILFELLIGIPPF-- 988
D + + GTP Y+APE+LLG+ +D WS+GI L+ELL G+PPF
Sbjct: 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213
Query: 989 --NAKTPQQIFDNIMNRDIPW------PNIPEEMSVEACDLIDKLLTENPVQRLGATGA- 1039
N+ Q I+ P P+ PE +S A DL+ KLL ++P RL ++
Sbjct: 214 EKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
Query: 1040 -REVKQHPFFKNINWDTLARQKAMFIPAAESLDTSYFVSRYVWNPEDENVQGGSDFDDLT 1098
++ H K + L + A L + + + + G D +
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPD---DSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDS 330
Query: 1099 DTCSSGSFSNTLDEEQADECGSLAEFSAPALAVQYSFSNFSFKNLSQLASINYD 1152
+ + SL +A + S S ++ S +
Sbjct: 331 NFSK--ELAPNGVSSSPHNSSSLLLSTASSKRS--SLPKISARSSPSSLSSSSR 380
|
Length = 384 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 97/296 (32%), Positives = 150/296 (50%), Gaps = 54/296 (18%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
I G FG+V+ A TG+L A+K ++ D K ++ I E +L +++P +V+++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELLKHPNLVKYYG 66
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLK 885
RE +Y+ MEY +GG L LL + LDE + RVY +L+ L YLHS ++HRD+K
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 886 PDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQK 945
P N+ + +G IKL DFG + L + T +
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVK--------LKNNT------------------TTMGEEV 160
Query: 946 HSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN--- 999
S+AGTP Y+APE++ G GHG AD WS+G ++ E+ G P++ DN
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE------LDNEFQ 214
Query: 1000 IM------NRDIPWPNIPE--EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
IM ++ P IP+ ++S E D +D+ L +P +R A+ E+ QHPF
Sbjct: 215 IMFHVGAGHK----PPIPDSLQLSPEGKDFLDRCLESDPKKRPTAS---ELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 7e-48
Identities = 87/293 (29%), Positives = 150/293 (51%), Gaps = 41/293 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E F+I++ + +G++G V+ A + TG + AIKV+ + ++ I+ E +IL +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV-----EEDLQEIIKEISILKQCDS 57
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHS 876
P++V+++ S+ +L++VMEY G + +++ L E+ + + + LEYLHS
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
IHRD+K N+L+ ++G KL DFG+S
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQ----------------------------- 148
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP-FNAKTPQQ 995
LT ++++V GTP ++APE++ +G+ AD WS+GI E+ G PP + +
Sbjct: 149 -LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA 207
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
IF I N+ P + PE+ S E D + K L ++P +R A ++ QHPF
Sbjct: 208 IF-MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAI---QLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 7e-48
Identities = 101/304 (33%), Positives = 158/304 (51%), Gaps = 44/304 (14%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN---PFVVR 822
I +G FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
Y+F + L +++ +NGGDL+ L G E R Y AE++L LE++H+ V++R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLKP N+L+ + GH++++D GL+ D K +P
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA-----------------------CDFSKKKP------ 152
Query: 943 RQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLIGIPPF---NAKTPQQIFD 998
H+ GT Y+APE+L G+ + ++ADW+S+G +LF+LL G PF K +I
Sbjct: 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209
Query: 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTL 1056
+ + P+ S E L++ LL + +RLG GA+EVK+HPFF++++W +
Sbjct: 210 MTLTMAVELPD---SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266
Query: 1057 ARQK 1060
QK
Sbjct: 267 FLQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 171 bits (434), Expect = 8e-48
Identities = 86/285 (30%), Positives = 136/285 (47%), Gaps = 38/285 (13%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKAD--MIRKNAVESILAERNILISVRNPFVVRF 823
+ G+FG V+ GD FA+K + AD + AV+ + E +L +++P +V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRD 883
+ +NLY+ +E + GG L LL+ G E + R+Y +++L LEYLH N +HRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
+K N+L+ +G +KL DFG++K E
Sbjct: 128 IKGANILVDTNGVVKLADFGMAKQ-------------------------------VVEFS 156
Query: 944 QKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002
S G+P ++APE++ G +G AD WS+G + E+ G PP++ I
Sbjct: 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR 216
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
P IP+ +S EA D I K L +P R A E+ +HPF
Sbjct: 217 SKE-LPPIPDHLSDEAKDFILKCLQRDPSLRPTAA---ELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-47
Identities = 82/286 (28%), Positives = 143/286 (50%), Gaps = 44/286 (15%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
D+E+++ I +G+FG V R+++ G + K + +M K + +++E NIL +++P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEK-QQLVSEVNILRELKHP 59
Query: 819 FVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALE 872
+VR++ R N LY+VMEY GGDL L++ ++E+ + +L+LAL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 873 YLHSLN-----VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
H+ + V+HRDLKP N+ + + ++KL DFGL+K+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-------------------- 159
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987
L + + GTP Y++PE L M + +D WS+G +++EL PP
Sbjct: 160 ----------LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
Query: 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
F A+ Q+ I ++ + IP S E ++I +L +P +R
Sbjct: 210 FTARNQLQLASKI--KEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 8e-47
Identities = 89/301 (29%), Positives = 145/301 (48%), Gaps = 44/301 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNA-VESILAERNILISVR 816
+D+E+I+ I GA V+ A + AIK + D+ + V+ + E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI---DLEKCQTSVDELRKEVQAMSQCN 57
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDMARVYIAELVLALEY 873
+P VV+++ SF + L+LVM YL+GG L +++ G LDE + + E++ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LHS IHRD+K N+L+G+DG +K+ DFG+S SL GG
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVSA-------------SLADGG-------- 156
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEIL-LGMGHGATADWWSVGIILFELLIGIPPFNAKT 992
R ++ + + GTP ++APE++ G+ AD WS GI EL G P++
Sbjct: 157 -----DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP 211
Query: 993 PQQIFDNIMNRDIPWPNIPEEMSVEAC-----DLIDKLLTENPVQRLGATGAREVKQHPF 1047
P ++ + D P P++ + +I L ++P +R A E+ +H F
Sbjct: 212 PMKVLMLTLQND-P-PSLETGADYKKYSKSFRKMISLCLQKDPSKR---PTAEELLKHKF 266
Query: 1048 F 1048
F
Sbjct: 267 F 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 90/297 (30%), Positives = 146/297 (49%), Gaps = 43/297 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKV--LKKADMIRKNAVESILAERNILISV 815
E F +++ I +G+FG V+ A + T + AIKV L++A+ + +E I E L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
R+P++ +++ SF L+++MEY GG LL+ G LDE + E++L LEYLH
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-PGKLDETYIAFILREVLLGLEYLH 115
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
IHRD+K N+L+ ++G +KL DFG+S G
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGVS----------------GQ------------ 147
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
LT ++++ GTP ++APE++ G+ AD WS+GI EL G PP + P +
Sbjct: 148 --LTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR 205
Query: 996 IFDNIMNRDIPWPNIPEEM-SVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
+ I + P++ S D + L ++P +R A+E+ +H F K
Sbjct: 206 VLFLIPKNNP--PSLEGNKFSKPFKDFVSLCLNKDPKERP---SAKELLKHKFIKKA 257
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 3e-46
Identities = 93/302 (30%), Positives = 151/302 (50%), Gaps = 36/302 (11%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F + + +G FG V + RATG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSL 877
VV Y++ ++ L LV+ +NGGDL + N+G DE+ A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+++RDLKP+N+L+ GHI+++D GL+ E+ +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAV------------------------EIPEG-- 155
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
+ + V GT Y+APE++ + + DWW +G +++E++ G PF + +
Sbjct: 156 ----ETIRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR 210
Query: 998 DNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWD 1054
+ + R E+ S A + +LLT++P RLG GA EVK HPFF+ N+
Sbjct: 211 EEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270
Query: 1055 TL 1056
L
Sbjct: 271 RL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 89/298 (29%), Positives = 151/298 (50%), Gaps = 37/298 (12%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
+ +G FG V + RATG L+A K L K + ++ E + E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 826 SFTCRENLYLVMEYLNGGDL----YSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIH 881
+F + +L LVM +NGGDL Y++ E A Y A+++ LE+LH +I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 882 RDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTRE 941
RDLKP+N+L+ DG+++++D GL+ ELKD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV------------------------ELKDG------ 150
Query: 942 QRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIM 1001
Q + AGTP ++APE+L G + + D++++G+ L+E++ PF A+ + +
Sbjct: 151 QSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 210
Query: 1002 NRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAR--EVKQHPFFKNINWDTL 1056
R + P++ S + + LL ++P +RLG ++ HP F+++NW L
Sbjct: 211 QRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 5e-44
Identities = 98/324 (30%), Positives = 143/324 (44%), Gaps = 73/324 (22%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVL---KKADMIRKNAVESILAERNILISV 815
++I+ I +GA G VF A+ R TG+ A+K + + I A+ I A L +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA----LQAC 56
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYL 874
++P+VV+ F LVMEY+ DL +LR+ L E + Y+ L+ + Y+
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
H+ ++HRDLKP NLLI DG +K+ DFGL+++ S ++ S
Sbjct: 116 HANGIMHRDLKPANLLISADGVLKIADFGLARL---FSEEEPRLYS-------------- 158
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAK-- 991
H VA T Y APE+L G D W+VG I ELL G P F +
Sbjct: 159 -----------HQVA-TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206
Query: 992 ------------TPQQ---------------IFDNIMNRDIPWPNIPEEMSVEACDLIDK 1024
TP + F ++ IP I + S EA DL+
Sbjct: 207 IEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPE--SKPIPLEEIFPDASPEALDLLKG 264
Query: 1025 LLTENPVQRLGATGAREVKQHPFF 1048
LL +P +RL A E +HP+F
Sbjct: 265 LLVYDPSKRLSAA---EALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 1e-43
Identities = 100/304 (32%), Positives = 157/304 (51%), Gaps = 44/304 (14%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN---PFVVR 822
I +G FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
Y+F + L +++ +NGGDL+ L G E R Y E++L LE++H+ V++R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLKP N+L+ + GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLAC--------DFS------------------------K 149
Query: 943 RQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLIGIPPF---NAKTPQQIFD 998
++ H+ GT Y+APE+L G + ++ADW+S+G +LF+LL G PF K +I
Sbjct: 150 KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 209
Query: 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTL 1056
+ ++ +P+ S E L++ LL + +RLG GA+EVK+H FFK I+W +
Sbjct: 210 MTLTVNV---ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQV 266
Query: 1057 ARQK 1060
QK
Sbjct: 267 YLQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 97/313 (30%), Positives = 159/313 (50%), Gaps = 38/313 (12%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F + + +G FG V + RATG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSL 877
VV Y++ ++ L LV+ +NGGDL + N+G +E+ A Y AE++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
N ++RDLKP+N+L+ GHI+++D GL+ + P G + +
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA----------VKIPE----GESIRGRV----- 162
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
GT Y+APE+L + + D+W +G +++E++ G PF + +
Sbjct: 163 ------------GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR 210
Query: 998 DNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWD 1054
+ + R + + + S EA + LLT++P QRLG GA EVK+HPFF+N+N+
Sbjct: 211 EEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270
Query: 1055 TL--ARQKAMFIP 1065
L F+P
Sbjct: 271 RLEAGMLDPPFVP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-42
Identities = 71/130 (54%), Positives = 91/130 (70%), Gaps = 4/130 (3%)
Query: 950 GTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPN 1009
GTPDYLAPE+LLG HG DWW++G+ LFE L GIPPFN +TPQQ+F NI+NRDIPWP
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601
Query: 1010 IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES 1069
E++SV A + I+ LLT +P +R G +E+KQHP F ++W+ L Q FIP +
Sbjct: 602 GEEKLSVNAQNAIEILLTMDPTKR---AGLKELKQHPLFHGVDWENLQNQTMPFIPQPDD 658
Query: 1070 -LDTSYFVSR 1078
DTSYF +R
Sbjct: 659 ETDTSYFEAR 668
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 100/302 (33%), Positives = 143/302 (47%), Gaps = 54/302 (17%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
ED+E+I+ I G +G V+ AR ATG+L AIKV+K + E I E ++L R+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRH 59
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGG---DLYSLLRNLGCLDEDMARVYIA----ELVLA 870
P +V +F S+ R+ L++VMEY GG D+Y + R G L E IA E +
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQ----IAYVCRETLKG 113
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
L YLH IHRD+K N+L+ +DG +KL DFG+S
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQ----------------------- 150
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEIL---LGMGHGATADWWSVGIILFELLIGIPP 987
LT ++ S GTP ++APE+ G+ D W++GI EL PP
Sbjct: 151 -------LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
Query: 988 FNAKTPQQIFDNIMNRDIPWPNI--PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
P + I + P P + E+ S D I K LT++P +R A ++ QH
Sbjct: 204 MFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR---PTATKLLQH 260
Query: 1046 PF 1047
PF
Sbjct: 261 PF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 3e-42
Identities = 97/302 (32%), Positives = 149/302 (49%), Gaps = 36/302 (11%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F + + +G FG V + RATG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSL 877
VV Y++ ++ L LV+ +NGGDL + N+G DE A Y AEL LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+++RDLKP+N+L+ GHI+++D GL+ Q P
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAV----------------------------QIP 153
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
R + GT Y+APE++ + + DWW +G +++E++ G PF + +
Sbjct: 154 EGETVRGR---VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR 210
Query: 998 DNIMNR-DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWD 1054
+ + R E+ S +A + LLT+NP +RLG GA VKQHP FKNIN+
Sbjct: 211 EEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270
Query: 1055 TL 1056
L
Sbjct: 271 RL 272
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 1e-41
Identities = 86/288 (29%), Positives = 137/288 (47%), Gaps = 35/288 (12%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLK--KADMIRKNAVESILAERNILISVRNPFVV 821
K + QGAFGRV+L TG A+K + K V ++ E +L ++++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 822 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIH 881
+++ E L + MEY+ GG + L+ G L E + R Y +++ +EYLHS ++H
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 882 RDLKPDNLLIGQDGHIKLTDFGLSK-VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTR 940
RD+K N+L G++KL DFG SK + I S SG +
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICS----------SGTGM------------- 164
Query: 941 EQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNI 1000
SV GTP +++PE++ G G+G AD WSVG + E+L PP+ I
Sbjct: 165 -----KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219
Query: 1001 MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
+ P +P +S +A + + + EN +R A E+ +H F
Sbjct: 220 ATQP-TNPQLPSHVSPDARNFLRRTFVENAKKR---PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 73/292 (25%), Positives = 130/292 (44%), Gaps = 42/292 (14%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
DF+++K + +G++G V+ ++ + +A+K + M +K +++ E IL SV +P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHP 59
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----LDEDMARVYIAELVLALEYL 874
++ + +F L +VMEY GDL + + E +L+ L+ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
H ++HRDLK N+L+ + +K+ D G+SKV LK
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKV------------------------LK- 154
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994
+ + GTP Y+APE+ G + +D WS+G +L+E+ PPF A++ Q
Sbjct: 155 -------KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207
Query: 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046
+ + +P IP S + + I +L P R ++ P
Sbjct: 208 DLRYKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCD---KILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 98/325 (30%), Positives = 144/325 (44%), Gaps = 74/325 (22%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI--SVRN 817
+E I I +G +G+V+ AR + TG+L A LKK M + I A R I + +R+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 818 PFVVRFFYSFTCRE--NLYLVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYL 874
P +VR T + ++Y+V EY++ DL LL + E + Y+ +L+ L+YL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
HS ++HRD+K N+LI DG +KL DFGL++
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLAR---------------------------- 148
Query: 935 QPPLTREQRQKHS--VAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAK 991
P T+ ++ V T Y PE+LLG D WSVG IL EL +G P F
Sbjct: 149 --PYTKRNSADYTNRVI-TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGS 205
Query: 992 TPQ----QIFD-------------------NIMNRDIPWPNIPEE-----MSVEACDLID 1023
T +IF+ + P+ E + A DL+D
Sbjct: 206 TELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLD 265
Query: 1024 KLLTENPVQRLGATGAREVKQHPFF 1048
KLLT +P +R+ A A QH +F
Sbjct: 266 KLLTLDPKKRISADQAL---QHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 3e-41
Identities = 97/321 (30%), Positives = 147/321 (45%), Gaps = 70/321 (21%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKK---ADMIRKNAVESILAERNILISVR 816
++ + I +G +G V+ AR + TG++ AIK +K ++ I K A L E +L +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA----LREIKLLKELN 56
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMARVYIAELVLALEYLH 875
+P +++ F + +LYLV E+++ DLY L++ L E + + Y+ +L+ L + H
Sbjct: 57 HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S ++HRDLKP+NLLI +G +KL DFGL++ S GS
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLAR-------------SFGS----------PV 152
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAK--- 991
P T H V T Y APE+LLG G+ D WSVG I ELL P F K
Sbjct: 153 RPYT------HYVV-TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI 205
Query: 992 -----------TPQQIFDNIMNR-------------DIPWPNIPEEMSVEACDLIDKLLT 1027
TP +P P + S +A DL+ ++L
Sbjct: 206 DQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLH 265
Query: 1028 ENPVQRLGATGAREVKQHPFF 1048
+P +R+ A A HP+F
Sbjct: 266 YDPHKRITAEQAL---AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 4e-41
Identities = 95/304 (31%), Positives = 156/304 (51%), Gaps = 38/304 (12%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F + + +G FG V + RATG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSL 877
VV Y++ ++ L LV+ +NGGDL + ++G +E A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+++RDLKP+N+L+ GHI+++D GL+ +H +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEG---------------------- 155
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
Q K V GT Y+APE++ + + DWW++G +L+E++ G PF + +
Sbjct: 156 ----QTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 210
Query: 998 DNI--MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATG--AREVKQHPFFKNINW 1053
+ + + +++ E+ S +A L LL ++P +RLG G AREVK+HP FK IN+
Sbjct: 211 EEVERLVKEVQ-EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269
Query: 1054 DTLA 1057
L
Sbjct: 270 KRLE 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 94/323 (29%), Positives = 147/323 (45%), Gaps = 75/323 (23%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESI----LAERNILISV 815
+E ++ + +G +G V+ AR + TG++ A+K ++ + + E I L E ++L +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR---LDNEE--EGIPSTALREISLLKEL 55
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYL 874
++P +V+ LYLV EY + DL L G L ++ + + +L+ L Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
HS ++HRDLKP N+LI +DG +KL DFGL++ F +
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARA------------------FGIPL---- 152
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAKTP 993
T H V T Y APEILLG H +TA D WSVG I E++ G P F +
Sbjct: 153 -RTYT------HEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE 204
Query: 994 Q----QIFDNIM---NRDIPWPNIPE------EMSV---------------EACDLIDKL 1025
+IF I+ + WP + + E DL+ K+
Sbjct: 205 IDQLFKIFQ-ILGTPTEES-WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKM 262
Query: 1026 LTENPVQRLGATGAREVKQHPFF 1048
L NP +R+ A+E +HP+F
Sbjct: 263 LQYNPAKRI---SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 5e-40
Identities = 102/317 (32%), Positives = 157/317 (49%), Gaps = 46/317 (14%)
Query: 735 DEDTVRSLRT--SPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLK 792
DE+ + LRT S +P K + + I QGA G V+ A ATG AIK +
Sbjct: 1 DEEILEKLRTIVSVGDPKKK-------YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN 53
Query: 793 KADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 852
+K E I+ E ++ ++P +V + S+ + L++VMEYL GG L ++
Sbjct: 54 LQQQPKK---ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 110
Query: 853 GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912
C+DE E + ALE+LHS VIHRD+K DN+L+G DG +KLTDFG
Sbjct: 111 -CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------ 163
Query: 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWW 972
+T EQ ++ ++ GTP ++APE++ +G D W
Sbjct: 164 ------------------------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 973 SVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQ 1032
S+GI+ E++ G PP+ + P + I P PE++S D +++ L E V+
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL-EMDVE 258
Query: 1033 RLGATGAREVKQHPFFK 1049
+ G+ A+E+ QHPF K
Sbjct: 259 KRGS--AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 94/324 (29%), Positives = 145/324 (44%), Gaps = 69/324 (21%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD---MIRKNAVESILAERNILIS 814
+E++ + +GA+G V R +ATG++ AIK K+++ ++K + L E +L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKK----TALREVKVLRQ 56
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
+R+ +V +F + LYLV EY+ L L + G L D R YI +L+ A+ Y
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
HS N+IHRD+KP+N+L+ + G +KL DFG ++ L A
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGFARA--------LRARP-------------- 154
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK-- 991
PLT T Y APE+L+G +G D W++G I+ ELL G P F
Sbjct: 155 ASPLT-------DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207
Query: 992 --------------TPQQ--IFD-NIMNRDIPWPNIPEEMSVE----------ACDLIDK 1024
P +F N + +P + S+E A D +
Sbjct: 208 IDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKA 267
Query: 1025 LLTENPVQRLGATGAREVKQHPFF 1048
L +P +RL E+ QHP+F
Sbjct: 268 CLRMDPKERL---TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-38
Identities = 85/296 (28%), Positives = 147/296 (49%), Gaps = 43/296 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ I +G+ G V +A ++TG A+K K D+ ++ E + E I+ ++
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMRDYQH 75
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL-ALEYLHS 876
P +V + S+ + L++VME+L GG L ++ + +E +A + VL AL +LH+
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALSFLHA 133
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
VIHRD+K D++L+ DG +KL+DFG
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCA------------------------------ 163
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
+++E ++ S+ GTP ++APE++ + +G D WS+GI++ E++ G PP+ + P Q
Sbjct: 164 QVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223
Query: 997 FDNIMNRDIPWPNI--PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
I RD P + ++S +D++L +P QR AT A E+ HPF
Sbjct: 224 MKRI--RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQR--AT-AAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 4e-38
Identities = 107/339 (31%), Positives = 162/339 (47%), Gaps = 44/339 (12%)
Query: 735 DEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKA 794
DE+ + LR+ I + FE I QGA G V+ A ATG AIK +
Sbjct: 1 DEEILEKLRS--IVSVGDPKKKYTRFE---KIGQGASGTVYTAIDIATGQEVAIKQMNLQ 55
Query: 795 DMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 854
+K E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++ C
Sbjct: 56 QQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-C 111
Query: 855 LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914
+DE E + AL++LHS VIHRD+K DN+L+G DG +KLTDFG
Sbjct: 112 MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-------- 163
Query: 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974
+T EQ ++ ++ GTP ++APE++ +G D WS+
Sbjct: 164 ----------------------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201
Query: 975 GIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRL 1034
GI+ E++ G PP+ + P + I P PE +S D +++ L E V R
Sbjct: 202 GIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCL-EMDVDRR 260
Query: 1035 GATGAREVKQHPFFKNINWDTLARQKAMFIPAAESLDTS 1073
G+ A+E+ QHPF K L+ + I A E++ S
Sbjct: 261 GS--AKELLQHPFLKLAK--PLSSLTPLIIAAKEAIKNS 295
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 5e-38
Identities = 105/316 (33%), Positives = 158/316 (50%), Gaps = 44/316 (13%)
Query: 735 DEDTVRSLRT-SPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKK 793
DE+ + LRT I K T E I QGA G VF A ATG AIK +
Sbjct: 1 DEEIMEKLRTIVSIGDPKKKYTRYEK------IGQGASGTVFTAIDVATGQEVAIK---Q 51
Query: 794 ADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 853
++ ++ E I+ E ++ ++NP +V F SF + L++VMEYL GG L ++
Sbjct: 52 INLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET- 110
Query: 854 CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913
C+DE E + ALE+LH+ VIHRD+K DN+L+G DG +KLTDFG
Sbjct: 111 CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA------- 163
Query: 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWS 973
+T EQ ++ ++ GTP ++APE++ +G D WS
Sbjct: 164 -----------------------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 974 VGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
+GI+ E++ G PP+ + P + I P PE++S D +++ L E V++
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCL-EMDVEK 259
Query: 1034 LGATGAREVKQHPFFK 1049
G+ A+E+ QHPF K
Sbjct: 260 RGS--AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 82/301 (27%), Positives = 140/301 (46%), Gaps = 42/301 (13%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ +EII + GAFG+V+ A+ + TG A K+ + + +E + E +IL +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKI---IQIESEEELEDFMVEIDILSECK 60
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLH 875
+P +V + ++ L++++E+ +GG L S++ L L E R +++ AL +LH
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S VIHRDLK N+L+ DG +KL DFG+S
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN--------------------------- 153
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGIPPFNA 990
+++ + GTP ++APE++ + AD WS+GI L EL PP +
Sbjct: 154 ---KSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
P ++ I+ + P + P + S D + L ++P R A E+ +HPF +
Sbjct: 211 LNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDR---PTAAELLKHPFVSD 267
Query: 1051 I 1051
Sbjct: 268 Q 268
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 90/303 (29%), Positives = 145/303 (47%), Gaps = 53/303 (17%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKA--DMIRKNAVESILAERNILISV 815
+D E + + G G V R TG + A+K ++ + I+K IL E +IL
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQK----QILRELDILHKC 56
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDED-MARVYIAELVLALEY 873
+P++V F+ +F ++ + MEY++GG L +L+ + G + E + ++ +A ++ L Y
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTY 115
Query: 874 LHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
LH +IHRD+KP N+L+ G IKL DFG+S G LVN
Sbjct: 116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVS-------------------GQLVNSLA 156
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG---IPPFN 989
K GT Y+APE + G + +D WS+G+ L EL G PP N
Sbjct: 157 KT-------------FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203
Query: 990 AKTPQQIFDNIMNR--DIPWPNIPEEM-SVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046
P IF+ ++ + P P +P S + D ++ L ++P +R +E+ +HP
Sbjct: 204 D-PPDGIFE-LLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRER---PSYKELLEHP 258
Query: 1047 FFK 1049
F K
Sbjct: 259 FIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 87/298 (29%), Positives = 152/298 (51%), Gaps = 40/298 (13%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
+ +G FG V + + TG ++A K L K + +K+ + L E+ IL V +PF+V Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV--YIAELVLALEYLHSLNVIHRD 883
+F + +L LVM +NGGDL + N+G +M RV Y A++ + +LHS+++++RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
+KP+N+L+ G+ +L+D GL+ ELKD +T+
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV------------------------ELKDGKTITQR-- 154
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003
AGT Y+APEIL + DW+++G ++E++ G PF + + + R
Sbjct: 155 -----AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR 209
Query: 1004 ----DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR-EVKQHPFFKNINWDTL 1056
++ + + + + E+ D+ L + P RLG+ + ++H FFK IN+ L
Sbjct: 210 TLEDEVKFEH--QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 2e-37
Identities = 88/326 (26%), Positives = 143/326 (43%), Gaps = 70/326 (21%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES--ILAERNILISVRN 817
+E++KPI GA+G V A + TG AIK K + + +++ IL E +L +R+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 818 PFVVR---FFY--SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALE 872
++ S ++Y+V E + DL+ ++++ L +D + ++ +++ L+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
YLHS NVIHRDLKP N+L+ + +K+ DFGL++ V+ +
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARG--------------------VDPDE 157
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAK 991
++ LT V T Y APE+LL D WSVG I ELL P F +
Sbjct: 158 DEKGFLT------EYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210
Query: 992 TPQQ----IFD-------------------NIMNRD-----IPWPNIPEEMSVEACDLID 1023
I + N + P + S EA DL++
Sbjct: 211 DYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLE 270
Query: 1024 KLLTENPVQRLGATGAREVKQHPFFK 1049
K+L +P +R+ T A E HP+
Sbjct: 271 KMLVFDPKKRI--T-ADEALAHPYLA 293
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 79/278 (28%), Positives = 142/278 (51%), Gaps = 37/278 (13%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
DFEI+ I +G+FG VF ++A ++A+K + + M R+ E+I E +L + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDMARVYIAELVLALEYLH 875
+++R++ SF + L +VMEY GDL+ LL R ++ + R +I +++L L +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S ++HRD+K NL + ++K+ D G++K+ L D
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL------------------------LSDN 154
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
++ GTP YL+PE+ + +D W++G++L+E G PF+A
Sbjct: 155 TNFAN------TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA 208
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
+ I+ R + +P + + S + LID+ LT++ QR
Sbjct: 209 LILKII-RGV-FPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 98/323 (30%), Positives = 145/323 (44%), Gaps = 69/323 (21%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESI----LAERNILISV 815
+E K + +G + V+ AR + TG + AIK +K + RK A + I L E +L +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQEL 59
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV--YIAELVLALEY 873
++P ++ F + N+ LV E++ DL ++++ + A + Y+ + LEY
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD-KSIVLTPADIKSYMLMTLRGLEY 117
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LHS ++HRDLKP+NLLI DG +KL DFGL++ S GS
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-------------SFGS---------- 154
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAKT 992
P + H V T Y APE+L G H G D WSVG I ELL+ +P +
Sbjct: 155 --PNR----KMTHQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207
Query: 993 PQQIFDNIMN-----RDIPWPNIPEEM--------------------SVEACDLIDKLLT 1027
I + WP + S +A DL+ +LLT
Sbjct: 208 DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLT 267
Query: 1028 ENPVQRLGATGAREVKQHPFFKN 1050
NP +R+ A A E HP+F N
Sbjct: 268 LNPNKRITARQALE---HPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-36
Identities = 99/315 (31%), Positives = 154/315 (48%), Gaps = 42/315 (13%)
Query: 735 DEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKA 794
DE+ + LR+ I + FE I QGA G V+ A ATG AI+ +
Sbjct: 2 DEEILEKLRS--IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQ 56
Query: 795 DMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 854
+K E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++ C
Sbjct: 57 QQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-C 112
Query: 855 LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914
+DE E + ALE+LHS VIHRD+K DN+L+G DG +KLTDFG
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-------- 164
Query: 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974
+T EQ ++ ++ GTP ++APE++ +G D WS+
Sbjct: 165 ----------------------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 975 GIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRL 1034
GI+ E++ G PP+ + P + I P PE++S D +++ L + V++
Sbjct: 203 GIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD-VEKR 261
Query: 1035 GATGAREVKQHPFFK 1049
G+ A+E+ QH F K
Sbjct: 262 GS--AKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 4e-36
Identities = 90/328 (27%), Positives = 138/328 (42%), Gaps = 84/328 (25%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKA-----DMIRKNAVESILAERNILIS 814
+++IK + G FG V+LAR + TG+L AIK +KK + + V+S+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNE---- 56
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDMARVYIAELVLALE 872
+P +V+ F + LY V EY+ G +LY L+ R E + R I +++ L
Sbjct: 57 --HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
++H HRDLKP+NLL+ +K+ DFGL++ E+
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR------------------------EI 149
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAK 991
+ +PP T T Y APEILL + + D W++G I+ EL P F
Sbjct: 150 RSRPPYT-------DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202
Query: 992 --------------TP-QQIFD------NIMNRDIP----------WPNIPEEMSVEACD 1020
TP +Q + + + P PN EA D
Sbjct: 203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASP----EAID 258
Query: 1021 LIDKLLTENPVQRLGATGAREVKQHPFF 1048
LI +L +P +R A + QHP+F
Sbjct: 259 LIKDMLRWDPKKRP---TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 89/306 (29%), Positives = 137/306 (44%), Gaps = 53/306 (17%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
FE+++ I +G +G+V+ AR + TG L AIK++ I ++ E I E NIL N
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61
Query: 818 -PFVVRFFYSF------TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA----E 866
P + F+ +F + L+LVME GG + L++ L + + +IA E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+ L YLH VIHRD+K N+L+ ++ +KL DFG+S
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-------------------- 161
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-----GHGATADWWSVGIILFEL 981
L ++++ GTP ++APE++ + A +D WS+GI EL
Sbjct: 162 ----------QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
Query: 982 LIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041
G PP P + I P PE S + D I + L +N QR E
Sbjct: 212 ADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFME---E 268
Query: 1042 VKQHPF 1047
+ +HPF
Sbjct: 269 LLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 93/330 (28%), Positives = 140/330 (42%), Gaps = 84/330 (25%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLK--------KADMIRKNAVESILAERNI 811
+E + I +GA+G V+ AR TG A+K ++ +R+ A+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFE- 59
Query: 812 LISVRNPFVVRFFYSF----TCRE-NLYLVMEYLNGGDLYSLLRNLGC----LDEDMARV 862
+P +VR T RE L LV E+++ DL + L C L + +
Sbjct: 60 -----HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK--CPKPGLPPETIKD 111
Query: 863 YIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922
+ +L+ +++LHS ++HRDLKP N+L+ DG +K+ DFGL+++
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI--------------- 156
Query: 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
+ LT SV T Y APE+LL + D WSVG I EL
Sbjct: 157 ---------YSFEMALT-------SVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
Query: 983 IGIPPFNAKTP----QQIFDNI---------MNRDIPWPNIPE-----------EMSVEA 1018
P F + +IFD I N +P + P E+ E
Sbjct: 201 RRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEG 260
Query: 1019 CDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
DL+ K+LT NP +R+ A E QHP+F
Sbjct: 261 LDLLKKMLTFNPHKRI---SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 92/298 (30%), Positives = 155/298 (52%), Gaps = 46/298 (15%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
R+ +E++ IK I +G+ G V +AR++ +G A+K++ D+ ++ E + E I+
Sbjct: 20 RSLLENY--IK-IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMR 73
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL-ALE 872
++ VV + S+ E L+++ME+L GG L ++ +E +A V E VL AL
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV--CESVLQALC 131
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
YLHS VIHRD+K D++L+ DG +KL+DFG +S
Sbjct: 132 YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCA--------QIS--------------- 168
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992
KD P ++ S+ GTP ++APE++ +G D WS+GI++ E++ G PP+ + +
Sbjct: 169 KDVP-------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221
Query: 993 PQQIFDNIMNRDIPWPNIPEEMSVEAC--DLIDKLLTENPVQRLGATGAREVKQHPFF 1048
P Q + RD P P + + D ++++LT P +R A+E+ HPF
Sbjct: 222 PVQAMKRL--RDSPPPKLKNAHKISPVLRDFLERMLTREPQER---ATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 87/314 (27%), Positives = 153/314 (48%), Gaps = 42/314 (13%)
Query: 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI 811
+D E +EII + GAFG+V+ A+ + TG L A KV++ + +E + E I
Sbjct: 6 RDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEI 62
Query: 812 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLA 870
L + +P++V+ +F L++++E+ GG + +++ L L E +V +++ A
Sbjct: 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEA 122
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
L+YLHS+ +IHRDLK N+L+ DG IKL DFG+S
Sbjct: 123 LQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN---------------------- 160
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGI 985
+ +++ S GTP ++APE+++ + AD WS+GI L E+
Sbjct: 161 --------VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 212
Query: 986 PPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
PP + P ++ I + P + P + S+E D + L ++P R A ++ +H
Sbjct: 213 PPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR---PSAAQLLEH 269
Query: 1046 PFFKNINWDTLARQ 1059
PF ++ + R+
Sbjct: 270 PFVSSVTSNRPLRE 283
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 77/301 (25%), Positives = 129/301 (42%), Gaps = 56/301 (18%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLF----AIKVLKKADMIRKNAVESILAERNILISV 815
E+ K + +GAFG V+ + G+ A+K LK+ E L E +I+ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMARVYIAELVLALEYL 874
+P +VR T E LY+V EY+ GGDL LR + L ++ +EYL
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
S N +HRDL N L+ ++ +K++DFGLS+ I+ D GG L
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGLSR--DIYEDDYYRK---RGGGKL------- 166
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTP 993
K ++APE L + +D WS G++L+E+ +G P+ +
Sbjct: 167 --------PIK--------WMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN 210
Query: 994 QQIFDNIMNR---DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+++ + + + P N P+E+ +L+ + +P R P F
Sbjct: 211 EEVLELLEDGYRLPRP-ENCPDELY----ELMLQCWAYDPEDR------------PTFSE 253
Query: 1051 I 1051
+
Sbjct: 254 L 254
|
Length = 258 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 85/293 (29%), Positives = 138/293 (47%), Gaps = 41/293 (13%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLK---KADMIRKNAVESILAERNILISVRNPFVVR 822
+ GAF + AR TG L A+K + ++ VE++ E ++ + +P ++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 823 FFYSFTCRENLY-LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIH 881
TC ++ + L +E++ GG + LL G E + Y +L+ L YLH +IH
Sbjct: 68 M-LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 882 RDLKPDNLLIGQDGH-IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTR 940
RD+K NLLI G +++ DFG + L+A G+G E + Q
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFG--------AAARLAAKGTGAG------EFQGQ----- 167
Query: 941 EQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP----QQI 996
+ GT ++APE+L G +G + D WSVG ++ E+ PP+NA+ I
Sbjct: 168 -------LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220
Query: 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
F I + P+IPE +S D+ + L P R +RE+ +HP F+
Sbjct: 221 F-KIASATTA-PSIPEHLSPGLRDVTLRCLELQPEDR---PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 93/304 (30%), Positives = 151/304 (49%), Gaps = 49/304 (16%)
Query: 760 FEIIKP--ISQGAFGRVFLARKRATGDLFAIK-------VLKKADMIRKNAVESILAERN 810
F+ +K I +G +GRV+LA TG++ A+K + + D +K+ V+++ +E
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
L + + +V++ T E L + +EY+ GG + S LR G +E + R + +++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
L YLHS ++HRDLK DNLL+ DG K++DFG+SK +DD+ ND
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-----KSDDIYD----------ND 165
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEI--LLGMGHGATADWWSVGIILFELLIGIPPF 988
Q S+ G+ ++APE+ G+ A D WS+G ++ E+ G P+
Sbjct: 166 -------------QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212
Query: 989 -NAKTPQQIFDNIMNRDIPWPNIPEE----MSVEACDLIDKLLTENPVQRLGATGAREVK 1043
+ + +F R P P IP + +S A D ++ T NP R ARE+
Sbjct: 213 SDEEAIAAMFKLGNKRSAP-P-IPPDVSMNLSPVALDFLNACFTINPDNR---PTARELL 267
Query: 1044 QHPF 1047
QHPF
Sbjct: 268 QHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 46/283 (16%)
Query: 761 EIIKPISQGAFGRVFLARKRATGDLF----AIKVLKKADMIRKNAVESILAERNILISVR 816
+ K + +GAFG V+ + GD A+K LK+ +E L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY-----IAELVLAL 871
+P +V+ T E L +VMEY+ GGDL LR + ++ + IA +
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR---GM 116
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
EYL S N IHRDL N L+G++ +K++DFGLS+ ++ D GG L
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYKV----KGGKL---- 166
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNA 990
P+ ++APE L + +D WS G++L+E+ +G P+
Sbjct: 167 -----PIR--------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPG 207
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
+ ++ + + P E L+ + E+P R
Sbjct: 208 MSNAEVLEYLKKGYRLPK--PPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 47/283 (16%)
Query: 761 EIIKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ K + +GAFG V+ + A+K LK+ + +E L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---CLDE--DMARVYIAELVLAL 871
+P VV+ T E LY+VMEY+ GGDL S LR L + A + IA +
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFA-LQIAR---GM 115
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
EYL S N IHRDL N L+G++ +K++DFGLS+ ++ D
Sbjct: 116 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDD----------------- 156
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNA 990
R++ K + ++APE L + +D WS G++L+E+ +G P+
Sbjct: 157 ------YYRKRGGKLPIR----WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 206
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
+ +++ + + N P E DL+ + E+P R
Sbjct: 207 MSNEEVLEYLKNGYRLPQ--PPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 79/290 (27%), Positives = 138/290 (47%), Gaps = 47/290 (16%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKV--LKKADMIRKNAVESILAERNILISVRN---PFV 820
I +GA+G V+ + TG + A+K+ L D + V I E +L +R P +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPD----DDVSDIQREVALLSQLRQSQPPNI 64
Query: 821 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVI 880
+++ S+ L+++MEY GG + +L++ G + E V I E+++AL+Y+H + VI
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVI 123
Query: 881 HRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTR 940
HRD+K N+L+ G++KL DFG+ A L
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGV-------------AALLNQN---------------- 154
Query: 941 EQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999
++ + GTP ++APE++ G + AD WS+GI ++E+ G PP++ +
Sbjct: 155 -SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213
Query: 1000 IMNRDIPWPNIPE-EMSVEACDLIDKLLTENPVQRLGA---TGAREVKQH 1045
I + P P + + S + + L E P +RL A ++ +K H
Sbjct: 214 IP-KSKP-PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 81/278 (29%), Positives = 136/278 (48%), Gaps = 39/278 (14%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILA--ERNILISVRN 817
+ I+ + +GAFG L R+ L V K+ ++ R + E A E IL +++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLV---VWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRNLGCL-DEDMARVYIAELVLALEYLH 875
P ++ ++ F L + MEY NGG LY ++R G L +E+M Y+ ++V A+ Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
++HRD+K N+ + + G IKL DFG+SK+ LGS
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-------------LGS------------ 153
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
E +V GTP Y++PE+ G+ + +D W++G +L+ELL F+A P
Sbjct: 154 -----EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN 208
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
+ I+ + + + S E L+ LL ++P +R
Sbjct: 209 LVVKIVQGN--YTPVVSVYSSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 107/332 (32%), Positives = 157/332 (47%), Gaps = 69/332 (20%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI- 811
D+ + +EI++ + +GA+G V+ A R T ++ A+K K D R NA ++ R I
Sbjct: 2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFR-NATDAQRTFREIM 58
Query: 812 -LISVRN-PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA-E 866
L + + P +V+ + +YLV EY+ DL++++R L ED+ + YI +
Sbjct: 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA-NIL-EDVHKRYIMYQ 115
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
L+ AL+Y+HS NVIHRDLKP N+L+ D +KL DFGL A SL
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGL-------------ARSLSEL-- 160
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGI 985
+E + P LT VA T Y APEILLG D WSVG IL E+L+G
Sbjct: 161 ---EENPENPVLT------DYVA-TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
Query: 986 PPF---------------------------NAKTPQQIFDNIMNRDI-PWPNIPEEMSVE 1017
P F + + D++ +R P + + S +
Sbjct: 211 PLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDD 270
Query: 1018 ACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
A DL+ KLL NP +RL A E +HP+
Sbjct: 271 ALDLLKKLLVFNPNKRL---TAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 82/282 (29%), Positives = 126/282 (44%), Gaps = 50/282 (17%)
Query: 769 GAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828
G +V L T F +K L+K+ + ER +I P +V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 829 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDN 888
++++LV+++ GG L+S + + E+ + + AE+V+AL+ LH ++ RDL P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 889 LLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSV 948
+L+ GHI+LT F + S D + ++
Sbjct: 116 ILLDDRGHIQLTYFS-RWSEVEDSCDGEAVENM--------------------------- 147
Query: 949 AGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWP 1008
Y APE+ DWWS+G ILFELL G KT + + +N
Sbjct: 148 -----YCAPEVGGISEETEACDWWSLGAILFELLTG------KTLVECHPSGINTHTTL- 195
Query: 1009 NIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFF 1048
NIPE +S EA L+ +LL NP +RLGA G ++K HPFF
Sbjct: 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-31
Identities = 86/286 (30%), Positives = 145/286 (50%), Gaps = 41/286 (14%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
I +G+ G V +A ++ TG A+K K D+ ++ E + E I+ + VV +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLK 885
S+ + L++VME+L GG L ++ + +E +A V ++ ++ AL YLH+ VIHRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSYLHNQGVIHRDIK 145
Query: 886 PDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQK 945
D++L+ DG IKL+DFG +++E ++
Sbjct: 146 SDSILLTSDGRIKLSDFGFCA------------------------------QVSKEVPKR 175
Query: 946 HSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI 1005
S+ GTP ++APE++ + +G D WS+GI++ E++ G PP+ + P Q I RD
Sbjct: 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--RDN 233
Query: 1006 PWPNIPEEMSVEAC--DLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
P + + V + +D +L P QR A+E+ QHPF K
Sbjct: 234 LPPRVKDSHKVSSVLRGFLDLMLVREPSQR---ATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 4e-31
Identities = 78/276 (28%), Positives = 136/276 (49%), Gaps = 35/276 (12%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+ +K I +G+FG+ L + + G + IK + + M K ES E +L ++++P
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPN 60
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCL-DEDMARVYIAELVLALEYLHSL 877
+V++ SF NLY+VM+Y GGDLY + G L ED + ++ LAL+++H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
++HRD+K N+ + +DG IKL DFG+++V ++ST +L+
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA-------------------- 158
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
+ GTP YL+PEI + +D W++G +L+E+ F A + +
Sbjct: 159 --------RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV 210
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
I+ +P + S + +L+ +L NP R
Sbjct: 211 LKIIRGS--YPPVSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 84/292 (28%), Positives = 148/292 (50%), Gaps = 43/292 (14%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIK------VLKKADMIRKNAVESILAERNILISVRNPF 819
I G+FG V+L ++G+L A+K V + +++ ++++ E +L +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
+V++ S ++L + +EY+ GG + +LL N G +E + R ++ +++ L YLH+ +
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
IHRD+K N+L+ G IK++DFG+SK L A SL + T
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISK--------KLEANSLSTK--------------T 165
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF-NAKTPQQIF- 997
R S+ G+ ++APE++ + AD WS+G ++ E+L G PF + Q IF
Sbjct: 166 NGARP--SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK 223
Query: 998 --DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
+N P IP +S EA D ++K + +R A E+ +HPF
Sbjct: 224 IGENAS------PEIPSNISSEAIDFLEKTFEIDHNKR---PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 93/297 (31%), Positives = 141/297 (47%), Gaps = 43/297 (14%)
Query: 758 EDF-EIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
E+F EII + GAFG+V+ A+ + TG L A KV+ D + +E + E +IL S
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI---DTKSEEELEDYMVEIDILASCD 60
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLH 875
+P +V+ +F NL++++E+ GG + +++ L L E RV + + AL YLH
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
+IHRDLK N+L DG IKL DFG+S
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN--------------------------- 153
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGIPPFNA 990
TR +++ S GTP ++APE+++ + AD WS+GI L E+ PP +
Sbjct: 154 ---TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
P ++ I + P P S E D + K L +N R T ++ QHPF
Sbjct: 211 LNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTT---QLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 78/295 (26%), Positives = 135/295 (45%), Gaps = 37/295 (12%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ +F+I K I +G F V+ A G + A+K ++ +M+ A + L E ++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDMARVYIAELVLALE 872
+P V+++ SF L +V+E + GDL ++++ + E Y +L ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
++HS ++HRD+KP N+ I G +KL D GL G S+ +A
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGL---GRFFSSKTTAA-------------- 163
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992
HS+ GTP Y++PE + G+ +D WS+G +L+E+ PF
Sbjct: 164 -------------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
Query: 993 PQ--QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
+ I D P P + S E DL+ + + +P +R + +V +
Sbjct: 211 MNLYSLCKKIEKCDYP-PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 86/300 (28%), Positives = 138/300 (46%), Gaps = 53/300 (17%)
Query: 758 EDFEIIKPI--SQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
++ EI+K + G FG+V + + + T LF K++K + NA+E ++ + +
Sbjct: 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF---NAIEPMVHQ----LMK 66
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
NP ++ +YS T + L+M+Y+ GDL+ LL+ G L E + I +LV AL LH
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 876 SLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGLIH--STDDLSAPSLGSGGFLVNDEL 932
N+IH D+K +N+L + I L D+GL K+ I S D
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IGTPSCYD----------------- 167
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992
GT DY +PE + G + + DWW+VG++ +ELL G PF +
Sbjct: 168 -----------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK-ED 209
Query: 993 PQQIFD-NIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+ D + + + +S A D + +L N RL T E+ +HPF K
Sbjct: 210 EDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRL--TNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 9e-31
Identities = 87/295 (29%), Positives = 151/295 (51%), Gaps = 40/295 (13%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
RT +++F IK I +G+ G V +A +++G L A+K K D+ ++ E + E I+
Sbjct: 19 RTYLDNF--IK-IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMR 72
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
++ VV + S+ + L++VME+L GG L ++ + +E +A V +A L AL
Sbjct: 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK-ALSV 131
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LH+ VIHRD+K D++L+ DG +KL+DFG
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA--------------------------- 164
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993
+++E ++ S+ GTP ++APE++ + +G D WS+GI++ E++ G PP+ + P
Sbjct: 165 ---QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 221
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
+ I + P ++S +D+LL +P QR A E+ +HPF
Sbjct: 222 LKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR---ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 91/325 (28%), Positives = 143/325 (44%), Gaps = 78/325 (24%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR----KNAVESI-LAERNILIS 814
++ ++ I +G +G V+ AR + TG++ A LKK IR V S + E ++L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVA---LKK---IRLETEDEGVPSTAIREISLLKE 54
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALE 872
+ +P +VR LYLV E+L+ DL + + LD + + Y+ +L+ +
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK-VGLIHSTDDLSAPSLGSGGFLVNDE 931
Y HS V+HRDLKP NLLI ++G +KL DFGL++ G+
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV---------------------- 151
Query: 932 LKDQPPLTREQRQ-KHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFN 989
P+ R H V T Y APEILLG +T D WS+G I E++ P F
Sbjct: 152 -----PV----RTYTHEVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201
Query: 990 AKTP-QQIF---------DNIMNRDI----------------PWPNIPEEMSVEACDLID 1023
+ Q+F D + + + + + DL+
Sbjct: 202 GDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLS 261
Query: 1024 KLLTENPVQRLGATGAREVKQHPFF 1048
K+L +P +R+ A+ QHP+F
Sbjct: 262 KMLVYDPAKRI---SAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 88/323 (27%), Positives = 137/323 (42%), Gaps = 64/323 (19%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
++ I+ I GA+G V A +G AIK + A + A + L E IL ++
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT-LRELKILRHFKHDN 65
Query: 820 VVRFFYSFTCRENL----YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
++ Y+VM+ L DL+ ++ + L E+ R ++ +L+ L+Y+H
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S NVIHRDLKP NLL+ +D +++ DFG+++ LS+ F+
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARG--------LSSSPTEHKYFMT------- 169
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAKTPQ 994
VA Y APE+LL + TA D WSVG I E+L F K
Sbjct: 170 ----------EYVATRW-YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218
Query: 995 -QI--------------------------FDNIMNRD-IPWPNIPEEMSVEACDLIDKLL 1026
Q+ N+ + +PW I + S EA DL+ ++L
Sbjct: 219 HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQML 278
Query: 1027 TENPVQRLGATGAREVKQHPFFK 1049
+P +R+ A QHPF
Sbjct: 279 QFDPEERITVEQAL---QHPFLA 298
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-30
Identities = 85/290 (29%), Positives = 138/290 (47%), Gaps = 38/290 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E F ++ I +G+FG VF T + AIK++ + ++ +E I E +L +
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDS 61
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P+V +++ S+ L+++MEYL GG LLR G DE + E++ L+YLHS
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
IHRD+K N+L+ + G +KL DFG++
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAG------------------------------Q 150
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
LT Q ++++ GTP ++APE++ + + AD WS+GI EL G PP + P ++
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL 210
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
I P + E S + ID L ++P R A+E+ +H F
Sbjct: 211 FLIPK--NNPPTLTGEFSKPFKEFIDACLNKDPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 98/341 (28%), Positives = 151/341 (44%), Gaps = 98/341 (28%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
S++++E + I +G +G V+ AR + TG++ A+K LK + S L E NIL+ +
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS-LREINILLKL 61
Query: 816 RNPFVVRFFYSFTCRE--------NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY-IAE 866
++P +V T +E +Y+VMEY+ DL SL+ E M + + +E
Sbjct: 62 QHPNIV------TVKEVVVGSNLDKIYMVMEYVEH-DLKSLM-------ETMKQPFLQSE 107
Query: 867 -------LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919
L+ + +LH ++HRDLK NLL+ G +K+ DFGL++
Sbjct: 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR------------- 154
Query: 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIIL 978
LK P T+ + T Y APE+LLG +TA D WSVG I
Sbjct: 155 -------EYGSPLK---PYTQ-------LVVTLWYRAPELLLGAKEYSTAIDMWSVGCIF 197
Query: 979 FELLIGIPPFNAKTP----QQIFDNIM---NRDIPWPNIPE------------------- 1012
ELL P F K+ +IF ++ I WP E
Sbjct: 198 AELLTKKPLFPGKSEIDQLNKIF-KLLGTPTEKI-WPGFSELPGAKKKTFTKYPYNQLRK 255
Query: 1013 -----EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
+S DL+++LLT +P +R+ A A +HP+F
Sbjct: 256 KFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL---KHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 84/310 (27%), Positives = 134/310 (43%), Gaps = 65/310 (20%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVL---KKADMIRKNAVESILAERNILIS 814
ED E I + G G V + TG + A KV+ K+ + ++ IL E I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMHE 59
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
R+P++V F+ +F N+ + ME+++ G L + + G + ++ +V L YL
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYL 119
Query: 875 HS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
++ ++HRD+KP N+L+ G IKL DFG+S G L+N
Sbjct: 120 YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-------------------GELIN---- 156
Query: 934 DQPPLTREQRQKHSVA----GTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989
S+A GT Y++PE + G + +D WS+GI + EL +G PF
Sbjct: 157 -------------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203
Query: 990 AK--------TPQQIFD---NIMNRDIPWPNIPEEMSVEAC-DLIDKLLTENPVQRLGAT 1037
P I D I+ P P +P E D +D L ++P +R T
Sbjct: 204 FSNIDDDGQDDPMGILDLLQQIVQE--PPPRLPSSDFPEDLRDFVDACLLKDPTER--PT 259
Query: 1038 GAREVKQHPF 1047
+ PF
Sbjct: 260 PQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 78/291 (26%), Positives = 141/291 (48%), Gaps = 43/291 (14%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIK--VLKKADMIR-KNAVESILAERNILISVRNPFVVR 822
+ +GA+G V+ G L A+K L ++++ + E + E ++L S+++ +V+
Sbjct: 8 LGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 823 FFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVI 880
Y TC ++ + + ME++ GG + S+L G L E + Y +++ + YLH+ V+
Sbjct: 67 --YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 881 HRDLKPDNLLIGQDGHIKLTDFGLSK----VGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
HRD+K +N+++ +G IKL DFG ++ VGL + ++ LK
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM---------------LK--- 166
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
S+ GTP ++APE++ G+G +D WS+G +FE+ G PP +
Sbjct: 167 ----------SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA 216
Query: 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
I P +P+ S A D + LT + +R A ++ +H F
Sbjct: 217 MFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER---PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 70/268 (26%), Positives = 114/268 (42%), Gaps = 49/268 (18%)
Query: 764 KPISQGAFGRVFLAR---KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV 820
K + +GAFG V+ + K A+K LK+ + + L E ++ + +P V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNV 58
Query: 821 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL---------AL 871
VR T E LYLV+EY+ GGDL LR + + ++ L +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
EYL S +HRDL N L+G+D +K++DFGLS+ DD
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD---VYDDD-------------YYR 162
Query: 932 LKDQPPL-TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFN 989
K L R ++APE L + +D WS G++L+E+ +G P+
Sbjct: 163 KKTGGKLPIR-------------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP 209
Query: 990 AKTPQQIFDNIMNR---DIPWPNIPEEM 1014
+ +++ + + P P+E+
Sbjct: 210 GLSNEEVLEYLRKGYRLPKP-EYCPDEL 236
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 80/288 (27%), Positives = 143/288 (49%), Gaps = 38/288 (13%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F ++ I +G+FG V+ T ++ AIK++ + ++ +E I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
+ R++ S+ L+++MEYL GG LL+ G L+E + E++ L+YLHS
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERK 122
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
IHRD+K N+L+ + G +KL DFG++ LT
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG------------------------------QLT 152
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999
Q ++++ GTP ++APE++ + AD WS+GI EL G PP + P ++
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL-F 211
Query: 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
++ ++ P P + + S + ++ L ++P R T A+E+ +H F
Sbjct: 212 LIPKNSP-PTLEGQYSKPFKEFVEACLNKDP--RFRPT-AKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 92/332 (27%), Positives = 145/332 (43%), Gaps = 79/332 (23%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DFE + + G G V R +G + A K++ I+ I+ E +L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNS 58
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED-MARVYIAELVLALEYLHS 876
P++V F+ +F + + ME+++GG L +L+ G + E+ + ++ IA ++ L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLRGLTYLRE 117
Query: 877 -LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
++HRD+KP N+L+ G IKL DFG+S G L++
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------------------GQLIDS----- 153
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG---IPPFNAKT 992
+S GT Y++PE L G + +D WS+G+ L E+ IG IPP +AK
Sbjct: 154 --------MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE 205
Query: 993 ------------------------------PQQIF---DNIMNRDIPWPNIPEE-MSVEA 1018
P IF D I+N P P +P S E
Sbjct: 206 LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE--PPPKLPSGAFSDEF 263
Query: 1019 CDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
D +DK L +NP +R E+ +HPF K
Sbjct: 264 QDFVDKCLKKNPKERADLK---ELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 91/325 (28%), Positives = 137/325 (42%), Gaps = 79/325 (24%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR--- 816
++I+ I +G F V A+ R TG +AIK +KK ++E + R I R
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 817 NPFVVRF----FYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLAL 871
+P ++R F T R L LV E ++ +LY L++ L E + Y+ +L+ +L
Sbjct: 57 HPNILRLIEVLFDRKTGR--LALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
+++H + HRD+KP+N+LI D +KL DFG S + S
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFG-------------SCRGIYS-------- 151
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNA 990
+PP T T Y APE LL G +G D W+VG + FE+L P F
Sbjct: 152 ---KPPYT-------EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201
Query: 991 K--------------TPQQIFD------NIMNRDIPWPNIPEE-------MSVEACDLID 1023
TP MN + P S E DL+
Sbjct: 202 TNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP-SKKGTGLRKLLPNASAEGLDLLK 260
Query: 1024 KLLTENPVQRLGATGAREVKQHPFF 1048
KLL +P +R+ A++ +HP+F
Sbjct: 261 KLLAYDPDERI---TAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 76/281 (27%), Positives = 132/281 (46%), Gaps = 36/281 (12%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
+ +++ + +G+FGR L + + +A+K ++ +AVE E +L +++P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP--KSSSAVEDSRKEAVLLAKMKHP 58
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHS 876
+V F SF +LY+VMEY +GGDL ++ ED + ++ L ++++H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
V+HRD+K N+ + Q+G +KL DFG +++ L++P G +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--------LTSP----GAYAC-------- 158
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
+ GTP Y+ PEI M + +D WS+G IL+EL PF A + + +
Sbjct: 159 ----------TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208
Query: 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT 1037
+ +P S E LI ++ NP R AT
Sbjct: 209 ILKVCQGSY--KPLPSHYSYELRSLIKQMFKRNPRSRPSAT 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 8e-29
Identities = 87/315 (27%), Positives = 142/315 (45%), Gaps = 66/315 (20%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVL--KKADMIRKNAVESILAERNILISV 815
E + + +GA G V R + TG +FA+K + ++K IL E I S
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQ----ILRELEINKSC 56
Query: 816 RNPFVVRFFYSFTCRE--NLYLVMEYLNGGDLYSLLRNLGCLDEDMARV------YIAEL 867
++P++V+++ +F ++ + MEY GG L S+ + + + R+ IAE
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKV---KKRGGRIGEKVLGKIAES 113
Query: 868 VL-ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
VL L YLHS +IHRD+KP N+L+ + G +KL DFG+S G
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS-------------------GE 154
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
LVN + GT Y+APE + G + T+D WS+G+ L E+
Sbjct: 155 LVN-------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRF 201
Query: 987 PFNAKTPQ-----QIFDNIMNRDIPWPNIPEEMSV------EACDLIDKLLTENPVQRLG 1035
PF + ++ I+N +P P + +E E D I + L ++P +R
Sbjct: 202 PFPPEGEPPLGPIELLSYIVN--MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR-- 257
Query: 1036 ATGAREVKQHPFFKN 1050
++ +HP+ K
Sbjct: 258 -PTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 76/277 (27%), Positives = 132/277 (47%), Gaps = 37/277 (13%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+E I+ + +GAFG V L R++A L IK + M + + E +L + +P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPN 60
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSL 877
++ ++ +F + L +VMEY GG L ++ LDED + +++LAL ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 878 NVIHRDLKPDNLLIGQDGHI-KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
++HRDLK N+L+ + + K+ DFG+SK+ LS+ S
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LSSKS---------------- 156
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
+ ++V GTP Y++PE+ G + +D W++G +L+EL F A +
Sbjct: 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL 209
Query: 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
IM P I + S + LI +L +P +R
Sbjct: 210 VLKIM-SGTFAP-ISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-28
Identities = 82/290 (28%), Positives = 140/290 (48%), Gaps = 38/290 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E F ++ I +G+FG VF T + AIK++ + ++ +E I E +L +
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDS 61
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P+V +++ S+ L+++MEYL GG LL G LDE + E++ L+YLHS
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
IHRD+K N+L+ + G +KL DFG++
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAG------------------------------Q 150
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
LT Q ++++ GTP ++APE++ + + AD WS+GI EL G PP + P ++
Sbjct: 151 LTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL 210
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
++ ++ P P + S + ++ L + P R A+E+ +H F
Sbjct: 211 -FLIPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 80/289 (27%), Positives = 138/289 (47%), Gaps = 48/289 (16%)
Query: 760 FEIIKPISQGAFGRVFLARKRATG-DLFAIK-------VLKKADMIRKNAVESILAERNI 811
+ +++ + GAFG V+ RK+ G +L A+K K R ++ I++E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 812 LI-SVRNPFVVRFFYSFTCRENLYLVMEYLNG---GDLYSLLRNLG-CLDEDMARVYIAE 866
+ +R+P +VR++ +F + LY+VM+ + G G+ ++ L+ E+ +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 867 LVLALEYLH-SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+VLAL YLH ++HRDL P+N+++G+D + +TDFGL+K
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------- 162
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985
+ + + LT SV GT Y PEI+ +G AD W+ G IL+++
Sbjct: 163 -----QKQPESKLT-------SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
Query: 986 PPFNAKTPQQIFDNIMNRDIPWPNIPEEM-SVEACDLIDKLLTENPVQR 1033
PPF + + I+ + +PE M S + D+I LT + R
Sbjct: 211 PPFYSTNMLSLATKIVEAV--YEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 91/333 (27%), Positives = 143/333 (42%), Gaps = 81/333 (24%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKA--DMIRKNAVESILAERNILISV 815
+ +E ++ I +G +G+V+ AR + TG L A LKK +M + + L E ++L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVA---LKKTRLEMDEEGIPPTALREISLLQML 57
Query: 816 -RNPFVVRFFYSFTCREN-----LYLVMEYLNGGDLYSLLRNLG-----CLDEDMARVYI 864
+ ++VR E LYLV EYL+ DL + + G L + ++
Sbjct: 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 865 AELVLALEYLHSLNVIHRDLKPDNLLIGQD-GHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
+L+ + + H V+HRDLKP NLL+ + G +K+ D GL + I
Sbjct: 117 YQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI------------- 163
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELL 982
P+ + H + T Y APE+LLG H +T D WSVG I E+
Sbjct: 164 -------------PV---KSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
Query: 983 IGIPPFNAK--------------TP-QQIFDNIMN-RDIPWPNIP-----------EEMS 1015
P F TP +Q++ + RD W P ++S
Sbjct: 207 RKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRD--WHEFPQWKPQDLSRAVPDLS 264
Query: 1016 VEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
E DL+ K+L +P +R+ A A HP+F
Sbjct: 265 PEGLDLLQKMLRYDPAKRISAKAAL---THPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 41/299 (13%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
R EDFE+I+ I G +G V+ AR TG+L AIKV+K + + E ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMK 61
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
++ +V +F S+ R+ L++ ME+ GG L + G L E E + L Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LHS +HRD+K N+L+ +GH+KL DFG+S
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSA--------------------------- 154
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPPFNA 990
+T ++ S GTP ++APE+ G+ D W+VGI EL PP
Sbjct: 155 ---QITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEM--SVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
P + + + P + ++M S + LT+NP +R A ++ QHPF
Sbjct: 212 LHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKR---PTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 96/328 (29%), Positives = 148/328 (45%), Gaps = 72/328 (21%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-KNAVE-SILAERNILI 813
S+ +FE + I +G +G V+ AR +G++ A LKK M ++ + S L E +L+
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVA---LKKVRMDNERDGIPISSLREITLLL 61
Query: 814 SVRNPFVVRFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLA 870
++R+P +V + ++++LVMEY DL SLL N+ E + + +L+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
L+YLH +IHRDLK NLL+ G +K+ DFGL++ + +
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK----------------- 163
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFN 989
P+T T Y APE+LLG TA D W+VG IL ELL P
Sbjct: 164 ------PMT-------PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210
Query: 990 AKTPQQIFDNIM------NRDIPWPNI-----------PEE-----------MSVEACDL 1021
K+ + D I+ N I WP P++ +S L
Sbjct: 211 GKSEIEQLDLIIQLLGTPNESI-WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRL 269
Query: 1022 IDKLLTENPVQRLGATGAREVKQHPFFK 1049
++ LL +P +R AT A E + +FK
Sbjct: 270 LNFLLMYDPKKR--AT-AEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 94/332 (28%), Positives = 146/332 (43%), Gaps = 84/332 (25%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIK-------------VLKKADMIRKNAVES 804
++ + I +GA+G V A + TG AIK L++ ++R+ E+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 805 ILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYI 864
I+ +I+ F SF ++Y+V E + DLY L++ L D + ++
Sbjct: 65 IIGILDIIRP-------PSFESF---NDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFL 112
Query: 865 AELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSG 924
+++ L+Y+HS NV+HRDLKP NLL+ + +K+ DFGL+++ + P
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI---------ADPEHDHT 163
Query: 925 GFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLI 983
GFL VA T Y APEI+L A D WSVG IL E+L
Sbjct: 164 GFLT-----------------EYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
Query: 984 GIPPFNAK--------------TPQQI-FDNIMN---RD----------IPWPNIPEEMS 1015
P F K TP Q + I++ R+ +PW +
Sbjct: 206 NRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNAD 265
Query: 1016 VEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
+A DL+DK+LT NP +R+ E HP+
Sbjct: 266 PKALDLLDKMLTFNPHKRITVE---EALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 92/335 (27%), Positives = 146/335 (43%), Gaps = 69/335 (20%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES--ILAERNIL 812
+ + D+EI+ + +G FG V+ AR+ TG + A LKK ++ N + I A R I
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVA---LKK--ILMHNEKDGFPITALREIK 59
Query: 813 I--SVRNPFVVRF---FYSFTCREN-----LYLVMEYLNGGDLYSLLRNLGC-LDEDMAR 861
I +++P VV + +Y+V Y++ DL LL N L E +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIK 118
Query: 862 VYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921
Y+ +L+ + YLH +++HRD+K N+LI G +K+ DFGL++ D P+
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY------DGPPPNP 172
Query: 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFE 980
GG TR+ ++ T Y PE+LLG TA D W +G + E
Sbjct: 173 KGGG----------GGGTRKYT---NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAE 219
Query: 981 LLIGIPPFNAKTP----QQIFDNIMN-RDIPWPN---IP-------------------EE 1013
+ P K+ IF + WP +P +
Sbjct: 220 MFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGK 279
Query: 1014 MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
+ E DL+ KLL+ +P +RL A+ A +HP+F
Sbjct: 280 LGPEGLDLLSKLLSLDPYKRLTASDA---LEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 72/240 (30%), Positives = 117/240 (48%), Gaps = 34/240 (14%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+EIIK I +G+FG+++LA+ ++ + IK + M K E+ E +L +++P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCL-DEDMARVYIAELVLALEYLHSL 877
+V FF SF L++VMEY +GGDL + R G L ED + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 878 NVIHRDLKPDNLLIGQDGHI-KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
++HRD+K N+ + ++G + KL DFG+++ L D
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ------------------------LNDSM 156
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
L + GTP YL+PEI + D WS+G +L+EL PF Q+
Sbjct: 157 ELAY------TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 92/307 (29%), Positives = 143/307 (46%), Gaps = 52/307 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ +EII+ I +G +G+V+ + G L A+K+L D I + E I AE NIL S+ N
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPIS-DVDEEIEAEYNILQSLPN 77
Query: 818 -PFVVRFFYSFTCREN-----LYLVMEYLNGGDLYSLLRNL-GC---LDEDMARVYIAEL 867
P VV+F+ F + L+LV+E NGG + L++ L C LDE M +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 868 VLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
+L L++LH+ +IHRD+K +N+L+ +G +KL DFG+S
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 176
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL-----LGMGHGATADWWSVGIILFELL 982
LT + ++++ GTP ++APE++ + A D WS+GI EL
Sbjct: 177 ---------QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227
Query: 983 IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042
G PP P + I P PE+ I + L ++ R T +
Sbjct: 228 DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVT---HL 284
Query: 1043 KQHPFFK 1049
+HPF K
Sbjct: 285 LEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 91/317 (28%), Positives = 142/317 (44%), Gaps = 73/317 (23%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES--ILAE-RNI 811
+ D E + I G G+V+ R + TG + A+K +++ N E+ IL + +
Sbjct: 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMDLDVV 67
Query: 812 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY--IAELVL 869
L S P++V+ + F ++++ ME ++ CLD+ + R+ I E +L
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELMST-----------CLDKLLKRIQGPIPEDIL 116
Query: 870 ---------ALEYL---HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917
AL YL H VIHRD+KP N+L+ G++KL DFG+S
Sbjct: 117 GKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS------------ 162
Query: 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL----LGMGHGATADWWS 973
G LV+ + K TR AG Y+APE + + AD WS
Sbjct: 163 -------GRLVDSKAK-----TRS-------AGCAAYMAPERIDPPDPNPKYDIRADVWS 203
Query: 974 VGIILFELLIGIPPF-NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQ 1032
+GI L EL G P+ N KT ++ I+ + P E S + C +D LT++ +
Sbjct: 204 LGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRK 263
Query: 1033 RLGATGAREVKQHPFFK 1049
R RE+ QHPF +
Sbjct: 264 R---PKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 90/305 (29%), Positives = 142/305 (46%), Gaps = 52/305 (17%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ +EII+ I +G +G+VF + G A+K+L I E I AE NIL ++ +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALSD 73
Query: 818 -PFVVRFFYSFTCRE-----NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA----EL 867
P VV+F+ + ++ L+LV+E NGG + L++ E M IA E
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 868 VLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
++ L++LH IHRD+K +N+L+ +G +KL DFG+S
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 172
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL-----LGMGHGATADWWSVGIILFELL 982
LT + ++++ GTP ++APE++ L + A D WS+GI EL
Sbjct: 173 ---------QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELG 223
Query: 983 IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042
G PP P + I P + PE S E D I K LT++ +R + ++
Sbjct: 224 DGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVS---DL 280
Query: 1043 KQHPF 1047
QH F
Sbjct: 281 LQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 94/323 (29%), Positives = 144/323 (44%), Gaps = 69/323 (21%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD---MIRKNAVESILAERNILIS 814
E +E + I +G++G VF R R TG + AIK +++ +I+K A L E +L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA----LREIRMLKQ 56
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
+++P +V F + L+LV EY + L L +N + E + + I + + A+ +
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
H N IHRD+KP+N+LI + G IKL DFG +++ L+ P D+ D
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARI--------LTGPG---------DDYTD 159
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTP 993
VA T Y APE+L+G +G D W++G + ELL G P + K+
Sbjct: 160 Y------------VA-TRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206
Query: 994 ------------------QQIFDN---IMNRDIPWPN--IPEEM-----SVEACDLIDKL 1025
QQIF IP P P E S A +
Sbjct: 207 VDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGC 266
Query: 1026 LTENPVQRLGATGAREVKQHPFF 1048
L +P +RL E+ +HP+F
Sbjct: 267 LQMDPTERLSCE---ELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 89/334 (26%), Positives = 127/334 (38%), Gaps = 82/334 (24%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI--SVRN 817
+E + I QG FG VF AR + T + A LKK M + I A R I I +++
Sbjct: 14 YEKLAKIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQLLKH 70
Query: 818 PFVVRFF---------YSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAEL 867
VV Y+ + + YLV E+ DL LL N + + L
Sbjct: 71 ENVVNLIEICRTKATPYN-RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 868 VLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
+ L Y+H ++HRD+K N+LI +DG +KL DFGL++ S
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA--------FSLS-------- 172
Query: 928 VNDELKDQPPLTREQRQKHS--VAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIG 984
+ +++ V T Y PE+LLG G D W G I+ E+
Sbjct: 173 -----------KNSKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
Query: 985 IPPFNAKTPQQIFDNI------MNRDIPWPNI------------------------PEEM 1014
P T Q I + ++ WP + P
Sbjct: 221 SPIMQGNTEQHQLTLISQLCGSITPEV-WPGVDKLELFKKMELPQGQKRKVKERLKPYVK 279
Query: 1015 SVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
A DLIDKLL +P +R+ A A H FF
Sbjct: 280 DPHALDLIDKLLVLDPAKRIDADTALN---HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 90/318 (28%), Positives = 149/318 (46%), Gaps = 64/318 (20%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F+ ++ I +G +G V+ AR + TG++ A+K ++ D + + + E ++L + +P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDL--YSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
+V+ LYLV E+L+ DL + L + + + Y+ +L+ L + HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
V+HRDLKP NLLI +G IKL DFGL++ F V P
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLAR------------------AFGV--------P 153
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLI--GIPPFNAKTPQ 994
+ + H V T Y APEILLG + +TA D WS+G I E++ + P +++ Q
Sbjct: 154 V---RTYTHEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 209
Query: 995 --QIFDNIMNRD-IPWPNI--------------PEEMSV-------EACDLIDKLLTENP 1030
+IF + D + WP + ++ S + DL+ ++L +P
Sbjct: 210 LFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDP 269
Query: 1031 VQRLGATGAREVKQHPFF 1048
+R+ A A HPFF
Sbjct: 270 NKRISAKAAL---AHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 81/307 (26%), Positives = 140/307 (45%), Gaps = 56/307 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
++ E++ + +G +G V+ R TG A+K ++ + ++ I+ E +IL +
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGD---LYSLLRNLGCLDEDMARVYIAELVLALEYL 874
P++V F+ +F +Y+ MEY++ G LY+ + ED+ R +V L++L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 875 -HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
N+IHRD+KP N+L+ +G +KL DFG+S G LV K
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS-------------------GNLVASLAK 159
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEIL--LGMGHGAT----ADWWSVGIILFELLIGIPP 987
G Y+APE + G T +D WS+G+ + E+ +G P
Sbjct: 160 TN-------------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
Query: 988 FNAKTPQQIFDNIMNR-----DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042
+ P + + NI + D P +P S +A D + K L + P +R T A ++
Sbjct: 207 Y----PPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR--PTYA-QL 259
Query: 1043 KQHPFFK 1049
+HP+
Sbjct: 260 LEHPWLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-26
Identities = 97/331 (29%), Positives = 146/331 (44%), Gaps = 81/331 (24%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+E+IK + QGA+G V AR T + + + K ++ K ILA+R ++R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK----KILAKR----ALRELK 53
Query: 820 VVRFFY---SFTCR-----------ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA 865
++R F + TC LYL E L DL+ ++R+ L + + +I
Sbjct: 54 LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIY 112
Query: 866 ELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+++ L+Y+HS NV+HRDLKP NLL+ D +K+ DFGL++ G
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR------------------G 154
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIG 984
F N ++ +T VA T Y APEI+L A D WSVG IL ELL
Sbjct: 155 FSENPG-ENAGFMT------EYVA-TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
Query: 985 IPPFNAK--------------TP----------QQIFDNIMN----RDIPWPNIPEEMSV 1016
P F K TP + + I + P+ +I +
Sbjct: 207 KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANP 266
Query: 1017 EACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
A DL++KLL +P +R+ A E HP+
Sbjct: 267 LALDLLEKLLAFDPTKRISVEEALE---HPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 87/318 (27%), Positives = 139/318 (43%), Gaps = 64/318 (20%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+E ++ I +G +G VF A+ R T ++ A+K ++ D + S L E +L +++
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKN 60
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLN 878
+VR + + L LV EY + DL + G +D ++ + ++ +L+ L + HS N
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
V+HRDLKP NLLI ++G +KL DFGL++ + G V
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR----------------AFGIPV---------- 153
Query: 939 TREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFEL---------------- 981
R + T Y P++L G + + D WS G I EL
Sbjct: 154 ----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 209
Query: 982 ------LIGIP-----PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENP 1030
L+G P P +K P + N+ +++ DL+ LL NP
Sbjct: 210 LKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNP 269
Query: 1031 VQRLGATGAREVKQHPFF 1048
VQR+ A A QHP+F
Sbjct: 270 VQRISAEEAL---QHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 96/330 (29%), Positives = 153/330 (46%), Gaps = 67/330 (20%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI-LISVR 816
+D E+I+ + +GA+G V R TG + A+K ++ + + +L + +I + SV
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT--VNSQEQKRLLMDLDISMRSVD 58
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL------- 869
P+ V F+ + ++++ ME ++ L + + D+ + I E +L
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTS-LDKFYKKV--YDKGL---TIPEDILGKIAVSI 112
Query: 870 --ALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
ALEYLHS L+VIHRD+KP N+LI ++G +KL DFG+S G+
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS-------------------GY 153
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG----MGHGATADWWSVGIILFELL 982
LV+ K AG Y+APE + G+ +D WS+GI + EL
Sbjct: 154 LVDSVAKTID------------AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA 201
Query: 983 IGIPPF-NAKTPQQIFDNIMNRDIPWPNIPEE-MSVEACDLIDKLLTENPVQRLGATGAR 1040
G P+ + KTP Q ++ P P +P E S E D ++K L +N +R
Sbjct: 202 TGRFPYDSWKTPFQQLKQVVEE--PSPQLPAEKFSPEFQDFVNKCLKKNYKER---PNYP 256
Query: 1041 EVKQHPFFKNINWDTLARQKAMFIPAAESL 1070
E+ QHPFF L K + + SL
Sbjct: 257 ELLQHPFF------ELHLSKNTDVASFVSL 280
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 36/288 (12%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLK--KADMIRKNAVESILAERNILISVRNPFVV 821
K + QGAFGRV+L TG A K ++ V ++ E +L ++++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 822 RFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
+++ R + L + MEY+ GG + L+ G L E + R Y +++ + YLHS +
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
+HRD+K N+L G++KL DFG SK L + G
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK--------RLQTICMSGTGI------------- 166
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999
SV GTP +++PE++ G G+G AD WS+G + E+L PP+
Sbjct: 167 ------RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK 220
Query: 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
I + P +P +S A D + + E R A E+ +HPF
Sbjct: 221 IATQPTN-PQLPSHISEHARDFLGCIFVEAR-HR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 90/343 (26%), Positives = 146/343 (42%), Gaps = 103/343 (30%)
Query: 760 FEI------IKPISQGAFGRVFLARKRATGDLFAIK--------------VLKKADMIRK 799
FE+ IKPI +GA+G V A+ T + AIK L++ ++R
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 800 NAVESILAERNILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 858
E+++A ++I+ R F ++Y+V E L DL+ ++R+ L +D
Sbjct: 61 LDHENVIAIKDIMPPPHREAF-----------NDVYIVYE-LMDTDLHQIIRSSQTLSDD 108
Query: 859 MARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918
+ ++ +L+ L+Y+HS NV+HRDLKP NLL+ + +K+ DFGL++
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----------- 157
Query: 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGII 977
+ G F+ + +TR Y APE+LL + D WSVG I
Sbjct: 158 -TSEKGDFMT------EYVVTRW------------YRAPELLLNCSEYTTAIDVWSVGCI 198
Query: 978 LFELLIGIPPFNAK--------------TPQQI-FDNIMN-------RDIP--------- 1006
ELL P F K +P + I N R +P
Sbjct: 199 FAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR 258
Query: 1007 -WPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
+P+ + A DL++K+L +P +R+ E HP+
Sbjct: 259 LFPH----ANPLAIDLLEKMLVFDPSKRITVE---EALAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 72/235 (30%), Positives = 117/235 (49%), Gaps = 38/235 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVL---KKADMIRKNAVESILAERNILIS 814
E +E + + +G++G V + + TG + AIK + M++K A+ I +L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREI----RMLKQ 56
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
+R+ +V F ++ LYLV E+++ L L + LDE R Y+ +++ +E+
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
HS N+IHRD+KP+N+L+ Q G +KL DFG A +L + G + D
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGF-------------ARTLAAPGEVYTD---- 159
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPF 988
VA T Y APE+L+G +G D W+VG ++ E+L G P F
Sbjct: 160 ------------YVA-TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 76/285 (26%), Positives = 125/285 (43%), Gaps = 38/285 (13%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
R D+E+I+ + G +G V+ AR TG+L A+K++K + + I E ++
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVK 61
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
++ +V +F S+ RE L++ MEY GG L + G L E E + L Y
Sbjct: 62 ECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LHS +HRD+K N+L+ +G +KL DFG++
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAA--------------------------- 154
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPPFNA 990
+T ++ S GTP ++APE+ G+ D W+VGI EL PP
Sbjct: 155 ---KITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEM--SVEACDLIDKLLTENPVQR 1033
P + + + P + ++ S + + LT+NP +R
Sbjct: 212 LHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKR 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 37/295 (12%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ +F I K I +G F V+ A G A+K ++ D++ A + E ++L +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDMARVYIAELVLALE 872
+P V++++ SF L +V+E + GDL ++++ + E Y +L ALE
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
++HS V+HRD+KP N+ I G +KL D GL G S+ +A
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGL---GRFFSSKTTAA-------------- 163
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF--NA 990
HS+ GTP Y++PE + G+ +D WS+G +L+E+ PF +
Sbjct: 164 -------------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
+ I D P P + S E L++ + +P +R T +V +
Sbjct: 211 MNLYSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 84/317 (26%), Positives = 129/317 (40%), Gaps = 58/317 (18%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES---ILAERNILISVR 816
F ++ I G+FG V+ AR T ++ AIK K K + E I+ E L +R
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNG--GDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
+P + + + +LVMEY G D+ + + L E + L YL
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK--PLQEVEIAAICHGALQGLAYL 131
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
HS IHRD+K N+L+ + G +KL DFG + L +P+
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFG---------SASLVSPA-------------- 168
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHG---ATADWWSVGIILFELLIGIPP-FNA 990
+S GTP ++APE++L M G D WS+GI EL PP FN
Sbjct: 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK- 1049
++ +I D P + + S + +D L + P R + E+ +H F
Sbjct: 218 NAMSALY-HIAQNDSPTLS-SNDWSDYFRNFVDSCLQKIPQDR---PSSEELLKHRFVLR 272
Query: 1050 ----NINWDTLARQKAM 1062
+ D + R K
Sbjct: 273 ERPPTVIIDLIQRTKDA 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 36/288 (12%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLK--KADMIRKNAVESILAERNILISVRNPFVV 821
K + QGAFGRV+L TG A+K ++ V ++ E +L ++ + +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 822 RFFYSF--TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
+++ L + ME++ GG + L++ G L E++ R Y +++ + YLHS +
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
+HRD+K N+L G++KL DFG SK L L G
Sbjct: 128 VHRDIKGANILRDSVGNVKLGDFGASK--------RLQTICLSGTGMK------------ 167
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999
SV GTP +++PE++ G G+G AD WSVG + E+L PP+
Sbjct: 168 -------SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK 220
Query: 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
I + P +P +S D + ++ E ++ A E+ +H F
Sbjct: 221 IATQPTN-PVLPPHVSDHCRDFLKRIFVEAKLR----PSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 89/296 (30%), Positives = 135/296 (45%), Gaps = 58/296 (19%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADM------IRKNAVESILAERNILISVRNPF 819
+ +G +G V+ AR +T AIK + + D + A+ S L RNI
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI-------- 67
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCL--DEDMARVYIAELVLALEYLHS 876
V++ S + + ME + GG L +LLR+ G L +E Y +++ L+YLH
Sbjct: 68 -VQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 877 LNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
++HRD+K DN+L+ G +K++DFG SK L
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK------------------------RLAGI 162
Query: 936 PPLTREQRQKHSVAGTPDYLAPEIL-LGM-GHGATADWWSVGIILFELLIGIPPF-NAKT 992
P T + GT Y+APE++ G G+GA AD WS+G + E+ G PPF
Sbjct: 163 NPCTE------TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216
Query: 993 PQ-QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
PQ +F M + P IPE +S EA + I + +P +R A ++ Q PF
Sbjct: 217 PQAAMFKVGMFKI--HPEIPESLSAEAKNFILRCFEPDPDKRASAH---DLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 79/271 (29%), Positives = 123/271 (45%), Gaps = 41/271 (15%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
FE++ + +GA+G V R + T ++ AIK K ++ + E+ L E +L +++
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQEN 61
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
+V +F R LYLV EY+ L L + + R YI +L+ A+ + H ++
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
+HRD+KP+NLLI + +KL DFG ++ +L G ++ + T
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFAR-------------NLSEG----SNANYTEYVAT 164
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999
R Y +PE+LLG +G D WSVG IL EL G P F ++
Sbjct: 165 RW------------YRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
Query: 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENP 1030
I P P E+M KL NP
Sbjct: 213 IQKVLGPLP--AEQM---------KLFYSNP 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 95/335 (28%), Positives = 139/335 (41%), Gaps = 77/335 (22%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
+ ++ F+II I +G +G+V+ AR + TG+L A LKK + + I A R I I
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVA---LKKVRLDNEKEGFPITAIREIKI 59
Query: 814 --SVRNPFVVRFFYSFTC----------RENLYLVMEYLNGGDLYSLLRN-LGCLDEDMA 860
+ + +V T + YLV EY++ DL LL + L ED
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118
Query: 861 RVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920
+ ++ +L+ L Y H N +HRD+K N+L+ G IKL DFGL++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR-------------- 164
Query: 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILF 979
L N E + P T + T Y PE+LLG +G D WS G IL
Sbjct: 165 ------LYNSE--ESRPYTNK-------VITLWYRPPELLLGEERYGPAIDVWSCGCILG 209
Query: 980 ELLIGIPPFNAKTPQ---QIFDNIMNRDIP--WPN-------------------IPEEMS 1015
EL P F A ++ + P WP+ + EE S
Sbjct: 210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS 269
Query: 1016 V---EACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
A DL+D +LT +P +R A E P+
Sbjct: 270 FIPTPALDLLDHMLTLDPSKR---CTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 71/276 (25%), Positives = 135/276 (48%), Gaps = 40/276 (14%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVL--KKADMIRKNAVESILAERNILISVRNPFV 820
++ + +G++G V L R R G + IK L + A + A E E +L +++P +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNI 61
Query: 821 VRFFYSFTCREN-LYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSL 877
V + S+ + LY+VM + GGDLY L+ L E+ + ++ +AL+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+++HRDLK N+ + + IK+ D G+++V + + D+++
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMAS------------------- 160
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
++ GTP Y++PE+ + +D W++G ++E+ FNAK +
Sbjct: 161 ---------TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV 211
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
I+ + P +P++ S E +LI +L++ P +R
Sbjct: 212 YRIIEGKL--PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 87/331 (26%), Positives = 141/331 (42%), Gaps = 86/331 (25%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES-ILAER-----NILI 813
++ + P+ GA+G+V A TG AIK L + +S I A+R +L
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-------FQSAIHAKRTYRELRLLK 69
Query: 814 SVRNPFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL 867
+ + V+ FT +L YLV L G DL ++++ L +D + + ++
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVK-CQKLSDDHIQFLVYQI 127
Query: 868 VLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
+ L+Y+HS +IHRDLKP N+ + +D +K+ DFGL++ H+ D+++ G++
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----HTDDEMT-------GYV 176
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIP 986
TR Y APEI+L H T D WSVG I+ ELL G
Sbjct: 177 A----------TRW------------YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
Query: 987 PFNAKTPQQIFDNIMN----------------------RDIP------WPNIPEEMSVEA 1018
F IMN + +P + + + A
Sbjct: 215 LFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLA 274
Query: 1019 CDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
DL++K+L +P +R+ A E HP+
Sbjct: 275 IDLLEKMLVLDPDKRITAA---EALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 79/305 (25%), Positives = 135/305 (44%), Gaps = 55/305 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+D + + + G G V+ A T + A+KV+ I + I++E IL +
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDS 58
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
P+++ F+ +F + + E+++GG D+Y + + + R+ +A +V L YL
Sbjct: 59 PYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIP-----EHVLGRIAVA-VVKGLTYLW 112
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
SL ++HRD+KP N+L+ G +KL DFG+S LVN K
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQ-------------------LVNSIAK-- 151
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF------- 988
+ GT Y+APE + G +G +D WS+GI EL +G P+
Sbjct: 152 -----------TYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQ 200
Query: 989 NAKTPQQIFDNIMNRDIPWPNIPE-EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
+ P Q+ I++ D P +P + S + I + + + P +R + HPF
Sbjct: 201 GSLMPLQLLQCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERP---APENLMDHPF 255
Query: 1048 FKNIN 1052
N
Sbjct: 256 IVQYN 260
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 85/324 (26%), Positives = 145/324 (44%), Gaps = 73/324 (22%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLK---KADMIRKNAVESILAERNILISV 815
D+ I+ I +G +G V+ R + TG + A+K ++ + + + A+ I ++L +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI----SLLKEL 56
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---LDEDMARVYIAELVLALE 872
++P +V LYL+ E+L+ DL L +L +D ++ + Y+ +++ +
Sbjct: 57 QHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL 115
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
+ HS V+HRDLKP NLLI G IKL DFGL++ I
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI---------------------- 153
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT-ADWWSVGIILFELLIGIPPFNAK 991
P+ + H V T Y APE+LLG +T D WS+G I E+ P F+
Sbjct: 154 ----PV---RVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205
Query: 992 TP-QQIFD-----NIMNRDIPWPNI---PE------------------EMSVEACDLIDK 1024
+ Q+F D+ WP + P+ + + DL++K
Sbjct: 206 SEIDQLFRIFRILGTPTEDV-WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEK 264
Query: 1025 LLTENPVQRLGATGAREVKQHPFF 1048
+L +P +R+ A++ HP+F
Sbjct: 265 MLIYDPAKRI---SAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 72/290 (24%), Positives = 127/290 (43%), Gaps = 51/290 (17%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ +F+I K I +G F V+ A A+K ++ +M+ A + + E ++L +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDMARVYIAELVLALE 872
+P V+++ SF L +V+E + GDL +++ + E Y +L A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
++HS V+HRD+KP N+ I G +KL D GL +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF------------------------- 155
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992
+ + HS+ GTP Y++PE + G+ +D WS+G +L+E+ PF
Sbjct: 156 -----FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF---- 206
Query: 993 PQQIFDNIMN--------RDIPWPNIPEEMSVEAC-DLIDKLLTENPVQR 1033
+ + MN +P +P E E +L+ + +P QR
Sbjct: 207 ----YGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 78/295 (26%), Positives = 138/295 (46%), Gaps = 38/295 (12%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNA--VESILAERNILISV 815
++ + K + +GAFG V+L TG A+K + ++ + V ++ E +L ++
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 816 RNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
R+ +V+++ E L + +EY+ GG + L+ G L E++ R Y +++ + Y
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK-VGLIHSTDDLSAPSLGSGGFLVNDEL 932
LHS ++HRD+K N+L G++KL DFG SK + I + G+G
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS--------GTG-------- 165
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992
SV GTP +++PE++ G G+G AD WSV + E+L PP+
Sbjct: 166 ------------IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213
Query: 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
I + P +P+ +S D + ++ E + A + +HPF
Sbjct: 214 AMAAIFKIATQPTK-PMLPDGVSDACRDFLKQIFVEEKRRPT----AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 2e-22
Identities = 86/338 (25%), Positives = 142/338 (42%), Gaps = 83/338 (24%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DFE I + G G VF + +G + A K++ I+ I+ E +L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNS 62
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED-MARVYIAELVLALEYLHS 876
P++V F+ +F + + ME+++GG L +L+ G + E + +V IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-VIKGLTYLRE 121
Query: 877 LN-VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
+ ++HRD+KP N+L+ G IKL DFG+S G L++
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS-------------------GQLIDS----- 157
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG---IPPFNAKT 992
+S GT Y++PE L G + +D WS+G+ L E+ IG IPP +AK
Sbjct: 158 --------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKE 209
Query: 993 PQQIFDNIMNRDI---------------------------------------PWPNIPE- 1012
+ +F + D P P +P
Sbjct: 210 LELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSG 269
Query: 1013 EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
E D ++K L +NP +R +++ H F K
Sbjct: 270 VFGAEFQDFVNKCLIKNPAER---ADLKQLMVHAFIKR 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 4e-22
Identities = 74/288 (25%), Positives = 136/288 (47%), Gaps = 42/288 (14%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILA--ERNILISVRNPFVVRF 823
+ +G+FG V+L + + +KVLK+ + N E++ A E +L + +P +V+F
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE----LVLALEYLHSLNV 879
SF R+ ++ EY G DL L L + ++ + E L+L + Y+H +
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
+HRDLK N+ + ++ +K+ DFG+S+ L+ + DL+
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGVSR--LLMGSCDLAT--------------------- 163
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999
+ GTP Y++PE L G+ + +D WS+G IL+E+ F + +
Sbjct: 164 -------TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR 216
Query: 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
I+ P++PE S + ++ +L ++P R A E+ ++PF
Sbjct: 217 IVEGPT--PSLPETYSRQLNSIMQSMLNKDPSLRPSAA---EILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-22
Identities = 85/327 (25%), Positives = 137/327 (41%), Gaps = 89/327 (27%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKA--------DMIRKNAVESILAERNILIS 814
++P+ GAFG V AR + TG AIK + K R+ + L NI IS
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-IS 73
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
+ + F+ + E++Y V E L G DL+ LL + L++ + ++ +++ L+Y+
Sbjct: 74 LSDIFI-------SPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYV 124
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
HS V+HRDLKP N+LI ++ +K+ DFGL+++
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI--------------------------- 157
Query: 935 QPPLTREQRQKHSVAG---TPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNA 990
Q + G T Y APEI+L + D WS G I E+L G P F
Sbjct: 158 ---------QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208
Query: 991 KT---------------PQQIFDNIMNRD-------------IPWPNIPEEMSVEACDLI 1022
K P + + I + + +P+ + A DL+
Sbjct: 209 KDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLL 268
Query: 1023 DKLLTENPVQRLGATGAREVKQHPFFK 1049
+K+L +P +R+ A E HP+
Sbjct: 269 EKMLVFDPQKRISAA---EALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 5e-22
Identities = 89/324 (27%), Positives = 139/324 (42%), Gaps = 76/324 (23%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVE----SILAERNILISV 815
F+ ++ + +G + V+ R R TG++ A+K I +A E + + E +++ +
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKE------IHLDAEEGTPSTAIREISLMKEL 55
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDMARVYIAELVLALE 872
++ +VR L LV EY++ DL + G LD + + + +L+ +
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
+ H V+HRDLKP NLLI + G +KL DFGL++ + G VN
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGELKLADFGLAR----------------AFGIPVNTFS 158
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPF--- 988
+ L Y AP++LLG +T+ D WSVG I+ E++ G P F
Sbjct: 159 NEVVTLW--------------YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204
Query: 989 -NAKTPQQIFDNIMN--RDIPWPNI---PE------------------EMSVEACDLIDK 1024
N +IF IM + WP I PE DL+ +
Sbjct: 205 NNEDQLLKIF-RIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHR 263
Query: 1025 LLTENPVQRLGATGAREVKQHPFF 1048
LL NP R+ A A QHP+F
Sbjct: 264 LLQLNPELRISAHDAL---QHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-22
Identities = 79/304 (25%), Positives = 138/304 (45%), Gaps = 56/304 (18%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV---R 816
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L R
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 817 NPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELV 868
N + ++ +F + + L+LVME+ G + L++N L ED E++
Sbjct: 74 N--IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
L +LH+ VIHRD+K N+L+ ++ +KL DFG+S
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 169
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLI 983
L R ++++ GTP ++APE++ + +D WS+GI E+
Sbjct: 170 --------QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE 221
Query: 984 GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043
G PP P + ++ R+ P ++ S + D I+ L +N + R ++
Sbjct: 222 GAPPLCDMHPMRAL-FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSR---PSTEQLL 277
Query: 1044 QHPF 1047
+HPF
Sbjct: 278 KHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-21
Identities = 85/327 (25%), Positives = 144/327 (44%), Gaps = 80/327 (24%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKK---ADMIRKNAVESILAERNILISVRNPF 819
+K + GA+G V A R TG AIK L + +++ K A E +L +++
Sbjct: 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR----ELRLLKHMKHEN 75
Query: 820 VVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
V+ FT +L YLVM ++ G DL L+++ L ED + + +++ L+Y
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-LSEDRIQFLVYQMLKGLKY 133
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
+H+ +IHRDLKP NL + +D +K+ DFGL++ + +++ G++V
Sbjct: 134 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMT-------GYVV----- 177
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK- 991
T Y APE++L M + T D WSVG I+ E+L G P F
Sbjct: 178 -----------------TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220
Query: 992 -------------TPQQIF------DNIMNRDIPWPNIPEE--------MSVEACDLIDK 1024
TP + F ++ N P ++ + A ++++K
Sbjct: 221 HLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEK 280
Query: 1025 LLTENPVQRLGATGAREVKQHPFFKNI 1051
+L + R+ A E HP+F+
Sbjct: 281 MLVLDAESRITAA---EALAHPYFEEF 304
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 9e-21
Identities = 85/326 (26%), Positives = 132/326 (40%), Gaps = 71/326 (21%)
Query: 741 SLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVL--KKADMIR 798
S +S S+ + E + I GA G V+ R TG L+A+KV+ D +R
Sbjct: 57 SSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR 116
Query: 799 KNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 858
+ I E IL V +P VV+ F + +++E+++GG L D
Sbjct: 117 R----QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD 172
Query: 859 MARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918
+AR +++ + YLH +++HRD+KP NLLI ++K+ DFG+S++
Sbjct: 173 VAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI----------- 217
Query: 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPE-ILLGMGHGA----TADWWS 973
L + +S GT Y++PE I + HGA D WS
Sbjct: 218 -------------------LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWS 258
Query: 974 VGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPW------------PNIPEEMSVEACDL 1021
+G+ + E +G PF + R W P P S E
Sbjct: 259 LGVSILEFYLGRFPFG-----------VGRQGDWASLMCAICMSQPPEAPATASREFRHF 307
Query: 1022 IDKLLTENPVQRLGATGAREVKQHPF 1047
I L P +R A ++ QHPF
Sbjct: 308 ISCCLQREPAKRWSAM---QLLQHPF 330
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-20
Identities = 72/245 (29%), Positives = 119/245 (48%), Gaps = 40/245 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DFE I + G G V + + +G + A K++ I+ I+ E +L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNS 62
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED-MARVYIAELVLALEYLHS 876
P++V F+ +F + + ME+++GG L +L+ + E+ + +V IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-VLRGLAYLRE 121
Query: 877 LN-VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
+ ++HRD+KP N+L+ G IKL DFG+S G L++
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS-------------------GQLIDS----- 157
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG---IPPFNAKT 992
+S GT Y++PE L G + +D WS+G+ L EL IG IPP +AK
Sbjct: 158 --------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE 209
Query: 993 PQQIF 997
+ IF
Sbjct: 210 LEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 2e-20
Identities = 78/303 (25%), Positives = 135/303 (44%), Gaps = 54/303 (17%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
FE+++ + G +G+V+ R TG L AIKV+ + + E I E N+L +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 820 VVRFFYSFTCREN-------LYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLA 870
+ +Y ++N L+LVME+ G + L++N L E+ E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
L +LH VIHRD+K N+L+ ++ +KL DFG+S
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------------------------ 159
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGI 985
L R ++++ GTP ++APE++ + +D WS+GI E+ G
Sbjct: 160 ------QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 213
Query: 986 PPFNAKTPQQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044
PP P + ++ R+ P P + ++ S + I+ L +N QR ++ +
Sbjct: 214 PPLCDMHPMRAL-FLIPRN-PAPRLKSKKWSKKFQSFIESCLVKNHSQR---PTTEQLMK 268
Query: 1045 HPF 1047
HPF
Sbjct: 269 HPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 88/332 (26%), Positives = 139/332 (41%), Gaps = 85/332 (25%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER--------- 809
D E +PI GAFG V+ G A LKK + +N V R
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVA---LKKMPNVFQNLVSCKRVFRELKMLCFFK 57
Query: 810 --NIL--ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA 865
N+L + + P + F E +Y+V E + DL+ ++ + L D +V++
Sbjct: 58 HDNVLSALDILQPPHIDPF------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLY 110
Query: 866 ELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+++ L+YLHS ++HRD+KP NLL+ + +K+ DFGL++V
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV------------------ 152
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIG 984
+E + +T+E T Y APEIL+G H +A D WSVG I ELL
Sbjct: 153 ----EEPDESKHMTQE-------VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201
Query: 985 IPPFNAKTPQQIFDNIMN----------------------RDIPWP-------NIPEEMS 1015
F A++P Q D I + R P + + +
Sbjct: 202 RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQAT 261
Query: 1016 VEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
EA L+ ++L +P +R+ A + HP+
Sbjct: 262 HEAVHLLCRMLVFDPDKRISAA---DALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 2e-20
Identities = 85/341 (24%), Positives = 152/341 (44%), Gaps = 73/341 (21%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
+ + + I + + GA G V A++ + G+ FA+KV+ M + + AE L
Sbjct: 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA-QAEVCCL 85
Query: 813 ISVRNPFVVRFFYSFTCRENLY--------------LVMEYLNGGDLYSLLRNLG----C 854
++ FF C E+ LV++Y N GDL +++
Sbjct: 86 LNCD------FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRT 139
Query: 855 LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914
E A + +++LA+ ++HS ++IHRD+K N+L+ +G +KL DFG SK+ +D
Sbjct: 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD 199
Query: 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974
D+ + GTP Y+APEI + AD +S+
Sbjct: 200 DVG----------------------------RTFCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 975 GIILFELLIGIPPFNAKTPQQIFDNIMNRDIP--WPNIPEEMSVEACDLIDKLLTENPVQ 1032
G++L+ELL PF+ + ++ +M++ + + +P +S E +++ LL+ +P +
Sbjct: 232 GVLLYELLTLKRPFDGENMEE----VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKR 287
Query: 1033 R-------------LGATGAREVKQ-HPFFKNINWDTLARQ 1059
R L +G E+ Q P F DT++RQ
Sbjct: 288 RPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQ 328
|
Length = 496 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 84/315 (26%), Positives = 145/315 (46%), Gaps = 64/315 (20%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES----ILAERNILI 813
ED + + I +GAFG V + +G + A+K IR E +L + ++++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK------RIRSTVDEKEQKRLLMDLDVVM 57
Query: 814 SVRN-PFVVRFFYSFTCRE-NLYLVMEYLNGG--DLYSLLRNL--GCLDEDM-ARVYIAE 866
+ P++V+F Y RE + ++ ME ++ Y + + + E++ ++ +A
Sbjct: 58 RSSDCPYIVKF-YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA- 115
Query: 867 LVLALEYL-HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
V AL YL L +IHRD+KP N+L+ ++G+IKL DFG+S G
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS-------------------G 156
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELL 982
LV+ K TR+ AG Y+APE + G+ +D WS+GI L+E+
Sbjct: 157 QLVDSIAK-----TRD-------AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVA 204
Query: 983 IGIPPFNAKTPQQIFDNI---MNRDIPW--PNIPEEMSVEACDLIDKLLTENPVQRLGAT 1037
G P+ +FD + + D P + E S + I+ L ++ +R
Sbjct: 205 TGKFPYPKWNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKR---P 259
Query: 1038 GAREVKQHPFFKNIN 1052
+E+ +HPF K+
Sbjct: 260 KYKELLEHPFIKDYE 274
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 5e-20
Identities = 83/330 (25%), Positives = 142/330 (43%), Gaps = 78/330 (23%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVR 822
++P+ G+ G VF A A+K K + +V+ L E I+ + + +V+
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 823 FFY--------------SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV 868
+ S T ++Y+V EY+ DL ++L G L E+ AR+++ +L+
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLL 124
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHI-KLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
L+Y+HS NV+HRDLKP N+ I + + K+ DFGL+++ P G+L
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI---------VDPHYSHKGYL 175
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIP 986
+ T Y +P +LL + A D W+ G I E+L G P
Sbjct: 176 SEGLV------------------TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
Query: 987 PFNA----KTPQQIFDNI-MNRDI----------------------PWPNIPEEMSVEAC 1019
F + Q I +++ + R+ P ++ ++ EA
Sbjct: 218 LFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL 277
Query: 1020 DLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
D ++++LT NP+ RL A E HP+
Sbjct: 278 DFLEQILTFNPMDRL---TAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 1e-19
Identities = 72/220 (32%), Positives = 106/220 (48%), Gaps = 38/220 (17%)
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDL----YSLLRNLGCLDEDMARVYIAELVLALEYLH 875
+V+ F F + L L+MEY +GGDL L+ E + ++VLAL+ +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S ++HRDLK N+ + G IKL DFG SK +D +S + S
Sbjct: 187 SRKMMHRDLKSANIFLMPTGIIKLGDFGFSK----QYSDSVSL-DVAS------------ 229
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
S GTP YLAPE+ + AD WS+G+IL+ELL PF + ++
Sbjct: 230 -----------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE 278
Query: 996 IFDNIM--NRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
I ++ D P+P P ++A L+D LL++NP R
Sbjct: 279 IMQQVLYGKYD-PFP-CPVSSGMKA--LLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-19
Identities = 88/324 (27%), Positives = 145/324 (44%), Gaps = 81/324 (25%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKK---ADMIRKNAVESILAERNILISVRNPF 819
+K + GA+G V A + TG+ AIK L + +++ K A E +L +++
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR----ELTLLKHMQHEN 75
Query: 820 VVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
V+ FT ++ YLVM Y+ DL ++ + L ED + + +++ L+Y
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQMLCGLKY 132
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
+HS +IHRDLKP NL + +D +K+ DFGL++ H+ +++ G++V
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMT-------GYVV----- 176
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKT 992
T Y APE++L M + T D WSVG I+ E+L G F K
Sbjct: 177 -----------------TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
Query: 993 PQQIFDNIMN-RDIPWPNIPEEM---------------------------SVEACDLIDK 1024
I+ +P P +++ S +A DL++K
Sbjct: 220 YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEK 279
Query: 1025 LLTENPVQRLGATGAREVKQHPFF 1048
+L + +RL AT A E HP+F
Sbjct: 280 MLELDVDKRLTATEALE---HPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-19
Identities = 92/350 (26%), Positives = 143/350 (40%), Gaps = 96/350 (27%)
Query: 760 FEIIKPISQGAFGRVFLAR--KRATGDLFAIKVLKKADMIRKNAVESILAERNI--LISV 815
+EI I +G +GRV+ A+ G +AIK K D + + S A R I L +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK-GDKEQYTGI-SQSACREIALLREL 59
Query: 816 RNPFVV---RFFYSFTCRENLYLVMEYLNGGDLYSLLR-----NLGCLDEDMARVYIAEL 867
++ VV F + +YL+ +Y DL+ +++ + M + + ++
Sbjct: 60 KHENVVSLVEVFLEHADKS-VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117
Query: 868 VLALEYLHSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
+ + YLHS V+HRDLKP N+L+ + G +K+ D GL++
Sbjct: 118 LNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR----------------- 160
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELL 982
L N LK P + V T Y APE+LLG H A D W++G I ELL
Sbjct: 161 ---LFNAPLK--PLADLDP-----VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
Query: 983 IGIPPFNAK-------TPQQ------IFDNIMN--RDIPWPNI---PE------------ 1012
P F + P Q IF ++ + WP+I PE
Sbjct: 211 TLEPIFKGREAKIKKSNPFQRDQLERIF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKT 269
Query: 1013 --------------EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
+ + DL+ KLL +P +R+ A E +HP+F
Sbjct: 270 YPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI---TAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 72/259 (27%), Positives = 113/259 (43%), Gaps = 46/259 (17%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
I +G FG VF R RA A+K + + + + L E IL +P +VR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV-------LALEYLHSLN 878
T ++ +Y+VME + GGD + LR G R+ + EL+ +EYL S +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH 114
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
IHRDL N L+ + +K++DFG+S+ D + A +GG Q P+
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYA---STGGM-------KQIPV 160
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQQIF 997
+ APE L + + +D WS GI+L+E +G P+ + QQ
Sbjct: 161 K--------------WTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR 206
Query: 998 DNIMN--RDIPWPNIPEEM 1014
+ I R P+ +
Sbjct: 207 EAIEQGVRLPCPELCPDAV 225
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 90/327 (27%), Positives = 147/327 (44%), Gaps = 69/327 (21%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKV--LKKADMIRKNAVESILAERNILIS 814
++ +E ++ I +G +G V+ AR R T + A+K L++ D + + + E ++L
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED---EGVPSTAIREISLLKE 57
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED--MARVYIAELVLALE 872
+++ +VR + LYLV EYL+ DL + + ++ + + Y+ +++ +
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGH-IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
Y HS V+HRDLKP NLLI + + +KL DFGL++ I
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--------------------- 155
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT-ADWWSVGIILFELLIGIPPFNA 990
P T H V T Y APEILLG H +T D WSVG I E++ P F
Sbjct: 156 ----PVRTF----THEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206
Query: 991 KTP-QQIFDNIMNRDIP----WP---NIPEEMSV------------------EACDLIDK 1024
+ ++F P WP ++P+ S DL+ K
Sbjct: 207 DSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSK 266
Query: 1025 LLTENPVQRLGATGAREVKQHPFFKNI 1051
+L +P +R+ A A E H +FK++
Sbjct: 267 MLRLDPSKRITARAALE---HEYFKDL 290
|
Length = 294 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 3e-19
Identities = 81/326 (24%), Positives = 138/326 (42%), Gaps = 68/326 (20%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ +E ++ + +G++ V+ + + G L A+KV++ + + + + E ++L +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
+V +E L LV EY++ + ++ G L + ++++ +L+ L Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
++HRDLKP NLLI G +KL DFGL++ S PS +V
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAK--------SVPSHTYSNEVV--------- 165
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPF-NAKTPQQ 995
T Y P++LLG +T D W VG I E++ G+ F K Q
Sbjct: 166 -------------TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD 212
Query: 996 IFDNIM------NRDIPWPNI-------PEEMSV-----------------EACDLIDKL 1025
+ I N D WP + PE ++ A DL KL
Sbjct: 213 QLERIFLVLGTPNEDT-WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKL 271
Query: 1026 LTENPVQRLGATGAREVKQHPFFKNI 1051
L P RL A A H +F ++
Sbjct: 272 LQCFPKNRLSAQAAL---SHEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-18
Identities = 79/304 (25%), Positives = 131/304 (43%), Gaps = 55/304 (18%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
++ ++II+ I +G G V+LA A LKK IR++ E+ L ++ L +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVA---LKK---IREDLSENPLLKKRFLREAK 54
Query: 817 ------NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
+P +V + + + +Y M Y+ G L SLL+++ + + V A
Sbjct: 55 IAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 871 L-----------EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD--DLS 917
EY+HS V+HRDLKPDN+L+G G + + D+G + + D D+
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGII 977
+ GTPDY+APE LLG+ + D +++G+I
Sbjct: 175 VDERNI--------------CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
Query: 978 LFELLIGIPPFNAKTPQQIFDNIMNRDI--------PWPNIPEEMSVEACDLIDKLLTEN 1029
L+++L P+ K I RD+ P+ IP +S A K L +
Sbjct: 221 LYQMLTLSFPYRRKK----GRKISYRDVILSPIEVAPYREIPPFLSQIAM----KALAVD 272
Query: 1030 PVQR 1033
P +R
Sbjct: 273 PAER 276
|
Length = 932 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-18
Identities = 94/343 (27%), Positives = 155/343 (45%), Gaps = 57/343 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E ++ + P+ GA+G V A TG A+K L + +A + E +L +++
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLKHMKH 75
Query: 818 PFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVL 869
V+ FT +L YLV +L G DL ++++ C L +D + I +++
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIVK---CQKLTDDHVQFLIYQILR 131
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
L+Y+HS ++IHRDLKP NL + +D +K+ DFGL++ H+ D+++ G++
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMT-------GYV-- 178
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPF 988
T Y APEI+L M + T D WSVG I+ ELL G F
Sbjct: 179 --------------------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
Query: 989 NAKTPQQIFDNIMN-RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQH 1045
I+ P + +++S E+ + LT+ P GA +
Sbjct: 219 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 278
Query: 1046 PFFKNINWDTLARQKAMFIPAAESLDTSYFVSRYVWNPEDENV 1088
K + D+ R I AA++L +YF + +P+DE V
Sbjct: 279 LLEKMLVLDSDKR-----ITAAQALAHAYFAQYH--DPDDEPV 314
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 83/329 (25%), Positives = 135/329 (41%), Gaps = 78/329 (23%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVE----SILAERNIL 812
+E ++ + + +G++ V+ R + TG L A+K IR E + + E ++L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE------IRLEHEEGAPFTAIREASLL 57
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLAL 871
+++ +V ++ L LV EYL+ DL + + G L R+++ +L+ L
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
Y H V+HRDLKP NLLI + G +KL DFGL++ S PS
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAK--------SVPS----------- 157
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNA 990
+ + V T Y P++LLG +T+ D W VG I +E+ G P F
Sbjct: 158 ----------KTYSNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206
Query: 991 KTP-----QQIFDNIMNRDIP--WPNIPE------------------------EMSVEAC 1019
T +IF ++ WP + +
Sbjct: 207 STDVEDQLHKIF-RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGE 265
Query: 1020 DLIDKLLTENPVQRLGATGAREVKQHPFF 1048
+L K L P +R+ A E +HP+F
Sbjct: 266 ELALKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 74/267 (27%), Positives = 121/267 (45%), Gaps = 49/267 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E ++ + + G FG V++ T + A+K LK M + E+ L E I+ +R+
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-------LGCLDEDMARVYIAELVLA 870
+V+ + + E +Y+V EY++ G L L++ L L DMA A++
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-VDMA----AQIAEG 115
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+ YL S N IHRDL N+L+G++ K+ DFGL++ LI DD G+
Sbjct: 116 MAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR--LIE--DDEYTAREGA------- 164
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFN 989
K + T APE +D WS GI+L E++ G P+
Sbjct: 165 --------------KFPIKWT----APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206
Query: 990 AKTPQQIFDNIM-NRDIPWP-NIPEEM 1014
T +++ + + +P P N PEE+
Sbjct: 207 GMTNREVLEQVERGYRMPRPPNCPEEL 233
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-18
Identities = 94/327 (28%), Positives = 143/327 (43%), Gaps = 73/327 (22%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFA----IKVLKKADMIRKNAVESILAERNILI 813
+ +E + I +GA+G+VF AR G F ++V + + + + + R+ L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LE 59
Query: 814 SVRNPFVVRFF----YSFTCREN-LYLVMEYLNGGDLYSLLRNL---GCLDEDMARVYIA 865
+ +P VVR F S T RE L LV E+++ DL + L + G E + + +
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM-MF 117
Query: 866 ELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+L+ L++LHS V+HRDLKP N+L+ G IKL DFGL++ I+S
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALT------- 167
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985
SV T Y APE+LL + D WSVG I E+
Sbjct: 168 ---------------------SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
Query: 986 PPF--NAKTPQ--QIFDNI-MNRDIPWPN---IPE----------------EMSVEACDL 1021
P F ++ Q +I D I + + WP +P ++ DL
Sbjct: 207 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 266
Query: 1022 IDKLLTENPVQRLGATGAREVKQHPFF 1048
+ K LT NP +R+ A A HP+F
Sbjct: 267 LLKCLTFNPAKRISAYSALS---HPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 73/263 (27%), Positives = 120/263 (45%), Gaps = 53/263 (20%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKK---ADMIRKNAVESILAERNILISVRNPFVVR 822
I +G FG V+ + ++ A+K + D+ RK L E IL +P +V+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV-------LALEYLH 875
++ +Y+VME + GG L + LR R+ + +L+ +EYL
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLE 110
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S N IHRDL N L+G++ +K++DFG+S+ + G + V+D LK Q
Sbjct: 111 SKNCIHRDLAARNCLVGENNVLKISDFGMSR-----EEEG--------GIYTVSDGLK-Q 156
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQ 994
P+ + APE L + + +D WS GI+L+E +G P+ + Q
Sbjct: 157 IPIK--------------WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ 202
Query: 995 QIFDNI-MNRDIPWPNI-PEEMS 1015
Q + I +P P + PEE+
Sbjct: 203 QTRERIESGYRMPAPQLCPEEIY 225
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-17
Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 46/273 (16%)
Query: 711 NLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGA 770
+L I D L+ S+ + ES D+D L P +++ + + +IK ++ G+
Sbjct: 23 DLYSDISDGDLEYSDDDSASESDDDDDD--GLI--PTKQKAREVVASLGYTVIKTLTPGS 78
Query: 771 FGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830
GRVF+A K D +K+ +K + L E +L +V +P V+R +
Sbjct: 79 EGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSG 129
Query: 831 ENLYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889
+V+ + + DLY+ L + L D A + +++ L YLH+ +IHRD+K +N+
Sbjct: 130 AITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENI 188
Query: 890 LIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVA 949
I + + D G ++ ++ LG +A
Sbjct: 189 FINDVDQVCIGDLGAAQFPVVAPAF------LG-------------------------LA 217
Query: 950 GTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
GT + APE+L + + AD WS GI+LFE+L
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 79/323 (24%), Positives = 127/323 (39%), Gaps = 59/323 (18%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES------------ILAERNILI 813
+ +G +G+V A TG + AIK +K + I + + L E I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIE-ISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
+++ ++ + + + LVM+ + DL ++ L E + + +++ L
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LH +HRDL P N+ I G K+ DFGL++ G +D L
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLAR---------------RYGYPPYSDTLS 179
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAKT 992
+ R + V T Y APE+L+G + D WSVG I ELL G P F +
Sbjct: 180 KDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 993 PQQIFDNIMN-----RDIPWP--------------------NIPEEMSVEACDLIDKLLT 1027
I + WP I S +A DL+ LL
Sbjct: 239 EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298
Query: 1028 ENPVQRLGATGAREVKQHPFFKN 1050
NP++R+ A A + H +FK+
Sbjct: 299 LNPLERISAKEALK---HEYFKS 318
|
Length = 335 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 92/324 (28%), Positives = 143/324 (44%), Gaps = 72/324 (22%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIK---VLKKADMIRKNAV-ESILAERNILISV 815
+E + I GA+G V+ AR +G A+K V D + + V E L +R L +
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKR--LEAF 59
Query: 816 RNPFVVRFF----YSFTCRE-NLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELV 868
+P +VR S T RE + LV E+++ DL + L + L + + + + +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
L++LH+ ++HRDLKP+N+L+ G +KL DFGL++ I+S P
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTP--------- 166
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988
V T Y APE+LL + D WSVG I E+ P F
Sbjct: 167 -------------------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207
Query: 989 --NAKTPQ--QIFDNI-MNRDIPWP-------------------NIPEEMSVEACDLIDK 1024
N++ Q +IFD I + + WP ++ E+ L+ +
Sbjct: 208 CGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLE 267
Query: 1025 LLTENPVQRLGATGAREVKQHPFF 1048
+LT NP +R+ A A QHPFF
Sbjct: 268 MLTFNPHKRISAFRAL---QHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 89/343 (25%), Positives = 141/343 (41%), Gaps = 104/343 (30%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVL----------KKADMIRKNAVESILAERNIL 812
+KPI GA G V A TG AIK L K+A R+ + ++ +NI
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRA--YRELVLMKLVNHKNI- 77
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC------LDEDMARVYIAE 866
I + N F + S +++YLVME ++ NL C LD + + +
Sbjct: 78 IGLLNVFTPQ--KSLEEFQDVYLVMELMDA--------NL-CQVIQMDLDHERMSYLLYQ 126
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
++ +++LHS +IHRDLKP N+++ D +K+ DFGL++ F
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------------AGTSF 172
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
++ + +TR Y APE++LGMG+ D WSVG I+ E++ G
Sbjct: 173 MMTPYV-----VTRY------------YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215
Query: 987 PFNAK--------------TPQQIFDN---------IMNR-------------DIPWPNI 1010
F TP F + + NR D+ +P
Sbjct: 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPD 275
Query: 1011 PEEMS----VEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
E + +A DL+ K+L +P +R+ A QHP+
Sbjct: 276 SESHNKLKASQARDLLSKMLVIDPEKRISVDDAL---QHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 64/251 (25%), Positives = 112/251 (44%), Gaps = 48/251 (19%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+D +K + G FG V + R D+ AIK++K+ M +E E +++ + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSH 58
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL-------A 870
+V+ + T + +Y+V EY++ G L + LR E R ++L+
Sbjct: 59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR------EHGKRFQPSQLLEMCKDVCEG 112
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+ YL S IHRDL N L+ G +K++DFGLS+ L DD S+GS
Sbjct: 113 MAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL----DDEYTSSVGS------- 161
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFN 989
K V +P PE+LL + +D W+ G++++E+ +G P+
Sbjct: 162 --------------KFPVRWSP----PEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
Query: 990 AKTPQQIFDNI 1000
+ + +
Sbjct: 204 RFNNSETVEKV 214
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 63/276 (22%), Positives = 117/276 (42%), Gaps = 50/276 (18%)
Query: 758 EDFEIIKPISQGAFGRVF--LARKRATGDLF---AIKVLKKADMIRKNAVESILAERNIL 812
E +I+ + QG+FG V+ LA+ G+ AIK + + +R+ L E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVM 63
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYI-------- 864
VVR + + +VME + GDL S LR+ + +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRP-EAENNPGLGPPTLQKFI 122
Query: 865 ---AELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921
AE+ + YL + +HRDL N ++ +D +K+ DFG+++ I+ TD
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRK--- 177
Query: 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981
G G L P+ ++APE L +D WS G++L+E+
Sbjct: 178 GGKGLL---------PVR--------------WMAPESLKDGVFTTKSDVWSFGVVLWEM 214
Query: 982 L-IGIPPFNAKTPQQIFDNIMNRDI-PWP-NIPEEM 1014
+ P+ + +++ +++ P N P+++
Sbjct: 215 ATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKL 250
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 43/229 (18%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
+ ++ ++ I +G FG V L R G A+K LK A ++ LAE +++ ++
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD----DSTAAQAFLAEASVMTTL 57
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEY 873
R+P +V+ LY+V EY+ G L LR+ G + + ++ +EY
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
L N +HRDL N+L+ +D K++DFGL+K
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--------------------------- 150
Query: 934 DQPPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADWWSVGIILFEL 981
E Q P + APE L +D WS GI+L+E+
Sbjct: 151 -------EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 4e-17
Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 50/240 (20%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F ++ I G+FG V+ AR T ++ AIK + + + I+ E L +++P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 820 VVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDMARVYIAEL----VLALEY 873
+ + + +LVMEY G DL + + + + V IA + + L Y
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAITHGALQGLAY 140
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LHS N+IHRD+K N+L+ + G +KL DFG + +++P+
Sbjct: 141 LHSHNMIHRDIKAGNILLTEPGQVKLADFG---------SASIASPA------------- 178
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHG---ATADWWSVGIILFELLIGIPP-FN 989
+S GTP ++APE++L M G D WS+GI EL PP FN
Sbjct: 179 ------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 5e-17
Identities = 78/321 (24%), Positives = 134/321 (41%), Gaps = 74/321 (23%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESI----LAERNILISVRNP 818
++ + +G++ V+ R G L A+KV I E + + E ++L +++
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN 878
+V +E L V EY++ ++++ G L R+++ +L+ L Y+H +
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
++HRDLKP NLLI G +KL DFGL++ S PS +V
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAK--------SIPSQTYSSEVV---------- 165
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPF--NAKTPQQ 995
T Y P++LLG ++A D W G I E+L G P F + +Q
Sbjct: 166 ------------TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213
Query: 996 IFDNIMNRDIP----WPNI---------------PEEMSV---------EACDLIDKLLT 1027
+ +P WP + P+++ V +A DL ++L
Sbjct: 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLM 273
Query: 1028 ENPVQRLGATGAREVKQHPFF 1048
P R+ A++ HP+F
Sbjct: 274 MFPKDRI---SAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 35/241 (14%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+E + + + +G + VF R + T +L A+K ++ + A + + E ++L +++
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLK 61
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCL-DEDMARVYIAELVLALEYLH 875
+ +V L LV EYL+ DL L N G L ++++ +L+ L Y H
Sbjct: 62 HANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
++HRDLKP NLLI + G +KL DFGL++ S P+ +V
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAK--------SVPTKTYSNEVV------- 165
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAKTPQ 994
T Y P++LLG +T D W VG IL+E+ G P F T +
Sbjct: 166 ---------------TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK 210
Query: 995 Q 995
+
Sbjct: 211 E 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-17
Identities = 66/234 (28%), Positives = 100/234 (42%), Gaps = 38/234 (16%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F ++ I G+FG V+ AR ++ AIK + + + I+ E L +R+P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
+++ + +LVMEY G L + L E + L YLHS N+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
IHRD+K N+L+ + G +KL DFG + + AP+
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASI---------MAPA------------------- 168
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHG---ATADWWSVGIILFELLIGIPP-FN 989
+ GTP ++APE++L M G D WS+GI EL PP FN
Sbjct: 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 1e-16
Identities = 76/295 (25%), Positives = 140/295 (47%), Gaps = 36/295 (12%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS 814
+ + ++E+IK I G FG VFL + + T + F K + + + + ++ E N++
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-EVNVMRE 68
Query: 815 VRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELV 868
+++ +VR+ F + N LY++ME+ + GDL ++ G ++E +L+
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 869 LALEYLHSLN-------VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS-TDDLSA-P 919
AL Y H+L V+HRDLKP N+ + G+ +G I + ++L+ P
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLST---------GIRHIGKITAQANNLNGRP 179
Query: 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL--GMGHGATADWWSVGII 977
G F ++ + + HS GTP Y +PE+LL + +D W++G I
Sbjct: 180 IAKIGDFGLSKNIGI-------ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 978 LFELLIGIPPFNAKT--PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENP 1030
++EL G PF+ Q I + D+P +E+++ +L++ E P
Sbjct: 233 IYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 1e-16
Identities = 71/259 (27%), Positives = 112/259 (43%), Gaps = 51/259 (19%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E F + I G+FG V+ A T ++ A+K + + + I+ E L +++
Sbjct: 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH 80
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDMARVYIAEL----VLAL 871
P + + + +LVMEY G DL + + + + V IA + + L
Sbjct: 81 PNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAITHGALQGL 134
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
YLHS N+IHRD+K N+L+ + G +KL DFG + S+P+
Sbjct: 135 AYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK---------SSPA----------- 174
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHG---ATADWWSVGIILFELLIGIPP- 987
+S GTP ++APE++L M G D WS+GI EL PP
Sbjct: 175 --------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
Query: 988 FNAKTPQQIFDNIMNRDIP 1006
FN ++ +I D P
Sbjct: 221 FNMNAMSALY-HIAQNDSP 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 73/285 (25%), Positives = 129/285 (45%), Gaps = 52/285 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E +++K + G FG V++ + AIK LK+ M + E+ LAE N++ +++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE------DMARVYIAELVLAL 871
P +VR Y+ +E +Y++ EY+ G L L+ + DMA A++ +
Sbjct: 61 PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA----AQIAEGM 115
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
++ N IHRDL+ N+L+ + K+ DFGL+++ + ++E
Sbjct: 116 AFIERKNYIHRDLRAANILVSETLCCKIADFGLARL-------------------IEDNE 156
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990
T + K + T APE + +D WS GI+L E++ G P+
Sbjct: 157 ------YTAREGAKFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
Query: 991 KTPQQIFDNI-MNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQR 1033
T ++ N+ +P P N PEE+ +L+ E P +R
Sbjct: 207 MTNPEVIQNLERGYRMPRPDNCPEELY----ELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 60/251 (23%), Positives = 115/251 (45%), Gaps = 50/251 (19%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
+ +K + G FG V L + R D+ AIK++++ M + +E E +++ + +P
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----EAKVMMKLSHP 59
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL--------A 870
+V+ + T + +++V EY+ G L + LR + E +L A
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR-------ERKGKLGTEWLLDMCSDVCEA 112
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+EYL S IHRDL N L+G+D +K++DFGL++ ++++D
Sbjct: 113 MEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR-------------------YVLDD 153
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFN 989
+ T Q K V P PE+ + +D WS G++++E+ G P+
Sbjct: 154 Q------YTSSQGTKFPVKWAP----PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
Query: 990 AKTPQQIFDNI 1000
+ ++ +++
Sbjct: 204 RFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-16
Identities = 101/376 (26%), Positives = 164/376 (43%), Gaps = 86/376 (22%)
Query: 715 QIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRV 774
+++D+KLD + DED + + + IN R+ + +++ I G+FG V
Sbjct: 29 EMNDKKLDEEERSHNNNAGEDEDEEKMID-NDIN-----RSPNKSYKLGNIIGNGSFGVV 82
Query: 775 FLARKRATGDLFAIK-VLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN- 832
+ A T + AIK VL+ D KN I+ N + F+ ++Y+ ++N
Sbjct: 83 YEAICIDTSEKVAIKKVLQ--DPQYKNRELLIMKNLN---HINIIFLKDYYYTECFKKNE 137
Query: 833 ----LYLVMEYLNGG-----DLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRD 883
L +VME++ Y+ RN L + ++Y +L AL Y+HS + HRD
Sbjct: 138 KNIFLNVVMEFIPQTVHKYMKHYA--RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRD 195
Query: 884 LKPDNLLIGQDGH-IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
LKP NLLI + H +KL DFG SA +L +G Q
Sbjct: 196 LKPQNLLIDPNTHTLKLCDFG-------------SAKNLLAG-----------------Q 225
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGAT-ADWWSVGIILFELLIGIPPFNAK---------- 991
R + + Y APE++LG + T D WS+G I+ E+++G P F+ +
Sbjct: 226 RSVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284
Query: 992 ----TPQQIFDNIMN---RDIPWPNI---------PEEMSVEACDLIDKLLTENPVQRLG 1035
TP + MN DI +P++ P+ +A + I + L P++RL
Sbjct: 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN 344
Query: 1036 ATGAREVKQHPFFKNI 1051
E PFF ++
Sbjct: 345 PI---EALADPFFDDL 357
|
Length = 440 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 59/281 (20%)
Query: 763 IKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
IK + +G FG+V L R TG+ A+K L + E IL ++ +
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH--SGEEQHRSDFEREIEILRTLDHE 66
Query: 819 FVVRFFYSFT--CRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL------- 869
+V++ +L L+MEYL G L L+ ++ + L+L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ------RHRDQINLKRLLLFSSQICK 120
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
++YL S IHRDL N+L+ + +K++DFGL+KV + V
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV-----------LPEDKDYYYVK 169
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989
E + P + APE L + +D WS G+ L+EL P
Sbjct: 170 -EPGESPIF---------------WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS- 212
Query: 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENP 1030
++P F ++ + + L++ LL E
Sbjct: 213 -QSPPAEFLRMIG--------IAQGQMIVTRLLE-LLKEGE 243
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 80/324 (24%), Positives = 137/324 (42%), Gaps = 65/324 (20%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+E + + + +G + V+ R + T +L A+K ++ + A + + E ++L ++
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLH 875
+ +V ++L LV EYL+ DL L + G ++ ++++ +L+ L Y H
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH 121
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
V+HRDLKP NLLI + G +KL DFGL++ S P+ +V
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAK--------SIPTKTYSNEVV------- 166
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAKTPQ 994
T Y P+ILLG +T D W VG I +E+ G P F T +
Sbjct: 167 ---------------TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE 211
Query: 995 QIFDNIMN-----RDIPWP-----------NIPE-----------EMSVEACDLIDKLLT 1027
+ I + WP N P+ + + +L+ KLL
Sbjct: 212 EQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQ 271
Query: 1028 ENPVQRLGATGAREVKQHPFFKNI 1051
+R+ A E +HP+F +
Sbjct: 272 FEGRKRI---SAEEAMKHPYFHCL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-16
Identities = 72/280 (25%), Positives = 113/280 (40%), Gaps = 34/280 (12%)
Query: 782 TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN-LYLVMEYL 840
TG AIK+L+ ++ E + + +P +V S L+ V EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 841 NGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---HI 897
G L +L G L + +++ AL H+ ++HRDLKP N+++ Q G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 898 KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAP 957
K+ DFG+ +L G V D LTR V GTP Y AP
Sbjct: 122 KVLDFGIG--------------TLLPG---VRDADVAT--LTRT----TEVLGTPTYCAP 158
Query: 958 EILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI-FDNIMNRDIPWPNIPEEMSV 1016
E L G +D ++ G+I E L G + +I + + D+ P P
Sbjct: 159 EQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP--PWIAGH 216
Query: 1017 EACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTL 1056
++ K L ++P QR A A + + F+ + L
Sbjct: 217 PLGQVLRKALNKDPRQR--AASAPALAER--FRALELCAL 252
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-16
Identities = 90/339 (26%), Positives = 142/339 (41%), Gaps = 53/339 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E ++ + P+ GA+G V A A+K L + +A + E +L +++
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT-YRELRLLKHMKH 73
Query: 818 PFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLAL 871
V+ FT ++ YLV L G DL ++++ L ++ + I +L+ L
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIVK-CQKLSDEHVQFLIYQLLRGL 131
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
+Y+HS +IHRDLKP N+ + +D +++ DFGL++ DD
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADD---------------- 170
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNA 990
+ T Y APEI+L M + T D WSVG I+ ELL G F
Sbjct: 171 ------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218
Query: 991 KTPQQIFDNIMN-RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPF 1047
IM P P + +++S E + L P Q L GA +
Sbjct: 219 NDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLL 278
Query: 1048 FKNINWDTLARQKAMFIPAAESLDTSYFVSRYVWNPEDE 1086
K + D+ R I A+E+L YF + +PEDE
Sbjct: 279 EKMLVLDSDKR-----ISASEALAHPYFSQYH--DPEDE 310
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 67/242 (27%), Positives = 114/242 (47%), Gaps = 40/242 (16%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAV--ESILAERNILISVRNPFV 820
+K + G FG V L + RA IKV KA I + A+ E + E +++ + +P +
Sbjct: 9 MKELGSGQFGVVHLGKWRAQ-----IKVAIKA--INEGAMSEEDFIEEAKVMMKLSHPKL 61
Query: 821 VRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMARVYIAELVLALEYLHSLNV 879
V+ + T ++ LY+V E++ G L + LR G L +DM ++ +EYL +
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
IHRDL N L+ G +K++DFG+++ L DD S G+
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVL----DDEYTSSSGA---------------- 161
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFD 998
K V +P PE+ + + +D WS G++++E+ G PF K+ ++ +
Sbjct: 162 -----KFPVKWSP----PEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVE 212
Query: 999 NI 1000
I
Sbjct: 213 MI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 59/249 (23%), Positives = 106/249 (42%), Gaps = 41/249 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E+F + + + G FG V+ + + AIK+LK D++++ + E L +R+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQK---EVQALKRLRH 61
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMAR-VYIAELVL-ALEYLH 875
++ F + E +Y++ E + G L + LR+ +A + +A V + YL
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV--GLIHSTDDLSAPSLGSGGFLVNDELK 933
N IHRDL N+L+G+D K+ DFGL+++ ++ + D P
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY------------- 168
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992
+ APE +D WS GI+L+E+ G P+
Sbjct: 169 -------------------KWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209
Query: 993 PQQIFDNIM 1001
+++D I
Sbjct: 210 NHEVYDQIT 218
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 74/271 (27%), Positives = 120/271 (44%), Gaps = 50/271 (18%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
DRTSI+ +++ + G FG V+ T + A+K LK M + LAE I+
Sbjct: 4 DRTSIQ---LLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIM 55
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC----LDE--DMARVYIAE 866
+R+P +++ + T E +Y+V E + G L L+ L + DMA A+
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQ 111
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+ + YL + N IHRDL N+L+G++ K+ DFGL++V
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV------------------- 152
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GI 985
+K+ RE K + T APE L +D WS GI+L E++ G
Sbjct: 153 -----IKEDIYEAREG-AKFPIKWT----APEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
Query: 986 PPFNAKTPQQIFDNI-MNRDIPWP-NIPEEM 1014
P+ T ++ + +P P P+E+
Sbjct: 203 MPYPGMTNAEVLQQVDQGYRMPCPPGCPKEL 233
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 1e-15
Identities = 49/176 (27%), Positives = 86/176 (48%), Gaps = 23/176 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKR---ATGD--LFAIKVLKKADMIRKNAVESILAERNIL 812
+ + + + +GAFG+VFL D L A+K LK + +A + E +L
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAELL 62
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-------LGCLDEDMARVYIA 865
+ ++ +V+F+ T + +V EY+ GDL LR+ L D M + ++
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 866 ELV-------LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914
+L+ + YL S + +HRDL N L+G D +K+ DFG+S+ +++TD
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD--VYTTD 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-15
Identities = 81/340 (23%), Positives = 144/340 (42%), Gaps = 87/340 (25%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI- 813
T ++ ++ +KPI GA G V A G A+K L + +N + A R +++
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLL 74
Query: 814 -SVRNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE 866
V + ++ FT + +++YLVME ++ + L D + + +
Sbjct: 75 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMEL---DHERMSYLLYQ 131
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
++ +++LHS +IHRDLKP N+++ D +K+ DFGL++ T+ + P +
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYV----- 183
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL---- 982
+TR Y APE++LGMG+ D WSVG I+ EL+
Sbjct: 184 -----------VTRY------------YRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220
Query: 983 -----------------IGIPP--FNAKTPQQIFDNIMNR-------------DIPWPNI 1010
+G P F + + + + NR D +P+
Sbjct: 221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSE 280
Query: 1011 PEEMSV---EACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
E + +A DL+ K+L +P +R+ E +HP+
Sbjct: 281 SERDKLKTSQARDLLSKMLVIDPDKRI---SVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 90/334 (26%), Positives = 140/334 (41%), Gaps = 81/334 (24%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKK-----ADMIRKNAVESILAERNILIS 814
++I + I +G++G V A TG+ AIK + +D R IL E +L
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR------ILREIKLLRL 55
Query: 815 VRNPFVV---RFFYSFTCRE--NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL 869
+R+P +V + RE ++Y+V E L DL+ +++ L + + ++ +L+
Sbjct: 56 LRHPDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
AL+Y+H+ NV HRDLKP N+L D +K+ DFGL++V
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA--------------------- 153
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGIP 986
D P VA T Y APE L G + D WS+G I E+L G P
Sbjct: 154 --FNDTPTAI---FWTDYVA-TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 206
Query: 987 PFNAK----------------TPQQI----------FDNIMNRDIPWP---NIPEEMSVE 1017
F K +P+ I + + M + P P P +
Sbjct: 207 LFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPL- 265
Query: 1018 ACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
A L+++LL +P R A E P+FK +
Sbjct: 266 ALRLLERLLAFDPKDR---PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 78/284 (27%), Positives = 119/284 (41%), Gaps = 55/284 (19%)
Query: 763 IKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
I+ + +G FG V L R + TG++ A+K L+ + + E IL S+++
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHD 65
Query: 819 FVVRFFYSFTC----RENLYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLALEY 873
+V+ Y C R NL LVMEYL G L L ++ LD +Y +++ +EY
Sbjct: 66 NIVK--YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
L S +HRDL N+L+ + +K+ DFGL+KV
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKV-------------------------- 157
Query: 934 DQPPLTREQRQKHSVAGTPDY-LAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992
P +E + +P + APE L +D WS G++L+EL + +
Sbjct: 158 --LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSD--KSCS 213
Query: 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA 1036
P F +M D I LI+ LL N RL A
Sbjct: 214 PPAEFMRMMGNDKQGQMI-------VYHLIE-LLKNN--GRLPA 247
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 69/250 (27%), Positives = 110/250 (44%), Gaps = 46/250 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E ++IK + G FG V++ + A+K LK M + ES L E I+ +R+
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTM----SPESFLEEAQIMKKLRH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-----RNLGCLD-EDMARVYIAELVLAL 871
+V+ Y+ E +Y+V EY++ G L L R L + DMA A++ +
Sbjct: 61 DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGM 115
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
Y+ +N IHRDL+ N+L+G K+ DFGL++ L+ D
Sbjct: 116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--------------------LIEDN 155
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990
T Q K + T APE L +D WS GI+L EL+ G P+
Sbjct: 156 -----EYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206
Query: 991 KTPQQIFDNI 1000
+++ + +
Sbjct: 207 MNNREVLEQV 216
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-15
Identities = 64/229 (27%), Positives = 101/229 (44%), Gaps = 40/229 (17%)
Query: 763 IKPISQGAFGRVFLARKRA----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
I+ + +G FG+V L R TG+ A+K LK N + + E IL ++ +
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 66
Query: 819 FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLALEY 873
+V+ Y C E+ + L+ME+L G L L RN ++ Y ++ ++Y
Sbjct: 67 NIVK--YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
L S +HRDL N+L+ + +K+ DFGL+K A + V D+L
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-----------AIETDKEYYTVKDDL- 172
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
D P + APE L+ +D WS G+ L+ELL
Sbjct: 173 DSPVF---------------WYAPECLIQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 8e-15
Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 35/238 (14%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+E + ++ + +G + VF R + T +L A+K ++ + A + + E ++L ++
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLK 62
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLH 875
+ +V ++L LV EYL+ DL + + G + ++++ +++ L Y H
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH 121
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
V+HRDLKP NLLI + G +KL DFGL++ S P+ +V
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAK--------SVPTKTYSNEVV------- 166
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAKT 992
T Y P++LLG +T D W VG I FE+ G P F T
Sbjct: 167 ---------------TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 67/237 (28%), Positives = 106/237 (44%), Gaps = 51/237 (21%)
Query: 766 ISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV 820
+ +GAFG+VFLA L A+K LK+A ++A + E +L +++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHI 69
Query: 821 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDMAR----------VYIAE 866
VRF+ T L +V EY+ GDL LR+ G L + IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 867 LVLA-LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+ + + YL SL+ +HRDL N L+GQ +K+ DFG+S+ I+STD GG
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD--IYSTDYYRV-----GG 182
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
+ P+ ++ PE +L +D WS G++L+E+
Sbjct: 183 -------RTMLPIR--------------WMPPESILYRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 58/234 (24%), Positives = 105/234 (44%), Gaps = 38/234 (16%)
Query: 769 GAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828
G +G V+ + A+K LK+ M VE L E ++ +++P +V+ T
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 829 CRENLYLVMEYLNGGDLYSLLRNLGCLDED-MARVYIA-ELVLALEYLHSLNVIHRDLKP 886
Y++ E++ G+L LR + + + +Y+A ++ A+EYL N IHRDL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 887 DNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKH 946
N L+G++ +K+ DFGLS++ +T + H
Sbjct: 133 RNCLVGENHLVKVADFGLSRL------------------------------MTGDTYTAH 162
Query: 947 SVAGTP-DYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFD 998
+ A P + APE L +D W+ G++L+E+ G+ P+ Q+++
Sbjct: 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 216
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 1e-14
Identities = 85/347 (24%), Positives = 152/347 (43%), Gaps = 88/347 (25%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI- 813
T ++ ++ +KPI GA G V A AIK L + +N + A R +++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLM 70
Query: 814 -SVRNPFVVRFFYSFTCRENL------YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE 866
V + ++ FT +++L YLVME ++ +L +++ LD + + +
Sbjct: 71 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME--LDHERMSYLLYQ 127
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
++ +++LHS +IHRDLKP N+++ D +K+ DFGL++ T + P +
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV----- 179
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL---- 982
+TR Y APE++LGMG+ D WSVG I+ E++
Sbjct: 180 -----------VTRY------------YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216
Query: 983 -----------------IGI--PPFNAKTPQQIFDNIMNR----DIPWPNI-PEEM---- 1014
+G P F K + + + NR + +P + P+ +
Sbjct: 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPAD 276
Query: 1015 -------SVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054
+ +A DL+ K+L +P +R+ A QHP+ N+ +D
Sbjct: 277 SEHNKLKASQARDLLSKMLVIDPAKRISVDEAL---QHPYI-NVWYD 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 70/238 (29%), Positives = 112/238 (47%), Gaps = 46/238 (19%)
Query: 766 ISQGAFGRVF---LARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVR 822
+ +G FG VF L K A+K K+ D+ ++ ++ L+E IL +P +V+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV----AVKTCKE-DLPQELKIK-FLSEARILKQYDHPNIVK 56
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL----ALEYLHSLN 878
T R+ +Y+VME + GGD S LR +++ + + L + YL S N
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
IHRDL N L+G++ +K++DFG+S+ DD G + LK Q P+
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-----QEDD---------GIYSSSGLK-QIPI 158
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQQ 995
+ APE L + + +D WS GI+L+E +G+ P+ T QQ
Sbjct: 159 K--------------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 72/308 (23%), Positives = 132/308 (42%), Gaps = 78/308 (25%)
Query: 764 KPISQGAFGRV-----FLARKRATGDLFAIKVLKKADMIRKNAVE--SILAERNILISVR 816
K + +G FG+V F + RA A+K+LK+ ++ E +L+E N+L V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN----ASSSELRDLLSEFNLLKQVN 61
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR----------------NLGCLDEDMA 860
+P V++ + + + L L++EY G L S LR N LD
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121
Query: 861 RVYIAELVLA--------LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912
R +++ ++YL + ++HRDL N+L+ + +K++DFGLS+
Sbjct: 122 RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR------ 175
Query: 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADW 971
D ++ + R + + P ++A E L + +D
Sbjct: 176 -----------------DVYEEDSYVKRSKGR------IPVKWMAIESLFDHIYTTQSDV 212
Query: 972 WSVGIILFELL-IGIPPFNAKTPQQIFDNI-----MNRDIPWPNIPEEMSVEACDLIDKL 1025
WS G++L+E++ +G P+ P+++F+ + M R PE S E +L+
Sbjct: 213 WSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER-------PENCSEEMYNLMLTC 265
Query: 1026 LTENPVQR 1033
+ P +R
Sbjct: 266 WKQEPDKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-14
Identities = 62/238 (26%), Positives = 113/238 (47%), Gaps = 45/238 (18%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI- 813
T ++ ++ +KPI GA G V A AIK L + +N + A R +++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP---FQNQTHAKRAYRELVLM 77
Query: 814 -SVRNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE 866
V + ++ FT + +++Y+VME ++ +L +++ LD + + +
Sbjct: 78 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME--LDHERMSYLLYQ 134
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
++ +++LHS +IHRDLKP N+++ D +K+ DFGL++ F
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------------AGTSF 180
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG 984
++ + +TR Y APE++LGMG+ D WSVG I+ E++ G
Sbjct: 181 MMTPYV-----VTRY------------YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 78/324 (24%), Positives = 134/324 (41%), Gaps = 78/324 (24%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATG-------DLFAIKVLKK---ADMIRKNAVESILAE 808
+ E ++ I QGAFGRVF AR A G + A+K+LK+ ADM E+ L
Sbjct: 6 NIEYVRDIGQGAFGRVFQAR--APGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL-- 61
Query: 809 RNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----------------- 851
+ +P +V+ + + L+ EY+ GDL LR+
Sbjct: 62 ---MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118
Query: 852 --------LGCLDEDMARVYIAELVLA-LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902
L C ++ + IA+ V A + YL +HRDL N L+G++ +K+ DF
Sbjct: 119 KCGLNPLPLSCTEQ----LCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 174
Query: 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG 962
GLS+ I+S D A ND + P+ ++ PE +
Sbjct: 175 GLSRN--IYSADYYKASE--------NDAI----PIR--------------WMPPESIFY 206
Query: 963 MGHGATADWWSVGIILFELL-IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDL 1021
+ +D W+ G++L+E+ G+ P+ +++ + RD + P+ +E +L
Sbjct: 207 NRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYV--RDGNVLSCPDNCPLELYNL 264
Query: 1022 IDKLLTENPVQRLGATGAREVKQH 1045
+ ++ P R + Q
Sbjct: 265 MRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 66/285 (23%), Positives = 123/285 (43%), Gaps = 51/285 (17%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E +++K + G FG V++ + + A+K LK M +V++ L E N++ ++++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV-------YIAELVLA 870
+VR + T E +Y++ EY+ G L L++ ++ +V + A++
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKS-----DEGGKVLLPKLIDFSAQIAEG 115
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+ Y+ N IHRDL+ N+L+ + K+ DFGL++V
Sbjct: 116 MAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARV----------------------- 152
Query: 931 ELKDQPPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988
++D RE A P + APE + +D WS GI+L+E++ G P+
Sbjct: 153 -IEDNEYTAREG------AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
Query: 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
+ + + R P E E D++ E +R
Sbjct: 206 PGMSNSDVMSAL-QRGYRMPR-MENCPDELYDIMKTCWKEKAEER 248
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 64/230 (27%), Positives = 104/230 (45%), Gaps = 45/230 (19%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
++++ ++++ I +G FG V L R G+ A+K +K ++ LAE +++ +
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 56
Query: 816 RNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLAL 871
R+ +V+ E LY+V EY+ G L LR+ G L D + ++ A+
Sbjct: 57 RHSNLVQLL-GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
EYL + N +HRDL N+L+ +D K++DFGL+K ST D
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTG-------------- 159
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981
K V T APE L +D WS GI+L+E+
Sbjct: 160 -------------KLPVKWT----APEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 4e-13
Identities = 70/270 (25%), Positives = 116/270 (42%), Gaps = 40/270 (14%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
+ QG FG V++ T + AIK LK M + E+ L E ++ +R+ +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV--YIAELVLALEYLHSLNVIHRD 883
+ E +Y+V EY++ G L L+ + ++ A++ + Y+ +N +HRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
L+ N+L+G++ K+ DFGL++ L+ D T Q
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--------------------LIEDN-----EYTARQG 162
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNI-M 1001
K + T APE L +D WS GI+L EL G P+ +++ D +
Sbjct: 163 AKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
Query: 1002 NRDIPWP-NIPEEMSVEACDLIDKLLTENP 1030
+P P PE + C K E P
Sbjct: 219 GYRMPCPPECPESLHDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 69/257 (26%), Positives = 111/257 (43%), Gaps = 54/257 (21%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDL----FAIKVLKKADMIRKNAVESILAERNILISV 815
E IK + GAFG V+ G+ AIKVL++ + K E IL E ++ SV
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKE-ILDEAYVMASV 66
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLAL 871
+P VVR + L+ + + G L +RN +G V IA+ +
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---GM 122
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
YL ++HRDL N+L+ H+K+TDFGL+K+
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL------------------------ 158
Query: 932 LKDQPPLTREQRQKHSVAG-TP-DYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989
L ++++ H+ G P ++A E +L + +D WS G+ ++EL+ F
Sbjct: 159 ------LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT----FG 208
Query: 990 AKTPQQIFDNIMNRDIP 1006
AK ++ I +IP
Sbjct: 209 AKP----YEGIPAVEIP 221
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 64/287 (22%), Positives = 105/287 (36%), Gaps = 62/287 (21%)
Query: 764 KPISQGAFGRV---FLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV 820
K + G FG V K A+K LK+ + + L E +++ + +P +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI--AAGKKEFLREASVMAQLDHPCI 58
Query: 821 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL----ALEYLHS 876
VR E L LVME G L L+ ++ + EL + YL S
Sbjct: 59 VRLI-GVCKGEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLES 113
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+ +HRDL N+L+ K++DFG+S+ +LG+G +D +
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSR-------------ALGAG----SDYYRATT 156
Query: 937 ----PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAK 991
PL + APE + + +D WS G+ L+E G P+
Sbjct: 157 AGRWPLK--------------WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
Query: 992 TPQQIFDNI-----MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
++ + + R PEE E ++ P R
Sbjct: 203 KGAEVIAMLESGERLPR-------PEECPQEIYSIMLSCWKYRPEDR 242
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 46/145 (31%), Positives = 77/145 (53%), Gaps = 10/145 (6%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
I +G FG V + TG A+K +K D+ ++ L E ++ + + +VR
Sbjct: 14 IGEGEFGAVL--QGEYTGQKVAVKNIK-CDV----TAQAFLEETAVMTKLHHKNLVRLL- 65
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA--LEYLHSLNVIHRD 883
LY+VME ++ G+L + LR G + ++ L +A +EYL S ++HRD
Sbjct: 66 GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVG 908
L N+L+ +DG K++DFGL++VG
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVG 150
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 73/312 (23%), Positives = 134/312 (42%), Gaps = 66/312 (21%)
Query: 763 IKPISQGAFGRVFLARKRATG----DLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
++ + + AFG+++ G L AIK LK D+ E +++ + +P
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHP 67
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLL------RNLGCLDEDMARV---------- 862
+V T + + ++ EYLN GDL+ L ++GC ++ V
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 863 YIA-ELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921
+IA ++ +EYL S +H+DL N+LIG+ H+K++D GLS+ I+S
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSRE--IYSA-------- 177
Query: 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981
D + QP R ++ PE ++ + +D WS G++L+E+
Sbjct: 178 --------DYYRVQPKSLLPIR----------WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
Query: 982 L-IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040
G+ P+ + Q++ + + R + P E+ L+ + E P +R
Sbjct: 220 FSFGLQPYYGFSNQEVIEMVRKRQL-LP-CSEDCPPRMYSLMTECWQEGPSRR------- 270
Query: 1041 EVKQHPFFKNIN 1052
P FK+I+
Sbjct: 271 -----PRFKDIH 277
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 64/237 (27%), Positives = 109/237 (45%), Gaps = 49/237 (20%)
Query: 764 KPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
+ + +GAFG+VFLA L A+K LK A NA + E +L ++++
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHE 67
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMAR------------VYIAE 866
+V+F+ + L +V EY+ GDL LR G MA ++IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 867 LVLA-LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+ A + YL S + +HRDL N L+G++ +K+ DFG+S+ ++STD GG
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRD--VYSTDYYRV-----GG 180
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
H++ ++ PE ++ +D WS+G++L+E+
Sbjct: 181 --------------------HTMLPI-RWMPPESIMYRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 61/238 (25%), Positives = 98/238 (41%), Gaps = 38/238 (15%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKV--LKKADMIRKNAVESILAERNILISVR 816
I K V LA+ + T L A+K L ++ + E ++
Sbjct: 3 LTLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKED---LKLLQQEIITSRQLQ 57
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA----ELVLALE 872
+P ++ + SF LY+V + G LL+ E + + IA +++ AL+
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALD 115
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
Y+HS IHR +K ++L+ DG + L+ GL + S+ G +
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLS--GLR-----------YSVSMIKHGKR-QRVV 161
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPF 988
D P K SV P +L+PE+L G+ +D +SVGI EL G PF
Sbjct: 162 HDFP--------KSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 62/223 (27%), Positives = 97/223 (43%), Gaps = 45/223 (20%)
Query: 769 GAFG----RVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFF 824
G FG V+ RK+ AIKVLK + K+ + ++ E I+ + NP++VR
Sbjct: 6 GNFGCVKKGVYKMRKKQID--VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 825 YSFTCR-ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV----LALEYLHSLNV 879
C E L LVME +GG L L +++ + EL+ + ++YL N
Sbjct: 62 G--VCEAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
+HRDL N+L+ + K++DFGLSK DD + +G + PL
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKA---LGADDSYYKARSAGKW----------PLK 163
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
+ APE + + +D WS GI ++E
Sbjct: 164 --------------WYAPECINFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 70/281 (24%), Positives = 113/281 (40%), Gaps = 49/281 (17%)
Query: 710 VNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIED--FEIIKPIS 767
+N + DD+ L M + + D S + + C++ R IE F I++ +
Sbjct: 42 MNPGIESDDDCLYEDKHMDIDIFDIFADEDESDADASLALCAEARAGIEKAGFSILETFT 101
Query: 768 QGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSF 827
GA G F T + IK ++ E +IL ++ +P +++ +F
Sbjct: 102 PGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTF 152
Query: 828 TCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDMARVYIAELVL-ALEYLHSLNVIHRD 883
T + L++ DLY L RN+ D + I VL A++YLH +IHRD
Sbjct: 153 TYNKFTCLILPRYKT-DLYCYLAAKRNIAICD----ILAIERSVLRAIQYLHENRIIHRD 207
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
+K +N+ I G + L DFG + P+
Sbjct: 208 IKAENIFINHPGDVCLGDFGAACF-----------------------------PVDINAN 238
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG 984
+ + AGT APE+L +G D WS GI+LFE+
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 70/287 (24%), Positives = 120/287 (41%), Gaps = 48/287 (16%)
Query: 717 DDEKLDSSNAMTEEESSMDEDTVRSL---------RTSPINPCSKDRTSIEDFEIIKPIS 767
DE DS + + DE+++ TS +P S R + I+ ++
Sbjct: 45 CDELGDSDDVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQ---YNILSSLT 101
Query: 768 QGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSF 827
G+ G VF+ K GD KV+ KA K I +IL ++ + ++ +++
Sbjct: 102 PGSEGEVFVCTKH--GDEQRKKVIVKAVTGGKTPGREI----DILKTISHRAIINLIHAY 155
Query: 828 TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPD 887
+ + +VM DL++ + G L + A L+ AL YLH +IHRD+K +
Sbjct: 156 RWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTE 214
Query: 888 NLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHS 947
N+ + + + L DFG +A L D D P Q +
Sbjct: 215 NIFLDEPENAVLGDFG-------------AACKL--------DAHPDTP-------QCYG 246
Query: 948 VAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTP 993
+GT + +PE+L + A D WS G++LFE+ + + F +
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293
|
Length = 392 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 59/300 (19%)
Query: 759 DFEIIKPISQGAFGRVFLAR---KRATGD--LFAIKVLKKADMIRKNAVESILAERNILI 813
D + + + +GAFG+VFLA T D L A+K LK + A + E +L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLT 62
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDEDMARVYIAELVL 869
++++ +V+F+ + L +V EY+ GDL LR G L + R EL L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 870 A------------LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917
+ + YL S + +HRDL N L+G + +K+ DFG+S+ ++STD
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--VYSTDYYR 180
Query: 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGII 977
GG H++ ++ PE ++ +D WS G+I
Sbjct: 181 V-----GG--------------------HTMLPI-RWMPPESIMYRKFTTESDVWSFGVI 214
Query: 978 LFELLI-GIPPFNAKTPQQIFDNIMN-RDIPWPNI-PEEMSVEACDLIDKLLTENPVQRL 1034
L+E+ G P+ + ++ + I R + P + P+E+ D++ P QRL
Sbjct: 215 LWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY----DIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 64/229 (27%), Positives = 103/229 (44%), Gaps = 42/229 (18%)
Query: 763 IKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
I+ + +G FG+V L TG++ A+K LK + ++N E NIL ++ +
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLK-RECGQQNT-SGWKKEINILKTLYHE 66
Query: 819 FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLALEY 873
+V+ Y C E L L+MEY+ G L L ++ L + + ++ ++ + Y
Sbjct: 67 NIVK--YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL--LFAQQICEGMAY 122
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LHS + IHRDL N+L+ D +K+ DFGL+K A G + V ++
Sbjct: 123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-----------AVPEGHEYYRVRED-G 170
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
D P + A E L +D WS G+ L+ELL
Sbjct: 171 DSPVF---------------WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 68/238 (28%), Positives = 109/238 (45%), Gaps = 55/238 (23%)
Query: 785 LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 844
L A+K+L+ D KNA L E IL +++P ++R + L ++ EY+ GD
Sbjct: 48 LVAVKILR-PDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 845 LYSLLRNLGCLDED-------------MARVYIAELVLALE------YLHSLNVIHRDLK 885
L L + D++ A Y + L +AL+ YL SLN +HRDL
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 886 PDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQK 945
N L+G++ IK+ DFG+S+ +L +G + R Q +
Sbjct: 166 TRNCLVGENLTIKIADFGMSR-------------NLYAGDYY------------RIQGR- 199
Query: 946 HSVAGTP-DYLAPEILLGMGHGATA-DWWSVGIILFELLI--GIPPFNAKTPQQIFDN 999
A P ++A E +L MG TA D W+ G+ L+E+L+ P+ T +Q+ +N
Sbjct: 200 ---AVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 65/257 (25%), Positives = 114/257 (44%), Gaps = 60/257 (23%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ +++ I G FG V+L AIK +++ M ++ +E E +++ + +
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFIE----EAQVMMKLSH 58
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----------LG-CLD--EDMARVYI 864
P +V+ + T R + LV E++ G L LR LG CLD E MA
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA---- 114
Query: 865 AELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSG 924
YL S NVIHRDL N L+G++ +K++DFG+++ L DD S G+
Sbjct: 115 --------YLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL----DDQYTSSTGT- 161
Query: 925 GFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI- 983
K V + +PE+ + + +D WS G++++E+
Sbjct: 162 --------------------KFPVK----WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSE 197
Query: 984 GIPPFNAKTPQQIFDNI 1000
G P+ ++ ++ + I
Sbjct: 198 GKTPYENRSNSEVVETI 214
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 51/175 (29%), Positives = 77/175 (44%), Gaps = 33/175 (18%)
Query: 761 EIIKPISQGAFGRVFLA-----------------RKRATGDLFAIKVLKK-ADMIRKNAV 802
++ + +G FG V L A L A+KVL+ A NA
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAP-VLVAVKVLRPDAS---DNAR 63
Query: 803 ESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMAR- 861
E L E IL + +P + R T L ++MEY+ GDL L+ +A
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 862 ---------VYIAELVLA-LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906
+Y+A + + + YL SLN +HRDL N L+G++ IK+ DFG+S+
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 48/243 (19%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY 825
+ QG FG V++ T + AIK LK M E+ L E I+ +R+ +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPL-Y 67
Query: 826 SFTCRENLYLVMEYLNGGDLYSLLR-------NLGCLDEDMARVYIAELVLALEYLHSLN 878
+ E +Y+V E++ G L L+ L L DMA A++ + Y+ +N
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMA----AQIADGMAYIERMN 122
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
IHRDL+ N+L+G + K+ DFGL++ L+ D
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLAR--------------------LIEDN-----EY 157
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIF 997
T Q K + T APE L +D WS GI+L EL+ G P+ +++
Sbjct: 158 TARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213
Query: 998 DNI 1000
+ +
Sbjct: 214 EQV 216
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 40/133 (30%), Positives = 66/133 (49%), Gaps = 13/133 (9%)
Query: 785 LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 844
L A+K+L+ D KNA L E I+ +++P ++R + L ++ EY+ GD
Sbjct: 48 LVAVKMLR-EDA-NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 845 LYSLLRNL----GCLDEDMARVYIAELVL-------ALEYLHSLNVIHRDLKPDNLLIGQ 893
L L D+ + + L+ ++YL SLN +HRDL N L+G+
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165
Query: 894 DGHIKLTDFGLSK 906
+ IK+ DFG+S+
Sbjct: 166 NYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 52/274 (18%)
Query: 754 RTSIEDFEIIKPISQGAFGRV-----FLARKRATGDLFAIKVLKKADMIRKNAVESILAE 808
+ ++ + +GAFG+V +R + AIK LK+ + + E
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQE 58
Query: 809 RNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRN-----LGCLDEDMAR- 861
++ +++P +V T + ++ EYL GDL+ L+RN +G D
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 862 --------VYIAELVLA-LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912
++IA + A +EYL S + +HRDL N L+G+ +K++DFGLS+ I+S
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR--DIYS 176
Query: 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWW 972
D S + L ++ PE +L +D W
Sbjct: 177 ADYYRVQS--------------KSLLPVR------------WMPPEAILYGKFTTESDIW 210
Query: 973 SVGIILFELL-IGIPPFNAKTPQQIFDNIMNRDI 1005
S G++L+E+ G+ P+ + Q++ + I +R +
Sbjct: 211 SFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 5e-11
Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 59/284 (20%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLF----AIKVLKKADMIRKNAVESILAERNILIS 814
+F+ IK + GAFG V+ G+ AIK L++A + N + IL E ++ S
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 65
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV-------YIAEL 867
V NP V R + L+ + + G L +R E + + ++
Sbjct: 66 VDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVR------EHKDNIGSQYLLNWCVQI 118
Query: 868 VLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
+ YL ++HRDL N+L+ H+K+TDFGL+K+
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL-------------------- 158
Query: 928 VNDELKDQPPLTREQRQKHSVAG-TP-DYLAPEILLGMGHGATADWWSVGIILFELL-IG 984
L ++++ H+ G P ++A E +L + +D WS G+ ++EL+ G
Sbjct: 159 ----------LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 208
Query: 985 IPPFNAKTPQQIFDNIMNRD--IPWP---NIPEEMSVEACDLID 1023
P++ P +I+ + +P P I M + C +ID
Sbjct: 209 SKPYDG-IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMID 251
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 8e-11
Identities = 70/305 (22%), Positives = 115/305 (37%), Gaps = 67/305 (21%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-- 815
+ + KP+ +GAFG+V A D M++ +A E L++ L+S
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGL-DNPNETSTVAVKMLKDDATEKDLSD---LVSEME 67
Query: 816 ------RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-----NLGCLDEDMARVYI 864
++ ++ T LY+V+EY G+L LR D R
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA-SPDDPRPPE 126
Query: 865 AELVL------------ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912
L +E+L S IHRDL N+L+ +D +K+ DFGL++ IH
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARD--IHH 184
Query: 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADW 971
D +K + P ++APE L + +D
Sbjct: 185 ID---------------------------YYRKTTNGRLPVKWMAPEALFDRVYTHQSDV 217
Query: 972 WSVGIILFELL-IGIPPFNAKTPQQIFDNIMN--RDIPWPNIPEEMSVEACDLIDKLLTE 1028
WS G++L+E+ +G P+ +++F + R N +E+ D E
Sbjct: 218 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRD----CWHE 273
Query: 1029 NPVQR 1033
P QR
Sbjct: 274 VPSQR 278
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 69/282 (24%), Positives = 114/282 (40%), Gaps = 48/282 (17%)
Query: 764 KPISQGAFGRV---FLARKRATGDLFAIKVLKKADMIRKNAV-ESILAERNILISVRNPF 819
+ G FG V K+ + A+K+LK + A+ + +L E N++ + NP+
Sbjct: 1 GELGSGNFGTVKKGMYKMKK-SEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPY 57
Query: 820 VVRFFYSFTCR-ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV----LALEYL 874
+VR C E+ LVME G L L+ ++ + I ELV + ++YL
Sbjct: 58 IVRMIG--ICEAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYL 111
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
N +HRDL N+L+ + K++DFGLSK L DE
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKA-------------------LGADE--- 149
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTP 993
+ + H Y APE + + +D WS G++++E G P+
Sbjct: 150 ----NYYKAKTHGKWPVKWY-APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG 1035
++ I + + P+ E DL+ T +R G
Sbjct: 205 NEVTQMIESGE--RMECPQRCPPEMYDLMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 60/248 (24%), Positives = 94/248 (37%), Gaps = 46/248 (18%)
Query: 764 KPISQGAFGRVFLARKRAT-----GDLF--AIKVLKKADMIRKNAVESILAERNILISVR 816
K + G+FG V +R G + A+K LK + + ++ L E I+ S+
Sbjct: 1 KKLGDGSFGVV----RRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLD 54
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV---YIAELVLALEY 873
+ ++R Y L +V E G L LR L + Y ++ + Y
Sbjct: 55 HENLIRL-YGVVLTHPLMMVTELAPLGSLLDRLR-KDALGHFLISTLCDYAVQIANGMRY 112
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
L S IHRDL N+L+ D +K+ DFGL + N++
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLMR------------------ALPQNEDH- 153
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKT 992
E+ K A + APE L +D W G+ L+E+ G P+ +
Sbjct: 154 ----YVMEEHLKVPFA----WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS 205
Query: 993 PQQIFDNI 1000
QI I
Sbjct: 206 GSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 63/280 (22%), Positives = 123/280 (43%), Gaps = 63/280 (22%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E ++ K + G FG V++A + A+K +K M +VE+ LAE N++ ++++
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV--YIAELVLALEYLH 875
+V+ ++ +E +Y++ E++ G L L++ + + ++ + A++ + ++
Sbjct: 61 DKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 119
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
N IHRDL+ N+L+ K+ DFGL++V ++D
Sbjct: 120 QRNYIHRDLRAANILVSASLVCKIADFGLARV------------------------IEDN 155
Query: 936 PPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKT- 992
RE A P + APE + +D WS GI+L E++ G P+ +
Sbjct: 156 EYTAREG------AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209
Query: 993 -------------------PQQIFDNIMNRDIPWPNIPEE 1013
P+++++ +M W N PEE
Sbjct: 210 PEVIRALERGYRMPRPENCPEELYNIMMR---CWKNRPEE 246
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 71/295 (24%), Positives = 126/295 (42%), Gaps = 65/295 (22%)
Query: 766 ISQGAFGRVFLARKR-----ATGDL-FAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+ GAFG V+ +G + A+K L+K ++ L E +++ + +P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNHPN 60
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY-----IAELV-LALE- 872
+V+ E Y++ME + GGDL S LR D + R + EL+ + L+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLR-----DARVERFGPPLLTLKELLDICLDV 115
Query: 873 -----YLHSLNVIHRDLKPDNLLIGQDGH-----IKLTDFGLSKVGLIHSTDDLSAPSLG 922
YL ++ IHRDL N L+ + G+ +K+ DFGL++ I+ +D G
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD--IYKSDYYRKE--G 171
Query: 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
G V ++APE LL +D WS G++++E+L
Sbjct: 172 EGLLPVR------------------------WMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
Query: 983 -IGIPPFNAKTPQQIFDNIMN--RDIPWPNIPEEMSVEACDLIDKLLTENPVQRL 1034
+G P+ A Q++ ++ R N P+++ L+ ++P +R
Sbjct: 208 TLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIY----QLMTNCWAQDPSERP 258
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 14/134 (10%)
Query: 785 LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 844
L A+K+L+ AD + K A L E I+ ++NP ++R + L ++ EY+ GD
Sbjct: 46 LVAVKMLR-AD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 845 LYSLL------------RNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG 892
L L N+ + ++ ++YL SLN +HRDL N L+G
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 893 QDGHIKLTDFGLSK 906
IK+ DFG+S+
Sbjct: 164 NHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 64/252 (25%), Positives = 100/252 (39%), Gaps = 49/252 (19%)
Query: 762 IIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
I K I G FG V R + G AIK LK L E +I+ +P
Sbjct: 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK--AGSSDKQRLDFLTEASIMGQFDHP 65
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLAL------- 871
++R T + ++ EY+ G L LR E+ + + +LV L
Sbjct: 66 NIIRLEGVVTKSRPVMIITEYMENGSLDKFLR------ENDGKFTVGQLVGMLRGIASGM 119
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
+YL +N +HRDL N+L+ + K++DFGLS+ +D A GG
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR-----LEDSEATYTTKGG------ 168
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELL-IGIPPFN 989
K + T APE + +A D WS GI+++E++ G P+
Sbjct: 169 -------------KIPIRWT----APEA-IAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210
Query: 990 AKTPQQIFDNIM 1001
+ Q + +
Sbjct: 211 DMSNQDVIKAVE 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 47/154 (30%), Positives = 69/154 (44%), Gaps = 9/154 (5%)
Query: 758 EDFEIIKPISQGAFGRVFLA-RKRATGDLF--AIKVLKKADMIRKNAVESILAERNILIS 814
ED + + I +G FG V+ + A+K K E L E I+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQ 63
Query: 815 VRNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLALE 872
+P +V+ EN +++VME G+L S L N LD +Y +L AL
Sbjct: 64 FDHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906
YL S +HRD+ N+L+ +KL DFGLS+
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 62/251 (24%), Positives = 107/251 (42%), Gaps = 48/251 (19%)
Query: 763 IKPISQGAFGRVFLARKRATGD----LFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
+K + GAFG V+ G+ AIKVL++ + N + IL E ++ V +P
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMARVYIAELVLALEYLHSL 877
+V R + LV + + G L +R N + + ++ + YL +
Sbjct: 70 YVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV 128
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
++HRDL N+L+ H+K+TDFGL+++
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARL------------------------------ 158
Query: 938 LTREQRQKHSVAG-TP-DYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
L ++ + H+ G P ++A E +L +D WS G+ ++EL+ F AK
Sbjct: 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT----FGAKP--- 211
Query: 996 IFDNIMNRDIP 1006
+D I R+IP
Sbjct: 212 -YDGIPAREIP 221
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 74/299 (24%), Positives = 128/299 (42%), Gaps = 62/299 (20%)
Query: 758 EDFEIIKPISQGAFGRVF--LARKRATGDL---FAIKVLKKADMIRKNAVESILAERNIL 812
E +++ + QG+FG V+ AR G+ A+K + ++ +R+ L E +++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVM 63
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED-------------- 858
VVR + + +VME + GDL S LR+L E+
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 859 MARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918
MA AE+ + YL++ +HRDL N ++ D +K+ DFG+++ I+ TD
Sbjct: 124 MA----AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRD--IYETDYYRK 177
Query: 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978
G G L P+ ++APE L ++D WS G++L
Sbjct: 178 ---GGKGLL---------PVR--------------WMAPESLKDGVFTTSSDMWSFGVVL 211
Query: 979 FEL-LIGIPPFNAKTPQQIFDNIMN---RDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
+E+ + P+ + +Q+ +M+ D P N PE ++ DL+ NP R
Sbjct: 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP-DNCPERVT----DLMRMCWQFNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 45/231 (19%)
Query: 762 IIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
I K I G FG V R + G AIK LK ++ L+E +I+ +P
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHP 65
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV-------LAL 871
++ T + + +V EY+ G L + LR + + + +LV +
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR------KHDGQFTVIQLVGMLRGIASGM 119
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
+YL + +HRDL N+L+ + K++DFGLS+V DD A GG
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV----LEDDPEAAYTTRGG------ 169
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
+ P+ + APE + + +D WS GI+++E++
Sbjct: 170 ---KIPIR--------------WTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-09
Identities = 58/261 (22%), Positives = 105/261 (40%), Gaps = 51/261 (19%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RN 817
D + I +G FG+V AR + G + + + K+ E +L + +
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV--------------- 862
P ++ + R LYL +EY G+L LR L+ D A
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 863 -YIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921
+ A++ ++YL IHRDL N+L+G++ K+ DFGLS+
Sbjct: 128 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--------------- 172
Query: 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADWWSVGIILFE 980
+E K ++ P ++A E L + +D WS G++L+E
Sbjct: 173 -----------------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
Query: 981 LL-IGIPPFNAKTPQQIFDNI 1000
++ +G P+ T ++++ +
Sbjct: 216 IVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 62/259 (23%), Positives = 114/259 (44%), Gaps = 55/259 (21%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKA-DMIRKNAVES----ILAERNILISV-RN 817
KP+ +G FG+V +A +V K A M++ +A E +++E ++ + ++
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-----------NLGCLDEDMARVYIAE 866
++ + T LY+++EY + G+L LR N + E+ + +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ--LSFKD 141
Query: 867 LV-------LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919
LV +EYL S IHRDL N+L+ +D +K+ DFGL++ IH D
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD--IHHIDYYKKT 199
Query: 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979
+ G + P+ ++APE L + +D WS G++L+
Sbjct: 200 TNG------------RLPVK--------------WMAPEALFDRIYTHQSDVWSFGVLLW 233
Query: 980 ELL-IGIPPFNAKTPQQIF 997
E+ +G P+ +++F
Sbjct: 234 EIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 53/268 (19%)
Query: 763 IKPISQGAFGRVFLARKRATGD-----LFAIKVLKKADMIRKNAVESILAERNILISVRN 817
I + +G FG VFLA+ + + L +K L+K +N E ++ + +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67
Query: 818 PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDM--------ARVYIA-E 866
VVR CRE Y+++EY + GDL LR DE + +V + +
Sbjct: 68 KNVVRLLG--LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+ L +++L + +HRDL N L+ +K++ LSK
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-------------------- 165
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADWWSVGIILFELL-IG 984
D + K A P +LAPE + +D WS G++++E+ G
Sbjct: 166 ---DVYNS-------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215
Query: 985 IPPFNAKTPQQIFDNIMNRDIPWPNIPE 1012
PF + +++ + + + P +PE
Sbjct: 216 ELPFYGLSDEEVLNRLQAGKLELP-VPE 242
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 63/245 (25%), Positives = 111/245 (45%), Gaps = 53/245 (21%)
Query: 766 ISQGAFGRVFLARKRATGDL--FAIKVLKKADMIRKNAVESILAERNILISVRNPFVV-- 821
+ +G +G V+ A+++ D +A+K ++ + S E +L +++P V+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIAL 63
Query: 822 -RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---------LDEDMARVYIAELVLAL 871
+ F S + R+ ++L+ +Y DL+ +++ L M + + +++ +
Sbjct: 64 QKVFLSHSDRK-VWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 872 EYLHSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
YLH+ V+HRDLKP N+L+ + G +K+ D G ++ L
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--------------------L 161
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIP 986
N LK PL V T Y APE+LLG H A D W++G I ELL P
Sbjct: 162 FNSPLK---PLA----DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
Query: 987 PFNAK 991
F+ +
Sbjct: 215 IFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 83/347 (23%), Positives = 144/347 (41%), Gaps = 102/347 (29%)
Query: 766 ISQGAFGRVFLARKRATGDL--FAIKVLKKADMIRKNAVESILAERNILISVRNPFVV-- 821
+ +G +G V+ A+++ D +A+K ++ + S E +L +++P V+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISL 63
Query: 822 -RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC---------LDEDMARVYIAELVLAL 871
+ F S R+ ++L+ +Y DL+ +++ L M + + +++ +
Sbjct: 64 QKVFLSHADRK-VWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 872 EYLHSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
YLH+ V+HRDLKP N+L+ + G +K+ D G ++ L
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--------------------L 161
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIP 986
N LK PL V T Y APE+LLG H A D W++G I ELL P
Sbjct: 162 FNSPLK---PLA----DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
Query: 987 -------------PFNAKTPQQIFDNIMN--RDIPWPNI---PEEMSV------------ 1016
P++ +IF N+M D W +I PE ++
Sbjct: 215 IFHCRQEDIKTSNPYHHDQLDRIF-NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC 273
Query: 1017 ---------------EACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
+A L+ KLLT +P++R+ + + Q P+F
Sbjct: 274 SLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI---TSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 58/246 (23%), Positives = 104/246 (42%), Gaps = 44/246 (17%)
Query: 766 ISQGAFGRVFLARKRATG---DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVR 822
I G FG V R + G AIK LK ++ L+E +I+ +P ++
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPNIIH 69
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV-------LALEYLH 875
T + ++ E++ G L S LR ++ + + +LV ++YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLR------QNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
+N +HRDL N+L+ + K++DFGLS+ ++D SLG +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG-----------K 172
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQ 994
P+ + APE + + +D WS GI+++E++ G P+ + Q
Sbjct: 173 IPIR--------------WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218
Query: 995 QIFDNI 1000
+ + I
Sbjct: 219 DVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 60/245 (24%), Positives = 103/245 (42%), Gaps = 40/245 (16%)
Query: 764 KPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILISVRNPFV 820
K I G FG VF + G AIK LK K + L+E +I+ + +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQD-FLSEASIMGQFSHHNI 68
Query: 821 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV----LALEYLHS 876
+R T + ++ EY+ G L LR+ D + + + ++ ++YL
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+N +HRDL N+L+ + K++DFGLS+V DD SGG +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRV----LEDDPEGTYTTSGG---------KI 172
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQQ 995
P+ + APE + + +D WS GI+++E++ G P+ + +
Sbjct: 173 PIR--------------WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
Query: 996 IFDNI 1000
+ I
Sbjct: 219 VMKAI 223
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 58/259 (22%), Positives = 114/259 (44%), Gaps = 55/259 (21%)
Query: 764 KPISQGAFGRVFLAR-------KRATGDLFAIKVLKKADMIRKNAVESILAERNILISV- 815
KP+ +G FG+V +A K A+K+LK D + + +++E ++ +
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIG 78
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE----DMARVYIAELVL-- 869
++ ++ + T LY+++EY + G+L LR D+ARV ++
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 870 ----------ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919
+EYL S IHRDL N+L+ ++ +K+ DFGL++ +++ D
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--VNNIDYYKKT 196
Query: 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979
+ G + P+ ++APE L + +D WS G++++
Sbjct: 197 TNG------------RLPVK--------------WMAPEALFDRVYTHQSDVWSFGVLMW 230
Query: 980 ELL-IGIPPFNAKTPQQIF 997
E+ +G P+ +++F
Sbjct: 231 EIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 69/295 (23%), Positives = 119/295 (40%), Gaps = 47/295 (15%)
Query: 764 KPISQGAFGRVFLARKRATGDLF---AIKVLKKADMIRKNAVESILAERNILISVRNPFV 820
K + +G FG V + A+K +K D+ + +E L+E + +P V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 821 VRFF-YSFTCRENLYL-----VMEYLNGGDLYSLL--RNLGCLDE----DMARVYIAELV 868
++ F + ++ ++ GDL+S L LG L E ++ ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
L +EYL + N IHRDL N ++ +D + + DFGLSK I+S D
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK--IYSGD-------------- 167
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPP 987
RQ ++A E L + + +D W+ G+ ++E+ G P
Sbjct: 168 ------------YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
Query: 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042
+ +I+D + + + PE+ E DL+ +P R T REV
Sbjct: 216 YPGVENHEIYDYLRHGN--RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 61/264 (23%), Positives = 108/264 (40%), Gaps = 55/264 (20%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLF--AIKVLKKADMIRKNAVESILAERNILISV 815
ED + I +G FG+V A + G AIK+LK + +N E +L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 816 -RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV------------ 862
+P ++ + R LY+ +EY G+L LR L+ D A
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 863 ----YIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918
+ +++ ++YL IHRDL N+L+G++ K+ DFGLS+
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------------ 167
Query: 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADWWSVGII 977
E K ++ P ++A E L + +D WS G++
Sbjct: 168 --------------------GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVL 207
Query: 978 LFELL-IGIPPFNAKTPQQIFDNI 1000
L+E++ +G P+ T ++++ +
Sbjct: 208 LWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 760 FEIIKPISQGAFGRV---FLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
F + + + +G FG V L + + A+K+LK AD+ + +E L E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59
Query: 817 NPFVVRFF-YSFTCRENLYL-----VMEYLNGGDLYS--LLRNLG----CLDEDMARVYI 864
+P V++ S R L ++ ++ GDL++ L+ +G L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 865 AELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914
++ +EYL S N IHRDL N ++ ++ + + DFGLSK I+S D
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKK--IYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 63/241 (26%), Positives = 107/241 (44%), Gaps = 36/241 (14%)
Query: 774 VFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833
V LAR + TG+ ++ + + V + E ++ +P +V + +F L
Sbjct: 16 VNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 74
Query: 834 YLVMEYLNGGDLYSLLRNLGCLD-----EDMARVYIAELVL-ALEYLHSLNVIHRDLKPD 887
++V ++ Y ++L C ++A YI + VL AL+Y+H + +HR +K
Sbjct: 75 WVVTSFM----AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKAS 130
Query: 888 NLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHS 947
++LI DG + L+ GL LS + G +V+D K+S
Sbjct: 131 HILISVDGKVYLS--GLRSN--------LSMINHGQRLRVVHD------------FPKYS 168
Query: 948 VAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI 1005
V P +L+PE+L G+ A +D +SVGI EL G PF Q+ +N +
Sbjct: 169 VKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV 227
Query: 1006 P 1006
P
Sbjct: 228 P 228
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-07
Identities = 39/138 (28%), Positives = 59/138 (42%), Gaps = 29/138 (21%)
Query: 844 DLYSLL-RNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902
DLY+ L L L +L+ A++Y+H +IHRD+K +N+L+ I L DF
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304
Query: 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG 962
G A G + + +AGT D APE+L G
Sbjct: 305 G--------------AACFARG--------------SWSTPFHYGIAGTVDTNAPEVLAG 336
Query: 963 MGHGATADWWSVGIILFE 980
+ + D WS G+++FE
Sbjct: 337 DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 59/236 (25%), Positives = 105/236 (44%), Gaps = 43/236 (18%)
Query: 764 KPISQGAFGRVF------LARKRATGDLFAIKVLK-KADMIRKNAVESILAERNILISVR 816
K + GAFG+V L++ A + A+K+LK A + A+ S L + L +
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTAHSSEREALMSELKIMSHLGNHE 99
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYL 874
N +V + T + ++ EY GDL + LR L + + ++ + +L
Sbjct: 100 N--IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 875 HSLNVIHRDLKPDNLLIGQDGHI-KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
S N IHRDL N+L+ G I K+ DFGL++ +++ ++ + + L
Sbjct: 158 ASKNCIHRDLAARNVLLTH-GKIVKICDFGLAR-DIMNDSNYVVKGN----ARL------ 205
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPF 988
P+ ++APE + + +D WS GI+L+E+ +G P+
Sbjct: 206 ---PVK--------------WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 60/260 (23%), Positives = 110/260 (42%), Gaps = 46/260 (17%)
Query: 758 EDFEIIKPISQGAFGRVF--LAR---KRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
E + + + QG+FG V+ +A+ K AIK + +A +R+ L E +++
Sbjct: 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVM 63
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYI-------- 864
VVR + + ++ME + GDL S LR+L E+
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 865 --AELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922
E+ + YL++ +HRDL N ++ +D +K+ DFG+++ I+ TD G
Sbjct: 124 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRK---G 178
Query: 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL- 981
G L P+ +++PE L +D WS G++L+E+
Sbjct: 179 GKGLL---------PVR--------------WMSPESLKDGVFTTYSDVWSFGVVLWEIA 215
Query: 982 LIGIPPFNAKTPQQIFDNIM 1001
+ P+ + +Q+ +M
Sbjct: 216 TLAEQPYQGMSNEQVLRFVM 235
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 61/262 (23%), Positives = 112/262 (42%), Gaps = 61/262 (23%)
Query: 764 KPISQGAFGRVFLAR-------KRATGDLFAIKVLKKADMIRKNAVESILAERNILISV- 815
KP+ +G FG+V +A K A+K+LK D K+ + +++E ++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD-DATDKD-LSDLVSEMEMMKMIG 75
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-------------------NLGCLD 856
++ ++ + T LY+++EY + G+L LR L D
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 857 EDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916
+A +EYL S IHRDL N+L+ +D +K+ DFGL++ +H+ D
Sbjct: 136 LVSCAYQVAR---GMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARD--VHNIDYY 190
Query: 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGI 976
+ G + P+ ++APE L + +D WS G+
Sbjct: 191 KKTTNG------------RLPVK--------------WMAPEALFDRVYTHQSDVWSFGV 224
Query: 977 ILFELL-IGIPPFNAKTPQQIF 997
+L+E+ +G P+ +++F
Sbjct: 225 LLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 50/259 (19%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRA-TGDLFAIKVLKKA--DMIRKNAVESILAERNILIS 814
+ +++ + GAFG V+ R GD ++V K + + L E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 815 VRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRN----------LGCLDEDMARVY 863
+ +VR SF R ++++E + GGDL S LR L D
Sbjct: 66 FNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920
+A +YL + IHRD+ N L+ G K+ DFG+++ D A
Sbjct: 125 VA---KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-------DIYRASY 174
Query: 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFE 980
GG R + P PE L + D WS G++L+E
Sbjct: 175 YRKGG-----------------RAMLPIKWMP----PEAFLDGIFTSKTDVWSFGVLLWE 213
Query: 981 LL-IGIPPFNAKTPQQIFD 998
+ +G P+ +T Q++ +
Sbjct: 214 IFSLGYMPYPGRTNQEVME 232
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 55/256 (21%)
Query: 766 ISQGAFGRVFLARKRATGDLF--AIKVLKKADMIRKNAVESILAERNILISV-RNPFVVR 822
I +G FG+V AR + G AIK +K + K+ E +L + +P ++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV----------------YIAE 866
+ R LYL +EY G+L LR L+ D A + A+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+ ++YL IHRDL N+L+G++ K+ DFGLS+
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-------------------- 160
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADWWSVGIILFELL-IG 984
+E K ++ P ++A E L + +D WS G++L+E++ +G
Sbjct: 161 ------------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 208
Query: 985 IPPFNAKTPQQIFDNI 1000
P+ T ++++ +
Sbjct: 209 GTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-07
Identities = 59/245 (24%), Positives = 109/245 (44%), Gaps = 46/245 (18%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNA-VESILAERNILIS 814
S + F+I+ + +G FG+V A R + A+K+++ ++A +E E+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 815 VRNPF----VVRFFYSFTCRENLYLVM-EYLNGGDLYSLLRNLGCLDEDMARVYIAELVL 869
+ F + R+F + T ++ +VM +Y G L + G I + +
Sbjct: 187 PADRFPLMKIQRYFQNET--GHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGV 242
Query: 870 ALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
AL+Y H+ L+++H DLKP+N+L+ ++D + P +
Sbjct: 243 ALDYFHTELHLMHTDLKPENILM-------------------ETSDTVVDP-------VT 276
Query: 929 NDELKDQPPLTR---------EQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979
N L P R E+ + ++ T Y +PE++LG+G + D WS+G I++
Sbjct: 277 NRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIY 336
Query: 980 ELLIG 984
EL G
Sbjct: 337 ELYTG 341
|
Length = 467 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 6e-07
Identities = 66/299 (22%), Positives = 107/299 (35%), Gaps = 84/299 (28%)
Query: 719 EKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFL-A 777
E D+S+ +E D L + + D + F +I + GAFG++F+ A
Sbjct: 113 EDSDASHLDFDEAPP-DAAGPVPLAQAKLK---HDDEFLAHFRVIDDLPAGAFGKIFICA 168
Query: 778 RKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837
+ +T + A + + + + ER I V+ EN L +
Sbjct: 169 LRASTEEAEARRGVNSTNQGKPKC------ERLIAKRVKAGSRAAIQL-----ENEILAL 217
Query: 838 EYLNGG------------------------DLYSLLRNLGCLDEDM----------ARVY 863
LN DLYS + DE R
Sbjct: 218 GRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM-----YDEAFDWKDRPLLKQTRAI 272
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
+ +L+ A+EY+H +IHRD+K +N+ + DG I L DFG +
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP---------------- 316
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
++ + + GT +PEIL G G+ D WS G+IL ++L
Sbjct: 317 ---------FEKEREAFD----YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-06
Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 36/223 (16%)
Query: 774 VFLARKRATGDLFAIKV--LKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831
V+LAR TG L +++ L+ A+++ + + R+P ++ + FT
Sbjct: 16 VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF---RHPNIMTSWTVFTTGS 72
Query: 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL----VLALEYLHSLNVIHRDLKPD 887
L+++ ++ G SLL+ E M+ I + + L YLH IHR++K
Sbjct: 73 WLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKAS 130
Query: 888 NLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHS 947
++LI DG + L+ GLS ++S LV + K + Q S
Sbjct: 131 HILISGDGLVSLS--GLSH---LYS--------------LVRNGQKAKVVYDFPQ---FS 168
Query: 948 VAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPF 988
+ P +L+PE+L G+ +D +SVGI EL G PF
Sbjct: 169 TSVLP-WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 34/159 (21%), Positives = 59/159 (37%), Gaps = 33/159 (20%)
Query: 762 IIKPISQGAFGRVFLAR--------KRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
IK + G RV+L K ++ +++ +LA + + +
Sbjct: 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQ------LLARKGLPV 55
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE-LVLALE 872
P V+ S YL+ME++ G L + + + IAE L L
Sbjct: 56 ----PKVL---ASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLA 100
Query: 873 YLHSLN---VIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908
LH L + H DL P N+L+ + + D+ + G
Sbjct: 101 KLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 59/251 (23%), Positives = 107/251 (42%), Gaps = 46/251 (18%)
Query: 764 KPISQGAFGRVFLARKRATGDLF--AIKVLKKADMIRKNAVESILAERNILISVRNPFVV 821
K + +G FG V + + A+K +K A + ++ +E L+E + +P V+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 822 RFF---YSFTCRENL---YLVMEYLNGGDLYSLL--RNLG----CLDEDMARVYIAELVL 869
R E +++ ++ GDL+S L LG L M ++ ++
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
+EYL S + IHRDL N ++ ++ ++ + DFGLSK I++ D
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK--IYNGD--------------- 166
Query: 930 DELKDQPPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADWWSVGIILFELLI-GIPP 987
R+ R +A P ++A E L + +D WS G+ ++E+ G P
Sbjct: 167 --------YYRQGR----IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
Query: 988 FNAKTPQQIFD 998
+ +I+D
Sbjct: 215 YPGVENSEIYD 225
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 62/265 (23%), Positives = 109/265 (41%), Gaps = 67/265 (25%)
Query: 764 KPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISV---- 815
KP+ +G FG+V A ++ D +K M++ NA + LA+ LIS
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVK---MLKDNATDKDLAD---LISEMELM 71
Query: 816 ----RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR------------------NLG 853
++ ++ T LY+++EY G+L LR
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 854 CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913
+ ++ Y ++ +EYL S IHRDL N+L+ +D +K+ DFGL++ +H
Sbjct: 132 SFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARG--VHDI 187
Query: 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWS 973
D S G + P+ ++APE L + +D WS
Sbjct: 188 DYYKKTSNG------------RLPVK--------------WMAPEALFDRVYTHQSDVWS 221
Query: 974 VGIILFELL-IGIPPFNAKTPQQIF 997
GI+++E+ +G P+ +++F
Sbjct: 222 FGILMWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 32/159 (20%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKV-----LKKADMIRKNAVESILAERNI----LI 813
+K I +GA ++L GD IK + K + E I ER ++
Sbjct: 1 MKLIKRGAEAEIYL------GDFLGIKAVIKWRIPKRYRHPELD-ERIRRERTRREARIM 53
Query: 814 S------VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL 867
S V P V EN +VMEY+ G L L+ + G + +++R E+
Sbjct: 54 SRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGMEELELSR----EI 104
Query: 868 VLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906
+ LHS +IH DL N+++ G I L DFGL++
Sbjct: 105 GRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 5e-06
Identities = 18/48 (37%), Positives = 33/48 (68%)
Query: 856 DEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFG 903
D ++ + + +++ L LH + ++HRD+KP+NLL+ DG +K+ DFG
Sbjct: 307 DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-05
Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 763 IKPISQGAFGRVFLARKRATGDLF----AIKVLKKADMIRKNAVESILAERNILISVRNP 818
+K + GAFG V+ G+ AIK+L + + N + E I+ S+ +P
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHP 69
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR----NLGCLDEDMARVYIAELVLALEYL 874
+VR + LV + + G L + N+G + + ++ + YL
Sbjct: 70 HLVRLL-GVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIG---SQLLLNWCVQIAKGMMYL 125
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
++HRDL N+L+ H+K+TDFGL+++
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 44/196 (22%), Positives = 80/196 (40%), Gaps = 38/196 (19%)
Query: 833 LYLVMEYLNGGDLYSLLRN-----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPD 887
LV+E+ GDL + LR+ +D+ + E+ L +LH + IH DL
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALR 129
Query: 888 NLLIGQDGHIKLTDFGLS----KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQR 943
N + D +K+ D+GL+ + D + P LV E++ Q L ++Q
Sbjct: 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV--EIRGQDLLPKDQT 187
Query: 944 QKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQQIFDN-IM 1001
+K ++ WS+G+ ++EL P+ + +Q+ +
Sbjct: 188 KKSNI-----------------------WSLGVTMWELFTAADQPYPDLSDEQVLKQVVR 224
Query: 1002 NRDI--PWPNIPEEMS 1015
+DI P P + + S
Sbjct: 225 EQDIKLPKPQLDLKYS 240
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 4e-05
Identities = 52/241 (21%), Positives = 103/241 (42%), Gaps = 48/241 (19%)
Query: 787 AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 846
AIK LK D E E + +++P +V T + L ++ Y + DL+
Sbjct: 39 AIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96
Query: 847 SLL------RNLGCLDEDMARV----------YIAELVLALEYLHSLNVIHRDLKPDNLL 890
L ++G D+D + ++ +E+L S +V+H+DL N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 891 IGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAG 950
+ ++K++D GL + +++ D L+ + L P+
Sbjct: 157 VFDKLNVKISDLGLFRE--VYAADYYK---------LMGNSLL---PIR----------- 191
Query: 951 TPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQQIFDNIMNRDI-PWP 1008
+++PE ++ +D WS G++L+E+ G+ P+ + Q + + I NR + P P
Sbjct: 192 ---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP 248
Query: 1009 N 1009
+
Sbjct: 249 D 249
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-05
Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 29/134 (21%)
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+E+L S N +HRDL N+LI + +K+ DFGL++ ++ ++ +S S FL
Sbjct: 252 MEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGST----FL--- 303
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFN 989
PL ++APE + + +D WS GI+L+E+ +G P+
Sbjct: 304 ------PLK--------------WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343
Query: 990 AKTPQQIFDNIMNR 1003
+ F N + R
Sbjct: 344 ELPMNEQFYNAIKR 357
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 30/165 (18%)
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
+E+L S N +HRDL N+L+ Q +K+ DFGL++ ++H ++ +S S FL
Sbjct: 249 GMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-DIMHDSNYVSKGST----FL-- 301
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPF 988
P+ ++APE + + +D WS GI+L+E+ +G P+
Sbjct: 302 -------PVK--------------WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY 340
Query: 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
F N + P+ + E D++ K P +R
Sbjct: 341 PGMIVDSTFYNKIKSGYRMAK-PDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 38/168 (22%), Positives = 56/168 (33%), Gaps = 51/168 (30%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK-----NAVESILAERNIL----- 812
+ I QGA ++L D + + K I K E + ER
Sbjct: 1 MDLIKQGAEAIIYL------TDFLGLPAVVKE-RIPKRYRHPELDEKLRRERTRREARIL 53
Query: 813 -----ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL--------YSLLRNLGCLDEDM 859
V P +V N +VMEY+ G L LLR +G +
Sbjct: 54 AKAREAGVPVP-IVYDVDPD----NGLIVMEYIEGELLKDALEEARPDLLREVG---RLV 105
Query: 860 ARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
+ LH ++H DL N+++ G I DFGL +
Sbjct: 106 GK------------LHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 2e-04
Identities = 33/115 (28%), Positives = 49/115 (42%), Gaps = 24/115 (20%)
Query: 803 ESILAERNI----LIS------VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 852
E + ER L+S V P + Y E +VMEY+ G DL +L
Sbjct: 376 ERLRTERTRAEARLLSEARRAGVPTPVI----YDVD-PEEKTIVMEYIGGKDLKDVLEG- 429
Query: 853 GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
+ ++ R + E+V L H ++H DL N ++ D + L DFGL K
Sbjct: 430 ---NPELVRK-VGEIVAKL---HKAGIVHGDLTTSNFIVR-DDRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 33/115 (28%), Positives = 48/115 (41%), Gaps = 23/115 (20%)
Query: 803 ESILAERNI----LIS------VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 852
E I ER L+S V P VV +N +VMEY+ G L ++
Sbjct: 37 ERIRRERTRNEARLLSRARKAGVNTP-VVYDVD----PDNKTIVMEYIEGKPLKDVIEEG 91
Query: 853 GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
DE + E+ + LH ++H DL N+++ D + L DFGL K
Sbjct: 92 N--DE-----LLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 36/153 (23%), Positives = 69/153 (45%), Gaps = 13/153 (8%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIK----VLKKADMIRKNAVESILAERNILISVRNPFVV 821
+ QG F ++F +R GD + +LK D +N ES +++ + + +V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 822 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA-ELVLALEYLHSLNVI 880
+ C + +V EY+ G L + L+ L ++ +A +L AL +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 881 HRDLKPDNLLIGQDGH--------IKLTDFGLS 905
H ++ N+L+ ++ IKL+D G+S
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 52/241 (21%), Positives = 96/241 (39%), Gaps = 35/241 (14%)
Query: 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKA--DMIRKNAVESILAERNILISVRNPFV 820
+K + G FG V GD I V K D + + I + S+ + ++
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 821 VRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMARVYIAELVLALEYLHSLNV 879
VR +L LV + G L +R + LD + ++ + YL +
Sbjct: 72 VRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
+HR+L N+L+ D +++ DFG++ DL P
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVA---------DLLYPD------------------- 162
Query: 940 REQRQKHSVAGTP-DYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQQIF 997
+++ +S TP ++A E +L + +D WS G+ ++E++ G P+ P ++
Sbjct: 163 -DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP 221
Query: 998 D 998
D
Sbjct: 222 D 222
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 34/127 (26%), Positives = 57/127 (44%), Gaps = 29/127 (22%)
Query: 863 YIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922
Y ++ +E+L S IHRDL N+L+ ++ +K+ DFGL++
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---------------- 222
Query: 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
D KD P R K S ++APE + + +D WS G++L+E+
Sbjct: 223 -------DIYKD-PDYVR----KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 270
Query: 983 -IGIPPF 988
+G P+
Sbjct: 271 SLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 57/217 (26%)
Query: 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA-------ELVLALEYLHSLNVIHRD 883
EN+ +V E++ G L LR ++ RV +A +L AL YL N++H +
Sbjct: 90 ENI-MVEEFVEHGPLDVCLR------KEKGRVPVAWKITVAQQLASALSYLEDKNLVHGN 142
Query: 884 LKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD---DLSAPSLGSGGFLVNDELKDQPPLTR 940
+ N+L L+++GL T LS P + L+R
Sbjct: 143 VCAKNIL-------------LARLGLAEGTSPFIKLSDPGVSFTA------------LSR 177
Query: 941 EQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLI-GIPPFNAKTP--QQI 996
E+R V P ++APE + G +TA D WS G L E+ G P +TP ++
Sbjct: 178 EER----VERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232
Query: 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
F +R +PE E LI + LT P QR
Sbjct: 233 FYEKKHR------LPEPSCKELATLISQCLTYEPTQR 263
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 19/90 (21%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 822 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIH 881
R +Y F E L + + + + C ++ + + + +++ LEY+H + H
Sbjct: 98 RMYYRFILLEKLVE--------NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149
Query: 882 RDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911
D+KP+N+++ + + D+G++ +IH
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
|
Length = 294 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 32/127 (25%), Positives = 58/127 (45%), Gaps = 29/127 (22%)
Query: 863 YIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922
Y ++ +E+L S IHRDL N+L+ ++ +K+ DFGL++
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR---------------- 227
Query: 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
D KD P R+ + + ++APE + + +D WS G++L+E+
Sbjct: 228 -------DIYKD-PDYVRKGDARLPL----KWMAPETIFDRVYTIQSDVWSFGVLLWEIF 275
Query: 983 -IGIPPF 988
+G P+
Sbjct: 276 SLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 38/155 (24%), Positives = 67/155 (43%), Gaps = 44/155 (28%)
Query: 839 YLNGGDLYSLLRNLGCLDEDMAR-------VYIA-ELVLALEYLHSLNVIHRDLKPDNLL 890
Y+N G+L L+ + + + V++A ++ + YLH VIH+D+ N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 891 IGQDGHIKLTDFGLSKVGLIHSTDDLSAPS----LGSGGFLVNDELKDQPPLTREQRQKH 946
I ++ +K+TD LS+ DL P LG N +K
Sbjct: 150 IDEELQVKITDNALSR--------DL-FPMDYHCLGDNE---NRPVK------------- 184
Query: 947 SVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981
++A E L+ + + +D WS G++L+EL
Sbjct: 185 -------WMALESLVNKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 63/309 (20%), Positives = 111/309 (35%), Gaps = 80/309 (25%)
Query: 766 ISQGAFGRVFLARKRATGDLFA----------IKVLKKADMIRKNAVESILAERNILISV 815
+ QG F ++ R DL +KVL E+ +++ +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETA----SLMSQL 58
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA-ELVLALEYL 874
+ +V+ + EN+ +V EY+ G L L ++ +A +L AL YL
Sbjct: 59 SHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYL 117
Query: 875 HSLNVIHRDLKPDNLLIGQDGH-------IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
++H ++ N+L+ + G IKL+D G+
Sbjct: 118 EDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--------------------- 156
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT--ADWWSVGIILFELLIGI 985
L+RE+R + ++APE + T AD WS G L E+
Sbjct: 157 --------TVLSREERVERI-----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNG 203
Query: 986 P-PFNAKTPQQ--IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042
P + + + F +R +P P+ E +LI++ T +P +R
Sbjct: 204 EEPLSTLSSSEKERFYQDQHR-LPMPDCA-----ELANLINQCWTYDPTKR--------- 248
Query: 1043 KQHPFFKNI 1051
P F+ I
Sbjct: 249 ---PSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 36/151 (23%), Positives = 56/151 (37%), Gaps = 44/151 (29%)
Query: 854 CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913
L+E+ A + L L L HR K N+L+ DG +KL
Sbjct: 13 PLNEEEI---WAVCLQCLGALREL---HRQAKSGNILLTWDGLLKLD------------- 53
Query: 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWS 973
GS F + P P ++APE++ G + AD +S
Sbjct: 54 --------GSVAF--------KTPEQSRP--------DPYFMAPEVIQGQSYTEKADIYS 89
Query: 974 VGIILFELLIGIPPFNAKTP-QQIFDNIMNR 1003
+GI L+E L P+N + I + ++N
Sbjct: 90 LGITLYEALDYELPYNEERELSAILEILLNG 120
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 21/155 (13%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRF 823
K I G FG+V L +V+ K +R +A S+ + L + P+
Sbjct: 1 KEIGNGWFGKVILGE--VNSGYTPAQVVVKE--LRVSA--SVQEQMKFLEEAQ-PYRSLQ 53
Query: 824 FYSF-----TCRENL--YLVMEYLNGGDLYSLLR------NLGCLDEDMARVYIAELVLA 870
+ C E LVME+ GDL LR + + R+ E+ L
Sbjct: 54 HSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM-ACEIALG 112
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905
L +LH N IH DL N L+ D +K+ D+GLS
Sbjct: 113 LLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 45/212 (21%)
Query: 787 AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV-MEYLNGGDL 845
A+K L + + + VE L E I+ +P V+ E LV + Y+ GDL
Sbjct: 27 AVKSLNRITDLEE--VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDL 84
Query: 846 YSLLRNLGCLDEDMARVYIAELV-------LALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898
+ +R+ + + +L+ +EYL S +HRDL N ++ + +K
Sbjct: 85 RNFIRS------ETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVK 138
Query: 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTP-DYLAP 957
+ DFGL++ D + D+ H+ A P ++A
Sbjct: 139 VADFGLAR-------D-------------IYDKEYYSV-------HNHTGAKLPVKWMAL 171
Query: 958 EILLGMGHGATADWWSVGIILFELLI-GIPPF 988
E L +D WS G++L+EL+ G PP+
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.003
Identities = 47/182 (25%), Positives = 74/182 (40%), Gaps = 40/182 (21%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLA-----RKRATGDLFAIKVLKKADMIRKNAVESILAE 808
+DF + K + +GAFG V+ A + + G VLKKA AVE + E
Sbjct: 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKY----VLKKAT--EYGAVEIWMNE 181
Query: 809 RNILISVRNPFVVRFFYSFTCREN------LYLVMEYLNGGDLYSL-------------- 848
R + + N F Y F + +LV Y L L
Sbjct: 182 R-VRRACPN-SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYL 239
Query: 849 LRNLGCLDEDMAR------VYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTD 901
L + L + + R + +++ AL+ LHS ++HRD+KP N++ + G K+ D
Sbjct: 240 LGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIID 299
Query: 902 FG 903
G
Sbjct: 300 LG 301
|
Length = 566 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1170 | |||
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1113 | 368 | consensus cAMP-dependent protein kinase types I an | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.66 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.61 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.56 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.76 | |
| KOG1113 | 368 | consensus cAMP-dependent protein kinase types I an | 98.72 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.68 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.68 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.67 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 98.5 | |
| PF00027 | 91 | cNMP_binding: Cyclic nucleotide-binding domain; In | 98.45 | |
| COG0664 | 214 | Crp cAMP-binding proteins - catabolite gene activa | 98.44 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.39 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.34 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.34 | |
| PLN03192 | 823 | Voltage-dependent potassium channel; Provisional | 98.21 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.11 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.09 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.09 | |
| cd00038 | 115 | CAP_ED effector domain of the CAP family of transc | 98.04 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.02 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.99 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.93 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.89 | |
| PRK10402 | 226 | DNA-binding transcriptional activator YeiL; Provis | 97.85 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.85 | |
| PRK09392 | 236 | ftrB transcriptional activator FtrB; Provisional | 97.82 | |
| PRK11753 | 211 | DNA-binding transcriptional dual regulator Crp; Pr | 97.81 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.77 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.71 | |
| smart00100 | 120 | cNMP Cyclic nucleotide-monophosphate binding domai | 97.7 | |
| TIGR03697 | 193 | NtcA_cyano global nitrogen regulator NtcA, cyanoba | 97.69 | |
| PRK13918 | 202 | CRP/FNR family transcriptional regulator; Provisio | 97.6 | |
| KOG0498 | 727 | consensus K+-channel ERG and related proteins, con | 97.58 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.57 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.54 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.47 | |
| PRK09391 | 230 | fixK transcriptional regulator FixK; Provisional | 97.46 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.35 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.08 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.92 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.86 | |
| PLN02868 | 413 | acyl-CoA thioesterase family protein | 96.86 | |
| PRK11161 | 235 | fumarate/nitrate reduction transcriptional regulat | 96.82 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.82 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.68 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.67 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.57 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.52 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.46 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.33 | |
| KOG0499 | 815 | consensus Cyclic nucleotide-gated cation channel C | 96.15 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.9 | |
| PLN02236 | 344 | choline kinase | 95.88 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-84 Score=730.00 Aligned_cols=484 Identities=30% Similarity=0.501 Sum_probs=422.6
Q ss_pred ccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCchh
Q 001057 553 DDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQ 629 (1170)
Q Consensus 553 ~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~ 629 (1170)
|.-.+..++|+.|||||+.|+++||+++|+++|+.+|+.|.+|++|+.|||||++ +|+|||.|+|+|++|+|||
T Consensus 176 ~Myp~~~~~gs~IIrege~Gs~~yV~aeG~~~V~~~g~ll~~m~~gtvFGELAILynctRtAsV~alt~~~lWaidR--- 252 (732)
T KOG0614|consen 176 CMYPVEYRAGSWIIREGEPGSHLYVSAEGELQVSREGKLLGKMGAGTVFGELAILYNCTRTASVRALTDVRLWAIDR--- 252 (732)
T ss_pred hhCcccccCCcEEEecCCCCceEEEeecceEEEeeCCeeeeccCCchhhhHHHHHhCCcchhhhhhhhhhhHHHHHH---
Confidence 4444667899999999999999999999999999999999999999999999999 9999999999999999999
Q ss_pred hhhhhhhhhhhccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh---
Q 001057 630 IELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR--- 700 (1170)
Q Consensus 630 ~~~~~~tfr~Il~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R--- 700 (1170)
++|+.|+|.+...+++.|..||++||+|.+|++.-|+||||.|+...| |++|++||.||||..|+.
T Consensus 253 -----~vFq~IM~~tg~~r~~~~~~fLrsv~~~q~l~Ee~L~KiaD~le~~~Yd~g~yIirqge~G~~ffii~~G~V~vt 327 (732)
T KOG0614|consen 253 -----EVFQAIMMRTGLERHEQYMNFLRSVPLFQNLPEELLLKIADVLEEEYYDAGEYIIRQGEKGDTFFIISKGTVKVT 327 (732)
T ss_pred -----HHHHHHHHHHHHHHHHHHHHHHHhhhhhccCCHHHHHHHHHHHHHHhhcCCceEEeecCCCCeEEEEecceEEEe
Confidence 999999999999999999999999999999999999999999999999 677899999999999974
Q ss_pred -----------HHHHHHHhHh---------------------hccccccccccccccccccccCCCcc-hhhcc--cc-C
Q 001057 701 -----------IEKLLQEKYV---------------------NLCGQIDDEKLDSSNAMTEEESSMDE-DTVRS--LR-T 744 (1170)
Q Consensus 701 -----------IeKl~rek~v---------------------~ic~qlddEkl~Ss~~~~eeess~de-e~v~s--l~-~ 744 (1170)
+.-+.+-+|+ ..|..+|.+.+.+.....++-.+.+- +.... .. .
T Consensus 328 q~~e~~~q~~~lr~l~kGd~FGE~al~~edvRtAniia~~~gv~cl~lDresF~~liG~l~~l~ek~~~D~~r~A~~~~~ 407 (732)
T KOG0614|consen 328 QQDEGSTQPQELRTLNKGDYFGERALLGEDVRTANIIAQAPGVECLTLDRESFKKLIGDLEELKEKDYGDEERRASVVIK 407 (732)
T ss_pred ecCCCCCchhHHhhccccchhhHHHhhccCccchhhhccCCCceEEEecHHHHHHhcccHHHhhhhhccchhhhhhhHHH
Confidence 2222233333 24445555555443332222111110 00000 00 0
Q ss_pred CCCCCCCCCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEE
Q 001057 745 SPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFF 824 (1170)
Q Consensus 745 sp~~p~~~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~ 824 (1170)
..+ .....++.+.+++.+..||-||||.|=+++.+.....+|+|+++|..+.+..+.+++..|.+||..+++|+||+||
T Consensus 408 ~~~-~~e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLY 486 (732)
T KOG0614|consen 408 EDF-AEEFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLY 486 (732)
T ss_pred HHH-HhhhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHH
Confidence 000 0012356778899999999999999999998776667999999999999999999999999999999999999999
Q ss_pred eeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCC
Q 001057 825 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGL 904 (1170)
Q Consensus 825 ~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGL 904 (1170)
-.|.+..++||+||-|-||+|+..|+..+.|.+..+++|++.+++|++|||++|||||||||+|+||+.+|.+||.|||+
T Consensus 487 rTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGF 566 (732)
T KOG0614|consen 487 RTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGF 566 (732)
T ss_pred HHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhC
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG 984 (1170)
|+.. ..+.++.++||||.|.|||++++++++.++|+||||+++||||+|
T Consensus 567 AKki-------------------------------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G 615 (732)
T KOG0614|consen 567 AKKI-------------------------------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG 615 (732)
T ss_pred HHHh-------------------------------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC
Confidence 9964 224567899999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCC--hhhHHHHHcCCCCCCCChhhhhhc-
Q 001057 985 IPPFNAKTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTLARQ- 1059 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpS--a~~AeEILqHPfF~~idwe~L~~~- 1059 (1170)
.|||.+.+++.+|+.|+++- +.|| ..++..+.+||++++..+|.+|++ ..++.||.+|.||.+.||+.|..+
T Consensus 616 ~pPFs~~dpmktYn~ILkGid~i~~P---r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~ 692 (732)
T KOG0614|consen 616 SPPFSGVDPMKTYNLILKGIDKIEFP---RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRT 692 (732)
T ss_pred CCCCCCCchHHHHHHHHhhhhhhhcc---cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhcc
Confidence 99999999999999999864 4444 789999999999999999999999 789999999999999999999887
Q ss_pred -cCCCCCCCCC-CCCCcccccc
Q 001057 1060 -KAMFIPAAES-LDTSYFVSRY 1079 (1170)
Q Consensus 1060 -~ppfiP~~~s-lDts~F~s~~ 1079 (1170)
.||++|.+.+ .|++||+...
T Consensus 693 L~pPi~~~va~ptD~s~Fd~~p 714 (732)
T KOG0614|consen 693 LPPPIIPSVANPTDVSNFDNFP 714 (732)
T ss_pred CCCCccccCCCcccchhccCCC
Confidence 7899999888 8999999853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-77 Score=720.06 Aligned_cols=1033 Identities=35% Similarity=0.425 Sum_probs=789.8
Q ss_pred ceeeeeccCCcceecccccCCCCccccccccCCCCccchhhhhcccccccccCCC----cc-----ccCCCCCCCCccCC
Q 001057 67 SILVASSLGLNHIRTKSVSSSPSPLRFFSAAGTPSSFTNEAKKNKTETAAADVKP----KF-----AVPPSNKPPSLESG 137 (1170)
Q Consensus 67 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-----~~~~~~~~~~~~~~ 137 (1170)
++.+.+..|+||||++|- .++.+++|..---|-.-|.- |-||..-.+....+ -| +-+--|.+|---.+
T Consensus 76 s~~~p~e~df~~Iklisn-gAygavylvrh~~trqrfa~--kiNkq~lilRnilt~a~npfvvgDc~tllk~~g~lPvdm 152 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISN-GAYGAVYLVRHKETRQRFAM--KINKQNLILRNILTFAGNPFVVGDCATLLKNIGPLPVDM 152 (1205)
T ss_pred cccCCCccccceeEeecc-CCCCceeeeeccccccchhh--cccccchhhhccccccCCcceechhhhhcccCCCCcchh
Confidence 489999999999999985 46777888766666666655 55554333322221 12 22223433333334
Q ss_pred -CCccccccccccCCCCCCccccccHHHHHhhccChhhhhHHhhccccccccccccccccccccCCCccccccccccCCC
Q 001057 138 -KKGQWTQSKSLRFPSPLNPELEVSHAAFAKEMQSPRFQAILRVTSGRKKKAPEIKSFSHELNSKGVRPFPVWKSRAFGH 216 (1170)
Q Consensus 138 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (1170)
.+-+|-++....-+.--++.|++.+..-+|..+..+++.+|+.+.. .+++-.|++|+||++.|||...|.+....+++
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at-nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT-NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc-hhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 7889999999999999999999999999999999999999999988 89999999999999999999999999999999
Q ss_pred hH--------HHHHHHHHHhHhhhhhhccc-----ccccchhhhhhhhccCCCChhhhhhHhHHHHHHHHhhccCcccee
Q 001057 217 ME--------EIMVAIRAKFDKLKEEVNCD-----LGVLAGDLVGILEKSSDSHPEWQESLEDLLVIARKCATMSPSEFW 283 (1170)
Q Consensus 217 ~~--------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (1170)
++ +.||.|+.+|..-++=|+.| +|++++|.|-..|+..-.-||-|+.+++||..+..|..|.++.||
T Consensus 232 rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 232 RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence 99 99999999999999999999 999999999999999999999999999999999999999999999
Q ss_pred EEeeeeeeecccc---cccCchhhHHHHHHHHHHHhHhhhhhhhhhhhccCcccccccccccccCCCchhhhh----hhh
Q 001057 284 VKCEGIVLNLDDR---RQELPMGILKQAYTRLLFILTRCTRLVQFQKESGYEEEHILGLHQLSDLGVYPEQIL----QIR 356 (1170)
Q Consensus 284 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 356 (1170)
|+|++||+-||.- ||+++++-+++++.+++||+|||+|.+||.+|.++++|++++.||.+...+++.|.. +.-
T Consensus 312 vk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~~se~~~~ees~~~~~qFsscs~r~~kv~ss~~~l~ 391 (1205)
T KOG0606|consen 312 VKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHFESEDTGDEESSLEFRQFSSCSPRFSKVYSSWESLA 391 (1205)
T ss_pred hhhccceeecccchhhhhhccccccccccccchhhcccchheeeccccCCccccccccccccccccccccccccchhhhh
Confidence 9999999999999 999999999999999999999999999999999999999999999999999876642 111
Q ss_pred ccCCcccCCCCcccchhhhhhccccccccCCcchhhh-hcccc----ccccccccccCCCCCcccccccccccCCCCccC
Q 001057 357 QQDFSGPLTGGKVMNEKQRKKSHGQELGSLNLKEDQV-DQHET----ENVEVGTAKSGDSTTSSYRMSSWKRLPSGSRRK 431 (1170)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (1170)
++. +. -+ -++.-+++++-... + ...|. +|... ..++..++-+..++. .+++.|+.+++.--..
T Consensus 392 ~~~--t~--~~---~~~~~~~~~~~~~~--~-~~g~k~~~~~~sp~~~kl~~st~~ss~s~~--~~~s~~~~~~~~~s~~ 459 (1205)
T KOG0606|consen 392 QLE--TA--TP---REKSSQSSQGEVSP--S-SAGQKDSWKSNSPESSKLELSTALSSVSPN--HPGSPSKSLTSAASTL 459 (1205)
T ss_pred ccc--cc--cc---cccccccccccccC--C-ccccccccccCChhhhhccccchhhhcccc--cCCCccccccchhhhh
Confidence 111 11 00 01112222222221 1 22333 35443 445556655555555 7999999998765432
Q ss_pred cccccccCCCCCChhhhhccCCCCcccC----CCCCCCcCccc-----ccccccc----cccccccc-------Ccccee
Q 001057 432 KGSEAAADTPPKDKTEAFQNKDEPKIGS----DDGNDNLDGLY-----HHASSRI----TKSWGFWG-------ENSMIC 491 (1170)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~-----~~~~~~~----~~~~~~~~-------~~~~~~ 491 (1170)
. ...... .-++|+++.|...- -..-+..+... -.-++++ .--|++|+ .+++||
T Consensus 460 ~-~~~~~s------~~~~ds~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~s~~~~d~s~~~~~~r~~~~~v~~~d~~i~ 532 (1205)
T KOG0606|consen 460 R-TALRTS------SPSEDSKIFPLRAPPPPSSYASEEPESPKPKFSVSPESGQPGDDSEALDRSRLWSKCVGTSDSGIC 532 (1205)
T ss_pred c-cccccC------CCCCCccccccCCCCCccccccCCCCCCCcccccCCCCCCcccchhhhccccccccccccCCcccc
Confidence 2 222111 23355555554211 11111122111 0001111 12377774 789999
Q ss_pred eccccccceeeecccccccccccccccCCcchhHHHHHHHHHHHHHhcccCCCc-cCc--------ccccccccCCCccc
Q 001057 492 RICEVEIPVVHVEEHSRICTIADRCDLKSLTVNERLERVAETLEKILDSWSPKK-HTK--------KRTHDDLNLMSPKQ 562 (1170)
Q Consensus 492 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--------~~~~~~~~~~~~k~ 562 (1170)
||||.++|++|+|+|++||+++++|+.+++.++.|+.+|.+-++++..||+..- .+- .+=..++-..+++.
T Consensus 533 ~~~e~~~p~~~~e~~~~~~~~~~ks~~~s~e~~~~~~kv~ks~s~~alS~~i~s~~~~~~~~l~s~lS~~~~sS~p~Srd 612 (1205)
T KOG0606|consen 533 RICEAEGPRLHSENHSRICKHQAKSELNSIEVKSRLRKVNKSLSASALSLMINSSDTPTGGPLCSPLSPRSLSSNPSSRD 612 (1205)
T ss_pred cccccccccccccCcchHHHhhhhcccCccccccchhhHHHHHHhhhcccccccccCCcccccccccCCCCCCCCcccCc
Confidence 999999999999999999999999999999999999999999999999999854 111 11112222333477
Q ss_pred ccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh-hh-----------cccccccCCCcccccCCchhh
Q 001057 563 NSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA-AK-----------TSSAGSLTPRSPLLTPRTSQI 630 (1170)
Q Consensus 563 ~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~-pR-----------AATv~A~t~~~lw~ldR~~~~ 630 (1170)
+.|+|.+.+++.-... ...+--. |..|| +-++ .| --.|.++++.++--..|.+|-
T Consensus 613 sspsrd~s~~~~~~~p---pI~i~~~---------~~~yG-ft~~airVy~Gd~d~ytvhh~v~sv~egsPA~~agls~~ 679 (1205)
T KOG0606|consen 613 SSPSRDSSAAMLSLRP---PITIHFS---------GKKYG-FTLRAIRVYMGDKDVYTVHHSVGSVEEGSPAFEAGLSAG 679 (1205)
T ss_pred cccccccchhhcCcCC---ceeeecc---------ccccC-ceeeeEEEecCCcccceeeeeeeeecCCCCccccCCCcc
Confidence 7888888877765544 1222222 22233 1111 11 145678888888888999999
Q ss_pred hhhhhhhhhhccCCCHHHHHHHHH--HhhccccCCCCCHHHHHHHHHHHHHHHHHHhccccCcEEeeeeh-hhHHHHHHH
Q 001057 631 ELLVNGHRTITELQNPQQIKKLLD--VSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVETFG-RRIEKLLQE 707 (1170)
Q Consensus 631 ~~~~~tfr~Il~~~~~~kr~~y~~--fl~~V~~l~~l~~~el~klADaLe~~~fIiqgekgD~FyI~~~G-~RIeKl~re 707 (1170)
||+.-.--.++.+-...+...+.. --+.+..+..|..-.+..........+.+.+..+-...-.+++| +++.+++++
T Consensus 680 DlIthvnge~v~gl~H~ev~~Lll~~gn~v~~~ttplenTSik~g~arr~~~k~~m~~R~kk~~~~E~~~~rr~~kLlr~ 759 (1205)
T KOG0606|consen 680 DLITHVNGEPVHGLVHTEVMELLLKSGNKVTLRTTPLENTSIKSGPARRDSYKAVMARRKKKALVPETFGIRRIEKLLRK 759 (1205)
T ss_pred ceeEeccCcccchhhHHHHHHHHHhcCCeeEEEeeccccchhhhhHHHHHHHHHHHhhcccccccccccccccHHHHHHH
Confidence 998776667777766666655554 33445556667777788888888888888888888899999999 899999999
Q ss_pred hHhhccccccccccccccccccccCCCcchhhccccCCCCCCCCCCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEE
Q 001057 708 KYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFA 787 (1170)
Q Consensus 708 k~v~ic~qlddEkl~Ss~~~~eeess~dee~v~sl~~sp~~p~~~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VA 787 (1170)
.+...|.-+.++... ....++...+....+...+..+.. .....+.+.+++.+-.|+++.++.+.-..+|...+
T Consensus 760 ~~~q~~~l~~~~~s~-----~ss~eS~pgdp~~sls~sP~sp~~-yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~ 833 (1205)
T KOG0606|consen 760 ISKQDCELLHTSRSF-----LSSSESLPGDPTRSLSASPRSPTK-YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRP 833 (1205)
T ss_pred HHhhhhhhhcccccc-----ccccccCCCCcccccccCCCCccc-ccCCCccceecccccCCCCcccccCCccccccccc
Confidence 998877766554432 222334444445566655665554 56788899999999999999999999999999999
Q ss_pred EEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHH
Q 001057 788 IKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL 867 (1170)
Q Consensus 788 IKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQI 867 (1170)
+|+..+.........+....+.+++....||.++..+..|.....++|||+|++|++|...+++.+..+++.++.++..+
T Consensus 834 ~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~ 913 (1205)
T KOG0606|consen 834 SKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILER 913 (1205)
T ss_pred hhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHH
Confidence 99988877777777778888888887788999999998888899999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcc-ccccccCCCCC-CCCCCCCCccccccccCCCCCccccccc
Q 001057 868 VLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK-VGLIHSTDDLS-APSLGSGGFLVNDELKDQPPLTREQRQK 945 (1170)
Q Consensus 868 L~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk-~~~~~~~~d~~-a~sl~s~~~l~~~~l~~~~~lt~~~~~~ 945 (1170)
.++++|||...++|||++|.|+|+..+|+.+++|||... ...+....+.. ..+.+....+.......... ....+..
T Consensus 914 vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~-~~~~~~~ 992 (1205)
T KOG0606|consen 914 VQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLS-ADEARRK 992 (1205)
T ss_pred HhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccc-cchhhcc
Confidence 999999999999999999999999999999999999544 33222222221 01100001111111111111 1123456
Q ss_pred ccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHh
Q 001057 946 HSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKL 1025 (1170)
Q Consensus 946 ~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkL 1025 (1170)
....||+.|.+||.+.+..++..+|||++|++++|.++|.+||....++.++++|.+...+||..+...+.++++++.++
T Consensus 993 ~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~l 1072 (1205)
T KOG0606|consen 993 HAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRL 1072 (1205)
T ss_pred ccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhh
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCCC-CCCCccccccccCCCCccccCCCCCccccCCCCCC
Q 001057 1026 LTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES-LDTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSG 1104 (1170)
Q Consensus 1026 Lq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~s-lDts~F~s~~~~~pede~v~~~~~f~d~~d~~~~G 1104 (1170)
|..+|.+|.++.++.++..||||+.++|+.|..+..+|+|...+ .|++||.+.|.|.+.++.+.....+.+..+.+...
T Consensus 1073 l~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s~~dtS~~~~r~~~~~~~e~~sg~s~~~~~~s~~~~~ 1152 (1205)
T KOG0606|consen 1073 LTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEFVPQPESTQDTSYFESRFSEESQDETVSGSSSGSKLDSPDESP 1152 (1205)
T ss_pred hccCchhccCcccccccccCCccCCCCccccccccCccCCCCCCCCccchhhcccccccccccccCCCcccCccCccccc
Confidence 99999999999889999999999999999999999999999986 89999999999998888888777776665555432
Q ss_pred CCCCCcChhhHhhhcccccccccccccccccCCceeecCCcccccchHHHHh
Q 001057 1105 SFSNTLDEEQADECGSLAEFSAPALAVQYSFSNFSFKNLSQLASINYDLVVK 1156 (1170)
Q Consensus 1105 s~s~~~~e~~~~~~~~~~e~~~~~~~~~y~fs~f~~~~~~~~~~~~~~~~~~ 1156 (1170)
..... +...+.|+ .-+|.||++.|.+++.|++|+.+.+
T Consensus 1153 ~~~~p--e~~~~~~~------------~~sl~~~~~k~~s~l~s~~p~~~l~ 1190 (1205)
T KOG0606|consen 1153 ECTTP--ELKPAMCG------------NLSLINFSFKNLSQLASINPDKLLQ 1190 (1205)
T ss_pred cccCc--cccCCcCc------------cccccccCccChhhccccChHhhcC
Confidence 22211 01122333 2229999999999999999999877
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-69 Score=620.00 Aligned_cols=375 Identities=44% Similarity=0.728 Sum_probs=310.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..++|+++++||+|+||.||+|+.+.||++||||+++|+.+...+++++++.|++||...++|+||+||++|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||||++|||+.++|.+.+.|+++.+++|+++++.||+.||++|||||||||+|+|||..||+||+|||||+.......
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999964432111
Q ss_pred CCC------CCCCCCCCCcccccccc-------------CCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHH
Q 001057 914 DDL------SAPSLGSGGFLVNDELK-------------DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974 (1170)
Q Consensus 914 ~d~------~a~sl~s~~~l~~~~l~-------------~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSL 974 (1170)
.+. ....+.. ....+... ...+...+....++++|||.||||||+.+.+|+..+|||||
T Consensus 297 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSE--AKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhcchhhhhhhhcc--CCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 110 0001100 00000000 01111233445678999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 975 GIILFELLIGIPPFNAKTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 975 GVILYELLTG~pPF~g~~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
||||||||.|+|||.+.++.+++++|+++. +.||. ...++.+++|||.+||+ ||.+|++..+++||++||||++++
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 999999999999999999999999999987 66664 35688999999999999 999999999999999999999999
Q ss_pred hhhhhhccCCCCCCCCC-CCCCccccccccCCCCccccCCCCCccccCCCCCCCCCCCcChhhHhhhccccccccccccc
Q 001057 1053 WDTLARQKAMFIPAAES-LDTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSFSNTLDEEQADECGSLAEFSAPALAV 1131 (1170)
Q Consensus 1053 we~L~~~~ppfiP~~~s-lDts~F~s~~~~~pede~v~~~~~f~d~~d~~~~Gs~s~~~~e~~~~~~~~~~e~~~~~~~~ 1131 (1170)
|+.|....|||+|.+.+ .|++||+.. ++..........+..+. .+....... ..+....++
T Consensus 453 W~~l~~~~apfvP~v~~~~DT~yFddF----------------~e~~~~~~~~~~~~~~~-k~~~~~~~~-~~~~~~~Fv 514 (550)
T KOG0605|consen 453 WDHLREMPAPFVPQVNSELDTQYFDDF----------------PEEDSMTPTADKSGPSR-KMLSMVDTN-NSSKDINFV 514 (550)
T ss_pred cchhhcCCCCCCCCCCCcccccccccC----------------cccccCcccccccccch-hhhhccccc-CCccccccc
Confidence 99999999999999999 999999842 22122222222222222 111111111 224556799
Q ss_pred ccccCCceeecCCcccccc
Q 001057 1132 QYSFSNFSFKNLSQLASIN 1150 (1170)
Q Consensus 1132 ~y~fs~f~~~~~~~~~~~~ 1150 (1170)
+|+|.+|.+++..+.+.++
T Consensus 515 gfTyk~~~~~~~~~~~~~~ 533 (550)
T KOG0605|consen 515 GFTYKNFDGLNKANSLLIN 533 (550)
T ss_pred ceeeecccccccccccccc
Confidence 9999999999999998877
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-64 Score=561.75 Aligned_cols=298 Identities=49% Similarity=0.895 Sum_probs=278.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|+++++||+|+||+||+++.+.|++.||||+++|..+.....+.++.+|+.||..++||+||++++.||+.+++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 56778999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|||+||+.||+|+.+|++.+.|+++.+++|+++|+.||.|||++|||||||||||||||.+||++|+|||||+...
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~---- 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL---- 176 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
..+..+.++|||+.|||||++.+.+|+.++||||||+++||||+|.+||.+.+.
T Consensus 177 --------------------------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 177 --------------------------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred --------------------------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 123345679999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC-hhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG-ATGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES- 1069 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS-a~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s- 1069 (1170)
..++++|..++...+ +..++.++++||+++|..||.+|++ ..++.+|.+||||.+++|+.+..+ .|||+|...+
T Consensus 231 ~~~~~~I~~~k~~~~--p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~ 308 (357)
T KOG0598|consen 231 KKMYDKILKGKLPLP--PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGL 308 (357)
T ss_pred HHHHHHHhcCcCCCC--CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCc
Confidence 999999999985544 3569999999999999999999997 457999999999999999999887 7899999888
Q ss_pred CCCCccccccccCC
Q 001057 1070 LDTSYFVSRYVWNP 1083 (1170)
Q Consensus 1070 lDts~F~s~~~~~p 1083 (1170)
.++++|+.+|+...
T Consensus 309 ~~~~~Fd~eft~~~ 322 (357)
T KOG0598|consen 309 EDTSNFDNEFTSYT 322 (357)
T ss_pred cccccccHHHHhcc
Confidence 89999999887543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-62 Score=529.94 Aligned_cols=288 Identities=43% Similarity=0.842 Sum_probs=272.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
..+++|+.++.||.|+||+|.+++++.+|.+||+|++.+..+.+..+++++.+|..||+.+.||++++|++.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|||||++||.|+.++++.++|++..+++|++||+.||+|||+++|+||||||||||||.+|++||+|||+|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v------ 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV------ 194 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999953
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
...+.+.||||.|+|||++...+|+.++|||||||++|||+.|.+||.+.++.
T Consensus 195 ---------------------------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~ 247 (355)
T KOG0616|consen 195 ---------------------------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI 247 (355)
T ss_pred ---------------------------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence 12367899999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC--hhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCC-CC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTLARQ--KAMFIPAA-ES 1069 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS--a~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~-~s 1069 (1170)
.+|++|+.+++.|| ..++.++++||+++|+.|-.+|.+ .+|..+|+.||||++++|+.+..+ ++|++|.. ..
T Consensus 248 ~iY~KI~~~~v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~ 324 (355)
T KOG0616|consen 248 QIYEKILEGKVKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHG 324 (355)
T ss_pred HHHHHHHhCcccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccC
Confidence 99999999999988 689999999999999999999987 458999999999999999999887 78888833 22
Q ss_pred -CCCCccccc
Q 001057 1070 -LDTSYFVSR 1078 (1170)
Q Consensus 1070 -lDts~F~s~ 1078 (1170)
.|+++|+..
T Consensus 325 ~gdtsnfd~y 334 (355)
T KOG0616|consen 325 PGDTSNFDDY 334 (355)
T ss_pred Cccccccccc
Confidence 788888864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-60 Score=557.77 Aligned_cols=295 Identities=39% Similarity=0.799 Sum_probs=275.9
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRE 831 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~ 831 (1170)
..+.+++|.++++||+|+||+|+++..+.++++||||+++|..+.....++..+.|..|+.... ||++++||.+|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4678899999999999999999999999999999999999999999999999999999998776 999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
++|+||||+.||||+ ++...+.|++..+++|+++|+.||.|||++||||||||.+|||||.+|++||+|||+|+...
T Consensus 443 ~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-- 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-- 519 (694)
T ss_pred eEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--
Confidence 999999999999944 44455789999999999999999999999999999999999999999999999999999632
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
..+..+.++||||.|||||++.+..|+.++|||||||+|||||.|+.||.|+
T Consensus 520 ----------------------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 520 ----------------------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred ----------------------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 1233667899999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAA 1067 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~ 1067 (1170)
+.+++++.|++....+| ..+|.++.+++++||.+||++|+++ .++.+|+.||||+.|+|+.|..+ +|||+|..
T Consensus 572 dEee~FdsI~~d~~~yP---~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i 648 (694)
T KOG0694|consen 572 DEEEVFDSIVNDEVRYP---RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTI 648 (694)
T ss_pred CHHHHHHHHhcCCCCCC---CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCccc
Confidence 99999999999998877 7899999999999999999999995 57999999999999999999987 89999999
Q ss_pred CC-CCCCcccccccc
Q 001057 1068 ES-LDTSYFVSRYVW 1081 (1170)
Q Consensus 1068 ~s-lDts~F~s~~~~ 1081 (1170)
++ .|.+||+.+|+.
T Consensus 649 ~~~~D~snFd~eFt~ 663 (694)
T KOG0694|consen 649 KGPEDVSNFDEEFTS 663 (694)
T ss_pred CChhhhcccchhhhc
Confidence 98 899999998864
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-58 Score=497.82 Aligned_cols=299 Identities=41% Similarity=0.787 Sum_probs=282.9
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
...+.+++|+.+++||+|.||+|.+|+.+.+|++||||+++|..+..+..+.+.+.|-.+|...+||++..|.++|+..+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 45678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
++|+||||.+||+|+.+|.+...|+++.+++|-++|+.||.|||+++||+||||.+|+|||.+|||||+|||||+...
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-- 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-- 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998531
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
..+..+.++||||.|+|||++....|+.++|||.+||+||||++|+.||+..
T Consensus 320 ----------------------------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 320 ----------------------------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred ----------------------------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 1234567899999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC--hhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTLARQ--KAMFIPAA 1067 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS--a~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~ 1067 (1170)
+...+++.|+...+.|| ..++++++.|+..+|.+||.+|++ ..+|+||..|+||.+++|+....+ .|||+|++
T Consensus 372 dh~kLFeLIl~ed~kFP---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 372 DHEKLFELILMEDLKFP---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred chhHHHHHHHhhhccCC---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 99999999999999988 689999999999999999999998 578999999999999999998776 79999999
Q ss_pred CC-CCCCccccccccCC
Q 001057 1068 ES-LDTSYFVSRYVWNP 1083 (1170)
Q Consensus 1068 ~s-lDts~F~s~~~~~p 1083 (1170)
.+ .|++||+.+|+..|
T Consensus 449 tSetDTryFD~EFT~q~ 465 (516)
T KOG0690|consen 449 TSETDTRYFDEEFTSQP 465 (516)
T ss_pred ccccchhhhhhhhhcce
Confidence 98 99999999987654
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-56 Score=502.75 Aligned_cols=317 Identities=39% Similarity=0.692 Sum_probs=273.7
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
...+.+++|++++.||.|.-|+||||+.+.++..+|||++.|..+...+...++..|.+||+.++||+++.||..|+.+.
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 45677889999999999999999999999999999999999999888888999999999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..|+|||||+||+|..+++++ +.|++..+++|+++|+.||+|||-+||||||||||||||-++|||.|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999999999875 579999999999999999999999999999999999999999999999999987653
Q ss_pred cccCCCCCC--------CCCC---CCCcccc----ccc--c-C------CCCC--cccccccccccCCCCCCchHHHhcC
Q 001057 910 IHSTDDLSA--------PSLG---SGGFLVN----DEL--K-D------QPPL--TREQRQKHSVAGTPDYLAPEILLGM 963 (1170)
Q Consensus 910 ~~~~~d~~a--------~sl~---s~~~l~~----~~l--~-~------~~~l--t~~~~~~~s~vGTp~YmAPEVL~g~ 963 (1170)
...+-.... +... .+.+... ... + + .+.+ .....+.++++||-+|+|||++.|.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 211110000 0000 1111111 000 0 0 0001 2334567899999999999999999
Q ss_pred CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC-hhhHHHH
Q 001057 964 GHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG-ATGAREV 1042 (1170)
Q Consensus 964 ~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS-a~~AeEI 1042 (1170)
+++.++|||+|||++||||.|..||.|.+..+++.+|+...+.||..+ .++..++|||++||.+||.+|++ ..||.||
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eI 389 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEI 389 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHh
Confidence 999999999999999999999999999999999999999999999765 78999999999999999999998 5689999
Q ss_pred HcCCCCCCCChhhhhhccCCCCCCCCC
Q 001057 1043 KQHPFFKNINWDTLARQKAMFIPAAES 1069 (1170)
Q Consensus 1043 LqHPfF~~idwe~L~~~~ppfiP~~~s 1069 (1170)
++||||++++|..++...||+||....
T Consensus 390 K~HpFF~gVnWaLir~~~PP~iP~~~d 416 (459)
T KOG0610|consen 390 KRHPFFEGVNWALIRCARPPEIPKPVD 416 (459)
T ss_pred hcCccccCCChhheeccCCCcCCCccc
Confidence 999999999999888889999998754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-57 Score=547.87 Aligned_cols=293 Identities=41% Similarity=0.753 Sum_probs=270.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
++..++|.++++||+|+||.|.+++++.|++.||||++.|..+........|..|++||...+.++||.|+++|++..++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 45668999999999999999999999999999999999998888888888999999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||||++||||..++.+.++++++.++||+++|+.||+.||+.|+|||||||+|||||..|||||+|||.|-...
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~---- 226 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD---- 226 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999886421
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
..+.......+|||.|++||+|.. ..|+..||||||||++||||+|..||
T Consensus 227 -------------------------~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPF 281 (1317)
T KOG0612|consen 227 -------------------------ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPF 281 (1317)
T ss_pred -------------------------CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcc
Confidence 012234456799999999999973 35899999999999999999999999
Q ss_pred CCCCHHHHHHHHhcc--CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCC
Q 001057 989 NAKTPQQIFDNIMNR--DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPA 1066 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~--~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~ 1066 (1170)
+.++..++|.+|++. .+.||.. ..+|.++++||.++|+ +|..|++.+|+++|..||||.+++|+.++...|||+|.
T Consensus 282 YadslveTY~KIm~hk~~l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 282 YADSLVETYGKIMNHKESLSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred hHHHHHHHHHHHhchhhhcCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 999999999999986 5777733 4699999999999999 99999999999999999999999999999999999999
Q ss_pred CCC-CCCCcccc
Q 001057 1067 AES-LDTSYFVS 1077 (1170)
Q Consensus 1067 ~~s-lDts~F~s 1077 (1170)
+.+ .||++|+-
T Consensus 360 vssd~DTsnFd~ 371 (1317)
T KOG0612|consen 360 VSSDDDTSNFDV 371 (1317)
T ss_pred CCCCCccccccc
Confidence 988 89999943
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-56 Score=509.61 Aligned_cols=286 Identities=39% Similarity=0.736 Sum_probs=259.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~ 832 (1170)
.....+|.+.+.||.|+|++|++|+++.+++.||||++.|..+.++..+..+..|.++|.+| .||+|++||..|+|...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 56778999999999999999999999999999999999999998998999999999999999 79999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+|+||+++|+|.++|++.+.|++..+++|++||+.||+|||++|||||||||||||||.||++||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999753111
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
... . +... . ........+++||..|.+||+|.....++.+|||+||||||.|+.|.+||.+.+
T Consensus 229 ~~~-------~-~~~~-------~--~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 229 KSQ-------E-NPVD-------P--NQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred ccc-------c-CccC-------c--ccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 100 0 0000 0 001112467999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCC
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAM 1062 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~pp 1062 (1170)
.--++++|+.-.+.|| ..+++.++|||+++|..||.+|+| +.+|++||||.+++|+.|..+.||
T Consensus 292 eyliFqkI~~l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt---~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 292 EYLIFQKIQALDYEFP---EGFPEDARDLIKKLLVRDPSDRLT---SQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred HHHHHHHHHHhcccCC---CCCCHHHHHHHHHHHccCcccccc---HHHHhhCcccccCChhhhhhcCCC
Confidence 9999999999999888 689999999999999999999999 799999999999999999888654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-55 Score=487.40 Aligned_cols=263 Identities=35% Similarity=0.598 Sum_probs=235.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHH----HHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKN----AVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~----~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
..+.|.+.+.||.|+||.|-+|..+.||+.||||++.+....... ....+.+|++||++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 456799999999999999999999999999999999886654422 2345689999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC---CcEEEEecCCcccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD---GHIKLTDFGLSKVG 908 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d---G~VKLsDFGLAk~~ 908 (1170)
..||||||+.||+|++.+-.++.+.++..+.|++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|+..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999876 68999999999963
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC---CcchhhhHHHHHHHHHHhCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH---GATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y---s~ksDIWSLGVILYELLTG~ 985 (1170)
.....+.+.||||.|.|||++.+.++ ..++|||||||+||-+|+|.
T Consensus 330 -------------------------------g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~ 378 (475)
T KOG0615|consen 330 -------------------------------GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGY 378 (475)
T ss_pred -------------------------------ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccC
Confidence 12345678999999999999998763 45789999999999999999
Q ss_pred CCCCCCCHHH-HHHHHhccCCCCC-CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 986 PPFNAKTPQQ-IFDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 986 pPF~g~~~~e-i~qkIl~~~l~fP-~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
+||.+..... +.++|..+.+.|- .....++.++.+||.+||..||++|++ +.|+|+||||+.++
T Consensus 379 pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s---~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 379 PPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS---ADEALNHPWFKDAP 444 (475)
T ss_pred CCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC---HHHHhcChhhhccc
Confidence 9999876655 8899999998765 344689999999999999999999999 88999999999775
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-53 Score=492.74 Aligned_cols=256 Identities=38% Similarity=0.664 Sum_probs=245.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
.+|...+.||+|||++||.+++..+|+.||+|++.+..+....+.+.+.+|++|.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 67999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|+|..++|..++++.+.++|.++++|++||+.||.|||+++|||||||..||||+.+.+|||+|||||..+
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l--------- 168 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL--------- 168 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeee---------
Confidence 99999999999999899999999999999999999999999999999999999999999999999999863
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.....+..+.||||.|+||||+...+++..+||||+||+||-||+|+|||...+..++|
T Consensus 169 ---------------------e~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety 227 (592)
T KOG0575|consen 169 ---------------------EYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY 227 (592)
T ss_pred ---------------------cCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH
Confidence 12345677899999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
.+|....+.+| ..+|.+|++||.+||+.||.+||+ +.+||.|+||.
T Consensus 228 ~~Ik~~~Y~~P---~~ls~~A~dLI~~lL~~~P~~Rps---l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 228 NKIKLNEYSMP---SHLSAEAKDLIRKLLRPNPSERPS---LDEVLDHPFFK 273 (592)
T ss_pred HHHHhcCcccc---cccCHHHHHHHHHHhcCCcccCCC---HHHHhcCHhhh
Confidence 99999999887 589999999999999999999999 89999999993
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-53 Score=487.57 Aligned_cols=317 Identities=46% Similarity=0.753 Sum_probs=272.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
...-|..++.||-|+||.|.|++..+|...||+|.+.|.++..++++.+++.|++||...++++||+||+.|++++++|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 33459999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||+|++||||..+|-+.+.|.|+.++||++++.+|+++.|..|+|||||||+|||||.+|||||+|||||.-+.. +.+
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW--THd 784 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW--THD 784 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccccccee--ccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999985321 111
Q ss_pred CCCCCCCCCCcccc------ccccCC----CCCc------ccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHH
Q 001057 916 LSAPSLGSGGFLVN------DELKDQ----PPLT------REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~------~~l~~~----~~lt------~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILY 979 (1170)
. .+.+.|+..-- ++..+. ..+. ...-...+.+||+.|+|||||...+|+..|||||.|||||
T Consensus 785 s--kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 785 S--KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred c--ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 11111111100 000000 0011 1112346789999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhh
Q 001057 980 ELLIGIPPFNAKTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLA 1057 (1170)
Q Consensus 980 ELLTG~pPF~g~~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~ 1057 (1170)
||+.|++||...++-+...+|.++. +.++. ..++|.++.+||.+|++ ++..|++..++++++.||||++|||..|+
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~-~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslR 940 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINWRNFLHIPY-QGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLR 940 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeehhhcccccc-ccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhh
Confidence 9999999999999988888888765 33332 25899999999999888 99999999999999999999999999999
Q ss_pred hccCCCCCCCCC-CCCCccccc
Q 001057 1058 RQKAMFIPAAES-LDTSYFVSR 1078 (1170)
Q Consensus 1058 ~~~ppfiP~~~s-lDts~F~s~ 1078 (1170)
.+.++|||.+.. .|+++|+..
T Consensus 941 kq~ApYIP~ItHptDTSNFdpv 962 (1034)
T KOG0608|consen 941 KQRAPYIPRITHPTDTSNFDPV 962 (1034)
T ss_pred hccCCcCccccCCCccccCCcC
Confidence 999999999988 999999863
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-53 Score=471.05 Aligned_cols=299 Identities=38% Similarity=0.782 Sum_probs=276.9
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecc
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCR 830 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~ 830 (1170)
...+...+|..+.+||+|+||+|.+|..+.|.+.||||+++|..+.....++..+.|..+|.... -|++++|+.+|+.-
T Consensus 343 ~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm 422 (683)
T KOG0696|consen 343 RDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM 422 (683)
T ss_pred ccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence 34567789999999999999999999999999999999999999888888899999999998764 68999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
+.+|+||||+.||+|..+|+..+.|.+..+.+|+++|+.||-+||++||||||||.+||||+.+|||||+|||+|+...
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni- 501 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI- 501 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999998532
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.....+.++||||.|+|||++...+|+.++||||+||+|||||.|++||.|
T Consensus 502 -----------------------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 502 -----------------------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred -----------------------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 113346789999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPA 1066 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~ 1066 (1170)
.+.+++++.|+..+..+| ..+|.++.++++.+|.+.|.+|++. .+-.+|..||||+.|||+.++.. +|||.|.
T Consensus 553 eDE~elF~aI~ehnvsyP---KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk 629 (683)
T KOG0696|consen 553 EDEDELFQAIMEHNVSYP---KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPK 629 (683)
T ss_pred CCHHHHHHHHHHccCcCc---ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCc
Confidence 999999999999999877 7899999999999999999999983 45689999999999999999887 8999999
Q ss_pred CCC-CCCCccccccccCC
Q 001057 1067 AES-LDTSYFVSRYVWNP 1083 (1170)
Q Consensus 1067 ~~s-lDts~F~s~~~~~p 1083 (1170)
++. -+.++|+..|+..+
T Consensus 630 ~k~~r~~eNFD~~Ft~~~ 647 (683)
T KOG0696|consen 630 IKCGRDAENFDKFFTREP 647 (683)
T ss_pred cccCCchhhhhHHHhcCC
Confidence 855 89999999887654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-52 Score=468.12 Aligned_cols=290 Identities=36% Similarity=0.661 Sum_probs=261.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..+.|+..++||+||||.||-|+.+.||+.||+|.+.|..+..+......++|..||.+++.++||.|-++|++.+.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 45667899999999999999999999999999999999998887777788899999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
||||..|+||||..+|.+.+ .|++..+++|++||++||++||+.+||||||||+|||||+.|||+|+|+|||..+.
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~-- 338 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP-- 338 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC--
Confidence 99999999999999998876 79999999999999999999999999999999999999999999999999998531
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.+......+||.+|||||++.+..|+.++|||||||++|||+.|+.||...
T Consensus 339 -----------------------------~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 339 -----------------------------EGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred -----------------------------CCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 122334559999999999999999999999999999999999999999764
Q ss_pred C----HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCC
Q 001057 992 T----PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMF 1063 (1170)
Q Consensus 992 ~----~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppf 1063 (1170)
. .+++-+.+++....++ ..+|+++++|+..+|++||.+|++. .++.++.+||||++++|..+... .|||
T Consensus 390 KeKvk~eEvdrr~~~~~~ey~---~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPf 466 (591)
T KOG0986|consen 390 KEKVKREEVDRRTLEDPEEYS---DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPF 466 (591)
T ss_pred hhhhhHHHHHHHHhcchhhcc---cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCC
Confidence 3 3467777777777666 7899999999999999999999993 58999999999999999999987 8999
Q ss_pred CCCCCC------CCCCcccc
Q 001057 1064 IPAAES------LDTSYFVS 1077 (1170)
Q Consensus 1064 iP~~~s------lDts~F~s 1077 (1170)
+|.... +|+..|+.
T Consensus 467 iPdp~aVyakDv~DIeqFs~ 486 (591)
T KOG0986|consen 467 IPDPGAVYAKDVLDIEQFST 486 (591)
T ss_pred CCCccccchhhhhhhhhccc
Confidence 997644 56666654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-50 Score=447.34 Aligned_cols=316 Identities=41% Similarity=0.732 Sum_probs=248.9
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+..|+.++..++||||+++++.|.+...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766555566678899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999753211000000
Q ss_pred C---CCCCCCCcccc---ccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 918 A---PSLGSGGFLVN---DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 918 a---~sl~s~~~l~~---~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
. .... ...... ........-..........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 161 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLP-SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccc-ccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0 0000 000000 00000000000111234568999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCCC
Q 001057 992 TPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES 1069 (1170)
Q Consensus 992 ~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~s 1069 (1170)
+..+.+..+.... +.+|.. ..++.++++||.+||+ +|.+|++..++.||++||||++++|+.+....++..+...+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPE-VPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKS 317 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCc-CCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCccCCC
Confidence 9999999888643 444421 3578999999999887 78888766669999999999999999987764443332222
Q ss_pred -CCCCccc
Q 001057 1070 -LDTSYFV 1076 (1170)
Q Consensus 1070 -lDts~F~ 1076 (1170)
.++++|+
T Consensus 318 ~~~~~~~~ 325 (363)
T cd05628 318 IDDTSNFD 325 (363)
T ss_pred cchhhccC
Confidence 3444444
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-50 Score=445.62 Aligned_cols=318 Identities=42% Similarity=0.748 Sum_probs=255.1
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||.|+||+||+|++..+|+.||||++.+...........+.+|+.+|..++||||++++++|.+.+++||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765555566778889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||+++...........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999753211000000
Q ss_pred ---CCCCCCCC----ccccccccCCCCC-cccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 918 ---APSLGSGG----FLVNDELKDQPPL-TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 918 ---a~sl~s~~----~l~~~~l~~~~~l-t~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
........ ............+ ........+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 00000000 0000000000000 001112335689999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCC--CCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCC
Q 001057 990 AKTPQQIFDNIMNRDIP--WPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAA 1067 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~--fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~ 1067 (1170)
+.+..+.+..+...... +|. ...+++++++||.+||. +|.+|++...+.++++||||++++|+.+....++++|..
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 318 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPEL 318 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCCC
Confidence 99988888888765432 332 13579999999999997 999999877799999999999999999888788888876
Q ss_pred CC-CCCCcccc
Q 001057 1068 ES-LDTSYFVS 1077 (1170)
Q Consensus 1068 ~s-lDts~F~s 1077 (1170)
.+ .+.++|+.
T Consensus 319 ~~~~~~~~~~~ 329 (364)
T cd05599 319 KSITDTSNFDD 329 (364)
T ss_pred CCchhhhhccc
Confidence 55 55566653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-50 Score=432.95 Aligned_cols=284 Identities=40% Similarity=0.804 Sum_probs=249.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||+|+||.||+|+++.+|+.||||++...........+.+.+|+.+|..++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998765444456678889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~-------- 152 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------- 152 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc--------
Confidence 999999999999988889999999999999999999999999999999999999999999999999987420
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++
T Consensus 153 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~ 207 (291)
T cd05612 153 -------------------------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY 207 (291)
T ss_pred -------------------------CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0112457999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDT 1072 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDt 1072 (1170)
+.+..+...+| ..++..+++||.+||+.||.+|++. ..+.++++||||+.++|..+... .++++|.... .++
T Consensus 208 ~~i~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 284 (291)
T cd05612 208 EKILAGKLEFP---RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDT 284 (291)
T ss_pred HHHHhCCcCCC---ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCcccc
Confidence 99988877665 5679999999999999999999962 35899999999999999987765 4455555333 555
Q ss_pred Ccccc
Q 001057 1073 SYFVS 1077 (1170)
Q Consensus 1073 s~F~s 1077 (1170)
.+|++
T Consensus 285 ~~~~~ 289 (291)
T cd05612 285 SNFDD 289 (291)
T ss_pred ccccC
Confidence 55543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=440.18 Aligned_cols=271 Identities=40% Similarity=0.835 Sum_probs=245.8
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
....+++|++.+.||.|+||.||+|+++.+++.||+|++.+.........+.+.+|+.+|..++||||++++++|.+.+.
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE
Confidence 34567899999999999999999999999999999999987655555567788999999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~--- 169 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--- 169 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC---
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987420
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 170 ------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 170 ------------------------------DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred ------------------------------CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 01124579999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
..+++..+..+...+| ..++..+++||.+||+.||.+|+++ ..+.++++||||.+.+|+.+..+
T Consensus 220 ~~~~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~ 285 (329)
T PTZ00263 220 PFRIYEKILAGRLKFP---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYAR 285 (329)
T ss_pred HHHHHHHHhcCCcCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhC
Confidence 9999999988877655 5689999999999999999999983 45899999999999999988754
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=434.42 Aligned_cols=282 Identities=42% Similarity=0.845 Sum_probs=248.7
Q ss_pred eccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCCh
Q 001057 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 845 (1170)
Q Consensus 766 LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL 845 (1170)
||+|+||.||+|++..+++.||+|++.+...........+..|+.+|..++||||++++++|.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876555556677888999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCC
Q 001057 846 YSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925 (1170)
Q Consensus 846 ~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~ 925 (1170)
.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~---------------- 144 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNM---------------- 144 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCc----------------
Confidence 9999888889999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC
Q 001057 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI 1005 (1170)
Q Consensus 926 ~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l 1005 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..++++.+.....
T Consensus 145 --------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~ 210 (312)
T cd05585 145 --------------KDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL 210 (312)
T ss_pred --------------cCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC
Confidence 001112346799999999999999999999999999999999999999999999999999888776
Q ss_pred CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCccccccc
Q 001057 1006 PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVSRYV 1080 (1170)
Q Consensus 1006 ~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s~~~ 1080 (1170)
.+| ..++.++++||.+||+.||.+|++..+|.++++||||...+|..+... .+++.|...+ .++++|+..+.
T Consensus 211 ~~~---~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (312)
T cd05585 211 RFP---DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFT 285 (312)
T ss_pred CCC---CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCcccc
Confidence 655 678999999999999999999999878999999999999999877554 4566666544 66777765544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=437.40 Aligned_cols=283 Identities=42% Similarity=0.785 Sum_probs=247.1
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 843 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GG 843 (1170)
+.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|..++||||++++++|...+.+||||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765555566678889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCC
Q 001057 844 DLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923 (1170)
Q Consensus 844 SL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s 923 (1170)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~-------------- 146 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-------------- 146 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc--------------
Confidence 999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q 001057 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003 (1170)
Q Consensus 924 ~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~ 1003 (1170)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+...++..+...
T Consensus 147 ----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~ 210 (323)
T cd05571 147 ----------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210 (323)
T ss_pred ----------------cCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC
Confidence 0011123467999999999999999999999999999999999999999999988888888877
Q ss_pred CCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCccccc
Q 001057 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVSR 1078 (1170)
Q Consensus 1004 ~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s~ 1078 (1170)
...+| ..++.++.+||.+||+.||.+||+. ..+.++++||||.+++|..+... .+++.|...+ .++.+|+..
T Consensus 211 ~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (323)
T cd05571 211 EIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEE 287 (323)
T ss_pred CCCCC---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcc
Confidence 76655 6799999999999999999999952 24899999999999999988754 4566665544 566666544
Q ss_pred c
Q 001057 1079 Y 1079 (1170)
Q Consensus 1079 ~ 1079 (1170)
+
T Consensus 288 ~ 288 (323)
T cd05571 288 F 288 (323)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=444.17 Aligned_cols=316 Identities=44% Similarity=0.797 Sum_probs=252.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||.|+||+||+|+++.+++.||||++.+...........+.+|+.+|..++|||||+++++|.+..++||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765555566778899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~- 159 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY- 159 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc-
Confidence 9999999999999888899999999999999999999999999999999999999999999999999974211000000
Q ss_pred CCCCCCCC-----------ccccc---cccCC---CCC-cccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHH
Q 001057 918 APSLGSGG-----------FLVND---ELKDQ---PPL-TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979 (1170)
Q Consensus 918 a~sl~s~~-----------~l~~~---~l~~~---~~l-t~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILY 979 (1170)
........ ..... ..... ... ........+.+||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 00000000 00000 00000 000 00001122468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhh
Q 001057 980 ELLIGIPPFNAKTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLA 1057 (1170)
Q Consensus 980 ELLTG~pPF~g~~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~ 1057 (1170)
||++|.+||.+.+..+.+..+.... +.+|. ...++.++++||.+||+ +|.+|++..++.+++.||||++++|+.+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~~ 317 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIR 317 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHc
Confidence 9999999999988888888887643 33342 13578999999999998 89998865669999999999999999998
Q ss_pred hccCCCCCCCCC-CCCCccc
Q 001057 1058 RQKAMFIPAAES-LDTSYFV 1076 (1170)
Q Consensus 1058 ~~~ppfiP~~~s-lDts~F~ 1076 (1170)
...++++|.... .+..+|.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~ 337 (377)
T cd05629 318 QIRAPFIPQLKSITDTSYFP 337 (377)
T ss_pred cCCCCcccCCCCccccccCC
Confidence 878888887665 4555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=446.84 Aligned_cols=259 Identities=32% Similarity=0.593 Sum_probs=235.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc-
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN- 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~- 832 (1170)
.+...+.+.+..||+|..|+||+|+++.|++.+|+|++.. ..+.....++.+|++|+..++|||||.+|++|.....
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 3556689999999999999999999999999999999843 2356677889999999999999999999999999995
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
++|+||||.||+|..++...++++|.....++.+|+.||.|||+ ++||||||||+||||+..|.|||||||.++...
T Consensus 153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv-- 230 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV-- 230 (364)
T ss_pred EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence 99999999999999999999999999999999999999999995 999999999999999999999999999998631
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
....++++||..|||||.+.+..|+.++||||||++++||++|+.||...
T Consensus 231 ------------------------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 231 ------------------------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ------------------------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 12457899999999999999999999999999999999999999999874
Q ss_pred -----CHHHHHHHHhccCCCCCCCCcc-CCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 992 -----TPQQIFDNIMNRDIPWPNIPEE-MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 992 -----~~~ei~qkIl~~~l~fP~ip~~-lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+..+++..|+.+..+ .+|.. +|+++++||..||++||.+|++ ++++++|||++..
T Consensus 281 ~~~~~~~~~Ll~~Iv~~ppP--~lP~~~fS~ef~~FV~~CL~Kdp~~R~s---~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 281 NPPYLDIFELLCAIVDEPPP--RLPEGEFSPEFRSFVSCCLRKDPSERPS---AKQLLQHPFIKKF 341 (364)
T ss_pred CCCCCCHHHHHHHHhcCCCC--CCCcccCCHHHHHHHHHHhcCCcccCCC---HHHHhcCHHHhhc
Confidence 677888899886653 45565 9999999999999999999999 8999999999864
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-49 Score=444.85 Aligned_cols=317 Identities=46% Similarity=0.750 Sum_probs=251.6
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|..++|||||+++++|.+.+.+|||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999987766566677889999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.............
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999986421000000000
Q ss_pred CC---C-CCCCccc----------cccc---cCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHH
Q 001057 919 PS---L-GSGGFLV----------NDEL---KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 919 ~s---l-~s~~~l~----------~~~l---~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYEL 981 (1170)
.. . ....+.. .... ..............+.+||+.|+|||++.+..|+.++|||||||+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~el 241 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241 (382)
T ss_pred cccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHH
Confidence 00 0 0000000 0000 0000000111123456899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhccCC--CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc
Q 001057 982 LIGIPPFNAKTPQQIFDNIMNRDI--PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei~qkIl~~~l--~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
++|.+||.+.+..+....+..... .+|. ...+++++.+||.+|+. +|.+|++..++.++++||||++++|.....+
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~ 319 (382)
T cd05625 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPP-QAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTIDFSSDLRQ 319 (382)
T ss_pred HhCCCCCCCCCHHHHHHHHHccCCCcCCCC-cccCCHHHHHHHHHHcc-CHhHcCCCCCHHHHhcCCCcCCcChHHHHhc
Confidence 999999999988887777776433 2331 24689999999999875 9999999778999999999999999874443
Q ss_pred -cCCCCCCCCC-CCCCcccc
Q 001057 1060 -KAMFIPAAES-LDTSYFVS 1077 (1170)
Q Consensus 1060 -~ppfiP~~~s-lDts~F~s 1077 (1170)
.++++|.... .++.+|+.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~ 339 (382)
T cd05625 320 QSAPYIPKITHPTDTSNFDP 339 (382)
T ss_pred CCCCccCcCCCcchhhhcCC
Confidence 6677777655 66667654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=430.03 Aligned_cols=286 Identities=38% Similarity=0.792 Sum_probs=246.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CcEEEEEeeeecccceEEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H-PNIVrL~~~Fqd~~~LyLVM 837 (1170)
+|++++.||+|+||.||+|++..+++.||||++.+.........+.+..|+.++..+.| ++|++++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999987655455566788899999999976 46889999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~------- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF------- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+++
T Consensus 154 -----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~ 210 (324)
T cd05587 154 -----------------------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 210 (324)
T ss_pred -----------------------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 001123467999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDT 1072 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDt 1072 (1170)
..+......+| ..++.++.+||.+||..||.+|++. ....++++||||..++|..+... .+++.|.... .+.
T Consensus 211 ~~i~~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (324)
T cd05587 211 QSIMEHNVSYP---KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSA 287 (324)
T ss_pred HHHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchh
Confidence 99988776555 6789999999999999999999984 34589999999999999988655 4555555433 344
Q ss_pred Ccccc
Q 001057 1073 SYFVS 1077 (1170)
Q Consensus 1073 s~F~s 1077 (1170)
.+|+.
T Consensus 288 ~~~~~ 292 (324)
T cd05587 288 ENFDK 292 (324)
T ss_pred hhcCc
Confidence 44443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=444.11 Aligned_cols=262 Identities=36% Similarity=0.653 Sum_probs=239.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
....+|.+.+.||+|+||+||+|+++.++..||||.+.+..+ ..+.++.+..|+.||+.++|||||+|++++.+++.+|
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence 346789999999999999999999999999999999988754 4567788899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC------CcEEEEecCCcccc
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD------GHIKLTDFGLSKVG 908 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d------G~VKLsDFGLAk~~ 908 (1170)
||||||.||||..+|++.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+..
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999999999999999999999999999999999999999999999999999999865 35899999999963
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
.......+.||||.|||||++....|+.++|+||+|+|||+|++|++||
T Consensus 166 -------------------------------~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf 214 (429)
T KOG0595|consen 166 -------------------------------QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPF 214 (429)
T ss_pred -------------------------------CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCc
Confidence 1233456789999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
...+..+++..+..+.-..|.++..++....+|+..+|+.+|..|.+ ..+.+.|++...-
T Consensus 215 ~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~---~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 215 DAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS---FEDFFDHPFLAAN 274 (429)
T ss_pred cccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCc---hHHhhhhhhcccC
Confidence 99999999999988877777777889999999999999999999998 6677889888653
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=428.89 Aligned_cols=288 Identities=38% Similarity=0.769 Sum_probs=249.8
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
+|++++.||+|+||.||+|+++.+++.||||++.+...........+..|..++..+ +|++|++++++|.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876544455566777888888877 5899999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||+++|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~-------- 152 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM-------- 152 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecC--------
Confidence 999999999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...++
T Consensus 153 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~ 210 (323)
T cd05616 153 ----------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 210 (323)
T ss_pred ----------------------CCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH
Confidence 0011123467999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAESLDTS 1073 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~slDts 1073 (1170)
+.+......+| ..++.++.+||.+||+.||.+|++. ....++++||||+.++|+.+..+ ++++.|.....+..
T Consensus 211 ~~i~~~~~~~p---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (323)
T cd05616 211 QSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKACGRDAE 287 (323)
T ss_pred HHHHhCCCCCC---CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCchhh
Confidence 99988777655 6789999999999999999999984 35789999999999999998766 56676655444555
Q ss_pred cccccc
Q 001057 1074 YFVSRY 1079 (1170)
Q Consensus 1074 ~F~s~~ 1079 (1170)
+|+..+
T Consensus 288 ~~~~~~ 293 (323)
T cd05616 288 NFDKFF 293 (323)
T ss_pred hcCchh
Confidence 554433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=437.47 Aligned_cols=282 Identities=40% Similarity=0.801 Sum_probs=249.5
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCC-CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATG-DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TG-e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
......++|++++.||+|+||.||+|++..++ ..||+|++.+.........+.+.+|+.++..++||||++++++|.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 34567789999999999999999999876655 78999999876655556677889999999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
..+|+||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~- 182 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD- 182 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC-
Confidence 9999999999999999999988889999999999999999999999999999999999999999999999999987420
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
......+||+.|||||++.+..++.++|||||||++|||++|.+||.+
T Consensus 183 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 183 --------------------------------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred --------------------------------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 011245799999999999998899999999999999999999999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPA 1066 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~ 1066 (1170)
.+...+++.+..+...+| ..++..+.+||++||+.||.+|++. .+++++++||||++++|..+... .++++|.
T Consensus 231 ~~~~~~~~~i~~~~~~~p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~ 307 (340)
T PTZ00426 231 NEPLLIYQKILEGIIYFP---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPK 307 (340)
T ss_pred CCHHHHHHHHhcCCCCCC---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 999889999988777655 6789999999999999999999852 35899999999999999987755 4566666
Q ss_pred CCC
Q 001057 1067 AES 1069 (1170)
Q Consensus 1067 ~~s 1069 (1170)
...
T Consensus 308 ~~~ 310 (340)
T PTZ00426 308 YKN 310 (340)
T ss_pred CCC
Confidence 543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=436.73 Aligned_cols=317 Identities=41% Similarity=0.744 Sum_probs=250.5
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||+|+||+||+|+++.+++.||||++.+...........+..|+.++..++||||+++++.|.+.+++||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765555566778899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998753211000000
Q ss_pred C--CCCCCCCccc---cccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 918 A--PSLGSGGFLV---NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 918 a--~sl~s~~~l~---~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
. ......+..+ +.................+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 0 0000000000 0000000000011122345689999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCCC-
Q 001057 993 PQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES- 1069 (1170)
Q Consensus 993 ~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~s- 1069 (1170)
....+..+.+.. +.+|. ...++.++++||.+|+. ||.+|+++.++.++++||||++++|..+....++..+...+
T Consensus 241 ~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~ 318 (360)
T cd05627 241 PQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSI 318 (360)
T ss_pred HHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCccCCCc
Confidence 999888888643 33342 12478999999999875 99999997789999999999999999987764433232323
Q ss_pred CCCCccc
Q 001057 1070 LDTSYFV 1076 (1170)
Q Consensus 1070 lDts~F~ 1076 (1170)
.+.++|.
T Consensus 319 ~~~~~~~ 325 (360)
T cd05627 319 DDTSNFD 325 (360)
T ss_pred chhhhcC
Confidence 4555554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-49 Score=447.37 Aligned_cols=260 Identities=39% Similarity=0.708 Sum_probs=236.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH--HHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK--NAVESILAERNILISVR-NPFVVRFFYSFTCRE 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~--~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~ 831 (1170)
...+.|.+.+.||.|+||+|++|.+..+|+.||+|++.+...... ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 556789999999999999999999999999999998776532211 34566778999999999 999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC-CcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD-GHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d-G~VKLsDFGLAk~~~~ 910 (1170)
.+|||||||.||+|++++.+.+++.|..++.+++||+.|++|||++||+||||||||||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998520
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-C-CcchhhhHHHHHHHHHHhCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-H-GATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-y-s~ksDIWSLGVILYELLTG~pPF 988 (1170)
.......+.|||+.|+|||++.+.. | +.++||||+||+||.|++|+.||
T Consensus 173 -----------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF 223 (370)
T KOG0583|consen 173 -----------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPF 223 (370)
T ss_pred -----------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCC
Confidence 1123456789999999999999977 7 48899999999999999999999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccC-CHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEM-SVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~l-S~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
...+...++..|..+.+.+| ..+ |.++++||.+||..||.+|++ +.+|+.||||+.
T Consensus 224 ~d~~~~~l~~ki~~~~~~~p---~~~~S~~~~~Li~~mL~~~P~~R~t---~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 224 DDSNVPNLYRKIRKGEFKIP---SYLLSPEARSLIEKMLVPDPSTRIT---LLEILEHPWFQK 280 (370)
T ss_pred CCccHHHHHHHHhcCCccCC---CCcCCHHHHHHHHHHcCCCcccCCC---HHHHhhChhhcc
Confidence 99999999999999999877 566 999999999999999999999 889999999986
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-48 Score=435.75 Aligned_cols=315 Identities=43% Similarity=0.722 Sum_probs=245.7
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|..++||||++++++|.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999988766666677889999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC-
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS- 917 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~- 917 (1170)
|++||+|.+++.+.+.+++..++.+++||+.||.|||++||+||||||+||||+.+|++||+|||+++...........
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999998643110000000
Q ss_pred ------CCCCCCCC-------cccccccc---CCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHH
Q 001057 918 ------APSLGSGG-------FLVNDELK---DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 918 ------a~sl~s~~-------~l~~~~l~---~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYEL 981 (1170)
........ ........ .............+.+||+.|||||++.+..|+.++|||||||++|||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 00000000 00000000 000000011123457899999999999998999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCC--CCCCCChhhHHHHHcCCCCCCCChhhhh
Q 001057 982 LIGIPPFNAKTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTEN--PVQRLGATGAREVKQHPFFKNINWDTLA 1057 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~D--PskRpSa~~AeEILqHPfF~~idwe~L~ 1057 (1170)
++|.+||...+..+....+.... ..+|. ...+++++.+||.+||+.+ |..|++ +.++++||||++++|....
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~---~~~~l~hp~f~~~~~~~~~ 317 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENTLHIPP-QVKLSPEAVDLITKLCCSAEERLGRNG---ADDIKAHPFFSEVDFSSDI 317 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHccccccCCCC-CCCCCHHHHHHHHHHccCcccccCCCC---HHHHhcCcccCCCChhHHh
Confidence 99999999888877776666432 33332 2368999999999977654 444887 8999999999999998754
Q ss_pred hc-cCCCCCCCCC-CCCCcccc
Q 001057 1058 RQ-KAMFIPAAES-LDTSYFVS 1077 (1170)
Q Consensus 1058 ~~-~ppfiP~~~s-lDts~F~s 1077 (1170)
.. .++++|.... .++++|+.
T Consensus 318 ~~~~~~~~p~~~~~~~~~~~~~ 339 (381)
T cd05626 318 RTQPAPYVPKISHPMDTSNFDP 339 (381)
T ss_pred hcCCCCccCcCCCcchhhhcCC
Confidence 44 5677776544 56666643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=428.01 Aligned_cols=281 Identities=40% Similarity=0.792 Sum_probs=245.1
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||+||+|+++.+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999876544455667788899998876 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~------------- 147 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI------------- 147 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecC-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+..
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 210 (320)
T cd05590 148 -----------------FNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210 (320)
T ss_pred -----------------cCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc
Confidence 001112345799999999999998999999999999999999999999999999999999988
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh---hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCccc
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFV 1076 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa---~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~ 1076 (1170)
....+| ..++.++.+||.+||+.||.+|+++ .+.+++++||||.+++|+.+..+ .+++.|...+ .+.++|+
T Consensus 211 ~~~~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (320)
T cd05590 211 DEVVYP---TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFD 287 (320)
T ss_pred CCCCCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcC
Confidence 776655 5789999999999999999999995 23589999999999999988665 5677777655 5556665
Q ss_pred c
Q 001057 1077 S 1077 (1170)
Q Consensus 1077 s 1077 (1170)
.
T Consensus 288 ~ 288 (320)
T cd05590 288 P 288 (320)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=432.50 Aligned_cols=296 Identities=35% Similarity=0.724 Sum_probs=268.5
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~ 831 (1170)
..+.+++|+++++||+|+|++|.+++.+.|.+.||||+++|.-....+.+..++.|..+..+. +||++|.|+.+|+...
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 356788999999999999999999999999999999999998887888889999999998765 6999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+++|.||++||+|..++++...++++.+++|.++|+.||+|||++|||+||||.+|+|||..|++||+|+|+|+...
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l-- 402 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-- 402 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998531
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC-
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA- 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g- 990 (1170)
..+..+.++||||.|+|||++.+..|++++|||+|||+||||+.|+.||.-
T Consensus 403 ----------------------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 403 ----------------------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred ----------------------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 123356789999999999999999999999999999999999999999951
Q ss_pred -------CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC---hhhHHHHHcCCCCCCCChhhhhhc-
Q 001057 991 -------KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG---ATGAREVKQHPFFKNINWDTLARQ- 1059 (1170)
Q Consensus 991 -------~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS---a~~AeEILqHPfF~~idwe~L~~~- 1059 (1170)
.+.+-+++-|+..++..| ..+|-.+..+++..|++||.+|++ -.+..++..|+||+.++|+.+..+
T Consensus 455 gm~n~d~ntedylfqvilekqirip---rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~ 531 (593)
T KOG0695|consen 455 GMDNPDMNTEDYLFQVILEKQIRIP---RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQ 531 (593)
T ss_pred cCCCcccchhHHHHHHHhhhccccc---ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcc
Confidence 234557788888888665 689999999999999999999998 347899999999999999999887
Q ss_pred -cCCCCCCCCC-CCCCcccccccc
Q 001057 1060 -KAMFIPAAES-LDTSYFVSRYVW 1081 (1170)
Q Consensus 1060 -~ppfiP~~~s-lDts~F~s~~~~ 1081 (1170)
.|||.|.+.+ .+..+|+..|+.
T Consensus 532 v~ppf~p~i~~d~~l~~fd~qft~ 555 (593)
T KOG0695|consen 532 VLPPFQPQITDDYGLDNFDTQFTS 555 (593)
T ss_pred cCCCCCCccccccCcccccccccc
Confidence 6899999887 788899988764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=416.86 Aligned_cols=274 Identities=35% Similarity=0.613 Sum_probs=234.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+|..++|+||++++++|.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999887654444445667899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 839 YLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~------- 153 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIP------- 153 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcC-------
Confidence 99999999888643 358999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH--
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ-- 994 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~-- 994 (1170)
........+||+.|||||++.+..++.++|||||||++|+|++|.+||.+.+..
T Consensus 154 ------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 209 (285)
T cd05631 154 ------------------------EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK 209 (285)
T ss_pred ------------------------CCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh
Confidence 000112457999999999999999999999999999999999999999876543
Q ss_pred --HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCC
Q 001057 995 --QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPA 1066 (1170)
Q Consensus 995 --ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~ 1066 (1170)
.+...+...... ++..++.++.+||.+||+.||.+|++. .++.++++||||.+++|+.+... .|+|+|.
T Consensus 210 ~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 210 REEVDRRVKEDQEE---YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred HHHHHHHhhccccc---CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 223333333333 336789999999999999999999984 35899999999999999999987 7788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=428.49 Aligned_cols=284 Identities=40% Similarity=0.779 Sum_probs=246.6
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 843 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GG 843 (1170)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||++++++|...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765555566778889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCC
Q 001057 844 DLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923 (1170)
Q Consensus 844 SL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s 923 (1170)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~-------------- 146 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI-------------- 146 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCC--------------
Confidence 999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q 001057 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003 (1170)
Q Consensus 924 ~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~ 1003 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+++..+...
T Consensus 147 ----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~ 210 (328)
T cd05593 147 ----------------TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210 (328)
T ss_pred ----------------CcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC
Confidence 0001123457999999999999989999999999999999999999999998888888888777
Q ss_pred CCCCCCCCccCCHHHHHHHHHhccCCCCCCCC--hhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCccccc
Q 001057 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVSR 1078 (1170)
Q Consensus 1004 ~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS--a~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s~ 1078 (1170)
...+| ..++.++.+||.+||+.||.+|++ ...+.++++||||.+++|..+... .+++.|...+ .++.+|...
T Consensus 211 ~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (328)
T cd05593 211 DIKFP---RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEE 287 (328)
T ss_pred CccCC---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCcc
Confidence 76655 679999999999999999999985 235999999999999999987655 4566666554 556666654
Q ss_pred cc
Q 001057 1079 YV 1080 (1170)
Q Consensus 1079 ~~ 1080 (1170)
+.
T Consensus 288 ~~ 289 (328)
T cd05593 288 FT 289 (328)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=431.57 Aligned_cols=318 Identities=45% Similarity=0.734 Sum_probs=247.1
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|..++||||+++++.|.+.+.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765545556678889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|............
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998642110000000
Q ss_pred C-------CCCCCCCccccccccCCCCC------cccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhC
Q 001057 918 A-------PSLGSGGFLVNDELKDQPPL------TREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 918 a-------~sl~s~~~l~~~~l~~~~~l------t~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG 984 (1170)
. ...................+ ..........+||+.|||||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 0 00000000000000000000 0001122356899999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc-cCC
Q 001057 985 IPPFNAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ-KAM 1062 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~-~pp 1062 (1170)
.+||.+.+..+....+.......+. ....++.++.+||.+|+. +|.+|++...+.++++||||++++|..+... .++
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~~ 319 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAP 319 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCCC
Confidence 9999998888777777654332211 123689999999999875 9999996555999999999999999988543 566
Q ss_pred CCCCCCC-CCCCccc
Q 001057 1063 FIPAAES-LDTSYFV 1076 (1170)
Q Consensus 1063 fiP~~~s-lDts~F~ 1076 (1170)
++|.... .++++|.
T Consensus 320 ~~~~~~~~~~~~~~~ 334 (376)
T cd05598 320 YIPKITHPTDTSNFD 334 (376)
T ss_pred CCCcCCCcchhhhcC
Confidence 6666543 4444544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=425.38 Aligned_cols=282 Identities=46% Similarity=0.830 Sum_probs=247.5
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||.|+||.||+|++..+++.||||++.+...........+.+|+.+|..++||||++++++|.+.+.+||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444556678899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~-------- 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-------- 152 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc--------
Confidence 999999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+.+
T Consensus 153 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 207 (333)
T cd05600 153 -------------------------TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW 207 (333)
T ss_pred -------------------------cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH
Confidence 0223467999999999999999999999999999999999999999999988888
Q ss_pred HHHhccCC--CCCCCC---ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCCC-CC
Q 001057 998 DNIMNRDI--PWPNIP---EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES-LD 1071 (1170)
Q Consensus 998 qkIl~~~l--~fP~ip---~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~s-lD 1071 (1170)
..+..... ..|... ..++.++.+||.+||..+|.+|++ +.++++||||.+++|..+....++++|...+ .+
T Consensus 208 ~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s---~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (333)
T cd05600 208 ENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS---LEDIKNHPFFKEVDWNELRELKPPFVPELESEID 284 (333)
T ss_pred HHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC---HHHHHhCcccCCCCHHHHhhCCCCCCCCCCCcch
Confidence 77765432 222211 256999999999999999999999 8899999999999999988777888887654 44
Q ss_pred CCcc
Q 001057 1072 TSYF 1075 (1170)
Q Consensus 1072 ts~F 1075 (1170)
..+|
T Consensus 285 ~~~~ 288 (333)
T cd05600 285 TGYF 288 (333)
T ss_pred hhhc
Confidence 4444
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=425.00 Aligned_cols=282 Identities=41% Similarity=0.775 Sum_probs=245.1
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 843 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GG 843 (1170)
+.||+|+||.||+|++..+|..||+|++.+...........+.+|+.++..++||||++++++|...+.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765545556677889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCC
Q 001057 844 DLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923 (1170)
Q Consensus 844 SL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s 923 (1170)
+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~------------- 147 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS------------- 147 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Q 001057 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR 1003 (1170)
Q Consensus 924 ~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~ 1003 (1170)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+..+...
T Consensus 148 -----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~ 210 (323)
T cd05595 148 -----------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210 (323)
T ss_pred -----------------CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 001122457999999999999989999999999999999999999999999988888888877
Q ss_pred CCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCccccc
Q 001057 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVSR 1078 (1170)
Q Consensus 1004 ~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s~ 1078 (1170)
...+| ..+++++.+||.+||+.||.+|++. ..+.++++||||.+++|..+... .+++.|...+ .++.+|+..
T Consensus 211 ~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (323)
T cd05595 211 EIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDE 287 (323)
T ss_pred CCCCC---CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCcc
Confidence 76655 6789999999999999999999952 35899999999999999987655 3566666555 555566544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=426.03 Aligned_cols=313 Identities=47% Similarity=0.832 Sum_probs=251.9
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||+|+||+||+|++..+|+.||||++.+...........+..|+.+|..++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998766555566778899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999753211100000
Q ss_pred CCCCCCCCcccc-ccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 918 APSLGSGGFLVN-DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 918 a~sl~s~~~l~~-~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.......... ....................||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....
T Consensus 161 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 161 --LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred --ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 0000000000 0000000001111223456799999999999999999999999999999999999999999998888
Q ss_pred HHHHhc--cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCCC-CCCC
Q 001057 997 FDNIMN--RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES-LDTS 1073 (1170)
Q Consensus 997 ~qkIl~--~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~s-lDts 1073 (1170)
+..+.. ....+|.. ..+++++.+||.+||. ||.+|++ .+.++++||||++++|+......++++|...+ .++.
T Consensus 239 ~~~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~--s~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (350)
T cd05573 239 YNKIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLG--SFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTS 314 (350)
T ss_pred HHHHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCC--CHHHHhcCCCcCCCCHHHHhhCCCCcCCCCCCchhhh
Confidence 888887 44444432 2479999999999998 9999998 37799999999999999888777778777655 4444
Q ss_pred ccc
Q 001057 1074 YFV 1076 (1170)
Q Consensus 1074 ~F~ 1076 (1170)
.|+
T Consensus 315 ~~~ 317 (350)
T cd05573 315 NFD 317 (350)
T ss_pred hcC
Confidence 443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=420.26 Aligned_cols=281 Identities=41% Similarity=0.808 Sum_probs=239.7
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILsk-L~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||+||+|++..+++.||||++++.........+.+..|..++.. .+||||++++++|.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999987654444455666777777765 4799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~------------- 147 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENM------------- 147 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECC-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+..
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 210 (316)
T cd05592 148 -----------------NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210 (316)
T ss_pred -----------------CCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 001122346799999999999998999999999999999999999999999999888888876
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCcccccc
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVSRY 1079 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s~~ 1079 (1170)
....+ +..++.++.+||.+||+.||.+|++. +.++++||||..++|..+... .+++.|.... .+..+|+..+
T Consensus 211 ~~~~~---~~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (316)
T cd05592 211 DRPHF---PRWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREF 285 (316)
T ss_pred CCCCC---CCCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccc
Confidence 55444 46789999999999999999999983 458899999999999987755 4556665544 5556665443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=420.21 Aligned_cols=288 Identities=36% Similarity=0.759 Sum_probs=249.0
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
+|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+..|..++..+. |++|++++++|.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765444555677888999998886 577889999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~-------- 152 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM-------- 152 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccC--------
Confidence 999999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+...++
T Consensus 153 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~ 210 (323)
T cd05615 153 ----------------------VDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF 210 (323)
T ss_pred ----------------------CCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0011123457999999999999989999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh--hHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWDTLARQ--KAMFIPAAESLDTS 1073 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~--~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~slDts 1073 (1170)
+.+......+| ..++.++.+||.+||+.||.+|++.. .+.++++||||..++|..+... .+++.|........
T Consensus 211 ~~i~~~~~~~p---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (323)
T cd05615 211 QSIMEHNVSYP---KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCGKGAE 287 (323)
T ss_pred HHHHhCCCCCC---ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCCCchh
Confidence 99988777655 67899999999999999999999843 4789999999999999988766 56777754444445
Q ss_pred cccccc
Q 001057 1074 YFVSRY 1079 (1170)
Q Consensus 1074 ~F~s~~ 1079 (1170)
+|+..+
T Consensus 288 ~~~~~~ 293 (323)
T cd05615 288 NFDKFF 293 (323)
T ss_pred hcCccc
Confidence 554443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=422.56 Aligned_cols=281 Identities=37% Similarity=0.726 Sum_probs=238.0
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||+||+|++..+++.||+|++.+...........+..|+.++.++ +||||++++++|.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999876555556677888999999888 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~------------- 147 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL------------- 147 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceecc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC-------CHHH
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK-------TPQQ 995 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~-------~~~e 995 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||... ....
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~ 210 (327)
T cd05617 148 -----------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY 210 (327)
T ss_pred -----------------CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHH
Confidence 0011123467999999999999999999999999999999999999999632 2334
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh---hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES- 1069 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa---~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s- 1069 (1170)
+++.+......+| ..++..+.+||.+||+.||.+|+++ .++.++++||||+.++|+.+... .+++.|....
T Consensus 211 ~~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 287 (327)
T cd05617 211 LFQVILEKPIRIP---RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDD 287 (327)
T ss_pred HHHHHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCC
Confidence 5555655555444 6789999999999999999999984 35789999999999999988765 4566666544
Q ss_pred CCCCcccc
Q 001057 1070 LDTSYFVS 1077 (1170)
Q Consensus 1070 lDts~F~s 1077 (1170)
.+..+|+.
T Consensus 288 ~~~~~~~~ 295 (327)
T cd05617 288 YGLENFDT 295 (327)
T ss_pred cchhhcCC
Confidence 34455544
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=419.96 Aligned_cols=271 Identities=40% Similarity=0.802 Sum_probs=237.5
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||.||+|+++.+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999876554555667788899999865 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~------------- 147 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGI------------- 147 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..++++.+..
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~ 210 (321)
T cd05591 148 -----------------LNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210 (321)
T ss_pred -----------------cCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 001112345799999999999998999999999999999999999999999999999999988
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh----hHHHHHcCCCCCCCChhhhhhc--cCCCCCCC
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT----GAREVKQHPFFKNINWDTLARQ--KAMFIPAA 1067 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~----~AeEILqHPfF~~idwe~L~~~--~ppfiP~~ 1067 (1170)
....+| ..++.++.+||.+||+.||.+|++.. .+.++++||||..++|..+... .+++.|..
T Consensus 211 ~~~~~p---~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~ 278 (321)
T cd05591 211 DDVLYP---VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKI 278 (321)
T ss_pred CCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCC
Confidence 776655 56899999999999999999999532 4899999999999999988665 34555544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=422.51 Aligned_cols=283 Identities=41% Similarity=0.776 Sum_probs=245.0
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 843 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GG 843 (1170)
+.||+|+||.||+|++..+|+.||+|++.+...........+..|+.++..++||||++++++|...+.+||||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765545556677889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 844 DLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 844 SL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+...
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~------------- 147 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI------------- 147 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecC-------------
Confidence 999999888889999999999999999999997 799999999999999999999999999987421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
.........+||+.|||||++.+..++.++|||||||++|+|++|..||.+.+...++..+..
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~ 210 (325)
T cd05594 148 -----------------KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210 (325)
T ss_pred -----------------CCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc
Confidence 000112245799999999999998999999999999999999999999999998888888887
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCcccc
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVS 1077 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s 1077 (1170)
....+| ..+++++.+||.+||+.||.+|++. ..+.++++||||.++.|...... .+++.|...+ .++.+|+.
T Consensus 211 ~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (325)
T cd05594 211 EEIRFP---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDE 287 (325)
T ss_pred CCCCCC---CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCc
Confidence 776655 6789999999999999999999842 24899999999999999987654 3556665544 56666665
Q ss_pred cc
Q 001057 1078 RY 1079 (1170)
Q Consensus 1078 ~~ 1079 (1170)
.+
T Consensus 288 ~~ 289 (325)
T cd05594 288 EF 289 (325)
T ss_pred hh
Confidence 44
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-48 Score=424.07 Aligned_cols=282 Identities=43% Similarity=0.802 Sum_probs=240.5
Q ss_pred eccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeeecccceEEEEeeccC
Q 001057 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV---RNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 766 LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL---~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
||+|+||+||+|+++.+++.||||++.+..............|..++..+ +||||++++++|.....+|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876554555556677788888765 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~------------- 147 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANL------------- 147 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCC-------------
Confidence 9999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIM 1001 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl 1001 (1170)
.........+||+.|||||++.+. .++.++|||||||++|+|++|..||.+.+..+++..+.
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~ 210 (330)
T cd05586 148 -----------------TDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210 (330)
T ss_pred -----------------CCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHH
Confidence 001122356799999999999764 48999999999999999999999999999999998888
Q ss_pred ccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh-hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCcccc
Q 001057 1002 NRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA-TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVS 1077 (1170)
Q Consensus 1002 ~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa-~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s 1077 (1170)
.+...++. ..++.++.+||.+||+.||.+||++ ..+.++++||||...+|+.+... .+++.|.... .+.++|+.
T Consensus 211 ~~~~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (330)
T cd05586 211 FGKVRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDP 288 (330)
T ss_pred cCCCCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCc
Confidence 87776653 3579999999999999999999974 36899999999999999987665 4556665544 45555554
Q ss_pred cc
Q 001057 1078 RY 1079 (1170)
Q Consensus 1078 ~~ 1079 (1170)
.+
T Consensus 289 ~~ 290 (330)
T cd05586 289 EF 290 (330)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=418.95 Aligned_cols=284 Identities=40% Similarity=0.784 Sum_probs=242.7
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHH---HhcCCCcEEEEEeeeecccceEEE
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL---ISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieIL---skL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
|++++.||+|+||.||+|.+..+|+.||||++.+.........+.+..|+.++ ..++||||++++++|.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876544455566777787766 456799999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||++||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~------- 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM------- 152 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCC-------
Confidence 999999999988865 579999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.........+||+.|||||++.+..++.++|||||||++|+|++|..||.+.+..++
T Consensus 153 -----------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~ 209 (324)
T cd05589 153 -----------------------GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV 209 (324)
T ss_pred -----------------------CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 001122356799999999999998999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LD 1071 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lD 1071 (1170)
+..+......+| ..++..+.+||.+||+.||.+||++ ..+.++++||||++++|..+... .++++|.... .|
T Consensus 210 ~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d 286 (324)
T cd05589 210 FDSIVNDEVRYP---RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPED 286 (324)
T ss_pred HHHHHhCCCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcch
Confidence 888888776555 6789999999999999999999963 25899999999999999987654 4566665443 34
Q ss_pred CCcccc
Q 001057 1072 TSYFVS 1077 (1170)
Q Consensus 1072 ts~F~s 1077 (1170)
.++|..
T Consensus 287 ~~~~~~ 292 (324)
T cd05589 287 VSNFDE 292 (324)
T ss_pred hhhcCc
Confidence 444443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=418.81 Aligned_cols=281 Identities=39% Similarity=0.784 Sum_probs=240.2
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHH-HHhcCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI-LISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieI-LskL~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|..+ ++.++||||++++++|...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 369999999999999999999999999987644444445566666654 6779999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~------------- 147 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI------------- 147 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCC-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
.........+||+.|||||++.+..++.++|||||||++|+|++|.+||.+.+..++++.+..
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~ 210 (325)
T cd05604 148 -----------------AQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH 210 (325)
T ss_pred -----------------CCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc
Confidence 001112346799999999999999999999999999999999999999999999999998887
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh-hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCcccc
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA-TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVS 1077 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa-~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s 1077 (1170)
.....+ ...+..+.++|.+||+.||.+||++ ..+.++++||||..++|..+... .+++.|...+ .+.++|+.
T Consensus 211 ~~~~~~---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (325)
T cd05604 211 KPLVLR---PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDA 286 (325)
T ss_pred CCccCC---CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCC
Confidence 765544 4689999999999999999999995 36789999999999999987765 4556665544 45555554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=417.93 Aligned_cols=282 Identities=42% Similarity=0.817 Sum_probs=240.6
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHH-HHhcCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI-LISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieI-LskL~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||+||+|+++.+|+.||||++.+...........+..|..+ ++.++||||+++++.|...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 369999999999999999999999999987654444445566666664 5779999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~------------- 147 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGI------------- 147 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccc-------------
Confidence 9999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+++..+..
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 210 (323)
T cd05575 148 -----------------EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN 210 (323)
T ss_pred -----------------cCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence 001112345799999999999999999999999999999999999999999999999998887
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh-hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCccccc
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA-TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVSR 1078 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa-~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s~ 1078 (1170)
.....+ ..++..+.+||.+||+.||.+|+++ ....++++||||..++|..+... .+++.|.... .+...|+..
T Consensus 211 ~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (323)
T cd05575 211 KPLRLK---PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPE 287 (323)
T ss_pred CCCCCC---CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCcc
Confidence 766544 5689999999999999999999995 35689999999999999988755 4566665443 445555443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-47 Score=417.82 Aligned_cols=281 Identities=37% Similarity=0.742 Sum_probs=235.7
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||.||+|+++.+++.||||++++...........+..|..++..+ +||||++++++|.+...+||||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3699999999999999999999999999876554555667788999999988 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~------------- 147 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI------------- 147 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999987311
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC---------CH
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK---------TP 993 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~---------~~ 993 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||... ..
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~ 210 (329)
T cd05588 148 -----------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE 210 (329)
T ss_pred -----------------cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccch
Confidence 0011223468999999999999999999999999999999999999999631 12
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh---hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAE 1068 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa---~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~ 1068 (1170)
..+++.+......+| ..++.++.+||.+||+.||.+|+++ .++.++++||||..++|..+... .+++.|...
T Consensus 211 ~~~~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
T cd05588 211 DYLFQVILEKQIRIP---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIE 287 (329)
T ss_pred HHHHHHHHcCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCC
Confidence 335556666655544 6789999999999999999999984 24889999999999999987654 344555443
Q ss_pred C-CCCCcccc
Q 001057 1069 S-LDTSYFVS 1077 (1170)
Q Consensus 1069 s-lDts~F~s 1077 (1170)
. .+..+|..
T Consensus 288 ~~~~~~~~~~ 297 (329)
T cd05588 288 SDRDLDNFDP 297 (329)
T ss_pred CcchhhhcCC
Confidence 3 33344443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=415.41 Aligned_cols=279 Identities=39% Similarity=0.766 Sum_probs=236.9
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILsk-L~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||.||+|+++.+|+.||+|++++..............|..++.. ++||||++++++|.+.+++|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999987544333455667778888875 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~------------- 147 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV------------- 147 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999986310
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
.........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++++.+..
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~ 210 (316)
T cd05620 148 -----------------FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV 210 (316)
T ss_pred -----------------cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 000112346799999999999999999999999999999999999999999998888888876
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCcccc
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVS 1077 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s 1077 (1170)
....+| ..++.++++||.+||+.||.+|+++ +.++++||||..++|..+... .+++.|.... .+..+|..
T Consensus 211 ~~~~~~---~~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (316)
T cd05620 211 DTPHYP---RWITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDR 283 (316)
T ss_pred CCCCCC---CCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCc
Confidence 655444 6789999999999999999999983 357999999999999987654 4555555443 34444443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-48 Score=447.86 Aligned_cols=261 Identities=33% Similarity=0.596 Sum_probs=242.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
.++-|++.+.||.|+.|.|.+|++..||+.+|||++.+...........+.+|+-||+.+.||||++||+++.+..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 45679999999999999999999999999999999988754555566788899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|+||++||.|++++-+.++|++.+++.|+.||+.|+.|||..+|+||||||+|+|||..+.|||+|||+|..-
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe------- 162 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE------- 162 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999752
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
..+....+.||+|.|.|||++.|..| +.++||||.|||||.||+|..||.+++..
T Consensus 163 ------------------------~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir 218 (786)
T KOG0588|consen 163 ------------------------VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR 218 (786)
T ss_pred ------------------------cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH
Confidence 22344567899999999999999887 78899999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
.++.++..+.+..| ..++.++++||.+||..||.+|++ .+||++|||+.+..-
T Consensus 219 ~LLlKV~~G~f~MP---s~Is~eaQdLLr~ml~VDp~~RiT---~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 219 VLLLKVQRGVFEMP---SNISSEAQDLLRRMLDVDPSTRIT---TEEILKHPFLSGYTS 271 (786)
T ss_pred HHHHHHHcCcccCC---CcCCHHHHHHHHHHhccCcccccc---HHHHhhCchhhcCCC
Confidence 99999999999766 789999999999999999999999 789999999988653
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=414.13 Aligned_cols=283 Identities=40% Similarity=0.811 Sum_probs=243.2
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||+||+|++..+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999876554555667778899999887 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~------------- 147 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI------------- 147 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecC-------------
Confidence 9999999988889999999999999999999999999999999999999999999999999986421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+...++..+..
T Consensus 148 -----------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~ 210 (318)
T cd05570 148 -----------------LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210 (318)
T ss_pred -----------------cCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 001112345799999999999999999999999999999999999999999999888888887
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCcccc
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVS 1077 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s 1077 (1170)
....+| ..++.++.+||.+||+.||.+||++ ..+.+++.||||+.++|..+... .+++.|.... .+..+|+.
T Consensus 211 ~~~~~~---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (318)
T cd05570 211 DEVRYP---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDD 287 (318)
T ss_pred CCCCCC---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCc
Confidence 776555 5789999999999999999999993 22389999999999999877654 4556665544 45555554
Q ss_pred cc
Q 001057 1078 RY 1079 (1170)
Q Consensus 1078 ~~ 1079 (1170)
.+
T Consensus 288 ~~ 289 (318)
T cd05570 288 EF 289 (318)
T ss_pred hh
Confidence 43
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=415.58 Aligned_cols=282 Identities=39% Similarity=0.770 Sum_probs=240.8
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS-VRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILsk-L~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||+||+|++..+++.||||++++..............|..++.. ++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999999999999999987543333445567778888876 5899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC------------
Confidence 99999998878899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++++.+..
T Consensus 149 ------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~ 210 (316)
T cd05619 149 ------------------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM 210 (316)
T ss_pred ------------------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 00112345799999999999998999999999999999999999999999998888888776
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCcccccc
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVSRY 1079 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s~~ 1079 (1170)
....+| ..++.++++||.+||+.||.+|+++ ..++++||||+.++|..+... .+++.|...+ .+.++|+..+
T Consensus 211 ~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (316)
T cd05619 211 DNPCYP---RWLTREAKDILVKLFVREPERRLGV--KGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEF 285 (316)
T ss_pred CCCCCC---ccCCHHHHHHHHHHhccCHhhcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhh
Confidence 554443 5789999999999999999999993 248999999999999987655 5677776655 5666776654
Q ss_pred c
Q 001057 1080 V 1080 (1170)
Q Consensus 1080 ~ 1080 (1170)
.
T Consensus 286 ~ 286 (316)
T cd05619 286 L 286 (316)
T ss_pred h
Confidence 3
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-47 Score=415.74 Aligned_cols=286 Identities=41% Similarity=0.747 Sum_probs=244.9
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.++..++||||++++++|.+.+.+||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544556677889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~------ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA------ 154 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCC------
Confidence 999999999999876 6799999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh------cCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL------GMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~------g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.........+||+.|+|||++. +..++.++|||||||++|+|++|..||.+
T Consensus 155 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 211 (330)
T cd05601 155 -----------------------NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211 (330)
T ss_pred -----------------------CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCC
Confidence 0000122347999999999997 45678899999999999999999999999
Q ss_pred CCHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCC
Q 001057 991 KTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAE 1068 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~ 1068 (1170)
.+....+..+.... ..+|. ...++.++.+||.+||+ ||.+|++ +.++++||||..++|..+....+++.|...
T Consensus 212 ~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t---~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~ 286 (330)
T cd05601 212 GTSAKTYNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLG---YEGLCCHPFFSKIDWNNIRNSLPPFVPTLK 286 (330)
T ss_pred CCHHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCC---HHHHhCCCCcCCCCHHHHhhCCCCccCcCC
Confidence 88888888887643 33342 23589999999999998 9999999 889999999999999998877777777665
Q ss_pred C-CCCCcccc
Q 001057 1069 S-LDTSYFVS 1077 (1170)
Q Consensus 1069 s-lDts~F~s 1077 (1170)
. .+..+|..
T Consensus 287 ~~~~~~~~~~ 296 (330)
T cd05601 287 SDDDTSNFDE 296 (330)
T ss_pred CcchhhhcCC
Confidence 5 34445543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=413.19 Aligned_cols=278 Identities=45% Similarity=0.845 Sum_probs=232.9
Q ss_pred CeEEEEEeccCCCeEEEEeeec---CCCCEEEEEEeeccccc-cHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccce
Q 001057 759 DFEIIKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMI-RKNAVESILAERNILISVR-NPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~-~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~L 833 (1170)
+|++++.||+|+||+||+|++. .+++.||+|++.+.... .....+.+..|+.+|..++ ||||++++++|...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 57899999999865432 2334567888999999995 89999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~--- 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--- 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCC-
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAK- 991 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~- 991 (1170)
.........+||+.|||||++.+. .++.++|||||||++|||++|..||...
T Consensus 158 --------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 158 --------------------------EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred --------------------------cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 001122346799999999999875 4788999999999999999999999643
Q ss_pred ---CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh--hHHHHHcCCCCCCCChhhhhhc--cCCCC
Q 001057 992 ---TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWDTLARQ--KAMFI 1064 (1170)
Q Consensus 992 ---~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~--~AeEILqHPfF~~idwe~L~~~--~ppfi 1064 (1170)
....+...+......+ +..++..+.+||.+||+.||.+|+++. .++++++||||++.+|..+... .+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~ 288 (332)
T cd05614 212 ERNTQSEVSRRILKCDPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFR 288 (332)
T ss_pred CCCCHHHHHHHHhcCCCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcC
Confidence 3344555555554443 367899999999999999999999765 6999999999999999987654 44555
Q ss_pred CCCC
Q 001057 1065 PAAE 1068 (1170)
Q Consensus 1065 P~~~ 1068 (1170)
|...
T Consensus 289 ~~~~ 292 (332)
T cd05614 289 PSIR 292 (332)
T ss_pred CCCC
Confidence 5443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=411.08 Aligned_cols=270 Identities=43% Similarity=0.849 Sum_probs=233.3
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN-ILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~Eie-ILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||.||+|++..+++.||+|++.+...........+..|+. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999998765444444555666655 57889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~------------- 147 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGV------------- 147 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCC-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999987411
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
.........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...++..+..
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (321)
T cd05603 148 -----------------EPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210 (321)
T ss_pred -----------------CCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc
Confidence 000112345799999999999998899999999999999999999999999998888888887
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh-hhHHHHHcCCCCCCCChhhhhhc--cCCCCCC
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA-TGAREVKQHPFFKNINWDTLARQ--KAMFIPA 1066 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa-~~AeEILqHPfF~~idwe~L~~~--~ppfiP~ 1066 (1170)
....+| ...+..+.++|.+||+.||.+|+++ ..+.++++||||..++|..+... .+++.|.
T Consensus 211 ~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T cd05603 211 KPLQLP---GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPN 274 (321)
T ss_pred CCCCCC---CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCC
Confidence 766554 5788999999999999999999984 46789999999999999987654 3444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=414.15 Aligned_cols=289 Identities=41% Similarity=0.780 Sum_probs=243.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765555556677889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||+.||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA------ 154 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCC------
Confidence 99999999999976 45799999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.........+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 155 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 155 -----------------------DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred -----------------------CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 00001123469999999999974 34788999999999999999999999998
Q ss_pred CHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCCC
Q 001057 992 TPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES 1069 (1170)
Q Consensus 992 ~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~s 1069 (1170)
+..+.+..+.... ..++.....++..+++||.+||+. |.+|++..++.++++||||.+++|..+....++++|...+
T Consensus 212 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~ 290 (331)
T cd05597 212 SLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSS 290 (331)
T ss_pred CHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHHHhcCCCCCCCCHHHHhhCCCCccCcCCC
Confidence 8888888887543 334433346899999999999985 5666555559999999999999999988777777776544
Q ss_pred -CCCCccc
Q 001057 1070 -LDTSYFV 1076 (1170)
Q Consensus 1070 -lDts~F~ 1076 (1170)
.++.+|+
T Consensus 291 ~~~~~~~~ 298 (331)
T cd05597 291 PTDTSNFD 298 (331)
T ss_pred cchhhhcC
Confidence 4444443
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=413.39 Aligned_cols=282 Identities=40% Similarity=0.770 Sum_probs=240.9
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|+++++||+|+||+||+++++.+++.||+|++.+...........+..|+.++..++|+||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998755445555667888999999999999999999999999999999
Q ss_pred eeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||+.||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~------ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME------ 154 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheeccc------
Confidence 99999999999987 36799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.........+||+.|||||++.+ ..++.++|||||||++|||++|..||.+.
T Consensus 155 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 155 -----------------------DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred -----------------------CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 00011223579999999999973 45788999999999999999999999999
Q ss_pred CHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCCC
Q 001057 992 TPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES 1069 (1170)
Q Consensus 992 ~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~s 1069 (1170)
+..+.+..+.... ..+|.....++.++++||.+||+.+ .+|++..++.++++||||.+++|+.+....++++|...+
T Consensus 212 ~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~-~~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~ 290 (332)
T cd05623 212 SLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSR-EHRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSS 290 (332)
T ss_pred CHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccCh-hhhcCCCCHHHHhCCCCcCCCCHHHHhhCCCCccCCCCC
Confidence 9988888887654 3445444578999999999999864 455544459999999999999999998877777776543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=414.41 Aligned_cols=280 Identities=37% Similarity=0.748 Sum_probs=234.7
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|+.++.++ +||||++++++|.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999999999999999999876554555667788899998776 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~------------- 147 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL------------- 147 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCcccccc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC---------CCH
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA---------KTP 993 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g---------~~~ 993 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.. ...
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~ 210 (329)
T cd05618 148 -----------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 210 (329)
T ss_pred -----------------CCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccH
Confidence 000112346799999999999999999999999999999999999999952 122
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh---hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAE 1068 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa---~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~ 1068 (1170)
..+.+.+......+| ..++..+.+||.+||+.||.+|+++ .++.++++||||++++|+.+... .+++.|...
T Consensus 211 ~~~~~~i~~~~~~~p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
T cd05618 211 DYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNIS 287 (329)
T ss_pred HHHHHHHhcCCCCCC---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCC
Confidence 334555666655544 6789999999999999999999984 24689999999999999987654 455555543
Q ss_pred C-CCCCccc
Q 001057 1069 S-LDTSYFV 1076 (1170)
Q Consensus 1069 s-lDts~F~ 1076 (1170)
. .+..+|.
T Consensus 288 ~~~~~~~~~ 296 (329)
T cd05618 288 GEFGLDNFD 296 (329)
T ss_pred CcccchhcC
Confidence 3 3333443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=413.96 Aligned_cols=281 Identities=41% Similarity=0.791 Sum_probs=236.4
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN-ILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~Eie-ILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|.. ++..++||||++++++|...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999999999999999998755433344445555554 46789999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~------------- 147 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI------------- 147 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccc-------------
Confidence 9999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
.........+||+.|||||++.+..++.++|||||||++|+|++|.+||.+.+..+++..+..
T Consensus 148 -----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 210 (325)
T cd05602 148 -----------------EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 210 (325)
T ss_pred -----------------cCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh
Confidence 001112346799999999999999999999999999999999999999999999999888887
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh-hHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCcccc
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT-GAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYFVS 1077 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~-~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F~s 1077 (1170)
....++ ..++..+.+||.+||+.||.+|+++. ...++++|+||..++|+.+... .+++.|.... .+...|+.
T Consensus 211 ~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (325)
T cd05602 211 KPLQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDP 286 (325)
T ss_pred CCcCCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCC
Confidence 665543 57899999999999999999999953 5779999999999999988654 3444444333 33344443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=414.57 Aligned_cols=282 Identities=40% Similarity=0.750 Sum_probs=241.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++|+||++++++|.+.+.+||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998755444555667888999999999999999999999999999999
Q ss_pred eeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||++||+|..++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD----- 155 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-----
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
........+||+.|||||++.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 156 ------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 156 ------------------------GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred ------------------------CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 0001123579999999999976 45788999999999999999999999999
Q ss_pred CHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCCC
Q 001057 992 TPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES 1069 (1170)
Q Consensus 992 ~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~s 1069 (1170)
+..+.+..+.... .++|.....++.++++||.+||+.+ .+|++..+++++++||||++++|+.+....++++|....
T Consensus 212 ~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~-~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~~ 290 (331)
T cd05624 212 SLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSR-ERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSS 290 (331)
T ss_pred CHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCc-hhhcCCCCHHHHhcCCCcCCCCHHHHhhCCCCccCCCCC
Confidence 8888888887644 3444433467999999999999965 466655569999999999999999998777788776543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=420.32 Aligned_cols=283 Identities=42% Similarity=0.767 Sum_probs=239.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+...+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45568999999999999999999999999999999999876554555566788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||++||+|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~--- 194 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK--- 194 (371)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc---
Confidence 9999999999999998764 589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC----CCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG----HGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~----ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.........+||+.|||||++.+.. ++.++|||||||++|||++|.+||.
T Consensus 195 --------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 195 --------------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred --------------------------CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 0001123567999999999997643 7889999999999999999999999
Q ss_pred CCCHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh--hhhhhccCCCCC
Q 001057 990 AKTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW--DTLARQKAMFIP 1065 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw--e~L~~~~ppfiP 1065 (1170)
+.+....+..|+... ..+|. ...++.++++||.+||. +|..|++..++.++++||||++.+| +.+....++++|
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~ 326 (371)
T cd05622 249 ADSLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP 326 (371)
T ss_pred CCCHHHHHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCCChhHHhcCCCCCCCCC
Confidence 999988898888644 34442 24689999999999998 7777776666999999999998655 444444566666
Q ss_pred CCC
Q 001057 1066 AAE 1068 (1170)
Q Consensus 1066 ~~~ 1068 (1170)
...
T Consensus 327 ~~~ 329 (371)
T cd05622 327 DLS 329 (371)
T ss_pred CCC
Confidence 543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=411.79 Aligned_cols=264 Identities=45% Similarity=0.863 Sum_probs=230.9
Q ss_pred EEEeccCCCeEEEEeeec---CCCCEEEEEEeeccccc-cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 763 IKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMI-RKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~-~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
++.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+|..++||||++++++|...+.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999864 57899999999875432 22344567889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
|+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~--------- 151 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI--------- 151 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecc---------
Confidence 99999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~q 998 (1170)
.........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+....+.
T Consensus 152 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~ 210 (323)
T cd05584 152 ---------------------HEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210 (323)
T ss_pred ---------------------cCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 00111234579999999999999889999999999999999999999999999888888
Q ss_pred HHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC--hhhHHHHHcCCCCCCCChhhhhhc
Q 001057 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 999 kIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS--a~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
.+..+...+| ..+++.+.+||.+||+.||.+|++ ...+.++++||||...+|..+...
T Consensus 211 ~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~ 270 (323)
T cd05584 211 KILKGKLNLP---PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLAR 270 (323)
T ss_pred HHHcCCCCCC---CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcC
Confidence 8888776554 678999999999999999999994 234899999999999999887654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=421.07 Aligned_cols=289 Identities=41% Similarity=0.731 Sum_probs=242.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+...+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35567899999999999999999999999999999999876544455556788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||++||+|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~--- 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA--- 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC---
Confidence 9999999999999998764 689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC----CCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM----GHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~----~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.........+||+.|||||++.+. .++.++|||||||++|||++|.+||.
T Consensus 195 --------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 195 --------------------------NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred --------------------------CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 000112346799999999999754 37889999999999999999999999
Q ss_pred CCCHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCC--CCChhhHHHHHcCCCCCCCChhhhh--hccCCC
Q 001057 990 AKTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQ--RLGATGAREVKQHPFFKNINWDTLA--RQKAMF 1063 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPsk--RpSa~~AeEILqHPfF~~idwe~L~--~~~ppf 1063 (1170)
+.+....+..|.... +.+|. ...++.++++||.+||+.+|.+ |++ +.++++||||++.+|.... ...+++
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s---~~ell~h~~~~~~~~~~~~~~~~~~~~ 324 (370)
T cd05596 249 ADSLVGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNG---VDEIKSHPFFKNDQWTFDNIRETVAPV 324 (370)
T ss_pred CCCHHHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCC---HHHHhcCcccCCCChhhHHhcCCCcCc
Confidence 999888888887654 33442 1357999999999999988877 877 8999999999998887543 335566
Q ss_pred CCCCCC-CCCCccc
Q 001057 1064 IPAAES-LDTSYFV 1076 (1170)
Q Consensus 1064 iP~~~s-lDts~F~ 1076 (1170)
+|.... .++.+|+
T Consensus 325 ~p~~~~~~~~~~~~ 338 (370)
T cd05596 325 VPELSSDIDTSNFD 338 (370)
T ss_pred cCcCCCcchhhhcC
Confidence 666544 4444443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=420.30 Aligned_cols=290 Identities=41% Similarity=0.746 Sum_probs=238.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+...+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 44578999999999999999999999999999999998765544555667889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~---- 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE---- 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc----
Confidence 999999999999999764 689999999999999999999999999999999999999999999999999974210
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC----CCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG----HGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~----ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.......+.+||+.|||||++.+.. ++.++|||||||++|+|++|.+||.+
T Consensus 195 -------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 195 -------------------------TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred -------------------------CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 0001123567999999999998643 78899999999999999999999999
Q ss_pred CCHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhh--hhhccCCCCCC
Q 001057 991 KTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT--LARQKAMFIPA 1066 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~--L~~~~ppfiP~ 1066 (1170)
.+....+..|.... +.+|. ...++..+++||.+||+ ++.+|++..++.++++||||+...|.. +....+++.|.
T Consensus 250 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~-~~~~r~~R~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05621 250 DSLVGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPE 327 (370)
T ss_pred CCHHHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHcc-CchhccCCCCHHHHhcCcccCCCCcChHhcCCCCCCcCCC
Confidence 99888888887644 34442 13579999999999998 444444333489999999999866653 33335666666
Q ss_pred CCC-CCCCccc
Q 001057 1067 AES-LDTSYFV 1076 (1170)
Q Consensus 1067 ~~s-lDts~F~ 1076 (1170)
..+ .+..+|+
T Consensus 328 ~~~~~~~~~~~ 338 (370)
T cd05621 328 LSSDIDSSNFD 338 (370)
T ss_pred CCCcchhhhcC
Confidence 544 3444443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=439.43 Aligned_cols=257 Identities=35% Similarity=0.637 Sum_probs=237.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|.+...||+|+||+||+|+.+.|.+.||||++.|... ....+..+.+|++|++.++|||||.++++|+...++++|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 3689999999999999999999999999999999988653 345678899999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
.|||.| +|+.+|...+.++|+.++.++++++.||.|||+++|+|||+||.|||++..|++|+||||+|+...
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~------- 151 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMS------- 151 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcc-------
Confidence 999976 999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.......++-|||.|||||++.+..|+..+|+||||||+|||++|+|||......++
T Consensus 152 -----------------------~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~L 208 (808)
T KOG0597|consen 152 -----------------------TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQL 208 (808)
T ss_pred -----------------------cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHH
Confidence 122334567899999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
...|......|| ..++..+.+||..+|.+||.+|++ .-+++.|||.++-
T Consensus 209 v~~I~~d~v~~p---~~~S~~f~nfl~gLL~kdP~~Rlt---W~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 209 VKSILKDPVKPP---STASSSFVNFLQGLLIKDPAQRLT---WTDLLGHPFWKGK 257 (808)
T ss_pred HHHHhcCCCCCc---ccccHHHHHHHHHHhhcChhhccc---HHHHhcChHHhhh
Confidence 999999999888 589999999999999999999999 5688999998753
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=411.28 Aligned_cols=270 Identities=44% Similarity=0.822 Sum_probs=235.3
Q ss_pred EEeccCCCeEEEEeee---cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeec
Q 001057 764 KPISQGAFGRVFLARK---RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYL 840 (1170)
Q Consensus 764 k~LG~GgFGtVyLArd---k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~ 840 (1170)
+.||+|+||.||++++ ..+|+.||+|++.+... .......+..|+.+|.+++||||++++++|.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999986 35789999999987543 2233456778999999999999999999999999999999999
Q ss_pred cCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCC
Q 001057 841 NGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920 (1170)
Q Consensus 841 ~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~s 920 (1170)
.+|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~----------- 149 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI----------- 149 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccC-----------
Confidence 999999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 001057 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNI 1000 (1170)
Q Consensus 921 l~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkI 1000 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 150 -------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i 210 (318)
T cd05582 150 -------------------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210 (318)
T ss_pred -------------------CCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH
Confidence 0011223467999999999999988999999999999999999999999999998888888
Q ss_pred hccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhh--HHHHHcCCCCCCCChhhhhhc--cCCCCCCC
Q 001057 1001 MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATG--AREVKQHPFFKNINWDTLARQ--KAMFIPAA 1067 (1170)
Q Consensus 1001 l~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~--AeEILqHPfF~~idwe~L~~~--~ppfiP~~ 1067 (1170)
......+| ..++..+.+||.+||+.||.+||++.+ +.+++.||||..++|..+... .+++.|..
T Consensus 211 ~~~~~~~p---~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (318)
T cd05582 211 LKAKLGMP---QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAV 278 (318)
T ss_pred HcCCCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCC
Confidence 87776554 678999999999999999999999766 899999999999999987754 34444443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=416.13 Aligned_cols=250 Identities=30% Similarity=0.551 Sum_probs=226.0
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEe-eeeccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY-SFTCRE 831 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~-~Fqd~~ 831 (1170)
......+|+++++||+|+||+||++++..+|+.+|.|.+. -...+..+.+.+..|+.+|++|+|||||++|+ .|..+.
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 3556778999999999999999999999999999999988 44567778889999999999999999999998 666666
Q ss_pred c-eEEEEeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--CC--eeeccCCCCcEEeCCCCcEEEEec
Q 001057 832 N-LYLVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHS--LN--VIHRDLKPDNLLIGQDGHIKLTDF 902 (1170)
Q Consensus 832 ~-LyLVMEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs--~G--IIHRDIKPENILLd~dG~VKLsDF 902 (1170)
. ++||||||.+|||...|+.. ..++|..++.|+.|++.||.+||+ .. |+||||||.||+|+.+|.|||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 99999999999999999643 569999999999999999999998 44 999999999999999999999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELL 982 (1170)
||++.+. .......+.+|||.||+||++.+.+|++++|||||||++|||+
T Consensus 173 GL~r~l~------------------------------s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMc 222 (375)
T KOG0591|consen 173 GLGRFLS------------------------------SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMC 222 (375)
T ss_pred hhHhHhc------------------------------chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 9999641 2334567899999999999999999999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCCCC-ccCCHHHHHHHHHhccCCCCCCCC
Q 001057 983 IGIPPFNAKTPQQIFDNIMNRDIPWPNIP-EEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 983 TG~pPF~g~~~~ei~qkIl~~~l~fP~ip-~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
.-++||+|++..++.++|.++++ |.+| ...|.++..||..|++.||..||+
T Consensus 223 aL~~PF~g~n~~~L~~KI~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 223 ALQSPFYGDNLLSLCKKIEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred hcCCCcccccHHHHHHHHHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCC
Confidence 99999999999999999999865 4555 578999999999999999999998
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=413.10 Aligned_cols=260 Identities=28% Similarity=0.498 Sum_probs=221.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
++.|+.+.++|+|+||+||+|+++.||+.||||.+..+. .+....+-.++|+.+|++++|||+|.|.++|.....++||
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 367999999999999999999999999999999987653 2344556678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
+|||.. ++.+.|.+. ..++++.++.|+.|++.|+.|||++++||||||||||||+.+|.+||||||+|+...
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~------ 152 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS------ 152 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc------
Confidence 999965 566666554 569999999999999999999999999999999999999999999999999999631
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
..+.....++.|.||+|||.+.| ..|+.++||||+||++.||++|.+.|.|.+.-
T Consensus 153 ------------------------~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi 208 (396)
T KOG0593|consen 153 ------------------------APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI 208 (396)
T ss_pred ------------------------CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH
Confidence 11223345788999999999998 67999999999999999999999999999887
Q ss_pred HHHHHHhcc-------------------CCCCCCCC---------ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCC
Q 001057 995 QIFDNIMNR-------------------DIPWPNIP---------EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046 (1170)
Q Consensus 995 ei~qkIl~~-------------------~l~fP~ip---------~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHP 1046 (1170)
+++..|... .+.+|..+ ..++.-+.||+++||..||.+|++ .+++|.||
T Consensus 209 DQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s---c~qll~H~ 285 (396)
T KOG0593|consen 209 DQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS---CEQLLHHP 285 (396)
T ss_pred HHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc---HHHHhcCh
Confidence 766666531 11122211 256778999999999999999999 88999999
Q ss_pred CCCCC
Q 001057 1047 FFKNI 1051 (1170)
Q Consensus 1047 fF~~i 1051 (1170)
||.++
T Consensus 286 yFd~~ 290 (396)
T KOG0593|consen 286 YFDGF 290 (396)
T ss_pred HHHHH
Confidence 99654
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=403.21 Aligned_cols=261 Identities=37% Similarity=0.713 Sum_probs=245.1
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
.....+++|++.+.||+|-||.||+|+.+.++-.||+|++.|+++.......++.+|++|.+.|+||||+++|++|-+..
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 45788899999999999999999999999999999999999998877777788999999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLR--NLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk--~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
.+||++||..+|+|+..|+ ....|++..+..|++|++.||.|+|.++||||||||+|+|++.+|.+||+|||.+...
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~- 174 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA- 174 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec-
Confidence 9999999999999999999 6678999999999999999999999999999999999999999999999999998641
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
...+..+.|||..|.+||+..+..++..+|+|++|++.||+|.|.+||.
T Consensus 175 -------------------------------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFe 223 (281)
T KOG0580|consen 175 -------------------------------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFE 223 (281)
T ss_pred -------------------------------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchh
Confidence 1234568899999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
..+..++|+.|..-++.+| ..++.++.|||.+||.++|.+|+. ..|++.|||...
T Consensus 224 s~~~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~a 278 (281)
T KOG0580|consen 224 SQSHSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERLA---LTEVMDHPWIVA 278 (281)
T ss_pred hhhhHHHHHHHHHccccCC---cccChhHHHHHHHHhccCcccccc---HHHHhhhHHHHh
Confidence 9999999999999999887 789999999999999999999998 889999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=425.00 Aligned_cols=270 Identities=37% Similarity=0.654 Sum_probs=231.1
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHH-----------HHHHHHHHHHHHHhcCCCcE
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKN-----------AVESILAERNILISVRNPFV 820 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~-----------~ve~~l~EieILskL~HPNI 820 (1170)
.....+++|++++.||+|.||.|-+|++..+++.||||++.|....... .++.+.+|+.||++++||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 3456789999999999999999999999999999999999875433221 24689999999999999999
Q ss_pred EEEEeeeecc--cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEE
Q 001057 821 VRFFYSFTCR--ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 821 VrL~~~Fqd~--~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VK 898 (1170)
|+|+++..+. +.+|||+|||..|.+...-.....+++.+++.|++.++.||+|||.+|||||||||+|+||+.+|+||
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEE
Confidence 9999998775 57999999999998766444433499999999999999999999999999999999999999999999
Q ss_pred EEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC----CCcchhhhHH
Q 001057 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG----HGATADWWSV 974 (1170)
Q Consensus 899 LsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~----ys~ksDIWSL 974 (1170)
|+|||.+..... + . ...........+|||.|||||.+.+.. .+.+.|||||
T Consensus 251 IsDFGVs~~~~~-------------~-~-----------~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal 305 (576)
T KOG0585|consen 251 ISDFGVSNEFPQ-------------G-S-----------DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL 305 (576)
T ss_pred eeccceeeeccc-------------C-C-----------ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence 999999874210 0 0 001111223378999999999998732 3678899999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 975 GIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 975 GVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
||+||.|+.|+.||.+....+++.+|++..+.||..+ .+..+++|||.+||++||.+|++ +.+|+.|||...
T Consensus 306 GVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~p-e~~e~~kDli~~lL~KdP~~Ri~---l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 306 GVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPENP-EINEDLKDLIKRLLEKDPEQRIT---LPDIKLHPWVTR 377 (576)
T ss_pred hhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCcc-cccHHHHHHHHHHhhcChhheee---hhhheecceecc
Confidence 9999999999999999999999999999999999654 68999999999999999999999 889999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=396.07 Aligned_cols=273 Identities=34% Similarity=0.600 Sum_probs=231.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.|...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976544344445567889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 839 YLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|+.||+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~------- 153 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIP------- 153 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecC-------
Confidence 99999999888654 459999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
........+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+....
T Consensus 154 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~ 209 (285)
T cd05605 154 ------------------------EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK 209 (285)
T ss_pred ------------------------CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH
Confidence 00011235789999999999988899999999999999999999999998765433
Q ss_pred H----HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh--hHHHHHcCCCCCCCChhhhhhc--cCCCCC
Q 001057 997 F----DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWDTLARQ--KAMFIP 1065 (1170)
Q Consensus 997 ~----qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~--~AeEILqHPfF~~idwe~L~~~--~ppfiP 1065 (1170)
. ..+...... .+..++..+.+||.+||..||.+||+.. .+.++++||||...+|..+... .+|+.|
T Consensus 210 ~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (285)
T cd05605 210 REEVERRVKEDQEE---YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCP 283 (285)
T ss_pred HHHHHHHhhhcccc---cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCC
Confidence 3 223322222 3356899999999999999999999533 5899999999999999988765 456655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=395.96 Aligned_cols=267 Identities=33% Similarity=0.643 Sum_probs=224.8
Q ss_pred eccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCCh
Q 001057 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 845 (1170)
Q Consensus 766 LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL 845 (1170)
||+|+||+||+|.++.+++.||+|++.+.........+.+..|+.+|+.++||||++++++|.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876544444556788899999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCC
Q 001057 846 YSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921 (1170)
Q Consensus 846 ~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl 921 (1170)
..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~------------ 148 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELK------------ 148 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecC------------
Confidence 988743 3469999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH----HHHH
Q 001057 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP----QQIF 997 (1170)
Q Consensus 922 ~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~----~ei~ 997 (1170)
..........||+.|+|||++.+..++.++|+|||||++|+|++|..||..... ....
T Consensus 149 ------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 210 (280)
T cd05608 149 ------------------DGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 210 (280)
T ss_pred ------------------CCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH
Confidence 000112245799999999999999999999999999999999999999986542 3334
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh--hHHHHHcCCCCCCCChhhhhhc--cCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWDTLARQ--KAMFIP 1065 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~--~AeEILqHPfF~~idwe~L~~~--~ppfiP 1065 (1170)
..+......+ +..++..+.+||.+||+.||.+|++.. .++++++||||++++|..+... .+|+.|
T Consensus 211 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 211 QRILNDSVTY---PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred HhhcccCCCC---cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 4444443333 357899999999999999999999642 4899999999999999988665 334443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=421.01 Aligned_cols=261 Identities=39% Similarity=0.667 Sum_probs=238.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~Ly 834 (1170)
....|++.+.||+|.||+||+|+++.||+.||+|++.+.........+.+.+|+.||+++. |||||.++++|++...+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4457999999999999999999999999999999999887666566788999999999999 999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC----CcEEEEecCCcccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD----GHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d----G~VKLsDFGLAk~~~~ 910 (1170)
+|||+|.||+|++.|... .+++..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||+|....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~- 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK- 190 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc-
Confidence 999999999999999876 49999999999999999999999999999999999999643 579999999998631
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
........|||+.|+|||++...+|+..+||||+||++|.||+|.+||.+
T Consensus 191 ------------------------------~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~ 240 (382)
T KOG0032|consen 191 ------------------------------PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWG 240 (382)
T ss_pred ------------------------------CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcC
Confidence 13345678999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhccCCCCCCCC-ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIP-EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip-~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+....+.+|..+.+.|+.-+ ..++..+++||.+||..||.+|++ |.++|+|||+++.
T Consensus 241 ~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t---a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 241 ETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT---AAQALQHPWIKSI 299 (382)
T ss_pred CChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC---HHHHhcCccccCC
Confidence 999999999999988766433 468999999999999999999999 8899999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=428.85 Aligned_cols=260 Identities=30% Similarity=0.493 Sum_probs=222.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccc-c
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRE-N 832 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~-~ 832 (1170)
...++|.++++||.|+||.||+|+.+.+|+.||||.|++.-. . -..-.-++|+.-|++|+ |||||+|++++.+.+ +
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-S-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-c-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 456789999999999999999999999999999999887532 2 22233467999999999 999999999999988 9
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+|+||||| ..+|+++++.. ..|++..++.|+.||++||+|+|++|++||||||||||+..+..|||+|||||+...
T Consensus 85 L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-- 161 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR-- 161 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--
Confidence 99999999 56999999865 469999999999999999999999999999999999999988999999999999631
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
..+ ....++.|.||+|||+|+.. .|+.++|+|++|||++|+++-++.|.|
T Consensus 162 ----------------------Skp-------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG 212 (538)
T KOG0661|consen 162 ----------------------SKP-------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPG 212 (538)
T ss_pred ----------------------cCC-------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCC
Confidence 111 22357899999999999754 589999999999999999999999999
Q ss_pred CCHHHHHHHHhc-------------------cCCCCCCC--------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 991 KTPQQIFDNIMN-------------------RDIPWPNI--------PEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 991 ~~~~ei~qkIl~-------------------~~l~fP~i--------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.+..+++.+|.. -.+.||.+ -...+.++.+||.+||.+||.+||| |.++|
T Consensus 213 ~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT---A~~al 289 (538)
T KOG0661|consen 213 ASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT---ASQAL 289 (538)
T ss_pred CcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc---HHHHh
Confidence 998877777653 12233322 1348999999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001057 1044 QHPFFKNI 1051 (1170)
Q Consensus 1044 qHPfF~~i 1051 (1170)
+||||+.-
T Consensus 290 ~~pffq~~ 297 (538)
T KOG0661|consen 290 QHPFFQVG 297 (538)
T ss_pred cCcccccc
Confidence 99999853
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=392.01 Aligned_cols=297 Identities=51% Similarity=0.909 Sum_probs=252.2
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||.|+||.||++.+..+++.||+|.+.+...........+.+|++++..++||||+++++.|...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999988765444455678889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~-- 158 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN-- 158 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc--
Confidence 999999999999888889999999999999999999999999999999999999999999999999987421100000
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
...... .............|+..|+|||.+.+..++.++|+|||||++|||++|..||.+.+..+.+
T Consensus 159 ---------~~~~~~----~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~ 225 (305)
T cd05609 159 ---------LYEGHI----EKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 225 (305)
T ss_pred ---------cccccc----ccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 000000 0000011122356899999999999888999999999999999999999999999988888
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES 1069 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~s 1069 (1170)
..+......+|.....++.++.+||.+||+.||.+||+..++.++++||||...+|..+......++|..++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (305)
T cd05609 226 GQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLES 297 (305)
T ss_pred HHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCCCC
Confidence 888877766665555789999999999999999999998889999999999999999988777777787766
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=404.37 Aligned_cols=262 Identities=31% Similarity=0.536 Sum_probs=236.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...+.|++...||+|.|+.|+.|.+..||+.+|+|++..... .....+.+.+|+.|-+.|+|||||+|++.+......|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-ccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 344679999999999999999999999999999999876544 3346788999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC---CcEEEEecCCccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD---GHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d---G~VKLsDFGLAk~~~~~ 911 (1170)
||+|+|.|++|..-|-....++|..+-.|++||+.||.|+|.+||||||+||+|+|+... .-+||+|||+|....
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 999999999999877666679999999999999999999999999999999999999643 369999999998531
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.+.....++|||.|||||++...+|+..+|||+.|||||-||.|++||++.
T Consensus 165 -----------------------------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~ 215 (355)
T KOG0033|consen 165 -----------------------------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE 215 (355)
T ss_pred -----------------------------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence 123445689999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+...+|+.|+.+.+.++. .-..+++++++||.+||..||.+|+| |.|.|+|||+.+-
T Consensus 216 ~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt---a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 216 DQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT---ADEALKHPWICNR 273 (355)
T ss_pred cHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc---HHHHhCCchhcch
Confidence 999999999999988775 34589999999999999999999999 8899999999864
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=413.49 Aligned_cols=261 Identities=35% Similarity=0.604 Sum_probs=221.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc--ceE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE--NLY 834 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~--~Ly 834 (1170)
..+|...+.||+|+||+||++.+..+|..+|+|.+..... ...+.+.+|+.+|.+++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 4568899999999999999999999999999999876522 22677899999999999999999999755555 599
Q ss_pred EEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-CCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-dG~VKLsDFGLAk~~~~~~ 912 (1170)
|.|||++||+|.+++.+.+ .|++..++.|.+||+.||.|||++|||||||||+||||+. +|.+||+|||+++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~-- 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES-- 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc--
Confidence 9999999999999999887 7999999999999999999999999999999999999999 79999999999985310
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCC-
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNA- 990 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g- 990 (1170)
............||+.|||||++... ...+++|||||||++.||+||.+||..
T Consensus 171 -------------------------~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 171 -------------------------KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred -------------------------ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 00111223467899999999999952 234599999999999999999999987
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
....+.+-.|.... ..|.+|..+|.++++||.+||..||.+||+ |.++|+|||.+..
T Consensus 226 ~~~~~~~~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt---a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 226 FEEAEALLLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPT---AEELLEHPFLKQN 282 (313)
T ss_pred cchHHHHHHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcC---HHHHhhChhhhcc
Confidence 44444444554444 445778899999999999999999999999 8999999999764
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=388.04 Aligned_cols=274 Identities=47% Similarity=0.894 Sum_probs=243.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||.||++.+..+++.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998766555566788999999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||+|.|||++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~-------- 152 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-------- 152 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC--------
Confidence 999999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
. .....+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus 153 ----------------------~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 207 (290)
T cd05580 153 ----------------------G---RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY 207 (290)
T ss_pred ----------------------C---CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0 022456899999999998888899999999999999999999999988888888
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAA 1067 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~ 1067 (1170)
+.+..+...+| ..++..++++|.+||+.||.+|++. ..++++++||||+.++|..+... .+++.|..
T Consensus 208 ~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (290)
T cd05580 208 EKILEGKVRFP---SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKV 278 (290)
T ss_pred HHHhcCCccCC---ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCC
Confidence 88877666554 5789999999999999999999952 35899999999999999988765 44555543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=388.25 Aligned_cols=258 Identities=31% Similarity=0.494 Sum_probs=214.6
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+.++..++||||++++++|...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999876532 2334567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++++.|..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------- 152 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE------- 152 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc-------
Confidence 9999877766555556799999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
..........||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+..
T Consensus 153 ----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~ 210 (287)
T cd07848 153 ----------------------GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL 210 (287)
T ss_pred ----------------------cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0001112357899999999999988999999999999999999999999987655443
Q ss_pred HHHhcc-------------------CCCCCCC----------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 998 DNIMNR-------------------DIPWPNI----------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 998 qkIl~~-------------------~l~fP~i----------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
..+... ...++.. ...++.++.+||.+||++||.+||+ ++++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s---~~~~l~hp~f 287 (287)
T cd07848 211 FTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL---TEQCLNHPAF 287 (287)
T ss_pred HHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 333211 0111110 1236888999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=387.91 Aligned_cols=267 Identities=30% Similarity=0.590 Sum_probs=223.0
Q ss_pred eccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCCh
Q 001057 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 845 (1170)
Q Consensus 766 LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL 845 (1170)
||+|+||.||+++++.+|+.||+|++.+...........+..|++++..++||||++++++|....++|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998765443333445567799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCC
Q 001057 846 YSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923 (1170)
Q Consensus 846 ~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s 923 (1170)
.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~-------------- 146 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK-------------- 146 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecC--------------
Confidence 98886543 48899999999999999999999999999999999999999999999999987421
Q ss_pred CCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Q 001057 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP----QQIFDN 999 (1170)
Q Consensus 924 ~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~----~ei~qk 999 (1170)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .++...
T Consensus 147 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~ 209 (277)
T cd05607 147 -----------------DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR 209 (277)
T ss_pred -----------------CCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHH
Confidence 00011234689999999999998899999999999999999999999976432 344444
Q ss_pred HhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh-hHHHHHcCCCCCCCChhhhhhc--cCCCCC
Q 001057 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT-GAREVKQHPFFKNINWDTLARQ--KAMFIP 1065 (1170)
Q Consensus 1000 Il~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~-~AeEILqHPfF~~idwe~L~~~--~ppfiP 1065 (1170)
+......++ ...++.++++||.+||+.||.+||++. ...+++.||||+.++|..+... .+||+|
T Consensus 210 ~~~~~~~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 210 TLEDEVKFE--HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred hhccccccc--cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 444444332 246899999999999999999999953 2478999999999999998865 455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=389.94 Aligned_cols=256 Identities=28% Similarity=0.511 Sum_probs=214.4
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|++++.||.|+||+||+|++..++..||+|++..... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5689999999999999999999999999999999875432 22334677899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+.+ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~----- 155 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV----- 155 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC-----
Confidence 999974 9999987654 589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~ 210 (288)
T cd07871 156 -------------------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK 210 (288)
T ss_pred -------------------------CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0011123468999999999876 46899999999999999999999999988877
Q ss_pred HHHHHHhccC-------------------CCCCC--------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 995 QIFDNIMNRD-------------------IPWPN--------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 995 ei~qkIl~~~-------------------l~fP~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
+.+..+.... ..+|. ....++.++++||.+||++||.+|+| |+|+++|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t---~~~~l~hp~ 287 (288)
T cd07871 211 EELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS---AEAALRHSY 287 (288)
T ss_pred HHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC---HHHHhcCCC
Confidence 6665553210 00111 11246889999999999999999999 889999999
Q ss_pred C
Q 001057 1048 F 1048 (1170)
Q Consensus 1048 F 1048 (1170)
|
T Consensus 288 f 288 (288)
T cd07871 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=409.19 Aligned_cols=257 Identities=31% Similarity=0.589 Sum_probs=239.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
....+|++.+.||+|.||+|-+|.....|+.||||.++|..+.+....-++.+|++||+.|+||||+.+|.+|+..+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34468999999999999999999999999999999999999988889999999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|||||..+|+|++|+.+.+.|++.+++.+++||+.|+.|||+++++|||||.+|||||.++++||+||||+..+
T Consensus 130 ivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly------ 203 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY------ 203 (668)
T ss_pred EEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.......++||+|.|.+||++.|..| ++.+|.|||||+||.|+.|..||.|.+.
T Consensus 204 -------------------------~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh 258 (668)
T KOG0611|consen 204 -------------------------ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH 258 (668)
T ss_pred -------------------------ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH
Confidence 12334568999999999999999988 6889999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
..+..+|.++.+.-| .-+..+.-||+.||-.||.+|.| +.+|-+|-|.+
T Consensus 259 k~lvrQIs~GaYrEP----~~PSdA~gLIRwmLmVNP~RRAT---ieDiAsHWWvN 307 (668)
T KOG0611|consen 259 KRLVRQISRGAYREP----ETPSDASGLIRWMLMVNPERRAT---IEDIASHWWVN 307 (668)
T ss_pred HHHHHHhhcccccCC----CCCchHHHHHHHHHhcCcccchh---HHHHhhhheee
Confidence 999999999998766 35668899999999999999988 88999998864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=389.93 Aligned_cols=261 Identities=28% Similarity=0.514 Sum_probs=211.7
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||.|+||+||+|+++.+++.||||++..... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999875432 12234567899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+. ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~------ 154 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS------ 154 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc------
Confidence 99995 6888887654 568999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCH-
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTP- 993 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~- 993 (1170)
.........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+...
T Consensus 155 ------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 210 (303)
T cd07869 155 ------------------------VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210 (303)
T ss_pred ------------------------CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 000111235689999999998764 578899999999999999999999987543
Q ss_pred HHHHHHHhc--cC---CCCCC------C------------------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 994 QQIFDNIMN--RD---IPWPN------I------------------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 994 ~ei~qkIl~--~~---l~fP~------i------------------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
.+.+..+.. +. ..|+. . ....+..+.+||.+||+.||.+||| +.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s---~~~~l~ 287 (303)
T cd07869 211 QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS---AQAALS 287 (303)
T ss_pred HHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC---HHHHhc
Confidence 233332211 00 00000 0 0124578999999999999999999 889999
Q ss_pred CCCCCCCCh
Q 001057 1045 HPFFKNINW 1053 (1170)
Q Consensus 1045 HPfF~~idw 1053 (1170)
||||+++.+
T Consensus 288 h~~f~~~~~ 296 (303)
T cd07869 288 HEYFSDLPP 296 (303)
T ss_pred CcccccCCh
Confidence 999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=422.72 Aligned_cols=256 Identities=34% Similarity=0.571 Sum_probs=229.8
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
..|+...+||+|+.|.||.|+...+++.||||.+...... ..+-+++|+.+|+..+|+|||++++.|.-.+.+++||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 4688899999999999999999999999999999876433 3467899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|||+||+|.+++... .++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+.
T Consensus 350 Eym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~-------- 420 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS-------- 420 (550)
T ss_pred eecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc--------
Confidence 999999999988764 59999999999999999999999999999999999999999999999999997531
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.......+.+|||+|||||++....|++++||||||++++||+-|.+||...++-..+
T Consensus 421 ----------------------~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl 478 (550)
T KOG0578|consen 421 ----------------------EEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 478 (550)
T ss_pred ----------------------cccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH
Confidence 2233556889999999999999999999999999999999999999999988887777
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
..|.....+-...+..+|+++++||.+||+.|+.+|++ |.|+|+||||+-
T Consensus 479 yLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras---A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 479 YLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS---AKELLEHPFLKM 528 (550)
T ss_pred HHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC---HHHHhcChhhhh
Confidence 77766544433456789999999999999999999999 899999999953
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=385.40 Aligned_cols=275 Identities=34% Similarity=0.627 Sum_probs=229.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.++..++|+||+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999887654444455677889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 839 YLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~------- 153 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVP------- 153 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecC-------
Confidence 99999999988654 358999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH--
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ-- 994 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~-- 994 (1170)
.........||+.|+|||++.+..++.++|||||||++|+|++|.+||......
T Consensus 154 ------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~ 209 (285)
T cd05630 154 ------------------------EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 209 (285)
T ss_pred ------------------------CCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch
Confidence 000112347999999999999988999999999999999999999999875432
Q ss_pred -HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh--hHHHHHcCCCCCCCChhhhhhc--cCCCCCC
Q 001057 995 -QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWDTLARQ--KAMFIPA 1066 (1170)
Q Consensus 995 -ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~--~AeEILqHPfF~~idwe~L~~~--~ppfiP~ 1066 (1170)
.....+..... ...+..+++++.+||.+||+.||.+|++.. .+.++++||||+.++|..+... .|+++|.
T Consensus 210 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 210 REEVERLVKEVQ--EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred HHHHHhhhhhhh--hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 22222221111 123357889999999999999999999843 4899999999999999987663 5667664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=390.53 Aligned_cols=262 Identities=29% Similarity=0.460 Sum_probs=212.6
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----cce
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-----ENL 833 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-----~~L 833 (1170)
+|++.+.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5999999999999999999999999999999987432 1223345688999999999999999999887543 358
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||+ +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 157 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT- 157 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc-
Confidence 9999999 57999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g--~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 158 --------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 158 --------------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred --------------------------CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 00011234679999999999876 57899999999999999999999999877
Q ss_pred CHHHHHHHHhc--------------------------cC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 992 TPQQIFDNIMN--------------------------RD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 992 ~~~ei~qkIl~--------------------------~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
+.......+.. .. ..+......+++.+.+||.+||+.||.+||+ +.+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~e~l 288 (338)
T cd07859 212 NVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT---AEEAL 288 (338)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC---HHHHh
Confidence 65433322211 00 0111111246788999999999999999999 88999
Q ss_pred cCCCCCCCC
Q 001057 1044 QHPFFKNIN 1052 (1170)
Q Consensus 1044 qHPfF~~id 1052 (1170)
+||||+++.
T Consensus 289 ~hp~f~~~~ 297 (338)
T cd07859 289 ADPYFKGLA 297 (338)
T ss_pred cCchhhhcC
Confidence 999998764
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=413.75 Aligned_cols=263 Identities=32% Similarity=0.549 Sum_probs=225.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--c
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--E 831 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~ 831 (1170)
....+.|+.+.+||+|+||.||+|++..||+.||+|.+..... +........+|+.||++|+||||++|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 4556789999999999999999999999999999999886542 344556778999999999999999999988776 6
Q ss_pred ceEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
.+|||+|||+. ||.-++...+ .|++.+++.|++||+.||+|||++||+|||||.+|||||.+|.+||+|||||++...
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 79999999965 9999998754 699999999999999999999999999999999999999999999999999996421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
. ......+.+-|.+|+|||+|+|. .|+.++|+||+||||.||+.|++.|.
T Consensus 271 ~-----------------------------~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 271 S-----------------------------GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred C-----------------------------CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 0 01123456789999999999985 59999999999999999999999999
Q ss_pred CCCHHHHHHHHhcc--C---CCCC--CC-------------------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 990 AKTPQQIFDNIMNR--D---IPWP--NI-------------------PEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 990 g~~~~ei~qkIl~~--~---l~fP--~i-------------------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
|.+..+++..|.+- . -.|+ .+ ...++..+.+|+..||+.||.+|.| |.++|
T Consensus 322 G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t---A~~aL 398 (560)
T KOG0600|consen 322 GRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT---ASSAL 398 (560)
T ss_pred CccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc---HHHHh
Confidence 99999999988751 0 0011 11 1357899999999999999999999 77889
Q ss_pred cCCCCCC
Q 001057 1044 QHPFFKN 1050 (1170)
Q Consensus 1044 qHPfF~~ 1050 (1170)
+|+||..
T Consensus 399 ~seyF~t 405 (560)
T KOG0600|consen 399 QSEYFTT 405 (560)
T ss_pred cCccccc
Confidence 9999943
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=382.29 Aligned_cols=308 Identities=42% Similarity=0.786 Sum_probs=247.6
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||+||+|.+..+++.||||.+.+...........+..|+.+|..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765554456678899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 838 EYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||+.|++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999999764 569999999999999999999999999999999999999999999999999987532110000
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.............. ...................||..|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVN-SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccc-ccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 00000000000000 00000000111223345689999999999999889999999999999999999999999988888
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC-hhhHHHHHcCCCCCCCChhhhhhccCCCCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG-ATGAREVKQHPFFKNINWDTLARQKAMFIPAA 1067 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS-a~~AeEILqHPfF~~idwe~L~~~~ppfiP~~ 1067 (1170)
.+..+......++.. ..++..+.+||.+||+.||.+||+ +..++++++||||++.+|..+....+|.+|..
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 311 (316)
T cd05574 240 TFSNILKKEVTFPGS-PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRP 311 (316)
T ss_pred HHHHHhcCCccCCCc-cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCc
Confidence 888887766665532 237999999999999999999998 55689999999999999999888766666544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=378.83 Aligned_cols=277 Identities=34% Similarity=0.604 Sum_probs=231.9
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|+..+.||.|+||+||+|.+..+++.||+|++.+...........+.+|+.+|..++|+||+.++++|...+.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 38889999999999999999999999999999877654444445667889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 839 YLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|+.+++|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~------- 153 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIP------- 153 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecC-------
Confidence 99999999888654 369999999999999999999999999999999999999999999999999986420
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||.+......
T Consensus 154 ------------------------~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~ 209 (285)
T cd05632 154 ------------------------EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK 209 (285)
T ss_pred ------------------------CCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 00011234799999999999988899999999999999999999999988766544
Q ss_pred HHHHhccCCC-CCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCC
Q 001057 997 FDNIMNRDIP-WPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPA 1066 (1170)
Q Consensus 997 ~qkIl~~~l~-fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~ 1066 (1170)
...+...... ....+..++.++.+||.+||+.||.+||+. ..+.+++.|+||+.++|..+... .++|+|.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 210 REEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred HHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 3333221111 112335788999999999999999999984 24789999999999999987655 5566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=393.51 Aligned_cols=265 Identities=32% Similarity=0.515 Sum_probs=224.4
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC-- 829 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd-- 829 (1170)
..-.+++.|+.+..|++|+||.||.|+++.|++.||+|.++... .....--..++|+++|.+++|||||.+-.+...
T Consensus 70 ~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 70 GGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred cCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 44567789999999999999999999999999999999987543 222233456899999999999999999877654
Q ss_pred ccceEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
-+.+|||||||+. ||..++.+.+ +|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||||+..
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 4579999999965 9999998875 8999999999999999999999999999999999999999999999999999964
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
. .........+-|.+|+|||++++. .|+.++|+||+|||+.||+++.|.
T Consensus 228 g------------------------------sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl 277 (419)
T KOG0663|consen 228 G------------------------------SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL 277 (419)
T ss_pred c------------------------------CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence 2 111223456789999999999985 599999999999999999999999
Q ss_pred CCCCCHHHHHHHHhcc-------------------CCCCCCCC---------c-cCCHHHHHHHHHhccCCCCCCCChhh
Q 001057 988 FNAKTPQQIFDNIMNR-------------------DIPWPNIP---------E-EMSVEACDLIDKLLTENPVQRLGATG 1038 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~-------------------~l~fP~ip---------~-~lS~eakDLIkkLLq~DPskRpSa~~ 1038 (1170)
|.|....+++++|..- ...++..| . .++....+|+..+|.+||.+|+|
T Consensus 278 f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t--- 354 (419)
T KOG0663|consen 278 FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT--- 354 (419)
T ss_pred CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc---
Confidence 9999998888888641 11122111 1 26689999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 001057 1039 AREVKQHPFFKNI 1051 (1170)
Q Consensus 1039 AeEILqHPfF~~i 1051 (1170)
|.|.|+|.||.+.
T Consensus 355 A~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 355 AEDGLKHEYFRET 367 (419)
T ss_pred HHHhhcccccccC
Confidence 7888999999975
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=399.07 Aligned_cols=261 Identities=32% Similarity=0.509 Sum_probs=222.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-----ccc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC-----REN 832 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd-----~~~ 832 (1170)
..|..++.||+|+||.|+.|.++.||+.||||.+... .......++..+|+.+|+.++|+||+.+++.+.. -..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3566689999999999999999999999999987643 2344566788999999999999999999999876 245
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+|+|+| +.||...|+....+++++++++++||+.||+|+|+.||+||||||.|+|++.+..+||||||+|+.....
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 99999999 6799999999888999999999999999999999999999999999999999999999999999963100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
........++-|.+|+|||++.. ..|+.++||||+||||.|||+|++.|.|.
T Consensus 179 ---------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~ 231 (359)
T KOG0660|consen 179 ---------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK 231 (359)
T ss_pred ---------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence 11123346788999999999875 56999999999999999999999999998
Q ss_pred CHHHHHHHHhcc----------------------------CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 992 TPQQIFDNIMNR----------------------------DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 992 ~~~ei~qkIl~~----------------------------~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
+...+++.|+.- ..+|..+-.+.++.+.||+.+||..||.+|+| |+|+|
T Consensus 232 d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit---a~eAL 308 (359)
T KOG0660|consen 232 DYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT---AEEAL 308 (359)
T ss_pred chHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC---HHHHh
Confidence 877776666531 11122222478999999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001057 1044 QHPFFKNI 1051 (1170)
Q Consensus 1044 qHPfF~~i 1051 (1170)
.||||...
T Consensus 309 ~hPYl~~~ 316 (359)
T KOG0660|consen 309 AHPYLAPY 316 (359)
T ss_pred cChhhhhh
Confidence 99999875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=398.50 Aligned_cols=268 Identities=31% Similarity=0.528 Sum_probs=233.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|++..+||.|..++||+|+...++++||||++.-.... ...+.+.+|+..|+.++||||++++.+|..+..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence 45668999999999999999999999999999999999876543 3378899999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
++||.||.+|++.++++.. ..|+|..+..++++++.||.|||++|.||||||+.||||+.+|.|||+|||.+-....
T Consensus 100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~- 178 (516)
T KOG0582|consen 100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD- 178 (516)
T ss_pred EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecc-
Confidence 9999999999999999865 4599999999999999999999999999999999999999999999999998764210
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g--~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
+| .......++++|||+|||||++.. .+|+.++||||||++..||++|..||.
T Consensus 179 ------------~G-------------~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 179 ------------SG-------------DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred ------------cC-------------ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 00 011112278899999999999654 579999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCCCCC-------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 990 AKTPQQIFDNIMNRDIPWPNI-------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~i-------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
...+..++-..+++..+.+.. ...++..++.+|..||++||.+||+ |.++|+|+||+...
T Consensus 234 k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt---AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 234 KYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT---ASKLLKHAFFKKAK 300 (516)
T ss_pred cCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC---HHHHhccHHHhhcc
Confidence 999999887777777664431 1346778999999999999999999 88999999998753
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=386.81 Aligned_cols=260 Identities=27% Similarity=0.470 Sum_probs=220.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++++.||+|+||.||+|++..+|..||+|++.... .......+.+|+.+|..++||||+++++++...+.+|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999987542 23455678999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL-NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~-GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~----- 155 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----- 155 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc-----
Confidence 999999999999999888899999999999999999999986 69999999999999999999999999987421
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..
T Consensus 156 ---------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~ 208 (331)
T cd06649 156 ---------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208 (331)
T ss_pred ---------------------------ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 00112457999999999999989999999999999999999999999876655
Q ss_pred HHHHHHhccC--------------------------------------------CCCCCC-CccCCHHHHHHHHHhccCC
Q 001057 995 QIFDNIMNRD--------------------------------------------IPWPNI-PEEMSVEACDLIDKLLTEN 1029 (1170)
Q Consensus 995 ei~qkIl~~~--------------------------------------------l~fP~i-p~~lS~eakDLIkkLLq~D 1029 (1170)
++...+.... ...+.. ...++.++++||.+||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~ 288 (331)
T cd06649 209 ELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKN 288 (331)
T ss_pred HHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCC
Confidence 4433221100 000111 1246889999999999999
Q ss_pred CCCCCChhhHHHHHcCCCCCCCC
Q 001057 1030 PVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1030 PskRpSa~~AeEILqHPfF~~id 1052 (1170)
|++||+ +.++++||||+...
T Consensus 289 P~~Rpt---~~ell~h~~~~~~~ 308 (331)
T cd06649 289 PAERAD---LKMLMNHTFIKRSE 308 (331)
T ss_pred cccCCC---HHHHhcChHHhhcc
Confidence 999999 88999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=389.51 Aligned_cols=261 Identities=30% Similarity=0.528 Sum_probs=233.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccc-----ccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM-----IRKNAVESILAERNILISVR-NPFVVRFFYSFTCR 830 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i-----~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~ 830 (1170)
.+.|..-+.||+|..++|..|.++.||..+|+|++..... .-....+....|+.||+++. ||+|+.+.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 4568888899999999999999999999999999864221 12334567788999999985 99999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
..+++|+|.|+.|.|+++|...-.+++...+.+++|++.|++|||.++||||||||+|||++++.++||+|||+|...
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l-- 173 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL-- 173 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc--
Confidence 999999999999999999999888999999999999999999999999999999999999999999999999999853
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc------CCCCcchhhhHHHHHHHHHHhC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG------MGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g------~~ys~ksDIWSLGVILYELLTG 984 (1170)
..+.+....||||+|+|||.+.. .+|+..+|+|++|||||.||.|
T Consensus 174 -----------------------------~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG 224 (411)
T KOG0599|consen 174 -----------------------------EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG 224 (411)
T ss_pred -----------------------------CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence 22345567899999999999964 4689999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 985 IPPFNAKTPQQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+||+.....-++..|+.+++.|..- -.++|..++|||.+||+.||.+|+| ++|+|.||||..+
T Consensus 225 cpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit---ake~LaHpff~q~ 289 (411)
T KOG0599|consen 225 CPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT---AKEALAHPFFIQI 289 (411)
T ss_pred CCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc---HHHHhcChHHHHH
Confidence 99999999999999999999987642 2478999999999999999999999 8899999999765
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=382.41 Aligned_cols=259 Identities=32% Similarity=0.569 Sum_probs=222.5
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
.+|..++.||+|.||.||+|++..||+.||||.++..+. ....-...++|+..|+.++|+||+.|.++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 478899999999999999999999999999999987643 2233456789999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||++ .||..+|+.. ..|+...++.|+.+++.||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p----- 154 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP----- 154 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC-----
Confidence 9996 4999999876 46999999999999999999999999999999999999999999999999999974211
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.......+-|.+|+|||.+.|. .|+..+|+||+|||+.||+.|.|-|.|.+.-+
T Consensus 155 -------------------------~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid 209 (318)
T KOG0659|consen 155 -------------------------NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID 209 (318)
T ss_pred -------------------------CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence 1111122789999999999975 59999999999999999999999999999988
Q ss_pred HHHHHhcc-----CCCCCC--------------------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 996 IFDNIMNR-----DIPWPN--------------------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 996 i~qkIl~~-----~l~fP~--------------------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
++..|... .-.||+ +-...+.++.||+.+||.+||.+|++ |.|+|+|+||..
T Consensus 210 QL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit---a~qaL~~~yf~~ 286 (318)
T KOG0659|consen 210 QLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT---ASQALKHPYFKS 286 (318)
T ss_pred HHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc---HHHHhcchhhhc
Confidence 88887641 112222 11346788999999999999999999 889999999986
Q ss_pred C
Q 001057 1051 I 1051 (1170)
Q Consensus 1051 i 1051 (1170)
.
T Consensus 287 ~ 287 (318)
T KOG0659|consen 287 L 287 (318)
T ss_pred C
Confidence 4
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=374.83 Aligned_cols=255 Identities=33% Similarity=0.513 Sum_probs=208.6
Q ss_pred CCeEEEEEeccCCCeEEEEeeecC-CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeee-----
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRA-TGDLFAIKVLKKADMIRKNAVESILAERNILISV---RNPFVVRFFYSFT----- 828 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~-TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL---~HPNIVrL~~~Fq----- 828 (1170)
.+|++++.||+|+||+||+|++.. ++..||+|++...... ......+.+|+.++..+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 5789999998754322 22234456677777665 6999999999875
Q ss_pred cccceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcc
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk 906 (1170)
....+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 2456899999995 6999998754 358999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~p 986 (1170)
... .........||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 159 ~~~-------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (290)
T cd07862 159 IYS-------------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207 (290)
T ss_pred ecc-------------------------------CCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCC
Confidence 421 0011234578999999999998899999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhccCC-----CCC-------------------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 987 PFNAKTPQQIFDNIMNRDI-----PWP-------------------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 987 PF~g~~~~ei~qkIl~~~l-----~fP-------------------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
||.+.+..+.+..|..... .++ .+...++..+++||.+||+.||.+||+ +.++
T Consensus 208 ~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~ 284 (290)
T cd07862 208 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSA 284 (290)
T ss_pred CcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC---HHHH
Confidence 9999888777776653210 011 011357888999999999999999999 8899
Q ss_pred HcCCCC
Q 001057 1043 KQHPFF 1048 (1170)
Q Consensus 1043 LqHPfF 1048 (1170)
|+||||
T Consensus 285 l~hp~f 290 (290)
T cd07862 285 LSHPYF 290 (290)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=404.36 Aligned_cols=259 Identities=33% Similarity=0.581 Sum_probs=236.7
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
..=|.+.+.||+|-|++|-+|++..||+.||||++.|..+. .-...+++.|+..|+.++|||||+||++......+|||
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 34599999999999999999999999999999999998753 44567899999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe-CCCCcEEEEecCCccccccccCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI-GQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL-d~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
+|+-.+|+|++||.++ ..+.|+.++.|++||+.||.|||+..+|||||||+||.+ .+-|-|||+|||++..+
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf------ 169 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF------ 169 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC------
Confidence 9999999999999876 469999999999999999999999999999999999876 56699999999998642
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCC-cchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHG-ATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys-~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
..+.+..+.||+..|-|||+++|..|+ +++||||||||||.|++|++||...+.
T Consensus 170 -------------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND 224 (864)
T KOG4717|consen 170 -------------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND 224 (864)
T ss_pred -------------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc
Confidence 224456789999999999999999986 568999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
.+.+.+|+..++..| ..++.+++|||..||..||.+|.+ +++|..|+|++.+|-
T Consensus 225 SETLTmImDCKYtvP---shvS~eCrdLI~sMLvRdPkkRAs---lEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 225 SETLTMIMDCKYTVP---SHVSKECRDLIQSMLVRDPKKRAS---LEEIVSTSWLQAGDR 278 (864)
T ss_pred hhhhhhhhcccccCc---hhhhHHHHHHHHHHHhcCchhhcc---HHHHhccccccCCCC
Confidence 999999999999766 789999999999999999999988 899999999998863
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=404.22 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=209.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc----
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR---- 830 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~---- 830 (1170)
....+|++++.||+|+||+||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34568999999999999999999999999999999876432 1234699999999999999998876432
Q ss_pred ----cceEEEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-cEEEEe
Q 001057 831 ----ENLYLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTD 901 (1170)
Q Consensus 831 ----~~LyLVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-~VKLsD 901 (1170)
..+|+||||+++ +|..++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 247899999964 78777643 45799999999999999999999999999999999999999765 699999
Q ss_pred cCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHH
Q 001057 902 FGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFE 980 (1170)
Q Consensus 902 FGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYE 980 (1170)
||+|+... ........+||+.|||||++.+. .|+.++|||||||+|||
T Consensus 215 FGla~~~~-------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~e 263 (440)
T PTZ00036 215 FGSAKNLL-------------------------------AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE 263 (440)
T ss_pred cccchhcc-------------------------------CCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHH
Confidence 99997421 00112245789999999998764 68999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhcc-----------------CCCCCC---------CCccCCHHHHHHHHHhccCCCCCCC
Q 001057 981 LLIGIPPFNAKTPQQIFDNIMNR-----------------DIPWPN---------IPEEMSVEACDLIDKLLTENPVQRL 1034 (1170)
Q Consensus 981 LLTG~pPF~g~~~~ei~qkIl~~-----------------~l~fP~---------ip~~lS~eakDLIkkLLq~DPskRp 1034 (1170)
|++|.+||.+.+..+.+..+... .+.+|. ++...+.++.+||.+||++||.+|+
T Consensus 264 lltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ 343 (440)
T PTZ00036 264 MILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL 343 (440)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc
Confidence 99999999998776665555321 111221 2345788999999999999999999
Q ss_pred ChhhHHHHHcCCCCCCCC
Q 001057 1035 GATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1035 Sa~~AeEILqHPfF~~id 1052 (1170)
+ +.|+|+||||..+.
T Consensus 344 t---a~e~l~hp~f~~~~ 358 (440)
T PTZ00036 344 N---PIEALADPFFDDLR 358 (440)
T ss_pred C---HHHHhCChhHHhhh
Confidence 9 88999999998764
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=366.05 Aligned_cols=257 Identities=60% Similarity=1.069 Sum_probs=223.6
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHH-HhcCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieIL-skL~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+.||.|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+||||++++++|...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998775443333444455665554 455899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+|||++.++.++|+|||++....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------------- 148 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------------- 148 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc-------------
Confidence 9999999988889999999999999999999999999999999999999999999999999986421
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
......|++.|+|||.+.+..++.++||||||+++|+|++|.+||...+...++..+..
T Consensus 149 ---------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 207 (260)
T cd05611 149 ---------------------ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS 207 (260)
T ss_pred ---------------------ccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 01234688899999999988889999999999999999999999999888888888877
Q ss_pred cCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 1003 RDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 1003 ~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
....++. ....++.++.++|.+||+.||.+||++.+++|++.||||++++|+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 208 RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 6655543 233689999999999999999999998889999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=370.91 Aligned_cols=254 Identities=30% Similarity=0.498 Sum_probs=206.6
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeeecc-----
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV---RNPFVVRFFYSFTCR----- 830 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL---~HPNIVrL~~~Fqd~----- 830 (1170)
+|++++.||+|+||+||+|+++.+++.||+|.+...... ......+.+|+.++..+ +||||++++++|...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 599999999999999999999999999999998754221 11223455677776655 799999999988652
Q ss_pred cceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
..+++||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 45899999996 5899988764 34899999999999999999999999999999999999999999999999998742
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
. .........||+.|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus 159 ~-------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f 207 (288)
T cd07863 159 S-------------------------------CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207 (288)
T ss_pred c-------------------------------CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc
Confidence 1 000112346899999999999989999999999999999999999999
Q ss_pred CCCCHHHHHHHHhccC-----CCCC-------------------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 989 NAKTPQQIFDNIMNRD-----IPWP-------------------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~-----l~fP-------------------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
.+......+..+.... ..|+ .....++..+.+||.+||+.||.+||+ +.+++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~l~ 284 (288)
T cd07863 208 CGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS---AFRALQ 284 (288)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC---HHHHhc
Confidence 8887766655554210 0011 011356788999999999999999999 889999
Q ss_pred CCCC
Q 001057 1045 HPFF 1048 (1170)
Q Consensus 1045 HPfF 1048 (1170)
||||
T Consensus 285 hp~f 288 (288)
T cd07863 285 HPFF 288 (288)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=396.59 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=210.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+...+|++++.||+|+||.||+|++..+++.||||.... ..+.+|+.+|+.++|||||+++++|......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3556789999999999999999999999999999996432 3467899999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+|||++ +++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~--- 234 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD--- 234 (391)
T ss_pred EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc---
Confidence 9999999 579999998878899999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC-
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT- 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~- 992 (1170)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+..
T Consensus 235 --------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~ 288 (391)
T PHA03212 235 --------------------------INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288 (391)
T ss_pred --------------------------ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccc
Confidence 00112234689999999999999899999999999999999999998875432
Q ss_pred ------HHHHHHHHhcc--------------------------CCCCCC-C-----CccCCHHHHHHHHHhccCCCCCCC
Q 001057 993 ------PQQIFDNIMNR--------------------------DIPWPN-I-----PEEMSVEACDLIDKLLTENPVQRL 1034 (1170)
Q Consensus 993 ------~~ei~qkIl~~--------------------------~l~fP~-i-----p~~lS~eakDLIkkLLq~DPskRp 1034 (1170)
....+..+... ....+. . ...++.++.+||.+||+.||.+||
T Consensus 289 ~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rp 368 (391)
T PHA03212 289 LDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRP 368 (391)
T ss_pred ccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCC
Confidence 11112211110 000000 0 013567899999999999999999
Q ss_pred ChhhHHHHHcCCCCCCC
Q 001057 1035 GATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1035 Sa~~AeEILqHPfF~~i 1051 (1170)
+ |.|+|+||||+.+
T Consensus 369 t---a~elL~hp~f~~~ 382 (391)
T PHA03212 369 S---AEALLDFAAFQDI 382 (391)
T ss_pred C---HHHHhcChhhccC
Confidence 9 8899999999875
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=376.16 Aligned_cols=260 Identities=27% Similarity=0.513 Sum_probs=214.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|.+++.||.|+||.||+|+++.+++.||+|.+..... ......+.+|+.++..++||||+++++++...+.+|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 81 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL 81 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999875432 2223456789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 836 VMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---- 156 (309)
T cd07872 82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV---- 156 (309)
T ss_pred EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC----
Confidence 9999964 888888765 4589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.
T Consensus 157 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 157 --------------------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred --------------------------CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 0001123467999999999875 4588999999999999999999999998876
Q ss_pred HHHHHHHhcc-------------------CCCCCC--------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCC
Q 001057 994 QQIFDNIMNR-------------------DIPWPN--------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046 (1170)
Q Consensus 994 ~ei~qkIl~~-------------------~l~fP~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHP 1046 (1170)
.+....+... ...++. ....++.++++||.+||+.||.+|++ +.|+++||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~ 287 (309)
T cd07872 211 EDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS---AEEAMKHA 287 (309)
T ss_pred HHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC---HHHHhcCh
Confidence 6555444321 011111 11247889999999999999999999 88999999
Q ss_pred CCCCC
Q 001057 1047 FFKNI 1051 (1170)
Q Consensus 1047 fF~~i 1051 (1170)
||+.+
T Consensus 288 ~~~~~ 292 (309)
T cd07872 288 YFRSL 292 (309)
T ss_pred hhhhc
Confidence 99875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=360.45 Aligned_cols=260 Identities=32% Similarity=0.523 Sum_probs=223.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI--RKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~--~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
++|++.+.||.|+||.||+|.+..+++.||+|.+...... .......+.+|+.++..++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4699999999999999999999999999999998754322 22345678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~---- 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI---- 157 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccc----
Confidence 9999999999999998888999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
...........|+..|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 158 -----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 214 (263)
T cd06625 158 -----------------------CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA 214 (263)
T ss_pred -----------------------ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence 000011124568899999999999889999999999999999999999998877666
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
....+...... +.++..++..+.+||.+||..+|.+||+ +.++++||||
T Consensus 215 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 263 (263)
T cd06625 215 AIFKIATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPS---AEELLRHFFV 263 (263)
T ss_pred HHHHHhccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCC---HHHHhhCCCC
Confidence 65555544332 2355678999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=368.40 Aligned_cols=266 Identities=35% Similarity=0.668 Sum_probs=222.7
Q ss_pred eccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCCh
Q 001057 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 845 (1170)
Q Consensus 766 LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL 845 (1170)
||.|+||+||+|.+..+|+.||+|++.+...........+..|+.+|+.++||||++++++|...+.+|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999875544444556678899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCC
Q 001057 846 YSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923 (1170)
Q Consensus 846 ~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s 923 (1170)
.+++.+.+ .+++..+..++.|++.||.|||++||+||||+|+|||++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 99997765 699999999999999999999999999999999999999999999999999864210
Q ss_pred CCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH----HHHHHH
Q 001057 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP----QQIFDN 999 (1170)
Q Consensus 924 ~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~----~ei~qk 999 (1170)
........|+..|+|||++.+..++.++|||||||++|+|++|..||..... ..+...
T Consensus 148 ------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 209 (277)
T cd05577 148 ------------------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209 (277)
T ss_pred ------------------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhc
Confidence 0011234578899999999888899999999999999999999999987543 333333
Q ss_pred HhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh-h-hHHHHHcCCCCCCCChhhhhhc--cCCCCC
Q 001057 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA-T-GAREVKQHPFFKNINWDTLARQ--KAMFIP 1065 (1170)
Q Consensus 1000 Il~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa-~-~AeEILqHPfF~~idwe~L~~~--~ppfiP 1065 (1170)
+...... .+..+++.+.+||.+||+.||.+||+. . .+.+++.||||..++|+.+... .++|+|
T Consensus 210 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 210 TLEMAVE---YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred ccccccc---CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 3332222 345689999999999999999999952 2 4889999999999999887544 445543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=400.92 Aligned_cols=255 Identities=25% Similarity=0.438 Sum_probs=206.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC------CcEEEEEeeeec
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN------PFVVRFFYSFTC 829 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H------PNIVrL~~~Fqd 829 (1170)
..++|+++++||+|+||+||+|.+..+++.||||++++.. ........|+.++..++| ++|++++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 4578999999999999999999999999999999986532 222344567777766654 568999988876
Q ss_pred c-cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCC------------
Q 001057 830 R-ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDG------------ 895 (1170)
Q Consensus 830 ~-~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG------------ 895 (1170)
. .++|||||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 5 5799999998 78999999888889999999999999999999998 5999999999999998765
Q ss_pred ----cEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhh
Q 001057 896 ----HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADW 971 (1170)
Q Consensus 896 ----~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDI 971 (1170)
.+||+|||++... .......+||+.|||||++.+..|+.++||
T Consensus 282 ~~~~~vkl~DfG~~~~~---------------------------------~~~~~~~~gt~~Y~APE~~~~~~~~~~~Di 328 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDE---------------------------------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDM 328 (467)
T ss_pred CCCceEEECCCCccccC---------------------------------ccccccccCCccccCcHHhhcCCCCcHHHH
Confidence 4999999987531 011234689999999999999999999999
Q ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC------------------------CC-C--------------c
Q 001057 972 WSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWP------------------------NI-P--------------E 1012 (1170)
Q Consensus 972 WSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP------------------------~i-p--------------~ 1012 (1170)
|||||++|||++|++||.+.+..+.+..+......+| .. + .
T Consensus 329 wSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (467)
T PTZ00284 329 WSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV 408 (467)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhh
Confidence 9999999999999999998776655444322110000 00 0 0
Q ss_pred cCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1013 EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1013 ~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..++.+.|||.+||++||.+||+ |.|+|+||||...
T Consensus 409 ~~~~~~~dli~~mL~~dP~~R~t---a~e~L~Hp~~~~~ 444 (467)
T PTZ00284 409 IRDDLLCDLIYGLLHYDRQKRLN---ARQMTTHPYVLKY 444 (467)
T ss_pred hchHHHHHHHHHhCCcChhhCCC---HHHHhcCcccccc
Confidence 12456789999999999999999 8899999999864
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=383.14 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=210.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc---
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE--- 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~--- 831 (1170)
...++|++++.||.|+||.||+|++..+|+.||+|++.+.. ........+.+|+.++..++||||++++++|....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 34678999999999999999999999999999999987543 23344567889999999999999999999886543
Q ss_pred ---ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 832 ---NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 832 ---~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
.+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 47999999965 67776643 5889999999999999999999999999999999999999999999999998742
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
. .........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 174 ~-------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 222 (359)
T cd07876 174 C-------------------------------TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF 222 (359)
T ss_pred c-------------------------------cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 1 001122357899999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHhc----------------------cCCCCCC-----------------CCccCCHHHHHHHHHhccCC
Q 001057 989 NAKTPQQIFDNIMN----------------------RDIPWPN-----------------IPEEMSVEACDLIDKLLTEN 1029 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~----------------------~~l~fP~-----------------ip~~lS~eakDLIkkLLq~D 1029 (1170)
.+.+....+..+.. ....++. .....+.++++||.+||+.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 302 (359)
T cd07876 223 QGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVID 302 (359)
T ss_pred CCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccC
Confidence 88765443332221 1111110 11124678999999999999
Q ss_pred CCCCCChhhHHHHHcCCCCCC
Q 001057 1030 PVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 1030 PskRpSa~~AeEILqHPfF~~ 1050 (1170)
|.+||+ +.|+|+||||..
T Consensus 303 P~~R~t---~~e~l~hp~~~~ 320 (359)
T cd07876 303 PDKRIS---VDEALRHPYITV 320 (359)
T ss_pred cccCCC---HHHHhcCchhhh
Confidence 999999 889999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=414.13 Aligned_cols=151 Identities=60% Similarity=1.005 Sum_probs=142.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|.++++||+|+||+||+|.+..+++.||||++.+...........+..|+.++..++||||+++++++....++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876666666678889999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
|||+.|++|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 99999999999998888899999999999999999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=386.88 Aligned_cols=261 Identities=29% Similarity=0.456 Sum_probs=217.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----ce
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE-----NL 833 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~-----~L 833 (1170)
+|++++.||+|+||+||+|.+..+|+.||||.+.... ........+.+|+.+|..++||||+++++++.... .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986532 22334567889999999999999999999998776 79
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~--- 155 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP--- 155 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc---
Confidence 99999995 68999998878899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
..........||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+
T Consensus 156 --------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 156 --------------------------DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred --------------------------CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 000111234689999999999874 47899999999999999999999999888
Q ss_pred HHHHHHHHhcc-----------------------CCCCC------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 993 PQQIFDNIMNR-----------------------DIPWP------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 993 ~~ei~qkIl~~-----------------------~l~fP------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
....+..|... ....+ .+....+.++.+||.+||+.||.+||+ +.+++
T Consensus 210 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t---~~e~l 286 (372)
T cd07853 210 PIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS---AADAL 286 (372)
T ss_pred HHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC---HHHHh
Confidence 76665554321 11111 122356889999999999999999999 88999
Q ss_pred cCCCCCCCCh
Q 001057 1044 QHPFFKNINW 1053 (1170)
Q Consensus 1044 qHPfF~~idw 1053 (1170)
+||||.+..+
T Consensus 287 ~hp~~~~~~~ 296 (372)
T cd07853 287 AHPYLDEGRL 296 (372)
T ss_pred cCHhhCCCcc
Confidence 9999998643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=379.43 Aligned_cols=257 Identities=29% Similarity=0.518 Sum_probs=217.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+++|..++||||++++++|.+.+++|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 4578999999999999999999999999999999887542 23445678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL-NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~-GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~----- 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----- 155 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh-----
Confidence 999999999999999888899999999999999999999975 79999999999999999999999999986421
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 156 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 156 ---------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred ---------------------------hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 00112357899999999999888999999999999999999999999866544
Q ss_pred HHHHHH--------------------------------------------hccCCCCCCCC-ccCCHHHHHHHHHhccCC
Q 001057 995 QIFDNI--------------------------------------------MNRDIPWPNIP-EEMSVEACDLIDKLLTEN 1029 (1170)
Q Consensus 995 ei~qkI--------------------------------------------l~~~l~fP~ip-~~lS~eakDLIkkLLq~D 1029 (1170)
.+...+ .+... +..+ ..++.++++||.+||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~ 286 (333)
T cd06650 209 ELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKN 286 (333)
T ss_pred HHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCC
Confidence 332211 11110 1111 236788999999999999
Q ss_pred CCCCCChhhHHHHHcCCCCCCC
Q 001057 1030 PVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1030 PskRpSa~~AeEILqHPfF~~i 1051 (1170)
|.+||+ +.|++.||||+..
T Consensus 287 P~~Rpt---~~ell~h~~~~~~ 305 (333)
T cd06650 287 PAERAD---LKQLMVHAFIKRS 305 (333)
T ss_pred cccCcC---HHHHhhCHHHhcC
Confidence 999999 8899999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=358.50 Aligned_cols=265 Identities=62% Similarity=1.116 Sum_probs=230.2
Q ss_pred eccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCCh
Q 001057 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 845 (1170)
Q Consensus 766 LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL 845 (1170)
||.|+||.||+|++..+|+.||+|++.+...........+.+|++++..++||||+++++.+.....+|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999876554556677899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCC
Q 001057 846 YSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925 (1170)
Q Consensus 846 ~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~ 925 (1170)
.+++.+.+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~---------- 150 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN---------- 150 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc----------
Confidence 9999987889999999999999999999999999999999999999999999999999987532110000
Q ss_pred ccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC
Q 001057 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI 1005 (1170)
Q Consensus 926 ~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l 1005 (1170)
............++..|+|||++.+..++.++|+||||+++|+|++|..||......+.+..+..+..
T Consensus 151 ------------~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 218 (265)
T cd05579 151 ------------LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI 218 (265)
T ss_pred ------------cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc
Confidence 00111122345688999999999988899999999999999999999999999999888888887776
Q ss_pred CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 1006 PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 1006 ~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
.++.. ..++..+.+||.+||+.+|.+||++..+.++++||||++++|
T Consensus 219 ~~~~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 219 EWPED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred CCCcc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 66632 235899999999999999999999877899999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=381.17 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=212.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR----- 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~----- 830 (1170)
..++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4578999999999999999999999999999999987543 2234456778999999999999999999887654
Q ss_pred -cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 -~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..+|+||||+. ++|..++.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 101 ~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 35799999995 478877754 48899999999999999999999999999999999999999999999999997421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 178 -------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 226 (364)
T cd07875 178 -------------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 226 (364)
T ss_pred -------------------------------CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCC
Confidence 0011124578999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhccC----------------------CCC---------C--------CCCccCCHHHHHHHHHhccCCC
Q 001057 990 AKTPQQIFDNIMNRD----------------------IPW---------P--------NIPEEMSVEACDLIDKLLTENP 1030 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~----------------------l~f---------P--------~ip~~lS~eakDLIkkLLq~DP 1030 (1170)
+.+..+.+..+...- ..+ + ......+..+++||.+||+.||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 306 (364)
T cd07875 227 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306 (364)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCc
Confidence 888766665554210 000 0 0011235678999999999999
Q ss_pred CCCCChhhHHHHHcCCCCCC
Q 001057 1031 VQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 1031 skRpSa~~AeEILqHPfF~~ 1050 (1170)
.+||+ +.++|+||||..
T Consensus 307 ~~R~t---~~e~L~hp~~~~ 323 (364)
T cd07875 307 SKRIS---VDEALQHPYINV 323 (364)
T ss_pred ccCCC---HHHHhcCccccc
Confidence 99999 889999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=403.79 Aligned_cols=257 Identities=31% Similarity=0.545 Sum_probs=230.5
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
..|+.+..||+|+||.||+|.+..+++.||||++.-.. ....++.+..|+.+|.+++++||.++|++|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 45888899999999999999999999999999987654 3456788999999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|||.||++.++++....+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.+||+|||.+...
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql--------- 161 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQL--------- 161 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeee---------
Confidence 99999999999998887899999999999999999999999999999999999999999999999998742
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
+....+..+++|||.||||||+.+.+|+.++||||||++.|||++|.|||....++..+
T Consensus 162 ---------------------~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl 220 (467)
T KOG0201|consen 162 ---------------------TNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL 220 (467)
T ss_pred ---------------------echhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE
Confidence 12233447899999999999999999999999999999999999999999998886555
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..|-+... |.+...+|+.+++||..||.+||+.||+ |.++|+|+|++..
T Consensus 221 flIpk~~P--P~L~~~~S~~~kEFV~~CL~k~P~~Rps---A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 221 FLIPKSAP--PRLDGDFSPPFKEFVEACLDKNPEFRPS---AKELLKHKFIKRA 269 (467)
T ss_pred EeccCCCC--CccccccCHHHHHHHHHHhhcCcccCcC---HHHHhhhHHHHhc
Confidence 44544333 4455689999999999999999999999 8999999999864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=388.72 Aligned_cols=252 Identities=33% Similarity=0.563 Sum_probs=213.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----cc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-----EN 832 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-----~~ 832 (1170)
-.|+..+++|.|+||.||.|....+++.||||.+-...... .+|..||..++|||||+|..+|... -+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 36999999999999999999999999999999875443222 3699999999999999999888643 25
Q ss_pred eEEEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC-CcEEEEecCCccc
Q 001057 833 LYLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD-GHIKLTDFGLSKV 907 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d-G~VKLsDFGLAk~ 907 (1170)
+.+|||||+ .+|+.+++. +..++.-.++.|+.||+.||.|||+.||+||||||.|||+|.+ |.+||||||.|+.
T Consensus 97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 778999996 499999984 4678999999999999999999999999999999999999976 8999999999996
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~p 986 (1170)
.. .+....++..|..|+|||.+.|. .|+.++||||.||++.||+-|++
T Consensus 176 L~-------------------------------~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~p 224 (364)
T KOG0658|consen 176 LV-------------------------------KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQP 224 (364)
T ss_pred ec-------------------------------cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCc
Confidence 42 12233567889999999999975 69999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhcc-----------------CCCCCC---------CCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 987 PFNAKTPQQIFDNIMNR-----------------DIPWPN---------IPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 987 PF~g~~~~ei~qkIl~~-----------------~l~fP~---------ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
.|.|++..+++..|.+- ...+|. ....+++++.+|+.++|.++|.+|.+ +.
T Consensus 225 lFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~---~~ 301 (364)
T KOG0658|consen 225 LFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS---AL 301 (364)
T ss_pred ccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC---HH
Confidence 99999887777766530 112222 23467999999999999999999999 88
Q ss_pred HHHcCCCCCCC
Q 001057 1041 EVKQHPFFKNI 1051 (1170)
Q Consensus 1041 EILqHPfF~~i 1051 (1170)
|++.||||+.+
T Consensus 302 ~~l~h~fFdel 312 (364)
T KOG0658|consen 302 EALAHPFFDEL 312 (364)
T ss_pred HHhcchhhHHh
Confidence 99999999865
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=367.50 Aligned_cols=260 Identities=37% Similarity=0.671 Sum_probs=211.0
Q ss_pred EeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHH---HhcCCCcEEEEEeeeecccceEEEEeecc
Q 001057 765 PISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL---ISVRNPFVVRFFYSFTCRENLYLVMEYLN 841 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieIL---skL~HPNIVrL~~~Fqd~~~LyLVMEY~~ 841 (1170)
.||+|+||.||++.+..+++.||+|++.+.............+|..++ ...+||||+.++++|...+.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998765443333233344454443 34579999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCC
Q 001057 842 GGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921 (1170)
Q Consensus 842 GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl 921 (1170)
||+|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~------------ 148 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc------------
Confidence 99999999888889999999999999999999999999999999999999999999999999986320
Q ss_pred CCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-cCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH---HHHH
Q 001057 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLIGIPPFNAKTP---QQIF 997 (1170)
Q Consensus 922 ~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~---~ei~ 997 (1170)
........||+.|+|||++. +..++.++||||+||++|+|++|..||..... ..+.
T Consensus 149 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 208 (279)
T cd05633 149 --------------------KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208 (279)
T ss_pred --------------------ccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH
Confidence 00112346899999999986 45689999999999999999999999975432 2222
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC--hhhHHHHHcCCCCCCCChhhhhhc
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS--a~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
........ .++..++.++.+||.+||..||.+|++ ...+.++++||||++++|......
T Consensus 209 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 269 (279)
T cd05633 209 RMTLTVNV---ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269 (279)
T ss_pred HHhhcCCc---CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcC
Confidence 22222222 234678999999999999999999995 224889999999999999876544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=384.13 Aligned_cols=257 Identities=29% Similarity=0.493 Sum_probs=211.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.....+|+.++.||.|+||.||+|++..+++.||||++.... .......+.+|+.+|..++|+||++++++|...+.+
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 345678999999999999999999999999999999986542 234456788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||+.+|+|... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~---- 219 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILA---- 219 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecc----
Confidence 999999999998653 345678888999999999999999999999999999999999999999999987521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
.........+||+.|+|||++.. ..++.++|||||||++|||++|..||
T Consensus 220 --------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf 273 (353)
T PLN00034 220 --------------------------QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273 (353)
T ss_pred --------------------------cccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCC
Confidence 00011234579999999999843 23456899999999999999999999
Q ss_pred CCCCHH---HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 989 NAKTPQ---QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 989 ~g~~~~---ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
...... .....+.... .+..+..++.++++||.+||+.||.+||+ +.|+++||||...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~ell~hp~~~~~ 334 (353)
T PLN00034 274 GVGRQGDWASLMCAICMSQ--PPEAPATASREFRHFISCCLQREPAKRWS---AMQLLQHPFILRA 334 (353)
T ss_pred CCCCCccHHHHHHHHhccC--CCCCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccccC
Confidence 743322 2222222221 22334678999999999999999999999 8899999999875
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=359.34 Aligned_cols=257 Identities=40% Similarity=0.798 Sum_probs=224.2
Q ss_pred eccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCCh
Q 001057 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 845 (1170)
Q Consensus 766 LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL 845 (1170)
||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.++..++||||+++++.+.+...+|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999999999999999999876554455667899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCC
Q 001057 846 YSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925 (1170)
Q Consensus 846 ~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~ 925 (1170)
.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~---------------- 144 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK---------------- 144 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccC----------------
Confidence 9999988789999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcc
Q 001057 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT--PQQIFDNIMNR 1003 (1170)
Q Consensus 926 ~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~--~~ei~qkIl~~ 1003 (1170)
. ........|++.|+|||++.+..++.++|+|||||++|+|++|..||.... ....+..+..+
T Consensus 145 --------------~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 209 (262)
T cd05572 145 --------------S-GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG 209 (262)
T ss_pred --------------c-ccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc
Confidence 0 001234568999999999988889999999999999999999999998777 66777777632
Q ss_pred CCCCCCCCccCCHHHHHHHHHhccCCCCCCCC--hhhHHHHHcCCCCCCCChh
Q 001057 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 1004 ~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS--a~~AeEILqHPfF~~idwe 1054 (1170)
... +..+...+.++.+||.+||+.||.+|++ ...++|+++||||++.+|+
T Consensus 210 ~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 210 NGK-LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred CCC-CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 221 2234566899999999999999999998 2458899999999999886
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=388.16 Aligned_cols=256 Identities=30% Similarity=0.508 Sum_probs=218.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCE-EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-c
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDL-FAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE-N 832 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~-VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~-~ 832 (1170)
+...+..+...||.|+||+||.+.++ |.. ||+|++......... ...+.+|+.+|.+++|||||++++++.... .
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 44455667777999999999999876 555 999999876544444 789999999999999999999999999887 7
Q ss_pred eEEEEeeccCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCCCcEEeCCCC-cEEEEecCCcccc
Q 001057 833 LYLVMEYLNGGDLYSLLRN--LGCLDEDMARVYIAELVLALEYLHSLN-VIHRDLKPDNLLIGQDG-HIKLTDFGLSKVG 908 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~--~~~LSEe~ar~IaaQIL~ALeYLHs~G-IIHRDIKPENILLd~dG-~VKLsDFGLAk~~ 908 (1170)
++|||||+++|+|..++.. ...++...+..++.||+.|++|||+++ ||||||||+||||+.++ ++||+|||+++..
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 9999999999999999987 578999999999999999999999999 99999999999999998 9999999999852
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh--cCCCCcchhhhHHHHHHHHHHhCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL--GMGHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~--g~~ys~ksDIWSLGVILYELLTG~p 986 (1170)
.. .........||+.|||||++. +..|+.++||||||++||||+||..
T Consensus 195 ~~------------------------------~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 195 VI------------------------------SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred cc------------------------------ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 10 001222368999999999999 5689999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 987 PF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
||.+....+....+..... .|.++..+++.+..|+.+|+..||.+||+...+...|.
T Consensus 245 Pf~~~~~~~~~~~v~~~~~-Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGGL-RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred CCCCCCHHHHHHHHHhcCC-CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 9999998666666654433 24456779999999999999999999999665544443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=382.88 Aligned_cols=261 Identities=30% Similarity=0.557 Sum_probs=220.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeeccc----
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF-VVRFFYSFTCRE---- 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN-IVrL~~~Fqd~~---- 831 (1170)
...|..+++||+|+||+||+|+.+.+|+.||+|++.-.... +..-....+|+.+|+.++|+| ||+|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56688889999999999999999999999999998765321 234456789999999999999 999999998877
Q ss_pred --ceEEEEeeccCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 832 --NLYLVMEYLNGGDLYSLLRNLG----CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 832 --~LyLVMEY~~GGSL~dlLk~~~----~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
.+||||||+ .-+|..++.... .++...++.+++||+.||+|||+++|+||||||+||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 459999998765 5888899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG 984 (1170)
+...+ ........++|.+|+|||++.+. .|+..+||||+|||++||+++
T Consensus 168 ra~~i------------------------------p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~ 217 (323)
T KOG0594|consen 168 RAFSI------------------------------PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTR 217 (323)
T ss_pred HHhcC------------------------------CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhC
Confidence 85310 11123345789999999999987 799999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhc-----cCCCCCC-------------CC---------ccCCHHHHHHHHHhccCCCCCCCChh
Q 001057 985 IPPFNAKTPQQIFDNIMN-----RDIPWPN-------------IP---------EEMSVEACDLIDKLLTENPVQRLGAT 1037 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~-----~~l~fP~-------------ip---------~~lS~eakDLIkkLLq~DPskRpSa~ 1037 (1170)
++.|.|.+..++...|.. ....||. .. ...++.+.+|+.+||+++|.+|.+
T Consensus 218 ~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S-- 295 (323)
T KOG0594|consen 218 RPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS-- 295 (323)
T ss_pred CCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC--
Confidence 999999998887777754 1112221 11 233468999999999999999999
Q ss_pred hHHHHHcCCCCCCCC
Q 001057 1038 GAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1038 ~AeEILqHPfF~~id 1052 (1170)
|+.+|.||||..+.
T Consensus 296 -a~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 296 -AKGALTHPYFSELP 309 (323)
T ss_pred -HHHHhcChhhcccc
Confidence 77889999999873
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.75 Aligned_cols=266 Identities=32% Similarity=0.575 Sum_probs=225.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.+.|++++.||.|+||.||+|++..+++.||+|++... .....+.+.+|+.+++.++||||+++++.|.....+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 36799999999999999999999999999999998754 344567788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||++|++|..++.+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~------ 161 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV------ 161 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc------
Confidence 999999999988765 3568999999999999999999999999999999999999999999999999886421
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
..........|++.|+|||++.+ ..++.++|||||||++|+|++|.+||..
T Consensus 162 ------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 162 ------------------------KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred ------------------------ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 00011123568899999999853 3467889999999999999999999988
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhh
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLAR 1058 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~ 1058 (1170)
.+....+..+.....+....+..++.++.+||.+||..||.+||+ +.++++||||..+.|.....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~~ 282 (292)
T cd06644 218 LNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS---AAQLLEHPFVSSVTSNRPLR 282 (292)
T ss_pred ccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccccccchhHH
Confidence 777766666654433322334578899999999999999999999 78999999999998876443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.53 Aligned_cols=255 Identities=36% Similarity=0.649 Sum_probs=214.6
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
|++++.||+|+||+||+|++..+++.||+|++........ ......+|+.++..++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987654332 233445699999999999999999999999999999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCC
Q 001057 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~ 919 (1170)
+.+++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||.+....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~---------- 149 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS---------- 149 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 9999999999977889999999999999999999999999999999999999999999999999987410
Q ss_pred CCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-cCCCCcchhhhHHHHHHHHHHhCCCCCCCCC---HHH
Q 001057 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLIGIPPFNAKT---PQQ 995 (1170)
Q Consensus 920 sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-g~~ys~ksDIWSLGVILYELLTG~pPF~g~~---~~e 995 (1170)
..........||+.|+|||++. +..++.++||||||+++|+|++|..||.... ...
T Consensus 150 --------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~ 209 (260)
T PF00069_consen 150 --------------------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE 209 (260)
T ss_dssp --------------------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH
T ss_pred --------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh
Confidence 1112334567899999999998 7789999999999999999999999999873 333
Q ss_pred HHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.+............ .....+.++.+||.+||+.||.+||+ +.++++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~l~~~~~~ 260 (260)
T PF00069_consen 210 IIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS---AEELLKHPWF 260 (260)
T ss_dssp HHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT---HHHHHTSGGG
T ss_pred hhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcC---HHHHhcCCCC
Confidence 33333322211110 00123489999999999999999999 8899999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=351.68 Aligned_cols=254 Identities=27% Similarity=0.536 Sum_probs=219.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-cceEEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-ENLYLVM 837 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-~~LyLVM 837 (1170)
+|++++.||.|+||.||++.++.+++.||+|.+..... .......+.+|+.+++.++||||+++++.+... ..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 49999999999999999999999999999999875432 234456788899999999999999999888654 4689999
Q ss_pred eeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 838 EYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~----- 154 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN----- 154 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc-----
Confidence 999999999999763 4589999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+...
T Consensus 155 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~ 209 (257)
T cd08223 155 -------------------------QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209 (257)
T ss_pred -------------------------cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 0011224568999999999999889999999999999999999999999888777
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
+...+..+..+ ..+..++.++.+||.+||+.||.+||+ +.+++.||||
T Consensus 210 ~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 257 (257)
T cd08223 210 LVYRIIEGKLP--PMPKDYSPELGELIATMLSKRPEKRPS---VKSILRQPYI 257 (257)
T ss_pred HHHHHHhcCCC--CCccccCHHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 77777665542 345678999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=366.33 Aligned_cols=261 Identities=28% Similarity=0.521 Sum_probs=216.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
.+++|++++.||.|+||.||+|++..+++.||+|.+..... ......+.+|+.++..++||||+++++++.....+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 45789999999999999999999999999999999875432 2233456789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 836 VMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---- 156 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI---- 156 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC----
Confidence 999996 5899888764 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.........+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.
T Consensus 157 --------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 157 --------------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred --------------------------CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 00011234578999999998764 478899999999999999999999998887
Q ss_pred HHHHHHHhcc-------------------CCCCCC--------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCC
Q 001057 994 QQIFDNIMNR-------------------DIPWPN--------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046 (1170)
Q Consensus 994 ~ei~qkIl~~-------------------~l~fP~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHP 1046 (1170)
.+....+... ...++. ....++.++++||.+||+.||.+||+ +.++++||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~eil~h~ 287 (301)
T cd07873 211 EEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS---AEEAMKHP 287 (301)
T ss_pred HHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC---HHHHhcCc
Confidence 6655444321 001111 11357889999999999999999999 88999999
Q ss_pred CCCCCC
Q 001057 1047 FFKNIN 1052 (1170)
Q Consensus 1047 fF~~id 1052 (1170)
||+.+.
T Consensus 288 ~f~~~~ 293 (301)
T cd07873 288 YFHCLG 293 (301)
T ss_pred cccccc
Confidence 998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=377.85 Aligned_cols=258 Identities=27% Similarity=0.465 Sum_probs=210.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR----- 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~----- 830 (1170)
..++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4578999999999999999999999999999999987543 2334456778899999999999999999988654
Q ss_pred -cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 -~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..+|+||||+.+ +|...+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999965 77777754 58899999999999999999999999999999999999999999999999987421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 171 -------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 171 -------------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred -------------------------------CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0011224578999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhcc----------------------C-----CCCC------------CCCccCCHHHHHHHHHhccCCC
Q 001057 990 AKTPQQIFDNIMNR----------------------D-----IPWP------------NIPEEMSVEACDLIDKLLTENP 1030 (1170)
Q Consensus 990 g~~~~ei~qkIl~~----------------------~-----l~fP------------~ip~~lS~eakDLIkkLLq~DP 1030 (1170)
+.+..+.+..+... . ..++ ..+...+.++++||.+||+.||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 299 (355)
T cd07874 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299 (355)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCc
Confidence 87755443332210 0 0000 0112245788999999999999
Q ss_pred CCCCChhhHHHHHcCCCCCCC
Q 001057 1031 VQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1031 skRpSa~~AeEILqHPfF~~i 1051 (1170)
.+||+ +.|+|+||||+..
T Consensus 300 ~~Rps---~~ell~hp~~~~~ 317 (355)
T cd07874 300 AKRIS---VDEALQHPYINVW 317 (355)
T ss_pred hhcCC---HHHHhcCcchhcc
Confidence 99999 8899999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=373.92 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=206.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeee-----cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARK-----RATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFT 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArd-----k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fq 828 (1170)
+..++|++.+.||.|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+|..+ +||||++++++|.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 3456899999999999999999975 3456789999987532 234456789999999999 8999999999887
Q ss_pred cc-cceEEEEeeccCCChHHHHHhc-------------------------------------------------------
Q 001057 829 CR-ENLYLVMEYLNGGDLYSLLRNL------------------------------------------------------- 852 (1170)
Q Consensus 829 d~-~~LyLVMEY~~GGSL~dlLk~~------------------------------------------------------- 852 (1170)
.. ..+|+||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 4589999999999999999752
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCC
Q 001057 853 -------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925 (1170)
Q Consensus 853 -------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~ 925 (1170)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~-------------- 227 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD-------------- 227 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccC--------------
Confidence 23778888999999999999999999999999999999999999999999999742100
Q ss_pred ccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhcc
Q 001057 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQ-IFDNIMNR 1003 (1170)
Q Consensus 926 ~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~e-i~qkIl~~ 1003 (1170)
..........+++.|||||++.+..++.++|||||||+||||++ |.+||.+....+ +...+..+
T Consensus 228 --------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 293 (338)
T cd05102 228 --------------PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293 (338)
T ss_pred --------------cchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC
Confidence 00001123456789999999999899999999999999999997 999998865443 33444433
Q ss_pred CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 1004 DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 1004 ~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.. +..+..+++.+.+||.+||+.||.+||++.++.+.|
T Consensus 294 ~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 294 TR--MRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331 (338)
T ss_pred CC--CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 32 223467899999999999999999999965554444
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=362.50 Aligned_cols=260 Identities=36% Similarity=0.655 Sum_probs=213.4
Q ss_pred EeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHH---HHHhcCCCcEEEEEeeeecccceEEEEeecc
Q 001057 765 PISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN---ILISVRNPFVVRFFYSFTCRENLYLVMEYLN 841 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~Eie---ILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~ 841 (1170)
.||.|+||.||+|++..+++.||+|++.+..............|.. ++....||||+.++++|...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987654332222222334433 4445679999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCC
Q 001057 842 GGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921 (1170)
Q Consensus 842 GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl 921 (1170)
||+|..++...+.+++..++.++.|++.||.|||+++|+||||||+|||++.++.++|+|||++....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~------------ 148 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC------------
Confidence 99999999888889999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCC---CHHHHH
Q 001057 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAK---TPQQIF 997 (1170)
Q Consensus 922 ~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~---~~~ei~ 997 (1170)
.......+||..|+|||++.+. .++.++||||+||++|+|++|..||.+. ......
T Consensus 149 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~ 208 (278)
T cd05606 149 --------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 208 (278)
T ss_pred --------------------ccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH
Confidence 0011234789999999999754 6889999999999999999999999876 333333
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh--hHHHHHcCCCCCCCChhhhhhc
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~--~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
..+...... ++..++.++.++|.+||..+|.+|+... .+.++++||||+.++|..+...
T Consensus 209 ~~~~~~~~~---~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 209 RMTLTMAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred HHhhccCCC---CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 334333333 3356799999999999999999999322 3889999999999999987655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=378.17 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=211.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR------ 830 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~------ 830 (1170)
.++|++++.||.|+||+||+|.+..+++.||+|++.+... .......+.+|+.+|+.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3679999999999999999999999999999999876432 223445677899999999999999999888643
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
..+|++|+++ +++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~- 169 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD- 169 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC-
Confidence 3579999998 7899887764 569999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 170 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 170 --------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred --------------------------------CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 01123578999999999987 568999999999999999999999998
Q ss_pred CCCHHHHHHHHhccCC--------------------CCCC--------CCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 990 AKTPQQIFDNIMNRDI--------------------PWPN--------IPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l--------------------~fP~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+.+..+.+..+..... .++. .....++.+.+||.+||+.||.+||+ +.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s---~~e 294 (343)
T cd07878 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS---ASE 294 (343)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC---HHH
Confidence 8776555544432100 0011 11245677899999999999999999 889
Q ss_pred HHcCCCCCCC
Q 001057 1042 VKQHPFFKNI 1051 (1170)
Q Consensus 1042 ILqHPfF~~i 1051 (1170)
+++||||...
T Consensus 295 ll~hp~~~~~ 304 (343)
T cd07878 295 ALAHPYFSQY 304 (343)
T ss_pred HhcCcchhcc
Confidence 9999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=349.99 Aligned_cols=254 Identities=30% Similarity=0.543 Sum_probs=222.9
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|.+.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 58999999999999999999999999999999876543 24456778899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 839 YLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|++|++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~------- 152 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS------- 152 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceecc-------
Confidence 99999999999764 568999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
..........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+....
T Consensus 153 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 209 (256)
T cd08529 153 -----------------------DNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209 (256)
T ss_pred -----------------------CccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 000111245688999999999998899999999999999999999999998888777
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
...+..+..+ .++..++..+.++|.+||+.+|.+||+ +.+++.|||+
T Consensus 210 ~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 256 (256)
T cd08529 210 ILKIIRGVFP--PVSQMYSQQLAQLIDQCLTKDYRQRPD---TFQLLRNPSL 256 (256)
T ss_pred HHHHHcCCCC--CCccccCHHHHHHHHHHccCCcccCcC---HHHHhhCCCC
Confidence 7777765433 344578899999999999999999999 8899999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=394.62 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=224.1
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCC-CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRAT-GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~T-Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|..++|||||+++++|...+++||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998877 788999976543 23445677889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 836 VMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999988753 346899999999999999999999999999999999999999999999999999752100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 223 ----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 223 ----------------------------VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred ----------------------------cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 0011233568999999999999989999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+..+++..+..+... ..+..++.++.+||.+||..||.+||+ +.+++.|+|++.+
T Consensus 275 ~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~~~~~~~~ 329 (478)
T PTZ00267 275 SQREIMQQVLYGKYD--PFPCPVSSGMKALLDPLLSKNPALRPT---TQQLLHTEFLKYV 329 (478)
T ss_pred CHHHHHHHHHhCCCC--CCCccCCHHHHHHHHHHhccChhhCcC---HHHHHhCHHHHHH
Confidence 988888888776543 234678999999999999999999999 7889999998643
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=353.83 Aligned_cols=261 Identities=30% Similarity=0.542 Sum_probs=220.8
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc------cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI------RKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~------~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
+|.+...||.|+||.||+|.+..+++.||+|.+...... .....+.+.+|+.++..++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477888999999999999999989999999988654322 12344678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||||+++++|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987531000
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
. . ...........|+..|+|||++.+..++.++|+|||||++|+|++|..||.+.+
T Consensus 161 ~--------~----------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 161 L--------S----------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred c--------c----------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 0 0 000111224568999999999998889999999999999999999999998876
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
....+..+... ..+.++..++..+.+||.+||+.||.+||+ +.++++||||
T Consensus 217 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 267 (267)
T cd06628 217 QLQAIFKIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRPT---AAELLKHPFL 267 (267)
T ss_pred HHHHHHHHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCcC---HHHHhhCCCC
Confidence 65555554442 233455678999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=396.09 Aligned_cols=263 Identities=27% Similarity=0.462 Sum_probs=226.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc---
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE--- 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~--- 831 (1170)
...++|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|..++|+||++++..|...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345689999999999999999999999999999999876543 3445667889999999999999999988775432
Q ss_pred -----ceEEEEeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEec
Q 001057 832 -----NLYLVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902 (1170)
Q Consensus 832 -----~LyLVMEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDF 902 (1170)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 378999999999999998643 46899999999999999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELL 982 (1170)
|+++..... .........+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 188 Gls~~~~~~----------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLl 239 (496)
T PTZ00283 188 GFSKMYAAT----------------------------VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239 (496)
T ss_pred ccCeecccc----------------------------ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999753100 0011223568999999999999989999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 983 IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 983 TG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+|..||.+.+..+++..+..+... .++..+++++.+||.+||+.||.+||+ +.++++|||++..
T Consensus 240 tG~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs---~~ell~~p~~~~~ 303 (496)
T PTZ00283 240 TLKRPFDGENMEEVMHKTLAGRYD--PLPPSISPEMQEIVTALLSSDPKRRPS---SSKLLNMPICKLF 303 (496)
T ss_pred HCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcC---HHHHHhCHHHHHh
Confidence 999999999988888888766543 345788999999999999999999999 7899999998754
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=358.92 Aligned_cols=256 Identities=32% Similarity=0.515 Sum_probs=215.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++.+.||.|+||.||+|++..+++.||+|+++... ......+.+|+.++..++||||+++++++...+.+|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 3468999999999999999999999999999999987542 2334567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||+++++|.+++...+.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~----- 158 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA----- 158 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC-----
Confidence 999999999999998888899999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........||+.|+|||++. ...++.++|+|||||++|+|++|.+||....
T Consensus 159 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 159 -------------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred -------------------------cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 001122457899999999985 4458889999999999999999999997766
Q ss_pred HHHHHHHHhccCCCCCCCC--ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 993 PQQIFDNIMNRDIPWPNIP--EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip--~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
.......+.......+... ..++..+.+||.+||+.||.+||+ +.++++|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~ll~~~~ 267 (267)
T cd06645 214 PMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT---AEKLLQHPF 267 (267)
T ss_pred chhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC---HHHHhcCCC
Confidence 5444433333333322221 257789999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=354.57 Aligned_cols=262 Identities=26% Similarity=0.472 Sum_probs=221.3
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccc---cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD---MIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~---i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
+|++.+.||.|+||.||+|.+ .+++.+|+|.+.... .........+.+|+++|+.++|+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588899999999999999986 478999999886432 1223445678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||++|++|.+++.+.+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 158 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH- 158 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998742100000
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
...........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+...
T Consensus 159 -----------------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~ 215 (265)
T cd06631 159 -----------------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA 215 (265)
T ss_pred -----------------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH
Confidence 000111234568999999999998889999999999999999999999998877655
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
....+.......+.++..++.++.+||.+||..+|.+||+ +.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~ 265 (265)
T cd06631 216 AMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS---ALQLLRHDFL 265 (265)
T ss_pred HHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 5555554434455566789999999999999999999998 8899999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=359.95 Aligned_cols=260 Identities=32% Similarity=0.559 Sum_probs=223.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||.|+||.||+|.+..++..||+|++... .....+.+..|+.+++.++||||+++++.+.....+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998643 344567788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+++++|..++... ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~------ 154 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK------ 154 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhc------
Confidence 9999999999998764 469999999999999999999999999999999999999999999999999876421
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
..........||+.|+|||++.. ..++.++|+|||||++|+|++|.+||.+
T Consensus 155 ------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 155 ------------------------STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred ------------------------ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 00011224568999999999863 3467789999999999999999999998
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
.+....+..+.....+....+..++.++.+||.+||+.+|.+||+ +.++++||||....
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~ 269 (280)
T cd06611 211 LNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT---AAELLKHPFVSDQS 269 (280)
T ss_pred CCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcC---HHHHhcChhhcccc
Confidence 887777777766544333334678999999999999999999999 88999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=381.16 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=215.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeec--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKR--ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk--~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
....+|.+++.||.|+||.||+|... .++..||+|.+.+.. ...+|+.+|+.++|||||+++++|.....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 34457999999999999999999764 356889999876532 24579999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+|......
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~- 238 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH- 238 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc-
Confidence 999999994 699999977788999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+..
T Consensus 239 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 239 ---------------------------PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred ---------------------------cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 00111235679999999999999999999999999999999999999998754
Q ss_pred H---HHHHHHHhc----cCCCC-------------------------CCC--CccCCHHHHHHHHHhccCCCCCCCChhh
Q 001057 993 P---QQIFDNIMN----RDIPW-------------------------PNI--PEEMSVEACDLIDKLLTENPVQRLGATG 1038 (1170)
Q Consensus 993 ~---~ei~qkIl~----~~l~f-------------------------P~i--p~~lS~eakDLIkkLLq~DPskRpSa~~ 1038 (1170)
. ...+..+.. ....+ +.. ...++.++.+||.+||..||.+||+
T Consensus 292 ~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps--- 368 (392)
T PHA03207 292 VKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS--- 368 (392)
T ss_pred CCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC---
Confidence 2 112222211 01111 100 1245778999999999999999999
Q ss_pred HHHHHcCCCCCCCChhhhhh
Q 001057 1039 AREVKQHPFFKNINWDTLAR 1058 (1170)
Q Consensus 1039 AeEILqHPfF~~idwe~L~~ 1058 (1170)
+.++|.||||....|+.+..
T Consensus 369 a~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 369 AQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred HHHHhhCchhhccchhhhcC
Confidence 88999999999998887654
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=394.62 Aligned_cols=258 Identities=30% Similarity=0.547 Sum_probs=234.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc-eEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN-LYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~-LyL 835 (1170)
.++|.+++.+|+|+||.+++++++..++.|++|.+.-.....+ .......|..+++++.|||||.+++.|..+++ +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 5689999999999999999999999999999999987665443 34477899999999999999999999999998 999
Q ss_pred EEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 836 VMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||+||+||+|.+.|.+.+ .|+++.+..|+.|++.|++|||+++|+|||||+.||+++.++.|||.|||+|+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~---- 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN---- 157 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC----
Confidence 999999999999997653 59999999999999999999999999999999999999999999999999999631
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.......+.+|||.||.||++.+.+|+.++|||||||++|||++-+++|.+.+.
T Consensus 158 --------------------------~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 158 --------------------------PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred --------------------------CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 112245678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
..+..+|..... ..+|...+.+++.||..||..+|..||+ |.++|.+|....
T Consensus 212 ~~Li~ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RPs---a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 212 SELILKINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRPS---ALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHhhccC--CCCCccccHHHHHHHHHHhhcCCccCCC---HHHHhhChhhhh
Confidence 999999998773 3466889999999999999999999999 889999998763
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=358.79 Aligned_cols=257 Identities=34% Similarity=0.546 Sum_probs=219.6
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
-|++++.||.|+||.||+|.+..++..+|+|.+.... ....+.+.+|+.++..++||||+++++.|.....+|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3788999999999999999999999999999986532 3456778899999999999999999999999999999999
Q ss_pred eccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 839 YLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 839 Y~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|+++++|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~-------- 154 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT-------- 154 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccc--------
Confidence 9999999988765 4569999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-----cCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
..........||+.|+|||++. +..++.++|||||||++|+|++|.+||...+
T Consensus 155 ----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 155 ----------------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred ----------------------ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 0001122356899999999984 3457789999999999999999999999888
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..+....+.....+....+..++.++.+||.+||+.||.+||+ +.++++||||...
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 268 (282)
T cd06643 213 PMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT---TTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCCCEecc
Confidence 7777666655443333344678899999999999999999999 7899999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=355.07 Aligned_cols=255 Identities=41% Similarity=0.754 Sum_probs=222.0
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++.+.||.|+||.||+|++..+++.||+|++.+...........+.+|+.++++++||||+++++.|.....+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987665555667889999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
|+.|++|..++.....+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~-------- 152 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-------- 152 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC--------
Confidence 999999999998877899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC---HHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT---PQQ 995 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~---~~e 995 (1170)
........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+ ...
T Consensus 153 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (258)
T cd05578 153 -----------------------DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209 (258)
T ss_pred -----------------------CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH
Confidence 001123468889999999998889999999999999999999999998776 344
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
+...+.... +..+..++..+.++|.+||+.||.+|++.. ..|+++||||
T Consensus 210 ~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 210 IRAKQETAD---VLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred HHHHhcccc---ccCcccCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 433333222 234467899999999999999999999943 4999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=397.43 Aligned_cols=253 Identities=30% Similarity=0.518 Sum_probs=216.8
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-C-----CcEEEEEeeeeccc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-N-----PFVVRFFYSFTCRE 831 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-H-----PNIVrL~~~Fqd~~ 831 (1170)
.+|.+++.||+|+||.|.+|.+..|++.||||++++. .....+...|+.||..|+ | -|||+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 3899999999999999999999999999999999864 345566778999999997 4 48999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC--cEEEEecCCccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG--HIKLTDFGLSKV 907 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG--~VKLsDFGLAk~ 907 (1170)
++|||+|.+ +.+|+++|+.+ ..|+...++.++.||+.||.+||++||||+|||||||||..-+ .|||+|||.|..
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 67999999876 4699999999999999999999999999999999999997644 799999999875
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
. ....++++.+..|+|||||+|..|+.+.||||||||++||++|.+.
T Consensus 341 ~---------------------------------~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PL 387 (586)
T KOG0667|consen 341 E---------------------------------SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPL 387 (586)
T ss_pred c---------------------------------CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccc
Confidence 2 1223477889999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHhcc--------------------C-CCCCC----------------------------CC-------
Q 001057 988 FNAKTPQQIFDNIMNR--------------------D-IPWPN----------------------------IP------- 1011 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~--------------------~-l~fP~----------------------------ip------- 1011 (1170)
|.|.+..+++..|+.- . ..++. .|
T Consensus 388 fpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~ 467 (586)
T KOG0667|consen 388 FPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLE 467 (586)
T ss_pred cCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccc
Confidence 9999998888877531 0 00000 01
Q ss_pred ----ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1012 ----EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1012 ----~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..-...+.|||++||.+||.+|++ +.++|+||||...
T Consensus 468 ~~~~~~~~~~F~dflk~~L~~dP~~R~t---p~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 468 SGLPKADDKLFIDFLKRCLEWDPAERIT---PAQALNHPFLTGT 508 (586)
T ss_pred hhcccccHHHHHHHHHHHhccCchhcCC---HHHHhcCcccccc
Confidence 012345789999999999999999 6788999999865
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.70 Aligned_cols=255 Identities=30% Similarity=0.540 Sum_probs=208.7
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++++.||.|+||.||+|++..++..||||++..... .......+.+|+.++..++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999865432 22334567889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 839 YLNGGDLYSLLRNL---GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~---~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 153 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI----- 153 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC-----
Confidence 996 6898888653 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........|++.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..
T Consensus 154 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~ 208 (285)
T cd07861 154 -------------------------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI 208 (285)
T ss_pred -------------------------CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 00011233678999999998754 4788999999999999999999999887654
Q ss_pred HHHHHHhccC------------------CCCC--------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 995 QIFDNIMNRD------------------IPWP--------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 995 ei~qkIl~~~------------------l~fP--------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.....+...- ..++ .....++.++++||.+||+.||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~~ll~~~~~ 285 (285)
T cd07861 209 DQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS---AKKALNHPYF 285 (285)
T ss_pred HHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC---HHHHhcCCCC
Confidence 3332221100 0000 012357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=363.33 Aligned_cols=257 Identities=30% Similarity=0.523 Sum_probs=216.4
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||.||++.+..++..||+|.+.... .......+.+|++++..++||||++++++|.+.+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999886532 2344567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||++|++|.+++.+.+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------- 151 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------- 151 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc-------
Confidence 999999999999988889999999999999999999997 699999999999999999999999999986420
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.......+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+....
T Consensus 152 -------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 206 (308)
T cd06615 152 -------------------------DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206 (308)
T ss_pred -------------------------ccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH
Confidence 0011245789999999999888899999999999999999999999976654443
Q ss_pred HHHHhccCC----------------------------------CCCCCC-ccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 997 FDNIMNRDI----------------------------------PWPNIP-EEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 997 ~qkIl~~~l----------------------------------~fP~ip-~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
...+..... ..|..+ ..++.++++||.+||..||.+||+ +.+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ 283 (308)
T cd06615 207 EAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD---LKE 283 (308)
T ss_pred HHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC---HHH
Confidence 322211100 001111 136788999999999999999999 889
Q ss_pred HHcCCCCCCC
Q 001057 1042 VKQHPFFKNI 1051 (1170)
Q Consensus 1042 ILqHPfF~~i 1051 (1170)
+++||||.+.
T Consensus 284 ll~~~~~~~~ 293 (308)
T cd06615 284 LTKHPFIKRA 293 (308)
T ss_pred HhcChhhhhc
Confidence 9999999763
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=357.66 Aligned_cols=269 Identities=45% Similarity=0.843 Sum_probs=226.2
Q ss_pred CeEEEEEeccCCCeEEEEeeec---CCCCEEEEEEeeccccc-cHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccce
Q 001057 759 DFEIIKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMI-RKNAVESILAERNILISV-RNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~-~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~L 833 (1170)
+|++.+.||.|+||.||++++. .+++.||||++++.... .......+.+|+.++..+ +||||+++++.|.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998865432 233456788999999999 599999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||+.+|+|..++.....+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-- 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc--
Confidence 999999999999999988778999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC--CCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG--HGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~--ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.........|++.|+|||++.+.. ++.++|+||||+++|+|++|..||...
T Consensus 159 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 159 ---------------------------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred ---------------------------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 001122456899999999987654 788999999999999999999999643
Q ss_pred C----HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc
Q 001057 992 T----PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 992 ~----~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
. ..++.+.+.....+ .+..++..+.+||.+||+.||.+||++.++.++|+||||+.++|+.+...
T Consensus 212 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~ 280 (288)
T cd05583 212 GEQNSQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAK 280 (288)
T ss_pred cccchHHHHHHHHHccCCC---CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhh
Confidence 2 23444444444333 34668899999999999999999999999999999999999999988665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=347.95 Aligned_cols=260 Identities=32% Similarity=0.564 Sum_probs=220.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||+||+|....++..||+|++....... ....+.+|+.+|+.++|+||+++++.+.....+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999987544322 5678899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 838 EYLNGGDLYSLLRNL---GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~---~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~- 157 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD- 157 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc-
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999875310000
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.........+|+..|+|||++... .++.++|+|||||++|+|++|..||...+.
T Consensus 158 -------------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 158 -------------------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred -------------------------ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 000122345789999999999876 789999999999999999999999998877
Q ss_pred HHHHHHHhccCCC-CCCCC--ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 994 QQIFDNIMNRDIP-WPNIP--EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 994 ~ei~qkIl~~~l~-fP~ip--~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
...+..+...... ++... ..++..+.+||.+||+.||.+||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~ll~~p~~ 267 (267)
T cd06610 213 MKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLKHKFF 267 (267)
T ss_pred hhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC---HHHHhhCCCC
Confidence 7666666544322 11111 367899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=364.72 Aligned_cols=250 Identities=27% Similarity=0.485 Sum_probs=193.3
Q ss_pred EEEeccCCCeEEEEeeec--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--ccceEEEEe
Q 001057 763 IKPISQGAFGRVFLARKR--ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC--RENLYLVME 838 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk--~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd--~~~LyLVME 838 (1170)
.++||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+|+.++||||++++++|.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 357999999999999976 4678999999875432 2346789999999999999999998854 456899999
Q ss_pred eccCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe----CCCCcEEEEecCCc
Q 001057 839 YLNGGDLYSLLRNL---------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLS 905 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~---------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL----d~dG~VKLsDFGLA 905 (1170)
|+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 994 5898887532 248999999999999999999999999999999999999 45678999999999
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG 984 (1170)
+...... .........+||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 160 ~~~~~~~---------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (317)
T cd07868 160 RLFNSPL---------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 212 (317)
T ss_pred eccCCCC---------------------------ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhC
Confidence 7521000 001112346789999999999874 589999999999999999999
Q ss_pred CCCCCCCCH---------HHHHHHHhccC-C----------CCCC------------------------CCccCCHHHHH
Q 001057 985 IPPFNAKTP---------QQIFDNIMNRD-I----------PWPN------------------------IPEEMSVEACD 1020 (1170)
Q Consensus 985 ~pPF~g~~~---------~ei~qkIl~~~-l----------~fP~------------------------ip~~lS~eakD 1020 (1170)
.+||.+... ...+..+.+.. . ..+. .....+.++.+
T Consensus 213 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 292 (317)
T cd07868 213 EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 292 (317)
T ss_pred CCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHH
Confidence 999975332 11222221100 0 0000 00123567899
Q ss_pred HHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 1021 LIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 1021 LIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
||.+||++||.+|+| |+|+|+||||
T Consensus 293 li~~mL~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07868 293 LLQKLLTMDPIKRIT---SEQAMQDPYF 317 (317)
T ss_pred HHHHHhccCcccCCC---HHHHhcCCCC
Confidence 999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=351.53 Aligned_cols=260 Identities=30% Similarity=0.505 Sum_probs=216.9
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccc--ccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cce
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM--IRKNAVESILAERNILISVRNPFVVRFFYSFTCR--ENL 833 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i--~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~L 833 (1170)
.+|++.+.||+|+||.||+|.+..++..||+|++..... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 469999999999999999999999999999998865432 1234556788999999999999999999988753 568
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|++|||+++++|.+++...+.+++.....++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~- 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC- 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc-
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
..........|+..|+|||++.+..++.++|||||||++|+|++|.+||...+.
T Consensus 161 --------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~ 214 (266)
T cd06651 161 --------------------------MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214 (266)
T ss_pred --------------------------ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch
Confidence 000011234588999999999988899999999999999999999999987766
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
......+.... ..+.++..++..+++|| +||..+|.+||+ ++++++||||+
T Consensus 215 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~---~~eil~hp~~~ 265 (266)
T cd06651 215 MAAIFKIATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPS---AEELLRHPFAQ 265 (266)
T ss_pred HHHHHHHhcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcC---HHHHhcCcccc
Confidence 55554443322 23445567889999999 567789999999 88999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.83 Aligned_cols=253 Identities=28% Similarity=0.506 Sum_probs=212.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||.|+||.||+|++..+++.||+|++.+.. .......+.+|+.+|.+++||||+++++.|...+.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46899999999999999999999999999999987542 2344567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~-------- 146 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-------- 146 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc--------
Confidence 99999998654 357889999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC-----
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT----- 992 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~----- 992 (1170)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus 147 ------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~ 202 (279)
T cd06619 147 ------------------------NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202 (279)
T ss_pred ------------------------cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc
Confidence 001224578999999999999889999999999999999999999996532
Q ss_pred --HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 993 --PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 993 --~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
.......+........ .....++++.+||.+||+.||.+||+ +.++++||||...+
T Consensus 203 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~---~~eil~~~~~~~~~ 260 (279)
T cd06619 203 LMPLQLLQCIVDEDPPVL-PVGQFSEKFVHFITQCMRKQPKERPA---PENLMDHPFIVQYN 260 (279)
T ss_pred cchHHHHHHHhccCCCCC-CCCcCCHHHHHHHHHHhhCChhhCCC---HHHHhcCccccccc
Confidence 1233333333221111 12357889999999999999999999 88999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=348.92 Aligned_cols=260 Identities=29% Similarity=0.493 Sum_probs=218.5
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccc--cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cce
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD--MIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--ENL 833 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~--i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~L 833 (1170)
.+|++.+.||.|+||.||+|.+..+++.||||.+.... .......+.+.+|+.++..++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999886432 12234567888999999999999999999988764 468
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||++|++|.+++.+.+.+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~-- 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI-- 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc--
Confidence 899999999999999988778999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
. ..........||..|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 160 ------~-------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 214 (265)
T cd06652 160 ------C-------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214 (265)
T ss_pred ------c-------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch
Confidence 0 000112234689999999999988899999999999999999999999988766
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
...+..+.... ..+..+..++..+.++|.+||. +|.+||+ +.++++|||+.
T Consensus 215 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~---~~~il~~~~~~ 265 (265)
T cd06652 215 MAAIFKIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPS---ADELLRHTFVH 265 (265)
T ss_pred HHHHHHHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCC---HHHHhcCcccC
Confidence 65555544322 2344556788999999999995 9999999 88999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.44 Aligned_cols=253 Identities=33% Similarity=0.598 Sum_probs=218.2
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||.||+|++..++..||+|.+.... ..+.+.+|+.+++.++||||+++++.+.+...+|++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 67999999999999999999999889999999987542 2578899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||+.+++|.+++.. ...+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~------- 150 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLT------- 150 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcc-------
Confidence 99999999999975 3568999999999999999999999999999999999999999999999999987521
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
..........|+..|+|||++.+..++.++|||||||++|+|++|.+||........
T Consensus 151 -----------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~ 207 (256)
T cd06612 151 -----------------------DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA 207 (256)
T ss_pred -----------------------cCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh
Confidence 000012234588999999999998899999999999999999999999988776655
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
...+..........+..++.++.+||.+||+.||.+||+ +.+++.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~il~~~~~ 256 (256)
T cd06612 208 IFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS---AIQLLQHPFI 256 (256)
T ss_pred hhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC---HHHHhcCCCC
Confidence 544443332222233467889999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=353.57 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=214.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
...+|++++.||+|+||.||+|++..+++.||+|++.... ......+.+|+.++..++||||+++++++.....+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3468999999999999999999999999999999986542 2234567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~----- 158 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA----- 158 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc-----
Confidence 999999999999998878899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........|++.|+|||++. ...++.++|+|||||++|||++|..||....
T Consensus 159 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 159 -------------------------TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred -------------------------cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 000112356899999999985 3447789999999999999999999997665
Q ss_pred HHHHHHHHhccCCCCCCC--CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 993 PQQIFDNIMNRDIPWPNI--PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~i--p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
.......+.......+.. ...++..+.+||.+||+.||.+||+ +.++++|+|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~l~ 267 (267)
T cd06646 214 PMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT---AERLLTHLF 267 (267)
T ss_pred hhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC---HHHHhcCCC
Confidence 544433333333332221 2357899999999999999999999 889999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=352.49 Aligned_cols=257 Identities=30% Similarity=0.505 Sum_probs=212.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||.|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.++..++||||++++++|.....+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999875432 1223356788999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++++.|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 152 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG------- 152 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC-------
Confidence 9999988888887777899999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.........|+..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 153 -----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~ 209 (286)
T cd07847 153 -----------------------PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ 209 (286)
T ss_pred -----------------------CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 0001123457889999999876 4578899999999999999999999988776544
Q ss_pred HHHHhcc-------------------CCCCCC---------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 997 FDNIMNR-------------------DIPWPN---------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 997 ~qkIl~~-------------------~l~fP~---------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
...+... ....|. ....++..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~eil~~~~f 286 (286)
T cd07847 210 LYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS---CEELLEHPYF 286 (286)
T ss_pred HHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC---HHHHhcCCCC
Confidence 4333210 000110 01246888999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=347.48 Aligned_cols=254 Identities=37% Similarity=0.570 Sum_probs=219.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+...+|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999987643 235578889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||+++++|..++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~------- 152 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLT------- 152 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhh-------
Confidence 999999999999776 689999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC---CCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM---GHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~---~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
..........|+..|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+.
T Consensus 153 -----------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~ 209 (262)
T cd06613 153 -----------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP 209 (262)
T ss_pred -----------------------hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 001112245789999999999876 788999999999999999999999998776
Q ss_pred HHHHHHHhccCCCCCC--CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 994 QQIFDNIMNRDIPWPN--IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~--ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
......+....+..+. .+...+.++.+||.+||..+|..||+ +.+++.|+|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~ 262 (262)
T cd06613 210 MRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT---ATKLLQHPF 262 (262)
T ss_pred HHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC---HHHHhcCCC
Confidence 6665555544333221 22356788999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.75 Aligned_cols=261 Identities=29% Similarity=0.512 Sum_probs=217.3
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc---cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI---RKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~---~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
+|+..+.||+|+||.||++.+..+++.||+|++...... .......+.+|+.+|+.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 488889999999999999999999999999998754321 12345788999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-cEEEEecCCccccccccCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||++|++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~-- 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG-- 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc--
Confidence 999999999999998888899999999999999999999999999999999999998776 59999999987531000
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
...........||..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 159 ------------------------~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 214 (268)
T cd06630 159 ------------------------TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214 (268)
T ss_pred ------------------------ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Confidence 00011123456899999999999888999999999999999999999999765433
Q ss_pred HHHHHH---hccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 995 QIFDNI---MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 995 ei~qkI---l~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
.....+ .... ..+..+..+++++.++|.+||..+|.+||+ +.++++||||+
T Consensus 215 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~ll~~~~~~ 268 (268)
T cd06630 215 NHLALIFKIASAT-TAPSIPEHLSPGLRDVTLRCLELQPEDRPP---SRELLKHPVFR 268 (268)
T ss_pred chHHHHHHHhccC-CCCCCchhhCHHHHHHHHHHcCCCcccCcC---HHHHhcCcccC
Confidence 222222 2211 223455678999999999999999999999 88999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=357.29 Aligned_cols=255 Identities=33% Similarity=0.556 Sum_probs=208.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++++.||.|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 58999999999999999999999999999999875432 22234567789999999999999999999999999999999
Q ss_pred eccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 839 YLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 839 Y~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|+. ++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~------- 151 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI------- 151 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC-------
Confidence 996 588888765 46799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCC-CCCCHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPF-NAKTPQQ 995 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF-~g~~~~e 995 (1170)
.........+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+
T Consensus 152 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~ 208 (284)
T cd07839 152 -----------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 208 (284)
T ss_pred -----------------------CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH
Confidence 00011234578999999998774 4789999999999999999988875 4555554
Q ss_pred HHHHHhccC-----------------CCCC---------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRD-----------------IPWP---------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~-----------------l~fP---------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.+..+...- ..++ .....++.++++||.+||+.||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~il~h~~f 284 (284)
T cd07839 209 QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS---AEEALQHPYF 284 (284)
T ss_pred HHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC---HHHHhcCCCC
Confidence 444432210 0011 111357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=352.55 Aligned_cols=253 Identities=30% Similarity=0.504 Sum_probs=211.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc------
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCR------ 830 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~------ 830 (1170)
+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +||||++++++|...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 56899999999999999999999999999999987542 2235678899999988 699999999988753
Q ss_pred cceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 4689999999999999999864 46899999999999999999999999999999999999999999999999998742
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHHHHh
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFELLI 983 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYELLT 983 (1170)
. ..........|++.|+|||++.+ ..++.++|||||||++|||++
T Consensus 162 ~------------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~ 211 (272)
T cd06637 162 D------------------------------RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211 (272)
T ss_pred c------------------------------cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh
Confidence 1 00011234578999999999963 357889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 984 GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 984 G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
|..||...........+....... .....++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~~ 272 (272)
T cd06637 212 GAPPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPT---TEQLMKHPFI 272 (272)
T ss_pred CCCCccccCHHHHHHHHhcCCCCC-CCCCCcCHHHHHHHHHHcCCChhhCCC---HHHHhhCCCC
Confidence 999998776655554444322211 123467899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=355.10 Aligned_cols=269 Identities=43% Similarity=0.823 Sum_probs=224.4
Q ss_pred CeEEEEEeccCCCeEEEEeeec---CCCCEEEEEEeeccccc-cHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccce
Q 001057 759 DFEIIKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMI-RKNAVESILAERNILISV-RNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~-~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~L 833 (1170)
+|++.+.||.|+||.||+|.+. .+|+.||+|++...... .....+++.+|+.+|..+ +|+||++++++|.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999874 47899999998764332 223446778899999999 589999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 157 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE--- 157 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC--CCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM--GHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~--~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
..........|+..|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 158 --------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 158 --------------------------DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred --------------------------ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 000112245789999999998753 4678999999999999999999999743
Q ss_pred C----HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc
Q 001057 992 T----PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 992 ~----~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
. ...+...+.....++ +..++..+.+||.+||+.||.+|++. ..+.+++.||||+.++|+.+...
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 282 (290)
T cd05613 212 GEKNSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAK 282 (290)
T ss_pred CccccHHHHHHHhhccCCCC---CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhc
Confidence 2 344445554444433 36789999999999999999999852 46899999999999999987544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=358.67 Aligned_cols=258 Identities=34% Similarity=0.574 Sum_probs=219.6
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
..+|++++.||.|+||.||+|++..++..||+|.+..... ...+.+.+|+.++..++||||+++++.|....++|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4689999999999999999999999999999999876442 2346788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||++|++|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~------- 167 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------- 167 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc-------
Confidence 999999999999865 468999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
..........|++.|+|||.+.+..++.++|||||||++|+|++|.+||...+....
T Consensus 168 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~ 224 (296)
T cd06654 168 -----------------------PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224 (296)
T ss_pred -----------------------ccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh
Confidence 000111234689999999999988899999999999999999999999988776554
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
...+..........+..++..+.+||.+||..||.+||+ +.++++||||...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~eil~~~~~~~~ 276 (296)
T cd06654 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKIA 276 (296)
T ss_pred HHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC---HHHHhhChhhhcc
Confidence 433333222222234578899999999999999999999 8899999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=352.76 Aligned_cols=257 Identities=33% Similarity=0.590 Sum_probs=222.6
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46899999999999999999999999999999987543 2334567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||+++++|.+++... .+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~------- 150 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS------- 150 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc-------
Confidence 999999999999875 789999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.........|++.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.....
T Consensus 151 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~ 207 (274)
T cd06609 151 -----------------------TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL 207 (274)
T ss_pred -----------------------cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH
Confidence 001123456889999999999888999999999999999999999999887777666
Q ss_pred HHHhccCCCCCCCCcc-CCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEE-MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~-lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
..+.....+ ..+.. ++.++.++|.+||..||.+||+ +.++++||||....
T Consensus 208 ~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~~p~~Rpt---~~~il~~~~~~~~~ 258 (274)
T cd06609 208 FLIPKNNPP--SLEGNKFSKPFKDFVSLCLNKDPKERPS---AKELLKHKFIKKAK 258 (274)
T ss_pred HHhhhcCCC--CCcccccCHHHHHHHHHHhhCChhhCcC---HHHHhhChhhcCCC
Confidence 666554332 22333 8899999999999999999999 88999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=345.00 Aligned_cols=254 Identities=28% Similarity=0.532 Sum_probs=222.4
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++++.||.|+||.||++++..+|+.||+|.+..... .......+.+|+.+++.++||||++++++|...+++|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 59999999999999999999999999999999876433 23345678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 839 YLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~------- 152 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN------- 152 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecC-------
Confidence 99999999999764 258899999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
..........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..++
T Consensus 153 -----------------------~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~ 209 (256)
T cd08218 153 -----------------------STVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209 (256)
T ss_pred -----------------------cchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH
Confidence 000111234588999999999988889999999999999999999999998888888
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
...+..+..+ ..+..++.++.++|.+||+.+|.+||+ +.++++||||
T Consensus 210 ~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~vl~~~~~ 256 (256)
T cd08218 210 VLKIIRGSYP--PVSSHYSYDLRNLVSQLFKRNPRDRPS---VNSILEKNFI 256 (256)
T ss_pred HHHHhcCCCC--CCcccCCHHHHHHHHHHhhCChhhCcC---HHHHhhCcCC
Confidence 8887766543 345678999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=354.23 Aligned_cols=266 Identities=23% Similarity=0.362 Sum_probs=218.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRA-----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~-----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
..++|++.+.||+|+||.||+|..+. .+..||+|.+.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45689999999999999999997652 35589999876543 223345678899999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEE
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG----------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLT 900 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~----------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLs 900 (1170)
...|+||||+++|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999997532 24567788899999999999999999999999999999999999999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFE 980 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYE 980 (1170)
|||+++...... .........++..|+|||.+.+..++.++|+|||||++||
T Consensus 162 Dfg~~~~~~~~~----------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~e 213 (288)
T cd05061 162 DFGMTRDIYETD----------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE 213 (288)
T ss_pred cCCccccccccc----------------------------cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHH
Confidence 999987421000 0001112345678999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc---CCCCCCCCh
Q 001057 981 LLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ---HPFFKNINW 1053 (1170)
Q Consensus 981 LLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq---HPfF~~idw 1053 (1170)
|++ |.+||.+.+..+.+..+..+... ..+..++..+.++|.+||+.||.+||++.++.+.++ ||||++++|
T Consensus 214 l~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 214 ITSLAEQPYQGLSNEQVLKFVMDGGYL--DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 998 89999998888887777654432 234577899999999999999999999665555443 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=359.22 Aligned_cols=244 Identities=17% Similarity=0.206 Sum_probs=209.9
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec----ccceEEEEee
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC----RENLYLVMEY 839 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd----~~~LyLVMEY 839 (1170)
..||.|++|.||+|.. +|+.||||++.+.........+.+.+|+.+|.+++|||||+++++|.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5699999999999987 689999999987654445556788899999999999999999999876 3578999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
++||+|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~--------- 174 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS--------- 174 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc---------
Confidence 9999999999988889999999999999999999998 499999999999999999999999999987421
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g--~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.+..++
T Consensus 175 ------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~ 230 (283)
T PHA02988 175 ------------------------SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230 (283)
T ss_pred ------------------------cccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 00113468899999999976 6789999999999999999999999999998888
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
+..+......++ .+..++.++++||.+||+.||.+||++.++.+.|
T Consensus 231 ~~~i~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 231 YDLIINKNNSLK-LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred HHHHHhcCCCCC-CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 888866544432 4457899999999999999999999955544433
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=374.74 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=203.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
....+|++++.||.|+||.||+|++..+++.||+|+..+. ....|+.+|..++||||++++++|......|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3445799999999999999999999999999999985443 2346899999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+||||+. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~---- 208 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV---- 208 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc----
Confidence 9999994 688888865 3569999999999999999999999999999999999999999999999999987411
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCC-CCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP-FNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pP-F~g~~ 992 (1170)
.........||+.|+|||++.+..++.++|||||||++|||+++..| |....
T Consensus 209 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~ 261 (357)
T PHA03209 209 ---------------------------VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261 (357)
T ss_pred ---------------------------cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCC
Confidence 00112245799999999999999999999999999999999985444 44321
Q ss_pred H----------HHHHHHHhcc---CCCCC-----------------------C---C-CccCCHHHHHHHHHhccCCCCC
Q 001057 993 P----------QQIFDNIMNR---DIPWP-----------------------N---I-PEEMSVEACDLIDKLLTENPVQ 1032 (1170)
Q Consensus 993 ~----------~ei~qkIl~~---~l~fP-----------------------~---i-p~~lS~eakDLIkkLLq~DPsk 1032 (1170)
. ..+...+... ...++ . + ...++.++.+||.+||+.||.+
T Consensus 262 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 341 (357)
T PHA03209 262 STPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAM 341 (357)
T ss_pred CcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCccc
Confidence 1 1111111100 00111 0 0 0245778889999999999999
Q ss_pred CCChhhHHHHHcCCCCCCC
Q 001057 1033 RLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1033 RpSa~~AeEILqHPfF~~i 1051 (1170)
||+ |.|+|+||||+++
T Consensus 342 Rpt---a~e~l~hp~f~~~ 357 (357)
T PHA03209 342 RPS---AEEILNYPMFAQL 357 (357)
T ss_pred CcC---HHHHhcCchhccC
Confidence 999 8899999999864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=365.36 Aligned_cols=264 Identities=23% Similarity=0.381 Sum_probs=210.7
Q ss_pred EEEEeccC--CCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 762 IIKPISQG--AFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 762 vlk~LG~G--gFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
++.+||+| +||+||+++++.+|+.||+|.+..... .......+.+|+.+++.++||||++++++|..++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999875432 334556788899999999999999999999999999999999
Q ss_pred ccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 840 LNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 840 ~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~---- 156 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ---- 156 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc----
Confidence 9999999999753 4589999999999999999999999999999999999999999999999987643210000
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g--~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.. ...........++..|+|||++.+ ..|+.++|||||||++|||++|..||.......
T Consensus 157 -------------~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 217 (327)
T cd08227 157 -------------RL------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217 (327)
T ss_pred -------------cc------cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 00 000001122457888999999976 458999999999999999999999998766544
Q ss_pred HHHHHhccCCCC-------------------------------------------CCCCccCCHHHHHHHHHhccCCCCC
Q 001057 996 IFDNIMNRDIPW-------------------------------------------PNIPEEMSVEACDLIDKLLTENPVQ 1032 (1170)
Q Consensus 996 i~qkIl~~~l~f-------------------------------------------P~ip~~lS~eakDLIkkLLq~DPsk 1032 (1170)
.......+..+. ......+++++.+||.+||+.||.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 297 (327)
T cd08227 218 MLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDA 297 (327)
T ss_pred HHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchh
Confidence 443333222110 0011235778999999999999999
Q ss_pred CCChhhHHHHHcCCCCCCCC
Q 001057 1033 RLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1033 RpSa~~AeEILqHPfF~~id 1052 (1170)
||+ +.++++||||+.+.
T Consensus 298 Rpt---~~ell~~p~f~~~~ 314 (327)
T cd08227 298 RPS---ASTLLNHSFFKQIK 314 (327)
T ss_pred cCC---HHHHhcChhhhhcc
Confidence 999 88999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=343.85 Aligned_cols=254 Identities=30% Similarity=0.530 Sum_probs=223.4
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++++.||.|+||.||++++..+++.+++|.+..... .......+.+|+.++++++|+||++++++|.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 59999999999999999999999999999999875442 23455678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 839 YLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~------ 153 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS------ 153 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccc------
Confidence 99999999999765 4689999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+.
T Consensus 154 ------------------------~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~ 209 (256)
T cd08221 154 ------------------------EYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL 209 (256)
T ss_pred ------------------------ccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 00012345689999999999988889999999999999999999999999888888
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
...+..+... ..+..++.++.++|.+||+.+|.+||+ +.++++|||+
T Consensus 210 ~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s---~~~ll~~~~l 256 (256)
T cd08221 210 VVKIVQGNYT--PVVSVYSSELISLVHSLLQQDPEKRPT---ADEVLDQPLL 256 (256)
T ss_pred HHHHHcCCCC--CCccccCHHHHHHHHHHcccCcccCCC---HHHHhhCcCC
Confidence 8888766543 234678999999999999999999999 8899999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=350.55 Aligned_cols=278 Identities=39% Similarity=0.734 Sum_probs=230.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyLV 836 (1170)
++|.+.+.||.|+||.||+|.+..+++.||+|++.+...........+..|+.++..++ ||||++++++|.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765555555678889999999999 99999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||+.+++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~- 159 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE- 159 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc-
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987532111000
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
... .... .................|+..|+|||++.+..++.++|+|||||++|+|++|..||...+....
T Consensus 160 --~~~--~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 160 --SNK--GDAT-----NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred --cCC--CCCc-----cccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 000 0000 0000001112233456789999999999988899999999999999999999999998887777
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh-hHHHHHcCCCC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT-GAREVKQHPFF 1048 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~-~AeEILqHPfF 1048 (1170)
++.+......+| ..++..+.+||.+||+.||.+||++. +..++++||||
T Consensus 231 ~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 231 FQKILKLEYSFP---PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHhcCCCCC---CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 777776555544 57899999999999999999999920 11899999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=342.54 Aligned_cols=254 Identities=32% Similarity=0.596 Sum_probs=220.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--ccceEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC--RENLYLV 836 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd--~~~LyLV 836 (1170)
+|++++.||.|+||.||+|.+..++..||+|++..... .....+.+..|+.+++.++||||+++++.+.. ...+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999876543 34455778899999999999999999987754 4568999
Q ss_pred EeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH-----hCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 837 MEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLH-----SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLH-----s~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
|||+++++|.+++... ..+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999999753 57899999999999999999999 89999999999999999999999999999875
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
.. ..........|++.|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus 160 ~~------------------------------~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 209 (265)
T cd08217 160 LG------------------------------HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209 (265)
T ss_pred cc------------------------------CCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCc
Confidence 21 000112234689999999999988899999999999999999999999
Q ss_pred CCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
|...+...+.+.+..... +.++..++..+.+||.+||+.+|.+||+ +.++++|||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~il~~~~~ 265 (265)
T cd08217 210 FTARNQLQLASKIKEGKF--RRIPYRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265 (265)
T ss_pred ccCcCHHHHHHHHhcCCC--CCCccccCHHHHHHHHHHccCCcccCCC---HHHHhhCCCC
Confidence 998887777777766543 3455788999999999999999999999 8899999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=359.36 Aligned_cols=258 Identities=35% Similarity=0.579 Sum_probs=218.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
..+|++++.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.|.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3689999999999999999999999999999999875432 2346678899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~------- 166 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------- 166 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEcc-------
Confidence 999999999999875 468999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
..........|++.|+|||.+.+..++.++|+|||||++|+|++|.+||.+.+....
T Consensus 167 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~ 223 (297)
T cd06656 167 -----------------------PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (297)
T ss_pred -----------------------CCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh
Confidence 000111234688999999999988899999999999999999999999987765443
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
...+.....+....+..++..+++||.+||..||.+||+ +.++++||||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 275 (297)
T cd06656 224 LYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS---AKELLQHPFLKLA 275 (297)
T ss_pred eeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhccc
Confidence 333332222222234678899999999999999999999 8899999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=358.22 Aligned_cols=257 Identities=36% Similarity=0.592 Sum_probs=221.1
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
.+|++++.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++.|.....+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 579999999999999999999999999999999875432 33467889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||+.+++|..++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~-------- 166 (296)
T cd06655 96 EYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT-------- 166 (296)
T ss_pred EecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcc--------
Confidence 999999999988754 68999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
..........|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.....
T Consensus 167 ----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~ 224 (296)
T cd06655 167 ----------------------PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL 224 (296)
T ss_pred ----------------------cccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0001112346899999999999888999999999999999999999999988776555
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..+.....+....+..+++.+.+||.+||..||.+||+ +.+++.||||+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~il~~~~~~~~ 275 (296)
T cd06655 225 YLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKLA 275 (296)
T ss_pred HHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhhc
Confidence 55544333222344678999999999999999999999 8899999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=346.50 Aligned_cols=255 Identities=33% Similarity=0.536 Sum_probs=213.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccc----
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRE---- 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~---- 831 (1170)
.++|++.+.||.|+||.||+|.++.+++.||+|++.... ...+.+.+|+.++.++ +||||++++++|....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 478999999999999999999999999999999987643 2346788999999998 6999999999997644
Q ss_pred --ceEEEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 832 --NLYLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 832 --~LyLVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
.+|+||||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 48999999999999999865 347999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHH
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFE 980 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYE 980 (1170)
.... ..........|++.|+|||++.. ..++.++|||||||+||+
T Consensus 161 ~~~~------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~ 210 (275)
T cd06608 161 AQLD------------------------------STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210 (275)
T ss_pred eecc------------------------------cchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHH
Confidence 7421 00011223568999999999864 246788999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 981 LLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 981 LLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
|++|.+||...........+..........+..++.++++||.+||..||.+||+ +.++++|||+
T Consensus 211 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~ll~~~~~ 275 (275)
T cd06608 211 LADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF---MEELLEHPFI 275 (275)
T ss_pred HHhCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC---HHHHhcCCCC
Confidence 9999999987766665555554433221222347889999999999999999999 8899999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=355.28 Aligned_cols=255 Identities=29% Similarity=0.551 Sum_probs=215.4
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||.|+||.||+|++..++..||+|.+.... .......+.+|+.++..++||||+++++.|...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999999999999886531 3344567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 838 EYLNGGDLYSLLRNL---GCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~---~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||++|++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+|||++.++.++|+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999998763 379999999999999999999996 599999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC------CCcchhhhHHHHHHHHHHhCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG------HGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~------ys~ksDIWSLGVILYELLTG~pP 987 (1170)
........|++.|+|||++.+.. ++.++|||||||++|+|++|..|
T Consensus 155 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~p 206 (286)
T cd06622 155 ----------------------------ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206 (286)
T ss_pred ----------------------------CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCC
Confidence 00112346888999999986543 57889999999999999999999
Q ss_pred CCCCCHHHHHHH---HhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 988 FNAKTPQQIFDN---IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 988 F~g~~~~ei~qk---Il~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
|........+.. +.... .+.++..++.++.+||.+||+.+|.+||+ +.+++.||||...
T Consensus 207 f~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~~~~~~~~ 268 (286)
T cd06622 207 YPPETYANIFAQLSAIVDGD--PPTLPSGYSDDAQDFVAKCLNKIPNRRPT---YAQLLEHPWLVKY 268 (286)
T ss_pred CCCcchhhHHHHHHHHhhcC--CCCCCcccCHHHHHHHHHHcccCcccCCC---HHHHhcChhhhhc
Confidence 987665544433 33222 23445678999999999999999999999 7899999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.63 Aligned_cols=257 Identities=33% Similarity=0.513 Sum_probs=213.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCR---- 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~---- 830 (1170)
..++|.+.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+.++.++ +||||++++++|...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 3578999999999999999999999999999999986532 2235667899999988 799999999988653
Q ss_pred -cceEEEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 831 -ENLYLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 831 -~~LyLVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
..+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 358999999999999998863 356899999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-----CCCcchhhhHHHHHHHH
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-----GHGATADWWSVGIILFE 980 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-----~ys~ksDIWSLGVILYE 980 (1170)
..... .........|+..|+|||++... .++.++|||||||++|+
T Consensus 176 ~~~~~------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~e 225 (291)
T cd06639 176 AQLTS------------------------------TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225 (291)
T ss_pred hhccc------------------------------ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHH
Confidence 74210 00011234688999999998643 36789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 981 LLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 981 LLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
|++|.+||...+....+..+..........+...+..+.+||.+||+.||.+||+ +.++++||||+
T Consensus 226 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~ 291 (291)
T cd06639 226 LGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLLEHPFIK 291 (291)
T ss_pred HhhCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC---HHHHhcCcccC
Confidence 9999999998777666555554433222223467789999999999999999999 88999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=350.28 Aligned_cols=257 Identities=32% Similarity=0.508 Sum_probs=210.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeee-----
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFT----- 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fq----- 828 (1170)
...++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++..+ +||||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 34578999999999999999999999999999999876532 2235677899999998 6999999999873
Q ss_pred cccceEEEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCC
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGL 904 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGL 904 (1170)
....+|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 44579999999999999998753 24688999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHH
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILF 979 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILY 979 (1170)
++... ..........|++.|+|||++.. ..++.++|||||||++|
T Consensus 171 ~~~~~------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~ 220 (286)
T cd06638 171 SAQLT------------------------------STRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAI 220 (286)
T ss_pred eeecc------------------------------cCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHH
Confidence 87421 00011223468999999999853 44788999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 980 ELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 980 ELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
+|++|..||........+..+..........+..++..+.+||.+||+.||.+||+ +.++++|+||
T Consensus 221 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~~~~ 286 (286)
T cd06638 221 ELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQHVFI 286 (286)
T ss_pred HHhcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC---HHHHhhcccC
Confidence 99999999987766554444332221111123456889999999999999999999 8899999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=351.44 Aligned_cols=252 Identities=24% Similarity=0.407 Sum_probs=214.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCC-----CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATG-----DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TG-----e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
..++|++++.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 4568999999999999999999876555 689999886542 234456788999999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD 894 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d 894 (1170)
...|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 9999999999999999999764 457888999999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHH
Q 001057 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974 (1170)
Q Consensus 895 G~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSL 974 (1170)
+.++|+|||+++..... ..........+++.|+|||++.+..++.++|||||
T Consensus 161 ~~~~L~dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl 212 (283)
T cd05048 161 LTVKISDFGLSRDIYSA----------------------------DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212 (283)
T ss_pred CcEEECCCcceeecccc----------------------------ccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence 99999999998742100 00011223456889999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 975 GIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 975 GVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
||++|||++ |..||.+.+..++...+...... ..+..++.++.+|+.+||+.||.+||++.++
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i 276 (283)
T cd05048 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLL--PCPEDCPARVYALMIECWNEIPARRPRFKDI 276 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999998 99999999988888888765543 3457899999999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.06 Aligned_cols=258 Identities=23% Similarity=0.352 Sum_probs=207.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecC----------------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRA----------------TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~----------------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN 819 (1170)
..++|++.++||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+|..++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 34689999999999999999998532 34579999987542 3445667899999999999999
Q ss_pred EEEEEeeeecccceEEEEeeccCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCee
Q 001057 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-------------------CLDEDMARVYIAELVLALEYLHSLNVI 880 (1170)
Q Consensus 820 IVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~-------------------~LSEe~ar~IaaQIL~ALeYLHs~GII 880 (1170)
|+++++++.+.+.+|+||||+.+|+|.+++.... .++...+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 357778889999999999999999999
Q ss_pred eccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHH
Q 001057 881 HRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL 960 (1170)
Q Consensus 881 HRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL 960 (1170)
||||||+|||++.++.+||+|||+++..... ..........++..|||||++
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~ 212 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAG----------------------------DYYRIQGRAVLPIRWMAWECI 212 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccC----------------------------ceeEecCcCCCCccccCHHHH
Confidence 9999999999999999999999998742100 000112234567899999999
Q ss_pred hcCCCCcchhhhHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhcc-----CCCCCCCCccCCHHHHHHHHHhccCCCCCC
Q 001057 961 LGMGHGATADWWSVGIILFELLI--GIPPFNAKTPQQIFDNIMNR-----DIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033 (1170)
Q Consensus 961 ~g~~ys~ksDIWSLGVILYELLT--G~pPF~g~~~~ei~qkIl~~-----~l~fP~ip~~lS~eakDLIkkLLq~DPskR 1033 (1170)
.+..++.++|||||||++|||++ |..||.+.+..+....+... ...++..+..++..+.+||.+||+.||.+|
T Consensus 213 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 292 (304)
T cd05096 213 LMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRER 292 (304)
T ss_pred hcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhC
Confidence 98889999999999999999986 67889887776665544321 111222345678999999999999999999
Q ss_pred CChhhHHHHH
Q 001057 1034 LGATGAREVK 1043 (1170)
Q Consensus 1034 pSa~~AeEIL 1043 (1170)
|++.++..+|
T Consensus 293 Ps~~~i~~~l 302 (304)
T cd05096 293 PSFSDIHAFL 302 (304)
T ss_pred cCHHHHHHHH
Confidence 9965554443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.05 Aligned_cols=255 Identities=33% Similarity=0.578 Sum_probs=218.9
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccc--ccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM--IRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i--~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+|+..+.||+|+||+||+|.+..+++.||+|.+..... ........+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999988999999999875432 2234567788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~------ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE------ 154 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
........|++.|+|||.+.... ++.++|+|||||++|+|++|.+||.......
T Consensus 155 -------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~ 209 (258)
T cd06632 155 -------------------------FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA 209 (258)
T ss_pred -------------------------cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH
Confidence 00123456899999999998766 8999999999999999999999998776555
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
....+... ...+.++..++..+.+||.+||+.+|.+||+ +.+++.|||+
T Consensus 210 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 258 (258)
T cd06632 210 AVFKIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRPT---AAELLEHPFV 258 (258)
T ss_pred HHHHHHhc-ccCCCcCCCcCHHHHHHHHHHhhcCcccCcC---HHHHhcCCCC
Confidence 54444431 2334455678999999999999999999998 8899999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.25 Aligned_cols=254 Identities=34% Similarity=0.551 Sum_probs=219.9
Q ss_pred CCCCeEEE-EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec----
Q 001057 756 SIEDFEII-KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTC---- 829 (1170)
Q Consensus 756 ~iedYevl-k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd---- 829 (1170)
..++|.+- ++||-|-.|.|..|.++.||+.+|+|++... ....+|+++.... .|||||.++++|..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 44677664 5799999999999999999999999987643 3456788877655 49999999988764
Q ss_pred ccceEEEEeeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---CCcEEEEecCC
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ---DGHIKLTDFGL 904 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~~~--LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~---dG~VKLsDFGL 904 (1170)
..++.+|||.|+||+|+..|+..+. |+|.++..|++||..|+.|||+.+|.||||||||+|... |..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 4679999999999999999988764 999999999999999999999999999999999999975 45799999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhC
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG 984 (1170)
|+... ......+.|-||+|.|||++....|+..+|+||+|||||-||+|
T Consensus 211 AK~t~-------------------------------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCG 259 (400)
T KOG0604|consen 211 AKETQ-------------------------------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_pred ccccC-------------------------------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcC
Confidence 99521 11233467899999999999999999999999999999999999
Q ss_pred CCCCCCCC----HHHHHHHHhccCCCCCCCC-ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 985 IPPFNAKT----PQQIFDNIMNRDIPWPNIP-EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 985 ~pPF~g~~----~~ei~qkIl~~~l~fP~ip-~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
++||++.. ...+..+|..+.+.||+-. ..+|.+++|+|++||..+|.+|++ +.++++|||+.+.
T Consensus 260 yPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT---I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 260 YPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT---IEEVMDHPWINQY 328 (400)
T ss_pred CCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee---HHHhhcCchhccc
Confidence 99998754 4567889999999998632 368999999999999999999999 8899999999865
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=342.87 Aligned_cols=249 Identities=29% Similarity=0.528 Sum_probs=216.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++.+.||.|+||.||++.+..+++.||+|.+.... .....+.+.+|+.+++.++||||+++++.|.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999986543 23456778899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 839 YLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|+++|+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~------- 151 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLT------- 151 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeec-------
Confidence 99999999998653 458999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
..........|++.|+|||++.+..++.++|+||||+++|+|++|.+||...+....
T Consensus 152 -----------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 208 (255)
T cd08219 152 -----------------------SPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208 (255)
T ss_pred -----------------------ccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence 001112245689999999999988899999999999999999999999999888887
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
...+..+... ..+..++..+.+||.+||+.||.+||+ +.+++.
T Consensus 209 ~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~ 251 (255)
T cd08219 209 ILKVCQGSYK--PLPSHYSYELRSLIKQMFKRNPRSRPS---ATTILS 251 (255)
T ss_pred HHHHhcCCCC--CCCcccCHHHHHHHHHHHhCCcccCCC---HHHHhh
Confidence 7777665543 244678899999999999999999999 666664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=393.61 Aligned_cols=261 Identities=32% Similarity=0.565 Sum_probs=233.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
+.|.++..||.|+||.||+|..+.++-..|.|++... ....++.++-|++||..++||+||+|+++|...+.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 5689999999999999999999999999999988643 4577889999999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||.||-...++-.. ..|++.+++.+++|+|.||+|||+++|||||||..|||++.+|.|+|+|||.+-..
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn-------- 180 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN-------- 180 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc--------
Confidence 999999998887665 46999999999999999999999999999999999999999999999999986531
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
........+++|||+||||||+.. .+|++++||||||++|.||..+.||-...
T Consensus 181 ----------------------~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel 238 (1187)
T KOG0579|consen 181 ----------------------KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL 238 (1187)
T ss_pred ----------------------hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc
Confidence 112234567899999999999864 57999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
+++..+-+|.+...+-..-|..++..+.||+++||.+||..||+ +.++|+||||++++-.
T Consensus 239 npMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~---aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 239 NPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP---AAQLLKHPFVQNAPSN 298 (1187)
T ss_pred chHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC---HHHHhhCcccccCCcc
Confidence 99999999988776655557889999999999999999999999 8899999999987643
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=340.89 Aligned_cols=253 Identities=29% Similarity=0.505 Sum_probs=220.0
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++++.||.|+||.||+|.+..+++.||+|.+..... .......+.+|+.+|+.++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999876543 33456788899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-cEEEEecCCccccccccCCC
Q 001057 839 YLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-~VKLsDFGLAk~~~~~~~~d 915 (1170)
|++|++|.+++... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++ .++|+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS----- 154 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC-----
Confidence 99999999999764 3489999999999999999999999999999999999998654 589999999875210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||.+.+...
T Consensus 155 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~ 208 (256)
T cd08220 155 --------------------------KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208 (256)
T ss_pred --------------------------CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH
Confidence 011123468999999999998888999999999999999999999999888877
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
....+...... .++..++.++.+||.+||..||.+||+ +.++++||||
T Consensus 209 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~ll~~p~~ 256 (256)
T cd08220 209 LVLKIMSGTFA--PISDRYSPDLRQLILSMLNLDPSKRPQ---LSQIMAQPIC 256 (256)
T ss_pred HHHHHHhcCCC--CCCCCcCHHHHHHHHHHccCChhhCCC---HHHHhhCCCC
Confidence 77777654432 344678999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=368.79 Aligned_cols=262 Identities=27% Similarity=0.501 Sum_probs=225.4
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEEEEeeccC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
..||.|+|+.|--|....||..||||++.|.. .....++.+|++++.+++ |+||+.|+++|+++..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 46999999999999999999999999998863 345678999999999986 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---cEEEEecCCccccccccCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---HIKLTDFGLSKVGLIHSTDDLSAP 919 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG---~VKLsDFGLAk~~~~~~~~d~~a~ 919 (1170)
|.|..+|.+...|++.++..++++|+.||+|||.+||.||||||+|||-.... -||||||.|+.-. +...+.+
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~--k~~~~~s-- 236 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGI--KLNNDCS-- 236 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccc--ccCCCCC--
Confidence 99999999999999999999999999999999999999999999999987655 4899999987532 1111110
Q ss_pred CCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-----cCCCCcchhhhHHHHHHHHHHhCCCCCCCCC--
Q 001057 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGIPPFNAKT-- 992 (1170)
Q Consensus 920 sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~ksDIWSLGVILYELLTG~pPF~g~~-- 992 (1170)
+ .......+.+|+..|||||+.. ...|+..+|.||||||||-||+|++||.|..
T Consensus 237 -----------------p--astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~ 297 (463)
T KOG0607|consen 237 -----------------P--ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA 297 (463)
T ss_pred -----------------C--CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC
Confidence 0 1112345679999999999874 2458999999999999999999999997642
Q ss_pred -------------HHHHHHHHhccCCCCCCCC-ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 993 -------------PQQIFDNIMNRDIPWPNIP-EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 993 -------------~~ei~qkIl~~~l~fP~ip-~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
...+++.|..+.+.||+.. ..+|.+++|||..+|..|+.+|++ |.++++|||++.+.-+
T Consensus 298 dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls---a~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 298 DCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS---AAQVLNHPWVQRCAPE 370 (463)
T ss_pred cCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh---hhhccCCccccccchh
Confidence 3578899999999999643 368999999999999999999999 7889999999987533
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=341.59 Aligned_cols=258 Identities=34% Similarity=0.592 Sum_probs=223.2
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|++|.||+|++..+++.||+|++...... .....+.+|+.++..++||||+++++++.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4699999999999999999999999999999998765321 45577889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||+++++|.+++.....+++..+..++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~------- 151 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE------- 151 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecc-------
Confidence 999999999999887889999999999999999999999 999999999999999999999999999987521
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC---CH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK---TP 993 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~---~~ 993 (1170)
..........|+..|+|||++.+..++.++|+||||+++|+|++|.+||... ..
T Consensus 152 -----------------------~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~ 208 (264)
T cd06623 152 -----------------------NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208 (264)
T ss_pred -----------------------cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH
Confidence 0001112346889999999999888999999999999999999999999876 45
Q ss_pred HHHHHHHhccCCCCCCCCcc-CCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEE-MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~-lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
.+....+..... +..+.. ++..+.++|.+||..+|.+||+ +.++++||||+.++
T Consensus 209 ~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~ll~~~~~~~~~ 263 (264)
T cd06623 209 FELMQAICDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRPS---AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHHHHhcCCC--CCCCcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCHHHHhcc
Confidence 555555554332 223345 8899999999999999999999 88999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=351.46 Aligned_cols=257 Identities=29% Similarity=0.486 Sum_probs=213.5
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||.|+||.||+|.+..+++.||+|.+.+.... ....+.+.+|+.++..++||||++++++|.....+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999999999999998764332 234566788999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||+.++.|..+......+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~-------- 151 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA-------- 151 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeecc--------
Confidence 999999998887766679999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
..........|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 152 ----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~ 209 (286)
T cd07846 152 ----------------------APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ 209 (286)
T ss_pred ----------------------CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 000111234688999999998763 478899999999999999999999987765444
Q ss_pred HHHHhccC-------------------CCCCC---------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 997 FDNIMNRD-------------------IPWPN---------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 997 ~qkIl~~~-------------------l~fP~---------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
...+.... ...+. ....++..+.+||.+||+.+|.+||+ +.++++||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~~~~ 286 (286)
T cd07846 210 LYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS---SSQLLHHEFF 286 (286)
T ss_pred HHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh---HHHHhcCCCC
Confidence 33333100 01111 12357889999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.82 Aligned_cols=255 Identities=20% Similarity=0.262 Sum_probs=213.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeec---CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..++|++.+.||+|+||.||+|..+ ..+..||+|.++... .......+.+|+.++..++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4567999999999999999999765 456799999987642 23445678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+||||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~- 159 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS- 159 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc-
Confidence 99999999999999999764 5789999999999999999999999999999999999999999999999998753100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
..........++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 160 ----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 160 ----------------------------EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ----------------------------cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 00001112345678999999999999999999999999999775 9999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.+..++...+..+.. .+ .+..++..+.+++.+||+.+|.+||++.++.+++
T Consensus 212 ~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 212 MSGQDVIKAVEDGFR-LP-APRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred CCHHHHHHHHHCCCC-CC-CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 888888777765432 22 3567899999999999999999999965555544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.82 Aligned_cols=255 Identities=30% Similarity=0.506 Sum_probs=211.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec-----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTC----- 829 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd----- 829 (1170)
..+.|++.+.||.|+||.||+|++..+++.||+|++.... .....+..|+.++..+ +||||++++++|..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3468999999999999999999999999999999986542 3345678899999888 69999999998853
Q ss_pred -ccceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcc
Q 001057 830 -RENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 830 -~~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk 906 (1170)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 45789999999999999999753 458899999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-----cCCCCcchhhhHHHHHHHHH
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~ksDIWSLGVILYEL 981 (1170)
... ..........|++.|+|||++. ...++.++|||||||++|+|
T Consensus 170 ~~~------------------------------~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el 219 (282)
T cd06636 170 QLD------------------------------RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219 (282)
T ss_pred hhh------------------------------ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHH
Confidence 421 0001123457899999999986 34578899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 982 LIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
++|.+||...........+...... ......++.++.+||.+||..||.+||+ +.++++||||
T Consensus 220 ~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~---~~ell~~~~~ 282 (282)
T cd06636 220 AEGAPPLCDMHPMRALFLIPRNPPP-KLKSKKWSKKFIDFIEGCLVKNYLSRPS---TEQLLKHPFI 282 (282)
T ss_pred HhCCCCccccCHHhhhhhHhhCCCC-CCcccccCHHHHHHHHHHhCCChhhCcC---HHHHhcCCCC
Confidence 9999999877655544444332211 1123468899999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=352.85 Aligned_cols=259 Identities=34% Similarity=0.550 Sum_probs=215.0
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI--RKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~--~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+|++++.||.|+||.||+|.+..+|+.||||.+...... .......+..|+.++..++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999765433 123345677899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+ +|+|..++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.+|.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~----- 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS----- 154 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC-----
Confidence 9999 899999998766 799999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..
T Consensus 155 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~ 209 (298)
T cd07841 155 -------------------------PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209 (298)
T ss_pred -------------------------CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH
Confidence 0011122356889999999865 45788999999999999999999999887765
Q ss_pred HHHHHHhccCC-----CC---------------C-----CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 995 QIFDNIMNRDI-----PW---------------P-----NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 995 ei~qkIl~~~l-----~f---------------P-----~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
+.+..+..... .+ + ......+.++.+||.+||.+||.+||+ +.+++.||||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~e~l~~~~~~ 286 (298)
T cd07841 210 DQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT---ARQALEHPYFS 286 (298)
T ss_pred HHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC---HHHHhhCcccc
Confidence 55555432100 00 0 011345788999999999999999999 88999999998
Q ss_pred CC
Q 001057 1050 NI 1051 (1170)
Q Consensus 1050 ~i 1051 (1170)
+.
T Consensus 287 ~~ 288 (298)
T cd07841 287 ND 288 (298)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=348.52 Aligned_cols=257 Identities=35% Similarity=0.565 Sum_probs=214.6
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++.+.||.|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 589999999999999999999999999999998765422 3345678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 839 YLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|+ +++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~------ 152 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE------ 152 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC------
Confidence 99 99999998653 56999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.........|+..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....
T Consensus 153 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~ 209 (286)
T cd07832 153 -----------------------EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ 209 (286)
T ss_pred -----------------------CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH
Confidence 00111234689999999998754 468899999999999999999999988777665
Q ss_pred HHHHhccC-------------------CCCC--------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 997 FDNIMNRD-------------------IPWP--------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 997 ~qkIl~~~-------------------l~fP--------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
+..+...- ..++ ......+.++.+||.+||..||.+||+ +.+++.||||.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~~l~h~~~~ 286 (286)
T cd07832 210 LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS---AAEALRHPYFT 286 (286)
T ss_pred HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC---HHHHhhCcCcC
Confidence 55544310 0111 111246789999999999999999999 88999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=346.11 Aligned_cols=255 Identities=31% Similarity=0.568 Sum_probs=218.6
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+++++.++||||+++++.+.....+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468889999999999999999999999999999876532 245567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 838 EYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~------ 152 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV------ 152 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhH------
Confidence 999999999999876 789999999999999999999999 999999999999999999999999999986421
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC----
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK---- 991 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~---- 991 (1170)
. .......|+..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 153 ------------------------~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 206 (265)
T cd06605 153 ------------------------N--SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP 206 (265)
T ss_pred ------------------------H--HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc
Confidence 0 0011267889999999999989999999999999999999999999764
Q ss_pred -CHHHHHHHHhccCCCCCCCCcc-CCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 992 -TPQQIFDNIMNRDIPWPNIPEE-MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 992 -~~~ei~qkIl~~~l~fP~ip~~-lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
...+..+.+..... +.++.. ++.++.+||.+||..||.+||+ +.+++.||||+..
T Consensus 207 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~~~~ 263 (265)
T cd06605 207 DGIFELLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPS---YKELLEHPFIKKY 263 (265)
T ss_pred ccHHHHHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcC---HHHHhhCchhhcc
Confidence 23344444444322 223333 8899999999999999999999 8899999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=351.52 Aligned_cols=256 Identities=28% Similarity=0.517 Sum_probs=217.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++++.||+|+||+||++.+..+|+.||+|++.... .......+.+|++++..++||||+++++++.....+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4568999999999999999999999999999999886532 23445778899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||+++++|..++...+.+++..++.++.|++.||.|||+ .||+||||||+||+++.++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~----- 155 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----- 155 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh-----
Confidence 99999999999999888889999999999999999999997 699999999999999999999999999986320
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.......+||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 156 ---------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 156 ---------------------------NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred ---------------------------hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 00112357899999999998888999999999999999999999999865442
Q ss_pred -----------HHHHHHhccCCCCCCCCc-cCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 995 -----------QIFDNIMNRDIPWPNIPE-EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 995 -----------ei~qkIl~~~l~fP~ip~-~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
+....+..... +.++. .++.++.+||.+||+.||.+||+ +.|+++|+||..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~e~~~~~~~~~ 271 (284)
T cd06620 209 DDGQDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERPT---PQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccc
Confidence 23333333221 12222 37889999999999999999999 889999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=343.50 Aligned_cols=259 Identities=32% Similarity=0.551 Sum_probs=215.0
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc-------cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI-------RKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~-------~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... .....+.+..|+.++..++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999999999999999988642111 1223457888999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+++||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC--CCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG--HGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~--ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
..........|+..|+|||++.+.. ++.++|+||||+++|+|++|..||.
T Consensus 162 ----------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 162 ----------------------------YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred ----------------------------ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 0001123456899999999998754 7889999999999999999999998
Q ss_pred CCCHHHHHHHHhccC--CCCC-CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 990 AKTPQQIFDNIMNRD--IPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~--l~fP-~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.....+.+..+.... ..++ .....++.++.+||.+||..+|.+||+ +.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~ 272 (272)
T cd06629 214 DEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT---ARELLQHPFI 272 (272)
T ss_pred CcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC---HHHHhhCCCC
Confidence 666554444433222 1222 122356899999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=348.51 Aligned_cols=256 Identities=29% Similarity=0.538 Sum_probs=206.4
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|++.+.||.|+||.||+|.++.+++.||||.+..... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999875431 12234567899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 155 (291)
T cd07844 82 FEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV----- 155 (291)
T ss_pred EecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC-----
Confidence 99997 4999988764 4689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCC-H
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKT-P 993 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~-~ 993 (1170)
.........++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.. .
T Consensus 156 -------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~ 210 (291)
T cd07844 156 -------------------------PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV 210 (291)
T ss_pred -------------------------CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 0000112346889999999876 458899999999999999999999997665 3
Q ss_pred HHHHHHHhcc-------------------CCCCCC--------CCccCC--HHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 994 QQIFDNIMNR-------------------DIPWPN--------IPEEMS--VEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 994 ~ei~qkIl~~-------------------~l~fP~--------ip~~lS--~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
.+....+... ...++. ....++ .++.+||.+||+.||.+||+ +.+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps---~~e~l~ 287 (291)
T cd07844 211 EDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS---AAEAMK 287 (291)
T ss_pred HHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC---HHHHhc
Confidence 3333222110 000000 001234 88899999999999999999 889999
Q ss_pred CCCC
Q 001057 1045 HPFF 1048 (1170)
Q Consensus 1045 HPfF 1048 (1170)
||||
T Consensus 288 ~~~f 291 (291)
T cd07844 288 HPYF 291 (291)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=353.43 Aligned_cols=261 Identities=32% Similarity=0.503 Sum_probs=214.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cce
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--ENL 833 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~L 833 (1170)
..++|++.+.||.|+||.||+|.+..+|+.||+|++..... .......+.+|+.++.+++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46789999999999999999999999999999999875432 122233456799999999999999999998765 568
Q ss_pred EEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~- 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP- 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc-
Confidence 99999996 5898888763 56999999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
........+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 162 -----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 162 -----------------------------AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred -----------------------------cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 001112345789999999876 45789999999999999999999999998
Q ss_pred CHHHHHHHHhccC-------------------CCCCCC--------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 992 TPQQIFDNIMNRD-------------------IPWPNI--------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 992 ~~~ei~qkIl~~~-------------------l~fP~i--------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+..+.+..+.... ...+.. ....++.+.+||.+||+.||.+||+ +.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~~il~ 289 (309)
T cd07845 213 SEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT---AEEALE 289 (309)
T ss_pred CHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC---HHHHhc
Confidence 8887777665411 000100 0135889999999999999999999 889999
Q ss_pred CCCCCCC
Q 001057 1045 HPFFKNI 1051 (1170)
Q Consensus 1045 HPfF~~i 1051 (1170)
||||++.
T Consensus 290 h~~f~~~ 296 (309)
T cd07845 290 SSYFKEK 296 (309)
T ss_pred ChhhccC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.94 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=214.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRA-----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~-----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
..+|.+++.||+|+||.||+|.+.. +++.||+|++.... .....+.+.+|+++|..++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998753 46899999987543 2334578899999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcE
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLG--------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHI 897 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~--------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~V 897 (1170)
.+|+||||+++++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999997542 37888999999999999999999999999999999999999999
Q ss_pred EEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHH
Q 001057 898 KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGII 977 (1170)
Q Consensus 898 KLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVI 977 (1170)
||+|||+++..... ..........+++.|+|||++.+..++.++|||||||+
T Consensus 162 kl~d~g~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 213 (280)
T cd05049 162 KIGDFGMSRDVYTT----------------------------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213 (280)
T ss_pred EECCcccceecccC----------------------------cceecCCCCcccceecChhhhccCCcchhhhHHHHHHH
Confidence 99999998742100 00001123346789999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 978 LFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 978 LYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
+|||++ |..||.+.+..+....+..+.... .+..++..+.+||.+||+.||.+||++.++.+.+
T Consensus 214 l~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 214 LWEIFTYGKQPWYGLSNEEVIECITQGRLLQ--RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 999998 999999988888888887655433 3467899999999999999999999955554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=348.05 Aligned_cols=258 Identities=32% Similarity=0.555 Sum_probs=222.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
..|+.++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.++..++||||+++++++.+...+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 458889999999999999999999999999999875432 345678889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||+.||+|.+++.. +.+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~------- 153 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD------- 153 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC-------
Confidence 99999999999875 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.........|+..|+|||++.+..++.++|+|||||++|+|++|.+||...+.....
T Consensus 154 -----------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~ 210 (277)
T cd06640 154 -----------------------TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL 210 (277)
T ss_pred -----------------------CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh
Confidence 001112346888999999999888999999999999999999999999988777666
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
..+..... +.++..++..+.+||.+||+.+|.+||+ +.++++||||.....
T Consensus 211 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 261 (277)
T cd06640 211 FLIPKNNP--PTLTGEFSKPFKEFIDACLNKDPSFRPT---AKELLKHKFIVKNAK 261 (277)
T ss_pred hhhhcCCC--CCCchhhhHHHHHHHHHHcccCcccCcC---HHHHHhChHhhhcch
Confidence 55543322 3344578899999999999999999999 889999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=352.67 Aligned_cols=249 Identities=26% Similarity=0.478 Sum_probs=191.4
Q ss_pred EEeccCCCeEEEEeeecC--CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--ccceEEEEee
Q 001057 764 KPISQGAFGRVFLARKRA--TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC--RENLYLVMEY 839 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~--TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd--~~~LyLVMEY 839 (1170)
.+||+|+||+||+|+.+. ++..||+|.+..... ...+.+|+.+|..++||||++++++|.. ...+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999754 668999998875432 2356789999999999999999998854 5678999999
Q ss_pred ccCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe----CCCCcEEEEecCCcc
Q 001057 840 LNGGDLYSLLRNL---------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLSK 906 (1170)
Q Consensus 840 ~~GGSL~dlLk~~---------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL----d~dG~VKLsDFGLAk 906 (1170)
+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 95 5888887522 248899999999999999999999999999999999999 566799999999997
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~ 985 (1170)
...... .........+||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus 161 ~~~~~~---------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~ 213 (317)
T cd07867 161 LFNSPL---------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213 (317)
T ss_pred ccCCCc---------------------------ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCC
Confidence 531000 000112345789999999999874 5789999999999999999999
Q ss_pred CCCCCCCHH---------HHHHHHhcc--------------CCCCC---------------------CCCccCCHHHHHH
Q 001057 986 PPFNAKTPQ---------QIFDNIMNR--------------DIPWP---------------------NIPEEMSVEACDL 1021 (1170)
Q Consensus 986 pPF~g~~~~---------ei~qkIl~~--------------~l~fP---------------------~ip~~lS~eakDL 1021 (1170)
+||...... .....+... ...++ ......+..+.+|
T Consensus 214 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 293 (317)
T cd07867 214 PIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLL 293 (317)
T ss_pred CCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHH
Confidence 999754321 111111100 00000 0011345678899
Q ss_pred HHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 1022 IDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 1022 IkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
|.+||+.||.+||| |.|+|+||||
T Consensus 294 l~~~l~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07867 294 LQKLLTMDPTKRIT---SEQALQDPYF 317 (317)
T ss_pred HHHHhccCcccccC---HHHHhcCCCC
Confidence 99999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.33 Aligned_cols=250 Identities=52% Similarity=0.961 Sum_probs=222.0
Q ss_pred eccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCCh
Q 001057 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 845 (1170)
Q Consensus 766 LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL 845 (1170)
||.|+||.||++.+..+++.||+|++.+...........+..|+.+++.++||||+++++.+.....+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887665556777899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCC
Q 001057 846 YSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925 (1170)
Q Consensus 846 ~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~ 925 (1170)
.+++.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~--------------- 145 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS--------------- 145 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceeccc---------------
Confidence 99999887899999999999999999999999999999999999999999999999999874210
Q ss_pred ccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCC
Q 001057 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI 1005 (1170)
Q Consensus 926 ~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l 1005 (1170)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+....++.+.....
T Consensus 146 ---------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 210 (250)
T cd05123 146 ---------------EGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL 210 (250)
T ss_pred ---------------CCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence 00112345688999999999988889999999999999999999999998888777888777555
Q ss_pred CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 1006 PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 1006 ~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.++ ..++..+.+||.+||..||.+||++..+.++++||||
T Consensus 211 ~~~---~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 211 RFP---EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCC---CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 544 6679999999999999999999995445999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=340.42 Aligned_cols=252 Identities=28% Similarity=0.472 Sum_probs=212.1
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999987655555666678899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 838 EYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 838 EY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~---- 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS---- 157 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceecc----
Confidence 99999999988853 2458999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC-
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT- 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~- 992 (1170)
..........|++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 158 --------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~ 211 (267)
T cd08228 158 --------------------------SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred --------------------------chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc
Confidence 00111223568899999999998889999999999999999999999997653
Q ss_pred -HHHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 993 -PQQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 993 -~~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
.......+.... ++.. ....+..+.+||.+||+.+|.+||++..+.+
T Consensus 212 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 212 NLFSLCQKIEQCD--YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred cHHHHHHHHhcCC--CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 344555554333 2222 2467889999999999999999999544433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.95 Aligned_cols=257 Identities=31% Similarity=0.517 Sum_probs=208.2
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccc----
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCREN---- 832 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~---- 832 (1170)
++|++.+.||.|+||.||+|.+..+++.||||++.... ........+.+|+.++..+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999999999999999876542 12223456788999999995 6999999999887665
Q ss_pred -eEEEEeeccCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-CCcEEEEecCCc
Q 001057 833 -LYLVMEYLNGGDLYSLLRNL-----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLS 905 (1170)
Q Consensus 833 -LyLVMEY~~GGSL~dlLk~~-----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-dG~VKLsDFGLA 905 (1170)
+|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 898888643 35799999999999999999999999999999999999998 889999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG 984 (1170)
...... ........+++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 159 ~~~~~~------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 208 (295)
T cd07837 159 RAFSIP------------------------------VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208 (295)
T ss_pred eecCCC------------------------------ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcC
Confidence 742100 001112357889999999875 4578999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhccC-----CCC------------CC--------CCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 985 IPPFNAKTPQQIFDNIMNRD-----IPW------------PN--------IPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~-----l~f------------P~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
.+||.+.+....+..+...- ..+ +. ....++.++.+||.+||..||.+||+ +
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~---~ 285 (295)
T cd07837 209 QPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS---A 285 (295)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC---H
Confidence 99999877665554443210 000 00 01357889999999999999999999 8
Q ss_pred HHHHcCCCCC
Q 001057 1040 REVKQHPFFK 1049 (1170)
Q Consensus 1040 eEILqHPfF~ 1049 (1170)
.+++.||||+
T Consensus 286 ~eil~~~~~~ 295 (295)
T cd07837 286 KAALTHPYFD 295 (295)
T ss_pred HHHhcCCCcC
Confidence 8999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=345.68 Aligned_cols=258 Identities=33% Similarity=0.562 Sum_probs=214.2
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||.||+|.++.+++.||+|++..... .....+.+.+|+.+++.++|+||++++++|...+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 469999999999999999999999999999998875432 2334567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||++++.|..++.....+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~------ 153 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR------ 153 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC------
Confidence 99998777776666677999999999999999999999999999999999999999999999999998753100
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.........|+..|+|||++.+. .++.++||||||+++|+|++|.+||.+.+..+.
T Consensus 154 -----------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~ 210 (288)
T cd07833 154 -----------------------PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ 210 (288)
T ss_pred -----------------------ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 00112235688999999999888 789999999999999999999999987765544
Q ss_pred HHHHhccC-------------------CCCC----------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 997 FDNIMNRD-------------------IPWP----------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 997 ~qkIl~~~-------------------l~fP----------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
...+.... ..++ ..+..++.++.+||.+||..+|.+||+ +.++++|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~ 287 (288)
T cd07833 211 LYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT---CDELLQHPY 287 (288)
T ss_pred HHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc---HHHHhcCCC
Confidence 33322100 0010 012345889999999999999999999 889999999
Q ss_pred C
Q 001057 1048 F 1048 (1170)
Q Consensus 1048 F 1048 (1170)
|
T Consensus 288 f 288 (288)
T cd07833 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.23 Aligned_cols=258 Identities=32% Similarity=0.522 Sum_probs=207.5
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHH-HHhcCCCcEEEEEeeeecccceEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI-LISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieI-LskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
++|++++.||.|+||.||+|+++.+|+.||||.+..... ... ...+..|..+ ++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999876432 222 2345556655 5667899999999999999999999
Q ss_pred EeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 837 MEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSL-NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~-GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
|||++ |+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~-- 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-- 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccc--
Confidence 99996 688887754 24689999999999999999999997 99999999999999999999999999987421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc----CCCCcchhhhHHHHHHHHHHhCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG----MGHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g----~~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
. ........|+..|+|||++.+ ..++.++|+|||||++|+|++|..|
T Consensus 156 ----------------------------~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (283)
T cd06617 156 ----------------------------D-SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206 (283)
T ss_pred ----------------------------c-ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence 0 001122468899999999865 4568899999999999999999999
Q ss_pred CCCCC-HHHHHHHHhccC-CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 988 FNAKT-PQQIFDNIMNRD-IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 988 F~g~~-~~ei~qkIl~~~-l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
|.... ..+.+..+.... ...+ ...++.++.+||.+||..+|.+||+ +.++++||||......
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~ 270 (283)
T cd06617 207 YDSWKTPFQQLKQVVEEPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPN---YPELLQHPFFELHLSK 270 (283)
T ss_pred CCccccCHHHHHHHHhcCCCCCC--ccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhhhcccc
Confidence 97532 223333333322 2222 1357899999999999999999999 7899999999986544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=337.11 Aligned_cols=259 Identities=35% Similarity=0.603 Sum_probs=216.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ......+..|+.+++.++|+||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 589999999999999999999999999999998866432 4567889999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
|+++++|.+++.....+++..++.++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~----- 154 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT----- 154 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC-----
Confidence 999999999998877799999999999999999999999999999999999999999999999999875310000
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC---CCcchhhhHHHHHHHHHHhCCCCCCCCC-HH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG---HGATADWWSVGIILFELLIGIPPFNAKT-PQ 994 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~---ys~ksDIWSLGVILYELLTG~pPF~g~~-~~ 994 (1170)
..........|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. ..
T Consensus 155 ---------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~ 213 (264)
T cd06626 155 ---------------------TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF 213 (264)
T ss_pred ---------------------cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH
Confidence 0000022356889999999998766 8899999999999999999999997653 33
Q ss_pred HHHHHHhccC-CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 995 QIFDNIMNRD-IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 995 ei~qkIl~~~-l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.+...+.... ..+|. ...++..+.+||.+||+.+|.+||+ +.+++.|||+
T Consensus 214 ~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~---~~~i~~~~~~ 264 (264)
T cd06626 214 QIMFHVGAGHKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPT---ASELLQHPFV 264 (264)
T ss_pred HHHHHHhcCCCCCCCc-ccccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 3333333322 12221 1245899999999999999999999 8899999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=340.94 Aligned_cols=252 Identities=31% Similarity=0.458 Sum_probs=206.2
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
+.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+.++..++|+||+++++++...+.+|+||||
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEec
Confidence 334458999999999999999999999999876542 34456788999999999999999999999999999999999
Q ss_pred ccCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-CCcEEEEecCCccccccccCCC
Q 001057 840 LNGGDLYSLLRNL-GCL--DEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 840 ~~GGSL~dlLk~~-~~L--SEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
+++++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.....
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~----- 161 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG----- 161 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc-----
Confidence 9999999999764 455 88889999999999999999999999999999999986 67999999999864210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC--CCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG--HGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~--ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.........|++.|+|||++.+.. ++.++|+||||+++|+|++|.+||.....
T Consensus 162 -------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 162 -------------------------INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred -------------------------CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 000112245789999999987643 78899999999999999999999976432
Q ss_pred HH-HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 994 QQ-IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 994 ~e-i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.. ....+.. .-..+.++..++.++++||.+||+.+|.+||+ +.+++.||||
T Consensus 217 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 268 (268)
T cd06624 217 PQAAMFKVGM-FKIHPEIPESLSAEAKNFILRCFEPDPDKRAS---AHDLLQDPFL 268 (268)
T ss_pred hhhhHhhhhh-hccCCCCCcccCHHHHHHHHHHcCCCchhCCC---HHHHHhCCCC
Confidence 21 1111111 11123455678999999999999999999999 8899999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=360.38 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=211.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR----- 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~----- 830 (1170)
..++|++++.||+|+||.||+|++..+|+.||||++.+.. ........+.+|+.++..++||||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3578999999999999999999999999999999986542 2233456677899999999999999999988654
Q ss_pred -cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 -~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..+|+||||+. ++|...+... +++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 35799999995 5888888654 8999999999999999999999999999999999999999999999999987421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 170 -------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 170 -------------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred -------------------------------CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 0001223468899999999999999999999999999999999999998
Q ss_pred CCCHHHHHHHHhccC----------------------C-----C---------CCCC----CccCCHHHHHHHHHhccCC
Q 001057 990 AKTPQQIFDNIMNRD----------------------I-----P---------WPNI----PEEMSVEACDLIDKLLTEN 1029 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~----------------------l-----~---------fP~i----p~~lS~eakDLIkkLLq~D 1029 (1170)
+.+....+..+...- . . ++.. +...+..+++||.+||+.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 298 (353)
T cd07850 219 GTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVID 298 (353)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCC
Confidence 877655444442200 0 0 0000 1134667899999999999
Q ss_pred CCCCCChhhHHHHHcCCCCCC
Q 001057 1030 PVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 1030 PskRpSa~~AeEILqHPfF~~ 1050 (1170)
|.+||+ +.|+|.||||+.
T Consensus 299 P~~R~t---~~eiL~~~~~~~ 316 (353)
T cd07850 299 PEKRIS---VDDALQHPYINV 316 (353)
T ss_pred hhhCcC---HHHHhcChhHhh
Confidence 999999 889999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=333.01 Aligned_cols=254 Identities=34% Similarity=0.639 Sum_probs=223.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++.+.||.|+||.||++.+..++..||+|++..... .......+..|+++++.++|||++++++.+.....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999999999999999876432 23456678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 839 YLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~----- 154 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS----- 154 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc-----
Confidence 99999999999764 679999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
..........|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..
T Consensus 155 -------------------------~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 209 (258)
T cd08215 155 -------------------------STVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL 209 (258)
T ss_pred -------------------------cCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH
Confidence 0001123457899999999999888999999999999999999999999988888
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.+...+..... +.++..++..+.++|.+||..+|.+||+ +.++++||||
T Consensus 210 ~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 258 (258)
T cd08215 210 ELALKILKGQY--PPIPSQYSSELRNLVSSLLQKDPEERPS---IAQILQSPFI 258 (258)
T ss_pred HHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCCCC
Confidence 87777765543 3455688999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=367.91 Aligned_cols=258 Identities=23% Similarity=0.349 Sum_probs=209.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCC-----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRAT-----GDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFT 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~T-----Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fq 828 (1170)
...++|++.+.||+|+||.||+|++..+ +..||+|++.... .......+.+|+.+|+.+ +|||||+++++|.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 4456899999999999999999986443 4589999987643 233456788999999999 8999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhc--------------------------------------------------------
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNL-------------------------------------------------------- 852 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~-------------------------------------------------------- 852 (1170)
....+|+|||||.+|+|.+++...
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999999999998642
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 853 --------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 853 --------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~------- 265 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND------- 265 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCC-------
Confidence 13778889999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIF 997 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~ 997 (1170)
..........+++.|||||++.+..++.++|||||||++|+|++ |..||........+
T Consensus 266 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~ 324 (374)
T cd05106 266 ---------------------SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324 (374)
T ss_pred ---------------------cceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH
Confidence 00001122345678999999998899999999999999999997 99999877655444
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..+....... ..+..+++++.+||.+||+.||.+||++.++.++|
T Consensus 325 ~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 325 YKMVKRGYQM-SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHHHHcccCc-cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 4444433322 23456789999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.03 Aligned_cols=255 Identities=30% Similarity=0.533 Sum_probs=209.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|+.++.||.|+||.||+|+++.+|+.||||.+..... .......+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999998865432 22334578889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 839 YLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|+. ++|..++... ..+++..++.++.||+.||+|||++||+||||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~------ 152 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV------ 152 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhccc------
Confidence 995 6899888653 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.........+++.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+...
T Consensus 153 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~ 208 (284)
T cd07860 153 ------------------------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208 (284)
T ss_pred ------------------------CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence 000112235788999999887644 5888999999999999999999998877654
Q ss_pred HHHHHhccC------------------CCCCC--------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRD------------------IPWPN--------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~------------------l~fP~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
....+.... ..++. ....++.++++||.+||+.||.+||+ +.++++||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~f 284 (284)
T cd07860 209 QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS---AKAALAHPFF 284 (284)
T ss_pred HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC---HHHHhcCCCC
Confidence 443332210 00110 11347889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=346.92 Aligned_cols=256 Identities=30% Similarity=0.556 Sum_probs=220.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|...+.||.|++|.||++.+..+++.||+|.+... .....+.+.+|+.++..++||||++++++|...+..|+|||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 466667999999999999999999999999987643 22344668899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
|+.|++|.+++.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~--------- 166 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVS--------- 166 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhc---------
Confidence 9999999999987 679999999999999999999999999999999999999999999999999876421
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~q 998 (1170)
..........|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+....+.
T Consensus 167 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~ 225 (285)
T cd06648 167 ---------------------KEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK 225 (285)
T ss_pred ---------------------cCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH
Confidence 00011123568999999999998889999999999999999999999999888877777
Q ss_pred HHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 999 kIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+.....+....+..++..+.+||.+||+.+|.+||+ +.++++||||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~ 275 (285)
T cd06648 226 RIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT---AAELLNHPFLAKA 275 (285)
T ss_pred HHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcC---HHHHccCcccccC
Confidence 7765543332223457899999999999999999998 8899999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.88 Aligned_cols=254 Identities=29% Similarity=0.526 Sum_probs=211.0
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++++.||.|++|.||+|++..+|+.||||++..... ......+.+|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999876432 2234567789999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 839 YLNGGDLYSLLRNL---GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~---~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~----- 152 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI----- 152 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC-----
Confidence 9974 899888754 3589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........+|+.|++||++.+. .++.++|||||||++|+|++|.+||.+.+..
T Consensus 153 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 207 (284)
T cd07836 153 -------------------------PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE 207 (284)
T ss_pred -------------------------CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 00011234578999999998764 5788999999999999999999999988776
Q ss_pred HHHHHHhccC------------------CCCCC--------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 995 QIFDNIMNRD------------------IPWPN--------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 995 ei~qkIl~~~------------------l~fP~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
+.+..+.... ..++. +...++..++++|.+||+.||.+||+ +.++++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~f 284 (284)
T cd07836 208 DQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS---AHDALQHPWF 284 (284)
T ss_pred HHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 6655543210 00110 11245788999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=340.06 Aligned_cols=254 Identities=23% Similarity=0.377 Sum_probs=215.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
...+|.+.+.||.|+||.||+|.++.+++.||+|++.+.. .....+.+|+.++..++||||+++++++.....+|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 79 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence 3457999999999999999999999999999999987542 234678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 836 VMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~-- 157 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-- 157 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc--
Confidence 99999999999999754 35899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
.........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus 158 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 158 ---------------------------TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred ---------------------------eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 0000112234678999999998899999999999999999998 999999988
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
..+.+..+..... +..+..++.++.+||.+||+.||.+||++.++.+.|+
T Consensus 211 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 211 LSQVYELLEKGYR--MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred HHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 8888777765321 2344678999999999999999999999766665554
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=346.32 Aligned_cols=249 Identities=32% Similarity=0.564 Sum_probs=202.6
Q ss_pred CCeEEEEEe--ccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeecccceE
Q 001057 758 EDFEIIKPI--SQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS-VRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 758 edYevlk~L--G~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILsk-L~HPNIVrL~~~Fqd~~~Ly 834 (1170)
++|++.+.+ |.|+||.||++.++.++..||+|++.+..... .|..+... .+||||+++++.|...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666665 99999999999999999999999987643211 12222222 26999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-cEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-~VKLsDFGLAk~~~~~~~ 913 (1170)
+||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~---- 161 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG---- 161 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC----
Confidence 9999999999999998877899999999999999999999999999999999999999998 99999999987421
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
......|+..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 162 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 211 (267)
T PHA03390 162 ------------------------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211 (267)
T ss_pred ------------------------------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc
Confidence 01123588999999999998999999999999999999999999986543
Q ss_pred HHHH-HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 994 QQIF-DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 994 ~ei~-qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
..+. ..+..........+..++..+.+||.+||+.||.+|++ .++++|+||||.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--~~~~~l~h~~~~~ 267 (267)
T PHA03390 212 EELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT--NYNEIIKHPFLKI 267 (267)
T ss_pred chhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCc--hHHHHhcCCcccC
Confidence 3221 11111111111233578999999999999999999996 2689999999974
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=336.95 Aligned_cols=254 Identities=30% Similarity=0.533 Sum_probs=218.2
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++.+.||.|+||.||+|.++.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+.....+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58999999999999999999999999999999876432 22344677899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc-EEEEecCCccccccccCCC
Q 001057 839 YLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH-IKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~-VKLsDFGLAk~~~~~~~~d 915 (1170)
|+++++|.+++.... .+++..+..++.||+.||.|||+++|+|+||||+||+++.++. ++|+|||.+....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~------ 153 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN------ 153 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhcc------
Confidence 999999999997643 4799999999999999999999999999999999999998864 6999999886421
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
..........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+
T Consensus 154 ------------------------~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 209 (257)
T cd08225 154 ------------------------DSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209 (257)
T ss_pred ------------------------CCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 00011123468999999999988889999999999999999999999999888777
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
....+...... ..+..++.++.++|.+||..+|.+||+ +.++++||||
T Consensus 210 ~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~~~~~ 257 (257)
T cd08225 210 LVLKICQGYFA--PISPNFSRDLRSLISQLFKVSPRDRPS---ITSILKRPFL 257 (257)
T ss_pred HHHHHhcccCC--CCCCCCCHHHHHHHHHHhccChhhCcC---HHHHhhCCCC
Confidence 77666654432 334578899999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=378.66 Aligned_cols=253 Identities=25% Similarity=0.342 Sum_probs=206.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
...|.+.+.||+|+||.||+|++..+++.||||.... ..+.+|+.+|++++|||||++++++...+..|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999995322 2356899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+. ++|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~---- 313 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS---- 313 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc----
Confidence 99994 6999888754 46999999999999999999999999999999999999999999999999999752100
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC---
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT--- 992 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~--- 992 (1170)
.........+||+.|||||++.+..++.++|||||||+||||++|..|+....
T Consensus 314 ------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~ 369 (461)
T PHA03211 314 ------------------------WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369 (461)
T ss_pred ------------------------cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCccc
Confidence 00011224679999999999999999999999999999999999887654321
Q ss_pred -----HHHHHHHHhccCCC---CCCC----------------------------CccCCHHHHHHHHHhccCCCCCCCCh
Q 001057 993 -----PQQIFDNIMNRDIP---WPNI----------------------------PEEMSVEACDLIDKLLTENPVQRLGA 1036 (1170)
Q Consensus 993 -----~~ei~qkIl~~~l~---fP~i----------------------------p~~lS~eakDLIkkLLq~DPskRpSa 1036 (1170)
..++.+.|...... ++.. ...++.++.+||.+||+.||.+||+
T Consensus 370 ~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs- 448 (461)
T PHA03211 370 ERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS- 448 (461)
T ss_pred ccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC-
Confidence 23333333322211 1100 0135668999999999999999999
Q ss_pred hhHHHHHcCCCCCC
Q 001057 1037 TGAREVKQHPFFKN 1050 (1170)
Q Consensus 1037 ~~AeEILqHPfF~~ 1050 (1170)
+.|+|+||||+.
T Consensus 449 --a~elL~hp~f~~ 460 (461)
T PHA03211 449 --AAELLRLPLFQS 460 (461)
T ss_pred --HHHHhhCcccCC
Confidence 889999999974
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=383.28 Aligned_cols=261 Identities=33% Similarity=0.568 Sum_probs=238.5
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
.......|.+++.||+|.|++|.+|++..|+..||||++.|..... ...+.+.+|+++|..++|||||++|.+......
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 3556778999999999999999999999999999999999887544 444568999999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||||+.+|++++++.++++..+..++.++.|++.|++|||+++|+|||||.+||||+.+..+||+|||++..+.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--- 206 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--- 206 (596)
T ss_pred eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998641
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
......+.||++.|.|||++.+..| ++.+|+||+|++||-|++|..||.+.
T Consensus 207 ----------------------------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 207 ----------------------------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred ----------------------------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 1234467899999999999999877 67899999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+..++-...+.+++..| ..++-++.+||+++|..+|.+|++ .++|..|.|....
T Consensus 259 ~lk~Lr~rvl~gk~rIp---~~ms~dce~lLrk~lvl~Pskr~~---~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 259 NLKELRPRVLRGKYRIP---FYMSCDCEDLLRKFLVLNPSKRGP---CDQIMKDRWRNDL 312 (596)
T ss_pred ccccccchheeeeeccc---ceeechhHHHHHHhhccCccccCC---HHHhhhhcccchh
Confidence 99988888888888655 679999999999999999999999 8899999998754
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.94 Aligned_cols=257 Identities=36% Similarity=0.595 Sum_probs=219.7
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cceEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--ENLYLV 836 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~LyLV 836 (1170)
+|++.+.||.|++|.||+|.+..+++.|++|++..... .....+.+.+|+.++++++||||+++++.+... ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 58899999999999999999999999999999876543 245677889999999999999999999999988 889999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||+.+++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE---- 155 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccc----
Confidence 9999999999999888789999999999999999999999999999999999999999999999999987531000
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC-HHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT-PQQ 995 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~-~~e 995 (1170)
.........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ...
T Consensus 156 ------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~ 211 (260)
T cd06606 156 ------------------------TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA 211 (260)
T ss_pred ------------------------ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence 0001224568899999999988889999999999999999999999998766 333
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
....+.. ....+.++..++..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 260 (260)
T cd06606 212 ALYKIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT---ADELLQHPFL 260 (260)
T ss_pred HHHhccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCC---HHHHhhCCCC
Confidence 3333322 12334456778999999999999999999998 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=347.11 Aligned_cols=261 Identities=30% Similarity=0.508 Sum_probs=211.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|++.+.||.|+||+||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999998865432 223445678899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-CCcEEEEecCCccccccccC
Q 001057 837 MEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~--LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|||++ ++|..++..... +++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~--- 155 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--- 155 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC---
Confidence 99995 588888865433 578888999999999999999999999999999999985 45799999999874210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........|++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+
T Consensus 156 ---------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 156 ---------------------------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred ---------------------------CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 00011234678999999998764 57889999999999999999999998877
Q ss_pred HHHHHHHHhccC---------------------CCCCC-----CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCC
Q 001057 993 PQQIFDNIMNRD---------------------IPWPN-----IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046 (1170)
Q Consensus 993 ~~ei~qkIl~~~---------------------l~fP~-----ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHP 1046 (1170)
..+.+.++.... ..++. ....++.++.++|.+||+.||.+||+ +.+++.||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~~l~~~ 285 (294)
T PLN00009 209 EIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT---ARAALEHE 285 (294)
T ss_pred HHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC---HHHHhcCc
Confidence 665554443210 00000 11357889999999999999999999 88999999
Q ss_pred CCCCCC
Q 001057 1047 FFKNIN 1052 (1170)
Q Consensus 1047 fF~~id 1052 (1170)
||.+++
T Consensus 286 ~~~~~~ 291 (294)
T PLN00009 286 YFKDLG 291 (294)
T ss_pred hHhHHh
Confidence 998753
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.57 Aligned_cols=257 Identities=32% Similarity=0.548 Sum_probs=217.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
+.|.....||.|+||.||++.+..++..||||.+.... ....+.+.+|+.++..++||||+++++.|...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 44666788999999999999999999999999886532 334567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~-------- 169 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-------- 169 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcc--------
Confidence 99999999998865 468999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
..........|++.|+|||++.+..++.++|+|||||++|||++|..||.+.+....+
T Consensus 170 ----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~ 227 (292)
T cd06658 170 ----------------------KEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM 227 (292)
T ss_pred ----------------------cccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0001112356899999999998888999999999999999999999999988877666
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..+..............+..+.+||.+||..||.+||+ +.++++||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~~~~ 278 (292)
T cd06658 228 RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT---AQELLQHPFLKLA 278 (292)
T ss_pred HHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhhcc
Confidence 65543322211122357889999999999999999999 8899999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=345.19 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=216.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeee-----cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARK-----RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArd-----k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
.-.+|.+.+.||.|+||.||++.+ ..++..||+|.+.... ......+.+|+.++.+++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 346799999999999999999985 3356679999887542 34566789999999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcE
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG-------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHI 897 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~-------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~V 897 (1170)
+.+|+||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999997543 48999999999999999999999999999999999999999999
Q ss_pred EEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHH
Q 001057 898 KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGII 977 (1170)
Q Consensus 898 KLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVI 977 (1170)
+|+|||+++..... ..........+++.|+|||++.+..++.++|||||||+
T Consensus 160 kl~dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~i 211 (288)
T cd05093 160 KIGDFGMSRDVYST----------------------------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV 211 (288)
T ss_pred EeccCCccccccCC----------------------------ceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHH
Confidence 99999998742100 00001122346788999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 978 LFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 978 LYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+|+|++ |.+||.+....+....+..+... ..+..++.++.+||.+||+.||.+||++.++...++.
T Consensus 212 l~~l~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~ 278 (288)
T cd05093 212 LWEIFTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN 278 (288)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 999998 99999998888888888776543 2345688999999999999999999997666555543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=353.48 Aligned_cols=255 Identities=31% Similarity=0.554 Sum_probs=218.4
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
|+....||.|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++..++||||+++++.|...+.+|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 5555689999999999999999999999999865432 2345678899999999999999999999999999999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCC
Q 001057 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~ 919 (1170)
+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~---------- 168 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS---------- 168 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcc----------
Confidence 999999998765 568999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 001057 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999 (1170)
Q Consensus 920 sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qk 999 (1170)
.........+|++.|+|||++.+..++.++|+|||||++|||++|..||...+..+....
T Consensus 169 --------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 228 (297)
T cd06659 169 --------------------KDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 228 (297)
T ss_pred --------------------cccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 000112345789999999999988899999999999999999999999998887777666
Q ss_pred HhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1000 Il~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+.............++..+.++|.+||+.+|.+||+ +.++++||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps---~~~ll~~~~~~~~ 277 (297)
T cd06659 229 LRDSPPPKLKNAHKISPVLRDFLERMLTREPQERAT---AQELLDHPFLLQT 277 (297)
T ss_pred HhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC---HHHHhhChhhccC
Confidence 655443333334567899999999999999999999 8899999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.97 Aligned_cols=255 Identities=29% Similarity=0.504 Sum_probs=214.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||.||+|.+..+|+.||+|.++..........+.+.+|+.+++.++|+||++++++|...+.+++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999999999999987655555556778899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 838 EYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~--- 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--- 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC---
Confidence 999999999998642 4589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC-
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT- 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~- 992 (1170)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||....
T Consensus 159 ---------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08224 159 ---------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred ---------------------------CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc
Confidence 0011123468899999999998889999999999999999999999997543
Q ss_pred -HHHHHHHHhccCCCCCCCCc-cCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 -PQQIFDNIMNRDIPWPNIPE-EMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 -~~ei~qkIl~~~l~fP~ip~-~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
.....+.+..+.. +..+. .++..+.++|.+||..+|.+||++.++.+.++
T Consensus 212 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 212 NLYSLCKKIEKCDY--PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred cHHHHHhhhhcCCC--CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 3344455444332 22333 68889999999999999999999665555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=343.37 Aligned_cols=256 Identities=29% Similarity=0.553 Sum_probs=216.4
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC---CCcEEEEEeeeecccceEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR---NPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~---HPNIVrL~~~Fqd~~~LyL 835 (1170)
.|++++.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++ ||||++++++|.....+|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4888999999999999999999999999999987542 2344567888999999987 9999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||++|++|.+++.. +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~----- 153 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ----- 153 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC-----
Confidence 9999999999999876 4799999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........|+..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+....
T Consensus 154 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 208 (277)
T cd06917 154 -------------------------NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208 (277)
T ss_pred -------------------------CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 0011223468999999999875 45688999999999999999999999887766
Q ss_pred HHHHHHhccCCCCCCCCc-cCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPE-EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~-~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
.....+.... .+.++. .++.++.+||.+||+.||.+||+ +.+++.||||++..
T Consensus 209 ~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~il~~~~~~~~~ 262 (277)
T cd06917 209 RAMMLIPKSK--PPRLEDNGYSKLLREFVAACLDEEPKERLS---AEELLKSKWIKAHS 262 (277)
T ss_pred hhhhccccCC--CCCCCcccCCHHHHHHHHHHcCCCcccCcC---HHHHhhChHhhccc
Confidence 5554443332 223333 37889999999999999999999 88999999998764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.54 Aligned_cols=254 Identities=32% Similarity=0.624 Sum_probs=221.3
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++.+.||.|++|.||++.+..+++.||+|.+..... .......+.+|++++.+++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58999999999999999999999999999999987643 23456789999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
|+.+++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~-------- 151 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND-------- 151 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCC--------
Confidence 999999999998888899999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~q 998 (1170)
.........|+..|+|||.+.+..++.++||||||+++|+|++|..||...+......
T Consensus 152 ----------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~ 209 (254)
T cd06627 152 ----------------------VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF 209 (254)
T ss_pred ----------------------CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 0001233568899999999988888999999999999999999999998777655554
Q ss_pred HHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 999 kIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.+.... .+..+..++..+.++|.+||..+|++||+ +.+++.||||
T Consensus 210 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~~ 254 (254)
T cd06627 210 RIVQDD--HPPLPEGISPELKDFLMQCFQKDPNLRPT---AKQLLKHPWI 254 (254)
T ss_pred HHhccC--CCCCCCCCCHHHHHHHHHHHhCChhhCcC---HHHHhcCCCC
Confidence 444322 23455778999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=347.31 Aligned_cols=257 Identities=31% Similarity=0.521 Sum_probs=212.0
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cceE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--ENLY 834 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~Ly 834 (1170)
.++|++.+.||.|+||.||+|.++.+++.||+|.++..... ......+.+|+.++..++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46799999999999999999999999999999998755332 23334567899999999999999999998877 8899
Q ss_pred EEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 159 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-- 159 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC--
Confidence 9999996 59999987654 5999999999999999999999999999999999999999999999999998753100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
........+++.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+
T Consensus 160 ----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 160 ----------------------------LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred ----------------------------ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 01112345788999999987644 6889999999999999999999999887
Q ss_pred HHHHHHHHhccCC-------------------CC---------CCCCcc-CCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 993 PQQIFDNIMNRDI-------------------PW---------PNIPEE-MSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 993 ~~ei~qkIl~~~l-------------------~f---------P~ip~~-lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
....+..+...-. .+ ..++.. ++..+.+||.+||+.||.+||+ +.|++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t---~~ell 288 (293)
T cd07843 212 EIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS---AEDAL 288 (293)
T ss_pred hHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC---HHHHh
Confidence 7666555432100 00 011122 5888999999999999999999 88999
Q ss_pred cCCCC
Q 001057 1044 QHPFF 1048 (1170)
Q Consensus 1044 qHPfF 1048 (1170)
.||||
T Consensus 289 ~~~~f 293 (293)
T cd07843 289 KHPYF 293 (293)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.18 Aligned_cols=256 Identities=23% Similarity=0.395 Sum_probs=212.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeec----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKR----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
...+|++.+.||+|+||+||+|... .++..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 456799999987532 2344567889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL-----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD 894 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~-----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d 894 (1170)
..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 237888899999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHH
Q 001057 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974 (1170)
Q Consensus 895 G~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSL 974 (1170)
+.+||+|||+++..... ..........++..|+|||++.+..++.++|||||
T Consensus 161 ~~~kl~dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 161 LHVKISDLGLSREIYSA----------------------------DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred CcEEeccccccccccCC----------------------------cceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 99999999999752100 00011223446778999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 975 GIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 975 GVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
||++|||++ |.+||.+.+...+.+.+..... +..+..++..+.++|.+||+.||.+||++.++.+.+
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL--LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 999999998 9999998888777777665443 234567899999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=400.10 Aligned_cols=263 Identities=30% Similarity=0.528 Sum_probs=216.7
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-- 830 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-- 830 (1170)
....+++|++++.||.|+||+||+|++..++..||+|++..... .......+..|+.+|..++|||||+++++|.+.
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34566899999999999999999999999999999999876543 334567788999999999999999999988653
Q ss_pred cceEEEEeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-------CeeeccCCCCcEEeCC------
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSL-------NVIHRDLKPDNLLIGQ------ 893 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~-------GIIHRDIKPENILLd~------ 893 (1170)
..+||||||+.+|+|..+|... +.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5699999999999999999752 5799999999999999999999985 4999999999999964
Q ss_pred -----------CCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc
Q 001057 894 -----------DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG 962 (1170)
Q Consensus 894 -----------dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g 962 (1170)
.+.+||+|||++..... .......+||+.|+|||++.+
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~-------------------------------~s~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGI-------------------------------ESMAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccc-------------------------------cccccccCCCccccCHHHHhc
Confidence 23589999999874210 011234579999999999965
Q ss_pred --CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 963 --MGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 963 --~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
..++.++||||||||||+|++|..||...+....+..++.....++ ....+.++.+||..||+.+|.+||+ +.
T Consensus 216 e~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPS---a~ 290 (1021)
T PTZ00266 216 ETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP--IKGKSKELNILIKNLLNLSAKERPS---AL 290 (1021)
T ss_pred cCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcC---HH
Confidence 3488999999999999999999999986654443333333333322 1357899999999999999999999 88
Q ss_pred HHHcCCCCCCCC
Q 001057 1041 EVKQHPFFKNIN 1052 (1170)
Q Consensus 1041 EILqHPfF~~id 1052 (1170)
++|.||||..+.
T Consensus 291 QlL~h~~ik~i~ 302 (1021)
T PTZ00266 291 QCLGYQIIKNVG 302 (1021)
T ss_pred HHhccHHHhhcC
Confidence 999999998764
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=341.85 Aligned_cols=251 Identities=31% Similarity=0.505 Sum_probs=205.1
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecc--cceEEE
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCR--ENLYLV 836 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~--~~LyLV 836 (1170)
|++++.||.|+||.||+|.+..+++.||+|++.+... .. ......+|+.++.++. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 7889999999999999999999999999999876422 11 2223457888888885 99999999999987 889999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++. +.+||+|||+++....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~----- 151 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS----- 151 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc-----
Confidence 99996 5888888754 57899999999999999999999999999999999999999 9999999999874210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
........+++.|+|||++.. ..++.++|||||||++|||++|.+||.+.+..
T Consensus 152 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~ 205 (282)
T cd07831 152 --------------------------KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL 205 (282)
T ss_pred --------------------------CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH
Confidence 001112457899999998764 45688999999999999999999999988776
Q ss_pred HHHHHHhcc------------------CCCCCC--------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 995 QIFDNIMNR------------------DIPWPN--------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 995 ei~qkIl~~------------------~l~fP~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
+.+..+... ...++. ....++.++.+||.+||.+||.+||+ +.++++||||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~~l~~~~~ 282 (282)
T cd07831 206 DQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT---AKQALRHPYF 282 (282)
T ss_pred HHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC---HHHHhhCCCC
Confidence 655544321 111111 11256899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.48 Aligned_cols=259 Identities=29% Similarity=0.499 Sum_probs=217.9
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccc--cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cce
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD--MIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--ENL 833 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~--i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~L 833 (1170)
.+|++.+.||+|+||.||+|++..+++.||+|.+.... .........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875421 12334567888999999999999999999988764 458
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI-- 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc--
Confidence 999999999999999988778999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
...........|+..|+|||++.+..++.++|+|||||++|+|++|.+||.....
T Consensus 160 -------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 214 (264)
T cd06653 160 -------------------------CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214 (264)
T ss_pred -------------------------cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH
Confidence 0000111235689999999999988899999999999999999999999988776
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
......+..... .+.++..++..+.++|.+||. +|..||+ +.+++.|||.
T Consensus 215 ~~~~~~~~~~~~-~~~~p~~~~~~~~~~i~~~l~-~~~~r~~---~~~~~~~~~~ 264 (264)
T cd06653 215 MAAIFKIATQPT-KPMLPDGVSDACRDFLKQIFV-EEKRRPT---AEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHcCCC-CCCCCcccCHHHHHHHHHHhc-CcccCcc---HHHHhcCCCC
Confidence 665555543322 234567899999999999999 6799999 7799999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=327.18 Aligned_cols=252 Identities=38% Similarity=0.625 Sum_probs=215.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++.+.||.|++|.||++.+..+++.|++|++..... .....+.+|+.++..++||||+++++.|......|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58999999999999999999998999999999876532 355788899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 839 YLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|++|++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~-------- 149 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-------- 149 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccc--------
Confidence 99999999999876 579999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
. ........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+.....
T Consensus 150 ----------------------~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 206 (253)
T cd05122 150 ----------------------D-TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL 206 (253)
T ss_pred ----------------------c-cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH
Confidence 0 00023456889999999999888899999999999999999999999887655554
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
..+.....+....+..++..+.++|.+||+.||.+||+ +.++++|||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~~~l~~~~ 253 (253)
T cd05122 207 FKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT---AEQLLKHPF 253 (253)
T ss_pred HHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCC---HHHHhcCCC
Confidence 44443222111111234899999999999999999999 889999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=340.55 Aligned_cols=254 Identities=29% Similarity=0.494 Sum_probs=213.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++.+.||.|+||.||+|+++.+++.||||.+.+...........+.+|+.+++.++||||++++++|...+.+|+||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999987765555556678899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 838 EYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 838 EY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||++|++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~--- 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--- 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc---
Confidence 99999999999864 34589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||.+...
T Consensus 159 ---------------------------~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 211 (267)
T cd08229 159 ---------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211 (267)
T ss_pred ---------------------------CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 00111235689999999999988899999999999999999999999976543
Q ss_pred --HHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 994 --QQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 994 --~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
......+.... ++.. +..++..+++||.+||..||.+||++..+-+++
T Consensus 212 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 212 NLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred hHHHHhhhhhcCC--CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 34444444322 2222 246889999999999999999999965554444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=349.92 Aligned_cols=256 Identities=30% Similarity=0.547 Sum_probs=218.8
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|+.++.||.|+||.||+|.+..++..||+|++.... .....+.+.+|+.+++.++||||++++++|.....+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4777889999999999999999999999999987543 23345678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
|+++++|.+++.. +.+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~-------- 153 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-------- 153 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC--------
Confidence 9999999998865 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~q 998 (1170)
.........|+..|+|||++.+..++.++|+|||||++|||++|..||..........
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~ 211 (277)
T cd06642 154 ----------------------TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF 211 (277)
T ss_pred ----------------------cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh
Confidence 0011123468899999999998889999999999999999999999998776666555
Q ss_pred HHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 999 kIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
.+.... .+..+..++.++.+||.+||+.+|.+||+ +.++++||||....
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~ 260 (277)
T cd06642 212 LIPKNS--PPTLEGQYSKPFKEFVEACLNKDPRFRPT---AKELLKHKFITRYT 260 (277)
T ss_pred hhhcCC--CCCCCcccCHHHHHHHHHHccCCcccCcC---HHHHHHhHHHHHHh
Confidence 544332 22344568889999999999999999999 88999999997654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=344.47 Aligned_cols=262 Identities=31% Similarity=0.472 Sum_probs=206.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE---- 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~---- 831 (1170)
.+++|++++.||.|+||.||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN 88 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence 45689999999999999999999999999999998865422 2222345678999999999999999999876654
Q ss_pred ----ceEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcc
Q 001057 832 ----NLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 832 ----~LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk 906 (1170)
..|+||||+. ++|..++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.
T Consensus 89 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 89 RYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4599999995 58888887643 68999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CCcchhhhHHHHHHHHHHhCC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLGVILYELLTG~ 985 (1170)
....... ..........++..|+|||++.+.. ++.++||||||+++|+|++|.
T Consensus 168 ~~~~~~~--------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~ 221 (310)
T cd07865 168 AFSLSKN--------------------------SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRS 221 (310)
T ss_pred cccCCcc--------------------------cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCC
Confidence 5310000 0001112346789999999987643 688999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhc--cCC-----------------CCCCC----------CccCCHHHHHHHHHhccCCCCCCCCh
Q 001057 986 PPFNAKTPQQIFDNIMN--RDI-----------------PWPNI----------PEEMSVEACDLIDKLLTENPVQRLGA 1036 (1170)
Q Consensus 986 pPF~g~~~~ei~qkIl~--~~l-----------------~fP~i----------p~~lS~eakDLIkkLLq~DPskRpSa 1036 (1170)
+||.+.+.......+.. +.. .++.. +...+..+.+||.+||+.||.+||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t- 300 (310)
T cd07865 222 PIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID- 300 (310)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC-
Confidence 99988776544333222 100 01100 0123567889999999999999999
Q ss_pred hhHHHHHcCCCC
Q 001057 1037 TGAREVKQHPFF 1048 (1170)
Q Consensus 1037 ~~AeEILqHPfF 1048 (1170)
+.++++||||
T Consensus 301 --~~e~l~h~~f 310 (310)
T cd07865 301 --ADTALNHDFF 310 (310)
T ss_pred --HHHHhcCCCC
Confidence 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=342.51 Aligned_cols=255 Identities=31% Similarity=0.560 Sum_probs=219.9
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
-|++++.||.|+||.||+|.+..+++.||||++..... ......+.+|+.++..++||||++++++|.....+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37889999999999999999999999999998765432 2345678899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
|+.+++|..++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~-------- 153 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------- 153 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc--------
Confidence 9999999999875 4689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~q 998 (1170)
.........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+......
T Consensus 154 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 211 (277)
T cd06641 154 ----------------------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF 211 (277)
T ss_pred ----------------------chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH
Confidence 0001123468899999999988888999999999999999999999998877776666
Q ss_pred HHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 999 kIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+..... +.++..++.++.++|.+||+.+|.+||+ +.++++||||...
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~~~~ 259 (277)
T cd06641 212 LIPKNNP--PTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFIVRF 259 (277)
T ss_pred HHhcCCC--CCCCcccCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhhh
Confidence 6654332 3345678999999999999999999999 8899999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=363.66 Aligned_cols=258 Identities=24% Similarity=0.345 Sum_probs=206.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeee-----cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARK-----RATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFT 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArd-----k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fq 828 (1170)
+..++|++.+.||+|+||+||+|++ ..++..||+|+++... .....+.+.+|+.+|..+ +|||||+++++|.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 4456899999999999999999974 3567799999986543 223456788999999999 8999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhcC-------------------------------------------------------
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNLG------------------------------------------------------- 853 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~~------------------------------------------------------- 853 (1170)
.....|+|||||+||+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999999986421
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 854 --------------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 854 --------------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 268 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS- 268 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc-
Confidence 36788889999999999999999999999999999999999999999999987521000
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
.........++..|+|||++.+..++.++|||||||++|||++ |.+||.+..
T Consensus 269 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 269 ---------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred ---------------------------cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 0001112345678999999999999999999999999999997 999998765
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
....+..+...... +..+...+.++.+||.+||+.||.+||++.++.+.|
T Consensus 322 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 322 VDSKFYKMIKEGYR-MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred chHHHHHHHHhCcc-CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 44333333333222 123356788999999999999999999955554444
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=338.14 Aligned_cols=256 Identities=22% Similarity=0.328 Sum_probs=212.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCC-----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRAT-----GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~T-----Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
+..++|++.+.||.|+||.||+|.++.. +..||+|.+.... .......+.+|+.+|..++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 3456899999999999999999988643 4889999986543 23345678899999999999999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEE
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNL----------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKL 899 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~----------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKL 899 (1170)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999999653 23677889999999999999999999999999999999999999999
Q ss_pred EecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHH
Q 001057 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979 (1170)
Q Consensus 900 sDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILY 979 (1170)
+|||+++..... ..........+|..|+|||++.+..++.++|||||||++|
T Consensus 161 ~dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 212 (277)
T cd05032 161 GDFGMTRDIYET----------------------------DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212 (277)
T ss_pred CCcccchhhccC----------------------------cccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence 999998743100 0001112345678999999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 980 ELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 980 ELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
||++ |.+||.+.+..+..+.+..... +..+..++.++.+||.+||+.+|.+||++.++.+.
T Consensus 213 el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 213 EMATLAEQPYQGLSNEEVLKFVIDGGH--LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred HhhccCCCCCccCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9998 9999999888888777764432 23456789999999999999999999995444433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.44 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=209.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
..++|++.+.||+|+||.||+|.++ .++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4568999999999999999999864 245789999886532 223445688999999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEE
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG----------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLT 900 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~----------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLs 900 (1170)
...|+||||+++|+|.+++.... .++...+..++.|++.||.|||++|++||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999997532 25677888899999999999999999999999999999999999999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFE 980 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYE 980 (1170)
|||+++...... .........+++.|||||++.+..++.++|||||||++||
T Consensus 162 dfg~~~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 213 (277)
T cd05062 162 DFGMTRDIYETD----------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 213 (277)
T ss_pred CCCCccccCCcc----------------------------eeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHH
Confidence 999987421000 0001112346788999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 981 LLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 981 LLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
|++ |..||.+.+.......+...... ..+..++..+.+||.+||+.||.+||+ +.++++
T Consensus 214 l~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~ 273 (277)
T cd05062 214 IATLAEQPYQGMSNEQVLRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPS---FLEIIS 273 (277)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 998 79999998888887777665432 344678899999999999999999999 445443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=346.39 Aligned_cols=256 Identities=28% Similarity=0.491 Sum_probs=204.4
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
..+|.+++.||.|+||.||+|.+..+|..||||++..... ......+.+|+.+++.++|+||+++++++......|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999865432 22234567899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~----- 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI----- 155 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC-----
Confidence 99995 678777654 35688899999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCH-
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTP- 993 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~- 993 (1170)
.........+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.
T Consensus 156 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~ 210 (291)
T cd07870 156 -------------------------PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210 (291)
T ss_pred -------------------------CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH
Confidence 00011234578999999998764 578899999999999999999999986543
Q ss_pred HHHHHHHhcc-CCC------------------CCCC----------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 994 QQIFDNIMNR-DIP------------------WPNI----------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 994 ~ei~qkIl~~-~l~------------------fP~i----------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
.+.+..+... ..+ ++.. ....+..+.+||.+||+.||.+||+ +.+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t---~~~~l~ 287 (291)
T cd07870 211 FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS---AQDALL 287 (291)
T ss_pred HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC---HHHHhc
Confidence 2222222110 000 0000 0123678999999999999999999 889999
Q ss_pred CCCC
Q 001057 1045 HPFF 1048 (1170)
Q Consensus 1045 HPfF 1048 (1170)
||||
T Consensus 288 h~~~ 291 (291)
T cd07870 288 HPYF 291 (291)
T ss_pred CCCC
Confidence 9998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=346.92 Aligned_cols=259 Identities=29% Similarity=0.502 Sum_probs=206.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecC--CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cceE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRA--TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--ENLY 834 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~--TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~Ly 834 (1170)
+|++++.||.|+||.||+|.+.. ++..||||.+.............+.+|+.++..++||||++++++|.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48999999999999999999988 8999999998874322233446678899999999999999999999988 7899
Q ss_pred EEEeeccCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC----CCcEEEEecCCc
Q 001057 835 LVMEYLNGGDLYSLLRNL-----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ----DGHIKLTDFGLS 905 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~-----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~----dG~VKLsDFGLA 905 (1170)
+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999996 4787777532 26899999999999999999999999999999999999999 899999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG 984 (1170)
....... .........++|+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 160 ~~~~~~~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~ 212 (316)
T cd07842 160 RLFNAPL---------------------------KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL 212 (316)
T ss_pred cccCCCc---------------------------ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc
Confidence 7531000 000112345789999999998764 578999999999999999999
Q ss_pred CCCCCCCCHHH---------HHHHHhc--------------------------cCCCCCC------C--CccCCHHHHHH
Q 001057 985 IPPFNAKTPQQ---------IFDNIMN--------------------------RDIPWPN------I--PEEMSVEACDL 1021 (1170)
Q Consensus 985 ~pPF~g~~~~e---------i~qkIl~--------------------------~~l~fP~------i--p~~lS~eakDL 1021 (1170)
.+||.+..... .+..+.. ....++. . ....+.++.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (316)
T cd07842 213 EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDL 292 (316)
T ss_pred CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHH
Confidence 99998654321 1111100 0001110 0 01567789999
Q ss_pred HHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 1022 IDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 1022 IkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
|.+||+.||.+||+ +.++++||||
T Consensus 293 i~~~l~~~P~~Rps---~~eil~~~~f 316 (316)
T cd07842 293 LRKLLEYDPTKRIT---AEEALEHPYF 316 (316)
T ss_pred HHHHhcCCcccCcC---HHHHhcCCCC
Confidence 99999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=377.02 Aligned_cols=257 Identities=35% Similarity=0.619 Sum_probs=225.7
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 843 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GG 843 (1170)
++||.|.||+||-|+++.+|+.||||++.|.....+ +...+.+|+.||.+++||.||.|-..|+..+.+++|||-+. |
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 579999999999999999999999999998776544 45889999999999999999999999999999999999995 4
Q ss_pred ChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---cEEEEecCCccccccccCCCCCC
Q 001057 844 DLYSLLR--NLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---HIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 844 SL~dlLk--~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG---~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
|+.+.|- ..++|++...++++.||+.||.|||-+||+|.|||||||||.... ++||||||+|++..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--------- 718 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--------- 718 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecc---------
Confidence 7766663 457899999999999999999999999999999999999997543 79999999999742
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~q 998 (1170)
......+.+|||.|+|||++.+++|+.+-|+||+|||+|--|+|..||..+ +++-+
T Consensus 719 ----------------------EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdInd 774 (888)
T KOG4236|consen 719 ----------------------EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDIND 774 (888)
T ss_pred ----------------------hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhH
Confidence 122346789999999999999999999999999999999999999999753 45667
Q ss_pred HHhccCCCCCCCC-ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC-hhhhhh
Q 001057 999 NIMNRDIPWPNIP-EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN-WDTLAR 1058 (1170)
Q Consensus 999 kIl~~~l~fP~ip-~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id-we~L~~ 1058 (1170)
+|.+..+-+|.-| ..+++++.|||..+|+..-.+|.+ ++..|.|||+++.. |-.|+.
T Consensus 775 QIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys---vdk~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 775 QIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS---VDKSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred HhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc---hHhhccchhhhcchHHHHHHH
Confidence 7888887777655 479999999999999999999999 88899999999874 665554
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=348.74 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=209.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCE--EEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDL--FAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~--VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~ 830 (1170)
.+..++|++.+.||+|+||.||+|.++.++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 35567899999999999999999999877764 466665432 2344556788999999999 899999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD 894 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d 894 (1170)
+.+|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997542 47899999999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHH
Q 001057 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974 (1170)
Q Consensus 895 G~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSL 974 (1170)
+.+||+|||++.... .........++..|+|||++.+..++.++|||||
T Consensus 161 ~~~kl~dfg~~~~~~-------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 209 (303)
T cd05088 161 YVAKIADFGLSRGQE-------------------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY 209 (303)
T ss_pred CcEEeCccccCcccc-------------------------------hhhhcccCCCcccccCHHHHhccCCcccccchhh
Confidence 999999999986310 0000111234667999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 975 GIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 975 GVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
||++|||++ |.+||.+.+..+.+..+.... . +..+..++.++.+||.+||+.+|.+||+ +.+++.+
T Consensus 210 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~ 276 (303)
T cd05088 210 GVLLWEIVSLGGTPYCGMTCAELYEKLPQGY-R-LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILVS 276 (303)
T ss_pred hhHHHHHHhcCCCCcccCChHHHHHHHhcCC-c-CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 999999998 999999888877777665432 1 1233567899999999999999999999 5555554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=335.63 Aligned_cols=247 Identities=25% Similarity=0.425 Sum_probs=208.4
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||.||++..+ .+..+|+|.+..... ....+.+|+.+|+.++||||++++++|.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 467999999999999999999875 456799998765432 235678899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~----- 152 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD----- 152 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCC-----
Confidence 9999999999999753 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ 994 (1170)
..........++..|+|||++.+..++.++|||||||++|+|++ |.+||...+..
T Consensus 153 ------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 153 ------------------------DEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred ------------------------CceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 00001112345678999999998889999999999999999999 99999998888
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
+.+..+..+... ..+...+..+.+||.+||+.||.+||++.++
T Consensus 209 ~~~~~i~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l 251 (256)
T cd05114 209 EVVEMISRGFRL--YRPKLASMTVYEVMYSCWHEKPEGRPTFAEL 251 (256)
T ss_pred HHHHHHHCCCCC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 888888765432 2235678899999999999999999995444
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.13 Aligned_cols=257 Identities=31% Similarity=0.517 Sum_probs=212.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cceEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--ENLYL 835 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~LyL 835 (1170)
++|+.++.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||++++++|.+. ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 469999999999999999999999999999999875432 24456788999999999999999999988654 46899
Q ss_pred EEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 836 VMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
||||++|++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999988753 34589999999999999999999999999999999999999999999999999864210
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.......++..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 158 -------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 -------------------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred -------------------------------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 0011245788999999999888999999999999999999999999865
Q ss_pred -----CHHHHHHHHhccCCC-CCCCC---ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 992 -----TPQQIFDNIMNRDIP-WPNIP---EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 992 -----~~~ei~qkIl~~~l~-fP~ip---~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
...+....+...... .+..+ ...++.+.+||.+||..||.+||+ +.|++.||||...
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~eil~~~~~~~~ 272 (287)
T cd06621 207 GEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT---PWDMLEHPWIKAQ 272 (287)
T ss_pred cCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC---HHHHHhCcccccc
Confidence 234444444432211 11111 235678999999999999999999 8899999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=344.34 Aligned_cols=263 Identities=26% Similarity=0.463 Sum_probs=211.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyL 835 (1170)
.++|...+.||.|+||.||++.+..+++.||+|.+.+... ......+.+|+.++.++. ||||+++++++......++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3567788899999999999999999999999999876432 244567889999999996 9999999999999999999
Q ss_pred EEeeccCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 836 VMEYLNGGDLYSLLR-----NLGCLDEDMARVYIAELVLALEYLHSL-NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk-----~~~~LSEe~ar~IaaQIL~ALeYLHs~-GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
+|||+. ++|.++.. ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 999985 45554432 235699999999999999999999974 99999999999999999999999999987421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC---CCCcchhhhHHHHHHHHHHhCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM---GHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~---~ys~ksDIWSLGVILYELLTG~p 986 (1170)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|.+
T Consensus 160 ~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 208 (288)
T cd06616 160 D-------------------------------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208 (288)
T ss_pred c-------------------------------CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCC
Confidence 0 0011233688999999999876 68899999999999999999999
Q ss_pred CCCCCCH-HHHHHHHhccCCC-CC-CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhh
Q 001057 987 PFNAKTP-QQIFDNIMNRDIP-WP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTL 1056 (1170)
Q Consensus 987 PF~g~~~-~ei~qkIl~~~l~-fP-~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L 1056 (1170)
||..... .+....+.....+ .+ ..+..++.++.+||.+||+.||.+||+ +.+++.||||+...|.+.
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~i~~~~~~~~~~~~~~ 278 (288)
T cd06616 209 PYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK---YKELLEHPFIKDYEERNV 278 (288)
T ss_pred CchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcChhhhchhhcch
Confidence 9976542 2222333322211 11 112357899999999999999999999 889999999998766544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=355.34 Aligned_cols=260 Identities=31% Similarity=0.523 Sum_probs=208.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----cc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-----EN 832 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-----~~ 832 (1170)
++|++.+.||.|+||.||+|++..+|+.||||++.... .......+.+|+.++..++||||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 67999999999999999999999999999999986422 233456678899999999999999999876544 35
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 899999995 588888764 569999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 161 ---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 161 ---------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ---------------------------cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 00011224578999999999765 46889999999999999999999999876
Q ss_pred CHHHHHHHHhc---------------cC-------C------CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 992 TPQQIFDNIMN---------------RD-------I------PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 992 ~~~ei~qkIl~---------------~~-------l------~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
+.......+.. .. . ++.......+.++.+||.+||+.||.+||+ +.+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~e~l 290 (336)
T cd07849 214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT---VEEAL 290 (336)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC---HHHHh
Confidence 54433322211 00 0 000011246788999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001057 1044 QHPFFKNI 1051 (1170)
Q Consensus 1044 qHPfF~~i 1051 (1170)
+||||+..
T Consensus 291 ~hp~~~~~ 298 (336)
T cd07849 291 AHPYLEQY 298 (336)
T ss_pred cCcccccc
Confidence 99999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.14 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=212.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|+++++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+.+...+|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 34578999999999999999999865 56679999876532 23567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+||||+++|+|.+++... ..++...+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 156 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN- 156 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC-
Confidence 999999999999999753 46888999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
.........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 157 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 157 ----------------------------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred ----------------------------ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 0001112345678999999998889999999999999999998 99999988
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+.......+.... .++ ....++.++.+||.+||..+|.+||++..+.++|+
T Consensus 209 ~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 209 SNSDVMSALQRGY-RMP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred CHHHHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 8877777766442 333 23568899999999999999999999776666654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.66 Aligned_cols=262 Identities=35% Similarity=0.589 Sum_probs=224.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.++..++|+||+++++.|.....+|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34569999999999999999999998999999999876432 45678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 836 VMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||++|++|.+++.... .++...+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~----- 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT----- 167 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc-----
Confidence 999999999999998876 89999999999999999999999999999999999999999999999999876421
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
..........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..
T Consensus 168 -------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~ 222 (286)
T cd06614 168 -------------------------KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL 222 (286)
T ss_pred -------------------------cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0000112345788999999999888999999999999999999999999988776
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
.....+..........+..++..+.+||.+||+.+|.+||+ +.+++.||||....|.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~ 279 (286)
T cd06614 223 RALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS---AEELLQHPFLKKACPK 279 (286)
T ss_pred HHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC---HHHHhhChHhhccCch
Confidence 66666554433222222347899999999999999999999 8899999999986554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=355.95 Aligned_cols=259 Identities=30% Similarity=0.456 Sum_probs=212.6
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----cc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-----EN 832 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-----~~ 832 (1170)
++|.+++.||+|+||+||+|++..+++.||||.+..... .......+.+|+.++..++||||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 579999999999999999999999999999999875422 233445677899999999999999999887654 35
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+||||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~-- 160 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-- 160 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC--
Confidence 899999995 79999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.........||..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 161 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 161 ----------------------------KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ----------------------------CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 0011223467899999999875 46889999999999999999999999877
Q ss_pred CHHHHHHHHhcc----------------------------CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 992 TPQQIFDNIMNR----------------------------DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 992 ~~~ei~qkIl~~----------------------------~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
+....+..+... ...+......+++++.+||.+||+.||.+||+ +.+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps---~~ell 289 (337)
T cd07858 213 DYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT---VEEAL 289 (337)
T ss_pred ChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC---HHHHH
Confidence 654433322210 00001112367899999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001057 1044 QHPFFKNI 1051 (1170)
Q Consensus 1044 qHPfF~~i 1051 (1170)
+||||..+
T Consensus 290 ~h~~~~~~ 297 (337)
T cd07858 290 AHPYLASL 297 (337)
T ss_pred cCcchhhh
Confidence 99999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=331.40 Aligned_cols=252 Identities=28% Similarity=0.491 Sum_probs=220.8
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+|++.+.||.|+||.||+++++.+++.||+|.+...... ......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999999999999998765432 3445677889999999999999999999999999999999
Q ss_pred eccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 839 YLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 839 Y~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|+++++|..++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~---- 155 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK---- 155 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc----
Confidence 9999999999876 35689999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 156 ----------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 207 (256)
T cd08530 156 ----------------------------NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207 (256)
T ss_pred ----------------------------CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0112245788999999999888999999999999999999999999998887
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
++...+..... +..+..++.+++++|.+||+.+|.+||+ +.++++||++
T Consensus 208 ~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~p~~ 256 (256)
T cd08530 208 DLRYKVQRGKY--PPIPPIYSQDLQNFIRSMLQVKPKLRPN---CDKILASPAV 256 (256)
T ss_pred HHHHHHhcCCC--CCCchhhCHHHHHHHHHHcCCCcccCCC---HHHHhcCCCC
Confidence 77777665443 3445678999999999999999999999 8899999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=335.38 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=208.6
Q ss_pred EeccCCCeEEEEeee--cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 765 PISQGAFGRVFLARK--RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 765 ~LG~GgFGtVyLArd--k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+||+|+||.||+|.+ ..++..||+|++.... ......+.+.+|+.++..++||||+++++++. .+.+++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999964 4678899999986543 23445678899999999999999999998875 4567999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 843 GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
|+|.+++.....+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||++.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~---------- 149 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---------- 149 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCC----------
Confidence 9999999887789999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIM 1001 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl 1001 (1170)
..........+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..++...+.
T Consensus 150 -----------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~ 212 (257)
T cd05116 150 -----------------NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE 212 (257)
T ss_pred -----------------CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 00001112245679999999988889999999999999999997 999999888888888777
Q ss_pred ccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 1002 NRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 1002 ~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
++.. +..+..++.++.+||.+||+.||.+||++..+.+.|+.
T Consensus 213 ~~~~--~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 213 SGER--MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCC--CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 6543 23456799999999999999999999997766665543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.52 Aligned_cols=247 Identities=28% Similarity=0.442 Sum_probs=212.0
Q ss_pred EEeccCCCeEEEEeeecCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeec
Q 001057 764 KPISQGAFGRVFLARKRAT---GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYL 840 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~T---Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~ 840 (1170)
+.||+|+||.||+|.+... +..||+|++...... .....+.+|+.++..++|+||+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 3699999999999999866 899999998765432 25678899999999999999999999999999999999999
Q ss_pred cCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 841 NGGDLYSLLRNL---------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 841 ~GGSL~dlLk~~---------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 67999999999999999999999999999999999999999999999999998753100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
. .........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 159 ~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 159 D----------------------------YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred c----------------------------ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 0 0011234567889999999998889999999999999999999 6999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.+..++.+.+..... ...+..++.++.++|.+||+.||.+||+ +.++++|
T Consensus 211 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~l~~~ 260 (262)
T cd00192 211 LSNEEVLEYLRKGYR--LPKPEYCPDELYELMLSCWQLDPEDRPT---FSELVER 260 (262)
T ss_pred CCHHHHHHHHHcCCC--CCCCccCChHHHHHHHHHccCCcccCcC---HHHHHHh
Confidence 988888888876332 2345678999999999999999999999 5566654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=340.66 Aligned_cols=256 Identities=25% Similarity=0.376 Sum_probs=210.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCC----------------CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATG----------------DLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TG----------------e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN 819 (1170)
...+|++++.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 3468999999999999999999876544 568999987643 2345678899999999999999
Q ss_pred EEEEEeeeecccceEEEEeeccCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCc
Q 001057 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-----------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDN 888 (1170)
Q Consensus 820 IVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~-----------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPEN 888 (1170)
|++++++|...+.+++||||+.+++|..++.... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998765 68999999999999999999999999999999999
Q ss_pred EEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcc
Q 001057 889 LLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT 968 (1170)
Q Consensus 889 ILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~k 968 (1170)
||++.++.++|+|||+++..... ..........+++.|+|||++.+..++.+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSS----------------------------DYYRVQGRAPLPIRWMAWESVLLGKFTTK 212 (296)
T ss_pred eeecCCCceEEccccceeecccC----------------------------cceeecCcCCCCceecCHHHhhcCCCCcc
Confidence 99999999999999998742100 00011223456789999999998889999
Q ss_pred hhhhHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhcc-----CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 969 ADWWSVGIILFELLI--GIPPFNAKTPQQIFDNIMNR-----DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 969 sDIWSLGVILYELLT--G~pPF~g~~~~ei~qkIl~~-----~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+|||||||++|||++ |..||...+...++..+... .......+..++.++.+||.+||+.||.+||++.++.+
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 999999999999998 78899887777776665432 11111223467899999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=347.40 Aligned_cols=257 Identities=35% Similarity=0.577 Sum_probs=217.6
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
..+|++++.||.|+||.||++.+..++..||+|.+.... ....+.+.+|+.+++.++||||+++++.|...+.+|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 468999999999999999999998899999999986432 23346788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||+++++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~------- 166 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------- 166 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccc-------
Confidence 9999999999998764 58899999999999999999999999999999999999999999999999886421
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
..........|++.|+|||++.+..++.++|+|||||++|+|++|.+||...+....
T Consensus 167 -----------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~ 223 (293)
T cd06647 167 -----------------------PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223 (293)
T ss_pred -----------------------ccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh
Confidence 000112234689999999999888899999999999999999999999987766544
Q ss_pred HHHHhccC-CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 997 FDNIMNRD-IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 997 ~qkIl~~~-l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
...+.... ..++ .+..++..+.+||.+||..+|.+||+ +.+++.||||+..
T Consensus 224 ~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~h~~~~~~ 275 (293)
T cd06647 224 LYLIATNGTPELQ-NPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKIA 275 (293)
T ss_pred eeehhcCCCCCCC-CccccCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhcC
Confidence 33333222 2222 23467889999999999999999998 8899999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=356.02 Aligned_cols=263 Identities=30% Similarity=0.457 Sum_probs=213.8
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec----ccce
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC----RENL 833 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd----~~~L 833 (1170)
++|++.+.||.|+||.||+|.++.+|+.||+|++..... .......+.+|+.+|..++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 679999999999999999999999999999999875432 22345677889999999999999999988763 3568
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 69999998777899999999999999999999999999999999999999999999999999875310000
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........+|+..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 163 --------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 163 --------------------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred --------------------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 00111224578999999999876 458899999999999999999999998876
Q ss_pred HHHHHHHHhcc----------------------------CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 PQQIFDNIMNR----------------------------DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 ~~ei~qkIl~~----------------------------~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
....+..+... ...+..+....+.++.+||.+||+.+|.+||+ +.+++.
T Consensus 217 ~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~ 293 (334)
T cd07855 217 YVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT---VEQALQ 293 (334)
T ss_pred hHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC---HHHHHh
Confidence 54443332210 00111112356899999999999999999999 789999
Q ss_pred CCCCCCC
Q 001057 1045 HPFFKNI 1051 (1170)
Q Consensus 1045 HPfF~~i 1051 (1170)
||||.+.
T Consensus 294 ~~~~~~~ 300 (334)
T cd07855 294 HPFLAQY 300 (334)
T ss_pred Chhhhhc
Confidence 9999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.40 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=216.1
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
...|++++.||.|+||+||+|.+..+++.||+|++.............+.+|+.++..++||||++++++|.+.+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35699999999999999999999999999999998765444455567788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+. |+|.+++.. .+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------ 166 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------ 166 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC------
Confidence 99996 577777754 4569999999999999999999999999999999999999999999999999986420
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
......|++.|+|||++. ...++.++||||||+++|+|++|.+||.+.+
T Consensus 167 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 167 ----------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred ----------------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 011346788999999985 3457889999999999999999999999887
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.......+.....+. ..+..++..+.+||.+||+.||.+||+ +.+++.||||..-
T Consensus 219 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 273 (307)
T cd06607 219 AMSALYHIAQNDSPT-LSSNDWSDYFRNFVDSCLQKIPQDRPS---SEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHHHhcCCCCC-CCchhhCHHHHHHHHHHhcCChhhCcC---HHHHhcChhhccc
Confidence 766555544332211 112457889999999999999999999 8899999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=338.19 Aligned_cols=255 Identities=22% Similarity=0.348 Sum_probs=211.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRA-----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~-----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 44679999999999999999999987 78899999876432 233456788999999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---cEEEE
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG-------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---HIKLT 900 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~-------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG---~VKLs 900 (1170)
...|+||||+.|++|.+++...+ .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 99999999999999999997653 488999999999999999999999999999999999998765 59999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFE 980 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYE 980 (1170)
|||+++...... .........++..|+|||++.+..++.++|||||||++|+
T Consensus 162 dfg~~~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e 213 (277)
T cd05036 162 DFGMARDIYRAS----------------------------YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWE 213 (277)
T ss_pred cCccccccCCcc----------------------------ceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHH
Confidence 999987521000 0000112233568999999998889999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 981 LLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 981 LLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|++ |..||.+.+..++...+..... +..+..++..+.+||.+||+.+|.+||+ +.++++|
T Consensus 214 l~~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps---~~~vl~~ 274 (277)
T cd05036 214 IFSLGYMPYPGRTNQEVMEFVTGGGR--LDPPKGCPGPVYRIMTDCWQHTPEDRPN---FATILER 274 (277)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 997 9999999888777776654322 1234678999999999999999999999 6666665
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=341.75 Aligned_cols=254 Identities=20% Similarity=0.345 Sum_probs=212.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCC-----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRAT-----GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~T-----Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
...+|++++.||.|+||.||+|.+..+ +..||||++.... .....+.+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 445788999999999999999987543 5789999987542 233456788999999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD 894 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d 894 (1170)
..+++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998531 247888899999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHH
Q 001057 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974 (1170)
Q Consensus 895 G~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSL 974 (1170)
+.+||+|||+++..... ..........+++.|+|||++.+..++.++|||||
T Consensus 161 ~~~kl~Dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05091 161 LNVKISDLGLFREVYAA----------------------------DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212 (283)
T ss_pred CceEecccccccccccc----------------------------hheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence 99999999998742100 00011223456789999999998889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 975 GIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 975 GVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
||++|||++ |.+||.+....+++..+...... ..+..++.++.+||.+||+.+|.+||+ +.+|+.
T Consensus 213 G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~---~~~i~~ 278 (283)
T cd05091 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPR---FKDIHS 278 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCC---HHHHHH
Confidence 999999998 99999998888888888876543 245689999999999999999999999 445543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=378.15 Aligned_cols=269 Identities=25% Similarity=0.351 Sum_probs=201.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCC-CCEEEEE--------------EeeccccccHHHHHHHHHHHHHHHhcCCCc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRAT-GDLFAIK--------------VLKKADMIRKNAVESILAERNILISVRNPF 819 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~T-Ge~VAIK--------------vLkKs~i~~~~~ve~~l~EieILskL~HPN 819 (1170)
...++|++++.||+|+||+||+|..+.. +..+++| ++.+...........+.+|+.+|..++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 3457899999999999999999876532 2222222 111111112234566889999999999999
Q ss_pred EEEEEeeeecccceEEEEeeccCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC
Q 001057 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD 894 (1170)
Q Consensus 820 IVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~-----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d 894 (1170)
||++++++...+..|+||+++ +++|..++... .......++.++.||+.||.|||++|||||||||+||||+.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999999999999999999 56888877542 234466788899999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHH
Q 001057 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974 (1170)
Q Consensus 895 G~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSL 974 (1170)
|.+||+|||+|+.... .........+||+.|+|||++.+..|+.++|||||
T Consensus 304 ~~vkL~DFGla~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 354 (501)
T PHA03210 304 GKIVLGDFGTAMPFEK-----------------------------EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSC 354 (501)
T ss_pred CCEEEEeCCCceecCc-----------------------------ccccccccccCCcCCCCchhhcCCCCCcHHHHHHH
Confidence 9999999999975210 00112234689999999999999999999999999
Q ss_pred HHHHHHHHhCCCC-CCCC--CHHHHHHHHhcc----CCCCCC----------------C---------CccCCHHHHHHH
Q 001057 975 GIILFELLIGIPP-FNAK--TPQQIFDNIMNR----DIPWPN----------------I---------PEEMSVEACDLI 1022 (1170)
Q Consensus 975 GVILYELLTG~pP-F~g~--~~~ei~qkIl~~----~l~fP~----------------i---------p~~lS~eakDLI 1022 (1170)
||+||||++|..+ |... .....+..+... ...+|. . ...++.++.++|
T Consensus 355 Gvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li 434 (501)
T PHA03210 355 GLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPL 434 (501)
T ss_pred HHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHH
Confidence 9999999998754 4322 222222222110 001110 0 013567788999
Q ss_pred HHhccCCCCCCCChhhHHHHHcCCCCCCCChhhh
Q 001057 1023 DKLLTENPVQRLGATGAREVKQHPFFKNINWDTL 1056 (1170)
Q Consensus 1023 kkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L 1056 (1170)
.+||++||.+||+ |.|+|.||||.....+.+
T Consensus 435 ~kmL~~DP~~Rps---a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 435 VKMLTFDWHLRPG---AAELLALPLFSAEEEEEI 465 (501)
T ss_pred HHHhccCcccCcC---HHHHhhChhhhcCCchHH
Confidence 9999999999999 889999999998765543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=332.33 Aligned_cols=247 Identities=28% Similarity=0.383 Sum_probs=204.4
Q ss_pred EeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCC
Q 001057 765 PISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 844 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGS 844 (1170)
.||.|+||.||+|+++.+++.||+|.+.... .......+.+|+.+++.++||||+++++++.....+|+||||+++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 6999999999999999999999999876432 34455678999999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCC
Q 001057 845 LYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923 (1170)
Q Consensus 845 L~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s 923 (1170)
|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~------------- 146 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED------------- 146 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccc-------------
Confidence 99999764 4589999999999999999999999999999999999999999999999999874210
Q ss_pred CCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q 001057 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 924 ~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~ 1002 (1170)
+.. ........++..|+|||++.+..++.++|||||||++|+|++ |.+||...+.......+..
T Consensus 147 -~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~ 211 (252)
T cd05084 147 -GVY--------------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ 211 (252)
T ss_pred -ccc--------------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence 000 000001123457999999998889999999999999999997 9999988777666665554
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
... +..+...+..+.+||.+||+.||.+||++.++.+.|
T Consensus 212 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 212 GVR--LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred CCC--CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 321 123467889999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=336.08 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=214.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
..+|++++.||.|+||.||+|++.. +..+|+|++.... ......+..|+.+++.++||||+++++++.+...+|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999987 8899999987653 23345688899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 837 MEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~---- 156 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE---- 156 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC----
Confidence 9999999999999763 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~ 993 (1170)
.........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 157 --------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 157 --------------------------DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred --------------------------ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 0000112345678999999998889999999999999999998 8999999888
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
.+++..+.... .. ..+..++..+.++|.+||+.||.+||++..+.+.|+
T Consensus 211 ~~~~~~~~~~~-~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 211 HEVYDQITAGY-RM-PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred HHHHHHHHhCC-cC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 88888777542 22 234678999999999999999999999666655543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=352.01 Aligned_cols=256 Identities=30% Similarity=0.474 Sum_probs=212.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE----- 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~----- 831 (1170)
.++|++++.||.|+||.||+|.+..+|..||||++.+.. ........+.+|+.+|+.++||||++++++|....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 467999999999999999999999999999999986532 22334557889999999999999999999987654
Q ss_pred -ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 -NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 -~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~- 169 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD- 169 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc-
Confidence 358999999 7799888864 579999999999999999999999999999999999999999999999999987420
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.......+++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.
T Consensus 170 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 170 --------------------------------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred --------------------------------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 01123467899999999976 457889999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCC----------------------------CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 990 AKTPQQIFDNIMNRDIPW----------------------------PNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~f----------------------------P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+.+....+..++...... ......++.++.++|.+||+.||.+||+ +.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t---~~~ 294 (343)
T cd07880 218 GHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT---AAE 294 (343)
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC---HHH
Confidence 877665555443321110 0112357888999999999999999999 789
Q ss_pred HHcCCCCCCC
Q 001057 1042 VKQHPFFKNI 1051 (1170)
Q Consensus 1042 ILqHPfF~~i 1051 (1170)
++.||||+..
T Consensus 295 ~l~~~~~~~~ 304 (343)
T cd07880 295 ALAHPYFEEF 304 (343)
T ss_pred HhcCccHhhh
Confidence 9999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=332.84 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=207.2
Q ss_pred eEEEEEeccCCCeEEEEeeecC---CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc----
Q 001057 760 FEIIKPISQGAFGRVFLARKRA---TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN---- 832 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~---TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~---- 832 (1170)
|++.+.||+|+||.||+|.... ++..||+|.++... ........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 5788999999999999998764 34789999987543 234456788999999999999999999988765443
Q ss_pred --eEEEEeeccCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCC
Q 001057 833 --LYLVMEYLNGGDLYSLLRNL------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGL 904 (1170)
Q Consensus 833 --LyLVMEY~~GGSL~dlLk~~------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGL 904 (1170)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999998542 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI- 983 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT- 983 (1170)
++....... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~ 211 (273)
T cd05035 160 SKKIYSGDY----------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211 (273)
T ss_pred eeecccccc----------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhC
Confidence 875310000 001112234678999999988889999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 984 GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 984 G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
|.+||.+....++++.+..+.. +..+..++..+.++|.+||+.||.+||++.++...
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 212 GQTPYPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999888888877765532 23456889999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=365.05 Aligned_cols=258 Identities=32% Similarity=0.555 Sum_probs=226.7
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.+-|.++.+||+|+||.||+|.++.+|..+|||.+... ..++.+..|+.||.++++|+||++|+.|.....++||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 34599999999999999999999999999999987643 4567899999999999999999999999988899999
Q ss_pred EeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||..|++.++++. ++.|+++++..+++..+.||+|||...-||||||..||||+.+|+.||+|||.|...
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL------- 179 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL------- 179 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchh-------
Confidence 999999999999974 468999999999999999999999999999999999999999999999999998642
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
+......++..|||.|||||++..-+|+..+||||||++..||..|++||....++.
T Consensus 180 -----------------------TDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 180 -----------------------TDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred -----------------------hhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 122335578899999999999999999999999999999999999999999887765
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
.+-.|-....+--..|...|.++.|||++||-++|++|-+ |-++++|||.++..
T Consensus 237 AIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 237 AIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNAP 290 (502)
T ss_pred eeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCCC
Confidence 5444433333222345678999999999999999999987 88999999998653
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=375.29 Aligned_cols=249 Identities=33% Similarity=0.537 Sum_probs=214.3
Q ss_pred EeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCC
Q 001057 765 PISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 844 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGS 844 (1170)
+||+|.||+||.|++..|....|||.+... .....+-+..|+.+.+.|+|.|||++++++...+++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 699999999999999999999999988653 23556778899999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-CCcEEEEecCCccccccccCCCCCCCC
Q 001057 845 LYSLLRNL-GCL--DEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGLIHSTDDLSAPS 920 (1170)
Q Consensus 845 L~dlLk~~-~~L--SEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-dG~VKLsDFGLAk~~~~~~~~d~~a~s 920 (1170)
|.++|+.. +++ .|..+-+|.+||++||.|||++.|||||||-+|+||+. .|.+||+|||-++...
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA----------- 727 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA----------- 727 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc-----------
Confidence 99999865 777 88899999999999999999999999999999999974 6899999999998631
Q ss_pred CCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC--CCCcchhhhHHHHHHHHHHhCCCCCCCCC--HHHH
Q 001057 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM--GHGATADWWSVGIILFELLIGIPPFNAKT--PQQI 996 (1170)
Q Consensus 921 l~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~--~ys~ksDIWSLGVILYELLTG~pPF~g~~--~~ei 996 (1170)
.-...+.++.||..|||||++... +|+.++|||||||++.||.||+|||.... ...+
T Consensus 728 -------------------ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM 788 (1226)
T KOG4279|consen 728 -------------------GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM 788 (1226)
T ss_pred -------------------cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh
Confidence 112234578999999999999754 69999999999999999999999997433 3333
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
++-=+ -+ .-|++|..+|.+++.||.+|+.+||..||+ |.++|..||++.-
T Consensus 789 FkVGm-yK-vHP~iPeelsaeak~FilrcFepd~~~R~s---A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 789 FKVGM-YK-VHPPIPEELSAEAKNFILRCFEPDPCDRPS---AKDLLQDPFLQHN 838 (1226)
T ss_pred hhhcc-ee-cCCCCcHHHHHHHHHHHHHHcCCCcccCcc---HHHhccCcccccC
Confidence 33211 11 235677999999999999999999999999 8899999999864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.72 Aligned_cols=253 Identities=34% Similarity=0.542 Sum_probs=208.5
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeeecccc----
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV---RNPFVVRFFYSFTCREN---- 832 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL---~HPNIVrL~~~Fqd~~~---- 832 (1170)
|++.+.||.|+||.||+|+++.+++.||+|++..... .......+.+|+.++..+ +||||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999998999999999875432 222334566788777665 59999999999988776
Q ss_pred -eEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 833 -LYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 833 -LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
+|++|||+. ++|.+++.... .+++..++.++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 48999887643 58999999999999999999999999999999999999999999999999987421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
. ........+++.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 159 ~-------------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 159 F-------------------------------EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred C-------------------------------CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 0 001122357889999999999889999999999999999999999999
Q ss_pred CCCHHHHHHHHhccC-----CCCC-------------------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 990 AKTPQQIFDNIMNRD-----IPWP-------------------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~-----l~fP-------------------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+.+..+.+..+.... ..++ .....++..+.+||.+||+.||.+||+ +.+++.|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~il~~ 284 (287)
T cd07838 208 GTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS---AFEALQH 284 (287)
T ss_pred CCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC---HHHHhcC
Confidence 988777766664311 0111 001245688899999999999999999 8899999
Q ss_pred CCC
Q 001057 1046 PFF 1048 (1170)
Q Consensus 1046 PfF 1048 (1170)
|||
T Consensus 285 ~~~ 287 (287)
T cd07838 285 PYF 287 (287)
T ss_pred cCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=340.06 Aligned_cols=254 Identities=31% Similarity=0.545 Sum_probs=209.6
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
|++++.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999875432 223345678899999999999999999999999999999999
Q ss_pred ccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 840 LNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
++ ++|.+++.... .+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~------- 151 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV------- 151 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC-------
Confidence 94 69999997765 689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
.........+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+....
T Consensus 152 -----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 208 (283)
T cd07835 152 -----------------------PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ 208 (283)
T ss_pred -----------------------CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 00011223568899999988764 468899999999999999999999988776544
Q ss_pred HHHHhccCC------------------CC--------CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 997 FDNIMNRDI------------------PW--------PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 997 ~qkIl~~~l------------------~f--------P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
...+..... .+ ......++..+.+||.+||+.||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~ 283 (283)
T cd07835 209 LFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS---AKAALQHPYF 283 (283)
T ss_pred HHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC---HHHHhcCCCC
Confidence 443322100 00 1112457789999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=351.08 Aligned_cols=261 Identities=31% Similarity=0.460 Sum_probs=219.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----ce
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE-----NL 833 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~-----~L 833 (1170)
+|++.+.||.|+||.||+|++..+++.||||++.+.. ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999999999999987642 12345567889999999999999999999988775 79
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||++ ++|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~- 157 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE- 157 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc-
Confidence 99999996 5899999887789999999999999999999999999999999999999999999999999987531000
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
..........||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+
T Consensus 158 --------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 158 --------------------------DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred --------------------------cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 000112334689999999999887 78999999999999999999999999988
Q ss_pred HHHHHHHHhccCCC----------------------------CCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 PQQIFDNIMNRDIP----------------------------WPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~----------------------------fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
..+.+..+...... +......++.++.+||.+||+++|.+||+ +.+++.
T Consensus 212 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~ 288 (330)
T cd07834 212 YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT---ADEALA 288 (330)
T ss_pred HHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC---HHHHHh
Confidence 87776666542111 00112346889999999999999999999 889999
Q ss_pred CCCCCCC
Q 001057 1045 HPFFKNI 1051 (1170)
Q Consensus 1045 HPfF~~i 1051 (1170)
||||+++
T Consensus 289 ~~~~~~~ 295 (330)
T cd07834 289 HPYLAQL 295 (330)
T ss_pred CccHHhh
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=338.76 Aligned_cols=257 Identities=24% Similarity=0.398 Sum_probs=212.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCC-----CEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATG-----DLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSF 827 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TG-----e~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~F 827 (1170)
.+..++|++.+.||+|+||.||++.....+ ..||+|.+.... .......+.+|+.++..+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455578999999999999999999876443 789999987542 233456788999999999 799999999999
Q ss_pred ecccceEEEEeeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe
Q 001057 828 TCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI 891 (1170)
Q Consensus 828 qd~~~LyLVMEY~~GGSL~dlLk~~----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL 891 (1170)
.....+|+||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 9999999999999999999999642 358899999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhh
Q 001057 892 GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADW 971 (1170)
Q Consensus 892 d~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDI 971 (1170)
+.++.+||+|||+++...... .........++..|+|||++.+..++.++||
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 217 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHID----------------------------YYRKTTNGRLPVKWMAPEALFDRVYTHQSDV 217 (293)
T ss_pred cCCCeEEeCcccccccccccc----------------------------ceeccCCCCCCccccCHHHhccCCcCcccce
Confidence 999999999999987521000 0000111234678999999998899999999
Q ss_pred hHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 972 WSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 972 WSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|||||++|||++ |..||.+....+.++.+..... +..+...+..+.+||.+||..||.+||+ +.+++++
T Consensus 218 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~eil~~ 287 (293)
T cd05053 218 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRPT---FKQLVED 287 (293)
T ss_pred eehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcC---HHHHHHH
Confidence 999999999997 9999999888888877765432 2234578899999999999999999999 5555543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=337.50 Aligned_cols=257 Identities=23% Similarity=0.413 Sum_probs=214.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRA-----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~-----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
..++|++++.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.++..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45689999999999999999998753 67899999987542 234456788899999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG----------------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDN 888 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~----------------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPEN 888 (1170)
..+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997432 36788889999999999999999999999999999
Q ss_pred EEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcc
Q 001057 889 LLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT 968 (1170)
Q Consensus 889 ILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~k 968 (1170)
||++.++.++|+|||++....... .........++..|+|||++.+..++.+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSAD----------------------------YYKASENDAIPIRWMPPESIFYNRYTTE 212 (288)
T ss_pred eEecCCCceEECccccceecccCc----------------------------cccccCCCccChhhcCHHHHhcCCCCch
Confidence 999999999999999987421000 0000112234567999999998899999
Q ss_pred hhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 969 ADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 969 sDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+|||||||++|+|++ |..||.+.+..+....+..+... ..+..++.++.+||.+||+.||.+||++.++...|+
T Consensus 213 ~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 999999999999997 88999998888888877765542 234678899999999999999999999766666554
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=330.72 Aligned_cols=247 Identities=26% Similarity=0.459 Sum_probs=207.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeee-ecccceE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSF-TCRENLY 834 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~F-qd~~~Ly 834 (1170)
...+|++.+.||+|+||.||++... |..||+|.+... ...+.+.+|+.+++.++|+||+++++++ .....+|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 4568999999999999999999764 788999987643 2345688999999999999999999875 4556799
Q ss_pred EEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-- 154 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 154 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc--
Confidence 9999999999999997653 488999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
......++..|+|||++.+..++.++|||||||++|+|++ |.+||...
T Consensus 155 -------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~ 203 (256)
T cd05082 155 -------------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred -------------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 0012234568999999998889999999999999999997 99999988
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+..++...+..+.. +..+..+++.+.+||.+||+.+|.+||++.++.+.|+
T Consensus 204 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 204 PLKDVVPRVEKGYK--MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred CHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 88777777755422 2344678999999999999999999999666655554
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=337.53 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=212.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
...+|.+.++||+|+||.||+|... .++..+|+|.+.... ......+.+|++++..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4467999999999999999999743 356789999876542 34566889999999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG---------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG 895 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~---------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG 895 (1170)
..+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999997643 478899999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHH
Q 001057 896 HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVG 975 (1170)
Q Consensus 896 ~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLG 975 (1170)
.+||+|||++...... ..........+++.|+|||++.+..++.++||||||
T Consensus 160 ~~kL~dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 211 (280)
T cd05092 160 VVKIGDFGMSRDIYST----------------------------DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211 (280)
T ss_pred CEEECCCCceeEcCCC----------------------------ceeecCCCccccccccCHHHhccCCcCchhhHHHHH
Confidence 9999999998742100 000111233467889999999998999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 976 IILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 976 VILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
|++|+|++ |.+||......+....+..+... ..+..+++.+.+||.+||+.||.+||++.++.+.|
T Consensus 212 ~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 212 VVLWEIFTYGKQPWYQLSNTEAIECITQGREL--ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred HHHHHHHcCCCCCCccCCHHHHHHHHHcCccC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 99999998 99999888877777777654322 23457899999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=338.42 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=213.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
...+|.+.+.||+|+||.||+|++. .++..+|+|.+.... ......+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 3467999999999999999999854 345679999876532 33446788999999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD 894 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d 894 (1170)
..+++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997542 37899999999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHH
Q 001057 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974 (1170)
Q Consensus 895 G~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSL 974 (1170)
+.++|+|||++...... ..........|++.|+|||++.+..++.++|||||
T Consensus 160 ~~~~l~dfg~a~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 211 (291)
T cd05094 160 LLVKIGDFGMSRDVYST----------------------------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211 (291)
T ss_pred CcEEECCCCcccccCCC----------------------------ceeecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence 99999999998742100 00011223457889999999999899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 975 GIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 975 GVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
||++|+|++ |.+||...+..+..+.+..+... ..+..++..+.+||.+||+.||.+||++.++.+.++
T Consensus 212 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 212 GVILWEIFTYGKQPWFQLSNTEVIECITQGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 999999998 99999988888887777665443 234567899999999999999999999666555543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=344.57 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=207.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCE----EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDL----FAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~----VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
+...+|++++.||+|+||+||+|++..+++. ||+|++.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 3456899999999999999999998766654 8999886432 234556788999999999999999999988764
Q ss_pred cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999999875 468899999999999999999999999999999999999999999999999998531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
... .........++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 161 ~~~----------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~ 212 (316)
T cd05108 161 ADE----------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212 (316)
T ss_pred CCC----------------------------cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 000 0001112334678999999999999999999999999999997 99999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.+....++...+.. ...++ .+..++.++.++|.+||..||.+||+ +.+++.+
T Consensus 213 ~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps---~~~l~~~ 264 (316)
T cd05108 213 DGIPASEISSILEK-GERLP-QPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 264 (316)
T ss_pred CCCCHHHHHHHHhC-CCCCC-CCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 98877666544433 33333 23567889999999999999999999 5555554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=332.16 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=205.6
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCC--EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------c
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGD--LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR------E 831 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe--~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~------~ 831 (1170)
|.+.+.||+|+||.||+|++..++. .||+|.++... ......+.+..|+.++..++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567889999999999999887775 69999887542 2445567888999999999999999999865322 2
Q ss_pred ceEEEEeeccCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 832 NLYLVMEYLNGGDLYSLLRN------LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~------~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
..++||||+.+|+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988742 134889999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-C
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-G 984 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G 984 (1170)
+...... .........+++.|+|||++.+..++.++|||||||++|||++ |
T Consensus 160 ~~~~~~~----------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g 211 (272)
T cd05075 160 KKIYNGD----------------------------YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRG 211 (272)
T ss_pred cccCccc----------------------------ceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCC
Confidence 7521000 0001122346778999999999889999999999999999999 8
Q ss_pred CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 985 IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.+||.+....+++..+.++... ..+..++..+.++|.+||+.||.+||++.++.+.|
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 212 QTPYPGVENSEIYDYLRQGNRL--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred CCCCCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999988888888877765432 23357889999999999999999999955444333
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=331.48 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=212.6
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRAT---GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~T---Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.++|++.+.||+|+||+||+|+++.+ ...||+|++.... .......+.+|+.++..++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46799999999999999999998654 4589999886542 344556788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|+||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS- 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc-
Confidence 9999999999999999764 46899999999999999999999999999999999999999999999999999853100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
..........+++.|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 160 ---------------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 160 ---------------------------EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred ---------------------------ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 00001112335678999999998889999999999999999997 99999888
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
...+....+...... + .+...+..+.+|+.+||+.+|.+||++.++.+.|
T Consensus 213 ~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 213 SNQDVIKAVEDGYRL-P-PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred CHHHHHHHHHcCCCC-C-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 888777777654321 1 2357899999999999999999999955444443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=332.05 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=209.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
..+|++++.||.|+||+||+|.... +..||+|.+..... ..+.+.+|+.++..++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998754 44699998875432 235688999999999999999999999998999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++....
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~----- 152 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD----- 152 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCC-----
Confidence 9999999999999764 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ 994 (1170)
..........++..|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 153 ------------------------~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 208 (256)
T cd05113 153 ------------------------DEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS 208 (256)
T ss_pred ------------------------CceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH
Confidence 00001112345678999999998889999999999999999998 99999988888
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+....+..+...+ .+...+..+.++|.+||+.||.+||+ +.+++.
T Consensus 209 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~---~~~ll~ 253 (256)
T cd05113 209 ETVEKVSQGLRLY--RPHLASEKVYAIMYSCWHEKAEERPT---FQQLLS 253 (256)
T ss_pred HHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 8888777654432 23567899999999999999999999 556654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=334.06 Aligned_cols=253 Identities=23% Similarity=0.376 Sum_probs=208.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCC----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGD----LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe----~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
+...+|++++.||.|+||+||+|++..+++ .||+|++.... .......+.+|+.++..++||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 345789999999999999999999877776 48999886532 33445678899999999999999999998875
Q ss_pred cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
...+++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 4578999999999999999764 569999999999999999999999999999999999999999999999999987531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
... .........+++.|+|||++.+..++.++|||||||++|||++ |.+||
T Consensus 161 ~~~----------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 212 (279)
T cd05109 161 IDE----------------------------TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred ccc----------------------------ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 000 0000112235678999999998889999999999999999998 99999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.......+...+...... ..+...+.++.++|.+||+.||.+||+ +.+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~l~ 262 (279)
T cd05109 213 DGIPAREIPDLLEKGERL--PQPPICTIDVYMIMVKCWMIDSECRPR---FRELV 262 (279)
T ss_pred CCCCHHHHHHHHHCCCcC--CCCccCCHHHHHHHHHHcCCChhhCcC---HHHHH
Confidence 888777766666544322 234578999999999999999999999 44555
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=339.79 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=206.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCC--EEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGD--LFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe--~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~Ly 834 (1170)
++|++.+.||.|+||.||+|+...++. .+|+|.++.. ......+.+.+|+.++.++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877765 4688877632 2334456788999999999 7999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEE
Q 001057 835 LVMEYLNGGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VK 898 (1170)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997532 478899999999999999999999999999999999999999999
Q ss_pred EEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHH
Q 001057 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978 (1170)
Q Consensus 899 LsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVIL 978 (1170)
|+|||++..... ........++..|+|||++.+..++.++|||||||++
T Consensus 160 l~dfg~~~~~~~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il 208 (297)
T cd05089 160 IADFGLSRGEEV-------------------------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLL 208 (297)
T ss_pred ECCcCCCccccc-------------------------------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHH
Confidence 999999863100 0000111234579999999988899999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 979 FELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 979 YELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
|||++ |.+||.+.+..+.+..+..+.. +..+..++..+.+||.+||+.+|.+||++.++
T Consensus 209 ~el~t~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 209 WEIVSLGGTPYCGMTCAELYEKLPQGYR--MEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 99997 9999999888888877765432 22346789999999999999999999994443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=333.30 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=213.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRA-----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~-----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
.++|++++.||.|+||.||+|+.+. +.+.||+|.+.... .....+.+.+|+.+|.+++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4689999999999999999999754 45689999876532 2235677899999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEec
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLG---------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~---------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDF 902 (1170)
..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999998655 6899999999999999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELL 982 (1170)
|++..... ..........++..|+|||.+.+..++.++|||||||++|+|+
T Consensus 162 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~ 212 (275)
T cd05046 162 SLSKDVYN-----------------------------SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212 (275)
T ss_pred ccccccCc-----------------------------ccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHH
Confidence 99864210 0000112335677899999998888899999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 983 I-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 983 T-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+ |..||........+..+..+...++ .+..++..+.++|.+||+.||.+||+ +.+++.
T Consensus 213 ~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~~l~ 271 (275)
T cd05046 213 TQGELPFYGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDRPS---FSELVS 271 (275)
T ss_pred hCCCCCccccchHHHHHHHHcCCcCCC-CCCCCCHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 8 8999988887788888776666554 34578899999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=330.67 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=211.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++.+.||.|+||.||+|.+. +++.||+|.++.... ..+.+.+|+.++.+++||||+++++++...+.+|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 3467999999999999999999975 457899999875432 23567889999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 836 VMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-- 156 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-- 156 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC--
Confidence 999999999999997654 6899999999999999999999999999999999999999999999999999753100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
.........++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+
T Consensus 157 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 157 ---------------------------IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred ---------------------------cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 0000011223468999999998889999999999999999999 999999988
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
....+..+.... ..+ .+..++..+.+||.+||+.+|.+||++.++.+.|+
T Consensus 210 ~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 210 NAEVLQQVDQGY-RMP-CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred HHHHHHHHHcCC-CCC-CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 887777775442 222 34578899999999999999999999666655543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=331.00 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=208.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++++.||+|+||.||+|.+. ++..||+|.+..... ..+.+.+|+.+++.++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 3468999999999999999999876 566799999876432 2346889999999999999999998875 456899
Q ss_pred EEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 836 VMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~-- 155 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN-- 155 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc--
Confidence 99999999999999763 35899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
.........++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 156 ---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~ 208 (260)
T cd05070 156 ---------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208 (260)
T ss_pred ---------------------------ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 0001112335678999999988889999999999999999999 999999888
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..++...+.... .. ..+...+..+.+||.+||..||.+||++..+.++|
T Consensus 209 ~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 209 NREVLEQVERGY-RM-PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HHHHHHHHHcCC-CC-CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 888777776532 22 23467899999999999999999999966665554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.33 Aligned_cols=257 Identities=22% Similarity=0.330 Sum_probs=212.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe---~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..++|+..+.||+|+||.||+|+.+.++. .+|+|.+.... .....+.+..|+.++..++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 44679999999999999999999876654 79999886542 23345678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+|+||||+++++|..++... +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999764 57899999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
. ...........++.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 161 ~---------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 161 P---------------------------EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred c---------------------------ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 0 00000111223567999999998889999999999999999997 9999998
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.+..++...+.... ..| .+..++..+.+||.+||+.+|.+||++.++.+.|
T Consensus 214 ~~~~~~~~~i~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 214 MSNHEVMKAINDGF-RLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred CCHHHHHHHHhcCC-CCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 88888887776542 222 2356789999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.99 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=206.2
Q ss_pred EEeccCCCeEEEEeeecCCC---CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeec
Q 001057 764 KPISQGAFGRVFLARKRATG---DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYL 840 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TG---e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~ 840 (1170)
++||+|+||.||+|....++ ..||+|.+...... ...+.+.+|+.+++.++||||+++++++. ...+++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876554 79999998765432 34567889999999999999999999776 45689999999
Q ss_pred cCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCC
Q 001057 841 NGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920 (1170)
Q Consensus 841 ~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~s 920 (1170)
.+|+|.+++.....+++..+..++.|++.||.|||.+||+||||||+|||++.++.+||+|||+++......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~-------- 149 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS-------- 149 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCC--------
Confidence 999999999888789999999999999999999999999999999999999999999999999987531000
Q ss_pred CCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 001057 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDN 999 (1170)
Q Consensus 921 l~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qk 999 (1170)
..........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..++...
T Consensus 150 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~ 210 (257)
T cd05060 150 -------------------DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM 210 (257)
T ss_pred -------------------cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 00000111224568999999998889999999999999999997 9999998887777777
Q ss_pred HhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 1000 Il~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+..... ...+..++..+++||.+||..+|.+||++.++.++++
T Consensus 211 ~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 211 LESGER--LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred HHcCCc--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 655432 2344678899999999999999999999766666554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=338.62 Aligned_cols=268 Identities=29% Similarity=0.471 Sum_probs=209.4
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR------ 830 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~------ 830 (1170)
.++|+++++||.|+||.||+|.++.+++.||||++...... ......+.+|+.+++.++||||+++++.+.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 68999999999999999999999999999999998654321 12234567899999999999999999877543
Q ss_pred --cceEEEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 831 --ENLYLVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 831 --~~LyLVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
..+|+||||+. ++|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 34799999995 478777765 35799999999999999999999999999999999999999999999999999875
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~p 986 (1170)
....... .. .. ............|++.|+|||++.+. .++.++|||||||++|+|++|.+
T Consensus 165 ~~~~~~~------~~------------~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~ 225 (311)
T cd07866 165 YDGPPPN------PK------------GG-GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225 (311)
T ss_pred ccCCCcc------cc------------cC-CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCC
Confidence 3110000 00 00 00011122345789999999998754 57899999999999999999999
Q ss_pred CCCCCCHHHHHHHHhccCCC--------------------CCCC-------CccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 987 PFNAKTPQQIFDNIMNRDIP--------------------WPNI-------PEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 987 PF~g~~~~ei~qkIl~~~l~--------------------fP~i-------p~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
||.+.+.......+...... .... ...++..+.+||.+||+.||.+||+ +
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~ 302 (311)
T cd07866 226 ILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT---A 302 (311)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC---H
Confidence 99988876665554421000 0000 0234578899999999999999999 8
Q ss_pred HHHHcCCCC
Q 001057 1040 REVKQHPFF 1048 (1170)
Q Consensus 1040 eEILqHPfF 1048 (1170)
.+++.||||
T Consensus 303 ~ell~~~~f 311 (311)
T cd07866 303 SDALEHPYF 311 (311)
T ss_pred HHHhcCCCC
Confidence 899999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=349.83 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=206.2
Q ss_pred EEeccC--CCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeecc
Q 001057 764 KPISQG--AFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLN 841 (1170)
Q Consensus 764 k~LG~G--gFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~ 841 (1170)
..||+| +||+||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|...+.+|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 999999999999999999999875433 23455788899999999999999999999999999999999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCC
Q 001057 842 GGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919 (1170)
Q Consensus 842 GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~ 919 (1170)
+++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~------ 156 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ------ 156 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc------
Confidence 99999999864 3589999999999999999999999999999999999999999999999986542110000
Q ss_pred CCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC--CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM--GHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 920 sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~--~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.. ...........++..|||||++.+. .++.++|||||||++|+|++|.+||.+.......
T Consensus 157 ----~~-------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~ 219 (328)
T cd08226 157 ----KA-------------KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219 (328)
T ss_pred ----cc-------------cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH
Confidence 00 0000001122356779999999763 4789999999999999999999999887655544
Q ss_pred HHHhccCCCCC--------------------------------------------CCCccCCHHHHHHHHHhccCCCCCC
Q 001057 998 DNIMNRDIPWP--------------------------------------------NIPEEMSVEACDLIDKLLTENPVQR 1033 (1170)
Q Consensus 998 qkIl~~~l~fP--------------------------------------------~ip~~lS~eakDLIkkLLq~DPskR 1033 (1170)
..+.......| ..+..++..+.+||.+||+.||.+|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 299 (328)
T cd08226 220 LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKR 299 (328)
T ss_pred HHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccC
Confidence 44332211100 0112357789999999999999999
Q ss_pred CChhhHHHHHcCCCCCCC
Q 001057 1034 LGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1034 pSa~~AeEILqHPfF~~i 1051 (1170)
|+ +.++++||||..+
T Consensus 300 pt---a~e~l~~~~~~~~ 314 (328)
T cd08226 300 PS---ASSLLSHAFFKQV 314 (328)
T ss_pred CC---HHHHhhCHHHHHH
Confidence 99 8899999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=332.48 Aligned_cols=252 Identities=26% Similarity=0.415 Sum_probs=209.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++.++||.|+||.||+|++..++ .||+|++.+... ..+.+.+|+.++..++||||+++++.+. ....|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 3467999999999999999999987654 599999876432 2246788999999999999999998775 456899
Q ss_pred EEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 836 VMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~-- 155 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-- 155 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc--
Confidence 99999999999999763 35889999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
.........++..|+|||++.+..++.++|||||||++|+|++ |.+||.+..
T Consensus 156 ---------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 156 ---------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred ---------------------------ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 0001112346778999999988889999999999999999999 899999888
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
..+++..+.... ..+ .+..++..+.+||.+||+.||.+||++..+.++|+
T Consensus 209 ~~~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 209 NREVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred hHHHHHHHhcCC-CCC-CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 888777775543 222 23578899999999999999999999776666654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=331.63 Aligned_cols=249 Identities=23% Similarity=0.428 Sum_probs=207.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
..+|++.+.||.|+||.||+|+++ ++..+|+|++.+... ....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 356999999999999999999886 466899999875432 124577899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~----- 152 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----- 152 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccc-----
Confidence 9999999999999764 4689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ 994 (1170)
..........++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..
T Consensus 153 ------------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 208 (256)
T cd05059 153 ------------------------DQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS 208 (256)
T ss_pred ------------------------ccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH
Confidence 00000111224567999999998899999999999999999998 89999988887
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+....+..... . ..+...+.++.+|+.+||+.+|.+||+ +.++++
T Consensus 209 ~~~~~~~~~~~-~-~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~~~l~ 253 (256)
T cd05059 209 EVVESVSAGYR-L-YRPKLAPTEVYTIMYSCWHEKPEDRPA---FKKLLS 253 (256)
T ss_pred HHHHHHHcCCc-C-CCCCCCCHHHHHHHHHHhcCChhhCcC---HHHHHH
Confidence 77777765421 1 233568999999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=350.52 Aligned_cols=255 Identities=32% Similarity=0.517 Sum_probs=208.6
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc------
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE------ 831 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~------ 831 (1170)
.+|.+.+.||.|+||.||+|++..+|+.||+|++.+... .......+.+|+.++..++||||++++++|....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 579999999999999999999999999999999876432 2233456789999999999999999999887543
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+|+||||+. .+|..++. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~-- 168 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD-- 168 (342)
T ss_pred eEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC--
Confidence 4699999995 47776653 368999999999999999999999999999999999999999999999999987410
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 169 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~ 217 (342)
T cd07879 169 -------------------------------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217 (342)
T ss_pred -------------------------------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 01123467899999999876 4588899999999999999999999998
Q ss_pred CCHHHHHHHHhccC-----------------------CCCC-----CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 991 KTPQQIFDNIMNRD-----------------------IPWP-----NIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~-----------------------l~fP-----~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
.+....+..+.... ...+ ......+..+.+||.+||+.||.+||+ +.++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~---~~e~ 294 (342)
T cd07879 218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT---ATEA 294 (342)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC---HHHH
Confidence 87655554443210 0000 001246788999999999999999999 8899
Q ss_pred HcCCCCCCCC
Q 001057 1043 KQHPFFKNIN 1052 (1170)
Q Consensus 1043 LqHPfF~~id 1052 (1170)
+.||||..+.
T Consensus 295 l~h~~f~~~~ 304 (342)
T cd07879 295 LEHPYFDSFR 304 (342)
T ss_pred hcCcchhhcc
Confidence 9999998874
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.78 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=212.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe---~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
..+|++.+.||.|+||.||+|+++.++. .||+|.+.... .......+.+|+.++..++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4679999999999999999999865543 79999886532 233456788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|+||||+++++|.+++... +.++...+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999987531000
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
..........++..|+|||++.+..++.++|+|||||++|+|++ |..||.+.
T Consensus 161 ---------------------------~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 161 ---------------------------EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred ---------------------------ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 00001111234568999999998889999999999999999886 99999988
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+..+....+.... ..+ .+..++..+.+|+.+||+.+|.+||++.++.++|.
T Consensus 214 ~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 214 SNQDVIKAIEEGY-RLP-APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred CHHHHHHHHhCCC-cCC-CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 8777777776542 222 23567899999999999999999999766655543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.29 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=215.6
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|..+++||.|+||+||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 37778889999999999999999999999999876554445556778899999999999999999999999999999999
Q ss_pred eccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 839 YLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 839 Y~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 102 ~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-------- 172 (313)
T cd06633 102 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-------- 172 (313)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC--------
Confidence 995 578887765 4568999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
......|+..|+|||++. ...++.++|||||||++|+|++|.+||...+..
T Consensus 173 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~ 226 (313)
T cd06633 173 --------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 226 (313)
T ss_pred --------------------------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 112356889999999985 345788999999999999999999999887766
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
.....+.....+.. ....++..+++||.+||+.+|.+||+ +.+++.||||+...
T Consensus 227 ~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rp~---~~~~l~~~~~~~~~ 280 (313)
T cd06633 227 SALYHIAQNDSPTL-QSNEWTDSFRGFVDYCLQKIPQERPA---SAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHHhcCCCCC-CccccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCc
Confidence 65555544332211 12356788999999999999999999 88999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=359.73 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=210.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCC-----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRAT-----GDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFT 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~T-----Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fq 828 (1170)
...++|++++.||.|+||.||+|.+... +..||||++.... .....+.+.+|+.+|..+. |||||+++++|.
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3456899999999999999999987433 3579999986542 3344578899999999996 999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhc--------------------------------------------------------
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNL-------------------------------------------------------- 852 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~-------------------------------------------------------- 852 (1170)
....+|||||||++|+|.++|...
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 999999999999999999988642
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC
Q 001057 853 ----------------------------------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG 892 (1170)
Q Consensus 853 ----------------------------------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd 892 (1170)
..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~ 271 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence 1367788889999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhh
Q 001057 893 QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWW 972 (1170)
Q Consensus 893 ~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIW 972 (1170)
.++.+||+|||+++..... ..........+++.|+|||++.+..++.++|||
T Consensus 272 ~~~~~kL~DfGla~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 323 (400)
T cd05105 272 QGKIVKICDFGLARDIMHD----------------------------SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323 (400)
T ss_pred CCCEEEEEeCCcceecccc----------------------------ccccccCCcCCCcceEChhhhcCCCCCchhhHH
Confidence 9999999999998752100 000112234578899999999998899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 973 SVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 973 SLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
||||++|||++ |..||........+.........+ ..+..++.++.+||.+||+.||.+||++.++.+++.
T Consensus 324 SlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM-AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC-CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 99999999997 999998765444333333333222 234678999999999999999999999777766664
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.82 Aligned_cols=247 Identities=27% Similarity=0.442 Sum_probs=210.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.++..++|+||+++++++.+....|+
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 4568999999999999999999864 88999999876432 45778999999999999999999999999899999
Q ss_pred EEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 836 VMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++...
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~---- 153 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS---- 153 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccc----
Confidence 999999999999998765 69999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
. ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 154 --------------------------~---~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 204 (256)
T cd05039 154 --------------------------Q---GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204 (256)
T ss_pred --------------------------c---ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 0 0001234567999999988889999999999999999997 999999888
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..++...+..... +..+..+++.+.+||.+||..+|.+||++.++.+.|
T Consensus 205 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 205 LKDVVPHVEKGYR--MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred HHHHHHHHhcCCC--CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 8777766654322 233467899999999999999999999965555444
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=345.85 Aligned_cols=274 Identities=28% Similarity=0.424 Sum_probs=215.4
Q ss_pred CCeEE-EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHH-----------HHHHHHHHHHHHHhcCCCcEEEEEe
Q 001057 758 EDFEI-IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKN-----------AVESILAERNILISVRNPFVVRFFY 825 (1170)
Q Consensus 758 edYev-lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~-----------~ve~~l~EieILskL~HPNIVrL~~ 825 (1170)
++|.. .+.||.|+||+||+|.++.+++.||||++......... ....+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 46764 46799999999999999999999999998764322210 0124678999999999999999999
Q ss_pred eeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 826 SFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 826 ~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
+|...+.+|+||||+. |+|.+++.....+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 699999988788999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG 984 (1170)
........... ..... ............+++.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 167 ~~~~~~~~~~~---------------~~~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg 230 (335)
T PTZ00024 167 RRYGYPPYSDT---------------LSKDE-TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230 (335)
T ss_pred eeccccccccc---------------ccccc-cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhC
Confidence 75321100000 00000 00011122234578999999999764 468899999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhccC-----CCCC--------------------CCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 985 IPPFNAKTPQQIFDNIMNRD-----IPWP--------------------NIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~-----l~fP--------------------~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
.+||.+.+..+.+..+.... ..|+ ......+.++.+||.+||+.+|.+||+ +
T Consensus 231 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~ 307 (335)
T PTZ00024 231 KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS---A 307 (335)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC---H
Confidence 99999888776665554310 0011 011245788999999999999999999 8
Q ss_pred HHHHcCCCCCCC
Q 001057 1040 REVKQHPFFKNI 1051 (1170)
Q Consensus 1040 eEILqHPfF~~i 1051 (1170)
.+++.||||+..
T Consensus 308 ~~~l~~~~~~~~ 319 (335)
T PTZ00024 308 KEALKHEYFKSD 319 (335)
T ss_pred HHHhcCcccCCC
Confidence 899999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=329.25 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=207.2
Q ss_pred EeccCCCeEEEEeeec--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 765 PISQGAFGRVFLARKR--ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk--~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
.||.|+||.||+|... .++..||+|++.... .....+.+.+|+.+++.++||||+++++++. ...+|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999765 456679999886542 3445567899999999999999999999876 4578999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCC
Q 001057 843 GDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921 (1170)
Q Consensus 843 GSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl 921 (1170)
|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--------- 149 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD--------- 149 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCc---------
Confidence 999999975 4578999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 001057 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNI 1000 (1170)
Q Consensus 922 ~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkI 1000 (1170)
..........+++.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....+
T Consensus 150 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05115 150 ------------------SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI 211 (257)
T ss_pred ------------------cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 00000111234678999999988889999999999999999996 99999988887777766
Q ss_pred hccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 1001 MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 1001 l~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
..+.. +..+...+.++.+||.+||..||.+||++.++.+.++.-||
T Consensus 212 ~~~~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05115 212 EQGKR--LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY 257 (257)
T ss_pred HCCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhcC
Confidence 65442 23446789999999999999999999998878777776654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.28 Aligned_cols=256 Identities=30% Similarity=0.458 Sum_probs=209.7
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR------ 830 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~------ 830 (1170)
.++|.+++.||+|+||.||+|.+..+++.||+|++.+... .....+.+.+|+.++.+++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4789999999999999999999999999999999876422 223346678899999999999999999887643
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
..+|++++++ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~- 171 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD- 171 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc-
Confidence 3478899987 7899888765 469999999999999999999999999999999999999999999999999986410
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 172 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 172 --------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred --------------------------------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 01123468899999999876 468889999999999999999999998
Q ss_pred CCCHHHHHHHHhccCC----------------------------CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 990 AKTPQQIFDNIMNRDI----------------------------PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l----------------------------~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+.+....+..+..... .+.......++++.+||.+||+.||.+|++ +.+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e 296 (345)
T cd07877 220 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQ 296 (345)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC---HHH
Confidence 7766554443322110 011111246888999999999999999999 789
Q ss_pred HHcCCCCCCC
Q 001057 1042 VKQHPFFKNI 1051 (1170)
Q Consensus 1042 ILqHPfF~~i 1051 (1170)
++.||||++.
T Consensus 297 ~l~h~~f~~~ 306 (345)
T cd07877 297 ALAHAYFAQY 306 (345)
T ss_pred HhcChhhhhc
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.40 Aligned_cols=261 Identities=31% Similarity=0.460 Sum_probs=209.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecCC--CCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec----cc
Q 001057 759 DFEIIKPISQGAFGRVFLARKRAT--GDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTC----RE 831 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~T--Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd----~~ 831 (1170)
+|++.+.||.|+||.||+|++..+ +..||+|++.... ........+.+|+.++..+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999888 8999999986432 2223356678899999999 59999999986432 24
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+|++|+|+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5889999985 699999988888999999999999999999999999999999999999999999999999999753100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.. ..........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+
T Consensus 159 ~~--------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 159 PG--------------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred cc--------------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 00 00111234578999999998876 4689999999999999999999999987
Q ss_pred CCHHHHHHHHhcc----------------------------CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 991 KTPQQIFDNIMNR----------------------------DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 991 ~~~~ei~qkIl~~----------------------------~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
.+....+..++.. ...++......+..+.+||.+||+.||.+||+ +.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~l 289 (332)
T cd07857 213 KDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS---VEEA 289 (332)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC---HHHH
Confidence 7654444333221 01111122346889999999999999999999 8899
Q ss_pred HcCCCCCC
Q 001057 1043 KQHPFFKN 1050 (1170)
Q Consensus 1043 LqHPfF~~ 1050 (1170)
+.||||+.
T Consensus 290 l~~~~~~~ 297 (332)
T cd07857 290 LEHPYLAI 297 (332)
T ss_pred hcChhhhh
Confidence 99999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=341.35 Aligned_cols=255 Identities=29% Similarity=0.439 Sum_probs=217.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
..|...+.||.|+||.||++++..++..||+|++.+...........+.+|+.+++.++|||++++++++.+....|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34889999999999999999999999999999987654444455678889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus 105 e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------- 176 (317)
T cd06635 105 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------- 176 (317)
T ss_pred eCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-------
Confidence 9996 478777754 4568999999999999999999999999999999999999999999999999876310
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
......|++.|+|||++. ...++.++|||||||++|+|++|.+||...+.
T Consensus 177 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 229 (317)
T cd06635 177 ---------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229 (317)
T ss_pred ---------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 012346889999999985 34578899999999999999999999988877
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
......+........ ....++..+++||.+||+.+|.+||+ +.++++|+|+...
T Consensus 230 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~ 283 (317)
T cd06635 230 MSALYHIAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQDRPT---SEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHHHhccCCCC-CCccccHHHHHHHHHHccCCcccCcC---HHHHHhChhhhcc
Confidence 766666655443322 13467889999999999999999999 8899999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.58 Aligned_cols=257 Identities=22% Similarity=0.342 Sum_probs=207.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCC--------------CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATG--------------DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVR 822 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TG--------------e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVr 822 (1170)
.++|++.+.||+|+||.||+|++..++ ..||+|.+.... .......+.+|+++|..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 468999999999999999999875432 359999987532 3345567899999999999999999
Q ss_pred EEeeeecccceEEEEeeccCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEE
Q 001057 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLG------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLL 890 (1170)
Q Consensus 823 L~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENIL 890 (1170)
+++++.....+|+||||+.+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999986532 3678888999999999999999999999999999999
Q ss_pred eCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchh
Q 001057 891 IGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATAD 970 (1170)
Q Consensus 891 Ld~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksD 970 (1170)
++.++.+||+|||++...... ..........+++.|+|||++.+..++.++|
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 213 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSG----------------------------DYYRIQGRAVLPIRWMAWESILLGKFTTASD 213 (295)
T ss_pred EcCCCcEEecccccccccccC----------------------------cceeccCcCcCceeecChhhhccCCcCchhh
Confidence 999999999999998742100 0001112334578899999999888999999
Q ss_pred hhHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhc-----cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 971 WWSVGIILFELLI--GIPPFNAKTPQQIFDNIMN-----RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 971 IWSLGVILYELLT--G~pPF~g~~~~ei~qkIl~-----~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
||||||++|+|++ |..||...+..+....+.. ....+...+..++..+.+||.+||+.||.+||++..+.+.|
T Consensus 214 vwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9999999999988 7789988777666655432 12222223456789999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=328.07 Aligned_cols=251 Identities=26% Similarity=0.417 Sum_probs=208.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|+++++||.|+||.||+|..+ +++.||+|.+..... ....+.+|+.+++.++||||+++++++. .+.+|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 4568999999999999999999865 577899999875432 2356888999999999999999998764 567899
Q ss_pred EEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 836 VMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 155 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN-- 155 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC--
Confidence 99999999999998753 35899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
.........++..|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 156 ---------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 156 ---------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred ---------------------------CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 0001112345778999999998889999999999999999998 999999888
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..+....+.... .. ..+...+.++.+||.+||+.+|.+||++..+..+|
T Consensus 209 ~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 209 NPEVIQNLERGY-RM-PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred hHHHHHHHHcCC-CC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 877777665432 21 24467889999999999999999999966665554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=349.36 Aligned_cols=256 Identities=30% Similarity=0.478 Sum_probs=213.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc----
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN---- 832 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~---- 832 (1170)
.++|++.+.||.|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 467999999999999999999999999999999886542 223345667889999999999999999988876554
Q ss_pred --eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 833 --LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 833 --LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~- 169 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD- 169 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc-
Confidence 89999999 6799998876 569999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 170 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 170 --------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred --------------------------------ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 01123467889999999875 367889999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCC----------------------------CCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 990 AKTPQQIFDNIMNRDIP----------------------------WPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~----------------------------fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+.+..+.+..+...... +......++..+.+||.+||+.||.+||+ +.+
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt---~~e 294 (343)
T cd07851 218 GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT---AAE 294 (343)
T ss_pred CCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC---HHH
Confidence 88776666655432110 00111246889999999999999999999 889
Q ss_pred HHcCCCCCCC
Q 001057 1042 VKQHPFFKNI 1051 (1170)
Q Consensus 1042 ILqHPfF~~i 1051 (1170)
+++||||+..
T Consensus 295 ll~h~~~~~~ 304 (343)
T cd07851 295 ALAHPYLAEY 304 (343)
T ss_pred HhcCCCcccc
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=325.83 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=212.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++.+.||.|+||.||+|.+. .+..||||.+..... ....+.+|+.+++.++||||+++++++.....+|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 34578999999999999999999975 457899999875432 2356888999999999999999999999889999
Q ss_pred EEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+||||+++++|.+++... ..++...+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD- 156 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch-
Confidence 999999999999999764 36899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
.........++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.
T Consensus 157 ----------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 157 ----------------------------EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred ----------------------------hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 0000112234578999999998889999999999999999998 99999988
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+....++.+.... .. ..+...+.++.++|.+||+.+|.+||++..+.++++
T Consensus 209 ~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 209 TNREVLEQVERGY-RM-PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred CHHHHHHHHHcCC-CC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 8888777776532 21 223567899999999999999999999666665554
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=338.65 Aligned_cols=257 Identities=23% Similarity=0.357 Sum_probs=211.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecC-------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRA-------TGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYS 826 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~-------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~ 826 (1170)
...++|.+.+.||+|+||.||+|++.. ....||+|++.... .......+..|+.++..+ +||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 344689999999999999999998632 34579999987532 234566788999999999 59999999999
Q ss_pred eecccceEEEEeeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEE
Q 001057 827 FTCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLL 890 (1170)
Q Consensus 827 Fqd~~~LyLVMEY~~GGSL~dlLk~~----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENIL 890 (1170)
+.+...+|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 99999999999999999999999753 24788889999999999999999999999999999999
Q ss_pred eCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchh
Q 001057 891 IGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATAD 970 (1170)
Q Consensus 891 Ld~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksD 970 (1170)
++.++.+||+|||+++...... .........+++.|||||++.+..++.++|
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDID----------------------------YYKKTSNGRLPVKWMAPEALFDRVYTHQSD 218 (314)
T ss_pred EcCCCcEEEccccccccccccc----------------------------cccccccCCCCccccCHHHHccCCcCccch
Confidence 9999999999999997421000 000011123456899999999888999999
Q ss_pred hhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 971 WWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 971 IWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
||||||++|+|++ |..||.+.+..+.+..+..... +..+..++.++++||.+||..||.+||++.++.+.+
T Consensus 219 iwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 219 VWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred hhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999999999999 9999999888888887766542 223467889999999999999999999965554444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=350.54 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=203.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCR 830 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~ 830 (1170)
.++|++.+.||.|+||.||+|+.. .+++.||+|++.... .....+.+..|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 357999999999999999999754 345899999986532 233456778899999999 799999999987654
Q ss_pred -cceEEEEeeccCCChHHHHHhc---------------------------------------------------------
Q 001057 831 -ENLYLVMEYLNGGDLYSLLRNL--------------------------------------------------------- 852 (1170)
Q Consensus 831 -~~LyLVMEY~~GGSL~dlLk~~--------------------------------------------------------- 852 (1170)
..+|++|||+++|+|.+++...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5789999999999999998542
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccc
Q 001057 853 ----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928 (1170)
Q Consensus 853 ----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~ 928 (1170)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||+++.....
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~----------------- 226 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD----------------- 226 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccC-----------------
Confidence 25788999999999999999999999999999999999999999999999999753100
Q ss_pred cccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCC
Q 001057 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPW 1007 (1170)
Q Consensus 929 ~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~f 1007 (1170)
..........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+.........
T Consensus 227 -----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~- 294 (337)
T cd05054 227 -----------PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR- 294 (337)
T ss_pred -----------cchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-
Confidence 00011223456778999999999999999999999999999997 99999876544443333332222
Q ss_pred CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 1008 PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 1008 P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+..+...+.++.+++.+||+.+|.+||+ +.++++|
T Consensus 295 ~~~~~~~~~~~~~l~~~cl~~~p~~RPs---~~ell~~ 329 (337)
T cd05054 295 MRAPEYATPEIYSIMLDCWHNNPEDRPT---FSELVEI 329 (337)
T ss_pred CCCCccCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 2234678899999999999999999999 4455543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=330.53 Aligned_cols=254 Identities=27% Similarity=0.500 Sum_probs=214.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI--RKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~--~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+|.+.+.||.|+||.||++++..++..+++|+++..... .......+..|+.++..++||||+++++++.+...+|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 589999999999999999999888887888877643321 223344567899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 837 MEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|||+++++|..++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999998864 346899999999999999999999999999999999999974 6799999999875210
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+..
T Consensus 158 ----------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 158 ----------------------------SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred ----------------------------CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 0011223468899999999988888999999999999999999999998877
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.......+..+.. +..+..++.++.++|.+||..||.+||+ +.++++||||
T Consensus 210 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 260 (260)
T cd08222 210 FLSVVLRIVEGPT--PSLPETYSRQLNSIMQSMLNKDPSLRPS---AAEILRNPFI 260 (260)
T ss_pred HHHHHHHHHcCCC--CCCcchhcHHHHHHHHHHhcCChhhCcC---HHHHhhCCCC
Confidence 7777666655433 3445678999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.27 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=208.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecC-------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRA-------TGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYS 826 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~-------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~ 826 (1170)
+..++|.+.+.||+|+||.||+|++.. +...||+|.+.... .......+..|+.++..+ +||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 334789999999999999999998643 23579999987542 234456788899999999 79999999999
Q ss_pred eecccceEEEEeeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEE
Q 001057 827 FTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLL 890 (1170)
Q Consensus 827 Fqd~~~LyLVMEY~~GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENIL 890 (1170)
+...+.+|+||||+++|+|.+++.... .++...+..++.||+.||+|||++||+||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997642 4788889999999999999999999999999999999
Q ss_pred eCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchh
Q 001057 891 IGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATAD 970 (1170)
Q Consensus 891 Ld~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksD 970 (1170)
++.++.+||+|||+++...... .........+++.|+|||++.+..++.++|
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 224 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHID----------------------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224 (307)
T ss_pred EcCCCcEEECCCcccccccccc----------------------------hhhccccCCCccceeChHHhccCCCCcHHH
Confidence 9999999999999987421000 000011123457899999999888999999
Q ss_pred hhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 971 WWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 971 IWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
||||||++|+|++ |..||.+.+..+++..+..... +..+..++.++.+||.+||..+|.+||++.++
T Consensus 225 vwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 225 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred HHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 9999999999998 9999998888777777655432 23446789999999999999999999995444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=384.26 Aligned_cols=266 Identities=26% Similarity=0.405 Sum_probs=208.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|+++++||+|+||.||+|++..+|+.||||++...........+.+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999998765433445567889999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 837 MEYLNGGDLYSLLRNL-----------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-----------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||+|
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 23455667889999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
+....... ..........+ ............+||+.|||||++.+..++.++|||||||++|||++|.
T Consensus 161 k~i~~~~~-~~~~l~~~~~~-----------s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~ 228 (932)
T PRK13184 161 IFKKLEEE-DLLDIDVDERN-----------ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS 228 (932)
T ss_pred eecccccc-ccccccccccc-----------ccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCC
Confidence 85311000 00000000000 0001111223468999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHH-hccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC
Q 001057 986 PPFNAKTPQQIFDNI-MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 986 pPF~g~~~~ei~qkI-l~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
+||.+.+...+.... ........ ....+++.+.+++.+||+.||.+|++
T Consensus 229 ~PF~~~~~~ki~~~~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 229 FPYRRKKGRKISYRDVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred CCCCCcchhhhhhhhhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcC
Confidence 999876654433221 11111111 11367899999999999999999988
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.90 Aligned_cols=255 Identities=35% Similarity=0.600 Sum_probs=210.9
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cceEEEE
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--ENLYLVM 837 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~LyLVM 837 (1170)
|++++.||.|+||.||+|.+..+++.||+|++.... ........+.+|+.++..++||||+++++++.+. ..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998753 2334456788899999999999999999999988 8899999
Q ss_pred eeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||++ ++|..++... ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.......
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~---- 154 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---- 154 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC----
Confidence 9996 5899988765 579999999999999999999999999999999999999999999999999987531000
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
........++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+...
T Consensus 155 -------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~ 209 (287)
T cd07840 155 -------------------------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE 209 (287)
T ss_pred -------------------------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 001122356889999998765 457899999999999999999999999888766
Q ss_pred HHHHHhccC-----CCCCC-----------------------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 996 IFDNIMNRD-----IPWPN-----------------------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 996 i~qkIl~~~-----l~fP~-----------------------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
.+..+.... ..|+. +...++..+.++|.+||+.||.+||+ +.+++.|||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~~~ 286 (287)
T cd07840 210 QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS---ADQALQHEY 286 (287)
T ss_pred HHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC---HHHHhhCcC
Confidence 665554311 00110 00113889999999999999999999 889999999
Q ss_pred C
Q 001057 1048 F 1048 (1170)
Q Consensus 1048 F 1048 (1170)
|
T Consensus 287 ~ 287 (287)
T cd07840 287 F 287 (287)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=346.82 Aligned_cols=259 Identities=30% Similarity=0.485 Sum_probs=208.4
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-------
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR------- 830 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~------- 830 (1170)
.+|++.+.||.|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 689999999999999999999999999999999865432 4456788999999999999999999776553
Q ss_pred -------cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-CCcEEEEec
Q 001057 831 -------ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDF 902 (1170)
Q Consensus 831 -------~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-dG~VKLsDF 902 (1170)
..+|+||||+. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35799999996 589888864 46899999999999999999999999999999999999975 557899999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYEL 981 (1170)
|++....... ..........|+..|+|||++.+ ..++.++|||||||++|+|
T Consensus 160 g~~~~~~~~~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 212 (342)
T cd07854 160 GLARIVDPHY---------------------------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212 (342)
T ss_pred ccceecCCcc---------------------------ccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHH
Confidence 9987421000 00001112357899999998765 5678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhccC-------------------------C--CCCCCCccCCHHHHHHHHHhccCCCCCCC
Q 001057 982 LIGIPPFNAKTPQQIFDNIMNRD-------------------------I--PWPNIPEEMSVEACDLIDKLLTENPVQRL 1034 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei~qkIl~~~-------------------------l--~fP~ip~~lS~eakDLIkkLLq~DPskRp 1034 (1170)
++|..||.+.+..+....+.... . ++......++.++.+||.+||+.||.+||
T Consensus 213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 292 (342)
T cd07854 213 LTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL 292 (342)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc
Confidence 99999998877655554443210 0 00011135788999999999999999999
Q ss_pred ChhhHHHHHcCCCCCCC
Q 001057 1035 GATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1035 Sa~~AeEILqHPfF~~i 1051 (1170)
+ +.+++.||||+.+
T Consensus 293 t---~~ell~h~~~~~~ 306 (342)
T cd07854 293 T---AEEALMHPYMSCY 306 (342)
T ss_pred C---HHHHhCCCccccc
Confidence 9 8899999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.94 Aligned_cols=258 Identities=23% Similarity=0.365 Sum_probs=211.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeee-----cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARK-----RATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSF 827 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArd-----k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~F 827 (1170)
....++|.+.+.||+|+||.||+|.+ ..++..||+|++++.. .....+.+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 45567899999999999999999975 3456689999987543 234557789999999999 799999999999
Q ss_pred ecccceEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 828 TCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 828 qd~~~LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
...+.+|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999999997643 3899999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-C
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-G 984 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G 984 (1170)
+...... .........+++.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 189 ~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g 240 (302)
T cd05055 189 RDIMNDS----------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 240 (302)
T ss_pred ccccCCC----------------------------ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCC
Confidence 7421000 0001122346789999999998889999999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 985 IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
.+||.+......+.......... ..+...+.++.+||.+||..+|.+||++.++.+.
T Consensus 241 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~ 297 (302)
T cd05055 241 SNPYPGMPVDSKFYKLIKEGYRM-AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQL 297 (302)
T ss_pred CCCcCCCCchHHHHHHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 99998877665554444333322 2345678999999999999999999995544333
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=331.96 Aligned_cols=254 Identities=33% Similarity=0.582 Sum_probs=211.3
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
|++.+.||.|++|.||+|.+..+++.+|+|.+..... .......+.+|+.+|+.++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999999999999999876532 223456788899999999999999999999999999999999
Q ss_pred ccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 840 LNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 840 ~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
+.+ +|..++... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+.....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~-------- 150 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGS-------- 150 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC--------
Confidence 965 888888764 5799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.........++..|+|||.+.+. .++.++|+|||||++|+|++|++||.+.+..+.+
T Consensus 151 ----------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~ 208 (283)
T cd05118 151 ----------------------PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL 208 (283)
T ss_pred ----------------------CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 00011224578899999999876 7899999999999999999999999887766555
Q ss_pred HHHhccC-------------------CCCC--------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 998 DNIMNRD-------------------IPWP--------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 998 qkIl~~~-------------------l~fP--------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
..+...- ..++ .....++.++.+||.+||+.||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~ll~~~~~ 283 (283)
T cd05118 209 FKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT---AEQALAHPYF 283 (283)
T ss_pred HHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC---HHHHhhCCCC
Confidence 4443210 0000 111246889999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=332.82 Aligned_cols=253 Identities=24% Similarity=0.402 Sum_probs=207.9
Q ss_pred CeEEEEEeccCCCeEEEEeeecC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 759 DFEIIKPISQGAFGRVFLARKRA-----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~-----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... .......+.+|+.++..++||||+++++.|...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 33579999886543 233456788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcE
Q 001057 834 YLVMEYLNGGDLYSLLRNL------------------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~------------------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENI 889 (1170)
|+||||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2477888999999999999999999999999999999
Q ss_pred EeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcch
Q 001057 890 LIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA 969 (1170)
Q Consensus 890 LLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ks 969 (1170)
|++.++.+||+|||+++...... .........++..|+|||++.+..++.++
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~----------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~ 210 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEED----------------------------SYVKRSKGRIPVKWMAIESLFDHIYTTQS 210 (290)
T ss_pred EEcCCCcEEeccccccccccCcc----------------------------chhcccCCCCCccccCHHHHccCCcchHh
Confidence 99999999999999987421000 00011123456789999999888899999
Q ss_pred hhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 970 DWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 970 DIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
|||||||++|+|++ |..||.+..+..+.+.+... ..+ ..+..++.++.+||.+||+.||.+||++.++.+.|
T Consensus 211 Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 211 DVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCC-CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 99999999999998 99999998888877766543 222 23467899999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.37 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=207.0
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++...||.|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. ....|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46799999999999999999988655 4599998765432 2356788999999999999999998875 4568999
Q ss_pred EeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 837 MEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|||+.+|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~--- 155 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN--- 155 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC---
Confidence 9999999999999764 34789999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~ 993 (1170)
.........++..|+|||++.+..++.++|||||||++|+|++ |.+||.+...
T Consensus 156 --------------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 156 --------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred --------------------------cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 0001112345778999999988889999999999999999999 9999999888
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
.+....+.... .. ..+..++..+.+||.+||..||.+||++..+.+.|+
T Consensus 210 ~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 210 REVLEQVERGY-RM-PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred HHHHHHHHcCC-CC-CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 87777766542 22 234678999999999999999999999666655543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=340.32 Aligned_cols=255 Identities=30% Similarity=0.545 Sum_probs=214.0
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
|+...+||.|+||.||++..+.+++.||||.+... .......+.+|+.+++.++||||+++++.|...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 33446799999999999999999999999987532 223456788999999999999999999999999999999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCC
Q 001057 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~ 919 (1170)
+++++|.+++.. +.+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....
T Consensus 99 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~---------- 167 (292)
T cd06657 99 LEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS---------- 167 (292)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecc----------
Confidence 999999998754 468999999999999999999999999999999999999999999999999876421
Q ss_pred CCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 001057 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999 (1170)
Q Consensus 920 sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qk 999 (1170)
..........|++.|+|||++.+..++.++|+||+||++|+|++|.+||.+.........
T Consensus 168 --------------------~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~ 227 (292)
T cd06657 168 --------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 227 (292)
T ss_pred --------------------cccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 000111235689999999999888889999999999999999999999998877666555
Q ss_pred HhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1000 Il~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+.............++..+.++|.+||+.||.+||+ +.+++.||||...
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~---~~~ll~~~~~~~~ 276 (292)
T cd06657 228 IRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 276 (292)
T ss_pred HHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcC---HHHHhcChHHhcc
Confidence 543222111122457899999999999999999999 8899999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=335.03 Aligned_cols=260 Identities=32% Similarity=0.520 Sum_probs=210.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc---
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE--- 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~--- 831 (1170)
...++|++.+.||.|+||.||+|.++.+|+.||+|++..... .......+.+|+.++..++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456789999999999999999999999999999999875432 2223356678999999999999999999887655
Q ss_pred -------ceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecC
Q 001057 832 -------NLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFG 903 (1170)
Q Consensus 832 -------~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFG 903 (1170)
.+|+||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999975 777777654 469999999999999999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHH
Q 001057 904 LSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELL 982 (1170)
Q Consensus 904 LAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELL 982 (1170)
++....... ........++..|+|||++.+. .++.++|||||||++|+|+
T Consensus 162 ~~~~~~~~~-----------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~ 212 (302)
T cd07864 162 LARLYNSEE-----------------------------SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212 (302)
T ss_pred ccccccCCc-----------------------------ccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHH
Confidence 987531000 0011123467889999998753 4788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhcc---CC--CCCC----------------------CCccCCHHHHHHHHHhccCCCCCCCC
Q 001057 983 IGIPPFNAKTPQQIFDNIMNR---DI--PWPN----------------------IPEEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 983 TG~pPF~g~~~~ei~qkIl~~---~l--~fP~----------------------ip~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
+|++||...+..+.+..+... .. .+|. ....++..+.+||.+||+.||.+||+
T Consensus 213 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 292 (302)
T cd07864 213 TKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT 292 (302)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC
Confidence 999999887765555444331 10 0110 01246889999999999999999999
Q ss_pred hhhHHHHHcCCCC
Q 001057 1036 ATGAREVKQHPFF 1048 (1170)
Q Consensus 1036 a~~AeEILqHPfF 1048 (1170)
+.+++.||||
T Consensus 293 ---~~~il~~~~~ 302 (302)
T cd07864 293 ---AEEALNSPWL 302 (302)
T ss_pred ---HHHHhcCCCC
Confidence 8899999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=327.20 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=209.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe---~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
..+|++.+.||+|+||.||+|.++.+++ .||||++.+.. .......+..|+.++..++||||+++++++.....+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999887665 69999986532 344567889999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|+||||+++|+|.+++... +.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999999764 568999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
. . ..........++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 161 ~---------------------~----~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 161 S---------------------D----PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred c---------------------c----cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 0 0 00000011122467999999998889999999999999999886 99999988
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
+.......+... ...| .+..++..+.+++.+||+.+|.+||++..+.
T Consensus 216 ~~~~~~~~i~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~ 262 (269)
T cd05065 216 SNQDVINAIEQD-YRLP-PPMDCPTALHQLMLDCWQKDRNARPKFGQIV 262 (269)
T ss_pred CHHHHHHHHHcC-CcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 887777777533 2222 2356789999999999999999999954443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.21 Aligned_cols=261 Identities=30% Similarity=0.533 Sum_probs=210.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCREN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~ 832 (1170)
....++|++.+.||.|+||.||+|.+..+++.||||.+.+... ......+..|+.++..+. ||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 3556889999999999999999999999999999999876532 223455666777676665 9999999999999999
Q ss_pred eEEEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
+|+||||+. ++|..++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~- 166 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV- 166 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc-
Confidence 999999984 578777765 3578999999999999999999997 599999999999999999999999999986421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC----CCcchhhhHHHHHHHHHHhCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG----HGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~----ys~ksDIWSLGVILYELLTG~p 986 (1170)
. ........|++.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 167 -~-----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (296)
T cd06618 167 -D-----------------------------SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQF 216 (296)
T ss_pred -C-----------------------------CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCC
Confidence 0 00111235788999999997653 7889999999999999999999
Q ss_pred CCCCCCH-HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 987 PFNAKTP-QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 987 PF~g~~~-~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
||..... .+.+..+.............++.++.+||.+||..||.+||+ +.+++.||||...
T Consensus 217 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 279 (296)
T cd06618 217 PYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK---YRELLQHPFIRRY 279 (296)
T ss_pred CCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhcc
Confidence 9976433 344555554433221112357899999999999999999999 8899999999854
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.81 Aligned_cols=254 Identities=33% Similarity=0.580 Sum_probs=211.8
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
|++.+.||.|+||.||+|+...+++.||+|++.... ......+.+..|+.+++.++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678889999999999999999999999999988654 2233446678899999999999999999999999999999999
Q ss_pred ccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 840 LNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 840 ~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
++ ++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~-------- 150 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI-------- 150 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC--------
Confidence 97 5999999876 5799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.........++..|+|||++.+. .++.++|+|||||++|||++|.+||.+.+....+
T Consensus 151 ----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~ 208 (282)
T cd07829 151 ----------------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL 208 (282)
T ss_pred ----------------------CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 00011223467889999999876 7889999999999999999999999988766655
Q ss_pred HHHhcc------------------CCCCCCC--------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 998 DNIMNR------------------DIPWPNI--------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 998 qkIl~~------------------~l~fP~i--------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
..+... ...++.. ...++..+.++|.+||..||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~p~~ 282 (282)
T cd07829 209 FKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS---AKEALKHPYF 282 (282)
T ss_pred HHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC---HHHHhhCcCC
Confidence 544321 1111110 1135788999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=369.26 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=223.7
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|.-++.||.|+||.||-|++..+.+.||||.+.-+.......-+.++.|+..|.+++|||+|.+-++|--+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 47778899999999999999999999999999987665555666789999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 839 YLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
||- |+-.+++.-+ +++.+.++..|+.+.+.||.|||+++.||||||..||||++.|.|||+|||.|...
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~--------- 176 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM--------- 176 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc---------
Confidence 995 5777777644 57999999999999999999999999999999999999999999999999998752
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc---CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g---~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
...++++|||+|||||||+. +.|+-++||||||++..||...+||+..++.+
T Consensus 177 -------------------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM 231 (948)
T KOG0577|consen 177 -------------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 231 (948)
T ss_pred -------------------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH
Confidence 13468999999999999974 46999999999999999999999999999988
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
..+.-|.....+... ...+|..++.|+..||++-|.+||+ .+++|.|+|...
T Consensus 232 SALYHIAQNesPtLq-s~eWS~~F~~Fvd~CLqKipqeRpt---se~ll~H~fv~R 283 (948)
T KOG0577|consen 232 SALYHIAQNESPTLQ-SNEWSDYFRNFVDSCLQKIPQERPT---SEELLKHRFVLR 283 (948)
T ss_pred HHHHHHHhcCCCCCC-CchhHHHHHHHHHHHHhhCcccCCc---HHHHhhcchhcc
Confidence 877777655543221 3578999999999999999999999 789999999864
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=324.21 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=206.5
Q ss_pred EEeccCCCeEEEEeeecC-CC--CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeec
Q 001057 764 KPISQGAFGRVFLARKRA-TG--DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYL 840 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~-TG--e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~ 840 (1170)
+.||.|+||.||+|.+.. .+ ..||||.+...... ...+.+.+|+.++++++||||+++++.+.. ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 33 36999998875432 566788999999999999999999999988 8899999999
Q ss_pred cCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 841 NGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 841 ~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~------ 151 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE------ 151 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc------
Confidence 9999999997754 68999999999999999999999999999999999999999999999999987531000
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIF 997 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~ 997 (1170)
. .........++..|+|||++.+..++.++|||||||++|+|++ |..||...+..++.
T Consensus 152 ------~---------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 210 (257)
T cd05040 152 ------D---------------HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL 210 (257)
T ss_pred ------c---------------ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 0 0001113457789999999998899999999999999999998 99999988888777
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..+......++ .+...+..+.+||.+||+.+|.+||++.++.+.|
T Consensus 211 ~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 211 KKIDKEGERLE-RPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred HHHHhcCCcCC-CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence 77664333222 3456889999999999999999999955554443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=321.43 Aligned_cols=249 Identities=28% Similarity=0.453 Sum_probs=211.3
Q ss_pred eEEEEEeccCCCeEEEEeeecCCC----CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 760 FEIIKPISQGAFGRVFLARKRATG----DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TG----e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
+++.+.||.|+||.||+|++..++ ..||+|++..... ......+..|+.++..++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 456789999999999999998766 8999999865432 2256788999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 836 VMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~--LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+|||+++++|.+++..... +++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD- 157 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc-
Confidence 9999999999999976544 9999999999999999999999999999999999999999999999999987531000
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
. . . .....+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||.+.+
T Consensus 158 ------------~-----------~-~----~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~ 209 (258)
T smart00219 158 ------------Y-----------Y-K----KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS 209 (258)
T ss_pred ------------c-----------c-c----cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 0 0 0 001226789999999988889999999999999999998 899999988
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
...+++.+...... ..+...+.++.++|.+||..||.+||+ +.++++
T Consensus 210 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~ 256 (258)
T smart00219 210 NEEVLEYLKKGYRL--PKPENCPPEIYKLMLQCWAEDPEDRPT---FSELVE 256 (258)
T ss_pred HHHHHHHHhcCCCC--CCCCcCCHHHHHHHHHHCcCChhhCcC---HHHHHh
Confidence 88888887765543 234568999999999999999999999 555553
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=335.56 Aligned_cols=254 Identities=21% Similarity=0.363 Sum_probs=210.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec-------CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEe
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR-------ATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFY 825 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk-------~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~ 825 (1170)
.+...+|.+.+.||.|+||.||+|+.. .++..||+|.+.... .......+.+|+.++..+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 355678999999999999999999753 234589999886532 234557788999999999 7999999999
Q ss_pred eeecccceEEEEeeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcE
Q 001057 826 SFTCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889 (1170)
Q Consensus 826 ~Fqd~~~LyLVMEY~~GGSL~dlLk~~----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENI 889 (1170)
++.....+|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999999763 2367778889999999999999999999999999999
Q ss_pred EeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcch
Q 001057 890 LIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA 969 (1170)
Q Consensus 890 LLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ks 969 (1170)
|++.++.+||+|||+++...... .........+++.|+|||++.+..++.++
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 220 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNID----------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQS 220 (304)
T ss_pred EEcCCCcEEECCCccceeccccc----------------------------ccccccCCCCCceeeCchhhccCCCCchh
Confidence 99999999999999987531000 00011223467789999999988899999
Q ss_pred hhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 970 DWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 970 DIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
|||||||++|+|++ |..||.+.+..++...+...... ..+..++.++.+||.+||..+|.+||++.++
T Consensus 221 Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 221 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred hHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 99999999999998 89999999888888887654422 2346789999999999999999999995444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=332.61 Aligned_cols=258 Identities=22% Similarity=0.362 Sum_probs=206.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecC----------------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRA----------------TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV 820 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~----------------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNI 820 (1170)
.++|++.+.||.|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|..++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986432 34579999987542 33455788899999999999999
Q ss_pred EEEEeeeecccceEEEEeeccCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcE
Q 001057 821 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-----------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889 (1170)
Q Consensus 821 VrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~-----------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENI 889 (1170)
+++++++...+.+|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999997642 366778999999999999999999999999999999
Q ss_pred EeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcch
Q 001057 890 LIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA 969 (1170)
Q Consensus 890 LLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ks 969 (1170)
|++.++.++|+|||+++...... .........+++.|+|||++.+..++.++
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~ 213 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGD----------------------------YYRIQGRAVLPIRWMSWESILLGKFTTAS 213 (296)
T ss_pred EEcCCCCEEeccCcccccccCCc----------------------------ceeccCcCcCccccCCHHHHhcCCccchh
Confidence 99999999999999987421000 00011223456789999999888899999
Q ss_pred hhhHHHHHHHHHHh--CCCCCCCCCHHHHHHHHhc-----cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 970 DWWSVGIILFELLI--GIPPFNAKTPQQIFDNIMN-----RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 970 DIWSLGVILYELLT--G~pPF~g~~~~ei~qkIl~-----~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
|||||||++|||++ |..||...+..+....... ........+..++..+.+||.+||+.||.+||++.++.++
T Consensus 214 DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 293 (296)
T cd05095 214 DVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHAT 293 (296)
T ss_pred hhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 99999999999998 7899988776665544321 1111112235678999999999999999999997666555
Q ss_pred Hc
Q 001057 1043 KQ 1044 (1170)
Q Consensus 1043 Lq 1044 (1170)
|+
T Consensus 294 l~ 295 (296)
T cd05095 294 LL 295 (296)
T ss_pred Hh
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=330.08 Aligned_cols=252 Identities=19% Similarity=0.293 Sum_probs=204.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCE----EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDL----FAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~----VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
+...+|++++.||.|+||+||+|.+..+++. ||+|.+... ........+..|+.++..++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 3456899999999999999999999877774 666665432 12334456778888999999999999999875 4
Q ss_pred cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..+++||||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 5678999999999999999764 568999999999999999999999999999999999999999999999999987521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
.. ..........|+..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 161 ~~----------------------------~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 161 PD----------------------------DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred CC----------------------------CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 00 00001123456778999999998889999999999999999998 99999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
.+.....+.+.+.++... ..+...+..+.+++.+|+..||.+||++.++
T Consensus 213 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 213 AGMRPHEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred CCCCHHHHHHHHHCCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 988877766666544432 2235578889999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=327.50 Aligned_cols=240 Identities=27% Similarity=0.399 Sum_probs=199.2
Q ss_pred EeccCCCeEEEEeeecCCCC--EEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEEEEeecc
Q 001057 765 PISQGAFGRVFLARKRATGD--LFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYLVMEYLN 841 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TGe--~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyLVMEY~~ 841 (1170)
.||+|+||.||+|++..++. .+|+|.+... ......+.+.+|+.++.++ +||||++++++|.....+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 58999999999999988776 4688877642 2334556788999999999 79999999999999999999999999
Q ss_pred CCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 842 GGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 842 GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
+|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997542 4788999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-C
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-G 984 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G 984 (1170)
.... ..........+..|+|||++.+..++.++|||||||++|||++ |
T Consensus 160 ~~~~-------------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g 208 (270)
T cd05047 160 RGQE-------------------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 208 (270)
T ss_pred cccc-------------------------------hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence 5210 0000011233567999999988889999999999999999997 9
Q ss_pred CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 985 IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
..||.+.+..+.++.+..... +..+..++.++.+||.+||..||.+||++.++
T Consensus 209 ~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 209 GTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred CCCccccCHHHHHHHHhCCCC--CCCCCcCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 999998888777777654321 12345688999999999999999999995444
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=326.04 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=197.8
Q ss_pred EeccCCCeEEEEeeecC--CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 765 PISQGAFGRVFLARKRA--TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~--TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 69999999999996532 44578888765432 234456788899999999999999999999999999999999999
Q ss_pred CChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 843 GDLYSLLRNLG-----CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 843 GSL~dlLk~~~-----~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~------ 153 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE------ 153 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccc------
Confidence 99999997642 2467788899999999999999999999999999999999999999999998642100
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-------CCCCcchhhhHHHHHHHHHHh-CCCCCC
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-------MGHGATADWWSVGIILFELLI-GIPPFN 989 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-------~~ys~ksDIWSLGVILYELLT-G~pPF~ 989 (1170)
+ .........+++.|+|||++.. ..++.++|||||||++|||++ |.+||.
T Consensus 154 -------~---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (269)
T cd05042 154 -------D---------------YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211 (269)
T ss_pred -------h---------------heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCC
Confidence 0 0001123346778999999853 346789999999999999999 889998
Q ss_pred CCCHHHHHHHHhc-cCCCC--CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 990 AKTPQQIFDNIMN-RDIPW--PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 990 g~~~~ei~qkIl~-~~l~f--P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.....+.+..+.. ....+ |..+..++....+++..|+ .||.+||++.++.+++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~~ 269 (269)
T cd05042 212 DLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLTY 269 (269)
T ss_pred cCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhcC
Confidence 8776666555443 32222 3344578899999999998 599999998777777765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=328.83 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=198.9
Q ss_pred CCe-EEEEEeccCCCeEEEEee----ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--
Q 001057 758 EDF-EIIKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-- 830 (1170)
Q Consensus 758 edY-evlk~LG~GgFGtVyLAr----dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-- 830 (1170)
++| ++++.||+|+||+||++. ...++..||+|++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 345 999999999999998865 34578899999987542 223456788899999999999999999987653
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
..+|+||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 4589999999999999999764 599999999999999999999999999999999999999999999999999875210
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.. ..........++..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 160 ~~---------------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 160 GH---------------------------EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred cc---------------------------hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 00 000001122456779999999888899999999999999999999999865
Q ss_pred CCHH--HHH------------HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 991 KTPQ--QIF------------DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 991 ~~~~--ei~------------qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.... +.. ......... +..+..++.++.+|+.+||+.||++||++.++.+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 213 PPKKFEEMIGPKQGQMTVVRLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred CcchhhhhhcccccccchhhhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 3321 110 011111111 123467889999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=336.12 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=204.0
Q ss_pred EeccC--CCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 765 PISQG--AFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 765 ~LG~G--gFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
+||+| ++|.||+++...+++.||||++.... ........+..|+.+++.++||||++++++|...+.+|++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34444 55667777777899999999987653 2345667899999999999999999999999999999999999999
Q ss_pred CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCC
Q 001057 843 GDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920 (1170)
Q Consensus 843 GSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~s 920 (1170)
|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||.+........ .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~--~---- 157 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK--R---- 157 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc--c----
Confidence 9999999764 4589999999999999999999999999999999999999999999999999874310000 0
Q ss_pred CCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001057 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998 (1170)
Q Consensus 921 l~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g--~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~q 998 (1170)
............++..|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 158 -----------------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~ 220 (314)
T cd08216 158 -----------------QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (314)
T ss_pred -----------------ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 0000111234467889999999976 358899999999999999999999998765544332
Q ss_pred HHhccCCC-------CC------------------------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 999 NIMNRDIP-------WP------------------------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 999 kIl~~~l~-------fP------------------------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
....+... ++ .....++.++.+||.+||+.||.+||+ +.++++|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~p~ 297 (314)
T cd08216 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS---ASQLLNHSF 297 (314)
T ss_pred HHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC---HHHHhcCch
Confidence 21111100 00 001234578899999999999999999 889999999
Q ss_pred CCCC
Q 001057 1048 FKNI 1051 (1170)
Q Consensus 1048 F~~i 1051 (1170)
|+.+
T Consensus 298 ~~~~ 301 (314)
T cd08216 298 FKQC 301 (314)
T ss_pred Hhhh
Confidence 9866
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=337.60 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=215.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
..|+.++.||.|+||.||+|+++.+++.||+|.+.............+.+|+.+++.++|+|++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45888999999999999999999999999999987543334445567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||+. |+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------- 166 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec-------
Confidence 9996 588877754 4568999999999999999999999999999999999999999999999999986420
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc---CCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g---~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 167 ---------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 167 ---------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred ---------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 0123468899999999853 4578899999999999999999999988776
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
......+.....+.. ....++..+.+||.+||+.+|.+||+ +.+++.||||...
T Consensus 220 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~---~~~ll~~~~~~~~ 273 (308)
T cd06634 220 MSALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHHhhcCCCCc-CcccccHHHHHHHHHHhhCCcccCCC---HHHHhhCcccccc
Confidence 655555554433321 13468899999999999999999999 8899999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=321.28 Aligned_cols=249 Identities=23% Similarity=0.423 Sum_probs=208.6
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
..+|++.+.||.|+||.||+|.+. .+..+|+|.+..... ....+.+|+++++.++||||+++++++.....+|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 357999999999999999999875 467899998875432 124578899999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+.+++|.+++... +.++++.++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 153 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD---- 153 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC----
Confidence 9999999999999764 46899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ 994 (1170)
.........++..|+|||++.+..++.++|||||||++|||++ |.+||......
T Consensus 154 -------------------------~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05112 154 -------------------------QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208 (256)
T ss_pred -------------------------cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 0000112335678999999998889999999999999999998 99999988888
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
.+.+.+..+...+ .+...+..+.+|+.+||+.+|.+||+ +.++++
T Consensus 209 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~~l~ 253 (256)
T cd05112 209 EVVETINAGFRLY--KPRLASQSVYELMQHCWKERPEDRPS---FSLLLH 253 (256)
T ss_pred HHHHHHhCCCCCC--CCCCCCHHHHHHHHHHcccChhhCCC---HHHHHH
Confidence 8887776543222 23457899999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=328.02 Aligned_cols=232 Identities=34% Similarity=0.531 Sum_probs=194.1
Q ss_pred CCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCChHHH
Q 001057 769 GAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL 848 (1170)
Q Consensus 769 GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL~dl 848 (1170)
|.||.||+|+++.+++.||+|.+.+.. ....|...+....||||+++++++.+.+.+|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999987643 122344555566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccc
Q 001057 849 LRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928 (1170)
Q Consensus 849 Lk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~ 928 (1170)
+.+...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~------------------- 136 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE------------------- 136 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccc-------------------
Confidence 9887789999999999999999999999999999999999999999999999999875321
Q ss_pred cccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC
Q 001057 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWP 1008 (1170)
Q Consensus 929 ~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP 1008 (1170)
.......++..|+|||++.+..++.++|+||+||++|||++|..||...... +. .... .
T Consensus 137 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~-~~~~-~ 195 (237)
T cd05576 137 --------------DSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----IN-THTT-L 195 (237)
T ss_pred --------------cccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc-cccc-c
Confidence 0011234577899999998888999999999999999999999998653321 10 0111 1
Q ss_pred CCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCC
Q 001057 1009 NIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFF 1048 (1170)
Q Consensus 1009 ~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF 1048 (1170)
.++..++..+++||.+||+.||.+|+++ ..+.++++||||
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 2346789999999999999999999985 346999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=398.95 Aligned_cols=259 Identities=34% Similarity=0.577 Sum_probs=223.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
++.-...||.|.||.||-|.+..||+..|+|-+.-.... ......+.+|..+|..++|||+|++|++-.+.+.+||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 466677899999999999999999999999988766544 5667788999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
||.||+|.+++...+..++...+.|..|++.||.|||++|||||||||+||||+.+|.+|++|||.|..+..+.
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~------ 1388 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA------ 1388 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch------
Confidence 99999999999988888999999999999999999999999999999999999999999999999998642110
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc---CCCCcchhhhHHHHHHHHHHhCCCCCCCCCH-H
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGIPPFNAKTP-Q 994 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g---~~ys~ksDIWSLGVILYELLTG~pPF~g~~~-~ 994 (1170)
..-......++|||.|||||++.+ .++..++|||||||++.||+||+.||...+. -
T Consensus 1389 --------------------~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1389 --------------------QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred --------------------hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence 001123347899999999999986 4688899999999999999999999986554 3
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
.++..+..+.. |.+|..+|.+.+|||.+||+.||.+|++ |.|++.|.|-+
T Consensus 1449 aIMy~V~~gh~--Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~---~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1449 AIMYHVAAGHK--PQIPERLSSEGRDFLEHCLEQDPKMRWT---ASQLLEHAFGK 1498 (1509)
T ss_pred HHHhHHhccCC--CCCchhhhHhHHHHHHHHHhcCchhhhH---HHHHHHhhccc
Confidence 44444444443 4566889999999999999999999998 77999998864
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=362.05 Aligned_cols=260 Identities=27% Similarity=0.482 Sum_probs=209.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccce
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~L 833 (1170)
+....|++++.||+||-+.||++...+. ..||+|.+.-. ..+...+..+.+|+.+|.+|+ |.+||+||++-..++.+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 4556799999999999999999987544 45666654322 335667889999999999997 89999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~-LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
||||||= ..||..+|+.... ++...+++|..||++|++++|++||||.||||.|+|+ -.|.+||+|||.|.....+.
T Consensus 436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT 513 (677)
T ss_pred EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence 9999965 6799999987754 4446899999999999999999999999999999998 57899999999998542111
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-----------CCcchhhhHHHHHHHHH
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-----------HGATADWWSVGIILFEL 981 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-----------ys~ksDIWSLGVILYEL 981 (1170)
+ .-...+.+||+.||+||.+.... .+.++||||||||||+|
T Consensus 514 T----------------------------sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqM 565 (677)
T KOG0596|consen 514 T----------------------------SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQM 565 (677)
T ss_pred c----------------------------ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHH
Confidence 0 11234679999999999997543 35789999999999999
Q ss_pred HhCCCCCCCCC-HHHHHHHHhcc--CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 982 LIGIPPFNAKT-PQQIFDNIMNR--DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 982 LTG~pPF~g~~-~~ei~qkIl~~--~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+.|++||.... ...-+..|..- .++||.++.. .++.++++.||.+||.+||+ +.++|+|||++.+
T Consensus 566 vYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~s---i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 566 VYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWS---IPELLQHPFLQIQ 633 (677)
T ss_pred HhcCCchHHHHHHHHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCC---cHHHhcCcccccc
Confidence 99999997533 23333445443 4577766543 34999999999999999999 8899999999863
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.58 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=210.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCC----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGD----LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe----~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
...+|++++.||.|+||+||+|.++.+|+ .||+|.+.+... ......+.+|+.++..++||||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 34689999999999999999999877665 689998776532 4455778899999999999999999998887 7
Q ss_pred ceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
..++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 899999999999999999874 4699999999999999999999999999999999999999999999999999975310
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~ 989 (1170)
.. .........++..|+|||.+....++.++|+|||||++|||++ |..||.
T Consensus 162 ~~----------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 162 DE----------------------------KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred cc----------------------------cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 00 0000111224678999999988889999999999999999998 999999
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
+....++.+.+..+... ..+...+..+.++|.+||..||.+||++..+
T Consensus 214 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l 261 (279)
T cd05057 214 GIPAVEIPDLLEKGERL--PQPPICTIDVYMVLVKCWMIDAESRPTFKEL 261 (279)
T ss_pred CCCHHHHHHHHhCCCCC--CCCCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 98888888777754322 2235678899999999999999999995544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=340.76 Aligned_cols=257 Identities=32% Similarity=0.516 Sum_probs=209.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-ccceE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC-RENLY 834 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd-~~~Ly 834 (1170)
..++|++++.||.|+||.||+|.++.+++.||+|++.+.. ........+..|+.++..++||||++++++|.. ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3467999999999999999999999999999999886542 223345677899999999999999999999876 56789
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||||.|||++.++.++|+|||++....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 999999 6689888765 468899999999999999999999999999999999999999999999999986310
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+...
T Consensus 160 ----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 160 ----------------------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred ----------------------------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 01123467889999999866 5689999999999999999999999987765
Q ss_pred HHHHHHHhc---------------c-------------CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 994 QQIFDNIMN---------------R-------------DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 994 ~ei~qkIl~---------------~-------------~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
...+..+.+ . ..++......++..+.++|.+||+.+|.+||+ +.+++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~ell~~ 288 (328)
T cd07856 212 VNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS---AAEALAH 288 (328)
T ss_pred HHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcC
Confidence 333222111 0 00111111356889999999999999999999 8899999
Q ss_pred CCCCCC
Q 001057 1046 PFFKNI 1051 (1170)
Q Consensus 1046 PfF~~i 1051 (1170)
|||...
T Consensus 289 ~~~~~~ 294 (328)
T cd07856 289 PYLAPY 294 (328)
T ss_pred Cccccc
Confidence 999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.10 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=209.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++.+.||+|+||.||++.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++.+.. ..+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 34578999999999999999999865 4567999987653 2345678899999999999999999999887 7889
Q ss_pred EEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+||||+++++|.+++... ..++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~- 155 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN- 155 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC-
Confidence 999999999999999763 35788889999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
.........++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.
T Consensus 156 ----------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 156 ----------------------------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred ----------------------------CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 0000112345678999999998889999999999999999998 99999988
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+...+...+..+. ..+ .+...+.++.+++.+||+.+|.+||++..+.++|+
T Consensus 208 ~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 208 SNPEVIRALERGY-RMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred CHHHHHHHHhCCC-CCC-CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 8777777665442 222 33578899999999999999999999666655553
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=343.60 Aligned_cols=265 Identities=34% Similarity=0.528 Sum_probs=212.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc--cc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCR--EN 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~--~~ 832 (1170)
..++|++.+.||.|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.++.++ +||||++++++|... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 4568999999999999999999999999999999886532 1223445677899999999 999999999988654 36
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 899999996 5999998775 78899999999999999999999999999999999999999999999999987531000
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
. ...........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.
T Consensus 162 ~-------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 162 E-------------------------NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred c-------------------------cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 0 000112223578999999998865 45788999999999999999999999877
Q ss_pred CHHHHHHHHhccC----------------------------CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 992 TPQQIFDNIMNRD----------------------------IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 992 ~~~ei~qkIl~~~----------------------------l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
...+....+.... .........++.++.+||.+||+.||.+||+ +.+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps---~~~il 293 (337)
T cd07852 217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT---AEEAL 293 (337)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC---HHHHh
Confidence 6555444332211 0011111347889999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001057 1044 QHPFFKNI 1051 (1170)
Q Consensus 1044 qHPfF~~i 1051 (1170)
+||||+..
T Consensus 294 ~~~~~~~~ 301 (337)
T cd07852 294 EHPYVAQF 301 (337)
T ss_pred hChhhhhh
Confidence 99999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.83 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=206.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRAT---GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~T---Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
...+|.+.+.||.|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999987644 4579999876532 23456788999999999999999999998875 56
Q ss_pred eEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||+++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 789999999999999997654 5899999999999999999999999999999999999999999999999998752100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
.........+++.|+|||++....++.++|||||||++|+|++ |..||.+
T Consensus 161 -----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 161 -----------------------------SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred -----------------------------cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 0000112234578999999988889999999999999999996 9999998
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
.+..+....+.++... ..+..++..+.+||.+||..+|.+||++.++.
T Consensus 212 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~ 259 (270)
T cd05056 212 VKNNDVIGRIENGERL--PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELK 259 (270)
T ss_pred CCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 8877777666654322 23467899999999999999999999954443
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=318.28 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=201.0
Q ss_pred EeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCC
Q 001057 765 PISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 844 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGS 844 (1170)
+||.|+||.||+|... ++..||+|++.... .......+.+|+.++..++||||+++++++......|+||||+++++
T Consensus 2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred ccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 6899999999999864 68899999876542 23344578899999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCC
Q 001057 845 LYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923 (1170)
Q Consensus 845 L~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s 923 (1170)
|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~------------ 146 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG------------ 146 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc------------
Confidence 99998754 46899999999999999999999999999999999999999999999999998642100
Q ss_pred CCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhc
Q 001057 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 924 ~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~ 1002 (1170)
. ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 147 --~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~ 209 (250)
T cd05085 147 --I---------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEK 209 (250)
T ss_pred --c---------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHc
Confidence 0 000111234578999999988889999999999999999998 9999998887777666654
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
... ...+..++..+.+||.+||+.+|.+||++.++.
T Consensus 210 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 245 (250)
T cd05085 210 GYR--MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQ 245 (250)
T ss_pred CCC--CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 322 123457899999999999999999999954443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=328.35 Aligned_cols=252 Identities=33% Similarity=0.523 Sum_probs=206.5
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEEEEe
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
|++.+.||.|+||+||+|+...+++.||||.+.+.... .......+|+..+..++ ||||+++++++.+.+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78899999999999999999999999999988654321 12233456889999999 9999999999999999999999
Q ss_pred eccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 839 YLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|+ +|+|.+++.... .+++..+..++.|++.||.|||++||+|+||+|.||+++.++.++|+|||++.....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~------ 151 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS------ 151 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC------
Confidence 99 889999997764 789999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
........|+..|+|||++.+ ..++.++|+||||+++|+|++|.+||.+....+
T Consensus 152 -------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~ 206 (283)
T cd07830 152 -------------------------RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID 206 (283)
T ss_pred -------------------------CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH
Confidence 001123468899999998854 457889999999999999999999998877655
Q ss_pred HHHHHhccC-------------------CCCCC--------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 996 IFDNIMNRD-------------------IPWPN--------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 996 i~qkIl~~~-------------------l~fP~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.+..+...- ..++. .....+..+.+||.+||+.||.+||+ +.|++.||||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei~~~~~~ 283 (283)
T cd07830 207 QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT---ASQALQHPYF 283 (283)
T ss_pred HHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC---HHHHhhCCCC
Confidence 554433210 00000 01123688999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=337.39 Aligned_cols=256 Identities=23% Similarity=0.372 Sum_probs=209.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCC-------CCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRAT-------GDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYS 826 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~T-------Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~ 826 (1170)
+...+|++.+.||+|+||.||+|++... +..||+|++.... .......+.+|+.++.++ +||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3345799999999999999999986432 2379999876432 334567888999999999 79999999999
Q ss_pred eecccceEEEEeeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEE
Q 001057 827 FTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLL 890 (1170)
Q Consensus 827 Fqd~~~LyLVMEY~~GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENIL 890 (1170)
|.....+|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 999999999999999999999997532 3677888889999999999999999999999999999
Q ss_pred eCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchh
Q 001057 891 IGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATAD 970 (1170)
Q Consensus 891 Ld~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksD 970 (1170)
++.++.+||+|||+++..... ..........++..|+|||++.+..++.++|
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNI----------------------------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 218 (334)
T ss_pred EcCCCcEEECCcccceecccc----------------------------cccccccCCCcCceEcCHHHhccCCcCchhh
Confidence 999999999999998742100 0000111223456899999999989999999
Q ss_pred hhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 971 WWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 971 IWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
||||||++|||++ |..||.+.+..+.+..+..... +..+..++.++.+||.+||+.+|.+||+ +.+++.+
T Consensus 219 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~ell~~ 289 (334)
T cd05100 219 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRPT---FKQLVED 289 (334)
T ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcC---HHHHHHH
Confidence 9999999999998 8999999988888887765432 1234578899999999999999999999 5555554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=363.74 Aligned_cols=239 Identities=26% Similarity=0.437 Sum_probs=209.4
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
..-++-||.|+.|.||+|+.. ++.||||.++.. -..++.-|++|+||||+.+.++|....++||||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred hhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 344566999999999999865 789999976421 12467788999999999999999999999999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCC
Q 001057 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~ 919 (1170)
|..|-|+.+|+....++......+..+|+.|++|||.+.|||||||.-||||..+..|||+|||-++..
T Consensus 194 Ca~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~----------- 262 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKEL----------- 262 (904)
T ss_pred cccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhh-----------
Confidence 999999999999999999999999999999999999999999999999999999999999999988742
Q ss_pred CCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 001057 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999 (1170)
Q Consensus 920 sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qk 999 (1170)
.......+++||..|||||+|.+.+.+.++|||||||+|||||||..||..-+...++--
T Consensus 263 --------------------~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwG 322 (904)
T KOG4721|consen 263 --------------------SDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWG 322 (904)
T ss_pred --------------------hhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEe
Confidence 112345678999999999999999999999999999999999999999998877766554
Q ss_pred HhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 1000 Il~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+-...+.+| +|..++..++-||+.||+..|..||+ ..+||.|
T Consensus 323 VGsNsL~Lp-vPstcP~GfklL~Kqcw~sKpRNRPS---Frqil~H 364 (904)
T KOG4721|consen 323 VGSNSLHLP-VPSTCPDGFKLLLKQCWNSKPRNRPS---FRQILLH 364 (904)
T ss_pred ccCCccccc-CcccCchHHHHHHHHHHhcCCCCCcc---HHHHHHH
Confidence 444445544 56889999999999999999999999 6777877
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.69 Aligned_cols=248 Identities=25% Similarity=0.412 Sum_probs=203.4
Q ss_pred EeccCCCeEEEEeeecCCC------CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 765 PISQGAFGRVFLARKRATG------DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TG------e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.||.|+||.||+|+++... ..||+|.+.+.. .......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 5899999999999986544 789999876532 12345678889999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-----cEEEEecCCcc
Q 001057 839 YLNGGDLYSLLRNL-------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-----HIKLTDFGLSK 906 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~-------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-----~VKLsDFGLAk 906 (1170)
|+++++|.+++... ..+++..+..++.||+.||.|||+++++|+||||+|||++.++ .++|+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999642 2478889999999999999999999999999999999999887 89999999987
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GI 985 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~ 985 (1170)
..... ..........++..|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 160 ~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~ 211 (269)
T cd05044 160 DIYKS----------------------------DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQ 211 (269)
T ss_pred ccccc----------------------------cccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCC
Confidence 42100 00001122345788999999998889999999999999999998 99
Q ss_pred CCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 986 PPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 986 pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
.||...+..+....+...... ..+..++..+.+||.+||+.+|.+||++..+.+.|+
T Consensus 212 ~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 212 QPYPALNNQEVLQHVTAGGRL--QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCCcccCHHHHHHHHhcCCcc--CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 999988877777666543321 234578899999999999999999999666655554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.42 Aligned_cols=257 Identities=19% Similarity=0.298 Sum_probs=211.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecC----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRA----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC- 829 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd- 829 (1170)
+..++|++.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 455789999999999999999999876 3688999987643 244556788999999999999999999997655
Q ss_pred ccceEEEEeeccCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEe
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNL--------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTD 901 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~--------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsD 901 (1170)
....+++++|+.+|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56789999999999999999753 3588999999999999999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHH
Q 001057 902 FGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 902 FGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYEL 981 (1170)
||+++...... .........++..|+|||++.+..++.++|||||||++|||
T Consensus 161 ~g~~~~~~~~~----------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el 212 (280)
T cd05043 161 NALSRDLFPMD----------------------------YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212 (280)
T ss_pred CCCcccccCCc----------------------------eEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHH
Confidence 99997421000 00001123456789999999988899999999999999999
Q ss_pred Hh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 982 LI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 982 LT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
++ |.+||...+..++...+..+. .++ .+..++.++.++|.+||..||.+||++.++.+.|
T Consensus 213 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 213 MTLGQTPYVEIDPFEMAAYLKDGY-RLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred hcCCCCCcCcCCHHHHHHHHHcCC-CCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 98 999999888877776665432 222 2356789999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=318.68 Aligned_cols=244 Identities=26% Similarity=0.370 Sum_probs=203.4
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCC
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 843 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GG 843 (1170)
++||.|+||.||+|.+.. ++.||+|.+...... .....+.+|++++++++||||+++++++.+....|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 369999999999999877 999999988765432 45567899999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCC
Q 001057 844 DLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922 (1170)
Q Consensus 844 SL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~ 922 (1170)
+|.+++... ..++...+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~------------ 145 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEG------------ 145 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccC------------
Confidence 999999764 4688999999999999999999999999999999999999999999999999874210
Q ss_pred CCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Q 001057 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIM 1001 (1170)
Q Consensus 923 s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl 1001 (1170)
+.. ........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 146 -~~~---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~ 209 (251)
T cd05041 146 -GIY---------------TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE 209 (251)
T ss_pred -Ccc---------------eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh
Confidence 000 000011234567999999988889999999999999999998 899999888777766665
Q ss_pred ccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 1002 NRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 1002 ~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
... .. ..+..++.++.+||.+||+.+|.+||+ +.+++
T Consensus 210 ~~~-~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~ell 246 (251)
T cd05041 210 SGY-RM-PAPQLCPEEIYRLMLQCWAYDPENRPS---FSEIY 246 (251)
T ss_pred cCC-CC-CCCccCCHHHHHHHHHHhccChhhCcC---HHHHH
Confidence 432 11 234678899999999999999999999 44554
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=321.83 Aligned_cols=246 Identities=25% Similarity=0.429 Sum_probs=205.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
...+|++.+.||+|+||.||++. .+++.||+|.+.... ....+.+|+.++..++||||+++++++... .+|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 34679999999999999999986 478899999886432 235788999999999999999999988754 5799
Q ss_pred EEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 836 VMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||+.+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.... .
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~--~- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS--M- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecc--c-
Confidence 999999999999997653 48899999999999999999999999999999999999999999999999987421 0
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
.......+..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+
T Consensus 153 ------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 202 (254)
T cd05083 153 ------------------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202 (254)
T ss_pred ------------------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC
Confidence 0011223567999999988889999999999999999997 999999988
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
..+....+..+... ..+..++..+.+||.+||+.+|.+||++.++.+.++
T Consensus 203 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 203 LKEVKECVEKGYRM--EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHHHHhCCCCC--CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 88777776654322 224578899999999999999999999665555443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=323.87 Aligned_cols=254 Identities=26% Similarity=0.409 Sum_probs=198.8
Q ss_pred CCeEEEEEeccCCCeEEEEee----ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--cc
Q 001057 758 EDFEIIKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC--RE 831 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLAr----dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd--~~ 831 (1170)
.+|++++.||.|+||.||+|. +..+++.||+|.+.... ......+.+|+.+|..++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 579999999999999999997 34578999999986542 3455678899999999999999999987643 35
Q ss_pred ceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999999764 4689999999999999999999999999999999999999999999999999875310
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.. ..........++..|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus 161 ~~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 161 DK---------------------------EYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CC---------------------------cceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 00 000000112244569999999988899999999999999999999877654
Q ss_pred CCHHHH---------------HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 991 KTPQQI---------------FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 991 ~~~~ei---------------~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
...... +..+......++ .+..++.++.+||.+||..+|.+||++.++...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 214 PPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred cchhhhhhcccccccccchHHHHHHHhcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 321100 111222222222 335688999999999999999999995544433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=341.70 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=202.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEeee-----cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARK-----RATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTC 829 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArd-----k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd 829 (1170)
..++|++.+.||.|+||+||+|++ ..+++.||||+++... .......+.+|+.+|..+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 346899999999999999999984 3567899999987542 234456788999999999 68999999987765
Q ss_pred c-cceEEEEeeccCCChHHHHHhc--------------------------------------------------------
Q 001057 830 R-ENLYLVMEYLNGGDLYSLLRNL-------------------------------------------------------- 852 (1170)
Q Consensus 830 ~-~~LyLVMEY~~GGSL~dlLk~~-------------------------------------------------------- 852 (1170)
. ..+|+||||+.+|+|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 4 4689999999999999998642
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCC
Q 001057 853 -----------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921 (1170)
Q Consensus 853 -----------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl 921 (1170)
..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~---------- 232 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD---------- 232 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccC----------
Confidence 13677788889999999999999999999999999999999999999999998742100
Q ss_pred CCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHH-HHHH
Q 001057 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQ-IFDN 999 (1170)
Q Consensus 922 ~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~e-i~qk 999 (1170)
..........+++.|+|||++.+..++.++|||||||++|+|++ |..||.+..... ....
T Consensus 233 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 294 (343)
T cd05103 233 ------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294 (343)
T ss_pred ------------------cchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH
Confidence 00001112345678999999999899999999999999999996 999998765433 3333
Q ss_pred HhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 1000 Il~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+..+.. +..+...++++.+++.+||+.||.+||+ +.++++|
T Consensus 295 ~~~~~~--~~~~~~~~~~~~~~~~~cl~~~p~~Rps---~~eil~~ 335 (343)
T cd05103 295 LKEGTR--MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 335 (343)
T ss_pred HhccCC--CCCCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 333322 1234567889999999999999999999 5666655
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=322.27 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=195.5
Q ss_pred EEeccCCCeEEEEeeec--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeecc
Q 001057 764 KPISQGAFGRVFLARKR--ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLN 841 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk--~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~ 841 (1170)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.++..++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999864 3567899998765432 2334578889999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 842 GGDLYSLLRNLG-----CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 842 GGSL~dlLk~~~-----~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
+|+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~------ 152 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK------ 152 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccC------
Confidence 999999997532 356777888999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-------CCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-------GHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-------~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
.. .........|++.|+|||++.+. .++.++|||||||++|||++ |..||
T Consensus 153 -------~~---------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 210 (269)
T cd05087 153 -------ED---------------YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210 (269)
T ss_pred -------cc---------------eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 00 00011234678899999998642 35789999999999999996 99999
Q ss_pred CCCCHHHHHHHHhc-cCC--CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 989 NAKTPQQIFDNIMN-RDI--PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~-~~l--~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
......+....... ... ..|......+..+.+++.+|+ .+|.+||++.++...|.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 211 RHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 87776655443332 222 222333457888999999998 58999999665555443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=373.24 Aligned_cols=254 Identities=27% Similarity=0.456 Sum_probs=209.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeee-cc--
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFT-CR-- 830 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fq-d~-- 830 (1170)
+.-.+++|.+.|.+|||+.||+|++...|..||+|.+... ++..++.+.+|+++|++|. |+|||.+++... ..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 4445789999999999999999999988899999987654 5778899999999999998 999999998322 11
Q ss_pred ----cceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeCCCCcEEEEec
Q 001057 831 ----ENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIGQDGHIKLTDF 902 (1170)
Q Consensus 831 ----~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd~dG~VKLsDF 902 (1170)
-.++|+||||.||.|-+++... .+|++.++..|+.++++|+.+||... |||||||-|||||+.+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 2478999999999999999743 56999999999999999999999998 999999999999999999999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILF 979 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILY 979 (1170)
|.|...... +.-..+-.+ ....-....|+.|+|||+|. +.+.+.++|||+|||+||
T Consensus 191 GSatt~~~~-------~~~~~e~~~--------------ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLY 249 (738)
T KOG1989|consen 191 GSATTKILS-------PTSAQEVNY--------------VEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLY 249 (738)
T ss_pred cccccccCC-------CccHHHHHH--------------HHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHH
Confidence 998742100 000000000 00111234699999999985 667899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh
Q 001057 980 ELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT 1037 (1170)
Q Consensus 980 ELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~ 1037 (1170)
-|+....||..... -.|+++++.||.. ...+..+++||..||+.||.+||+..
T Consensus 250 kLCy~t~PFe~sg~----laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~ 302 (738)
T KOG1989|consen 250 KLCYFTTPFEESGK----LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIY 302 (738)
T ss_pred HHHHhCCCcCcCcc----eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHH
Confidence 99999999987643 3678899999965 47899999999999999999999943
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.51 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=198.4
Q ss_pred EEeccCCCeEEEEeeecC---CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee-cccceEEEEee
Q 001057 764 KPISQGAFGRVFLARKRA---TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT-CRENLYLVMEY 839 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~---TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq-d~~~LyLVMEY 839 (1170)
+.||+|+||.||+|.+.. .+..||||.+... ......+.+.+|+.+++.++||||+++++++. .....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998653 3457999987542 23345678889999999999999999999765 45568999999
Q ss_pred ccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 840 LNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 840 ~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
+.+|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~------ 152 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE------ 152 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCc------
Confidence 9999999999764 346777788899999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIF 997 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~ 997 (1170)
. ..........+++.|+|||++.+..++.++|||||||++|||++ |.+||...+..++.
T Consensus 153 -------------------~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~ 212 (262)
T cd05058 153 -------------------Y-YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT 212 (262)
T ss_pred -------------------c-eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 0 00001123346778999999998889999999999999999999 57788887777777
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..+..+... ..+..++..+.+++.+||..+|.+||++.++...+
T Consensus 213 ~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 213 VYLLQGRRL--LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred HHHhcCCCC--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 666554322 23456789999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.81 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=200.1
Q ss_pred CeEEEEEeccCCCeEEEEeee----cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cc
Q 001057 759 DFEIIKPISQGAFGRVFLARK----RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--EN 832 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArd----k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~ 832 (1170)
.|++++.||+|+||.||+|+. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 479999999999999999974 4678899999986542 234456789999999999999999999988775 56
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+|+||||++|++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999999764 35899999999999999999999999999999999999999999999999998753100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
. ..........|+..|+|||++.+..++.++|||||||++|+|+++..|+...
T Consensus 163 ~---------------------------~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~ 215 (284)
T cd05079 163 K---------------------------EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSP 215 (284)
T ss_pred c---------------------------cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccc
Confidence 0 0001112345778899999999888999999999999999999987765321
Q ss_pred C---------------HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 992 T---------------PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 992 ~---------------~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
. .......+.. ...+ ..+..++..+.+||.+||+.||.+||+ +.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~ 278 (284)
T cd05079 216 MTLFLKMIGPTHGQMTVTRLVRVLEE-GKRL-PRPPNCPEEVYQLMRKCWEFQPSKRTT---FQNLIE 278 (284)
T ss_pred cchhhhhcccccccccHHHHHHHHHc-CccC-CCCCCCCHHHHHHHHHHccCCcccCcC---HHHHHH
Confidence 1 1111111211 1122 234578999999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.98 Aligned_cols=236 Identities=24% Similarity=0.383 Sum_probs=192.6
Q ss_pred EeccCCCeEEEEeeecCCCC-------EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 765 PISQGAFGRVFLARKRATGD-------LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TGe-------~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
.||.|+||.||+|.+..++. .||+|.+.+.. ....+.+.+|..++..++||||+++++++......++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 69999999999999866544 48888875432 344567888999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc--------EEEEecCCcccc
Q 001057 838 EYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH--------IKLTDFGLSKVG 908 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~--------VKLsDFGLAk~~ 908 (1170)
||+.+|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++. ++|+|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9999999999997654 5899999999999999999999999999999999999987765 689999987531
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhC-CC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIG-IP 986 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG-~p 986 (1170)
. ......|++.|+|||++.+. .++.++|||||||++|+|++| .+
T Consensus 159 ~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~ 204 (258)
T cd05078 159 L----------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK 204 (258)
T ss_pred C----------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 0 01134678899999999864 578999999999999999998 57
Q ss_pred CCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 987 PF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
||...+...... +......+ +...+.++.+||.+||+.||.+||+ +.++++
T Consensus 205 ~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~ 255 (258)
T cd05078 205 PLSALDSQKKLQ-FYEDRHQL---PAPKWTELANLINQCMDYEPDFRPS---FRAIIR 255 (258)
T ss_pred ChhhccHHHHHH-HHHccccC---CCCCcHHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 777666554433 23333333 3456789999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=354.64 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=213.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.+.+++++.||+|-||.||+|..+.+ ..||+|.++...+ ..+.+.+|++||++|+|+|||++++++...+.+|||
T Consensus 205 r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 205 REELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred HHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 34577889999999999999998643 3699999876432 235788999999999999999999999998899999
Q ss_pred EeeccCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 837 MEYLNGGDLYSLLRN--LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~--~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||+.|+|.++|+. ...+...+...++.||++|++||+++++|||||-..||||+.++.+||+|||||+... ..
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~-d~-- 356 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG-DD-- 356 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC-CC--
Confidence 999999999999987 4569999999999999999999999999999999999999999999999999999421 00
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~ 993 (1170)
.+ .. ....---.-|.|||.+....++.++|||||||+||||+| |+.||.+.+.
T Consensus 357 -----------~Y-----------~~----~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 357 -----------EY-----------TA----SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred -----------ce-----------ee----cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 00 00 000011236999999999999999999999999999998 9999999999
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.+.++.+..+.. .| .|..+|+++-+++..|+..+|++|||.......+..
T Consensus 411 ~ev~~~le~GyR-lp-~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 411 EEVLELLERGYR-LP-RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred HHHHHHHhccCc-CC-CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 999999987653 22 357899999999999999999999996655554444
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=363.07 Aligned_cols=253 Identities=26% Similarity=0.494 Sum_probs=219.1
Q ss_pred EEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc-cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc--eEEEE
Q 001057 761 EIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI-RKNAVESILAERNILISVRNPFVVRFFYSFTCREN--LYLVM 837 (1170)
Q Consensus 761 evlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~-~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~--LyLVM 837 (1170)
+.-.+||+|+|-+||+|.|..+|..||--.++-.++. .....+++..|+.+|+.|+|||||++|+++.+... +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4556899999999999999999998886444333322 34567899999999999999999999999988765 88899
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeCCC-CcEEEEecCCccccccccCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIGQD-GHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd~d-G~VKLsDFGLAk~~~~~~~~ 914 (1170)
|++.+|+|..|+++++..+...++.|++||+.||.|||++. |||||||.+||+|+.+ |.|||+|+|||...
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~------ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL------ 196 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh------
Confidence 99999999999999999999999999999999999999986 9999999999999864 89999999999862
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC-CCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN-AKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~-g~~~ 993 (1170)
......+.+|||.|||||++. ..|+..+||||||++|.||+|+..||. ..++
T Consensus 197 --------------------------r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~ 249 (632)
T KOG0584|consen 197 --------------------------RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP 249 (632)
T ss_pred --------------------------hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH
Confidence 122334578999999999997 689999999999999999999999996 4678
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.++|+++..+..+-. +..--.+++++||.+||.. .+.|++ |.|+|.||||..-
T Consensus 250 AQIYKKV~SGiKP~s-l~kV~dPevr~fIekCl~~-~~~R~s---a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 250 AQIYKKVTSGIKPAA-LSKVKDPEVREFIEKCLAT-KSERLS---AKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHcCCCHHH-hhccCCHHHHHHHHHHhcC-chhccC---HHHHhhChhhccc
Confidence 899999988765421 2233478999999999998 999999 8999999999864
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=348.17 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=207.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSF 827 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~F 827 (1170)
.+..++|.+.+.||+|+||.||+|++. .+++.||+|++.... .....+.+.+|+.+|..+. |||||++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 455567999999999999999999854 355789999997542 2334567889999999998 99999999999
Q ss_pred ecccceEEEEeeccCCChHHHHHhcC------------------------------------------------------
Q 001057 828 TCRENLYLVMEYLNGGDLYSLLRNLG------------------------------------------------------ 853 (1170)
Q Consensus 828 qd~~~LyLVMEY~~GGSL~dlLk~~~------------------------------------------------------ 853 (1170)
.....+||||||+.+|+|.+++...+
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 99999999999999999999996431
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcE
Q 001057 854 --------------------------------------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889 (1170)
Q Consensus 854 --------------------------------------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENI 889 (1170)
.++...+..++.||+.||.|||+.||+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256677888999999999999999999999999999
Q ss_pred EeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcch
Q 001057 890 LIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA 969 (1170)
Q Consensus 890 LLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ks 969 (1170)
|++.++.+||+|||+++...... .........|++.|||||++.+..++.++
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 322 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDS----------------------------NYISKGSTFLPLKWMAPESIFNNLYTTLS 322 (401)
T ss_pred EEeCCCEEEEEecCcceeccccc----------------------------ccccCCCcCCCCceeChHHhcCCCCCcHh
Confidence 99999999999999987421000 00011234578899999999988899999
Q ss_pred hhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 970 DWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 970 DIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
|||||||++|||++ |..||......+............ ..+..++.++.+||.+||+.+|.+||++.++.+
T Consensus 323 DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 323 DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999998 899998766555544433333222 234678999999999999999999999544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=360.07 Aligned_cols=244 Identities=36% Similarity=0.571 Sum_probs=212.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~Ly 834 (1170)
..+.|.+...+|.|+|+.|-.|.+..+++.+|+|++.+.. ....+|+.++... +||||+++++.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 4678999999999999999999999999999999998752 2234567666554 6999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe-CCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI-GQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL-d~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+|||++.|+.|.+.+.....+. ..+..|++||+.|+.|||.+|||||||||+|||+ +..|+++|+|||.++...
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~---- 467 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE---- 467 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc----
Confidence 9999999999999988776666 7888899999999999999999999999999999 689999999999998521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
....+.|-|..|.|||++...+|+.++||||||++||+||+|+.||.....
T Consensus 468 -----------------------------~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 468 -----------------------------RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred -----------------------------hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 002234668899999999999999999999999999999999999987665
Q ss_pred H-HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 994 Q-QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 994 ~-ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
. ++..+|..+... ..+|.++++||.+||+.||.+||+ +.+++.||||
T Consensus 519 ~~ei~~~i~~~~~s-----~~vS~~AKdLl~~LL~~dP~~Rl~---~~~i~~h~w~ 566 (612)
T KOG0603|consen 519 GIEIHTRIQMPKFS-----ECVSDEAKDLLQQLLQVDPALRLG---ADEIGAHPWF 566 (612)
T ss_pred hHHHHHhhcCCccc-----cccCHHHHHHHHHhccCChhhCcC---hhhhccCcch
Confidence 5 666666554433 689999999999999999999999 8899999999
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=317.83 Aligned_cols=251 Identities=29% Similarity=0.522 Sum_probs=208.9
Q ss_pred CeEEEEEeccCCCeEEEEeeecC-CCCEEEEEEeeccc-------cccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeec
Q 001057 759 DFEIIKPISQGAFGRVFLARKRA-TGDLFAIKVLKKAD-------MIRKNAVESILAERNILIS-VRNPFVVRFFYSFTC 829 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~-TGe~VAIKvLkKs~-------i~~~~~ve~~l~EieILsk-L~HPNIVrL~~~Fqd 829 (1170)
+|++.+.||.|+||.||+|.+.. +++.+|+|.+.... .........+..|+.++.+ ++||||++++++|..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 78999999876432 1233455667788888865 799999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCC
Q 001057 830 RENLYLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGL 904 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGL 904 (1170)
.+.+|+||||++|++|.+++.. ...+++..++.++.|++.||.|||+ .||+|+||||.|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhC
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG 984 (1170)
+.... . ........|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 161 ~~~~~------------------------------~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g 209 (269)
T cd08528 161 AKQKQ------------------------------P-ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL 209 (269)
T ss_pred eeecc------------------------------c-ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhC
Confidence 87421 0 0012345688999999999988899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 985 IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
.+||...+.......+...... +.....++..+.+||.+||+.||.+||++.++.+
T Consensus 210 ~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 210 QPPFYSTNMLSLATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred CCcccccCHHHHHHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 9999988877777776655433 2122367899999999999999999999554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=323.17 Aligned_cols=247 Identities=31% Similarity=0.504 Sum_probs=202.4
Q ss_pred EEEEEeccCCCeEEEEeeec----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 761 EIIKPISQGAFGRVFLARKR----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 761 evlk~LG~GgFGtVyLArdk----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.+.+.||.|+||.||+|... ..+..|+||+++.. ......+.+.+|++++.+++||||+++++++.....+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 45678999998542 2344578899999999999999999999999988889999
Q ss_pred EeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 837 MEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|||+++|+|.++|... ..+++.....++.||+.||.|||+++|+|+||++.|||++.++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~--- 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK--- 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 9999999999999886 67999999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~ 993 (1170)
..........+...|+|||++.+..++.++||||||+++|||++ |..||...+.
T Consensus 157 -------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 157 -------------------------SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp -------------------------SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred -------------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 00011223346678999999999889999999999999999999 7899999988
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
.++...+...... ..+..++..+.++|.+||..||.+||++.++
T Consensus 212 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i 255 (259)
T PF07714_consen 212 EEIIEKLKQGQRL--PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEI 255 (259)
T ss_dssp HHHHHHHHTTEET--TSBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred ccccccccccccc--eeccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence 8888888554432 2346789999999999999999999994433
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=318.94 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=205.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeec----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--c
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKR----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC--R 830 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd--~ 830 (1170)
..+|++++.||+|+||.||+|+.. .+++.||+|++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 357889999999999999999864 35889999998765432 356788999999999999999999998877 5
Q ss_pred cceEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..+|+||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 67999999999999999997654 58999999999999999999999999999999999999999999999999987531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
... ..........++..|+|||.+.+..++.++|||||||++|||++|..||.
T Consensus 161 ~~~---------------------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 161 EDK---------------------------DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred cCC---------------------------cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 000 00000112245567999999998889999999999999999999999987
Q ss_pred CCCHHH--------------HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 990 AKTPQQ--------------IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 990 g~~~~e--------------i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
...... ....++.....++ .+..++.++.+|+.+||+.+|.+||++.++.+.|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 214 SPPAEFLRMIGIAQGQMIVTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred cccchhccccccccccccHHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 543221 1112222222222 23567889999999999999999999666555443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=325.77 Aligned_cols=252 Identities=21% Similarity=0.340 Sum_probs=204.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCC----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGD----LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe----~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
+..++|+.++.||.|+||.||+|.+..+|. .||+|.+.... .......+.+|+.++..++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345789999999999999999999887776 46888876532 233345688999999999999999999988754
Q ss_pred cceEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..+++|||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 5789999999999999997654 58999999999999999999999999999999999999999999999999987421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
.. ..........++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 161 ~~----------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~ 212 (303)
T cd05110 161 GD----------------------------EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212 (303)
T ss_pred Cc----------------------------ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 00 00001122346778999999998889999999999999999997 99999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
.+.........+..+. .++ .+...+..+.++|.+|+..+|.+||++.++
T Consensus 213 ~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l 261 (303)
T cd05110 213 DGIPTREIPDLLEKGE-RLP-QPPICTIDVYMVMVKCWMIDADSRPKFKEL 261 (303)
T ss_pred CCCCHHHHHHHHHCCC-CCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 8877666655554333 222 235678899999999999999999995443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=316.24 Aligned_cols=253 Identities=22% Similarity=0.332 Sum_probs=203.9
Q ss_pred eEEEEEeccCCCeEEEEeeec---CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----
Q 001057 760 FEIIKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE----- 831 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~----- 831 (1170)
|++.+.||+|+||.||+|... .+++.||||++.... ......+.+.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677889999999999999864 367899999986543 33445677889999999999999999999876532
Q ss_pred -ceEEEEeeccCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCC
Q 001057 832 -NLYLVMEYLNGGDLYSLLRNL------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGL 904 (1170)
Q Consensus 832 -~LyLVMEY~~GGSL~dlLk~~------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGL 904 (1170)
..+++++|+.+|+|..++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999999887432 2478899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI- 983 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT- 983 (1170)
++...... .........+++.|++||.+.+..++.++|||||||++|+|++
T Consensus 160 ~~~~~~~~----------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~ 211 (273)
T cd05074 160 SKKIYSGD----------------------------YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR 211 (273)
T ss_pred cccccCCc----------------------------ceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhC
Confidence 87421000 0001112345678999999998889999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 984 GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 984 G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
|.+||.+.+..+.+..+...... ..+...+..+.+|+.+||..+|.+||++..+.+.|
T Consensus 212 g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 212 GQTPYAGVENSEIYNYLIKGNRL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 99999988887777776654321 22356789999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=324.90 Aligned_cols=261 Identities=15% Similarity=0.229 Sum_probs=193.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCC---CCEEEEEEeeccccccHHH--------HHHHHHHHHHHHhcCCCcEEE
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRAT---GDLFAIKVLKKADMIRKNA--------VESILAERNILISVRNPFVVR 822 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~T---Ge~VAIKvLkKs~i~~~~~--------ve~~l~EieILskL~HPNIVr 822 (1170)
.+...+|++.+.||+|+||+||+|++..+ +..+|+|+........... ......+...+..++|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34456899999999999999999998877 6778888643221110000 011223334456678999999
Q ss_pred EEeeeeccc----ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEE
Q 001057 823 FFYSFTCRE----NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 823 L~~~Fqd~~----~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VK 898 (1170)
+++++.... ..|++|+++ ..++.+.+.....+++..++.++.|++.||.|||++||+||||||+|||++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 998765543 347888887 447777777666678999999999999999999999999999999999999999999
Q ss_pred EEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHH
Q 001057 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978 (1170)
Q Consensus 899 LsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVIL 978 (1170)
|+|||+|+........ ............||+.|+|||++.+..++.++|||||||++
T Consensus 167 l~DFGla~~~~~~~~~-----------------------~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l 223 (294)
T PHA02882 167 IIDYGIASHFIIHGKH-----------------------IEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCM 223 (294)
T ss_pred EEEcCCceeeccCCcc-----------------------cccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999999853210000 00001122345799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCH-H--------HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 979 FELLIGIPPFNAKTP-Q--------QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 979 YELLTG~pPF~g~~~-~--------ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
|||++|.+||.+... . +.+..+....... ...+.++.+++..|+..+|.+||+...+.++
T Consensus 224 ~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 224 LKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred HHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 999999999987632 2 2223343333333 3468899999999999999999995544443
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=318.68 Aligned_cols=237 Identities=20% Similarity=0.283 Sum_probs=191.1
Q ss_pred EeccCCCeEEEEeeecC------------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 765 PISQGAFGRVFLARKRA------------TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~------------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
.||+|+||.||+|+... ....||+|++.... ......+..|+.++..++||||+++++++.....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 68999999999998532 22368888876532 3344577889999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc-------EEEEecCC
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH-------IKLTDFGL 904 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~-------VKLsDFGL 904 (1170)
.++||||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999999988754 56999999999999999999999999999999999999987664 89999998
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-cCCCCcchhhhHHHHHHHHHH-
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELL- 982 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-g~~ys~ksDIWSLGVILYELL- 982 (1170)
+.... ......|+..|+|||++. +..++.++|||||||++|||+
T Consensus 159 ~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~ 204 (262)
T cd05077 159 PITVL----------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICY 204 (262)
T ss_pred Ccccc----------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHh
Confidence 86421 011245788899999987 466899999999999999998
Q ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 983 IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 983 TG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.|..||......+... +....... ....+.++.+||.+||+.||.+||+ +.+|+.+
T Consensus 205 ~~~~p~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~li~~cl~~dp~~Rp~---~~~il~~ 260 (262)
T cd05077 205 NGEIPLKDKTLAEKER-FYEGQCML---VTPSCKELADLMTHCMNYDPNQRPF---FRAIMRD 260 (262)
T ss_pred CCCCCCCCcchhHHHH-HHhcCccC---CCCChHHHHHHHHHHcCCChhhCcC---HHHHHHh
Confidence 5899998766554432 22222221 1345678999999999999999999 5666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=330.38 Aligned_cols=261 Identities=29% Similarity=0.505 Sum_probs=218.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCREN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~ 832 (1170)
...+++.+.+..||.|+.|+||+++.+.+|...|||.+.+.. ..+...+++..++++...+ +|+||+.|++|..+..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 345567888899999999999999999999999999998764 4556678888888876665 8999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
++|.||.| +..+..++++. ++++|..+-.+...++.||.||-. +||||||+||+|||+|..|+|||||||.+-...
T Consensus 166 V~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv- 243 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV- 243 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee-
Confidence 99999988 45666666654 679999888999999999999995 589999999999999999999999999986531
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc---CCCCcchhhhHHHHHHHHHHhCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g---~~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
.........|.+.|||||.+.- ..|+..+||||||++|+||+||+.|
T Consensus 244 ------------------------------dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yP 293 (391)
T KOG0983|consen 244 ------------------------------DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYP 293 (391)
T ss_pred ------------------------------cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCC
Confidence 0111123468999999999964 3588999999999999999999999
Q ss_pred CCCC-CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 988 FNAK-TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 988 F~g~-~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
|.+. +..+++.+|++...+.......+|+.+++|+..||++|+.+||. -.++|+|||+...
T Consensus 294 y~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~---Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 294 YKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK---YNKLLEHPFIKRY 355 (391)
T ss_pred CCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcc---hHHHhcCcceeec
Confidence 9984 45677888888655433223459999999999999999999998 7789999999765
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=314.37 Aligned_cols=232 Identities=21% Similarity=0.306 Sum_probs=190.1
Q ss_pred EEeccCCCeEEEEeeecCCC----------CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 764 KPISQGAFGRVFLARKRATG----------DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TG----------e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
+.||+|+||.||+|.+..++ ..|++|++.... .....+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998777 357888765432 115778899999999999999999999888 778
Q ss_pred EEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-------cEEEEecCCc
Q 001057 834 YLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-------HIKLTDFGLS 905 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-------~VKLsDFGLA 905 (1170)
|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998765 789999999999999999999999999999999999999888 7999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC--CCCcchhhhHHHHHHHHHHh
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM--GHGATADWWSVGIILFELLI 983 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~--~ys~ksDIWSLGVILYELLT 983 (1170)
.... ......++..|+|||++.+. .++.++|||||||++|+|++
T Consensus 156 ~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~ 201 (259)
T cd05037 156 ITVL----------------------------------SREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201 (259)
T ss_pred cccc----------------------------------cccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHh
Confidence 7421 01123467789999999876 78999999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhh
Q 001057 984 -GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATG 1038 (1170)
Q Consensus 984 -G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~ 1038 (1170)
|..||...+..+....... ....+ ......+.+||.+||+.+|.+||++.+
T Consensus 202 ~~~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (259)
T cd05037 202 NGEEPLSTLSSSEKERFYQD-QHRLP---MPDCAELANLINQCWTYDPTKRPSFRA 253 (259)
T ss_pred CCCCCcccCCchhHHHHHhc-CCCCC---CCCchHHHHHHHHHhccChhhCCCHHH
Confidence 6888877654444333322 21112 223478999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=321.46 Aligned_cols=237 Identities=24% Similarity=0.343 Sum_probs=190.9
Q ss_pred EeccCCCeEEEEeeecCC------------------------CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE
Q 001057 765 PISQGAFGRVFLARKRAT------------------------GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV 820 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~T------------------------Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNI 820 (1170)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 599999999999975322 2468899876532 2344578889999999999999
Q ss_pred EEEEeeeecccceEEEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC----
Q 001057 821 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---- 895 (1170)
Q Consensus 821 VrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG---- 895 (1170)
+++++++......||||||+++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999875 46789999999999999999999999999999999999997644
Q ss_pred ---cEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhh
Q 001057 896 ---HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADW 971 (1170)
Q Consensus 896 ---~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDI 971 (1170)
.+||+|||++.... ......++..|+|||++.+ ..++.++||
T Consensus 159 ~~~~~kl~d~g~~~~~~----------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv 204 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL----------------------------------SREERVERIPWIAPECVPGGNSLSTAADK 204 (274)
T ss_pred ccceeeecCCccccccc----------------------------------cccccccCCcccCchhhcCCCCCCcHHHH
Confidence 48999999875310 0012356788999999875 568999999
Q ss_pred hHHHHHHHHHH-hCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 972 WSVGIILFELL-IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 972 WSLGVILYELL-TG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|||||++|||+ +|..||.+....+....+ ......| ...++.+.+||.+||+.+|.+||+ +.+++++
T Consensus 205 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps---~~~il~~ 272 (274)
T cd05076 205 WSFGTTLLEICFDGEVPLKERTPSEKERFY-EKKHRLP---EPSCKELATLISQCLTYEPTQRPS---FRTILRD 272 (274)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHH-HhccCCC---CCCChHHHHHHHHHcccChhhCcC---HHHHHHh
Confidence 99999999995 799999887665543332 2222222 446778999999999999999999 5666654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.37 Aligned_cols=248 Identities=19% Similarity=0.293 Sum_probs=194.3
Q ss_pred EeccCCCeEEEEeeecCC--CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccC
Q 001057 765 PISQGAFGRVFLARKRAT--GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~T--Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~G 842 (1170)
.||+|+||.||++..... ...+++|.+.... .....+.+.+|+.++..++||||+++++.|.+...+|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 699999999999975433 2356667655432 234457889999999999999999999999999999999999999
Q ss_pred CChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 843 GDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 843 GSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
|+|.+++.+. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~------- 152 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE------- 152 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc-------
Confidence 9999999754 23567778889999999999999999999999999999999999999999998631000
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-------CCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-------MGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-------~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
.........+|++.|+|||++.. ..++.++|||||||++|||++ |.+||..
T Consensus 153 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 153 ---------------------DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred ---------------------hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 00011124568899999999853 235778999999999999996 6889988
Q ss_pred CCHHHHHHHHhccC-C--CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 991 KTPQQIFDNIMNRD-I--PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~-l--~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.+..+.+..+.... . .-|.++..++..+.++|..|+ .+|.+||++.++.+.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 212 LSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 78777777655432 2 223344568899999999999 5899999955554433
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=314.66 Aligned_cols=259 Identities=34% Similarity=0.582 Sum_probs=218.2
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
..|.-.++||+|.||+||+|+++.+++.||+|.++-.+ .+...-...++|+-+|+.+.|.|||+++++...+..+.+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 35777889999999999999999999999999987653 23344567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||. .+|..+.... +.+..+.++.++.|++.||.|+|+++++||||||.|+||+.+|.+||+|||+|+-+.+.
T Consensus 81 e~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip----- 154 (292)
T KOG0662|consen 81 EFCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP----- 154 (292)
T ss_pred HHhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc-----
Confidence 9994 5898888764 67999999999999999999999999999999999999999999999999999854211
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CCcchhhhHHHHHHHHHHh-CCCCCCCCCHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLI-GIPPFNAKTPQ 994 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ 994 (1170)
.+.....+-|.+|++|.++.+.. |+.+.|+||.|||+.|+.. |++.|.|.+..
T Consensus 155 -------------------------vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd 209 (292)
T KOG0662|consen 155 -------------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_pred -------------------------eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH
Confidence 11112345699999999999865 8999999999999999985 89999999998
Q ss_pred HHHHHHhcc-----CCCCCC------------CC---------ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 995 QIFDNIMNR-----DIPWPN------------IP---------EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 995 ei~qkIl~~-----~l~fP~------------ip---------~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
+++.+|... .-.||. +| ..++..-+||++++|.-+|.+|++ |++.++||||
T Consensus 210 dqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris---aeaalqhpyf 286 (292)
T KOG0662|consen 210 DQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS---AEAALQHPYF 286 (292)
T ss_pred HHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC---HHHHhcCccc
Confidence 888887641 112221 11 245566789999999999999999 7788999999
Q ss_pred CCC
Q 001057 1049 KNI 1051 (1170)
Q Consensus 1049 ~~i 1051 (1170)
.+.
T Consensus 287 ~d~ 289 (292)
T KOG0662|consen 287 SDF 289 (292)
T ss_pred ccc
Confidence 864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=372.04 Aligned_cols=274 Identities=28% Similarity=0.453 Sum_probs=213.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec------
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC------ 829 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd------ 829 (1170)
-..+|+.+..||+||||.||+|+++-+|+.||||.+.-.. .......+.+|+.+|++|+|||||++|.++..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3567999999999999999999999999999999987653 44556778999999999999999999864400
Q ss_pred ------------------------------------------------------------------------c-------
Q 001057 830 ------------------------------------------------------------------------R------- 830 (1170)
Q Consensus 830 ------------------------------------------------------------------------~------- 830 (1170)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------cceEEEEeeccCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHH
Q 001057 831 ----------------------------------ENLYLVMEYLNGGDLYSLLRNLGCL-DEDMARVYIAELVLALEYLH 875 (1170)
Q Consensus 831 ----------------------------------~~LyLVMEY~~GGSL~dlLk~~~~L-SEe~ar~IaaQIL~ALeYLH 875 (1170)
..+||-||||+...|.+++.++... ..+.++.+++||+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1268999999988888888776554 57888999999999999999
Q ss_pred hCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCC
Q 001057 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYL 955 (1170)
Q Consensus 876 s~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~Ym 955 (1170)
++|||||||||.||+|+.++.|||+|||+|+...........+. ..+.... ........+.+||..|+
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~-----------~~~~~~~-g~~~~~~Ts~VGTalYv 782 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDL-----------SFSTNRA-GSNDGDLTSQVGTALYV 782 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhcc-----------Ccccccc-CCCCcccccccceeeee
Confidence 99999999999999999999999999999986211000000000 0000000 01111345678999999
Q ss_pred chHHHhcCC---CCcchhhhHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCC-CCCccCCHHHHHHHHHhccCCC
Q 001057 956 APEILLGMG---HGATADWWSVGIILFELLIGIPPFNA-KTPQQIFDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENP 1030 (1170)
Q Consensus 956 APEVL~g~~---ys~ksDIWSLGVILYELLTG~pPF~g-~~~~ei~qkIl~~~l~fP-~ip~~lS~eakDLIkkLLq~DP 1030 (1170)
|||++.+.. |+.++|+||||+|+|||+. ||.. +....++..+.++.++++ .+....-+....+|.+||+.||
T Consensus 783 APEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 783 APELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred cHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCC
Confidence 999998755 9999999999999999984 6753 445567777777777766 1223445567799999999999
Q ss_pred CCCCChhhHHHHHcCCCCC
Q 001057 1031 VQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 1031 skRpSa~~AeEILqHPfF~ 1049 (1170)
++||| |.|+|++.||-
T Consensus 860 ~kRPt---A~eLL~s~llp 875 (1351)
T KOG1035|consen 860 SKRPT---ATELLNSELLP 875 (1351)
T ss_pred ccCCC---HHHHhhccCCC
Confidence 99999 88999999997
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=349.38 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=211.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..+...+...||+|.||+||+|++-. .||||++..... ...+.+.|++|+.++++-+|.||+-+.+++.....
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 4556778899999999999999999864 399999987654 44588999999999999999999999999988776
Q ss_pred EEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
.||..+|+|.+|+.+|+.. ..|.....+.|++||++|+.|||.++|||||||..||+|.+++.|||+||||+..-...
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w- 541 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW- 541 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee-
Confidence 8999999999999999754 45888999999999999999999999999999999999999999999999999752111
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc---CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g---~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
..........|...|||||++.. ..|++.+|||||||++|||++|..||.
T Consensus 542 ---------------------------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 542 ---------------------------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred ---------------------------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 11222334568889999999974 468999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCC--CCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 990 AKTPQQIFDNIMNRDIP--WPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~--fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
..+.++++-.+-.+.+. .......++.++++|+..|+.+++++||....+..
T Consensus 595 i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 595 IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 77777666555444221 11223567889999999999999999999554433
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=340.33 Aligned_cols=258 Identities=29% Similarity=0.557 Sum_probs=213.9
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--C----cEEEEEee
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN--P----FVVRFFYS 826 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H--P----NIVrL~~~ 826 (1170)
+....++|.++..+|+|.||.|..|.+..++..||||+++.-. ...+..+-|+++|.++.+ | -+|.+.++
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 3455789999999999999999999999999999999987643 344567789999999842 3 37889999
Q ss_pred eecccceEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-----------
Q 001057 827 FTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ----------- 893 (1170)
Q Consensus 827 Fqd~~~LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~----------- 893 (1170)
|.-.++.|||+|.+ |-+++++|.+++ +|+-+.++.+.+|++.+++|||+++++|.||||||||+-+
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 99999999999998 779999998764 6999999999999999999999999999999999999841
Q ss_pred ---------CCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC
Q 001057 894 ---------DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG 964 (1170)
Q Consensus 894 ---------dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ 964 (1170)
+..|+|+|||.|+... ....+.+.|..|+|||++++-+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~---------------------------------e~hs~iVsTRHYRAPEViLgLG 285 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDH---------------------------------EHHSTIVSTRHYRAPEVILGLG 285 (415)
T ss_pred ccceeccCCCcceEEEecCCcceec---------------------------------cCcceeeeccccCCchheeccC
Confidence 3358999999997521 1124678899999999999999
Q ss_pred CCcchhhhHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhc------------------cCCCCCCCC------------
Q 001057 965 HGATADWWSVGIILFELLIGIPPFNAKTPQQ---IFDNIMN------------------RDIPWPNIP------------ 1011 (1170)
Q Consensus 965 ys~ksDIWSLGVILYELLTG~pPF~g~~~~e---i~qkIl~------------------~~l~fP~ip------------ 1011 (1170)
++.++||||+||||+|+.+|...|++.+..+ +++.|+. +.+.||+..
T Consensus 286 wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~c 365 (415)
T KOG0671|consen 286 WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPC 365 (415)
T ss_pred cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCC
Confidence 9999999999999999999999999877544 5555542 233344211
Q ss_pred ----------ccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1012 ----------EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1012 ----------~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
...-.++.|||++||.+||.+|+| +.|+|.||||+..
T Consensus 366 kpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT---l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 366 KPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT---LREALSHPFFARL 412 (415)
T ss_pred ccHHHHhccCcHHHhHHHHHHHHHHccCcccccc---HHHHhcCHHhhcC
Confidence 011234789999999999999999 8899999999864
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=345.13 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=217.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCC---E-EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGD---L-FAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe---~-VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
++-.+.++||+|+||.||+|+.+..+. . ||+|..+........++..+++|.++|++++|||||++||+.....-+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 345566899999999999999875432 3 899988764545678889999999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|||||+|+||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+||||++...
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~--- 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS--- 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc---
Confidence 99999999999999999886 49999999999999999999999999999999999999999999999999987521
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
.+. . .....---..|+|||.+....|+.++|||||||++||+.+ |..||.+.
T Consensus 314 -------------~~~-----------~---~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 314 -------------QYV-----------M---KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred -------------cee-----------e---ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 000 0 0000012347999999999999999999999999999998 89999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
...++...|....+..+ .+...+.++..++.+|+..||++|+++..+.+.++
T Consensus 367 ~~~~v~~kI~~~~~r~~-~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 367 KNYEVKAKIVKNGYRMP-IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred CHHHHHHHHHhcCccCC-CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 99999999966555443 34678999999999999999999999776655443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=295.38 Aligned_cols=243 Identities=49% Similarity=0.838 Sum_probs=209.3
Q ss_pred CCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCChHHHH
Q 001057 770 AFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL 849 (1170)
Q Consensus 770 gFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL~dlL 849 (1170)
+||.||+|.+..+|+.||+|++........ .+.+.+|+.+++.++|+||+++++.+......+++|||+.+++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999998999999999876543221 578889999999999999999999999889999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCcccc
Q 001057 850 RNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929 (1170)
Q Consensus 850 k~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~ 929 (1170)
.....++...+..++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~------------------- 139 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP------------------- 139 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecc-------------------
Confidence 8776689999999999999999999999999999999999999999999999999875210
Q ss_pred ccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhccCCCCC
Q 001057 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA-KTPQQIFDNIMNRDIPWP 1008 (1170)
Q Consensus 930 ~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g-~~~~ei~qkIl~~~l~fP 1008 (1170)
........|+..|++||.+.+..++.++||||||+++|+|++|..||.. .+...+.+.+........
T Consensus 140 ------------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 207 (244)
T smart00220 140 ------------GGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP 207 (244)
T ss_pred ------------ccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc
Confidence 0022345688899999999988899999999999999999999999988 666666666665555443
Q ss_pred CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 1009 NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 1009 ~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.....++.++.+++.+||..+|.+||+ +.++++||||
T Consensus 208 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~~~~~~~ 244 (244)
T smart00220 208 PPEWKISPEAKDLIRKLLVKDPEKRLT---AEEALQHPFF 244 (244)
T ss_pred cccccCCHHHHHHHHHHccCCchhccC---HHHHhhCCCC
Confidence 222228899999999999999999998 8899999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=320.98 Aligned_cols=264 Identities=25% Similarity=0.357 Sum_probs=211.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc--
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE-- 831 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~-- 831 (1170)
.++.++|++.+.||.|||+.||+++...+++.||+|.+.-.. .+..+..++|++..++++||||++++++...+.
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 356678999999999999999999999999999999887543 466788999999999999999999987665433
Q ss_pred ---ceEEEEeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeCCCCcEEEEec
Q 001057 832 ---NLYLVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIGQDGHIKLTDF 902 (1170)
Q Consensus 832 ---~LyLVMEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd~dG~VKLsDF 902 (1170)
..||+++|...|+|.+.+... ..+++.++..|+.+|+.||++||... ++||||||.|||+...+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 499999999999999999753 36999999999999999999999998 999999999999999999999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC---CCCcchhhhHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM---GHGATADWWSVGIILF 979 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~---~ys~ksDIWSLGVILY 979 (1170)
|.+........... +...+ + ....-..|..|+|||.+.-. ..+.++|||||||+||
T Consensus 174 GS~~~a~i~i~~~~-----------------~a~~l---Q-e~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLY 232 (302)
T KOG2345|consen 174 GSATQAPIQIEGSR-----------------QALRL---Q-EWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLY 232 (302)
T ss_pred cCccccceEeechH-----------------HHHHH---H-HHHHHhCCCcccCchheecccCcccccccchhhhhHHHH
Confidence 99875321111000 00000 0 11123458889999998643 4688999999999999
Q ss_pred HHHhCCCCCCCCCH--HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 980 ELLIGIPPFNAKTP--QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 980 ELLTG~pPF~g~~~--~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.|+.|..||...-. ..+.-.+.++++.||+-+ ..|..+.+||+.||+.||.+||+ +.+++.+
T Consensus 233 a~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~---i~~ll~~ 296 (302)
T KOG2345|consen 233 AMMFGESPFERIYQQGGSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPT---IPELLSK 296 (302)
T ss_pred HHHHcCCcchHHhhcCCeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCC---HHHHHHH
Confidence 99999999953211 111224556788888654 48999999999999999999999 5566654
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=333.65 Aligned_cols=254 Identities=27% Similarity=0.365 Sum_probs=199.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-ceE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE-NLY 834 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~-~Ly 834 (1170)
..++|..-..||+|+||.||+|.... |..||||.+....... ...|.+|+.+|.+++|||+|+|+++|.+.+ +.+
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~ 148 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRL 148 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEE
Confidence 34678888899999999999998754 4899999776543211 345999999999999999999999999988 599
Q ss_pred EEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLN---VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~G---IIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
||+|||++|+|.++|.... .+++.....|+.+++.||+|||... ||||||||+|||||.+...||+|||+|+...
T Consensus 149 LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~ 228 (361)
T KOG1187|consen 149 LVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGP 228 (361)
T ss_pred EEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCC
Confidence 9999999999999998764 8999999999999999999999854 9999999999999999999999999997521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccc-cCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSV-AGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~-vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
. . .....+. .||.+|+|||++.....+.++|||||||+|.||++|+.|.
T Consensus 229 ~-----------------------------~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~ 278 (361)
T KOG1187|consen 229 E-----------------------------G-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAV 278 (361)
T ss_pred c-----------------------------c-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCccc
Confidence 0 0 0011112 7999999999999888999999999999999999999888
Q ss_pred CCCC---HHHHHH----HHhccC---CCCCCCC-ccCC--HH---HHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 989 NAKT---PQQIFD----NIMNRD---IPWPNIP-EEMS--VE---ACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 989 ~g~~---~~ei~q----kIl~~~---l~fP~ip-~~lS--~e---akDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.... ...+.. .+.++. +--|.+. ...+ .+ +..+..+|++.+|..||++.++.+.|
T Consensus 279 d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 279 DQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred CCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 7432 111111 111111 1112221 1222 22 55677899999999999987765555
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=325.50 Aligned_cols=263 Identities=32% Similarity=0.549 Sum_probs=207.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCC----CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-cc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATG----DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC-RE 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TG----e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd-~~ 831 (1170)
...|+++..||+|+||.||+|..+.++ +.||||.++...- .........+|+.+++.++||||+.|..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 346999999999999999999665543 3799998875422 22334567899999999999999999999887 78
Q ss_pred ceEEEEeeccCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC----CcEEEEec
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL-----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD----GHIKLTDF 902 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~-----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d----G~VKLsDF 902 (1170)
.++|++||.+. ||+.+|+-+ ..++..+++.++.||+.|+.|||++=|+||||||.||||..+ |.|||+||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 89999999965 999999633 358999999999999999999999999999999999999888 89999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFEL 981 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYEL 981 (1170)
|+|+.+. . .++. + ......+-|.+|+|||.++|. .|+.++|+|++|||+.||
T Consensus 181 GlaR~~~--~------------------plkp---l----~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaEl 233 (438)
T KOG0666|consen 181 GLARLFN--N------------------PLKP---L----ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAEL 233 (438)
T ss_pred cHHHHhh--c------------------cccc---c----ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHH
Confidence 9999742 0 0000 0 011235679999999999986 489999999999999999
Q ss_pred HhCCCCCCCCCH---------HHHHHHHhc-----cCCCCCCC---C--------------------------ccCCHHH
Q 001057 982 LIGIPPFNAKTP---------QQIFDNIMN-----RDIPWPNI---P--------------------------EEMSVEA 1018 (1170)
Q Consensus 982 LTG~pPF~g~~~---------~ei~qkIl~-----~~l~fP~i---p--------------------------~~lS~ea 1018 (1170)
|+-.|.|.+... .+++++|++ ..-.||.+ | ..-++.+
T Consensus 234 Ltl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a 313 (438)
T KOG0666|consen 234 LTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSA 313 (438)
T ss_pred HccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchH
Confidence 999999976432 234445543 11122211 0 1135568
Q ss_pred HHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1019 CDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1019 kDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+|+.+||++||.+|++ |++.|+|+||..-
T Consensus 314 ~~LL~klL~yDP~kRIt---a~qAleh~yF~~d 343 (438)
T KOG0666|consen 314 LDLLQKLLTYDPIKRIT---AEQALEHPYFTED 343 (438)
T ss_pred HHHHHHHhccCchhhcc---HHHHhcccccccC
Confidence 99999999999999999 7888999999865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=327.08 Aligned_cols=153 Identities=26% Similarity=0.448 Sum_probs=132.9
Q ss_pred cchhhccccCCCCCCCCCCCCCC-CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHH
Q 001057 735 DEDTVRSLRTSPINPCSKDRTSI-EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813 (1170)
Q Consensus 735 dee~v~sl~~sp~~p~~~~~i~i-edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILs 813 (1170)
+++....|+.+.|+|+..+.... .+|-+.++||+|-|++||||.+..+.++||||+.+... ...+..+.|+.+|+
T Consensus 54 eqE~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~ 129 (590)
T KOG1290|consen 54 EQEDPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQ 129 (590)
T ss_pred cccChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHH
Confidence 34455678899999998776666 89999999999999999999999999999999988754 44567788999999
Q ss_pred hcC-----C---CcEEEEEeeeec----ccceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 001057 814 SVR-----N---PFVVRFFYSFTC----RENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHS-LN 878 (1170)
Q Consensus 814 kL~-----H---PNIVrL~~~Fqd----~~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs-~G 878 (1170)
+++ | .+||+|++.|.. ..++|||+|++ |-+|..+|... +.++...++.|++|||.||.|||. .|
T Consensus 130 ~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg 208 (590)
T KOG1290|consen 130 QVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG 208 (590)
T ss_pred HHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence 874 3 479999999975 45899999999 78999999764 569999999999999999999995 59
Q ss_pred eeeccCCCCcEEeC
Q 001057 879 VIHRDLKPDNLLIG 892 (1170)
Q Consensus 879 IIHRDIKPENILLd 892 (1170)
|||.||||+|||+.
T Consensus 209 IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 209 IIHTDLKPENVLLC 222 (590)
T ss_pred ccccCCCcceeeee
Confidence 99999999999994
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=341.88 Aligned_cols=262 Identities=21% Similarity=0.336 Sum_probs=181.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCC----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEee---
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRAT----GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYS--- 826 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~T----Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~--- 826 (1170)
....++|.+.+.||+|+||.||+|++..+ +..||+|.+..... .+....+ .+....+.+++.++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhc
Confidence 44668999999999999999999999988 99999998764321 1111111 1112222222222221
Q ss_pred ---eecccceEEEEeeccCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCeeecc
Q 001057 827 ---FTCRENLYLVMEYLNGGDLYSLLRNLGC--------------------LDEDMARVYIAELVLALEYLHSLNVIHRD 883 (1170)
Q Consensus 827 ---Fqd~~~LyLVMEY~~GGSL~dlLk~~~~--------------------LSEe~ar~IaaQIL~ALeYLHs~GIIHRD 883 (1170)
......++|||||+.+++|.+++..... .....+..++.||+.||.|||++||+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 2345679999999999999999875421 12344667999999999999999999999
Q ss_pred CCCCcEEeCC-CCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc
Q 001057 884 LKPDNLLIGQ-DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG 962 (1170)
Q Consensus 884 IKPENILLd~-dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g 962 (1170)
|||+|||++. ++.+||+|||+|+.... + ........+||+.|||||++..
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~-------------~----------------~~~~~~~~~~t~~Y~APE~~~~ 331 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRV-------------G----------------INYIPKEFLLDPRYAAPEQYIM 331 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcccccc-------------c----------------cccCCcccccCCCccChHHhhc
Confidence 9999999986 57999999999974210 0 0112235688999999997753
Q ss_pred CC----------------------CCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hccCCC------------C
Q 001057 963 MG----------------------HGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNI-MNRDIP------------W 1007 (1170)
Q Consensus 963 ~~----------------------ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkI-l~~~l~------------f 1007 (1170)
.. ++.++|||||||+||||+++..|+.. ....+..+ ...... .
T Consensus 332 ~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 409 (566)
T PLN03225 332 STQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRAS 409 (566)
T ss_pred cCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccc
Confidence 22 34456999999999999997665432 22222221 111110 0
Q ss_pred CC------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhh
Q 001057 1008 PN------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTL 1056 (1170)
Q Consensus 1008 P~------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L 1056 (1170)
+. +.......+++||.+||++||.+||+ +.++|+||||++..+..+
T Consensus 410 ~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t---a~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 410 PDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS---AKAALAHPYFDREGLLGL 461 (566)
T ss_pred hhhhhhhhhccccchHHHHHHHHHccCCcccCCC---HHHHhCCcCcCCCCcccc
Confidence 00 00112345669999999999999999 889999999998876543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=347.99 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=222.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
.+...+-...+.||+|+||+||+|+-. .....||||.++... ...+.+.|.+|+++|..++|||||+|++++.
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 345567788899999999999999864 244689999998653 3457789999999999999999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNLG----------C----LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD 894 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~~----------~----LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d 894 (1170)
.++-+|||+|||..|||.++|.... . |+..+...++.||+.|+.||-++.+|||||-..|+||+++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 9999999999999999999996431 2 7888899999999999999999999999999999999999
Q ss_pred CcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHH
Q 001057 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974 (1170)
Q Consensus 895 G~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSL 974 (1170)
-.|||+||||++..... +++ + ......=-..||+||.|+...|+.++||||+
T Consensus 640 l~VKIsDfGLsRdiYss-------------DYY-----k----------~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSS-------------DYY-----K----------VRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred eEEEecccccchhhhhh-------------hhh-----c----------ccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 99999999999864200 000 0 0001111347999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 975 GIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 975 GVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
||+|||+++ |..||++.+.++.++.|.++++ + ..|.+++.++.+|+..|++.+|.+||++.++.-+|++
T Consensus 692 GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L-~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 692 GVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-L-SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred hhhhhhhhccccCcccccchHHHHHHHHcCCc-c-cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 999999997 9999999999999999999987 4 4689999999999999999999999997777766654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=341.65 Aligned_cols=253 Identities=31% Similarity=0.464 Sum_probs=199.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc------
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE------ 831 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~------ 831 (1170)
..+..-..||+||||.||+++++.||+.||||.+++.. .....+...+|++||++++|||||+++++=.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 44677788999999999999999999999999988754 3345677889999999999999999998755443
Q ss_pred ceEEEEeeccCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC--CCC--cEEEEecCC
Q 001057 832 NLYLVMEYLNGGDLYSLLRN---LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG--QDG--HIKLTDFGL 904 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~---~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd--~dG--~VKLsDFGL 904 (1170)
...+|||||.||+|+.++.+ ...|++.+.+.++..++.||.|||++||+||||||.||++- .+| ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 46899999999999999974 35699999999999999999999999999999999999983 334 369999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-cCCCCcchhhhHHHHHHHHHHh
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLI 983 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-g~~ys~ksDIWSLGVILYELLT 983 (1170)
|+.. ..+....+.+||+.|++||++. ...|+..+|.|||||++|+++|
T Consensus 171 Arel-------------------------------~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT 219 (732)
T KOG4250|consen 171 AREL-------------------------------DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT 219 (732)
T ss_pred cccC-------------------------------CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc
Confidence 9853 1122456889999999999998 4789999999999999999999
Q ss_pred CCCCCCCCC----HHHHHHHHhc---------------cCCC----CCCCCccCCHH----HHHHHHHhccCCCCCCC--
Q 001057 984 GIPPFNAKT----PQQIFDNIMN---------------RDIP----WPNIPEEMSVE----ACDLIDKLLTENPVQRL-- 1034 (1170)
Q Consensus 984 G~pPF~g~~----~~ei~qkIl~---------------~~l~----fP~ip~~lS~e----akDLIkkLLq~DPskRp-- 1034 (1170)
|..||...- ..++.-.+.. +.+. +| .|..++.. +-..+..+|..+|.+|.
T Consensus 220 G~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~ 298 (732)
T KOG4250|consen 220 GELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRGHE 298 (732)
T ss_pred cCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhCCC
Confidence 999995321 2223222221 1111 22 13344443 44667788999999998
Q ss_pred C----hhhHHHHHc
Q 001057 1035 G----ATGAREVKQ 1044 (1170)
Q Consensus 1035 S----a~~AeEILq 1044 (1170)
+ .....+||+
T Consensus 299 ~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 299 GFDRFFAEVDDILN 312 (732)
T ss_pred CcchHHHHHHHHHh
Confidence 3 234555555
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=339.53 Aligned_cols=257 Identities=32% Similarity=0.529 Sum_probs=221.1
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec-----cc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTC-----RE 831 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd-----~~ 831 (1170)
+.|+++.+||.|.+|.||+++++.+++..|+|++.... ..-+.+..|.+||+.+ +|||++.+|++|.- ++
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 56999999999999999999999999999999976543 3345677899999876 59999999998864 46
Q ss_pred ceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
.++||||||.||+..+++++. .++.|+.+..|+++++.||.+||.+.+||||||-.|||++.+|.|||+|||++...
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl- 173 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL- 173 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee-
Confidence 799999999999999999764 57999999999999999999999999999999999999999999999999998742
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-----CCCcchhhhHHHHHHHHHHhC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-----GHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-----~ys~ksDIWSLGVILYELLTG 984 (1170)
+....+.++.+|||.|||||++... .|+..+|+||||++..||.-|
T Consensus 174 -----------------------------dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG 224 (953)
T KOG0587|consen 174 -----------------------------DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEG 224 (953)
T ss_pred -----------------------------ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCC
Confidence 2334466788999999999999753 478889999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 985 IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+|+....+...+-.|-....+-..-+...+.++.+||..||.+|-.+||+ ..++|.|||+..-
T Consensus 225 ~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~---~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 225 APPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS---TEELLKHPFITEQ 288 (953)
T ss_pred CCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc---hhhhccCCccccc
Confidence 999999888776655544433322235688999999999999999999999 8899999999844
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.39 Aligned_cols=269 Identities=29% Similarity=0.451 Sum_probs=218.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccc----cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD----MIRKNAVESILAERNILISVRNPFVVRFFYSFTC- 829 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~----i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd- 829 (1170)
...++|-++.+||+|||+.||+|.+....++||+|+-.... ....+..++..+|..|.+.|+||-||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 44568999999999999999999999999999999854322 1123456788999999999999999999999975
Q ss_pred ccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CeeeccCCCCcEEeCC---CCcEEEEecCC
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL--NVIHRDLKPDNLLIGQ---DGHIKLTDFGL 904 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~--GIIHRDIKPENILLd~---dG~VKLsDFGL 904 (1170)
.+.+|-|+|||+|.+|..+|+.+..+++.+++.|+.||+.||.||... -|||-||||.||||-. .|.|||+||||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 467999999999999999999999999999999999999999999976 5999999999999953 47899999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC----CCCcchhhhHHHHHHHH
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM----GHGATADWWSVGIILFE 980 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~----~ys~ksDIWSLGVILYE 980 (1170)
+++..-. +..+ . .....+....||.||++||.+.-. ..+.++||||+|||+|.
T Consensus 620 SKIMddd--------Sy~~-----------v----dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQ 676 (775)
T KOG1151|consen 620 SKIMDDD--------SYNS-----------V----DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 676 (775)
T ss_pred hhhccCC--------ccCc-----------c----cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhh
Confidence 9974200 0000 0 112234556899999999988632 35788999999999999
Q ss_pred HHhCCCCCCCCC-HHHHHH--HHhc-cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 981 LLIGIPPFNAKT-PQQIFD--NIMN-RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 981 LLTG~pPF~g~~-~~ei~q--kIl~-~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
+|.|+.||...- ...+++ .|++ ..+.||.. ..++.++++||++||++.-..|.. +.++-.||||..
T Consensus 677 ClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~D---V~qLA~dpyllP 746 (775)
T KOG1151|consen 677 CLYGRKPFGHNQSQQDILQENTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRID---VQQLACDPYLLP 746 (775)
T ss_pred hhccCCCCCCchhHHHHHhhhchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhh---HHHHccCccccc
Confidence 999999997543 333433 2333 45667754 468999999999999999999976 889999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=332.59 Aligned_cols=263 Identities=30% Similarity=0.495 Sum_probs=217.7
Q ss_pred CCCCCCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC------CcEE
Q 001057 748 NPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN------PFVV 821 (1170)
Q Consensus 748 ~p~~~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H------PNIV 821 (1170)
+....+.+.-.+|.+....|+|-||+|..|.+...|..||||+|...... ...-+.|++||++|+. -+++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 33444566678999999999999999999999999999999999876533 2345789999999973 4789
Q ss_pred EEEeeeecccceEEEEeeccCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-cE
Q 001057 822 RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HI 897 (1170)
Q Consensus 822 rL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~---~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-~V 897 (1170)
+|+-.|...+++|||+|-+ ..+|.++|++.+ .|....++.|+.|++.||..|-..||+|.||||.|||++... .+
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence 9999999999999999988 679999999876 488889999999999999999999999999999999998764 68
Q ss_pred EEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHH
Q 001057 898 KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGII 977 (1170)
Q Consensus 898 KLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVI 977 (1170)
||||||.|..... .....+.-+..|.|||+|+|..|++..|+||+||+
T Consensus 577 KLCDfGSA~~~~e--------------------------------neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgct 624 (752)
T KOG0670|consen 577 KLCDFGSASFASE--------------------------------NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCT 624 (752)
T ss_pred eeccCcccccccc--------------------------------ccccHHHHHHhccCcceeecCcccCCccceeecee
Confidence 9999999875310 01112334668999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC------------------------------------------------
Q 001057 978 LFELLIGIPPFNAKTPQQIFDNIMNRDIPWPN------------------------------------------------ 1009 (1170)
Q Consensus 978 LYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~------------------------------------------------ 1009 (1170)
||||.||+..|.|.+...++...+..+-+||.
T Consensus 625 LYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~ 704 (752)
T KOG0670|consen 625 LYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSE 704 (752)
T ss_pred eEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHH
Confidence 99999999999999988887766543333331
Q ss_pred ------CCc---cCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 1010 ------IPE---EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 1010 ------ip~---~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
++. .+-..+++||.+||..||++|++ +.++|.||||++
T Consensus 705 l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit---~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 705 LIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT---VNQALKHPFITE 751 (752)
T ss_pred HhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC---HHHHhcCCcccC
Confidence 000 11235889999999999999999 778899999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.02 Aligned_cols=263 Identities=31% Similarity=0.482 Sum_probs=211.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR------ 830 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~------ 830 (1170)
.+.|+-+.+||+|.||.||+|+.+.+|+.||+|++--.. .....-...++|+.||..+.|+|++.+++.+...
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 456888899999999999999999999999998653211 1222334568999999999999999988766432
Q ss_pred --cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 831 --ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 831 --~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
..+||||.+|+. +|.-+|.+. .+|+..+++.++.+++.||.|+|++.|+|||+|++|+||+.+|.+||+|||+|+.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 349999999965 999999876 5799999999999999999999999999999999999999999999999999985
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~p 986 (1170)
+..... .........+-|.+|++||.++|. .|+++.|||..||||.||.+|.+
T Consensus 174 fs~~~n--------------------------~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp 227 (376)
T KOG0669|consen 174 FSTSKN--------------------------VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP 227 (376)
T ss_pred eecccc--------------------------cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence 421110 000112345679999999999975 59999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhc--cC---CCCCCC--------------Cc-------------cCCHHHHHHHHHhccCCCCCCC
Q 001057 987 PFNAKTPQQIFDNIMN--RD---IPWPNI--------------PE-------------EMSVEACDLIDKLLTENPVQRL 1034 (1170)
Q Consensus 987 PF~g~~~~ei~qkIl~--~~---l~fP~i--------------p~-------------~lS~eakDLIkkLLq~DPskRp 1034 (1170)
-|.+.+...++..|.. +. -.||++ +. .-.+++.||+.+||..||.+|+
T Consensus 228 imqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~ 307 (376)
T KOG0669|consen 228 IMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI 307 (376)
T ss_pred cccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc
Confidence 9999988877766642 11 123321 11 1245889999999999999999
Q ss_pred ChhhHHHHHcCCCCCC
Q 001057 1035 GATGAREVKQHPFFKN 1050 (1170)
Q Consensus 1035 Sa~~AeEILqHPfF~~ 1050 (1170)
. +.++++|.||..
T Consensus 308 ~---ad~alnh~~F~k 320 (376)
T KOG0669|consen 308 D---ADQALNHDFFWK 320 (376)
T ss_pred c---hHhhhchhhhhc
Confidence 8 788899999964
|
|
| >KOG1113 consensus cAMP-dependent protein kinase types I and II, regulatory subunit [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=323.48 Aligned_cols=187 Identities=13% Similarity=0.065 Sum_probs=169.4
Q ss_pred cccccceeeecccccccccccccccCCcchhHHHHHHHHHHHHHh--cccCCCccCcccccccccCCCcccccccccCCC
Q 001057 494 CEVEIPVVHVEEHSRICTIADRCDLKSLTVNERLERVAETLEKIL--DSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSK 571 (1170)
Q Consensus 494 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~ 571 (1170)
||++-|-. -..+.--++| ++|-+.|..|++.|++ -+|.|.+++ ..+++..++.+++|..+|+|||+
T Consensus 95 aE~~tp~~--------d~~~~~~~pK---d~e~~~~L~~a~r~~~LF~~Ld~eq~~-~v~dam~~~~v~~G~~Vi~qGde 162 (368)
T KOG1113|consen 95 AEEITPDD--------DEFKRKYIPK---DDETRRRLEEAFRKNLLFANLDDEQLS-QVLDAMFEKRVKAGETVIKQGDE 162 (368)
T ss_pred eeecCccc--------hhhhhcCCCC---CHHHHHHHHHHHHhccccccCCHHHHH-HHHHhhceeeecCCcEEEecCCc
Confidence 67777754 1223333444 5788899999999976 889885543 34999999999999999999999
Q ss_pred CCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCchhhhhhhhhhhhhccCCCHHH
Q 001057 572 EMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQ 648 (1170)
Q Consensus 572 Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~~k 648 (1170)
||+||||++|++||||+|+.|+++++|++||||||| ||||||+|+|+++||+||| .|||+|+|.++.+|
T Consensus 163 Gd~fYvI~kGt~dVyv~~~~v~~~~~g~sFGElALmyn~PRaATv~a~t~~klWgldr--------~SFrrIi~~s~~kk 234 (368)
T KOG1113|consen 163 GDNFYVIDKGTFDVYVNGTYVTTYSPGGSFGELALMYNPPRAATVVAKSLKKLWGLDR--------TSFRRIIMKSCIKK 234 (368)
T ss_pred CCcEEEEecceEEEEECCeEEeeeCCCCchhhhHhhhCCCcccceeeccccceEEEee--------ceeEEEeeccchhh
Confidence 999999999999999999999999999999999999 9999999999999999999 99999999999999
Q ss_pred HHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 649 IKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 649 r~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
|+||++||+++|+|++|+.|++.+|+|++.++.| |.+++.||.||++.+|..
T Consensus 235 rkMy~~~l~s~pil~~l~k~er~kv~dal~~k~y~~G~~Vi~qg~~ge~f~~i~eGEv 292 (368)
T KOG1113|consen 235 RKMYEPFLESVPILESLEKLERAKVADALGTKSYKDGERVIVQGDQGEHFYIIEEGEV 292 (368)
T ss_pred hhhhhhhhhcchhhHHHHHHHHHhhhcccceeeccCCceEEeccCCcceEEEeccccc
Confidence 9999999999999999999999999999999999 778899999999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=323.41 Aligned_cols=265 Identities=21% Similarity=0.308 Sum_probs=191.0
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeec----------------CCCCEEEEEEeeccccccH-----------HHHHHH
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKR----------------ATGDLFAIKVLKKADMIRK-----------NAVESI 805 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk----------------~TGe~VAIKvLkKs~i~~~-----------~~ve~~ 805 (1170)
.....++|++.++||+|+||+||+|... ..++.||||.+........ ...+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3456789999999999999999999642 3456899999864321100 011233
Q ss_pred HHHHHHHHhcCCCcE-----EEEEeeeec--------ccceEEEEeeccCCChHHHHHhcC-------------------
Q 001057 806 LAERNILISVRNPFV-----VRFFYSFTC--------RENLYLVMEYLNGGDLYSLLRNLG------------------- 853 (1170)
Q Consensus 806 l~EieILskL~HPNI-----VrL~~~Fqd--------~~~LyLVMEY~~GGSL~dlLk~~~------------------- 853 (1170)
..|+.++.+++|.++ ++++++|.. ....+|||||+++|+|.+++....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 457777777776654 556665542 356899999999999999886421
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccc
Q 001057 854 -----CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928 (1170)
Q Consensus 854 -----~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~ 928 (1170)
.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..... +
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~-------------~---- 362 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT-------------G---- 362 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCcccccc-------------C----
Confidence 235567888999999999999999999999999999999999999999999864210 0
Q ss_pred cccccCCCCCcccccccccccCCCCCCchHHHhcCC--------------------CC--cchhhhHHHHHHHHHHhCCC
Q 001057 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG--------------------HG--ATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 929 ~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~--------------------ys--~ksDIWSLGVILYELLTG~p 986 (1170)
.........+|+.|+|||++.... |+ ...||||+|||+|+|++|..
T Consensus 363 ------------~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l 430 (507)
T PLN03224 363 ------------INFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPEL 430 (507)
T ss_pred ------------CccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCC
Confidence 000011223589999999986432 22 24799999999999999875
Q ss_pred -CCCCCCH-----------HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCC---CCCCChhhHHHHHcCCCCCC
Q 001057 987 -PFNAKTP-----------QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENP---VQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 987 -PF~g~~~-----------~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DP---skRpSa~~AeEILqHPfF~~ 1050 (1170)
||.+... ...+..+....+.++. ....+..++|||.+||..+| .+|++ |.|+|+||||..
T Consensus 431 ~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlS---a~eaL~Hp~f~~ 505 (507)
T PLN03224 431 RPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLS---VGQALSHRFFLP 505 (507)
T ss_pred CCccchhhhhhHHhhccchHHHHHhhcccCCCccc-ccccChHHHHHHHHHhccCCCCcccCCC---HHHHhCCCCcCC
Confidence 7754221 1112222333444442 34678999999999999876 68999 889999999964
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=340.06 Aligned_cols=250 Identities=22% Similarity=0.404 Sum_probs=211.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCC-C----CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRAT-G----DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~T-G----e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
+....-++.+.||+|.||.||.|....- | ..||||.+.+. .+...+..|++|..+|+.++|||||++++++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 4556788899999999999999987542 2 24899988764 356778899999999999999999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEec
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNL-------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~-------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDF 902 (1170)
....+|++|||.||||..+|++. ..++......++.+|+.|.+||+++++|||||-..|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999875 24888899999999999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELL 982 (1170)
|+|+... .. .++ ..... ..--..|||||.+....++.++|||||||+|||++
T Consensus 847 GlArDiy--~~-----------~yy-----------r~~~~----a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif 898 (1025)
T KOG1095|consen 847 GLARDIY--DK-----------DYY-----------RKHGE----AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF 898 (1025)
T ss_pred chhHhhh--hc-----------hhe-----------eccCc----cccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence 9999421 00 000 00000 01124799999999999999999999999999999
Q ss_pred h-CCCCCCCCCHHHHHHHHhccC-CCCCCCCccCCHHHHHHHHHhccCCCCCCCChh
Q 001057 983 I-GIPPFNAKTPQQIFDNIMNRD-IPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT 1037 (1170)
Q Consensus 983 T-G~pPF~g~~~~ei~qkIl~~~-l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~ 1037 (1170)
+ |..||.+.+..+++...+.+. ++. |..++..+.+++..|++.+|++||+..
T Consensus 899 slG~~PY~~~~n~~v~~~~~~ggRL~~---P~~CP~~ly~lM~~CW~~~pe~RP~F~ 952 (1025)
T KOG1095|consen 899 SLGATPYPSRSNFEVLLDVLEGGRLDP---PSYCPEKLYQLMLQCWKHDPEDRPSFR 952 (1025)
T ss_pred hCCCCCCCCcchHHHHHHHHhCCccCC---CCCCChHHHHHHHHHccCChhhCccHH
Confidence 8 999999999999988666554 333 478999999999999999999999943
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=309.69 Aligned_cols=256 Identities=29% Similarity=0.492 Sum_probs=211.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc---
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE--- 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~--- 831 (1170)
....+|.-++.+|.|.- .|..|-+..+++.||+|.+.... .......+..+|..++..+.|+||++++.+|.-..
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34568999999999999 78889999999999999887652 22334456788999999999999999999997543
Q ss_pred ---ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 832 ---NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 832 ---~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
.+|+||||| ..+|...+.. .+.-..+.+++.|+++|++|||+.||+||||||+||++..++.+||.|||+|+..
T Consensus 92 ~~~e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 92 EFQEVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHhHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 589999999 5699988873 4777889999999999999999999999999999999999999999999999842
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
. .......++.|..|.|||++.+.+|...+||||+|||+.||++|...|
T Consensus 169 ~-------------------------------~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf 217 (369)
T KOG0665|consen 169 D-------------------------------TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLF 217 (369)
T ss_pred C-------------------------------cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEe
Confidence 1 011334578999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHhcc---------------------------CCC----CCC-----C---CccCCHHHHHHHHHhccCC
Q 001057 989 NAKTPQQIFDNIMNR---------------------------DIP----WPN-----I---PEEMSVEACDLIDKLLTEN 1029 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~---------------------------~l~----fP~-----i---p~~lS~eakDLIkkLLq~D 1029 (1170)
.|.+.-+++.++... .+. ||+ . +..-+..+++|+.+||..|
T Consensus 218 ~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~ 297 (369)
T KOG0665|consen 218 PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVID 297 (369)
T ss_pred cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccC
Confidence 998766555554320 011 111 0 1123567999999999999
Q ss_pred CCCCCChhhHHHHHcCCCCC
Q 001057 1030 PVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 1030 PskRpSa~~AeEILqHPfF~ 1049 (1170)
|++|.+ ++++|.||||+
T Consensus 298 pe~Ris---v~daL~HPY~~ 314 (369)
T KOG0665|consen 298 PEKRIS---VDDALRHPYIK 314 (369)
T ss_pred hhhccc---HHHHhcCCeee
Confidence 999999 89999999998
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=304.79 Aligned_cols=261 Identities=25% Similarity=0.455 Sum_probs=212.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeecccc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS-VRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILsk-L~HPNIVrL~~~Fqd~~~ 832 (1170)
.+..++.+-+..||.|+||+|++..++.+|+..|+|.++.... .....+++.|.+...+ -+.||||++|++...++.
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 4555667778899999999999999999999999999987653 4455677788776554 568999999999888888
Q ss_pred eEEEEeeccCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCcc
Q 001057 833 LYLVMEYLNGGDLYSLLR-----NLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk-----~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk 906 (1170)
.+|.||+| ..+|..+-+ ....++|...-.+..-.+.||+||-. ..||||||||+||||+..|.|||||||.|.
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 99999999 446655443 23569998888888889999999995 589999999999999999999999999986
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--CCCCcchhhhHHHHHHHHHHhC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g--~~ys~ksDIWSLGVILYELLTG 984 (1170)
... ..-....-+|...|||||.+.. .+|+-++|+||||++|||++||
T Consensus 217 qLv-------------------------------~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG 265 (361)
T KOG1006|consen 217 QLV-------------------------------DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG 265 (361)
T ss_pred hHH-------------------------------HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC
Confidence 431 0111223468899999999963 4689999999999999999999
Q ss_pred CCCCCCCCH-HHHHHHHhccCCCCCCCCc---cCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 985 IPPFNAKTP-QQIFDNIMNRDIPWPNIPE---EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 985 ~pPF~g~~~-~ei~qkIl~~~l~fP~ip~---~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..||.+.+. .+++..+..+..+....+. ..+..++.||..||.+|-+.||. ..+++++||++-.
T Consensus 266 ~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk---y~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 266 NFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK---YDDLKKFPFYRMY 333 (361)
T ss_pred CCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc---hhhhhcCchhhhh
Confidence 999988654 4566666667655433233 48999999999999999999998 7899999999754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-34 Score=332.71 Aligned_cols=274 Identities=42% Similarity=0.753 Sum_probs=243.7
Q ss_pred EeccCCCeEEEEeee---cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEEEEeec
Q 001057 765 PISQGAFGRVFLARK---RATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLVMEYL 840 (1170)
Q Consensus 765 ~LG~GgFGtVyLArd---k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyLVMEY~ 840 (1170)
.+|.|+||.|++++. ...|..||+|++++......... +...|..++..++ ||++|++++.|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 379999999999865 35678999999988765444333 7778999999998 999999999999999999999999
Q ss_pred cCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCC
Q 001057 841 NGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920 (1170)
Q Consensus 841 ~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~s 920 (1170)
.||+|+..+.....+.+...++|.++++.|++++|+.||+|||+|++||+++.+|++++.|||+++...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v----------- 148 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV----------- 148 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhH-----------
Confidence 999999999998899999999999999999999999999999999999999999999999999998632
Q ss_pred CCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 001057 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNI 1000 (1170)
Q Consensus 921 l~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkI 1000 (1170)
.....|||..|||||++. ++..++||||+|+++|||++|..||.+ ++...|
T Consensus 149 -----------------------~~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I 199 (612)
T KOG0603|consen 149 -----------------------KEKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI 199 (612)
T ss_pred -----------------------hhhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH
Confidence 001129999999999998 788999999999999999999999998 777888
Q ss_pred hccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCCCcc
Q 001057 1001 MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDTSYF 1075 (1170)
Q Consensus 1001 l~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDts~F 1075 (1170)
....+.+| ..++.++++++..|+..+|.+|++. .++.++++|+||+.++|..+..+ .++|+|.... .++.+|
T Consensus 200 l~~~~~~p---~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~f 276 (612)
T KOG0603|consen 200 LKAELEMP---RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQF 276 (612)
T ss_pred hhhccCCc---hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhc
Confidence 88777666 7899999999999999999999985 58999999999999999988776 7889998877 788999
Q ss_pred ccccccC
Q 001057 1076 VSRYVWN 1082 (1170)
Q Consensus 1076 ~s~~~~~ 1082 (1170)
+.+|+..
T Consensus 277 d~eft~~ 283 (612)
T KOG0603|consen 277 DPEFTSQ 283 (612)
T ss_pred CchhccC
Confidence 9877643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-33 Score=292.44 Aligned_cols=253 Identities=29% Similarity=0.524 Sum_probs=205.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccc--c
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRE--N 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~--~ 832 (1170)
..++|++++++|+|.|+.||.|++..+++.++||+++.- ....+.+|+.||..|. ||||++|++...+.. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 457899999999999999999999999999999998753 2357889999999998 999999999988764 4
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC-CcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD-GHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d-G~VKLsDFGLAk~~~~~ 911 (1170)
..||+||+++.+...+.. .|+...+++|+.|++.||.|||++||+|||+||.|++||.. -.++|+|+|||.+.-
T Consensus 110 paLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-- 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-- 184 (338)
T ss_pred chhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC--
Confidence 789999998877766554 48888999999999999999999999999999999999975 479999999998631
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCC-
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFN- 989 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~- 989 (1170)
.+..-+..+.+..|--||.+..- .|+++-|+|||||+|..|+..+-||.
T Consensus 185 -----------------------------p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 185 -----------------------------PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred -----------------------------CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 11122345678889999999764 58999999999999999999988874
Q ss_pred CCCHHHHHHHHhc-------------cC----------------CCCCCC-----CccCCHHHHHHHHHhccCCCCCCCC
Q 001057 990 AKTPQQIFDNIMN-------------RD----------------IPWPNI-----PEEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 990 g~~~~ei~qkIl~-------------~~----------------l~fP~i-----p~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
|.+..+++-+|.+ -. .+|..+ ..-.++++.|||.++|.+|..+|+|
T Consensus 236 G~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 236 GHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred CCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc
Confidence 5554444333321 00 111111 1235799999999999999999999
Q ss_pred hhhHHHHHcCCCCCCC
Q 001057 1036 ATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1036 a~~AeEILqHPfF~~i 1051 (1170)
|+|++.||||..+
T Consensus 316 ---akEam~HpyF~~~ 328 (338)
T KOG0668|consen 316 ---AKEAMAHPYFAPV 328 (338)
T ss_pred ---hHHHhcCchHHHH
Confidence 8899999999764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=338.53 Aligned_cols=240 Identities=23% Similarity=0.310 Sum_probs=186.4
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|.....||+|+||.||+|++..++..||+|.+...... ...|+.++.+++|||||++++++.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 456667899999999999999999999999988653321 1245788999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH---SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLH---s~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|+++|+|.++++. +++..+..++.||+.||+||| +.+|+||||||+|||++.++..++. ||.+....
T Consensus 764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~------ 833 (968)
T PLN00113 764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC------ 833 (968)
T ss_pred CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc------
Confidence 9999999999964 889999999999999999999 6699999999999999998888775 66543210
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC---
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT--- 992 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~--- 992 (1170)
......||+.|||||++.+..|+.++|||||||++|||++|+.||....
T Consensus 834 ----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~ 885 (968)
T PLN00113 834 ----------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH 885 (968)
T ss_pred ----------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC
Confidence 0112368899999999999899999999999999999999999995421
Q ss_pred --HHHHHHHHhcc-C---CCCCC------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 993 --PQQIFDNIMNR-D---IPWPN------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 993 --~~ei~qkIl~~-~---l~fP~------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..+........ . ..-|. .+.....++.+++.+|++.||.+||++.++.+.+
T Consensus 886 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 886 GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred CcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 11111111100 0 00011 1112234577899999999999999965554444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-33 Score=300.43 Aligned_cols=260 Identities=30% Similarity=0.506 Sum_probs=212.4
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----cce
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-----ENL 833 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-----~~L 833 (1170)
+.+.-+.||.|+||+||.+.+..+|+.||+|.+..- ...-...+.+.+|+.+|..++|.|++..++..+.. ..+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 445557899999999999999999999999987643 22334567899999999999999999988776654 247
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+|.|+|. .+|..+|-.-..++.+.++.+++||+.||+|||+.||+||||||.|+|++.+..+||||||+|+.-. .
T Consensus 133 YV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee---~ 208 (449)
T KOG0664|consen 133 YVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD---Q 208 (449)
T ss_pred HHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc---h
Confidence 89999995 5999999888899999999999999999999999999999999999999999999999999998521 0
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.....+...+-|-+|+|||++.|. .|+.++||||+|||+.|||..+..|...+
T Consensus 209 --------------------------d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~ 262 (449)
T KOG0664|consen 209 --------------------------RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAG 262 (449)
T ss_pred --------------------------hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccC
Confidence 111222334568899999999985 48999999999999999999999999988
Q ss_pred HHHHHHHHhc-----------------------cCCCCCCC--------CccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 993 PQQIFDNIMN-----------------------RDIPWPNI--------PEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 993 ~~ei~qkIl~-----------------------~~l~fP~i--------p~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+-+.++.|.. +...-|.. +..-..++.+++.+||..||.+|.+ ..+
T Consensus 263 PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris---~~~ 339 (449)
T KOG0664|consen 263 PIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS---VEE 339 (449)
T ss_pred hHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc---Hhh
Confidence 8777776642 12222222 1234567889999999999999998 778
Q ss_pred HHcCCCCCCCC
Q 001057 1042 VKQHPFFKNIN 1052 (1170)
Q Consensus 1042 ILqHPfF~~id 1052 (1170)
.+.|++..+..
T Consensus 340 A~~~~~~~e~R 350 (449)
T KOG0664|consen 340 ALQHRYLEEGR 350 (449)
T ss_pred hcccccccccc
Confidence 89999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=330.11 Aligned_cols=268 Identities=52% Similarity=0.894 Sum_probs=224.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|..++.|.-|+||.||+++++.+.+.+|+|+ .+..+.-+ +||....+|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilR----------nilt~a~npfvv-------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILR----------NILTFAGNPFVV-------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhh----------ccccccCCccee--------------
Confidence 45789999999999999999999999999999965 33322111 155555666666
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||=..+++..+.++.+. +.+++|||+.||+|||+||+|+||+.-|++|++|||+++........
T Consensus 136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at- 199 (1205)
T KOG0606|consen 136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT- 199 (1205)
T ss_pred -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc-
Confidence 56666777777777655 78999999999999999999999999999999999999864311110
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.+....+.. ..........||||.|+||||+...+|+..+|||+||+|+||.|.|+.||.++++++
T Consensus 200 ----------nl~eg~I~k----~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 200 ----------NLKEGHIEK----DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred ----------hhhhcchHH----HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 011111110 122334556799999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCCCCCCC-CCCCc
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES-LDTSY 1074 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfiP~~~s-lDts~ 1074 (1170)
++..++...+.||+-...++++++++|.+||+.+|..|++..++.++++|+||+.+||..|..+++.|+|...+ .|+.|
T Consensus 266 lfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsy 345 (1205)
T KOG0606|consen 266 LFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSY 345 (1205)
T ss_pred HHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchh
Confidence 99999999999998777899999999999999999999998899999999999999999999999999999988 78999
Q ss_pred cccc
Q 001057 1075 FVSR 1078 (1170)
Q Consensus 1075 F~s~ 1078 (1170)
|+++
T Consensus 346 fdTR 349 (1205)
T KOG0606|consen 346 FDTR 349 (1205)
T ss_pred hccc
Confidence 9885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=318.09 Aligned_cols=250 Identities=30% Similarity=0.445 Sum_probs=196.7
Q ss_pred eEEEEEeccCCCeE-EEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEEEE
Q 001057 760 FEIIKPISQGAFGR-VFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 760 Yevlk~LG~GgFGt-VyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
|.--+.+|.|+-|+ ||+|.. .|+.||||.+-. .-..-..+|+..|+..+ |||||++|+.-++.+.+||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 33445689999886 788875 588999997643 23345678999998875 999999999999999999999
Q ss_pred eeccCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---CC--cEEEEecCCcccc
Q 001057 838 EYLNGGDLYSLLRNLG----CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ---DG--HIKLTDFGLSKVG 908 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~----~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~---dG--~VKLsDFGLAk~~ 908 (1170)
|.|. .+|.+++.... .......+..+.|++.||++||+.+||||||||.||||+. ++ .++|+|||+|+..
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9995 59999998741 1111345778899999999999999999999999999976 34 6899999999964
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhC-CCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG-IPP 987 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG-~pP 987 (1170)
. .+- ..-....+..||-+|+|||++....-..++|||||||++|+.++| ..|
T Consensus 662 ~-------------~~~--------------sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~Hp 714 (903)
T KOG1027|consen 662 A-------------GGK--------------SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHP 714 (903)
T ss_pred C-------------CCc--------------chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccC
Confidence 2 010 011124567899999999999998888899999999999999985 999
Q ss_pred CCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
|...-.. -.+|+++....-.+......++.|||.+||+++|..||+ |.++|.||||-.
T Consensus 715 FGd~~~R--~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs---a~~VL~HPlFW~ 772 (903)
T KOG1027|consen 715 FGDSLER--QANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS---ATDVLNHPLFWD 772 (903)
T ss_pred CCchHHh--hhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC---HHHHhCCCccCC
Confidence 9764433 346777665543332222229999999999999999999 889999999953
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=306.92 Aligned_cols=205 Identities=27% Similarity=0.508 Sum_probs=182.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHH-----HHHHHHHHHHHhcC---CCcEEEEEe
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAV-----ESILAERNILISVR---NPFVVRFFY 825 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~v-----e~~l~EieILskL~---HPNIVrL~~ 825 (1170)
-....+|..++.+|.|+||.|++|.++.+...|+||.+.|.++.-...+ -.+--|+.||..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 3456789999999999999999999999999999999998776544333 24567999999998 999999999
Q ss_pred eeecccceEEEEeecc-CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCC
Q 001057 826 SFTCRENLYLVMEYLN-GGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGL 904 (1170)
Q Consensus 826 ~Fqd~~~LyLVMEY~~-GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGL 904 (1170)
+|++++++||+||... |-+|+++|..+..++|.+++.+++||+.|+++||+.||||||||-+|+.++.+|-+||+|||.
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 9999999999999864 569999999999999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHh
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLI 983 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLT 983 (1170)
|... .......++||..|.|||++.|..| +..-|||+||++||.++.
T Consensus 717 aa~~--------------------------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy 764 (772)
T KOG1152|consen 717 AAYT--------------------------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY 764 (772)
T ss_pred hhhh--------------------------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe
Confidence 8642 1112346899999999999999887 677899999999999999
Q ss_pred CCCCCCC
Q 001057 984 GIPPFNA 990 (1170)
Q Consensus 984 G~pPF~g 990 (1170)
...||+.
T Consensus 765 kenpyyn 771 (772)
T KOG1152|consen 765 KENPYYN 771 (772)
T ss_pred ccCCCcC
Confidence 9999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=300.04 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=208.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+......+.++||+|-||.|.+|... .+..||+|+++... .......|..|+.+|.+|+|||||+|+++|..++.+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEec-CceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 34456788899999999999999864 36899999987653 3455688999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
||||||+.|+|.+++..+. .+.......++.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++...
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly--- 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY--- 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc---
Confidence 9999999999999998873 33455566799999999999999999999999999999999999999999998532
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHH--hCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL--IGIPPFNA 990 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELL--TG~pPF~g 990 (1170)
++.++ +.....+-...|||+|.|.-..++.++|+|+||++||||+ +...||..
T Consensus 689 ----------sg~yy---------------~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~ 743 (807)
T KOG1094|consen 689 ----------SGDYY---------------RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ 743 (807)
T ss_pred ----------cCCce---------------eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh
Confidence 11111 0011123346899999999999999999999999999986 58899998
Q ss_pred CCHHHHHHHHhc-----cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 991 KTPQQIFDNIMN-----RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 991 ~~~~ei~qkIl~-----~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
.+.+++.++... +.-..+..|.-++..+..|+.+|+..|-.+||+.+.+
T Consensus 744 lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 744 LTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred hhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 888877766542 1112334457789999999999999999999995443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=301.05 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=217.1
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
.+..+..+||-|.||.||.|.++.-.-.||||.++.. .-.++.|+.|..+|+.++|||+|+|+++|....-+|||.
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEE
Confidence 3566778999999999999999999999999998754 346789999999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 838 EYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~--LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||..|+|.+||++..+ ++.-...+++.||..|++||..+++|||||-..|+|+..+..||++||||+++.. ..+
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt-gDT-- 419 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT-GDT-- 419 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc-CCc--
Confidence 99999999999987643 6666667777899999999999999999999999999999999999999999631 000
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ 994 (1170)
++... ..--..-|.|||-|....++.++|||+|||+|||+.| |..||.|.+..
T Consensus 420 ----------------------YTAHA----GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS 473 (1157)
T KOG4278|consen 420 ----------------------YTAHA----GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 473 (1157)
T ss_pred ----------------------eeccc----CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH
Confidence 00000 0011346999999998899999999999999999997 99999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
+.|..+.++-.- .-|..+++.+..|+..|+++.|..||++.++.+.++.-|-.
T Consensus 474 qVY~LLEkgyRM--~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 474 QVYGLLEKGYRM--DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHHHhccccc--cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 998877665432 23579999999999999999999999977777666665543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=310.41 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=216.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCC---CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATG---DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TG---e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
.+....-.+.++||.|.||.||.|+.+..| ..||||.++.. ...++...|+.|..||-+++||||++|-++....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 345566789999999999999999998766 48999999864 3567778999999999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
.-++||.|||++|+|..+|+.+ +.|+.-+..-+++.|+.|++||-++|+|||||-..|||++.+-.+|++||||++..-
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999999876 569999999999999999999999999999999999999999999999999998531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccC---CCCCCchHHHhcCCCCcchhhhHHHHHHHHHH-hCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAG---TPDYLAPEILLGMGHGATADWWSVGIILFELL-IGI 985 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vG---Tp~YmAPEVL~g~~ys~ksDIWSLGVILYELL-TG~ 985 (1170)
++. ...++..| ...|.|||.|....++.++|+||+|++|||.+ .|.
T Consensus 783 ----dd~--------------------------~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 783 ----DDP--------------------------EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred ----cCC--------------------------CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCC
Confidence 110 01111111 24799999999999999999999999999977 599
Q ss_pred CCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 986 PPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 986 pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
.||..++.++.+..|..+-. +|. |-+++..+-.|+..|+++|-.+||.+.++
T Consensus 833 RPYWdmSNQdVIkaIe~gyR-LPp-PmDCP~aL~qLMldCWqkdR~~RP~F~qi 884 (996)
T KOG0196|consen 833 RPYWDMSNQDVIKAIEQGYR-LPP-PMDCPAALYQLMLDCWQKDRNRRPKFAQI 884 (996)
T ss_pred CcccccchHHHHHHHHhccC-CCC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHH
Confidence 99999999999999986543 331 46899999999999999999999995443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=301.65 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=205.2
Q ss_pred eEEEEEeccCCCeEEEEeeecCC----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 760 FEIIKPISQGAFGRVFLARKRAT----GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~T----Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..+.++||.|-||.||.|..... .--||||..++.. .....+.|+.|.-||++++|||||+|++++.+ ...+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 34456899999999999986432 3368999887654 23447899999999999999999999999875 45789
Q ss_pred EEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 836 VMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|||+++-|.|..+|+.+ ..++......|+.||+.||.|||+..+|||||-..|||+.....|||+||||++...
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e----- 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE----- 542 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc-----
Confidence 99999999999999865 468988999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccc-cCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSV-AGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~-vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
.......+. .-..-|||||-+.-..++.++|||.|||+|||+|. |..||.+-.
T Consensus 543 -------------------------d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 543 -------------------------DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred -------------------------ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 000000110 11246999999988899999999999999999986 999999988
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
..+.+-.|.++... .+|.++++.+..|+.+|+.++|.+||....+..+|.
T Consensus 598 NsDVI~~iEnGeRl--P~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls 647 (974)
T KOG4257|consen 598 NSDVIGHIENGERL--PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS 647 (974)
T ss_pred ccceEEEecCCCCC--CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence 77777777666532 356899999999999999999999999655544443
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=305.05 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=211.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCC-C--CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRAT-G--DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~T-G--e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
-+..++..+.++||.|+||+|+.|.+... | -.||||+++..... .....|++|+.+|.+|+|||+|+||++..+
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 34556777888999999999999988642 3 47999999865432 267899999999999999999999999887
Q ss_pred cceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
..+.||||+++.|+|.+.|++. ..|.....-.|+.||+.|+.||..+++|||||-..||||-....||||||||.+..
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 7788999999999999999872 45888888899999999999999999999999999999999999999999999854
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPP 987 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pP 987 (1170)
..... .|. .....---..|+|||.|....++.++|+|++||++|||++ |.-|
T Consensus 263 g~ned------------~Yv---------------m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEeP 315 (1039)
T KOG0199|consen 263 GENED------------MYV---------------MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEP 315 (1039)
T ss_pred CCCCc------------ceE---------------ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCC
Confidence 21110 000 0000111347999999999999999999999999999997 8999
Q ss_pred CCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
|.|....+++++|-.+.. + .-|..++.++.++++.|+..+|..||++..+
T Consensus 316 W~G~~g~qIL~~iD~~er-L-pRPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 316 WVGCRGIQILKNIDAGER-L-PRPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred CCCCCHHHHHHhcccccc-C-CCCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 999999999999985442 2 2357899999999999999999999996544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=313.22 Aligned_cols=260 Identities=31% Similarity=0.516 Sum_probs=226.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|+++..+|.|+||.||+++++.+++..|+|+++-.. .....-+..|+-+++.++|||||.+++.|...+.++|
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 3468999999999999999999999999999999987543 2344567789999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
.||||.||+|.+.-+-.+.+++.++.+..++.+.||+|||+.|=+|||||-.|||+++.|.+||+|||.+-.+.
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit------ 163 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT------ 163 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh------
Confidence 99999999999988888999999999999999999999999999999999999999999999999999875421
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
..-.+..++.|||+|||||+-. ..+|+..+|||++|++..|+..-++|.....
T Consensus 164 ------------------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 164 ------------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred ------------------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 1123456789999999999863 5689999999999999999999999988777
Q ss_pred HHHHHHHHhccCCCCCCC--CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 993 PQQIFDNIMNRDIPWPNI--PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~i--p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
++......-+..+..|.+ +...++.+-+|++.+|.++|.+||+ ++.+|.|||....
T Consensus 220 pmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt---aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 220 PMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT---AEKLLQHPFVSQT 277 (829)
T ss_pred hHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC---hhhheeceeeccc
Confidence 776665555555554443 2467899999999999999999999 7788999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-29 Score=245.72 Aligned_cols=212 Identities=43% Similarity=0.744 Sum_probs=184.9
Q ss_pred eccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeeccCCCh
Q 001057 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 845 (1170)
Q Consensus 766 LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL 845 (1170)
||.|++|.||++....+++.+++|++....... ....+.+|+.++..+.|++|+++++++......+++|||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987653211 356788999999999999999999999998999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-CCcEEEEecCCccccccccCCCCCCCCCCC
Q 001057 846 YSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923 (1170)
Q Consensus 846 ~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s 923 (1170)
..++... ..++...+..++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||.+......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~------------ 146 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD------------ 146 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC------------
Confidence 9999876 56899999999999999999999999999999999999999 899999999998752100
Q ss_pred CCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Q 001057 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN 1002 (1170)
Q Consensus 924 ~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~ 1002 (1170)
........++..|++||.+... .++.+.|+|+||+++|+|
T Consensus 147 ------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------- 187 (215)
T cd00180 147 ------------------KSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------- 187 (215)
T ss_pred ------------------cchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------
Confidence 0012234578899999999877 788999999999999999
Q ss_pred cCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCC
Q 001057 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046 (1170)
Q Consensus 1003 ~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHP 1046 (1170)
..+.++|.+||+.||.+||+ +.++++|+
T Consensus 188 -------------~~~~~~l~~~l~~~p~~R~~---~~~l~~~~ 215 (215)
T cd00180 188 -------------PELKDLIRKMLQKDPEKRPS---AKEILEHL 215 (215)
T ss_pred -------------HHHHHHHHHHhhCCcccCcC---HHHHhhCC
Confidence 67889999999999999999 77888774
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-29 Score=254.05 Aligned_cols=214 Identities=46% Similarity=0.766 Sum_probs=184.1
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
|++.+.||.|++|.||++.+..+++.+|+|.+...... .....+.+|+..+..++|+|++++++.+......+++|||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999988999999998765432 2567888999999999999999999999998999999999
Q ss_pred ccCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 840 LNGGDLYSLLRNLGC-LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~~-LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
+.+++|.+++..... +++..+..++.+++.+|.|||+++++|+||+|.||+++.++.++|+|||++......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~------- 151 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD------- 151 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc-------
Confidence 999999999988766 899999999999999999999999999999999999999999999999998753100
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHH-hcCCCCcchhhhHHHHHHHHHHhCCCCCCC--CCHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL-LGMGHGATADWWSVGIILFELLIGIPPFNA--KTPQQ 995 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL-~g~~ys~ksDIWSLGVILYELLTG~pPF~g--~~~~e 995 (1170)
.........++..|++||.+ ....++.++|+|+||+++|+|++|+.||.+ .+...
T Consensus 152 ----------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~ 209 (225)
T smart00221 152 ----------------------LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSL 209 (225)
T ss_pred ----------------------ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHH
Confidence 00012345678899999999 666778899999999999999999999987 44457
Q ss_pred HHHHHhccC
Q 001057 996 IFDNIMNRD 1004 (1170)
Q Consensus 996 i~qkIl~~~ 1004 (1170)
+.+.|..+.
T Consensus 210 ~~~~~~~~~ 218 (225)
T smart00221 210 LSDVWSFGV 218 (225)
T ss_pred HHHHHhcCC
Confidence 777777665
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=288.78 Aligned_cols=286 Identities=24% Similarity=0.410 Sum_probs=208.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecC---CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRA---TGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRE 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~---TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~ 831 (1170)
..+.|.++.+||.|+|++||++.+.. ..++||+|.+.... ....+.+|+++|..+. +.||+++.+++...+
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34679999999999999999999877 78999999876543 3356889999999886 899999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-CCcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-dG~VKLsDFGLAk~~~~ 910 (1170)
++++||||++..+..++... ++-..++.|++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||||.....
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 99999999998888888775 668889999999999999999999999999999999985 46789999999973111
Q ss_pred ccCCCCC-C----CCCC-CCCccccccccC---CCCC-----cccccccccccCCCCCCchHHHhcCC-CCcchhhhHHH
Q 001057 911 HSTDDLS-A----PSLG-SGGFLVNDELKD---QPPL-----TREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVG 975 (1170)
Q Consensus 911 ~~~~d~~-a----~sl~-s~~~l~~~~l~~---~~~l-----t~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLG 975 (1170)
....... . .... .+..+....... ...+ ...........||++|+|||++...+ .+.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 0000000 0 0000 111111111111 0000 11223345678999999999998754 67899999999
Q ss_pred HHHHHHHhCCCCCCCCC-HHHHHHHHh--------------ccC------CC----------CCCC--------------
Q 001057 976 IILFELLIGIPPFNAKT-PQQIFDNIM--------------NRD------IP----------WPNI-------------- 1010 (1170)
Q Consensus 976 VILYELLTG~pPF~g~~-~~ei~qkIl--------------~~~------l~----------fP~i-------------- 1010 (1170)
||+.-++++..||.... ....+..|. .+. -. |-.+
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999985422 111111110 011 00 0000
Q ss_pred ----CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 1011 ----PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1011 ----p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
....+..+.||+.+||..||.+|++ |++.|+||||...+
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRit---AEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRIT---AEDALKHPFFDEAD 388 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhccc---HHHHhcCcCCcchh
Confidence 1234568999999999999999999 88889999998653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=292.71 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=208.6
Q ss_pred CCeEEEEEeccCCCeEEEEeeecC-------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeec
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRA-------TGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTC 829 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~-------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd 829 (1170)
++..+.+.||.|.||.|++|.-.. ....||+|.++.... ..+.+.+..|+++|..+- ||||+.+.+++..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 344666699999999999997431 145799999876542 367788999999999885 9999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ 893 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~ 893 (1170)
...+++|+||+..|+|..+++..+ .++......++.||+.|++||++..+|||||-..|||+..
T Consensus 374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITK 453 (609)
T ss_pred CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecC
Confidence 999999999999999999998765 3888889999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCC--CCCCchHHHhcCCCCcchhh
Q 001057 894 DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGT--PDYLAPEILLGMGHGATADW 971 (1170)
Q Consensus 894 dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGT--p~YmAPEVL~g~~ys~ksDI 971 (1170)
+..+||+|||+|+...... ........|| ..|||||.+....|+.++||
T Consensus 454 ~~~~kIaDFGlar~~~~~~-----------------------------~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDV 504 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKD-----------------------------YYRTKSSAGTLPVKWMAPESLFDRVFTSKSDV 504 (609)
T ss_pred CCEEEEccccceeccCCCC-----------------------------ceEecCCCCccceeecCHHHhccCcccccchh
Confidence 9999999999998421000 0000111222 24999999999999999999
Q ss_pred hHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 972 WSVGIILFELLI-GIPPFNAKT-PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 972 WSLGVILYELLT-G~pPF~g~~-~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
||+|++||||++ |..||.+.. ..++++.+..+... ..|..++.++.++++.|++.+|.+||+..+..+.+.
T Consensus 505 WSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~--~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 505 WSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRM--EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred hHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 999999999998 999999866 67777777776643 335788999999999999999999999766655443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=260.58 Aligned_cols=218 Identities=30% Similarity=0.522 Sum_probs=179.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~ 832 (1170)
.+..++...+..||+|+||.|-+.++..+|...|+|.+...- ..+...+.++|+++..+. .+|++|++|+.+.....
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 344456677888999999999999999999999999987543 344556778888887654 69999999999999999
Q ss_pred eEEEEeeccCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 833 LYLVMEYLNGGDLYSLL----RNLGCLDEDMARVYIAELVLALEYLHSL-NVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlL----k~~~~LSEe~ar~IaaQIL~ALeYLHs~-GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
++|.||.| ..+|..+- ...+.++|..+-.++-.++.||.|||++ .+||||+||+||||+.+|+||+||||.+-.
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999999 44776554 4557899999999999999999999975 899999999999999999999999999865
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc----CCCCcchhhhHHHHHHHHHHh
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG----MGHGATADWWSVGIILFELLI 983 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g----~~ys~ksDIWSLGVILYELLT 983 (1170)
.. +.-......|...|||||.+.. .+|+-++||||||++++||++
T Consensus 199 L~-------------------------------dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~ 247 (282)
T KOG0984|consen 199 LV-------------------------------DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAI 247 (282)
T ss_pred eh-------------------------------hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhh
Confidence 31 0001112468889999999863 479999999999999999999
Q ss_pred CCCCCCC-CCHHHHHHHHhccCC
Q 001057 984 GIPPFNA-KTPQQIFDNIMNRDI 1005 (1170)
Q Consensus 984 G~pPF~g-~~~~ei~qkIl~~~l 1005 (1170)
++.||.. .++.+++.+++....
T Consensus 248 lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 248 LRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred ccccccccCCHHHHHHHHhcCCC
Confidence 9999975 467778888876544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=274.30 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=188.9
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHH--hcCCCcEEEEEeeeec
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI--SVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILs--kL~HPNIVrL~~~Fqd 829 (1170)
.......+..+++.||+|-||.||.|+++ |+.||||++... ......+|.+|.+ .|+|+||+.++++-..
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 33455678899999999999999999876 889999998753 2356678888875 4799999999876543
Q ss_pred c----cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCCCCcEEeCCCCcE
Q 001057 830 R----ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL--------NVIHRDLKPDNLLIGQDGHI 897 (1170)
Q Consensus 830 ~----~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~--------GIIHRDIKPENILLd~dG~V 897 (1170)
+ .+++||.+|.+.|+|+++|.+ ..++.+.+..++..++.||.+||.. .|.|||||..|||+..+|..
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 3 369999999999999999998 5789999999999999999999943 49999999999999999999
Q ss_pred EEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC------CCcchhh
Q 001057 898 KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG------HGATADW 971 (1170)
Q Consensus 898 KLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~------ys~ksDI 971 (1170)
.|+|+|||..... .++ .-.-..+..+||..|||||+|...- .-..+||
T Consensus 356 ~IADLGLAv~h~~-~t~-------------------------~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADI 409 (513)
T KOG2052|consen 356 CIADLGLAVRHDS-DTD-------------------------TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADI 409 (513)
T ss_pred EEeeceeeEEecc-cCC-------------------------cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHH
Confidence 9999999975210 000 0112345679999999999997531 1235899
Q ss_pred hHHHHHHHHHHhC----------CCCCCCC-----CHHHHHHHHhccCCCCCCCCccC--C---HHHHHHHHHhccCCCC
Q 001057 972 WSVGIILFELLIG----------IPPFNAK-----TPQQIFDNIMNRDIPWPNIPEEM--S---VEACDLIDKLLTENPV 1031 (1170)
Q Consensus 972 WSLGVILYELLTG----------~pPF~g~-----~~~ei~qkIl~~~l~fP~ip~~l--S---~eakDLIkkLLq~DPs 1031 (1170)
||||.+|||++.. ++||++. +.+++.+-+...++ -|.+|... . ..+..|++.|+..||.
T Consensus 410 YafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~-RP~ipnrW~s~~~l~~m~klMkeCW~~Np~ 488 (513)
T KOG2052|consen 410 YAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKL-RPNIPNRWKSDPALRVMAKLMKECWYANPA 488 (513)
T ss_pred HHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeeccc-CCCCCcccccCHHHHHHHHHHHHhhcCCch
Confidence 9999999999862 6788753 23444333332332 23333322 2 2345788999999999
Q ss_pred CCCCh
Q 001057 1032 QRLGA 1036 (1170)
Q Consensus 1032 kRpSa 1036 (1170)
-|+++
T Consensus 489 aRltA 493 (513)
T KOG2052|consen 489 ARLTA 493 (513)
T ss_pred hhhHH
Confidence 99993
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=276.11 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=191.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh--cCCCcEEEEEeeeeccc--
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS--VRNPFVVRFFYSFTCRE-- 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILsk--L~HPNIVrL~~~Fqd~~-- 831 (1170)
.....+++.+||+|.||.||+|+. +++.||||++.. ...+.+.+|.+|... +.|+||++++++-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 355677888999999999999975 479999999864 455788899998764 57999999997655444
Q ss_pred --ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeeccCCCCcEEeCCCCcEEEE
Q 001057 832 --NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL---------NVIHRDLKPDNLLIGQDGHIKLT 900 (1170)
Q Consensus 832 --~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~---------GIIHRDIKPENILLd~dG~VKLs 900 (1170)
.+.||++|.+.|+|.++|+.+ .+++.....++..|+.||+|||+- .|+|||||..||||..|+...|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 789999999999999999974 689999999999999999999953 59999999999999999999999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CC-----cchhhhHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HG-----ATADWWSV 974 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys-----~ksDIWSL 974 (1170)
|||||..+. + ..........+||..|||||+|.+.- .. ...||||+
T Consensus 359 DFGLAl~~~---------p-------------------~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYam 410 (534)
T KOG3653|consen 359 DFGLALRLE---------P-------------------GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAM 410 (534)
T ss_pred ccceeEEec---------C-------------------CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHH
Confidence 999998642 0 01112233478999999999998742 22 34799999
Q ss_pred HHHHHHHHhCCCC------------CC-----CCCHHHHHHHHhccCCCCCCCCc-----cCCHHHHHHHHHhccCCCCC
Q 001057 975 GIILFELLIGIPP------------FN-----AKTPQQIFDNIMNRDIPWPNIPE-----EMSVEACDLIDKLLTENPVQ 1032 (1170)
Q Consensus 975 GVILYELLTG~pP------------F~-----g~~~~ei~qkIl~~~l~fP~ip~-----~lS~eakDLIkkLLq~DPsk 1032 (1170)
|.+||||++...- |. ..+.+++...++..+ .-|.++. .--..+++.|..|+..||+.
T Consensus 411 gLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK-~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeA 489 (534)
T KOG3653|consen 411 GLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKK-QRPKIPDAWRKHAGMAVLCETIEECWDHDAEA 489 (534)
T ss_pred HHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhc-cCCCChhhhhcCccHHHHHHHHHHHcCCchhh
Confidence 9999999986433 32 122344444444332 2222222 22456889999999999999
Q ss_pred CCChhhHHH
Q 001057 1033 RLGATGARE 1041 (1170)
Q Consensus 1033 RpSa~~AeE 1041 (1170)
|+|+.-|.|
T Consensus 490 RLTA~Cv~e 498 (534)
T KOG3653|consen 490 RLTAGCVEE 498 (534)
T ss_pred hhhhHHHHH
Confidence 999665544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-26 Score=235.27 Aligned_cols=259 Identities=40% Similarity=0.697 Sum_probs=208.0
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC-cEEEEEeeeecccceEEEEe
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP-FVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HP-NIVrL~~~Fqd~~~LyLVME 838 (1170)
|.+...||.|+||.||++.+. ..+|+|.+.............+.+|..++..+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999987 78999999876554444678899999999999988 79999999987777899999
Q ss_pred eccCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-cEEEEecCCccccccccCC
Q 001057 839 YLNGGDLYSLLRNLG---CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~---~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-~VKLsDFGLAk~~~~~~~~ 914 (1170)
|+.+++|..++.... .++...+..++.|++.++.|+|+.|++||||||+|||++..+ .++++|||+++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~- 157 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS- 157 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc-
Confidence 999999998877664 799999999999999999999999999999999999999988 799999999874210000
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccc-cccccccCCCCCCchHHHhc---CCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQ-RQKHSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~-~~~~s~vGTp~YmAPEVL~g---~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.... ......+||..|+|||++.+ ..+....|+||+|++++++++|..||..
T Consensus 158 ------------------------~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 158 ------------------------TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred ------------------------cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 0000 13456789999999999988 5788999999999999999999999887
Q ss_pred CCH----HHHHHHHhccCCC-CC-CCCccC----CHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 991 KTP----QQIFDNIMNRDIP-WP-NIPEEM----SVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 991 ~~~----~ei~qkIl~~~l~-fP-~ip~~l----S~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
... ......+.....+ .. ...... ...+.+++.+++..+|..|.+ ..+...++|..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~---~~~~~~~~~~~ 279 (384)
T COG0515 214 EKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS---SSSDLSHDLLA 279 (384)
T ss_pred CCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC---HHHHhhchHhh
Confidence 763 4555555544433 11 111111 257899999999999999998 44445554443
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=286.36 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=206.5
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCC----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGD----LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe----~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
..+..++||.|+||+||+|.+.-.|+ +||||++.... .......++.|+-+|.+++|||+++|++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 35567789999999999998865554 78999887654 3445678999999999999999999999988766 88
Q ss_pred EEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||++|+++|+|.++++.+ +.+-......|..||++|+.|||.++++||||-..||||..-.++||+|||+|+......
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~- 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE- 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc-
Confidence 999999999999999875 568889999999999999999999999999999999999999999999999999642110
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
.+. ......--+-|||-|.+....|+.++||||+||++||++| |..||.+..
T Consensus 853 ~ey---------------------------~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~ 905 (1177)
T KOG1025|consen 853 KEY---------------------------SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP 905 (1177)
T ss_pred ccc---------------------------cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC
Confidence 000 0001112356899999999999999999999999999997 999999999
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT 1037 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~ 1037 (1170)
..++-+.+..+.. + ..|..++.++.-++.+||-.|+..||++.
T Consensus 906 ~~eI~dlle~geR-L-sqPpiCtiDVy~~mvkCwmid~~~rp~fk 948 (1177)
T KOG1025|consen 906 AEEIPDLLEKGER-L-SQPPICTIDVYMVMVKCWMIDADSRPTFK 948 (1177)
T ss_pred HHHhhHHHhcccc-C-CCCCCccHHHHHHHHHHhccCcccCccHH
Confidence 9999888776654 2 23567999999999999999999999943
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=302.20 Aligned_cols=229 Identities=15% Similarity=0.167 Sum_probs=155.9
Q ss_pred cCC-CcEEEEEeee-------ecccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Q 001057 815 VRN-PFVVRFFYSF-------TCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLK 885 (1170)
Q Consensus 815 L~H-PNIVrL~~~F-------qd~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIK 885 (1170)
++| +||++++++| .....++++|||+ +++|+++|... ..+++.+++.|+.||+.||.|||++||||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 344 5777777777 2334688889988 67999999753 469999999999999999999999999999999
Q ss_pred CCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCcc---ccccccCC--CCCcccccccccccCCCCCCchHHH
Q 001057 886 PDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL---VNDELKDQ--PPLTREQRQKHSVAGTPDYLAPEIL 960 (1170)
Q Consensus 886 PENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l---~~~~l~~~--~~lt~~~~~~~s~vGTp~YmAPEVL 960 (1170)
|+||||+..|.+|++|||++...............++..... ........ .............+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999988888888888876421110000000001000000 00000000 0000000112235799999999999
Q ss_pred hcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 961 LGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 961 ~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
.+..|+.++|||||||+||||++|.+||.... ..+..+..... |.......+.+.+++.+||++||.+||+ +.
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~L~~~P~~Rps---~~ 260 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQILLNWPKEASFCLWLLHPEPSCRPS---MS 260 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--ChhhhhcCHHHHHHHHHhCCCChhhCcC---hH
Confidence 99999999999999999999999999986432 12222222111 1111123456779999999999999999 88
Q ss_pred HHHcCCCCCCC
Q 001057 1041 EVKQHPFFKNI 1051 (1170)
Q Consensus 1041 EILqHPfF~~i 1051 (1170)
++++||||...
T Consensus 261 eil~h~~~~~~ 271 (793)
T PLN00181 261 ELLQSEFINEP 271 (793)
T ss_pred HHhhchhhhhh
Confidence 99999999763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=257.32 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=196.0
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEe-eeecccceE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFY-SFTCRENLY 834 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~-~Fqd~~~Ly 834 (1170)
.+.|.+.+.||.|-||.+.+|+++.++..+++|.+.+.. .....|.+|..---.|. |.||+.-|+ +|+..+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 357999999999999999999999999999999988764 34456777776544454 889998774 688888999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC--CCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG--QDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd--~dG~VKLsDFGLAk~~~~~~ 912 (1170)
++|||++-|+|..-+... .+-|.-.+.+++|++.||.|||++++||||||.+||||- +...|||||||+.+...
T Consensus 99 F~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--- 174 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--- 174 (378)
T ss_pred EeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC---
Confidence 999999999999988764 488899999999999999999999999999999999984 23489999999986421
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-----CCcchhhhHHHHHHHHHHhCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-----HGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-----ys~ksDIWSLGVILYELLTG~pP 987 (1170)
. ...-.--+..|.+||+..... ..+..|+|.||+|+|.+|+|++|
T Consensus 175 -------------~-----------------tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~P 224 (378)
T KOG1345|consen 175 -------------T-----------------TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFP 224 (378)
T ss_pred -------------c-----------------eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCc
Confidence 0 001112355799999886432 46788999999999999999999
Q ss_pred CCCCCH-----HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 988 FNAKTP-----QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 988 F~g~~~-----~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
|..... -+..+.........|.....+++.+..+.++-|..+|+.|-..-+++.....-|.
T Consensus 225 WQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 225 WQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred chhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 974321 1222222233344555556789999999999999999999443335555555443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=228.49 Aligned_cols=161 Identities=25% Similarity=0.285 Sum_probs=129.5
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCC
Q 001057 843 GDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921 (1170)
Q Consensus 843 GSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl 921 (1170)
|+|.+++... ..+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~------------ 60 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKT------------ 60 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeec------------
Confidence 6899999874 46999999999999999999999999 999999999999999 99987521
Q ss_pred CCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Q 001057 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP-QQIFDNI 1000 (1170)
Q Consensus 922 ~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~-~ei~qkI 1000 (1170)
. ....||+.|||||++.+..|+.++|||||||++|||++|.+||..... ...+..+
T Consensus 61 ------------------~-----~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~ 117 (176)
T smart00750 61 ------------------P-----EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEIL 117 (176)
T ss_pred ------------------c-----ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHH
Confidence 0 012589999999999999999999999999999999999999976543 2333343
Q ss_pred hccCCCC-C---CCCccCCH--HHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 1001 MNRDIPW-P---NIPEEMSV--EACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 1001 l~~~l~f-P---~ip~~lS~--eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
....... + ..+..++. ++++||.+||..||.+||+ +.+++.|+|+.
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~---~~~ll~~~~~~ 169 (176)
T smart00750 118 LNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA---ANHYLAHCRAL 169 (176)
T ss_pred HHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC---HHHHHHHHHHH
Confidence 3322211 0 01123344 6999999999999999999 88999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-26 Score=275.06 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=204.0
Q ss_pred EEEEEeccCCCeEEEEeeecCCCCEEEEEEeec---cccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 761 EIIKPISQGAFGRVFLARKRATGDLFAIKVLKK---ADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 761 evlk~LG~GgFGtVyLArdk~TGe~VAIKvLkK---s~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
.....+|.|++|.|+.+......+.++.|.+.. ...........+..|.-+-..+.|||++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456789999999999998887777777776542 11112222223666777778899999988777666666655669
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|||++ ||+.++...+.++...+..++.|++.|++|||+.||.||||||+|+|+..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~------ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP------ 473 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC------
Confidence 99999 99999999888999999999999999999999999999999999999999999999999998753211
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcc-hhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT-ADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~k-sDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
...........+|+..|+|||++.+..|.+. +||||.|++++.|++|+.||.-....+.
T Consensus 474 --------------------~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~ 533 (601)
T KOG0590|consen 474 --------------------WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDN 533 (601)
T ss_pred --------------------cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccccc
Confidence 1111234567899999999999999988764 7999999999999999999975433221
Q ss_pred --HHHHhccCCCC----CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 997 --FDNIMNRDIPW----PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 997 --~qkIl~~~l~f----P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
++......... -.+-..++.+.+.+|.+||+.||.+|.+ +++|++.+||+.++
T Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t---i~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 534 SFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT---IEQILNDEWIRSIE 592 (601)
T ss_pred chhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec---HHHHhhChHhhhcc
Confidence 11111111110 0122467889999999999999999999 88999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-23 Score=231.18 Aligned_cols=259 Identities=24% Similarity=0.319 Sum_probs=193.8
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCC-CEEEEEEeeccccccHHHHHHHHHHHHHHHhcC----CCcEEEEEeee-ecccc
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATG-DLFAIKVLKKADMIRKNAVESILAERNILISVR----NPFVVRFFYSF-TCREN 832 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TG-e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~----HPNIVrL~~~F-qd~~~ 832 (1170)
+|.+.++||.|+||.||+|.+..++ ..+|+|+......... ..+..|..++..+. .+++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988774 6899998765432111 15667888888876 26899999988 47778
Q ss_pred eEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC-----CcEEEEecCCc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD-----GHIKLTDFGLS 905 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d-----G~VKLsDFGLA 905 (1170)
-||||+.+ |.+|.++.... +.|+...+..++.|++.+|++||+.|+|||||||+|+++... -.+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 89999988 88999988654 579999999999999999999999999999999999999865 36999999999
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
+........ +.. ..........+.||..|+++.+..+...+...|+||++.++.+|+.|.
T Consensus 175 r~~~~~~~~---------~~~-----------~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~ 234 (322)
T KOG1164|consen 175 RRFKYVGDS---------GGN-----------LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS 234 (322)
T ss_pred ccccccCCC---------Ccc-----------cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence 832100000 000 001111124566999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHH---hccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 986 PPFNAKTPQQIFDNI---MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 986 pPF~g~~~~ei~qkI---l~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
.||.+.........+ ........ .....+.++..+...+-..+...+|.......+
T Consensus 235 LPW~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 235 LPWEALEMTDLKSKFEKDPRKLLTDR-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred CCCccccccchHHHHHHHhhhhcccc-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 999765532222222 21111110 223456777777777777888888885444444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=243.43 Aligned_cols=178 Identities=21% Similarity=0.173 Sum_probs=134.2
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecC-CCCEEEEEEeecccc--ccHHHHHHHHHHHHHHHhcCCCcEEE-EEeee
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRA-TGDLFAIKVLKKADM--IRKNAVESILAERNILISVRNPFVVR-FFYSF 827 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~-TGe~VAIKvLkKs~i--~~~~~ve~~l~EieILskL~HPNIVr-L~~~F 827 (1170)
......++|++.+.||+|+||+||+|+++. +++.||||++..... ........+.+|+.+|..++|+||+. +++.
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 445667889999999999999999999876 788889998653211 12334567899999999999999985 5432
Q ss_pred ecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC-CCCcEEeCCCCcEEEEecCCcc
Q 001057 828 TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDL-KPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 828 qd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDI-KPENILLd~dG~VKLsDFGLAk 906 (1170)
...||||||++|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 45799999999999973 211 11 1457889999999999999999999 9999999999999999999998
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG 962 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g 962 (1170)
...... . ...+.. .....+.+|++.|+|||.+..
T Consensus 161 ~~~~~~-----------~----------~~~~~~-~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 161 VFRRRG-----------A----------LYRIAA-YEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ecccCc-----------c----------hhhhhh-hhhhhhhhccCccCCcccCCh
Confidence 642100 0 000000 011136778999999999864
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=231.43 Aligned_cols=257 Identities=20% Similarity=0.258 Sum_probs=204.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCC-----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGD-----LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe-----~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
+...+++....+-+|.||.||.|.++.... .|-+|.++.. ...-++..++.|.-+|..+.|||+..+.++...
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 445678888899999999999997764332 3445554432 244567788999999999999999999887655
Q ss_pred -ccceEEEEeeccCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEE
Q 001057 830 -RENLYLVMEYLNGGDLYSLLRNL--------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLT 900 (1170)
Q Consensus 830 -~~~LyLVMEY~~GGSL~dlLk~~--------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLs 900 (1170)
....+.++.++.-|+|..+|... +.++..+...++.|+..|++|||++||||.||-..|.+|++.-+|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 45678889999999999999722 246677778888999999999999999999999999999999999999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFE 980 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYE 980 (1170)
|=.+++..- .. .-++++ . .-.-...||+||.+.+..|+.++|+|||||+|||
T Consensus 439 DsaLSRDLF-P~----DYhcLG-----------------D------nEnRPvkWMslEal~n~~yssasDvWsfGVllWE 490 (563)
T KOG1024|consen 439 DSALSRDLF-PG----DYHCLG-----------------D------NENRPVKWMSLEALQNSHYSSASDVWSFGVLLWE 490 (563)
T ss_pred cchhccccC-cc----cccccC-----------------C------CCCCcccccCHHHHhhhhhcchhhhHHHHHHHHH
Confidence 999987431 00 000110 0 0011346999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 981 LLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 981 LLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
|+| |+.||...++.++...++.+..- .-|.++++++..++.-|+..+|++||+..+....|
T Consensus 491 Lmtlg~~PyaeIDPfEm~~ylkdGyRl--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 491 LMTLGKLPYAEIDPFEMEHYLKDGYRL--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred HHhcCCCCccccCHHHHHHHHhcccee--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 997 99999999999999988876532 22478999999999999999999999966665544
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=224.49 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=196.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccce
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~L 833 (1170)
+.--.|++.++||.|+||+.++|.+..++++||||.-... ...-++..|....+.|. .++|...|++.++.-+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 3445799999999999999999999999999999975432 23345667877777775 69999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-----cEEEEecCCccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-----HIKLTDFGLSKV 907 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-----~VKLsDFGLAk~ 907 (1170)
.||||++ |.+|.+++.-++ .|+...+..++.|++.-++|+|++++|+|||||+|+||...+ .|.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 889999988765 599999999999999999999999999999999999997544 589999999996
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
..- ...+...+ -+...+..||..||+-...+|...+...|+=|||-++++.|-|..|
T Consensus 179 YrD-------------------p~TkqHIP----YrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLP 235 (449)
T KOG1165|consen 179 YRD-------------------PKTKQHIP----YREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 235 (449)
T ss_pred hcC-------------------ccccccCc----cccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCc
Confidence 421 11111111 2234577899999999999999999999999999999999999999
Q ss_pred CCCC---CHHHHHHHHhccCCCCC--CCCccCCHHHHHHHHHhccCCCCCCCC
Q 001057 988 FNAK---TPQQIFDNIMNRDIPWP--NIPEEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 988 F~g~---~~~ei~qkIl~~~l~fP--~ip~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
|.|. +..+-|++|-..+..-| .+-.+++.++..-+.-.-..+-.+-|.
T Consensus 236 WQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 236 WQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred cccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 9874 55677788865543322 112345555555554444444444444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=216.80 Aligned_cols=277 Identities=22% Similarity=0.319 Sum_probs=213.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CcEEEEEeeeecccc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFFYSFTCREN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H-PNIVrL~~~Fqd~~~ 832 (1170)
-+....|+++++||.|+||.+|+|....+|+.||||+-.+.. .-.++..|..+...|++ ..|..+..++.+..+
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 355678999999999999999999999999999999865432 11356778888888875 788888888999999
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC---CcEEEEecCCcccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD---GHIKLTDFGLSKVG 908 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d---G~VKLsDFGLAk~~ 908 (1170)
-.|||+++ |.+|.+++.-. ..|+...+..++-|++.-|+|+|.+++|||||||+|+|+.-+ ..+.|+|||||+..
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999 88999988644 469999999999999999999999999999999999999754 46899999999964
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
. ...... . ..-+......||..|.+-....+...+...|+=|+|.+|..+.-|..||
T Consensus 165 ~-d~~t~~--------------------H--Ipyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPW 221 (341)
T KOG1163|consen 165 R-DIRTRQ--------------------H--IPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPW 221 (341)
T ss_pred c-cccccc--------------------c--CccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcc
Confidence 2 000000 0 1122334678999999999988888899999999999999999999999
Q ss_pred CCCCH---HHHHHHHhccCCCCC--CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH-------cCCCCCCCChhhh
Q 001057 989 NAKTP---QQIFDNIMNRDIPWP--NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK-------QHPFFKNINWDTL 1056 (1170)
Q Consensus 989 ~g~~~---~ei~qkIl~~~l~fP--~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL-------qHPfF~~idwe~L 1056 (1170)
.+... .+-+++|...+...| .+-..+|.++.-.|.-|-..--.+-|...-..++. +|.+=--.||..+
T Consensus 222 Qglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~l 301 (341)
T KOG1163|consen 222 QGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTML 301 (341)
T ss_pred cccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHH
Confidence 98653 455677776665443 12357788888888888777666666633333333 2333223578887
Q ss_pred hhc
Q 001057 1057 ARQ 1059 (1170)
Q Consensus 1057 ~~~ 1059 (1170)
..+
T Consensus 302 kqk 304 (341)
T KOG1163|consen 302 KQK 304 (341)
T ss_pred HHH
Confidence 754
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.6e-22 Score=205.98 Aligned_cols=141 Identities=23% Similarity=0.194 Sum_probs=110.8
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHH-----------------------HHHHHHHHHHHHHhcCCCc
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKN-----------------------AVESILAERNILISVRNPF 819 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~-----------------------~ve~~l~EieILskL~HPN 819 (1170)
...||+|+||.||+|.+. +|+.||||+++........ .......|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999987 8999999999764321111 0123345999999998776
Q ss_pred EEEEEeeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCeeeccCCCCcEEeCCCCcEE
Q 001057 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL-HSLNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 820 IVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYL-Hs~GIIHRDIKPENILLd~dG~VK 898 (1170)
+...+.. ... ..+|||||++|++|...+...+.++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~-~~~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPI-LLK-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEE-Eec-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6332221 112 2389999999888776654456799999999999999999999 799999999999999998 58899
Q ss_pred EEecCCccc
Q 001057 899 LTDFGLSKV 907 (1170)
Q Consensus 899 LsDFGLAk~ 907 (1170)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.7e-21 Score=197.41 Aligned_cols=141 Identities=22% Similarity=0.152 Sum_probs=112.0
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeecccccc-----------------------HHHHHHHHHHHHHHHhcCCCc
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-----------------------KNAVESILAERNILISVRNPF 819 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~-----------------------~~~ve~~l~EieILskL~HPN 819 (1170)
...||+|+||+||+|++. +|+.||||++....... .........|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 89999999988652110 001233467899999999998
Q ss_pred EEEEEeeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEE
Q 001057 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 820 IVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VK 898 (1170)
|.....+... ..||||||++|+++.........++...+..++.|++.+|.+||+ +||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7443332222 248999999988665443334568888999999999999999999 9999999999999998 89999
Q ss_pred EEecCCccc
Q 001057 899 LTDFGLSKV 907 (1170)
Q Consensus 899 LsDFGLAk~ 907 (1170)
|+|||+|+.
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.4e-21 Score=205.69 Aligned_cols=175 Identities=17% Similarity=0.191 Sum_probs=136.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHH------HHHHHHHHHhcCCCcEEEEEeeee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES------ILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~------~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
+..++|++++.||.|+||.||++.. ++..||||++............. +.+|+..+.++.||+|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4457899999999999999999755 46689999997654444444444 578999999999999999888766
Q ss_pred cc--------cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEE
Q 001057 829 CR--------ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLT 900 (1170)
Q Consensus 829 d~--------~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLs 900 (1170)
+. ...+|||||++|.+|.++.. +++. ...+++.+|..||+.||+||||||+|||++.+| ++|+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh----ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 43 35799999999999988632 3332 456999999999999999999999999999999 9999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFE 980 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYE 980 (1170)
|||..+... . ... -.-+++...|+.++|+||||+++..
T Consensus 177 Dfg~~~~~~------------------------------e--~~a----------~d~~vler~y~~~~di~~lg~~~~~ 214 (232)
T PRK10359 177 DLSGKRCTA------------------------------Q--RKA----------KDRIDLERHYGIKNEIKDLGYYLLI 214 (232)
T ss_pred ECCCccccc------------------------------c--hhh----------HHHHHHHhHhcccccccceeEeehH
Confidence 999876320 0 000 0114455567789999999999875
Q ss_pred HH
Q 001057 981 LL 982 (1170)
Q Consensus 981 LL 982 (1170)
+.
T Consensus 215 ~~ 216 (232)
T PRK10359 215 YK 216 (232)
T ss_pred HH
Confidence 54
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=207.90 Aligned_cols=234 Identities=26% Similarity=0.347 Sum_probs=153.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-----------CcEE-----E
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-----------PFVV-----R 822 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H-----------PNIV-----r 822 (1170)
.+.....||.|+++.||.+++..||+.+|+|++...........+.+.+|.-....+.+ ..++ +
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 36677899999999999999999999999999876554444556666666544433222 1222 2
Q ss_pred EE---eeeecc---c-----ceEEEEeeccCCChHHHHHh---cCCC---CHHHHH-HHHHHHHHHHHHHHhCCeeeccC
Q 001057 823 FF---YSFTCR---E-----NLYLVMEYLNGGDLYSLLRN---LGCL---DEDMAR-VYIAELVLALEYLHSLNVIHRDL 884 (1170)
Q Consensus 823 L~---~~Fqd~---~-----~LyLVMEY~~GGSL~dlLk~---~~~L---SEe~ar-~IaaQIL~ALeYLHs~GIIHRDI 884 (1170)
+- .++... . +.+++|+-+ .+||..++.- .... ....++ .+..|++..+++||..||+|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 011111 1 347788877 5688888642 2222 122333 34479999999999999999999
Q ss_pred CCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-
Q 001057 885 KPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM- 963 (1170)
Q Consensus 885 KPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~- 963 (1170)
||+|+|++.+|.++|+||+...... ........+..|.+||+....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g---------------------------------~~~~~~~~~~~~~PPe~~~~~~ 218 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAG---------------------------------TRYRCSEFPVAFTPPELESCAG 218 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETT---------------------------------EEEEGGGS-TTTS-HHHHHHHT
T ss_pred ceeeEEEcCCCCEEEcChHHHeecC---------------------------------ceeeccCCCcccCChhhhhhhc
Confidence 9999999999999999998765311 011112345789999987542
Q ss_pred -------CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCC
Q 001057 964 -------GHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033 (1170)
Q Consensus 964 -------~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskR 1033 (1170)
.++.+.|.|+||+++|.|.||..||.......... ..|..+. +++..+++||..||++||.+|
T Consensus 219 ~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 219 QFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 46888999999999999999999998665432211 1344565 899999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=193.79 Aligned_cols=203 Identities=22% Similarity=0.246 Sum_probs=143.5
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccccc-HHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEEEE
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-KNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~-~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
+.+...|++|+||+||++.. .+..++.+.+....... .-+...+.+|+++|.+|. |++|++++++ ...|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 44677899999999998865 57778877665443211 112235789999999996 4789999875 4469999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC-CCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDL-KPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDI-KPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|....... ..
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~--~~ 148 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA--RW 148 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc--hH
Confidence 99999998764422 1 1347789999999999999999999 7999999999999999999998421000 00
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCC-cchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHG-ATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys-~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.-.+.... -......-...++.|++|+...-- ..+ ...+|++.|+-+|.|+|+..|+.++.
T Consensus 149 -------~r~L~~rD--------l~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 -------MRLLARED--------LRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred -------HHHHHHHH--------HHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 00000000 000011122378999999865432 223 56799999999999999999987654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.8e-20 Score=206.09 Aligned_cols=274 Identities=26% Similarity=0.377 Sum_probs=191.0
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCC-----------------------------------CEEEEEEeeccccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATG-----------------------------------DLFAIKVLKKADMI 797 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TG-----------------------------------e~VAIKvLkKs~i~ 797 (1170)
..+.+++|++...||+|.-..||.|+....| -+.|||.+-.-+..
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 4677899999999999999999998754311 14577766543222
Q ss_pred c--HHHHHHHHHHHH------HH--------Hh--------cCCCcEEEEEeeeecc-----------------------
Q 001057 798 R--KNAVESILAERN------IL--------IS--------VRNPFVVRFFYSFTCR----------------------- 830 (1170)
Q Consensus 798 ~--~~~ve~~l~Eie------IL--------sk--------L~HPNIVrL~~~Fqd~----------------------- 830 (1170)
. ...+..+-+|.- .+ +. -.|||||+++.+|.+.
T Consensus 232 s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g 311 (598)
T KOG4158|consen 232 SGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSG 311 (598)
T ss_pred CchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccc
Confidence 1 112222222211 11 11 2499999999888653
Q ss_pred ----cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC--CCC--cEEEEec
Q 001057 831 ----ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG--QDG--HIKLTDF 902 (1170)
Q Consensus 831 ----~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd--~dG--~VKLsDF 902 (1170)
..+|+||.-.. .+|..++... ..+....+.+++|+++|+.|||++||.|||+|.+||||. +|+ .+.|+||
T Consensus 312 ~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 312 AGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred cCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 24799998884 5999999864 456677888999999999999999999999999999984 444 5899999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC------CCcchhhhHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG------HGATADWWSVGI 976 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~------ys~ksDIWSLGV 976 (1170)
|.|--...+. +..+ +.. -.-..-|...-||||+....+ .-.++|.|+.|.
T Consensus 390 GCcLAd~~hG---lqlp------------------y~S---~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~Ga 445 (598)
T KOG4158|consen 390 GCCLADDNHG---LQLP------------------YES---DEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGA 445 (598)
T ss_pred ceeeeccccc---cccc------------------ccc---ccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhh
Confidence 9875321110 0000 000 111234777899999987532 124789999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 977 ILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 977 ILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
+.||++....||++...+-+-.... .+-..|.+|..+++.+++|+..+|+.||++|+++.-|..+++--.|..-+|
T Consensus 446 laYEIfg~~NPFY~rGem~L~~r~Y-qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 446 LAYEIFGRSNPFYKRGEMLLDTRTY-QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGED 521 (598)
T ss_pred hHHHHhccCCcccccchheechhhh-hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchH
Confidence 9999999999999844322211111 122456778999999999999999999999999877777887655554444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-20 Score=227.52 Aligned_cols=244 Identities=26% Similarity=0.366 Sum_probs=182.7
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccc-cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD-MIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~-i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
+|...+.||.+.|=+|.+|++. .|. |++|++-+.. ...-....+-+.|+. ...++|||.+.+..+-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 6888999999999999999875 454 8899987764 233333344445555 56678999999988777778899999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
+|+. -+|++.|.....+..-+-+.|+.|++.||.-+|..||+|+|||.|||||+.-+-+.|+||..-|......
T Consensus 101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe----- 174 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE----- 174 (1431)
T ss_pred HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCC-----
Confidence 9995 4999999988888888999999999999999999999999999999999998899999998655422110
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-----------CCcchhhhHHHHHHHHHHh-CC
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-----------HGATADWWSVGIILFELLI-GI 985 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-----------ys~ksDIWSLGVILYELLT-G~ 985 (1170)
...+++.+- ..+..--.+|+|||.+.... .+++.||||+||+++||++ |+
T Consensus 175 ---DNPadf~fF---------------FDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~ 236 (1431)
T KOG1240|consen 175 ---DNPADFTFF---------------FDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGR 236 (1431)
T ss_pred ---CCcccceEE---------------EecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCC
Confidence 001111100 00111224799999886522 5678899999999999987 89
Q ss_pred CCCCC-----------CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 986 PPFNA-----------KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 986 pPF~g-----------~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|||.- .+.+..+++| -+..++.||..|++.||.+|++ |++.|+.
T Consensus 237 PlF~LSQL~aYr~~~~~~~e~~Le~I-------------ed~~~Rnlil~Mi~rdPs~RlS---AedyL~~ 291 (1431)
T KOG1240|consen 237 PLFTLSQLLAYRSGNADDPEQLLEKI-------------EDVSLRNLILSMIQRDPSKRLS---AEDYLQK 291 (1431)
T ss_pred CcccHHHHHhHhccCccCHHHHHHhC-------------cCccHHHHHHHHHccCchhccC---HHHHHHh
Confidence 99941 1222222222 1336789999999999999999 7777765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9e-19 Score=186.95 Aligned_cols=136 Identities=15% Similarity=0.203 Sum_probs=108.5
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-----CCCcEEEEEeeeeccc---ce
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-----RNPFVVRFFYSFTCRE---NL 833 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-----~HPNIVrL~~~Fqd~~---~L 833 (1170)
-.+.||+|+||.||. ++.++.. +||++..... ...+.+.+|+.++..+ +||||+++|+++.++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 356899999999995 7777666 6998765422 2346789999999999 5799999999999874 43
Q ss_pred E-EEEee--ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCeeeccCCCCcEEeCCC----CcEEEEecCCc
Q 001057 834 Y-LVMEY--LNGGDLYSLLRNLGCLDEDMARVYIAELVLAL-EYLHSLNVIHRDLKPDNLLIGQD----GHIKLTDFGLS 905 (1170)
Q Consensus 834 y-LVMEY--~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~AL-eYLHs~GIIHRDIKPENILLd~d----G~VKLsDFGLA 905 (1170)
| +|||| +.+|+|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 5579999999764 57666 35678888888 99999999999999999999743 37999995444
Q ss_pred c
Q 001057 906 K 906 (1170)
Q Consensus 906 k 906 (1170)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=177.61 Aligned_cols=137 Identities=29% Similarity=0.339 Sum_probs=113.5
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeecccc-----ccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADM-----IRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i-----~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
+.||+|++|.||+|.. .|..|++|+...... ........+.+|+.++..+.|++|+....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 677899997653221 111223467889999999999988766666667778899999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
|++|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999875432 7778899999999999999999999999999999 78999999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.7e-18 Score=215.13 Aligned_cols=202 Identities=24% Similarity=0.339 Sum_probs=161.0
Q ss_pred CCCCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC---CCcEEEEEee
Q 001057 750 CSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR---NPFVVRFFYS 826 (1170)
Q Consensus 750 ~~~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~---HPNIVrL~~~ 826 (1170)
.....+....|.|-+.||.|+||+||+|.... |+.||||+-+......-.... +++.+|+ -+.|..++.+
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHH
Confidence 33445667789999999999999999999876 999999987655433222222 2333333 2456666666
Q ss_pred eecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-------CCcEEE
Q 001057 827 FTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-------DGHIKL 899 (1170)
Q Consensus 827 Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-------dG~VKL 899 (1170)
+.-.+.-+||+||.+.|+|.+++...+.+++..+.+++.|++..++.||..+|||+||||+|+||.. .--++|
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred HccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEE
Confidence 6666777899999999999999998888999999999999999999999999999999999999953 235899
Q ss_pred EecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHH
Q 001057 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979 (1170)
Q Consensus 900 sDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILY 979 (1170)
+|||-|-... +-..+......++|-.+--+|+..|..+++.+|.|.|..++|
T Consensus 843 IDfG~siDm~----------------------------lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h 894 (974)
T KOG1166|consen 843 IDFGRSIDMK----------------------------LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVH 894 (974)
T ss_pred Eecccceeee----------------------------EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHH
Confidence 9999875311 001223455678899999999999999999999999999999
Q ss_pred HHHhCCC
Q 001057 980 ELLIGIP 986 (1170)
Q Consensus 980 ELLTG~p 986 (1170)
.||.|+.
T Consensus 895 ~mLFG~y 901 (974)
T KOG1166|consen 895 VMLFGKY 901 (974)
T ss_pred HHHHHHH
Confidence 9999853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=185.65 Aligned_cols=144 Identities=21% Similarity=0.140 Sum_probs=115.0
Q ss_pred CeEEEEEeccCCCeEEEEee-ecCCCCEEEEEEeecccccc---------------------HHHHHHHHHHHHHHHhcC
Q 001057 759 DFEIIKPISQGAFGRVFLAR-KRATGDLFAIKVLKKADMIR---------------------KNAVESILAERNILISVR 816 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLAr-dk~TGe~VAIKvLkKs~i~~---------------------~~~ve~~l~EieILskL~ 816 (1170)
.|.+.+.||.|+||.||+|. +..+|+.||||++....... ......+..|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38888999999999999998 66799999999987543110 001234678999999997
Q ss_pred CC--cEEEEEeeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-eeeccCCCCcEEeCC
Q 001057 817 NP--FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN-VIHRDLKPDNLLIGQ 893 (1170)
Q Consensus 817 HP--NIVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~G-IIHRDIKPENILLd~ 893 (1170)
+. .+.+++.. ...||||||++|++|...+.....+....+..++.||+.+|.+||++| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34455432 235899999999888776544455677778899999999999999999 99999999999999
Q ss_pred CCcEEEEecCCccc
Q 001057 894 DGHIKLTDFGLSKV 907 (1170)
Q Consensus 894 dG~VKLsDFGLAk~ 907 (1170)
++.++|+|||+|..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-19 Score=216.97 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=209.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeec-CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKR-ATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk-~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~Ly 834 (1170)
...|.+.+.||+|+|+.|-++... .+...+|+|.+.... .......++..|..+-..+. |+|++++++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 567999999999999999998774 455677777765543 23345566677888888887 999999999999999999
Q ss_pred EEEeeccCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCCCcEEeCCCC-cEEEEecCCcccccc
Q 001057 835 LVMEYLNGGDLYSLL-RNLG-CLDEDMARVYIAELVLALEYLH-SLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSKVGLI 910 (1170)
Q Consensus 835 LVMEY~~GGSL~dlL-k~~~-~LSEe~ar~IaaQIL~ALeYLH-s~GIIHRDIKPENILLd~dG-~VKLsDFGLAk~~~~ 910 (1170)
++++|..|++++..+ .... ..+...+.+++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 5544 6788889999999999999999 99999999999999999999 999999999985320
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccC-CCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAG-TPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vG-Tp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
. ..........+| ++.|+|||...+. ..+...|+||.|+++.-|++|..|+
T Consensus 178 ~---------------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~ 230 (601)
T KOG0590|consen 178 K---------------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPW 230 (601)
T ss_pred c---------------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCc
Confidence 0 112233445678 9999999999885 4578899999999999999999999
Q ss_pred CCCCHHHHH-HHHhccCCC-CCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 989 NAKTPQQIF-DNIMNRDIP-WPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 989 ~g~~~~ei~-qkIl~~~l~-fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
......... ......... -......++..+.+++.++|..+|..|.+ .+++..+||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s---~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 231 DFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS---IEELKLDNWLSS 291 (601)
T ss_pred cccccccccceeecccccccccCccccCChhhhhcccccccCCchhccc---cccccccccccc
Confidence 754433211 111111111 01123578899999999999999999998 889999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=169.70 Aligned_cols=133 Identities=25% Similarity=0.285 Sum_probs=106.7
Q ss_pred EeccCCCeEEEEeeecCCCCEEEEEEeeccccc-----cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 765 PISQGAFGRVFLARKRATGDLFAIKVLKKADMI-----RKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~-----~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
.||+|+||.||++.. +|..|++|+....... .......+.+|+.++..+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 5788999986532211 122346678899999999987654443344556678999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
++|++|.+++..... .++.|++.+|.+||+.|++|+|++|.|||++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 7888999999999999999999999999999 89999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-17 Score=180.97 Aligned_cols=250 Identities=21% Similarity=0.334 Sum_probs=195.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+...+..++.+|...-.|..|+|++. |.-++.|++.-.+. .......|..|.--|+-+.||||+.+++++....++
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred CcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 355567778889999999999999886 44466787765433 333445788888888889999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC-ee-eccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALEYLHSLN-VI-HRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~--LSEe~ar~IaaQIL~ALeYLHs~G-II-HRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
.++..||+-|+|+.+|+.... .+..++..++..|+.|+.|||+.. +| ---|....++||++-+.+|+ .+-+++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfs- 340 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFS- 340 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceee-
Confidence 999999999999999987543 567788899999999999999985 33 34578889999988766653 1111110
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC---CcchhhhHHHHHHHHHHhCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH---GATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y---s~ksDIWSLGVILYELLTG~p 986 (1170)
.......-.|.||+||.+...+- -.++|+|||.+++|||.|...
T Consensus 341 ---------------------------------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trev 387 (448)
T KOG0195|consen 341 ---------------------------------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREV 387 (448)
T ss_pred ---------------------------------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccc
Confidence 00112234789999999987653 356899999999999999999
Q ss_pred CCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 987 PF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
||...++++.--+|.-..+. +.+|..++.....|+.-|++.||.+||....+.-|
T Consensus 388 pfadlspmecgmkialeglr-v~ippgis~hm~klm~icmnedpgkrpkfdmivpi 442 (448)
T KOG0195|consen 388 PFADLSPMECGMKIALEGLR-VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPI 442 (448)
T ss_pred ccccCCchhhhhhhhhcccc-ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhh
Confidence 99999998887777655544 24668999999999999999999999985444333
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=169.67 Aligned_cols=137 Identities=20% Similarity=0.200 Sum_probs=108.2
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccccc-------------------HHHHHHHHHHHHHHHhcCCC--
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-------------------KNAVESILAERNILISVRNP-- 818 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~-------------------~~~ve~~l~EieILskL~HP-- 818 (1170)
|.+.+.||.|+||.||++... +|+.||||++....... .........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999875 79999999876532100 01112367789999998877
Q ss_pred cEEEEEeeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEE
Q 001057 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 819 NIVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VK 898 (1170)
.++..+. ....|+||||++|++|..+... .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4444443 2345899999999998765431 34567888999999999999999999999999999999999
Q ss_pred EEecCCccc
Q 001057 899 LTDFGLSKV 907 (1170)
Q Consensus 899 LsDFGLAk~ 907 (1170)
|+|||+|..
T Consensus 166 liDfg~~~~ 174 (198)
T cd05144 166 IIDWPQMVS 174 (198)
T ss_pred EEECCcccc
Confidence 999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=189.87 Aligned_cols=139 Identities=24% Similarity=0.233 Sum_probs=111.8
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccc-----cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD-----MIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~-----i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..|...+.||+|+||+||++..... .+++|+..... .......+.+.+|+.++..++|++|+..+.++.+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 3456788999999999999986543 34444332211 1111234578899999999999999887766777777
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
.++||||++|++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||+|+.
T Consensus 411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999886 346788999999999999999999999999999 678999999999985
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=161.69 Aligned_cols=137 Identities=21% Similarity=0.260 Sum_probs=99.5
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHH---------------------HHHHHHHHHHhcCCCc--
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVE---------------------SILAERNILISVRNPF-- 819 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve---------------------~~l~EieILskL~HPN-- 819 (1170)
.+.||+|+||+||+|.+. +|+.||||++............ ....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999986 8999999998764321111111 1135666666665433
Q ss_pred EEEEEeeeecccceEEEEeeccCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcE
Q 001057 820 VVRFFYSFTCRENLYLVMEYLNGGDLYS-LLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHI 897 (1170)
Q Consensus 820 IVrL~~~Fqd~~~LyLVMEY~~GGSL~d-lLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~V 897 (1170)
+.+.++. ...++||||++|+.+.. .+.... .. ..++.++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444433 24689999999855432 122211 11 6678899999999999999 9999999999999999 8999
Q ss_pred EEEecCCccc
Q 001057 898 KLTDFGLSKV 907 (1170)
Q Consensus 898 KLsDFGLAk~ 907 (1170)
+|+|||.|..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.6e-17 Score=188.21 Aligned_cols=252 Identities=24% Similarity=0.293 Sum_probs=163.6
Q ss_pred CeEEEEEeccCCCeEEEEeeecCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEe-------eee
Q 001057 759 DFEIIKPISQGAFGRVFLARKRAT---GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFY-------SFT 828 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~T---Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~-------~Fq 828 (1170)
.+.+.+..+..++|.+...+.... .+.++-+... ...........+++-.+....|-+..-+.+ .+.
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~---~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD---VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhh---ccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 455556666777776665544332 2233322211 111123333444444444444333222221 111
Q ss_pred -----cccceEEEEeeccCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEE
Q 001057 829 -----CRENLYLVMEYLNGGDLYSLLRNLG---CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLT 900 (1170)
Q Consensus 829 -----d~~~LyLVMEY~~GGSL~dlLk~~~---~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLs 900 (1170)
...++||.|++|...+|.++|.... ..+......++.|+..|++| +|.+|||+||.||+...+..+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 1236899999999999999997542 36677788899999999999 999999999999999999999999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFE 980 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYE 980 (1170)
|||+........ +.. .........+||.+||+||.|.+..|+.++||||||+||||
T Consensus 399 DFgl~ts~~~~~-----------------------~~~-~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~E 454 (516)
T KOG1033|consen 399 DFGLVTSQDKDE-----------------------TVA-PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAE 454 (516)
T ss_pred hhhheeecccCC-----------------------ccc-chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHH
Confidence 999976421000 000 11123345689999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 981 LLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 981 LLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
++. =..+|. ....+..|..+.++ .....-.++..+|+.+||...|.+||+ +.+.--|+|.
T Consensus 455 L~~~f~T~~e---r~~t~~d~r~g~ip--~~~~~d~p~e~~ll~~lls~~p~~RP~---~~~~~~~~~~ 515 (516)
T KOG1033|consen 455 LLIQFSTQFE---RIATLTDIRDGIIP--PEFLQDYPEEYTLLQQLLSPSPEERPS---AIEVALHEFL 515 (516)
T ss_pred HHHHhccHHH---HHHhhhhhhcCCCC--hHHhhcCcHHHHHHHHhcCCCcccCch---HHHHhhhhhc
Confidence 997 222332 22233344444443 111122345569999999999999996 5565556654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=142.82 Aligned_cols=132 Identities=23% Similarity=0.309 Sum_probs=112.0
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CcEEEEEeeeecccceEEEEee
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN--PFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H--PNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
+++.||.|+++.||++.... ..+++|.+..... ...+..|..++..+.| .++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999753 7899998765432 4567889999999976 5899999888888889999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL---NVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~---GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
+.|+.+..+ +......++.+++.+|.+||.. +++|+||+|.|||++..+.++++|||++..
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 998877654 4556677888999999999985 799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.8e-15 Score=159.60 Aligned_cols=137 Identities=20% Similarity=0.338 Sum_probs=105.2
Q ss_pred EEec-cCCCeEEEEeeecCCCCEEEEEEeeccccc----------cHHHHHHHHHHHHHHHhcCCCcE--EEEEeeeecc
Q 001057 764 KPIS-QGAFGRVFLARKRATGDLFAIKVLKKADMI----------RKNAVESILAERNILISVRNPFV--VRFFYSFTCR 830 (1170)
Q Consensus 764 k~LG-~GgFGtVyLArdk~TGe~VAIKvLkKs~i~----------~~~~ve~~l~EieILskL~HPNI--VrL~~~Fqd~ 830 (1170)
..|| .||.|+||.+... +..++||.+...... .......+.+|+.++..+.|++| +..+.+....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3577 7888888888753 778999988653211 11233567889999999998775 5666554332
Q ss_pred cc----eEEEEeeccC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 831 EN----LYLVMEYLNG-GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 831 ~~----LyLVMEY~~G-GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
.. .+|||||++| .+|.+++.. ..+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999997 689888865 3566543 568999999999999999999999999999999999999998
Q ss_pred cc
Q 001057 906 KV 907 (1170)
Q Consensus 906 k~ 907 (1170)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 75
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-14 Score=170.08 Aligned_cols=207 Identities=26% Similarity=0.349 Sum_probs=158.3
Q ss_pred HHhcCCCcEEEEEeeeecccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe-eeccCCCCcE
Q 001057 812 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNV-IHRDLKPDNL 889 (1170)
Q Consensus 812 LskL~HPNIVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GI-IHRDIKPENI 889 (1170)
|+.+.|.|+.++++.+.+...+++|.+||..|+|.+.+... ..++.-....++++|+.||.|||...| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35688999999999999999999999999999999999874 356777777788999999999998876 9999999999
Q ss_pred EeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-----
Q 001057 890 LIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG----- 964 (1170)
Q Consensus 890 LLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~----- 964 (1170)
+++....+||+|||+...... ... ........-...|.|||.+.+..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~-----~~~-----------------------~~~~~~~~~~~lw~aPellr~~~~~~~~ 132 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE-----TAE-----------------------PEAHHPIRKALLWTAPELLRGALSQSLE 132 (484)
T ss_pred eeeeeEEEEechhhhcccccc-----ccc-----------------------ccccchhHHHHhccCHHHhccccccccc
Confidence 999999999999999765210 000 00000111234699999998742
Q ss_pred --CCcchhhhHHHHHHHHHHhCCCCCCC----CCHHHHHHHHhc-cCC-CCCCCC--ccCCHHHHHHHHHhccCCCCCCC
Q 001057 965 --HGATADWWSVGIILFELLIGIPPFNA----KTPQQIFDNIMN-RDI-PWPNIP--EEMSVEACDLIDKLLTENPVQRL 1034 (1170)
Q Consensus 965 --ys~ksDIWSLGVILYELLTG~pPF~g----~~~~ei~qkIl~-~~l-~fP~ip--~~lS~eakDLIkkLLq~DPskRp 1034 (1170)
.+.+.||||+|+++||+++...||.. .++.++...+.+ +.- .-|.+. ..+.+++..++..|+..+|.+||
T Consensus 133 ~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rP 212 (484)
T KOG1023|consen 133 SALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRP 212 (484)
T ss_pred ccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCc
Confidence 35568999999999999999999975 234567766666 221 122222 14566899999999999999999
Q ss_pred ChhhHHHHHcCC
Q 001057 1035 GATGAREVKQHP 1046 (1170)
Q Consensus 1035 Sa~~AeEILqHP 1046 (1170)
+...+...+.-.
T Consensus 213 s~~~i~~~~~~~ 224 (484)
T KOG1023|consen 213 SIEQIRSKLLTI 224 (484)
T ss_pred cHHHHHhhhhhh
Confidence 976665555443
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.7e-13 Score=158.41 Aligned_cols=266 Identities=24% Similarity=0.250 Sum_probs=195.7
Q ss_pred CCCCCeEEEEEecc--CCCeEEEEeee--cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeec
Q 001057 755 TSIEDFEIIKPISQ--GAFGRVFLARK--RATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTC 829 (1170)
Q Consensus 755 i~iedYevlk~LG~--GgFGtVyLArd--k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd 829 (1170)
.....|.+...+|. |.+|.||.++. ..++..+|+|.-+... .......+=++|..-...++ |+|.++.+..+..
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCccccc
Confidence 34456778889999 99999999998 8899999999733211 11111223345555555665 8999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCeeeccCCCCcEEeCCC-CcEEEEecC
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVL----ALEYLHSLNVIHRDLKPDNLLIGQD-GHIKLTDFG 903 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~~~-LSEe~ar~IaaQIL~----ALeYLHs~GIIHRDIKPENILLd~d-G~VKLsDFG 903 (1170)
.+.+|+-+|+| |.+|..+...... +++..++.++.+... ||.++|+.+|+|-|+||+||++..+ ...+++|||
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 99999999999 5788888876544 889999999999999 9999999999999999999999999 789999999
Q ss_pred CccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh
Q 001057 904 LSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI 983 (1170)
Q Consensus 904 LAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT 983 (1170)
+..... .+++. ..........|..-|++||++.+ -++...|||+||.++.+-.+
T Consensus 269 ~v~~i~-------------~~~~~------------~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l 322 (524)
T KOG0601|consen 269 LVSKIS-------------DGNFS------------SVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAIL 322 (524)
T ss_pred eeEEcc-------------CCccc------------cceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHh
Confidence 987531 11100 01111123356778999999865 58899999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 984 GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 984 G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
|..++........ ..+.+..++ .++-...+..+...+..|+..+|..|++ +..+++|++.....+
T Consensus 323 ~~~~~~~g~~~~W-~~~r~~~ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~~---~q~~~~l~~i~s~~~ 387 (524)
T KOG0601|consen 323 GSHLPSVGKNSSW-SQLRQGYIP-LEFCEGGSSSLRSVTSQMLDEDPRLRLT---AQILTALNVIHSKLF 387 (524)
T ss_pred hcccccCCCCCCc-cccccccCc-hhhhcCcchhhhhHHHHhcCcchhhhhH---HHHHhccccccchhh
Confidence 8776643311111 111111111 1122355677777999999999999998 788999999886543
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.7e-13 Score=160.47 Aligned_cols=144 Identities=22% Similarity=0.355 Sum_probs=97.0
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc--------------------------c-----HHHHHHH
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI--------------------------R-----KNAVESI 805 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~--------------------------~-----~~~ve~~ 805 (1170)
..+|+. +.||.|++|+||.|+.+.+|+.||||+++..-.. + .+....+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 7899999999999999888999999998753100 0 0112223
Q ss_pred HHHHH------HHHhcC----CCcEEEEEeeeec-ccceEEEEeeccCCChHHH--HHhcC----CCCHHHHHHHHHHHH
Q 001057 806 LAERN------ILISVR----NPFVVRFFYSFTC-RENLYLVMEYLNGGDLYSL--LRNLG----CLDEDMARVYIAELV 868 (1170)
Q Consensus 806 l~Eie------ILskL~----HPNIVrL~~~Fqd-~~~LyLVMEY~~GGSL~dl--Lk~~~----~LSEe~ar~IaaQIL 868 (1170)
.+|++ .+.++. +...+.+-.+|.+ ....+|||||+.|+.|.++ +...+ .+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 33333 333332 3222322222222 3346799999999999774 33333 255555666666654
Q ss_pred HHHHHHHhCCeeeccCCCCcEEeCCCC----cEEEEecCCcccc
Q 001057 869 LALEYLHSLNVIHRDLKPDNLLIGQDG----HIKLTDFGLSKVG 908 (1170)
Q Consensus 869 ~ALeYLHs~GIIHRDIKPENILLd~dG----~VKLsDFGLAk~~ 908 (1170)
..|++|+|+||.||+++.+| .++++|||++...
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 58999999999999999888 9999999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=7e-12 Score=147.44 Aligned_cols=138 Identities=25% Similarity=0.333 Sum_probs=94.8
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeecccccc---------------------------HHHH----------HHHH
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR---------------------------KNAV----------ESIL 806 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~---------------------------~~~v----------e~~l 806 (1170)
+.||.|++|+||+|+.+ +|+.||||+.+...... .... -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999874 79999999975431000 0000 0234
Q ss_pred HHHHHHHhcC-----CCcE--EEEEeeeecccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 001057 807 AERNILISVR-----NPFV--VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVL-ALEYLHSL 877 (1170)
Q Consensus 807 ~EieILskL~-----HPNI--VrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~-ALeYLHs~ 877 (1170)
+|...+..+. +++| .++|..+ ....+|||||++|++|.++.... ..+. ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555442 3433 2333222 33468999999999998876532 1222 2334555554 47789999
Q ss_pred CeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 878 GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
|++|+|+||.||+++.+|.++|+|||++..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 999999999999999999999999999875
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.9e-12 Score=126.62 Aligned_cols=128 Identities=19% Similarity=0.312 Sum_probs=96.0
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE-EEEEeeeecccceEEEEeecc
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV-VRFFYSFTCRENLYLVMEYLN 841 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNI-VrL~~~Fqd~~~LyLVMEY~~ 841 (1170)
++.|+.|.++.||+++.. +..|++|+...... ....+..|..++..+.+.++ .+++..+. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 567899999999999864 77899998754321 11245678888888765444 34554432 34589999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe-----eeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 842 GGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV-----IHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 842 GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GI-----IHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.|..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887653 01123456799999999999985 9999999999998 67899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.2e-11 Score=142.18 Aligned_cols=183 Identities=20% Similarity=0.351 Sum_probs=135.8
Q ss_pred eEEEEEeccCCCeEEE-EeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 760 FEIIKPISQGAFGRVF-LARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVy-LArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
|++ ...+-++.+ || .|..+.++.+|.+.+++.... ...+.+.+-+.-|+.++||||++++..+...+++|||+|
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTE 89 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTE 89 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEee
Confidence 444 333334444 33 466678899999998876542 445667778888999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH-SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLH-s~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
-+. .|..++++.+ ...+..-+.||+.||.||| +.+++|++|.-..|+|+..|+.||.+|.++....
T Consensus 90 rV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~-------- 156 (690)
T KOG1243|consen 90 RVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS-------- 156 (690)
T ss_pred ccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc--------
Confidence 884 6777887644 6667777889999999998 6789999999999999999999999999875310
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhC
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG 984 (1170)
.. + . ......---.|..|+.+.... ...|.|-|||+++|++.|
T Consensus 157 --~~--~---------------~---~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 157 --GF--N---------------A---PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cC--C---------------c---ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 00 0 0 000111122366676654332 568999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.9e-11 Score=127.74 Aligned_cols=139 Identities=20% Similarity=0.165 Sum_probs=100.6
Q ss_pred EEeccCCCeEEEEeeecC------CCCEEEEEEeeccccc-------------------cHHHHHH----HHHHHHHHHh
Q 001057 764 KPISQGAFGRVFLARKRA------TGDLFAIKVLKKADMI-------------------RKNAVES----ILAERNILIS 814 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~------TGe~VAIKvLkKs~i~-------------------~~~~ve~----~l~EieILsk 814 (1170)
..||.|--+.||.|.... .+..+|||+++..... ..+.... ..+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 3579999987632100 0111223 3489999988
Q ss_pred cCC--CcEEEEEeeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCeeeccCCCCcEEe
Q 001057 815 VRN--PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL-HSLNVIHRDLKPDNLLI 891 (1170)
Q Consensus 815 L~H--PNIVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYL-Hs~GIIHRDIKPENILL 891 (1170)
+.. -++..++++ ..-+|||||+.++.+..-.-+...+++..+..+..+++.+|.+| |+.||||+||++.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 863 355556543 34589999997654432222223466667777889999999999 89999999999999999
Q ss_pred CCCCcEEEEecCCccc
Q 001057 892 GQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 892 d~dG~VKLsDFGLAk~ 907 (1170)
+ ++.+.|+|||.|..
T Consensus 159 ~-~~~v~iIDF~qav~ 173 (197)
T cd05146 159 H-DGKVWFIDVSQSVE 173 (197)
T ss_pred E-CCcEEEEECCCcee
Confidence 6 57899999998874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.8e-12 Score=149.28 Aligned_cols=251 Identities=26% Similarity=0.294 Sum_probs=185.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeec-CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKR-ATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk-~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~ 832 (1170)
....+|..+..||.|.|+.|+.+... .++..|++|.+.+........+ .-+.|+.+...+ .|.++++++..|...++
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34568999999999999999998765 6788999998766543332222 234566666555 48999999988888888
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC-CcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD-GHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d-G~VKLsDFGLAk~~~~~ 911 (1170)
.|+-.|||.++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.++.....
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 89999999999888777555568889999999999999999999999999999999999886 67899999987632110
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccC-CCCC-CchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAG-TPDY-LAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vG-Tp~Y-mAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
. ....+ +..| .++..+....+..++|++|||..+++.++|.+.=.
T Consensus 421 ~---------------------------------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 421 S---------------------------------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred c---------------------------------ccccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 0 01112 2333 35555566778999999999999999999865322
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
... ....|..+..+ .. .....++..+.+.++..++..|+. +.++..|.=|
T Consensus 468 ~~~---~~~~i~~~~~p--~~-~~~~~~~q~~~kv~~~~~~~~~~l---~~~l~~~~~~ 517 (524)
T KOG0601|consen 468 SGV---QSLTIRSGDTP--NL-PGLKLQLQVLLKVMINPDRKRRPS---AVELSLHSEF 517 (524)
T ss_pred ccc---cceeeeccccc--CC-CchHHhhhhhhhhhcCCccccchh---hhhhcccchh
Confidence 211 12233444443 22 334488999999999999999988 6666666544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.5e-11 Score=131.10 Aligned_cols=250 Identities=23% Similarity=0.313 Sum_probs=164.1
Q ss_pred EEEEeeecCCCCEEEEEEeecccccc-HHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----ceEEEEeeccCCChH
Q 001057 773 RVFLARKRATGDLFAIKVLKKADMIR-KNAVESILAERNILISVRNPFVVRFFYSFTCRE-----NLYLVMEYLNGGDLY 846 (1170)
Q Consensus 773 tVyLArdk~TGe~VAIKvLkKs~i~~-~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~-----~LyLVMEY~~GGSL~ 846 (1170)
.||++.+...|..|.--.+....... ..+.+....-..-|.++.|-|||+++.++.+.. ...++.|||..|+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 46777666666554332221111000 111122223334456677999999998876653 488999999999999
Q ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCC
Q 001057 847 SLLRNL----GCLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920 (1170)
Q Consensus 847 dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~s 920 (1170)
.+|++. ..+.....+.|+.||+.||.|||+.. |+|+++...-|++..+|.||+.---.... .+.
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~----------h~s 230 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDST----------HPS 230 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCcccc----------chh
Confidence 999754 35788888999999999999999985 99999999999999999888742111100 000
Q ss_pred CCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCC-CCCCCHHHHHHH
Q 001057 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP-FNAKTPQQIFDN 999 (1170)
Q Consensus 921 l~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pP-F~g~~~~ei~qk 999 (1170)
. + ...........|-++|.|||.=.....+.++|||++|....+|..|..- -.+.+..+.-..
T Consensus 231 ~-------~---------~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ 294 (458)
T KOG1266|consen 231 V-------N---------STREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEEN 294 (458)
T ss_pred h-------h---------hhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhh
Confidence 0 0 0011112223467899999976656677889999999999999987654 233322222222
Q ss_pred HhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhh
Q 001057 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLA 1057 (1170)
Q Consensus 1000 Il~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~ 1057 (1170)
|.+..+.. -...-+++|.+||+..|..||+ +.+++.||.+=++.-..+.
T Consensus 295 ia~~i~~l------en~lqr~~i~kcl~~eP~~rp~---ar~llfHpllfeVhslkll 343 (458)
T KOG1266|consen 295 IANVIIGL------ENGLQRGSITKCLEGEPNGRPD---ARLLLFHPLLFEVHSLKLL 343 (458)
T ss_pred hhhheeec------cCccccCcCcccccCCCCCCcc---hhhhhcCceeeecchHHHH
Confidence 22211111 1122357899999999999998 8899999988776655443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.1e-10 Score=115.95 Aligned_cols=140 Identities=19% Similarity=0.250 Sum_probs=105.2
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CcEEEEEeeeecc---cceEEEEe
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN--PFVVRFFYSFTCR---ENLYLVME 838 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H--PNIVrL~~~Fqd~---~~LyLVME 838 (1170)
+.||.|.++.||++... +|+.|++|+....... .....+..|..++..+.+ .++.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 57899999999999874 3678999987654321 123467889999999875 3456666665553 36789999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS------------------------------------------ 876 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs------------------------------------------ 876 (1170)
|++|.+|...+.. ..+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888775532 346666666777777777777773
Q ss_pred --------------CCeeeccCCCCcEEeCC--CCcEEEEecCCccc
Q 001057 877 --------------LNVIHRDLKPDNLLIGQ--DGHIKLTDFGLSKV 907 (1170)
Q Consensus 877 --------------~GIIHRDIKPENILLd~--dG~VKLsDFGLAk~ 907 (1170)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1e-09 Score=115.87 Aligned_cols=133 Identities=26% Similarity=0.270 Sum_probs=98.3
Q ss_pred EeccCCCeEEEEeeecCCCCEEEEEEeec-----cccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 765 PISQGAFGRVFLARKRATGDLFAIKVLKK-----ADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TGe~VAIKvLkK-----s~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
.+++|+-+.+|.+... |..+.+|.=.+ ..+...-......+|..+|.++.--.|..-+-++.+.+...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 5789999999988653 54566665222 2222223345678899999988754443333335566777899999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
++|..|.+.+... .-.++..|=.-+.-||.+||+|+||.++||++..++ +.++||||+..
T Consensus 81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9998888888765 134666777778889999999999999999997654 99999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=8.3e-09 Score=108.99 Aligned_cols=144 Identities=24% Similarity=0.246 Sum_probs=105.8
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEee-----ccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLK-----KADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLk-----Ks~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.+..|-+|+-+.|+.+.. .|+.+.||.=. -..+...-...+..+|+.+|.++.--.|.--.-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567788999999998875 58888888522 22222233445788899999988754443322336666677899
Q ss_pred EeeccC-CChHHHHHhcC-C-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---cEEEEecCCccc
Q 001057 837 MEYLNG-GDLYSLLRNLG-C-LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---HIKLTDFGLSKV 907 (1170)
Q Consensus 837 MEY~~G-GSL~dlLk~~~-~-LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG---~VKLsDFGLAk~ 907 (1170)
|||++| .++.+++.... . ........++..|-..|.-||.++|||+||..+||+|..+| .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999976 47888886542 2 23333367888999999999999999999999999997765 358999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.6e-08 Score=103.71 Aligned_cols=127 Identities=23% Similarity=0.276 Sum_probs=83.2
Q ss_pred EEEEeeecCCCCEEEEEEeecccc-----------------------ccHHHHHHHHHHHHHHHhcCCC--cEEEEEeee
Q 001057 773 RVFLARKRATGDLFAIKVLKKADM-----------------------IRKNAVESILAERNILISVRNP--FVVRFFYSF 827 (1170)
Q Consensus 773 tVyLArdk~TGe~VAIKvLkKs~i-----------------------~~~~~ve~~l~EieILskL~HP--NIVrL~~~F 827 (1170)
.||.|.. ..|..+|||+.+.... ..........+|...|..+..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888887 4677999998764210 0111235678899999999865 456666432
Q ss_pred ecccceEEEEeecc--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCeeeccCCCCcEEeCCCCcEEEEecCC
Q 001057 828 TCRENLYLVMEYLN--GGDLYSLLRNLGCLDEDMARVYIAELVLALEY-LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGL 904 (1170)
Q Consensus 828 qd~~~LyLVMEY~~--GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeY-LHs~GIIHRDIKPENILLd~dG~VKLsDFGL 904 (1170)
.-+|||||++ |..+..+.... ++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 65555544322 2244556677788885555 579999999999999999876 899999998
Q ss_pred ccc
Q 001057 905 SKV 907 (1170)
Q Consensus 905 Ak~ 907 (1170)
|..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1113 consensus cAMP-dependent protein kinase types I and II, regulatory subunit [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.3e-09 Score=118.68 Aligned_cols=83 Identities=4% Similarity=-0.087 Sum_probs=75.5
Q ss_pred ccccccCCCcccccccccCCCCCcceeecCCcEEEEEcC--ccccccCCCCCchHhhhh---hhcccccccCCCcccccC
Q 001057 551 THDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL--NVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 551 ~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~--~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ld 625 (1170)
.+.++-+-.-+|+.+++||+.||.||+|++|+|+|...+ ..| .++.|.-|||+||+ ||||||.|.+..++-.+|
T Consensus 260 ~dal~~k~y~~G~~Vi~qg~~ge~f~~i~eGEvdv~~~~~~v~v-kl~~~dyfge~al~~~~pr~Atv~a~~~~kc~~~d 338 (368)
T KOG1113|consen 260 ADALGTKSYKDGERVIVQGDQGEHFYIIEEGEVDVLKKRDGVEV-KLKKGDYFGELALLKNLPRAATVVAKGRLKCAKLD 338 (368)
T ss_pred hcccceeeccCCceEEeccCCcceEEEecccccchhhccCCeEE-EechhhhcchHHHHhhchhhceeeccCCceeeeeC
Confidence 678888999999999999999999999999999999765 345 89999999999999 999999999999999999
Q ss_pred Cchhhhhhhhhhhhhcc
Q 001057 626 RTSQIELLVNGHRTITE 642 (1170)
Q Consensus 626 R~~~~~~~~~tfr~Il~ 642 (1170)
| .+|.+.|.
T Consensus 339 k--------~~ferllg 347 (368)
T KOG1113|consen 339 K--------PRFERLLG 347 (368)
T ss_pred h--------HHHHHHhh
Confidence 9 78877663
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.3e-07 Score=108.26 Aligned_cols=217 Identities=20% Similarity=0.237 Sum_probs=152.4
Q ss_pred CeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec----ccceEEEEeeccC-CCh
Q 001057 771 FGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC----RENLYLVMEYLNG-GDL 845 (1170)
Q Consensus 771 FGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd----~~~LyLVMEY~~G-GSL 845 (1170)
-.+.|+|....+|..|++|.+...+.... .....-+++++++.|+|||++..+|.+ +..+++|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 34689999999999999999843322111 123345678899999999999999884 3468999999986 578
Q ss_pred HHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 846 YSLLRN---------------LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 846 ~dlLk~---------------~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
+++--. ....+|...+.|+.|+..||.++|+.|+..+-|.|.+||++.+-.++|...|......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~- 444 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ- 444 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec-
Confidence 776521 1246789999999999999999999999999999999999988888888777654321
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCC-CC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP-FN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pP-F~ 989 (1170)
.+ . + +.+.+ -.+-|.=.||.+++.|.||.-- +.
T Consensus 445 ------------------~d-----------~-------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~ 478 (655)
T KOG3741|consen 445 ------------------ED-----------P-------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNR 478 (655)
T ss_pred ------------------CC-----------C-------C-------cchhH---HhhhhHHHHHHHHHHHhhccccccc
Confidence 00 0 0 11111 1356888999999999999532 22
Q ss_pred CCCHHHH-HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC---CCCCCC
Q 001057 990 AKTPQQI-FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH---PFFKNI 1051 (1170)
Q Consensus 990 g~~~~ei-~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH---PfF~~i 1051 (1170)
....+.. ...| ....+.+++++|.-+...++.. -+ +.+++.| .||..+
T Consensus 479 ~d~~~~s~~~~I----------~~~yS~D~rn~v~yl~s~~~~~-ks---I~~llp~~~~~ff~vm 530 (655)
T KOG3741|consen 479 TDSTQSSHLTRI----------TTTYSTDLRNVVEYLESLNFRE-KS---IQDLLPMIGSRFFTVM 530 (655)
T ss_pred ccchHHHHHHHh----------hhhhhHHHHHHHHHHHhcCccc-cc---HHHHHHHHHHHHHHHH
Confidence 2222222 2222 2457889999999999988884 23 4455544 455433
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.3e-08 Score=123.00 Aligned_cols=168 Identities=20% Similarity=0.326 Sum_probs=120.4
Q ss_pred HHHHHHHHHHhC-CeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccc
Q 001057 866 ELVLALEYLHSL-NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQ 944 (1170)
Q Consensus 866 QIL~ALeYLHs~-GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~ 944 (1170)
+++.||.|+|.. ++||+.|.|++|.++.+|.+||+.|+++.... .. .. ++-. ...+. .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~--~~----------~~-~p~~--~yd~~------l 165 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNAN--GP----------TE-YPFS--EYDPP------L 165 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccC--CC----------Cc-cccc--cCCCC------C
Confidence 556999999965 89999999999999999999999999986421 00 00 0000 00111 1
Q ss_pred cccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHH-hCCCCCCCCCHHHHHHHHh-ccCCCCCCCCccCCHHHHHHH
Q 001057 945 KHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQQIFDNIM-NRDIPWPNIPEEMSVEACDLI 1022 (1170)
Q Consensus 945 ~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELL-TG~pPF~g~~~~ei~qkIl-~~~l~fP~ip~~lS~eakDLI 1022 (1170)
.....-...|.|||++.+...+.++|+|||||++|.+. .|+.-|.+......+..-. ..+.........++.++++=|
T Consensus 166 p~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 166 PLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred ChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHH
Confidence 11223467899999999988899999999999999998 5666666554333332211 122222223478999999999
Q ss_pred HHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhh
Q 001057 1023 DKLLTENPVQRLGATGAREVKQHPFFKNINWDTLA 1057 (1170)
Q Consensus 1023 kkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~ 1057 (1170)
.++|..++.-||+ +..++.-|||.+..-.+|.
T Consensus 246 ~k~l~~~~~~rp~---~~~l~~~~ff~D~~~~aLr 277 (700)
T KOG2137|consen 246 KKLLNGDSAVRPT---LDLLLSIPFFSDPGLKALR 277 (700)
T ss_pred HHHhcCCcccCcc---hhhhhcccccCCchhhhhh
Confidence 9999999999996 8899999999987555444
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.67 E-value=2.1e-07 Score=103.63 Aligned_cols=126 Identities=14% Similarity=0.130 Sum_probs=88.1
Q ss_pred CCCEEEEEEeeccccc---cH-----HHHHHHHHHHHHHHhcCCCcE--EEEEeeeec-----ccceEEEEeeccCC-Ch
Q 001057 782 TGDLFAIKVLKKADMI---RK-----NAVESILAERNILISVRNPFV--VRFFYSFTC-----RENLYLVMEYLNGG-DL 845 (1170)
Q Consensus 782 TGe~VAIKvLkKs~i~---~~-----~~ve~~l~EieILskL~HPNI--VrL~~~Fqd-----~~~LyLVMEY~~GG-SL 845 (1170)
.|+.|.||........ .. .-...+.+|...+..|..-+| +.+..++.. ...-+||||++++. +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 4667888865432210 00 011136788888877753222 222222322 23468999999876 79
Q ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-------CCcEEEEecCCccc
Q 001057 846 YSLLRN--LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-------DGHIKLTDFGLSKV 907 (1170)
Q Consensus 846 ~dlLk~--~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-------dG~VKLsDFGLAk~ 907 (1170)
.+++.. ....+......++.+++..+.-||.+||+|+|+++.|||++. ++.+.|+||+.+..
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 888864 234667778889999999999999999999999999999975 46899999998863
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.3e-07 Score=95.99 Aligned_cols=105 Identities=27% Similarity=0.326 Sum_probs=82.2
Q ss_pred HHHHHHHHHHHhcCCCcE--EEEEeeeecc----cceEEEEeeccCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 001057 803 ESILAERNILISVRNPFV--VRFFYSFTCR----ENLYLVMEYLNGG-DLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875 (1170)
Q Consensus 803 e~~l~EieILskL~HPNI--VrL~~~Fqd~----~~LyLVMEY~~GG-SL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLH 875 (1170)
....+|...+..|..-+| ...+.+.... ...|||||+++|. +|.+++.....++......++.++...+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 356777777776653222 3333333322 2458999999874 89999987555778888899999999999999
Q ss_pred hCCeeeccCCCCcEEeCCCC---cEEEEecCCccc
Q 001057 876 SLNVIHRDLKPDNLLIGQDG---HIKLTDFGLSKV 907 (1170)
Q Consensus 876 s~GIIHRDIKPENILLd~dG---~VKLsDFGLAk~ 907 (1170)
.+||+|+|+++.|||++.++ .+.|+||+-++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=8.8e-08 Score=112.15 Aligned_cols=78 Identities=13% Similarity=0.059 Sum_probs=70.2
Q ss_pred CCcccccccccCCCCCcceeecCCcEEEEEcCc------cccccCCCCCchHhhhh---hhcccccccCC-CcccccCCc
Q 001057 558 MSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLN------VLPEISCDKNPTAADIA---AKTSSAGSLTP-RSPLLTPRT 627 (1170)
Q Consensus 558 ~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~------~v~~~~~g~sFGELAL~---pRAATv~A~t~-~~lw~ldR~ 627 (1170)
---+|++|||||+.||.||||-.|+|.|...++ .|.+...|+.|||=||+ -|+|.+.|..+ +.+..|||
T Consensus 299 ~Yd~g~yIirqge~G~~ffii~~G~V~vtq~~e~~~q~~~lr~l~kGd~FGE~al~~edvRtAniia~~~gv~cl~lDr- 377 (732)
T KOG0614|consen 299 YYDAGEYIIRQGEKGDTFFIISKGTVKVTQQDEGSTQPQELRTLNKGDYFGERALLGEDVRTANIIAQAPGVECLTLDR- 377 (732)
T ss_pred hhcCCceEEeecCCCCeEEEEecceEEEeecCCCCCchhHHhhccccchhhHHHhhccCccchhhhccCCCceEEEecH-
Confidence 345799999999999999999999999997653 58999999999999999 99999999998 78999999
Q ss_pred hhhhhhhhhhhhhccC
Q 001057 628 SQIELLVNGHRTITEL 643 (1170)
Q Consensus 628 ~~~~~~~~tfr~Il~~ 643 (1170)
++|.+.+-.
T Consensus 378 -------esF~~liG~ 386 (732)
T KOG0614|consen 378 -------ESFKKLIGD 386 (732)
T ss_pred -------HHHHHhccc
Confidence 999887754
|
|
| >PF00027 cNMP_binding: Cyclic nucleotide-binding domain; InterPro: IPR000595 Proteins that bind cyclic nucleotides (cAMP or cGMP) share a structural domain of about 120 residues [, , ] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.8e-08 Score=89.18 Aligned_cols=79 Identities=13% Similarity=-0.011 Sum_probs=70.7
Q ss_pred CCCcccccccccCCCCCcceeecCCcEEEEEcC---c--cccccCCCCCchHhhhh---hhcccccccCCCcccccCCch
Q 001057 557 LMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL---N--VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTS 628 (1170)
Q Consensus 557 ~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~---~--~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~ 628 (1170)
+..+||..|++||+..+.+|+|.+|.+.++... + .+..+.+|+.||+.+++ |+.+++.|.+++.+|.|++
T Consensus 2 ~~~~~g~~i~~~g~~~~~~~~i~~G~v~~~~~~~~~~~~~~~~~~~g~~~g~~~~~~~~~~~~~~~a~~~~~~~~i~~-- 79 (91)
T PF00027_consen 2 KTYKKGEVIYRQGDPCDHIYIILSGEVKVSSINEDGKEQIIFFLGPGDIFGEIELLTGKPSPFTVIALTDSEVLRIPR-- 79 (91)
T ss_dssp EEESTTEEEEETTSBESEEEEEEESEEEEEEETTTSEEEEEEEEETTEEESGHHHHHTSBBSSEEEESSSEEEEEEEH--
T ss_pred eEECCCCEEEeCCCcCCEEEEEEECceEEEeceecceeeeecceeeeccccceeecCCCccEEEEEEccCEEEEEEeH--
Confidence 457899999999999999999999999999753 2 37899999999999999 8999999999999999999
Q ss_pred hhhhhhhhhhhhccC
Q 001057 629 QIELLVNGHRTITEL 643 (1170)
Q Consensus 629 ~~~~~~~tfr~Il~~ 643 (1170)
..|..++..
T Consensus 80 ------~~~~~~~~~ 88 (91)
T PF00027_consen 80 ------EDFLQLLQQ 88 (91)
T ss_dssp ------HHHHHHHHH
T ss_pred ------HHHHHHHHh
Confidence 888877653
|
The best studied of these proteins is the prokaryotic catabolite gene activator (also known as the cAMP receptor protein) (gene crp) where such a domain is known to be composed of three alpha-helices and a distinctive eight-stranded, antiparallel beta-barrel structure. There are six invariant amino acids in this domain, three of which are glycine residues that are thought to be essential for maintenance of the structural integrity of the beta-barrel. cAMP- and cGMP-dependent protein kinases (cAPK and cGPK) contain two tandem copies of the cyclic nucleotide-binding domain. The cAPK's are composed of two different subunits, a catalytic chain and a regulatory chain, which contains both copies of the domain. The cGPK's are single chain enzymes that include the two copies of the domain in their N-terminal section. Vertebrate cyclic nucleotide-gated ion-channels also contain this domain. Two such cations channels have been fully characterised, one is found in rod cells where it plays a role in visual signal transduction.; PDB: 1O7F_A 2BYV_E 3E97_A 3U10_A 2H6B_A 3SHR_A 2OZ6_A 1WGP_A 3LA2_A 3LA3_B .... |
| >COG0664 Crp cAMP-binding proteins - catabolite gene activator and regulatory subunit of cAMP-dependent protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-07 Score=97.16 Aligned_cols=83 Identities=14% Similarity=0.015 Sum_probs=74.6
Q ss_pred ccccCCCcccccccccCCCCCcceeecCCcEEEEEcC---c--cccccCCCCCchHhhhh---hhcccccccCCCccccc
Q 001057 553 DDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL---N--VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLT 624 (1170)
Q Consensus 553 ~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~---~--~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~l 624 (1170)
.......|+|..+.+|||.++++|+|.+|.+.++... + .+..+.+|+.|||.+++ ||.+|+.|++++.+|.+
T Consensus 22 ~~~~~~~~~g~~l~~~g~~~~~~y~v~~G~v~~~~~~~~G~~~~~~~~~~g~~fg~~~l~~~~~~~~~~~a~~~~~~~~~ 101 (214)
T COG0664 22 KLEVRKLPKGEVLFTEGEEADSLYIILSGIVKLYANTEDGREIILGFLGPGDFFGELALLGGDPRSASAVALTDVEVLEI 101 (214)
T ss_pred hceeEeeCCCCEEEcCCCcCceEEEEEEeEEEEEEECCCCcEEEEEEecCCchhhhHHHhcCCCccceEEEcceEEEEEe
Confidence 3455678999999999999999999999999999764 2 47789999999999999 79999999999999999
Q ss_pred CCchhhhhhhhhhhhhccC
Q 001057 625 PRTSQIELLVNGHRTITEL 643 (1170)
Q Consensus 625 dR~~~~~~~~~tfr~Il~~ 643 (1170)
+| ..|+.++..
T Consensus 102 ~~--------~~~~~~~~~ 112 (214)
T COG0664 102 PR--------KDFLELLAE 112 (214)
T ss_pred cH--------HHHHHHHhh
Confidence 99 888888877
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.2e-06 Score=99.50 Aligned_cols=231 Identities=18% Similarity=0.297 Sum_probs=148.1
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEE--------EEeeeeccc-c
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVR--------FFYSFTCRE-N 832 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVr--------L~~~Fqd~~-~ 832 (1170)
.+.||+|+.+.+|-.-.- +. .+.|++.+...--.. .-+..|... .||-+-. |++ .+.. .
T Consensus 16 gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G--~~~~~~ 84 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHG--GRRGKV 84 (637)
T ss_pred CccccCCccceeeecchh--hc-hhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhC--CCccce
Confidence 457999999999954321 22 345888765421111 122233332 4554332 121 1222 2
Q ss_pred eEEEEeeccCCC-hHHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 833 LYLVMEYLNGGD-LYSLL------RNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 833 LyLVMEY~~GGS-L~dlL------k~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
.-++|..+.|.. +..++ +....+.++.+....+.++.+...||..|.+-+|+.++|+|+++++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 678888887652 22222 12234778888899999999999999999999999999999999999999984422
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-----cCCCCcchhhhHHHHHHHH
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFE 980 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~ksDIWSLGVILYE 980 (1170)
.. ...+......+|.+.|.+||.-. +..-+...|-|.||+++|+
T Consensus 165 qi-------------------------------~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~ 213 (637)
T COG4248 165 QI-------------------------------NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFH 213 (637)
T ss_pred ee-------------------------------ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHH
Confidence 11 11122334568999999999865 3345667899999999999
Q ss_pred HHhC-CCCCCCCC-------HHHHHHHHhccC-----------CCCCC-CC-ccCCHHHHHHHHHhccC--CCCCCCChh
Q 001057 981 LLIG-IPPFNAKT-------PQQIFDNIMNRD-----------IPWPN-IP-EEMSVEACDLIDKLLTE--NPVQRLGAT 1037 (1170)
Q Consensus 981 LLTG-~pPF~g~~-------~~ei~qkIl~~~-----------l~fP~-ip-~~lS~eakDLIkkLLq~--DPskRpSa~ 1037 (1170)
+|.| +.||.|.. +-+ ..|..+. .+-|. .| .-+++.+..|..+|+.. ++.-||++.
T Consensus 214 lL~ggrHPysGI~~~~~ap~p~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 214 LLFGGRHPYSGIPLISDAPNPLE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred HHhcCCCCCCcccccCCCCCcch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 9986 99997632 111 1222111 11111 11 24788999999999984 355899943
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.6e-08 Score=116.03 Aligned_cols=243 Identities=21% Similarity=0.187 Sum_probs=165.0
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeecccceEEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF-VVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN-IVrL~~~Fqd~~~LyLVM 837 (1170)
-|.....+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++.++.++...++|
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 3666677899999999999877666555 6655432 34456889999999999 777788888888999999
Q ss_pred eeccCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 838 EYLNGG-DLYSLL-RNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 838 EY~~GG-SL~dlL-k~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
+|+.++ +-.... ...-.|.+.+.....+.-+.+|+|||+.-=+||| |||... +..++.||+.+....
T Consensus 314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~------ 382 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLT------ 382 (829)
T ss_pred hhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccC------
Confidence 999877 221111 1111234444555666778899999998778999 887754 788999999765320
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
. ....++..+|+.++|||+.....+....|.|++|+--.+|.-|-+|-.... .
T Consensus 383 ------------------------~-~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~--~ 435 (829)
T KOG0576|consen 383 ------------------------R-TMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP--A 435 (829)
T ss_pred ------------------------c-ccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc--c
Confidence 0 113457789999999999999999999999999998888888888764411 1
Q ss_pred HHHHHhccCCCCCCCC-ccCCHH-HHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 996 IFDNIMNRDIPWPNIP-EEMSVE-ACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip-~~lS~e-akDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..-.+-++.-.+.... ...++. -.++...||..-|..|+. +..++.|.+|++-
T Consensus 436 ~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv---~mgacfsKvfngC 490 (829)
T KOG0576|consen 436 VLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV---HMGACFSKVFNGC 490 (829)
T ss_pred ccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcc---hhhHHHHHHhccC
Confidence 1111111110000000 001111 124777899999998888 5566888888764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.6e-06 Score=96.67 Aligned_cols=137 Identities=23% Similarity=0.250 Sum_probs=99.7
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccc-------ccc------------HHHHHHHHHHHHHHHhcCCC--
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD-------MIR------------KNAVESILAERNILISVRNP-- 818 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~-------i~~------------~~~ve~~l~EieILskL~HP-- 818 (1170)
+.+...||-|--|.||.|.+. .|..+|||.=+-.. ..+ .-......+|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456678999999999999985 78999999632110 000 01233567899999888754
Q ss_pred cEEEEEeeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEE
Q 001057 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 819 NIVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VK 898 (1170)
.|.+.++ .+.-.+||||+.|-.|...- +..+.+..++..|+.-+.-+-..||||+|+.+-|||++.+|.+.
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 5555543 24557999999987766532 13444555666677777766699999999999999999999999
Q ss_pred EEecCCcc
Q 001057 899 LTDFGLSK 906 (1170)
Q Consensus 899 LsDFGLAk 906 (1170)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99998665
|
|
| >PLN03192 Voltage-dependent potassium channel; Provisional | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.8e-07 Score=112.14 Aligned_cols=102 Identities=9% Similarity=0.032 Sum_probs=91.1
Q ss_pred CCCcccccccccCCCCCcceeecCCcEEEEEc--C--ccccccCCCCCchHhhhh---hhcccccccCCCcccccCCchh
Q 001057 557 LMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED--L--NVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQ 629 (1170)
Q Consensus 557 ~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~--~--~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~ 629 (1170)
...|+|..|++|||.++.+|+|.+|.|+++.. + ..+..+.+|+.|||.+++ ||.+||.|.+.|.||.|+|
T Consensus 400 ~~~~pge~I~~qge~~~~lY~I~~G~V~i~~~~~~~e~~l~~l~~Gd~FGE~~~l~~~p~~~t~ra~~~s~ll~l~~--- 476 (823)
T PLN03192 400 EYIPPREDVIMQNEAPDDVYIVVSGEVEIIDSEGEKERVVGTLGCGDIFGEVGALCCRPQSFTFRTKTLSQLLRLKT--- 476 (823)
T ss_pred eeeCCCCEEEECCCCCceEEEEEecEEEEEEecCCcceeeEEccCCCEecchHHhcCCCCCCeEEEcccEEEEEEEH---
Confidence 45889999999999999999999999999863 2 347899999999999998 9999999999999999999
Q ss_pred hhhhhhhhhhhccCCCHHHHHHHHHHhhccccCCCCC
Q 001057 630 IELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCD 666 (1170)
Q Consensus 630 ~~~~~~tfr~Il~~~~~~kr~~y~~fl~~V~~l~~l~ 666 (1170)
..|..++.....-.+.++..+++...-++++.
T Consensus 477 -----~~f~~ll~~~p~d~~~i~~~~l~~~~~l~~l~ 508 (823)
T PLN03192 477 -----STLIEAMQTRQEDNVVILKNFLQHHKELHDLN 508 (823)
T ss_pred -----HHHHHHHHHhhHHHHHHHHHHHHHhhhhcccc
Confidence 99999999888888888999988877666654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.19 E-value=2e-05 Score=86.02 Aligned_cols=141 Identities=23% Similarity=0.341 Sum_probs=91.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHH------HHHHHHHHHhcCC---CcEEEEEe
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES------ILAERNILISVRN---PFVVRFFY 825 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~------~l~EieILskL~H---PNIVrL~~ 825 (1170)
+...+|.+++++-......|.+.. ..|+.+.+|..+............ ..+++..+..+.. -....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 445679999999888888787765 457889999876533222222221 1223333333321 22222222
Q ss_pred e-----eecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEE
Q 001057 826 S-----FTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLT 900 (1170)
Q Consensus 826 ~-----Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLs 900 (1170)
+ +.-....+|||||++|..|.++.. ++++ +...|+.+|.-||+.|++|+|+.|.|++++.++ ++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 1 222244578999999988776532 3332 445677889999999999999999999998554 9999
Q ss_pred ecCCcc
Q 001057 901 DFGLSK 906 (1170)
Q Consensus 901 DFGLAk 906 (1170)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.11 E-value=6e-05 Score=78.26 Aligned_cols=138 Identities=28% Similarity=0.390 Sum_probs=81.9
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--cEEEEEeeeec---ccceEEEE
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP--FVVRFFYSFTC---RENLYLVM 837 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HP--NIVrL~~~Fqd---~~~LyLVM 837 (1170)
++.|+.|..+.||++.... ..+++|+.... .....+..|..++..+... .+.+++..... ....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998754 48899986543 3455677888888777532 34556553322 23478999
Q ss_pred eeccCCChHH----------------HHH---hc----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 001057 838 EYLNGGDLYS----------------LLR---NL----GCLDEDM------ARVY---------------IAELVL-ALE 872 (1170)
Q Consensus 838 EY~~GGSL~d----------------lLk---~~----~~LSEe~------ar~I---------------aaQIL~-ALe 872 (1170)
++++|..+.. .+. .. ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 111 11 0111100 0000 111222 333
Q ss_pred HHHh-------CCeeeccCCCCcEEeC-CCCcEEEEecCCccc
Q 001057 873 YLHS-------LNVIHRDLKPDNLLIG-QDGHIKLTDFGLSKV 907 (1170)
Q Consensus 873 YLHs-------~GIIHRDIKPENILLd-~dG~VKLsDFGLAk~ 907 (1170)
.+++ ..++|+|+.|.|||++ .++.+.|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 3332 3599999999999999 667778999998864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.4e-05 Score=85.00 Aligned_cols=139 Identities=14% Similarity=0.186 Sum_probs=99.4
Q ss_pred ccCCCeEEEEeeecCCCCEEEEEEeeccc---cccHHHHHHHHHHHHHHHhcCCCc--EEEEEeeeec----ccceEEEE
Q 001057 767 SQGAFGRVFLARKRATGDLFAIKVLKKAD---MIRKNAVESILAERNILISVRNPF--VVRFFYSFTC----RENLYLVM 837 (1170)
Q Consensus 767 G~GgFGtVyLArdk~TGe~VAIKvLkKs~---i~~~~~ve~~l~EieILskL~HPN--IVrL~~~Fqd----~~~LyLVM 837 (1170)
|+||-+-|+..... |+.|-+|.-.... .........+.+|...|..+..-+ +.+....-.. .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56888889976543 4467788643111 000224467899999998886422 3344321111 12368999
Q ss_pred eeccC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc--EEEEecCCccc
Q 001057 838 EYLNG-GDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH--IKLTDFGLSKV 907 (1170)
Q Consensus 838 EY~~G-GSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~--VKLsDFGLAk~ 907 (1170)
|-+.| -+|.+++... .+.++.....++.++..+|.-||+.|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98754 5888888663 34577777889999999999999999999999999999987777 99999997764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.09 E-value=2.5e-05 Score=86.40 Aligned_cols=138 Identities=22% Similarity=0.220 Sum_probs=94.6
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHH---------------------HHHHHHHHHHHHHhcCC--Cc
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKN---------------------AVESILAERNILISVRN--PF 819 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~---------------------~ve~~l~EieILskL~H--PN 819 (1170)
...|+.|--+.||+|.. .++..||+|+++........ .......|..-|.++.. -.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34788999999999975 56889999998754322221 11234556666766542 23
Q ss_pred EEEEEeeeecccceEEEEeeccCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcE
Q 001057 820 VVRFFYSFTCRENLYLVMEYLNGG-DLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHI 897 (1170)
Q Consensus 820 IVrL~~~Fqd~~~LyLVMEY~~GG-SL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~V 897 (1170)
+.+-+.++ .-.|||||+... .-.-.|+.- .+..+.+..+..+++..+.-|-. .|+||+||..-|||+. ++.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 33334333 236899999543 111112221 23444678888899999998877 8999999999999998 8899
Q ss_pred EEEecCCccc
Q 001057 898 KLTDFGLSKV 907 (1170)
Q Consensus 898 KLsDFGLAk~ 907 (1170)
.++|||-|..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998874
|
|
| >cd00038 CAP_ED effector domain of the CAP family of transcription factors; members include CAP (or cAMP receptor protein (CRP)), which binds cAMP, FNR (fumarate and nitrate reduction), which uses an iron-sulfur cluster to sense oxygen) and CooA, a heme containing CO sensor | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.7e-06 Score=77.97 Aligned_cols=81 Identities=14% Similarity=0.075 Sum_probs=70.9
Q ss_pred CCCcccccccccCCCCCcceeecCCcEEEEEcC-----ccccccCCCCCchHhhhh---hhcccccccCCCcccccCCch
Q 001057 557 LMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL-----NVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTS 628 (1170)
Q Consensus 557 ~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~-----~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~ 628 (1170)
...++|..+..+|+..+++|+|.+|.+.++... ..+..+.+|+.||+.+++ ++..++.|.++|.+|.+++
T Consensus 20 ~~~~~g~~l~~~~~~~~~~~~i~~G~v~~~~~~~~g~~~~~~~~~~g~~~g~~~~~~~~~~~~~~~a~~~~~~~~i~~-- 97 (115)
T cd00038 20 RRFPAGEVIIRQGDPADSLYIVLSGSVEVYKLDEDGREQIVGFLGPGDLFGELALLGNGPRSATVRALTDSELLVLPR-- 97 (115)
T ss_pred eeeCCCCEEEcCCCCCCeEEEEEeCEEEEEEECCCCcEEEEEecCCccCcChHHHhcCCCCCceEEEcCceEEEEEeH--
Confidence 457899999999999999999999999998765 457889999999998886 8899999999999999999
Q ss_pred hhhhhhhhhhhhccCCC
Q 001057 629 QIELLVNGHRTITELQN 645 (1170)
Q Consensus 629 ~~~~~~~tfr~Il~~~~ 645 (1170)
+.|..++....
T Consensus 98 ------~~~~~~~~~~~ 108 (115)
T cd00038 98 ------SDFRRLLQEYP 108 (115)
T ss_pred ------HHHHHHHHHCc
Confidence 77777765543
|
In all cases binding of the effector leads to conformational changes and the ability to activate transcription. Cyclic nucleotide-binding domain similar to CAP are also present in cAMP- and cGMP-dependent protein kinases (cAPK and cGPK) and vertebrate cyclic nucleotide-gated ion-channels. Cyclic nucleotide-monophosphate binding domain; proteins that bind cyclic nucleotides (cAMP or cGMP) share a structural domain of about 120 residues; the best studied is the prokaryotic catabolite gene activator, CAP, where such a domain is known to be composed of three alpha-helices and a distinctive eight-stranded, antiparallel beta-barrel structure; three conserved glycine residues are thought to be essential for maintenance of |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.5e-05 Score=99.56 Aligned_cols=205 Identities=23% Similarity=0.276 Sum_probs=141.4
Q ss_pred HHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 001057 801 AVESILAERNILISVRNPFVVRFFYSFTCRE----NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876 (1170)
Q Consensus 801 ~ve~~l~EieILskL~HPNIVrL~~~Fqd~~----~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs 876 (1170)
.+.....|...+.++.|+|++.++.+..... .+.+..+||.+-++...+...+.++.+.++.+..++++||.|+|+
T Consensus 225 ~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 225 EIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3444556777788899999999987765433 234556899999999999999999999999999999999999999
Q ss_pred CCeeeccCCCC---cEEeCCCCcEEEE--ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCC
Q 001057 877 LNVIHRDLKPD---NLLIGQDGHIKLT--DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGT 951 (1170)
Q Consensus 877 ~GIIHRDIKPE---NILLd~dG~VKLs--DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGT 951 (1170)
....|.-+.-. +...+..+.+..+ ||+..+... ......+..-.
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~-------------------------------d~~~~~~~~~~ 353 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLP-------------------------------DNEKSFSDLLA 353 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCC-------------------------------CcccchhhcCc
Confidence 85555444333 3333445556555 777665321 00111122345
Q ss_pred CCCCchHHHhcCCCCcc--hhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCC
Q 001057 952 PDYLAPEILLGMGHGAT--ADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTEN 1029 (1170)
Q Consensus 952 p~YmAPEVL~g~~ys~k--sDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~D 1029 (1170)
..+.|||......+..+ .|+|.+|..+..+..|..+-.-. .....+ ++.....+..+++.+|+.-+
T Consensus 354 ~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~---------l~~~~~~~~~d~~~~~~~~~ 421 (1351)
T KOG1035|consen 354 EIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSL---------LDVLSTSELLDALPKCLDED 421 (1351)
T ss_pred cccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhh---------hccccchhhhhhhhhhcchh
Confidence 56788888877666555 69999999999998875442110 000111 11122226788999999999
Q ss_pred CCCCCChhhHHHHHcCCCCCCC
Q 001057 1030 PVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1030 PskRpSa~~AeEILqHPfF~~i 1051 (1170)
+++|++ +.+++.|+|.+.-
T Consensus 422 ~~~Rl~---~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 422 SEERLS---ALELLTHPFLRFP 440 (1351)
T ss_pred hhhccc---hhhhhhchhcccc
Confidence 999999 8899999998643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.7e-05 Score=82.09 Aligned_cols=134 Identities=16% Similarity=0.150 Sum_probs=82.6
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc--EEEEEeeeecccceEEEEeecc
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF--VVRFFYSFTCRENLYLVMEYLN 841 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN--IVrL~~~Fqd~~~LyLVMEY~~ 841 (1170)
..||.|..+.||+. .|..+++|...... ....+.+|.+++..+..-. +.+.+++..+.+.+.+|||++.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999974 24457789876422 2234678999998876433 4566666667777889999998
Q ss_pred CCC-hH--------------HHH----HhcCCC-----CH-HHHHHHHH----------HHHH-HHHHHHh----CCeee
Q 001057 842 GGD-LY--------------SLL----RNLGCL-----DE-DMARVYIA----------ELVL-ALEYLHS----LNVIH 881 (1170)
Q Consensus 842 GGS-L~--------------dlL----k~~~~L-----SE-e~ar~Iaa----------QIL~-ALeYLHs----~GIIH 881 (1170)
|.+ +. ..+ .+...+ .. .....+.. .+.. ...+|.. ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 864 11 111 000111 10 00011100 1111 1222321 24789
Q ss_pred ccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 882 RDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 882 RDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
+|+.|.||+++.++ +.++||+.|..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.93 E-value=4.5e-05 Score=92.28 Aligned_cols=138 Identities=23% Similarity=0.354 Sum_probs=87.5
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccc--------------------------c-HHHH----H------HHH
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMI--------------------------R-KNAV----E------SIL 806 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~--------------------------~-~~~v----e------~~l 806 (1170)
..|+.++-|+||.|+.+ +|+.||||+.+..-.. + ...+ + .+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56999999999999975 5999999987542100 0 0001 1 233
Q ss_pred HHHHHHHhcC-----CCcE--EEEEeeeecccceEEEEeeccCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 001057 807 AERNILISVR-----NPFV--VRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDMARVYIAELVLALEYLHSL 877 (1170)
Q Consensus 807 ~EieILskL~-----HPNI--VrL~~~Fqd~~~LyLVMEY~~GGSL~dlL--k~~~~LSEe~ar~IaaQIL~ALeYLHs~ 877 (1170)
+|..-+.++. .|+| .++|. +-...-.|+|||+.|-.+.+.. +. ..++...+.....++ -+.-+=..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~w--e~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYW--EYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeeh--hccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhc
Confidence 4444444432 3433 33432 2234457999999998888874 44 334432222211111 12223358
Q ss_pred CeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 878 GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
|++|.|.+|.||+++.+|.+.+.|||+...
T Consensus 285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 285 GFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred CccccCCCccceEEecCCcEEEEcCcceec
Confidence 999999999999999999999999998764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.0001 Score=79.50 Aligned_cols=134 Identities=17% Similarity=0.132 Sum_probs=81.4
Q ss_pred eccCCC-eEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEEEEeeccCC
Q 001057 766 ISQGAF-GRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGG 843 (1170)
Q Consensus 766 LG~GgF-GtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyLVMEY~~GG 843 (1170)
|-.|.. ..||++... +..+.+|+..... ...+.+|+.++..+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 789988653 4678888765432 234567888887774 334567777776666789999999987
Q ss_pred ChHHHH----------------HhcCCCCH-------H------HHHHHHH----------------HHHHHHHHHH---
Q 001057 844 DLYSLL----------------RNLGCLDE-------D------MARVYIA----------------ELVLALEYLH--- 875 (1170)
Q Consensus 844 SL~dlL----------------k~~~~LSE-------e------~ar~Iaa----------------QIL~ALeYLH--- 875 (1170)
+|.... .+...++. . .....+. .+...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 765331 11111110 0 0000000 0111122221
Q ss_pred ----hCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 876 ----SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 876 ----s~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
...++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 22489999999999999887789999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PRK10402 DNA-binding transcriptional activator YeiL; Provisional | Back alignment and domain information |
|---|
Probab=97.85 E-value=9.3e-06 Score=87.32 Aligned_cols=84 Identities=7% Similarity=-0.018 Sum_probs=73.1
Q ss_pred cccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---hhcccccccCCCcccccC
Q 001057 554 DLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 554 ~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ld 625 (1170)
......+||..+.+|||..+++|+|.+|.|.++. +|+ .+..+.+|+.||+.+++ |+.++|.|.+++.+|.++
T Consensus 31 ~~~~~~~kge~l~~~G~~~~~~y~V~~G~v~v~~~~~~G~e~~~~~~~~g~~~G~~~~~~~~~~~~~~~A~~~~~i~~i~ 110 (226)
T PRK10402 31 TELFHFLAREYIVQEGQQPSYLFYLTRGRAKLYATLANGKVSLIDFFAAPCFIGEIELIDKDHETKAVQAIEECWCLALP 110 (226)
T ss_pred hhheeeCCCCEEEcCCCCCceEEEEEeCEEEEEEECCCCCEeeeeecCCCCeEEeehhhcCCCCCccEEEeccEEEEEEE
Confidence 3455789999999999999999999999999986 564 47789999999999987 999999999999999999
Q ss_pred CchhhhhhhhhhhhhccCCC
Q 001057 626 RTSQIELLVNGHRTITELQN 645 (1170)
Q Consensus 626 R~~~~~~~~~tfr~Il~~~~ 645 (1170)
+ ..|+.++..+.
T Consensus 111 ~--------~~~~~ll~~~p 122 (226)
T PRK10402 111 M--------KDCRPLLLNDA 122 (226)
T ss_pred H--------HHHHHHHhcCH
Confidence 9 78877775543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00032 Score=75.88 Aligned_cols=128 Identities=23% Similarity=0.346 Sum_probs=89.6
Q ss_pred CCeEEEEEeccCCC-eEEEEeeecCCCCEEEEEEeeccc----------cccH--------HHHHHHHHHHHHHHhcC--
Q 001057 758 EDFEIIKPISQGAF-GRVFLARKRATGDLFAIKVLKKAD----------MIRK--------NAVESILAERNILISVR-- 816 (1170)
Q Consensus 758 edYevlk~LG~GgF-GtVyLArdk~TGe~VAIKvLkKs~----------i~~~--------~~ve~~l~EieILskL~-- 816 (1170)
.+++.++.||.|.. |.||+++. .|+.||||++..-. .... ....-|..|-....+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 99999975 58899999933210 0000 12234566666655554
Q ss_pred -CCcE--EEEEeeeecc------------------cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 001057 817 -NPFV--VRFFYSFTCR------------------ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875 (1170)
Q Consensus 817 -HPNI--VrL~~~Fqd~------------------~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLH 875 (1170)
+.++ |+.|+++.-. ....||.||++... .++. .-+.+|+.-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4556 8888887322 12467888886543 1222 23557888889999
Q ss_pred hCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 876 s~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
..||+-+|+++.|.. + -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---C--CEEEecccC
Confidence 999999999999987 3 389999964
|
|
| >PRK09392 ftrB transcriptional activator FtrB; Provisional | Back alignment and domain information |
|---|
Probab=97.82 E-value=1.4e-05 Score=85.88 Aligned_cols=83 Identities=17% Similarity=0.013 Sum_probs=71.9
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEEc--C--ccccccCCCCCchHhhhh---hhcccccccCCCcccccCCch
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED--L--NVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTS 628 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~--~--~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~ 628 (1170)
-...+||..|.+|||..+++|+|-+|.+.++.. | ..+..+.+|+.||+.+++ |+.++|.|.++|.+|.+++
T Consensus 32 ~~~~~~ge~l~~~g~~~~~~~~v~~G~v~~~~~~~~~~~~i~~~~~g~~~g~~~~~~~~~~~~~~~A~~~~~~~~i~~-- 109 (236)
T PRK09392 32 LQRFPPGTMLITEGEPADFLFVVLDGLVELSASSQDRETTLAILRPVSTFILAAVVLDAPYLMSARTLTRSRVLMIPA-- 109 (236)
T ss_pred eeecCCCCEEEeCCCccceEEEEEeCEEEEEEcCCCceEEEEEeCCCchhhhHHHhCCCCCceEEEEcCceEEEEEeH--
Confidence 356789999999999999999999999999852 2 347788999999999987 9999999999999999999
Q ss_pred hhhhhhhhhhhhccCCCH
Q 001057 629 QIELLVNGHRTITELQNP 646 (1170)
Q Consensus 629 ~~~~~~~tfr~Il~~~~~ 646 (1170)
..|+.++..+..
T Consensus 110 ------~~~~~l~~~~p~ 121 (236)
T PRK09392 110 ------ELVREAMSEDPG 121 (236)
T ss_pred ------HHHHHHHHHCHH
Confidence 888887765443
|
|
| >PRK11753 DNA-binding transcriptional dual regulator Crp; Provisional | Back alignment and domain information |
|---|
Probab=97.81 E-value=1.1e-05 Score=84.61 Aligned_cols=80 Identities=10% Similarity=0.019 Sum_probs=69.6
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh----hhcccccccCCCcccccCC
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA----AKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~----pRAATv~A~t~~~lw~ldR 626 (1170)
....+||..+.+||+..+++|+|.+|.+.++. +|+ .+..+.+|+.||+.+++ +.++++.|.++|.+|.+++
T Consensus 22 ~~~~~kg~~l~~~g~~~~~~y~V~~G~v~~~~~~~~g~~~~~~~~~~g~~~g~~~~~~~~~~~~~~~~a~~~~~v~~i~~ 101 (211)
T PRK11753 22 IHKYPAKSTLIHAGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISY 101 (211)
T ss_pred EEEeCCCCEEEeCCCCCCeEEEEEeCEEEEEEECCCCCEEEEEEcCCCCEEeehhhccCCCCceEEEEEcCcEEEEEEcH
Confidence 45789999999999999999999999999885 344 46689999999999887 5678999999999999999
Q ss_pred chhhhhhhhhhhhhccC
Q 001057 627 TSQIELLVNGHRTITEL 643 (1170)
Q Consensus 627 ~~~~~~~~~tfr~Il~~ 643 (1170)
..|..+++.
T Consensus 102 --------~~~~~l~~~ 110 (211)
T PRK11753 102 --------KKFRQLIQV 110 (211)
T ss_pred --------HHHHHHHHH
Confidence 788877664
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=5.6e-06 Score=106.61 Aligned_cols=253 Identities=19% Similarity=0.110 Sum_probs=166.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--cc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI--RKNAVESILAERNILISVRNPFVVRFFYSFTCR--EN 832 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~--~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~~ 832 (1170)
..+|++.--+|-|.+++--.-+.+.. .+.+|+.+..... .+-..+....|++-++...|++++..+.-.... ..
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 45566666666665554322222211 2455665443221 122345566777777788999998877555443 34
Q ss_pred eEEEEeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC-C----eeeccCCCCcEEeCCCCcEEEEecC
Q 001057 833 LYLVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSL-N----VIHRDLKPDNLLIGQDGHIKLTDFG 903 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~-G----IIHRDIKPENILLd~dG~VKLsDFG 903 (1170)
.|.+|+|+.+|.++..|.+. ..+....+.....+.+.+..-+|+. | .+|++||+-|.+|..+..+|+.++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 78999999999999999654 2344444444444548888888854 2 6899999999999999999999999
Q ss_pred CccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh
Q 001057 904 LSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI 983 (1170)
Q Consensus 904 LAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT 983 (1170)
+.+... .........++++.|++|++.....++.+.|+|..|+-+|+.--
T Consensus 1386 LdKIkn------------------------------p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1386 LDKIKN------------------------------PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred cccccC------------------------------chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence 998310 11122345678999999999998889888999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhccCC---CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 984 GIPPFNAKTPQQIFDNIMNRDI---PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 984 G~pPF~g~~~~ei~qkIl~~~l---~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
|..+|.. ..+.++.+.+ .+..++.-.|.++-.....+|-..-..||+ ....+.-+.|.
T Consensus 1436 ~n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~---q~isls~d~~a 1496 (2724)
T KOG1826|consen 1436 GNAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPG---QYISLSRDHFA 1496 (2724)
T ss_pred ccHHHHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcch---hhhhccccccc
Confidence 9888743 2333333222 122233333455555666666667778887 44556666554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00035 Score=89.03 Aligned_cols=145 Identities=19% Similarity=0.374 Sum_probs=89.9
Q ss_pred EEEEeccCCCeEEEEeeecCCC--CEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcE--EEEEeeeecc---cce
Q 001057 762 IIKPISQGAFGRVFLARKRATG--DLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFV--VRFFYSFTCR---ENL 833 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TG--e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNI--VrL~~~Fqd~---~~L 833 (1170)
.++.|+.|.+..+|+......+ ..+++|+........ ....+.+|..+|..+. |++| .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3577899999999998765432 357777654322111 1245778999999985 6654 7777776654 467
Q ss_pred EEEEeeccCCChHH--------------------HHHhcCCCC----------------HHHHHHHHHH-----------
Q 001057 834 YLVMEYLNGGDLYS--------------------LLRNLGCLD----------------EDMARVYIAE----------- 866 (1170)
Q Consensus 834 yLVMEY~~GGSL~d--------------------lLk~~~~LS----------------Ee~ar~IaaQ----------- 866 (1170)
|+||||++|..+.+ .|.....++ ..++..+..+
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999998754321 111110110 1122221111
Q ss_pred ----HHHHHHHHHh-----------CCeeeccCCCCcEEeCCC-Cc-EEEEecCCcccc
Q 001057 867 ----LVLALEYLHS-----------LNVIHRDLKPDNLLIGQD-GH-IKLTDFGLSKVG 908 (1170)
Q Consensus 867 ----IL~ALeYLHs-----------~GIIHRDIKPENILLd~d-G~-VKLsDFGLAk~~ 908 (1170)
+...+.+|.. ..+||+|+++.|||++.+ +. +-|.||++|...
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2233556632 249999999999999853 33 579999998753
|
|
| >smart00100 cNMP Cyclic nucleotide-monophosphate binding domain | Back alignment and domain information |
|---|
Probab=97.70 E-value=2.1e-05 Score=72.25 Aligned_cols=81 Identities=12% Similarity=-0.016 Sum_probs=68.5
Q ss_pred CCCcccccccccCCCCCcceeecCCcEEEEEc---C--ccccccCCCCCchHhhhh-----hhcccccccCCCcccccCC
Q 001057 557 LMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED---L--NVLPEISCDKNPTAADIA-----AKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 557 ~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~---~--~~v~~~~~g~sFGELAL~-----pRAATv~A~t~~~lw~ldR 626 (1170)
...++|..+.+||+.-+++|+|.+|.+.++.. | ..+..+++|+.||+..++ |...++.+.+++.+|.+++
T Consensus 20 ~~~~~g~~l~~~g~~~~~~y~v~~G~v~~~~~~~~g~~~~~~~~~~g~~~g~~~~~~~~~~~~~~~~~~~~~~~v~~~~~ 99 (120)
T smart00100 20 VRYPAGEVIIRQGDVGDSFYIILSGEVRVYKVLEDGREQILGILGPGDFFGELALLTNSRRAASATAVALELATLLRIDF 99 (120)
T ss_pred EEeCCCCEEEeCCCcCCcEEEEEeeEEEEEEECCCCceEEEEeecCCceechhhhccCCCcccceEEEEEeeEEEEccCH
Confidence 45689999999999999999999999999863 3 368899999999999876 7788889999999999999
Q ss_pred chhhhhhhhhhhhhccCCC
Q 001057 627 TSQIELLVNGHRTITELQN 645 (1170)
Q Consensus 627 ~~~~~~~~~tfr~Il~~~~ 645 (1170)
..|..++....
T Consensus 100 --------~~~~~~~~~~~ 110 (120)
T smart00100 100 --------RDFLQLLQENP 110 (120)
T ss_pred --------HHHHHHHHHhH
Confidence 66666654433
|
Catabolite gene activator protein (CAP) is a prokaryotic homologue of eukaryotic cNMP-binding domains, present in ion channels, and cNMP-dependent kinases. |
| >TIGR03697 NtcA_cyano global nitrogen regulator NtcA, cyanobacterial | Back alignment and domain information |
|---|
Probab=97.69 E-value=2.3e-05 Score=81.02 Aligned_cols=77 Identities=8% Similarity=-0.071 Sum_probs=66.0
Q ss_pred cccccccCCCCCcceeecCCcEEEEE---cCcc--ccccCCCCCchHhhhh-----hhcccccccCCCcccccCCchhhh
Q 001057 562 QNSLSRQGSKEMLDHVPDDDNAFVIE---DLNV--LPEISCDKNPTAADIA-----AKTSSAGSLTPRSPLLTPRTSQIE 631 (1170)
Q Consensus 562 ~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~~--v~~~~~g~sFGELAL~-----pRAATv~A~t~~~lw~ldR~~~~~ 631 (1170)
|..+.+|||..+++|+|.+|.|.++. +|+. +..+++|+.||+.+++ ++.+++.|.++|.+|.+++
T Consensus 1 g~~l~~~g~~~~~~~~i~~G~v~~~~~~~~G~e~~l~~~~~g~~~G~~~~~~~~~~~~~~~~~A~~~~~v~~i~~----- 75 (193)
T TIGR03697 1 GKTIFFPGDPAEKVYFLRRGAVKLSRVYESGEEITVALLRENSVFGVLSLITGHRSDRFYHAVAFTRVELLAVPI----- 75 (193)
T ss_pred CCceecCCCCCCcEEEEEecEEEEEEeCCCCcEeeeEEccCCCEeeeeeeccCCCCccceEEEEecceEEEEeeH-----
Confidence 57889999999999999999999886 5654 6789999999999888 3567889999999999999
Q ss_pred hhhhhhhhhccCCCH
Q 001057 632 LLVNGHRTITELQNP 646 (1170)
Q Consensus 632 ~~~~tfr~Il~~~~~ 646 (1170)
..|+.++..+..
T Consensus 76 ---~~~~~l~~~~p~ 87 (193)
T TIGR03697 76 ---EQVEKAIEEDPD 87 (193)
T ss_pred ---HHHHHHHHHChH
Confidence 888888765443
|
Members of this protein family, found in the cyanobacteria, are the global nitrogen regulator NtcA. This DNA-binding transcriptional regulator is required for expressing many different ammonia-repressible genes. The consensus NtcA-binding site is G T A N(8)T A C. |
| >PRK13918 CRP/FNR family transcriptional regulator; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=3.8e-05 Score=80.27 Aligned_cols=74 Identities=8% Similarity=-0.121 Sum_probs=64.7
Q ss_pred ccccCCCcccccccccCC--CCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh--hhcccccccCCCcccc
Q 001057 553 DDLNLMSPKQNSLSRQGS--KEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA--AKTSSAGSLTPRSPLL 623 (1170)
Q Consensus 553 ~~~~~~~~k~~~~~~QGd--~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~--pRAATv~A~t~~~lw~ 623 (1170)
..+-..++||..+.+||| ..+.+|+|-+|.|.++. ||+ .+.-+.+|+.||+.++. |+.+++.|.+++.+|.
T Consensus 5 ~~~~~~~~kg~~l~~~Gd~~~~~~~y~I~~G~vr~~~~~~~G~e~~l~~~~~Gd~~G~~~~~~~~~~~~~~A~~~~~v~~ 84 (202)
T PRK13918 5 VVDTVTYRPGAVILYPGVPGPSDMLYRVRSGLVRLHTVDDEGNALTLRYVRPGEYFGEEALAGAERAYFAEAVTDSRIDV 84 (202)
T ss_pred ccceeEecCCCEEEcCCCCCCCCeEEEEEeeEEEEEEECCCCCEEEEEEecCCCeechHHhcCCCCCceEEEcCceEEEE
Confidence 445567899999999999 67999999999999986 465 46677999999997765 8999999999999999
Q ss_pred cCC
Q 001057 624 TPR 626 (1170)
Q Consensus 624 ldR 626 (1170)
+++
T Consensus 85 i~~ 87 (202)
T PRK13918 85 LNP 87 (202)
T ss_pred EEH
Confidence 998
|
|
| >KOG0498 consensus K+-channel ERG and related proteins, contain PAS/PAC sensor domain [Inorganic ion transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.58 E-value=3.2e-05 Score=96.04 Aligned_cols=71 Identities=10% Similarity=-0.115 Sum_probs=65.1
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEEcC----ccccccCCCCCch-Hh---hh-hhhcccccccCCCcccccCC
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL----NVLPEISCDKNPT-AA---DI-AAKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~----~~v~~~~~g~sFG-EL---AL-~pRAATv~A~t~~~lw~ldR 626 (1170)
.--+|+|++|+||||..+.+|+|-.|.+++...+ ..+..+++|+.|| || |+ +|.++||+|.|.|.+.+|.+
T Consensus 444 ~~~f~pge~iireGd~v~~myFI~rG~le~~~~~~g~~~~~~~L~~Gd~~GeEl~~~~~~~p~t~TVralt~~el~~L~~ 523 (727)
T KOG0498|consen 444 PEYFTPGEYIIREGDPVTDMYFIVRGSLESITTDGGGFFVVAILGPGDFFGEELLTWCLDLPQTRTVRALTYCELFRLSA 523 (727)
T ss_pred hhccCCCCeEEecCCccceeEEEEeeeEEEEEccCCceEEEEEecCCCccchHHHHHHhcCCCCceeehhhhhhHHhccH
Confidence 3457899999999999999999999999999877 7899999999999 65 44 48899999999999999999
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.0011 Score=71.48 Aligned_cols=133 Identities=22% Similarity=0.255 Sum_probs=91.3
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeecccc-------------ccHHHHHHHHHHHHHHHhcC------CCcEEEEE
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADM-------------IRKNAVESILAERNILISVR------NPFVVRFF 824 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i-------------~~~~~ve~~l~EieILskL~------HPNIVrL~ 824 (1170)
..||+|+.=.|| .++.+ ....||++..... ..........+|+.-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy--~HP~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCY--QHPDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEE--ECCCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 469999999999 44433 3356898876540 00112344555555544444 78999999
Q ss_pred eeeecccceEEEEeeccC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---
Q 001057 825 YSFTCRENLYLVMEYLNG------GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG--- 895 (1170)
Q Consensus 825 ~~Fqd~~~LyLVMEY~~G------GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG--- 895 (1170)
++.+++..+-+|+|.+.. .+|.+++.+. .+++ .. ...+-.-..||-+++|+.+||+|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998743 3788888653 4665 32 33334456688899999999999999996432
Q ss_pred -cEEEEe-cCC
Q 001057 896 -HIKLTD-FGL 904 (1170)
Q Consensus 896 -~VKLsD-FGL 904 (1170)
.+.|+| ||-
T Consensus 159 ~~lvlIDG~G~ 169 (199)
T PF10707_consen 159 FRLVLIDGLGE 169 (199)
T ss_pred eEEEEEeCCCC
Confidence 577777 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00046 Score=74.47 Aligned_cols=74 Identities=16% Similarity=0.140 Sum_probs=45.2
Q ss_pred EEEeccCCCe-EEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC---cEEEEEeeeecc---cceEE
Q 001057 763 IKPISQGAFG-RVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP---FVVRFFYSFTCR---ENLYL 835 (1170)
Q Consensus 763 lk~LG~GgFG-tVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HP---NIVrL~~~Fqd~---~~LyL 835 (1170)
+..|+.||.. .||... ..+.+|+.... .....+.+|..+|..+... -+.++++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567777776 499752 24667865432 1234678899998877531 234444433332 23588
Q ss_pred EEeeccCCChH
Q 001057 836 VMEYLNGGDLY 846 (1170)
Q Consensus 836 VMEY~~GGSL~ 846 (1170)
||++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00057 Score=83.04 Aligned_cols=137 Identities=23% Similarity=0.361 Sum_probs=85.6
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH-----------------------------HHHH------HHHHH
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK-----------------------------NAVE------SILAE 808 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~-----------------------------~~ve------~~l~E 808 (1170)
+.||.-+.|.|+.|+.+. |+.||+|+-+.. +... +..+ .+.+|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 468999999999999875 999999986532 1110 0001 22333
Q ss_pred HHHHHh----cCCCc------EEEEEeeeecccceEEEEeeccCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 001057 809 RNILIS----VRNPF------VVRFFYSFTCRENLYLVMEYLNGGDLYSL--LRNLGCLDEDMARVYIAELVLALEYLHS 876 (1170)
Q Consensus 809 ieILsk----L~HPN------IVrL~~~Fqd~~~LyLVMEY~~GGSL~dl--Lk~~~~LSEe~ar~IaaQIL~ALeYLHs 876 (1170)
.+-..+ +.|-+ |.++|..+. ..-.|+||||.|..+.++ |.+. .++...+...+.+.. ++-|=.
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAY--LEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHH--HHHHHh
Confidence 333222 23434 555553332 345799999999876654 4443 355543333222221 112235
Q ss_pred CCeeeccCCCCcEEeCC----CCcEEEEecCCccc
Q 001057 877 LNVIHRDLKPDNLLIGQ----DGHIKLTDFGLSKV 907 (1170)
Q Consensus 877 ~GIIHRDIKPENILLd~----dG~VKLsDFGLAk~ 907 (1170)
.|++|.|=+|.||+++. ++.+.+-|||+...
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 68999999999999984 56899999999875
|
|
| >PRK09391 fixK transcriptional regulator FixK; Provisional | Back alignment and domain information |
|---|
Probab=97.46 E-value=8.6e-05 Score=80.34 Aligned_cols=83 Identities=7% Similarity=-0.079 Sum_probs=70.6
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhhhhcccccccCCCcccccCCchh
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIAAKTSSAGSLTPRSPLLTPRTSQ 629 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~pRAATv~A~t~~~lw~ldR~~~ 629 (1170)
....++||..+.+|||..+++|+|.+|.|.++. +|+ .+.-+.+|+.||+.+..|+..++.|++++.+|.+++
T Consensus 39 ~~~~~~kge~l~~~Gd~~~~ly~I~~G~vkl~~~~~~G~e~i~~~~~~Gd~fG~~~~~~~~~~~~A~~ds~v~~i~~--- 115 (230)
T PRK09391 39 SEFSYKKGEEIYGEGEPADYVYQVESGAVRTYRLLSDGRRQIGAFHLPGDVFGLESGSTHRFTAEAIVDTTVRLIKR--- 115 (230)
T ss_pred eeEEECCCCEEECCCCCCCeEEEEEeCEEEEEEECCCCcEEEEEEecCCceecccCCCcCCeEEEEcCceEEEEEEH---
Confidence 446789999999999999999999999999986 565 355678999999876668899999999999999999
Q ss_pred hhhhhhhhhhhccCCC
Q 001057 630 IELLVNGHRTITELQN 645 (1170)
Q Consensus 630 ~~~~~~tfr~Il~~~~ 645 (1170)
..|+.++..+.
T Consensus 116 -----~~f~~l~~~~p 126 (230)
T PRK09391 116 -----RSLEQAAATDV 126 (230)
T ss_pred -----HHHHHHHhhCh
Confidence 77777766543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00079 Score=71.77 Aligned_cols=130 Identities=22% Similarity=0.315 Sum_probs=90.8
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEE-EEEeeeecccceEEEEe
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVV-RFFYSFTCRENLYLVME 838 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIV-rL~~~Fqd~~~LyLVME 838 (1170)
-++.+.||+|.+|.||+|.+. |..+|+|+-+.. .-...+..|.++|..+.--++- ++|.+..+ ++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d-----s~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD-----SPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCC-----cchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 356678999999999999864 678999985543 2335678899999998876663 45544332 45699
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCC-CCcEEeCCCCcEEEEecCCccc
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLK-PDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIK-PENILLd~dG~VKLsDFGLAk~ 907 (1170)
|+.|-.|...-... +.. -+..++.+---|-..||-|..|. |..++|-.++.+.|+||..|+.
T Consensus 93 ~i~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 93 YIDGRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhcCcchhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 99998887755421 222 22345555444667899999886 5555555566999999999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.002 Score=68.88 Aligned_cols=137 Identities=18% Similarity=0.241 Sum_probs=80.0
Q ss_pred EEEeccCCCeEEEEeeecC-CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CcEEEEEeeeecccceEEEEeec
Q 001057 763 IKPISQGAFGRVFLARKRA-TGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFFYSFTCRENLYLVMEYL 840 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~-TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H-PNIVrL~~~Fqd~~~LyLVMEY~ 840 (1170)
++.|..|-...||++.... .++.|.+|+...... ......+|..++..+.. ...+++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888888999987543 356788997654211 11123468888887753 234455544332 3799999
Q ss_pred cCCChHHH--------------HHhc---C-CCC-----------HHHHHHHHHH----------------------HH-
Q 001057 841 NGGDLYSL--------------LRNL---G-CLD-----------EDMARVYIAE----------------------LV- 868 (1170)
Q Consensus 841 ~GGSL~dl--------------Lk~~---~-~LS-----------Ee~ar~IaaQ----------------------IL- 868 (1170)
+|.++... +.+. . ... .+.+..+... +.
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98765211 1110 0 110 1121122111 11
Q ss_pred --HHHH-HHH----hCCeeeccCCCCcEEeCC-CCcEEEEecCCccc
Q 001057 869 --LALE-YLH----SLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKV 907 (1170)
Q Consensus 869 --~ALe-YLH----s~GIIHRDIKPENILLd~-dG~VKLsDFGLAk~ 907 (1170)
..|. .+- ..+++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1111 111 235899999999999997 57899999998874
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.0017 Score=69.06 Aligned_cols=98 Identities=24% Similarity=0.277 Sum_probs=78.5
Q ss_pred HHHHHHHHhcCC-CcEEEEEeeeecccceEEEEeeccCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 001057 806 LAERNILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSL---LRNLGCLDEDMARVYIAELVLALEYLHS---LN 878 (1170)
Q Consensus 806 l~EieILskL~H-PNIVrL~~~Fqd~~~LyLVMEY~~GGSL~dl---Lk~~~~LSEe~ar~IaaQIL~ALeYLHs---~G 878 (1170)
..|.-+|..+.+ +++++++|++-. ++|.||...+++... +...-..++.....++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888888886 699999998843 568999987766421 2222346888999999999999999997 34
Q ss_pred eeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 879 IIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
+.-.|++|+|+-++.+|++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 77799999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0095 Score=67.47 Aligned_cols=78 Identities=13% Similarity=0.058 Sum_probs=53.9
Q ss_pred EEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC---CcEEEEEeeeec---ccceE
Q 001057 761 EIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN---PFVVRFFYSFTC---RENLY 834 (1170)
Q Consensus 761 evlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H---PNIVrL~~~Fqd---~~~Ly 834 (1170)
.-.+.||.|..+.||..... ++ .+.+|..+.. .....+..|...|+.+.- ..+.++++++.+ .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34567999999999987542 23 4667774321 112467889999988753 356777766644 35689
Q ss_pred EEEeeccCCCh
Q 001057 835 LVMEYLNGGDL 845 (1170)
Q Consensus 835 LVMEY~~GGSL 845 (1170)
||||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998765
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.015 Score=68.96 Aligned_cols=80 Identities=18% Similarity=0.142 Sum_probs=53.6
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeecccc-c-c--HHHHHHHHHHHHHHHhcC---CCcEEEEEeeeecccceEE
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADM-I-R--KNAVESILAERNILISVR---NPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i-~-~--~~~ve~~l~EieILskL~---HPNIVrL~~~Fqd~~~LyL 835 (1170)
.+.||.|.+..||.+.....++.|.||.-..... . . .-..++...|.+.|..+. -.++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999864445899997431100 0 0 123456677888887753 2457777755 4466789
Q ss_pred EEeeccCCC
Q 001057 836 VMEYLNGGD 844 (1170)
Q Consensus 836 VMEY~~GGS 844 (1170)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999997643
|
|
| >PLN02868 acyl-CoA thioesterase family protein | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.00054 Score=80.73 Aligned_cols=71 Identities=10% Similarity=-0.090 Sum_probs=62.8
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEEc---C-ccccccCCCCCchHhhhh--hhcccccccCCCcccccCC
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED---L-NVLPEISCDKNPTAADIA--AKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~---~-~~v~~~~~g~sFGELAL~--pRAATv~A~t~~~lw~ldR 626 (1170)
.-...+||..|+++||..+.+|+|-+|.|.++.. | ..+..+++|+.||+. +. ++.+++.|.+++.+|.+++
T Consensus 32 ~~~~~~~Ge~I~~~Gd~~~~lyiI~~G~V~v~~~~~~ge~~l~~l~~Gd~fG~~-l~~~~~~~~~~A~~d~~v~~ip~ 108 (413)
T PLN02868 32 VPKRYGKGEYVVREGEPGDGLYFIWKGEAEVSGPAEEESRPEFLLKRYDYFGYG-LSGSVHSADVVAVSELTCLVLPH 108 (413)
T ss_pred eEEEECCCCEEEeCCCcCceEEEEEeCEEEEEEECCCCcEEEEEeCCCCEeehh-hCCCCcccEEEECCCEEEEEEcH
Confidence 3467899999999999999999999999999873 3 346778999999985 44 9999999999999999999
|
|
| >PRK11161 fumarate/nitrate reduction transcriptional regulator; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0008 Score=72.31 Aligned_cols=77 Identities=10% Similarity=-0.092 Sum_probs=63.4
Q ss_pred CCcccccccccCCCCCcceeecCCcEEEEE---cCcc--ccccCCCCCchHhhhh--hhcccccccCCCcccccCCchhh
Q 001057 558 MSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLNV--LPEISCDKNPTAADIA--AKTSSAGSLTPRSPLLTPRTSQI 630 (1170)
Q Consensus 558 ~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~~--v~~~~~g~sFGELAL~--pRAATv~A~t~~~lw~ldR~~~~ 630 (1170)
..+||..+.++||..+++|+|.+|.+.++. ||+. +.-+.+|+-||+.++. +..+++.|.+++.++.+++
T Consensus 41 ~~~kge~l~~~Gd~~~~ly~v~~G~v~~~~~~~~G~e~i~~~~~~gd~~g~~~~~~~~~~~~~~a~~~~~i~~ip~---- 116 (235)
T PRK11161 41 PIQKGQTLFKAGDELKSLYAIRSGTIKSYTITEQGDEQITGFHLAGDLVGFDAIGSGQHPSFAQALETSMVCEIPF---- 116 (235)
T ss_pred eecCCCEeECCCCCcceEEEEeeceEEEEEECCCCCEEEEEeccCCceeccccccCCCCcceEEEeccEEEEEEEH----
Confidence 578999999999999999999999999986 3543 5567899999986665 4445789999999999999
Q ss_pred hhhhhhhhhhcc
Q 001057 631 ELLVNGHRTITE 642 (1170)
Q Consensus 631 ~~~~~tfr~Il~ 642 (1170)
..|+.++.
T Consensus 117 ----~~f~~l~~ 124 (235)
T PRK11161 117 ----ETLDDLSG 124 (235)
T ss_pred ----HHHHHHHH
Confidence 66666554
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0065 Score=67.78 Aligned_cols=76 Identities=12% Similarity=0.101 Sum_probs=47.0
Q ss_pred EEEeccCCCeEEEEeeecC------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeecccceEE
Q 001057 763 IKPISQGAFGRVFLARKRA------TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF-VVRFFYSFTCRENLYL 835 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN-IVrL~~~Fqd~~~LyL 835 (1170)
++.|..|-...||++.... +++.|++|+..... .......+|..++..+...+ ..++++.+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3456667777888886533 35789999866532 11234567888887775322 3455555542 35
Q ss_pred EEeeccCCChH
Q 001057 836 VMEYLNGGDLY 846 (1170)
Q Consensus 836 VMEY~~GGSL~ 846 (1170)
||||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0097 Score=65.03 Aligned_cols=132 Identities=20% Similarity=0.225 Sum_probs=74.9
Q ss_pred eccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE-EEEEeeeecccceEEEEeeccCCC
Q 001057 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV-VRFFYSFTCRENLYLVMEYLNGGD 844 (1170)
Q Consensus 766 LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNI-VrL~~~Fqd~~~LyLVMEY~~GGS 844 (1170)
+..|-.+.+|+.. .+++.|++|+....... ..-...+|..++..+....+ .++++.+. -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~---~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA---LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccc---ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4567777889876 45667888875432110 00123568888887764322 33443332 268999999866
Q ss_pred hHH--------------HHHhcC-------CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCeeeccCC
Q 001057 845 LYS--------------LLRNLG-------CLDE-DMARVYIAEL---------VLALEYLHS--------LNVIHRDLK 885 (1170)
Q Consensus 845 L~d--------------lLk~~~-------~LSE-e~ar~IaaQI---------L~ALeYLHs--------~GIIHRDIK 885 (1170)
+.. .+.+.. .++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 531 111111 1111 1222222121 111222211 248999999
Q ss_pred CCcEEeCCCCcEEEEecCCccc
Q 001057 886 PDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 886 PENILLd~dG~VKLsDFGLAk~ 907 (1170)
|.|||++.++ +.|+||+.|..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999877 78999999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.017 Score=64.11 Aligned_cols=138 Identities=20% Similarity=0.163 Sum_probs=81.8
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--cEEEEEee------eecccce
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP--FVVRFFYS------FTCRENL 833 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HP--NIVrL~~~------Fqd~~~L 833 (1170)
-++.|..|....+|++.. .+..+++|+.... ....+..|+.++..+.+. .+.+++.. ....+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 356787888889998864 3446889987541 123455677777766432 24444321 1234567
Q ss_pred EEEEeeccCCChHH----HH----------Hhc-CCCCH--------HHHH------------HHHHHHHHHHHHHHh--
Q 001057 834 YLVMEYLNGGDLYS----LL----------RNL-GCLDE--------DMAR------------VYIAELVLALEYLHS-- 876 (1170)
Q Consensus 834 yLVMEY~~GGSL~d----lL----------k~~-~~LSE--------e~ar------------~IaaQIL~ALeYLHs-- 876 (1170)
++||+|++|..+.. .+ +.. ..+.. .... .....+..++.++-+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999998876421 11 100 00100 0000 011122334445443
Q ss_pred -----CCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 877 -----LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 877 -----~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
.+++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999877779999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.034 Score=62.60 Aligned_cols=31 Identities=35% Similarity=0.379 Sum_probs=26.6
Q ss_pred CCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 877 ~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
.++||+|+.|.|||++.+...-|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999998665568999999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.03 Score=63.11 Aligned_cols=141 Identities=23% Similarity=0.244 Sum_probs=81.3
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--cEEEEEee------eeccc
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP--FVVRFFYS------FTCRE 831 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HP--NIVrL~~~------Fqd~~ 831 (1170)
...++.++.|....||++.. .+| .+.+|+..... ....+..|..++..|... .+.+++.. ....+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 44567788888889998864 344 57789765421 122344566666666421 13343321 11235
Q ss_pred ceEEEEeeccCCChH-----------HHH---Hhc-CCCC--------HHH-----HH----------HHHHHHHHHHHH
Q 001057 832 NLYLVMEYLNGGDLY-----------SLL---RNL-GCLD--------EDM-----AR----------VYIAELVLALEY 873 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~-----------dlL---k~~-~~LS--------Ee~-----ar----------~IaaQIL~ALeY 873 (1170)
..++||+|++|..+. ..+ +.. ..++ ... .. .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999885431 111 110 0110 000 00 001123345555
Q ss_pred HHh-------CCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 874 LHS-------LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 874 LHs-------~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
+.. .+++|+|+++.||+++.++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 542 5799999999999999888778999998864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.46 E-value=0.019 Score=67.26 Aligned_cols=141 Identities=27% Similarity=0.260 Sum_probs=92.2
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHH-----------------------HHHHHHHHHHHHHhcCCC
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKN-----------------------AVESILAERNILISVRNP 818 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~-----------------------~ve~~l~EieILskL~HP 818 (1170)
+-.+|..|--+.||.|.. .+|..+|||+++.+-+.-.. ..-....|..-|.+++..
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345788999999999985 57888999998753221110 111234466667666543
Q ss_pred cEEEEEeeeecccceEEEEeeccCCChHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCCCcEEeCCCCc
Q 001057 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSL-LRNLGCLDEDMARVYIAELVLALEYLH-SLNVIHRDLKPDNLLIGQDGH 896 (1170)
Q Consensus 819 NIVrL~~~Fqd~~~LyLVMEY~~GGSL~dl-Lk~~~~LSEe~ar~IaaQIL~ALeYLH-s~GIIHRDIKPENILLd~dG~ 896 (1170)
.|.--- ...- ..-.|||+|+. .+=+-. .-+.-.++...++.+-.|++.-+.-|. ..++||.||.--|+|+ .+|.
T Consensus 227 GIP~Pe-PIlL-k~hVLVM~FlG-rdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 227 GIPCPE-PILL-KNHVLVMEFLG-RDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred CCCCCC-ceee-ecceEeeeecc-CCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 322100 0000 12368999995 332211 112235777788888888888887765 5699999999999999 6889
Q ss_pred EEEEecCCccc
Q 001057 897 IKLTDFGLSKV 907 (1170)
Q Consensus 897 VKLsDFGLAk~ 907 (1170)
+.++|-+-+..
T Consensus 303 lyiIDVSQSVE 313 (520)
T KOG2270|consen 303 LYIIDVSQSVE 313 (520)
T ss_pred EEEEEcccccc
Confidence 99999987653
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.0037 Score=71.96 Aligned_cols=136 Identities=16% Similarity=0.190 Sum_probs=93.5
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH-------------------HHHHHHHHHHHHHHhcC-CCc
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK-------------------NAVESILAERNILISVR-NPF 819 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~-------------------~~ve~~l~EieILskL~-HPN 819 (1170)
|.+...||-|--+-||++-+ ..|.++++|+=+-....-. -..-...+|...|+.|. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 67788999999999999987 4688899985321110000 01123456777777775 332
Q ss_pred -EEEEEeeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEE
Q 001057 820 -VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 820 -IVrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VK 898 (1170)
|.+.+ +.+.-|+|||++.|-.|...-+-. .+..+...++.-|--|-.+|+||+|..--||+++.++.++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v~------d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHVE------DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeecC------ChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 22222 234568999999998877654321 1233445566667778999999999999999999999999
Q ss_pred EEecCCcc
Q 001057 899 LTDFGLSK 906 (1170)
Q Consensus 899 LsDFGLAk 906 (1170)
++||--+.
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99997654
|
|
| >KOG0499 consensus Cyclic nucleotide-gated cation channel CNCG4 [Inorganic ion transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.0031 Score=75.92 Aligned_cols=70 Identities=9% Similarity=0.043 Sum_probs=62.9
Q ss_pred CCCcccccccccCCCCCcceeecCCcEEEEE--cC-ccccccCCCCCchHhhhh------hhcccccccCCCcccccCC
Q 001057 557 LMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE--DL-NVLPEISCDKNPTAADIA------AKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 557 ~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~--~~-~~v~~~~~g~sFGELAL~------pRAATv~A~t~~~lw~ldR 626 (1170)
..+=.|..+-+-|+.|-.+|||..|.|.|+= +| +.+-|+..|+.|||+.|+ -|||.|+|..=+.|+.||.
T Consensus 553 V~yLPgDfVCkKGeiGkEMYIIk~GqvQVlGGp~~~~Vl~tL~~GsVFGEISLLaigG~nRRTAnV~a~Gf~nLfvL~K 631 (815)
T KOG0499|consen 553 VLYLPGDFVCKKGEIGKEMYIIKHGQVQVLGGPDGTKVLVTLKAGSVFGEISLLAIGGGNRRTANVVAHGFANLFVLDK 631 (815)
T ss_pred eeecCCceeeecccccceeEEeecceEEEecCCCCCEEEEEecccceeeeeeeeeecCCCccchhhhhcccceeeEecH
Confidence 3455688999999999999999999999983 33 668899999999999998 8999999999999999999
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.047 Score=64.11 Aligned_cols=76 Identities=21% Similarity=0.176 Sum_probs=48.2
Q ss_pred EeccCCCeEEEEeeecCCCCEEEEEEeeccc-c---ccHHHHHHHHHHHHHHHhcC--CC-cEEEEEeeeecccceEEEE
Q 001057 765 PISQGAFGRVFLARKRATGDLFAIKVLKKAD-M---IRKNAVESILAERNILISVR--NP-FVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 765 ~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~-i---~~~~~ve~~l~EieILskL~--HP-NIVrL~~~Fqd~~~LyLVM 837 (1170)
.||.|....||++.....++.|+||.-.... . .-.-..++...|...|.... .| .++++| +.+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy--~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF--HFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE--EEccccceehH
Confidence 5899999999999976444678898532110 0 01223345567888886654 34 455565 34455667899
Q ss_pred eeccC
Q 001057 838 EYLNG 842 (1170)
Q Consensus 838 EY~~G 842 (1170)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.05 Score=62.97 Aligned_cols=137 Identities=17% Similarity=0.227 Sum_probs=78.2
Q ss_pred EEEeccCCCeEEEEeeecC----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE-EEEEeeeecccceEEEE
Q 001057 763 IKPISQGAFGRVFLARKRA----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV-VRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNI-VrL~~~Fqd~~~LyLVM 837 (1170)
++.|-.|-.-.+|++.... +++.|.+|+..... ...+. -.+|..++..+..-++ .++++.|... .|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 3455558888899886432 34688999876532 11112 2467788777754333 3455555432 589
Q ss_pred eeccCCChHHH--------------HHhc---C----C-C-CHHHHHHHHHHH-----------------HHHHHHH---
Q 001057 838 EYLNGGDLYSL--------------LRNL---G----C-L-DEDMARVYIAEL-----------------VLALEYL--- 874 (1170)
Q Consensus 838 EY~~GGSL~dl--------------Lk~~---~----~-L-SEe~ar~IaaQI-----------------L~ALeYL--- 874 (1170)
+|++|.+|... +.+. . . + ..+.+..+..++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665311 1110 1 0 1 112232332221 1111111
Q ss_pred -H----hCCeeeccCCCCcEEeCC-CCcEEEEecCCccc
Q 001057 875 -H----SLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKV 907 (1170)
Q Consensus 875 -H----s~GIIHRDIKPENILLd~-dG~VKLsDFGLAk~ 907 (1170)
. ...++|+|+++.|||++. ++.+.|+||..|..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999986 46899999999874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1170 | ||||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-61 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-60 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-60 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-59 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-59 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-59 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-59 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-59 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-59 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-59 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-59 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-59 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-59 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-59 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-58 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-58 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-58 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-58 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-58 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-58 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-58 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-58 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-58 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-58 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-58 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-58 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-58 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-58 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-58 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-58 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-58 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-58 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-58 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-58 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-58 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-58 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-58 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-58 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-58 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-58 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-58 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-58 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-58 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-58 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-58 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-58 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-58 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-58 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-58 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-58 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-57 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-57 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-57 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-57 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-57 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-57 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-57 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-57 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-57 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-57 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-57 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-57 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-57 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-57 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-56 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-56 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-56 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-56 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-56 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-56 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-56 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-56 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-56 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-56 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-56 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-56 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-55 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-55 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-55 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-55 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-55 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-54 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-54 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-54 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-54 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-53 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-52 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-52 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-52 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-52 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-52 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-52 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-51 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-51 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-51 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-51 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-51 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-51 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-51 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-51 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-51 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-51 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-51 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-51 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-51 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-51 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-51 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-51 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-50 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-50 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-50 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-47 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-46 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-45 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-45 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-45 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-45 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-45 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-45 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-45 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-45 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-45 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-45 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-45 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-45 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-45 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-45 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-45 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-45 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-44 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-44 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-44 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-44 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-44 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-44 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-44 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-44 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-44 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-44 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-44 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-44 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-44 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-44 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-44 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-44 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-44 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-43 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-43 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-40 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-40 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-40 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-40 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-37 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-35 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-35 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-35 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-34 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-34 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-34 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-34 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-34 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-34 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-34 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-34 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-34 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-34 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-32 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-32 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-32 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-32 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-32 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-31 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-31 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-31 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-31 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-31 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-31 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-31 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-31 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-31 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-31 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-31 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-30 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-30 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-30 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-30 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-30 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-30 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-30 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-30 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-30 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-30 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-30 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-30 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-29 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-29 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-29 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-29 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-29 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-29 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-29 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-29 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-29 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-28 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-28 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-28 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-28 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-28 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-28 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-28 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-28 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-28 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-28 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-28 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-28 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-28 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-28 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-28 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-27 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-27 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-27 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-27 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-27 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-27 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-27 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-27 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-27 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-27 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-27 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-27 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-27 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-27 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-27 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-27 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-27 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-27 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-26 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-26 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-26 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-26 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-26 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-26 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-25 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-25 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-25 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-25 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-25 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-25 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-25 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-25 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-25 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-25 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-25 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-25 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-25 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-25 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-25 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-25 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-24 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-24 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-24 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-24 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-24 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-24 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-24 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-24 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-24 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-24 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-24 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-23 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-23 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-23 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-23 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-23 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-23 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-23 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-23 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-23 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-23 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-23 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-23 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-23 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-23 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-23 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-23 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-23 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-23 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-23 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-23 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-23 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-23 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-23 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-23 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-23 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-23 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-23 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-23 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-23 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-23 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-23 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-23 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-23 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-22 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-22 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-22 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-22 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-22 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-22 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-21 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-21 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-21 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-21 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-21 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-21 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-21 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-21 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-21 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-21 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-21 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-21 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-21 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-21 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-21 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-21 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-21 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-21 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-21 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-21 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-21 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-21 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-21 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-21 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-21 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-21 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-21 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-21 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-21 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-21 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-21 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-20 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-20 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-20 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-20 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-20 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-20 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-20 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-20 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-19 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-19 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-19 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-19 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-18 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-18 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-18 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-18 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-18 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-18 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-18 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-18 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-18 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-18 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-18 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-17 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-17 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-17 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-17 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-17 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-17 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-17 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-16 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-16 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-15 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-15 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 7e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-14 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-14 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-14 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-14 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-13 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 5e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-10 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 6e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-09 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-09 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-09 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-09 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-09 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-09 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-09 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 8e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-09 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 8e-09 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-08 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 5e-08 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 5e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-08 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 9e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-07 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 2e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-07 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 3e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 8e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-07 |
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1170 | |||
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-139 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-132 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-132 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-131 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-127 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-127 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-127 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-127 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-126 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-125 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-124 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-124 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-123 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-122 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-121 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-121 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-121 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-120 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-118 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-110 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-110 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-108 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-104 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-104 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 4e-88 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-87 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 7e-87 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-86 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-85 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-84 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 9e-81 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-77 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 6e-73 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-73 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-72 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 2e-72 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-72 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-72 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-72 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-72 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-71 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-71 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 5e-71 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-70 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-70 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-70 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-70 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 7e-70 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 9e-70 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-69 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-69 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-69 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-69 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-68 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-68 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-68 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 3e-68 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-68 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-68 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 4e-67 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-67 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 8e-67 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 1e-66 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-66 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 2e-66 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-66 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 1e-65 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 3e-65 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-65 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 8e-65 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 9e-65 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-64 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-64 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 8e-64 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-63 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-63 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 3e-63 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-63 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 7e-63 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-62 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-62 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-62 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-62 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-61 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 3e-61 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 4e-61 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 5e-61 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 6e-61 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-60 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 3e-60 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-60 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-59 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 6e-59 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-58 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-58 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-58 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-56 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 2e-55 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 2e-55 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-55 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 6e-55 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-54 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-54 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-54 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 9e-53 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-52 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-52 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 6e-52 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 6e-52 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 9e-51 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 2e-50 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 5e-50 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 1e-49 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 7e-47 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-46 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-45 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 1e-44 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-44 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-44 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-44 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-44 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-44 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-44 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 3e-44 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 5e-44 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 5e-44 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-43 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-43 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-43 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 5e-43 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-42 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-42 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 9e-42 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 9e-42 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-41 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-41 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 5e-41 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 9e-41 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-40 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 7e-40 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-39 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 8e-39 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-38 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 5e-38 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-37 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-37 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-36 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 4e-36 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 5e-36 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 7e-36 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-35 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 2e-35 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-35 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 4e-35 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-35 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 9e-35 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-34 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-34 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-34 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 5e-34 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 7e-34 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 8e-34 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 4e-33 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 7e-33 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-32 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-32 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 3e-32 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 9e-32 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-31 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-29 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 7e-29 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-27 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-26 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 5e-25 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 6e-25 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-25 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-24 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-24 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-24 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-23 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 1e-23 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-23 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-23 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 3e-23 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-23 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 4e-23 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-23 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-22 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-22 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-22 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-22 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-22 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 7e-22 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 8e-22 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 9e-22 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-21 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-21 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-21 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-21 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-21 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 5e-21 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 8e-21 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-20 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 2e-20 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 2e-20 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-20 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 4e-20 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 4e-20 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 4e-20 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-20 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-19 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-19 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-19 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-19 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-19 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 5e-19 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 6e-19 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-18 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-18 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-18 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-18 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-18 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 3e-18 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-18 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 4e-18 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-18 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-18 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 7e-18 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 9e-18 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-17 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-17 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 6e-17 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 9e-17 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-14 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-13 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 5e-07 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-14 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-07 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 8e-06 | |
| 3k1f_M | 197 | Transcription initiation factor IIB; RNA polymeras | 3e-04 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 3e-04 |
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 426 bits (1098), Expect = e-139
Identities = 126/441 (28%), Positives = 200/441 (45%), Gaps = 72/441 (16%)
Query: 719 EKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLAR 778
++L +S ++ + + + + R +DFEI+K I +GAF V + +
Sbjct: 26 QELGASELAQDKYVADFLQWAEPI----VVRLKEVRLQRDDFEILKVIGRGAFSEVAVVK 81
Query: 779 KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838
+ TG ++A+K++ K DM+++ V ER++L++ ++ + ++F LYLVME
Sbjct: 82 MKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141
Query: 839 YLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHI 897
Y GGDL +LL G + +MAR Y+AE+V+A++ +H L +HRD+KPDN+L+ + GHI
Sbjct: 142 YYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI 201
Query: 898 KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAP 957
+L DFG T + GTPDYL+P
Sbjct: 202 RLADFGSCLKLRADGTV-----------------------------RSLVAVGTPDYLSP 232
Query: 958 EILLGMG-------HGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRD--IPWP 1008
EIL +G +G DWW++G+ +E+ G PF A + + + I++ + P
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP 292
Query: 1009 NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAE 1068
+ E + EA D I +LL P RLG GA + + HPFF ++WD L F P E
Sbjct: 293 LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFE 351
Query: 1069 S-LDTSYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSFSNTLDEEQADECGSLAEFSAP 1127
DT F D D LT SG D + G
Sbjct: 352 GATDTCNF---------DL------VEDGLT-AMVSGGGETLSDIREGAPLG-------- 387
Query: 1128 ALAVQYSFSNFSFKNLSQLAS 1148
V F +S+ ++ S
Sbjct: 388 ---VHLPFVGYSYSCMALRDS 405
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 410 bits (1056), Expect = e-132
Identities = 131/456 (28%), Positives = 210/456 (46%), Gaps = 73/456 (16%)
Query: 722 DSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRA 781
+ +N+ E ++ E + + + R EDFEI+K I +GAFG V + + +
Sbjct: 40 ECNNSPLRREKNILEYLEWA--KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN 97
Query: 782 TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLN 841
+FA+K+L K +M+++ ER++L++ + ++ Y+F NLYLVM+Y
Sbjct: 98 ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157
Query: 842 GGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLT 900
GGDL +LL L E+MAR Y+AE+V+A++ +H L+ +HRD+KPDN+L+ +GHI+L
Sbjct: 158 GGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLA 217
Query: 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL 960
DFG + T Q GTPDY++PEIL
Sbjct: 218 DFGSCLKLMEDGTV-----------------------------QSSVAVGTPDYISPEIL 248
Query: 961 LGM-----GHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR--DIPWPNIPEE 1013
M +G DWWS+G+ ++E+L G PF A++ + + IMN +P +
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
Query: 1014 MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES-LDT 1072
+S A DLI +L+ RLG G + K+HPFF I+WD + +A +IP S DT
Sbjct: 309 VSENAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDT 367
Query: 1073 SYFVSRYVWNPEDENVQGGSDFDDLTDTCSSGSFSNTLDEEQADECGSLAEFSAPALAVQ 1132
S F + +D+ ++ T T SG
Sbjct: 368 SNF------DVDDDCLKNSETMPPPTHTAFSG--------------------------HH 395
Query: 1133 YSFSNFSFKNLSQLASINYDLVVKSAKESAEASKSS 1168
F F++ + L+ + V + S
Sbjct: 396 LPFVGFTYTSSCVLSDRSCLRVTAGPTSAENLYFQS 431
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 403 bits (1039), Expect = e-132
Identities = 120/350 (34%), Positives = 196/350 (56%), Gaps = 43/350 (12%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
+ S++DF+I++ + G+FGRV L R R G +A+KVLKK ++R VE ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
V +PF++R + +F + ++++M+Y+ GG+L+SLLR +A+ Y AE+ LALEY
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LHS ++I+RDLKP+N+L+ ++GHIK+TDFG +K +
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAK------------------------YVP 157
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993
D T +++ GTPDY+APE++ + + DWWS GI+++E+L G PF
Sbjct: 158 DV---T------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNI 1051
+ ++ I+N ++ + P + + DL+ +L+T + QRLG G +VK HP+FK +
Sbjct: 209 MKTYEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265
Query: 1052 NWDTLARQK--AMFIPAAES--LDTSYFVSRYVWNPEDENVQGGSDFDDL 1097
W+ L + + P + DTS F +Y + VQG + DL
Sbjct: 266 VWEKLLSRNIETPYEPPIQQGQGDTSQF-DKYPEEDINYGVQGEDPYADL 314
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 401 bits (1032), Expect = e-131
Identities = 108/321 (33%), Positives = 173/321 (53%), Gaps = 34/321 (10%)
Query: 749 PCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAE 808
P + EDF+ K + +G+F V LAR+ AT +AIK+L+K +I++N V + E
Sbjct: 21 PPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 80
Query: 809 RNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV 868
R+++ + +PF V+ +++F E LY + Y G+L +R +G DE R Y AE+V
Sbjct: 81 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
ALEYLH +IHRDLKP+N+L+ +D HI++TDFG +K
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK---------------------- 178
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988
L + R +S GT Y++PE+L ++D W++G I+++L+ G+PPF
Sbjct: 179 --VLSPESKQAR----ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232
Query: 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT---GAREVKQH 1045
A IF I+ + + PE+ +A DL++KLL + +RLG G +K H
Sbjct: 233 RAGNEYLIFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 289
Query: 1046 PFFKNINWDTLARQKAMFIPA 1066
PFF+++ W+ L +Q + A
Sbjct: 290 PFFESVTWENLHQQTPPKLTA 310
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 393 bits (1013), Expect = e-127
Identities = 123/352 (34%), Positives = 193/352 (54%), Gaps = 38/352 (10%)
Query: 729 EEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAI 788
E ++ + + P S DF +K I +G+FG+V LAR +A +A+
Sbjct: 9 ELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAV 68
Query: 789 KVLKKADMIRKNAVESILAERNILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 847
KVL+K +++K + I++ERN+L+ +V++PF+V +SF + LY V++Y+NGG+L+
Sbjct: 69 KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 128
Query: 848 LLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
L+ C E AR Y AE+ AL YLHSLN+++RDLKP+N+L+ GHI LTDFGL K
Sbjct: 129 HLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188
Query: 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGA 967
+ H++ T + GTP+YLAPE+L +
Sbjct: 189 NIEHNS------------------------TT------STFCGTPEYLAPEVLHKQPYDR 218
Query: 968 TADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLT 1027
T DWW +G +L+E+L G+PPF ++ +++DNI+N+ + + ++ A L++ LL
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---QLKPNITNSARHLLEGLLQ 275
Query: 1028 ENPVQRLGA-TGAREVKQHPFFKNINWDTLARQKAM--FIPAAES-LDTSYF 1075
++ +RLGA E+K H FF INWD L +K F P D +F
Sbjct: 276 KDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHF 327
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 395 bits (1017), Expect = e-127
Identities = 133/395 (33%), Positives = 199/395 (50%), Gaps = 47/395 (11%)
Query: 696 TFGRRIEKLLQEKYVNLCGQIDDEKLDSSNAMTEE------ESSMDEDTVRSLRTSPINP 749
+F R EK+ D LD +A+ + + + D S IN
Sbjct: 1 SFETRFEKMDNLLRDPKSEVNSDCLLDGLDALVYDLDFPALRKNKNIDNFLSRYKDTINK 60
Query: 750 CSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER 809
R ED+E++K I +GAFG V L R ++T ++A+K+L K +MI+++ ER
Sbjct: 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120
Query: 810 NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL 869
+I+ +P+VV+ FY+F LY+VMEY+ GGDL +L+ N + E AR Y AE+VL
Sbjct: 121 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVL 179
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
AL+ +HS+ IHRD+KPDN+L+ + GH+KL DFG
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV--------------- 224
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG----HGATADWWSVGIILFELLIGI 985
+ + GTPDY++PE+L G +G DWWSVG+ L+E+L+G
Sbjct: 225 --------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
Query: 986 PPFNAKTPQQIFDNIMN--RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043
PF A + + IMN + +P+ ++S EA +LI LT + RLG G E+K
Sbjct: 271 TPFYADSLVGTYSKIMNHKNSLTFPDDN-DISKEAKNLICAFLT-DREVRLGRNGVEEIK 328
Query: 1044 QHPFFKNINWDTLARQKAM--FIPAAES-LDTSYF 1075
+H FFKN W + + +P S +DTS F
Sbjct: 329 RHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF 363
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-127
Identities = 124/334 (37%), Positives = 184/334 (55%), Gaps = 42/334 (12%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARK---RATGDLFAIKVLKKADMIRK-NAVESIL 806
++ E FE+++ + +G +G+VF RK TG +FA+KVLKKA ++R
Sbjct: 10 GPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK 69
Query: 807 AERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE 866
AERNIL V++PF+V Y+F LYL++EYL+GG+L+ L G ED A Y+AE
Sbjct: 70 AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAE 129
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+ +AL +LH +I+RDLKP+N+++ GH+KLTDFGL K +
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI----------------- 172
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
+ H+ GT +Y+APEIL+ GH DWWS+G +++++L G P
Sbjct: 173 -------------HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219
Query: 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQ 1044
PF + ++ D I+ + +P ++ EA DL+ KLL N RLGA A EV+
Sbjct: 220 PFTGENRKKTIDKILKCKLN---LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276
Query: 1045 HPFFKNINWDTLARQKAM--FIPAAES-LDTSYF 1075
HPFF++INW+ L +K F P +S D S F
Sbjct: 277 HPFFRHINWEELLARKVEPPFKPLLQSEEDVSQF 310
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 392 bits (1008), Expect = e-127
Identities = 122/363 (33%), Positives = 200/363 (55%), Gaps = 46/363 (12%)
Query: 718 DEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLA 777
+K ++ E + ED ++ T S++ ++ F+ IK + G+FGRV L
Sbjct: 6 AKKGSEQESVKEFLAKAKEDFLKKWETP-----SQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 778 RKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837
+ + +G+ +A+K+L K +++ +E L E+ IL +V PF+V+ +SF NLY+VM
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHI 897
EY+ GG+++S LR +G E AR Y A++VL EYLHSL++I+RDLKP+NLLI Q G+I
Sbjct: 121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYI 180
Query: 898 KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAP 957
++TDFG +K R + + ++ GTP+ LAP
Sbjct: 181 QVTDFGFAK---------------------------------RVKGRTWTLCGTPEALAP 207
Query: 958 EILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVE 1017
EI+L G+ DWW++G++++E+ G PPF A P QI++ I++ + +P+ S +
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS---HFSSD 264
Query: 1018 ACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQK--AMFIPAAES-LDT 1072
DL+ LL + +R G G ++K H +F +W + ++K A FIP + DT
Sbjct: 265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDT 324
Query: 1073 SYF 1075
S F
Sbjct: 325 SNF 327
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 389 bits (1003), Expect = e-126
Identities = 125/348 (35%), Positives = 194/348 (55%), Gaps = 42/348 (12%)
Query: 736 EDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRA---TGDLFAIKVLK 792
E +++ + + ++ FE++K + QG+FG+VFL +K + L+A+KVLK
Sbjct: 2 EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61
Query: 793 KADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 852
KA + ++ V ER+IL+ V +PF+V+ Y+F LYL++++L GGDL++ L
Sbjct: 62 KATLKVRDRVR-TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE 120
Query: 853 GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912
E+ + Y+AEL LAL++LHSL +I+RDLKP+N+L+ ++GHIKLTDFGLSK + H
Sbjct: 121 VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180
Query: 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWW 972
+ +S GT +Y+APE++ GH +ADWW
Sbjct: 181 K------------------------------KAYSFCGTVEYMAPEVVNRRGHTQSADWW 210
Query: 973 SVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQ 1032
S G+++FE+L G PF K ++ I+ + +P+ +S EA L+ L NP
Sbjct: 211 SFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLG---MPQFLSPEAQSLLRMLFKRNPAN 267
Query: 1033 RLGA--TGAREVKQHPFFKNINWDTLARQKAM--FIPAAES-LDTSYF 1075
RLGA G E+K+H FF I+W+ L R++ F PA DT YF
Sbjct: 268 RLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYF 315
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-125
Identities = 118/327 (36%), Positives = 187/327 (57%), Gaps = 38/327 (11%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
+ ++ DF+ +K + +G FG+V L R++ATG +A+K+L+K +I K+ V + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
+ R+PF+ Y+F + L VMEY NGG+L+ L E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LHS +V++RD+K +NL++ +DGHIK+TDFGL K G+
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI------------------------ 156
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993
+ + GTP+YLAPE+L +G DWW +G++++E++ G PF +
Sbjct: 157 ------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNI 1051
+++F+ I+ +I P +S EA L+ LL ++P QRLG + A+EV +H FF +I
Sbjct: 211 ERLFELILMEEIR---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
Query: 1052 NWDTLARQKAM--FIPAAES-LDTSYF 1075
NW + ++K + F P S +DT YF
Sbjct: 268 NWQDVVQKKLLPPFKPQVTSEVDTRYF 294
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 384 bits (988), Expect = e-124
Identities = 107/333 (32%), Positives = 180/333 (54%), Gaps = 38/333 (11%)
Query: 748 NPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILA 807
N ++DR + DF + + +G+FG+V L+ ++ T +L+A+K+LKK +I+ + VE +
Sbjct: 10 NNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV 69
Query: 808 ERNILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE 866
E+ +L PF+ + F + LY VMEY+NGGDL ++ +G E A Y AE
Sbjct: 70 EKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE 129
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+ + L +L S +I+RDLK DN+++ +GHIK+ DFG+ K +
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI----------------- 172
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
+ + GTPDY+APEI+ +G + DWW+ G++L+E+L G
Sbjct: 173 -------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
Query: 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQ 1044
PF + ++F +IM ++ P+ MS EA + L+T++P +RLG G R++K+
Sbjct: 220 PFEGEDEDELFQSIMEHNVA---YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276
Query: 1045 HPFFKNINWDTLARQKAM--FIPAAESLDTSYF 1075
H FF+ I+W+ L R++ + P A + F
Sbjct: 277 HAFFRYIDWEKLERKEIQPPYKPKACGRNAENF 309
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-124
Identities = 129/370 (34%), Positives = 198/370 (53%), Gaps = 48/370 (12%)
Query: 722 DSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRA 781
+ + + TV+ + ++ IE+FE++K + GA+G+VFL RK +
Sbjct: 18 AAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKIS 77
Query: 782 ---TGDLFAIKVLKKADMIRK-NAVESILAERNILISVRN-PFVVRFFYSFTCRENLYLV 836
TG L+A+KVLKKA +++K E ER +L +R PF+V Y+F L+L+
Sbjct: 78 GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 137
Query: 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH 896
++Y+NGG+L++ L E ++Y+ E+VLALE+LH L +I+RD+K +N+L+ +GH
Sbjct: 138 LDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH 197
Query: 897 IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLA 956
+ LTDFGLSK + D+ + GT +Y+A
Sbjct: 198 VVLTDFGLSKEF-----------------------VADETERA------YDFCGTIEYMA 228
Query: 957 PEILLGM--GHGATADWWSVGIILFELLIGIPPFNA----KTPQQIFDNIMNRDIPWPNI 1010
P+I+ G GH DWWS+G++++ELL G PF + +I I+ + P
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---Y 285
Query: 1011 PEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQK--AMFIPA 1066
P+EMS A DLI +LL ++P +RLG A E+K+H FF+ INWD LA +K A F P
Sbjct: 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPV 345
Query: 1067 AES-LDTSYF 1075
LD S F
Sbjct: 346 IRDELDVSNF 355
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 381 bits (982), Expect = e-123
Identities = 122/343 (35%), Positives = 186/343 (54%), Gaps = 40/343 (11%)
Query: 740 RSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK 799
S + I S +R I++FE I+ + +G+FG+V LAR + TGDL+A+KVLKK +++
Sbjct: 5 SSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD 64
Query: 800 NAVESILAERNILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDED 858
+ VE + E+ IL RN PF+ + F F + L+ VME++NGGDL ++ DE
Sbjct: 65 DDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA 124
Query: 859 MARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918
AR Y AE++ AL +LH +I+RDLK DN+L+ +GH KL DFG+ K G+
Sbjct: 125 RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI--------- 175
Query: 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978
+ GTPDY+APEIL M +G DWW++G++L
Sbjct: 176 ---------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLL 214
Query: 979 FELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA-- 1036
+E+L G PF A+ +F+ I+N ++ P + +A ++ +T+NP RLG+
Sbjct: 215 YEMLCGHAPFEAENEDDLFEAILNDEVV---YPTWLHEDATGILKSFMTKNPTMRLGSLT 271
Query: 1037 -TGAREVKQHPFFKNINWDTLARQKAM--FIPAAES-LDTSYF 1075
G + +HPFFK I+W L ++ F P +S D S F
Sbjct: 272 QGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNF 314
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-122
Identities = 121/331 (36%), Positives = 186/331 (56%), Gaps = 39/331 (11%)
Query: 749 PCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAE 808
P + + IEDF + K + +G+FG+VFLA + T FAIK LKK ++ + VE + E
Sbjct: 8 PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 809 RNIL-ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL 867
+ +L ++ +PF+ F +F +ENL+ VMEYLNGGDL +++ D A Y AE+
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 868 VLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
+L L++LHS +++RDLK DN+L+ +DGHIK+ DFG+ K +
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------------------ 169
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987
+ ++ GTPDY+APEILLG + + DWWS G++L+E+LIG P
Sbjct: 170 ------------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
Query: 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
F+ + +++F +I + P + EA DL+ KL P +RLG G +++QHP
Sbjct: 218 FHGQDEEELFHSIRMDNPF---YPRWLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPL 272
Query: 1048 FKNINWDTLARQKAM--FIPAAES-LDTSYF 1075
F+ INW+ L R++ F P +S D S F
Sbjct: 273 FREINWEELERKEIDPPFRPKVKSPFDCSNF 303
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-121
Identities = 96/333 (28%), Positives = 171/333 (51%), Gaps = 47/333 (14%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
+ + + FEI++ I +G+FG+V + +K T ++A+K + K + +N V ++ E
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
I+ + +PF+V +YSF E++++V++ L GGDL L+ E+ +++I ELV+A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
L+YL + +IHRD+KPDN+L+ + GH+ +TDF ++
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA------------------------ 163
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPP 987
L + +T ++AGT Y+APE+ G G+ DWWS+G+ +ELL G P
Sbjct: 164 MLPRETQIT-------TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
Query: 988 F---NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044
+ ++ + ++I + + P S E L+ KLL NP QR +V+
Sbjct: 217 YHIRSSTSSKEIVHTFETTVVTY---PSAWSQEMVSLLKKLLEPNPDQRFS--QLSDVQN 271
Query: 1045 HPFFKNINWDTLARQKAM--FIPAAESLDTSYF 1075
P+ +INWD + +++ + FIP +
Sbjct: 272 FPYMNDINWDAVFQKRLIPGFIP---NKGRLNC 301
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 376 bits (968), Expect = e-121
Identities = 108/341 (31%), Positives = 180/341 (52%), Gaps = 49/341 (14%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
+ D ++DF++++ I +G++ +V L R + T ++A+KV+KK + ++ + E++
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 811 ILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL 869
+ N PF+V F L+ V+EY+NGGDL ++ L E+ AR Y AE+ L
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
AL YLH +I+RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-------------------- 161
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989
R + GTP+Y+APEIL G +G + DWW++G+++FE++ G PF+
Sbjct: 162 ----------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211
Query: 990 ---------AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---T 1037
T +F I+ + I IP +SV+A ++ L ++P +RLG T
Sbjct: 212 IVGSSDNPDQNTEDYLFQVILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQT 268
Query: 1038 GAREVKQHPFFKNINWDTLARQKAM--FIPAAES-LDTSYF 1075
G +++ HPFF+N++WD + +++ + F P F
Sbjct: 269 GFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNF 309
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-121
Identities = 126/375 (33%), Positives = 193/375 (51%), Gaps = 39/375 (10%)
Query: 707 EKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPI 766
E++ + D + A + S D + K R ++ +FE +K +
Sbjct: 97 EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLL 156
Query: 767 SQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYS 826
+G FG+V L +++ATG +A+K+LKK ++ K+ V L E +L + R+PF+ YS
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 216
Query: 827 FTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLK 885
F + L VMEY NGG+L+ L ED AR Y AE+V AL+YLHS NV++RDLK
Sbjct: 217 FQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLK 276
Query: 886 PDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQK 945
+NL++ +DGHIK+TDFGL K G+ ++
Sbjct: 277 LENLMLDKDGHIKITDFGLCKEGI------------------------------KDGATM 306
Query: 946 HSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI 1005
+ GTP+YLAPE+L +G DWW +G++++E++ G PF + +++F+ I+ +I
Sbjct: 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 366
Query: 1006 PWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQKAM- 1062
P + EA L+ LL ++P QRLG A+E+ QH FF I W + +K
Sbjct: 367 R---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSP 423
Query: 1063 -FIPAAES-LDTSYF 1075
F P S DT YF
Sbjct: 424 PFKPQVTSETDTRYF 438
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 376 bits (968), Expect = e-120
Identities = 109/383 (28%), Positives = 190/383 (49%), Gaps = 49/383 (12%)
Query: 709 YVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQ 768
Y + D + + N + + + + + + ++DF++++ I +
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGR 62
Query: 769 GAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFFYSF 827
G++ +V L R + T ++A++V+KK + ++ + E+++ N PF+V F
Sbjct: 63 GSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF 122
Query: 828 TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPD 887
L+ V+EY+NGGDL ++ L E+ AR Y AE+ LAL YLH +I+RDLK D
Sbjct: 123 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 182
Query: 888 NLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHS 947
N+L+ +GHIKLTD+G+ K GL R +
Sbjct: 183 NVLLDSEGHIKLTDYGMCKEGL------------------------------RPGDTTST 212
Query: 948 VAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN---------AKTPQQIFD 998
GTP+Y+APEIL G +G + DWW++G+++FE++ G PF+ T +F
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272
Query: 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNINWDT 1055
I+ + I IP +SV+A ++ L ++P +RLG TG +++ HPFF+N++WD
Sbjct: 273 VILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDM 329
Query: 1056 LARQKAM--FIPAAES-LDTSYF 1075
+ +++ + F P F
Sbjct: 330 MEQKQVVPPFKPNISGEFGLDNF 352
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 381 bits (980), Expect = e-118
Identities = 140/609 (22%), Positives = 251/609 (41%), Gaps = 51/609 (8%)
Query: 481 WGFWGENSMICRICEVEIPVVHVEEHSRICTIADRCDLKSLTVNERLERVAETLEKILDS 540
WGF G+ C++C VVH H + D + + R + + +
Sbjct: 59 WGF-GKQGFQCQVCSF---VVHKRCHEFVTFSCPGADKGPASDDPRSKHKFKIHTYSSPT 114
Query: 541 WSP---------KKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNV 591
+ K +N+ ++ + + I+ +
Sbjct: 115 FCDHCGSLLYGLIHQGMKCDTCMMNVHKRCVMNVPSLCGTDHTERRGRIYIQAHIDREVL 174
Query: 592 LPEISCDKNPTAADIAAKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKK 651
+ + KN D + L + + + + + Q+K+
Sbjct: 175 IVVVRDAKNLVPMDPNGLSDPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKE 234
Query: 652 LLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVETFGRRIEKLLQEKYVN 711
R + D D S + L +Q VD F E
Sbjct: 235 SDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPE 294
Query: 712 LCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAF 771
++ + A + + E+ + + N ++DR + DF + + +G+F
Sbjct: 295 GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSF 354
Query: 772 GRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFFYSFTCR 830
G+V L+ ++ T +L+A+K+LKK +I+ + VE + E+ +L PF+ + F
Sbjct: 355 GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414
Query: 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLL 890
+ LY VMEY+NGGDL ++ +G E A Y AE+ + L +L S +I+RDLK DN++
Sbjct: 415 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 474
Query: 891 IGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAG 950
+ +GHIK+ DFG+ K + + G
Sbjct: 475 LDSEGHIKIADFGMCKENIWDGV------------------------------TTKTFCG 504
Query: 951 TPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNI 1010
TPDY+APEI+ +G + DWW+ G++L+E+L G PF + ++F +IM ++
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA---Y 561
Query: 1011 PEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQKAM--FIPA 1066
P+ MS EA + L+T++P +RLG G R++K+H FF+ I+W+ L R++ + P
Sbjct: 562 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPK 621
Query: 1067 AESLDTSYF 1075
A + F
Sbjct: 622 ASGRNAENF 630
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 356 bits (914), Expect = e-110
Identities = 99/408 (24%), Positives = 175/408 (42%), Gaps = 59/408 (14%)
Query: 700 RIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIED 759
R + + L E S+ R +
Sbjct: 133 RARAGAGDGLFQPLLRAVLAHL-GQAPFQEFLDSLYFL-----RFLQWKWLEAQPMGEDW 186
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F + + +G FG VF + +ATG L+A K L K + ++ + + E+ IL V + F
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDL----YSLLRNLGCLDEDMARVYIAELVLALEYLH 875
+V Y+F + +L LVM +NGGD+ Y++ + E A Y A++V LE+LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
N+I+RDLKP+N+L+ DG+++++D GL+
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK-------------------------- 340
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK---- 991
Q + AGTP ++APE+LLG + + D++++G+ L+E++ PF A+
Sbjct: 341 ----AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV 396
Query: 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFK 1049
+++ ++ + + P++ S + D + LL ++P +RLG ++ HP F+
Sbjct: 397 ENKELKQRVLEQAVT---YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453
Query: 1050 NINWDTLARQK--AMFIP------AAESLDTSYF--VSRYVWNPEDEN 1087
+I+W L F+P A D F V + D
Sbjct: 454 DISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTE 501
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-110
Identities = 119/435 (27%), Positives = 198/435 (45%), Gaps = 62/435 (14%)
Query: 666 DYNSLEHMLDRLEELKYII------QDRKVDALFVETFGRRIEKLLQEKYV--NLCGQID 717
Y LE +RL + I + F ++ ++ L +K V +L
Sbjct: 91 KYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYI 150
Query: 718 DEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLA 777
+E + ++ + R + N ++ DF + + I +G FG V+
Sbjct: 151 EEICQNLRGDVFQKFIESDKFTRFCQWK--NVELNIHLTMNDFSVHRIIGRGGFGEVYGC 208
Query: 778 RKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN---PFVVRFFYSFTCRENLY 834
RK TG ++A+K L K + K L ER +L V PF+V Y+F + L
Sbjct: 209 RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268
Query: 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD 894
+++ +NGGDL+ L G E R Y AE++L LE++H+ V++RDLKP N+L+ +
Sbjct: 269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEH 328
Query: 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDY 954
GH++++D GL+ + + P GT Y
Sbjct: 329 GHVRISDLGLAC------------------------DFSKKKPHAS--------VGTHGY 356
Query: 955 LAPEILL-GMGHGATADWWSVGIILFELLIGIPPF---NAKTPQQIFDNIMNRDIPWPNI 1010
+APE+L G+ + ++ADW+S+G +LF+LL G PF K +I + + +
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE---L 413
Query: 1011 PEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQKAM--FIP- 1065
P+ S E L++ LL + +RLG GA+EVK+ PFF++++W + QK IP
Sbjct: 414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 473
Query: 1066 -----AAESLDTSYF 1075
AA++ D F
Sbjct: 474 RGEVNAADAFDIGSF 488
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 350 bits (899), Expect = e-108
Identities = 99/389 (25%), Positives = 168/389 (43%), Gaps = 53/389 (13%)
Query: 700 RIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIED 759
R+E+ + ++ E L + D++ R + +
Sbjct: 132 RLEQGPCKDLFQELTRLTHEYLS------VAPFADYLDSIYFNRFLQWKWLERQPVTKNT 185
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
F + + +G FG V + RATG ++A K L+K + ++ L E+ IL V + F
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSL 877
VV Y++ ++ L LV+ +NGGDL + ++G E A Y AE+ LE LH
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
+++RDLKP+N+L+ GHI+++D GL+ + +
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAV------------------------HVPEGQT 341
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK----TP 993
+ GT Y+APE++ + + DWW++G +L+E++ G PF +
Sbjct: 342 I-------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNI 1051
+++ + E S +A L +LL ++P +RLG AREVK+HP FK +
Sbjct: 395 EEVERLVKEVPEE---YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
Query: 1052 NWDTLARQKAM--FIP---AAESLDTSYF 1075
N+ L F P A D
Sbjct: 452 NFKRLGAGMLEPPFKPDPQAIYCKDVLDI 480
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-104
Identities = 102/309 (33%), Positives = 152/309 (49%), Gaps = 38/309 (12%)
Query: 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI 811
K + ++EDFEI +P+ +G FG V+LAR++ + + A+KVL KA + + + E I
Sbjct: 3 KRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 62
Query: 812 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLAL 871
+R+P ++R + F +YL++EY G +Y L+ L DE YI EL AL
Sbjct: 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
Y HS VIHRD+KP+NLL+G G +K+ DFG S
Sbjct: 123 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH------------------------ 158
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991
++ + GT DYL PE++ G H D WS+G++ +E L+G PPF A
Sbjct: 159 --------APSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210
Query: 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
T Q+ + I + P+ ++ A DLI +LL NP QR REV +HP+
Sbjct: 211 TYQETYKRISRVEF---TFPDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITAN 264
Query: 1052 NWDTLARQK 1060
+ Q
Sbjct: 265 SSKPSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 327 bits (841), Expect = e-104
Identities = 95/299 (31%), Positives = 154/299 (51%), Gaps = 38/299 (12%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
K + +I+DF+I +P+ +G FG V+LAR++ + A+KVL K+ + ++ + E
Sbjct: 7 PKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIE 66
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
I +R+P ++R + F R+ +YL++E+ G+LY L+ G DE + ++ EL A
Sbjct: 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
L Y H VIHRD+KP+NLL+G G +K+ DFG S
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH----------------------- 163
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
++ ++ GT DYL PE++ G H D W G++ +E L+G+PPF++
Sbjct: 164 ---------APSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ + I+N D+ P +S + DLI KLL +P QRL V +HP+ K
Sbjct: 215 PSHTETHRRIVNVDL---KFPPFLSDGSKDLISKLLRYHPPQRLPLK---GVMEHPWVK 267
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 4e-88
Identities = 85/319 (26%), Positives = 140/319 (43%), Gaps = 41/319 (12%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
DFE I + QGAFG+V AR +AIK ++ + + +IL+E +L S+ +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNH 61
Query: 818 PFVVRFFYSFTCREN-------------LYLVMEYLNGGDLYSLLRNLGC-LDEDMARVY 863
+VVR++ ++ R N L++ MEY G LY L+ + D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
+++ AL Y+HS +IHRDLKP N+ I + ++K+ DFGL+K
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN---------------- 165
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELL 982
++ D L S GT Y+A E+L G GH D +S+GII FE++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 983 IGIPPFNAKTPQQIFDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041
P I + + I +P + + +I L+ +P +R GAR
Sbjct: 226 --YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GART 280
Query: 1042 VKQHPFFKNINWDTLARQK 1060
+ + + D + ++
Sbjct: 281 LLNSGWLPVKHQDEVIKEA 299
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 286 bits (734), Expect = 1e-87
Identities = 74/368 (20%), Positives = 145/368 (39%), Gaps = 79/368 (21%)
Query: 731 ESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKV 790
S D + S + I D+ II+ ++QG F ++ L K +A+K
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKK 61
Query: 791 LKKADMIRK--------------NAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836
+K+ + +K + + E I+ ++N + + T + +Y++
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYII 121
Query: 837 MEYLNGGDLYSLLRNLGCLD--------EDMARVYIAELVLALEYLHS-LNVIHRDLKPD 887
EY+ + LD + + I ++ + Y+H+ N+ HRD+KP
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181
Query: 888 NLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHS 947
N+L+ ++G +KL+DFG S+ + D
Sbjct: 182 NILMDKNGRVKLSDFGESE----YMVDKK----------------------------IKG 209
Query: 948 VAGTPDYLAPEILLGMG--HGATADWWSVGIILFELLIGIPPFNAK-TPQQIFDNIMNRD 1004
GT +++ PE +GA D WS+GI L+ + + PF+ K + ++F+NI ++
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKN 269
Query: 1005 IPWPNIPEE----------------MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
I +P +S E D + L +NP +R+ + + +H +
Sbjct: 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWL 326
Query: 1049 KNINWDTL 1056
+ N + L
Sbjct: 327 ADTNIEDL 334
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 7e-87
Identities = 78/336 (23%), Positives = 130/336 (38%), Gaps = 45/336 (13%)
Query: 717 DDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFL 776
++ S + + S + +L++ +P + + F+ + + G++G VF
Sbjct: 16 ENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFK 75
Query: 777 ARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYL 835
R + G L+A+K K+ LAE V ++P VR ++ LYL
Sbjct: 76 VRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134
Query: 836 VMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD 894
E G L G L E Y+ + +LAL +LHS ++H D+KP N+ +G
Sbjct: 135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPR 193
Query: 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDY 954
G KL DFGL L G G P Y
Sbjct: 194 GRCKLGDFGLLVE--------LGTAGAG-----------------------EVQEGDPRY 222
Query: 955 LAPEILLGMGHGATADWWSVGIILFELLIGIP-PFNAKTPQQIFDNIMNRDIPWPNIPEE 1013
+APE+L G +G AD +S+G+ + E+ + P + QQ+ + P
Sbjct: 223 MAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP-----PEFTAG 276
Query: 1014 MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+S E ++ +L +P R A + P +
Sbjct: 277 LSSELRSVLVMMLEPDPKLRA---TAEALLALPVLR 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 1e-86
Identities = 86/301 (28%), Positives = 146/301 (48%), Gaps = 37/301 (12%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
+ IEDF++ + +G+F V+ A TG AIK++ K M + V+ + E
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVL 869
I +++P ++ + F +YLV+E + G++ L+N + E+ AR ++ +++
Sbjct: 64 IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
+ YLHS ++HRDL NLL+ ++ +IK+ DFGL+
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA------------TQLKMPHEKH-- 169
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989
+++ GTP+Y++PEI HG +D WS+G + + LLIG PPF+
Sbjct: 170 ----------------YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213
Query: 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
T + + ++ D +P +S+EA DLI +LL NP RL + V HPF
Sbjct: 214 TDTVKNTLNKVVLADY---EMPSFLSIEAKDLIHQLLRRNPADRLSLS---SVLDHPFMS 267
Query: 1050 N 1050
Sbjct: 268 R 268
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 3e-85
Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 36/299 (12%)
Query: 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI 811
D S + + + +G F + F T ++FA K++ K+ +++ + E + E +I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 812 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLAL 871
S+ + VV F F + +++V+E L L + L E AR Y+ ++VL
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
+YLH VIHRDLK NL + +D +K+ DFGL+ + +
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--TKVEYDGER--------------- 171
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991
K + GTP+Y+APE+L GH D WS+G I++ LL+G PPF
Sbjct: 172 -------------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218
Query: 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
++ + I + P+ ++ A LI K+L +P R E+ FF +
Sbjct: 219 CLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARPTIN---ELLNDEFFTS 271
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 1e-84
Identities = 82/327 (25%), Positives = 137/327 (41%), Gaps = 36/327 (11%)
Query: 723 SSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRAT 782
+ + I D S + + + +G F + F T
Sbjct: 6 DPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADT 65
Query: 783 GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842
++FA K++ K+ +++ + E + E +I S+ + VV F F + +++V+E
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125
Query: 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902
L L + L E AR Y+ ++VL +YLH VIHRDLK NL + +D +K+ DF
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDF 185
Query: 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG 962
GL+ + + K + GTP+Y+APE+L
Sbjct: 186 GLA--TKVEYDGER----------------------------KKVLCGTPNYIAPEVLSK 215
Query: 963 MGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLI 1022
GH D WS+G I++ LL+G PPF ++ + I + P+ ++ A LI
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI---PKHINPVAASLI 272
Query: 1023 DKLLTENPVQRLGATGAREVKQHPFFK 1049
K+L +P R E+ FF
Sbjct: 273 QKMLQTDPTARPTIN---ELLNDEFFT 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 9e-81
Identities = 72/306 (23%), Positives = 135/306 (44%), Gaps = 38/306 (12%)
Query: 747 INPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESIL 806
+ + S+E + ++ I +G+FG+ L + G + IK + + M K E
Sbjct: 13 LGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESR 71
Query: 807 AERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDMARVYI 864
E +L ++++P +V++ SF +LY+VM+Y GGDL+ + + ED +
Sbjct: 72 REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 865 AELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSG 924
++ LAL+++H ++HRD+K N+ + +DG ++L DFG+++V
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV----------------- 174
Query: 925 GFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG 984
L + GTP YL+PEI + +D W++G +L+EL
Sbjct: 175 -------------LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
Query: 985 IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044
F A + + + I++ P + S + L+ +L NP R + +
Sbjct: 222 KHAFEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRP---SVNSILE 276
Query: 1045 HPFFKN 1050
F
Sbjct: 277 KGFIAK 282
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 7e-77
Identities = 82/307 (26%), Positives = 141/307 (45%), Gaps = 47/307 (15%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS 814
+ ED+E++ I G++GR R+++ G + K L M + +++E N+L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 815 VRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLG----CLDEDMARVYIAELV 868
+++P +VR++ R N LY+VMEY GGDL S++ LDE+ + +L
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 869 LALEYLHSLN-----VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
LAL+ H + V+HRDLKP N+ + ++KL DFGL+++
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI---------------- 165
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI 983
L + + GTP Y++PE + M + +D WS+G +L+EL
Sbjct: 166 --------------LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211
Query: 984 GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043
+PPF A + +++ I IP S E ++I ++L R E+
Sbjct: 212 LMPPFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEIL 266
Query: 1044 QHPFFKN 1050
++P
Sbjct: 267 ENPLILE 273
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 6e-73
Identities = 66/311 (21%), Positives = 136/311 (43%), Gaps = 42/311 (13%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ DFE I+ + +G FG VF A+ + +AIK ++ + + A E ++ E L +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE 61
Query: 817 NPFVVRFFYSFTCREN------------LYLVMEYLNGGDLYSLL---RNLGCLDEDMAR 861
+P +VR+F ++ + LY+ M+ +L + + + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 862 VYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921
++ A+E+LHS ++HRDLKP N+ D +K+ DFGL + ++
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQDEE------ 173
Query: 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981
+ + GT Y++PE + G + D +S+G+ILFEL
Sbjct: 174 ----------EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
Query: 982 LIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041
L P + ++ R++ +P + + ++ +L+ +P++R A
Sbjct: 224 L--YPFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI---N 276
Query: 1042 VKQHPFFKNIN 1052
+ ++ F++++
Sbjct: 277 IIENAVFEDLD 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 8e-73
Identities = 90/342 (26%), Positives = 150/342 (43%), Gaps = 48/342 (14%)
Query: 738 TVRSLRTSPINPCSKDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM 796
+ L +P D ++ + + +G+FG V L + + TG A+KV+ K +
Sbjct: 5 MMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQV 64
Query: 797 IRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLD 856
+K ES+L E +L + +P +++ + F + YLV E GG+L+ + +
Sbjct: 65 KQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS 124
Query: 857 EDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHST 913
E A I +++ + Y+H ++HRDLKP+NLL+ +D +I++ DFGLS
Sbjct: 125 EVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH------ 178
Query: 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWS 973
F + ++KD GT Y+APE+L G + D WS
Sbjct: 179 ------------FEASKKMKD-------------KIGTAYYIAPEVLHG-TYDEKCDVWS 212
Query: 974 VGIILFELLIGIPPFNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTE 1028
G+IL+ LL G PPFN I + W + S A DLI K+LT
Sbjct: 213 TGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKV----SESAKDLIRKMLTY 268
Query: 1029 NPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAESL 1070
P R+ AR+ H + + + ++ A ++
Sbjct: 269 VPSMRI---SARDALDHEWIQTYTKEQISVDVPSLDNAILNI 307
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 1e-72
Identities = 92/309 (29%), Positives = 147/309 (47%), Gaps = 51/309 (16%)
Query: 751 SKDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER 809
S T+I F ++ + GAF VFL ++R TG LFA+K +KK+ R +++E+ E
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EI 57
Query: 810 NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL 869
+L +++ +V + + YLVM+ ++GG+L+ + G E A + I +++
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS 117
Query: 870 ALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
A++YLH ++HRDLKP+NLL ++ I +TDFGLSK
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK-------------------M 158
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
N + GTP Y+APE+L + D WS+G+I + LL G P
Sbjct: 159 EQNGIMST-------------ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP 205
Query: 987 PFNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041
PF +T ++F+ I W +I S A D I LL ++P +R T +
Sbjct: 206 PFYEETESKLFEKIKEGYYEFESPFWDDI----SESAKDFICHLLEKDPNERY--T-CEK 258
Query: 1042 VKQHPFFKN 1050
HP+
Sbjct: 259 ALSHPWIDG 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 2e-72
Identities = 78/330 (23%), Positives = 136/330 (41%), Gaps = 40/330 (12%)
Query: 727 MTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLF 786
M E+ M V + ++ +F I K I +G F V+ A G
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 787 AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 846
A+K ++ D++ A + E ++L + +P V++++ SF L +V+E + GDL
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 847 SLLRNLG----CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902
++++ + E Y +L ALE++HS V+HRD+KP N+ I G +KL D
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDL 180
Query: 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG 962
GL + + + HS+ GTP Y++PE +
Sbjct: 181 GLGRF------------------------------FSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 963 MGHGATADWWSVGIILFELLIGIPPF--NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACD 1020
G+ +D WS+G +L+E+ PF + + I D P P + S E
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP-PLPSDHYSEELRQ 269
Query: 1021 LIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
L++ + +P +R V +
Sbjct: 270 LVNMCINPDPEKRP---DVTYVYDVAKRMH 296
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 2e-72
Identities = 69/307 (22%), Positives = 120/307 (39%), Gaps = 50/307 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR- 816
+ I+K I G +VF ++AIK + + ++S E L ++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQ 85
Query: 817 -NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
+ ++R + + +Y+VME DL S L+ +D + Y ++ A+ +H
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
++H DLKP N LI DG +KL DFG++ +T +
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV------------------- 184
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMG-----------HGATADWWSVGIILFELLIG 984
K S GT +Y+ PE + M +D WS+G IL+ + G
Sbjct: 185 ---------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235
Query: 985 IPPFNAKTPQ-QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043
PF Q I++ + P+ + D++ L +P QR+ E+
Sbjct: 236 KTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELL 291
Query: 1044 QHPFFKN 1050
HP+ +
Sbjct: 292 AHPYVQI 298
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-72
Identities = 69/317 (21%), Positives = 125/317 (39%), Gaps = 68/317 (21%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
D+ DF+ I+ I G FG+VF A+ R G + IK +K + E E L
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKAL 58
Query: 813 ISVRNPFVVRFFYSF----------------TCRENLYLVMEYLNGGDLYSLL--RNLGC 854
+ + +V + + + + L++ ME+ + G L + R
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 855 LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914
LD+ +A ++ ++Y+HS +I+RDLKP N+ + +K+ DFGL
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS------- 171
Query: 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974
L + ++ S GT Y++PE + +G D +++
Sbjct: 172 -----------------------LKNDGKRTRSK-GTLRYMSPEQISSQDYGKEVDLYAL 207
Query: 975 GIILFELL-IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
G+IL ELL + F + F ++ + I + + L+ KLL++ P R
Sbjct: 208 GLILAELLHVCDTAFETS---KFFTDLRD-----GIISDIFDKKEKTLLQKLLSKKPEDR 259
Query: 1034 LGATGAREVKQHPFFKN 1050
E+ +
Sbjct: 260 P---NTSEILRTLTVWK 273
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 3e-72
Identities = 80/305 (26%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 755 TSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
T D +++ + + +GAF V + TG FA K++ + ++ + + E I
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICR 60
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
+++P +VR S YLV + + GG+L+ + E A I +++ ++ Y
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 874 LHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
HS ++HR+LKP+NLL+ + +KL DFGL+
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI------------------------ 156
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
E+ D AGTP YL+PE+L + D W+ G+IL+ LL+G PPF
Sbjct: 157 EVNDSEAWH-------GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209
Query: 991 KTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
+ +++ I W + + EA LID +LT NP +R+ A + +
Sbjct: 210 EDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRI---TADQALKV 262
Query: 1046 PFFKN 1050
P+ N
Sbjct: 263 PWICN 267
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 3e-72
Identities = 89/301 (29%), Positives = 138/301 (45%), Gaps = 48/301 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E + I+ + +G+FG V + R T +A+KV+ KA K+ +IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDH 80
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P +++ F + Y+V E GG+L+ + E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 878 NVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
N++HRDLKP+N+L+ +D IK+ DFGLS F N ++KD
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC------------------FQQNTKMKD 182
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994
GT Y+APE+L G + D WS G+IL+ LL G PPF K
Sbjct: 183 -------------RIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 995 QIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
I + W I S +A DLI K+LT +P R+ A + +HP+ +
Sbjct: 229 DILKRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQ 281
Query: 1050 N 1050
Sbjct: 282 K 282
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 2e-71
Identities = 69/307 (22%), Positives = 120/307 (39%), Gaps = 50/307 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR- 816
+ I+K I G +VF ++AIK + + ++S E L ++
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQ 66
Query: 817 -NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
+ ++R + + +Y+VME DL S L+ +D + Y ++ A+ +H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
++H DLKP N LI DG +KL DFG++ +T +
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVV------------------- 165
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMG-----------HGATADWWSVGIILFELLIG 984
K S GT +Y+ PE + M +D WS+G IL+ + G
Sbjct: 166 ---------KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216
Query: 985 IPPFNAKTPQ-QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043
PF Q I++ + P+ + D++ L +P QR+ E+
Sbjct: 217 KTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELL 272
Query: 1044 QHPFFKN 1050
HP+ +
Sbjct: 273 AHPYVQI 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-71
Identities = 82/304 (26%), Positives = 141/304 (46%), Gaps = 45/304 (14%)
Query: 755 TSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
+I+D F + + GAFG V L +R++G IK + K + +E I AE +L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLK 75
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY----SLLRNLGCLDEDMARVYIAELVL 869
S+ +P +++ F F N+Y+VME GG+L S L E + +++
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 870 ALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
AL Y HS +V+H+DLKP+N+L IK+ DFGL+++ F
Sbjct: 136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL------------------F 177
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
++ + AGT Y+APE+ D WS G++++ LL G
Sbjct: 178 KSDEHSTN-------------AAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCL 223
Query: 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046
PF + +++ ++ + ++ +A DL+ ++LT++P +R A +V H
Sbjct: 224 PFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHE 280
Query: 1047 FFKN 1050
+FK
Sbjct: 281 WFKQ 284
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 5e-71
Identities = 85/303 (28%), Positives = 136/303 (44%), Gaps = 48/303 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E + I+ + +G+FG V + R T +A+KV+ KA K+ +IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDH 80
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P +++ F + Y+V E GG+L+ + E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 878 NVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
N++HRDLKP+N+L+ +D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994
++ + GT Y+APE+L G + D WS G+IL+ LL G PPF K
Sbjct: 174 ----FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228
Query: 995 QIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
I + W I S +A DLI K+LT +P R+ A + +HP+ +
Sbjct: 229 DILKRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQ 281
Query: 1050 NIN 1052
+
Sbjct: 282 KYS 284
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 1e-70
Identities = 84/308 (27%), Positives = 142/308 (46%), Gaps = 51/308 (16%)
Query: 752 KDRTSIEDF-EIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
+ I + + I +G++G V +A ++ T A K + K + V+ E
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIE 58
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
I+ S+ +P ++R + +F ++YLVME GG+L+ + + E A + +++ A
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 871 LEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
+ Y H LNV HRDLKP+N L D +KL DFGL+ F
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR------------------FK 160
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987
++ GTP Y++P++L G +G D WS G++++ LL G PP
Sbjct: 161 PGKMMRT-------------KVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPP 206
Query: 988 FNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042
F+A T ++ I W N+ S +A LI +LLT++P QR+ + +
Sbjct: 207 FSAPTDSEVMLKIREGTFTFPEKDWLNV----SPQAESLIRRLLTKSPKQRI---TSLQA 259
Query: 1043 KQHPFFKN 1050
+H +F+
Sbjct: 260 LEHEWFEK 267
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 2e-70
Identities = 81/308 (26%), Positives = 135/308 (43%), Gaps = 48/308 (15%)
Query: 752 KDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
T D +++ + + +GAF V + TG FA K++ + + + E
Sbjct: 22 NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREAR 80
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
I +++P +VR S YLV + + GG+L+ + E A I +++ +
Sbjct: 81 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 140
Query: 871 LEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
+ Y HS ++HR+LKP+NLL+ + +KL DFGL+
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--------------------- 179
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987
E+ D AGTP YL+PE+L + D W+ G+IL+ LL+G PP
Sbjct: 180 ---EVNDSEAWH-------GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
Query: 988 FNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042
F + +++ I W + + EA LID +LT NP +R+ T A +
Sbjct: 230 FWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRI--T-ADQA 282
Query: 1043 KQHPFFKN 1050
+ P+ N
Sbjct: 283 LKVPWICN 290
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 4e-70
Identities = 83/369 (22%), Positives = 134/369 (36%), Gaps = 85/369 (23%)
Query: 734 MDEDTVRSLRTSPINPCSKDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLK 792
M S + ++ + + I QG++G V +A + T + AIK++
Sbjct: 1 MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60
Query: 793 KADMIRKNA--VESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR 850
K + + N VE I E ++ + +P + R + + + + LVME +GG L L
Sbjct: 61 KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 851 NLG----------------------------------------CLDEDMARVYIAELVLA 870
E + + ++ A
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDG--HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
L YLH+ + HRD+KP+N L + IKL DFGLSK
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSK-------------------EFY 221
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH--GATADWWSVGIILFELLIGIP 986
+ +T + AGTP ++APE+L G D WS G++L LL+G
Sbjct: 222 KLNNGEYYGMT-------TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 987 PFNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041
PF ++N+ + + + S A DL+ LL N +R A
Sbjct: 275 PFPGVNDADTISQVLNKKLCFENPNYNVL----SPLARDLLSNLLNRNVDERF---DAMR 327
Query: 1042 VKQHPFFKN 1050
QHP+
Sbjct: 328 ALQHPWISQ 336
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 5e-70
Identities = 88/327 (26%), Positives = 136/327 (41%), Gaps = 57/327 (17%)
Query: 749 PCSKDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAV----- 802
P S + +E + + +G V + T +A+K++ +A
Sbjct: 7 PGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQEL 66
Query: 803 -ESILAERNILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMA 860
E+ L E +IL V P +++ ++ +LV + + G+L+ L L E
Sbjct: 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKET 126
Query: 861 RVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920
R + L+ + LH LN++HRDLKP+N+L+ D +IKLTDFG S
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ------------- 173
Query: 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM------GHGATADWWSV 974
L G L V GTP YLAPEI+ G+G D WS
Sbjct: 174 LDPGEKL------------------REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 975 GIILFELLIGIPPFNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTEN 1029
G+I++ LL G PPF + + IM+ + W + S DL+ + L
Sbjct: 216 GVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY----SDTVKDLVSRFLVVQ 271
Query: 1030 PVQRLGATGAREVKQHPFFKNINWDTL 1056
P +R T A E HPFF+ + +
Sbjct: 272 PQKRY--T-AEEALAHPFFQQYVVEEV 295
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 7e-70
Identities = 88/361 (24%), Positives = 148/361 (40%), Gaps = 58/361 (16%)
Query: 729 EEESSMDEDTVRSLRTSPINPCSKDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFA 787
S + + + +P K I + + ++ + GA+G V L +++ A
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKA 65
Query: 788 IKVLKKADMIR----------KNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837
IKV+KK+ + + E I E ++L S+ +P +++ F F ++ YLV
Sbjct: 66 IKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVT 125
Query: 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQD 894
E+ GG+L+ + N DE A + +++ + YLH N++HRD+KP+N+L+
Sbjct: 126 EFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL 185
Query: 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDY 954
+IK+ DFGLS L GT Y
Sbjct: 186 LNIKIVDFGLSSF--FSKDYKL-----------------------------RDRLGTAYY 214
Query: 955 LAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI-----PWPN 1009
+APE+L + D WS G+I++ LL G PPF + Q I + W N
Sbjct: 215 IAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKN 273
Query: 1010 IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES 1069
I S EA +LI +LT + +R A E + K + + A +
Sbjct: 274 I----SDEAKELIKLMLTYDYNKRC---TAEEALNSRWIKKYANNINKSDQKTLCGALSN 326
Query: 1070 L 1070
+
Sbjct: 327 M 327
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 9e-70
Identities = 92/321 (28%), Positives = 152/321 (47%), Gaps = 57/321 (17%)
Query: 748 NPCSKDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKK-----ADMIRKNA 801
+ S ++ D + + K + GA G V LA +R T AI+++ K +
Sbjct: 124 DDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADP 183
Query: 802 VESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMAR 861
++ E IL + +P +++ F E+ Y+V+E + GG+L+ + L E +
Sbjct: 184 ALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCK 242
Query: 862 VYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSA 918
+Y +++LA++YLH +IHRDLKP+N+L+ +D IK+TDFG SK+
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI----------- 291
Query: 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM---GHGATADWWSVG 975
LG + ++ GTP YLAPE+L+ + G+ D WS+G
Sbjct: 292 --LGETSLM------------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 976 IILFELLIGIPPFNA-KTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTEN 1029
+ILF L G PPF+ +T + D I + W + S +A DL+ KLL +
Sbjct: 332 VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV----SEKALDLVKKLLVVD 387
Query: 1030 PVQRLGATGAREVKQHPFFKN 1050
P R E +HP+ ++
Sbjct: 388 PKARF---TTEEALRHPWLQD 405
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 233 bits (598), Expect = 1e-69
Identities = 84/309 (27%), Positives = 143/309 (46%), Gaps = 51/309 (16%)
Query: 755 TSIEDF-EIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNA---VESILAERN 810
+ +ED E+ + + G F V R++ TG +A K +KK + E I E N
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
IL +R+P ++ F + ++ L++E ++GG+L+ L L ED A ++ +++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 871 LEYLHSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+ YLHS + H DLKP+N+++ + IKL DFG++
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK------------------I 162
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
+E K+ + GTP+++APEI+ G AD WS+G+I + LL G
Sbjct: 163 EAGNEFKN-------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 209
Query: 987 PFNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041
PF +T Q+ NI + + N S A D I +LL ++P +R+ +
Sbjct: 210 PFLGETKQETLTNISAVNYDFDEEYFSNT----SELAKDFIRRLLVKDPKRRMTIA---Q 262
Query: 1042 VKQHPFFKN 1050
+H + K
Sbjct: 263 SLEHSWIKA 271
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-69
Identities = 91/323 (28%), Positives = 153/323 (47%), Gaps = 49/323 (15%)
Query: 739 VRSLRTSPINPCSKDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI 797
L+ +P + + + + ++ +K + GA+G V L R + T AIK+++K +
Sbjct: 17 QGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS 76
Query: 798 RKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE 857
+ +L E +L + +P +++ + F + N YLVME GG+L+ + + +E
Sbjct: 77 TSS-NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE 135
Query: 858 DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTD 914
A V I +++ + YLH N++HRDLKP+NLL+ +D IK+ DFGLS V
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV------- 188
Query: 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974
Q++ GT Y+APE+L + D WS+
Sbjct: 189 ------------------------FENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSI 223
Query: 975 GIILFELLIGIPPFNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTEN 1029
G+ILF LL G PPF +T Q+I + W N+ S A DLI ++L +
Sbjct: 224 GVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV----SEGAKDLIKQMLQFD 279
Query: 1030 PVQRLGATGAREVKQHPFFKNIN 1052
+R+ A++ +HP+ K +
Sbjct: 280 SQRRI---SAQQALEHPWIKEMC 299
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 4e-69
Identities = 68/343 (19%), Positives = 125/343 (36%), Gaps = 50/343 (14%)
Query: 722 DSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRA 781
++ + + + + + I+K I G +VF
Sbjct: 20 TAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNE- 78
Query: 782 TGDLFAIKVLKKADMIRKNAVESILAERNILISVR--NPFVVRFFYSFTCRENLYLVMEY 839
++AIK + + ++S E L ++ + ++R + + +Y+VME
Sbjct: 79 KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 137
Query: 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKL 899
DL S L+ +D + Y ++ A+ +H ++H DLKP N LI DG +KL
Sbjct: 138 -GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKL 195
Query: 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEI 959
DFG++ +T + K S G +Y+ PE
Sbjct: 196 IDFGIANQMQPDTTSVV----------------------------KDSQVGAVNYMPPEA 227
Query: 960 LLGMG-----------HGATADWWSVGIILFELLIGIPPFNAKTPQ-QIFDNIMNRDIPW 1007
+ M +D WS+G IL+ + G PF Q I++ +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE- 286
Query: 1008 PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
P+ + D++ L +P QR+ E+ HP+ +
Sbjct: 287 IEFPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQI 326
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 5e-69
Identities = 73/348 (20%), Positives = 127/348 (36%), Gaps = 85/348 (24%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS 814
TS + + + QGA VF R + TGDLFAIKV +R V+ + E +L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63
Query: 815 VRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDMARVYIAELVL 869
+ + +V+ F T + L+ME+ G LY++L N L E + + ++V
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQ----DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+ +L ++HR++KP N++ KLTDFG ++ L
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-------------LEDDE 170
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL--------LGMGHGATADWWSVGII 977
S+ GT +YL P++ +GAT D WS+G+
Sbjct: 171 QF------------------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 978 LFELLIGIPPF----NAKTPQQIFDNIMN---------------------RDIP-WPNIP 1011
+ G PF + +++ I+ D+P ++
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272
Query: 1012 EEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ 1059
+ V ++ +L + + G + D L R
Sbjct: 273 RGLQVLLTPVLANILEADQEKCW---GFDQFFAET------SDILHRG 311
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 1e-68
Identities = 91/310 (29%), Positives = 149/310 (48%), Gaps = 56/310 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI-----RKNAVESILAERNIL 812
+++ + K + GA G V LA +R T AIK++ K + ++ E IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALE 872
+ +P +++ F E+ Y+V+E + GG+L+ + L E ++Y +++LA++
Sbjct: 70 KKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 873 YLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
YLH +IHRDLKP+N+L+ +D IK+TDFG SK+ LG +
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-------------LGETSLM-- 173
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM---GHGATADWWSVGIILFELLIGIP 986
++ GTP YLAPE+L+ + G+ D WS+G+ILF L G P
Sbjct: 174 ----------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217
Query: 987 PFNA-KTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040
PF+ +T + D I + W + S +A DL+ KLL +P R
Sbjct: 218 PFSEHRTQVSLKDQITSGKYNFIPEVWAEV----SEKALDLVKKLLVVDPKARF---TTE 270
Query: 1041 EVKQHPFFKN 1050
E +HP+ ++
Sbjct: 271 EALRHPWLQD 280
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-68
Identities = 84/325 (25%), Positives = 136/325 (41%), Gaps = 53/325 (16%)
Query: 741 SLRTSPINPCSKDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK 799
S I + D ED +E+ + I +G F V R TG FA+K++ A
Sbjct: 6 SGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS 65
Query: 800 NA--VESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY----SLLRNLG 853
E + E +I +++P +V +++ LY+V E+++G DL
Sbjct: 66 PGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGF 125
Query: 854 CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLI 910
E +A Y+ +++ AL Y H N+IHRD+KP +L+ +KL FG++
Sbjct: 126 VYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--- 182
Query: 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATAD 970
L GTP ++APE++ +G D
Sbjct: 183 ---------------------------LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVD 215
Query: 971 WWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKL 1025
W G+ILF LL G PF T +++F+ I+ W +I S A DL+ ++
Sbjct: 216 VWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHI----SESAKDLVRRM 270
Query: 1026 LTENPVQRLGATGAREVKQHPFFKN 1050
L +P +R+ T E HP+ K
Sbjct: 271 LMLDPAERI--T-VYEALNHPWLKE 292
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-68
Identities = 80/301 (26%), Positives = 140/301 (46%), Gaps = 46/301 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E++++ + + +GAF V K G +A ++ + + + E I +++
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKH 69
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P +VR S + + YL+ + + GG+L+ + E A I +++ A+ + H +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 878 NVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
V+HR+LKP+NLL+ + +KL DFGL+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--------------------------- 162
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994
+ EQ+ AGTP YL+PE+L +G D W+ G+IL+ LL+G PPF +
Sbjct: 163 ---VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219
Query: 995 QIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+++ I W + + EA DLI+K+LT NP +R+ T A E +HP+
Sbjct: 220 RLYQQIKAGAYDFPSPEWDTV----TPEAKDLINKMLTINPSKRI--T-AAEALKHPWIS 272
Query: 1050 N 1050
+
Sbjct: 273 H 273
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 3e-68
Identities = 95/334 (28%), Positives = 155/334 (46%), Gaps = 55/334 (16%)
Query: 727 MTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDF-EIIKPISQGAFGRVFLARKRATGDL 785
M+ +S T + I+ +R ++ DF E+ + +GA V+ +++ T
Sbjct: 23 MSSVTASAAPGTASLVPDYWIDG--SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKP 80
Query: 786 FAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDL 845
+A+KVLKK + + E +L+ + +P +++ F + LV+E + GG+L
Sbjct: 81 YALKVLKK-----TVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 846 YSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDF 902
+ + G E A + +++ A+ YLH ++HRDLKP+NLL D +K+ DF
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195
Query: 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG 962
GLSK+ ++ Q + +V GTP Y APEIL G
Sbjct: 196 GLSKI------------------------VEHQVLMK-------TVCGTPGYCAPEILRG 224
Query: 963 MGHGATADWWSVGIILFELLIGIPPFNAKTPQQ-IFDNIMNRDI-----PWPNIPEEMSV 1016
+G D WSVGII + LL G PF + Q +F I+N + W + S+
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEV----SL 280
Query: 1017 EACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
A DL+ KL+ +P +RL T + QHP+
Sbjct: 281 NAKDLVRKLIVLDPKKRL--T-TFQALQHPWVTG 311
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 5e-68
Identities = 83/305 (27%), Positives = 135/305 (44%), Gaps = 50/305 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNA---VESILAERNILIS 814
+ ++I + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
V + V+ + R ++ L++E ++GG+L+ L L E+ A +I +++ + YL
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 875 HSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
H+ + H DLKP+N+++ HIKL DFGL+
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE------------------IEDGV 173
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
E K+ + GTP+++APEI+ G AD WS+G+I + LL G PF
Sbjct: 174 EFKN-------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 991 KTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
T Q+ NI + + + S A D I KLL + +RL E +H
Sbjct: 221 DTKQETLANITSVSYDFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQ---EALRH 273
Query: 1046 PFFKN 1050
P+
Sbjct: 274 PWITP 278
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 9e-68
Identities = 82/319 (25%), Positives = 144/319 (45%), Gaps = 50/319 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNA---VESILAERNILIS 814
+ ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
+++P V+ + + ++ L++E + GG+L+ L L E+ A ++ +++ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 875 HSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
HSL + H DLKP+N+++ IK+ DFGL+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK------------------IDFGN 172
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
E K+ + GTP+++APEI+ G AD WS+G+I + LL G PF
Sbjct: 173 EFKN-------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 991 KTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
T Q+ N+ + + N S A D I +LL ++P +R+ + QH
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNT----SALAKDFIRRLLVKDPKKRMTIQ---DSLQH 272
Query: 1046 PFFKNINWDTLARQKAMFI 1064
P+ K + +KA +
Sbjct: 273 PWIKPKDTQQALSRKASAV 291
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 4e-67
Identities = 92/340 (27%), Positives = 138/340 (40%), Gaps = 56/340 (16%)
Query: 728 TEEESSMDEDTVRSLRTSPINPCSKDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLF 786
+ + +S+ P ++ I +G V RATG F
Sbjct: 63 DAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEF 122
Query: 787 AIKVLKKADMIRK-----NAVESILAERNILISVRN-PFVVRFFYSFTCRENLYLVMEYL 840
A+K+++ E+ E +IL V P ++ S+ ++LV + +
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182
Query: 841 NGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLT 900
G+L+ L L E R + L+ A+ +LH+ N++HRDLKP+N+L+ + I+L+
Sbjct: 183 RKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLS 242
Query: 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL 960
DFG S L G L + GTP YLAPEIL
Sbjct: 243 DFGFSCH-------------LEPGEKL------------------RELCGTPGYLAPEIL 271
Query: 961 LGM------GHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI-----PWPN 1009
G+G D W+ G+ILF LL G PPF + + IM W +
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD 331
Query: 1010 IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
S DLI +LL +P RL T A + QHPFF+
Sbjct: 332 R----SSTVKDLISRLLQVDPEARL--T-AEQALQHPFFE 364
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 4e-67
Identities = 90/327 (27%), Positives = 145/327 (44%), Gaps = 63/327 (19%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK----------- 799
S D + + + I +G++G V LA +A+KVL K +IR+
Sbjct: 6 SGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRG 65
Query: 800 ------------NAVESILAERNILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDL 845
+E + E IL + +P VV+ ++LY+V E +N G +
Sbjct: 66 TRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV 125
Query: 846 YSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905
+ L ED AR Y +L+ +EYLH +IHRD+KP NLL+G+DGHIK+ DFG
Sbjct: 126 MEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG-- 182
Query: 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG- 964
+S GS L + GTP ++APE L
Sbjct: 183 ----------VSNEFKGSDALL------------------SNTVGTPAFMAPESLSETRK 214
Query: 965 --HGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLI 1022
G D W++G+ L+ + G PF + + I ++ + +P+ P +++ + DLI
Sbjct: 215 IFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP-DIAEDLKDLI 273
Query: 1023 DKLLTENPVQRLGATGAREVKQHPFFK 1049
++L +NP R+ E+K HP+
Sbjct: 274 TRMLDKNPESRI---VVPEIKLHPWVT 297
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 8e-67
Identities = 80/302 (26%), Positives = 143/302 (47%), Gaps = 38/302 (12%)
Query: 749 PCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAE 808
R I + + + G FG+V + + TG A+K+L + + + V I E
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 809 RNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV 868
L R+P +++ + + + ++VMEY++GG+L+ + G ++E AR +++
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
A++Y H V+HRDLKP+N+L+ + K+ DFGLS + + G FL
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------------MSDGEFL- 167
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPP 987
+ G+P+Y APE++ G G D WS G+IL+ LL G P
Sbjct: 168 -----------------RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
Query: 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
F+ + +F I IPE ++ L+ +L +P++R +++++H +
Sbjct: 211 FDDEHVPTLFKKIRGGVF---YIPEYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEW 264
Query: 1048 FK 1049
FK
Sbjct: 265 FK 266
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-66
Identities = 83/305 (27%), Positives = 134/305 (43%), Gaps = 50/305 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNA---VESILAERNILIS 814
+ ++I + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
V +P ++ + R ++ L++E ++GG+L+ L L E+ A +I +++ + YL
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 875 HSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
H+ + H DLKP+N+++ HIKL DFGL+
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE------------------IEDGV 173
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
E K+ + GTP+++APEI+ G AD WS+G+I + LL G PF
Sbjct: 174 EFKN-------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 991 KTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
T Q+ NI + S A D I KLL + +RL E +H
Sbjct: 221 DTKQETLANITAVSYDFDEEFFSQT----SELAKDFIRKLLVKETRKRLTIQ---EALRH 273
Query: 1046 PFFKN 1050
P+
Sbjct: 274 PWITP 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-66
Identities = 75/298 (25%), Positives = 142/298 (47%), Gaps = 42/298 (14%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ED+++++ + +GA+G V LA R T + A+K++ + + E+I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876
+ VV+F+ YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+ + HRD+KP+NLL+ + ++K++DFGL+ V ++ + L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE----------RLL--------- 164
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFN-AKTPQ 994
+ + GT Y+APE+L H D WS GI+L +L G P++
Sbjct: 165 ---------NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 995 QIFDNIMNRD---IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
Q + + + PW +++ L+ K+L ENP R+ ++K+ ++
Sbjct: 216 QEYSDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 266
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-66
Identities = 83/333 (24%), Positives = 140/333 (42%), Gaps = 52/333 (15%)
Query: 741 SLRTSPINPCSKDRTSIEDFEII--KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR 798
+ N + + +F I+ K + +G F V ++TG +A K LKK +
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 799 KNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCL 855
IL E +L + P V+ + + L++EY GG+++SL +
Sbjct: 70 DC-RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMV 128
Query: 856 DEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHS 912
E+ I +++ + YLH N++H DLKP N+L+ G IK+ DFG+S+
Sbjct: 129 SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK----- 183
Query: 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWW 972
EL++ + GTP+YLAPEIL D W
Sbjct: 184 -------------IGHACELRE-------------IMGTPEYLAPEILNYDPITTATDMW 217
Query: 973 SVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLT 1027
++GII + LL PF + Q+ + NI ++ + ++ S A D I LL
Sbjct: 218 NIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV----SQLATDFIQSLLV 273
Query: 1028 ENPVQRLGATGAREVKQHPFFKNINWDTLARQK 1060
+NP +R A H + + +++ L +
Sbjct: 274 KNPEKRPTAE---ICLSHSWLQQWDFENLFHPE 303
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-66
Identities = 84/306 (27%), Positives = 147/306 (48%), Gaps = 39/306 (12%)
Query: 745 SPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES 804
+ I C+ ++ I ++ ++K I +G F +V LAR TG AIK++ K + +++
Sbjct: 2 NSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQK 60
Query: 805 ILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYI 864
+ E I+ + +P +V+ F + LYL+MEY +GG+++ L G + E AR
Sbjct: 61 LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKF 120
Query: 865 AELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSG 924
++V A++Y H ++HRDLK +NLL+ D +IK+ DFG S G
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE-------------FTVG 167
Query: 925 GFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLI 983
G L + G P Y APE+ G G D WS+G+IL+ L+
Sbjct: 168 GKL------------------DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 984 GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043
G PF+ + +++ + ++ IP MS + +L+ + L NP++R ++
Sbjct: 210 GSLPFDGQNLKELRERVLRGKYR---IPFYMSTDCENLLKRFLVLNPIKRG---TLEQIM 263
Query: 1044 QHPFFK 1049
+ +
Sbjct: 264 KDRWIN 269
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 1e-65
Identities = 70/325 (21%), Positives = 123/325 (37%), Gaps = 76/325 (23%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS 814
TS + + + QGA VF R + TGDLFAIKV +R V+ + E +L
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKK 63
Query: 815 VRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDMARVYIAELVL 869
+ + +V+ F T + L+ME+ G LY++L N L E + + ++V
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQ----DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+ +L ++HR++KP N++ KLTDFG ++ L
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-------------LEDDE 170
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL--------LGMGHGATADWWSVGII 977
S+ GT +YL P++ +GAT D WS+G+
Sbjct: 171 QF------------------VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 978 LFELLIGIPPF----NAKTPQQIFDNIMN---------------------RDIP-WPNIP 1011
+ G PF + +++ I+ D+P ++
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272
Query: 1012 EEMSVEACDLIDKLLTENPVQRLGA 1036
+ V ++ +L + + G
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGF 297
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 3e-65
Identities = 76/301 (25%), Positives = 135/301 (44%), Gaps = 50/301 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E + I + + +G FG V + ++ + K +K + + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLALEYLHS 876
++ SF E L ++ E+++G D++ + L+E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 877 LNVIHRDLKPDNLLIG--QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
N+ H D++P+N++ + IK+ +FG ++ D +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ------------------LKPGDNFRL 162
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994
+ P+Y APE+ D WS+G +++ LL GI PF A+T Q
Sbjct: 163 -------------LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209
Query: 995 QIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
QI +NIMN + + I S+EA D +D+LL + R+ A+ E QHP+ K
Sbjct: 210 QIIENIMNAEYTFDEEAFKEI----SIEAMDFVDRLLVKERKSRMTAS---EALQHPWLK 262
Query: 1050 N 1050
Sbjct: 263 Q 263
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-65
Identities = 78/303 (25%), Positives = 129/303 (42%), Gaps = 59/303 (19%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVR 822
KP+ +G+F + + FA+K+ I K + E L P +V+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKI------ISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
F + + +LVME LNGG+L+ ++ E A + +LV A+ ++H + V+HR
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 883 DLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
DLKP+NLL + IK+ DFG +++
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARL------------------------------KP 160
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT------- 992
+ + + T Y APE+L G+ + D WS+G+IL+ +L G PF +
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220
Query: 993 PQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
+I I D W N+ S EA DLI LLT +P +RL ++ + +
Sbjct: 221 AVEIMKKIKKGDFSFEGEAWKNV----SQEAKDLIQGLLTVDPNKRL--K-MSGLRYNEW 273
Query: 1048 FKN 1050
++
Sbjct: 274 LQD 276
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 8e-65
Identities = 75/298 (25%), Positives = 142/298 (47%), Gaps = 42/298 (14%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ED+++++ + +GA+G V LA R T + A+K++ + + E+I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876
+ VV+F+ YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+ + HRD+KP+NLL+ + ++K++DFGL+ V ++ + L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE----------RLL--------- 164
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFN-AKTPQ 994
+ + GT Y+APE+L H D WS GI+L +L G P++
Sbjct: 165 ---------NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 995 QIFDNIMNRD---IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
Q + + + PW +++ L+ K+L ENP R+ ++K+ ++
Sbjct: 216 QEYSDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 266
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-64
Identities = 70/325 (21%), Positives = 142/325 (43%), Gaps = 50/325 (15%)
Query: 735 DEDTVRSLRTSPINPCSKDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKK 793
D+ + P + S+ D ++I++ + GAFG V ++ATG +F K +
Sbjct: 27 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86
Query: 794 ADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY-SLLRNL 852
+ K ++ E +I+ + +P ++ +F + + L++E+L+GG+L+ +
Sbjct: 87 PYPLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 143
Query: 853 GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG--QDGHIKLTDFGLSKVGLI 910
+ E Y+ + L+++H +++H D+KP+N++ + +K+ DFGL+
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK--- 200
Query: 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATAD 970
++ +K T ++ APEI+ G D
Sbjct: 201 ---------------LNPDEIVKV-------------TTATAEFAAPEIVDREPVGFYTD 232
Query: 971 WWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKL 1025
W++G++ + LL G+ PF + + N+ D + ++ S EA D I L
Sbjct: 233 MWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV----SPEAKDFIKNL 288
Query: 1026 LTENPVQRLGATGAREVKQHPFFKN 1050
L + P +RL + +HP+ K
Sbjct: 289 LQKEPRKRLTVH---DALEHPWLKG 310
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-64
Identities = 79/313 (25%), Positives = 133/313 (42%), Gaps = 58/313 (18%)
Query: 752 KDRTSIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
++ D +E+ + I G++ +AT FA+K++ K K E
Sbjct: 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK----SK---RDPTEEIE 67
Query: 811 ILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL 869
IL+ ++P ++ + + +Y+V E + GG+L + E A + +
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITK 127
Query: 870 ALEYLHSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+EYLH+ V+HRDLKP N+L G I++ DFG +K
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ------------------ 169
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985
L E + T +++APE+L G+ A D WS+G++L+ +L G
Sbjct: 170 ------------LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY 217
Query: 986 PPFNAK---TPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGAT 1037
PF TP++I I + W ++ S A DL+ K+L +P QRL
Sbjct: 218 TPFANGPDDTPEEILARIGSGKFSLSGGYWNSV----SDTAKDLVSKMLHVDPHQRL--- 270
Query: 1038 GAREVKQHPFFKN 1050
A V +HP+ +
Sbjct: 271 TAALVLRHPWIVH 283
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 8e-64
Identities = 73/327 (22%), Positives = 127/327 (38%), Gaps = 37/327 (11%)
Query: 724 SNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATG 783
S + +++ L + R + + +G+FG V + + TG
Sbjct: 24 SAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTG 83
Query: 784 DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGG 843
A+K ++ + E + +P +V + + + + ME L GG
Sbjct: 84 FQCAVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGG 135
Query: 844 DLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTDF 902
L L++ +GCL ED A Y+ + + LEYLH+ ++H D+K DN+L+ DG L DF
Sbjct: 136 SLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDF 195
Query: 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG 962
G + D SL + GT ++APE+++G
Sbjct: 196 GHAL----CLQPDGLGKSLL---------------------TGDYIPGTETHMAPEVVMG 230
Query: 963 MGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLI 1022
A D WS ++ +L G P+ + I + P IP + I
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 1023 DKLLTENPVQRLGATGAREVKQHPFFK 1049
+ L + PV R A+ A E+++
Sbjct: 291 QEGLRKEPVHR--AS-AMELRRKVGKA 314
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 1e-63
Identities = 82/357 (22%), Positives = 154/357 (43%), Gaps = 59/357 (16%)
Query: 714 GQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIE----------DFEII 763
G + +++ S+ +TE + T P P D +
Sbjct: 35 GHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKT 94
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRF 823
+ + G FG+V + ATG A K++K M K E + E +++ + + +++
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHANLIQL 151
Query: 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLALEYLHSLNVIHR 882
+ +F + ++ LVMEY++GG+L+ + + L E +++ ++ + ++H + ++H
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 883 DLKPDNLLIG--QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTR 940
DLKP+N+L IK+ DFGL++ + ++LK
Sbjct: 212 DLKPENILCVNRDAKQIKIIDFGLARR------------------YKPREKLKV------ 247
Query: 941 EQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNI 1000
GTP++LAPE++ D WSVG+I + LL G+ PF + +NI
Sbjct: 248 -------NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI 300
Query: 1001 MNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052
+ + +I S EA + I KLL + R+ A+ E +HP+ +
Sbjct: 301 LACRWDLEDEEFQDI----SEEAKEFISKLLIKEKSWRISAS---EALKHPWLSDHK 350
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 2e-63
Identities = 75/321 (23%), Positives = 133/321 (41%), Gaps = 52/321 (16%)
Query: 736 EDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD 795
E+ +++ + C + + + + P+ GAFG V+ A + +K +KK
Sbjct: 4 EEPPKAVELEGLAACEGEY--SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61
Query: 796 MIRKNAVESILAER-----NILISVRNPFVVRFFYSFTCRENLYLVME-YLNGGDLYSLL 849
++ +E + IL V + +++ F + LVME + +G DL++ +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 850 RNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909
LDE +A +LV A+ YL ++IHRD+K +N++I +D IKL DFG +
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-- 179
Query: 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGAT 968
L G ++ GT +Y APE+L+G G
Sbjct: 180 -----------LERGKLF------------------YTFCGTIEYCAPEVLMGNPYRGPE 210
Query: 969 ADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTE 1028
+ WS+G+ L+ L+ PF + + I + P +S E L+ LL
Sbjct: 211 LEMWSLGVTLYTLVFEENPFCE------LEETVEAAI---HPPYLVSKELMSLVSGLLQP 261
Query: 1029 NPVQRLGATGAREVKQHPFFK 1049
P +R ++ P+
Sbjct: 262 VPERRTTLE---KLVTDPWVT 279
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 225 bits (574), Expect = 3e-63
Identities = 80/345 (23%), Positives = 141/345 (40%), Gaps = 50/345 (14%)
Query: 717 DDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIED-FEIIKPISQGAFGRVF 775
DE+ S+ D + P + D ++I + + GAFG V
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174
Query: 776 LARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835
+RATG+ FA K + ++ E++ E + +R+P +V +F + +
Sbjct: 175 RVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 231
Query: 836 VMEYLNGGDLYS-LLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG-- 892
+ E+++GG+L+ + + ED A Y+ ++ L ++H N +H DLKP+N++
Sbjct: 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK 291
Query: 893 QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTP 952
+ +KL DFGL+ +K GT
Sbjct: 292 RSNELKLIDFGLTAH------------------LDPKQSVKV-------------TTGTA 320
Query: 953 DYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI-----PW 1007
++ APE+ G G D WSVG++ + LL G+ PF + + N+ + D +
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 380
Query: 1008 PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052
I S + D I KLL +P R+ + +HP+ N
Sbjct: 381 SGI----SEDGKDFIRKLLLADPNTRMTIH---QALEHPWLTPGN 418
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 3e-63
Identities = 61/300 (20%), Positives = 115/300 (38%), Gaps = 30/300 (10%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-R 816
+F ++ I G FG VF KR G ++AIK KK + ++ L E + +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAVLGQ 69
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL----RNLGCLDEDMARVYIAELVLALE 872
+ VVR+F ++ +++ + EY NGG L + R + E + + ++ L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
Y+HS++++H D+KP N+ I + + + +G G
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF---KIGDLG------- 179
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK 991
G +LA E+L H AD +++ + + P
Sbjct: 180 -----HVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234
Query: 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
R P IP+ +S E +L+ ++ +P +R + A + +H +
Sbjct: 235 DQWHEI-----RQGRLPRIPQVLSQEFTELLKVMIHPDPERR--PS-AMALVKHSVLLSA 286
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 7e-63
Identities = 87/355 (24%), Positives = 141/355 (39%), Gaps = 70/355 (19%)
Query: 741 SLRTSPINPCSKDRTSIEDFEIIK-PISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK 799
L P K +D+++ K + G G+V R TG A+K+L + R+
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ 70
Query: 800 NAVESILAERNILISVRN-PFVVRFFYSF----TCRENLYLVMEYLNGGDLYS--LLRNL 852
E + P +V + + L ++ME + GG+L+S R
Sbjct: 71 --------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD 122
Query: 853 GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGL 909
E A + ++ A+++LHS N+ HRD+KP+NLL +D +KLTDFG +K
Sbjct: 123 QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--- 179
Query: 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA 969
+ L+ TP Y+APE+L + +
Sbjct: 180 ----------------ETTQNALQT-------------PCYTPYYVAPEVLGPEKYDKSC 210
Query: 970 DWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR---------DIPWPNIPEEMSVEACD 1020
D WS+G+I++ LL G PPF + T Q I + R + W + S +A
Sbjct: 211 DMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEV----SEDAKQ 266
Query: 1021 LIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAESLDTSYF 1075
LI LL +P +RL T + HP+ + Q + D ++
Sbjct: 267 LIRLLLKTDPTERLTIT---QFMNHPWINQ---SMVVPQTPLHTARVLQEDKDHW 315
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-62
Identities = 59/303 (19%), Positives = 107/303 (35%), Gaps = 40/303 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ + I+ + +G F V L G +A+K + + E E ++ +
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNH 85
Query: 818 PFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVL 869
P ++R +L++ + G L++ + L L ED + +
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
LE +H+ HRDLKP N+L+G +G L D G IH A +L
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ------- 198
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH---GATADWWSVGIILFELLIGIP 986
+ + T Y APE+ H D WS+G +L+ ++ G
Sbjct: 199 -----------DWAAQR---CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 987 PFNAKTPQ-QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
P++ + + + P S L++ ++T +P QR +
Sbjct: 245 PYDMVFQKGDSVALAVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIP---LLLSQ 300
Query: 1046 PFF 1048
Sbjct: 301 LEA 303
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 1e-62
Identities = 77/300 (25%), Positives = 150/300 (50%), Gaps = 39/300 (13%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
+ + I + I + + +G+FG+V LA T A+K + + + + + + E +
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
L +R+P +++ + T ++ +V+EY GG+L+ + + ED R + +++ A
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+EY H ++HRDLKP+NLL+ + ++K+ DFGLS + + G FL
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-------------MTDGNFL--- 164
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFN 989
+ G+P+Y APE++ G G D WS GI+L+ +L+G PF+
Sbjct: 165 ---------------KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
Query: 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ +F + + +P+ +S A LI +++ +P+QR+ +E+++ P+F
Sbjct: 210 DEFIPNLFKKVNSCVYV---MPDFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFN 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 2e-62
Identities = 56/361 (15%), Positives = 116/361 (32%), Gaps = 67/361 (18%)
Query: 732 SSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRA-----TGDLF 786
SS + I P ++ + + + + +GAF +V+ A + F
Sbjct: 39 SSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKF 98
Query: 787 AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 846
+KV K A+ L ++F+ + + LV E + G L
Sbjct: 99 VLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155
Query: 847 SLLR-----NLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG--------- 892
+ + + + + + ++ +E +H +IH D+KPDN ++G
Sbjct: 156 NAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215
Query: 893 --QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAG 950
+ L D G S D+ L + +
Sbjct: 216 DDLSAGLALIDLGQSI--------DMK--------------------LFPKGTIFTAKCE 247
Query: 951 TPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT-----PQQIFDNIMNRDI 1005
T + E+L D++ V ++ +L G P+ +F + + D+
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDM 307
Query: 1006 PWP-------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLAR 1058
W NIP+ + + DL+ + L + Q ++ + +R
Sbjct: 308 -WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI--RALRNRLIVLLLECKRSR 364
Query: 1059 Q 1059
+
Sbjct: 365 K 365
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 3e-62
Identities = 48/369 (13%), Positives = 99/369 (26%), Gaps = 90/369 (24%)
Query: 729 EEESSMDEDTVRSL--RTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLF 786
+S+ D SL P S+ + Q A + TG+ F
Sbjct: 42 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 787 AIKVLKKADMIRKNAVESILAERNILISVRN-------------------------PFVV 821
+ V + NA++ + E L +R ++
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 822 RFFYSFTCRE--NLYLVMEYLN------GGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
R + + + + G L S L +++ L
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LH ++H L+P ++++ Q G + LT F
Sbjct: 222 LHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL---------------------------- 253
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMG-----------HGATADWWSVGIILFELL 982
+ + + + PE+ + D W++G++++ +
Sbjct: 254 ------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 983 IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042
P + I NIP+ L++ L RL +
Sbjct: 308 CADLPITKDAALGGSEWIFRS---CKNIPQ----PVRALLEGFLRYPKEDRL---LPLQA 357
Query: 1043 KQHPFFKNI 1051
+ P ++ +
Sbjct: 358 METPEYEQL 366
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-61
Identities = 70/300 (23%), Positives = 128/300 (42%), Gaps = 42/300 (14%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES-ILAERNILISV 815
I + + + +G++G+V T A+K+LKK + R E+ + E +L +
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 816 RNPFVVRFF--YSFTCRENLYLVMEYLNGG--DLYSLLRNLGCLDEDMARVYIAELVLAL 871
R+ V++ ++ +Y+VMEY G ++ + A Y +L+ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGL 122
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
EYLHS ++H+D+KP NLL+ G +K++ G+++ +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA----------LHPFAADDTC---- 168
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG--HGATADWWSVGIILFELLIGIPPFN 989
+ G+P + PEI G+ G D WS G+ L+ + G+ PF
Sbjct: 169 --------------RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
Query: 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
++F+NI IP + DL+ +L P +R R+++QH +F+
Sbjct: 215 GDNIYKLFENIGKGSY---AIPGDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFR 268
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-61
Identities = 78/300 (26%), Positives = 142/300 (47%), Gaps = 38/300 (12%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
R I + + + G FG+V + + TG A+K+L + + + V I E
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
L R+P +++ + + ++++VMEY++GG+L+ + G LDE +R +++
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
++Y H V+HRDLKP+N+L+ + K+ DFGLS + + G FL
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM-------------MSDGEFL--- 172
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFN 989
+ G+P+Y APE++ G G D WS G+IL+ LL G PF+
Sbjct: 173 ---------------RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
Query: 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+F I + P+ ++ L+ +L +P++R +++++H +FK
Sbjct: 218 DDHVPTLFKKICDGIFY---TPQYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFK 271
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 4e-61
Identities = 90/323 (27%), Positives = 142/323 (43%), Gaps = 51/323 (15%)
Query: 734 MDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKK 793
MD + T P++ + ++ +K I G FG L R + T +L A+K +++
Sbjct: 1 MDR---APVTTGPLDM--PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER 55
Query: 794 ADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG 853
I +N + E S+R+P +VRF +L ++MEY +GG+LY + N G
Sbjct: 56 GAAIDEN----VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG 111
Query: 854 CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI--GQDGHIKLTDFGLSKVGLIH 911
ED AR + +L+ + Y HS+ + HRDLK +N L+ +K+ DFG SK
Sbjct: 112 RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----- 166
Query: 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATAD 970
S S GTP Y+APE+LL G AD
Sbjct: 167 --------SSVLHSQP------------------KSTVGTPAYIAPEVLLRQEYDGKIAD 200
Query: 971 WWSVGIILFELLIGIPPFNAKTPQQIF----DNIMNRDIPWPNIPEEMSVEACDLIDKLL 1026
WS G+ L+ +L+G PF + + I++ P+ +S E C LI ++
Sbjct: 201 VWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD-DIRISPECCHLISRIF 259
Query: 1027 TENPVQRLGATGAREVKQHPFFK 1049
+P R+ E+K H +F
Sbjct: 260 VADPATRI---SIPEIKTHSWFL 279
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 5e-61
Identities = 74/338 (21%), Positives = 132/338 (39%), Gaps = 54/338 (15%)
Query: 723 SSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRAT 782
S+ + S M L + + P + +++ + G FG V+ + +
Sbjct: 10 HSSGLVPRGSHMA--PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSD 67
Query: 783 GDLFAIKVLKKA---DMIRKNAVESILAERNILISVRN--PFVVRFFYSFTCRENLYLVM 837
AIK ++K D + E +L V + V+R F ++ L++
Sbjct: 68 NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127
Query: 838 EYLNG-GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI-GQDG 895
E DL+ + G L E++AR + +++ A+ + H+ V+HRD+K +N+LI G
Sbjct: 128 ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 187
Query: 896 HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYL 955
+KL DFG +L GT Y
Sbjct: 188 ELKLIDFGSG--------------ALLKDTVY------------------TDFDGTRVYS 215
Query: 956 APEILLGMG-HGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEM 1014
PE + HG +A WS+GI+L++++ G PF + I+ + + +
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQV---FFRQRV 266
Query: 1015 SVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052
S E LI L P R T E++ HP+ +++
Sbjct: 267 SSECQHLIRWCLALRPSDR--PT-FEEIQNHPWMQDVL 301
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 6e-61
Identities = 82/317 (25%), Positives = 131/317 (41%), Gaps = 64/317 (20%)
Query: 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVR 822
+ +GA RV T +A+K+++K ++ V E +L + V+
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHR 882
F + YLV E + GG + S + +E A V + ++ AL++LH+ + HR
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 883 DLKPDNLLI---GQDGHIKLTDFGLSK-VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
DLKP+N+L Q +K+ DF L + L +S P L
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL----------------- 178
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGHGAT-----ADWWSVGIILFELLIGIPPFNAK-- 991
+ G+ +Y+APE++ A+ D WS+G+IL+ LL G PPF +
Sbjct: 179 -------LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
Query: 992 -------------TPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPVQR 1033
+F++I W +I S A DLI KLL + QR
Sbjct: 232 SDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI----SCAAKDLISKLLVRDAKQR 287
Query: 1034 LGATGAREVKQHPFFKN 1050
L A +V QHP+ +
Sbjct: 288 LSAA---QVLQHPWVQG 301
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-60
Identities = 73/320 (22%), Positives = 122/320 (38%), Gaps = 54/320 (16%)
Query: 740 RSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK 799
+P ++ + + +G FG VF + AIKV+ + ++
Sbjct: 13 PPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW 72
Query: 800 NAVES---ILAERNILISVRN----PFVVRFFYSFTCRENLYLVMEY-LNGGDLYSLLRN 851
+ + E +L V P V+R F +E LV+E L DL+ +
Sbjct: 73 SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE 132
Query: 852 LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI-GQDGHIKLTDFGLSKVGLI 910
G L E +R + ++V A+++ HS V+HRD+K +N+LI + G KL DFG
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG----- 187
Query: 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATA 969
+L GT Y PE + H A
Sbjct: 188 ---------ALLHDEPY------------------TDFDGTRVYSPPEWISRHQYHALPA 220
Query: 970 DWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTEN 1029
WS+GI+L++++ G PF I+ ++ + P +S + C LI + L
Sbjct: 221 TVWSLGILLYDMVCGDIPFERD------QEILEAEL---HFPAHVSPDCCALIRRCLAPK 271
Query: 1030 PVQRLGATGAREVKQHPFFK 1049
P R E+ P+ +
Sbjct: 272 PSSRPSLE---EILLDPWMQ 288
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 3e-60
Identities = 56/383 (14%), Positives = 104/383 (27%), Gaps = 80/383 (20%)
Query: 712 LCGQIDDEKLDSSNAMTEEESSMDEDTVRSL--RTSPINPCSKDRTSIEDFEIIKPISQG 769
L + ++ +E ++M E ++ + + S ++++P+ G
Sbjct: 14 LLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVG 73
Query: 770 AFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFF----- 824
VFL R + FA+KV ++ +E + +
Sbjct: 74 DRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRL 133
Query: 825 ---------------------YSFTCRENLYLVMEYLNGGDLYSLLRNL-------GCLD 856
N L+M DL L L G
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEG 192
Query: 857 EDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916
+ A+L+ L S ++H PDNL I DG + L D
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---------- 242
Query: 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSV 974
+ + + + Y E L + W +
Sbjct: 243 -----------------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQL 279
Query: 975 GIILFELLIGIPPFNAKTP------QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTE 1028
G+ ++ + PF TP ++ + D + LI + L
Sbjct: 280 GLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF 339
Query: 1029 NPVQRLGATGAREVKQHPFFKNI 1051
+ +RL E + P F +
Sbjct: 340 DRRRRL---LPLEAMETPEFLQL 359
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 5e-60
Identities = 77/335 (22%), Positives = 122/335 (36%), Gaps = 69/335 (20%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
S + +E+ + + G FG V + TG+ AIK ++ ++ KN E E
Sbjct: 7 SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKN-RERWCLEIQ 64
Query: 811 ILISVRNPFVVRFF------YSFTCRENLYLVMEYLNGGDLYSLLR---NLGCLDEDMAR 861
I+ + +P VV + L MEY GGDL L N L E R
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 862 VYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSA 918
++++ AL YLH +IHRDLKP+N+++ Q K+ D G +K
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE----------- 173
Query: 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978
L G GT YLAPE+L + T D+WS G +
Sbjct: 174 --LDQGELC------------------TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
Query: 979 FELLIGIPPFNAKTPQQIFDNIMNR--------------------DIPWPN-IPEEMSVE 1017
FE + G PF + + +P PN + ++ +
Sbjct: 214 FECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK 273
Query: 1018 ACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052
+ +L + QR + F+ ++
Sbjct: 274 LERWLQCMLMWHQRQRGTDP---QNPNVGCFQALD 305
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 4e-59
Identities = 83/322 (25%), Positives = 135/322 (41%), Gaps = 48/322 (14%)
Query: 741 SLRTSPINPCSKDRTS----IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM 796
S+R++ C D ++ + +G +G V+ R + AIK + + D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD- 59
Query: 797 IRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--- 853
+ + E + +++ +V++ SF+ + + ME + GG L +LLR+
Sbjct: 60 --SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPL 117
Query: 854 CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGLIHS 912
+E Y +++ L+YLH ++HRD+K DN+LI G +K++DFG SK
Sbjct: 118 KDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR----- 172
Query: 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM--GHGATAD 970
L + GT Y+APEI+ G+G AD
Sbjct: 173 -------------------------LAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 971 WWSVGIILFELLIGIPPF-NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTEN 1029
WS+G + E+ G PPF PQ + + P IPE MS EA I K +
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH-PEIPESMSAEAKAFILKCFEPD 266
Query: 1030 PVQRLGATGAREVKQHPFFKNI 1051
P +R A A ++ F K
Sbjct: 267 PDKR--AC-ANDLLVDEFLKVS 285
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 6e-59
Identities = 87/319 (27%), Positives = 133/319 (41%), Gaps = 66/319 (20%)
Query: 752 KDRTSIEDFEII-KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
K I+D+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 106
Query: 811 ILISVRN-PFVVRF--FY--SFTCRENLYLVMEYLNGGDLYS--LLRNLGCLDEDMARVY 863
+ P +VR Y + R+ L +VME L+GG+L+S R E A
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920
+ + A++YLHS+N+ HRD+KP+NLL + +KLTDFG +K
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------------- 212
Query: 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFE 980
E LT + TP Y+APE+L + + D WS+G+I++
Sbjct: 213 ----------ETTSHNSLT-------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 255
Query: 981 LLIGIPPFNAK----TPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPV 1031
LL G PPF + + I W + S E LI LL P
Sbjct: 256 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----SEEVKMLIRNLLKTEPT 311
Query: 1032 QRLGATGAREVKQHPFFKN 1050
QR+ T E HP+
Sbjct: 312 QRMTIT---EFMNHPWIMQ 327
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 84/330 (25%), Positives = 155/330 (46%), Gaps = 46/330 (13%)
Query: 723 SSNAMTEEESSMDEDTVRSLRT--SPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKR 780
+ N + E +LR +P + I +G+ G V LAR++
Sbjct: 15 TENLYFQSGVVTHEQFKAALRMVVDQGDP-------RLLLDSYVKIGEGSTGIVCLAREK 67
Query: 781 ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYL 840
+G A+K++ D+ ++ E + E I+ ++ VV + S+ E L+++ME+L
Sbjct: 68 HSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124
Query: 841 NGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLT 900
GG L ++ L+E+ ++ AL YLH+ VIHRD+K D++L+ DG +KL+
Sbjct: 125 QGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLS 183
Query: 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL 960
DFG Q ++++ ++ S+ GTP ++APE++
Sbjct: 184 DFGFCA----------------------------Q--ISKDVPKRKSLVGTPYWMAPEVI 213
Query: 961 LGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACD 1020
+ D WS+GI++ E++ G PP+ + +P Q + + P ++S D
Sbjct: 214 SRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRD 273
Query: 1021 LIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
++++L +P +R AT A+E+ HPF
Sbjct: 274 FLERMLVRDPQER--AT-AQELLDHPFLLQ 300
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 63/352 (17%), Positives = 128/352 (36%), Gaps = 83/352 (23%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFA-------------------IKVLKKAD--- 795
DFE I+ + +G FG VF A+ + +A +K L K +
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 796 ---------------------------------MIRKNAVESILAERNILISVRNPFVVR 822
+ + +++ + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRN---LGCLDEDMARVYIAELVLALEYLHSLNV 879
+ + LY+ M+ +L + L + + ++ A+E+LHS +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
+HRDLKP N+ D +K+ DFGL + ++ +
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTA-MDQDEEE-----------------QTVLTPM 227
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999
GT Y++PE + G + D +S+G+ILFELL + +I +
Sbjct: 228 PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--RIITD 285
Query: 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
+ R++ +P + + + ++ +L+ +P +R AT ++ ++ F+N+
Sbjct: 286 V--RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT---DIIENAIFENL 332
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 3e-58
Identities = 97/318 (30%), Positives = 157/318 (49%), Gaps = 46/318 (14%)
Query: 735 DEDTVRSLRT--SPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLK 792
DE+ + LR+ S +P + + + I QGA G V+ A ATG AI+ +
Sbjct: 2 DEEILEKLRSIVSVGDP-------KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM- 53
Query: 793 KADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 852
++ ++ E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 54 --NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE- 110
Query: 853 GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912
C+DE E + ALE+LHS VIHRD+K DN+L+G DG +KLTDFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------ 164
Query: 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWW 972
Q +T EQ ++ ++ GTP ++APE++ +G D W
Sbjct: 165 ----------------------Q--ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 973 SVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQ 1032
S+GI+ E++ G PP+ + P + I P PE++S D +++ L + +
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 260
Query: 1033 RLGATGAREVKQHPFFKN 1050
R + A+E+ QH F K
Sbjct: 261 R--GS-AKELLQHQFLKI 275
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-56
Identities = 55/410 (13%), Positives = 109/410 (26%), Gaps = 84/410 (20%)
Query: 698 GRRIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSI 757
G + + L + + E + S+ S + P S+
Sbjct: 25 GDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTG-------QPFRVESELGERP 77
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI---LIS 814
+ Q A + TG+ F + V + NA++ + E L
Sbjct: 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137
Query: 815 VRNP------------------------FVVRFFYSFTCRENLYLVMEYLNG------GD 844
++N VR + + + +
Sbjct: 138 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEV 197
Query: 845 LYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGL 904
L S L +++ L LH ++H L+P ++++ Q G + LT F
Sbjct: 198 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG 964
A ++ G P+ A +L
Sbjct: 258 LVR--------DGASAVSPIGRGF---------------------APPETTAERMLPFGQ 288
Query: 965 HGAT-----ADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEAC 1019
H T D W++G+ ++ + P + I NIP+
Sbjct: 289 HHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC---KNIPQ----PVR 341
Query: 1020 DLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAES 1069
L++ L RL + + P ++ + + A +
Sbjct: 342 ALLEGFLRYPKEDRL---LPLQAMETPEYEQLRTELSAALPLYQTDGEPT 388
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-55
Identities = 86/335 (25%), Positives = 150/335 (44%), Gaps = 60/335 (17%)
Query: 734 MDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKV--L 791
M ED+ S IN +D+E+ + I GA V A + AIK L
Sbjct: 1 MSEDS--SALPWSINR--------DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL 50
Query: 792 KKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 851
+K +++ +L E + +P +V ++ SF ++ L+LVM+ L+GG + ++++
Sbjct: 51 EKCQ----TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH 106
Query: 852 L--------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFG 903
+ G LDE + E++ LEYLH IHRD+K N+L+G+DG +++ DFG
Sbjct: 107 IVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166
Query: 904 LSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPE-ILLG 962
+S + + D++ + + + GTP ++APE +
Sbjct: 167 VS--AFLATGGDIT-----------------------RNKVRKTFVGTPCWMAPEVMEQV 201
Query: 963 MGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIP-------WPNIPEEMS 1015
G+ AD WS GI EL G P++ P ++ + D P + ++
Sbjct: 202 RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYG 261
Query: 1016 VEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+I L ++P +R T A E+ +H FF+
Sbjct: 262 KSFRKMISLCLQKDPEKR--PT-AAELLRHKFFQK 293
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 2e-55
Identities = 64/330 (19%), Positives = 137/330 (41%), Gaps = 55/330 (16%)
Query: 729 EEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAI 788
+++ ++E +++ S K I +G+F V+ T A
Sbjct: 6 QQQDDIEELETKAVGMSNDGRFLKFD---------IEIGRGSFKTVYKGLDTETTVEVAW 56
Query: 789 KVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC----RENLYLVMEYLNGGD 844
L+ + K+ + E +L +++P +VRF+ S+ ++ + LV E + G
Sbjct: 57 CELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT 115
Query: 845 LYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLI-GQDGHIKLTD 901
L + L+ + + R + +++ L++LH+ +IHRDLK DN+ I G G +K+ D
Sbjct: 116 LKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD 175
Query: 902 FGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL 961
GL+ + + +V GTP+++APE+
Sbjct: 176 LGLATL--------------------------------KRASFAKAVIGTPEFMAPEMYE 203
Query: 962 GMGHGATADWWSVGIILFELLIGIPPF-NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACD 1020
+ + D ++ G+ + E+ P+ + QI+ + + P + + E +
Sbjct: 204 E-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFDKVAIPEVKE 261
Query: 1021 LIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+I+ + +N +R +++ H FF+
Sbjct: 262 IIEGCIRQNKDERY---SIKDLLNHAFFQE 288
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 3e-55
Identities = 86/325 (26%), Positives = 143/325 (44%), Gaps = 52/325 (16%)
Query: 727 MTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLF 786
M + ++ +P E F ++ I +G+FG VF T +
Sbjct: 1 MAHSPVQ---SGLPGMQNLKADPE-------ELFTKLEKIGKGSFGEVFKGIDNRTQKVV 50
Query: 787 AIKV--LKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGD 844
AIK+ L++A+ + +E I E +L +P+V +++ S+ L+++MEYL GG
Sbjct: 51 AIKIIDLEEAE----DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106
Query: 845 LYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGL 904
LL G LDE + E++ L+YLHS IHRD+K N+L+ + G +KL DFG+
Sbjct: 107 ALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV 165
Query: 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG 964
+ LT Q ++++ GTP ++APE++
Sbjct: 166 AG------------------------------QLTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 965 HGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDK 1024
+ + AD WS+GI EL G PP + P ++ I P + S + ++
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NPPTLEGNYSKPLKEFVEA 253
Query: 1025 LLTENPVQRLGATGAREVKQHPFFK 1049
L + P R A E+ +H F
Sbjct: 254 CLNKEPSFRPTAK---ELLKHKFIL 275
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 6e-55
Identities = 83/299 (27%), Positives = 145/299 (48%), Gaps = 42/299 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E +EI+ + GAFG+V+ A+ + TG L A KV+ + + +E + E IL + +
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDH 75
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHS 876
P++V+ ++ L++++E+ GG + +++ L L E +V +++ AL +LHS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+IHRDLK N+L+ +G I+L DFG+S
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAK----------------------------- 166
Query: 937 PLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGIPPFNAK 991
+ +++ S GTP ++APE+++ + AD WS+GI L E+ PP +
Sbjct: 167 -NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
Query: 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
P ++ I D P P + SVE D + L +NP R + A ++ +HPF +
Sbjct: 226 NPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR--PS-AAQLLEHPFVSS 281
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-54
Identities = 86/294 (29%), Positives = 145/294 (49%), Gaps = 39/294 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E F++++ + +G++G V+ A + TG + AIK + ++ I+ E +I+ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHS 876
P VV+++ S+ +L++VMEY G + ++R L ED + + LEYLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+ IHRD+K N+L+ +GH KL DFG++ Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAG----------------------------Q- 174
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
LT ++++V GTP ++APE++ +G+ AD WS+GI E+ G PP+ P +
Sbjct: 175 -LTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233
Query: 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
I P PE S D + + L ++P QR AT A ++ QHPF ++
Sbjct: 234 IFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR--AT-ATQLLQHPFVRS 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-54
Identities = 66/303 (21%), Positives = 111/303 (36%), Gaps = 49/303 (16%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI-SVRN 817
F + GA G + A+K + E +L S +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLALEYLHS 876
P V+R+F + R+ Y+ +E L + + + + L +LHS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 877 LNVIHRDLKPDNLLIGQDGH-----IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
LN++HRDLKP N+LI ++DFGL K L
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK-------------------KLAVGR 177
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGM---GHGATADWWSVGIILFELL-IGIPP 987
++ V GT ++APE+L T D +S G + + ++ G P
Sbjct: 178 --------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229
Query: 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
F +Q + + + + V A +LI+K++ +P +R A V +HPF
Sbjct: 230 FGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAK---HVLKHPF 286
Query: 1048 FKN 1050
F +
Sbjct: 287 FWS 289
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 195 bits (496), Expect = 4e-54
Identities = 75/327 (22%), Positives = 134/327 (40%), Gaps = 69/327 (21%)
Query: 756 SIEDFEII-KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI- 813
S+++ + K + G+ G V G A+K + + L E +L
Sbjct: 12 SLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFC------DIALMEIKLLTE 64
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDM-------ARVYIAE 866
S +P V+R++ S T LY+ +E +L L+ + DE++ + +
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLI-------------GQDGHIKLTDFGLSKVGLIHST 913
+ + +LHSL +IHRDLKP N+L+ ++ I ++DFGL K
Sbjct: 124 IASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK------- 176
Query: 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT----- 968
L + + + L ++ +GT + APE+L + T
Sbjct: 177 ------------KLDSGQSSFRTNL-------NNPSGTSGWRAPELLEESNNLQTKRRLT 217
Query: 969 --ADWWSVGIILFELL-IGIPPFNAKTPQQ--IFDNIMNRDIPWPNIPEEMSVEACDLID 1023
D +S+G + + +L G PF K ++ I I + D + EA DLI
Sbjct: 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS 277
Query: 1024 KLLTENPVQRLGATGAREVKQHPFFKN 1050
+++ +P++R A +V +HP F
Sbjct: 278 QMIDHDPLKRP---TAMKVLRHPLFWP 301
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 9e-53
Identities = 83/367 (22%), Positives = 140/367 (38%), Gaps = 83/367 (22%)
Query: 730 EESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIK 789
EE +DE + L +DFE I + G G VF + +G + A K
Sbjct: 5 EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 790 V--LKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYS 847
+ L+ IR I+ E +L +P++V F+ +F + + ME+++GG L
Sbjct: 65 LIHLEIKPAIRNQ----IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120
Query: 848 LLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906
+L+ G + E + ++ L YL ++HRD+KP N+L+ G IKL DFG+S
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS- 179
Query: 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHG 966
G L++ +S GT Y++PE L G +
Sbjct: 180 ------------------GQLIDS-------------MANSFVGTRSYMSPERLQGTHYS 208
Query: 967 ATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDI--------------------- 1005
+D WS+G+ L E+ +G P +++ +
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 1006 ----PWPNI----------------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
P I S+E D ++K L +NP +R +++ H
Sbjct: 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA---DLKQLMVH 325
Query: 1046 PFFKNIN 1052
F K +
Sbjct: 326 AFIKRSD 332
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-52
Identities = 77/319 (24%), Positives = 119/319 (37%), Gaps = 87/319 (27%)
Query: 752 KDRTSIEDFEII-KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
K I+D+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 62
Query: 811 ILISVRN-PFVVRFFYSF----TCRENLYLVMEYLNGGDLYS--LLRNLGCLDEDMARVY 863
+ P +VR + R+ L +VME L+GG+L+S R E A
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920
+ + A++YLHS+N+ HRD+KP+NLL + +KLTDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------- 165
Query: 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFE 980
A E + + D WS+G+I++
Sbjct: 166 ----------------------------------FAKETTGE-KYDKSCDMWSLGVIMYI 190
Query: 981 LLIGIPPFNAK----TPQQIFDNIMNRDI-----PWPNIPEEMSVEACDLIDKLLTENPV 1031
LL G PPF + + I W + S E LI LL P
Sbjct: 191 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----SEEVKMLIRNLLKTEPT 246
Query: 1032 QRLGATGAREVKQHPFFKN 1050
QR+ T E HP+
Sbjct: 247 QRM--T-ITEFMNHPWIMQ 262
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-52
Identities = 85/309 (27%), Positives = 136/309 (44%), Gaps = 55/309 (17%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES----ILAERNI 811
+D E I + +GA+G V R +G + A+K IR +L + +I
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR------IRATVNSQEQKRLLMDLDI 58
Query: 812 LI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG--DLY-SLLRNLGCLDEDMARVYIAEL 867
+ +V PF V F+ + ++++ ME ++ Y ++ + ED+ +
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 868 VLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
V ALE+LHS L+VIHRD+KP N+LI G +K+ DFG+S G+
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGIS-------------------GY 159
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT----ADWWSVGIILFELL 982
LV+ K AG Y+APE + + +D WS+GI + EL
Sbjct: 160 LVD------------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA 207
Query: 983 IGIPPFNA-KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041
I P+++ TP Q ++ P ++ S E D + L +N +R T E
Sbjct: 208 ILRFPYDSWGTPFQQLKQVVEEPSPQLP-ADKFSAEFVDFTSQCLKKNSKER--PT-YPE 263
Query: 1042 VKQHPFFKN 1050
+ QHPFF
Sbjct: 264 LMQHPFFTL 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 6e-52
Identities = 79/312 (25%), Positives = 133/312 (42%), Gaps = 52/312 (16%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES----IL 806
+ + I D E + + G G+V+ R R TG + A+K +R++ + IL
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ------MRRSGNKEENKRIL 71
Query: 807 AERNILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA 865
+ ++++ S P++V+ F +F ++++ ME + R G + E +
Sbjct: 72 MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTV 131
Query: 866 ELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSG 924
+V AL YL VIHRD+KP N+L+ + G IKL DFG+S
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS------------------- 172
Query: 925 GFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL-----LGMGHGATADWWSVGIILF 979
G LV+D + K AG Y+APE + + AD WS+GI L
Sbjct: 173 GRLVDD------------KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV 220
Query: 980 ELLIGIPPFNA-KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATG 1038
EL G P+ KT ++ ++ + P S + + LT++ +R
Sbjct: 221 ELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR--PK- 277
Query: 1039 AREVKQHPFFKN 1050
++ +H F K
Sbjct: 278 YNKLLEHSFIKR 289
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 6e-52
Identities = 70/304 (23%), Positives = 116/304 (38%), Gaps = 45/304 (14%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-P 818
+ + +++G F V+ A+ +G +A+K L + + +I+ E + + P
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHP 86
Query: 819 FVVRFFYSF--------TCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELV 868
+V+F + T + L+ E G + L + G L D +
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 869 LALEYLHSLN--VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
A++++H +IHRDLK +NLL+ G IKL DFG + + SA
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA-------- 198
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH---GATADWWSVGIILFELLI 983
+ L E+ ++ TP Y PEI+ + G D W++G IL+ L
Sbjct: 199 -------QRRALVEEEITRN---TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF 248
Query: 984 GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043
PF + I+N P LI +L NP +RL EV
Sbjct: 249 RQHPFEDGAKLR----IVNGKYSIPPHD-TQYTVFHSLIRAMLQVNPEERLSIA---EVV 300
Query: 1044 QHPF 1047
Sbjct: 301 HQLQ 304
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 9e-51
Identities = 75/327 (22%), Positives = 139/327 (42%), Gaps = 51/327 (15%)
Query: 738 TVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI 797
++ S I+P + ED + + I +GA+G V + +G + A+K +
Sbjct: 2 SIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI---RST 58
Query: 798 RKNAV-ESILAERNILI-SVRNPFVVRFFYSFTCRENLYLVMEYLNGG--DLYSLLRNL- 852
+ +L + ++++ S P++V+F+ + + ++ ME ++ Y + ++
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118
Query: 853 -GCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910
+ E++ V AL +L L +IHRD+KP N+L+ + G+IKL DFG+S
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS----- 173
Query: 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT-- 968
G LV+ K AG Y+APE +
Sbjct: 174 --------------GQLVDS------------IAKTRDAGCRPYMAPERIDPSASRQGYD 207
Query: 969 --ADWWSVGIILFELLIGIPPFNA-KTPQQIFDNIMNRDIPWPNIPEEM--SVEACDLID 1023
+D WS+GI L+EL G P+ + ++ D P + EE S + ++
Sbjct: 208 VRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVN 267
Query: 1024 KLLTENPVQRLGATGAREVKQHPFFKN 1050
LT++ +R +E+ +HPF
Sbjct: 268 LCLTKDESKR--PK-YKELLKHPFILM 291
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-50
Identities = 72/296 (24%), Positives = 114/296 (38%), Gaps = 41/296 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ F ++ I G+FG V+ AR ++ AIK + + + I+ E L +R+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P +++ + +LVMEY G L + L E + L YLHS
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
N+IHRD+K N+L+ + G +KL DFG +
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSAS------------------------------- 202
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGM---GHGATADWWSVGIILFELLIGIPPFNAKTPQ 994
+S GTP ++APE++L M + D WS+GI EL PP
Sbjct: 203 ---IMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 259
Query: 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+I + P S + +D L + P R T + + +H F
Sbjct: 260 SALYHIAQNESPALQ-SGHWSEYFRNFVDSCLQKIPQDR--PT-SEVLLKHRFVLR 311
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-50
Identities = 77/308 (25%), Positives = 133/308 (43%), Gaps = 52/308 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-R 816
FE+++ + G +G+V+ R TG L AIKV+ + + E I E N+L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 817 NPFVVRFFYSF------TCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELV 868
+ + ++ +F + L+LVME+ G + L++N L E+ E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
L +LH VIHRD+K N+L+ ++ +KL DFG+S
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 177
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-----GHGATADWWSVGIILFELLI 983
Q L R ++++ GTP ++APE++ + +D WS+GI E+
Sbjct: 178 ------Q--LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 984 GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043
G PP P + I P ++ S + I+ L +N QR ++
Sbjct: 230 GAPPLCDMHPMRALFLIPRNPAPRLK-SKKWSKKFQSFIESCLVKNHSQR--PA-TEQLM 285
Query: 1044 QHPFFKNI 1051
+HPF ++
Sbjct: 286 KHPFIRDQ 293
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 7e-47
Identities = 64/343 (18%), Positives = 120/343 (34%), Gaps = 76/343 (22%)
Query: 758 EDFEIIKPISQGA--FGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
+E++ I +G V LAR + TG+ ++ + + V + E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEY 873
+P +V + +F L++V ++ G L+ ++E + ++ AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
+H + +HR +K ++LI DG + L+ + +++ +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSN-------------------LSMISHGQR 184
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEIL--LGMGHGATADWWSVGIILFELLIGIPPFNAK 991
+ K+SV +L+PE+L G+ A +D +SVGI EL G PF
Sbjct: 185 QR---VVHDFPKYSV-KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
Query: 992 TPQQIFDNIMNRDIP-------------------------------------------WP 1008
Q+ +N +P
Sbjct: 241 PATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSH 300
Query: 1009 NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
S +++ L NP R A + H FFK I
Sbjct: 301 PYHRTFSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFKQI 340
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 85/313 (27%), Positives = 131/313 (41%), Gaps = 43/313 (13%)
Query: 729 EEESSMDEDTVRSLRTSPINPCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGDLF 786
D D + D I D I + I G+FG V A G
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDV 63
Query: 787 AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLY 846
A+K+L + D V L E I+ +R+P +V F + T NL +V EYL+ G LY
Sbjct: 64 AVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 847 SLLRNLGC---LDEDMARVYIA-ELVLALEYLHSLN--VIHRDLKPDNLLIGQDGHIKLT 900
LL G LDE R+ +A ++ + YLH+ N ++HR+LK NLL+ + +K+
Sbjct: 123 RLLHKSGAREQLDERR-RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVC 181
Query: 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL 960
DFGLS++ S AGTP+++APE+L
Sbjct: 182 DFGLSRL------------------------------KASTFLSSKSAAGTPEWMAPEVL 211
Query: 961 LGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACD 1020
+D +S G+IL+EL P+ P Q+ + + IP ++ +
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAA 270
Query: 1021 LIDKLLTENPVQR 1033
+I+ T P +R
Sbjct: 271 IIEGCWTNEPWKR 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 60/289 (20%), Positives = 116/289 (40%), Gaps = 47/289 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E EI + I +G FG+V+ R G++ AI+++ ++ +++ E R+
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWH--GEV-AIRLIDIERDN-EDQLKAFKREVMAYRQTRH 88
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA-ELVLALEYLHS 876
VV F + +L ++ G LYS++R+ + + IA E+V + YLH+
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
++H+DLK N+ +G + +TDFGL +
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSI-------------------------SGVL 182
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGAT---------ADWWSVGIILFELLIGIPP 987
R + + G +LAPEI+ + +D +++G I +EL P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 988 FNAKTPQQIFDNIMN---RDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
F + + I + ++ + +E+S D++ +R
Sbjct: 243 FKTQPAEAIIWQMGTGMKPNLSQIGMGKEIS----DILLFCWAFEQEER 287
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 86/328 (26%), Positives = 136/328 (41%), Gaps = 71/328 (21%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKA---DMIRKNAVESILAERNILIS 814
E +E I I +G++G VF R R TG + AIK ++ +I+K A L E +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA----LREIRMLKQ 58
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLALEY 873
+++P +V F + L+LV EY + + L + E + + + + A+ +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
H N IHRD+KP+N+LI + IKL DFG +++ L+ PS
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARL--------LTGPS------------- 156
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAKT 992
VA T Y +PE+L+G D W++G + ELL G+P + K+
Sbjct: 157 --DYYD------DEVA-TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS 207
Query: 993 -PQQIF--------------------DNIMNRDIPWPNIPE-------EMSVEACDLIDK 1024
Q++ IP P E +S A L+
Sbjct: 208 DVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKG 267
Query: 1025 LLTENPVQRLGATGAREVKQHPFFKNIN 1052
L +P +RL HP+F+NI
Sbjct: 268 CLHMDPTERLTCEQLL---HHPYFENIR 292
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 70/325 (21%), Positives = 139/325 (42%), Gaps = 46/325 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
D + + +G FG+ R TG++ +K L + D + + L E ++ + +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEH 66
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELV-LALEYLH 875
P V++F + L + EY+ GG L +++++ RV A+ + + YLH
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQ-RVSFAKDIASGMAYLH 125
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S+N+IHRDL N L+ ++ ++ + DFGL+++ D+ + P
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARL----MVDEKTQPEGLRS----------- 170
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
+++++++V G P ++APE++ G + D +S GI+L E++ + P+
Sbjct: 171 -LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 996 I-----FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+ ++R P PN P + + +P +R P F
Sbjct: 230 MDFGLNVRGFLDRYCP-PNCPPSFF----PITVRCCDLDPEKR------------PSFVK 272
Query: 1051 INW--DTLARQKAMFIPAAESLDTS 1073
+ +TL A +P L+
Sbjct: 273 LEHWLETLRMHLAGHLPLGPQLEQL 297
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 78/377 (20%), Positives = 140/377 (37%), Gaps = 92/377 (24%)
Query: 721 LDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKR 780
+ + S+ S + SI+ + I + +G +G V+ A
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAAPSAT----SIDRYRRITKLGEGTYGEVYKAIDT 56
Query: 781 ATGDLFAIKVLK--KAD------MIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832
T + AIK ++ + IR E ++L +++ ++
Sbjct: 57 VTNETVAIKRIRLEHEEEGVPGTAIR---------EVSLLKELQHRNIIELKSVIHHNHR 107
Query: 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI- 891
L+L+ EY DL + + + + ++ +L+ + + HS +HRDLKP NLL+
Sbjct: 108 LHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLS 166
Query: 892 ----GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHS 947
+ +K+ DFGL++ P T H
Sbjct: 167 VSDASETPVLKIGDFGLARA--------FGIPI---------------RQFT------HE 197
Query: 948 VAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAKTPQQ----IFDNIM- 1001
+ T Y PEILLG H +T+ D WS+ I E+L+ P F + IF ++
Sbjct: 198 II-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF-EVLG 255
Query: 1002 --NRDIPWPNI----------------------PEEMSVEACDLIDKLLTENPVQRLGAT 1037
+ WP + + E DL+ +L +PV+R+ A
Sbjct: 256 LPDDTT-WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAK 314
Query: 1038 GAREVKQHPFFKNINWD 1054
A +HP+F + ++D
Sbjct: 315 NAL---EHPYFSHNDFD 328
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-44
Identities = 63/293 (21%), Positives = 116/293 (39%), Gaps = 54/293 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILA----ERNILI 813
+ E K I +G FG V R + AIK L D + + E I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIA-ELVLAL 871
++ +P +V+ + +VME++ GDLY L + + + ++ + ++ L +
Sbjct: 79 NLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSV-KLRLMLDIALGI 135
Query: 872 EYLHSLN--VIHRDLKPDNLLIGQDG-----HIKLTDFGLSKVGLIHSTDDLSAPSLGSG 924
EY+ + N ++HRDL+ N+ + K+ DFGLS+
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----------------- 178
Query: 925 GFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT--ADWWSVGIILFELL 982
+ G ++APE + T AD +S +IL+ +L
Sbjct: 179 ----------------SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL 222
Query: 983 IGIPPFNAKTPQQI--FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
G PF+ + +I + I + P IPE+ ++I+ + +P +R
Sbjct: 223 TGEGPFDEYSYGKIKFINMIREEGLR-PTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 2e-44
Identities = 80/341 (23%), Positives = 137/341 (40%), Gaps = 86/341 (25%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESI----LAERN 810
+S F+ ++ + G + V+ + TG A LK+ ++ ++ E + E +
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVA---LKE---VKLDSEEGTPSTAIREIS 55
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC------LDEDMARVYI 864
++ +++ +VR + L LV E+++ DL + + L+ ++ + +
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 865 AELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSG 924
+L+ L + H ++HRDLKP NLLI + G +KL DFGL++ P
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA--------FGIPV---- 162
Query: 925 GFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLI 983
+ V T Y AP++L+G +T+ D WS G IL E++
Sbjct: 163 -----------NTFS------SEVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204
Query: 984 GIPPFNAKTPQQ----IFDNIM---NRDIPWPNI-------------------------- 1010
G P F ++ IFD IM N + WP++
Sbjct: 205 GKPLFPGTNDEEQLKLIFD-IMGTPNESL-WPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262
Query: 1011 PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
E + D + LL NP RL A A HP+F
Sbjct: 263 KEPLDGNLMDFLHGLLQLNPDMRLSAKQAL---HHPWFAEY 300
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 83/352 (23%), Positives = 138/352 (39%), Gaps = 74/352 (21%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
++ E+ + + +GAFG V A+ R AIK ++ ++ + E L V +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESER-----KAFIVELRQLSRVNH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDMARVYIA-ELVLALEY 873
P +V+ + + C + LVMEY GG LY++L L + + + Y
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH-AMSWCLQCSQGVAY 117
Query: 874 LHSLN---VIHRDLKPDNLLIGQDG-HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
LHS+ +IHRDLKP NLL+ G +K+ DFG + H T
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT---------------- 161
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989
+ G+ ++APE+ G + D +S GIIL+E++ PF+
Sbjct: 162 -----------------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD 204
Query: 990 --AKTPQQIFDNIMN--RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
+I + N R P + + + L+ + +++P QR
Sbjct: 205 EIGGPAFRIMWAVHNGTR----PPLIKNLPKPIESLMTRCWSKDPSQR------------ 248
Query: 1046 PFFKNINWDTLARQKAMFIPAAESLDTSYFVSRYVWNPEDENVQGGSDFDDL 1097
P + I + F A E L S + ED V+ DF +
Sbjct: 249 PSMEEIV-KIMTHLMRYFPGADEPLQYPCQHS--LPPGEDGRVEPYVDFAEF 297
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 90/331 (27%), Positives = 144/331 (43%), Gaps = 78/331 (23%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVE-----SILAERNI 811
+E + ++ I +G +G V+ A+ G+ FA LKK IR + + + E +I
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFA---LKK---IRLEKEDEGIPSTTIREISI 53
Query: 812 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLA 870
L +++ +V+ + ++ L LV E+L+ DL LL L+ A+ ++ +L+
Sbjct: 54 LKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+ Y H V+HRDLKP NLLI ++G +K+ DFGL++ P
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA--------FGIPV---------- 154
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFN 989
T H + T Y AP++L+G +T D WSVG I E++ G P F
Sbjct: 155 -----RKYT------HEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFP 202
Query: 990 AKTPQQ----IFDNIM---NRDIPWPNIPE---------------------EMSVEACDL 1021
+ IF I+ N WPN+ E + DL
Sbjct: 203 GVSEADQLMRIFR-ILGTPNSKN-WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260
Query: 1022 IDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052
+ K+L +P QR+ A A +H +FK N
Sbjct: 261 LSKMLKLDPNQRITAKQAL---EHAYFKENN 288
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-44
Identities = 81/351 (23%), Positives = 146/351 (41%), Gaps = 77/351 (21%)
Query: 737 DTVRSLRTSPINPCSKDRT--SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKA 794
+S ++ +++ S+E +E + + +G++G V R + TG + AIK ++
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLES 61
Query: 795 ---DMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN 851
M++K A + E +L +R+ +V ++ YLV E+++ + L
Sbjct: 62 DDDKMVKKIA----MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLEL 116
Query: 852 LGC-LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910
LD + + Y+ +++ + + HS N+IHRD+KP+N+L+ Q G +KL DFG ++
Sbjct: 117 FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART--- 173
Query: 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA- 969
L+AP VA T Y APE+L+G A
Sbjct: 174 -----LAAPG---------------EVYD------DEVA-TRWYRAPELLVGDVKYGKAV 206
Query: 970 DWWSVGIILFELLIGIPPFNAKT-PQQIFDNIM------NRDIPWP-----------NIP 1011
D W++G ++ E+ +G P F + Q++ +IM +P
Sbjct: 207 DVWAIGCLVTEMFMGEPLFPGDSDIDQLY-HIMMCLGNLIPRH-QELFNKNPVFAGVRLP 264
Query: 1012 E------------EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
E ++S DL K L +P +R H FF+
Sbjct: 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL---HHDFFQM 312
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-44
Identities = 85/331 (25%), Positives = 137/331 (41%), Gaps = 77/331 (23%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESI----LAERNIL 812
+E + + + +G + V+ + + T +L A LK+ IR E + E ++L
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVA---LKE---IRLEHEEGAPCTAIREVSLL 54
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLAL 871
+++ +V ++L LV EYL+ DL L + G ++ ++++ +L+ L
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
Y H V+HRDLKP NLLI + G +KL DFGL++ S P+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA--------KSIPT----------- 154
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNA 990
+ V T Y P+ILLG +T D W VG I +E+ G P F
Sbjct: 155 ----KTYD------NEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203
Query: 991 KTPQQ----IFDNIM---NRDIPWPNIPE----------------------EMSVEACDL 1021
T ++ IF I+ + WP I + + DL
Sbjct: 204 STVEEQLHFIFR-ILGTPTEET-WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADL 261
Query: 1022 IDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052
+ KLL R+ A A +HPFF ++
Sbjct: 262 LTKLLQFEGRNRISAEDAM---KHPFFLSLG 289
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-43
Identities = 86/330 (26%), Positives = 140/330 (42%), Gaps = 71/330 (21%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESI----LAER 809
++ + +E + + +G F V+ AR + T + AIK +K R A + I L E
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH--RSEAKDGINRTALREI 63
Query: 810 NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELV 868
+L + +P ++ +F + N+ LV +++ DL ++++ L + Y+ +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
LEYLH ++HRDLKP+NLL+ ++G +KL DFGL+K
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS--------------------F 162
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPP 987
+ T H V T Y APE+L G D W+VG IL ELL+ +P
Sbjct: 163 GSPNR---AYT------HQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 212
Query: 988 FNAKT-PQQ---IFDNIM---NRDIPWPNI---PE-----------------EMSVEACD 1020
+ Q IF+ + + WP++ P+ + D
Sbjct: 213 LPGDSDLDQLTRIFE-TLGTPTEEQ-WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD 270
Query: 1021 LIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
LI L NP R+ AT A + +F N
Sbjct: 271 LIQGLFLFNPCARITATQAL---KMKYFSN 297
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 84/331 (25%), Positives = 141/331 (42%), Gaps = 76/331 (22%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESI----LAERNIL 812
++ +E ++ I +G +G VF A+ R T ++ A+K ++ + E + L E +L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLL 55
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLAL 871
+++ +VR + L LV E+ + DL + LD ++ + ++ +L+ L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
+ HS NV+HRDLKP NLLI ++G +KL +FGL++ P
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA--------FGIPV----------- 155
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELL-IGIPPFN 989
+ V T Y P++L G +T+ D WS G I EL G P F
Sbjct: 156 ----RCYS------AEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204
Query: 990 AKTPQQ----IFDNIM---NRDIPWPNIPE---------------------EMSVEACDL 1021
IF ++ + WP++ + +++ DL
Sbjct: 205 GNDVDDQLKRIFR-LLGTPTEEQ-WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL 262
Query: 1022 IDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052
+ LL NPVQR+ A A QHP+F +
Sbjct: 263 LQNLLKCNPVQRISAEEAL---QHPYFSDFC 290
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 82/330 (24%), Positives = 140/330 (42%), Gaps = 69/330 (20%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
+ +E ++ ++ + +G +G V+ A+ G + A+K ++ D + + + E ++L
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIREISLLK 74
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLALE 872
+ +P +V L LV E++ DL +L L + ++Y+ +L+ +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
+ H ++HRDLKP NLLI DG +KL DFGL++ P
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARA--------FGIPV------------ 173
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAK 991
T H V T Y AP++L+G +T+ D WS+G I E++ G P F
Sbjct: 174 ---RSYT------HEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223
Query: 992 TPQQ----IFDNIM---NRDIPWPNIPE----------------------EMSVEACDLI 1022
T IF I+ N WP + E E DL+
Sbjct: 224 TDDDQLPKIFS-ILGTPNPRE-WPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLL 281
Query: 1023 DKLLTENPVQRLGATGAREVKQHPFFKNIN 1052
+L +P +R+ A A HP+FK+++
Sbjct: 282 SNMLCFDPNKRISARDAM---NHPYFKDLD 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 5e-43
Identities = 79/335 (23%), Positives = 129/335 (38%), Gaps = 77/335 (22%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESI----LAERNI 811
+ +E + I GA+G V+ AR +G A+K ++ + + + E +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN--GGGGGGGLPISTVREVAL 64
Query: 812 LISVRN---PFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDMAR 861
L + P VVR + LV E+++ DL + L L + +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 862 VYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921
+ + + L++LH+ ++HRDLKP+N+L+ G +KL DFGL+++ S
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI--------YSYQ-- 173
Query: 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981
LT V T Y APE+LL + D WSVG I E+
Sbjct: 174 --------------MALT------PVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212
Query: 982 LIGIPPFNAKTPQQ----IFDNIM----------NRDIPWPNIPE-----------EMSV 1016
P F + IFD ++ + +P P EM
Sbjct: 213 FRRKPLFCGNSEADQLGKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEE 271
Query: 1017 EACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
L+ ++LT NP +R+ A A QH +
Sbjct: 272 SGAQLLLEMLTFNPHKRISAFRAL---QHSYLHKD 303
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 57/283 (20%), Positives = 114/283 (40%), Gaps = 40/283 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ + I G+FG V+ + GD+ A+K+L +++ E +L R+
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAP-TPQQLQAFKNEVGVLRKTRH 79
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA-ELVLALEYLHS 876
++ F ++ L +V ++ G LY L E + IA + ++YLH+
Sbjct: 80 VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
++IHRDLK +N+ + +D +K+ DFGL+
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK---------------------------- 170
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGA---TADWWSVGIILFELLIGIPPFNAKTP 993
Q ++G+ ++APE++ +D ++ GI+L+EL+ G P++
Sbjct: 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230
Query: 994 -QQIFDNI--MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
QI + + + + L+ + L + +R
Sbjct: 231 RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 71/289 (24%), Positives = 115/289 (39%), Gaps = 50/289 (17%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKK-ADMIRKNAVESILAERNILISVR 816
+ + + I G FG+V+ A GD A+K + D +E++ E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA-ELVLALEYLH 875
+P ++ NL LVME+ GG L +L + D+ V A ++ + YLH
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDI-LVNWAVQIARGMNYLH 122
Query: 876 SLN---VIHRDLKPDNLLIGQDGH--------IKLTDFGLSKVGLIHSTDDLSAPSLGSG 924
+IHRDLK N+LI Q +K+TDFGL++ H T +SA
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSA------ 174
Query: 925 GFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG 984
AG ++APE++ +D WS G++L+ELL G
Sbjct: 175 ------------------------AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210
Query: 985 IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
PF + + + IP L++ +P R
Sbjct: 211 EVPFRGIDGLAVAYGVAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-42
Identities = 50/286 (17%), Positives = 99/286 (34%), Gaps = 48/286 (16%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ + +++ G ++ R + G+ +KVLK D E L
Sbjct: 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFS 65
Query: 817 NPFVVRFFYSFTC--RENLYLVMEYLNGGDLYSLLRNLGCLDEDMA-RVYIA-ELVLALE 872
+P V+ + + L+ ++ G LY++L D + V A ++ +
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 873 YLHSLN--VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+LH+L + L +++I +D +++ +
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS----------------------- 162
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT---ADWWSVGIILFELLIGIPP 987
Q P ++APE L AD WS ++L+EL+ P
Sbjct: 163 ------------FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
Query: 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
F + +I + + P IP +S L+ + E+P +R
Sbjct: 211 FADLSNMEIGMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-42
Identities = 90/341 (26%), Positives = 129/341 (37%), Gaps = 84/341 (24%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-KNAVESI----LAERN 810
+ +E + I QG FG VF AR R TG A LKK + +N E L E
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKK---VLMENEKEGFPITALREIK 68
Query: 811 ILISVRNPFVVR--------FFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMAR 861
IL +++ VV C+ ++YLV ++ DL LL N+ +
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIK 127
Query: 862 VYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921
+ L+ L Y+H ++HRD+K N+LI +DG +KL DFGL++
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-------------- 173
Query: 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFE 980
F + T + V T Y PE+LLG D W G I+ E
Sbjct: 174 ----FSLAKN-SQPNRYT------NRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAE 221
Query: 981 LLIGIPPFNAKTPQQ----IFDNIM---NRDIPWPNIPE--------------------- 1012
+ P T Q I + ++ WPN+
Sbjct: 222 MWTRSPIMQGNTEQHQLALIS-QLCGSITPEV-WPNVDNYELYEKLELVKGQKRKVKDRL 279
Query: 1013 ---EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
A DLIDKLL +P QR+ + A H FF +
Sbjct: 280 KAYVRDPYALDLIDKLLVLDPAQRIDSDDAL---NHDFFWS 317
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 87/340 (25%), Positives = 137/340 (40%), Gaps = 89/340 (26%)
Query: 756 SIEDFEIIKPISQGAFGRVFLAR-KRATGDLFAIKVLKKADM-----------IRKNAVE 803
+ + +E + I +GA+G+VF AR + G A LK+ + IR E
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVA---LKRVRVQTGEEGMPLSTIR----E 61
Query: 804 -SILAERNILISVRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGC--L 855
++L L + +P VVR F L LV E+++ DL + L + +
Sbjct: 62 VAVLRH---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV 117
Query: 856 DEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915
+ + + +L+ L++LHS V+HRDLKP N+L+ G IKL DFGL+++
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------- 169
Query: 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVG 975
S LT V T Y APE+LL + D WSVG
Sbjct: 170 YSFQ----------------MALT------SVVV-TLWYRAPEVLLQSSYATPVDLWSVG 206
Query: 976 IILFELLIGIPPFNAKT-PQQIF----------DNIM--NRDIPWPNIPE---------- 1012
I E+ P F + Q+ + + +P
Sbjct: 207 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFV 266
Query: 1013 -EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
++ DL+ K LT NP +R+ A A HP+F+++
Sbjct: 267 TDIDELGKDLLLKCLTFNPAKRISAYSAL---SHPYFQDL 303
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-41
Identities = 93/371 (25%), Positives = 147/371 (39%), Gaps = 93/371 (25%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIK--VLKKADMIRKNAVESILAE 808
+ R ++ F++ + QG FG V L ++++TG AIK + R L
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR------ELQI 69
Query: 809 RNILISVRNPFVVR---FFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGC----LDE 857
L + +P +V+ +FY+ R+ L +VMEY+ L+ RN
Sbjct: 70 MQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPP 128
Query: 858 DMARVYIAELVLALEYLH--SLNVIHRDLKPDNLLI-GQDGHIKLTDFGLSKVGLIHSTD 914
+ +V++ +L+ ++ LH S+NV HRD+KP N+L+ DG +KL DFG +K
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK------- 181
Query: 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWS 973
L E P + + Y APE++ G H TA D WS
Sbjct: 182 ------------LSPSE-----PNV------AYIC-SRYYRAPELIFGNQHYTTAVDIWS 217
Query: 974 VGIILFELLIGIPPFNAK--------------TPQQIFDNIMNRD-----------IPW- 1007
VG I E+++G P F P + +N IPW
Sbjct: 218 VGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWS 277
Query: 1008 ---PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFI 1064
+ + + EA DL+ LL P +R+ E HP+F + A +
Sbjct: 278 NVFSDHSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYFDEL------HDPATKL 328
Query: 1065 PAAESLDTSYF 1075
P + L F
Sbjct: 329 PNNKDLPEDLF 339
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 5e-41
Identities = 95/370 (25%), Positives = 144/370 (38%), Gaps = 82/370 (22%)
Query: 719 EKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLAR 778
+ + +A + S D+D + DR + K I G+FG V+ A+
Sbjct: 15 KPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAK 74
Query: 779 KRATGDLFAIK-VLKKADMIRKNAVESILAERNILISVRNPFVVR---FFYSFTCREN-- 832
+G+L AIK VL+ D KN E I+ + + +VR FFYS +++
Sbjct: 75 LCDSGELVAIKKVLQ--DKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126
Query: 833 -LYLVMEYLNGGDLYSLLRNLGC----LDEDMARVYIAELVLALEYLHSLNVIHRDLKPD 887
L LV++Y+ +Y + R+ L ++Y+ +L +L Y+HS + HRD+KP
Sbjct: 127 YLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 185
Query: 888 NLLIGQD-GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKH 946
NLL+ D +KL DFG +K L P
Sbjct: 186 NLLLDPDTAVLKLCDFGSAKQ------------------------LVRGEPNV------S 215
Query: 947 SVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAK-------------- 991
+ + Y APE++ G ++ D WS G +L ELL+G P F
Sbjct: 216 YIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274
Query: 992 TPQQIFDNIMNRD-----------IPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGA 1039
TP + MN + PW + EA L +LL P RL
Sbjct: 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL---TP 331
Query: 1040 REVKQHPFFK 1049
E H FF
Sbjct: 332 LEACAHSFFD 341
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 9e-41
Identities = 66/280 (23%), Positives = 109/280 (38%), Gaps = 55/280 (19%)
Query: 760 FEIIKPISQGAFGRVFLAR-KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP 818
+E+ I+ G G ++LA + G +K L + A +AER L V +P
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHP 139
Query: 819 FVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
+V+ F Y+VMEY+ G L L A Y+ E++ AL Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSY 197
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LHS+ +++ DLKP+N+++ ++ +KL D G
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS--------------------------- 229
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993
+ + GTP + APEI+ G D ++VG L L + +P N +
Sbjct: 230 ---RIN----SFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYV 281
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
+ D P + S L+ + + +P QR
Sbjct: 282 DGL-----PEDDPVLKTYD--SYGR--LLRRAIDPDPRQR 312
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 7e-40
Identities = 95/368 (25%), Positives = 143/368 (38%), Gaps = 83/368 (22%)
Query: 721 LDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKR 780
SNA D + + + K I G+FG VF A+
Sbjct: 3 FTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLV 62
Query: 781 ATGDLFAIK-VLKKADMIRKNAVESILAERNILISVRNPFVVR---FFYSFTCREN---L 833
+ + AIK VL+ D KN E I+ V++P VV FFYS +++ L
Sbjct: 63 ESDE-VAIKKVLQ--DKRFKNR------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113
Query: 834 YLVMEYLNGGDLYSLLRNLG----CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889
LV+EY+ +Y R+ + + ++Y+ +L+ +L Y+HS+ + HRD+KP NL
Sbjct: 114 NLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNL 172
Query: 890 LI-GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSV 948
L+ G +KL DFG +K+ L P +
Sbjct: 173 LLDPPSGVLKLIDFGSAKI------------------------LIAGEPNV------SYI 202
Query: 949 AGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAK--------------TP 993
+ Y APE++ G + T D WS G ++ EL+ G P F + TP
Sbjct: 203 C-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 994 QQIFDNIMNRDIPWPNIPE------------EMSVEACDLIDKLLTENPVQRLGATGARE 1041
+ MN + P+ +A DLI +LL P RL A E
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL---TAIE 318
Query: 1042 VKQHPFFK 1049
HPFF
Sbjct: 319 ALCHPFFD 326
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 3e-39
Identities = 66/280 (23%), Positives = 121/280 (43%), Gaps = 39/280 (13%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
++I+ + G V+LA AIK + ++ ++ E + + +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
+V + YLVMEY+ G L + + G L D A + +++ +++ H + +
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
+HRD+KP N+LI + +K+ DFG++K + LT
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKA-------------------------LSETSLT 167
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999
Q + V GT Y +PE G D +S+GI+L+E+L+G PPFN +T I
Sbjct: 168 ----QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK 223
Query: 1000 IMNRDIPW------PNIPEEMSVEACDLIDKLLTENPVQR 1033
+ +P +IP+ +S ++I + ++ R
Sbjct: 224 HIQDSVPNVTTDVRKDIPQSLS----NVILRATEKDKANR 259
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-39
Identities = 76/334 (22%), Positives = 134/334 (40%), Gaps = 83/334 (24%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+D+++++ + +G + VF A + +K+LK + I E IL ++R
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK------IKREIKILENLRG 89
Query: 818 -PFVVRFFYSFT--CRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
P ++ LV E++N D L + L D D+ R Y+ E++ AL+Y
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT--DYDI-RFYMYEILKALDYC 146
Query: 875 HSLNVIHRDLKPDNLLI-GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
HS+ ++HRD+KP N++I + ++L D+GL++ H + +
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYN---------------- 188
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPF---- 988
VA + + PE+L+ + D WS+G +L ++ PF
Sbjct: 189 ------------VRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
Query: 989 -------------------------NAKTPQQIFDNIMNRD-IPWPN-IPEE----MSVE 1017
N + + D + W + E +S E
Sbjct: 236 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPE 295
Query: 1018 ACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
A D +DKLL + RL T ARE +HP+F +
Sbjct: 296 ALDFLDKLLRYDHQSRL--T-AREAMEHPYFYTV 326
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 43/281 (15%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-KNAVESILAERNILISVRNP 818
+ + + + +G G V+ A + A+K++ + + E ++ P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL-ALEYLHSL 877
VV LY+ M +NG DL ++LR G L A V I + AL+ H+
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA-VAIVRQIGSALDAAHAA 153
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
HRD+KP+N+L+ D L DFG++
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASAT-------------------------TDEK 188
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
LT Q + GT Y+APE AD +++ +L+E L G PP+ +
Sbjct: 189 LT----QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG 244
Query: 998 DNIMNRDIPW-----PNIPEEMSVEACDLIDKLLTENPVQR 1033
+ +N+ IP P IP +I + + +NP R
Sbjct: 245 AH-INQAIPRPSTVRPGIPVAFD----AVIARGMAKNPEDR 280
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 5e-38
Identities = 82/336 (24%), Positives = 134/336 (39%), Gaps = 80/336 (23%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER-------- 809
DF++ + +GA+G V A + TG++ AIK K + K + A R
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDK----PLFALRTLREIKIL 63
Query: 810 ------NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY 863
NI I++ N F +F +Y++ E + DL+ ++ L +D + +
Sbjct: 64 KHFKHENI-ITIFNIQRPDSFENF---NEVYIIQELM-QTDLHRVIST-QMLSDDHIQYF 117
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
I + + A++ LH NVIHRDLKP NLLI + +K+ DFGL A +
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGL-------------ARIIDE 164
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELL 982
++ Q + VA T Y APE++L + D WS G IL EL
Sbjct: 165 SAADNSEPTGQQSGMVEF------VA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217
Query: 983 IGIPPFNAK----------------TPQQIFDNIMNRD-------------IPWPNIPEE 1013
+ P F + I + P +
Sbjct: 218 LRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR 277
Query: 1014 MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
++ + DL+ ++L +P +R+ A A E HP+ +
Sbjct: 278 VNPKGIDLLQRMLVFDPAKRITAKEALE---HPYLQ 310
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 72/284 (25%), Positives = 121/284 (42%), Gaps = 42/284 (14%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-KNAVESILAERNILISVRNP 818
+E+ + + G V LAR A+KVL+ AD+ R + E ++ +P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHP 72
Query: 819 FVVRFF----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
+V + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
H +IHRD+KP N++I +K+ DFG+++ + D
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR-----AIADSGNS--------------- 172
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994
+T Q +V GT YL+PE G A +D +S+G +L+E+L G PPF +P
Sbjct: 173 ---VT----QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
Query: 995 QIFDNIMNRDIPWP-----NIPEEMSVEACDLIDKLLTENPVQR 1033
+ + D P + ++ ++ K L +NP R
Sbjct: 226 SVAYQHVREDPIPPSARHEGLSADLD----AVVLKALAKNPENR 265
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-37
Identities = 78/354 (22%), Positives = 128/354 (36%), Gaps = 98/354 (27%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIK-VLKKA---------------------- 794
+ + + K + G+FG V +G FA+K VL+
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLV 66
Query: 795 DMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN--------LYLVMEYLNGGDLY 846
D E + + + L ++MEY+ L+
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 847 SLLRNLGC----LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI-GQDGHIKLTD 901
+L++ + ++ +YI +L A+ ++HSL + HRD+KP NLL+ +D +KL D
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 902 FGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL 961
FG +K L+ E P + + Y APE++L
Sbjct: 186 FGSAKK-------------------LIPSE-----PSV------AYIC-SRFYRAPELML 214
Query: 962 GMGHGATA-DWWSVGIILFELLIGIPPFNAK--------------TPQQIFDNIMNRD-- 1004
G + D WS+G + EL++G P F+ + TP + MN
Sbjct: 215 GATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYT 274
Query: 1005 ---------IPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
W I PE A DL++++L P R+ E HPFF
Sbjct: 275 EVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY---EAMAHPFF 325
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-36
Identities = 69/340 (20%), Positives = 114/340 (33%), Gaps = 88/340 (25%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAV---ESILAER----- 809
+ + + IS G++G V G AIK + + +S L +R
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 810 ---------NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDM 859
NI + +R+ FV + LYLV E + DL ++ +
Sbjct: 81 RLLNHFHHPNI-LGLRDIFVHFEEPAM---HKLYLVTELM-RTDLAQVIHDQRIVISPQH 135
Query: 860 ARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919
+ ++ ++L L LH V+HRDL P N+L+ + I + DF L++
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR------------- 182
Query: 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIIL 978
E T V Y APE+++ G D WS G ++
Sbjct: 183 -----------EDTADANKTHY------VT-HRWYRAPELVMQFKGFTKLVDMWSAGCVM 224
Query: 979 FELLIGIPPFNAK--------------TP-QQIFDNIMNRD--------------IPWPN 1009
E+ F TP + + W
Sbjct: 225 AEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA 284
Query: 1010 IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ A DLI K+L NP +R+ + +HP+F+
Sbjct: 285 VVPTADPVALDLIAKMLEFNPQRRISTE---QALRHPYFE 321
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-36
Identities = 86/335 (25%), Positives = 133/335 (39%), Gaps = 86/335 (25%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER-------- 809
+ + I +GA+G V A AIK K +R
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEH----QTYCQRTLREIKIL 79
Query: 810 ------NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY 863
NI I + + +++Y+V + + DLY LL+ L D +
Sbjct: 80 LRFRHENI-IGINDIIRAPTIEQM---KDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYF 133
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
+ +++ L+Y+HS NV+HRDLKP NLL+ +K+ DFGL++V
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV---------------- 177
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELL 982
+ + LT VA T Y APEI+L G+ + D WSVG IL E+L
Sbjct: 178 ----ADPDHDHTGFLT------EYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 983 IGIPPFNAK--------------TP-QQIFDNIMNRD-------------IPWPNIPEEM 1014
P F K +P Q+ + I+N +PW +
Sbjct: 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 286
Query: 1015 SVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+A DL+DK+LT NP +R+ + HP+ +
Sbjct: 287 DSKALDLLDKMLTFNPHKRIEVE---QALAHPYLE 318
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 68/325 (20%), Positives = 115/325 (35%), Gaps = 74/325 (22%)
Query: 751 SKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
S RT D +++ + +G +G V+ + G+ A+K+ D +S E
Sbjct: 1 SMQRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDE------KSWFRETE 52
Query: 811 I--LISVRNPFVVRFF----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYI 864
+ + +R+ ++ F S L+L+ Y G LY L+ LD +
Sbjct: 53 LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIV 111
Query: 865 AELVLALEYLHSL--------NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916
+ L +LH + HRDLK N+L+ ++G + D GL+ +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--------- 162
Query: 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT------AD 970
Q + V GT Y+APE+L D
Sbjct: 163 ----------------HSQSTNQLDVGNNPRV-GTKRYMAPEVLDETIQVDCFDSYKRVD 205
Query: 971 WWSVGIILFELLIGI----------PPFNAKTPQQIFDNIMNRDIPW----PNIPEEMSV 1016
W+ G++L+E+ + PPF P M + + PNIP
Sbjct: 206 IWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFS 265
Query: 1017 EAC-----DLIDKLLTENPVQRLGA 1036
+ L+ + +NP RL A
Sbjct: 266 DPTLTSLAKLMKECWYQNPSARLTA 290
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-36
Identities = 76/341 (22%), Positives = 128/341 (37%), Gaps = 90/341 (26%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES-ILAER------- 809
+ +KP+ G G VF A AIK K + +
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---------KIVLTDPQSVKHALREIKI 61
Query: 810 -------NI--LISVRNPFVVRFFYSFTCREN---LYLVMEYLNGGDLYSLLRNLGCLDE 857
NI + + P + +Y+V EY+ DL ++L G L E
Sbjct: 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLE 119
Query: 858 DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI-GQDGHIKLTDFGLSKVGLIHSTDDL 916
+ AR+++ +L+ L+Y+HS NV+HRDLKP NL I +D +K+ DFGL+++
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI--------- 170
Query: 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVG 975
++ + L+ + T Y +P +LL + D W+ G
Sbjct: 171 -----------MDPHYSHKGHLS------EGLV-TKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 976 IILFELLIGIPPFNAK--------------TP-QQIFDNIMN------------RDIPWP 1008
I E+L G F ++ +++ P
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT 272
Query: 1009 NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ +S EA D ++++LT +P+ RL A A HP+
Sbjct: 273 QLLPGISREAVDFLEQILTFSPMDRLTAEEALS---HPYMS 310
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 73/356 (20%), Positives = 127/356 (35%), Gaps = 107/356 (30%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL--ISVRN 817
+E++K I +G+FG+V A A+K+++ + A E IL + ++
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQD 154
Query: 818 P----FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLAL 871
V+ +FT R ++ + E L +LY L++ + R + ++ L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGH--IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929
+ LH +IH DLKP+N+L+ Q G IK+ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS------------------------ 249
Query: 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF- 988
E ++ ++ + Y APE++LG +G D WS+G IL ELL G P
Sbjct: 250 ---------CYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLP 300
Query: 989 ------------------------NAKTPQQIFDNIMNRDIPWPNIPEEMSV-------- 1016
+K + + + SV
Sbjct: 301 GEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSR 360
Query: 1017 -----------------EAC------DLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ C D + + L +P R+ T + +HP+ +
Sbjct: 361 RGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM--T-PGQALRHPWLR 413
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 77/332 (23%), Positives = 127/332 (38%), Gaps = 85/332 (25%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKA-----DMIRKNAVESILAERNIL 812
+ + + GA+G V A + +G+ AIK L + R E +L
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR------AYRELLLL 77
Query: 813 ISVRNPFVVR---FFYSFTCREN---LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAE 866
+++ V+ F + N YLVM ++ DL ++ E+ + + +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQ 134
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
++ L+Y+HS V+HRDLKP NL + +D +K+ DFGL++ T +
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV--------- 185
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGI 985
TR Y APE++L M + T D WSVG I+ E+L G
Sbjct: 186 ------------TRW------------YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
Query: 986 PPFNAKTPQQIFDNIMN----------------------------RDIPWPNIPEEMSVE 1017
F K I+ + + S +
Sbjct: 222 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQ 281
Query: 1018 ACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
A DL++K+L + +RL A + HPFF+
Sbjct: 282 AADLLEKMLELDVDKRLTAA---QALTHPFFE 310
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 79/351 (22%), Positives = 131/351 (37%), Gaps = 75/351 (21%)
Query: 726 AMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDL 785
E + E + S S + P RT + +++K I +G +G V++ + R G+
Sbjct: 6 PPGESLRDLIEQSQSSGSGSGL-PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEK 62
Query: 786 FAIKVLKKADMIRKNAVESILAERNI--LISVRNPFVVRFF----YSFTCRENLYLVMEY 839
A+KV + S E I + +R+ ++ F LYL+ +Y
Sbjct: 63 VAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN--------VIHRDLKPDNLLI 891
G LY L++ LD V L +LH+ + HRDLK N+L+
Sbjct: 117 HENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 892 GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGT 951
++G + D GL+ I T+++ P ++ GT
Sbjct: 176 KKNGTCCIADLGLAVK-FISDTNEVDIPP-------------------------NTRVGT 209
Query: 952 PDYLAPEILLGMGHGAT------ADWWSVGIILFELLIGI----------PPFNAKTPQQ 995
Y+ PE+L + AD +S G+IL+E+ P++ P
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 996 IFDNIMNRDIPW----PNIPEEMSVEACD-LIDKLLTE----NPVQRLGAT 1037
M + P+ P S + C + KL+TE NP RL A
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-35
Identities = 95/352 (26%), Positives = 153/352 (43%), Gaps = 87/352 (24%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER-------- 809
+E++K + +GA+G V+ + R TG++ A+K K D + S A+R
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQN----STDAQRTFREIMIL 62
Query: 810 -------NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV 862
NI +++ N ++YLV +Y+ DL++++R L+ +
Sbjct: 63 TELSGHENI-VNLLNVLRADND------RDVYLVFDYM-ETDLHAVIRA-NILEPVHKQY 113
Query: 863 YIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922
+ +L+ ++YLHS ++HRD+KP N+L+ + H+K+ DFGLS+ + ++
Sbjct: 114 VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS--FVNIRRVTNNIPL 171
Query: 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFEL 981
S + DQP LT VA T Y APEILLG + D WS+G IL E+
Sbjct: 172 SINENTENFDDDQPILTDY------VA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 982 LIGIPPF------------------------------NAKT--------PQQIFDNIMNR 1003
L G P F AKT + N +
Sbjct: 225 LCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDI 284
Query: 1004 DIPWPNIPEEM------SVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
W N+ ++ + EA DL+DKLL NP +R+ A + +HPF
Sbjct: 285 FTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN---DALKHPFVS 333
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 5e-35
Identities = 85/366 (23%), Positives = 144/366 (39%), Gaps = 100/366 (27%)
Query: 749 PCSKDRTSIED-FEIIKP-ISQGAFGRVFLARKR--ATGDLFAIKVLKKADMIRKNAVES 804
S +R +ED FE + +G +G V+ A+++ +A+K ++ + S
Sbjct: 10 KLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMS 64
Query: 805 ILAERNILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGC-------- 854
E +L +++P V+ F + ++L+ +Y DL+ +++
Sbjct: 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPV 123
Query: 855 -LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD----GHIKLTDFGLSKVGL 909
L M + + +++ + YLH+ V+HRDLKP N+L+ + G +K+ D G ++
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--- 180
Query: 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA 969
L N LK L V T Y APE+LLG H A
Sbjct: 181 -----------------LFNSPLKPLADLDPV------VV-TFWYRAPELLLGARHYTKA 216
Query: 970 -DWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRD----I------P----WPNI---P 1011
D W++G I ELL P F+ + N + D I P W +I P
Sbjct: 217 IDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMP 276
Query: 1012 E---------------------------EMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044
E + +A L+ KLLT +P++R+ + A Q
Sbjct: 277 EHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM---Q 333
Query: 1045 HPFFKN 1050
P+F
Sbjct: 334 DPYFLE 339
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-35
Identities = 80/335 (23%), Positives = 133/335 (39%), Gaps = 90/335 (26%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER-------- 809
+ ++P+ GA+G V A TG AIK K + + A+R
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK--KLYRPFQS----ELFAKRAYRELRLL 78
Query: 810 ------NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY 863
N+ I + + V + + YLVM ++ G DL L+++ L ED +
Sbjct: 79 KHMRHENV-IGLLD--VFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFL 133
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
+ +++ L Y+H+ +IHRDLKP NL + +D +K+ DFGL++ T +
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV------ 187
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELL 982
TR Y APE++L M + T D WSVG I+ E++
Sbjct: 188 ---------------TRW------------YRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
Query: 983 IGIPPFNAK--------------TP-QQIFDNIMNRD-------------IPWPNIPEEM 1014
G F TP + + + + + +I
Sbjct: 221 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA 280
Query: 1015 SVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
S A +L++K+L + QR+ A E HP+F+
Sbjct: 281 SPLAVNLLEKMLVLDAEQRVTAG---EALAHPYFE 312
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 83/333 (24%), Positives = 134/333 (40%), Gaps = 90/333 (27%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER---------- 809
++ + P+ GA+G V A TG A+K K + + I A+R
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQS----IIHAKRTYRELRLLKH 84
Query: 810 ----NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA 865
N+ I + + V S ++YLV + G DL ++++ L +D + I
Sbjct: 85 MKHENV-IGLLD--VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIY 139
Query: 866 ELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+++ L+Y+HS ++IHRDLKP NL + +D +K+ DFGL++ T
Sbjct: 140 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG----------- 188
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIG 984
VA T Y APEI+L M + T D WSVG I+ ELL G
Sbjct: 189 ---------------------YVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 985 IPPFNAK--------------TP-QQIFDNIMNRD-------------IPWPNIPEEMSV 1016
F TP ++ I + + + N+ +
Sbjct: 227 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 286
Query: 1017 EACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
A DL++K+L + +R+ A A H +F
Sbjct: 287 LAVDLLEKMLVLDSDKRITAAQALA---HAYFA 316
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 70/346 (20%), Positives = 122/346 (35%), Gaps = 78/346 (22%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR--- 816
F +I+ + G FGRV L + +A+KV++ ++A E +IL ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDD 92
Query: 817 --NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALE 872
N +V++ F +++ L+ E L G LY ++ + ++Y E++ AL
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPS------LGSGGF 926
YL +++ H DLKP+N+L+ K + + G F
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
+ S+ T Y APE++L +G ++D WS G +L EL G
Sbjct: 212 --------------KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 987 PFNAKTPQQIFDNIM-----------------------NRDIPWPNIPEEMSVEA----- 1018
F + + N+D PE S
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317
Query: 1019 ---------------CDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
CD + +L +P R E+ +H F +
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRP---SPAELLKHKFLE 360
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-34
Identities = 68/360 (18%), Positives = 125/360 (34%), Gaps = 110/360 (30%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP- 818
+ +++ + G F V+LA+ A+K+++ + + A E +L V +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDAD 76
Query: 819 ----------FVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGC--LDEDMARV 862
+++ F + + +V E L G +L +L++ + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 863 YIAELVLALEYLHS-LNVIHRDLKPDNLLI------GQDGHIKLTDFGLSKVGLIHSTDD 915
+L+L L+Y+H +IH D+KP+N+L+ IK+ D G + H T+
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195
Query: 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVG 975
+ TRE R +PE+LLG G AD WS
Sbjct: 196 IQ---------------------TREYR------------SPEVLLGAPWGCGADIWSTA 222
Query: 976 IILFELLIGIPPFNAKTPQQIFDN------IM---------------------------- 1001
++FEL+ G F + I+
Sbjct: 223 CLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR 282
Query: 1002 --NRDIPWP---NIPEEMSVEAC------DLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
++ WP + E+ D + +L +P +R A G HP+ K+
Sbjct: 283 NISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL---VNHPWLKD 339
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-34
Identities = 79/389 (20%), Positives = 145/389 (37%), Gaps = 63/389 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER-------- 809
+ +EI I G++G V A + + AIK I + + I +R
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK------KILRVFEDLIDCKRILREIAIL 106
Query: 810 ------NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY 863
++ + V + + + F + LY+V+E D L R L E +
Sbjct: 107 NRLNHDHV-VKVLDIVIPKDVEKF---DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTL 161
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
+ L++ ++Y+HS ++HRDLKP N L+ QD +K+ DFGL++ + ++ ++ S
Sbjct: 162 LYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART--VDYPENGNSQLPIS 219
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELL 982
+ + +++ V T Y APE++L + A D WS+G I ELL
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVV-TRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 983 IGIPPFNAKTPQQ--IF--DNIMNRDIPWPNIPEEMSVEAC-----DLIDKLL---TENP 1030
I A + +F + + ++I +L +E
Sbjct: 279 NMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEED 338
Query: 1031 VQRLGATGARE-VKQHPFFKNINWDTL---ARQKAM--------F-----IPAAESLDTS 1073
++ L A+ ++ P + + + A+ F I E L
Sbjct: 339 IEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHP 398
Query: 1074 YFVSRYVWNPEDENVQGGS---DFDDLTD 1099
+F E E F+D +
Sbjct: 399 FFKEVR--IAEVETNATEKVRLPFNDWMN 425
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-34
Identities = 71/360 (19%), Positives = 123/360 (34%), Gaps = 74/360 (20%)
Query: 717 DDEKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFL 776
+D LD + + + P RT + + I +G FG V+
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWR 60
Query: 777 ARKRATGDLFAIKVLKKADMIRKNAVESILAERNI--LISVRNPFVVRFFYSFTCREN-- 832
+ R G+ A+K+ + S E I + +R+ ++ F +
Sbjct: 61 GKWR--GEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112
Query: 833 --LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS--------LNVIHR 882
L+LV +Y G L+ L + + L +LH + HR
Sbjct: 113 TQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171
Query: 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
DLK N+L+ ++G + D GL+ D T +
Sbjct: 172 DLKSKNILVKKNGTCCIADLGLAVR-------------------------HDSATDTIDI 206
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGAT------ADWWSVGIILFELLIGIPPFNAKTPQQI 996
H V GT Y+APE+L + AD +++G++ +E+ Q+
Sbjct: 207 APNHRV-GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265
Query: 997 -FDNIMNRDIPW-------------PNIPEE-MSVEACDLIDKLLTE----NPVQRLGAT 1037
+ +++ D PNIP S EA ++ K++ E N RL A
Sbjct: 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-34
Identities = 86/386 (22%), Positives = 143/386 (37%), Gaps = 65/386 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER-------- 809
+++ I I +G++G V+LA + T AIK K M I +R
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFED----LIDCKRILREITIL 79
Query: 810 ------NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY 863
I I + + + F + LY+V+E DL L + L E+ +
Sbjct: 80 NRLKSDYI-IRLYDLIIPDDLLKF---DELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTI 134
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
+ L+L ++H +IHRDLKP N L+ QD +K+ DFGL++ + D L
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLAR-TINSEKDTNIVNDLEE 193
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELL 982
+ LT V T Y APE++L + + D WS G I ELL
Sbjct: 194 NEEPGPHNKNLKKQLTSH------VV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246
Query: 983 IGIPPFNAKTPQQ--IF----DNIMNRDIPWPNIPEEMSVEACDLIDKLL---TENPVQR 1033
+ + +F ++ D + E+ + + ++I ++ TE+ ++
Sbjct: 247 NMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN 306
Query: 1034 LGATGARE-VKQHPFFKNINWDTL---ARQKAM--------F-----IPAAESLDTSYFV 1076
+ + +K P K IN + F I ++LD Y
Sbjct: 307 INKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLK 366
Query: 1077 SRYVWNPEDENVQGGS---DFDDLTD 1099
+ EN FDD
Sbjct: 367 DVR--KKKLENFSTKKIILPFDDWMV 390
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 73/340 (21%), Positives = 128/340 (37%), Gaps = 72/340 (21%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGD-LFAIKVLKKADMIRKNAVESILAERNIL--ISVR 816
+EI+ + +GAFG+V G A+K++K D + A +E +L ++
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTT 71
Query: 817 NPF----VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLA 870
+P V+ F ++ +V E L G Y ++ G D R ++ +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+ +LHS + H DLKP+N+L Q + + + + + D+ GS +
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY---- 186
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
+ ++ T Y APE++L +G D WS+G IL E +G F
Sbjct: 187 ----------DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
Query: 991 KT---------------PQQIFDNIMNRD------IPWPN-------------------I 1010
P+ + R + W +
Sbjct: 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFML 296
Query: 1011 PEEMSVEAC-DLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+++ E DLI K+L +P +R+ RE +HPFF
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRI---TLREALKHPFFD 333
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-33
Identities = 78/347 (22%), Positives = 133/347 (38%), Gaps = 103/347 (29%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER-------- 809
+ ++ +KPI GA G V A AIK K + + A+R
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQN----QTHAKRAYRELVLM 78
Query: 810 ------NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY 863
NI I + N V S +++Y+VME + +L +++ LD +
Sbjct: 79 KCVNHKNI-IGLLN--VFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYL 132
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
+ +++ +++LHS +IHRDLKP N+++ D +K+ DFGL A + G+
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL-------------ARTAGT 179
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI 983
+ V T Y APE++LGMG+ D WSVG I+ E++
Sbjct: 180 SFMM-----------------TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 221
Query: 984 GIPPFNAK--------------TP---------------------------QQIFDNIMN 1002
G F TP +++F +++
Sbjct: 222 GGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLF 281
Query: 1003 RDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ + +A DL+ K+L + +R+ E QHP+
Sbjct: 282 P--ADSEHNKLKASQARDLLSKMLVIDASKRISVD---EALQHPYIN 323
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 79/363 (21%), Positives = 131/363 (36%), Gaps = 114/363 (31%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL--ISVRN 817
+EI I +G+FG+V A R + AIK++K A E +L ++ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHD 111
Query: 818 P----FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLAL 871
++V F R +L LV E L +LY LLRN + ++ R + ++ AL
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 872 EYLHS--LNVIHRDLKPDNLLIGQDGH--IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
+L + L++IH DLKP+N+L+ IK+ DFG S+
Sbjct: 171 LFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-------------SS--------- 208
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL------ 981
+ ++ + + Y +PE+LLGM + D WS+G IL E+
Sbjct: 209 -----------CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257
Query: 982 ---------------LIGIPP---------------------------------FNAKTP 993
++GIPP +
Sbjct: 258 FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGT 317
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEAC-------DLIDKLLTENPVQRLGATGAREVKQHP 1046
+++ + + S DLI ++L +P R+ QH
Sbjct: 318 RKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI--Q-PYYALQHS 374
Query: 1047 FFK 1049
FFK
Sbjct: 375 FFK 377
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-32
Identities = 70/342 (20%), Positives = 114/342 (33%), Gaps = 72/342 (21%)
Query: 760 FEIIKPISQGAFGRVFLARKRATG-DLFAIKVLKKADMIRKNAVESILAERNIL--ISVR 816
+EI+ + +G FG+V A G A+K+++ R+ A E N+L I +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEK 76
Query: 817 NPF----VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLA 870
+ V F ++ + E L G + + L+ R +L A
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
L +LH + H DLKP+N+L L + S + GS F
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF---- 191
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990
+ ++ T Y PE++L +G D WS+G ILFE G F
Sbjct: 192 ----------DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241
Query: 991 KT---------------PQQIFDNIMNRD------IPWPNIPEE---------------- 1013
P + + + W +
Sbjct: 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYML 301
Query: 1014 ----MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
V+ DL+ ++L +P QR+ E HPFF +
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRI---TLAEALLHPFFAGL 340
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-32
Identities = 78/345 (22%), Positives = 133/345 (38%), Gaps = 99/345 (28%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER-------- 809
+ ++ +KPI GA G V A AIK K + + A+R
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQN----QTHAKRAYRELVLM 115
Query: 810 ------NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVY 863
NI IS+ N V + +++YLVME + +L +++ LD +
Sbjct: 116 KCVNHKNI-ISLLN--VFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYL 169
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGS 923
+ +++ +++LHS +IHRDLKP N+++ D +K+ DFGL++
Sbjct: 170 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART---------------- 213
Query: 924 GGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI 983
+T V T Y APE++LGMG+ D WSVG I+ E++
Sbjct: 214 --------AGTSFMMT------PYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 258
Query: 984 GIPPFNAK--------------TPQQIFDNIMNRD-------------IPWPNI------ 1010
F + TP F + + +P +
Sbjct: 259 HKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLF 318
Query: 1011 ------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ + +A DL+ K+L +P +R+ A + HP+
Sbjct: 319 PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ---HPYIN 360
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 63/331 (19%), Positives = 112/331 (33%), Gaps = 77/331 (23%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI--LIS 814
+++ ++++ I +G +G V+ A+KV A+ ++ + E+NI +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR------QNFINEKNIYRVPL 63
Query: 815 VRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL 869
+ + + RF + R LVMEY G L L R+ +
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTR 122
Query: 870 ALEYLHS---------LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920
L YLH+ + HRDL N+L+ DG ++DFGLS +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-------MGHGATADWWS 973
+ S GT Y+APE+L G D ++
Sbjct: 183 NAA----------------------ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA 220
Query: 974 VGIILFELLIGI-------------PPFNAKTPQQIFDNIMNRDIPW----PNIPEEMSV 1016
+G+I +E+ + F + M + P PE
Sbjct: 221 LGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE 280
Query: 1017 EACDL--IDKLLTE----NPVQRLGATGARE 1041
+ + + + + + + RL A A E
Sbjct: 281 NSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 54/328 (16%), Positives = 111/328 (33%), Gaps = 81/328 (24%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI--LISV 815
++++ ++G FG V+ A+ + A+K+ D +S E + L +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK------QSWQNEYEVYSLPGM 75
Query: 816 RNPFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLAL 871
++ +++F + + L+L+ + G L L+ + + + L
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGL 134
Query: 872 EYLHS----------LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921
YLH + HRD+K N+L+ + + DFGL+ + +
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT---- 190
Query: 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL---LGMGHGAT--ADWWSVGI 976
H GT Y+APE+L + A D +++G+
Sbjct: 191 ------------------------HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226
Query: 977 ILFELLIGIPPFNAKTP--QQIFDNIMNRDIPW-------------PNIPEEMSVEA--- 1018
+L+EL + F+ + + P + + A
Sbjct: 227 VLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMA 286
Query: 1019 --CDLIDKLLTENPVQRLGATGAREVKQ 1044
C+ I++ + RL A V +
Sbjct: 287 MLCETIEECWDHDAEARL---SAGCVGE 311
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 36/293 (12%), Positives = 74/293 (25%), Gaps = 71/293 (24%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+ ++ + + A A A+ + ++ + ++ L+ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNV 879
V R R +V E++ GG L + A + L A + H V
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAADAAHRAGV 150
Query: 880 IHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLT 939
P + + DG + L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------------ 174
Query: 940 REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDN 999
+ D +G L+ LL+ P +
Sbjct: 175 --------------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP 213
Query: 1000 IMNRDIPWP--------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044
P +IP ++S + + + + R +T ++Q
Sbjct: 214 AERDTAGQPIEPADIDRDIPFQIS----AVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 69/372 (18%), Positives = 126/372 (33%), Gaps = 94/372 (25%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL--ISVRN 817
+ +I+ + G F V+L+ A+KV+K A+ + A++ E +L + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD----EIRLLKSVRNSD 94
Query: 818 P------FVVRFFYSFT---------CRENLYLVMEYLNGGDLYSLLR--NLGCLDEDMA 860
P VV+ F C +V E L G L + N L
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 861 RVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919
+ I +++ L+YLH+ +IH D+KP+N+L+ + + S
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAG----------------TPDYLAPEILLGM 963
++ + + L + ++ K +A T Y + E+L+G
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 964 GHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIM---------------------- 1001
G+ AD WS + FEL G F + ++ +
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKY 328
Query: 1002 -----NRD---------IPWP---------NIPEEMSVEACDLIDKLLTENPVQRLGATG 1038
+ PW +E + D + +L P +R AT
Sbjct: 329 SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR--AT- 385
Query: 1039 AREVKQHPFFKN 1050
A E +HP+ +
Sbjct: 386 AAECLRHPWLNS 397
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-26
Identities = 73/272 (26%), Positives = 112/272 (41%), Gaps = 42/272 (15%)
Query: 739 VRSLRTSPINPCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM 796
+ KD+ + ED + + I +G FG VF R RA L A+K ++
Sbjct: 93 TKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP 152
Query: 797 IRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--- 853
+ L E IL +P +VR T ++ +Y+VME + GGD + LR G
Sbjct: 153 --PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARL 210
Query: 854 CLDE--DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911
+ M A +EYL S IHRDL N L+ + +K++DFG+S+
Sbjct: 211 RVKTLLQMVG-DAAA---GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE--- 263
Query: 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADW 971
D + A S G V K + APE L + + +D
Sbjct: 264 -ADGVYAASGGLRQVPV----K--------------------WTAPEALNYGRYSSESDV 298
Query: 972 WSVGIILFELL-IGIPPFNAKTPQQIFDNIMN 1002
WS GI+L+E +G P+ + QQ + +
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 20/178 (11%)
Query: 743 RTSPINPCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGD----LFAIKVLKKADM 796
+D T + ++ + +G FG V + R D + A+K L+ +
Sbjct: 24 GAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE 83
Query: 797 IRKNAVESILAERNILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-NLG 853
+ E IL S+++ +V++ R NL L+MEYL G L L+ +
Sbjct: 84 ---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 140
Query: 854 CLDE----DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
+D I + +EYL + IHRDL N+L+ + +K+ DFGL+KV
Sbjct: 141 RIDHIKLLQYTS-QICK---GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 194
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 18/161 (11%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGD----LFAIKVLKKADMIRKNAVESILAERNILI 813
+ ++ + +G FG V + R D + A+K L+ + + E IL
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILK 66
Query: 814 SVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE----DMARVYIAE 866
S+++ +V++ R NL L+MEYL G L L+ + +D I +
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS-QICK 125
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
+EYL + IHRDL N+L+ + +K+ DFGL+KV
Sbjct: 126 ---GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 63/269 (23%), Positives = 98/269 (36%), Gaps = 45/269 (16%)
Query: 744 TSPINPCSKDRTSI--EDFEIIKPISQGAFGRVFLAR-KRATGDLF--AIKVLKKADMIR 798
++ P I +D +++ + G+FG V +G A+K LK + +
Sbjct: 2 SAGEGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ 61
Query: 799 KNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE 857
A++ + E N + S+ + ++R Y + +V E G L LR + G
Sbjct: 62 PEAMDDFIREVNAMHSLDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLL 120
Query: 858 ----DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913
A +AE + YL S IHRDL NLL+ +K+ DFGL + +
Sbjct: 121 GTLSRYAV-QVAE---GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR--ALPQN 174
Query: 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWW 972
DD K A APE L + A D W
Sbjct: 175 DDHYVMQEHR---------------------KVPFAWC----APESLK-TRTFSHASDTW 208
Query: 973 SVGIILFELL-IGIPPFNAKTPQQIFDNI 1000
G+ L+E+ G P+ QI I
Sbjct: 209 MFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 48/185 (25%), Positives = 79/185 (42%), Gaps = 18/185 (9%)
Query: 732 SSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGD----LFA 787
+ L P +P + ++ I+ + +G FG+V L T D + A
Sbjct: 8 HHHHHGALEVLFQGPGDPTVFHKRYLK---KIRDLGEGHFGKVSLYCYDPTNDGTGEMVA 64
Query: 788 IKVLKKADMIRKNAVESILAERNILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDL 845
+K LK E +IL ++ + ++++ +L LVMEY+ G L
Sbjct: 65 VKALKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 846 YSLLRN--LGCLD-EDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902
L +G A+ I E + YLH+ + IHRDL N+L+ D +K+ DF
Sbjct: 123 RDYLPRHSIGLAQLLLFAQQ-ICE---GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178
Query: 903 GLSKV 907
GL+K
Sbjct: 179 GLAKA 183
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 54/180 (30%), Positives = 83/180 (46%), Gaps = 26/180 (14%)
Query: 751 SKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGD----LFAIKVLKKADMIRKNAVES 804
+D T + I + +G FG V L R GD L A+K L+ + +
Sbjct: 14 CQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP---DQQRD 70
Query: 805 ILAERNILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV 862
E IL ++ + F+V++ R++L LVMEYL G L L+ AR+
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARL 124
Query: 863 YIAELVL-------ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915
+ L+L +EYL S +HRDL N+L+ + H+K+ DFGL+K L+ D
Sbjct: 125 DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK--LLPLDKD 182
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-24
Identities = 72/283 (25%), Positives = 118/283 (41%), Gaps = 54/283 (19%)
Query: 745 SPINPCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAV 802
+KD I E + + QG FG V++ T + AIK LK M +
Sbjct: 169 PQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SP 223
Query: 803 ESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARV 862
E+ L E ++ +R+ +V+ + + E +Y+V EY++ G L L+ E +
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYL 277
Query: 863 YIAELVL-------ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915
+ +LV + Y+ +N +HRDL+ N+L+G++ K+ DFGL++ LI +
Sbjct: 278 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEY 335
Query: 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVG 975
T Q K + T APE L +D WS G
Sbjct: 336 -----------------------TARQGAKFPIKWT----APEAALYGRFTIKSDVWSFG 368
Query: 976 IILFELL-IGIPPFNAKTPQQIFDNIMN--R-DIPWPNIPEEM 1014
I+L EL G P+ +++ D + R P P PE +
Sbjct: 369 ILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP-PECPESL 410
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 741 SLRTSPINPCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGD----LFAIKVLKKA 794
+ + D T + I+ + +G FG+V L R GD A+K LK
Sbjct: 2 DIVSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE 61
Query: 795 DMIRKNAVESILAERNILISVRNPFVVRFF--YSFTCRENLYLVMEYLNGGDLYSLLR-N 851
N + + E IL ++ + +V++ + + L+ME+L G L L N
Sbjct: 62 SG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN 119
Query: 852 LGCLDE----DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
++ A I + ++YL S +HRDL N+L+ + +K+ DFGL+K
Sbjct: 120 KNKINLKQQLKYAV-QICK---GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175
Query: 908 GLIHSTDD 915
I + +
Sbjct: 176 --IETDKE 181
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 51/252 (20%), Positives = 94/252 (37%), Gaps = 39/252 (15%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-P 818
+++ + I +G+FG +F AIK R++ + E +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCT 66
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSL 877
+ +Y + LV++ L G L LL G + +++ ++ +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 878 NVIHRDLKPDNLLIGQDGH-----IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
++++RD+KPDN LIG+ I + DFG+ K P
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF-YRDPVTKQHIP------------- 171
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP---FN 989
R+K +++GT Y++ LG D ++G + L G P
Sbjct: 172 ---------YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222
Query: 990 AKTPQQIFDNIM 1001
A T +Q ++ I
Sbjct: 223 AATNKQKYERIG 234
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 62/260 (23%), Positives = 104/260 (40%), Gaps = 53/260 (20%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-P 818
F + K I G FG + L + T + AIK+ K+ + E + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMAR-------VYIA-ELVLA 870
+ + +Y C + +V+E L G L L R + IA +L+
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-------RTFSLKTVLMIAIQLISR 117
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGH-----IKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+EY+HS N+I+RD+KP+N LIG+ G+ I + DF L+K
Sbjct: 118 MEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE------------------ 159
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985
++ + K P R+ S+ GT Y++ LG D ++G + L G
Sbjct: 160 YIDPETKKHIPY-----REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
Query: 986 PP---FNAKTPQQIFDNIMN 1002
P A T ++ + I +
Sbjct: 215 LPWQGLKADTLKERYQKIGD 234
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 14/155 (9%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ ++ I G FG V L + AIK +++ M + E + E +++ + +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE----DMARVYIAELVLALE 872
P +V+ + + + LV E++ G L LR G M + E +
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL-DVCE---GMA 118
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
YL VIHRDL N L+G++ IK++DFG+++
Sbjct: 119 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 57/251 (22%), Positives = 96/251 (38%), Gaps = 39/251 (15%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-P 818
+ + + I G+FG ++L A G+ AIK+ K + E I ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMMQGGV 65
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSL 877
+ + + +VME L G L L + +++ +EY+HS
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 878 NVIHRDLKPDNLLIGQDGH---IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
N IHRD+KPDN L+G + + DFGL+K + +D
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK------------------------KYRD 160
Query: 935 QPPLT-REQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP---FNA 990
R+ ++ GT Y + LG+ D S+G +L +G P A
Sbjct: 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220
Query: 991 KTPQQIFDNIM 1001
T +Q ++ I
Sbjct: 221 ATKRQKYERIS 231
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-23
Identities = 63/268 (23%), Positives = 112/268 (41%), Gaps = 50/268 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
D + + G +G V+ + A+K LK+ M VE L E ++ +++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE------DMARVYIAELVLAL 871
P +V+ T Y++ E++ G+L LR + MA I+ A+
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT-QISS---AM 331
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
EYL N IHR+L N L+G++ +K+ DFGLS++
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL------------------------ 367
Query: 932 LKDQPPLTREQRQKHSVAGTP-DYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFN 989
+T + H+ A P + APE L +D W+ G++L+E+ G+ P+
Sbjct: 368 ------MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421
Query: 990 AKTPQQIFDNIMN--R-DIPWPNIPEEM 1014
Q+++ + R + P PE++
Sbjct: 422 GIDLSQVYELLEKDYRMERP-EGCPEKV 448
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 58/268 (21%), Positives = 102/268 (38%), Gaps = 63/268 (23%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLF-------AIKVLKKADMIRKNAVESILAERN 810
ED + + QG F ++F +R GD +KVL KA N ES +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAAS 64
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE----DMARVYIA 865
++ + + +V + C + LV E++ G L + L+ N C++ ++A+ +A
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK-QLA 123
Query: 866 ELVLALEYLHSLNVIHRDLKPDNLLI--------GQDGHIKLTDFGLSKVGLIHSTDDLS 917
A+ +L +IH ++ N+L+ G IKL+D G+S + D L
Sbjct: 124 A---AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQ 178
Query: 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGI 976
+ ++ PE + + A D WS G
Sbjct: 179 ER------------IP--------------------WVPPECIENPKNLNLATDKWSFGT 206
Query: 977 ILFELL-IGIPPFNAKTPQQIFDNIMNR 1003
L+E+ G P +A Q+ +R
Sbjct: 207 TLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-23
Identities = 69/268 (25%), Positives = 114/268 (42%), Gaps = 52/268 (19%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E + + QG FG V++ T + AIK LK M + E+ L E ++ +R+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 321
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL-------A 870
+V+ + + E +Y+V EY++ G L L+ E + + +LV
Sbjct: 322 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 375
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+ Y+ +N +HRDL+ N+L+G++ K+ DFGL++ LI +
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEY--------------- 418
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFN 989
T Q K + T APE L +D WS GI+L EL G P+
Sbjct: 419 --------TARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 466
Query: 990 AKTPQQIFDNIMN--R-DIPWPNIPEEM 1014
+++ D + R P P PE +
Sbjct: 467 GMVNREVLDQVERGYRMPCP-PECPESL 493
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-22
Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 47/254 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLF----AIKVLKKADMIRKNAVESILAERNILI 813
+F+ IK + GAFG V+ G+ AIK L++A A + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE----DMARVYIAELV 868
SV NP V R + L+ + + G L +R + + + IA+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV-QIAK-- 128
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
+ YL ++HRDL N+L+ H+K+TDFGL+K L+ + + GG
Sbjct: 129 -GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK--LLGAEEKEYH---AEGG--- 179
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELL-IGIP 986
K + A E +L D WS G+ ++EL+ G
Sbjct: 180 ----------------KVPIKWM----ALESIL-HRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 987 PFNAKTPQQIFDNI 1000
P++ +I +
Sbjct: 219 PYDGIPASEISSIL 232
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 41/155 (26%), Positives = 81/155 (52%), Gaps = 14/155 (9%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E+ ++K + G FG V L + + D+ A+K++K+ M + + E ++ + +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG---CLDE--DMARVYIAELVLALE 872
P +V+F+ + +Y+V EY++ G L + LR+ G + +M + E +
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY-DVCE---GMA 118
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
+L S IHRDL N L+ +D +K++DFG+++
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
D + + G +G V+ + A+K LK+ M VE L E ++ +++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE------DMARVYIAELVLAL 871
P +V+ T Y++ E++ G+L LR + MA I+ A+
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT-QISS---AM 124
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
EYL N IHRDL N L+G++ +K+ DFGLS++
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 8/165 (4%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLF--AIKVLKKADMIRKNAVESILAERN 810
DR + + K + G FG V + + A+K+LK + +LAE N
Sbjct: 14 DRKLLTLED--KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEAN 70
Query: 811 ILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
++ + NP++VR E+ LVME G L L+ + + + ++ +
Sbjct: 71 VMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 129
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915
++YL N +HRDL N+L+ + K++DFGLSK + + ++
Sbjct: 130 MKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA--LRADEN 172
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 42/155 (27%), Positives = 79/155 (50%), Gaps = 14/155 (9%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+D +K + G FG V + R D+ AIK++K+ M + + + E +++++ +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE----DMARVYIAELVLALE 872
+V+ + T + ++++ EY+ G L + LR +M + + E A+E
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK-DVCE---AME 134
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
YL S +HRDL N L+ G +K++DFGLS+
Sbjct: 135 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 45/167 (26%), Positives = 86/167 (51%), Gaps = 18/167 (10%)
Query: 749 PCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESIL 806
P +D + E ++++ + G FG V++ + A+K LK+ M + ++ L
Sbjct: 2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFL 56
Query: 807 AERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG----CLDE--DMA 860
AE N++ +++ +VR + T +E +Y++ EY+ G L L+ +++ DMA
Sbjct: 57 AEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 115
Query: 861 RVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
IAE + ++ N IHRDL+ N+L+ K+ DFGL+++
Sbjct: 116 A-QIAE---GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 66/297 (22%), Positives = 120/297 (40%), Gaps = 58/297 (19%)
Query: 745 SPINPCSKDRTSIEDFEI-------IKPISQGAFGRVFLARKRATGDLF---AIKVLKKA 794
+ + + +ED I + + +G FG V A+ + F A+K+LK
Sbjct: 3 DSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA- 61
Query: 795 DMIRKNAVESILAERNILISVRNPFVVRFF------YSFTCRENLYLVMEYLNGGDLYSL 848
D+I + +E L E + +P V + + +++ ++ GDL++
Sbjct: 62 DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
Query: 849 LRNLGCLDEDMARVYIAELVL-------ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTD 901
L + E+ + + LV +EYL S N IHRDL N ++ +D + + D
Sbjct: 122 LLASR-IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180
Query: 902 FGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL 961
FGLS+ I+S D G L P+ K +LA E L
Sbjct: 181 FGLSRK--IYSGDYYRQ---GCASKL---------PV------K--------WLALESLA 212
Query: 962 GMGHGATADWWSVGIILFELL-IGIPPFNAKTPQQIFDNIMNR---DIPWPNIPEEM 1014
+ +D W+ G+ ++E++ G P+ +I++ ++ P P EE+
Sbjct: 213 DNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQP-PECMEEV 268
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 9e-22
Identities = 67/272 (24%), Positives = 106/272 (38%), Gaps = 51/272 (18%)
Query: 746 PINPCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGDLF----AIKVLKKADMIRK 799
P K T I K I G FG V+ + + AIK LK +
Sbjct: 30 PNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--E 87
Query: 800 NAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE- 857
L E I+ + ++R + + + ++ EY+ G L LR G
Sbjct: 88 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 147
Query: 858 ---DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914
M R IA ++YL ++N +HRDL N+L+ + K++DFGLS+V D
Sbjct: 148 QLVGMLR-GIAA---GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV----LED 199
Query: 915 DLSAPSLGSGGFLVNDELKDQPPL--TREQRQKHSVAGTPDYLAPEILLGMGHGATA-DW 971
D A SGG + P+ T APE + +A D
Sbjct: 200 DPEATYTTSGGKI---------PIRWT----------------APEAIS-YRKFTSASDV 233
Query: 972 WSVGIILFELL-IGIPPFNAKTPQQIFDNIMN 1002
WS GI+++E++ G P+ + ++ I +
Sbjct: 234 WSFGIVMWEVMTYGERPYWELSNHEVMKAIND 265
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 48/173 (27%), Positives = 68/173 (39%), Gaps = 16/173 (9%)
Query: 745 SPINPCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGDLF---AIKVLKKADMIRK 799
P I I K I G G V R R G AIK LK +
Sbjct: 34 EPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--E 91
Query: 800 NAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE- 857
L+E +I+ +P ++R T +V EY+ G L + LR + G
Sbjct: 92 RQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM 151
Query: 858 ---DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
M R + + YL L +HRDL N+L+ + K++DFGLS+V
Sbjct: 152 QLVGMLR-GVGA---GMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-21
Identities = 68/260 (26%), Positives = 103/260 (39%), Gaps = 47/260 (18%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLF---AIKVLKKADMIRKNAVESILAER 809
D T+I I K + G FG V R + AIK LK + L E
Sbjct: 43 DATNIS---IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEA 97
Query: 810 NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE----DMARVYI 864
+I+ +P ++R T + + +V EY+ G L S LR + M R I
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR-GI 156
Query: 865 AELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSG 924
A ++YL + +HRDL N+LI + K++DFGL +V DD A G
Sbjct: 157 AS---GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV----LEDDPEAAYTTRG 209
Query: 925 GFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELL- 982
G K + T +PE + +A D WS GI+L+E++
Sbjct: 210 G-------------------KIPIRWT----SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245
Query: 983 IGIPPFNAKTPQQIFDNIMN 1002
G P+ + Q + +
Sbjct: 246 YGERPYWEMSNQDVIKAVDE 265
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 2e-21
Identities = 61/265 (23%), Positives = 101/265 (38%), Gaps = 41/265 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLF---AIKVLKKADMIRKNAVESILAERNILIS 814
E E+ + I +G FG V + + AIK K E L E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQ 447
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMARVYIAELVLALEY 873
+P +V+ ++++ME G+L S L+ LD +Y +L AL Y
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
L S +HRD+ N+L+ + +KL DFGLS+ + +
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDST------------------- 545
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKT 992
+ + K + APE + + +D W G+ ++E+L G+ PF
Sbjct: 546 ----YYKASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 597
Query: 993 PQQIFDNIMNR---DIPWPNIPEEM 1014
+ I N +P PN P +
Sbjct: 598 NNDVIGRIENGERLPMP-PNCPPTL 621
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 18/170 (10%)
Query: 746 PINPCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVE 803
P P KD I E ++ K + G FG V++A + A+K +K M +VE
Sbjct: 174 PQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVE 228
Query: 804 SILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE------ 857
+ LAE N++ ++++ +V+ T +E +Y++ E++ G L L++ +
Sbjct: 229 AFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 287
Query: 858 DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
D + IAE + ++ N IHRDL+ N+L+ K+ DFGL++V
Sbjct: 288 DFSA-QIAE---GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 758 EDFEIIKPISQGAFGRVFLAR-KRATGDLF--AIKVLKKADMIRKNAVESILAERNILIS 814
ED + + + +G FG V+ G+ A+K KK + E ++E I+ +
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKN 69
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE----DMARVYIAELVL 869
+ +P +V+ E +++ME G+L L N L + I +
Sbjct: 70 LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL-QICK--- 124
Query: 870 ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
A+ YL S+N +HRD+ N+L+ +KL DFGLS+
Sbjct: 125 AMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 52/277 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
E + + + QG+FG V+ K AIK + +A +R L E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL---GCLDEDMARVYIAELVL 869
VVR + + ++ME + GDL S LR+L + +A +++++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 870 -------ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922
+ YL++ +HRDL N ++ +D +K+ DFG+++ I+ TD G
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD--IYETDYYRK---G 197
Query: 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFEL 981
G L P+ R +++PE L G T D WS G++L+E+
Sbjct: 198 GKGLL---------PV-R-------------WMSPESLK-DGVFTTYSDVWSFGVVLWEI 233
Query: 982 L-IGIPPFNAKTPQQIFDNIMNR---DIPWPNIPEEM 1014
+ P+ + +Q+ +M D P N P+ +
Sbjct: 234 ATLAEQPYQGLSNEQVLRFVMEGGLLDKP-DNCPDML 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 8e-21
Identities = 45/172 (26%), Positives = 83/172 (48%), Gaps = 20/172 (11%)
Query: 744 TSPINPCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNA 801
+ + + ++ ++ ++++ I +G FG V L G+ A+K +K
Sbjct: 5 VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDAT----- 57
Query: 802 VESILAERNILISVRNPFVVRFFYSFTCRE-NLYLVMEYLNGGDLYSLLRNLG----CLD 856
++ LAE +++ +R+ +V+ + LY+V EY+ G L LR+ G D
Sbjct: 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 117
Query: 857 E--DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906
+ + E A+EYL N +HRDL N+L+ +D K++DFGL+K
Sbjct: 118 CLLKFSL-DVCE---AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 60/252 (23%), Positives = 101/252 (40%), Gaps = 39/252 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLF----AIKVLKKADMIRKNAVESILAERNILI 813
+F+ IK + GAFG V+ G+ AIK L++A A + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMARVYIAELVLALE 872
SV NP V R + L+ + + G L +R + + + ++ +
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
YL ++HRDL N+L+ H+K+TDFGL+K L+ + + GG
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK--LLGAEEKEYH---AEGG------- 179
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELL-IGIPPFNA 990
K + A E +L D WS G+ ++EL+ G P++
Sbjct: 180 ------------KVPIKWM----ALESIL-HRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222
Query: 991 KTPQQIFDNIMN 1002
+I +
Sbjct: 223 IPASEISSILEK 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 43/163 (26%), Positives = 67/163 (41%), Gaps = 18/163 (11%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLF---AIKVLKKADMIRKNAVESILAER 809
R IE + + I +G FG V + + AIK K E L E
Sbjct: 13 QRERIE---LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEA 67
Query: 810 NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDE----DMARVYI 864
+ +P +V+ ++++ME G+L S L+ LD A +
Sbjct: 68 LTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY-QL 125
Query: 865 AELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
+ AL YL S +HRD+ N+L+ + +KL DFGLS+
Sbjct: 126 ST---ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 49/183 (26%), Positives = 80/183 (43%), Gaps = 29/183 (15%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGD-----LFAIKVLKKADMIRKNAVESILA 807
R I + + + +GAFG+VFLA L A+K LK + A +
Sbjct: 13 KRRDIV---LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQR 66
Query: 808 ERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL 867
E +L ++++ +V+F+ + L +V EY+ GDL LR G + +
Sbjct: 67 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 868 VLAL----------------EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911
L YL S + +HRDL N L+G + +K+ DFG+S+ ++
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD--VY 184
Query: 912 STD 914
STD
Sbjct: 185 STD 187
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 66/357 (18%), Positives = 133/357 (37%), Gaps = 59/357 (16%)
Query: 659 IASVNDCDYNSLEHMLDRLEELKYIIQDRKVDALFVETFGRRIEKLLQEKYVNLCGQIDD 718
++ ++ ++ H R I+ R L + L +K + ++
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGS-----EN 55
Query: 719 EKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLAR 778
+N + + S+++ + V++++ I P + + I +G FG V+
Sbjct: 56 LYFQGANTVHIDLSALNPELVQAVQHVVIGP---SSLIVH---FNEVIGRGHFGCVYHGT 109
Query: 779 KRATGDLF---AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFF-YSFTCRENLY 834
A+K L + I V L E I+ +P V+ +
Sbjct: 110 LLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167
Query: 835 LVMEYLNGGDLYSLLR----NLGCLD-EDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889
+V+ Y+ GDL + +R N D +A+ +++L S +HRDL N
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK---GMKFLASKKFVHRDLAARNC 223
Query: 890 LIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVA 949
++ + +K+ DFGL++ ++ + S + +G L P+
Sbjct: 224 MLDEKFTVKVADFGLARD--MYDKEFDSVHN-KTGAKL---------PVK---------- 261
Query: 950 GTPDYLAPEILLGMGHG---ATADWWSVGIILFELL-IGIPPFNAKTPQQIFDNIMN 1002
++A E L +D WS G++L+EL+ G PP+ I ++
Sbjct: 262 ----WMALESLQ---TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 311
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 94.3 bits (234), Expect = 4e-20
Identities = 57/250 (22%), Positives = 97/250 (38%), Gaps = 37/250 (14%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-P 818
F + + I G+FG ++L T + AIK+ K +L E I ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRILQGGT 63
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSL 877
+ + + LVM+ L G L L L + +++ +E++HS
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 878 NVIHRDLKPDNLLIGQDGH---IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
+ +HRD+KPDN L+G + + DFGL+K + +
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK------------------YRDTSTHQH 164
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP---FNAK 991
P R+ ++ GT Y + LG+ D S+G +L L G P A
Sbjct: 165 IPY-----RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
Query: 992 TPQQIFDNIM 1001
T +Q ++ I
Sbjct: 220 TKKQKYEKIS 229
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 46/154 (29%), Positives = 70/154 (45%), Gaps = 7/154 (4%)
Query: 758 EDFEIIK-PISQGAFGRVFLARKRATGDLF--AIKVLKKADMIRKNAVESILAERNILIS 814
++ I + G FG V R AIKVLK+ K E ++ E I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQ 66
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMARVYIAELVLALEY 873
+ NP++VR E L LVME GG L+ L + + ++ + ++Y
Sbjct: 67 LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 125
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
L N +HRDL N+L+ + K++DFGLSK
Sbjct: 126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 4e-20
Identities = 48/290 (16%), Positives = 89/290 (30%), Gaps = 63/290 (21%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+ + K I G FG ++LA + A V+K + + +E V
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK----VEYQENGPLFSELKFYQRVAKKD 94
Query: 820 V-----------------VRFFYSFTCRENLY--LVMEYLNGGDLYSLLRNLGCLDEDMA 860
+ Y +VME L G DL + G +
Sbjct: 95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV 153
Query: 861 RVYIA-ELVLALEYLHSLNVIHRDLKPDNLLIGQD--GHIKLTDFGLSKVGLIHSTDDLS 917
+ + ++ LEY+H +H D+K NLL+G + L D+GLS
Sbjct: 154 -LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR---------- 202
Query: 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGII 977
+ N K + + GT ++ + + G+ +D +G
Sbjct: 203 --------YCPNGNHKQYQ-----ENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYC 249
Query: 978 LFELLIG------IPPFNAKTPQQIFDNI------MNRDIPWPNIPEEMS 1015
+ L G + + + + P + E++
Sbjct: 250 MLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIA 299
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 59/283 (20%), Positives = 107/283 (37%), Gaps = 52/283 (18%)
Query: 732 SSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLF---AI 788
S+++ + V++++ I P + + I +G FG V+ A+
Sbjct: 5 SALNPELVQAVQHVVIGP---SSLIVH---FNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 58
Query: 789 KVLKKADMIRKNAVESILAERNILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYS 847
K L + I V L E I+ +P V+ + +V+ Y+ GDL +
Sbjct: 59 KSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 116
Query: 848 LLR----NLGCLD-EDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902
+R N D +A+ ++YL S +HRDL N ++ + +K+ DF
Sbjct: 117 FIRNETHNPTVKDLIGFGL-QVAK---GMKYLASKKFVHRDLAARNCMLDEKFTVKVADF 172
Query: 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTP-DYLAPEILL 961
GL++ ++ + S + A P ++A E L
Sbjct: 173 GLARD--MYDKEYYSV-------------------------HNKTGAKLPVKWMALESLQ 205
Query: 962 GMGHGATA-DWWSVGIILFELL-IGIPPFNAKTPQQIFDNIMN 1002
T D WS G++L+EL+ G PP+ I ++
Sbjct: 206 -TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 55/279 (19%), Positives = 110/279 (39%), Gaps = 56/279 (20%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLF---AIKVLKKADMIRKNAVESILAERNILIS 814
+ K + +G FG V + A+K +K + ++ +E L+E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR-EIEEFLSEAACMKD 92
Query: 815 VRNPFVVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL 869
+P V+R S +++ ++ GDL++ L L+ + + L+
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSR-LETGPKHIPLQTLLK 151
Query: 870 -------ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922
+EYL + N +HRDL N ++ D + + DFGLSK I+S D G
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--IYSGDYYRQ---G 206
Query: 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHG---ATADWWSVGIILF 979
+ P+ K ++A E L + +D W+ G+ ++
Sbjct: 207 RIAKM---------PV------K--------WIAIESLA---DRVYTSKSDVWAFGVTMW 240
Query: 980 ELL-IGIPPFNAKTPQQIFDNIMNR---DIPWPNIPEEM 1014
E+ G+ P+ +++D +++ P + +E+
Sbjct: 241 EIATRGMTPYPGVQNHEMYDYLLHGHRLKQP-EDCLDEL 278
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 56/182 (30%), Positives = 85/182 (46%), Gaps = 28/182 (15%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLAR-KRATGD----LFAIKVLKKADMIRKNAVESILA 807
R I + + +GAFG+VFLA + L A+K LK+A +A +
Sbjct: 39 KRRDIV---LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQR 92
Query: 808 ERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR--------NLGCLDEDM 859
E +L +++ +VRFF T L +V EY+ GDL LR G D
Sbjct: 93 EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 860 ARVYIAELV-------LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912
+ + +L+ + YL L+ +HRDL N L+GQ +K+ DFG+S+ I+S
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD--IYS 210
Query: 913 TD 914
TD
Sbjct: 211 TD 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 49/255 (19%), Positives = 94/255 (36%), Gaps = 42/255 (16%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLF----AIKVLKKADMIRKNAVESILAE 808
T + +K + G FG V G+ IKV++ + + +++
Sbjct: 11 KETELR---KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDH 65
Query: 809 RNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMARVYIAEL 867
+ S+ + +VR +L LV +YL G L +R + G L + + ++
Sbjct: 66 MLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI 124
Query: 868 VLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
+ YL ++HR+L N+L+ +++ DFG++ L+ D S
Sbjct: 125 AKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD--LLPPDDKQLL---YSEA-- 177
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELL-IGI 985
K + A E + G D WS G+ ++EL+ G
Sbjct: 178 -----------------KTPIKWM----ALESIH-FGKYTHQSDVWSYGVTVWELMTFGA 215
Query: 986 PPFNAKTPQQIFDNI 1000
P+ ++ D +
Sbjct: 216 EPYAGLRLAEVPDLL 230
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 37/183 (20%), Positives = 71/183 (38%), Gaps = 28/183 (15%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGD-----LFAIKVLKKADMIRKNAVESILA 807
+++ ++ + + FG+V+ AIK LK E
Sbjct: 7 SLSAVR---FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRH 61
Query: 808 ERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL 867
E + +++P VV T + L ++ Y + GDL+ L + + +
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 868 VLAL----------------EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911
AL EYL S +V+H+DL N+L+ ++K++D GL + ++
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VY 179
Query: 912 STD 914
+ D
Sbjct: 180 AAD 182
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 59/292 (20%), Positives = 106/292 (36%), Gaps = 61/292 (20%)
Query: 748 NPCSKDRTSIEDFEI---------IKPISQGAFGRVFLARKRATGDLF---AIKVLKKAD 795
+ S ++D I + I +G FG V+ AIK L +
Sbjct: 2 DLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT 61
Query: 796 MIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN-LYLVMEYLNGGDLYSLLRNLG- 853
++ VE+ L E ++ + +P V+ E ++++ Y+ GDL +R+
Sbjct: 62 EMQ--QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR 119
Query: 854 --CLDE--DMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909
+ + +A +EYL +HRDL N ++ + +K+ DFGL++
Sbjct: 120 NPTVKDLISFGL-QVAR---GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD-- 173
Query: 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHG--- 966
I + + L P+ K + A E L
Sbjct: 174 ILD-REYYSVQQHRHARL---------PV------K--------WTALESLQ---TYRFT 206
Query: 967 ATADWWSVGIILFELL-IGIPPFNAKTPQQIFDNIMNR---DIPWPNIPEEM 1014
+D WS G++L+ELL G PP+ P + + P P+ +
Sbjct: 207 TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP-EYCPDSL 257
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-19
Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 18/156 (11%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
++ ++++ I +G FG V L R G+ A+K +K ++ LAE +++ +R+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 245
Query: 818 PFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDE----DMARVYIAELVLA 870
+V+ + LY+V EY+ G L LR+ G L + + E A
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCE---A 301
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906
+EYL N +HRDL N+L+ +D K++DFGL+K
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 64/292 (21%), Positives = 116/292 (39%), Gaps = 53/292 (18%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-KNAVESILAERNILISVRNPFVVRFF 824
+ +G FG V+ + A+K L I + + E ++ ++ +V
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 825 -YSFTCRENLYLVMEYLNGGDLYSLL---RNLGCLDEDMARVYIAELVLA--LEYLHSLN 878
+S + LV Y+ G L L L M R IA A + +LH +
Sbjct: 97 GFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHM-RCKIA-QGAANGINFLHENH 153
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
IHRD+K N+L+ + K++DFGL++ + +
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLARAS---EKFAQTVMT------------------ 192
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGHGAT-ADWWSVGIILFELLIGIPPFNAKTPQQIF 997
+R + GT Y+APE L G +D +S G++L E++ G+P + Q
Sbjct: 193 SR-------IVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ-- 241
Query: 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENP---VQRLGATGAREVKQHP 1046
++ DI EE ++E D IDK + + V+ + + ++ + +
Sbjct: 242 -LLL--DIKEEIEDEEKTIE--DYIDKKMNDADSTSVEAMYSVASQCLHEKK 288
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-18
Identities = 30/168 (17%), Positives = 63/168 (37%), Gaps = 23/168 (13%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDL--------FAIKVLKK-------ADMIRKNAVES 804
+++ ++ G ++ A +T F++K+ K + ++ A
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 805 ILAERNILISVRNPFVVRFFYSFTCRENLY--LVMEYLNGGDLYSLLRNLGCLDEDMARV 862
+ + L S + F ++ Y LV+ L G L S L V
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMG-FGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV 161
Query: 863 Y-IA-ELVLALEYLHSLNVIHRDLKPDNLLIGQD--GHIKLTDFGLSK 906
+A L+ ALE+LH +H ++ +N+ + + + L +G +
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 63/290 (21%), Positives = 118/290 (40%), Gaps = 69/290 (23%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLF---------AIKVLKKADMIRKNAVESILAE 808
+ + KP+ +GAFG+V +A A G A+K+LK + + +++E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAE--AVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSE 90
Query: 809 RNILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL 867
++ + ++ ++ + T LY+++EY + G+L LR + +
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 868 VLAL----------------EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911
+ EYL S IHRDL N+L+ ++ +K+ DFGL++ I+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 208
Query: 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGA-TA- 969
+ D + G L P+ K ++APE L T
Sbjct: 209 NIDYYKK---TTNGRL---------PV------K--------WMAPEALF---DRVYTHQ 239
Query: 970 -DWWSVGIILFELL-IGIPPFNAKTPQQIFDNIMNR---DIPWPNIPEEM 1014
D WS G++++E+ +G P+ +++F + D P N E+
Sbjct: 240 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP-ANCTNEL 288
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 43/186 (23%), Positives = 80/186 (43%), Gaps = 33/186 (17%)
Query: 758 EDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
++ + K + +G FG+V A RA A+K+LK+ + +L+E N+L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLAL- 871
V +P V++ + + + L L++EY G L LR + + +L
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 872 -----------------------EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908
+YL + ++HRDL N+L+ + +K++DFGLS+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR-- 198
Query: 909 LIHSTD 914
++ D
Sbjct: 199 DVYEED 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 62/290 (21%), Positives = 117/290 (40%), Gaps = 69/290 (23%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLF---------AIKVLKKADMIRKNAVESILAE 808
+ + KP+ +G FG+V +A A G A+K+LK + + +++E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAE--AVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSE 136
Query: 809 RNILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL 867
++ + ++ ++ + T LY+++EY + G+L LR + +
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 868 VLAL----------------EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911
+ EYL S IHRDL N+L+ ++ +K+ DFGL++ I+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR--DIN 254
Query: 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGA-TA- 969
+ D + G L P+ K ++APE L T
Sbjct: 255 NIDYYKK---TTNGRL---------PV------K--------WMAPEALF---DRVYTHQ 285
Query: 970 -DWWSVGIILFELL-IGIPPFNAKTPQQIFDNIMNR---DIPWPNIPEEM 1014
D WS G++++E+ +G P+ +++F + D P N E+
Sbjct: 286 SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP-ANCTNEL 334
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 54/324 (16%), Positives = 101/324 (31%), Gaps = 67/324 (20%)
Query: 733 SMDEDTVRSLRTSPINPCSKDR----TSIED-----FEIIKPISQGAFGRVFLARKR--- 780
SM ++ R S ++ I D +++ PI QG FG ++LA
Sbjct: 1 SMRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSE 60
Query: 781 --ATGDLFAIKVLKK--------ADMIRKNAVESILAERNILISVRNPFVVRFFYS--FT 828
+ +KV ++ A + + ++ V +++ S
Sbjct: 61 SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHD 120
Query: 829 CRENLY--LVMEYLNGGDLYSLLR-NLGCLDEDMARVYIA-ELVLALEYLHSLNVIHRDL 884
Y ++M+ G DL + N + ++ ++ LEY+H +H D+
Sbjct: 121 KNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTV-LQLSLRILDILEYIHEHEYVHGDI 178
Query: 885 KPDNLLIG--QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQ 942
K NLL+ + L D+GL+ + K
Sbjct: 179 KASNLLLNYKNPDQVYLVDYGLAYR------------------YCPEGVHKAYAA----- 215
Query: 943 RQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP---FNAKTPQQIFDN 999
K GT ++ + + G+ D +G + + L G P
Sbjct: 216 DPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSK 275
Query: 1000 IMNRDIPWP---------NIPEEM 1014
I R+ N P E+
Sbjct: 276 IRYRENIASLMDKCFPAANAPGEI 299
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 62/238 (26%), Positives = 93/238 (39%), Gaps = 44/238 (18%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFF- 824
I G FG+V+ R G A+K +E E L R+P +V
Sbjct: 47 IGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 825 YSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDM---ARVYIA-ELVLALEYLHSLN 878
+ C E + L+ +Y+ G+L L M R+ I L YLH+
Sbjct: 103 F---CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
+IHRD+K N+L+ ++ K+TDFG+SK G LS
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS--------------------- 198
Query: 939 TREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAKTPQQ 995
T V GT Y+ PE + G +D +S G++LFE+L P++
Sbjct: 199 TV-------VKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 4e-18
Identities = 56/287 (19%), Positives = 98/287 (34%), Gaps = 21/287 (7%)
Query: 629 QIELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYIIQDRK 688
I G I E + +L++ + A L+E
Sbjct: 212 LISQDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIY----------CLKEACPNSSASN 261
Query: 689 VDALFVETFGRRIEKLLQE--KYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSLRTSP 746
T L + L + + + + +V S
Sbjct: 262 ASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSD 321
Query: 747 INPCSKDRTSIEDFEII---KPISQGAFGRVFLAR-KRATGDLF-AIKVLKKADMIRKNA 801
+ ++ ++ + G FG V + + AIKVLK+ K
Sbjct: 322 PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KAD 379
Query: 802 VESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMA 860
E ++ E I+ + NP++VR E L LVME GG L+ L +
Sbjct: 380 TEEMMREAQIMHQLDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV 438
Query: 861 RVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907
+ ++ + ++YL N +HR+L N+L+ + K++DFGLSK
Sbjct: 439 AELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 32/183 (17%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLF-------AIKVLKKADMIRKNAVESILAERN 810
K + GAFG+V A A G + A+K+LK + + E++++E
Sbjct: 23 NRLSFGKTLGAGAFGKVVEAT--AYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELK 78
Query: 811 ILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-----------GCLDED 858
+L + N +V + T ++ EY GDL + LR +++D
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 859 MARVYIAELVL-------ALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911
+ + +L+ + +L S N IHRDL N+L+ K+ DFGL++ I
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IK 196
Query: 912 STD 914
+
Sbjct: 197 NDS 199
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 5e-18
Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 28/181 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLAR-------KRATGDLFAIKVLKKADMIRKNAVESILAERN 810
+ + KP+ +GAFG+V LA K A+K+LK + + +++E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 811 ILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL 869
++ + ++ + T LY+++EY + G+L L+ + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 870 AL----------------EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913
L EYL S IHRDL N+L+ +D +K+ DFGL++ IH
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHI 244
Query: 914 D 914
D
Sbjct: 245 D 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 49/185 (26%), Positives = 73/185 (39%), Gaps = 23/185 (12%)
Query: 743 RTSPINPCSKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGD--LFAIKVLKKADMIR 798
NP + D + I +G FG+V AR + G AIK +K+
Sbjct: 8 HHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-- 65
Query: 799 KNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDE 857
K+ E +L + +P ++ + R LYL +EY G+L LR L+
Sbjct: 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLET 125
Query: 858 DMARVYIAELVLAL----------------EYLHSLNVIHRDLKPDNLLIGQDGHIKLTD 901
D A L +YL IHRDL N+L+G++ K+ D
Sbjct: 126 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 185
Query: 902 FGLSK 906
FGLS+
Sbjct: 186 FGLSR 190
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 7e-18
Identities = 47/186 (25%), Positives = 76/186 (40%), Gaps = 33/186 (17%)
Query: 758 EDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
+ E ++ I +GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 104
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-----------------LGCL 855
NP +V+ + + L+ EY+ GDL LR+
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 856 DEDMARVYIAELV-------LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908
+ AE + + YL +HRDL N L+G++ +K+ DFGLS+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN- 223
Query: 909 LIHSTD 914
I+S D
Sbjct: 224 -IYSAD 228
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-18
Identities = 42/177 (23%), Positives = 70/177 (39%), Gaps = 24/177 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLA-----RKRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
+ + K + GAFG+V A K A+K+LK E++++E I+
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIM 103
Query: 813 ISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLAL 871
+ +V + T + ++ EY GDL + LR + E IA +
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 872 --------------EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914
+L S N IHRD+ N+L+ K+ DFGL++ I +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMNDS 218
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 29/206 (14%)
Query: 734 MDEDTVRSLRTSPINPCSKDRTSI--EDFEIIKPISQGAFGRVFLAR-----KRATGDLF 786
MD D + P + + ++ KP+ +GAFG+V A K AT
Sbjct: 1 MDPDELPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV 60
Query: 787 AIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCREN-LYLVMEYLNGGD 844
A+K+LK+ ++++E ILI + + VV + T L +++E+ G+
Sbjct: 61 AVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 118
Query: 845 LYSLLRNLGCLDEDMARVYIAELVLAL----------------EYLHSLNVIHRDLKPDN 888
L + LR+ L E+L S IHRDL N
Sbjct: 119 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178
Query: 889 LLIGQDGHIKLTDFGLSKVGLIHSTD 914
+L+ + +K+ DFGL++ I+
Sbjct: 179 ILLSEKNVVKICDFGLARD--IYKDP 202
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 42/177 (23%), Positives = 73/177 (41%), Gaps = 22/177 (12%)
Query: 753 DRTSIEDFEIIKPISQGAFGRVFLAR-KRATGDLF----AIKVLKKADMIRKNAVESILA 807
R +I +I+ + GAFG V+ + D A+K L + + L
Sbjct: 28 PRKNIT---LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLM 82
Query: 808 ERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL 867
E I+ + +VR +++ME + GGDL S LR + + + +L
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 868 V-LAL------EYLHSLNVIHRDLKPDNLLIGQDGH---IKLTDFGLSKVGLIHSTD 914
+ +A +YL + IHRD+ N L+ G K+ DFG+++ I+
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAS 197
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 6e-17
Identities = 38/172 (22%), Positives = 70/172 (40%), Gaps = 19/172 (11%)
Query: 758 EDFEIIKPISQGAFGRVFLAR-KRATGDLF----AIKVLKKADMIRKNAVESILAERNIL 812
++ +I+ + GAFG V+ + D A+K L + + L E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV---- 868
+ +VR ++++E + GGDL S LR + + + +L+
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 869 ---LALEYLHSLNVIHRDLKPDNLLIGQDGH---IKLTDFGLSKVGLIHSTD 914
+YL + IHRD+ N L+ G K+ DFG+++ I+
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAG 238
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-17
Identities = 44/186 (23%), Positives = 75/186 (40%), Gaps = 33/186 (17%)
Query: 758 EDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
E+ E K + GAFG+V A K A+K+LK+ E++++E ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 102
Query: 813 ISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLAL 871
+ + +V + T +YL+ EY GDL + LR+ + Y + L
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 872 -----------------------EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908
E+L + +HRDL N+L+ +K+ DFGL++
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-- 220
Query: 909 LIHSTD 914
I S
Sbjct: 221 DIMSDS 226
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 78.4 bits (192), Expect = 2e-15
Identities = 50/235 (21%), Positives = 77/235 (32%), Gaps = 56/235 (23%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVL-----KKADMIRKNAVESILAERN 810
E + + I +G FG VF A AIK++ + + E IL E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI--ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 811 IL-----------------ISVRNPFVVRFFY----------------------SFTCRE 831
I I + + V+ Y F +
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 832 NLYLVMEYLNGG-DLYSLLRNLGCLDEDMARVYIAELVLALEYLH-SLNVIHRDLKPDNL 889
L++V+E+ GG DL + L A+ + +L +L SL HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 890 LIGQDGHIKLTDFGLSKV------GLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
L+ + KL K GL S D + L G +V ++ L
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDL 248
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 77.2 bits (189), Expect = 2e-14
Identities = 80/584 (13%), Positives = 165/584 (28%), Gaps = 162/584 (27%)
Query: 627 TSQIELLVNGHRTITELQNPQQIKKL-----LDVSRSIASVNDCDYNSLEHML---DRLE 678
T + + ++ I + + D+ +SI S + D H++ D +
Sbjct: 11 TGEHQY---QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEID-----HIIMSKDAVS 62
Query: 679 ELKYII------QDRKVDALFVETFGRRIEKLLQEKYVNLCGQIDDEKLDSSNAMTEEES 732
+ Q+ V FVE +L+ Y L I E+ S
Sbjct: 63 GTLRLFWTLLSKQEEMVQK-FVEE-------VLRINYKFLMSPIKTEQRQPSMMTRMYIE 114
Query: 733 SMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLK 792
D R + + F + ++R + L + L
Sbjct: 115 QRD----RLYNDNQV-----------------------FAKYNVSRLQPYLKL--RQALL 145
Query: 793 KADMIRKNAVE-------SILAE---RNILISVRNPFVVRFFYSFTCRENLYLVMEYLNG 842
+ + ++ + +A + + + F + F+ + + V+E L
Sbjct: 146 ELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKI-FWLNLKNCNSPETVLEMLQ- 203
Query: 843 GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD----GHIK 898
L + D + + L L + + + LL+ +
Sbjct: 204 -KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPY-ENCLLVLLNVQNAKAWN 260
Query: 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQK--HSVAGT-PDYL 955
+ K+ L+ + L + LT ++ + P L
Sbjct: 261 AFNLS-CKI-LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL 318
Query: 956 APEI------LLGM------GHGATADWW--------------SVGII-------LFELL 982
E+ L + AT D W S+ ++ +F+ L
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL 378
Query: 983 IGIPPFNAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041
+ P +A P + + W + I ++ V L L
Sbjct: 379 -SVFPPSAHIPTILL------SLIWFDVIKSDVMVVVNKLHKYSL--------------- 416
Query: 1042 VKQHPFFKNINWDTLARQKAMFIPAAESLDTSYFVSRYVWNPEDENVQGGSDFDDLTDTC 1101
V++ P I+ ++ + + + +L S V Y N+ D DDL
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRS-IVDHY-------NIPKTFDSDDLIPPY 468
Query: 1102 SSGSFSNTL-----DEEQADECGSLAEFSAPALAVQYSFSNFSF 1140
F + + + E + + F + F +F F
Sbjct: 469 LDQYFYSHIGHHLKNIEHPER---MTLF--RMV-----FLDFRF 502
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 72.2 bits (176), Expect = 7e-13
Identities = 69/462 (14%), Positives = 117/462 (25%), Gaps = 149/462 (32%)
Query: 570 SKEMLDHV---PDDDNAFVIEDLNVLPEISCDKNPTAADIAAKTS---------SAGSLT 617
SKE +DH+ D + L K + S
Sbjct: 47 SKEEIDHIIMSKDAVSG-----TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTE 101
Query: 618 PRSPLLTPRT--SQIELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLD 675
R P + R Q + L N + Q K +VSR Y L L
Sbjct: 102 QRQPSMMTRMYIEQRDRLYN---------DNQVFAKY-NVSRLQ------PYLKLRQALL 145
Query: 676 RLEELKYII-----------------QDRKVDALFVE-----TFGR-RIEKLLQEKYVNL 712
L K ++ KV + + E L
Sbjct: 146 ELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL 205
Query: 713 CGQIDDEKLDSSNAMTEEESSMDE--DTVRSLRTSPINPCS-------KDRTSIEDFEI- 762
QID S+ + + + +R L S ++ + F +
Sbjct: 206 LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS 265
Query: 763 --------------------IKPISQGAFGRVFLARKRATGDLFAIKVLK-KADMIRKNA 801
IS L K L + + +
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT--PDEVKSLLL-KYLDCRPQDLPREV 322
Query: 802 VE------SILAERNILISVRNPFVVRF-FYSFTCRENLYLVME----YLNGGDLYSLLR 850
+ SI+AE S+R+ + + + + L ++E L + +
Sbjct: 323 LTTNPRRLSIIAE-----SIRD-GLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD 376
Query: 851 NLGCLDEDMARVYIAELVLAL----------------------------EYLHSLNVIHR 882
L +I ++L+L E S+ I+
Sbjct: 377 RLSVFPPS---AHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYL 433
Query: 883 DL--KPDNLLIGQDGHIKLTD-FGLSKVGLIHSTDDLSAPSL 921
+L K +N H + D + + K +DDL P L
Sbjct: 434 ELKVKLENE---YALHRSIVDHYNIPKT---FDSDDLIPPYL 469
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 5e-07
Identities = 91/659 (13%), Positives = 181/659 (27%), Gaps = 230/659 (34%)
Query: 163 AAFAKEMQSPRFQAIL-RVTSGRKKKAPEIKSFSHELNS--KGVRPFP---VWKSRAFGH 216
F +E+ ++ ++ + + +++ + + + + + + F V +
Sbjct: 80 QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR------ 133
Query: 217 MEEIMVAIRAKFDKLKEE----VNCDLG----VLAGDLV--GILEKSSDSHPEW-----Q 261
+ + +R +L+ ++ LG +A D+ ++ D W
Sbjct: 134 -LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC 192
Query: 262 ESLEDLLVIARK-CATMSPSEFWVKCEG---IVLNLDDRRQELPMGILKQAYTRLLFIL- 316
S E +L + +K + P+ + + + I L + + EL + + Y L +L
Sbjct: 193 NSPETVLEMLQKLLYQIDPN-WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251
Query: 317 ------------TRC-----TR---------------LVQFQKESGYEEEHILGL----- 339
C TR + + + L
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 340 -HQLSDLGVYPEQILQIRQQDFSGPLTGGKVMNEKQRKKSHGQELGSLNLKEDQVDQHET 398
+ DL P ++L P + + + N K D+ T
Sbjct: 312 DCRPQDL---PREVLTT------NPRRLSIIAESIRDGLATWD-----NWKHVNCDKL-T 356
Query: 399 ENVEVGTAKSGDSTTSSYRMSSWKRLPSGSRRKKGSEAA---ADTP-PKDKTEAFQNKDE 454
+E SS L RK + P
Sbjct: 357 TIIE----------------SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 455 PKIGSDDGNDNLDGLYHHASSRITKSWGFWGENSMICRICEVEIPVVHVEEHSRICTIAD 514
D ++ L H S + K I S
Sbjct: 401 K----SDVMVVVNKL--HKYSLVEKQP-----KESTISI------------PSIY----- 432
Query: 515 RCDLKSLTVNER-LERVAETLEKILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEM 573
+LK NE L R I+D ++ K DDL
Sbjct: 433 -LELKVKLENEYALHR------SIVDHYNIP---KTFDSDDL--------------IPPY 468
Query: 574 LD---------HVPDDDNAFVIEDLNVLPEISCDKNPTAADIAAKTSSAGSLTPRSPLLT 624
LD H+ + ++ E + + + D I +++ + L
Sbjct: 469 LDQYFYSHIGHHLKNIEHP---ERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL- 524
Query: 625 PRTSQIELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKYII 684
QQ+K Y ++ D + KY
Sbjct: 525 ----------------------QQLKF---------------YK--PYICD--NDPKY-- 541
Query: 685 QDRKVDALFVETFGRRIE-KLLQEKYVNLCGQIDDEKLDSSNAMTEEESSMDEDTVRSL 742
+R V+A+ F +IE L+ KY +L +I A+ E+ ++ E+ + +
Sbjct: 542 -ERLVNAI--LDFLPKIEENLICSKYTDLL-RI---------ALMAEDEAIFEEAHKQV 587
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 65/243 (26%), Positives = 97/243 (39%), Gaps = 55/243 (22%)
Query: 766 ISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES-ILAERNILISVRNPFVVRFF 824
+ +G FG+V+ R A G L A+K LK+ R E E ++ + ++R
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEE---RTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 825 -YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDM---ARVYIAELVLA--LEYLH--- 875
+ T E L LV Y+ G + S LR + R IA L A L YLH
Sbjct: 94 GFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LGSARGLAYLHDHC 151
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK---VGLIHSTDDLSAPSLGSGGFLVNDEL 932
+IHRD+K N+L+ ++ + DFGL+K H T
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT------------------- 192
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT--ADWWSVGIILFELLIGIPPFNA 990
T V GT ++APE L G ++ D + G++L EL+ G F+
Sbjct: 193 ------TA-------VRGTIGHIAPEYLST-GK-SSEKTDVFGYGVMLLELITGQRAFDL 237
Query: 991 KTP 993
Sbjct: 238 ARL 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 35/156 (22%), Positives = 63/156 (40%), Gaps = 13/156 (8%)
Query: 758 EDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
+ ++ KP+ +GAFG+V A K AT A+K+LK + + ++++E IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 79
Query: 813 ISVRN-PFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
I + + VV L +++E+ G+L + LR+ + Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVPYKTKGARF 135
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906
+ + I DLK I + F K
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 29/110 (26%), Positives = 47/110 (42%), Gaps = 28/110 (25%)
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
E+L S IHRDL N+L+ + +K+ DFGL++ I+ D L
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVR---KGDARL---- 257
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981
PL ++APE + + +D WS G++L+E+
Sbjct: 258 -----PLK--------------WMAPETIFDRVYTIQSDVWSFGVLLWEI 288
|
| >3k1f_M Transcription initiation factor IIB; RNA polymerase II, TFIIB, transcription factor, DNA-binding, DNA-directed RNA polymerase; 4.30A {Saccharomyces cerevisiae} Length = 197 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 21/91 (23%), Positives = 30/91 (32%), Gaps = 34/91 (37%)
Query: 473 ASSRITKSWGFWGENS---MICRICEVEIPVVHVEEHSR---ICTIADRCDLKSLTVNER 526
I K G G N + C C+V P + VE S +C C L
Sbjct: 3 TRESIDKRAGRRGPNLNIVLTCPECKVYPPKI-VERFSEGDVVCA---LCGL-------- 50
Query: 527 LERVAETLEKILDS---WSPKKHTKKRTHDD 554
V +K++D+ W RT +
Sbjct: 51 ---VLS--DKLVDTRSEW--------RTFSN 68
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 20/78 (25%), Positives = 37/78 (47%), Gaps = 10/78 (12%)
Query: 830 RENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889
+N ++M Y+NG ++ ++++ Y ++ LH +VIH DL N
Sbjct: 411 LDNKRIMMSYINGKLAKDVI------EDNLDIAYKIGEIVGK--LHKNDVIHNDLTTSNF 462
Query: 890 LIGQDGHIKLTDFGLSKV 907
+ D + + DFGL K+
Sbjct: 463 IF--DKDLYIIDFGLGKI 478
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1170 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4din_B | 381 | CAMP-dependent protein kinase type I-beta regulat | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.67 | |
| 3of1_A | 246 | CAMP-dependent protein kinase regulatory subunit; | 99.66 | |
| 3shr_A | 299 | CGMP-dependent protein kinase 1; cyclic nucleotide | 99.61 | |
| 3tnp_B | 416 | CAMP-dependent protein kinase type II-beta regula | 99.59 | |
| 2qcs_B | 291 | CAMP-dependent protein kinase type I-alpha regula | 99.56 | |
| 4f7z_A | 999 | RAP guanine nucleotide exchange factor 4; cyclic n | 99.5 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 3pna_A | 154 | CAMP-dependent protein kinase type I-alpha regula | 99.12 | |
| 3ocp_A | 139 | PRKG1 protein; serine/threonine kinase, TF2I and I | 99.11 | |
| 1o7f_A | 469 | CAMP-dependent RAP1 guanine-nucleotide exchange fa | 99.1 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 4f7z_A | 999 | RAP guanine nucleotide exchange factor 4; cyclic n | 98.92 | |
| 3idb_B | 161 | CAMP-dependent protein kinase type II-beta regulat | 98.83 | |
| 3of1_A | 246 | CAMP-dependent protein kinase regulatory subunit; | 98.75 | |
| 3mdp_A | 142 | Cyclic nucleotide-binding domain (CNMP-BD) protei; | 98.74 | |
| 3ukn_A | 212 | Novel protein similar to vertebrate potassium VOL | 98.74 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.72 | |
| 2ptm_A | 198 | Hyperpolarization-activated (IH) channel; ION chan | 98.72 | |
| 1o7f_A | 469 | CAMP-dependent RAP1 guanine-nucleotide exchange fa | 98.7 | |
| 4ava_A | 333 | Lysine acetyltransferase; allosteric regulation, d | 98.68 | |
| 4din_B | 381 | CAMP-dependent protein kinase type I-beta regulat | 98.68 | |
| 4f8a_A | 160 | Potassium voltage-gated channel subfamily H membe; | 98.68 | |
| 3bpz_A | 202 | Potassium/sodium hyperpolarization-activated cycli | 98.65 | |
| 1vp6_A | 138 | CNBD, cyclic-nucleotide binding domain of mesorhiz | 98.61 | |
| 2z69_A | 154 | DNR protein; beta barrel, dimerization helix, tran | 98.6 | |
| 3shr_A | 299 | CGMP-dependent protein kinase 1; cyclic nucleotide | 98.6 | |
| 2pqq_A | 149 | Putative transcriptional regulator; APC7345, strep | 98.58 | |
| 3gyd_A | 187 | CNMP-BD protein, cyclic nucleotide-binding domain; | 98.55 | |
| 3tnp_B | 416 | CAMP-dependent protein kinase type II-beta regula | 98.53 | |
| 2d93_A | 134 | RAP guanine nucleotide exchange factor 6; CNMP_bin | 98.52 | |
| 2qcs_B | 291 | CAMP-dependent protein kinase type I-alpha regula | 98.51 | |
| 1wgp_A | 137 | Probable cyclic nucleotide-gated ION channel 6; cy | 98.49 | |
| 3d0s_A | 227 | Transcriptional regulatory protein; CAMP receptor | 98.43 | |
| 4ev0_A | 216 | Transcription regulator, CRP family; CAMP binding, | 98.39 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.37 | |
| 1o5l_A | 213 | Transcriptional regulator, CRP family; TM1171, str | 98.37 | |
| 3dkw_A | 227 | DNR protein; CRP-FNR, HTH, beta barrel, dimerizati | 98.36 | |
| 3e97_A | 231 | Transcriptional regulator, CRP/FNR family; YP_6044 | 98.35 | |
| 3iwz_A | 230 | CAP-like, catabolite activation-like protein; XCC, | 98.32 | |
| 1zyb_A | 232 | Transcription regulator, CRP family; NP_813211.1, | 98.31 | |
| 3fx3_A | 237 | Cyclic nucleotide-binding protein; helix_TURN_heli | 98.3 | |
| 3b02_A | 195 | Transcriptional regulator, CRP family; structural | 98.3 | |
| 3dn7_A | 194 | Cyclic nucleotide binding regulatory protein; stru | 98.28 | |
| 2gau_A | 232 | Transcriptional regulator, CRP/FNR family; structu | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.26 | |
| 3ryp_A | 210 | Catabolite gene activator; CAMP receptor protein ( | 98.26 | |
| 3kcc_A | 260 | Catabolite gene activator; helix-turn-helix, CAMP, | 98.23 | |
| 3dv8_A | 220 | Transcriptional regulator, CRP/FNR family; cyclic | 98.15 | |
| 2oz6_A | 207 | Virulence factor regulator; winged helix, helix-tu | 98.15 | |
| 2fmy_A | 220 | COOA, carbon monoxide oxidation system transcripti | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.11 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.1 | |
| 3la7_A | 243 | Global nitrogen regulator; activator, DNA-binding, | 98.09 | |
| 3beh_A | 355 | MLL3241 protein; transmembrane protein, membrane p | 98.08 | |
| 3cf6_E | 694 | RAP guanine nucleotide exchange factor (GEF) 4; EP | 98.07 | |
| 1ft9_A | 222 | Carbon monoxide oxidation system transcription reg | 97.93 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.93 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.88 | |
| 3e6c_C | 250 | CPRK, cyclic nucleotide-binding protein; CPRK, hal | 97.84 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.79 | |
| 2zcw_A | 202 | TTHA1359, transcriptional regulator, FNR/CRP famil | 97.78 | |
| 2bgc_A | 238 | PRFA; bacterial infection, human pathogen, transcr | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.52 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.22 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.98 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.82 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.74 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.68 | |
| 3idb_B | 161 | CAMP-dependent protein kinase type II-beta regulat | 96.66 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.55 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.43 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.29 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 95.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.89 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.81 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.77 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.71 | |
| 3pna_A | 154 | CAMP-dependent protein kinase type I-alpha regula | 93.3 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.25 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.39 | |
| 3ocp_A | 139 | PRKG1 protein; serine/threonine kinase, TF2I and I | 87.56 | |
| 3gyd_A | 187 | CNMP-BD protein, cyclic nucleotide-binding domain; | 80.33 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-64 Score=563.70 Aligned_cols=280 Identities=38% Similarity=0.716 Sum_probs=255.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|+.++|||||+++++|++.+++
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 44567899999999999999999999999999999999987665566678899999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|||||||+||+|.++|.+.+.+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~-- 185 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE-- 185 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT--
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999853100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.......+.|||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+.
T Consensus 186 --------------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 239 (311)
T 4aw0_A 186 --------------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239 (311)
T ss_dssp --------------------------TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------------------------CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112234578999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhh---HHHHHcCCCCCCCChhhhhhccCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATG---AREVKQHPFFKNINWDTLARQKAMFI 1064 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~---AeEILqHPfF~~idwe~L~~~~ppfi 1064 (1170)
.+++.+|.+..+.+| ..+|+++++||.+||++||.+|||+.+ ..+|++||||++++|+.|..+.||.+
T Consensus 240 ~~~~~~i~~~~~~~p---~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 240 GLIFAKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp HHHHHHHHHTCCCCC---TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred HHHHHHHHcCCCCCC---cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 999999999988776 679999999999999999999999654 46789999999999999988776653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-63 Score=548.96 Aligned_cols=277 Identities=42% Similarity=0.805 Sum_probs=243.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeec---CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
...++|++++.||+|+||+||+|++. .+++.||||++.+...... ....+.+|+.+|++++|||||+++++|++.+
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34478999999999999999999874 4789999999987653322 2346788999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+|||||||+||+|.++|.+.+.+++..++.|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-- 177 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI-- 177 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.
T Consensus 178 ----------------------------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 178 ----------------------------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp -------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------------------------CCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 1112345679999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIP 1065 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP 1065 (1170)
+..+++..|.+..+.+| ..+|+++++||.+||++||.+|||+ ..++|+++||||++++|+.+..+ .|||+|
T Consensus 230 ~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 230 DRKETMTMILKAKLGMP---QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp SHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred CHHHHHHHHHcCCCCCC---CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 99999999999887766 6799999999999999999999995 35899999999999999999776 688887
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-60 Score=571.04 Aligned_cols=291 Identities=34% Similarity=0.635 Sum_probs=250.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHH---HHHHhcCCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER---NILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~Ei---eILskL~HPNIVrL~~~Fqd~ 830 (1170)
.+++++|+++++||+|+||+||+|+++.+|+.||||++.+..+........+.+|. .++..++|||||+++++|++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 57789999999999999999999999999999999999887655444455555664 455567899999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
+++|||||||+||+|.++|.+.+.|++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~- 343 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS- 343 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-cCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.....+.|||+.|||||++. +..|+.++||||||||||||++|.+||.
T Consensus 344 -------------------------------~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 344 -------------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp -------------------------------SCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred -------------------------------CCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 11235679999999999997 4689999999999999999999999997
Q ss_pred CC---CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCC
Q 001057 990 AK---TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAM 1062 (1170)
Q Consensus 990 g~---~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~pp 1062 (1170)
+. +..+++..+....+.+| ..+|+++++||.+||++||.+|++. .+|.||++||||++++|+.+..+ .||
T Consensus 393 ~~~~~~~~~i~~~i~~~~~~~p---~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP 469 (689)
T 3v5w_A 393 QHKTKDKHEIDRMTLTMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPP 469 (689)
T ss_dssp GGGCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCS
T ss_pred CCChHHHHHHHHhhcCCCCCCC---ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcC
Confidence 64 45567778888777666 6899999999999999999999984 57999999999999999999876 789
Q ss_pred CCCCCCC------CCCCcccccc
Q 001057 1063 FIPAAES------LDTSYFVSRY 1079 (1170)
Q Consensus 1063 fiP~~~s------lDts~F~s~~ 1079 (1170)
|+|.... .|+.+|+..+
T Consensus 470 ~~P~~~~~~~~~~fD~~~fd~e~ 492 (689)
T 3v5w_A 470 LIPPRGEVNAADAFDIGSFDEED 492 (689)
T ss_dssp CCCCTTCSSTTBCCC--------
T ss_pred ccCCCCCCCcCCCCCCccCCccc
Confidence 9997654 4555555543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=514.16 Aligned_cols=257 Identities=31% Similarity=0.606 Sum_probs=220.0
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45799999999999999999999999999999999988766555666789999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||| +|+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~------ 163 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT------ 163 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecC------
Confidence 99999 78999999998999999999999999999999999999999999999999999999999999997521
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
......+.+||+.|||||++.+..| +.++|||||||++|+|++|++||.+.+..
T Consensus 164 -------------------------~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~ 218 (275)
T 3hyh_A 164 -------------------------DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218 (275)
T ss_dssp ------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 1112345789999999999998876 58999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
++++.|.++.+.+| ..+|+++++||.+||++||.+||| +.|+++||||+.
T Consensus 219 ~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hpw~k~ 268 (275)
T 3hyh_A 219 VLFKNISNGVYTLP---KFLSPGAAGLIKRMLIVNPLNRIS---IHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHHTCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHCHHHHT
T ss_pred HHHHHHHcCCCCCC---CCCCHHHHHHHHHHccCChhHCcC---HHHHHcCccccc
Confidence 99999999887766 679999999999999999999999 889999999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=525.06 Aligned_cols=257 Identities=30% Similarity=0.533 Sum_probs=231.6
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
..|+++++||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|.+.+++||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999865432 2356789999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|||+||+|.+++.+ +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~-------- 221 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------- 221 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecC--------
Confidence 99999999999976 579999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.......+.+||+.|||||++.+..|+.++||||||||||||++|.+||.+.+..+++
T Consensus 222 ----------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 279 (346)
T 4fih_A 222 ----------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 279 (346)
T ss_dssp ----------------------SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ----------------------CCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 1112345689999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..|.....+....+..+|+++++||.+||++||.+||| +.|+|+||||+..
T Consensus 280 ~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~e~l~Hp~~~~~ 330 (346)
T 4fih_A 280 KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred HHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhcCC
Confidence 99887654433344679999999999999999999999 8899999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-59 Score=527.33 Aligned_cols=259 Identities=27% Similarity=0.516 Sum_probs=229.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+.+.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 45799999999999999999999999999999999987654 34557889999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 836 VMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|||||+||+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~---- 176 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN---- 176 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC----
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec----
Confidence 99999999999999754 357999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+.
T Consensus 177 --------------------------~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 230 (350)
T 4b9d_A 177 --------------------------STVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230 (350)
T ss_dssp --------------------------HHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred --------------------------CCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 112234567899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
.+++.+|.++.++ ..+..+|+++++||.+||++||.+||+ +.|+|+||||+.
T Consensus 231 ~~~~~~i~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~ 282 (350)
T 4b9d_A 231 KNLVLKIISGSFP--PVSLHYSYDLRSLVSQLFKRNPRDRPS---VNSILEKGFIAK 282 (350)
T ss_dssp HHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHT
T ss_pred HHHHHHHHcCCCC--CCCccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHHhhc
Confidence 9999999987754 445789999999999999999999999 889999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=526.37 Aligned_cols=257 Identities=30% Similarity=0.533 Sum_probs=231.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
+.|+++++||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||++|++|.+.+.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 5799999999999999999999999999999999865432 2356889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|||.||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~-------- 298 (423)
T 4fie_A 228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS-------- 298 (423)
T ss_dssp ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECC--------
T ss_pred eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECC--------
Confidence 99999999999875 569999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++
T Consensus 299 ----------------------~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~ 356 (423)
T 4fie_A 299 ----------------------KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM 356 (423)
T ss_dssp ----------------------SSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ----------------------CCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH
Confidence 1112345679999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..|.....+....+..+|+++++||.+||++||.+|++ |.|+|+||||+..
T Consensus 357 ~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~ell~Hp~~~~~ 407 (423)
T 4fie_A 357 KMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred HHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHHhcCC
Confidence 99887654433345689999999999999999999999 8899999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-57 Score=498.08 Aligned_cols=255 Identities=24% Similarity=0.454 Sum_probs=221.5
Q ss_pred CCe-EEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec----ccc
Q 001057 758 EDF-EIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC----REN 832 (1170)
Q Consensus 758 edY-evlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd----~~~ 832 (1170)
.+| ++.++||+|+||+||+|+++.++..||+|++.+... .....+.+.+|+.+|++++|||||+++++|.+ ...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 344 788899999999999999999999999999987643 34556789999999999999999999999875 456
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeCC-CCcEEEEecCCccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd~-dG~VKLsDFGLAk~~~ 909 (1170)
+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999999999899999999999999999999999999 999999999999984 7999999999997420
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.....+.+|||.|||||++.+ .|+.++|||||||+||||+||.+||.
T Consensus 184 --------------------------------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 184 --------------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp --------------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred --------------------------------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 112346799999999999875 69999999999999999999999997
Q ss_pred CCC-HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 990 AKT-PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 990 g~~-~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
+.+ ...++..+..+..+ +..+..+++++++||.+||++||.+||| +.|+|+||||++
T Consensus 231 ~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~s---~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 231 ECQNAAQIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQE 288 (290)
T ss_dssp TCSSHHHHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC-
T ss_pred CCCcHHHHHHHHHcCCCC-CCCCccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccC
Confidence 654 55666666655432 3345678999999999999999999999 889999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=502.10 Aligned_cols=297 Identities=39% Similarity=0.781 Sum_probs=261.4
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecc
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCR 830 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~ 830 (1170)
...+.+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|..+ +||||++++++|++.
T Consensus 17 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 17 SNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp ------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 3457788999999999999999999999999999999999887655566677889999999988 699999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
+.+||||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~- 175 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI- 175 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc-
Confidence 9999999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+
T Consensus 176 -----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 176 -----------------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp -----------------------------C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------------------------cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 111233467899999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh---hhHHHHHcCCCCCCCChhhhhhc--cCCCCC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNINWDTLARQ--KAMFIP 1065 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa---~~AeEILqHPfF~~idwe~L~~~--~ppfiP 1065 (1170)
.+..+++..|......+| ..++.++.+||.+||++||.+||++ .++.++++||||++++|+.+..+ .|||+|
T Consensus 227 ~~~~~~~~~i~~~~~~~p---~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p 303 (353)
T 3txo_A 227 ENEDDLFEAILNDEVVYP---TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRP 303 (353)
T ss_dssp SSHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCC
T ss_pred CCHHHHHHHHHcCCCCCC---CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccC
Confidence 999999999999888776 5799999999999999999999995 45599999999999999998766 789999
Q ss_pred CCCC-CCCCcccccccc
Q 001057 1066 AAES-LDTSYFVSRYVW 1081 (1170)
Q Consensus 1066 ~~~s-lDts~F~s~~~~ 1081 (1170)
...+ .|+++|+..++.
T Consensus 304 ~~~~~~~~~~f~~~~~~ 320 (353)
T 3txo_A 304 RIKSREDVSNFDPDFIK 320 (353)
T ss_dssp CCCSTTCCTTSCHHHHT
T ss_pred CCCCcccccccCccccc
Confidence 8877 888999887653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=511.05 Aligned_cols=261 Identities=26% Similarity=0.426 Sum_probs=228.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...+.|++.++||+|+||+||+|+++.+|+.||||++++... ..+|+.+|+.++|||||++|++|.+.+.+|
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 345679999999999999999999999999999999986532 246999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-cEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-~VKLsDFGLAk~~~~~~~ 913 (1170)
||||||+||+|.++|++.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+......
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~- 205 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG- 205 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC-
Confidence 9999999999999999989999999999999999999999999999999999999999988 69999999998531000
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
...........+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+.
T Consensus 206 ------------------------~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 261 (336)
T 4g3f_A 206 ------------------------LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261 (336)
T ss_dssp --------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred ------------------------cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 00111123457899999999999999999999999999999999999999999888
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH-------------HcCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV-------------KQHPFFKNI 1051 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI-------------LqHPfF~~i 1051 (1170)
.+++..|.....+++.++..+++++++||.+||++||.+||| |.|+ ++|||+...
T Consensus 262 ~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---a~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 262 GPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS---AMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred HHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcC---HHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 888889988877666677899999999999999999999999 4554 578988765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-56 Score=506.34 Aligned_cols=295 Identities=36% Similarity=0.740 Sum_probs=261.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~ 832 (1170)
.+..++|+++++||+|+||+||+|+++.+++.||||++++...........+..|+.+|..+ +|||||+++++|++...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 46678999999999999999999999999999999999987666666667889999999887 89999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+||||||++||+|..++.+.+.+++..+++|++||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~--- 204 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--- 204 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC---
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC-
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK- 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~- 991 (1170)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 205 ---------------------------~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~ 257 (396)
T 4dc2_A 205 ---------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257 (396)
T ss_dssp ---------------------------CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred ---------------------------cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 0112345678999999999999999999999999999999999999999642
Q ss_pred --------CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh---hhHHHHHcCCCCCCCChhhhhhc-
Q 001057 992 --------TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNINWDTLARQ- 1059 (1170)
Q Consensus 992 --------~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa---~~AeEILqHPfF~~idwe~L~~~- 1059 (1170)
....+++.|....+.+| ..++.++++||.+||+.||.+||++ .++.|+++||||++++|+.+..+
T Consensus 258 ~~~~~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~ 334 (396)
T 4dc2_A 258 SSDNPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQ 334 (396)
T ss_dssp C------CCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTC
T ss_pred cccccchhhHHHHHHHHhccccCCC---CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCC
Confidence 34557788888877766 6799999999999999999999996 46899999999999999999876
Q ss_pred -cCCCCCCCCC-CCCCcccccccc
Q 001057 1060 -KAMFIPAAES-LDTSYFVSRYVW 1081 (1170)
Q Consensus 1060 -~ppfiP~~~s-lDts~F~s~~~~ 1081 (1170)
.|||+|...+ .|+++|+..|+.
T Consensus 335 ~~pp~~p~~~~~~d~~~fd~~~~~ 358 (396)
T 4dc2_A 335 VVPPFKPNISGEFGLDNFDSQFTN 358 (396)
T ss_dssp SCCSCCCCCCSSTTGGGSCHHHHT
T ss_pred CCCCCcCCCCCccchhhcChhhcc
Confidence 7899999877 899999987764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-56 Score=493.91 Aligned_cols=294 Identities=40% Similarity=0.771 Sum_probs=265.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+.+++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|..++||||++++++|++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45689999999999999999999999999999999998765544556678899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~----- 156 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI----- 156 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-----
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcc-----
Confidence 999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 157 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 211 (337)
T 1o6l_A 157 -------------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211 (337)
T ss_dssp -------------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------cCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH
Confidence 0111234578999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES- 1069 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s- 1069 (1170)
.++..|......+| ..+++++++||.+||+.||.+||+. .++.++++||||.+++|+.+..+ .|||+|...+
T Consensus 212 ~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~~~ 288 (337)
T 1o6l_A 212 RLFELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSE 288 (337)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSST
T ss_pred HHHHHHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCCCc
Confidence 99999998887766 6799999999999999999999952 35999999999999999998765 6899998877
Q ss_pred CCCCcccccccc
Q 001057 1070 LDTSYFVSRYVW 1081 (1170)
Q Consensus 1070 lDts~F~s~~~~ 1081 (1170)
.|+++|+..++.
T Consensus 289 ~d~~~f~~~~~~ 300 (337)
T 1o6l_A 289 VDTRYFDDEFTA 300 (337)
T ss_dssp TCCTTSCHHHHT
T ss_pred chhhcccchhcc
Confidence 889999876653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=494.92 Aligned_cols=295 Identities=36% Similarity=0.745 Sum_probs=263.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~ 832 (1170)
.+..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+..|+.+|..+ +||||++++++|++.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 46678999999999999999999999999999999999886554555667889999999887 79999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+||||||++||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--- 172 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--- 172 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC---
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 173 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 173 ---------------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp ---------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ---------------------------cCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 01112346789999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCC
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAE 1068 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~ 1068 (1170)
..++++.|....+.+| ..++.++++||.+||+.||.+||+. .++.++++||||++++|+.+..+ .|||+|...
T Consensus 226 ~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~ 302 (353)
T 2i0e_A 226 EDELFQSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAC 302 (353)
T ss_dssp HHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHHHHHHHHhCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCC
Confidence 9999999999887766 6899999999999999999999984 47899999999999999999765 789999887
Q ss_pred CCCCCcccccccc
Q 001057 1069 SLDTSYFVSRYVW 1081 (1170)
Q Consensus 1069 slDts~F~s~~~~ 1081 (1170)
+.|+++|+..+..
T Consensus 303 ~~~~~~f~~~~~~ 315 (353)
T 2i0e_A 303 GRNAENFDRFFTR 315 (353)
T ss_dssp CC--CHHHHHHHH
T ss_pred Ccchhhccchhcc
Confidence 7799999876653
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=481.09 Aligned_cols=294 Identities=36% Similarity=0.749 Sum_probs=261.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~ 832 (1170)
.+..++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|..+ +||||++++++|.+...
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999987766677788899999999987 89999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+||||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~--- 161 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--- 161 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC---
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc---
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC--
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA-- 990 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g-- 990 (1170)
.........+||+.|+|||++.+..|+.++|||||||++|||++|.+||..
T Consensus 162 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 162 ---------------------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp ---------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred ---------------------------CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence 001123457899999999999999999999999999999999999999975
Q ss_pred -------CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh---hhHHHHHcCCCCCCCChhhhhhc-
Q 001057 991 -------KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA---TGAREVKQHPFFKNINWDTLARQ- 1059 (1170)
Q Consensus 991 -------~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa---~~AeEILqHPfF~~idwe~L~~~- 1059 (1170)
.....+++.+......+| ..++.++++||.+||+.||.+||++ .++.++++||||++++|+.+..+
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~ 291 (345)
T 3a8x_A 215 SSDNPDQNTEDYLFQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQ 291 (345)
T ss_dssp C-------CHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTC
T ss_pred cccccccccHHHHHHHHHcCCCCCC---CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCC
Confidence 344567778887777665 6799999999999999999999995 36799999999999999998765
Q ss_pred -cCCCCCCCCC-CCCCccccccc
Q 001057 1060 -KAMFIPAAES-LDTSYFVSRYV 1080 (1170)
Q Consensus 1060 -~ppfiP~~~s-lDts~F~s~~~ 1080 (1170)
.|||+|...+ .|+++|+..+.
T Consensus 292 ~~~p~~p~~~~~~~~~~~~~~~~ 314 (345)
T 3a8x_A 292 VVPPFKPNISGEFGLDNFDSQFT 314 (345)
T ss_dssp SCCSCCCCCCTTTCGGGSCHHHH
T ss_pred CCCCcCCCCCCcchhhhcCcccc
Confidence 6789998776 78888887654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-55 Score=500.32 Aligned_cols=264 Identities=28% Similarity=0.421 Sum_probs=226.1
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec------cc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC------RE 831 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd------~~ 831 (1170)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+++|+.+|+.++|||||+++++|.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 579999999999999999999999999999999976542 34456788999999999999999999998764 36
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
++|||||||. |+|.+++.+.+.+++..++.|++||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7999999995 689999999899999999999999999999999999999999999999999999999999999853100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
. ........+.+||+.|||||++.+. .|+.++||||||||+|||++|.+||.+
T Consensus 212 ~--------------------------~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g 265 (398)
T 4b99_A 212 P--------------------------AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPG 265 (398)
T ss_dssp ------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred c--------------------------cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCC
Confidence 0 0112234568999999999999875 569999999999999999999999999
Q ss_pred CCHHHHHHHHhccCCCCC--------------------C--------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 991 KTPQQIFDNIMNRDIPWP--------------------N--------IPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP--------------------~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
.+..+++..|.......+ . +...++++++|||.+||++||.+||| |.|+
T Consensus 266 ~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~ 342 (398)
T 4b99_A 266 KNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS---AAAA 342 (398)
T ss_dssp SSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC---HHHH
T ss_pred CCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC---HHHH
Confidence 999998888865321111 0 11257899999999999999999999 8899
Q ss_pred HcCCCCCCCC
Q 001057 1043 KQHPFFKNIN 1052 (1170)
Q Consensus 1043 LqHPfF~~id 1052 (1170)
|+||||+...
T Consensus 343 L~Hp~f~~~~ 352 (398)
T 4b99_A 343 LRHPFLAKYH 352 (398)
T ss_dssp TTSGGGTTTC
T ss_pred hcCHhhCcCC
Confidence 9999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-55 Score=499.25 Aligned_cols=294 Identities=37% Similarity=0.711 Sum_probs=254.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|..++||||++++++|++.+++|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 44578999999999999999999999999999999998765545555667889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|||||++||+|.+++.+.+ .+++..+++|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~--- 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA--- 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT---
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC---
Confidence 9999999999999998764 799999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-------cCCCCcchhhhHHHHHHHHHHhCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-------GMGHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-------g~~ys~ksDIWSLGVILYELLTG~p 986 (1170)
.........+||+.|+|||++. +..|+.++|||||||++|||++|.+
T Consensus 215 --------------------------~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~ 268 (412)
T 2vd5_A 215 --------------------------DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268 (412)
T ss_dssp --------------------------TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSC
T ss_pred --------------------------CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCC
Confidence 0011234568999999999998 3568999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhcc--CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhccCCCC
Q 001057 987 PFNAKTPQQIFDNIMNR--DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFI 1064 (1170)
Q Consensus 987 PF~g~~~~ei~qkIl~~--~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~~ppfi 1064 (1170)
||.+.+..+++.+|... .+.+|..+..++.++++||.+||+ +|.+|++..++.|+++||||++++|+.+....|||+
T Consensus 269 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~ 347 (412)
T 2vd5_A 269 PFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFT 347 (412)
T ss_dssp TTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCC
T ss_pred CCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCC
Confidence 99999999999998864 355565556899999999999999 999999777799999999999999999988899999
Q ss_pred CCCCC-CCCCccccc
Q 001057 1065 PAAES-LDTSYFVSR 1078 (1170)
Q Consensus 1065 P~~~s-lDts~F~s~ 1078 (1170)
|...+ .|+++|+..
T Consensus 348 p~~~~~~d~~~f~~~ 362 (412)
T 2vd5_A 348 PDFEGATDTCNFDLV 362 (412)
T ss_dssp CC-----CCSSCC--
T ss_pred CcCCCcccccccCcc
Confidence 98877 788999753
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=489.58 Aligned_cols=295 Identities=40% Similarity=0.771 Sum_probs=248.0
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHH-HHhcCCCcEEEEEeeeeccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI-LISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieI-LskL~HPNIVrL~~~Fqd~~ 831 (1170)
.....++|++++.||+|+||+||+|+++.+++.||||++.+...........+..|..+ +..++|||||+++++|++.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 45677899999999999999999999999999999999998776666667788888887 46789999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+||||||+.||+|.+++.+.+.+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~-- 190 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI-- 190 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB--
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc--
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 191 ----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 242 (373)
T 2r5t_A 191 ----------------------------EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 242 (373)
T ss_dssp ----------------------------CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ----------------------------cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 0011234678999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh-hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA-TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAE 1068 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa-~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~ 1068 (1170)
+..++++.|....+.++ ..++.++++||.+||+.||.+||++ .++.++++||||++++|+.+..+ .|||+|...
T Consensus 243 ~~~~~~~~i~~~~~~~~---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~ 319 (373)
T 2r5t_A 243 NTAEMYDNILNKPLQLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVS 319 (373)
T ss_dssp BHHHHHHHHHHSCCCCC---SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCC
T ss_pred CHHHHHHHHHhcccCCC---CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCCCC
Confidence 99999999998877665 6799999999999999999999996 46889999999999999999766 789999887
Q ss_pred C-CCCCccccccc
Q 001057 1069 S-LDTSYFVSRYV 1080 (1170)
Q Consensus 1069 s-lDts~F~s~~~ 1080 (1170)
+ .|+++|+..|.
T Consensus 320 ~~~d~~~f~~~~~ 332 (373)
T 2r5t_A 320 GPNDLRHFDPEFT 332 (373)
T ss_dssp C------------
T ss_pred CcchhhhcCcccc
Confidence 7 78899987654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=482.28 Aligned_cols=270 Identities=25% Similarity=0.456 Sum_probs=208.2
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc------
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE------ 831 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~------ 831 (1170)
++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 57999999999999999999999999999999997653 3445678999999999999999999999997654
Q ss_pred ------ceEEEEeeccCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEec
Q 001057 832 ------NLYLVMEYLNGGDLYSLLRNLGC---LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902 (1170)
Q Consensus 832 ------~LyLVMEY~~GGSL~dlLk~~~~---LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDF 902 (1170)
++|||||||.||+|.+++..... .++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999987654 455678899999999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELL 982 (1170)
|+|+........... .. -........+.+||+.|||||++.+..|+.++|||||||+||||+
T Consensus 163 Gla~~~~~~~~~~~~-----------------~~-~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell 224 (299)
T 4g31_A 163 GLVTAMDQDEEEQTV-----------------LT-PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224 (299)
T ss_dssp CCC--------------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ccceecCCCcccccc-----------------cc-ccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHc
Confidence 999864211000000 00 001112345678999999999999999999999999999999999
Q ss_pred hCCCCCCCCCH-HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhh
Q 001057 983 IGIPPFNAKTP-QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 983 TG~pPF~g~~~-~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~ 1055 (1170)
+ ||.+... ...+..+.+ ..+|......++.+.+||.+||+.||.+||+ +.|+|+||||++++|..
T Consensus 225 ~---Pf~~~~~~~~~~~~~~~--~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 225 Y---PFSTQMERVRTLTDVRN--LKFPPLFTQKYPCEYVMVQDMLSPSPMERPE---AINIIENAVFEDLDFPG 290 (299)
T ss_dssp S---CCSSHHHHHHHHHHHHT--TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGCCC----
T ss_pred c---CCCCccHHHHHHHHHhc--CCCCCCCcccCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCCCCCCC
Confidence 6 8865432 233344443 3344334466788999999999999999999 88999999999999853
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=501.26 Aligned_cols=292 Identities=38% Similarity=0.718 Sum_probs=256.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|+++++||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|..++||||++++++|.+.+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 45678999999999999999999999999999999998765444444556889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~--- 227 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME--- 227 (437)
T ss_dssp EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT---
T ss_pred EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc---
Confidence 99999999999999987 46899999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-----cCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
.........+||+.|||||++. ...|+.++|||||||++|||++|.+||
T Consensus 228 --------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf 281 (437)
T 4aw2_A 228 --------------------------DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281 (437)
T ss_dssp --------------------------TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred --------------------------CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCC
Confidence 0111234568999999999997 456899999999999999999999999
Q ss_pred CCCCHHHHHHHHhcc--CCCCCCCCccCCHHHHHHHHHhccCCCCC--CCChhhHHHHHcCCCCCCCChhhhhhccCCCC
Q 001057 989 NAKTPQQIFDNIMNR--DIPWPNIPEEMSVEACDLIDKLLTENPVQ--RLGATGAREVKQHPFFKNINWDTLARQKAMFI 1064 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~--~l~fP~ip~~lS~eakDLIkkLLq~DPsk--RpSa~~AeEILqHPfF~~idwe~L~~~~ppfi 1064 (1170)
.+.+..+++..|+.. .+.+|.....+++++++||.+||+.+|.+ |++ ++|+++||||++++|+.+....+||+
T Consensus 282 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~---~~eil~Hpff~~i~w~~l~~~~~p~~ 358 (437)
T 4aw2_A 282 YAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNG---IEDFKKHPFFSGIDWDNIRNCEAPYI 358 (437)
T ss_dssp CCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTT---THHHHTSGGGTTCCTTTGGGSCCSCC
T ss_pred CCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCC---HHHHhCCCccCCCCHHHHhhCCCCCC
Confidence 999999999999864 35666555679999999999999988766 665 88999999999999999988899999
Q ss_pred CCCCC-CCCCccccc
Q 001057 1065 PAAES-LDTSYFVSR 1078 (1170)
Q Consensus 1065 P~~~s-lDts~F~s~ 1078 (1170)
|...+ .|+++|+..
T Consensus 359 P~~~~~~d~~~fd~~ 373 (437)
T 4aw2_A 359 PEVSSPTDTSNFDVD 373 (437)
T ss_dssp CCCSSTTCCTTSCCC
T ss_pred CcCCCccchhhcCCc
Confidence 98877 788888754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-54 Score=521.38 Aligned_cols=296 Identities=36% Similarity=0.751 Sum_probs=266.9
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~ 831 (1170)
..+.+++|++++.||+|+||+||+|+++.+++.||||++.+.........+.+..|+.+|..+ +||||++++++|++.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 346778999999999999999999999999999999999876555555667888999999887 6999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+||||||++||+|..++...+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~-- 493 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-- 493 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC--
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc--
Confidence 999999999999999999998899999999999999999999999999999999999999999999999999998421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.
T Consensus 494 ----------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 494 ----------------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp ----------------------------CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------------------------cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 0111234678999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAA 1067 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~ 1067 (1170)
+..++++.|+...+.+| ..++.++++||.+||+.||.+||++ .++.||++||||++++|+.+..+ .|||+|..
T Consensus 546 ~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~ 622 (674)
T 3pfq_A 546 DEDELFQSIMEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 622 (674)
T ss_dssp SHHHHHHHHHSSCCCCC---TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBC
T ss_pred CHHHHHHHHHhCCCCCC---ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcC
Confidence 99999999999888776 6899999999999999999999995 57899999999999999999876 78999998
Q ss_pred CCCCCCcccccccc
Q 001057 1068 ESLDTSYFVSRYVW 1081 (1170)
Q Consensus 1068 ~slDts~F~s~~~~ 1081 (1170)
.+.|+++|+..|+.
T Consensus 623 ~~~~~~~f~~~~~~ 636 (674)
T 3pfq_A 623 SGRNAENFDRFFTR 636 (674)
T ss_dssp CGGGHHHHTTTTTS
T ss_pred CCCchhhcCchhcc
Confidence 87888999887654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-55 Score=485.65 Aligned_cols=293 Identities=41% Similarity=0.774 Sum_probs=245.0
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~ 831 (1170)
.....++|++++.||+|+||+||+|+++.+|+.||||++.+...........+..|+.+|..+ +||||++++++|++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 356778999999999999999999999999999999999876544445567788999999876 8999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+||||||++||+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 169 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM-- 169 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc--
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 170 ----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 170 ----------------------------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp ----------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------------------------cCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 0011234678999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES 1069 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s 1069 (1170)
+..+++..|......+| ..++.++++||.+||+.||.+||++. .++++||||++++|+.+..+ .|||+|...+
T Consensus 222 ~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dp~~R~~~~--~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~~ 296 (345)
T 1xjd_A 222 DEEELFHSIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKS 296 (345)
T ss_dssp SHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC--------
T ss_pred CHHHHHHHHHhCCCCCC---cccCHHHHHHHHHHhcCCHhHcCCCh--HHHHcCccccCCCHHHHhhCCCCCCcCCCCCC
Confidence 99999999998877665 67999999999999999999999943 28999999999999999765 7899998877
Q ss_pred -CCCCccccccc
Q 001057 1070 -LDTSYFVSRYV 1080 (1170)
Q Consensus 1070 -lDts~F~s~~~ 1080 (1170)
.|+++|+..+.
T Consensus 297 ~~d~~~f~~~~~ 308 (345)
T 1xjd_A 297 PFDCSNFDKEFL 308 (345)
T ss_dssp ------------
T ss_pred cchhhhcchhhc
Confidence 78889987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-54 Score=473.80 Aligned_cols=287 Identities=39% Similarity=0.770 Sum_probs=253.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|..++||||++++++|.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45688999999999999999999999999999999998765544455678889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~----- 157 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----
Confidence 999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 158 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 209 (318)
T 1fot_A 158 ----------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209 (318)
T ss_dssp ----------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ----------------------------CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 1123568999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES- 1069 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s- 1069 (1170)
.++..|......+| ..++.++++||.+||+.||.+|++. .+++++++||||++++|+.+..+ .+||+|...+
T Consensus 210 ~~~~~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~~~ 286 (318)
T 1fot_A 210 KTYEKILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQG 286 (318)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC---
T ss_pred HHHHHHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcCCC
Confidence 99999998887766 6799999999999999999999953 25899999999999999999766 6889998763
Q ss_pred -CCCCcccc
Q 001057 1070 -LDTSYFVS 1077 (1170)
Q Consensus 1070 -lDts~F~s 1077 (1170)
.|+++|+.
T Consensus 287 ~~d~~~f~~ 295 (318)
T 1fot_A 287 QGDTSQFDK 295 (318)
T ss_dssp ---------
T ss_pred ccchhhcCC
Confidence 78888875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=494.30 Aligned_cols=290 Identities=41% Similarity=0.734 Sum_probs=253.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|+++++||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|..++|||||+++++|++...+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 45678999999999999999999999999999999998755444444556889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||||+||+|.+++.. ..+++..+++|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+....
T Consensus 146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~---- 220 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK---- 220 (410)
T ss_dssp EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT----
T ss_pred EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc----
Confidence 99999999999999976 4699999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC----CCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG----HGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~----ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.......+.+||+.|+|||++.+.. |+.++|||||||+||||++|.+||.+
T Consensus 221 -------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 275 (410)
T 3v8s_A 221 -------------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275 (410)
T ss_dssp -------------------------TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -------------------------CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCC
Confidence 0111234678999999999998766 78999999999999999999999999
Q ss_pred CCHHHHHHHHhccC--CCCCCCCccCCHHHHHHHHHhccCCCCC--CCChhhHHHHHcCCCCCCCChhhhhhc--cCCCC
Q 001057 991 KTPQQIFDNIMNRD--IPWPNIPEEMSVEACDLIDKLLTENPVQ--RLGATGAREVKQHPFFKNINWDTLARQ--KAMFI 1064 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~--l~fP~ip~~lS~eakDLIkkLLq~DPsk--RpSa~~AeEILqHPfF~~idwe~L~~~--~ppfi 1064 (1170)
.+..+++..|+... +.+|. ...++.++++||.+||+.+|.+ |++ +.||++||||++++|+.+..+ .|||+
T Consensus 276 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~---~~ei~~Hp~f~~~~w~~~~~~~~~~p~~ 351 (410)
T 3v8s_A 276 DSLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNG---VEEIKRHLFFKNDQWAWETLRDTVAPVV 351 (410)
T ss_dssp SSHHHHHHHHHTHHHHCCCCT-TCCCCHHHHHHHHHHSSCGGGCTTSSC---HHHHHTSGGGCCSSCCSTTGGGSCCSCC
T ss_pred CChhhHHHHHHhccccccCCC-cccccHHHHHHHHHHccChhhhCCCCC---HHHHhcCccccCCCHHHHhhcccCCCCC
Confidence 99999999998753 44553 2478999999999999988777 777 899999999999998765544 79999
Q ss_pred CCCCC-CCCCccccc
Q 001057 1065 PAAES-LDTSYFVSR 1078 (1170)
Q Consensus 1065 P~~~s-lDts~F~s~ 1078 (1170)
|...+ .|+++|+..
T Consensus 352 p~~~~~~d~~~fd~~ 366 (410)
T 3v8s_A 352 PDLSSDIDTSNFDDL 366 (410)
T ss_dssp CCCSSTTCCTTSCCC
T ss_pred CcCCCccchhhcCCc
Confidence 99877 889999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-54 Score=478.12 Aligned_cols=287 Identities=40% Similarity=0.789 Sum_probs=262.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|..++||||++++++|.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45678999999999999999999999999999999999876555555667889999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~---- 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---- 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS----
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 193 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 193 -----------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp -----------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -----------------------------CCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 012356899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC--hhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES 1069 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS--a~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s 1069 (1170)
.+++..|..+...+| ..++.++.+||.+||+.||.+||+ ..++.++++||||++++|+.+..+ .+||+|...+
T Consensus 244 ~~~~~~i~~~~~~~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~~ 320 (350)
T 1rdq_E 244 IQIYEKIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKG 320 (350)
T ss_dssp HHHHHHHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCS
T ss_pred HHHHHHHHcCCCCCC---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCCC
Confidence 999999999887766 679999999999999999999998 356899999999999999998765 7899998776
Q ss_pred -CCCCccc
Q 001057 1070 -LDTSYFV 1076 (1170)
Q Consensus 1070 -lDts~F~ 1076 (1170)
.|+++|+
T Consensus 321 ~~~~~~f~ 328 (350)
T 1rdq_E 321 PGDTSNFD 328 (350)
T ss_dssp TTCCTTSC
T ss_pred cccccccc
Confidence 7888887
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=508.99 Aligned_cols=265 Identities=27% Similarity=0.490 Sum_probs=238.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|.+..++|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34679999999999999999999999999999999997653 334567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC--CcEEEEecCCccccccc
Q 001057 835 LVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD--GHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d--G~VKLsDFGLAk~~~~~ 911 (1170)
||||||.||+|+++|.. .+.|++..++.|++||+.||+|||++||+||||||+|||++.+ |++||+|||+|+...
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~-- 308 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 308 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC--
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc--
Confidence 99999999999999964 4679999999999999999999999999999999999999854 899999999998531
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.
T Consensus 309 -----------------------------~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 309 -----------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp -----------------------------TTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred -----------------------------CCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 111234678999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhh
Q 001057 992 TPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTL 1056 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L 1056 (1170)
+..+++..|......++. ....+|.++++||.+||+.||.+||+ +.|+|+||||+..+|...
T Consensus 360 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t---~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 360 NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp SHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTSCCCCTTT
T ss_pred CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcCcCCCCCCCc
Confidence 999999999988776653 23578999999999999999999999 889999999999887643
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=481.73 Aligned_cols=281 Identities=30% Similarity=0.441 Sum_probs=210.5
Q ss_pred CCeEEEEEeccCCCeEEEEeeec---CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccce
Q 001057 758 EDFEIIKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~L 833 (1170)
++|+++++||+|+||+||+|+++ .+++.||||++.+.. ....+.+|+.+|..+ +|||||+++++|.+.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 57999999999999999999875 468899999987643 234578899999988 699999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC-CcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD-GHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d-G~VKLsDFGLAk~~~~~~ 912 (1170)
|||||||+||+|.+++. .+++.+++.|++||+.||+|||++|||||||||+|||++.+ +++||+|||+|+......
T Consensus 96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 99999999999999984 59999999999999999999999999999999999999877 899999999998532100
Q ss_pred CCCCCCCCCCCCCcccccccc-CCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELK-DQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~-~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.. ................ .............+.+||+.|||||++.+. .|+.++||||+|||+|||++|++||.+
T Consensus 173 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 173 IE---LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CG---GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred cc---ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 00 0000000000000000 000001112334567999999999999875 589999999999999999999999964
Q ss_pred -CCHHHHHHHHhc--------------------------------------cCCCCC-------------CCCccCCHHH
Q 001057 991 -KTPQQIFDNIMN--------------------------------------RDIPWP-------------NIPEEMSVEA 1018 (1170)
Q Consensus 991 -~~~~ei~qkIl~--------------------------------------~~l~fP-------------~ip~~lS~ea 1018 (1170)
.+..+++..|.. .....| .....+|+++
T Consensus 250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a 329 (361)
T 4f9c_A 250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA 329 (361)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence 444444444321 000011 0123578999
Q ss_pred HHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 1019 CDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1019 kDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
+|||.+||++||.+|+| |+|+|+||||++++
T Consensus 330 ~DLl~~lL~~dP~~R~t---a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 330 YDLLDKLLDLNPASRIT---AEEALLHPFFKDMS 360 (361)
T ss_dssp HHHHHHHTCSCTTTSCC---HHHHHTSGGGTTC-
T ss_pred HHHHHHHCcCChhHCcC---HHHHhcCcccCCCC
Confidence 99999999999999999 88999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=483.84 Aligned_cols=295 Identities=40% Similarity=0.773 Sum_probs=250.0
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|..++||||++++++|.+.+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999999987655555666788899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+||||||++||+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+...
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~-- 300 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-- 300 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC--
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceecc--
Confidence 99999999999999999988899999999999999999999998 999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 301 ----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 301 ----------------------------KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp ----------------------------C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------------------------CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 0111234578999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC--hhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTLARQ--KAMFIPAA 1067 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS--a~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~ 1067 (1170)
+...++..+......+| ..+++++.+||.+||+.||.+||+ ...+.|+++||||++++|+.+..+ .|||+|..
T Consensus 353 ~~~~~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~ 429 (446)
T 4ejn_A 353 DHEKLFELILMEEIRFP---RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQV 429 (446)
T ss_dssp SHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSC
T ss_pred CHHHHHHHHHhCCCCCC---ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCccCCC
Confidence 99999999998887766 679999999999999999999993 124899999999999999998766 78899988
Q ss_pred CC-CCCCccccccc
Q 001057 1068 ES-LDTSYFVSRYV 1080 (1170)
Q Consensus 1068 ~s-lDts~F~s~~~ 1080 (1170)
.+ .|+++|+.+|+
T Consensus 430 ~~~~~~~~~~~~~~ 443 (446)
T 4ejn_A 430 TSETDTRYFDEEFT 443 (446)
T ss_dssp SSTTCCTTC-----
T ss_pred CCccchhhcchhhh
Confidence 77 88999998775
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=463.32 Aligned_cols=253 Identities=25% Similarity=0.417 Sum_probs=218.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
+..++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.+|++++|||||+++++|.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 45578999999999999999999875 46889999999764 34556789999999999999999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNL-------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH 896 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~-------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~ 896 (1170)
.+.+|||||||+||+|.++|... ..+++..+..++.||+.||.|||+++||||||||+||||+.++.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 99999999999999999999764 36999999999999999999999999999999999999999999
Q ss_pred EEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHH
Q 001057 897 IKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGI 976 (1170)
Q Consensus 897 VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGV 976 (1170)
+||+|||+|+..... .........+||+.|||||++.+..|+.++|||||||
T Consensus 167 ~Ki~DFGla~~~~~~----------------------------~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gv 218 (299)
T 4asz_A 167 VKIGDFGMSRDVYST----------------------------DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 218 (299)
T ss_dssp EEECCCSCHHHHTGG----------------------------GCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred EEECCcccceecCCC----------------------------CceeecCceecChhhcCHHHHcCCCCCchhhHHHHHH
Confidence 999999999853100 0111233457999999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 977 ILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 977 ILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
+||||+| |++||.+.+..+++..+..+... ..|..+++++.+||.+||+.||.+||++.++.
T Consensus 219 vl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 219 VLWEIFTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPQEVYELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--CCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999998 99999999999999999887642 34578999999999999999999999955443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=456.65 Aligned_cols=294 Identities=42% Similarity=0.798 Sum_probs=240.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec---CCCCEEEEEEeecccccc-HHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMIR-KNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~~-~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
.+..++|++++.||+|+||.||+|++. .+|+.||||++.+..... ......+.+|+.+|..++||||++++++|.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 456789999999999999999999985 689999999998754322 2345667889999999999999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
.+.+||||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 173 ------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 222 (327)
T 3a62_A 173 ------------------------------HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222 (327)
T ss_dssp ------------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ------------------------------cCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCC
Confidence 01112345689999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh--hHHHHHcCCCCCCCChhhhhhc--cCCCCC
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWDTLARQ--KAMFIP 1065 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~--~AeEILqHPfF~~idwe~L~~~--~ppfiP 1065 (1170)
+.+..+++..+......+| ..++.++.+||.+||+.||.+||++. ++.++++||||++++|+.+... .+|+.|
T Consensus 223 ~~~~~~~~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p 299 (327)
T 3a62_A 223 GENRKKTIDKILKCKLNLP---PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKP 299 (327)
T ss_dssp CSSHHHHHHHHHHTCCCCC---TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHTTCSCCSCCC
T ss_pred CCCHHHHHHHHHhCCCCCC---CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhhccCCCCCCC
Confidence 9999999999988877665 67899999999999999999999754 6999999999999999998765 678888
Q ss_pred CCCC-CCCCccccccc
Q 001057 1066 AAES-LDTSYFVSRYV 1080 (1170)
Q Consensus 1066 ~~~s-lDts~F~s~~~ 1080 (1170)
...+ .+.++|+..+.
T Consensus 300 ~~~~~~~~~~~~~~~~ 315 (327)
T 3a62_A 300 LLQSEEDVSQFDSKFT 315 (327)
T ss_dssp C---------------
T ss_pred CcCChhhhhhcchhhh
Confidence 8766 67777776553
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=457.39 Aligned_cols=261 Identities=22% Similarity=0.333 Sum_probs=214.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++.++||+|+||+||+|+... .||||+++... ......+.+.+|+.+|++++|||||++++++. .+.+|
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~ 107 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLA 107 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEE
Confidence 455789999999999999999998653 59999987543 34556788999999999999999999999875 46799
Q ss_pred EEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||||+||+|.++|... +.+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~-- 185 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW-- 185 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC--
Confidence 999999999999999764 57999999999999999999999999999999999999999999999999999852100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC---CCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM---GHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~---~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.......+.+||+.|||||++.+. .|+.++|||||||+||||+||++||.+
T Consensus 186 --------------------------~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 186 --------------------------SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp ----------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --------------------------CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 011223457899999999999753 589999999999999999999999998
Q ss_pred CCHHHHHHHHhccCCCC---CCCCccCCHHHHHHHHHhccCCCCCCCChhhH---HHHHcCCCC
Q 001057 991 KTPQQIFDNIMNRDIPW---PNIPEEMSVEACDLIDKLLTENPVQRLGATGA---REVKQHPFF 1048 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~f---P~ip~~lS~eakDLIkkLLq~DPskRpSa~~A---eEILqHPfF 1048 (1170)
.+....+..+....... +..+..++.++.+||.+||+.||.+||++.++ .+.|+|++-
T Consensus 240 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 240 INNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 77665555554443333 34456899999999999999999999996544 345677653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=458.98 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=213.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
.+..++|.+.++||+|+||+||+|+.+ .+++.||||+++.. .....+.+.+|+.+|++++|||||+++++|.
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 113 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCT 113 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345578999999999999999999864 46889999999754 3455678999999999999999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNL---------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ 893 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~---------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~ 893 (1170)
+.+.+|||||||++|+|.++|... +.+++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 999999999999999999999754 35899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhH
Q 001057 894 DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWS 973 (1170)
Q Consensus 894 dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWS 973 (1170)
++.+||+|||+|+..... .........+||+.|||||++.+..|+.++||||
T Consensus 194 ~~~~Ki~DFGla~~~~~~----------------------------~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS 245 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYST----------------------------DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245 (329)
T ss_dssp TTEEEECCCC--------------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHH
T ss_pred CCcEEEcccccceeccCC----------------------------CcceecCcccccccccChhhhcCCCCCccccccc
Confidence 999999999999853100 0111223568999999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 974 VGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 974 LGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
|||+||||+| |++||.+.+..+++..|..+.. +..|..+++++.+||.+||+.||.+||++.++
T Consensus 246 ~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 310 (329)
T 4aoj_A 246 FGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE--LERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310 (329)
T ss_dssp HHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred hHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence 9999999998 9999999999999998887643 23457899999999999999999999994433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=464.84 Aligned_cols=281 Identities=33% Similarity=0.706 Sum_probs=249.4
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
...+..++|++++.||+|+||.||+|+++.+++.||||++.+...........+.+|+.+|..++|||||+++++|.+..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34677889999999999999999999999999999999998766555556778999999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+|+||||+.||+|..++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~-- 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP-- 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999997521
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc---CCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g---~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
......+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||
T Consensus 167 -----------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf 217 (384)
T 4fr4_A 167 -----------------------------RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217 (384)
T ss_dssp -----------------------------TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred -----------------------------CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence 0112345789999999999974 45899999999999999999999999
Q ss_pred CC---CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc--cCCC
Q 001057 989 NA---KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ--KAMF 1063 (1170)
Q Consensus 989 ~g---~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~--~ppf 1063 (1170)
.+ ....+++..+......+| ..++.++.+||.+||+.||.+||+ .+.++++||||++++|+.+..+ .|+|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~s--~~~~l~~hp~f~~~~w~~~~~~~~~p~~ 292 (384)
T 4fr4_A 218 HIRSSTSSKEIVHTFETTVVTYP---SAWSQEMVSLLKKLLEPNPDQRFS--QLSDVQNFPYMNDINWDAVFQKRLIPGF 292 (384)
T ss_dssp CCCTTSCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC--SHHHHHTSGGGTTCCHHHHHTTCSCCCC
T ss_pred CCCCCccHHHHHHHHhhcccCCC---CcCCHHHHHHHHHHhcCCHhHhcc--cHHHHHcChhhhcCCHHHHHhCCCCCCC
Confidence 74 345666677766666555 679999999999999999999998 3789999999999999998876 6788
Q ss_pred CCCCC
Q 001057 1064 IPAAE 1068 (1170)
Q Consensus 1064 iP~~~ 1068 (1170)
+|...
T Consensus 293 ~p~~~ 297 (384)
T 4fr4_A 293 IPNKG 297 (384)
T ss_dssp CCSCC
T ss_pred CCCCC
Confidence 88753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=454.73 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=221.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
.+...+++++++||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|.+++|||||++++++.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 355678999999999999999999863 467899999987542 2334567999999999999999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG 892 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd 892 (1170)
+.+.+|||||||++|+|.++|... ..+++..+..++.||+.||.|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999999999999643 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhh
Q 001057 893 QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWW 972 (1170)
Q Consensus 893 ~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIW 972 (1170)
.++.+||+|||+|+..... .........+||+.|||||++.+..|+.++|||
T Consensus 180 ~~~~~Ki~DFGlar~~~~~----------------------------~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVw 231 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAA----------------------------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIW 231 (308)
T ss_dssp GGGCEEECCSCCBCGGGGG----------------------------GCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred CCCCEEECCcccceeccCC----------------------------CceeEecccccCCcccCHHHHhCCCCCccchhh
Confidence 9999999999999853100 011123456899999999999999999999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 973 SVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 973 SLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
||||+||||+| |.+||.+.+..+++..|.++... ..|..++.++.+||.+||+.||.+||++.++.+.|+
T Consensus 232 SfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~--~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 232 SYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL--PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp HHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99999999998 89999999999999999876542 346789999999999999999999999665555443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=480.25 Aligned_cols=282 Identities=32% Similarity=0.630 Sum_probs=250.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|..++||||++++++|++...+
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876655445567889999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
||||||++||+|..++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999764 369999999999999999999999999999999999999999999999999998521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.
T Consensus 341 ------------------------------~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~ 390 (543)
T 3c4z_A 341 ------------------------------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFR 390 (543)
T ss_dssp ------------------------------TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ------------------------------CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCC
Confidence 00112235689999999999999999999999999999999999999998
Q ss_pred CC----CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh--hHHHHHcCCCCCCCChhhhhhc--cC
Q 001057 990 AK----TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWDTLARQ--KA 1061 (1170)
Q Consensus 990 g~----~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~--~AeEILqHPfF~~idwe~L~~~--~p 1061 (1170)
+. ...++++.+......+| ..++.++++||.+||+.||.+||++. ++.++++||||++++|+.+... .|
T Consensus 391 ~~~~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~p 467 (543)
T 3c4z_A 391 ARGEKVENKELKQRVLEQAVTYP---DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTP 467 (543)
T ss_dssp CTTCCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred CCccchhHHHHHHHHhhcccCCC---cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCC
Confidence 75 45778888887777665 68999999999999999999999853 5799999999999999999865 78
Q ss_pred CCCCCCC
Q 001057 1062 MFIPAAE 1068 (1170)
Q Consensus 1062 pfiP~~~ 1068 (1170)
||+|...
T Consensus 468 p~~P~~~ 474 (543)
T 3c4z_A 468 PFVPDSR 474 (543)
T ss_dssp SCCCCSS
T ss_pred CCCCCcc
Confidence 8998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=442.02 Aligned_cols=263 Identities=29% Similarity=0.567 Sum_probs=237.3
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
......++|++++.||+|+||.||+|++..+|+.||||++.+... .....+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 345667899999999999999999999999999999999987643 4455678899999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~-- 165 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-- 165 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS--
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC--
Confidence 999999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCC-cchhhhHHHHHHHHHHhCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHG-ATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys-~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
........+||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+
T Consensus 166 -----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 166 -----------------------------VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp -----------------------------SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------------------------CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 01123456899999999999988775 789999999999999999999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
.+..++...+..+...+| ..+++++.+||.+||+.||.+||+ +.++++||||+...
T Consensus 217 ~~~~~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 217 QNLKELRERVLRGKYRIP---FYMSTDCENLLKRFLVLNPIKRGT---LEQIMKDRWINAGH 272 (328)
T ss_dssp SSHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHCCSSTTTSCC---HHHHTTCTTTTTTC
T ss_pred CCHHHHHHHHHhCCCCCC---CCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCHhhcCCC
Confidence 999999999998887665 578999999999999999999999 88999999998653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=480.61 Aligned_cols=281 Identities=33% Similarity=0.607 Sum_probs=248.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|..++|||||+++++|.+.+.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35678899999999999999999999999999999999876555555567789999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
||||||++||+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~-- 337 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVP-- 337 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecc--
Confidence 99999999999999998754 39999999999999999999999999999999999999999999999999997521
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 338 -----------------------------~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 338 -----------------------------EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp -----------------------------TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred -----------------------------cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 011123458999999999999989999999999999999999999999875
Q ss_pred ----CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh--hHHHHHcCCCCCCCChhhhhhc--cCCC
Q 001057 992 ----TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINWDTLARQ--KAMF 1063 (1170)
Q Consensus 992 ----~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~--~AeEILqHPfF~~idwe~L~~~--~ppf 1063 (1170)
....+...+......++ ..+++++++||.+||+.||.+||+.. ++.|+++||||++++|+.+... .|||
T Consensus 389 ~~~~~~~~i~~~i~~~~~~~p---~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~ 465 (576)
T 2acx_A 389 KKKIKREEVERLVKEVPEEYS---ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPF 465 (576)
T ss_dssp SSCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred ccchhHHHHHHHhhcccccCC---ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCC
Confidence 34667777777666555 67999999999999999999999743 6999999999999999999865 6889
Q ss_pred CCCCC
Q 001057 1064 IPAAE 1068 (1170)
Q Consensus 1064 iP~~~ 1068 (1170)
+|...
T Consensus 466 ~p~~~ 470 (576)
T 2acx_A 466 KPDPQ 470 (576)
T ss_dssp CCCCC
T ss_pred CCCcc
Confidence 98754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=446.63 Aligned_cols=270 Identities=30% Similarity=0.491 Sum_probs=239.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH---HHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK---NAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~---~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..++|++++.||+|+||+||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|..++||||++++++|.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 44679999999999999999999999999999999987543221 134678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC----cEEEEecCCcccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG----HIKLTDFGLSKVG 908 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG----~VKLsDFGLAk~~ 908 (1170)
+||||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ++||+|||+|+..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999999888899999999999999999999999999999999999998877 7999999999752
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
. ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||
T Consensus 170 ~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf 218 (361)
T 2yab_A 170 E-------------------------------DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (361)
T ss_dssp C-------------------------------TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred C-------------------------------CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 1 011223568999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc
Q 001057 989 NAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
.+.+..+++..|....+.++. ....++.++++||.+||+.||.+||+ +.|+++||||+.++|......
T Consensus 219 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~~~~~~~~~~ 287 (361)
T 2yab_A 219 LGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDTQQAMVR 287 (361)
T ss_dssp CCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSTTTSCSSHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcCcCCCchhhhhhc
Confidence 999999999999988776652 22468999999999999999999999 889999999999999876543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-50 Score=451.48 Aligned_cols=256 Identities=24% Similarity=0.378 Sum_probs=214.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCC-----CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CcEEEEEeeee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRAT-----GDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFFYSFT 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~T-----Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H-PNIVrL~~~Fq 828 (1170)
+..++|++.+.||+|+||+||+|++..+ ++.||||++.... .....+.+.+|+.+|.+++| ||||+++++|.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 4457899999999999999999987654 4689999987643 33456789999999999975 89999999986
Q ss_pred cc-cceEEEEeeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe
Q 001057 829 CR-ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI 891 (1170)
Q Consensus 829 d~-~~LyLVMEY~~GGSL~dlLk~~----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL 891 (1170)
.. +.+|||||||++|+|.++|+.. ..+++..+..|+.||+.||+|||+++||||||||+||||
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 64 5799999999999999999753 348999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhh
Q 001057 892 GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADW 971 (1170)
Q Consensus 892 d~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDI 971 (1170)
+.++.+||+|||+|+..... .......+.+||+.|||||++.+..|+.++||
T Consensus 219 ~~~~~vKi~DFGlar~~~~~----------------------------~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDV 270 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKD----------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTC----------------------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred CCCCCEEECcchhhhhcccC----------------------------CCceeeccccccccccCHHHHhcCCCCCcccE
Confidence 99999999999999853100 01112345689999999999999999999999
Q ss_pred hHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 972 WSVGIILFELLI-GIPPFNAKTPQQ-IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 972 WSLGVILYELLT-G~pPF~g~~~~e-i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|||||+||||+| |.+||.+.+..+ +...+..+.. +..|..+++++.+||.+||+.||.+||+ +.+|++|
T Consensus 271 wS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~--~~~p~~~~~~~~~li~~c~~~dP~~RPt---~~eil~~ 341 (353)
T 4ase_A 271 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 341 (353)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcCcChhHCcC---HHHHHHH
Confidence 999999999998 999999876544 4444444432 2345789999999999999999999999 6666666
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=419.79 Aligned_cols=259 Identities=34% Similarity=0.570 Sum_probs=228.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+.+|+.++..++||||++++++|...+.+|+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence 346899999999999999999999999999999998765432 23568899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~------ 167 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------ 167 (297)
T ss_dssp EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC------
Confidence 99999999999999864 69999999999999999999999999999999999999999999999999987521
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+...
T Consensus 168 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 223 (297)
T 3fxz_A 168 ------------------------PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223 (297)
T ss_dssp ------------------------STTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred ------------------------CcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 00112235689999999999999999999999999999999999999999988877
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
....+..........+..++..+.+||.+||+.||.+||+ +.++++||||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~ 276 (297)
T 3fxz_A 224 ALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHQFLKIA 276 (297)
T ss_dssp HHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred HHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhccc
Confidence 7777665554433445789999999999999999999999 8899999999854
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=432.39 Aligned_cols=291 Identities=43% Similarity=0.817 Sum_probs=241.2
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeec---CCCCEEEEEEeeccccc-cHHHHHHHHHHHHHHHhc-CCCcEEEEEeee
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMI-RKNAVESILAERNILISV-RNPFVVRFFYSF 827 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~-~~~~ve~~l~EieILskL-~HPNIVrL~~~F 827 (1170)
.....++|++++.||+|+||+||+|++. .+++.||||++.+.... .....+.+.+|+.+|..+ +||||++++++|
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3566789999999999999999999984 58999999998764322 122334567899999999 699999999999
Q ss_pred ecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 828 TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 828 qd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
.....+||||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 99999999999999999999999888999999999999999999999999999999999999999999999999999975
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--CCCCcchhhhHHHHHHHHHHhCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g--~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
.. ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 209 ~~-----------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~ 259 (355)
T 1vzo_A 209 FV-----------------------------ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259 (355)
T ss_dssp CC-----------------------------GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred cc-----------------------------cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 21 011122345689999999999986 34789999999999999999999
Q ss_pred CCCCCC----CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc
Q 001057 986 PPFNAK----TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 986 pPF~g~----~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
.||... ....+...+......++ ..++..+.+||.+||+.||.+||+. ..+.++++||||+.++|+.+..+
T Consensus 260 ~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~ 336 (355)
T 1vzo_A 260 SPFTVDGEKNSQAEISRRILKSEPPYP---QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK 336 (355)
T ss_dssp CTTSCTTSCCCHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred CCCccCCccchHHHHHHHHhccCCCCC---cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhc
Confidence 999753 34556666665554444 6799999999999999999999953 25999999999999999998877
Q ss_pred --cCCCCCCCCC-CCCCcc
Q 001057 1060 --KAMFIPAAES-LDTSYF 1075 (1170)
Q Consensus 1060 --~ppfiP~~~s-lDts~F 1075 (1170)
.+||.|...+ .|.++|
T Consensus 337 ~~~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 337 KVPAPFKPVIRDELDVSNF 355 (355)
T ss_dssp CSCCSCCCCCCC-CCC---
T ss_pred cCCCCCCCccccccccccC
Confidence 4678787665 555554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=422.22 Aligned_cols=268 Identities=29% Similarity=0.489 Sum_probs=235.7
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH---HHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK---NAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~---~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|..++||||++++++|.+...+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4579999999999999999999999999999999986543211 1346788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC----cEEEEecCCccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG----HIKLTDFGLSKVGL 909 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG----~VKLsDFGLAk~~~ 909 (1170)
|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998888899999999999999999999999999999999999999887 89999999997521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 170 -------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 170 -------------------------------FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp -------------------------------TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred -------------------------------CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 0011234579999999999999899999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhh
Q 001057 990 AKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLAR 1058 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~ 1058 (1170)
+.+..+.+..+......++. ....++..+.+||.+||+.||.+||+ +.++++||||+..+|.....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~~~~~ 285 (326)
T 2y0a_A 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQALS 285 (326)
T ss_dssp CSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTSCCSHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcCCCccCCcchhhhh
Confidence 99998888888876665542 12468999999999999999999999 88999999999998865443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=410.89 Aligned_cols=260 Identities=31% Similarity=0.514 Sum_probs=218.4
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|..++||||++++++|.+...+|||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 3689999999999999999999999999999999986542 344557788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+.+ +|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~------ 152 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG------ 152 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecC------
Confidence 999975 56655544 5789999999999999999999999999999999999999999999999999997521
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CCcchhhhHHHHHHHHHHhCCCC-CCCCCH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPP-FNAKTP 993 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLGVILYELLTG~pP-F~g~~~ 993 (1170)
.........+||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+.
T Consensus 153 ------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~ 208 (292)
T 3o0g_A 153 ------------------------IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208 (292)
T ss_dssp ------------------------SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH
T ss_pred ------------------------CccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH
Confidence 0011223457899999999998765 89999999999999999987776 666777
Q ss_pred HHHHHHHhccCC-----C---------------------CCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 994 QQIFDNIMNRDI-----P---------------------WPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 994 ~ei~qkIl~~~l-----~---------------------fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
.+.+..+..... . .......++.++++||.+||+.||.+||+ +.|+++|||
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~ 285 (292)
T 3o0g_A 209 DDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPY 285 (292)
T ss_dssp HHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGG
T ss_pred HHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC---HHHHhcCcc
Confidence 776666643100 0 01112357899999999999999999999 889999999
Q ss_pred CCCC
Q 001057 1048 FKNI 1051 (1170)
Q Consensus 1048 F~~i 1051 (1170)
|+++
T Consensus 286 f~~~ 289 (292)
T 3o0g_A 286 FSDF 289 (292)
T ss_dssp GTTC
T ss_pred cccC
Confidence 9875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=430.63 Aligned_cols=259 Identities=30% Similarity=0.530 Sum_probs=232.1
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+|..++|||||+++++|.+.+.+|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4679999999999999999999999999999999986543 345567889999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---cEEEEecCCccccccccC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---HIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG---~VKLsDFGLAk~~~~~~~ 913 (1170)
|||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~---- 182 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---- 182 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT----
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec----
Confidence 99999999999998888899999999999999999999999999999999999998654 59999999997421
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.
T Consensus 183 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 235 (362)
T 2bdw_A 183 ---------------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235 (362)
T ss_dssp ---------------------------TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 00112346899999999999998999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
.+++..+..+...++.. ...+++++++||.+||+.||.+||+ +.++|+||||..
T Consensus 236 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~ 290 (362)
T 2bdw_A 236 HRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICN 290 (362)
T ss_dssp HHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSHHHHT
T ss_pred HHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCcccCC
Confidence 99999999888776532 1468999999999999999999999 889999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=420.48 Aligned_cols=267 Identities=28% Similarity=0.504 Sum_probs=219.7
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
..+...++|++++.||+|+||+||+|++. +|+.||+|++.... ........+.+|+.+|..++||||++++++|.+..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 34556789999999999999999999985 59999999987543 23334567889999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
.+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~- 170 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG- 170 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT-
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC-
Confidence 99999999974 888888765 459999999999999999999999999999999999999999999999999997521
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 171 -----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 221 (311)
T 3niz_A 171 -----------------------------IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFP 221 (311)
T ss_dssp -----------------------------SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred -----------------------------CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCC
Confidence 00111234578999999999986 568999999999999999999999999
Q ss_pred CCCHHHHHHHHhccC--C---CCC----------------------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 990 AKTPQQIFDNIMNRD--I---PWP----------------------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~--l---~fP----------------------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
+.+..+.+..+.... . .++ .....++.++.+||.+||+.||.+||+ +.|+
T Consensus 222 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~el 298 (311)
T 3niz_A 222 GVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS---ARDA 298 (311)
T ss_dssp CSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC---HHHH
T ss_pred CCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC---HHHH
Confidence 877766665554310 0 000 011347889999999999999999999 8899
Q ss_pred HcCCCCCCCChh
Q 001057 1043 KQHPFFKNINWD 1054 (1170)
Q Consensus 1043 LqHPfF~~idwe 1054 (1170)
++||||++++++
T Consensus 299 l~hp~f~~~~~~ 310 (311)
T 3niz_A 299 MNHPYFKDLDPQ 310 (311)
T ss_dssp HTSGGGTTSCTT
T ss_pred hcCcccccCCcc
Confidence 999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=408.84 Aligned_cols=260 Identities=38% Similarity=0.681 Sum_probs=233.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
...+++|++++.||+|+||+||+|++..++..||+|++.+...........+.+|+.++..++||||++++++|.+...+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 56778999999999999999999999999999999999776544444456788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~---- 160 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 160 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCC----
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999886320
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 161 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 212 (279)
T 3fdn_A 161 ----------------------------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212 (279)
T ss_dssp -----------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ----------------------------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH
Confidence 0112345799999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+.+..+......+| ..++..+.+||.+||+.||.+||+ +.++++||||+..
T Consensus 213 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 213 QETYKRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITAN 264 (279)
T ss_dssp HHHHHHHHHTCCCCC---TTSCHHHHHHHHHHCCSSGGGSCC---HHHHHHCHHHHHH
T ss_pred HHHHHHHHhCCCCCC---CcCCHHHHHHHHHHhccChhhCCC---HHHHhhCccccCC
Confidence 999988887776655 678999999999999999999999 8899999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=422.26 Aligned_cols=257 Identities=29% Similarity=0.493 Sum_probs=229.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||+||+|+++.+++.||+|++.... .....+.+|+.+|..++||||++++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 468999999999999999999999999999999987532 3446688999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC--CCcEEEEecCCccccccccC
Q 001057 837 MEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ--DGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~--dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~---- 155 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---- 155 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC----
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC----
Confidence 99999999999997654 6999999999999999999999999999999999999987 7899999999997521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.
T Consensus 156 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 156 ---------------------------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp ---------------------------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ---------------------------CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 01112346799999999999988899999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+++..+......++.. ...++.++.+||.+||+.||.+||+ +.|+|+||||++.
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~ 264 (321)
T 1tki_A 209 QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQK 264 (321)
T ss_dssp HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHSC
T ss_pred HHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcC---HHHHhcChhhccC
Confidence 99999999887765521 1368999999999999999999999 8899999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=439.84 Aligned_cols=260 Identities=30% Similarity=0.543 Sum_probs=231.6
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||+||+|.++.+|+.||+|++.+... .....+.+.+|+.+|+.++|||||+++++|.+.+.+|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 4679999999999999999999999999999999987543 334567789999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC---CCCcEEEEecCCccccccccC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG---QDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd---~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~---- 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE---- 164 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC----
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec----
Confidence 99999999999999888999999999999999999999999999999999999998 46789999999997421
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.
T Consensus 165 --------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~ 218 (444)
T 3soa_A 165 --------------------------GEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218 (444)
T ss_dssp --------------------------TTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred --------------------------CCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH
Confidence 011122356899999999999998999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
.+++..+..+...++.. ...+++++++||.+||+.||.+||+ +.|+|+||||+.
T Consensus 219 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~e~L~hp~~~~ 273 (444)
T 3soa_A 219 HRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT---AAEALKHPWISH 273 (444)
T ss_dssp HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSCTTHH
T ss_pred HHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC---HHHHhcCccccC
Confidence 99999999888776532 2478999999999999999999999 889999999964
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=435.30 Aligned_cols=296 Identities=27% Similarity=0.389 Sum_probs=209.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-----c
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC-----R 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd-----~ 830 (1170)
..++|++++.||+|+||+||+|+++.+|+.||||++.+. .......+.+.+|+.+|..++|||||+++++|.. .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 347899999999999999999999999999999998764 2344566789999999999999999999999844 3
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
..+||||||+ +|+|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 5799999998 679999999888899999999999999999999999999999999999999999999999999986421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-cCCCCcchhhhHHHHHHHHHHh------
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLI------ 983 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-g~~ys~ksDIWSLGVILYELLT------ 983 (1170)
........+...... ....................+||++|+|||++. +..|+.++||||||||||||++
T Consensus 209 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 209 PENGNSQLPISPRED---DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp CTTCCCCCC------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccccccccccCcccc---ccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 110000000000000 000000000001122345678999999999874 5679999999999999999998
Q ss_pred -----CCCCCCCCCH--------------------HHHHHHHhc--c--------------------------CCCCCCC
Q 001057 984 -----GIPPFNAKTP--------------------QQIFDNIMN--R--------------------------DIPWPNI 1010 (1170)
Q Consensus 984 -----G~pPF~g~~~--------------------~ei~qkIl~--~--------------------------~l~fP~i 1010 (1170)
|.++|.+.+. ...+..|.+ + ...+...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 7788876542 122222211 0 0001111
Q ss_pred CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc
Q 001057 1011 PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 1011 p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
...+++++.+||.+||+.||.+||| +.|+|+||||+++.|..+...
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t---~~e~L~Hp~f~~~~~~~~e~~ 411 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRIT---INECLAHPFFKEVRIAEVETN 411 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGTTTCCGGGCCC
T ss_pred CCCCCHHHHHHHHHHhccCccccCC---HHHHhcCHhhhhcCCCccCCC
Confidence 2356999999999999999999999 889999999999998876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=434.47 Aligned_cols=259 Identities=29% Similarity=0.579 Sum_probs=226.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
...+++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+...+
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34568899999999999999999999999999999999865433333345788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~---- 159 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---- 159 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT----
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc----
Confidence 9999999 78999999888899999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+..
T Consensus 160 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 160 ---------------------------DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp ---------------------------TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred ---------------------------CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 0112345689999999999988776 789999999999999999999998877
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
...++..+......+ +..+++++.+||.+||+.||.+||+ +.|+++||||+.
T Consensus 213 ~~~~~~~i~~~~~~~---p~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 264 (336)
T 3h4j_B 213 IPNLFKKVNSCVYVM---PDFLSPGAQSLIRRMIVADPMQRIT---IQEIRRDPWFNV 264 (336)
T ss_dssp STTCBCCCCSSCCCC---CTTSCHHHHHHHHTTSCSSGGGSCC---HHHHTTCHHHHT
T ss_pred HHHHHHHHHcCCCCC---cccCCHHHHHHHHHHcCCChhHCcC---HHHHHhChhhcc
Confidence 665555555444443 4678999999999999999999999 889999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=399.07 Aligned_cols=264 Identities=29% Similarity=0.511 Sum_probs=234.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.++..++||||+++++++.+....|+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 35789999999999999999999999999999999976543 44556788899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc---EEEEecCCcccccccc
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH---IKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~---VKLsDFGLAk~~~~~~ 912 (1170)
||||+.|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~--- 159 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--- 159 (284)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc---
Confidence 9999999999999988888999999999999999999999999999999999999987665 9999999997421
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 160 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 160 ----------------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 211 (284)
T ss_dssp ----------------------------SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc
Confidence 0111234679999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 993 PQQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
.......+..+...++.. ...+++++.+||.+||+.||.+||+ +.++++||||++..+.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 212 QHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICNRERV 271 (284)
T ss_dssp HHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSHHHHSCCCG
T ss_pred hhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCC---HHHHhcCccccCChhH
Confidence 999999888877665532 2478999999999999999999999 8899999999887544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=427.54 Aligned_cols=273 Identities=23% Similarity=0.359 Sum_probs=223.9
Q ss_pred CCCCCeEEEEEeccC--CCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 755 TSIEDFEIIKPISQG--AFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 755 i~iedYevlk~LG~G--gFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
...++|++++.||+| +||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456789999999999 999999999999999999999987543 34567788899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
+|||||||.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999875 6799999999999999999999999999999999999999999999999999874310
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--CCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g--~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
.... ...........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||
T Consensus 181 ~~~~-----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf 237 (389)
T 3gni_B 181 HGQR-----------------------QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237 (389)
T ss_dssp TTEE-----------------------CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred cccc-----------------------ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 0000 0000112234579999999999987 57899999999999999999999999
Q ss_pred CCCCHHHHHHHHhccCCC-------------------------------------------CCCCCccCCHHHHHHHHHh
Q 001057 989 NAKTPQQIFDNIMNRDIP-------------------------------------------WPNIPEEMSVEACDLIDKL 1025 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~-------------------------------------------fP~ip~~lS~eakDLIkkL 1025 (1170)
.+.+....+..+..+..+ ....+..+++++.+||.+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 317 (389)
T 3gni_B 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317 (389)
T ss_dssp TTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence 887665555444432211 0012346789999999999
Q ss_pred ccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 1026 LTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 1026 Lq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
|+.||.+||+ +.|+|+||||+++.|.
T Consensus 318 L~~dP~~Rpt---a~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 318 LQRNPDARPS---ASTLLNHSFFKQIKRR 343 (389)
T ss_dssp TCSCTTTSCC---HHHHTTSGGGGGC---
T ss_pred hhcCcccCCC---HHHHhcCHHHHHHhhc
Confidence 9999999999 8899999999988764
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=411.13 Aligned_cols=261 Identities=33% Similarity=0.612 Sum_probs=220.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccccc-----------------------HHHHHHHHHHHH
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-----------------------KNAVESILAERN 810 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~-----------------------~~~ve~~l~Eie 810 (1170)
....++|++.+.||+|+||.||+|++..+++.||||++.+..... ....+.+.+|+.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 456789999999999999999999999999999999997654321 122457889999
Q ss_pred HHHhcCCCcEEEEEeeeec--ccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCc
Q 001057 811 ILISVRNPFVVRFFYSFTC--RENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDN 888 (1170)
Q Consensus 811 ILskL~HPNIVrL~~~Fqd--~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPEN 888 (1170)
+|..++||||+++++++.+ ...+||||||+++++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999999987 567999999999999988654 3579999999999999999999999999999999999
Q ss_pred EEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC---C
Q 001057 889 LLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG---H 965 (1170)
Q Consensus 889 ILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~---y 965 (1170)
||++.++.+||+|||+++... .........+||+.|+|||++.+.. +
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 217 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFK------------------------------GSDALLSNTVGTPAFMAPESLSETRKIFS 217 (298)
T ss_dssp EEECTTSCEEECCCTTCEECS------------------------------SSSCEECCCCSCGGGCCGGGCCTTCCCEE
T ss_pred EEECCCCCEEEecCCCccccc------------------------------cccccccCCcCCccccChhhhccCCCCCC
Confidence 999999999999999997521 0011123457999999999998765 3
Q ss_pred CcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 966 GATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 966 s~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+.++|||||||++|+|++|..||.+.....+...+......++. ...++.++.+||.+||+.||.+||+ +.|+++|
T Consensus 218 ~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~R~s---~~e~l~h 293 (298)
T 2zv2_A 218 GKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD-QPDIAEDLKDLITRMLDKNPESRIV---VPEIKLH 293 (298)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS-SSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTC
T ss_pred CchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCC-ccccCHHHHHHHHHHhhcChhhCCC---HHHHhcC
Confidence 77899999999999999999999999988888888877766653 3478999999999999999999999 8899999
Q ss_pred CCCC
Q 001057 1046 PFFK 1049 (1170)
Q Consensus 1046 PfF~ 1049 (1170)
|||+
T Consensus 294 p~~~ 297 (298)
T 2zv2_A 294 PWVT 297 (298)
T ss_dssp HHHH
T ss_pred cccc
Confidence 9985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=408.42 Aligned_cols=259 Identities=30% Similarity=0.522 Sum_probs=215.6
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|++++.||+|+||+||+|++ .+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 6799999999875432 222345678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~------ 151 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG------ 151 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC------
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccC------
Confidence 999975 999998764 679999999999999999999999999999999999999999999999999997521
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..
T Consensus 152 ------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (288)
T 1ob3_A 152 ------------------------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA 207 (288)
T ss_dssp ------------------------C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ------------------------ccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 001112345789999999999764 5899999999999999999999999998887
Q ss_pred HHHHHHhcc--C---CCC---------------------CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 995 QIFDNIMNR--D---IPW---------------------PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 995 ei~qkIl~~--~---l~f---------------------P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
+.+..+... . ..| ......++.++.+||.+||+.||.+||+ +.|+++||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~f 284 (288)
T 1ob3_A 208 DQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYF 284 (288)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGG
T ss_pred HHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC---HHHHhcCcch
Confidence 776666431 0 001 1112457899999999999999999999 8899999999
Q ss_pred CCC
Q 001057 1049 KNI 1051 (1170)
Q Consensus 1049 ~~i 1051 (1170)
++.
T Consensus 285 ~~~ 287 (288)
T 1ob3_A 285 KEN 287 (288)
T ss_dssp GC-
T ss_pred hhc
Confidence 875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=426.22 Aligned_cols=261 Identities=30% Similarity=0.512 Sum_probs=226.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyL 835 (1170)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+++|.++ +||||++++++|.+...+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4679999999999999999999999999999999987542 234678888877 79999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC----CcEEEEecCCccccccc
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD----GHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d----G~VKLsDFGLAk~~~~~ 911 (1170)
||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+|+...
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~-- 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-- 171 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB--
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc--
Confidence 99999999999999988889999999999999999999999999999999999998543 359999999998531
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC-
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA- 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g- 990 (1170)
.......+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+
T Consensus 172 ----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 172 ----------------------------AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp ----------------------------CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ----------------------------CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 001123356899999999999988899999999999999999999999986
Q ss_pred --CCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc
Q 001057 991 --KTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 991 --~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
.+..+++..|..+.+.++. ....++.++++||.+||+.||.+||+ +.++++||||. +|+.+...
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~~il~hp~~~--~~~~~~~~ 290 (342)
T 2qr7_A 224 PDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT---AALVLRHPWIV--HWDQLPQY 290 (342)
T ss_dssp TTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHH--TGGGSCCS
T ss_pred CcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCCeec--Cccccccc
Confidence 4677888888887776543 23578999999999999999999999 88999999995 47765443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=412.84 Aligned_cols=270 Identities=30% Similarity=0.481 Sum_probs=237.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH---HHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK---NAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~---~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..++|++.+.||+|+||.||+|+++.+|+.||+|++.+...... ...+.+.+|+.+|..++||||++++++|.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 45679999999999999999999999999999999986543221 135678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC----cEEEEecCCcccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG----HIKLTDFGLSKVG 908 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG----~VKLsDFGLAk~~ 908 (1170)
+|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999999888899999999999999999999999999999999999999888 7999999999752
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
. .........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 170 ~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 170 E-------------------------------DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp C-------------------------------TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred C-------------------------------ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCC
Confidence 1 001123457999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc
Q 001057 989 NAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ 1059 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~ 1059 (1170)
.+.+..+.+..+......++. ....++..+.+||.+||+.||.+||+ +.++++||||+.++|.....+
T Consensus 219 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~hp~~~~~~~~~~~~~ 287 (321)
T 2a2a_A 219 LGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDNQQAMVR 287 (321)
T ss_dssp CCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCC---HHHHHHSTTTSCSSHHHHHHH
T ss_pred CCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhcCccccCCCccccccc
Confidence 999999998888877665442 12468899999999999999999999 889999999999998765543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=404.81 Aligned_cols=261 Identities=36% Similarity=0.685 Sum_probs=234.1
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
.....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.
T Consensus 9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence 35667899999999999999999999999999999999976544333345678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~--- 165 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--- 165 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECS---
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCc---
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 166 -----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 166 -----------------------------SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp -----------------------------SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred -----------------------------ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 001234579999999999999899999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..+....+......+| ..++.++++||.+||+.||.+||+ +.++++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 217 HTETHRRIVNVDLKFP---PFLSDGSKDLISKLLRYHPPQRLP---LKGVMEHPWVKAN 269 (284)
T ss_dssp HHHHHHHHHTTCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHHTCHHHHHH
T ss_pred HhHHHHHHhccccCCC---CcCCHHHHHHHHHHhhcCHhhCCC---HHHHhhCHHHHhh
Confidence 8888888888776655 678999999999999999999999 8899999999743
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=418.40 Aligned_cols=267 Identities=26% Similarity=0.447 Sum_probs=217.5
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
.....++|++++.||+|+||+||+|++..+++.||||++.... ........+.+|+.+|..++||||+++++++.+...
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc-cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE
Confidence 3566789999999999999999999999999999999987653 233345677899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC-----CCCcEEEEecCCccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG-----QDGHIKLTDFGLSKV 907 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd-----~dG~VKLsDFGLAk~ 907 (1170)
+||||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.
T Consensus 108 ~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 108 LHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 999999997 59999999888899999999999999999999999999999999999994 455699999999975
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~p 986 (1170)
.. .........+||+.|+|||++.+. .++.++|||||||++|+|++|.+
T Consensus 187 ~~------------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 187 FG------------------------------IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp HC-----------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cC------------------------------CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 31 001122345789999999999875 48999999999999999999999
Q ss_pred CCCCCCHHHHHHHHhccCC-----CC-------------CCC---------CccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 987 PFNAKTPQQIFDNIMNRDI-----PW-------------PNI---------PEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 987 PF~g~~~~ei~qkIl~~~l-----~f-------------P~i---------p~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
||.+.+..+.+..+..... .+ +.. +..++.++.+||.+||+.||.+||+ +
T Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~ 313 (329)
T 3gbz_A 237 LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS---A 313 (329)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC---H
T ss_pred CcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC---H
Confidence 9999988777776654210 01 100 1127899999999999999999999 8
Q ss_pred HHHHcCCCCCCCChh
Q 001057 1040 REVKQHPFFKNINWD 1054 (1170)
Q Consensus 1040 eEILqHPfF~~idwe 1054 (1170)
.|+|+||||++++|+
T Consensus 314 ~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 314 KNALEHPYFSHNDFD 328 (329)
T ss_dssp HHHHTSGGGSSSCSC
T ss_pred HHHhCCcccCCCCCC
Confidence 899999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=423.12 Aligned_cols=281 Identities=29% Similarity=0.493 Sum_probs=213.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeeccc--c
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRE--N 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~--~ 832 (1170)
..++|++++.||+|+||+||+|.+..+|+.||||++.+.. ........+.+|+.+|..+. ||||++++++|...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4578999999999999999999999999999999986542 34455677889999999997 999999999997544 7
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|||||||. |+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999999996 699999876 579999999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
... ........................+||++|+|||++.+ ..|+.++||||||||+|||++|.+||.+.
T Consensus 164 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 164 RVT---------NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp CCC---------CCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccc---------ccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 000 00000000000001112233456789999999999987 67899999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCC---------------------------------------------CCccCCHHHHHHHHHhc
Q 001057 992 TPQQIFDNIMNRDIPWPN---------------------------------------------IPEEMSVEACDLIDKLL 1026 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~---------------------------------------------ip~~lS~eakDLIkkLL 1026 (1170)
+...++..|... +.+|. .+..+++++.+||.+||
T Consensus 235 ~~~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 235 STMNQLERIIGV-IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SHHHHHHHHHHH-HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CHHHHHHHHHHh-cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 988887777531 11110 01267899999999999
Q ss_pred cCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 1027 TENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1027 q~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
+.||.+||| +.|+|+||||+.+.
T Consensus 314 ~~dP~~R~t---~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 314 QFNPNKRIS---ANDALKHPFVSIFH 336 (388)
T ss_dssp CSSGGGSCC---HHHHTTSTTTTTTC
T ss_pred ccCcccCCC---HHHHhCCHHHHHhc
Confidence 999999999 88999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=418.07 Aligned_cols=262 Identities=27% Similarity=0.493 Sum_probs=220.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++++.||+|+||+||+|++..+++.||||++..... ....+.+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875432 2234568899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||+.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~---- 158 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN---- 158 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET----
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC----
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999753100
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..
T Consensus 159 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 214 (323)
T 3tki_A 159 ------------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214 (323)
T ss_dssp ------------------------TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT
T ss_pred ------------------------CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 11122345689999999999988775 77899999999999999999999876543
Q ss_pred -HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 995 -QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 995 -ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..+..+.......+ ....++..+.+||.+||+.||.+||+ +.|+++||||+..
T Consensus 215 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~ 268 (323)
T 3tki_A 215 CQEYSDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (323)
T ss_dssp SHHHHHHHTTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred HHHHHHHhcccccCC-ccccCCHHHHHHHHHHccCChhhCcC---HHHHhhChhhccc
Confidence 33333333332222 23578999999999999999999999 8899999999865
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=420.59 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=192.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----ce
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE----NL 833 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~----~L 833 (1170)
.+|.+.++||+|+||+||+|++ +|+.||||++.... ........|+.++..++|||||++++++.+.+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999987 58999999987542 11122334555667889999999999998654 58
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL--------NVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~--------GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
|||||||+||+|.++|+.. .++++.+..++.|++.||.|||++ +||||||||+||||+.++.+||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999999864 689999999999999999999987 9999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC------CCCcchhhhHHHHHHH
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM------GHGATADWWSVGIILF 979 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~------~ys~ksDIWSLGVILY 979 (1170)
+...... ..........+||+.|||||++.+. .|+.++|||||||+||
T Consensus 156 ~~~~~~~--------------------------~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~ 209 (303)
T 3hmm_A 156 VRHDSAT--------------------------DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209 (303)
T ss_dssp EEEETTT--------------------------TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred ccccCCC--------------------------CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHH
Confidence 8531000 0011123356899999999999764 3567899999999999
Q ss_pred HHHhCCCCCCCC---------------CHHHHHHHHhccCCCCCCCCcc-----CCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 980 ELLIGIPPFNAK---------------TPQQIFDNIMNRDIPWPNIPEE-----MSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 980 ELLTG~pPF~g~---------------~~~ei~qkIl~~~l~fP~ip~~-----lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
||+||.+||... ....+...+....+. |.+|.. .+..+.+||.+||+.||.+|||+.++
T Consensus 210 El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~r-p~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 288 (303)
T 3hmm_A 210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp HHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred HHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCC-CCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 999998766321 223444445444332 333332 33578899999999999999995555
Q ss_pred HHHH
Q 001057 1040 REVK 1043 (1170)
Q Consensus 1040 eEIL 1043 (1170)
.+.|
T Consensus 289 ~~~L 292 (303)
T 3hmm_A 289 KKTL 292 (303)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=403.22 Aligned_cols=265 Identities=29% Similarity=0.472 Sum_probs=220.0
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|++++.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.++..++||||++++++|.+.+.+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999987653 2344567788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||+.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~------- 153 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT------- 153 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc-------
Confidence 9999999999999888889999999999999999999999999999999999999999999999999997521
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 154 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 210 (311)
T 4agu_A 154 -----------------------GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210 (311)
T ss_dssp -----------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------CcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 00112234578999999999986 568999999999999999999999999988776
Q ss_pred HHHHHhcc-------------------CCCCCCC---------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 996 IFDNIMNR-------------------DIPWPNI---------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 996 i~qkIl~~-------------------~l~fP~i---------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
....+... ....+.. ...++.++.+||.+||+.||.+||+ +.++++|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~ 287 (311)
T 4agu_A 211 QLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT---CEQLLHHPY 287 (311)
T ss_dssp HHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC---HHHHHTSGG
T ss_pred HHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC---HHHHhcChH
Confidence 66554321 0111110 1357889999999999999999999 889999999
Q ss_pred CCCCChhh
Q 001057 1048 FKNINWDT 1055 (1170)
Q Consensus 1048 F~~idwe~ 1055 (1170)
|+++.+..
T Consensus 288 f~~~~~~~ 295 (311)
T 4agu_A 288 FENIREIE 295 (311)
T ss_dssp GTTCC---
T ss_pred HHhccCHH
Confidence 99987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=443.50 Aligned_cols=263 Identities=29% Similarity=0.576 Sum_probs=236.3
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
.+....++|.+.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+..
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34567789999999999999999999999999999999998765433345678899999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+||||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~-- 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-- 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc--
Confidence 999999999999999999988889999999999999999999999999999999999999999999999999997521
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+
T Consensus 168 -----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 168 -----------------------------DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp -----------------------------TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------------------------ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 0112235689999999999998765 6899999999999999999999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+...++..+..+....| ..+++++.+||.+||+.||.+||+ +.++++||||+..
T Consensus 219 ~~~~~~~~~i~~~~~~~p---~~~s~~~~~Li~~~L~~dP~~Rpt---~~eil~hp~~~~~ 273 (476)
T 2y94_A 219 DHVPTLFKKICDGIFYTP---QYLNPSVISLLKHMLQVDPMKRAT---IKDIREHEWFKQD 273 (476)
T ss_dssp SSSHHHHHHHHTTCCCCC---TTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHTT
T ss_pred CCHHHHHHHHhcCCcCCC---ccCCHHHHHHHHHHcCCCchhCcC---HHHHHhCHHhhhc
Confidence 998999999988776554 678999999999999999999999 8899999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=414.84 Aligned_cols=263 Identities=27% Similarity=0.486 Sum_probs=208.0
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||+||+|+++.+|+.||+|++.... .......+.+|+.+|..++||||++++++|.+.+.+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 468999999999999999999999999999999987643 122335678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 837 MEYLNGGDLYSLLRNL------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
|||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5999998754 3589999999999999999999999999999999999999999999999999975210
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.
T Consensus 161 ------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 161 ------------------------------PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp ------------------------------CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ------------------------------CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 00112345789999999999864 68999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCC-----CC--------------------------CCCCccCCHHHHHHHHHhccCCCCCCCChhh
Q 001057 990 AKTPQQIFDNIMNRDI-----PW--------------------------PNIPEEMSVEACDLIDKLLTENPVQRLGATG 1038 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l-----~f--------------------------P~ip~~lS~eakDLIkkLLq~DPskRpSa~~ 1038 (1170)
+.+..+.+..+..... .| +..+..++.++.+||.+||+.||.+||+
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt--- 287 (317)
T 2pmi_A 211 GTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS--- 287 (317)
T ss_dssp CSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred CCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC---
Confidence 9988887776653100 00 0011257889999999999999999999
Q ss_pred HHHHHcCCCCCCCChhh
Q 001057 1039 AREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 1039 AeEILqHPfF~~idwe~ 1055 (1170)
+.|+|+||||++..|..
T Consensus 288 ~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 288 AKQALHHPWFAEYYHHA 304 (317)
T ss_dssp HHHHTTSGGGGGGCC--
T ss_pred HHHHhCChhhhcccchh
Confidence 88999999999876654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=423.39 Aligned_cols=263 Identities=28% Similarity=0.497 Sum_probs=224.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH--HHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK--NAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~--~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|..++||||++++++|.+.+.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4579999999999999999999999999999999876432211 13467889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc---EEEEecCCccc
Q 001057 835 LVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH---IKLTDFGLSKV 907 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~---VKLsDFGLAk~ 907 (1170)
||||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888643 25899999999999999999999999999999999999987654 99999999975
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
.. .........+||+.|+|||++.+..|+.++|||||||++|+|++|.+|
T Consensus 183 ~~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 232 (351)
T 3c0i_A 183 LG------------------------------ESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232 (351)
T ss_dssp CC------------------------------TTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ec------------------------------CCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCC
Confidence 31 001112346799999999999999999999999999999999999999
Q ss_pred CCCCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 988 FNAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
|.+. ...++..+..+...++. ....++.++++||.+||+.||.+||+ +.++++||||++.++
T Consensus 233 f~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 233 FYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT---VYEALNHPWLKERDR 295 (351)
T ss_dssp SCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHTHHH
T ss_pred CCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcChhhcCCcc
Confidence 9885 45677777776655431 11368999999999999999999999 889999999987543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=418.76 Aligned_cols=258 Identities=33% Similarity=0.599 Sum_probs=216.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|++++.||+|+||+||+|+++.+++.||||++.+..... +.+.+|+.+++.++||||++++++|.+...+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 345678999999999999999999999999999999998654322 4577999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc--EEEEecCCccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH--IKLTDFGLSKVGLIH 911 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~--VKLsDFGLAk~~~~~ 911 (1170)
|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~-- 169 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-- 169 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc--
Confidence 999999999999999998889999999999999999999999999999999999999987765 9999999987421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcc-hhhhHHHHHHHHHHhCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT-ADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~k-sDIWSLGVILYELLTG~pPF~g 990 (1170)
........+||+.|+|||++.+..+..+ +|||||||++|+|++|.+||.+
T Consensus 170 -----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 170 -----------------------------LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp ----------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred -----------------------------ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 0112234579999999999998887655 8999999999999999999987
Q ss_pred CC----HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 991 KT----PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 991 ~~----~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
.. ...+++.+......+|. ...+++++++||.+||+.||.+||+ +.++++||||..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~ 280 (361)
T 3uc3_A 221 PEEPRDYRKTIQRILSVKYSIPD-DIRISPECCHLISRIFVADPATRIS---IPEIKTHSWFLK 280 (361)
T ss_dssp ---CCCHHHHHHHHHTTCCCCCT-TSCCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSHHHHT
T ss_pred CccHHHHHHHHHHHhcCCCCCCC-cCCCCHHHHHHHHHHccCChhHCcC---HHHHHhCcchhc
Confidence 54 35566666666665553 2468999999999999999999999 889999999954
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=405.35 Aligned_cols=263 Identities=29% Similarity=0.451 Sum_probs=213.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccccc--HHHHHHHHHHHHHHHhc---CCCcEEEEEeeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR--KNAVESILAERNILISV---RNPFVVRFFYSFT 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~--~~~ve~~l~EieILskL---~HPNIVrL~~~Fq 828 (1170)
....++|++++.||+|+||+||+|++..+|+.||||++....... ......+.+|+.++..+ +||||++++++|.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 345679999999999999999999999999999999987543211 11123455677776655 5999999999998
Q ss_pred ccc-----ceEEEEeeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEe
Q 001057 829 CRE-----NLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTD 901 (1170)
Q Consensus 829 d~~-----~LyLVMEY~~GGSL~dlLk~~~~--LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsD 901 (1170)
... .+|+||||+. |+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 755 5899999996 599999987654 99999999999999999999999999999999999999999999999
Q ss_pred cCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHH
Q 001057 902 FGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 902 FGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYEL 981 (1170)
||+|+... ........+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 164 fg~a~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 212 (308)
T 3g33_A 164 FGLARIYS-------------------------------YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212 (308)
T ss_dssp CSCTTTST-------------------------------TCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHT
T ss_pred CccccccC-------------------------------CCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHH
Confidence 99997421 01122356899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhccCC-----CCCC-------------------CCccCCHHHHHHHHHhccCCCCCCCChh
Q 001057 982 LIGIPPFNAKTPQQIFDNIMNRDI-----PWPN-------------------IPEEMSVEACDLIDKLLTENPVQRLGAT 1037 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei~qkIl~~~l-----~fP~-------------------ip~~lS~eakDLIkkLLq~DPskRpSa~ 1037 (1170)
++|.+||.+.+..+.+..+..... .|+. ....++.++.+||.+||+.||.+||+
T Consensus 213 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-- 290 (308)
T 3g33_A 213 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS-- 290 (308)
T ss_dssp TTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC--
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC--
Confidence 999999999998888777754211 1110 11357899999999999999999999
Q ss_pred hHHHHHcCCCCCCC
Q 001057 1038 GAREVKQHPFFKNI 1051 (1170)
Q Consensus 1038 ~AeEILqHPfF~~i 1051 (1170)
+.|+|+||||+..
T Consensus 291 -~~e~l~h~~~~~~ 303 (308)
T 3g33_A 291 -AFRALQHSYLHKD 303 (308)
T ss_dssp -HHHHHTSTTC---
T ss_pred -HHHHhcCccccCC
Confidence 8899999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=400.89 Aligned_cols=260 Identities=33% Similarity=0.604 Sum_probs=203.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
.+++|++.+.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 45689999999999999999999999999999999976544333445778999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 836 VMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~----- 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLK----- 163 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeecc-----
Confidence 99999999999999875 579999999999999999999999999999999999999999999999999987521
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..
T Consensus 164 -------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 218 (278)
T 3cok_A 164 -------------------------MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK 218 (278)
T ss_dssp -----------------------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC
T ss_pred -------------------------CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH
Confidence 0011123457999999999999988999999999999999999999999987776
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.....+.......| ..++.++.+||.+||+.||.+||+ +.++++||||...
T Consensus 219 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 269 (278)
T 3cok_A 219 NTLNKVVLADYEMP---SFLSIEAKDLIHQLLRRNPADRLS---LSSVLDHPFMSRN 269 (278)
T ss_dssp -----CCSSCCCCC---TTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSTTTC--
T ss_pred HHHHHHhhcccCCc---cccCHHHHHHHHHHcccCHhhCCC---HHHHhcCccccCC
Confidence 66666655554433 678999999999999999999999 8899999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=397.72 Aligned_cols=269 Identities=30% Similarity=0.496 Sum_probs=231.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccc------ccHHHHHHHHHHHHHHHhcC-CCcEEEEEeee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM------IRKNAVESILAERNILISVR-NPFVVRFFYSF 827 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i------~~~~~ve~~l~EieILskL~-HPNIVrL~~~F 827 (1170)
...++|++.+.||+|+||.||+|+++.+|+.||||++..... ......+.+.+|+.+|.++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 446789999999999999999999999999999999875431 11234567889999999996 99999999999
Q ss_pred ecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 828 TCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 828 qd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
.....+|+||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999999999888899999999999999999999999999999999999999999999999999875
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh------cCCCCcchhhhHHHHHHHHH
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL------GMGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~------g~~ys~ksDIWSLGVILYEL 981 (1170)
.. ........+||+.|+|||++. ...++.++|||||||++|+|
T Consensus 174 ~~-------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l 222 (298)
T 1phk_A 174 LD-------------------------------PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 222 (298)
T ss_dssp CC-------------------------------TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred cC-------------------------------CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHH
Confidence 21 001123457999999999986 34678899999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhh
Q 001057 982 LIGIPPFNAKTPQQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLA 1057 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~ 1057 (1170)
++|..||.+.+.......+......++.. ...++..+.+||.+||+.||.+||+ +.++++||||++..++.+.
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 223 LAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCTTC-----
T ss_pred HHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCC---HHHHHhChHhhhccchhhc
Confidence 99999999999988888888877665421 2468999999999999999999999 8899999999999887654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=440.77 Aligned_cols=265 Identities=31% Similarity=0.536 Sum_probs=235.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|++.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|..++|||||+++++|.+...+|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 44568999999999999999999999999999999998765544455678899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe---CCCCcEEEEecCCccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL---d~dG~VKLsDFGLAk~~~~~ 911 (1170)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 180 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-- 180 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC--
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc--
Confidence 999999999999999988899999999999999999999999999999999999999 567899999999997521
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.
T Consensus 181 -----------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 181 -----------------------------ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp -----------------------------CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------------------------cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 0111234579999999999977 6999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 992 TPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
+..+++..+..+.+.++. ....+++++++||.+||+.||.+||+ +.++|+||||+...++
T Consensus 231 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 231 NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS---ARDALDHEWIQTYTKE 291 (484)
T ss_dssp SHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHHHTC-
T ss_pred CHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhhChhhcccccc
Confidence 999999999988766542 12468999999999999999999999 8899999999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=399.63 Aligned_cols=261 Identities=31% Similarity=0.517 Sum_probs=235.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|++.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 44578999999999999999999999999999999998776556667788999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~----- 166 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE----- 166 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecc-----
Confidence 999999999999999888889999999999999999999999999999999999999999999999999987521
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 167 -------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 221 (294)
T 2rku_A 167 -------------------------YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221 (294)
T ss_dssp -------------------------STTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred -------------------------cCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0011123457999999999999988999999999999999999999999999988
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+.+..+......+| ..++..+.+||.+||+.||.+||+ +.++++||||...
T Consensus 222 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~~~~~~~ 272 (294)
T 2rku_A 222 ETYLRIKKNEYSIP---KHINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 272 (294)
T ss_dssp HHHHHHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred HHHHHHhhccCCCc---cccCHHHHHHHHHHcccChhhCcC---HHHHhhChheecC
Confidence 88888887766554 678999999999999999999999 7789999999764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=394.47 Aligned_cols=256 Identities=32% Similarity=0.551 Sum_probs=227.6
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++.+.||+|+||+||+|++..++..||+|++.+... ...+.+.+|+.++..++||||++++++|.+...+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 4579999999999999999999999999999999876543 2346788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe---CCCCcEEEEecCCccccccccC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL---d~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~---- 160 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK---- 160 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc----
Confidence 9999999999999988889999999999999999999999999999999999999 788999999999987521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.........||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+.
T Consensus 161 ---------------------------~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 212 (277)
T 3f3z_A 161 ---------------------------PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD 212 (277)
T ss_dssp ---------------------------TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH
Confidence 01122345799999999998764 89999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
.+....+..+...++.. ...+++.+.+||.+||+.||.+||+ +.++++||||++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~ 267 (277)
T 3f3z_A 213 SEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT---SLQALEHEWFEK 267 (277)
T ss_dssp HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHHH
T ss_pred HHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhc
Confidence 99999988887765521 1268999999999999999999999 889999999974
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=422.03 Aligned_cols=262 Identities=24% Similarity=0.463 Sum_probs=230.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|++++.||+|+||+||+|+++.+|+.||+|++.... ......+.+|+.+|..++||||++++++|.+...+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999987643 233457889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC--CCcEEEEecCCccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ--DGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~--dG~VKLsDFGLAk~~~~~ 911 (1170)
|||||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~-- 202 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-- 202 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC--
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC--
Confidence 9999999999999997654 6999999999999999999999999999999999999974 4789999999997521
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.
T Consensus 203 -----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 203 -----------------------------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp -----------------------------TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred -----------------------------CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 001122457999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 992 TPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
+..+.+..+......++. ....++.++++||.+||+.||.+||+ +.++++||||++..+
T Consensus 254 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 254 DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGDHS 313 (387)
T ss_dssp SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSCCT
T ss_pred CHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhhCccccCCcc
Confidence 998888888877665442 23578999999999999999999999 889999999987643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=409.86 Aligned_cols=261 Identities=31% Similarity=0.517 Sum_probs=236.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
....+|.+.+.||+|+||.||+|++..+++.||+|++.+.........+.+.+|+.++..++||||++++++|.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 44578999999999999999999999999999999998776656667788999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~----- 192 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE----- 192 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecc-----
Confidence 999999999999999888889999999999999999999999999999999999999999999999999997521
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 193 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 247 (335)
T 2owb_A 193 -------------------------YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247 (335)
T ss_dssp -------------------------STTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred -------------------------cCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 0011123467999999999999999999999999999999999999999999988
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+.+..+......++ ..++.++.+||.+||+.||.+||+ +.++++||||...
T Consensus 248 ~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~ell~~~~~~~~ 298 (335)
T 2owb_A 248 ETYLRIKKNEYSIP---KHINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 298 (335)
T ss_dssp HHHHHHHHTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred HHHHHHhcCCCCCC---ccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccCC
Confidence 88888887776554 678999999999999999999999 7789999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=405.93 Aligned_cols=271 Identities=27% Similarity=0.469 Sum_probs=218.4
Q ss_pred CCCCeEEE-EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccce
Q 001057 756 SIEDFEII-KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 756 ~iedYevl-k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~L 833 (1170)
..+.|++. +.||+|+||+||+|++..+++.||||++.+... .....+.+|+.+|.++ +||||++++++|.+.+.+
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~ 86 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRF 86 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence 34679986 789999999999999999999999999976532 2346788999999885 799999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc---EEEEecCCcccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH---IKLTDFGLSKVGLI 910 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~---VKLsDFGLAk~~~~ 910 (1170)
|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999999999998888999999999999999999999999999999999999998776 99999999875310
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----CCCCcchhhhHHHHHHHHHHhCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----MGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
.... . ..........+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 167 ~~~~---------------------~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 223 (316)
T 2ac3_A 167 NGDC---------------------S--PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223 (316)
T ss_dssp --------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred CCcc---------------------c--cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC
Confidence 0000 0 001112234679999999999975 45889999999999999999999
Q ss_pred CCCCCCC---------------HHHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 986 PPFNAKT---------------PQQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 986 pPF~g~~---------------~~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
+||.+.. ...++..+......+|.. ...++.++++||.+||+.||.+||+ +.|+++||||+
T Consensus 224 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~ 300 (316)
T 2ac3_A 224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS---AAQVLQHPWVQ 300 (316)
T ss_dssp CSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSTTCC
T ss_pred CCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC---HHHHhcChhhc
Confidence 9998754 245667777777665521 1358999999999999999999999 88999999999
Q ss_pred CCChhh
Q 001057 1050 NINWDT 1055 (1170)
Q Consensus 1050 ~idwe~ 1055 (1170)
+..++.
T Consensus 301 ~~~~~~ 306 (316)
T 2ac3_A 301 GCAPEN 306 (316)
T ss_dssp ------
T ss_pred CCCCcc
Confidence 876553
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=397.43 Aligned_cols=262 Identities=29% Similarity=0.574 Sum_probs=224.9
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
+.+..++|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+.++..++||||+++++++...+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 45677899999999999999999999999999999999976543333445678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~--- 162 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--- 162 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC---
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC---
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.
T Consensus 163 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 163 ----------------------------DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp ----------------------------C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------------------------CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 0011234578999999999988765 68899999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+...+++.+......+| ..++..+.+||.+||+.||.+||+ +.++++||||++.
T Consensus 215 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps---~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 215 HVPTLFKKIRGGVFYIP---EYLNRSVATLLMHMLQVDPLKRAT---IKDIREHEWFKQD 268 (276)
T ss_dssp SHHHHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHTT
T ss_pred cHHHHHHHhhcCcccCc---hhcCHHHHHHHHHHccCChhhCCC---HHHHHhChhhccC
Confidence 98888888887765544 678999999999999999999999 8899999999753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=415.19 Aligned_cols=259 Identities=34% Similarity=0.561 Sum_probs=213.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|++.+.||+|+||+||+|++..+++.||||++.+.. ..+.+.+|+.+|..++||||++++++|.+...+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34567999999999999999999999999999999987642 2356788999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---CCcEEEEecCCccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ---DGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~---dG~VKLsDFGLAk~~~~~ 911 (1170)
+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~-- 202 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-- 202 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC--
Confidence 99999999999999998888999999999999999999999999999999999999975 8899999999987421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 203 -----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 253 (349)
T 2w4o_A 203 -----------------------------HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253 (349)
T ss_dssp ---------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCT
T ss_pred -----------------------------cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 011123467999999999999999999999999999999999999999876
Q ss_pred CHH-HHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 992 TPQ-QIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 992 ~~~-ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
... .++..+......++. ....++.++.+||.+||+.||.+||+ +.++++||||.+..
T Consensus 254 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 254 RGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT---TFQALQHPWVTGKA 313 (349)
T ss_dssp TCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTTSTT
T ss_pred cccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCc
Confidence 544 467777776654432 23578999999999999999999999 88999999998764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=410.25 Aligned_cols=257 Identities=28% Similarity=0.489 Sum_probs=220.4
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-----CCcEEEEEee
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-----NPFVVRFFYS 826 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-----HPNIVrL~~~ 826 (1170)
......++|+++++||+|+||+||+|++..+++.||||++... ......+..|+.++..+. ||||++++++
T Consensus 29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 4456678999999999999999999999999999999998753 234556778999999987 9999999999
Q ss_pred eecccceEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-----------
Q 001057 827 FTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ----------- 893 (1170)
Q Consensus 827 Fqd~~~LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~----------- 893 (1170)
|...+.+||||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 105 FMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp EEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred eeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence 99999999999999 899999998754 5999999999999999999999999999999999999975
Q ss_pred --------------CCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHH
Q 001057 894 --------------DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEI 959 (1170)
Q Consensus 894 --------------dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEV 959 (1170)
++.+||+|||+|+... ......+||+.|+|||+
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~---------------------------------~~~~~~~gt~~y~aPE~ 230 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKS---------------------------------DYHGSIINTRQYRAPEV 230 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETT---------------------------------SCCCSCCSCGGGCCHHH
T ss_pred cccccccccccccCCCCEEEEeccCceecC---------------------------------CCCcCccCcccccCcHH
Confidence 7899999999997421 01124679999999999
Q ss_pred HhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC--------------------------CC---
Q 001057 960 LLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWP--------------------------NI--- 1010 (1170)
Q Consensus 960 L~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP--------------------------~i--- 1010 (1170)
+.+..++.++|||||||++|+|++|.+||.+.+..+.+..+.....++| ..
T Consensus 231 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 310 (360)
T 3llt_A 231 ILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASS 310 (360)
T ss_dssp HTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSC
T ss_pred HcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccc
Confidence 9999999999999999999999999999999888777766654322222 10
Q ss_pred --------------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 1011 --------------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 1011 --------------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
+...++.+.+||.+||+.||.+||+ +.|+|+||||+
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~hp~f~ 360 (360)
T 3llt_A 311 INSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS---PAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGC
T ss_pred hhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC---HHHHhcCcccC
Confidence 0112477889999999999999999 88999999995
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=399.33 Aligned_cols=259 Identities=31% Similarity=0.531 Sum_probs=222.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|.+.+.||+|+||+||+|++..++..||+|++.+... ....+.+.+|+.+|..++||||++++++|.+...+|
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 344689999999999999999999999999999999876542 223567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe---CCCCcEEEEecCCccc
Q 001057 835 LVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL---d~dG~VKLsDFGLAk~ 907 (1170)
+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999999998543 679999999999999999999999999999999999999 4567899999999974
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
.. ........+||+.|+|||++. ..++.++|||||||++|+|++|..|
T Consensus 177 ~~-------------------------------~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~p 224 (285)
T 3is5_A 177 FK-------------------------------SDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224 (285)
T ss_dssp -----------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cC-------------------------------CcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCC
Confidence 21 011123457999999999986 4689999999999999999999999
Q ss_pred CCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
|.+.+..+....+......++.....+++++.+||.+||+.||.+||+ +.|+++||||++
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~f~~ 284 (285)
T 3is5_A 225 FTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS---AAQVLHHEWFKQ 284 (285)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCC---HHHHHTSGGGGC
T ss_pred CCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHhhc
Confidence 999998888887776665555444568999999999999999999999 889999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=417.34 Aligned_cols=259 Identities=31% Similarity=0.487 Sum_probs=216.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE----- 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~----- 831 (1170)
.++|++++.||+|+||.||+|++..+|+.||||++.+.. ......+.+.+|+.+|+.++||||++++++|....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 468999999999999999999999999999999986543 33455678899999999999999999999998763
Q ss_pred -ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 -NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 -~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
.+|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~- 179 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 179 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc-
Confidence 469999999 8899999986 579999999999999999999999999999999999999999999999999997521
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 180 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 227 (367)
T 1cm8_A 180 --------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227 (367)
T ss_dssp --------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred --------------------------------cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 01234578999999999987 679999999999999999999999999
Q ss_pred CCCHHHHHHHHhccC----------------------------CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 990 AKTPQQIFDNIMNRD----------------------------IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~----------------------------l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+.+..+++..|.... ..+..+....++++.+||.+||+.||.+||+ +.+
T Consensus 228 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t---~~e 304 (367)
T 1cm8_A 228 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGE 304 (367)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHH
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC---HHH
Confidence 998877776665311 1122233467999999999999999999999 889
Q ss_pred HHcCCCCCCCChh
Q 001057 1042 VKQHPFFKNINWD 1054 (1170)
Q Consensus 1042 ILqHPfF~~idwe 1054 (1170)
+|+||||+.+.+.
T Consensus 305 ~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 305 ALAHPYFESLHDT 317 (367)
T ss_dssp HHHSGGGTTTC--
T ss_pred HhcChHHHhhcCC
Confidence 9999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=434.52 Aligned_cols=257 Identities=27% Similarity=0.466 Sum_probs=213.6
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE---- 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~---- 831 (1170)
..++|++++.||+|+||+||+|++..+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 3578999999999999999999999999999999998653 34456678899999999999999999999997653
Q ss_pred --ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 832 --NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 832 --~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
.+||||||+.+ +|...+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 57999999965 57777754 59999999999999999999999999999999999999999999999999997521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||.
T Consensus 216 -------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 216 -------------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp --------------------------------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred -------------------------------CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 0112235689999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCC----------------------CCCCC------Ccc-----------CCHHHHHHHHHhccCCC
Q 001057 990 AKTPQQIFDNIMNRDI----------------------PWPNI------PEE-----------MSVEACDLIDKLLTENP 1030 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l----------------------~fP~i------p~~-----------lS~eakDLIkkLLq~DP 1030 (1170)
+.+..+++..|..... .+... +.. .++++++||.+||+.||
T Consensus 265 g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 344 (464)
T 3ttj_A 265 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 344 (464)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSST
T ss_pred CCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCCh
Confidence 9998877777654110 00000 000 15779999999999999
Q ss_pred CCCCChhhHHHHHcCCCCCC
Q 001057 1031 VQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 1031 skRpSa~~AeEILqHPfF~~ 1050 (1170)
.+||| +.|+|+||||+.
T Consensus 345 ~~R~t---a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 345 AKRIS---VDDALQHPYINV 361 (464)
T ss_dssp TTSCC---HHHHHTSTTTGG
T ss_pred hhCCC---HHHHhcChhhhh
Confidence 99999 889999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=435.92 Aligned_cols=264 Identities=31% Similarity=0.547 Sum_probs=230.8
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
.....++|++++.||+|+||+||+|+++.+++.||||++.+.... ......+.+|+.+|+.++|||||++++++.+...
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE
Confidence 344567899999999999999999999999999999999765422 2235678899999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC---CCCcEEEEecCCccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG---QDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd---~dG~VKLsDFGLAk~~~ 909 (1170)
+|+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 999999999999999998888999999999999999999999999999999999999995 45679999999997421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.
T Consensus 176 -------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 176 -------------------------------QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp -------------------------------CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -------------------------------CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0112234579999999999976 59999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 990 AKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
+.+..+++..+..+...++. ....+++++++||.+||+.||.+||+ +.++|+||||+...
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 224 GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYS 284 (486)
T ss_dssp CSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHHHCHHHHHTC
T ss_pred CCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCHhhccCc
Confidence 99999999999888766542 12468999999999999999999999 88999999998653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=403.18 Aligned_cols=268 Identities=26% Similarity=0.445 Sum_probs=212.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE----- 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~----- 831 (1170)
.++|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|..++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 467999999999999999999999999999999997643 3345678899999999999999999999886543
Q ss_pred ----------------------------------------------------ceEEEEeeccCCChHHHHHhcCC---CC
Q 001057 832 ----------------------------------------------------NLYLVMEYLNGGDLYSLLRNLGC---LD 856 (1170)
Q Consensus 832 ----------------------------------------------------~LyLVMEY~~GGSL~dlLk~~~~---LS 856 (1170)
.+|+|||||.||+|.+++..... .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999987543 56
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCC
Q 001057 857 EDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936 (1170)
Q Consensus 857 Ee~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~ 936 (1170)
+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........... ..
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~-----------------~~ 225 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV-----------------LT 225 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc-----------------cc
Confidence 6678999999999999999999999999999999999999999999999863211000000 00
Q ss_pred CCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCH
Q 001057 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSV 1016 (1170)
Q Consensus 937 ~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~ 1016 (1170)
. ..........+||+.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+... .++......++
T Consensus 226 ~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~ 300 (332)
T 3qd2_B 226 P-MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNL--KFPLLFTQKYP 300 (332)
T ss_dssp -------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTT--CCCHHHHHHCH
T ss_pred c-ccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhcc--CCCcccccCCh
Confidence 0 0001223456899999999999999999999999999999999999777532 22333333333 23333346678
Q ss_pred HHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1017 EACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1017 eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
++.+||.+||+.||.+||+ +.++++||||+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps---~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPE---ATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCC---HHHHHHSTTCCCC
T ss_pred hHHHHHHHHccCCCCcCCC---HHHHhhchhhhcC
Confidence 8999999999999999999 8899999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=413.13 Aligned_cols=274 Identities=24% Similarity=0.391 Sum_probs=218.1
Q ss_pred chhhccccCCCCCCCCCCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc
Q 001057 736 EDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815 (1170)
Q Consensus 736 ee~v~sl~~sp~~p~~~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL 815 (1170)
++....+....+++...+....++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+|..+
T Consensus 15 ~e~~~~~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l 90 (397)
T 1wak_A 15 QEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSV 90 (397)
T ss_dssp -------CC--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHH
T ss_pred ccccccCCCCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHH
Confidence 33445566666777777777789999999999999999999999999999999998754 34456788999999988
Q ss_pred C--------CCcEEEEEeeee----cccceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-Cee
Q 001057 816 R--------NPFVVRFFYSFT----CRENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSL-NVI 880 (1170)
Q Consensus 816 ~--------HPNIVrL~~~Fq----d~~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~-GII 880 (1170)
+ ||||++++++|. ...++||||||+ +++|.+++... +.+++..++.++.||+.||.|||++ ||+
T Consensus 91 ~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~giv 169 (397)
T 1wak_A 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRII 169 (397)
T ss_dssp HHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred hhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 5 788999999998 567899999999 66777776554 5699999999999999999999998 999
Q ss_pred eccCCCCcEEeCCCC-------------------------------------------------cEEEEecCCccccccc
Q 001057 881 HRDLKPDNLLIGQDG-------------------------------------------------HIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 881 HRDIKPENILLd~dG-------------------------------------------------~VKLsDFGLAk~~~~~ 911 (1170)
||||||+||||+.++ .+||+|||+|....
T Consensus 170 HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~-- 247 (397)
T 1wak_A 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH-- 247 (397)
T ss_dssp CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--
T ss_pred cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--
Confidence 999999999999776 79999999997521
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
......+||+.|+|||++.+..|+.++|||||||+||+|++|.+||.+.
T Consensus 248 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 296 (397)
T 1wak_A 248 -------------------------------KHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296 (397)
T ss_dssp -------------------------------BCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCC
T ss_pred -------------------------------ccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCC
Confidence 0122457999999999999999999999999999999999999999865
Q ss_pred C------HHHHHHHHhc--cCCC-------------------C------------------CCCCccCCHHHHHHHHHhc
Q 001057 992 T------PQQIFDNIMN--RDIP-------------------W------------------PNIPEEMSVEACDLIDKLL 1026 (1170)
Q Consensus 992 ~------~~ei~qkIl~--~~l~-------------------f------------------P~ip~~lS~eakDLIkkLL 1026 (1170)
+ .......+.. +..+ + ...+...+..+.+||.+||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 376 (397)
T 1wak_A 297 SGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPML 376 (397)
T ss_dssp CCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGG
T ss_pred cccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHh
Confidence 4 2222222221 0000 0 0112345678899999999
Q ss_pred cCCCCCCCChhhHHHHHcCCCCCC
Q 001057 1027 TENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 1027 q~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
+.||.+||+ +.|+|+||||++
T Consensus 377 ~~dP~~Rpt---~~e~l~hp~~~~ 397 (397)
T 1wak_A 377 ELIPEKRAT---AAECLRHPWLNS 397 (397)
T ss_dssp CSSGGGSCC---HHHHHTSGGGGC
T ss_pred ccChhhcCC---HHHHhhCccccC
Confidence 999999999 889999999974
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=410.22 Aligned_cols=269 Identities=30% Similarity=0.483 Sum_probs=225.1
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc--cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI--RKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~--~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
.++|++++.||+|+||+||+|++..+++.||+|++.+.... .....+.+.+|+.+|..++||||++++++|.+.+.+|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 35799999999999999999999999999999999865322 2345678999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 001057 835 LVMEYLNGGDLYSLLRNL----------------------------------------GCLDEDMARVYIAELVLALEYL 874 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~----------------------------------------~~LSEe~ar~IaaQIL~ALeYL 874 (1170)
+||||++||+|.+++... ..+++..++.++.||+.||.||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998521 1246778889999999999999
Q ss_pred HhCCeeeccCCCCcEEeCCCC--cEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCC
Q 001057 875 HSLNVIHRDLKPDNLLIGQDG--HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTP 952 (1170)
Q Consensus 875 Hs~GIIHRDIKPENILLd~dG--~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp 952 (1170)
|++||+||||||+|||++.++ .+||+|||+|+....... ..........||+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~--------------------------~~~~~~~~~~gt~ 238 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNN--------------------------GEYYGMTTKAGTP 238 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTC--------------------------C--------CCCG
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCc--------------------------cccccccccCCCc
Confidence 999999999999999998776 899999999985310000 0011223567999
Q ss_pred CCCchHHHhc--CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCC
Q 001057 953 DYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTEN 1029 (1170)
Q Consensus 953 ~YmAPEVL~g--~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~D 1029 (1170)
.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+......++.. ...+++++.+||.+||+.|
T Consensus 239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 318 (345)
T 3hko_A 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318 (345)
T ss_dssp GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCC
Confidence 9999999975 678999999999999999999999999999999888888877655421 1358999999999999999
Q ss_pred CCCCCChhhHHHHHcCCCCCCCChh
Q 001057 1030 PVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 1030 PskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
|.+||+ +.++++||||+++.|.
T Consensus 319 p~~Rps---~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 319 VDERFD---AMRALQHPWISQFSDK 340 (345)
T ss_dssp TTTSCC---HHHHHHSHHHHTTSSC
T ss_pred hhHCCC---HHHHhcChhhccChHh
Confidence 999999 8899999999987543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=421.64 Aligned_cols=290 Identities=27% Similarity=0.426 Sum_probs=218.2
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR----- 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~----- 830 (1170)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|..++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3468999999999999999999999999999999997642 3445567889999999999999999999999876
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
..+||||||+. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999995 69999999888899999999999999999999999999999999999999999999999999986421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-cCCCCcchhhhHHHHHHHHHHh------
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLI------ 983 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-g~~ys~ksDIWSLGVILYELLT------ 983 (1170)
........ .... . ....+............+||++|+|||++. +..|+.++||||||||+|||++
T Consensus 182 ~~~~~~~~-~~~~------~-~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 182 EKDTNIVN-DLEE------N-EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccc-cccc------c-ccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 11000000 0000 0 000000001112345778999999999974 5569999999999999999998
Q ss_pred -----CCCCCCCCCH-----------------HHHHHHHhc------------------------cCCCCC----CCCcc
Q 001057 984 -----GIPPFNAKTP-----------------QQIFDNIMN------------------------RDIPWP----NIPEE 1013 (1170)
Q Consensus 984 -----G~pPF~g~~~-----------------~ei~qkIl~------------------------~~l~fP----~ip~~ 1013 (1170)
|.++|.+.+. ...+..|.. .....+ .....
T Consensus 254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (432)
T 3n9x_A 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333 (432)
T ss_dssp SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 4555555431 122222211 000000 01135
Q ss_pred CCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhh
Q 001057 1014 MSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLAR 1058 (1170)
Q Consensus 1014 lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~ 1058 (1170)
+++++.+||.+||+.||.+||+ |.|+|+||||+++.|.....
T Consensus 334 ~s~~~~dLl~~mL~~dP~~R~t---a~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 334 ISDDGINLLESMLKFNPNKRIT---IDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCC---HHHHHTCGGGTTTCCTTTC-
T ss_pred CCHHHHHHHHHHhcCCcccCCC---HHHHhcChhhhhccCcccCc
Confidence 8999999999999999999999 88999999999999876554
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=432.96 Aligned_cols=262 Identities=31% Similarity=0.503 Sum_probs=227.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH----------HHHHHHHHHHHHHHhcCCCcEEEEE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK----------NAVESILAERNILISVRNPFVVRFF 824 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~----------~~ve~~l~EieILskL~HPNIVrL~ 824 (1170)
...++|++++.||+|+||+||+|+++.+++.||||++.+...... ...+.+.+|+.+|..++|||||+++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 345789999999999999999999999999999999987543221 2346788999999999999999999
Q ss_pred eeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---cEEEEe
Q 001057 825 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---HIKLTD 901 (1170)
Q Consensus 825 ~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG---~VKLsD 901 (1170)
++|.+...+|||||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999999998888999999999999999999999999999999999999999876 699999
Q ss_pred cCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHH
Q 001057 902 FGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 902 FGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYEL 981 (1170)
||+|+... ........+||+.|+|||++.+ .|+.++|||||||++|+|
T Consensus 193 fg~a~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l 240 (504)
T 3q5i_A 193 FGLSSFFS-------------------------------KDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYIL 240 (504)
T ss_dssp CTTCEECC-------------------------------TTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHH
T ss_pred CCCCEEcC-------------------------------CCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHH
Confidence 99997521 0112234679999999999874 699999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 982 LIGIPPFNAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
++|.+||.+.+..+++..+..+.+.++. ....+++++++||.+||+.||.+||+ +.++|+||||+..
T Consensus 241 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 241 LCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT---AEEALNSRWIKKY 308 (504)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHHT
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCC---HHHHhcCHhhhhc
Confidence 9999999999999999999988766541 11468999999999999999999999 8899999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=404.27 Aligned_cols=268 Identities=26% Similarity=0.406 Sum_probs=217.7
Q ss_pred ccCCCCCCCCCCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcE
Q 001057 742 LRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFV 820 (1170)
Q Consensus 742 l~~sp~~p~~~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNI 820 (1170)
+....+.|........++|+++++||+|+||+||+|+++.+|+.||||++...... .........|+..+..+ +||||
T Consensus 41 ~~~~~~~p~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~~~~~~~h~~i 119 (311)
T 3p1a_A 41 LQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG-PKDRARKLAEVGSHEKVGQHPCC 119 (311)
T ss_dssp CCCTTCCTTSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS-HHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cCCCCCCCCCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC-hHHHHHHHHHHHHHHHhcCCCcE
Confidence 44445566656666668899999999999999999999999999999998654332 23334455555555554 89999
Q ss_pred EEEEeeeecccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEE
Q 001057 821 VRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKL 899 (1170)
Q Consensus 821 VrL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKL 899 (1170)
++++++|.+.+.+||||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 120 v~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl 198 (311)
T 3p1a_A 120 VRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKL 198 (311)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEE
T ss_pred EEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999 77999988765 46999999999999999999999999999999999999999999999
Q ss_pred EecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHH
Q 001057 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979 (1170)
Q Consensus 900 sDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILY 979 (1170)
+|||+|.... ........+||+.|+|||++.+ .++.++|||||||++|
T Consensus 199 ~DFG~a~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~ 246 (311)
T 3p1a_A 199 GDFGLLVELG-------------------------------TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTIL 246 (311)
T ss_dssp CCCTTCEECC-------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHH
T ss_pred ccceeeeecc-------------------------------cCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHH
Confidence 9999987521 0111234569999999999886 7999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 980 ELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 980 ELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
||++|..||.+.. ....+.....+ +..+..++.++.+||.+||+.||.+||+ +.++++||||++
T Consensus 247 el~~g~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 310 (311)
T 3p1a_A 247 EVACNMELPHGGE---GWQQLRQGYLP-PEFTAGLSSELRSVLVMMLEPDPKLRAT---AEALLALPVLRQ 310 (311)
T ss_dssp HHHHTCCCCSSHH---HHHHHTTTCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGSC
T ss_pred HHHhCCCCCCCcc---HHHHHhccCCC-cccccCCCHHHHHHHHHHcCCChhhCcC---HHHHHhCccccC
Confidence 9999977776533 23344433322 2233578999999999999999999999 889999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=404.14 Aligned_cols=257 Identities=29% Similarity=0.527 Sum_probs=225.8
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|+..+.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.+|..++||||++++++|...+.+|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48888999999999999999999999999999875432 234568899999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
|++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~--------- 192 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--------- 192 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC---------
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecc---------
Confidence 9999999998875 469999999999999999999999999999999999999999999999999987521
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~q 998 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 193 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~ 251 (321)
T 2c30_A 193 ---------------------KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK 251 (321)
T ss_dssp ---------------------SSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ---------------------cCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 00011234679999999999999899999999999999999999999999999888888
Q ss_pred HHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 999 NIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 999 kIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
.+.....+....+..+++++.+||.+||+.||.+||+ +.++++||||....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~ 302 (321)
T 2c30_A 252 RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT---AQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGGGCC
T ss_pred HHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhccCC
Confidence 8776554333334578999999999999999999999 88999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=410.42 Aligned_cols=261 Identities=28% Similarity=0.513 Sum_probs=214.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|++++.||+|+||+||+|++..+++.||||++..... ......+.+|+.+|..++||||+++++++.+.+.+|||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 3689999999999999999999999999999999875431 11222455799999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~------ 151 (324)
T 3mtl_A 79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS------ 151 (324)
T ss_dssp EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccccc------
Confidence 99996 5999998765 459999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..
T Consensus 152 ------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (324)
T 3mtl_A 152 ------------------------IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE 207 (324)
T ss_dssp -----------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ------------------------CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 00112234578999999999987 56899999999999999999999999999988
Q ss_pred HHHHHHhccC-----CCCCC----------------------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 995 QIFDNIMNRD-----IPWPN----------------------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 995 ei~qkIl~~~-----l~fP~----------------------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
+....+.... ..|+. ....++.++.+||.+||+.||.+||+ +.|+|+|||
T Consensus 208 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~ 284 (324)
T 3mtl_A 208 EQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS---AEDAMKHPF 284 (324)
T ss_dssp HHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGG
T ss_pred HHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC---HHHHhcChh
Confidence 8777665411 11111 01257889999999999999999999 889999999
Q ss_pred CCCCCh
Q 001057 1048 FKNINW 1053 (1170)
Q Consensus 1048 F~~idw 1053 (1170)
|.++..
T Consensus 285 f~~~~~ 290 (324)
T 3mtl_A 285 FLSLGE 290 (324)
T ss_dssp GGGGCS
T ss_pred hhhccc
Confidence 987653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=431.77 Aligned_cols=259 Identities=34% Similarity=0.577 Sum_probs=224.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||+||+|+++.++..||||++.+.... ......+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999999875432 22346788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC---CcEEEEecCCccccccccC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD---GHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d---G~VKLsDFGLAk~~~~~~~ 913 (1170)
||||.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||+|+...
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~---- 190 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE---- 190 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB----
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC----
Confidence 9999999999999888899999999999999999999999999999999999999764 459999999997531
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+.
T Consensus 191 ---------------------------~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 242 (494)
T 3lij_A 191 ---------------------------NQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD 242 (494)
T ss_dssp ---------------------------TTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0112235679999999999864 699999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+++..+..+...++.. ...++.++++||.+||+.||.+||+ +.++|+||||+..
T Consensus 243 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~ 298 (494)
T 3lij_A 243 QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS---AQQALEHPWIKEM 298 (494)
T ss_dssp HHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHHH
T ss_pred HHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCcc---HHHHhcCcccccC
Confidence 99999999887765521 1368999999999999999999999 8899999999865
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=395.48 Aligned_cols=265 Identities=32% Similarity=0.567 Sum_probs=226.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|++++.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 34578999999999999999999999999999999987543 233567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+||||+++++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---- 168 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL---- 168 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH----
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc----
Confidence 99999999999999876 4569999999999999999999999999999999999999999999999999876321
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-----cCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
..........||+.|+|||++. +..++.++|||||||++|+|++|.+||
T Consensus 169 --------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 222 (302)
T 2j7t_A 169 --------------------------KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222 (302)
T ss_dssp --------------------------HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTT
T ss_pred --------------------------ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCC
Confidence 0111223457999999999984 567889999999999999999999999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhh
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~ 1055 (1170)
...+....+..+.....+....+..++.++.+||.+||+.||.+||+ +.++++||||+++.|..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~ 286 (302)
T 2j7t_A 223 HELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS---AAQLLEHPFVSSITSNK 286 (302)
T ss_dssp TTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCC---HHHHTTSTTTTTCCCCH
T ss_pred ccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCC---HHHHhcChHHhhhccch
Confidence 99988888777776655433345678999999999999999999999 88999999999988765
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=396.71 Aligned_cols=263 Identities=30% Similarity=0.528 Sum_probs=228.4
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH---HHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK---NAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~---~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
++|++++.||+|+||.||+|++..+|+.||+|++.+...... ...+.+.+|+.+|..++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999886543221 13567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC----cEEEEecCCcccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG----HIKLTDFGLSKVGLI 910 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG----~VKLsDFGLAk~~~~ 910 (1170)
+||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~- 163 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE- 163 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc-
Confidence 9999999999999998888899999999999999999999999999999999999998877 89999999987521
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 164 ------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 164 ------------------------------AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp --------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ------------------------------CCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 00112245699999999999998999999999999999999999999999
Q ss_pred CCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 991 KTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
.+..+....+......++. ....++..+.+||.+||+.||.+||+ +.++++||||+.+.+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 214 ETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT---IAQSLEHSWIKAIRRR 275 (283)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCC---HHHHHHCHHHHHHHHC
T ss_pred cchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcC---HHHHHhCHHHHHHHHH
Confidence 9988888888776654431 12467899999999999999999999 8899999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=392.91 Aligned_cols=257 Identities=23% Similarity=0.418 Sum_probs=219.6
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec----ccc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC----REN 832 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd----~~~ 832 (1170)
...|++.+.||+|+||+||+|.+..++..||+|++..... .....+.+.+|+.+|..++||||++++++|.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 3459999999999999999999999999999999886543 34566788999999999999999999998875 456
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeC-CCCcEEEEecCCccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIG-QDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd-~dG~VKLsDFGLAk~~~ 909 (1170)
+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999999998888999999999999999999999999 99999999999997 78999999999986421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
........||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 184 --------------------------------~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~ 230 (290)
T 1t4h_A 184 --------------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp --------------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred --------------------------------ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 011234579999999998875 58999999999999999999999998
Q ss_pred CCC-HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 990 AKT-PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 990 g~~-~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+.. ...++..+.... ..+..+...++++.+||.+||+.||.+||+ +.++++||||++.
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~f~~~ 289 (290)
T 1t4h_A 231 ECQNAAQIYRRVTSGV-KPASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQEE 289 (290)
T ss_dssp TCSSHHHHHHHHTTTC-CCGGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC--
T ss_pred CcCcHHHHHHHHhccC-CccccCCCCCHHHHHHHHHHccCChhhCCC---HHHHhhCcccccC
Confidence 744 445555554433 223344667899999999999999999999 8899999999863
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=400.25 Aligned_cols=257 Identities=33% Similarity=0.588 Sum_probs=227.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+|+.++..++||||++++++|.+...+|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 4679999999999999999999999999999999986532 2235678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe---CCCCcEEEEecCCccccccccC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL---d~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~---- 160 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---- 160 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC----
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC----
Confidence 9999999999999888889999999999999999999999999999999999999 778899999999987410
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 161 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 212 (304)
T 2jam_A 161 ----------------------------NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE 212 (304)
T ss_dssp ----------------------------CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ----------------------------CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 0112245799999999999998999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..++..+..+...++. ....++.++.+||.+||+.||.+||+ +.++++||||++.
T Consensus 213 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 268 (304)
T 2jam_A 213 SKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT---CEKALSHPWIDGN 268 (304)
T ss_dssp HHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCC---HHHHHTSHHHHSS
T ss_pred HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCccccCC
Confidence 9999888887665542 33578999999999999999999999 8899999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=406.78 Aligned_cols=266 Identities=29% Similarity=0.474 Sum_probs=229.4
Q ss_pred CCCeEEE-EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceE
Q 001057 757 IEDFEII-KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 757 iedYevl-k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~Ly 834 (1170)
.++|.+. +.||+|+||+||+|+++.+|+.||+|++.+.... ......+.+|+.++..+. ||||++++++|.+...+|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 3568887 8999999999999999999999999999875432 233467889999999985 699999999999999999
Q ss_pred EEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---CCcEEEEecCCccccc
Q 001057 835 LVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ---DGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~---dG~VKLsDFGLAk~~~ 909 (1170)
+||||+.||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999999999998653 67999999999999999999999999999999999999987 7899999999997521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 186 -------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 186 -------------------------------HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp ---------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -------------------------------CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0111234579999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhh
Q 001057 990 AKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLA 1057 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~ 1057 (1170)
+.+..+.+..+......++. ....++..+.+||.+||+.||.+||+ +.++|+||||++++|+.+.
T Consensus 235 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 235 GEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT---AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp CSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTCGGGCCCCTTCC-
T ss_pred CCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhCCHhhccccccccc
Confidence 99998888888776655432 23578999999999999999999999 8899999999999998654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=410.85 Aligned_cols=266 Identities=28% Similarity=0.488 Sum_probs=226.7
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..+..++|++++.||+|+||+||+|++..+++.||+|++.... .....+.+.+|+.+|..++||||++++++|.+.+.
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence 3566788999999999999999999999999999999987642 34556788999999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL-NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~-GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+|+||||++||+|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~-- 183 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-- 183 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH--
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc--
Confidence 999999999999999999888999999999999999999999996 99999999999999999999999999987421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 184 ------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 184 ------------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ------------------------------HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ------------------------------cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 11223467999999999999999999999999999999999999999887
Q ss_pred CHHHHHHH------------------------------------------HhccCCCCCCCCccCCHHHHHHHHHhccCC
Q 001057 992 TPQQIFDN------------------------------------------IMNRDIPWPNIPEEMSVEACDLIDKLLTEN 1029 (1170)
Q Consensus 992 ~~~ei~qk------------------------------------------Il~~~l~fP~ip~~lS~eakDLIkkLLq~D 1029 (1170)
+..++... +...... ......++.++.+||.+||+.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~d 312 (360)
T 3eqc_A 234 DAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKN 312 (360)
T ss_dssp CHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCC-CCCTTTSCHHHHHHHHHHHCSS
T ss_pred CHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCC-CCCcccccHHHHHHHHHHhhcC
Confidence 66544322 2222211 1112357899999999999999
Q ss_pred CCCCCChhhHHHHHcCCCCCCCChhhh
Q 001057 1030 PVQRLGATGAREVKQHPFFKNINWDTL 1056 (1170)
Q Consensus 1030 PskRpSa~~AeEILqHPfF~~idwe~L 1056 (1170)
|.+||+ +.++++||||++.+|+.+
T Consensus 313 P~~Rpt---~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 313 PAERAD---LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp TTTSCC---HHHHHTSHHHHHHHHSCC
T ss_pred hhhCCC---HHHHhhChHhhcchHhhh
Confidence 999999 889999999987665543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=411.25 Aligned_cols=255 Identities=29% Similarity=0.520 Sum_probs=203.3
Q ss_pred CCeEEE---EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccce
Q 001057 758 EDFEII---KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 758 edYevl---k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~L 833 (1170)
++|++. +.||+|+||+||+|+++.+|+.||||++.+. ....+.+|+.++..+. ||||++++++|.+...+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 457775 7899999999999999999999999998753 2346678999999997 99999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---cEEEEecCCcccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---HIKLTDFGLSKVGLI 910 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG---~VKLsDFGLAk~~~~ 910 (1170)
||||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~- 160 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP- 160 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC-
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC-
Confidence 99999999999999999988999999999999999999999999999999999999998766 89999999997521
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+
T Consensus 161 -----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 161 -----------------------------PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp -----------------------------C----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred -----------------------------CCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 011122356789999999999999999999999999999999999999986
Q ss_pred CC-------HHHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 991 KT-------PQQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 991 ~~-------~~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+ ..+++..+..+...++.. ...++.++++||.+||+.||.+||+ +.++++||||++.
T Consensus 212 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~h~w~~~~ 277 (325)
T 3kn6_A 212 HDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK---MSGLRYNEWLQDG 277 (325)
T ss_dssp ------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC---TTTSTTCGGGCTT
T ss_pred CccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC---HHHHhcChhhccC
Confidence 43 356778888777655421 1358999999999999999999999 7788999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=395.31 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=218.8
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
+....++|++++.||+|+||.||+|++..+++.||+|++...........+.+.+|+.++..++||||+++++++.+.+.
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~ 85 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC 85 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence 34556789999999999999999999999999999999977655566777889999999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 163 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-- 163 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccc--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 164 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 164 ---------------------------TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp --------------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred ---------------------------ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 00112234679999999999999999999999999999999999999999998
Q ss_pred HHHHHHHHhccCCCCC--CCCccCCHHHHHHHHHhccCCCCCCCC
Q 001057 993 PQQIFDNIMNRDIPWP--NIPEEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP--~ip~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
.............+.. ..+..++..+.++|.+||+.||.+||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 217 AVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK 261 (294)
T ss_dssp HHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS
T ss_pred hHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc
Confidence 8777666655443321 234578999999999999999999995
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=405.22 Aligned_cols=266 Identities=26% Similarity=0.387 Sum_probs=223.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc-
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN- 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~- 832 (1170)
....++|++++.||+|+||.||+|++..+++.||||++.............+.+|+.++..++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 3455789999999999999999999999999999999987655556667789999999999999999999999887654
Q ss_pred ---eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 833 ---LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 833 ---LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 49999999999999999988899999999999999999999999999999999999999999999999999997531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
... .........+||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 168 ~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 168 DSG---------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp -----------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccc---------------------------cccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 000 00112234679999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCCC-CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 990 AKTPQQIFDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP-~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
+.+.......+.......+ .....++.++.+||.+||+.||.+||+ +.+++.|+|++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 278 (311)
T 3ork_A 221 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ---TAAEMRADLVR 278 (311)
T ss_dssp CSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred CCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChh---hHHHHHHHHHH
Confidence 9998887776665544322 112468999999999999999999998 66788998875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=420.88 Aligned_cols=255 Identities=32% Similarity=0.539 Sum_probs=212.0
Q ss_pred CCCCCCeEEE-EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHH-hcCCCcEEEEEeeeec--
Q 001057 754 RTSIEDFEII-KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI-SVRNPFVVRFFYSFTC-- 829 (1170)
Q Consensus 754 ~i~iedYevl-k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILs-kL~HPNIVrL~~~Fqd-- 829 (1170)
....++|.++ +.||+|+||+||+|+++.+|+.||||++... ..+.+|+.++. ..+||||++++++|..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 3456789887 7899999999999999999999999998643 24567888874 4589999999998875
Q ss_pred --ccceEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---CCcEEEEec
Q 001057 830 --RENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ---DGHIKLTDF 902 (1170)
Q Consensus 830 --~~~LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~---dG~VKLsDF 902 (1170)
..++|||||||.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 678999999999999999998753 5999999999999999999999999999999999999997 789999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELL 982 (1170)
|+|+... ........+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 209 G~a~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 257 (400)
T 1nxk_A 209 GFAKETT-------------------------------SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_dssp TTCEECC------------------------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHH
T ss_pred ccccccC-------------------------------CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHH
Confidence 9998521 011123568999999999999999999999999999999999
Q ss_pred hCCCCCCCCCHH----HHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 983 IGIPPFNAKTPQ----QIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 983 TG~pPF~g~~~~----ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
+|.+||.+.+.. .+...+..+.+.++.. ...++.++++||.+||+.||.+||+ +.++++||||.+
T Consensus 258 ~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 327 (400)
T 1nxk_A 258 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 327 (400)
T ss_dssp HSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHT
T ss_pred hCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCccccC
Confidence 999999876532 2456666666655532 2468999999999999999999999 889999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=416.25 Aligned_cols=261 Identities=26% Similarity=0.481 Sum_probs=222.9
Q ss_pred CCeEE--EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 758 EDFEI--IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 758 edYev--lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..|.+ .+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+|..++||||++++++|.+.+.+||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 34555 678999999999999999999999999998643 2445678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe--CCCCcEEEEecCCcccccccc
Q 001057 836 VMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI--GQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL--d~dG~VKLsDFGLAk~~~~~~ 912 (1170)
||||++||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~--- 240 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK--- 240 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC---
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC---
Confidence 99999999999988654 469999999999999999999999999999999999999 567899999999998521
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 241 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 292 (373)
T 2x4f_A 241 ----------------------------PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292 (373)
T ss_dssp ----------------------------TTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ----------------------------CccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0011234579999999999998889999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhh
Q 001057 993 PQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~ 1055 (1170)
..+.+..+......++. ....+++++++||.+||+.||.+||+ +.++++||||++..|..
T Consensus 293 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~e~l~hp~~~~~~~~~ 353 (373)
T 2x4f_A 293 DAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS---ASEALKHPWLSDHKLHS 353 (373)
T ss_dssp HHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHCHHHHH
T ss_pred HHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCC---HHHHhcCcCcCCCchhh
Confidence 99999998887665442 12468999999999999999999999 88999999999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=384.79 Aligned_cols=252 Identities=24% Similarity=0.389 Sum_probs=213.4
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyL 835 (1170)
.++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.++..+ +||||++++++|.+.+.+|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4679999999999999999999999999999999886533 233456788899999998 89999999999999999999
Q ss_pred EEeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC-----------------
Q 001057 836 VMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD----------------- 894 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d----------------- 894 (1170)
||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 168 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS 168 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence 99999999999999765 679999999999999999999999999999999999999844
Q ss_pred --CcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhh
Q 001057 895 --GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADW 971 (1170)
Q Consensus 895 --G~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDI 971 (1170)
..+||+|||++.... ......||+.|+|||++.+. .++.++||
T Consensus 169 ~~~~~kl~Dfg~~~~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 214 (289)
T 1x8b_A 169 NKVMFKIGDLGHVTRIS----------------------------------SPQVEEGDSRFLANEVLQENYTHLPKADI 214 (289)
T ss_dssp -CCCEEECCCTTCEETT----------------------------------CSCCCCCCGGGCCHHHHTTCCTTHHHHHH
T ss_pred CceEEEEcccccccccC----------------------------------CccccCCCccccChhHhcCCCCCCchhhH
Confidence 479999999987521 01123589999999999876 56689999
Q ss_pred hHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 972 WSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 972 WSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
|||||++|+|++|.+||.... ....+..+.. +.++..++.++.+||.+||+.||.+||+ +.++++||||.+.
T Consensus 215 ~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 215 FALALTVVCAAGAEPLPRNGD---QWHEIRQGRL--PRIPQVLSQEFTELLKVMIHPDPERRPS---AMALVKHSVLLSA 286 (289)
T ss_dssp HHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTCTTC---
T ss_pred HHHHHHHHHHhcCCCCCcchh---HHHHHHcCCC--CCCCcccCHHHHHHHHHHhCCCcccCCC---HHHHhhChHhhhh
Confidence 999999999999998876543 2344444433 3456789999999999999999999999 8899999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=388.94 Aligned_cols=261 Identities=28% Similarity=0.499 Sum_probs=222.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.++..++||||+++++++.+.+.+|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 4679999999999999999999999999999999876542 23457788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----- 158 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN----- 158 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET-----
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCC-----
Confidence 999999999999988778999999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCCCCCHH-
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAKTPQ- 994 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~g~~~~- 994 (1170)
.........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....
T Consensus 159 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 215 (276)
T 2yex_A 159 -----------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215 (276)
T ss_dssp -----------------------TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS
T ss_pred -----------------------cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH
Confidence 01112335679999999999987665 77899999999999999999999876543
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..+..+.......+ ....++..+.+||.+||+.||.+||+ +.++++||||++.
T Consensus 216 ~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 268 (276)
T 2yex_A 216 QEYSDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (276)
T ss_dssp HHHHHHHTTCTTST-TGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred HHHHHhhhcccccC-chhhcCHHHHHHHHHHCCCCchhCCC---HHHHhcCccccCh
Confidence 33334433332222 23578999999999999999999999 8899999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=409.54 Aligned_cols=259 Identities=33% Similarity=0.561 Sum_probs=226.5
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccc-----ccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM-----IRKNAVESILAERNILISV-RNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i-----~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~ 831 (1170)
++|++.+.||.|+||.||+|+++.+|+.||||++..... ......+.+.+|+.++..+ +||||++++++|....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 579999999999999999999999999999999875431 1122356788999999999 7999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+|+||||+.|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~-- 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-- 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC--
Confidence 999999999999999999988889999999999999999999999999999999999999999999999999987521
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC------CCCcchhhhHHHHHHHHHHhCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM------GHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~------~ys~ksDIWSLGVILYELLTG~ 985 (1170)
........+||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 252 -----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~ 302 (365)
T 2y7j_A 252 -----------------------------PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302 (365)
T ss_dssp -----------------------------TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred -----------------------------CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC
Confidence 00112346899999999999743 5888999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 986 PPFNAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 986 pPF~g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
.||.+.+...++..+..+...++. ....++..+.+||.+||+.||.+||+ +.++++||||+.
T Consensus 303 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~r 365 (365)
T 2y7j_A 303 PPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT---AEQALQHPFFER 365 (365)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGCC
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCcccCC
Confidence 999999988888888877765441 11367899999999999999999999 889999999973
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=411.21 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=216.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH-----HHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK-----NAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~-----~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
.++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+.+|+.+|..++||||++++++|.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 4679999999999999999999999999999999987543221 13345678999999999999999999999999
Q ss_pred ceEEEEeeccCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGG-DLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GG-SL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
.+|+||||+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~- 181 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE- 181 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC-
Confidence 999999999766 999999998899999999999999999999999999999999999999999999999999997521
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 182 ------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 182 ------------------------------RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp ------------------------------TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred ------------------------------CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 0112234679999999999998876 789999999999999999999997
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
.... +....... +..++.++.+||.+||+.||.+||+ +.++++||||++
T Consensus 232 ~~~~------~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~Rps---~~ell~hp~~~~ 280 (335)
T 3dls_A 232 ELEE------TVEAAIHP---PYLVSKELMSLVSGLLQPVPERRTT---LEKLVTDPWVTQ 280 (335)
T ss_dssp SGGG------GTTTCCCC---SSCCCHHHHHHHHHHTCSSGGGSCC---HHHHHHCTTTTC
T ss_pred hHHH------HHhhccCC---CcccCHHHHHHHHHHccCChhhCcC---HHHHhcCccccC
Confidence 6321 22222222 3568999999999999999999999 889999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=409.12 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=211.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE---- 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~---- 831 (1170)
..++|++++.||+|+||.||+|++..+++.||||++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 3578999999999999999999999999999999987643 23455677889999999999999999999997765
Q ss_pred --ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 832 --NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 832 --~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
.+|+||||+. |+|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 6899999996 57888886 369999999999999999999999999999999999999999999999999997421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.
T Consensus 179 -------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 179 -------------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp ------------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred -------------------------------cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 0011234679999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCC----------------------CCCC-----------C------ccCCHHHHHHHHHhccCCC
Q 001057 990 AKTPQQIFDNIMNRDIP----------------------WPNI-----------P------EEMSVEACDLIDKLLTENP 1030 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~----------------------fP~i-----------p------~~lS~eakDLIkkLLq~DP 1030 (1170)
+.+..+.+..+...... +... + ...+.++++||.+||+.||
T Consensus 228 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP 307 (371)
T 2xrw_A 228 GTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307 (371)
T ss_dssp CSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSG
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCCh
Confidence 99888877777643111 0000 0 0125789999999999999
Q ss_pred CCCCChhhHHHHHcCCCCCCCC
Q 001057 1031 VQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1031 skRpSa~~AeEILqHPfF~~id 1052 (1170)
.+||| +.|+|+||||+...
T Consensus 308 ~~R~t---~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 308 SKRIS---VDEALQHPYINVWY 326 (371)
T ss_dssp GGSCC---HHHHHHSHHHHTTC
T ss_pred hhCCC---HHHHhCCcchhhhc
Confidence 99999 88999999998643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=405.09 Aligned_cols=267 Identities=28% Similarity=0.458 Sum_probs=224.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
..+++|++++.||+|+||.||+|++..+|+.||||++.... ......+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 45678999999999999999999999999999999987653 33445567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
+||||+.+++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~----- 175 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA----- 175 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec-----
Confidence 999999999999888877889999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.
T Consensus 176 -------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 176 -------------------------APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp ---------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred -------------------------CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 001122345799999999999875 689999999999999999999999999887
Q ss_pred HHHHHHHhcc-------------------CCCCCCC---------CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 994 QQIFDNIMNR-------------------DIPWPNI---------PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 994 ~ei~qkIl~~-------------------~l~fP~i---------p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.+....+... ...++.. ...++.++.+||.+||+.||.+||+ +.|+|+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~h 307 (331)
T 4aaa_A 231 IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF---CAELLHH 307 (331)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC---GGGGGGS
T ss_pred HHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC---HHHHhcC
Confidence 7666555421 1111111 1257899999999999999999999 7789999
Q ss_pred CCCCCCChhh
Q 001057 1046 PFFKNINWDT 1055 (1170)
Q Consensus 1046 PfF~~idwe~ 1055 (1170)
|||+...|..
T Consensus 308 p~f~~~~~~~ 317 (331)
T 4aaa_A 308 DFFQMDGFAE 317 (331)
T ss_dssp HHHHGGGHHH
T ss_pred chhccCChhh
Confidence 9999876654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=413.45 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=204.7
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc------
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR------ 830 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~------ 830 (1170)
.++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+|+.++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 368999999999999999999999999999999987542 2345567888999999999999999999998754
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
..+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~- 183 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA- 183 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc-
Confidence 5689999999 7899999876 579999999999999999999999999999999999999999999999999997421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.
T Consensus 184 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 231 (367)
T 2fst_X 184 --------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231 (367)
T ss_dssp ---------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred --------------------------------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 01234679999999999987 678999999999999999999999999
Q ss_pred CCCHHHHHHHHhccC----------------------------CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 990 AKTPQQIFDNIMNRD----------------------------IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~----------------------------l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+.+..+.+..|.... ..+.......++++.+||.+||+.||.+||+ +.+
T Consensus 232 ~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t---~~e 308 (367)
T 2fst_X 232 GTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQ 308 (367)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC---HHH
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC---HHH
Confidence 998877776665310 0001111356889999999999999999999 889
Q ss_pred HHcCCCCCCCCh
Q 001057 1042 VKQHPFFKNINW 1053 (1170)
Q Consensus 1042 ILqHPfF~~idw 1053 (1170)
+|+||||+....
T Consensus 309 ~L~hp~~~~~~~ 320 (367)
T 2fst_X 309 ALAHAYFAQYHD 320 (367)
T ss_dssp HHTSGGGTTTCC
T ss_pred HhcChhhhhccC
Confidence 999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=395.25 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=212.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeec--cc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTC--RE 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd--~~ 831 (1170)
...++|++++.||+|+||+||+|++..+++.||||++.... ...+.+|+.+|..++ ||||+++++++.+ ..
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 106 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSR 106 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence 34578999999999999999999999999999999987532 356889999999997 9999999999987 66
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-cEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-~VKLsDFGLAk~~~~ 910 (1170)
.+|+||||+.+++|..++.. +++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 107 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~- 182 (330)
T 3nsz_A 107 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH- 182 (330)
T ss_dssp CEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC-
T ss_pred ceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC-
Confidence 79999999999999998854 89999999999999999999999999999999999999777 89999999997521
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 183 ------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 183 ------------------------------PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp ------------------------------TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred ------------------------------CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 0111234578999999999987 668999999999999999999999995
Q ss_pred CC-CHHHHHHHH-------------hccCCCCC---------------------CCCccCCHHHHHHHHHhccCCCCCCC
Q 001057 990 AK-TPQQIFDNI-------------MNRDIPWP---------------------NIPEEMSVEACDLIDKLLTENPVQRL 1034 (1170)
Q Consensus 990 g~-~~~ei~qkI-------------l~~~l~fP---------------------~ip~~lS~eakDLIkkLLq~DPskRp 1034 (1170)
.. +..+....+ ......++ ..+..+++++.+||.+||+.||.+||
T Consensus 233 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 312 (330)
T 3nsz_A 233 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312 (330)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC
T ss_pred cCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC
Confidence 43 332222222 11111111 11123799999999999999999999
Q ss_pred ChhhHHHHHcCCCCCCCChh
Q 001057 1035 GATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 1035 Sa~~AeEILqHPfF~~idwe 1054 (1170)
+ +.|+|+||||+++.++
T Consensus 313 t---a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 313 T---AREAMEHPYFYTVVKD 329 (330)
T ss_dssp C---HHHHHTSGGGTTCC--
T ss_pred C---HHHHhcCccHhhhccC
Confidence 9 8899999999998765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=404.18 Aligned_cols=266 Identities=30% Similarity=0.452 Sum_probs=218.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR----- 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~----- 830 (1170)
..++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|..++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 45789999999999999999999999999999999866532 222335677899999999999999999998873
Q ss_pred ---cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcc
Q 001057 831 ---ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 831 ---~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk 906 (1170)
+.+||||||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp ---CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred cCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999965 787777654 579999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
....... .........+||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 173 ~~~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 226 (351)
T 3mi9_A 173 AFSLAKN--------------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226 (351)
T ss_dssp ECCCCSS--------------------------SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccccc--------------------------ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCC
Confidence 5310000 01112345679999999999986 45899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhccCCCC-----CCCCc------------------------cCCHHHHHHHHHhccCCCCCCCCh
Q 001057 986 PPFNAKTPQQIFDNIMNRDIPW-----PNIPE------------------------EMSVEACDLIDKLLTENPVQRLGA 1036 (1170)
Q Consensus 986 pPF~g~~~~ei~qkIl~~~l~f-----P~ip~------------------------~lS~eakDLIkkLLq~DPskRpSa 1036 (1170)
+||.+.+.......+......+ +.... ..++++.+||.+||+.||.+||+
T Consensus 227 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t- 305 (351)
T 3mi9_A 227 PIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID- 305 (351)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC-
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC-
Confidence 9999999888777665422111 11000 02778999999999999999999
Q ss_pred hhHHHHHcCCCCCCCC
Q 001057 1037 TGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1037 ~~AeEILqHPfF~~id 1052 (1170)
+.|+|+||||....
T Consensus 306 --~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 306 --SDDALNHDFFWSDP 319 (351)
T ss_dssp --HHHHHTSGGGGSSS
T ss_pred --HHHHhCCCCcCCCC
Confidence 88999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=404.23 Aligned_cols=260 Identities=30% Similarity=0.507 Sum_probs=218.6
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----cc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-----EN 832 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-----~~ 832 (1170)
++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+|..++||||+++++++... ..
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 58999999999999999999999999999999987532 344557889999999999999999999998765 36
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 899999996 599999876 469999999999999999999999999999999999999999999999999998531000
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.
T Consensus 183 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 235 (364)
T 3qyz_A 183 ---------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK 235 (364)
T ss_dssp ---------------------------CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---------------------------CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCC
Confidence 00111234689999999998765 45899999999999999999999999998
Q ss_pred CHHHHHHHHhcc----------------------------CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 992 TPQQIFDNIMNR----------------------------DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 992 ~~~ei~qkIl~~----------------------------~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
+..+.+..+... ..++......++.++.+||.+||+.||.+||+ +.|+|
T Consensus 236 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l 312 (364)
T 3qyz_A 236 HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQAL 312 (364)
T ss_dssp SGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC---HHHHH
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC---HHHHh
Confidence 877766665421 01111112467899999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001057 1044 QHPFFKNI 1051 (1170)
Q Consensus 1044 qHPfF~~i 1051 (1170)
+||||++.
T Consensus 313 ~hp~~~~~ 320 (364)
T 3qyz_A 313 AHPYLEQY 320 (364)
T ss_dssp TSGGGTTT
T ss_pred cCcchhhc
Confidence 99999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=404.59 Aligned_cols=265 Identities=29% Similarity=0.486 Sum_probs=215.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccccc--HHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR--KNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~--~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
..++|++++.||+|+||.||+|++..+|+.||||++....... ......+.+|+.++..++||||++++++|.+...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999999999999999987543211 11234678999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|+||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~--- 163 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--- 163 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT---
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc---
Confidence 999999975 899888765 469999999999999999999999999999999999999999999999999997521
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.
T Consensus 164 ---------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 164 ---------------------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp ---------------------------SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---------------------------CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 001122345799999999999764 5899999999999999999999999999
Q ss_pred CHHHHHHHHhccC-----CCCCC---------------C-----CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCC
Q 001057 992 TPQQIFDNIMNRD-----IPWPN---------------I-----PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046 (1170)
Q Consensus 992 ~~~ei~qkIl~~~-----l~fP~---------------i-----p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHP 1046 (1170)
+..+.+..+.... ..|+. . ...++.++.+||.+||+.||.+||+ +.|+++||
T Consensus 217 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~h~ 293 (346)
T 1ua2_A 217 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMK 293 (346)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSG
T ss_pred CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC---HHHHhcCh
Confidence 9888877776421 11111 0 1356789999999999999999999 88999999
Q ss_pred CCCCCChh
Q 001057 1047 FFKNINWD 1054 (1170)
Q Consensus 1047 fF~~idwe 1054 (1170)
||++..+.
T Consensus 294 ~f~~~~~~ 301 (346)
T 1ua2_A 294 YFSNRPGP 301 (346)
T ss_dssp GGTSSSCC
T ss_pred hhhcCCCC
Confidence 99876543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=408.27 Aligned_cols=254 Identities=28% Similarity=0.511 Sum_probs=211.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec------
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC------ 829 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd------ 829 (1170)
..++|++++.||+|+||+||+|++..+|+.||||++...... ..+|+.+|+.++|||||+++++|..
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 456899999999999999999999999999999998754321 2369999999999999999999843
Q ss_pred --------------------------------ccceEEEEeeccCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 001057 830 --------------------------------RENLYLVMEYLNGGDLYSLLR----NLGCLDEDMARVYIAELVLALEY 873 (1170)
Q Consensus 830 --------------------------------~~~LyLVMEY~~GGSL~dlLk----~~~~LSEe~ar~IaaQIL~ALeY 873 (1170)
..++|+||||++ |+|.+.+. ....+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 334899999997 57777765 34679999999999999999999
Q ss_pred HHhCCeeeccCCCCcEEeC-CCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCC
Q 001057 874 LHSLNVIHRDLKPDNLLIG-QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTP 952 (1170)
Q Consensus 874 LHs~GIIHRDIKPENILLd-~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp 952 (1170)
||++||+||||||+|||++ .++.+||+|||+|+... ........+||+
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~-------------------------------~~~~~~~~~~t~ 205 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI-------------------------------PSEPSVAYICSR 205 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECC-------------------------------TTSCCCCCCCCS
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccC-------------------------------CCCCCcCcccCC
Confidence 9999999999999999997 68899999999998521 011223457899
Q ss_pred CCCchHHHhcCC-CCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-----------------CCCCCC-----
Q 001057 953 DYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNR-----------------DIPWPN----- 1009 (1170)
Q Consensus 953 ~YmAPEVL~g~~-ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~-----------------~l~fP~----- 1009 (1170)
.|+|||++.+.. |+.++|||||||++|+|++|.+||.+.+..+.+..+... ...+|.
T Consensus 206 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 285 (383)
T 3eb0_A 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKD 285 (383)
T ss_dssp SCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCC
T ss_pred CccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCccc
Confidence 999999998754 899999999999999999999999999888777766531 112221
Q ss_pred ----CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1010 ----IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1010 ----ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
++..++.++.+||.+||+.||.+||+ +.|+++||||+++
T Consensus 286 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 286 WRKILPEGTPSLAIDLLEQILRYEPDLRIN---PYEAMAHPFFDHL 328 (383)
T ss_dssp HHHHSCTTCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSGGGHHH
T ss_pred HHhhCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcCHHHHHH
Confidence 23468899999999999999999999 8899999999865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=404.79 Aligned_cols=268 Identities=25% Similarity=0.536 Sum_probs=232.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHH--------------HHHHHHHHHHHHHhcCCCc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKN--------------AVESILAERNILISVRNPF 819 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~--------------~ve~~l~EieILskL~HPN 819 (1170)
....++|++++.||+|+||.||+|++ +|+.||||++......... ..+.+.+|+.++..++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 45668999999999999999999998 8999999998765332211 1267889999999999999
Q ss_pred EEEEEeeeecccceEEEEeeccCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEE
Q 001057 820 VVRFFYSFTCRENLYLVMEYLNGGDLYSL------LRN--LGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLL 890 (1170)
Q Consensus 820 IVrL~~~Fqd~~~LyLVMEY~~GGSL~dl------Lk~--~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENIL 890 (1170)
|+++++++.+.+.+|+||||+++|+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 665 5679999999999999999999999 99999999999999
Q ss_pred eCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCc-c
Q 001057 891 IGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGA-T 968 (1170)
Q Consensus 891 Ld~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~-k 968 (1170)
++.++.+||+|||++.... ........||+.|+|||++.+. .++. +
T Consensus 185 ~~~~~~~kl~dfg~~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 232 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMV--------------------------------DKKIKGSRGTYEFMPPEFFSNESSYNGAK 232 (348)
T ss_dssp ECTTSCEEECCCTTCEECB--------------------------------TTEECSSCSCGGGCCGGGGSSCCCEEHHH
T ss_pred EcCCCcEEEeccccccccc--------------------------------cccccCCCCCcCccCchhhcCCCCCCcch
Confidence 9999999999999987521 0022345799999999999887 5666 8
Q ss_pred hhhhHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhccCCCCCCC----------------CccCCHHHHHHHHHhccCCCC
Q 001057 969 ADWWSVGIILFELLIGIPPFNAKTP-QQIFDNIMNRDIPWPNI----------------PEEMSVEACDLIDKLLTENPV 1031 (1170)
Q Consensus 969 sDIWSLGVILYELLTG~pPF~g~~~-~ei~qkIl~~~l~fP~i----------------p~~lS~eakDLIkkLLq~DPs 1031 (1170)
+|||||||++|+|++|..||.+.+. .+++..+......+|.. ...++.++.+||.+||+.||.
T Consensus 233 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 312 (348)
T 2pml_X 233 VDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312 (348)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGG
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChh
Confidence 9999999999999999999998776 78888888776665521 146899999999999999999
Q ss_pred CCCChhhHHHHHcCCCCCCCChhhhhh
Q 001057 1032 QRLGATGAREVKQHPFFKNINWDTLAR 1058 (1170)
Q Consensus 1032 kRpSa~~AeEILqHPfF~~idwe~L~~ 1058 (1170)
+||+ +.++++||||++.+|..+..
T Consensus 313 ~Rps---~~e~l~hp~f~~~~~~~~~~ 336 (348)
T 2pml_X 313 ERIT---SEDALKHEWLADTNIEDLRE 336 (348)
T ss_dssp GSCC---HHHHHTSGGGTTCCHHHHHH
T ss_pred hCCC---HHHHhcCccccCCCHHHHHH
Confidence 9999 88999999999999988764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=392.08 Aligned_cols=264 Identities=31% Similarity=0.545 Sum_probs=222.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|++++.||.|+||.||+|++..+|+.||||++.... ..+.+.+|+.++..++||||+++++++.....+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 44578999999999999999999999999999999987643 2356789999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+||||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~---- 176 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT---- 176 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECB----
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhh----
Confidence 99999999999999974 4679999999999999999999999999999999999999999999999999987521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 177 --------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 230 (314)
T 3com_A 177 --------------------------DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230 (314)
T ss_dssp --------------------------TTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred --------------------------hhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh
Confidence 001112345799999999999998999999999999999999999999998887
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhh
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTL 1056 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L 1056 (1170)
......+..........+..++..+.+||.+||..||.+||+ +.++++||||++..+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~~ll~~~~~~~~~~~~~ 290 (314)
T 3com_A 231 MRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT---ATQLLQHPFVRSAKGVSI 290 (314)
T ss_dssp HHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHTCCCGGG
T ss_pred HHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhcCCcchH
Confidence 766665554443322334678999999999999999999999 889999999998765543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=423.35 Aligned_cols=265 Identities=33% Similarity=0.586 Sum_probs=215.4
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccccc-----HHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-----KNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~-----~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
.++|.+.+.||+|+||+||+|.+..+++.||||++.+..... ......+.+|+.+|.+++||||++++++|.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 468999999999999999999999999999999998754321 1223357899999999999999999998865 4
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---cEEEEecCCcccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---HIKLTDFGLSKVG 908 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG---~VKLsDFGLAk~~ 908 (1170)
.+||||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5899999999999999998888899999999999999999999999999999999999997554 5999999999752
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc---CCCCcchhhhHHHHHHHHHHhCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g---~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
. ........+||+.|+|||++.+ ..|+.++|||||||++|+|++|.
T Consensus 293 ~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~ 341 (419)
T 3i6u_A 293 G-------------------------------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341 (419)
T ss_dssp C------------------------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSS
T ss_pred C-------------------------------CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 1 0112235689999999999864 56788999999999999999999
Q ss_pred CCCCCCCH-HHHHHHHhccCCCCC-CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhh
Q 001057 986 PPFNAKTP-QQIFDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTL 1056 (1170)
Q Consensus 986 pPF~g~~~-~ei~qkIl~~~l~fP-~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L 1056 (1170)
+||.+... ..+...+..+...++ .....++..+.+||.+||+.||.+||+ +.++++||||++.+|...
T Consensus 342 ~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~~~~~~~ 411 (419)
T 3i6u_A 342 PPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDEDMKRK 411 (419)
T ss_dssp CSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGCCHHHHHH
T ss_pred CCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcC---HHHHhCCcccCChhHHHH
Confidence 99986543 344455555555432 122468999999999999999999999 889999999998877653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=414.77 Aligned_cols=257 Identities=30% Similarity=0.475 Sum_probs=212.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR----- 830 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~----- 830 (1170)
...+|++++.||+|+||+||+|++..+|+.||||++.+... ...+|+.+|+.++|||||+++++|...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999875432 224699999999999999999888542
Q ss_pred -cceEEEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC-CcEEEEecCC
Q 001057 831 -ENLYLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD-GHIKLTDFGL 904 (1170)
Q Consensus 831 -~~LyLVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d-G~VKLsDFGL 904 (1170)
.++++||||+++ +|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 347899999975 67766643 4679999999999999999999999999999999999999965 5789999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHh
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLI 983 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLT 983 (1170)
|+... ........+||+.|+|||++.+. .|+.++||||||||||||++
T Consensus 204 a~~~~-------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 252 (420)
T 1j1b_A 204 AKQLV-------------------------------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252 (420)
T ss_dssp CEECC-------------------------------TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred hhhcc-------------------------------cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh
Confidence 98521 00112346799999999999875 69999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcc-----------------CCCCCC---------CCccCCHHHHHHHHHhccCCCCCCCChh
Q 001057 984 GIPPFNAKTPQQIFDNIMNR-----------------DIPWPN---------IPEEMSVEACDLIDKLLTENPVQRLGAT 1037 (1170)
Q Consensus 984 G~pPF~g~~~~ei~qkIl~~-----------------~l~fP~---------ip~~lS~eakDLIkkLLq~DPskRpSa~ 1037 (1170)
|++||.+.+..+.+..|... .+.+|. ++..+++++.+||.+||+.||.+||+
T Consensus 253 G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t-- 330 (420)
T 1j1b_A 253 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT-- 330 (420)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC--
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC--
Confidence 99999998877666655431 122332 12457899999999999999999999
Q ss_pred hHHHHHcCCCCCCCChh
Q 001057 1038 GAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 1038 ~AeEILqHPfF~~idwe 1054 (1170)
+.|+++||||+++.+.
T Consensus 331 -~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 331 -PLEACAHSFFDELRDP 346 (420)
T ss_dssp -HHHHHTSGGGGGGGCT
T ss_pred -HHHHhCCHhhcccccc
Confidence 8899999999876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=396.85 Aligned_cols=274 Identities=28% Similarity=0.449 Sum_probs=220.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc----
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR---- 830 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~---- 830 (1170)
...++|++.+.||+|+||+||+|++..+|+.||||++.... .......+.+|+.+|..++||||+++++++...
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 34578999999999999999999999999999999986532 344566788999999999999999999887654
Q ss_pred -cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 -~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 67999999996 699999876 579999999999999999999999999999999999999999999999999998532
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
...... .............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus 164 ~~~~~~--------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 223 (353)
T 2b9h_A 164 ESAADN--------------------SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223 (353)
T ss_dssp ------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccc--------------------cCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC
Confidence 100000 000001112335689999999999875 67899999999999999999999999
Q ss_pred CCCCHHHHHHHHhcc--C----------------------CCCCC-----CCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 989 NAKTPQQIFDNIMNR--D----------------------IPWPN-----IPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~--~----------------------l~fP~-----ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
.+.+....+..+... . ..++. ....+++++.+||.+||+.||.+||+ +
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~ 300 (353)
T 2b9h_A 224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT---A 300 (353)
T ss_dssp CCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC---H
T ss_pred CCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC---H
Confidence 998876665544321 0 00010 11368899999999999999999999 8
Q ss_pred HHHHcCCCCCCCChhh
Q 001057 1040 REVKQHPFFKNINWDT 1055 (1170)
Q Consensus 1040 eEILqHPfF~~idwe~ 1055 (1170)
.++++||||+.+.+..
T Consensus 301 ~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 301 KEALEHPYLQTYHDPN 316 (353)
T ss_dssp HHHHTSGGGTTTCCTT
T ss_pred HHHhcCccccccCCcc
Confidence 8999999999876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=393.20 Aligned_cols=259 Identities=28% Similarity=0.485 Sum_probs=217.8
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeee-cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC------cEEEEE
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARK-RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP------FVVRFF 824 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArd-k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HP------NIVrL~ 824 (1170)
.+....++|++++.||+|+||+||+|.+ ..+++.||||++... ....+.+.+|+.++..++|+ +|++++
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 4456668999999999999999999998 568899999998753 24456788899999888765 499999
Q ss_pred eeeecccceEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---------
Q 001057 825 YSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ--------- 893 (1170)
Q Consensus 825 ~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~--------- 893 (1170)
++|...+++|+||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999999999 889999998765 6899999999999999999999999999999999999987
Q ss_pred ----------CCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC
Q 001057 894 ----------DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM 963 (1170)
Q Consensus 894 ----------dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~ 963 (1170)
++.+||+|||+++... ......+||+.|+|||++.+.
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~ 209 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDD---------------------------------EHHSTLVSTRHYRAPEVILAL 209 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETT---------------------------------SCCCSSCSCGGGCCHHHHTTS
T ss_pred ccccccccccCCCceEeeCcccccCc---------------------------------cccccccCCccccChHHhhCC
Confidence 6689999999987421 012245799999999999999
Q ss_pred CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-----------------------------------
Q 001057 964 GHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWP----------------------------------- 1008 (1170)
Q Consensus 964 ~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP----------------------------------- 1008 (1170)
.++.++|||||||++|||++|.+||.+.+..+....+.....++|
T Consensus 210 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (339)
T 1z57_A 210 GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289 (339)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc
Confidence 999999999999999999999999998887665554432111111
Q ss_pred ------CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1009 ------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1009 ------~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..+...+.++.+||.+||+.||.+||+ +.|+++||||+.+
T Consensus 290 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 335 (339)
T 1z57_A 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT---LREALKHPFFDLL 335 (339)
T ss_dssp CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGG
T ss_pred chhhhcccchhhHHHHHHHHHHHhCcCcccccC---HHHHhcCHHHHHH
Confidence 011234578899999999999999999 8899999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=385.44 Aligned_cols=259 Identities=31% Similarity=0.567 Sum_probs=225.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee--cccce
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT--CRENL 833 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq--d~~~L 833 (1170)
..++|++++.||+|+||.||+|+++.+|+.||+|++..... .....+.+.+|+.++..++||||+++++++. ....+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 35789999999999999999999999999999999986543 3455678999999999999999999999875 35679
Q ss_pred EEEEeeccCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCCCcEEeCCCCcEEEEecCC
Q 001057 834 YLVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLALEYLHSLN-----VIHRDLKPDNLLIGQDGHIKLTDFGL 904 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~----~~LSEe~ar~IaaQIL~ALeYLHs~G-----IIHRDIKPENILLd~dG~VKLsDFGL 904 (1170)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 9999999999999999754 34999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhC
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG 984 (1170)
++... ..........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 163 ~~~~~------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 212 (279)
T 2w5a_A 163 ARILN------------------------------HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 212 (279)
T ss_dssp HHHC---------------------------------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHS
T ss_pred heeec------------------------------cccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 87521 001112345799999999999998999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 985 IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
..||.+.+..++...+..+... .++..++.++.+||.+||+.||.+||+ +.++++|+|+.+
T Consensus 213 ~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~~~~~~ 273 (279)
T 2w5a_A 213 MPPFTAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLILE 273 (279)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTCCG
T ss_pred CCCCcccCHHHHHHHHhhcccc--cCCcccCHHHHHHHHHHcCCCcccCCC---HHHHHhChhhhh
Confidence 9999999988888888776653 345689999999999999999999999 889999999975
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=400.00 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=214.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CcEEEEEeeeecccc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN--PFVVRFFYSFTCREN 832 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H--PNIVrL~~~Fqd~~~ 832 (1170)
+..++|++++.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|+.+|..++| |||+++++++.+...
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 3456799999999999999999998 468999999987654 344566788999999999986 999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|||||| .+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.....
T Consensus 84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~- 160 (343)
T 3dbq_A 84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD- 160 (343)
T ss_dssp EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc-
Confidence 9999995 5889999999988999999999999999999999999999999999999996 688999999999753100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----------CCCCcchhhhHHHHHHHHH
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----------MGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----------~~ys~ksDIWSLGVILYEL 981 (1170)
.........+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 161 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~el 213 (343)
T 3dbq_A 161 ---------------------------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213 (343)
T ss_dssp ------------------------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHH
T ss_pred ---------------------------cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHH
Confidence 00112235689999999999975 5688999999999999999
Q ss_pred HhCCCCCCCCC-HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 982 LIGIPPFNAKT-PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 982 LTG~pPF~g~~-~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
++|.+||.+.. ....+..+...... ...+...+.++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 214 l~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~ 279 (343)
T 3dbq_A 214 TYGKTPFQQIINQISKLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQI 279 (343)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHCTTSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHS
T ss_pred HhCCCcchhhhhHHHHHHHHhcCCcc-cCCcccCCHHHHHHHHHHcCCChhHCCC---HHHHHhCccccc
Confidence 99999998743 33444444433322 2234667889999999999999999999 889999999974
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=387.77 Aligned_cols=259 Identities=30% Similarity=0.482 Sum_probs=204.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..++|++++.||+|+||+||+|++..+|+.||+|++..... .......+..+..+++.++||||+++++++.+.+.+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 3556889999999999999999999999999999999876432 233334455555667888999999999999999999
Q ss_pred EEEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 834 YLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSL-NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~-GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
|+||||++ |+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+..
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999996 588777753 46799999999999999999999998 9999999999999999999999999998752
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHH----hcCCCCcchhhhHHHHHHHHHHhC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL----LGMGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL----~g~~ys~ksDIWSLGVILYELLTG 984 (1170)
. .........||+.|+|||++ .+..++.++|||||||++|+|++|
T Consensus 161 ~-------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g 209 (290)
T 3fme_A 161 V-------------------------------DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209 (290)
T ss_dssp ----------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHT
T ss_pred c-------------------------------ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHC
Confidence 1 01112234699999999997 456789999999999999999999
Q ss_pred CCCCCC-CCHHHHHHHHhccC-CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 985 IPPFNA-KTPQQIFDNIMNRD-IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 985 ~pPF~g-~~~~ei~qkIl~~~-l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
..||.. .........+.... ...+ +..++.++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 210 ~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt---~~e~l~hp~f~~ 272 (290)
T 3fme_A 210 RFPYDSWGTPFQQLKQVVEEPSPQLP--ADKFSAEFVDFTSQCLKKNSKERPT---YPELMQHPFFTL 272 (290)
T ss_dssp SCSSCCCSCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHH
T ss_pred CCCccccCchHHHHHHHhccCCCCcc--cccCCHHHHHHHHHHhhcChhhCcC---HHHHHhCccccc
Confidence 999986 34444444444333 2222 3578999999999999999999999 889999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=400.66 Aligned_cols=264 Identities=33% Similarity=0.598 Sum_probs=217.6
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc-----cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI-----RKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~-----~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
.++|++++.||+|+||.||+|++..+++.||||++.+.... .......+.+|+.+|..++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 35799999999999999999999999999999998764321 1223345789999999999999999999987654
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc---EEEEecCCcccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH---IKLTDFGLSKVG 908 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~---VKLsDFGLAk~~ 908 (1170)
+|+||||+.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988888999999999999999999999999999999999999987664 999999999752
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHHHHHhCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
. ........+||+.|+|||++. ...++.++|||||||++|+|++|.
T Consensus 168 ~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (322)
T 2ycf_A 168 G-------------------------------ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216 (322)
T ss_dssp C-------------------------------CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSS
T ss_pred c-------------------------------cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 1 001123457999999999985 456889999999999999999999
Q ss_pred CCCCCCCHH-HHHHHHhccCCCCC-CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhh
Q 001057 986 PPFNAKTPQ-QIFDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 986 pPF~g~~~~-ei~qkIl~~~l~fP-~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~ 1055 (1170)
.||.+.... .+...+..+...+. .....++.++.+||.+||+.||.+||+ +.++++||||++.+|..
T Consensus 217 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~~~l~h~~~~~~~~~~ 285 (322)
T 2ycf_A 217 PPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDEDMKR 285 (322)
T ss_dssp CSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGCCHHHHH
T ss_pred CCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCC---HHHHhhCcCcCCHHHHH
Confidence 999865433 34445555554432 122468999999999999999999999 88999999999877653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=390.55 Aligned_cols=262 Identities=27% Similarity=0.494 Sum_probs=222.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccccc-HHHHHHHHHHHHHHHhcCCCcEEEEEeee--ecccce
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-KNAVESILAERNILISVRNPFVVRFFYSF--TCRENL 833 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~-~~~ve~~l~EieILskL~HPNIVrL~~~F--qd~~~L 833 (1170)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+..... ......+.+|+.++..++||||+++++++ .+...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999997654321 23457889999999999999999999998 445689
Q ss_pred EEEEeeccCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRN--LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~--~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
|+||||+.++ |.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 7777765 356999999999999999999999999999999999999999999999999999752100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC--CcchhhhHHHHHHHHHHhCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH--GATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y--s~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
..........||+.|+|||++.+... +.++|||||||++|+|++|..||.
T Consensus 163 ----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 163 ----------------------------AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp ----------------------------CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ----------------------------ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence 00111234569999999999986543 779999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
+.+..+++..+......++ ..++..+.+||.+||+.||.+||+ +.++++||||+....
T Consensus 215 ~~~~~~~~~~i~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 215 GDNIYKLFENIGKGSYAIP---GDCGPPLSDLLKGMLEYEPAKRFS---IRQIRQHSWFRKKHP 272 (305)
T ss_dssp CSSHHHHHHHHHHCCCCCC---SSSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSHHHHSCCC
T ss_pred CchHHHHHHHHhcCCCCCC---CccCHHHHHHHHHHccCChhhCCC---HHHHhcCcccccCCC
Confidence 9999999998888776554 678999999999999999999999 889999999987643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=394.59 Aligned_cols=268 Identities=26% Similarity=0.437 Sum_probs=221.6
Q ss_pred CCCCCCCCCCeEEEEEeccCCCeEEEEeeecCCC-CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc------EEE
Q 001057 750 CSKDRTSIEDFEIIKPISQGAFGRVFLARKRATG-DLFAIKVLKKADMIRKNAVESILAERNILISVRNPF------VVR 822 (1170)
Q Consensus 750 ~~~~~i~iedYevlk~LG~GgFGtVyLArdk~TG-e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN------IVr 822 (1170)
+..+....++|++++.||+|+||+||+|++..++ +.||+|++... ....+.+.+|+.++..++|++ ++.
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 3445666789999999999999999999998777 69999998753 234567788999999987655 999
Q ss_pred EEeeeecccceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe---------
Q 001057 823 FFYSFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI--------- 891 (1170)
Q Consensus 823 L~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL--------- 891 (1170)
++++|...+++||||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 999999999999999999 67788877655 369999999999999999999999999999999999999
Q ss_pred ----------CCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh
Q 001057 892 ----------GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL 961 (1170)
Q Consensus 892 ----------d~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~ 961 (1170)
+.++.+||+|||+|+... ......+||+.|+|||++.
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~ 212 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDH---------------------------------EHHTTIVATRHYRPPEVIL 212 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETT---------------------------------SCCCSSCSCGGGCCHHHHT
T ss_pred cccccccccccCCCcEEEeecCcccccc---------------------------------ccccCCcCCCcccCCeeee
Confidence 567899999999997421 0112457999999999999
Q ss_pred cCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC---------------------C-----------
Q 001057 962 GMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWP---------------------N----------- 1009 (1170)
Q Consensus 962 g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP---------------------~----------- 1009 (1170)
+..++.++|||||||++|||++|.+||.+.+..+....+.....+.| .
T Consensus 213 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (355)
T 2eu9_A 213 ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKEN 292 (355)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHH
T ss_pred cCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhcccccc
Confidence 99999999999999999999999999998887665554433211111 0
Q ss_pred ---------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhh
Q 001057 1010 ---------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLAR 1058 (1170)
Q Consensus 1010 ---------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~ 1058 (1170)
.....+.++.+||.+||+.||.+||+ +.++++||||++++|+....
T Consensus 293 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~~~~ 347 (355)
T 2eu9_A 293 CKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT---LAEALLHPFFAGLTPEERSF 347 (355)
T ss_dssp CCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGCCHHHHC-
T ss_pred CCcccccccccchhHHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcCCChhhccc
Confidence 01123568899999999999999999 88999999999998876543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=390.97 Aligned_cols=272 Identities=28% Similarity=0.507 Sum_probs=201.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..++|++.+.||+|+||.||+|++..+++.||||++..... ......+.+|+.++..++||||++++++|...+.+
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL 88 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCc
Confidence 4566899999999999999999999999999999998865432 23456788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 834 YLVMEYLNGGDLYSLLRN--------LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~--------~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
|+||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999999974 356999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIG 984 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG 984 (1170)
....... . . ..........||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 169 ~~~~~~~-------------~-----------~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 223 (303)
T 2vwi_A 169 AFLATGG-------------D-----------I-TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223 (303)
T ss_dssp HHCC----------------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHS
T ss_pred heeccCC-------------C-----------c-cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhC
Confidence 7531000 0 0 00112235679999999999976 5689999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhccCCCC-------CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhh
Q 001057 985 IPPFNAKTPQQIFDNIMNRDIPW-------PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~l~f-------P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~ 1055 (1170)
..||.+................. +.....++.++.+||.+||+.||.+||+ +.++++||||+...+..
T Consensus 224 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 224 AAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLRHKFFQKAKNKE 298 (303)
T ss_dssp SCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSTTC-------
T ss_pred CCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcC---HHHHhhChhhhcCCCCc
Confidence 99999877766555544333211 1223568899999999999999999999 88999999999876553
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=402.85 Aligned_cols=255 Identities=28% Similarity=0.420 Sum_probs=223.8
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
..|++++.||+|+||+||+|++..+|+.||||++...........+.+.+|+.+|..++||||++++++|.+.+.+||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45999999999999999999999999999999998665445556678999999999999999999999999999999999
Q ss_pred eeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||+. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------- 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 205 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC-------
Confidence 9996 688888754 4679999999999999999999999999999999999999999999999999987420
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.....+||+.|+|||++. +..++.++|||||||++|||++|.+||.+.+.
T Consensus 206 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 206 ---------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp ---------------------------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ---------------------------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 112457999999999996 45689999999999999999999999999888
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
......+.....+.. .+..++..+.+||.+||+.||.+||+ +.++++||||...
T Consensus 259 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 259 MSALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 312 (348)
T ss_dssp HHHHHHHHHSCCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHSC
T ss_pred HHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHcccChhhCcC---HHHHhhChhhhcc
Confidence 777777766544322 23578999999999999999999999 8899999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=389.76 Aligned_cols=265 Identities=30% Similarity=0.454 Sum_probs=214.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee-------
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT------- 828 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq------- 828 (1170)
..++|++++.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.++..++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 346899999999999999999999999999999998754 3456678899999999999999999998874
Q ss_pred -------cccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC-CCCcEEEE
Q 001057 829 -------CRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG-QDGHIKLT 900 (1170)
Q Consensus 829 -------d~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd-~dG~VKLs 900 (1170)
....+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 3467899999997 699999875 5799999999999999999999999999999999999997 56799999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILF 979 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILY 979 (1170)
|||+++...... ..........||+.|+|||++.+ ..++.++|||||||++|
T Consensus 164 Dfg~~~~~~~~~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~ 216 (320)
T 2i6l_A 164 DFGLARIMDPHY---------------------------SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 216 (320)
T ss_dssp CCTTCBCC-----------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHH
T ss_pred cCccccccCCCc---------------------------ccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHH
Confidence 999997521000 00112234568999999999876 67899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhccCCCC----------------------C-----CCCccCCHHHHHHHHHhccCCCCC
Q 001057 980 ELLIGIPPFNAKTPQQIFDNIMNRDIPW----------------------P-----NIPEEMSVEACDLIDKLLTENPVQ 1032 (1170)
Q Consensus 980 ELLTG~pPF~g~~~~ei~qkIl~~~l~f----------------------P-----~ip~~lS~eakDLIkkLLq~DPsk 1032 (1170)
+|++|..||.+.+..+.+..+....... + .....++.++.+||.+||+.||.+
T Consensus 217 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 296 (320)
T 2i6l_A 217 EMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296 (320)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccc
Confidence 9999999999988877777665432110 1 112358999999999999999999
Q ss_pred CCChhhHHHHHcCCCCCCCChhh
Q 001057 1033 RLGATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 1033 RpSa~~AeEILqHPfF~~idwe~ 1055 (1170)
||+ +.++++||||+..+|..
T Consensus 297 Rpt---~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 297 RLT---AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp SCC---HHHHHTSHHHHTTCC--
T ss_pred cCC---HHHHhCCcccccccCcc
Confidence 999 88999999999887654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=403.61 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=218.0
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce---
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL--- 833 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L--- 833 (1170)
.++|.+.+.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+++.++||||++++++|......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 368999999999999999999999999999999987643 3445567888999999999999999999999887665
Q ss_pred ---EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 834 ---YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 834 ---yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
|+||||+. ++|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~- 195 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 195 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc-
Confidence 99999996 688887743 59999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.
T Consensus 196 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 243 (371)
T 4exu_A 196 --------------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 243 (371)
T ss_dssp ------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred --------------------------------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 11234578999999999987 678999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCC----------------------------CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 990 AKTPQQIFDNIMNRDI----------------------------PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l----------------------------~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+.+..+.+..+..... .+......+++++.+||.+||+.||.+||+ +.|
T Consensus 244 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e 320 (371)
T 4exu_A 244 GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQ 320 (371)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC---HHH
T ss_pred CCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC---HHH
Confidence 9888777766643110 000112357899999999999999999999 889
Q ss_pred HHcCCCCCCCChh
Q 001057 1042 VKQHPFFKNINWD 1054 (1170)
Q Consensus 1042 ILqHPfF~~idwe 1054 (1170)
+|+||||+.+...
T Consensus 321 ll~hp~f~~~~~~ 333 (371)
T 4exu_A 321 ALTHPFFEPFRDP 333 (371)
T ss_dssp HHTSGGGTTTCCG
T ss_pred HhcCcccccCCCc
Confidence 9999999976543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=420.35 Aligned_cols=250 Identities=15% Similarity=0.182 Sum_probs=206.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHH---HHHHhcCCCcEEEEE-------ee
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAER---NILISVRNPFVVRFF-------YS 826 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~Ei---eILskL~HPNIVrL~-------~~ 826 (1170)
.++|++.+.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+ .+|..++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999999999999999999876555556778899999 455566899999998 55
Q ss_pred eeccc-----------------ceEEEEeeccCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCeeec
Q 001057 827 FTCRE-----------------NLYLVMEYLNGGDLYSLLRNLGCLDE-------DMARVYIAELVLALEYLHSLNVIHR 882 (1170)
Q Consensus 827 Fqd~~-----------------~LyLVMEY~~GGSL~dlLk~~~~LSE-------e~ar~IaaQIL~ALeYLHs~GIIHR 882 (1170)
+.+.+ ..||||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 55443 389999999 6899999987665665 7777899999999999999999999
Q ss_pred cCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc
Q 001057 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG 962 (1170)
Q Consensus 883 DIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g 962 (1170)
||||+||||+.+|.+||+|||+|+.. .......+| +.|+|||++.+
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~---------------------------------~~~~~~~~g-~~y~aPE~~~~ 276 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRD---------------------------------GARVVSSVS-RGFEPPELEAR 276 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET---------------------------------TCEEECCCC-TTCCCHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheec---------------------------------CCcccCCCC-cCccChhhhcc
Confidence 99999999999999999999999741 012234578 99999999998
Q ss_pred C-----------CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCC
Q 001057 963 M-----------GHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPV 1031 (1170)
Q Consensus 963 ~-----------~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPs 1031 (1170)
. .|+.++|||||||++|||++|..||.+.+.......+... ...++.++.+||.+||+.||.
T Consensus 277 ~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 277 RATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS-------CKNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp HTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGSS-------CCCCCHHHHHHHHHHTCSSGG
T ss_pred cccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhhh-------ccCCCHHHHHHHHHHcCCCch
Confidence 7 7999999999999999999999999876654444333321 246889999999999999999
Q ss_pred CCCChhhHHHHHcCCCCCCC
Q 001057 1032 QRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1032 kRpSa~~AeEILqHPfF~~i 1051 (1170)
+||+ +.++++||||+++
T Consensus 350 ~Rpt---~~e~l~hp~f~~~ 366 (377)
T 3byv_A 350 DRLL---PLQAMETPEYEQL 366 (377)
T ss_dssp GCCC---HHHHHTSHHHHHH
T ss_pred hCCC---HHHHhhChHHHHH
Confidence 9999 8899999999865
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=412.22 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=217.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc------CCCcEEEEEeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV------RNPFVVRFFYSF 827 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL------~HPNIVrL~~~F 827 (1170)
.....+|++++.||+|+||+||+|++..+++.||||++... ......+.+|+.++..+ +|+||++++++|
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 44567899999999999999999999999999999998754 23445677888888877 577999999999
Q ss_pred ecccceEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc--EEEEecC
Q 001057 828 TCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH--IKLTDFG 903 (1170)
Q Consensus 828 qd~~~LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~--VKLsDFG 903 (1170)
....++||||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999995 69999998653 4999999999999999999999999999999999999999987 9999999
Q ss_pred CccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh
Q 001057 904 LSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI 983 (1170)
Q Consensus 904 LAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT 983 (1170)
+|.... ....+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 248 ~a~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 294 (429)
T 3kvw_A 248 SSCYEH---------------------------------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294 (429)
T ss_dssp TCEETT---------------------------------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHH
T ss_pred cceecC---------------------------------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHh
Confidence 987420 11234689999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhccCC--------------------CCCC----------------------------------
Q 001057 984 GIPPFNAKTPQQIFDNIMNRDI--------------------PWPN---------------------------------- 1009 (1170)
Q Consensus 984 G~pPF~g~~~~ei~qkIl~~~l--------------------~fP~---------------------------------- 1009 (1170)
|.+||.+.+..+.+..+..... .+|.
T Consensus 295 G~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (429)
T 3kvw_A 295 GYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG 374 (429)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhH
Confidence 9999999988777666543100 0000
Q ss_pred --CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1010 --IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1010 --ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
++...++++.+||.+||++||.+||| +.|+|+||||+..
T Consensus 375 ~~l~~~~~~~~~dli~~~L~~dP~~Rpt---a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 375 NALKGCDDPLFLDFLKQCLEWDPAVRMT---PGQALRHPWLRRR 415 (429)
T ss_dssp HHTTTCCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSTTTC--
T ss_pred hhccccchHHHHHHHHHHCCCChhhCCC---HHHHhCChhhccC
Confidence 11234788999999999999999999 8899999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=391.38 Aligned_cols=256 Identities=31% Similarity=0.489 Sum_probs=213.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..++|++.+.||+|+||+||+|++ +|..||||++..... .....+.+.+|+.+|.+++||||++++++|.+...+
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 45667999999999999999999986 588999999876543 445567889999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGC---LDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~---LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
|+||||+.+|+|.+++...+. +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|+..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999999987653 999999999999999999999999 999999999999999999999999998742
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
. .........+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 190 ~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf 239 (309)
T 3p86_A 190 A------------------------------STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239 (309)
T ss_dssp ------------------------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTT
T ss_pred c------------------------------ccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 1 0011223467999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.+.+..+....+...... +.++..+++++.+||.+||+.||.+||++.++.+.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L 293 (309)
T 3p86_A 240 GNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293 (309)
T ss_dssp TTSCHHHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 999988887776533322 234578999999999999999999999955554444
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=389.27 Aligned_cols=262 Identities=32% Similarity=0.490 Sum_probs=218.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeec-CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeee----
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKR-ATGDLFAIKVLKKADMIRKNAVESILAERNILISV---RNPFVVRFFYSFT---- 828 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk-~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL---~HPNIVrL~~~Fq---- 828 (1170)
.++|++++.||+|+||+||+|++. .+|+.||+|++...... ......+.+|+.++..+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 468999999999999999999995 67899999998754321 11123455677777665 8999999999987
Q ss_pred -cccceEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 829 -CRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 829 -d~~~LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
....+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5678999999997 69999998753 4999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
+... .........||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 168 ~~~~-------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (326)
T 1blx_A 168 RIYS-------------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216 (326)
T ss_dssp CCCC-------------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccc-------------------------------CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCC
Confidence 7421 011223467999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhccC-----CCC-------------------CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 986 PPFNAKTPQQIFDNIMNRD-----IPW-------------------PNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 986 pPF~g~~~~ei~qkIl~~~-----l~f-------------------P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+||.+.+....+..+.... ..| ..+...++..+++||.+||+.||.+||+ +.+
T Consensus 217 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e 293 (326)
T 1blx_A 217 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYS 293 (326)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHH
T ss_pred CCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC---HHH
Confidence 9999998887777765310 001 1123468899999999999999999999 889
Q ss_pred HHcCCCCCCCChh
Q 001057 1042 VKQHPFFKNINWD 1054 (1170)
Q Consensus 1042 ILqHPfF~~idwe 1054 (1170)
+++||||+++.+.
T Consensus 294 ~l~hp~~~~~~~~ 306 (326)
T 1blx_A 294 ALSHPYFQDLERC 306 (326)
T ss_dssp HHTSGGGTTCCCC
T ss_pred HhcCccccccchh
Confidence 9999999988654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=390.07 Aligned_cols=263 Identities=29% Similarity=0.481 Sum_probs=219.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec----
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTC---- 829 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd---- 829 (1170)
...++|++++.||+|+||.||+|++..+|+.||||++..... ....+.+|+.++..+ +||||++++++|..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 456789999999999999999999999999999999875432 235678899999998 79999999999977
Q ss_pred --ccceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 830 --RENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 830 --~~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
...+|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 46799999999999999999864 57999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-----cCCCCcchhhhHHHHHHHH
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFE 980 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~ksDIWSLGVILYE 980 (1170)
.... .........+||+.|+|||++. +..++.++|||||||++|+
T Consensus 177 ~~~~------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 226 (326)
T 2x7f_A 177 AQLD------------------------------RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226 (326)
T ss_dssp C-------------------------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred eecC------------------------------cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence 7421 0011123457999999999997 4568899999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhh
Q 001057 981 LLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 981 LLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~ 1055 (1170)
|++|..||.+.+.......+.....+.. .+..++..+.+||.+||..||.+||+ +.++++||||++..+..
T Consensus 227 l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~~~~~ 297 (326)
T 2x7f_A 227 MAEGAPPLCDMHPMRALFLIPRNPAPRL-KSKKWSKKFQSFIESCLVKNHSQRPA---TEQLMKHPFIRDQPNER 297 (326)
T ss_dssp HHHSSCTTTTSCHHHHHHHHHHSCCCCC-SCSCSCHHHHHHHHHHCCSSGGGSCC---HHHHHTSHHHHCCTTHH
T ss_pred HHhCCCCCCCCcHHHHHHHhhcCccccC-CccccCHHHHHHHHHHhccChhhCCC---HHHHhhChHHhhCcccc
Confidence 9999999999888777666655443221 23578999999999999999999999 88999999999876654
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=409.37 Aligned_cols=259 Identities=30% Similarity=0.477 Sum_probs=211.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc--
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE-- 831 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~-- 831 (1170)
.....+|++++.||+|+||+||+|++..+++ ||+|++.+.... ..+|+.+|+.++||||++++++|....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 3445689999999999999999999987776 788877553321 236999999999999999999985543
Q ss_pred ----ceEEEEeeccCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC-CCCcEEEEec
Q 001057 832 ----NLYLVMEYLNGGDLYSLLR----NLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG-QDGHIKLTDF 902 (1170)
Q Consensus 832 ----~LyLVMEY~~GGSL~dlLk----~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd-~dG~VKLsDF 902 (1170)
.+|+||||+++ +|...+. ....+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+||
T Consensus 108 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DF 186 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186 (394)
T ss_dssp SSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred CCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeC
Confidence 38999999976 4444433 246799999999999999999999999999999999999999 7999999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFEL 981 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYEL 981 (1170)
|+|+... ........+||+.|+|||++.+. .|+.++|||||||++|||
T Consensus 187 G~a~~~~-------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 235 (394)
T 4e7w_A 187 GSAKILI-------------------------------AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAEL 235 (394)
T ss_dssp TTCEECC-------------------------------TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred CCccccc-------------------------------CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHH
Confidence 9998531 01112346789999999999875 589999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhcc-----------------CCCCCC---------CCccCCHHHHHHHHHhccCCCCCCCC
Q 001057 982 LIGIPPFNAKTPQQIFDNIMNR-----------------DIPWPN---------IPEEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei~qkIl~~-----------------~l~fP~---------ip~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
++|.+||.+.+..+.+..|... ...++. ++..+++++.+||.+||+.||.+||+
T Consensus 236 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 236 MQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence 9999999999887776665431 111221 12358899999999999999999999
Q ss_pred hhhHHHHHcCCCCCCCChhh
Q 001057 1036 ATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 1036 a~~AeEILqHPfF~~idwe~ 1055 (1170)
+.|+++||||+++.|..
T Consensus 316 ---~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 316 ---AIEALCHPFFDELRTGE 332 (394)
T ss_dssp ---HHHHHTSGGGSTTTSSC
T ss_pred ---HHHHhcChhhhhhcccc
Confidence 88999999999987654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=400.20 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=203.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc--
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN-- 832 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~-- 832 (1170)
..+++|++.+.||+|+||+||+|++..+|+.||||++....... ....+++..+..++||||++++++|.....
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 45678999999999999999999999999999999986643222 345677788888999999999999866443
Q ss_pred -----eEEEEeeccCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCCCcEEeCC-CCcEEEE
Q 001057 833 -----LYLVMEYLNGGDLYSLLR----NLGCLDEDMARVYIAELVLALEYLH--SLNVIHRDLKPDNLLIGQ-DGHIKLT 900 (1170)
Q Consensus 833 -----LyLVMEY~~GGSL~dlLk----~~~~LSEe~ar~IaaQIL~ALeYLH--s~GIIHRDIKPENILLd~-dG~VKLs 900 (1170)
+|+||||+.+ +|...+. ....+++..++.++.||+.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8999999976 5554443 4567999999999999999999999 999999999999999996 8999999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CCcchhhhHHHHHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILF 979 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLGVILY 979 (1170)
|||+|+... ........+||+.|+|||++.+.. ++.++|||||||++|
T Consensus 175 Dfg~a~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ 223 (360)
T 3e3p_A 175 DFGSAKKLS-------------------------------PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFA 223 (360)
T ss_dssp CCTTCBCCC-------------------------------TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred eCCCceecC-------------------------------CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHH
Confidence 999997521 011123457899999999997655 899999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhccCC-------------------------C----CCCCCccCCHHHHHHHHHhccCCC
Q 001057 980 ELLIGIPPFNAKTPQQIFDNIMNRDI-------------------------P----WPNIPEEMSVEACDLIDKLLTENP 1030 (1170)
Q Consensus 980 ELLTG~pPF~g~~~~ei~qkIl~~~l-------------------------~----fP~ip~~lS~eakDLIkkLLq~DP 1030 (1170)
+|++|.+||.+.+....+..+..... + ++......+.++.+||.+||+.||
T Consensus 224 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 303 (360)
T 3e3p_A 224 EMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP 303 (360)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSG
T ss_pred HHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCc
Confidence 99999999999988877776653110 0 112223467899999999999999
Q ss_pred CCCCChhhHHHHHcCCCCCCCC
Q 001057 1031 VQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1031 skRpSa~~AeEILqHPfF~~id 1052 (1170)
.+||+ +.|+|+||||+++.
T Consensus 304 ~~Rpt---~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 304 EERMK---PYEALCHPYFDELH 322 (360)
T ss_dssp GGSCC---HHHHTTSGGGGGGG
T ss_pred cccCC---HHHHhcCccccccC
Confidence 99999 88999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=385.89 Aligned_cols=256 Identities=31% Similarity=0.561 Sum_probs=225.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.+.|++++.||+|+||.||+|++..+++.||||++..... ....+.+.+|+.++..++||||+++++++.+...+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3569999999999999999999999999999999876542 23457789999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~------- 170 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT------- 170 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECB-------
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecC-------
Confidence 999999999999875 579999999999999999999999999999999999999999999999999987521
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQI 996 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei 996 (1170)
..........||+.|+|||++.+..++.++|||||||++|+|++|.+||........
T Consensus 171 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 227 (303)
T 3a7i_A 171 -----------------------DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227 (303)
T ss_dssp -----------------------TTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred -----------------------ccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH
Confidence 001122346799999999999998999999999999999999999999999888877
Q ss_pred HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 997 FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 997 ~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
...+..... +.++..++..+.+||.+||+.||.+||+ +.++++||||..
T Consensus 228 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~ 276 (303)
T 3a7i_A 228 LFLIPKNNP--PTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFILR 276 (303)
T ss_dssp HHHHHHSCC--CCCCSSCCHHHHHHHHHHCCSSGGGSCC---HHHHTTCHHHHH
T ss_pred HHHhhcCCC--CCCccccCHHHHHHHHHHcCCChhhCcC---HHHHhhChhhhc
Confidence 777665443 2345688999999999999999999999 889999999964
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=388.88 Aligned_cols=263 Identities=31% Similarity=0.539 Sum_probs=228.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++++.||+|+||.||+|++..+++.||||++.+.... ......+.+|+.++..++||||+++++++.+...+|+
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 346899999999999999999999999999999999765432 2345678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC---CcEEEEecCCcccccccc
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD---GHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d---G~VKLsDFGLAk~~~~~~ 912 (1170)
||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~--- 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ--- 175 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC---
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec---
Confidence 99999999999999888889999999999999999999999999999999999999764 479999999987421
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+
T Consensus 176 ----------------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 176 ----------------------------QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp ----------------------------CCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ----------------------------CCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 0011123468999999999876 48999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 993 PQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
..++...+..+...++. ....++.++.+||.+||+.||.+||+ +.++++||||++..|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 227 EYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHHHCCC
T ss_pred HHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC---HHHHhcCHHHhccccC
Confidence 98888888877665431 11468999999999999999999999 8899999999876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=395.29 Aligned_cols=257 Identities=29% Similarity=0.448 Sum_probs=217.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc----
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN---- 832 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~---- 832 (1170)
.++|.+.+.||+|+||.||+|+++.+|+.||||++.... ........+.+|+.+|..++||||++++++|.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 367999999999999999999999999999999987643 344556788999999999999999999999987654
Q ss_pred --eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 833 --LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 833 --LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
+|+||||+. |+|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~- 177 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD- 177 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC-
Confidence 499999996 688887753 59999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 178 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 225 (353)
T 3coi_A 178 --------------------------------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225 (353)
T ss_dssp --------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSB
T ss_pred --------------------------------CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 01124578999999999987 678999999999999999999999999
Q ss_pred CCCHHHHHHHHhcc----------------------------CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 990 AKTPQQIFDNIMNR----------------------------DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 990 g~~~~ei~qkIl~~----------------------------~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+.+..+.+..+... ...++.....++.++.+||.+||+.||.+||+ +.+
T Consensus 226 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt---~~e 302 (353)
T 3coi_A 226 GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT---AAQ 302 (353)
T ss_dssp SSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC---HHH
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC---HHH
Confidence 98877766655431 11223334578999999999999999999999 889
Q ss_pred HHcCCCCCCCCh
Q 001057 1042 VKQHPFFKNINW 1053 (1170)
Q Consensus 1042 ILqHPfF~~idw 1053 (1170)
+++||||+.+..
T Consensus 303 ~l~hp~f~~~~~ 314 (353)
T 3coi_A 303 ALTHPFFEPFRD 314 (353)
T ss_dssp HHTSGGGTTTCC
T ss_pred HhcCcchhhccC
Confidence 999999987653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=391.68 Aligned_cols=256 Identities=26% Similarity=0.429 Sum_probs=213.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc--c
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE--N 832 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~--~ 832 (1170)
...++|++.+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+|..++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 3456899999999999999999999999999999999765432 23466789999999999999999999988765 7
Q ss_pred eEEEEeeccCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe----CCCCcEEEEecCCc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGC---LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLS 905 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~---LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL----d~dG~VKLsDFGLA 905 (1170)
+||||||++||+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999986533 9999999999999999999999999999999999999 77888999999999
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh--------cCCCCcchhhhHHHHH
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL--------GMGHGATADWWSVGII 977 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~--------g~~ys~ksDIWSLGVI 977 (1170)
+... ........+||+.|+|||++. +..++.++|||||||+
T Consensus 164 ~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 212 (319)
T 4euu_A 164 RELE-------------------------------DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (319)
T ss_dssp EECC-------------------------------TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHH
T ss_pred eecC-------------------------------CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHH
Confidence 7521 011123457999999999997 4678999999999999
Q ss_pred HHHHHhCCCCCCCCC----HHHHHHHHhccCCC-------------------CC---CCCccCCHHHHHHHHHhccCCCC
Q 001057 978 LFELLIGIPPFNAKT----PQQIFDNIMNRDIP-------------------WP---NIPEEMSVEACDLIDKLLTENPV 1031 (1170)
Q Consensus 978 LYELLTG~pPF~g~~----~~ei~qkIl~~~l~-------------------fP---~ip~~lS~eakDLIkkLLq~DPs 1031 (1170)
+|||++|..||.... ..+++..+..+... ++ .+...++..+.+||.+||+.||.
T Consensus 213 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 292 (319)
T 4euu_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292 (319)
T ss_dssp HHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred HHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChh
Confidence 999999999997432 34455555543321 11 12245677899999999999999
Q ss_pred CCCChhhHHHHHcCC
Q 001057 1032 QRLGATGAREVKQHP 1046 (1170)
Q Consensus 1032 kRpSa~~AeEILqHP 1046 (1170)
+||+ +.|+++||
T Consensus 293 ~R~s---~~ell~h~ 304 (319)
T 4euu_A 293 KCWG---FDQFFAET 304 (319)
T ss_dssp TSCC---HHHHHHHH
T ss_pred hhcc---HHHhhhcc
Confidence 9999 88899986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=404.53 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=216.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC--CCcEEEEEeeeecccce
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR--NPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~--HPNIVrL~~~Fqd~~~L 833 (1170)
...+|++++.||+|+||+||+|.+.. ++.||||++..... .....+.+.+|+.+|..++ |||||++++++...+.+
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999865 99999999976543 4456678999999999997 59999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+.....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~-- 207 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD-- 207 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC--
Confidence 99999 55889999999888999999999999999999999999999999999999995 689999999999753100
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----------CCCCcchhhhHHHHHHHHHH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----------MGHGATADWWSVGIILFELL 982 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----------~~ys~ksDIWSLGVILYELL 982 (1170)
.........+||+.|+|||++.+ ..|+.++||||||||+|||+
T Consensus 208 --------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell 261 (390)
T 2zmd_A 208 --------------------------TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261 (390)
T ss_dssp --------------------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHH
T ss_pred --------------------------CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHH
Confidence 00112235689999999999976 36889999999999999999
Q ss_pred hCCCCCCCCC-HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 983 IGIPPFNAKT-PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 983 TG~pPF~g~~-~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+|.+||.+.. ....+..+......++ .+...+.++.+||.+||+.||.+||+ +.++++||||+..
T Consensus 262 ~G~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~~~~ 327 (390)
T 2zmd_A 262 YGKTPFQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQIQ 327 (390)
T ss_dssp HSSCTTTTCCCHHHHHHHHHCTTSCCC-CCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHSC
T ss_pred HCCCcchhhhHHHHHHHHHhCccccCC-CCccchHHHHHHHHHHcccChhhCCC---HHHHhhCcCcccc
Confidence 9999998754 3455556665443322 34567899999999999999999999 8899999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=410.46 Aligned_cols=260 Identities=20% Similarity=0.248 Sum_probs=199.4
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc--CCCcEEEEEeee-------e
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV--RNPFVVRFFYSF-------T 828 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL--~HPNIVrL~~~F-------q 828 (1170)
.+|++++.||+|+||+||+|++..+|+.||||++.+.........+.+.+|+.++..+ +||||++++..| .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999987655556677888886555444 699998866433 2
Q ss_pred cc-----------------cceEEEEeeccCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHhCCeeeccC
Q 001057 829 CR-----------------ENLYLVMEYLNGGDLYSLLRNLG-CLDEDMA------RVYIAELVLALEYLHSLNVIHRDL 884 (1170)
Q Consensus 829 d~-----------------~~LyLVMEY~~GGSL~dlLk~~~-~LSEe~a------r~IaaQIL~ALeYLHs~GIIHRDI 884 (1170)
.. .++||||||+. |+|.+++...+ .+++... ..++.||+.||.|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 22 34899999998 89999998643 3444444 466699999999999999999999
Q ss_pred CCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--
Q 001057 885 KPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-- 962 (1170)
Q Consensus 885 KPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-- 962 (1170)
||+||||+.+|.+||+|||+|+... .......||+.|+|||++.+
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~ 267 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVG---------------------------------TRGPASSVPVTYAPREFLNAST 267 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETT---------------------------------CEEEGGGSCGGGCCHHHHTCSE
T ss_pred CHHHEEECCCCCEEEEecceeeecC---------------------------------CCccCccCCcCCcChhhccCCC
Confidence 9999999999999999999998521 01113467799999999987
Q ss_pred CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC
Q 001057 963 MGHGATADWWSVGIILFELLIGIPPFNAKTPQQI--FDN-----IMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 963 ~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei--~qk-----Il~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
..|+.++|||||||+||||++|.+||.+...... +.. .......++. ...++..+.+||.+||+.||.+||+
T Consensus 268 ~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt 346 (371)
T 3q60_A 268 ATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGS-CTPLPDFVKTLIGRFLNFDRRRRLL 346 (371)
T ss_dssp EECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTT-SSCCCHHHHHHHHHHTCSSTTTCCC
T ss_pred CCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhh-ccCCCHHHHHHHHHHcCCChhhCCC
Confidence 6799999999999999999999999987643211 110 0111222222 2478999999999999999999999
Q ss_pred hhhHHHHHcCCCCCCCChhh
Q 001057 1036 ATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 1036 a~~AeEILqHPfF~~idwe~ 1055 (1170)
+.++++||||+++.|..
T Consensus 347 ---~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 347 ---PLEAMETPEFLQLQNEI 363 (371)
T ss_dssp ---HHHHTTSHHHHHHHHHH
T ss_pred ---HHHHhcCHHHHHHHHHH
Confidence 88999999999887764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=389.66 Aligned_cols=274 Identities=23% Similarity=0.333 Sum_probs=206.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe---~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
.+..++|++++.||+|+||+||+|++..++. .||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 3455789999999999999999999887775 899999876432 334567899999999999999999999999877
Q ss_pred cce------EEEEeeccCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEE
Q 001057 831 ENL------YLVMEYLNGGDLYSLLRNLG------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 831 ~~L------yLVMEY~~GGSL~dlLk~~~------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VK 898 (1170)
... |+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence 654 99999999999999996543 599999999999999999999999999999999999999999999
Q ss_pred EEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHH
Q 001057 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978 (1170)
Q Consensus 899 LsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVIL 978 (1170)
|+|||+|+..... ..........||+.|+|||++.+..++.++|||||||++
T Consensus 178 l~Dfg~a~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 229 (323)
T 3qup_A 178 VADFGLSRKIYSG----------------------------DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229 (323)
T ss_dssp ECCCCC---------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred Eeecccccccccc----------------------------ccccccccccCcccccCchhhcCCCCCCccchhhHHHHH
Confidence 9999999752100 000112234578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChh----hHHHHHcCCCCCCCCh
Q 001057 979 FELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT----GAREVKQHPFFKNINW 1053 (1170)
Q Consensus 979 YELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~----~AeEILqHPfF~~idw 1053 (1170)
|+|++ |.+||.+.+..+++..+...... ..+..++.++.+||.+||+.||.+||++. .+++++.|||+....+
T Consensus 230 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 230 WEIMTRGQTPYAGIENAEIYNYLIGGNRL--KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred HHHHhCCCCCccccChHHHHHHHhcCCCC--CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 99999 99999999988888888765532 23467899999999999999999999954 4688999999988766
Q ss_pred hhhhh
Q 001057 1054 DTLAR 1058 (1170)
Q Consensus 1054 e~L~~ 1058 (1170)
+.+..
T Consensus 308 ~pl~~ 312 (323)
T 3qup_A 308 DPLYI 312 (323)
T ss_dssp -----
T ss_pred CCCCC
Confidence 65543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=378.42 Aligned_cols=274 Identities=30% Similarity=0.508 Sum_probs=215.1
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--------
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC-------- 829 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd-------- 829 (1170)
++|++++.||+|+||.||+|++..+|+.||||++... ......+.+|+.++..++||||++++++|.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 5799999999999999999999999999999998653 3456788999999999999999999998754
Q ss_pred -----ccceEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecC
Q 001057 830 -----RENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFG 903 (1170)
Q Consensus 830 -----~~~LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFG 903 (1170)
...+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 467899999999999999998643 58889999999999999999999999999999999999999999999999
Q ss_pred CccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHH
Q 001057 904 LSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELL 982 (1170)
Q Consensus 904 LAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELL 982 (1170)
++........ . ... ...............+||+.|+|||++.+. .++.++|||||||++|+|+
T Consensus 162 ~~~~~~~~~~-~---~~~------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 225 (303)
T 1zy4_A 162 LAKNVHRSLD-I---LKL------------DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225 (303)
T ss_dssp CCSCTTC-----------------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHH
T ss_pred chhhcccccc-h---hcc------------ccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHH
Confidence 9975310000 0 000 000001112233456799999999999865 6899999999999999999
Q ss_pred hCCCCCCC-CCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhh
Q 001057 983 IGIPPFNA-KTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLA 1057 (1170)
Q Consensus 983 TG~pPF~g-~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~ 1057 (1170)
+ ||.. .+...+...+......+|. ++...+..+.+||.+||+.||.+||+ +.++++||||+...++...
T Consensus 226 ~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~~~~~~ 296 (303)
T 1zy4_A 226 Y---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG---ARTLLNSGWLPVKHQDEVI 296 (303)
T ss_dssp S---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC---HHHHHHSSCSCCCCHHHHH
T ss_pred h---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcC---HHHHhCCCCcCCCChHHHH
Confidence 8 5643 3445566666655554442 34567888999999999999999999 8899999999988776543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=397.03 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=218.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec-------CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEe
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR-------ATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFY 825 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk-------~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~ 825 (1170)
.+..++|++.+.||+|+||+||+|++. .++..||||++.... .....+.+.+|+.+|..+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 456688999999999999999999874 355689999987642 345667899999999999 8999999999
Q ss_pred eeecccceEEEEeeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcE
Q 001057 826 SFTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889 (1170)
Q Consensus 826 ~Fqd~~~LyLVMEY~~GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENI 889 (1170)
+|.+.+.+|+||||+.||+|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999998653 478999999999999999999999999999999999
Q ss_pred EeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcch
Q 001057 890 LIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA 969 (1170)
Q Consensus 890 LLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ks 969 (1170)
||+.+|.+||+|||+|+..... ..........||+.|+|||++.+..|+.++
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 286 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNI----------------------------DYYKKTTNGRLPVKWMAPEALFDRVYTHQS 286 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCC----------------------------CTTCTTTTTTSCGGGCCHHHHHTCCCCHHH
T ss_pred EECCCCCEEEccccCCcccCcc----------------------------cceecccCCCcccceECHhHhcCCCCCcHH
Confidence 9999999999999999853100 000112234678999999999999999999
Q ss_pred hhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 970 DWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 970 DIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
|||||||++|||++ |..||.+.+..+++..+..+.. +..+..++.++.+||.+||+.||.+||++.++.
T Consensus 287 DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 356 (370)
T 2psq_A 287 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356 (370)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 99999999999999 9999999998888887776543 234578999999999999999999999954443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=399.90 Aligned_cols=261 Identities=31% Similarity=0.465 Sum_probs=215.7
Q ss_pred CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CC-----cEEEEEe
Q 001057 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NP-----FVVRFFY 825 (1170)
Q Consensus 752 ~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HP-----NIVrL~~ 825 (1170)
......++|++++.||+|+||+||+|++..+++.||||++... ......+..|+.++..++ |+ +|+++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 4455678999999999999999999999999999999998753 234566778888888875 44 5999999
Q ss_pred eeecccceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCeeeccCCCCcEEeC--CCCcEEE
Q 001057 826 SFTCRENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLH--SLNVIHRDLKPDNLLIG--QDGHIKL 899 (1170)
Q Consensus 826 ~Fqd~~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLH--s~GIIHRDIKPENILLd--~dG~VKL 899 (1170)
+|...+.+||||||+. |+|.+++... +.+++..++.++.||+.||.||| +.||+||||||+||||+ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 9999999999999995 5999999865 46999999999999999999999 57999999999999995 4778999
Q ss_pred EecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHH
Q 001057 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979 (1170)
Q Consensus 900 sDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILY 979 (1170)
+|||+|+... ......+||+.|+|||++.+..++.++|||||||++|
T Consensus 203 ~DFG~a~~~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 249 (382)
T 2vx3_A 203 VDFGSSCQLG---------------------------------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILV 249 (382)
T ss_dssp CCCTTCEETT---------------------------------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred EeccCceecc---------------------------------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHH
Confidence 9999997521 0123467999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHhccCCCCC---------------CCCc--------------------------------
Q 001057 980 ELLIGIPPFNAKTPQQIFDNIMNRDIPWP---------------NIPE-------------------------------- 1012 (1170)
Q Consensus 980 ELLTG~pPF~g~~~~ei~qkIl~~~l~fP---------------~ip~-------------------------------- 1012 (1170)
||++|.+||.+.+..+++..+.......+ .++.
T Consensus 250 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 329 (382)
T 2vx3_A 250 EMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 329 (382)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhcccc
Confidence 99999999999988887777654211000 0000
Q ss_pred --------------cCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 1013 --------------EMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 1013 --------------~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
..+.++++||.+||+.||.+||| +.|+|+||||++..+
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt---a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 330 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ---PYYALQHSFFKKTAD 381 (382)
T ss_dssp SGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC---HHHHTTSGGGCC---
T ss_pred CCCccccccccccchhhHHHHHHHHHhcCCChhhCCC---HHHHhcCcccccCCC
Confidence 00147899999999999999999 889999999987644
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=388.51 Aligned_cols=260 Identities=23% Similarity=0.302 Sum_probs=220.2
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe---~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
..+..++|++.+.||+|+||+||+|++..+++ .||||++.... .....+.+.+|+.+|..++||||++++++|.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34567889999999999999999999986655 59999987542 34556788999999999999999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
.+.+||||||+.||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999765 57999999999999999999999999999999999999999999999999999853
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPP 987 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pP 987 (1170)
.... ..........||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 202 ~~~~---------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p 254 (325)
T 3kul_A 202 EDDP---------------------------DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254 (325)
T ss_dssp C-------------------------------CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccCc---------------------------cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 1000 00111223456889999999999899999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
|.+.+..++...+..+... ..+..++.++.+||.+||..||.+||++.++.+.|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L 308 (325)
T 3kul_A 255 YWNMTNRDVISSVEEGYRL--PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308 (325)
T ss_dssp TTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cccCCHHHHHHHHHcCCCC--CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999999888888765322 23468999999999999999999999965554444
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=392.62 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=213.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEee-----ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFT 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLAr-----dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fq 828 (1170)
+..++|++.+.||+|+||.||+|+ +..+++.||||++.... .....+.+.+|+.+|..+ +|||||++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 456789999999999999999998 56677999999997643 344567889999999999 7899999999988
Q ss_pred cccc-eEEEEeeccCCChHHHHHhcCC-----------------------------------------------------
Q 001057 829 CREN-LYLVMEYLNGGDLYSLLRNLGC----------------------------------------------------- 854 (1170)
Q Consensus 829 d~~~-LyLVMEY~~GGSL~dlLk~~~~----------------------------------------------------- 854 (1170)
+.+. +|+||||+.||+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 7654 9999999999999999986533
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCC
Q 001057 855 -------------LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921 (1170)
Q Consensus 855 -------------LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl 921 (1170)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~---------- 246 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD---------- 246 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC----------
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc----------
Confidence 899999999999999999999999999999999999999999999999999752100
Q ss_pred CCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 001057 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNI 1000 (1170)
Q Consensus 922 ~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkI 1000 (1170)
..........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+.+...
T Consensus 247 ------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 308 (359)
T 3vhe_A 247 ------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308 (359)
T ss_dssp ------------------TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHH
T ss_pred ------------------ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHH
Confidence 00112234578999999999999999999999999999999998 99999987754444333
Q ss_pred hccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 1001 MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 1001 l~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
...... +..+..+++++.+||.+||+.||.+||+ +.++++|
T Consensus 309 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 349 (359)
T 3vhe_A 309 LKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 349 (359)
T ss_dssp HHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHcCCC-CCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHHHH
Confidence 333222 2345678999999999999999999999 5565554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=394.91 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=210.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccc--------ccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM--------IRKNAVESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i--------~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
.++|++++.||+|+||.||+|.+.. |+.||||++..... ......+.+.+|+.+|..++||||++++++|.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4679999999999999999999864 99999999865321 22344578999999999999999999999984
Q ss_pred c-----ccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEec
Q 001057 829 C-----RENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDF 902 (1170)
Q Consensus 829 d-----~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDF 902 (1170)
. ...+|+||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3 346899999997 6888888754 46999999999999999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYEL 981 (1170)
|+|+... ........+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 179 g~~~~~~-------------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 227 (362)
T 3pg1_A 179 NLAREDT-------------------------------ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227 (362)
T ss_dssp TC----------------------------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHH
T ss_pred Ccccccc-------------------------------cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHH
Confidence 9997421 0111234578999999999987 6789999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHhccC------------------------CCCC-----CCCccCCHHHHHHHHHhccCCCCC
Q 001057 982 LIGIPPFNAKTPQQIFDNIMNRD------------------------IPWP-----NIPEEMSVEACDLIDKLLTENPVQ 1032 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei~qkIl~~~------------------------l~fP-----~ip~~lS~eakDLIkkLLq~DPsk 1032 (1170)
++|.+||.+.+..+.+..+.... ...+ ......++.+.+||.+||+.||.+
T Consensus 228 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 307 (362)
T 3pg1_A 228 FNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQR 307 (362)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGG
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhh
Confidence 99999999988877776664310 0011 112356889999999999999999
Q ss_pred CCChhhHHHHHcCCCCCCC
Q 001057 1033 RLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1033 RpSa~~AeEILqHPfF~~i 1051 (1170)
||+ +.++++||||+.+
T Consensus 308 Rpt---~~ell~hp~f~~~ 323 (362)
T 3pg1_A 308 RIS---TEQALRHPYFESL 323 (362)
T ss_dssp SCC---HHHHHTSGGGTTT
T ss_pred CCC---HHHHHcCchhhhc
Confidence 999 8899999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=385.94 Aligned_cols=259 Identities=24% Similarity=0.411 Sum_probs=221.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
.+..++|++++.||+|+||.||+|++. .+++.||||++.... .....+.+.+|+.+|..++||||++++++|.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 345678999999999999999999987 456899999987643 3455678899999999999999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNL------------------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDL 884 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~------------------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDI 884 (1170)
+.+.+|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 999999999999999999999764 56999999999999999999999999999999
Q ss_pred CCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC
Q 001057 885 KPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG 964 (1170)
Q Consensus 885 KPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ 964 (1170)
||+|||++.++.+||+|||+++..... ..........||+.|+|||++.+..
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~ 252 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSA----------------------------DYYKADGNDAIPIRWMPPESIFYNR 252 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGG----------------------------GCBC----CCBCGGGCCHHHHHHCC
T ss_pred CcceEEECCCCeEEEeecCCCcccccC----------------------------ccccccCCCcccceecChhhhccCC
Confidence 999999999999999999999753100 0001123456899999999999999
Q ss_pred CCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 965 HGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 965 ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
++.++|||||||++|+|++ |..||.+.+..++...+..+... ..+..++.++.+||.+||+.||.+||++.++.+.|
T Consensus 253 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 253 YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 9999999999999999999 99999999999888888776543 34578999999999999999999999965554444
Q ss_pred c
Q 001057 1044 Q 1044 (1170)
Q Consensus 1044 q 1044 (1170)
+
T Consensus 331 ~ 331 (343)
T 1luf_A 331 Q 331 (343)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=388.06 Aligned_cols=263 Identities=21% Similarity=0.385 Sum_probs=211.1
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++.+.||+|+||+||+|++..+++.||+|++... .....+.+.+|+.+|..++||||+++++++.+...+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4567899999999999999999999999999999988653 3456678999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+||||+.||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987 46799999999999999999999999999999999999999999999999999986321110
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
..... ..............+||+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 164 ~~~~~----------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~ 227 (310)
T 3s95_A 164 QPEGL----------------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLP 227 (310)
T ss_dssp --------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSC
T ss_pred ccccc----------------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhh
Confidence 00000 00000112233467899999999999999999999999999999999999999975432
Q ss_pred HH-----HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 994 QQ-----IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 994 ~e-----i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
.. ........ ..+..+++.+.+||.+||+.||.+||++.++.+
T Consensus 228 ~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 228 RTMDFGLNVRGFLDR-----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp BCTTSSBCHHHHHHH-----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHHhhhhhccccc-----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 01111111 123578889999999999999999999544433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=394.45 Aligned_cols=265 Identities=23% Similarity=0.409 Sum_probs=212.1
Q ss_pred CCCCCC-CCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC--------
Q 001057 746 PINPCS-KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-------- 816 (1170)
Q Consensus 746 p~~p~~-~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-------- 816 (1170)
.+.|.. ......++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.++..+.
T Consensus 6 ~~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~ 81 (373)
T 1q8y_A 6 GYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKED 81 (373)
T ss_dssp -CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred CceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchh
Confidence 344443 23455679999999999999999999999999999999987532 34466788999998876
Q ss_pred ---CCcEEEEEeeeeccc----ceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCC
Q 001057 817 ---NPFVVRFFYSFTCRE----NLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSL-NVIHRDLKP 886 (1170)
Q Consensus 817 ---HPNIVrL~~~Fqd~~----~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~-GIIHRDIKP 886 (1170)
||||++++++|.... .+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||
T Consensus 82 ~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp 160 (373)
T 1q8y_A 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160 (373)
T ss_dssp HHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG
T ss_pred ccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCCh
Confidence 899999999988654 799999999 89999999864 4599999999999999999999998 999999999
Q ss_pred CcEEeC------CCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHH
Q 001057 887 DNLLIG------QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL 960 (1170)
Q Consensus 887 ENILLd------~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL 960 (1170)
+||||+ ..+.+||+|||+|+... ......+||+.|+|||++
T Consensus 161 ~NIll~~~~~~~~~~~~kl~Dfg~a~~~~---------------------------------~~~~~~~~t~~y~aPE~~ 207 (373)
T 1q8y_A 161 ENVLMEIVDSPENLIQIKIADLGNACWYD---------------------------------EHYTNSIQTREYRSPEVL 207 (373)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETT---------------------------------BCCCSCCSCGGGCCHHHH
T ss_pred HHeEEeccCCCcCcceEEEcccccccccC---------------------------------CCCCCCCCCccccCcHHH
Confidence 999994 34489999999997521 011234789999999999
Q ss_pred hcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhccCCCC---------------------------
Q 001057 961 LGMGHGATADWWSVGIILFELLIGIPPFNAKT------PQQIFDNIMNRDIPW--------------------------- 1007 (1170)
Q Consensus 961 ~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~------~~ei~qkIl~~~l~f--------------------------- 1007 (1170)
.+..++.++|||||||++|||++|.+||.+.+ ....+..+.......
T Consensus 208 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (373)
T 1q8y_A 208 LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 287 (373)
T ss_dssp HTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCC
T ss_pred hCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccc
Confidence 99999999999999999999999999998654 222222222100000
Q ss_pred ------------CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 1008 ------------PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 1008 ------------P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..++..++.++.+||.+||+.||.+||+ +.|+++||||++.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 340 (373)
T 1q8y_A 288 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDT 340 (373)
T ss_dssp CBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTC
T ss_pred cccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC---HHHHhhChhhhcc
Confidence 0122456788999999999999999999 8899999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=373.21 Aligned_cols=252 Identities=22% Similarity=0.397 Sum_probs=217.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++++.||+|+||+||+|++. +++.||+|++...... .+.+.+|+.++.+++||||+++++++.+...+|
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 44578999999999999999999986 5778999999865432 246889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--- 158 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--- 158 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC---
T ss_pred EEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc---
Confidence 999999999999999764 4699999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 159 --------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~ 212 (269)
T 4hcu_A 159 --------------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 212 (269)
T ss_dssp --------------------------HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred --------------------------cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC
Confidence 11112234567889999999999999999999999999999999 999999999
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
..++...+...... ..+..++..+.+||.+||+.||.+||+ +.++++|
T Consensus 213 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~ 260 (269)
T 4hcu_A 213 NSEVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPA---FSRLLRQ 260 (269)
T ss_dssp HHHHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHhcCccC--CCCCcCCHHHHHHHHHHccCCcccCcC---HHHHHHH
Confidence 99988888765433 234678999999999999999999999 5555554
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=379.58 Aligned_cols=260 Identities=28% Similarity=0.420 Sum_probs=212.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|.....||+|+||.||+|++..+++.||||++.... ....+.+.+|+.++..++||||++++++|...+.+|
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 33445555668999999999999999999999999987643 344567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-CCcEEEEecCCcccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLG---CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~---~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-dG~VKLsDFGLAk~~~~ 910 (1170)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~- 174 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA- 174 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC-
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC-
Confidence 9999999999999998652 4678999999999999999999999999999999999987 8999999999987521
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC--CCcchhhhHHHHHHHHHHhCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG--HGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~--ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
..........||+.|+|||++.+.. ++.++|||||||++|+|++|..||
T Consensus 175 -----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 225 (295)
T 2clq_A 175 -----------------------------GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225 (295)
T ss_dssp -----------------------------C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTT
T ss_pred -----------------------------CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 0001123457999999999998643 889999999999999999999999
Q ss_pred CCCCHH-HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 989 NAKTPQ-QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 989 ~g~~~~-ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
...... .......... ..+.++..++.++.+||.+||+.||.+||+ +.++++||||+..
T Consensus 226 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~ 285 (295)
T 2clq_A 226 YELGEPQAAMFKVGMFK-VHPEIPESMSAEAKAFILKCFEPDPDKRAC---ANDLLVDEFLKVS 285 (295)
T ss_dssp GGGSSHHHHHHHHHHHC-CCCCCCTTSCHHHHHHHHHTTCSSTTTSCC---HHHHHTSGGGCC-
T ss_pred cCCCchhHHHHhhcccc-ccccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhhc
Confidence 764332 2222211111 123345789999999999999999999999 8899999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=380.32 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=218.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeee-----cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARK-----RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArd-----k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
.+..++|++.+.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+|..++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 45567899999999999999999987 3456899999987543 3456678899999999999999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNLGC------------------------LDEDMARVYIAELVLALEYLHSLNVIHRDL 884 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~~~------------------------LSEe~ar~IaaQIL~ALeYLHs~GIIHRDI 884 (1170)
+.+.+|+||||+.||+|.+++..... +++..++.++.||+.||.|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 99999999999999999999986543 899999999999999999999999999999
Q ss_pred CCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC
Q 001057 885 KPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG 964 (1170)
Q Consensus 885 KPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ 964 (1170)
||+|||++.++.+||+|||+++..... ..........||+.|+|||++.+..
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEE----------------------------DSYVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTT----------------------------SCEECSSCCCSCGGGCCHHHHHHCE
T ss_pred chheEEEcCCCCEEEcccccccccccc----------------------------ccceeccCCCCcccccChhhhcCCC
Confidence 999999999999999999999753100 0011123346788999999999988
Q ss_pred CCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 965 HGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 965 ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
++.++|||||||++|+|++ |..||.+.+...+...+..... +..+..++.++.+||.+||+.||.+||++.++
T Consensus 229 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 229 YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR--MERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc--CCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 9999999999999999999 9999999988888877766543 23456899999999999999999999994433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=371.20 Aligned_cols=252 Identities=22% Similarity=0.383 Sum_probs=216.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++++.||+|+||.||+|++. ++..||+|++...... .+.+.+|+.++..++||||+++++++.+...+|
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY 79 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence 45678999999999999999999876 5678999998765432 256889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~--- 156 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD--- 156 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT---
T ss_pred EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecch---
Confidence 9999999999999998754 599999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
..........||+.|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 157 --------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (268)
T 3sxs_A 157 --------------------------DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT 210 (268)
T ss_dssp --------------------------TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred --------------------------hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC
Confidence 00111234457888999999999899999999999999999999 999999999
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
..+....+........ +...++.+.+||.+||+.||.+||+ +.++++|
T Consensus 211 ~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 258 (268)
T 3sxs_A 211 NSEVVLKVSQGHRLYR--PHLASDTIYQIMYSCWHELPEKRPT---FQQLLSS 258 (268)
T ss_dssp HHHHHHHHHTTCCCCC--CTTSCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred hHHHHHHHHcCCCCCC--CCcChHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 8888888776654332 4678999999999999999999999 5555544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=398.83 Aligned_cols=261 Identities=20% Similarity=0.311 Sum_probs=221.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEee-----ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLAr-----dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
.+..++|++++.||+|+||+||+|+ +..+++.||||++.... .......+.+|+.+|..++|||||+++++|.
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 144 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 144 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 4556789999999999999999999 45578899999986532 3445567889999999999999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---cEE
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNLG-------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG---HIK 898 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~~-------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG---~VK 898 (1170)
+....||||||+.||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+.+| .+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999999998653 489999999999999999999999999999999999999655 599
Q ss_pred EEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHH
Q 001057 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978 (1170)
Q Consensus 899 LsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVIL 978 (1170)
|+|||+|+..... ..........||+.|+|||++.+..++.++|||||||++
T Consensus 225 L~DFG~a~~~~~~----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il 276 (367)
T 3l9p_A 225 IGDFGMARDIYRA----------------------------GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276 (367)
T ss_dssp ECCCHHHHHHHHH----------------------------SSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ECCCccccccccc----------------------------cccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHH
Confidence 9999999743100 001122345789999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 979 FELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 979 YELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
|||++ |.+||.+.+..+++..+..+... ..+..++..+.+||.+||+.||.+||+ +.++++|.++-
T Consensus 277 ~ellt~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps---~~eil~~l~~~ 343 (367)
T 3l9p_A 277 WEIFSLGYMPYPSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPN---FAIILERIEYC 343 (367)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCCHhHCcC---HHHHHHHHHHH
Confidence 99998 99999999999998888876543 234678999999999999999999999 77888886653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=382.06 Aligned_cols=269 Identities=21% Similarity=0.326 Sum_probs=225.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
.+..++|++.+.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+|..++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 455678999999999999999999876 467899999987543 3345567889999999999999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEE
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNL----------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~----------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VK 898 (1170)
+.+.+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 999999999999999999999753 3578999999999999999999999999999999999999999999
Q ss_pred EEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHH
Q 001057 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978 (1170)
Q Consensus 899 LsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVIL 978 (1170)
|+|||+++..... ..........||+.|+|||++.+..++.++|||||||++
T Consensus 179 l~Dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 230 (322)
T 1p4o_A 179 IGDFGMTRDIYET----------------------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 230 (322)
T ss_dssp ECCTTCCCGGGGG----------------------------GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ECcCccccccccc----------------------------cccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHH
Confidence 9999998753100 001122344678999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC---CCCCCCChh
Q 001057 979 FELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH---PFFKNINWD 1054 (1170)
Q Consensus 979 YELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH---PfF~~idwe 1054 (1170)
|+|++ |..||.+.+..++...+...... ..+..++..+.+||.+||+.||.+||++.++.+.|+. ++|+.++|.
T Consensus 231 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~ 308 (322)
T 1p4o_A 231 WEIATLAEQPYQGLSNEQVLRFVMEGGLL--DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308 (322)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred HHHHhcCCCccccCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccccc
Confidence 99999 89999999998888888776543 3456899999999999999999999995444333322 666555444
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=373.50 Aligned_cols=253 Identities=22% Similarity=0.371 Sum_probs=215.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..++|++++.||+|+||+||+|.+. ++..||+|++...... .+.+.+|+.++..++||||+++++++.+...+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 456679999999999999999999876 6778999999865432 24688999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|+||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~-- 172 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-- 172 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC--
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc--
Confidence 999999999999999987 46799999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
..........||+.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 173 ---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 173 ---------------------------DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp ---------------------------HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ---------------------------cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 11112234457889999999999999999999999999999998 99999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+..+....+....... .+...+..+.+||.+||+.||.+||+ +.++++|
T Consensus 226 ~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 274 (283)
T 3gen_A 226 TNSETAEHIAQGLRLY--RPHLASEKVYTIMYSCWHEKADERPT---FKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred ChhHHHHHHhcccCCC--CCCcCCHHHHHHHHHHccCChhHCcC---HHHHHHH
Confidence 9988888887664332 24678999999999999999999999 5566654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=402.29 Aligned_cols=261 Identities=27% Similarity=0.490 Sum_probs=195.8
Q ss_pred CCeEE-EEEeccCCCeEEEEeeec--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee--cccc
Q 001057 758 EDFEI-IKPISQGAFGRVFLARKR--ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT--CREN 832 (1170)
Q Consensus 758 edYev-lk~LG~GgFGtVyLArdk--~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq--d~~~ 832 (1170)
+.|++ .++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+|..++|||||+++++|. ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 34666 447999999999999966 5789999999876432 235778999999999999999999994 4678
Q ss_pred eEEEEeeccCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe----CCCCcEEE
Q 001057 833 LYLVMEYLNGGDLYSLLRNL---------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI----GQDGHIKL 899 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~---------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL----d~dG~VKL 899 (1170)
+||||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999999995 5888888632 249999999999999999999999999999999999999 67789999
Q ss_pred EecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHH
Q 001057 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIIL 978 (1170)
Q Consensus 900 sDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVIL 978 (1170)
+|||+|+..... ..........+||+.|+|||++.+. .|+.++|||||||++
T Consensus 174 ~Dfg~a~~~~~~---------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 174 ADMGFARLFNSP---------------------------LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp CCTTCCC-------------------------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred EECCCceecCCC---------------------------CcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence 999999753100 0001123456899999999999874 489999999999999
Q ss_pred HHHHhCCCCCCCCCHH---------HHHHHHhccC-CC----CCC------------------------------CCccC
Q 001057 979 FELLIGIPPFNAKTPQ---------QIFDNIMNRD-IP----WPN------------------------------IPEEM 1014 (1170)
Q Consensus 979 YELLTG~pPF~g~~~~---------ei~qkIl~~~-l~----fP~------------------------------ip~~l 1014 (1170)
|+|++|.+||.+.... +.+..|...- .+ |+. .....
T Consensus 227 ~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (405)
T 3rgf_A 227 AELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306 (405)
T ss_dssp HHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCT
T ss_pred HHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCC
Confidence 9999999999876542 3333333210 00 100 00123
Q ss_pred CHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 1015 SVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 1015 S~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
+..+.+||.+||+.||.+||| +.|+|+||||.+..+.
T Consensus 307 ~~~~~~Ll~~~L~~dP~~R~t---a~e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 307 DSKAFHLLQKLLTMDPIKRIT---SEQAMQDPYFLEDPLP 343 (405)
T ss_dssp TSHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGTSSSCC
T ss_pred CHHHHHHHHHHccCCcccCCC---HHHHhcChhhccCCCC
Confidence 778999999999999999999 8899999999986544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=371.18 Aligned_cols=251 Identities=27% Similarity=0.446 Sum_probs=205.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccccc-HHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR-KNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~-~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
+..++|++.+.||+|+||.||+|++. |+.||+|++....... ....+.+.+|+.++..++||||+++++++.+.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 45678999999999999999999974 8899999987643222 23356788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCCCcEEeCC--------CCcEEEEec
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN---VIHRDLKPDNLLIGQ--------DGHIKLTDF 902 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~G---IIHRDIKPENILLd~--------dG~VKLsDF 902 (1170)
|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||+||
T Consensus 82 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 999999999999998864 57999999999999999999999999 999999999999986 778999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELL 982 (1170)
|+++... ........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 161 g~~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 208 (271)
T 3dtc_A 161 GLAREWH--------------------------------RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208 (271)
T ss_dssp CC---------------------------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred Ccccccc--------------------------------cccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHH
Confidence 9987421 01112457999999999999999999999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 983 IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 983 TG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+|..||.+.+.......+.......+ .+..++..+.+||.+||+.||.+||++.++.+
T Consensus 209 ~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 209 TGEVPFRGIDGLAVAYGVAMNKLALP-IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp HCCCTTTTSCHHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCHHHHHHhhhcCCCCCC-CCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999888887777766655433 45788999999999999999999999444433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=384.64 Aligned_cols=269 Identities=23% Similarity=0.327 Sum_probs=218.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~Ly 834 (1170)
..++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+.++..+ +||||+++++++.+...+|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34689999999999999999999999999999999875432 23577899999999 8999999999999999999
Q ss_pred EEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc-----EEEEecCCcccc
Q 001057 835 LVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH-----IKLTDFGLSKVG 908 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~-----VKLsDFGLAk~~ 908 (1170)
|||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+..
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 99999999864 67999999999999999999999999999999999999999887 999999999853
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
...... ...........+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 161 ~~~~~~-----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf 217 (330)
T 2izr_A 161 IDPETK-----------------------KHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217 (330)
T ss_dssp BCTTTC-----------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCC-----------------------ccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCc
Confidence 110000 000011234678999999999999999999999999999999999999999
Q ss_pred CCC---CHHHHHHHHhccCCCCCC--CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc-------CCCCCCCChh
Q 001057 989 NAK---TPQQIFDNIMNRDIPWPN--IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ-------HPFFKNINWD 1054 (1170)
Q Consensus 989 ~g~---~~~ei~qkIl~~~l~fP~--ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq-------HPfF~~idwe 1054 (1170)
.+. ...+.+..+.......+. ....++ ++.+||.+||+.||.+||++..+.++++ ..+...++|+
T Consensus 218 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 218 QGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp TTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred cccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 874 445556666544333221 112345 9999999999999999999766655554 3344566776
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=390.11 Aligned_cols=265 Identities=25% Similarity=0.416 Sum_probs=219.6
Q ss_pred CCCCCCCCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH---HHHHHHHHHHHHHHhcC--CCcEE
Q 001057 747 INPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK---NAVESILAERNILISVR--NPFVV 821 (1170)
Q Consensus 747 ~~p~~~~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~---~~ve~~l~EieILskL~--HPNIV 821 (1170)
+.+........++|++.+.||+|+||.||+|++..+++.||||++........ .....+.+|+.++..++ ||||+
T Consensus 32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~ 111 (320)
T 3a99_A 32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI 111 (320)
T ss_dssp --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence 33444455667889999999999999999999999999999999976543221 12245667999999996 59999
Q ss_pred EEEeeeecccceEEEEeeccC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC-CCCcEEE
Q 001057 822 RFFYSFTCRENLYLVMEYLNG-GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG-QDGHIKL 899 (1170)
Q Consensus 822 rL~~~Fqd~~~LyLVMEY~~G-GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd-~dG~VKL 899 (1170)
+++++|...+.+|+||||+.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 112 ~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 112 RLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp CEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEE
Confidence 999999999999999999976 89999999888999999999999999999999999999999999999999 7899999
Q ss_pred EecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHH
Q 001057 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIIL 978 (1170)
Q Consensus 900 sDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVIL 978 (1170)
+|||+++... ........||+.|+|||++.+..+ +.++|||||||++
T Consensus 192 ~Dfg~~~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 239 (320)
T 3a99_A 192 IDFGSGALLK--------------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239 (320)
T ss_dssp CCCTTCEECC--------------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred eeCccccccc--------------------------------cccccCCCCCccCCChHHhccCCCCCccchHHhHHHHH
Confidence 9999987521 011224569999999999987765 6789999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhh
Q 001057 979 FELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 979 YELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~ 1055 (1170)
|+|++|..||.... .+......++ ..++.++.+||.+||+.||.+||+ +.++++||||+++.+..
T Consensus 240 ~el~~g~~pf~~~~------~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~hp~~~~~~~~~ 304 (320)
T 3a99_A 240 YDMVCGDIPFEHDE------EIIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVLLPQ 304 (320)
T ss_dssp HHHHHSSCSCCSHH------HHHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCCCHH
T ss_pred HHHHHCCCCCCChh------hhhccccccc---ccCCHHHHHHHHHHccCChhhCcC---HHHHhcCHhhcCccCcc
Confidence 99999999997632 2333444333 678999999999999999999999 88999999999886543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=382.29 Aligned_cols=262 Identities=23% Similarity=0.317 Sum_probs=212.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|++.+.||+|+||.||+|++..+++.||||++...........+.+.+|+.++..++||||+++++++...+.+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeE
Confidence 44568999999999999999999999999999999999876555556678899999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|+||||+.|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--- 186 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD--- 186 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc---
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 187 --------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 187 --------------------------EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp ------------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred --------------------------cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 001112345799999999999998899999999999999999999999998777
Q ss_pred HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCC-ChhhHHHHHc
Q 001057 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRL-GATGAREVKQ 1044 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRp-Sa~~AeEILq 1044 (1170)
..+...+..........+..++.++.+||.+||+.||.+|| ++..+.+.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 241 SVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp HHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 65554444333222234467899999999999999999999 6554444443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=372.21 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=213.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~ 832 (1170)
.+..++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.+|+.++..+ +|+||+++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 4556789999999999999999999999999999999875432 23577899999999 79999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc-----EEEEecCCcc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH-----IKLTDFGLSK 906 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~-----VKLsDFGLAk 906 (1170)
+|+||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 999999998754 5999999999999999999999999999999999999987776 9999999998
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~p 986 (1170)
........ ...........+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 160 ~~~~~~~~-----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 216 (298)
T 1csn_A 160 FYRDPVTK-----------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 216 (298)
T ss_dssp ESBCTTTC-----------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccccc-----------------------ccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCC
Confidence 53210000 0000112345689999999999999999999999999999999999999
Q ss_pred CCCCC---CHHHHHHHHhccCC--CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 987 PFNAK---TPQQIFDNIMNRDI--PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 987 PF~g~---~~~ei~qkIl~~~l--~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
||.+. .....+..+..... +.+.....++.++.+||.+||+.||.+||++.++.+.+
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l 278 (298)
T 1csn_A 217 PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 278 (298)
T ss_dssp TTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred CcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHH
Confidence 99874 34455555543322 22222346899999999999999999999966554443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=377.35 Aligned_cols=261 Identities=28% Similarity=0.474 Sum_probs=203.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++|++++.||+|+||.||+|+++.+|+.||||++..... .......+..+..++..++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 456789999999999999999999999999999999976542 2233344555566788889999999999999999999
Q ss_pred EEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSL-NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~-GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+||||+ ++.+..+... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~--- 176 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV--- 176 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc---
Confidence 999999 5566655544 46799999999999999999999995 99999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-----cCCCCcchhhhHHHHHHHHHHhCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
.........||+.|+|||++. +..++.++|||||||++|+|++|..|
T Consensus 177 ----------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (318)
T 2dyl_A 177 ----------------------------DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228 (318)
T ss_dssp --------------------------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ----------------------------CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCC
Confidence 001122356999999999994 45688999999999999999999999
Q ss_pred CCC-CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 988 FNA-KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 988 F~g-~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
|.. ....+.+..+.............++.++.+||.+||+.||.+||+ +.++++||||++.
T Consensus 229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 229 YKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK---YNKLLEHSFIKRY 290 (318)
T ss_dssp TTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHHH
T ss_pred CCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcC---HHHHhhCHHHHhc
Confidence 987 455566666666554332223468999999999999999999999 8899999999754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=375.80 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=207.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.++..++||||+++++++...+.+
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 45667899999999999999999999999999999999875555566778899999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 834 YLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999999864 3569999999999999999999999999999999999999999999999999987421
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
..........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 188 ------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 188 ------------------------------SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp -----------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ------------------------------CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 00111234579999999999999999999999999999999999999997
Q ss_pred CCC--HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 990 AKT--PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 990 g~~--~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
+.. ...+...+.....+.. ....++.++.+||.+||..||.+||++.++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~il 289 (310)
T 2wqm_A 238 GDKMNLYSLCKKIEQCDYPPL-PSDHYSEELRQLVNMCINPDPEKRPDVTYVY 289 (310)
T ss_dssp ---CCHHHHHHHHHTTCSCCC-CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccchhHHHHHHHhhcccCCCC-cccccCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 643 3455555555443211 1257899999999999999999999944443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=366.39 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=216.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc--c
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR--E 831 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~--~ 831 (1170)
.+..++|++++.||+|+||+||+|++. ++.||+|++..... .....+.+.+|+.++..++||||+++++++.+. .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 456789999999999999999999985 88999999876532 344567799999999999999999999999887 7
Q ss_pred ceEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 8999999999999999998765 4899999999999999999999999 99999999999999999999999998652
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCc---chhhhHHHHHHHHHHhC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGA---TADWWSVGIILFELLIG 984 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~---ksDIWSLGVILYELLTG 984 (1170)
. ......||+.|+|||++.+..++. ++|||||||++|+|++|
T Consensus 163 ~-----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 207 (271)
T 3kmu_A 163 F-----------------------------------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR 207 (271)
T ss_dssp T-----------------------------------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHC
T ss_pred e-----------------------------------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 1 112346899999999998765544 79999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 985 IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 985 ~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..||.+.+.......+...... +..+..++.++.+||.+||+.||.+||++.++.+.|
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 208 EVPFADLSNMEIGMKVALEGLR-PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCccccChHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999988887777655443 235578999999999999999999999955444433
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=372.03 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=210.7
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHH----HHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAV----ESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~v----e~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
..+..++|++.+.||+|+||+||+|++..+++.||+|++........... +.+.+|+.++..++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 34667899999999999999999999999999999999876443322222 67889999999999999999999987
Q ss_pred cccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeCCCCc-----EEEE
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIGQDGH-----IKLT 900 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd~dG~-----VKLs 900 (1170)
+.. ++||||+.+|+|.+++... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 655 7999999999999988654 46999999999999999999999999 999999999999988876 9999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh--cCCCCcchhhhHHHHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL--GMGHGATADWWSVGIIL 978 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~--g~~ys~ksDIWSLGVIL 978 (1170)
|||+|+... .......||+.|+|||++. ...++.++|||||||++
T Consensus 172 Dfg~~~~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l 218 (287)
T 4f0f_A 172 DFGLSQQSV---------------------------------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMIL 218 (287)
T ss_dssp CCTTCBCCS---------------------------------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHH
T ss_pred CCCcccccc---------------------------------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHH
Confidence 999987421 0122457999999999994 44578899999999999
Q ss_pred HHHHhCCCCCCCCCHHHH--HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 979 FELLIGIPPFNAKTPQQI--FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 979 YELLTG~pPF~g~~~~ei--~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
|+|++|..||...+.... ...+...... +..+..+++++.+||.+||+.||.+||++.++.+.|
T Consensus 219 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 219 YTILTGEGPFDEYSYGKIKFINMIREEGLR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp HHHHHSSCTTTTCCCCHHHHHHHHHHSCCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHcCCCCCccccccHHHHHHHHhccCCC-CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 999999999987654332 4444433332 345578999999999999999999999955554443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=386.86 Aligned_cols=256 Identities=19% Similarity=0.294 Sum_probs=210.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCE----EEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDL----FAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~----VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
.+..++|++++.||+|+||+||+|++..+++. ||+|++.... .......+.+|+.++..++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 45567899999999999999999999888876 6666654322 1222345678999999999999999999886
Q ss_pred ccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
...+|+||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 56789999999999999999875 57999999999999999999999999999999999999999999999999999853
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPP 987 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pP 987 (1170)
... ..........||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 166 ~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 217 (325)
T 3kex_A 166 PPD----------------------------DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217 (325)
T ss_dssp CCC----------------------------TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred Ccc----------------------------cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCC
Confidence 100 00111234568889999999999999999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|.+....++...+...... ..+..++.++.+||.+||+.||.+||++ .++++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~---~el~~~ 270 (325)
T 3kex_A 218 YAGLRLAEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENIRPTF---KELANE 270 (325)
T ss_dssp TTTSCTTHHHHHHHTTCBC--CCCTTBCTTTTHHHHHHTCSCTTTSCCH---HHHHHH
T ss_pred ccccCHHHHHHHHHcCCCC--CCCCcCcHHHHHHHHHHcCCChhhCcCH---HHHHHH
Confidence 9998888887777765432 2346788899999999999999999994 455544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=374.51 Aligned_cols=257 Identities=24% Similarity=0.349 Sum_probs=215.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeee-----cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARK-----RATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSF 827 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArd-----k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~F 827 (1170)
.+..++|++.+.||+|+||.||+|++ ..+++.||+|++.... .....+.+.+|+.+|..+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 34557899999999999999999984 4578899999987653 234557889999999999 899999999999
Q ss_pred ecccceEEEEeeccCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcE
Q 001057 828 TCRENLYLVMEYLNGGDLYSLLRNLG------------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889 (1170)
Q Consensus 828 qd~~~LyLVMEY~~GGSL~dlLk~~~------------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENI 889 (1170)
.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 99999999999999999999998653 489999999999999999999999999999999999
Q ss_pred EeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcch
Q 001057 890 LIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA 969 (1170)
Q Consensus 890 LLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ks 969 (1170)
|++.++.+||+|||+++..... ..........||+.|+|||++.+..++.++
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 228 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKND----------------------------SNYVVKGNARLPVKWMAPESIFNCVYTFES 228 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSC----------------------------TTSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred EEcCCCCEEEcccccccccccc----------------------------ccceeccCCCCcceeeChHHhcCCCCChHH
Confidence 9999999999999998752100 001112345678899999999999999999
Q ss_pred hhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 970 DWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 970 DIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
|||||||++|+|++ |..||.+......+..+.......+ .+..++.++.+||.+||+.||.+||++.++.+
T Consensus 229 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC-CcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999998 9999998776555555444433322 34678999999999999999999999544433
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=372.07 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=221.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..++|++.+.||+|+||+||+|.+..++..||+|++.... ...+.+.+|+.+++.++||||+++++++.+...+
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 84 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence 456678999999999999999999999999999999987543 3456788999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
|+||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~- 163 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG- 163 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS-
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC-
Confidence 9999999999999999864 4599999999999999999999999999999999999999999999999999975210
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+
T Consensus 164 ----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 164 ----------------------------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp ----------------------------SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ----------------------------CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 00112234467889999999999999999999999999999999 9999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
.+...+...+...... ..+..++..+.+||.+||+.||.+||++.++.+.|+
T Consensus 216 ~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 216 IDLSQVYELLEKDYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp CCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHHHHHHhccCCC--CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence 8888877777654322 234688999999999999999999999666655543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=372.52 Aligned_cols=253 Identities=25% Similarity=0.369 Sum_probs=206.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRAT---GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~T---Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
.+..++|++.+.||+|+||.||+|++..+ +..||+|++.... .....+.+.+|+.++..++||||+++++++. .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 34567899999999999999999998654 4579999886542 3455678899999999999999999999885 5
Q ss_pred cceEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
+.+|+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 67899999999999999998654 69999999999999999999999999999999999999999999999999997521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
. ..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||
T Consensus 168 ~-----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf 218 (281)
T 1mp8_A 168 D-----------------------------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218 (281)
T ss_dssp ----------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred c-----------------------------ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCC
Confidence 0 00011123457889999999999999999999999999999996 99999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
.+.+..++...+...... ..+..+++.+.+||.+||+.||.+||++.++.
T Consensus 219 ~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 268 (281)
T 1mp8_A 219 QGVKNNDVIGRIENGERL--PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELK 268 (281)
T ss_dssp TTCCGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CcCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 998888888887765432 34578999999999999999999999954443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=383.38 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=212.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeee-----cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARK-----RATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSF 827 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArd-----k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~F 827 (1170)
.+..++|++.+.||+|+||.||+|++ ..++..||+|++.... .....+.+.+|+.+|..+ +||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34567899999999999999999997 3466789999987542 233456789999999999 899999999999
Q ss_pred ecccceEEEEeeccCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Q 001057 828 TCRENLYLVMEYLNGGDLYSLLRNLG-----------------------CLDEDMARVYIAELVLALEYLHSLNVIHRDL 884 (1170)
Q Consensus 828 qd~~~LyLVMEY~~GGSL~dlLk~~~-----------------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDI 884 (1170)
...+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 99999999999999999999997653 3789999999999999999999999999999
Q ss_pred CCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC
Q 001057 885 KPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG 964 (1170)
Q Consensus 885 KPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ 964 (1170)
||+|||++.++.+||+|||++...... ..........||+.|+|||++.+..
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~ 250 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSD----------------------------SNYVVRGNARLPVKWMAPESLFEGI 250 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGC----------------------------TTSEEETTEEECGGGCCHHHHHHCC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccC----------------------------ccceeccCccCccCccCHHHhccCC
Confidence 999999999999999999999753100 0011223456789999999999999
Q ss_pred CCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 965 HGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 965 ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
++.++|||||||++|+|++ |..||.+......+..+....... ..+..++.++.+||.+||+.||.+||++.++.+
T Consensus 251 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 251 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999999999999999998 999999877665555555444332 245678999999999999999999999444433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=387.58 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=220.8
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCC-------CCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEE
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRAT-------GDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFF 824 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~T-------Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~ 824 (1170)
..+..++|.+.+.||+|+||+||+|++..+ +..||+|++.... .......+.+|+.++..+ +|||||+++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 355668999999999999999999997543 3589999987642 345667889999999999 899999999
Q ss_pred eeeecccceEEEEeeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCc
Q 001057 825 YSFTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDN 888 (1170)
Q Consensus 825 ~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPEN 888 (1170)
++|.+.+.+|+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 99999999999999999999999998653 49999999999999999999999999999999999
Q ss_pred EEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcc
Q 001057 889 LLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT 968 (1170)
Q Consensus 889 ILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~k 968 (1170)
|||+.++.+||+|||+|+..... ..........||+.|+|||++.+..++.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~ 273 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHI----------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQ 273 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCC----------------------------CTTCCCTTCCCGGGGSCHHHHHSCCCCHH
T ss_pred EEEcCCCcEEEcccCcccccccc----------------------------cccccccCCCCCcceeCHHHhcCCCCCch
Confidence 99999999999999999752100 00011223467889999999999999999
Q ss_pred hhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 969 ADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 969 sDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+|||||||++|+|++ |..||.+.+..++...+...... ..+..++.++.+||.+||+.||.+||+ +.+++++
T Consensus 274 ~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 346 (382)
T 3tt0_A 274 SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRM--DKPSNCTNELYMMMRDCWHAVPSQRPT---FKQLVED 346 (382)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC--CCCSSCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 999999999999999 99999999999888888765432 334789999999999999999999999 5555554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=373.85 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=208.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEee----ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLAr----dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
.+..++|++++.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|..++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567899999999999999999998 5678999999998754 34556788999999999999999999998865
Q ss_pred c--cceEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcc
Q 001057 830 R--ENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 830 ~--~~LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk 906 (1170)
. ..+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 4 56999999999999999998754 59999999999999999999999999999999999999999999999999997
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~p 986 (1170)
...... ..........||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 163 ~~~~~~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~ 215 (295)
T 3ugc_A 163 VLPQDK---------------------------EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 215 (295)
T ss_dssp ----------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTC
T ss_pred cccCCc---------------------------ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccc
Confidence 531000 00011223457788999999999999999999999999999999999
Q ss_pred CCCCCCHH----------------HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 987 PFNAKTPQ----------------QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 987 PF~g~~~~----------------ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
||...... .....+.... .. ..+..++.++.+||.+||+.||.+||++.++.+.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L 286 (295)
T 3ugc_A 216 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG-RL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286 (295)
T ss_dssp TTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC-CC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred ccCCChHHHHhhhcCccccchhHHHHHHHHhccC-cC-CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 98753221 1222222221 21 23568999999999999999999999955544433
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=379.77 Aligned_cols=255 Identities=27% Similarity=0.478 Sum_probs=207.4
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH---HHHHHHHHHHHHHHhc----CCCcEEEEEee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK---NAVESILAERNILISV----RNPFVVRFFYS 826 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~---~~ve~~l~EieILskL----~HPNIVrL~~~ 826 (1170)
....++|++.+.||+|+||.||+|++..+++.||||++........ .....+.+|+.++..+ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 4456789999999999999999999999999999999976543221 1233456799999988 89999999999
Q ss_pred eecccceEEEEee-ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC-CCCcEEEEecCC
Q 001057 827 FTCRENLYLVMEY-LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG-QDGHIKLTDFGL 904 (1170)
Q Consensus 827 Fqd~~~LyLVMEY-~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd-~dG~VKLsDFGL 904 (1170)
|.+.+.+|+|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9999999999999 78999999999888899999999999999999999999999999999999999 789999999999
Q ss_pred ccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCC-cchhhhHHHHHHHHHHh
Q 001057 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHG-ATADWWSVGIILFELLI 983 (1170)
Q Consensus 905 Ak~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys-~ksDIWSLGVILYELLT 983 (1170)
+.... ........||+.|+|||++.+..+. .++|||||||++|+|++
T Consensus 187 ~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 234 (312)
T 2iwi_A 187 GALLH--------------------------------DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234 (312)
T ss_dssp CEECC--------------------------------SSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred hhhcc--------------------------------cCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH
Confidence 87521 0012345699999999999877664 58999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 984 GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 984 G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
|..||.+.. .+......++ ..++.++.+||.+||+.||.+||+ +.++++||||+...
T Consensus 235 g~~pf~~~~------~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 235 GDIPFERDQ------EILEAELHFP---AHVSPDCCALIRRCLAPKPSSRPS---LEEILLDPWMQTPA 291 (312)
T ss_dssp SSCSCCSHH------HHHHTCCCCC---TTSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSTTTCC--
T ss_pred CCCCCCChH------HHhhhccCCc---ccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhcCch
Confidence 999997532 2333444443 678999999999999999999999 88999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=374.39 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=208.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCC-------CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATG-------DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYS 826 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TG-------e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~ 826 (1170)
.+..++|++.+.||+|+||+||+|++..++ ..||+|++.+.. ....+.+.+|+.++..++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 355678999999999999999999998877 479999987643 3445678999999999999999999999
Q ss_pred eecccceEEEEeeccCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc--------E
Q 001057 827 FTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH--------I 897 (1170)
Q Consensus 827 Fqd~~~LyLVMEY~~GGSL~dlLk~~~~-LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~--------V 897 (1170)
+.+.+..|+||||+.||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999987654 999999999999999999999999999999999999998887 9
Q ss_pred EEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHH
Q 001057 898 KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGI 976 (1170)
Q Consensus 898 KLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGV 976 (1170)
||+|||++.... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 161 kl~Dfg~~~~~~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 206 (289)
T 4fvq_A 161 KLSDPGISITVL----------------------------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGT 206 (289)
T ss_dssp EECCCCSCTTTS----------------------------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHH
T ss_pred eeccCccccccc----------------------------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHH
Confidence 999999986420 0123458899999999987 67899999999999
Q ss_pred HHHHHHhC-CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 977 ILFELLIG-IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 977 ILYELLTG-~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
++|+|++| .+||...+........ .....+ +...+.++.+||.+||+.||.+||+ +.++++|
T Consensus 207 il~el~~g~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 269 (289)
T 4fvq_A 207 TLWEICSGGDKPLSALDSQRKLQFY-EDRHQL---PAPKAAELANLINNCMDYEPDHRPS---FRAIIRD 269 (289)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHHHH-HTTCCC---CCCSSCTTHHHHHHHSCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHcCCCCCccccchHHHHHHh-hccCCC---CCCCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 99999995 5566665555444433 333333 3567889999999999999999999 4555544
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=389.24 Aligned_cols=257 Identities=32% Similarity=0.527 Sum_probs=186.9
Q ss_pred CCCCCCCCeEEEE-EeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-
Q 001057 752 KDRTSIEDFEIIK-PISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC- 829 (1170)
Q Consensus 752 ~~~i~iedYevlk-~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd- 829 (1170)
......++|.+++ .||+|+||+||+|+++.+|+.||||++.... .. .......+..+.||||++++++|..
T Consensus 22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~---~~e~~~~~~~~~h~~i~~~~~~~~~~ 94 (336)
T 3fhr_A 22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KA---RQEVDHHWQASGGPHIVCILDVYENM 94 (336)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HH---HHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HH---HHHHHHHHHhcCCCChHHHHHHHhhc
Confidence 3445668899976 6999999999999999999999999987532 11 1122334567799999999999876
Q ss_pred ---ccceEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---CCcEEEEe
Q 001057 830 ---RENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ---DGHIKLTD 901 (1170)
Q Consensus 830 ---~~~LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~---dG~VKLsD 901 (1170)
...+||||||+.||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|
T Consensus 95 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 95 HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp ETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred cCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEec
Confidence 456899999999999999998764 6999999999999999999999999999999999999986 45599999
Q ss_pred cCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHH
Q 001057 902 FGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 902 FGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYEL 981 (1170)
||+++... .......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 175 fg~~~~~~--------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (336)
T 3fhr_A 175 FGFAKETT--------------------------------QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222 (336)
T ss_dssp CTTCEEC------------------------------------------------------CHHHHHHHHHHHHHHHHHH
T ss_pred cccceecc--------------------------------ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHH
Confidence 99997421 0112345789999999999888899999999999999999
Q ss_pred HhCCCCCCCCCHHHH----HHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 982 LIGIPPFNAKTPQQI----FDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei----~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
++|..||.+...... ...+......++. ....++.++.+||.+||+.||.+||+ +.++++||||++
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 293 (336)
T 3fhr_A 223 LCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT---ITQFMNHPWINQ 293 (336)
T ss_dssp HHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHHSHHHHT
T ss_pred HHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCccccc
Confidence 999999987665443 2233333333331 12468999999999999999999999 889999999976
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=363.37 Aligned_cols=251 Identities=22% Similarity=0.394 Sum_probs=216.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++++.||+|+||.||+|.+. +++.||+|++...... .+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 34578999999999999999999986 6788999999865432 256889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~--- 156 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--- 156 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC---
T ss_pred EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc---
Confidence 999999999999999865 5699999999999999999999999999999999999999999999999999875210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+
T Consensus 157 --------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 210 (267)
T 3t9t_A 157 --------------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210 (267)
T ss_dssp --------------------------HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred --------------------------ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC
Confidence 01112234567889999999999999999999999999999999 999999999
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
..+....+..+... ..+...+..+.+||.+||+.||.+||+ +.++++
T Consensus 211 ~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 257 (267)
T 3t9t_A 211 NSEVVEDISTGFRL--YKPRLASTHVYQIMNHCWRERPEDRPA---FSRLLR 257 (267)
T ss_dssp HHHHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHHhcCCcC--CCCccCcHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 98888888765432 234678999999999999999999999 445544
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=391.97 Aligned_cols=257 Identities=28% Similarity=0.385 Sum_probs=218.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++.+.||+|+||.||+|+++.+++.||||++.... .....+.+.+|+.+|+.++|||||++++++...+.+|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence 45578999999999999999999999999999999987542 3445567889999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
|||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~--- 265 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD--- 265 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT---
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC---
Confidence 9999999999999998654 599999999999999999999999999999999999999999999999999974210
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
+ ..........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus 266 -----------~--------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~ 320 (377)
T 3cbl_A 266 -----------G--------------VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320 (377)
T ss_dssp -----------S--------------EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred -----------C--------------ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 0 00001112235778999999998889999999999999999998 999999999
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..+....+..+.. +..+..++.++.+||.+||+.||.+||++.++.+.|
T Consensus 321 ~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 369 (377)
T 3cbl_A 321 NQQTREFVEKGGR--LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369 (377)
T ss_dssp HHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 8888777765432 123467899999999999999999999965554433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=376.42 Aligned_cols=257 Identities=21% Similarity=0.341 Sum_probs=215.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCC-----EEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGD-----LFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSF 827 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe-----~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~F 827 (1170)
.+..++|++.+.||+|+||.||+|.+..++. .||+|++.... .....+.+.+|+.+|..+ +||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4556789999999999999999999877664 89999987643 344567889999999999 899999999999
Q ss_pred ecccceEEEEeeccCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC
Q 001057 828 TCRENLYLVMEYLNGGDLYSLLRNL--------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ 893 (1170)
Q Consensus 828 qd~~~LyLVMEY~~GGSL~dlLk~~--------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~ 893 (1170)
...+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN 199 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence 9999999999999999999999753 35799999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhH
Q 001057 894 DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWS 973 (1170)
Q Consensus 894 dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWS 973 (1170)
++.+||+|||+++..... ..........||+.|+|||++.+..++.++||||
T Consensus 200 ~~~~kl~Dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 251 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMND----------------------------SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251 (333)
T ss_dssp GGEEEBCCCGGGCCGGGC----------------------------TTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHH
T ss_pred CCeEEECccccccccccc----------------------------cceeecCCCCCCccccCHHHhccCCCChHHHHHH
Confidence 999999999999753100 0011123456788999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 974 VGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 974 LGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
|||++|+|++ |.+||.+......+..+.......+ .+...+..+.+||.+||+.||.+||++.++.+
T Consensus 252 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 252 YGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA-QPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC-CCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 9999999998 9999998776655555554443322 34678999999999999999999999544433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=378.82 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=214.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEE--EEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLF--AIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~V--AIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~ 831 (1170)
+..++|++.+.||+|+||.||+|++..++..+ |+|.+.... .......+.+|+.+|..+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 55689999999999999999999999888865 999887532 334456788999999999 8999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG 895 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG 895 (1170)
.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 699999999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHH
Q 001057 896 HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVG 975 (1170)
Q Consensus 896 ~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLG 975 (1170)
.+||+|||+++... .........+|+.|+|||++.+..++.++||||||
T Consensus 180 ~~kL~Dfg~~~~~~-------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 228 (327)
T 1fvr_A 180 VAKIADFGLSRGQE-------------------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 228 (327)
T ss_dssp CEEECCTTCEESSC-------------------------------EECCC----CCTTTCCHHHHHHCEECHHHHHHHHH
T ss_pred eEEEcccCcCcccc-------------------------------ccccccCCCCCccccChhhhccccCCchhcchHHH
Confidence 99999999987310 00111234578899999999998899999999999
Q ss_pred HHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 976 IILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 976 VILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|++|+|++ |.+||.+.+..+++..+..+... ..+..++.++.+||.+||+.||.+||+ +.++++|
T Consensus 229 ~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~~ 294 (327)
T 1fvr_A 229 VLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL--EKPLNCDDEVYDLMRQCWREKPYERPS---FAQILVS 294 (327)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC--CCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC--CCCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 99999998 99999999998888887765322 234678999999999999999999999 5555554
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=374.06 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=212.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeee-----cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARK-----RATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFT 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArd-----k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fq 828 (1170)
+..++|++.+.||+|+||+||+|++ ..+++.||||++.... .......+.+|+.++..+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 4457899999999999999999984 4577899999987643 344556789999999999 6899999999987
Q ss_pred ccc-ceEEEEeeccCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe
Q 001057 829 CRE-NLYLVMEYLNGGDLYSLLRNLGC----------------LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI 891 (1170)
Q Consensus 829 d~~-~LyLVMEY~~GGSL~dlLk~~~~----------------LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL 891 (1170)
..+ .+|+||||+.||+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 754 59999999999999999987543 8999999999999999999999999999999999999
Q ss_pred CCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhh
Q 001057 892 GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADW 971 (1170)
Q Consensus 892 d~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDI 971 (1170)
+.++.+||+|||+++..... ..........||+.|+|||++.+..++.++||
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di 233 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKD----------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 233 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTC----------------------------TTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred CCCCCEEECCCccccccccC----------------------------ccceeccCCCcceeecCchhhccccccchhHH
Confidence 99999999999999752100 00112234568999999999999999999999
Q ss_pred hHHHHHHHHHHh-CCCCCCCCCHHHH-HHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 972 WSVGIILFELLI-GIPPFNAKTPQQI-FDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 972 WSLGVILYELLT-G~pPF~g~~~~ei-~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|||||++|+|++ |..||.+...... ...+..+.. +..+..+++++.+||.+||+.||.+||+ +.++++|
T Consensus 234 ~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~~ 304 (316)
T 2xir_A 234 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR--MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 304 (316)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCcc--CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 999999999998 9999988764443 334433322 2234678999999999999999999999 5566654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=368.97 Aligned_cols=260 Identities=22% Similarity=0.322 Sum_probs=217.0
Q ss_pred CCCCCeEEEE-EeccCCCeEEEEee--ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 755 TSIEDFEIIK-PISQGAFGRVFLAR--KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 755 i~iedYevlk-~LG~GgFGtVyLAr--dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
+...+|++.. .||+|+||+||+|. ...+++.||||++.... ......+.+.+|+.++..++||||+++++++ ..+
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence 4456899998 99999999999994 45678999999987653 2334567899999999999999999999998 567
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+|+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 78999999999999999998888999999999999999999999999999999999999999999999999999753100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
. ..........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 171 ~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 171 E---------------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp C---------------------------SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred C---------------------------CcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 0 00111223457889999999998889999999999999999999 9999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.+..++...+..... +..+..++..+.+||.+||+.||.+||++.++.+.|+.
T Consensus 224 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 224 MKGSEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp CCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 998888887776543 23457899999999999999999999996666555543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=374.22 Aligned_cols=261 Identities=25% Similarity=0.418 Sum_probs=213.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC--CCcEEEEEeeeecccc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR--NPFVVRFFYSFTCREN 832 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~--HPNIVrL~~~Fqd~~~ 832 (1170)
+..++|++++.||+|+||.||+|++. +++.||||++..... .....+.+.+|+.++..++ ||||+++++++.....
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 44567999999999999999999985 589999999876432 3456678899999999997 5999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~- 179 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD- 179 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCc-
Confidence 999999 55889999999888899999999999999999999999999999999999996 589999999999752100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-----------CCCCcchhhhHHHHHHHHH
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-----------MGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-----------~~ys~ksDIWSLGVILYEL 981 (1170)
.........+||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 180 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 232 (313)
T 3cek_A 180 ---------------------------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232 (313)
T ss_dssp -------------------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHH
T ss_pred ---------------------------cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHH
Confidence 00111234579999999999976 4688899999999999999
Q ss_pred HhCCCCCCCCC-HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 982 LIGIPPFNAKT-PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 982 LTG~pPF~g~~-~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
++|..||.... ....+..+....... ..+...+.++.+||.+||+.||.+||+ +.++++||||+..
T Consensus 233 ~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~~~~~ 299 (313)
T 3cek_A 233 TYGKTPFQQIINQISKLHAIIDPNHEI-EFPDIPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYVQIQ 299 (313)
T ss_dssp HHSSCTTTTCCSHHHHHHHHHCTTSCC-CCCCCSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHCC
T ss_pred HhCCCchhhHHHHHHHHHHHHhccccc-CCcccchHHHHHHHHHHccCCcccCcC---HHHHhcCccccCC
Confidence 99999998754 334444444433222 234567899999999999999999999 8899999999754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=367.80 Aligned_cols=260 Identities=24% Similarity=0.325 Sum_probs=208.8
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEee----ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLAr----dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
.......|++++.||+|+||.||+|+ +..+++.||+|++.... .....+.+.+|+.+|..++||||+++++++.
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICT 93 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 34556779999999999999999998 57789999999987543 2234567889999999999999999999998
Q ss_pred cc--cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 829 CR--ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 829 d~--~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
+. ..+|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 76 6789999999999999999554 57999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
...... ...........||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 174 ~~~~~~---------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (302)
T 4e5w_A 174 KAIETD---------------------------KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226 (302)
T ss_dssp EECCTT---------------------------CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred ccccCC---------------------------CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHcc
Confidence 753100 00011233456889999999999999999999999999999999999
Q ss_pred CCCCCC--------------CH-HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 986 PPFNAK--------------TP-QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 986 pPF~g~--------------~~-~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.||... .. ..+...+... ... ..+..++.++.+||.+||+.||.+||++.++.+.|
T Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 227 DSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG-KRL-PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp CGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT-CCC-CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCcchhhHHhhccCCcccccCHHHHHHHHhcc-CCC-CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 986432 11 2222223222 222 24568999999999999999999999965554444
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=375.12 Aligned_cols=254 Identities=22% Similarity=0.366 Sum_probs=215.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec-------CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEe
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR-------ATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFY 825 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk-------~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~ 825 (1170)
.+..++|++.+.||+|+||+||+|++. .++..||||++.... .......+.+|+.++..+ +||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 455689999999999999999999975 467899999987543 345567889999999999 8999999999
Q ss_pred eeecccceEEEEeeccCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcE
Q 001057 826 SFTCRENLYLVMEYLNGGDLYSLLRNLG----------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNL 889 (1170)
Q Consensus 826 ~Fqd~~~LyLVMEY~~GGSL~dlLk~~~----------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENI 889 (1170)
++.+.+.+|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 9999999999999999999999998653 389999999999999999999999999999999999
Q ss_pred EeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcch
Q 001057 890 LIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA 969 (1170)
Q Consensus 890 LLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ks 969 (1170)
|++.++.+||+|||+++..... ..........||+.|+|||++.+..++.++
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 240 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNI----------------------------DYYKKTTNGRLPVKWMAPEALFDRVYTHQS 240 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTT----------------------------SSEECCSCCCCCGGGCCHHHHHHCEECHHH
T ss_pred EEcCCCCEEEcccccccccccc----------------------------ccccccCCCCcccceeChHHhcCCCcChHH
Confidence 9999999999999999753100 000112234578899999999998899999
Q ss_pred hhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 970 DWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 970 DIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
|||||||++|+|++ |..||.+.+..++...+..+... ..+..++.++.+||.+||+.||.+||++.++
T Consensus 241 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 309 (334)
T 2pvf_A 241 DVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM--DKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309 (334)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCC--CCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999999 99999999988888877765432 3346789999999999999999999994433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=379.42 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=206.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEE----EEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLF----AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~V----AIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
.+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+|..++||||++++++|.+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 345678999999999999999999998888765 666654322 23345678999999999999999999999987
Q ss_pred ccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
. ..++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 89 ~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 5 478999999999999999874 57999999999999999999999999999999999999999999999999999853
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPP 987 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pP 987 (1170)
... ..........||+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 168 ~~~----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 219 (327)
T 3poz_A 168 GAE----------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219 (327)
T ss_dssp TTT----------------------------CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cCC----------------------------cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCC
Confidence 100 00111223457889999999999999999999999999999999 9999
Q ss_pred CCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|.+.+..++...+...... ..+..++.++.+||.+||+.||.+||+ +.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~ 272 (327)
T 3poz_A 220 YDGIPASEISSILEKGERL--PQPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 272 (327)
T ss_dssp TTTCCGGGHHHHHHTTCCC--CCCTTBCHHHHHHHHHHTCSCGGGSCC---HHHHHHH
T ss_pred ccCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCChhhCCC---HHHHHHH
Confidence 9998888777766654422 234678999999999999999999999 5555554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=366.67 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=208.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecC-CCC--EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRA-TGD--LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~-TGe--~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
.+..++|++++.||+|+||+||+|++.. ++. .||+|++...........+.+.+|+.++..++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3456789999999999999999998643 333 6999998765544456678899999999999999999999999875
Q ss_pred cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
. .++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 89999999999999999764 569999999999999999999999999999999999999999999999999987531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
.. ...........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 173 ~~---------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 225 (291)
T 1u46_A 173 QN---------------------------DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225 (291)
T ss_dssp C----------------------------CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cc---------------------------ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 00 000112234567889999999999889999999999999999999 99999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
.+.+..++...+......++ .+..++.++.+||.+||..||.+||++.++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 226 IGLNGSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp TTCCHHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHccCCCCC-CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 99999988888876655443 346789999999999999999999995444433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=377.24 Aligned_cols=260 Identities=20% Similarity=0.309 Sum_probs=217.3
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEee-----ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLAr-----dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq 828 (1170)
.+..++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.++..++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3556789999999999999999999 55688899999986432 3445567889999999999999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC---CcEE
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNLG-------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD---GHIK 898 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~~-------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d---G~VK 898 (1170)
+...+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 9999999999999999999998753 48999999999999999999999999999999999999844 4699
Q ss_pred EEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHH
Q 001057 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978 (1170)
Q Consensus 899 LsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVIL 978 (1170)
|+|||++...... ..........||+.|+|||++.+..++.++|||||||++
T Consensus 184 l~Dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 235 (327)
T 2yfx_A 184 IGDFGMARDIYRA----------------------------SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235 (327)
T ss_dssp ECCCHHHHHHHC----------------------------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ECccccccccccc----------------------------cccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHH
Confidence 9999998742100 001112345689999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 979 FELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 979 YELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
|+|++ |..||.+.+..++...+..+... ..+..++..+.+||.+||+.||.+||+ +.++++|.|+
T Consensus 236 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~l~~ 301 (327)
T 2yfx_A 236 WEIFSLGYMPYPSKSNQEVLEFVTSGGRM--DPPKNCPGPVYRIMTQCWQHQPEDRPN---FAIILERIEY 301 (327)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHH
T ss_pred HHHHcCCCCCCCCcCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHhcCChhhCcC---HHHHHHHHHH
Confidence 99998 99999999988888888765433 234678999999999999999999999 7788888765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=365.47 Aligned_cols=256 Identities=25% Similarity=0.333 Sum_probs=215.6
Q ss_pred CCCCCeEEEE-EeccCCCeEEEEeeec--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 755 TSIEDFEIIK-PISQGAFGRVFLARKR--ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 755 i~iedYevlk-~LG~GgFGtVyLArdk--~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
+..++|.++. .||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++..++||||+++++++ ..+
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~ 82 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE 82 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence 3456788887 9999999999999864 468899999987642 345667899999999999999999999999 456
Q ss_pred ceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
.+|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 799999999999999999754 5699999999999999999999999999999999999999999999999999975310
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~ 989 (1170)
.. ..........||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 163 ~~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 215 (287)
T 1u59_A 163 DD---------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 215 (287)
T ss_dssp CS---------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred Cc---------------------------ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 00 00111223457899999999998889999999999999999998 999999
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+.+..++...+..+.. +..+..+++++.+||.+||+.||.+||+ +.++++|
T Consensus 216 ~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~~ 266 (287)
T 1u59_A 216 KMKGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPD---FLTVEQR 266 (287)
T ss_dssp TCCTHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred cCCHHHHHHHHhcCCc--CCCCCCcCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 9888888887776543 2345789999999999999999999999 4555544
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=378.84 Aligned_cols=264 Identities=26% Similarity=0.441 Sum_probs=196.3
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHH-HHHhcCCCcEEEEEeeeeccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN-ILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~Eie-ILskL~HPNIVrL~~~Fqd~~ 831 (1170)
-.+..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+..|+. +++.++||||+++++++.+.+
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 3466789999999999999999999999999999999997643 2333445556665 667789999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 832 NLYLVMEYLNGGDLYSLLRN-----LGCLDEDMARVYIAELVLALEYLHSL-NVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~-----~~~LSEe~ar~IaaQIL~ALeYLHs~-GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
.+|+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 99999999975 88888763 46799999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHH----hcCCCCcchhhhHHHHHHHHH
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL----LGMGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL----~g~~ys~ksDIWSLGVILYEL 981 (1170)
+... .........||+.|+|||++ .+..++.++|||||||++|+|
T Consensus 174 ~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l 222 (327)
T 3aln_A 174 GQLV-------------------------------DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222 (327)
T ss_dssp CC-------------------------------------------------------------CCSHHHHHHHHHHHHHH
T ss_pred eecc-------------------------------cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHH
Confidence 7421 00111234699999999999 456689999999999999999
Q ss_pred HhCCCCCCCCCH-HHHHHHHhccCCC-CCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCCh
Q 001057 982 LIGIPPFNAKTP-QQIFDNIMNRDIP-WPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053 (1170)
Q Consensus 982 LTG~pPF~g~~~-~ei~qkIl~~~l~-fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idw 1053 (1170)
++|..||.+... .+.+..+..+..+ ++. ....++..+.+||.+||+.||.+||+ +.++++||||....+
T Consensus 223 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 223 ATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK---YKELLKHPFILMYEE 294 (327)
T ss_dssp HHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHHHHH
T ss_pred HHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcC---HHHHHhChHHHHhHh
Confidence 999999987543 2233333332221 111 12368999999999999999999999 889999999976543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=364.10 Aligned_cols=252 Identities=22% Similarity=0.306 Sum_probs=210.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecC---CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRA---TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~---TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
.+..++|++.+.||+|+||+||+|++.. ++..||+|++.+.. .....+.+.+|+.++..++||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-
Confidence 4566789999999999999999998653 34579999987653 33456788999999999999999999998875
Q ss_pred cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
+..|+||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 85 EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 4578999999999999999765 459999999999999999999999999999999999999999999999999987521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
. ..........||+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 165 ~-----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~ 215 (281)
T 3cc6_A 165 D-----------------------------EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215 (281)
T ss_dssp -------------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred c-----------------------------ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCc
Confidence 0 00011223457889999999999999999999999999999998 99999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
...........+...... ..+..+++.+.+||.+||..||.+||++.++
T Consensus 216 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 264 (281)
T 3cc6_A 216 FWLENKDVIGVLEKGDRL--PKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL 264 (281)
T ss_dssp TTSCGGGHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ccCChHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 988877777766654332 2346789999999999999999999994433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=363.40 Aligned_cols=244 Identities=26% Similarity=0.424 Sum_probs=207.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-------
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC------- 829 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd------- 829 (1170)
..+|++++.||+|+||.||+|++..+|+.||+|++.... +.+.+|+.++..++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 357999999999999999999999999999999987643 245689999999999999999998864
Q ss_pred ---------ccceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEE
Q 001057 830 ---------RENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898 (1170)
Q Consensus 830 ---------~~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VK 898 (1170)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 45689999999999999999754 5799999999999999999999999999999999999999999999
Q ss_pred EEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHH
Q 001057 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978 (1170)
Q Consensus 899 LsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVIL 978 (1170)
|+|||++..... ........||+.|+|||++.+..++.++|||||||++
T Consensus 163 l~Dfg~~~~~~~-------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (284)
T 2a19_B 163 IGDFGLVTSLKN-------------------------------DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL 211 (284)
T ss_dssp ECCCTTCEESSC-------------------------------CSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHH
T ss_pred ECcchhheeccc-------------------------------cccccccCCcccccChhhhccCCCcchhhhHHHHHHH
Confidence 999999875210 0012235699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 979 FELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 979 YELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
|+|++|..||.. .......+....+ +..++..+.+||.+||..||.+||+ +.++++|.+.
T Consensus 212 ~~l~~~~~~~~~--~~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~~l~~ 271 (284)
T 2a19_B 212 AELLHVCDTAFE--TSKFFTDLRDGII-----SDIFDKKEKTLLQKLLSKKPEDRPN---TSEILRTLTV 271 (284)
T ss_dssp HHHHSCCSSHHH--HHHHHHHHHTTCC-----CTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHH
T ss_pred HHHHhcCCcchh--HHHHHHHhhcccc-----cccCCHHHHHHHHHHccCChhhCcC---HHHHHHHHHH
Confidence 999999999853 2233444443322 3568899999999999999999999 7788888654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=374.40 Aligned_cols=268 Identities=24% Similarity=0.368 Sum_probs=216.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEee----ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee--
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT-- 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLAr----dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq-- 828 (1170)
+..++|++++.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|..++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 455789999999999999999999 5678999999998764 3445577899999999999999999999886
Q ss_pred cccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
+...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 456699999999999999999874 5699999999999999999999999999999999999999999999999999985
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
.... ...........||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 177 ~~~~---------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p 229 (327)
T 3lxl_A 177 LPLD---------------------------KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229 (327)
T ss_dssp CCTT---------------------------CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred cccC---------------------------CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 3100 0011122345689999999999998899999999999999999999999
Q ss_pred CCCCCHH---------------HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 988 FNAKTPQ---------------QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 988 F~g~~~~---------------ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
|...... .+...+.... . +..+..+++++.+||.+||+.||.+||++.++.+.|+..|.....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQ-R-LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp GGSHHHHHHHHCC----CCHHHHHHHHHHTTC-C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred CccccchhhhhcccccccccHHHHHHHhhccc-C-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 9754332 2222222222 2 223568999999999999999999999977777778777776554
Q ss_pred hh
Q 001057 1053 WD 1054 (1170)
Q Consensus 1053 we 1054 (1170)
|.
T Consensus 308 ~~ 309 (327)
T 3lxl_A 308 CE 309 (327)
T ss_dssp --
T ss_pred cc
Confidence 44
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=385.93 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=208.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeec---CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKR---ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk---~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
.+..++|++.+.||+|+||.||+|+++ .++..||||++.... .....+.+.+|+.+|.+++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 455678999999999999999999886 467789999987542 345567899999999999999999999999999
Q ss_pred cceEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..+||||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999998754 69999999999999999999999999999999999999999999999999997531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
... ..........+|+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 199 ~~~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~ 251 (373)
T 2qol_A 199 DDP---------------------------EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251 (373)
T ss_dssp ------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTT
T ss_pred cCC---------------------------ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCC
Confidence 000 00001122346789999999999999999999999999999997 99999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.+.+..++...+..+... + .+..++..+.+||.+||+.||.+||++.++.+.|
T Consensus 252 ~~~~~~~~~~~i~~~~~~-~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L 304 (373)
T 2qol_A 252 WEMSNQDVIKAVDEGYRL-P-PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304 (373)
T ss_dssp TTCCHHHHHHHHHTTEEC-C-CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCC-C-CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHH
Confidence 999988888877654321 1 2357899999999999999999999965554443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=365.52 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=199.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh--cCCCcEEEEEeeeec--
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS--VRNPFVVRFFYSFTC-- 829 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILsk--L~HPNIVrL~~~Fqd-- 829 (1170)
....++|++++.||+|+||+||+|++ +|+.||||++.... ...+..|.+++.. ++||||+++++++..
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567899999999999999999987 68999999986532 2445667777776 789999999988654
Q ss_pred --ccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeeccCCCCcEEeCCCCcEEE
Q 001057 830 --RENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH--------SLNVIHRDLKPDNLLIGQDGHIKL 899 (1170)
Q Consensus 830 --~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLH--------s~GIIHRDIKPENILLd~dG~VKL 899 (1170)
...+|+||||+.+|+|.++++. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 3568999999999999999965 57999999999999999999999 999999999999999999999999
Q ss_pred EecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC------CCCcchhhhH
Q 001057 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM------GHGATADWWS 973 (1170)
Q Consensus 900 sDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~------~ys~ksDIWS 973 (1170)
+|||+|+...... ..........+||+.|+|||++.+. .++.++||||
T Consensus 155 ~Dfg~a~~~~~~~--------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvws 208 (301)
T 3q4u_A 155 ADLGLAVMHSQST--------------------------NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208 (301)
T ss_dssp CCCTTCEEEETTT--------------------------TEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHH
T ss_pred eeCCCeeeccccc--------------------------ccccccccccccccceeChhhhcCcCCCCcccCCchhhHHH
Confidence 9999997531000 0011122345899999999999876 3457899999
Q ss_pred HHHHHHHHHhC----------CCCCCCCC----HHHHHHHHhccCCCCCCCCc-----cCCHHHHHHHHHhccCCCCCCC
Q 001057 974 VGIILFELLIG----------IPPFNAKT----PQQIFDNIMNRDIPWPNIPE-----EMSVEACDLIDKLLTENPVQRL 1034 (1170)
Q Consensus 974 LGVILYELLTG----------~pPF~g~~----~~ei~qkIl~~~l~fP~ip~-----~lS~eakDLIkkLLq~DPskRp 1034 (1170)
|||++|||++| .+||.... .......+.......+..+. ..+.++.+||.+||+.||.+||
T Consensus 209 lG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 288 (301)
T 3q4u_A 209 FGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288 (301)
T ss_dssp HHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred HHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC
Confidence 99999999999 89996532 22333333322222232322 3567899999999999999999
Q ss_pred ChhhHHHHH
Q 001057 1035 GATGAREVK 1043 (1170)
Q Consensus 1035 Sa~~AeEIL 1043 (1170)
++.++.+.|
T Consensus 289 s~~~i~~~L 297 (301)
T 3q4u_A 289 TALRIKKTL 297 (301)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 955554443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.12 Aligned_cols=253 Identities=25% Similarity=0.397 Sum_probs=214.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++++.||+|+||.||+|++. ++..||+|++..... ..+.+.+|+.+|..++||||+++++++. .+.+|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcE
Confidence 44578999999999999999999975 567899999876432 2357889999999999999999999886 45689
Q ss_pred EEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+||||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-- 161 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-- 161 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC--
Confidence 9999999999999997643 699999999999999999999999999999999999999999999999999975310
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
..........||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 162 ---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 162 ---------------------------NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp ---------------------------SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ---------------------------cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 00011223457889999999998889999999999999999999 99999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+..++...+..+... ..+..++.++.+||.+||..||.+||++.++.+.|+
T Consensus 215 ~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 265 (279)
T 1qpc_A 215 TNPEVIQNLERGYRM--VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (279)
T ss_dssp CHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHhcccCC--CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 988888887765322 234678999999999999999999999666655554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=376.10 Aligned_cols=253 Identities=20% Similarity=0.315 Sum_probs=201.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc---
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE--- 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~--- 831 (1170)
+..++|++++.||+|+||+||+|++. ++.||||++.... ........|+.+|..++|||||++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD 94 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence 45678999999999999999999875 7999999987542 23345566888999999999999999998754
Q ss_pred -ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CeeeccCCCCcEEeCCCCcEEEE
Q 001057 832 -NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL----------NVIHRDLKPDNLLIGQDGHIKLT 900 (1170)
Q Consensus 832 -~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~----------GIIHRDIKPENILLd~dG~VKLs 900 (1170)
.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 37999999999999999976 4599999999999999999999999 99999999999999999999999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-----CCCcchhhhHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-----GHGATADWWSVG 975 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-----~ys~ksDIWSLG 975 (1170)
|||+|+..... .........+||+.|+|||++.+. .++.++||||||
T Consensus 174 DFg~a~~~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 225 (322)
T 3soc_A 174 DFGLALKFEAG----------------------------KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225 (322)
T ss_dssp CCTTCEEECTT----------------------------SCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred cCCcccccccc----------------------------cCccccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence 99999753100 001112346799999999999873 456678999999
Q ss_pred HHHHHHHhCCCCCCCCC----------------HHHHHHHHhccCCCCCCCCc-----cCCHHHHHHHHHhccCCCCCCC
Q 001057 976 IILFELLIGIPPFNAKT----------------PQQIFDNIMNRDIPWPNIPE-----EMSVEACDLIDKLLTENPVQRL 1034 (1170)
Q Consensus 976 VILYELLTG~pPF~g~~----------------~~ei~qkIl~~~l~fP~ip~-----~lS~eakDLIkkLLq~DPskRp 1034 (1170)
|++|||++|.+||.+.. ...+...+..... .|..+. ..+.++.+||.+||+.||.+||
T Consensus 226 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 304 (322)
T 3soc_A 226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKK-RPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304 (322)
T ss_dssp HHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCC-CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccC-CCCccccccccchHHHHHHHHHHHccCChhhCc
Confidence 99999999999997642 2333333333222 222222 2345699999999999999999
Q ss_pred ChhhHHHHH
Q 001057 1035 GATGAREVK 1043 (1170)
Q Consensus 1035 Sa~~AeEIL 1043 (1170)
++.++.+.|
T Consensus 305 s~~ell~~L 313 (322)
T 3soc_A 305 SAGCVGERI 313 (322)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 955554433
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=363.32 Aligned_cols=249 Identities=25% Similarity=0.446 Sum_probs=207.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-cc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-EN 832 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-~~ 832 (1170)
.+..++|++++.||+|+||+||+|.+. |+.||+|++.... ..+.+.+|+.++..++||||+++++++... +.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 355688999999999999999999874 8899999987542 346788999999999999999999986544 57
Q ss_pred eEEEEeeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~--LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
+|+||||+.+|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~- 168 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS- 168 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc-
Confidence 9999999999999999986543 8999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~ 989 (1170)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.
T Consensus 169 --------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 216 (278)
T 1byg_A 169 --------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216 (278)
T ss_dssp ---------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred --------------------------------ccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 00112357889999999999999999999999999999998 999999
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
..+..++...+..+.. +..+..+++.+.+||.+||+.||.+||++.++.+.|+
T Consensus 217 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 269 (278)
T 1byg_A 217 RIPLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269 (278)
T ss_dssp TSCGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHhcCCC--CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence 9888888777765532 2345688999999999999999999999665554443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=360.80 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=210.2
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce-E
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL-Y 834 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe---~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L-y 834 (1170)
.|++.+.||+|+||+||+|++..++. .||+|++... ......+.+.+|+.+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 57888999999999999999765554 8999998753 2445667889999999999999999999999877665 9
Q ss_pred EEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE- 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG-
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc-
Confidence 999999999999999874 568999999999999999999999999999999999999999999999999997421000
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~ 992 (1170)
...........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+
T Consensus 179 -------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 179 -------------------------YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp -------------------------GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred -------------------------ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 001112234568899999999999999999999999999999999 666677777
Q ss_pred HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
..++...+...... ..+..++..+.+||.+||+.||.+||++.++.+
T Consensus 234 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 234 PFDLTHFLAQGRRL--PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp GGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcCCCC--CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 77777766655432 234678999999999999999999999544433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=391.03 Aligned_cols=247 Identities=26% Similarity=0.453 Sum_probs=212.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-ce
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE-NL 833 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~-~L 833 (1170)
+..++|++++.||+|+||.||+|.+. |+.||||+++... ..+.+.+|+.+|.+++|||||++++++.... .+
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 45678999999999999999999875 7799999987643 3457889999999999999999999876655 79
Q ss_pred EEEEeeccCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~--LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
||||||+.+|+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~-- 340 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-- 340 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc--
Confidence 999999999999999987653 7999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
.......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+
T Consensus 341 -------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 341 -------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp -------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred -------------------------------ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 00112357889999999999999999999999999999998 9999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.+..++...+..+.. +..+..+++++.+||.+||+.||.+||++.++.+.|
T Consensus 390 ~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 390 IPLKDVVPRVEKGYK--MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp SCTTTHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 888888877766532 234578999999999999999999999966554444
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=370.89 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=212.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCC----CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATG----DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TG----e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
.+...+|++.+.||+|+||+||+|++..++ ..||+|++.... .......+.+|+.++..++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 455678999999999999999999987553 469999987543 34455678999999999999999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
.+.+||||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999765 57999999999999999999999999999999999999999999999999999753
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPP 987 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pP 987 (1170)
.... ..........||+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 198 ~~~~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 250 (333)
T 1mqb_A 198 EDDP---------------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250 (333)
T ss_dssp ----------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccc---------------------------ccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence 1000 00011123356889999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
|.+.+..++...+..+... ..+..++..+.+||.+||+.||.+||++.++.+.|
T Consensus 251 f~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 304 (333)
T 1mqb_A 251 YWELSNHEVMKAINDGFRL--PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304 (333)
T ss_dssp TTTCCHHHHHHHHHTTCCC--CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred cccCCHHHHHHHHHCCCcC--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999988888887765321 23467899999999999999999999955444433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=376.24 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=206.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEE----EEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLF----AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~V----AIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
+..++|++++.||+|+||+||+|++..+++.| |+|.+.... .......+.+|+.+|..++||||++++++|...
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 45678999999999999999999998888766 555543321 223456788999999999999999999999875
Q ss_pred cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
. .++||+|+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4 78999999999999999864 569999999999999999999999999999999999999999999999999997531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
.. ..........||+.|+|||++.+..++.++|||||||++|+|++ |.+||
T Consensus 169 ~~----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~ 220 (327)
T 3lzb_A 169 AE----------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220 (327)
T ss_dssp ---------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred Cc----------------------------cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCC
Confidence 00 00111223457889999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
.+.+..++...+...... ..+..++.++.+||.+||..||.+||++.++
T Consensus 221 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 221 DGIPASEISSILEKGERL--PQPPICTIDVYMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp TTCCGGGHHHHHHTTCCC--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 998888887777655422 2346789999999999999999999994433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=362.72 Aligned_cols=271 Identities=21% Similarity=0.323 Sum_probs=209.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEE-eeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFF-YSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~-~~Fqd~~~LyL 835 (1170)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+.++..++|++++..+ .++...+..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 4689999999999999999999999999999998765432 23477899999999987765554 44566778999
Q ss_pred EEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe---CCCCcEEEEecCCccccccc
Q 001057 836 VMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL---d~dG~VKLsDFGLAk~~~~~ 911 (1170)
||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999985 4579999999999999999999999999999999999999 78899999999999853210
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
... ............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 162 ~~~-----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 4hgt_A 162 RTH-----------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TTC-----------------------CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccC-----------------------ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCccc
Confidence 000 000011234568999999999999999999999999999999999999999874
Q ss_pred CH---HHHHHHHhccCCCCC--CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc-------CCCCCCCChhhh
Q 001057 992 TP---QQIFDNIMNRDIPWP--NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ-------HPFFKNINWDTL 1056 (1170)
Q Consensus 992 ~~---~ei~qkIl~~~l~fP--~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq-------HPfF~~idwe~L 1056 (1170)
+. ...+..+.......+ .....++.++.+||.+||+.||.+||++.++.+.++ ..|-...+|+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 219 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp CCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred chhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 32 223333333222211 122467899999999999999999999665555443 355555667654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=387.95 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=206.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc--c
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE--N 832 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~--~ 832 (1170)
...++|++.+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+|..++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 3456899999999999999999999999999999999765432 23466789999999999999999999988765 7
Q ss_pred eEEEEeeccCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe----CCCCcEEEEecCCc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLG---CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI----GQDGHIKLTDFGLS 905 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~---~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL----d~dG~VKLsDFGLA 905 (1170)
+||||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999997653 39999999999999999999999999999999999999 77788999999999
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--------CCCCcchhhhHHHHH
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--------MGHGATADWWSVGII 977 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g--------~~ys~ksDIWSLGVI 977 (1170)
+... ........+||+.|+|||++.+ ..++.++|||||||+
T Consensus 164 ~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~i 212 (396)
T 4eut_A 164 RELE-------------------------------DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (396)
T ss_dssp EECC-------------------------------CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHH
T ss_pred eEcc-------------------------------CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHH
Confidence 7521 0112234679999999999975 457889999999999
Q ss_pred HHHHHhCCCCCCC----CCHHHHHHHHhccCCC-------------------CC---CCCccCCHHHHHHHHHhccCCCC
Q 001057 978 LFELLIGIPPFNA----KTPQQIFDNIMNRDIP-------------------WP---NIPEEMSVEACDLIDKLLTENPV 1031 (1170)
Q Consensus 978 LYELLTG~pPF~g----~~~~ei~qkIl~~~l~-------------------fP---~ip~~lS~eakDLIkkLLq~DPs 1031 (1170)
+|||++|..||.+ ....+++..+..+... ++ .+...++..+.+||.+||+.||.
T Consensus 213 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~ 292 (396)
T 4eut_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292 (396)
T ss_dssp HHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred HHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChh
Confidence 9999999999964 2334555555544321 01 12234667899999999999999
Q ss_pred CCCChh
Q 001057 1032 QRLGAT 1037 (1170)
Q Consensus 1032 kRpSa~ 1037 (1170)
+|+++.
T Consensus 293 ~R~s~~ 298 (396)
T 4eut_A 293 KCWGFD 298 (396)
T ss_dssp TSCCHH
T ss_pred hhccHH
Confidence 999944
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.29 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=207.4
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEE-EeeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRF-FYSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL-~~~Fqd~~~LyL 835 (1170)
.++|++.+.||+|+||.||+|++..+|+.||||++...... ..+.+|+.++..++|++++.. ..++.....+|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 46899999999999999999999999999999998764322 357889999999998775544 444566778899
Q ss_pred EEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC---CCCcEEEEecCCccccccc
Q 001057 836 VMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG---QDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd---~dG~VKLsDFGLAk~~~~~ 911 (1170)
||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 8999999974 45799999999999999999999999999999999999994 7889999999999853210
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
... ............||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 162 ~~~-----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 162 RTH-----------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TTC-----------------------CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred ccc-----------------------cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 000 000011234568999999999999999999999999999999999999999874
Q ss_pred C---HHHHHHHHhccCCCCC--CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 992 T---PQQIFDNIMNRDIPWP--NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 992 ~---~~ei~qkIl~~~l~fP--~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
. ..+.+..+.......+ .....++.++.+||.+||+.||.+||++.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 219 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp CCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred CchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 3 2334444433322222 1225688999999999999999999997666665543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=362.84 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=210.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeee-eccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRAT---GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSF-TCRE 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~T---Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~F-qd~~ 831 (1170)
...+|++.+.||+|+||+||+|++..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++ ...+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 345799999999999999999997543 346899988753 2445667899999999999999999999984 5567
Q ss_pred ceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
..|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 899999999999999999764 4689999999999999999999999999999999999999999999999999975310
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~ 989 (1170)
.. ...........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.
T Consensus 181 ~~--------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 234 (298)
T 3f66_A 181 KE--------------------------YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234 (298)
T ss_dssp GG--------------------------GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cc--------------------------hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCc
Confidence 00 000112234568899999999999999999999999999999999 778888
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
+.+..+....+....... .+..++..+.+||.+||+.||.+||++.++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 235 DVNTFDITVYLLQGRRLL--QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp TSCTTTHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHhcCCCCC--CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 887777777776655432 246789999999999999999999995544443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=376.51 Aligned_cols=270 Identities=18% Similarity=0.203 Sum_probs=207.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecC---CCCEEEEEEeeccccccHH--------HHHHHHHHHHHHHhcCCCcEEEE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRA---TGDLFAIKVLKKADMIRKN--------AVESILAERNILISVRNPFVVRF 823 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~---TGe~VAIKvLkKs~i~~~~--------~ve~~l~EieILskL~HPNIVrL 823 (1170)
...++|++.+.||+|+||+||+|++.. ++..||||++......... ....+.+|+.++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 445789999999999999999999987 8889999998765321111 11246678899999999999999
Q ss_pred Eeeeec----ccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC--cE
Q 001057 824 FYSFTC----RENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG--HI 897 (1170)
Q Consensus 824 ~~~Fqd----~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG--~V 897 (1170)
++++.. ...+||||||+ |++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999887 67899999999 999999998877899999999999999999999999999999999999999887 99
Q ss_pred EEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHH
Q 001057 898 KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGII 977 (1170)
Q Consensus 898 KLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVI 977 (1170)
||+|||+|+........ ...........+||+.|+|||++.+..++.++|||||||+
T Consensus 193 kL~Dfg~a~~~~~~~~~-----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 249 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNH-----------------------KQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYC 249 (345)
T ss_dssp EECCCTTCEESSGGGCC-----------------------CCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHH
T ss_pred EEEeCCCceeccccccc-----------------------ccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHH
Confidence 99999999853210000 0001112245689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCC--CHHHHHHHHhccCCCCCC------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 978 LFELLIGIPPFNAK--TPQQIFDNIMNRDIPWPN------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 978 LYELLTG~pPF~g~--~~~ei~qkIl~~~l~fP~------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
+|||++|..||.+. +...............+. ....++.++.+||.+||+.||.+||++.++.+.|+...+
T Consensus 250 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 250 MLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 99999999999652 333222221111111110 012688999999999999999999997777777766443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.55 Aligned_cols=255 Identities=21% Similarity=0.333 Sum_probs=206.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecC---CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRA---TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~---TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
.+..++|.+.+.||+|+||.||+|++.. ++..||+|++.... ......+.+.+|+.++..++||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3456789999999999999999998765 56689999987543 2345567889999999999999999999998875
Q ss_pred c-----ceEEEEeeccCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEE
Q 001057 831 E-----NLYLVMEYLNGGDLYSLLRN------LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKL 899 (1170)
Q Consensus 831 ~-----~LyLVMEY~~GGSL~dlLk~------~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKL 899 (1170)
. .+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence 4 45999999999999999942 356999999999999999999999999999999999999999999999
Q ss_pred EecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHH
Q 001057 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979 (1170)
Q Consensus 900 sDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILY 979 (1170)
+|||+++..... ..........|++.|+|||++.+..++.++|||||||++|
T Consensus 189 ~Dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 240 (313)
T 3brb_A 189 ADFGLSKKIYSG----------------------------DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240 (313)
T ss_dssp CSCSCC--------------------------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred eecCcceecccc----------------------------cccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHH
Confidence 999998753100 0001122345788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 980 ELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 980 ELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
+|++ |.+||.+.+...+...+..+... ..+..++.++.+||.+||..||.+||++.++
T Consensus 241 el~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (313)
T 3brb_A 241 EIATRGMTPYPGVQNHEMYDYLLHGHRL--KQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299 (313)
T ss_dssp HHHTTSCCSSTTCCGGGHHHHHHTTCCC--CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred HHHhcCCCCCccCCHHHHHHHHHcCCCC--CCCccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9999 99999999888888887765432 3346789999999999999999999994443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=363.20 Aligned_cols=257 Identities=20% Similarity=0.328 Sum_probs=201.3
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..+..++|++.+.||+|+||+||+|++.. .||+|++.... ......+.+.+|+.+|+.++||||++++++ .....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCCc
Confidence 45677889999999999999999998643 59999987543 345566789999999999999999999985 45667
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+++||||+.|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 89999999999999999644 56999999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
..........||+.|+|||++. +..++.++|||||||++|+|++|..||
T Consensus 174 ----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 174 ----------------------------SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp --------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ----------------------------cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 0011223457999999999997 566888999999999999999999999
Q ss_pred CCCCHHH-HHHHHhccCCC--CCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 989 NAKTPQQ-IFDNIMNRDIP--WPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 989 ~g~~~~e-i~qkIl~~~l~--fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
.+....+ +...+...... ++.....++.++.+||.+||+.||.+||++.++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 226 SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp SSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 8765544 44444443322 223345789999999999999999999995544443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=388.78 Aligned_cols=255 Identities=23% Similarity=0.378 Sum_probs=218.0
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+..++|++.+.||+|+||+||+|++. ++..||||+++.... ..+.+.+|+.+|+.++|||||++++++. .+.+
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 345678999999999999999999985 467899999976432 3567899999999999999999999886 6679
Q ss_pred EEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
||||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~- 336 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED- 336 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC-
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC-
Confidence 9999999999999999754 3689999999999999999999999999999999999999999999999999985210
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
..........+|+.|+|||++....++.++|||||||+||||++ |..||.+
T Consensus 337 ----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 337 ----------------------------NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp ----------------------------HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ----------------------------CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 00111223456889999999998899999999999999999999 9999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.+..++...+..+.. . ..+..++.++.+||.+||..||.+||++.++.+.|+.
T Consensus 389 ~~~~~~~~~i~~~~~-~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~ 441 (454)
T 1qcf_A 389 MSNPEVIRALERGYR-M-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 441 (454)
T ss_dssp CCHHHHHHHHHHTCC-C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCHHHHHHHHHcCCC-C-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 999888888776532 2 2346899999999999999999999997777666654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=396.19 Aligned_cols=257 Identities=23% Similarity=0.376 Sum_probs=221.2
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.+...+|++.+.||+|+||.||+|+++.++..||||++..... ..+.+.+|+.+|..++|||||+++++|.....+
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 3455789999999999999999999999999999999876432 246789999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
||||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 370 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG- 370 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT-
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC-
Confidence 9999999999999999864 4589999999999999999999999999999999999999999999999999985210
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
..........+|+.|+|||++.+..++.++|||||||+||||++ |..||.+
T Consensus 371 ----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 371 ----------------------------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp ----------------------------CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ----------------------------CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 00011223456789999999999899999999999999999999 9999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.+..++++.+..+.. . ..+..++.++.+||.+||+.||.+||++.++.+.|+.
T Consensus 423 ~~~~~~~~~~~~~~~-~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 475 (495)
T 1opk_A 423 IDLSQVYELLEKDYR-M-ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475 (495)
T ss_dssp CCGGGHHHHHHTTCC-C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCHHHHHHHHHcCCC-C-CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 988888777665432 1 2356899999999999999999999997777666654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=380.96 Aligned_cols=263 Identities=16% Similarity=0.238 Sum_probs=203.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCC-----CCEEEEEEeeccccccHHHH--------HHHHHHHHHHHhcCCCcEE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRAT-----GDLFAIKVLKKADMIRKNAV--------ESILAERNILISVRNPFVV 821 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~T-----Ge~VAIKvLkKs~i~~~~~v--------e~~l~EieILskL~HPNIV 821 (1170)
...++|++++.||+|+||+||+|.+..+ ++.||||++........... ..+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 4456899999999999999999998764 58899999876532111111 2344566677788999999
Q ss_pred EEEeeeecc----cceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC--CC
Q 001057 822 RFFYSFTCR----ENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG--QD 894 (1170)
Q Consensus 822 rL~~~Fqd~----~~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd--~d 894 (1170)
++++++... .++||||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998775 4589999999 99999999876 6799999999999999999999999999999999999999 88
Q ss_pred CcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHH
Q 001057 895 GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSV 974 (1170)
Q Consensus 895 G~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSL 974 (1170)
+.+||+|||+|+........ ...........+||+.|+|||++.+..++.++|||||
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~-----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 247 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVH-----------------------KAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEIL 247 (364)
T ss_dssp TCEEECCCTTCEESSGGGCC-----------------------CCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred CeEEEEECCcceecccCCcc-----------------------cccccCcccccCCCCCccCHHHhCCCCCCchhhHHHH
Confidence 99999999999853211000 0001112245679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHhc----cCC------CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 975 GIILFELLIGIPPFNAKTPQQIFDNIMN----RDI------PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 975 GVILYELLTG~pPF~g~~~~ei~qkIl~----~~l------~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
||++|||++|..||.+......+..... ..+ .++ ...++.++.+||..||..||.+||++..+.++|
T Consensus 248 G~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 248 GYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp HHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred HHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 9999999999999986432222111111 000 011 146789999999999999999999966655544
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=365.19 Aligned_cols=246 Identities=27% Similarity=0.441 Sum_probs=200.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++.+.||+|+||+||+|++. ++.||+|++... ...+.+.+|+.+|..++||||+++++++. +.+|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcE
Confidence 45678999999999999999999874 788999998643 34567889999999999999999999887 4589
Q ss_pred EEEeeccCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCCCcEEeCCCCc-EEEEecCCccc
Q 001057 835 LVMEYLNGGDLYSLLRNLG---CLDEDMARVYIAELVLALEYLHS---LNVIHRDLKPDNLLIGQDGH-IKLTDFGLSKV 907 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~---~LSEe~ar~IaaQIL~ALeYLHs---~GIIHRDIKPENILLd~dG~-VKLsDFGLAk~ 907 (1170)
+||||++||+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999998654 47899999999999999999999 89999999999999998886 79999999874
Q ss_pred cccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCC
Q 001057 908 GLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 908 ~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 156 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 202 (307)
T 2eva_A 156 IQ---------------------------------THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202 (307)
T ss_dssp ------------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCT
T ss_pred cc---------------------------------cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 21 011234699999999999999999999999999999999999999
Q ss_pred CCCCC--HHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 988 FNAKT--PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 988 F~g~~--~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
|.... ...+...+..... +..+..++..+.+||.+||+.||.+||++.++.+.|.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 203 FDEIGGPAFRIMWAVHNGTR--PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp TTTTCSSHHHHHHHHHTTCC--CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred chhhCccHHHHHHHHhcCCC--CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 98543 3333333433322 3344678999999999999999999999655544443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=374.56 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=208.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+.+|+.+|..++||||+++++++.+.+.+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 445678999999999999999999964 68999999877543 23457789999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLG----CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~----~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 190 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGT 190 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECS
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999999996543 58999999999999999999999999999999999999999999999999997521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.. ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 191 ~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~ 242 (321)
T 2qkw_B 191 EL----------------------------DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242 (321)
T ss_dssp SS----------------------------SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred cc----------------------------cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccc
Confidence 00 00111234568999999999999999999999999999999999999997
Q ss_pred CCCHHHHH-------HHHhccCCC-------CCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 990 AKTPQQIF-------DNIMNRDIP-------WPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 990 g~~~~ei~-------qkIl~~~l~-------fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+..+.+.. .......+. ...++...+..+.+||.+||+.||.+||+ +.++++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 309 (321)
T 2qkw_B 243 QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS---MGDVLWK 309 (321)
T ss_dssp CSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred ccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 65432211 111111111 01123455678999999999999999999 5555554
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=365.69 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=187.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeee-----
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFT----- 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fq----- 828 (1170)
+...+|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|+.++..+. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 33458999999999999999999999999999999986542 345567889999999996 999999999883
Q ss_pred ---cccceEEEEeeccCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeCCCCcEEEE
Q 001057 829 ---CRENLYLVMEYLNGGDLYSLLRN---LGCLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIGQDGHIKLT 900 (1170)
Q Consensus 829 ---d~~~LyLVMEY~~GGSL~dlLk~---~~~LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd~dG~VKLs 900 (1170)
....+|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEe
Confidence 3456899999995 799998865 456999999999999999999999999 9999999999999999999999
Q ss_pred ecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHH---hcCCCCcchhhhHHHHH
Q 001057 901 DFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL---LGMGHGATADWWSVGII 977 (1170)
Q Consensus 901 DFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL---~g~~ys~ksDIWSLGVI 977 (1170)
|||+++.......... ..............+||+.|+|||++ .+..++.++|||||||+
T Consensus 181 Dfg~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~i 242 (337)
T 3ll6_A 181 DFGSATTISHYPDYSW------------------SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------------------------CCTTSCSSHHHHHHHHHHH
T ss_pred cCccceeccccCcccc------------------cccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHH
Confidence 9999985321000000 00000001122356799999999999 56678899999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 978 LFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 978 LYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+|+|++|..||.+.....+.. .....+ .+...+..+.+||.+||+.||.+||+ +.++++|
T Consensus 243 l~el~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~ 302 (337)
T 3ll6_A 243 LYLLCFRQHPFEDGAKLRIVN----GKYSIP-PHDTQYTVFHSLIRAMLQVNPEERLS---IAEVVHQ 302 (337)
T ss_dssp HHHHHHSSCCC----------------CCCC-TTCCSSGGGHHHHHHHSCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhCCCCCcchhHHHhhc----CcccCC-cccccchHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 999999999998765544333 233322 23567888999999999999999999 6666665
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=392.18 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=203.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..+|.+.+.||+|+||+||. ....+|+.||||++...... .+.+|+.+|..+ +|||||++++++.+...+||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 34699999999999999764 44568999999998764322 245799999999 79999999999999999999
Q ss_pred EEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---C--CcEEEEecCCccccc
Q 001057 836 VMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ---D--GHIKLTDFGLSKVGL 909 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~---d--G~VKLsDFGLAk~~~ 909 (1170)
|||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||||+. + ..+||+|||+|+...
T Consensus 96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 999995 69999998654 4566677889999999999999999999999999999953 2 358899999998531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh---cCCCCcchhhhHHHHHHHHHHh-CC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL---GMGHGATADWWSVGIILFELLI-GI 985 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~---g~~ys~ksDIWSLGVILYELLT-G~ 985 (1170)
... .........+||+.|+|||++. ...++.++|||||||++|||++ |.
T Consensus 175 ~~~---------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~ 227 (432)
T 3p23_A 175 VGR---------------------------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227 (432)
T ss_dssp --------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSC
T ss_pred CCC---------------------------cceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCC
Confidence 000 0011223567999999999998 3567889999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChh
Q 001057 986 PPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 986 pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe 1054 (1170)
+||...........+..........+...+..+.+||.+||+.||.+||+ +.++++||||.++.|.
T Consensus 228 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 228 HPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS---AKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp BTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC---HHHHHTSTTTCCHHHH
T ss_pred CCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCC---HHHHHhCccccChHHH
Confidence 99976655444333332223222222445677999999999999999999 8899999999998774
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=386.00 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=197.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~LyL 835 (1170)
.+.|.+.+.||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|..+ +|||||++++++.+...+||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 345777899999999999875 45689999999986532 24567899999876 89999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC-------------C
Q 001057 836 VMEYLNGGDLYSLLRNLGCLD-------EDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD-------------G 895 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LS-------Ee~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d-------------G 895 (1170)
|||||. |+|.+++....... +..+..++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCce
Confidence 999995 69999998764332 23456799999999999999999999999999999754 4
Q ss_pred cEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-------CCCCcc
Q 001057 896 HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-------MGHGAT 968 (1170)
Q Consensus 896 ~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-------~~ys~k 968 (1170)
.+||+|||+|+...... ..........+||+.|+|||++.+ ..++.+
T Consensus 166 ~~kL~DFG~a~~~~~~~--------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~ 219 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQ--------------------------SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219 (434)
T ss_dssp EEEECCCTTCEECCC----------------------------------------CCTTSCHHHHSCCCTTSCCCCCCTH
T ss_pred EEEEcccccceecCCCC--------------------------ccceeeecCCCCCCCccCHHHhccccccccccCcchh
Confidence 89999999998531000 000111234689999999999976 568999
Q ss_pred hhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCC----CccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 969 ADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNI----PEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 969 sDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~i----p~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
+|||||||++|||++ |.+||.+....+ ..+..+...++.. ...++.++.+||.+||+.||.+||+ +.+++
T Consensus 220 ~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil 294 (434)
T 2rio_A 220 IDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT---AMKVL 294 (434)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred hhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCC---HHHHH
Confidence 999999999999999 999998765443 3444444443322 1245789999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001057 1044 QHPFFKNI 1051 (1170)
Q Consensus 1044 qHPfF~~i 1051 (1170)
+||||...
T Consensus 295 ~hp~f~~~ 302 (434)
T 2rio_A 295 RHPLFWPK 302 (434)
T ss_dssp TSGGGSCH
T ss_pred hCCccCCc
Confidence 99999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=366.50 Aligned_cols=262 Identities=21% Similarity=0.358 Sum_probs=205.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee----cc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT----CR 830 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq----d~ 830 (1170)
+..++|++++.||+|+||.||+|++..+|+.||||++... .....+.+.+|+.++..++||||+++++++. ..
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 3456899999999999999999999999999999998653 3455678899999999999999999999887 34
Q ss_pred cceEEEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk 906 (1170)
..+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 578999999999999999976 3679999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC---CCcchhhhHHHHHHHHHHh
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG---HGATADWWSVGIILFELLI 983 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~---ys~ksDIWSLGVILYELLT 983 (1170)
........ ..............||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 183 ~~~~~~~~---------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 241 (317)
T 2buj_A 183 QACIHVEG---------------------SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF 241 (317)
T ss_dssp ESCEEEES---------------------HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHH
T ss_pred hccccccc---------------------ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHh
Confidence 52100000 00000001123456899999999997654 6889999999999999999
Q ss_pred CCCCCCCCCH--HHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 984 GIPPFNAKTP--QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 984 G~pPF~g~~~--~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|..||..... ......+. ....++ .+..++.++.+||.+||+.||.+||+ +.++++|
T Consensus 242 g~~p~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 300 (317)
T 2buj_A 242 GEGPYDMVFQKGDSVALAVQ-NQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPH---IPLLLSQ 300 (317)
T ss_dssp SSCTTHHHHHTTSCHHHHHH-CC--CC-CCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CCCChhhhhcccchhhHHhh-ccCCCC-ccccCCHHHHHHHHHHhhcChhhCCC---HHHHHHH
Confidence 9999954211 11222222 233333 23578999999999999999999999 5566654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=371.84 Aligned_cols=241 Identities=16% Similarity=0.241 Sum_probs=197.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEe-----eecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC---CCcEEEEEe
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLA-----RKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR---NPFVVRFFY 825 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLA-----rdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~---HPNIVrL~~ 825 (1170)
....++|++.+.||+|+||+||+| .+..+++.||||++.... ...+..|+.++..++ |+||+++++
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 455678999999999999999999 467789999999987542 235677888888887 899999999
Q ss_pred eeecccceEEEEeeccCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-------
Q 001057 826 SFTCRENLYLVMEYLNGGDLYSLLRN-----LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ------- 893 (1170)
Q Consensus 826 ~Fqd~~~LyLVMEY~~GGSL~dlLk~-----~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~------- 893 (1170)
++...+..|||||||+||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+||||+.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 99999999999999999999999974 456999999999999999999999999999999999999998
Q ss_pred ----CCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcch
Q 001057 894 ----DGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA 969 (1170)
Q Consensus 894 ----dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ks 969 (1170)
++.+||+|||+|+..... .........+||+.|||||++.+..|+.++
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 266 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLF----------------------------PKGTIFTAKCETSGFQCVEMLSNKPWNYQI 266 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGS----------------------------CTTEEECCSSCTTSCCCHHHHTTCCBSTHH
T ss_pred cccccCCEEEeeCchhhhhhcc----------------------------CCCceeeeecCCCCCCChHHhcCCCCCccc
Confidence 899999999999742100 011233456899999999999999999999
Q ss_pred hhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC
Q 001057 970 DWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 970 DIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
|||||||++|||++|..||....... ......+.. ...+....+++.+||+.+|.+|+.
T Consensus 267 DiwslG~il~elltg~~pf~~~~~~~-----~~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 267 DYFGVAATVYCMLFGTYMKVKNEGGE-----CKPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp HHHHHHHHHHHHHHSSCCCEEEETTE-----EEECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred cHHHHHHHHHHHHhCCCccccCCCCc-----eeechhccc--cCcHHHHHHHHHHHcCCCCCCcch
Confidence 99999999999999999996543211 001111222 134778899999999999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=364.78 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=205.1
Q ss_pred CCC-eEEEEEeccCCCeEEEEee----ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-
Q 001057 757 IED-FEIIKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR- 830 (1170)
Q Consensus 757 ied-Yevlk~LG~GgFGtVyLAr----dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~- 830 (1170)
.++ |++++.||+|+||+||++. +..+++.||||++.... .....+.+.+|+.+|..++||||+++++++.+.
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 344 4999999999999997765 45688999999997652 345567889999999999999999999999874
Q ss_pred -cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 -ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 -~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
..+|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 5789999999999999999765 49999999999999999999999999999999999999999999999999998531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
.. ...........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 186 ~~---------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 186 EG---------------------------HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp TT---------------------------CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cc---------------------------ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 00 000112234568899999999999899999999999999999999999997
Q ss_pred CCCHH---------------HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 990 AKTPQ---------------QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 990 g~~~~---------------ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..... .+...+. .... +..+..++.++.+||.+||+.||.+||++.++.+.|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 239 SPPTKFLELIGIAQGQMTVLRLTELLE-RGER-LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp SHHHHHHHHHCSCCHHHHHHHHHHHHH-TTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccchhhhhhhcccccchhHHHHHHHHh-cccC-CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 54321 1122222 2222 234578999999999999999999999965554444
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=373.27 Aligned_cols=255 Identities=16% Similarity=0.234 Sum_probs=202.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCC--------CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEE------
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRAT--------GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVR------ 822 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~T--------Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVr------ 822 (1170)
.++|++.+.||+|+||.||+|++..+ ++.||||++.+. ..+.+|+.++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47899999999999999999999874 889999998754 35778999999999999987
Q ss_pred ---------EEeeeec-ccceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEE
Q 001057 823 ---------FFYSFTC-RENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLL 890 (1170)
Q Consensus 823 ---------L~~~Fqd-~~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENIL 890 (1170)
+++++.. ...+||||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 4555554 67899999999 99999999876 78999999999999999999999999999999999999
Q ss_pred eCCCC--cEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcc
Q 001057 891 IGQDG--HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT 968 (1170)
Q Consensus 891 Ld~dG--~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~k 968 (1170)
++.++ .+||+|||+|+........ ............||+.|+|||++.+..++.+
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~-----------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 248 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKH-----------------------VAYVEGSRSPHEGDLEFISMDLHKGCGPSRR 248 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCC-----------------------CCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH
T ss_pred EcCCCCceEEEecCcceeeccCCCcc-----------------------ccccccccccccCCccccCHHHHccCCCCch
Confidence 99998 9999999999753210000 0001112234589999999999999999999
Q ss_pred hhhhHHHHHHHHHHhCCCCCCCCC--HHHHHHHHh---ccCCCCCCC---CccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 969 ADWWSVGIILFELLIGIPPFNAKT--PQQIFDNIM---NRDIPWPNI---PEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 969 sDIWSLGVILYELLTG~pPF~g~~--~~ei~qkIl---~~~l~fP~i---p~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
+|||||||++|+|++|..||.+.. ...+...+. .....++.. ...++.++.+||.+||+.||.+||++.++.
T Consensus 249 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 328 (352)
T 2jii_A 249 SDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLR 328 (352)
T ss_dssp HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHH
Confidence 999999999999999999998753 333333322 222221110 125789999999999999999999965554
Q ss_pred HHH
Q 001057 1041 EVK 1043 (1170)
Q Consensus 1041 EIL 1043 (1170)
+.|
T Consensus 329 ~~L 331 (352)
T 2jii_A 329 NNL 331 (352)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=382.86 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=212.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.+ +.+|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 455789999999999999999999865 46799999876432 23578899999999999999999998876 7799
Q ss_pred EEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 332 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-- 332 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC--
Confidence 999999999999999753 5699999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
..........||+.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 333 ---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 333 ---------------------------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp -------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ---------------------------CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 00011123457889999999999999999999999999999999 99999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+..++...+..+... ..+..++..+.+||.+||+.||.+||++.++.+.|+.
T Consensus 386 ~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~ 437 (452)
T 1fmk_A 386 VNREVLDQVERGYRM--PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437 (452)
T ss_dssp CHHHHHHHHHTTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 998888887765321 2346899999999999999999999996666665543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=366.48 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=203.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
....++|++.+.||+|+||+||+|++. +|+.||||++...... .....+.+|+.++..++||||++++++|.+....
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 345578999999999999999999854 6899999998764321 1223578999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCCCcEEeCCCCcEEEEecCCcc
Q 001057 834 YLVMEYLNGGDLYSLLRNLG----CLDEDMARVYIAELVLALEYLHSL---NVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~----~LSEe~ar~IaaQIL~ALeYLHs~---GIIHRDIKPENILLd~dG~VKLsDFGLAk 906 (1170)
|+||||+.+|+|.+++.... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+|+
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999998653 499999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~p 986 (1170)
.... ..........||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 183 ~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 233 (326)
T 3uim_A 183 LMDY-----------------------------KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233 (326)
T ss_dssp ECCS-----------------------------SSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCC
T ss_pred ccCc-----------------------------ccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCC
Confidence 5310 00112234569999999999999889999999999999999999999
Q ss_pred CCCCC-----CHHHHHHHHh---ccC-CC-------CCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 987 PFNAK-----TPQQIFDNIM---NRD-IP-------WPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 987 PF~g~-----~~~ei~qkIl---~~~-l~-------fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
||... ........+. ... .. .+..+...+..+.+||.+||+.||.+||++.++.+.|+
T Consensus 234 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred cccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 99521 1111111111 110 00 01122344578999999999999999999544444443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=363.43 Aligned_cols=266 Identities=24% Similarity=0.358 Sum_probs=194.5
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHH--HHhcCCCcEEEEEeeee---
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI--LISVRNPFVVRFFYSFT--- 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieI--LskL~HPNIVrL~~~Fq--- 828 (1170)
.+..++|++++.||+|+||+||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 56778999999999999999999976 68999999987542 1233444444 44589999999987443
Q ss_pred --cccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CeeeccCCCCcEEeCCCCcE
Q 001057 829 --CRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL---------NVIHRDLKPDNLLIGQDGHI 897 (1170)
Q Consensus 829 --d~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~---------GIIHRDIKPENILLd~dG~V 897 (1170)
....+||||||+++|+|.+++... .+++..+..++.||+.||.|||++ ||+||||||+||||+.++.+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 334689999999999999999765 458899999999999999999999 99999999999999999999
Q ss_pred EEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-------CCCCcchh
Q 001057 898 KLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-------MGHGATAD 970 (1170)
Q Consensus 898 KLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-------~~ys~ksD 970 (1170)
||+|||+|+....... .............+||+.|+|||++.+ ..++.++|
T Consensus 160 kL~DFG~a~~~~~~~~----------------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 217 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRL----------------------VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVD 217 (336)
T ss_dssp EECCCTTCEECSSSSC----------------------C---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHH
T ss_pred EEeeccceeecccccc----------------------cCccccccccccCCCccceeCchhhcCCcccccccccccccc
Confidence 9999999985310000 000011122345679999999999987 34567899
Q ss_pred hhHHHHHHHHHHhCCCCCCCCCH-----------------HHHHHHHhccCCCCCCCCcc------CCHHHHHHHHHhcc
Q 001057 971 WWSVGIILFELLIGIPPFNAKTP-----------------QQIFDNIMNRDIPWPNIPEE------MSVEACDLIDKLLT 1027 (1170)
Q Consensus 971 IWSLGVILYELLTG~pPF~g~~~-----------------~ei~qkIl~~~l~fP~ip~~------lS~eakDLIkkLLq 1027 (1170)
||||||++|||++|..||..... ......+.......+.++.. ++.++.+||.+||+
T Consensus 218 iwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 297 (336)
T 3g2f_A 218 MYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297 (336)
T ss_dssp HHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSC
T ss_pred hHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhc
Confidence 99999999999999776643211 11222222222222222222 45589999999999
Q ss_pred CCCCCCCChhhHHHH---HcCCCCCC
Q 001057 1028 ENPVQRLGATGAREV---KQHPFFKN 1050 (1170)
Q Consensus 1028 ~DPskRpSa~~AeEI---LqHPfF~~ 1050 (1170)
.||.+||++.++.+. +-++|-++
T Consensus 298 ~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 298 QDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred CChhhCcchHHHHHHHHHHHHHHHhc
Confidence 999999995544333 33566554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.93 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=196.7
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh--cCCCcEEEEEeeeecc-
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS--VRNPFVVRFFYSFTCR- 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILsk--L~HPNIVrL~~~Fqd~- 830 (1170)
....++|++++.||+|+||.||+|++. ++.||||++.... ......|.+++.. ++||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 344578999999999999999999875 8999999986532 2334456666654 4899999999998876
Q ss_pred ---cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CeeeccCCCCcEEeCCCCcEEE
Q 001057 831 ---ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL--------NVIHRDLKPDNLLIGQDGHIKL 899 (1170)
Q Consensus 831 ---~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~--------GIIHRDIKPENILLd~dG~VKL 899 (1170)
..+|+||||+.+|+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 6799999999999999999764 699999999999999999999999 9999999999999999999999
Q ss_pred EecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcc------hhhhH
Q 001057 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT------ADWWS 973 (1170)
Q Consensus 900 sDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~k------sDIWS 973 (1170)
+|||+|+...... ..........+||+.|+|||++.+..+... +||||
T Consensus 184 ~Dfg~a~~~~~~~--------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diws 237 (337)
T 3mdy_A 184 ADLGLAVKFISDT--------------------------NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237 (337)
T ss_dssp CCCTTCEECC-----------------------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHH
T ss_pred EeCCCceeecccc--------------------------ccccCCCCCCccCcceeChhhcccccCCccccCccccchHH
Confidence 9999997531000 000111235689999999999988776665 99999
Q ss_pred HHHHHHHHHhC----------CCCCCCCC-----HHHHHHHHhccCCCCCCCCc-----cCCHHHHHHHHHhccCCCCCC
Q 001057 974 VGIILFELLIG----------IPPFNAKT-----PQQIFDNIMNRDIPWPNIPE-----EMSVEACDLIDKLLTENPVQR 1033 (1170)
Q Consensus 974 LGVILYELLTG----------~pPF~g~~-----~~ei~qkIl~~~l~fP~ip~-----~lS~eakDLIkkLLq~DPskR 1033 (1170)
|||++|||++| ..||.... .......+..... .+..+. .++.++.+||.+||+.||.+|
T Consensus 238 lG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 316 (337)
T 3mdy_A 238 FGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKL-RPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316 (337)
T ss_dssp HHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC-CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGS
T ss_pred HHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhcc-CccccccchhhHHHHHHHHHHHHhhhhChhhC
Confidence 99999999999 77776432 2223333322222 222222 566789999999999999999
Q ss_pred CChhhHHHHHcC
Q 001057 1034 LGATGAREVKQH 1045 (1170)
Q Consensus 1034 pSa~~AeEILqH 1045 (1170)
|+ +.++++|
T Consensus 317 ps---~~ell~~ 325 (337)
T 3mdy_A 317 LT---ALRVKKT 325 (337)
T ss_dssp CC---HHHHHHH
T ss_pred CC---HHHHHHH
Confidence 99 5555544
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=398.74 Aligned_cols=261 Identities=24% Similarity=0.328 Sum_probs=217.0
Q ss_pred CCCCeEEEE-EeccCCCeEEEEeeec--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 756 SIEDFEIIK-PISQGAFGRVFLARKR--ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 756 ~iedYevlk-~LG~GgFGtVyLArdk--~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..++|.+.. .||+|+||+||+|.++ .++..||||+++... .....+.+.+|+.+|..++|||||++++++.. +.
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 345677777 8999999999999875 356789999997642 23345788999999999999999999999976 56
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+||||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999999999754 45999999999999999999999999999999999999999999999999999853100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
. ..........+|+.|+|||++.+..++.++|||||||+||||++ |..||.+
T Consensus 490 ~---------------------------~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 542 (613)
T 2ozo_A 490 D---------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542 (613)
T ss_dssp ---------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred C---------------------------ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 0 00001122346789999999999999999999999999999998 9999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
.+..+++..+..+... ..+..++.++.+||.+||+.||.+||++.++.+.|++.|+
T Consensus 543 ~~~~~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 543 MKGPEVMAFIEQGKRM--ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp CCSHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCC--CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 9988888888766532 3456899999999999999999999998888777777554
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=397.71 Aligned_cols=255 Identities=23% Similarity=0.337 Sum_probs=212.7
Q ss_pred CeEEE-EEeccCCCeEEEEeee--cCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 759 DFEII-KPISQGAFGRVFLARK--RATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 759 dYevl-k~LG~GgFGtVyLArd--k~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
.+.+. +.||+|+||+||+|.+ +.+++.||||+++... ......+.+.+|+.+|..++|||||++++++.. +.+||
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999954 5677899999987643 233456789999999999999999999998864 56899
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+......
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~--- 523 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--- 523 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc---
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998531000
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ 994 (1170)
..........||+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..
T Consensus 524 ------------------------~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 579 (635)
T 4fl3_A 524 ------------------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 579 (635)
T ss_dssp -----------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ------------------------cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 00011123457889999999999999999999999999999998 99999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
++...+..+... ..+..++.++.+||.+||+.||.+||++.++.+.|+
T Consensus 580 ~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 580 EVTAMLEKGERM--GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp HHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 988888766532 345789999999999999999999999766666554
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=360.01 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=207.9
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEee----ecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLAR----KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLAr----dk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
.....+|++++.||+|+||.||+|+ +..+|+.||||++... .....+.+.+|+.+|..++||||+++++++..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 4566789999999999999999998 4678999999998764 23456788999999999999999999998876
Q ss_pred cc--ceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcc
Q 001057 830 RE--NLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 830 ~~--~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk 906 (1170)
.+ .+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 54 789999999999999999876 459999999999999999999999999999999999999999999999999998
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~p 986 (1170)
...... ..........||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 194 ~~~~~~---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~ 246 (326)
T 2w1i_A 194 VLPQDK---------------------------EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246 (326)
T ss_dssp ECCSSC---------------------------SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTC
T ss_pred hccccc---------------------------cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCC
Confidence 531000 00011223457888999999999889999999999999999999999
Q ss_pred CCCCCCHH----------------HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 987 PFNAKTPQ----------------QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 987 PF~g~~~~----------------ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
||...... .+.+.+... ... ..+..++.++.+||.+||+.||.+||++.++.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~ 316 (326)
T 2w1i_A 247 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-GRL-PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316 (326)
T ss_dssp GGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT-CCC-CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHhhccccchhhhHHHHHHHhhcC-CCC-CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98643110 112222222 122 2346789999999999999999999995544443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=384.12 Aligned_cols=248 Identities=19% Similarity=0.248 Sum_probs=195.7
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc-----cHHHHHHHHHHHHHHHhcC---------CCcE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI-----RKNAVESILAERNILISVR---------NPFV 820 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~-----~~~~ve~~l~EieILskL~---------HPNI 820 (1170)
+..++|++++.||+|+||+||+|++ +|+.||||++.+.... .....+.+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999998 6899999999875321 2233467889999998886 6666
Q ss_pred EEEEee-----------------eec-------------ccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 001057 821 VRFFYS-----------------FTC-------------RENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870 (1170)
Q Consensus 821 VrL~~~-----------------Fqd-------------~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~A 870 (1170)
|+++++ |.+ ...+|||||||.+|++.+.+.+ +.+++..++.++.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 666554 333 6789999999999987777654 578999999999999999
Q ss_pred HHHHH-hCCeeeccCCCCcEEeCCCC--------------------cEEEEecCCccccccccCCCCCCCCCCCCCcccc
Q 001057 871 LEYLH-SLNVIHRDLKPDNLLIGQDG--------------------HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVN 929 (1170)
Q Consensus 871 LeYLH-s~GIIHRDIKPENILLd~dG--------------------~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~ 929 (1170)
|.||| ++||+||||||+||||+.++ .+||+|||+|+...
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~-------------------- 233 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLER-------------------- 233 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEE--------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecC--------------------
Confidence 99999 99999999999999999887 89999999998521
Q ss_pred ccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHhcc-CC-
Q 001057 930 DELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGII-LFELLIGIPPFNAKTP-QQIFDNIMNR-DI- 1005 (1170)
Q Consensus 930 ~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVI-LYELLTG~pPF~g~~~-~ei~qkIl~~-~l- 1005 (1170)
....+||+.|||||++.+.. +.++||||||++ .+++++|..||.+... ..+...+... ..
T Consensus 234 ---------------~~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 297 (336)
T 2vuw_A 234 ---------------DGIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK 297 (336)
T ss_dssp ---------------TTEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS
T ss_pred ---------------CCcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC
Confidence 11358999999999998766 889999998777 7888999999954321 2233333321 11
Q ss_pred --CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH-cCCCCC
Q 001057 1006 --PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK-QHPFFK 1049 (1170)
Q Consensus 1006 --~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL-qHPfF~ 1049 (1170)
..+..+..+++++++||.+||++| + |.|+| +||||+
T Consensus 298 ~~~~~~~~~~~s~~~~dli~~~L~~d-----s---a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 298 TKCNTPAMKQIKRKIQEFHRTMLNFS-----S---ATDLLCQHSLFK 336 (336)
T ss_dssp SCCCSHHHHHHHHHHHHHHHHGGGSS-----S---HHHHHHHCGGGC
T ss_pred cccchhhhhhcCHHHHHHHHHHhccC-----C---HHHHHhcCCCcC
Confidence 111112357899999999999977 5 89999 999995
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=374.73 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=201.9
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCC---CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeee-cccce
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATG---DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFT-CRENL 833 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TG---e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fq-d~~~L 833 (1170)
..|++.+.||+|+||+||+|++..++ ..||+|.+... ......+.+.+|+.+|..++||||+++++++. ..+.+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 46899999999999999999875433 46899988653 23456678999999999999999999999864 45688
Q ss_pred EEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999865 458999999999999999999999999999999999999999999999999997531000
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
. ..........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.
T Consensus 247 ~--------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~ 300 (373)
T 3c1x_A 247 F--------------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 300 (373)
T ss_dssp -------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred c--------------------------ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCC
Confidence 0 00111233467889999999999999999999999999999999 78899887
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
+..++...+..+... ..+..++..+.+||.+||+.||.+||++.++
T Consensus 301 ~~~~~~~~~~~~~~~--~~p~~~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 301 NTFDITVYLLQGRRL--LQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp CSSCHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 777777777665433 2346789999999999999999999995444
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=357.13 Aligned_cols=235 Identities=32% Similarity=0.558 Sum_probs=192.9
Q ss_pred CCCCCCeEEE-EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHH-HhcCCCcEEEEEeeeec--
Q 001057 754 RTSIEDFEII-KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL-ISVRNPFVVRFFYSFTC-- 829 (1170)
Q Consensus 754 ~i~iedYevl-k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieIL-skL~HPNIVrL~~~Fqd-- 829 (1170)
....++|.++ +.||+|+||.||+|++..+++.||||++... ..+.+|+.++ ..++||||++++++|..
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~ 84 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 84 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence 3456789988 7899999999999999999999999998653 2456788887 56689999999999887
Q ss_pred --ccceEEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---CCcEEEEec
Q 001057 830 --RENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ---DGHIKLTDF 902 (1170)
Q Consensus 830 --~~~LyLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~---dG~VKLsDF 902 (1170)
...+||||||++||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecc
Confidence 778999999999999999998764 6999999999999999999999999999999999999998 789999999
Q ss_pred CCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHH
Q 001057 903 GLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982 (1170)
Q Consensus 903 GLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELL 982 (1170)
|+|.... +..++.++|||||||++|+|+
T Consensus 165 g~a~~~~----------------------------------------------------~~~~~~~~DiwslG~il~el~ 192 (299)
T 3m2w_A 165 GFAKETT----------------------------------------------------GEKYDKSCDMWSLGVIMYILL 192 (299)
T ss_dssp TTCEECT----------------------------------------------------TCGGGGHHHHHHHHHHHHHHH
T ss_pred ccccccc----------------------------------------------------cccCCchhhHHHHHHHHHHHH
Confidence 9987410 134677899999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhc----cCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 983 IGIPPFNAKTPQQIFDNIMN----RDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 983 TG~pPF~g~~~~ei~qkIl~----~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+|.+||.+.........+.. ....++. ....++.++.+||.+||+.||.+||+ +.|+++||||++.
T Consensus 193 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 193 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQS 263 (299)
T ss_dssp HSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHTG
T ss_pred HCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCC---HHHHhcChhhccc
Confidence 99999987665443322211 1222110 01368999999999999999999999 8899999999764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.32 Aligned_cols=252 Identities=21% Similarity=0.325 Sum_probs=201.9
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccc-cccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD-MIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~-i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
|...+.||+|+||+||+|.+ +++.||+|++.... .......+.+.+|+.++..++||||+++++++.+.+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44457899999999999986 58899999987543 2233456788999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 839 YLNGGDLYSLLRNL---GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~---~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~---- 186 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF---- 186 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC----
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc----
Confidence 99999999999743 45999999999999999999999999999999999999999999999999998752100
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
..........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.....
T Consensus 187 ------------------------~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 241 (307)
T 2nru_A 187 ------------------------AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241 (307)
T ss_dssp ------------------------SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS
T ss_pred ------------------------cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH
Confidence 00111234579999999999875 58899999999999999999999998754322
Q ss_pred ----HHHHHhccCC--------CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH
Q 001057 996 ----IFDNIMNRDI--------PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV 1042 (1170)
Q Consensus 996 ----i~qkIl~~~l--------~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI 1042 (1170)
+...+..... ..+..+...+..+.+||.+||+.||.+||++.++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp BTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2222221111 1122334567789999999999999999995544433
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=363.25 Aligned_cols=262 Identities=24% Similarity=0.329 Sum_probs=211.9
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
-.+..++|++.+.||+|+||.||+|++.. .||+|++..... .....+.+.+|+.++..++||||+++++++.+...
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 35667899999999999999999998854 399999875432 22233456789999999999999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+|+||||+.|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999999999998754 699999999999999999999999999999999999998 789999999998742100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc---------CCCCcchhhhHHHHHHHHHH
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG---------MGHGATADWWSVGIILFELL 982 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g---------~~ys~ksDIWSLGVILYELL 982 (1170)
.. ...........||+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 183 ~~-------------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~ 237 (319)
T 2y4i_B 183 QA-------------------------GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELH 237 (319)
T ss_dssp ------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHH
T ss_pred cc-------------------------cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHH
Confidence 00 001112234568999999999975 34788999999999999999
Q ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 983 IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 983 TG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+|..||.+.+...+...+..+..+.. .+..++.++.+||.+||..||.+||++.++.+.|+.
T Consensus 238 ~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 299 (319)
T 2y4i_B 238 AREWPFKTQPAEAIIWQMGTGMKPNL-SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299 (319)
T ss_dssp HSSCSSSSCCHHHHHHHHHTTCCCCC-CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTT
T ss_pred hCCCCCCCCCHHHHHHHhccCCCCCC-CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 99999999998888887776554322 234688999999999999999999996655555443
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=386.98 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=216.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++.+.||+|+||.||+|++.. +..||||+++.... ..+.+.+|+.+|+.++|||||++++++.+ ..+|
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 455789999999999999999999865 46799999976442 23578899999999999999999998876 7799
Q ss_pred EEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 415 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-- 415 (535)
T ss_dssp EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC--
T ss_pred EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC--
Confidence 999999999999999753 5699999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
..........+|..|+|||++.+..++.++|||||||+||||++ |..||.+.
T Consensus 416 ---------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~ 468 (535)
T 2h8h_A 416 ---------------------------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468 (535)
T ss_dssp ---------------------------HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred ---------------------------CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 00111223457889999999999999999999999999999999 99999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
...+++..+..+.. . ..+..++.++.+||.+||+.||.+||++.++.+.|+.
T Consensus 469 ~~~~~~~~i~~~~~-~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~ 520 (535)
T 2h8h_A 469 VNREVLDQVERGYR-M-PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520 (535)
T ss_dssp CHHHHHHHHHTTCC-C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CHHHHHHHHHcCCC-C-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 99888888876532 1 2346889999999999999999999997666666654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=384.72 Aligned_cols=275 Identities=21% Similarity=0.305 Sum_probs=220.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CcEEEEEeeeecccceE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H-PNIVrL~~~Fqd~~~Ly 834 (1170)
..++|+++++||+|+||.||+|++..+++.||||++...... ..+..|+.++..+.| ++|+.+..++...+..|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 347899999999999999999999999999999988754322 246789999999987 56666777777788899
Q ss_pred EEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEe---CCCCcEEEEecCCcccccc
Q 001057 835 LVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILL---d~dG~VKLsDFGLAk~~~~ 910 (1170)
|||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999985 4579999999999999999999999999999999999999 5889999999999986321
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
.... ...........+||+.|+|||++.+..++.++|||||||+||||++|..||.+
T Consensus 159 ~~~~-----------------------~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~ 215 (483)
T 3sv0_A 159 TSTH-----------------------QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (483)
T ss_dssp TTTC-----------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred Cccc-----------------------cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 0000 00001123367899999999999999999999999999999999999999987
Q ss_pred CC---HHHHHHHHhccCCCC--CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHH-------HcCCCCCCCChhhhhh
Q 001057 991 KT---PQQIFDNIMNRDIPW--PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREV-------KQHPFFKNINWDTLAR 1058 (1170)
Q Consensus 991 ~~---~~ei~qkIl~~~l~f--P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEI-------LqHPfF~~idwe~L~~ 1058 (1170)
.. ..+.+..+....... ..+...++.++.+||.+||+.||.+||++..+.++ +.++|+..++|+.+..
T Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~ 295 (483)
T 3sv0_A 216 LKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (483)
T ss_dssp CCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC
T ss_pred ccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhcc
Confidence 54 344444444332211 11224678999999999999999999996655443 3479999999998765
Q ss_pred c
Q 001057 1059 Q 1059 (1170)
Q Consensus 1059 ~ 1059 (1170)
.
T Consensus 296 ~ 296 (483)
T 3sv0_A 296 Q 296 (483)
T ss_dssp -
T ss_pred c
Confidence 5
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.48 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=201.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh--cCCCcEEEEEeeeeccc--
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS--VRNPFVVRFFYSFTCRE-- 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILsk--L~HPNIVrL~~~Fqd~~-- 831 (1170)
..++|++.+.||+|+||+||+|++ +|+.||||++.... ...+.+|.+++.. ++||||+++++++....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 346899999999999999999987 58999999986532 3456788999887 78999999999998876
Q ss_pred --ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCeeeccCCCCcEEeCCCCcEEEEe
Q 001057 832 --NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH--------SLNVIHRDLKPDNLLIGQDGHIKLTD 901 (1170)
Q Consensus 832 --~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLH--------s~GIIHRDIKPENILLd~dG~VKLsD 901 (1170)
.+|+||||+.+|+|.+++.+ ..+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 190 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECC
T ss_pred cceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEE
Confidence 79999999999999999976 46999999999999999999999 89999999999999999999999999
Q ss_pred cCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC------CCcchhhhHHH
Q 001057 902 FGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG------HGATADWWSVG 975 (1170)
Q Consensus 902 FGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~------ys~ksDIWSLG 975 (1170)
||++....... ..........+||+.|+|||++.+.. ++.++||||||
T Consensus 191 fg~~~~~~~~~--------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 244 (342)
T 1b6c_B 191 LGLAVRHDSAT--------------------------DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244 (342)
T ss_dssp CTTCEEEETTT--------------------------TEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHH
T ss_pred CCCceeccccc--------------------------cccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHH
Confidence 99997531000 00011234557999999999998753 23689999999
Q ss_pred HHHHHHHhC----------CCCCCCC-----CHHHHHHHHhccCCCCCCCCc-----cCCHHHHHHHHHhccCCCCCCCC
Q 001057 976 IILFELLIG----------IPPFNAK-----TPQQIFDNIMNRDIPWPNIPE-----EMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 976 VILYELLTG----------~pPF~g~-----~~~ei~qkIl~~~l~fP~ip~-----~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
|++|||++| ..||... ....+...+...... +.++. ..+..+.+||.+||+.||.+||+
T Consensus 245 ~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 245 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC-CCCcccccchhHHHHHHHHHHHHhccChhhCCC
Confidence 999999999 7899764 234455555443332 22222 34567999999999999999999
Q ss_pred hhhHHHHHcC
Q 001057 1036 ATGAREVKQH 1045 (1170)
Q Consensus 1036 a~~AeEILqH 1045 (1170)
+ .++++|
T Consensus 324 ~---~~i~~~ 330 (342)
T 1b6c_B 324 A---LRIKKT 330 (342)
T ss_dssp H---HHHHHH
T ss_pred H---HHHHHH
Confidence 4 455543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=388.46 Aligned_cols=254 Identities=25% Similarity=0.369 Sum_probs=213.1
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCC---CCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRAT---GDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR 830 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~T---Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~ 830 (1170)
.+..++|++.+.||+|+||+||+|++..+ +..||+|++.... .....+.+.+|+.+|..++||||+++++++. .
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 462 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 462 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence 34567899999999999999999998653 4679999876532 3455678899999999999999999999885 4
Q ss_pred cceEEEEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
+.+|+||||+.+|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 67899999999999999998654 69999999999999999999999999999999999999999999999999997521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF 988 (1170)
. ..........||+.|+|||++.+..++.++|||||||++|||++ |.+||
T Consensus 543 ~-----------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 593 (656)
T 2j0j_A 543 D-----------------------------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593 (656)
T ss_dssp C---------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred C-----------------------------CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence 0 00011123457889999999999999999999999999999997 99999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
.+.+..++...+..+... ..+..+++.+.+||.+||..||.+||++.++.+
T Consensus 594 ~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 594 QGVKNNDVIGRIENGERL--PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp TTCCHHHHHHHHHHTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCC--CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998888888765432 345789999999999999999999999554443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=378.97 Aligned_cols=251 Identities=15% Similarity=0.143 Sum_probs=197.1
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-Cc----------------
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PF---------------- 819 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H-PN---------------- 819 (1170)
...|...+.||+|+||+||+|++..+|+.||||++...........+.+.+|+.++..+.| +|
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3468999999999999999999999999999999885443344446778899999999877 21
Q ss_pred -----EEEEEeeeec-----ccceEEEEeeccCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Q 001057 820 -----VVRFFYSFTC-----RENLYLVMEYLNGGDLYSLLRN-------LGCLDEDMARVYIAELVLALEYLHSLNVIHR 882 (1170)
Q Consensus 820 -----IVrL~~~Fqd-----~~~LyLVMEY~~GGSL~dlLk~-------~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHR 882 (1170)
...++.++.. ...+|++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111222 22467788876 6899999852 2347788888899999999999999999999
Q ss_pred cCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHH--
Q 001057 883 DLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEIL-- 960 (1170)
Q Consensus 883 DIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL-- 960 (1170)
||||+||||+.++.+||+|||+|+... ......+| +.|+|||++
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~---------------------------------~~~~~~~g-~~y~aPE~~~~ 281 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDG---------------------------------ASAVSPIG-RGFAPPETTAE 281 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT---------------------------------EEECCCCC-TTTCCHHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecC---------------------------------CccccCCC-CceeCchhhhc
Confidence 999999999999999999999987421 11345678 999999999
Q ss_pred --------hcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCC
Q 001057 961 --------LGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQ 1032 (1170)
Q Consensus 961 --------~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPsk 1032 (1170)
.+..|+.++|||||||++|||++|+.||.+.+..+....+.... ..++.++.+||.+||+.||.+
T Consensus 282 ~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dP~~ 354 (413)
T 3dzo_A 282 RMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC-------KNIPQPVRALLEGFLRYPKED 354 (413)
T ss_dssp HTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSC-------CCCCHHHHHHHHHHTCSSGGG
T ss_pred cccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhc-------ccCCHHHHHHHHHHccCChhh
Confidence 44457889999999999999999999999877655544443321 357899999999999999999
Q ss_pred CCChhhHHHHHcCCCCCCCC
Q 001057 1033 RLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1033 RpSa~~AeEILqHPfF~~id 1052 (1170)
||+ +.++++||||+.+.
T Consensus 355 Rpt---~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 355 RLL---PLQAMETPEYEQLR 371 (413)
T ss_dssp SCC---HHHHTTSHHHHHHH
T ss_pred CcC---HHHHHhCHHHHHHH
Confidence 999 88999999998763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=397.22 Aligned_cols=262 Identities=26% Similarity=0.377 Sum_probs=209.8
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec----
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC---- 829 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd---- 829 (1170)
....++|++.+.||.|+||+||+|++..+|+.||||++... ......+.+.+|+.+|..++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 34458899999999999999999999999999999998754 234556788999999999999999999998766
Q ss_pred --ccceEEEEeeccCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCc---EEEEe
Q 001057 830 --RENLYLVMEYLNGGDLYSLLRNLG---CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGH---IKLTD 901 (1170)
Q Consensus 830 --~~~LyLVMEY~~GGSL~dlLk~~~---~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~---VKLsD 901 (1170)
.+.+|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 677899999999999999998754 5999999999999999999999999999999999999997765 99999
Q ss_pred cCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHH
Q 001057 902 FGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFEL 981 (1170)
Q Consensus 902 FGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYEL 981 (1170)
||++.... ........+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 168 FG~a~~~~-------------------------------~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeL 216 (676)
T 3qa8_A 168 LGYAKELD-------------------------------QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFEC 216 (676)
T ss_dssp CCCCCBTT-------------------------------SCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHH
T ss_pred cccccccc-------------------------------cccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHH
Confidence 99997521 00112346799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHH--------------HhccCCCCC-------CCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 982 LIGIPPFNAKTPQQIFDN--------------IMNRDIPWP-------NIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 982 LTG~pPF~g~~~~ei~qk--------------Il~~~l~fP-------~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
++|..||.+......+.. ...+...++ .+...++..+.+||.+||+.||.+||+ +.
T Consensus 217 ltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT---a~ 293 (676)
T 3qa8_A 217 ITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT---DP 293 (676)
T ss_dssp HSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C---CT
T ss_pred HHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC---HH
Confidence 999999976543221100 011112221 123457889999999999999999999 66
Q ss_pred HHHcCCCCCCC
Q 001057 1041 EVKQHPFFKNI 1051 (1170)
Q Consensus 1041 EILqHPfF~~i 1051 (1170)
++++||||+.+
T Consensus 294 elL~hp~F~~l 304 (676)
T 3qa8_A 294 QNPNVGCFQAL 304 (676)
T ss_dssp TCCCCTTHHHH
T ss_pred HHhcCHHHHHH
Confidence 88999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=346.61 Aligned_cols=229 Identities=14% Similarity=0.150 Sum_probs=190.0
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.++..++||||+++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 55578999999999999999999999999999999998765555667788999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|||||+.|++|.+++... .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999999653 4666788899999999999999999999999999999999999987544
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
|++ .++.++|||||||++|+|++|..||.+.+..
T Consensus 175 ---------------------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 ---------------------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp ---------------------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred ---------------------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 222 2688999999999999999999999886653
Q ss_pred HHHH---HHhccCCCCC-CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 995 QIFD---NIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 995 ei~q---kIl~~~l~fP-~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
..+. .+.......+ .....++.++.+||.+||+.||.+| ++.++.+.|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L 260 (286)
T 3uqc_A 209 SGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLM 260 (286)
T ss_dssp CCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHH
T ss_pred hhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHH
Confidence 3211 1111111111 1234689999999999999999999 855444433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=384.30 Aligned_cols=245 Identities=27% Similarity=0.398 Sum_probs=201.0
Q ss_pred CCCCCCCeEEEEEeccCCCeEEEEeeecC-CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 753 DRTSIEDFEIIKPISQGAFGRVFLARKRA-TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 753 ~~i~iedYevlk~LG~GgFGtVyLArdk~-TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
+....++|++++.||+|+||+||+|.+.. +|+.||||++.... .......+.+|+.+|..++|||||+++++|...+
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 34556899999999999999999999976 79999999987532 3455677889999999999999999999998876
Q ss_pred c-----eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcc
Q 001057 832 N-----LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906 (1170)
Q Consensus 832 ~-----LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk 906 (1170)
. +||||||++|++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 6 7999999999999998765 79999999999999999999999999999999999999875 89999999997
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~p 986 (1170)
... .....+||+.|+|||++.+. ++.++|||||||++|+|++|.+
T Consensus 230 ~~~----------------------------------~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~ 274 (681)
T 2pzi_A 230 RIN----------------------------------SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLP 274 (681)
T ss_dssp ETT----------------------------------CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCC
T ss_pred hcc----------------------------------cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCC
Confidence 521 01345799999999999874 5889999999999999999999
Q ss_pred CCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 987 PF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
||.+.... .++........++.+.+||.+||+.||.+||+ ..+.+.|+|+.
T Consensus 275 ~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 325 (681)
T 2pzi_A 275 TRNGRYVD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT---TAEEMSAQLTG 325 (681)
T ss_dssp EETTEECS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred CCcccccc---------cccccccccccCHHHHHHHhhhccCChhhCCC---HHHHHHHHHHH
Confidence 98753211 11100001235678999999999999999998 45667777764
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-32 Score=323.92 Aligned_cols=192 Identities=17% Similarity=0.133 Sum_probs=140.7
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc-------cHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeecccceE
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI-------RKNAVESILAERNILISV-RNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~-------~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~~Ly 834 (1170)
...++.|++|.+..++....|+.||+|++.+.... .....+.+.+|+++|+++ .|+||++++++|+++..+|
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence 34578899999999998899999999999764211 233456799999999999 6999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||||+|++|.++|.+.+.+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~----- 390 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP----- 390 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCC-----
Confidence 999999999999999998888875 478999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCC
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF 988 (1170)
.......+.+||+.|||||++.+ .+..++|+||+|+++|+|++|..||
T Consensus 391 -------------------------~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 -------------------------QDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred -------------------------CCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 11123456789999999999976 4677899999999999887765544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-27 Score=277.82 Aligned_cols=194 Identities=19% Similarity=0.137 Sum_probs=146.0
Q ss_pred EEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc-----cHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 761 EIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI-----RKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 761 evlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~-----~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
...+.||+|+||+||+|. ..+..+|+|.+...... .....+.+.+|+.+|.+++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 446689999999999994 45788999986543221 12234568999999999999999955444556778899
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||++|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+|+.......
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~-- 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED-- 484 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH--
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc--
Confidence 9999999999999876 5689999999999999999999999999999998 999999999985310000
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc--CCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG--MGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g--~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
..........+.+||+.|||||++.. ..|+..+|+||..+-..+...++.+|.
T Consensus 485 ---------------------~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 485 ---------------------KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp ---------------------HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ---------------------cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 00000012346789999999999987 668888999999999998888777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=236.10 Aligned_cols=135 Identities=20% Similarity=0.202 Sum_probs=110.4
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH---------------HHHHHHHHHHHHHHhcCCCcEEEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK---------------NAVESILAERNILISVRNPFVVRF 823 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~---------------~~ve~~l~EieILskL~HPNIVrL 823 (1170)
.|.+.+.||.|+||.||+|++ .+|+.||||++........ .....+.+|+.+|..++| +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 466779999999999999999 8899999999865321111 245678899999999984 555
Q ss_pred EeeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecC
Q 001057 824 FYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFG 903 (1170)
Q Consensus 824 ~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFG 903 (1170)
+.++. .+.+|+||||++||+|.+ +.. .....++.||+.||.|||++||+||||||+|||++ +|.+||+|||
T Consensus 167 ~~~~~-~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 167 PKVYA-WEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp CCEEE-EETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred CeEEe-ccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 55443 366799999999999988 421 23557999999999999999999999999999999 9999999999
Q ss_pred Ccc
Q 001057 904 LSK 906 (1170)
Q Consensus 904 LAk 906 (1170)
+|+
T Consensus 238 ~a~ 240 (282)
T 1zar_A 238 QSV 240 (282)
T ss_dssp TCE
T ss_pred CCe
Confidence 986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.8e-20 Score=199.15 Aligned_cols=139 Identities=20% Similarity=0.197 Sum_probs=109.5
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCE--EEEEEeeccccc---------------------cHHHHHHHHHHHHHHHhcC
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDL--FAIKVLKKADMI---------------------RKNAVESILAERNILISVR 816 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~--VAIKvLkKs~i~---------------------~~~~ve~~l~EieILskL~ 816 (1170)
|++.+.||+|+||.||+|.+..+|+. ||||+++..... .......+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 88999999999999999998778999 999997643211 0112246788999999998
Q ss_pred CCcE--EEEEeeeecccceEEEEeeccC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCCCc
Q 001057 817 NPFV--VRFFYSFTCRENLYLVMEYLNG-G----DLYSLLRNLGCLDEDMARVYIAELVLALEYLH-SLNVIHRDLKPDN 888 (1170)
Q Consensus 817 HPNI--VrL~~~Fqd~~~LyLVMEY~~G-G----SL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLH-s~GIIHRDIKPEN 888 (1170)
|++| +.++.. ...||||||+.+ | +|.++... +++..+..++.||+.||.||| ++||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 8754 334432 467999999942 3 66665432 235567889999999999999 9999999999999
Q ss_pred EEeCCCCcEEEEecCCccc
Q 001057 889 LLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 889 ILLd~dG~VKLsDFGLAk~ 907 (1170)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99988 999999999974
|
| >4din_B CAMP-dependent protein kinase type I-beta regulat subunit, CAMP-dependent protein kinase catalytic subunit A; isoform diversity; HET: TPO SEP ATP; 3.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.6e-18 Score=194.52 Aligned_cols=139 Identities=14% Similarity=0.090 Sum_probs=132.1
Q ss_pred cccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCchhh
Q 001057 554 DLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQI 630 (1170)
Q Consensus 554 ~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~~ 630 (1170)
.....+++|..|++|||.|++||||.+|.|.++++|+.+..+.+|+.|||+|++ ||+|||.|.++|.+|.|+|
T Consensus 153 ~~~~~~~~ge~I~~~Gd~~~~~yiI~~G~v~v~~~~~~v~~l~~G~~fGe~all~~~~r~atv~A~~~~~l~~i~~---- 228 (381)
T 4din_B 153 MFPVTHIAGETVIQQGNEGDNFYVVDQGEVDVYVNGEWVTNISEGGSFGELALIYGTPRAATVKAKTDLKLWGIDR---- 228 (381)
T ss_dssp CEEEECCTTCBSSCTTSBCCEEEECSSSEEEEEETTEEEEEEESSCCBCGGGGTSCCBCSSEEEESSSCEEEEEEH----
T ss_pred ceEEEECCCCEEEeCCCCCCeEEEEEeeEEEEEECCeEeeeCCCCCEEEchHHhcCCCcceEEEECCCEEEEEEch----
Confidence 345678999999999999999999999999999999999999999999999999 9999999999999999999
Q ss_pred hhhhhhhhhhccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 631 ELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 631 ~~~~~tfr~Il~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
.+|++|++.....++.+|..++++++++.+|+.+++.++++.++...| +.+|+.++.||++..|+.
T Consensus 229 ----~~f~~ll~~~~~~~~~~~~~~L~~v~~f~~Ls~~el~~l~~~~~~~~~~~ge~I~~eGd~~~~~yiI~~G~v 300 (381)
T 4din_B 229 ----DSYRRILMGSTLRKRKMYEEFLSKVSILESLEKWERLTVADALEPVQFEDGEKIVVQGEPGDDFYIITEGTA 300 (381)
T ss_dssp ----HHHHHHHHHHHHHHHHHHHHHHHHCSTTTTCCTTHHHHHHTTCBCCCBCSSCBSSCTTSBCCEEEEEEESCE
T ss_pred ----HHHHHhhhhhhHHHHHHHHHHhhhhHHHHhccHHHHHHHHHhhhhccCCCCCEEEeCCCcCCEEEEEEeCEE
Confidence 999999999999999999999999999999999999999999998888 567799999999999984
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.67 E-value=1.7e-17 Score=190.49 Aligned_cols=137 Identities=12% Similarity=0.125 Sum_probs=100.8
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc---------------cHHH----HHHHHHHHHHHHhcCCCcE
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI---------------RKNA----VESILAERNILISVRNPFV 820 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~---------------~~~~----ve~~l~EieILskL~HPNI 820 (1170)
|++...||.|+||.||+|.+. +|+.||||+++..... .... ......|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999985 6999999997643110 0000 1122456677777755443
Q ss_pred E--EEEeeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC---
Q 001057 821 V--RFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG--- 895 (1170)
Q Consensus 821 V--rL~~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG--- 895 (1170)
. ..+.. ...+|||||+.|++|..+.. .+.+..++.||+.+|.|||++|||||||||.||||+.+|
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 2 22221 23479999999988865432 223566889999999999999999999999999998877
Q ss_pred -------cEEEEecCCccc
Q 001057 896 -------HIKLTDFGLSKV 907 (1170)
Q Consensus 896 -------~VKLsDFGLAk~ 907 (1170)
.+.|+||+-+..
T Consensus 246 d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CTTSEEEEEEECCCTTCEE
T ss_pred cccccccceEEEEeCCccc
Confidence 389999997753
|
| >3of1_A CAMP-dependent protein kinase regulatory subunit; cyclic nucleotide binding domain, evolution, PKA signaling, transfer; HET: CMP; 2.21A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.4e-17 Score=172.69 Aligned_cols=141 Identities=11% Similarity=0.056 Sum_probs=132.2
Q ss_pred cccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCch
Q 001057 552 HDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTS 628 (1170)
Q Consensus 552 ~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~ 628 (1170)
.......+++|..|++|||.++.||+|.+|.|.++.+|+.+..+.+|+.|||++++ ||++||.|.++|.+|.++|
T Consensus 28 ~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~v~~~~~~~~~~~~g~~fGe~~l~~~~~~~~tv~a~~~~~~~~i~~-- 105 (246)
T 3of1_A 28 NCLEEKSVPKGATIIKQGDQGDYFYVVEKGTVDFYVNDNKVNSSGPGSSFGELALMYNSPRAATVVATSDCLLWALDR-- 105 (246)
T ss_dssp TTCEEEEECTTCEEECTTCCCCEEEEEEECCEEEESTTSCCEEECTTCEECHHHHHHTCCCSSEEEESSCEEEEEEEH--
T ss_pred HhhceEEECCCCEEEecCCCCCEEEEEEeeEEEEEECCEEEEecCCCCeeehhHHhcCCCCCcEEEECCCeEEEEEEh--
Confidence 34456678999999999999999999999999999999999999999999999999 9999999999999999999
Q ss_pred hhhhhhhhhhhhccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 629 QIELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 629 ~~~~~~~tfr~Il~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
+.|+.++......++.++..++++++++..+++.++.++++.++...| +.+|+.++.+|++..|..
T Consensus 106 ------~~~~~~~~~~~~~~~~~~~~~l~~~~~f~~l~~~~l~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~I~~G~v 177 (246)
T 3of1_A 106 ------LTFRKILLGSSFKKRLMYDDLLKSMPVLKSLTTYDRAKLADALDTKIYQPGETIIREGDQGENFYLIEYGAV 177 (246)
T ss_dssp ------HHHHHTTTTTTSHHHHHSHHHHHHCGGGTTCCHHHHHHHHHTCEEEEECTTCEEECTTSBCCEEEEEEECEE
T ss_pred ------HHHHHHHHHhHHHHHHHHHHHHhhChhhhcCCHHHHHHHHHhhheEEeCCCCEEEeCCCcCCEEEEEEecEE
Confidence 999999999999999999999999999999999999999999988777 556799999999999973
|
| >3shr_A CGMP-dependent protein kinase 1; cyclic nucleotide binding domains, cyclic nucleotide protein transferase, PKG; HET: CMP; 2.50A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-17 Score=178.77 Aligned_cols=142 Identities=18% Similarity=0.170 Sum_probs=132.2
Q ss_pred ccccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCc
Q 001057 551 THDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRT 627 (1170)
Q Consensus 551 ~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~ 627 (1170)
........+++|..|++|||.++.||||.+|.|.++.+|+.+..+.+|+.|||++++ ||+|||.|.++|.+|.|+|
T Consensus 59 ~~~~~~~~~~~g~~i~~~G~~~~~~yiI~~G~v~v~~~g~~~~~~~~G~~fGe~~ll~~~~~~~tv~a~~~~~l~~i~~- 137 (299)
T 3shr_A 59 VDCMYPVEYGKDSCIIKEGDVGSLVYVMEDGKVEVTKEGVKLCTMGPGKVFGELAILYNCTRTATVKTLVNVKLWAIDR- 137 (299)
T ss_dssp HHHCEEEEECTTCEEECTTCBCCCEEEEEESCEEEEETTEEEEEECTTCEESCSGGGTTTBCCSEEEESSCEEEEEECH-
T ss_pred HHhcCeEEECCCCEEEcCCCcCceEEEEEEEEEEEEECCEEEEEeCCCCeeeHhHHhcCCCCCcEEEEcCCeEEEEEcH-
Confidence 344455678999999999999999999999999999999999999999999999999 9999999999999999999
Q ss_pred hhhhhhhhhhhhhccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 628 SQIELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 628 ~~~~~~~~tfr~Il~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
+.|+.|+......++.++..+++.++++..|++.++..+++.++...| +.+|+.++.+|++..|+.
T Consensus 138 -------~~~~~i~~~~~~~~~~~~~~~l~~~~~f~~l~~~~l~~l~~~~~~~~~~~g~~I~~~G~~~~~~yiI~~G~v 209 (299)
T 3shr_A 138 -------QCFQTIMMRTGLIKHTEYMEFLKSVPTFQSLPEEILSKLADVLEETHYENGEYIIRQGARGDTFFIISKGKV 209 (299)
T ss_dssp -------HHHHHHHHHHHHHHHHHHHHHHTTSHHHHHSCHHHHHHHTTTCEEEEECTTCEEECTTCEECEEEEEEESEE
T ss_pred -------HHHHHHhhHhHHHHHHHHHHHHhhCHHhhhCCHHHHHHHHHhccEEEECCCCEEEeCCCCCCEEEEEEeeEE
Confidence 999999999989999999999999999999999999999999977777 566799999999999984
|
| >3tnp_B CAMP-dependent protein kinase type II-beta regula subunit; PKA RIIB tetrameric holoenzyme, transferase; HET: SEP TPO; 2.30A {Mus musculus} PDB: 3tnq_A* 1cx4_A* 2qvs_B* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.9e-17 Score=190.00 Aligned_cols=139 Identities=14% Similarity=0.089 Sum_probs=128.8
Q ss_pred cccCCCcccccccccCCCCCcceeecCCcEEEEEc--C--ccccccCCCCCchHhhhh---hhcccccccCCCcccccCC
Q 001057 554 DLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED--L--NVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 554 ~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~--~--~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR 626 (1170)
.....+++|..|++|||.|++||||.+|.|.|+++ | ..|..+.+|+.|||+||+ ||+|||.|.++|.+|.|+|
T Consensus 168 ~~~~~~~~Ge~I~~qGd~~d~~YiI~sG~v~v~~~~~G~~~~v~~l~~G~~fGe~all~~~pr~atv~A~~d~~l~~i~r 247 (416)
T 3tnp_B 168 MFEKLVKEGEHVIDQGDDGDNFYVIDRGTFDIYVKCDGVGRCVGNYDNRGSFGELALMYNTPKAATITATSPGALWGLDR 247 (416)
T ss_dssp CEEEEECTTCEEECTTSCCCEEEEEEECEEEEEEECSSCEEEEEEEESCCEECGGGGTSCCCCSSEEEESSSEEEEEEEH
T ss_pred cEEEEeCCCCEEEeCCCCCceEEEEEeeEEEEEEecCCCEEEEEEecCCCEEeeHHHhcCCCcccEEEEccCeEEEEEee
Confidence 44567899999999999999999999999999975 3 458899999999999999 9999999999999999999
Q ss_pred chhhhhhhhhhhhhccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 627 TSQIELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 627 ~~~~~~~~~tfr~Il~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
.+|++|++.....++.++..++++++++..|+..++.++++.+....| +.+|+.++.||++..|+.
T Consensus 248 --------~~f~~ll~~~~~~~~~~~~~~L~~v~lf~~Ls~~el~~L~~~l~~~~~~~Ge~I~~eGd~~~~~yiI~sG~v 319 (416)
T 3tnp_B 248 --------VTFRRIIVKNNAKKRKMYESFIESLPFLKSLEVSERLKVVDVIGTKVYNDGEQIIAQGDLADSFFIVESGEV 319 (416)
T ss_dssp --------HHHHHHHHHHHHHHSSSSSSSGGGCGGGTTCCHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEEEEE
T ss_pred --------hhhhhhhhcchhHHHHHHHHHHhhchHhhcCCHHHHHHHHhhceEEEECCCCEEEeCCCcCCEEEEEEeCEE
Confidence 999999999999999999999999999999999999999999988877 566799999999999984
|
| >2qcs_B CAMP-dependent protein kinase type I-alpha regula subunit, CAMP-dependent protein kinase, alpha-catalytic SU; cyclic adenosine monophosphate; HET: SEP TPO ANP TAM; 2.20A {Bos taurus} PDB: 1rl3_A* 1rgs_A* 1ne6_A* 1ne4_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=4e-16 Score=167.09 Aligned_cols=138 Identities=13% Similarity=0.074 Sum_probs=129.3
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCchhhh
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQIE 631 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~~~ 631 (1170)
.-..+++|..|++|||.++.||+|.+|.|.++.+|+.+..+.+|+.|||++++ ||++||.|.++|.+|.++|
T Consensus 63 ~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~g~~~~~l~~G~~fGe~~l~~~~~~~~tv~a~~~~~~~~i~~----- 137 (291)
T 2qcs_B 63 FPVSFIAGETVIQQGDEGDNFYVIDQGEMDVYVNNEWATSVGEGGSFGELALIYGTPRAATVKAKTNVKLWGIDR----- 137 (291)
T ss_dssp EEEEECTTCEEECTTSBCCEEEEEEECCEEEEETTEEEEEECTTCEECGGGGTCCCBCSSEEEESSCEEEEEEEH-----
T ss_pred cEEEECCCCEEEeCCCCCceEEEEeeeEEEEEECCeEEEEcCCCCccchHHHhcCCCCceEEEECCCEEEEEEEh-----
Confidence 44668999999999999999999999999999999999999999999999999 9999999999999999999
Q ss_pred hhhhhhhhhccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 632 LLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 632 ~~~~tfr~Il~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
+.|+.++.......+.++..++++++++..|+..++..+++.++...| +.+|+.++.+|++..|+.
T Consensus 138 ---~~~~~~~~~~~~~~~~~~~~~l~~~~lf~~l~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v 209 (291)
T 2qcs_B 138 ---DSYRRILMGSTLRKRKMYEEFLSKVSILESLDKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSA 209 (291)
T ss_dssp ---HHHHHHHHHHHHHHHHHHHHHHHTCGGGTTCCHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEEEEE
T ss_pred ---HHHHHHHhhhHHHHHHHHHHHHhhchHhhhCCHHHHHHHHhhcEEEEECCCCEEEeCCccCCEEEEEEeCEE
Confidence 999999988888889999999999999999999999999999887777 566799999999999984
|
| >4f7z_A RAP guanine nucleotide exchange factor 4; cyclic nucleotide, regulation, auto-IN CDC25 homology domain, exocytosis; 2.60A {Mus musculus} PDB: 2byv_E | Back alignment and structure |
|---|
Probab=99.50 E-value=2.1e-15 Score=189.76 Aligned_cols=83 Identities=11% Similarity=-0.070 Sum_probs=74.2
Q ss_pred ccccccCCCcccccccccCCCCCcceeecCCcEEEEEc-------CccccccCCCCCchHhhhh---hhcccccccCCCc
Q 001057 551 THDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED-------LNVLPEISCDKNPTAADIA---AKTSSAGSLTPRS 620 (1170)
Q Consensus 551 ~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~-------~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~ 620 (1170)
..+..-...++|..++||||.||.||||.+|.|+|+++ +..|.++.+|++||| ||+ ||+|||+|.++|.
T Consensus 62 ~~~m~ye~~~~Ge~IfrqGd~gd~fYIIlsGsV~V~i~~~~~~~~~~~v~~l~~G~sFGE-all~n~pRtaTv~a~~~s~ 140 (999)
T 4f7z_A 62 CLCGYYENLEKGITLFRQGDIGTNWYAVLAGSLDVKVSETSSHQDAVTICTLGIGTAFGE-SILDNTPRHATIVTRESSE 140 (999)
T ss_dssp HHHCEEEEECTTCEEECTTSCCCEEEEEEESEEEEEECSSSCTTSCEEEEEEETTCEECG-GGGGTCCCSSEEEESSSEE
T ss_pred HhheEEEEECCCCEEEcCCCcCCEEEEEEeeEEEEEEecCCCCCCceeEEEecCCcchhh-hhccCCCcceEEEeccceE
Confidence 55566677899999999999999999999999999985 246889999999999 777 9999999999999
Q ss_pred ccccCCchhhhhhhhhhhhhcc
Q 001057 621 PLLTPRTSQIELLVNGHRTITE 642 (1170)
Q Consensus 621 lw~ldR~~~~~~~~~tfr~Il~ 642 (1170)
||+||| .+|+.|++
T Consensus 141 l~~l~r--------~~F~~i~~ 154 (999)
T 4f7z_A 141 LLRIEQ--------EDFKALWE 154 (999)
T ss_dssp EEEEEH--------HHHHHHHH
T ss_pred EEEEEH--------HHHHHHHH
Confidence 999999 77777753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.27 E-value=1.4e-11 Score=130.05 Aligned_cols=141 Identities=16% Similarity=0.145 Sum_probs=111.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyL 835 (1170)
+..|++...+|.|+++.||++... +..|++|+....... ....+.+|..+|..+. +..+.++++++.+.+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 356999999999999999998753 678999997643211 1235778999999885 6678889988888888999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS--------------------------------------- 876 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs--------------------------------------- 876 (1170)
||||++|.+|...+. +......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999999877531 122334678899999999998
Q ss_pred --------------------CCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 877 --------------------LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 877 --------------------~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
..++|+|++|.|||++.++.+.|+||+.|..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998755567999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=1.1e-10 Score=121.01 Aligned_cols=136 Identities=16% Similarity=0.147 Sum_probs=99.7
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc--EEEEEeeeecccceE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF--VVRFFYSFTCRENLY 834 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN--IVrL~~~Fqd~~~Ly 834 (1170)
...|.+....+.|..+.||++.. .+|..|++|+..... ...+..|..+|..+.+.+ +.+++.++...+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34577655445666799999964 467789999865431 134678888888886444 566888888778899
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN------------------------------------ 878 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~G------------------------------------ 878 (1170)
+||||++|.+|. .. ..+. ..++.++...|..||+..
T Consensus 92 ~v~e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998884 11 1222 245667777777777643
Q ss_pred ----------------------eeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 879 ----------------------VIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 879 ----------------------IIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
++|+|++|.|||++.++.+.|+|||.|..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998766677999999874
|
| >3pna_A CAMP-dependent protein kinase type I-alpha regula subunit; beta-barrel, CAMP-binding, catalytic subunit, transferase; HET: CMP; 1.50A {Bos taurus} PDB: 3fhi_B* 3iia_A 3plq_A* 1u7e_B* 3pvb_B* | Back alignment and structure |
|---|
Probab=99.12 E-value=4.9e-12 Score=123.70 Aligned_cols=118 Identities=11% Similarity=0.039 Sum_probs=95.4
Q ss_pred HHHHHHHHHHH--HhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchH
Q 001057 526 RLERVAETLEK--ILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTA 603 (1170)
Q Consensus 526 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGE 603 (1170)
....+.+.|.+ +|..+++..+... .........++|..|++||+.++.+|+|.+|.|.++.+|+.+..+.+|+.|||
T Consensus 32 ~~~~~~~~l~~~~~f~~l~~~~~~~l-~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~~~~~~~G~~fGe 110 (154)
T 3pna_A 32 TMAALAKAIEKNVLFSHLDDNERSDI-FDAMFPVSFIAGETVIQQGDEGDNFYVIDQGEMDVYVNNEWATSVGEGGSFGE 110 (154)
T ss_dssp HHHHHHHHHHHCGGGTTCCHHHHHHH-HHHCEEEEECTTCEEECTTSCCCEEEEEEESCEEEEETTEEEEEECTTCEECC
T ss_pred HHHHHHHHHHhChhhhhCCHHHHHHH-HHhceEEEECCCCEEEeCCCCCCeEEEEEecEEEEEECCEEEEEecCCCEeee
Confidence 34455566665 4565555333222 33345577899999999999999999999999999999999999999999999
Q ss_pred hhhh---hhcccccccCCCcccccCCchhhhhhhhhhhhhccCCCHHHHHHH
Q 001057 604 ADIA---AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKL 652 (1170)
Q Consensus 604 LAL~---pRAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~~kr~~y 652 (1170)
++++ ||.+||.|.++|.+|.|++ +.|+.++..+...++++|
T Consensus 111 ~~~~~~~~~~~~v~A~~~~~~~~i~~--------~~~~~ll~~~~~~~~~~~ 154 (154)
T 3pna_A 111 LALIYGTPRAATVKAKTNVKLWGIDR--------DSYRRILMGSTLRKRKMY 154 (154)
T ss_dssp HHHHHCCCCSSEEEESSCEEEEEEEH--------HHHHHHTHHHHHHC----
T ss_pred hHhhcCCCcceEEEECcceEEEEEeH--------HHHHHHHHhChHHHhhcC
Confidence 9998 9999999999999999999 999999998888888776
|
| >3ocp_A PRKG1 protein; serine/threonine kinase, TF2I and IRAG, transferase; HET: CMP; 2.49A {Homo sapiens} PDB: 3od0_A* 3ogj_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=1e-11 Score=118.93 Aligned_cols=119 Identities=13% Similarity=0.059 Sum_probs=90.5
Q ss_pred HHHHHHHHHHHH--HhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCch
Q 001057 525 ERLERVAETLEK--ILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPT 602 (1170)
Q Consensus 525 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFG 602 (1170)
+.+..+.+.|.+ +|..+++...... .........++|..|++||+.++.+|+|.+|.|.++.+|+.+..+.+|+.||
T Consensus 16 ~~~~~~~~~l~~~~~f~~l~~~~~~~l-~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~g~~~~~~~~G~~fG 94 (139)
T 3ocp_A 16 QSKDLIKEAILDNDFMKNLELSQIQEI-VDCMYPVEYGKDSCIIKEGDVGSLVYVMEDGKVEVTKEGVKLCTMGPGKVFG 94 (139)
T ss_dssp HHHHHHHHHHHHCTTTTTSCHHHHHHH-HHHCEEEEECSSCEEECTTSCCCEEEEEEECCEEEEETTEEEEEECTTCEES
T ss_pred HHHHHHHHHHhcCHhhhcCCHHHHHHH-HHhcEEEecCCCCEEEeCCCcCCEEEEEEeCEEEEEECCEEEEEeCCCCEec
Confidence 344555566665 3454444322111 2333557789999999999999999999999999999999999999999999
Q ss_pred Hhhhh---hhcccccccCCCcccccCCchhhhhhhhhhhhhccCCCHHHHHHH
Q 001057 603 AADIA---AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKL 652 (1170)
Q Consensus 603 ELAL~---pRAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~~kr~~y 652 (1170)
|++++ ||.+||.|.++|.+|.++| +.|+.++.....-+|++|
T Consensus 95 e~~~l~~~~~~~~~~a~~~~~v~~i~~--------~~~~~l~~~~p~~~r~~~ 139 (139)
T 3ocp_A 95 ELAILYNCTRTATVKTLVNVKLWAIDR--------QCFQTIMMRTGLIKHTEY 139 (139)
T ss_dssp CHHHHHCCCCSSEEEESSCEEEEEEEH--------HHHHHHHTC---------
T ss_pred cHHHHCCCCcceEEEECcceEEEEEcH--------HHHHHHHhhChHhhhhcC
Confidence 99988 9999999999999999999 999999998888877765
|
| >1o7f_A CAMP-dependent RAP1 guanine-nucleotide exchange factor; EPAC2, CAMP-GEF2, campb binding doamin, regulation; 2.5A {Mus musculus} SCOP: a.4.5.31 b.82.3.2 b.82.3.2 | Back alignment and structure |
|---|
Probab=99.10 E-value=2.2e-11 Score=139.64 Aligned_cols=72 Identities=10% Similarity=-0.109 Sum_probs=65.2
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEEc---C----ccccccCCCCCchHhhhh--hhcccccccCCCcccccC
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED---L----NVLPEISCDKNPTAADIA--AKTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~---~----~~v~~~~~g~sFGELAL~--pRAATv~A~t~~~lw~ld 625 (1170)
.-..+++|..|++|||.++.||||.+|.|.++.. | ..+..+++|+.|||+++. ||++||.|.++|.+|.|+
T Consensus 66 ~~~~~~~g~~i~~~Gd~~~~~y~i~~G~v~v~~~~~~g~~~~~~~~~~~~G~~fGe~~l~~~~~~~tv~A~~~~~l~~i~ 145 (469)
T 1o7f_A 66 YYENLEKGITLFRQGDIGTNWYAVLAGSLDVKVSETSSHQDAVTICTLGIGTAFGESILDNTPRHATIVTRESSELLRIE 145 (469)
T ss_dssp EEEEECTTCEEECTTSBCCEEEEEEESCEEEEECSSSCGGGCEEEEEECTTCEECGGGGGTCBCSSEEEESSSEEEEEEE
T ss_pred eEEEECCCCEEEeCCCCCCcEEEEEeeEEEEEEecCCCCCcceEEEEccCCCCcchhhhCCCCccceEEEccceeEEEEc
Confidence 3457899999999999999999999999999974 3 468899999999999933 999999999999999999
Q ss_pred C
Q 001057 626 R 626 (1170)
Q Consensus 626 R 626 (1170)
|
T Consensus 146 ~ 146 (469)
T 1o7f_A 146 Q 146 (469)
T ss_dssp H
T ss_pred H
Confidence 9
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=7.7e-10 Score=122.72 Aligned_cols=140 Identities=16% Similarity=0.306 Sum_probs=105.7
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEee--ccccccHHHHHHHHHHHHHHHhcC--CCcEEEEEeeeecc---cceE
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLK--KADMIRKNAVESILAERNILISVR--NPFVVRFFYSFTCR---ENLY 834 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLk--Ks~i~~~~~ve~~l~EieILskL~--HPNIVrL~~~Fqd~---~~Ly 834 (1170)
.++.|+.|.++.||++... +..+++|+.. .... ......+.+|..+|..+. +..+++++.++.+. +..|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 4678999999999998754 4678888765 3221 112346778999999887 45578888877766 4589
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-------------------------------------- 876 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-------------------------------------- 876 (1170)
+||||++|..+.+. ....+++.....++.+++.+|..||+
T Consensus 118 ~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999887542 12347788888899999999999997
Q ss_pred --------------------CCeeeccCCCCcEEeCCCCc--EEEEecCCccc
Q 001057 877 --------------------LNVIHRDLKPDNLLIGQDGH--IKLTDFGLSKV 907 (1170)
Q Consensus 877 --------------------~GIIHRDIKPENILLd~dG~--VKLsDFGLAk~ 907 (1170)
..++|+|++|.|||++.++. +.|+||+.|..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999997753 69999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=1e-09 Score=119.11 Aligned_cols=132 Identities=20% Similarity=0.241 Sum_probs=98.1
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCc--EEEEEeeeeccc---ceEEEE
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPF--VVRFFYSFTCRE---NLYLVM 837 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPN--IVrL~~~Fqd~~---~LyLVM 837 (1170)
+.++.|....||++. ..+++|+.... .....+.+|..+|..+. +.. +.+++....... ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 358999999999874 34888975432 34567889999998873 322 345554443333 358999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS----------------------------------------- 876 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs----------------------------------------- 876 (1170)
+|++|.+|..... ..++.++...++.|++..|..||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988875433 247777888888888888888886
Q ss_pred -----------------CCeeeccCCCCcEEeCC--CCcEEEEecCCccc
Q 001057 877 -----------------LNVIHRDLKPDNLLIGQ--DGHIKLTDFGLSKV 907 (1170)
Q Consensus 877 -----------------~GIIHRDIKPENILLd~--dG~VKLsDFGLAk~ 907 (1170)
..++|+|++|.|||++. .+.+.|+||+.+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 13799999999999998 45688999999875
|
| >4f7z_A RAP guanine nucleotide exchange factor 4; cyclic nucleotide, regulation, auto-IN CDC25 homology domain, exocytosis; 2.60A {Mus musculus} PDB: 2byv_E | Back alignment and structure |
|---|
Probab=98.92 E-value=1.9e-10 Score=145.10 Aligned_cols=75 Identities=11% Similarity=-0.046 Sum_probs=70.3
Q ss_pred cccccccccCCCCCcceeecCCcEEEEEcCc-cccccCCCCCchHhhhh---hhcccccccCC-CcccccCCchhhhhhh
Q 001057 560 PKQNSLSRQGSKEMLDHVPDDDNAFVIEDLN-VLPEISCDKNPTAADIA---AKTSSAGSLTP-RSPLLTPRTSQIELLV 634 (1170)
Q Consensus 560 ~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~-~v~~~~~g~sFGELAL~---pRAATv~A~t~-~~lw~ldR~~~~~~~~ 634 (1170)
++|+.|++|||+||.||||.+|+|.|+++++ .|.++++|+.|||+||+ ||+|||+|.++ |.+|.+||
T Consensus 367 kaGtvI~rQGE~gds~YIIlsG~V~V~~~~~~~v~~L~~Gd~FGElALL~~~PR~aTV~a~~d~c~fl~i~k-------- 438 (999)
T 4f7z_A 367 KGGTVLFNQGEEGTSWYIILKGSVNVVIYGKGVVCTLHEGDDFGKLALVNDAPRAASIVLREDNCHFLRVDK-------- 438 (999)
T ss_dssp STTCEEECTTSBCCEEEEEEESEEEEEETTTEEEEEEETTCEECGGGGTCSCBCSSEEEESSSSEEEEEEEH--------
T ss_pred cCCCEEEeCCCcCCeEEEEEeeEEEEEEcCCcceEEecCCCcccchhhccCCCeeEEEEEecCceEEEEeeH--------
Confidence 6799999999999999999999999999885 68999999999999999 99999999985 99999999
Q ss_pred hhhhhhcc
Q 001057 635 NGHRTITE 642 (1170)
Q Consensus 635 ~tfr~Il~ 642 (1170)
..|.+|+.
T Consensus 439 ~df~~il~ 446 (999)
T 4f7z_A 439 EDGNRILR 446 (999)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 88888874
|
| >3idb_B CAMP-dependent protein kinase type II-beta regulatory subunit, CAMP-dependent protein kinase catalytic subunit alpha; PKA, SPR, affinity; HET: TPO SEP ANP; 1.62A {Rattus norvegicus} PDB: 3idc_B* | Back alignment and structure |
|---|
Probab=98.83 E-value=1.3e-10 Score=114.17 Aligned_cols=122 Identities=11% Similarity=0.083 Sum_probs=92.5
Q ss_pred HHHHHHHHHHHH--HhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEEc--C--ccccccCCC
Q 001057 525 ERLERVAETLEK--ILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED--L--NVLPEISCD 598 (1170)
Q Consensus 525 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~--~--~~v~~~~~g 598 (1170)
+.+..+.+.|.+ +|..+++..+... .........++|..|++|||.++.+|+|.+|.|.++.+ | ..+..+++|
T Consensus 31 ~~~~~~~~~l~~~~~f~~l~~~~l~~l-~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~g~~~~~~~~~~G 109 (161)
T 3idb_B 31 DQRNRLQEACKDILLFKNLDPEQMSQV-LDAMFEKLVKEGEHVIDQGDDGDNFYVIDRGTFDIYVKCDGVGRCVGNYDNR 109 (161)
T ss_dssp HHHHHHHHHHTTCHHHHTSCHHHHHHH-HHHCEEEEECTTCEEECTTSCCCEEEEEEESEEEEEEEETTEEEEEEEEESC
T ss_pred HHHHHHHHHHhCCHhhhcCCHHHHHHH-HHhcceeEeCCCCEEEeCCCCCcEEEEEEeCEEEEEEcCCCCeEEEEEcCCC
Confidence 444555555553 4565555333221 23344567899999999999999999999999999863 3 357789999
Q ss_pred CCchHhhhh---hhcccccccCCCcccccCCchhhhhhhhhhhhhccCCCHHHHHHHHHH
Q 001057 599 KNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKLLDV 655 (1170)
Q Consensus 599 ~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~~kr~~y~~f 655 (1170)
+.|||++++ ||.+||.|.++|.+|.++| +.|+.++.....-++++|+.|
T Consensus 110 ~~fGe~~~~~~~~~~~~v~A~~~~~~~~i~~--------~~~~~l~~~~p~~~~~~~~~f 161 (161)
T 3idb_B 110 GSFGELALMYNTPRAATITATSPGALWGLDR--------VTFRRIIVKNNAKKRKMYESF 161 (161)
T ss_dssp CEECGGGGTCCCCCSSEEEESSSEEEEEEEH--------HHHHHHHHHHHHTSCCC----
T ss_pred CEechHHHHcCCCcccEEEECCCeEEEEEeH--------HHHHHHHHHCHHHHHHHHhcC
Confidence 999999999 9999999999999999999 899998877666666666544
|
| >3of1_A CAMP-dependent protein kinase regulatory subunit; cyclic nucleotide binding domain, evolution, PKA signaling, transfer; HET: CMP; 2.21A {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=98.75 E-value=2e-09 Score=111.55 Aligned_cols=98 Identities=8% Similarity=0.035 Sum_probs=81.7
Q ss_pred HhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEEcCc-cccccCCCCCchHhhhh---hhccc
Q 001057 537 ILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLN-VLPEISCDKNPTAADIA---AKTSS 612 (1170)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~-~v~~~~~g~sFGELAL~---pRAAT 612 (1170)
+|..|++..... -.........++|..|++|||.++.+|+|.+|.|.++..+. .+..+++|+.|||.+++ ||++|
T Consensus 132 ~f~~l~~~~l~~-l~~~~~~~~~~~g~~i~~~g~~~~~~y~I~~G~v~v~~~~~~~~~~l~~g~~fGe~~~~~~~~~~~~ 210 (246)
T 3of1_A 132 VLKSLTTYDRAK-LADALDTKIYQPGETIIREGDQGENFYLIEYGAVDVSKKGQGVINKLKDHDYFGEVALLNDLPRQAT 210 (246)
T ss_dssp GGTTCCHHHHHH-HHHTCEEEEECTTCEEECTTSBCCEEEEEEECEEEEEETTTEEEEEEETTCEECHHHHHHTCBCSSE
T ss_pred hhhcCCHHHHHH-HHHhhheEEeCCCCEEEeCCCcCCEEEEEEecEEEEEEcCCceEEEcCCCCcccHHHHhCCCCcccE
Confidence 345555432211 13444556789999999999999999999999999999876 78899999999999999 99999
Q ss_pred ccccCCCcccccCCchhhhhhhhhhhhhccC
Q 001057 613 AGSLTPRSPLLTPRTSQIELLVNGHRTITEL 643 (1170)
Q Consensus 613 v~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~ 643 (1170)
|.|.+++.+|.|+| ..|..++..
T Consensus 211 v~a~~~~~~~~i~~--------~~f~~ll~~ 233 (246)
T 3of1_A 211 VTATKRTKVATLGK--------SGFQRLLGP 233 (246)
T ss_dssp EEESSCEEEEEEEH--------HHHHHHCTT
T ss_pred EEECCCEEEEEEeH--------HHHHHHhcc
Confidence 99999999999999 888887754
|
| >3mdp_A Cyclic nucleotide-binding domain (CNMP-BD) protei; structural genomics, joint center for structural genomics; HET: MSE; 1.90A {Geobacter metallireducens} | Back alignment and structure |
|---|
Probab=98.74 E-value=1.6e-09 Score=102.92 Aligned_cols=95 Identities=12% Similarity=-0.016 Sum_probs=78.7
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--c---ccccCCCCCchHhhhh---hhcccccccCCCcccc
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--V---LPEISCDKNPTAADIA---AKTSSAGSLTPRSPLL 623 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~---v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ 623 (1170)
.....++|..|.+||+.++.+|+|.+|.|.++. +|+ . +..+++|+.|||++++ |+.+||.|.++|.+|.
T Consensus 30 ~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~g~~~~~~~~~~~~~G~~fG~~~~~~~~~~~~~~~a~~~~~~~~ 109 (142)
T 3mdp_A 30 EEKSFPTGSVIFKENSKADNLMLLLEGGVELFYSNGGAGSAANSTVCSVVPGAIFGVSSLIKPYHYTSSARATKPVRVVD 109 (142)
T ss_dssp EEEEECTTCEEECTTSBCCEEEEEEESCEEEECC---------CEEEEECTTCEECGGGSSTTCBCSSEEEESSCEEEEE
T ss_pred cEEecCCCCEEEeCCCCCCcEEEEEeCEEEEEEECCCCCceEeeeEEEecCCCEechHHHcCCCCceEEEEECCcEEEEE
Confidence 446679999999999999999999999999985 342 3 7789999999999998 9999999999999999
Q ss_pred cCCchhhhhhhhhhhhhccCCCHHHHHHHHHHhh
Q 001057 624 TPRTSQIELLVNGHRTITELQNPQQIKKLLDVSR 657 (1170)
Q Consensus 624 ldR~~~~~~~~~tfr~Il~~~~~~kr~~y~~fl~ 657 (1170)
++| +.|..++.....-....+..+.+
T Consensus 110 i~~--------~~~~~l~~~~p~~~~~l~~~l~~ 135 (142)
T 3mdp_A 110 ING--------ARLREMSENNQALGQVLMNNVAA 135 (142)
T ss_dssp EEH--------HHHHHHHHHCHHHHHHHHHHHHH
T ss_pred EeH--------HHHHHHHHHChHHHHHHHHHHHH
Confidence 999 89998887665555555554443
|
| >3ukn_A Novel protein similar to vertebrate potassium VOL channel, subfamily H (EAG-related)...; KCNH, ELK, ERG, CNBD, CNBHD, C-linker, ION channel; 2.20A {Danio rerio} PDB: 3ukt_B 3ukv_B | Back alignment and structure |
|---|
Probab=98.74 E-value=1.5e-09 Score=111.77 Aligned_cols=95 Identities=15% Similarity=0.078 Sum_probs=82.6
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh-----hhcccccccCCCcccccCCchhh
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA-----AKTSSAGSLTPRSPLLTPRTSQI 630 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~-----pRAATv~A~t~~~lw~ldR~~~~ 630 (1170)
....++|..|++|||.++.+|+|.+|.|.++.+|..+..+++|+.|||.+++ ||++||.|.++|.+|.|+|
T Consensus 100 ~~~~~~ge~I~~~G~~~~~ly~I~~G~v~v~~~~~~~~~l~~G~~fGe~~~~~~~~~~~~~~v~a~~~~~l~~i~~---- 175 (212)
T 3ukn_A 100 TSFCAPGEFLIRQGDALQAIYFVCSGSMEVLKDNTVLAILGKGDLIGSDSLTKEQVIKTNANVKALTYCDLQYISL---- 175 (212)
T ss_dssp EEEECTTCEEECTTSBCCEEEEEEECCEEEESSSCEEEEECTTCEEECSCCSSSSCCBBCSEEEESSCEEEEEEEH----
T ss_pred eEEeCCCCEEEECCCcccEEEEEEecEEEEEECCeEEEEecCCCCcCcHHhccCCCCCcceEEEEcccEEEEEEeH----
Confidence 3467899999999999999999999999999999999999999999999988 7899999999999999999
Q ss_pred hhhhhhhhhhccCCCHHHHHHHHHHhhc
Q 001057 631 ELLVNGHRTITELQNPQQIKKLLDVSRS 658 (1170)
Q Consensus 631 ~~~~~tfr~Il~~~~~~kr~~y~~fl~~ 658 (1170)
+.|..++.....-.+..+..+.+.
T Consensus 176 ----~~f~~ll~~~p~~~~~~~~~l~~~ 199 (212)
T 3ukn_A 176 ----KGLREVLRLYPEYAQKFVSEIQHD 199 (212)
T ss_dssp ----HHHHHHHHHCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHChHHHHHHHHHHHHh
Confidence 899988876555455544444433
|
| >2ptm_A Hyperpolarization-activated (IH) channel; ION channel, cyclic nucleotide binding domain, C-linker, CAM SPHCN1, HCN; HET: CMP; 1.93A {Strongylocentrotus purpuratus} | Back alignment and structure |
|---|
Probab=98.72 E-value=2.5e-09 Score=108.96 Aligned_cols=86 Identities=7% Similarity=-0.138 Sum_probs=77.2
Q ss_pred cccccCCCcccccccccCCCCCcceeecCCcEEEEE-cCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCc
Q 001057 552 HDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE-DLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRT 627 (1170)
Q Consensus 552 ~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~-~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~ 627 (1170)
........++|..|++|||.++.+|+|.+|.|.++. +|+.+..+++|+.|||.+++ ||.+||.|.++|.+|.++|
T Consensus 92 ~~~~~~~~~~ge~I~~~G~~~~~ly~I~~G~v~~~~~~g~~~~~l~~G~~fGe~~~~~~~~~~~~~~a~~~~~l~~i~~- 170 (198)
T 2ptm_A 92 TLLEFEVFQPADYVIQEGTFGDRMFFIQQGIVDIIMSDGVIATSLSDGSYFGEICLLTRERRVASVKCETYCTLFSLSV- 170 (198)
T ss_dssp HHCEEEEECTTCEEECTTSCCSEEEEEEECCEEEECTTSCEEEEECTTCEESCHHHHHSSCCSSEEEESSCEEEEEEEH-
T ss_pred HhccceeeCCCCEEEECCCcCcEEEEEEeCEEEEEecCCeEEEEecCCCEechHHHcCCCccceEEEEeeEEEEEEEeH-
Confidence 344567789999999999999999999999999995 77889999999999999998 9999999999999999999
Q ss_pred hhhhhhhhhhhhhccCCC
Q 001057 628 SQIELLVNGHRTITELQN 645 (1170)
Q Consensus 628 ~~~~~~~~tfr~Il~~~~ 645 (1170)
+.|..++....
T Consensus 171 -------~~f~~ll~~~p 181 (198)
T 2ptm_A 171 -------QHFNQVLDEFP 181 (198)
T ss_dssp -------HHHHHHHHHCH
T ss_pred -------HHHHHHHHHCh
Confidence 88888876543
|
| >1o7f_A CAMP-dependent RAP1 guanine-nucleotide exchange factor; EPAC2, CAMP-GEF2, campb binding doamin, regulation; 2.5A {Mus musculus} SCOP: a.4.5.31 b.82.3.2 b.82.3.2 | Back alignment and structure |
|---|
Probab=98.70 E-value=1.3e-09 Score=125.00 Aligned_cols=95 Identities=9% Similarity=-0.008 Sum_probs=75.6
Q ss_pred CCCcccccccccCCCCCcceeecCCcEEEEEcCc-cccccCCCCCchHhhhh---hhcccccccC-CCcccccCCchhhh
Q 001057 557 LMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLN-VLPEISCDKNPTAADIA---AKTSSAGSLT-PRSPLLTPRTSQIE 631 (1170)
Q Consensus 557 ~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~-~v~~~~~g~sFGELAL~---pRAATv~A~t-~~~lw~ldR~~~~~ 631 (1170)
..+++|..|++|||.++.||+|.+|.|.|+.+++ .+..+.+|+.|||++++ ||+|||.|++ +|.+|.|+|
T Consensus 364 ~~~~~g~~i~~~G~~~~~~yiI~~G~v~v~~~~~~~~~~l~~G~~fGe~~ll~~~~~~~tv~a~~~~~~~~~i~~----- 438 (469)
T 1o7f_A 364 SHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYGKGVVCTLHEGDDFGKLALVNDAPRAASIVLREDNCHFLRVDK----- 438 (469)
T ss_dssp EECSTTCEEECTTSCCCEEEEEEESEEEEEETTTEEEEEEETTCEECGGGGTCCSCCSSEEEESSSSEEEEEEEH-----
T ss_pred eEecCCCEEEeCCCcCCeEEEEEEeEEEEEEcCCeeEEEecCCCEEEEehhhcCCCceEEEEEecCCEEEEEEcH-----
Confidence 4689999999999999999999999999999886 78899999999999999 9999999998 799999999
Q ss_pred hhhhhhhhhccCCCHHHHHHHHHHhhccc
Q 001057 632 LLVNGHRTITELQNPQQIKKLLDVSRSIA 660 (1170)
Q Consensus 632 ~~~~tfr~Il~~~~~~kr~~y~~fl~~V~ 660 (1170)
..|..++.....-.+. +.+..+.|-
T Consensus 439 ---~~f~~ll~~~p~~~~~-l~e~~~~v~ 463 (469)
T 1o7f_A 439 ---EDFNRILRDVEANTVR-LKEHDQDVL 463 (469)
T ss_dssp ---HHHHHHHHHTTCC-------------
T ss_pred ---HHHHHHHHHChHHHHH-HHhcCceEE
Confidence 8888887654443333 333344443
|
| >4ava_A Lysine acetyltransferase; allosteric regulation, domain coupling; HET: ACO; 1.70A {Mycobacterium tuberculosis} PDB: 4avb_A* 4avc_A* | Back alignment and structure |
|---|
Probab=98.68 E-value=5.6e-09 Score=114.44 Aligned_cols=80 Identities=13% Similarity=0.086 Sum_probs=72.7
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEEcCc----cccccCCCCCchHhhhh---hhcccccccCCCcccccCCc
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLN----VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRT 627 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~----~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~ 627 (1170)
....++||..|++|||.++.+|+|.+|.|.++..+. .+..+.+|+.|||++++ ||.+||.|.++|.+|.|+|
T Consensus 37 ~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~g~~~~~~~~~G~~fGe~~l~~~~~~~~~v~A~~~~~~~~i~~- 115 (333)
T 4ava_A 37 QPLRAAAGQVLLRQGEPAVSFLLISSGSAEVSHVGDDGVAIIARALPGMIVGEIALLRDSPRSATVTTIEPLTGWTGGR- 115 (333)
T ss_dssp EEEEECTTCEEECTTSBCCCEEEEEECCEEEEEECTTCCEEEEEECTTCEESHHHHHHTCBCSSEEEESSCEEEEEECH-
T ss_pred eEEEECCCCEEEeCCCcCCEEEEEEeeEEEEEEECCCCcEEEEEecCCCEeeHHHhcCCCCceEEEEEecCEEEEEEcH-
Confidence 345689999999999999999999999999997432 68899999999999998 9999999999999999999
Q ss_pred hhhhhhhhhhhhhcc
Q 001057 628 SQIELLVNGHRTITE 642 (1170)
Q Consensus 628 ~~~~~~~~tfr~Il~ 642 (1170)
+.|+.++.
T Consensus 116 -------~~~~~l~~ 123 (333)
T 4ava_A 116 -------GAFATMVH 123 (333)
T ss_dssp -------HHHHHHHH
T ss_pred -------HHHHHHHh
Confidence 99998883
|
| >4din_B CAMP-dependent protein kinase type I-beta regulat subunit, CAMP-dependent protein kinase catalytic subunit A; isoform diversity; HET: TPO SEP ATP; 3.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.68 E-value=4.6e-09 Score=118.97 Aligned_cols=85 Identities=7% Similarity=-0.034 Sum_probs=76.0
Q ss_pred ccccccCCCcccccccccCCCCCcceeecCCcEEEEEc---Cc---cccccCCCCCchHhhhh---hhcccccccCCCcc
Q 001057 551 THDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED---LN---VLPEISCDKNPTAADIA---AKTSSAGSLTPRSP 621 (1170)
Q Consensus 551 ~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~---~~---~v~~~~~g~sFGELAL~---pRAATv~A~t~~~l 621 (1170)
.........++|..|++|||.++.||+|.+|.|.++.. |+ .+..+++|+.|||+||+ ||+|||.|.++|.+
T Consensus 268 ~~~~~~~~~~~ge~I~~eGd~~~~~yiI~~G~v~v~~~~~~~~~~~~v~~l~~Gd~fGe~all~~~~r~~tv~A~~~~~l 347 (381)
T 4din_B 268 ADALEPVQFEDGEKIVVQGEPGDDFYIITEGTASVLQRRSPNEEYVEVGRLGPSDYFGEIALLLNRPRAATVVARGPLKC 347 (381)
T ss_dssp HTTCBCCCBCSSCBSSCTTSBCCEEEEEEESCEEEECCSSSSSCCCEEEEECTTCEECTTGGGSCCBCSSEEEESSCBEE
T ss_pred HHhhhhccCCCCCEEEeCCCcCCEEEEEEeCEEEEEEecCCCCceEEEEEeCCCCEechHHHhCCCCceeEEEEcCCEEE
Confidence 44556688999999999999999999999999999974 22 47899999999999999 99999999999999
Q ss_pred cccCCchhhhhhhhhhhhhccC
Q 001057 622 LLTPRTSQIELLVNGHRTITEL 643 (1170)
Q Consensus 622 w~ldR~~~~~~~~~tfr~Il~~ 643 (1170)
|.|+| ..|.+++..
T Consensus 348 l~i~~--------~~f~~ll~~ 361 (381)
T 4din_B 348 VKLDR--------PRFERVLGP 361 (381)
T ss_dssp EEEEH--------HHHHHHHCC
T ss_pred EEEeH--------HHHHHHHhh
Confidence 99999 888887765
|
| >4f8a_A Potassium voltage-gated channel subfamily H membe; probable regulatory domain of potassium channel, membrane PR transport protein; 2.20A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.68 E-value=3.1e-09 Score=103.15 Aligned_cols=86 Identities=10% Similarity=-0.005 Sum_probs=77.8
Q ss_pred ccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh-----hhcccccccCCCcccccCCc
Q 001057 553 DDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA-----AKTSSAGSLTPRSPLLTPRT 627 (1170)
Q Consensus 553 ~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~-----pRAATv~A~t~~~lw~ldR~ 627 (1170)
.......++|..|.+|||.++.+|+|.+|.|.++.++..+..+++|+.|||++++ |+.+||.|.++|.+|.+++
T Consensus 49 ~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~~~~~~~G~~fG~~~~~~~~~~~~~~~~~a~~~~~v~~i~~- 127 (160)
T 4f8a_A 49 EFQTVHCAPGDLIYHAGESVDSLCFVVSGSLEVIQDDEVVAILGKGDVFGDVFWKEATLAQSCANVRALTYCDLHVIKR- 127 (160)
T ss_dssp TCEEEEECTTCEEECTTSBCCEEEEEEESEEEEEETTEEEEEEETTCEEECCTTTCSSCCBCSSEEEESSCEEEEEEEH-
T ss_pred hceeeeeCCCCEEEeCCCCccEEEEEEeeEEEEEECCEEEEEecCCCEeCcHHHhcCcccceEEEEEECCceEEEEEcH-
Confidence 3445678999999999999999999999999999999999999999999999987 7899999999999999999
Q ss_pred hhhhhhhhhhhhhccCCCH
Q 001057 628 SQIELLVNGHRTITELQNP 646 (1170)
Q Consensus 628 ~~~~~~~~tfr~Il~~~~~ 646 (1170)
+.|+.++.....
T Consensus 128 -------~~~~~l~~~~p~ 139 (160)
T 4f8a_A 128 -------DALQKVLEFYTA 139 (160)
T ss_dssp -------HHHHHHHHHCHH
T ss_pred -------HHHHHHHHHHHH
Confidence 899988865443
|
| >3bpz_A Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2; CNBD, C-linker, pacemaker, HCN, HCN2, CAP, PKA, CAMP, ION channel; HET: CMP; 1.65A {Mus musculus} PDB: 3ffq_A 1q3e_A* 1q43_A* 1q5o_A* 3u10_A* 2q0a_A* 3etq_A* 3u11_A* 3otf_A* 3u0z_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=5.4e-09 Score=106.96 Aligned_cols=85 Identities=11% Similarity=-0.100 Sum_probs=74.9
Q ss_pred ccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCchh
Q 001057 553 DDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQ 629 (1170)
Q Consensus 553 ~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~ 629 (1170)
.......++|..|++|||.++.+|+|.+|.|.++.++....++++|+.|||.+++ ||.+||.|.++|.+|.|+|
T Consensus 94 ~~~~~~~~~ge~I~~~g~~~~~ly~I~~G~v~v~~~~g~~~~l~~G~~fGe~~~~~~~~~~~~v~a~~~~~l~~i~~--- 170 (202)
T 3bpz_A 94 KLKFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKEMKLSDGSYFGEICLLTRGRRTASVRADTYCRLYSLSV--- 170 (202)
T ss_dssp HCEEEEECTTCEEECTTSBCCEEEEEEECEEEEECTTSCCEEEETTCEECHHHHHHCSBCSSEEEESSCEEEEEEEH---
T ss_pred hCCceEECCCCEEEECCCcCCeEEEEeccEEEEEECCCeEEEEcCCCEeccHHHhcCCCcccEEEEeeEEEEEEEEH---
Confidence 3456678999999999999999999999999999765555689999999999998 9999999999999999999
Q ss_pred hhhhhhhhhhhccCCC
Q 001057 630 IELLVNGHRTITELQN 645 (1170)
Q Consensus 630 ~~~~~~tfr~Il~~~~ 645 (1170)
+.|..++....
T Consensus 171 -----~~f~~ll~~~p 181 (202)
T 3bpz_A 171 -----DNFNEVLEEYP 181 (202)
T ss_dssp -----HHHHHHHHHSG
T ss_pred -----HHHHHHHHHCH
Confidence 88887776443
|
| >1vp6_A CNBD, cyclic-nucleotide binding domain of mesorhizobium LOTI CNG potassium channel; dimer helical bundle beta barrel core with cyclic AMP bound; HET: CMP; 1.70A {Mesorhizobium loti} SCOP: b.82.3.2 PDB: 3cl1_A* 2k0g_A* 2kxl_A 3clp_A* 1u12_A 3co2_A | Back alignment and structure |
|---|
Probab=98.61 E-value=8.4e-09 Score=97.90 Aligned_cols=93 Identities=9% Similarity=-0.069 Sum_probs=77.9
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCchhhh
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQIE 631 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~~~ 631 (1170)
.....++|..|.+||+..+.+|+|.+|.+.++..+ ...+++|+.|||.+++ |+.+||.|.++|.+|.+++
T Consensus 35 ~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~--~~~~~~G~~~G~~~~~~~~~~~~~~~a~~~~~~~~i~~----- 107 (138)
T 1vp6_A 35 RARTVPAGAVICRIGEPGDRMFFVVEGSVSVATPN--PVELGPGAFFGEMALISGEPRSATVSAATTVSLLSLHS----- 107 (138)
T ss_dssp EEEEECTTCEEECTTSCCCEEEEEEESCEEECSSS--CEEECTTCEECHHHHHHCCCCSSCEEESSSEEEEEEEH-----
T ss_pred cEEEeCCCCEEEeCCCCcceEEEEEeeEEEEEeCC--cceECCCCEeeehHhccCCCceeEEEECCCEEEEEECH-----
Confidence 45678999999999999999999999999999877 4589999999999988 8999999999999999999
Q ss_pred hhhhhhhhhccCCCHHHHHHHHHHhh
Q 001057 632 LLVNGHRTITELQNPQQIKKLLDVSR 657 (1170)
Q Consensus 632 ~~~~tfr~Il~~~~~~kr~~y~~fl~ 657 (1170)
..|+.++.....=.+..+..+.+
T Consensus 108 ---~~~~~l~~~~p~~~~~~~~~~~~ 130 (138)
T 1vp6_A 108 ---ADFQMLCSSSPEIAEIFRKTALE 130 (138)
T ss_dssp ---HHHHHHHHHCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHCHHHHHHHHHHHHH
Confidence 88888876554433443443333
|
| >2z69_A DNR protein; beta barrel, dimerization helix, transcription regulator; 2.10A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=98.60 E-value=1.3e-08 Score=97.81 Aligned_cols=98 Identities=11% Similarity=0.003 Sum_probs=80.4
Q ss_pred cccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---h-hcccccccCCCccccc
Q 001057 554 DLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---A-KTSSAGSLTPRSPLLT 624 (1170)
Q Consensus 554 ~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---p-RAATv~A~t~~~lw~l 624 (1170)
......++|..|.+||+..+.+|+|.+|.|.++. +|+ .+..+++|+.|||++++ | +.+||.|.++|.+|.+
T Consensus 35 ~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~g~~~~~~~~~~G~~~G~~~~~~~~~~~~~~~~a~~~~~~~~i 114 (154)
T 2z69_A 35 SDLVNLDKGAYVFRQGEPAHAFYYLISGCVKIYRLTPEGQEKILEVTNERNTFAEAMMFMDTPNYVATAQAVVPSQLFRF 114 (154)
T ss_dssp CEEEEECTTCEEECTTSBCCEEEEEEESCEEEECCCC-----CCEEECTTEEESGGGGGSSCSBCSSEEEESSSEEEEEE
T ss_pred CcEEEecCCCEEecCCCccceEEEEEeCEEEEEEECCCCCEEEEEEccCCCeeccHhhccCCCCCceEEEEccceEEEEE
Confidence 4556789999999999999999999999999995 454 47899999999999998 7 9999999999999999
Q ss_pred CCchhhhhhhhhhhhhccCCCHHHHHHHHHHhhcc
Q 001057 625 PRTSQIELLVNGHRTITELQNPQQIKKLLDVSRSI 659 (1170)
Q Consensus 625 dR~~~~~~~~~tfr~Il~~~~~~kr~~y~~fl~~V 659 (1170)
++ +.|+.++.....=.+..+..+.+++
T Consensus 115 ~~--------~~~~~l~~~~p~~~~~l~~~~~~rl 141 (154)
T 2z69_A 115 SN--------KAYLRQLQDNTPLALALLAKLSTRL 141 (154)
T ss_dssp EH--------HHHHHHHTTCHHHHHHHHHHHHHHH
T ss_pred CH--------HHHHHHHHHChHHHHHHHHHHHHHH
Confidence 99 8999888766544444454444443
|
| >3shr_A CGMP-dependent protein kinase 1; cyclic nucleotide binding domains, cyclic nucleotide protein transferase, PKG; HET: CMP; 2.50A {Bos taurus} | Back alignment and structure |
|---|
Probab=98.60 E-value=6.7e-09 Score=111.92 Aligned_cols=110 Identities=11% Similarity=0.021 Sum_probs=86.8
Q ss_pred HhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEEcC------ccccccCCCCCchHhhhh---
Q 001057 537 ILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL------NVLPEISCDKNPTAADIA--- 607 (1170)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~------~~v~~~~~g~sFGELAL~--- 607 (1170)
+|..|++..... -.........++|..|++|||.++.+|+|.+|.|.++... ..+..+++|+.|||.+++
T Consensus 164 ~f~~l~~~~l~~-l~~~~~~~~~~~g~~I~~~G~~~~~~yiI~~G~v~~~~~~~~~g~~~~~~~l~~G~~fGe~~ll~~~ 242 (299)
T 3shr_A 164 TFQSLPEEILSK-LADVLEETHYENGEYIIRQGARGDTFFIISKGKVNVTREDSPNEDPVFLRTLGKGDWFGEKALQGED 242 (299)
T ss_dssp HHHHSCHHHHHH-HTTTCEEEEECTTCEEECTTCEECEEEEEEESEEEEEECCSSSCCCEEEEEEETTCEECGGGGSSSE
T ss_pred HhhhCCHHHHHH-HHHhccEEEECCCCEEEeCCCCCCEEEEEEeeEEEEEEecCCCCcceEEEEcCCCCEeChHHHhCCC
Confidence 456666543321 1344466778999999999999999999999999999754 357899999999999999
Q ss_pred hhcccccccCCCcccccCCchhhhhhhhhhhhhccCCCHHHHHHHHHH
Q 001057 608 AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKLLDV 655 (1170)
Q Consensus 608 pRAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~~kr~~y~~f 655 (1170)
||.+||.|.++|.+|.|+| +.|..++.....=....+..+
T Consensus 243 ~~~~tv~a~~~~~l~~i~~--------~~f~~ll~~~p~~~~~~~~~l 282 (299)
T 3shr_A 243 VRTANVIAAEAVTCLVIDR--------DSFKHLIGGLDDVSNKAYEDA 282 (299)
T ss_dssp ECSSEEEESSSEEEEEEEH--------HHHHHHHTTCCCCCHHHHHHH
T ss_pred CcceEEEECCCEEEEEEeH--------HHHHHHHccHHHHHHHHHHHH
Confidence 9999999999999999999 888888875544333333333
|
| >2pqq_A Putative transcriptional regulator; APC7345, streptomyces coelicolor structural genomics, PSI-2, protein structure initiative; 2.00A {Streptomyces coelicolor A3} | Back alignment and structure |
|---|
Probab=98.58 E-value=1.7e-08 Score=96.30 Aligned_cols=83 Identities=11% Similarity=0.067 Sum_probs=73.3
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---hhcccccccCCCcccccCCc
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRT 627 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~ 627 (1170)
....++|..|.+||+..+.+|+|.+|.+.++. +|+ .+..+++|+.||+.+++ |+.+|+.|.++|.+|.+++
T Consensus 30 ~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~g~~~~~~~~~~g~~~G~~~~~~~~~~~~~~~a~~~~~~~~i~~- 108 (149)
T 2pqq_A 30 EVTLARGDTLFHEGDPGDRLYVVTEGKVKLHRTSPDGRENMLAVVGPSELIGELSLFDPGPRTATGTALTEVKLLALGH- 108 (149)
T ss_dssp EEEECTTCEEECTTSEECEEEEEEESCEEEEEECTTSSEEEEEEECTTCEESGGGGTSCEECSSEEEESSCEEEEEEEG-
T ss_pred EEEeCCCCEEECCCCCCCeEEEEEecEEEEEEECCCCcEEEEEEcCCcCEechHHhcCCCCcceEEEEccceEEEEEeH-
Confidence 45678999999999999999999999999996 454 47799999999999998 9999999999999999999
Q ss_pred hhhhhhhhhhhhhccCCCH
Q 001057 628 SQIELLVNGHRTITELQNP 646 (1170)
Q Consensus 628 ~~~~~~~~tfr~Il~~~~~ 646 (1170)
..|+.++.....
T Consensus 109 -------~~~~~l~~~~p~ 120 (149)
T 2pqq_A 109 -------GDLQPWLNVRPE 120 (149)
T ss_dssp -------GGHHHHHHHCTH
T ss_pred -------HHHHHHHHhCcH
Confidence 888887765443
|
| >3gyd_A CNMP-BD protein, cyclic nucleotide-binding domain; nucleotide binding protein, structural genomics; HET: MSE CMP; 1.79A {Methylobacillus flagellatus KT} | Back alignment and structure |
|---|
Probab=98.55 E-value=7.4e-09 Score=105.24 Aligned_cols=120 Identities=13% Similarity=0.119 Sum_probs=89.1
Q ss_pred HHHHHHHHHH--HhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEEc---C--ccccccCCCC
Q 001057 527 LERVAETLEK--ILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED---L--NVLPEISCDK 599 (1170)
Q Consensus 527 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~---~--~~v~~~~~g~ 599 (1170)
+..+.+.|.+ +|..+++..+... .........++|..|.+||+.++.+|+|.+|.|.++.. | ..+..+++|+
T Consensus 34 ~~~~~~~L~~~~~f~~l~~~~l~~l-~~~~~~~~~~~ge~i~~~G~~~~~ly~I~~G~v~v~~~~~~g~~~~~~~~~~G~ 112 (187)
T 3gyd_A 34 FEEILEIVNKIKLFGDFSNEEVRYL-CSYMQCYAAPRDCQLLTEGDPGDYLLLILTGEVNVIKDIPNKGIQTIAKVGAGA 112 (187)
T ss_dssp HHHHHHHHTTCCSSCCCCHHHHHHH-HTTCEEEEECTTCEEECTTSCCCEEEEEEEEEEEEEEEETTTEEEEEEEEETTC
T ss_pred HHHHHHHHhcCHhhhcCCHHHHHHH-HHhcEEEEeCCCCEEEcCCCCCCeEEEEEeCEEEEEEECCCCCeEEEEEccCCC
Confidence 3334444443 3344444332221 23344567899999999999999999999999999964 3 3588999999
Q ss_pred CchHhhhh---hhcccccccCCCcccccCCchhhhhhhhhhhhhccCCCHHHHHHHHHH
Q 001057 600 NPTAADIA---AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKLLDV 655 (1170)
Q Consensus 600 sFGELAL~---pRAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~~kr~~y~~f 655 (1170)
.|||++++ ||.+||.|.++|.+|.++| +.|+.++.....=....+..+
T Consensus 113 ~fGe~~~l~~~~~~~~v~A~~~~~v~~i~~--------~~~~~l~~~~p~~~~~l~~~l 163 (187)
T 3gyd_A 113 IIGEMSMIDGMPRSASCVASLPTDFAVLSR--------DALYQLLANMPKLGNKVLIRL 163 (187)
T ss_dssp EESHHHHHHCCCCSSEEEEEEEEEEEEEEH--------HHHHHHHHHCHHHHHHHHHHH
T ss_pred eeeeHHHhCCCCeeEEEEECCCeEEEEEcH--------HHHHHHHHHChHHHHHHHHHH
Confidence 99999988 9999999999999999999 889888876544444444333
|
| >3tnp_B CAMP-dependent protein kinase type II-beta regula subunit; PKA RIIB tetrameric holoenzyme, transferase; HET: SEP TPO; 2.30A {Mus musculus} PDB: 3tnq_A* 1cx4_A* 2qvs_B* | Back alignment and structure |
|---|
Probab=98.53 E-value=1.4e-08 Score=116.77 Aligned_cols=85 Identities=6% Similarity=-0.073 Sum_probs=73.9
Q ss_pred ccccccCCCcccccccccCCCCCcceeecCCcEEEEEc---------C--ccccccCCCCCchHhhhh---hhccccccc
Q 001057 551 THDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED---------L--NVLPEISCDKNPTAADIA---AKTSSAGSL 616 (1170)
Q Consensus 551 ~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~---------~--~~v~~~~~g~sFGELAL~---pRAATv~A~ 616 (1170)
.........++|..|++|||.++.||+|.+|.|.|+.. | ..+..+++|..|||++|+ ||+|||.|.
T Consensus 287 ~~~l~~~~~~~Ge~I~~eGd~~~~~yiI~sG~v~v~~~~~~~~~~~~g~~~~l~~l~~G~~fGE~all~~~~r~~tv~A~ 366 (416)
T 3tnp_B 287 VDVIGTKVYNDGEQIIAQGDLADSFFIVESGEVKITMKRKGKSEVEENGAVEIARCFRGQYFGELALVTNKPRAASAHAI 366 (416)
T ss_dssp HHHCEEEEECTTCEEECTTSCCCEEEEEEEEEEEEECC------------CEEEEECTTCEESGGGGTCCSCCSSEEEEE
T ss_pred HhhceEEEECCCCEEEeCCCcCCEEEEEEeCEEEEEEecCCcccccCCceeEEEEeCCCCEecHHHHhCCCCceeEEEEc
Confidence 34455667899999999999999999999999999965 3 248899999999999999 999999999
Q ss_pred CCCcccccCCchhhhhhhhhhhhhccC
Q 001057 617 TPRSPLLTPRTSQIELLVNGHRTITEL 643 (1170)
Q Consensus 617 t~~~lw~ldR~~~~~~~~~tfr~Il~~ 643 (1170)
++|.+|.|+| ..|.+++..
T Consensus 367 ~~~~ll~I~~--------~~f~~ll~~ 385 (416)
T 3tnp_B 367 GTVKCLAMDV--------QAFERLLGP 385 (416)
T ss_dssp EEEEEEEEEH--------HHHHHHHCC
T ss_pred CCeEEEEEEH--------HHHHHHhcc
Confidence 9999999999 777766654
|
| >2d93_A RAP guanine nucleotide exchange factor 6; CNMP_binding domain, PDZ domain containing guanine nucleotide exchange factor 2, PDZ-GEF2, RA-GEF-2; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.52 E-value=1.5e-08 Score=96.52 Aligned_cols=107 Identities=6% Similarity=-0.069 Sum_probs=81.6
Q ss_pred HHHHHHHHHHH--hcccCCCccCcccccccccCCCc-ccccccccCCCCCcceeecCCcEEEEEc-CccccccCCCCCch
Q 001057 527 LERVAETLEKI--LDSWSPKKHTKKRTHDDLNLMSP-KQNSLSRQGSKEMLDHVPDDDNAFVIED-LNVLPEISCDKNPT 602 (1170)
Q Consensus 527 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~-k~~~~~~QGd~Gd~fYVie~G~~~v~~~-~~~v~~~~~g~sFG 602 (1170)
+..+.+.|.++ |..+++...... .........+ +|..|++|||.++.+|+|-+|.|.++.. |+. ..+.+|+.||
T Consensus 11 ~~~~~~~l~~~~~f~~l~~~~~~~l-~~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~g~~-~~l~~G~~fG 88 (134)
T 2d93_A 11 IEQLLEFMHQLPAFANMTMSVRREL-CSVMIFEVVEQAGAIILEDGQELDSWYVILNGTVEISHPDGKV-ENLFMGNSFG 88 (134)
T ss_dssp HHHHHHHHHHSSTTTSSCHHHHHHH-TTTEEEEEECSSSCEEECTTCEECEEEECCBSCEEEECSSSCE-EEECTTCEES
T ss_pred HHHHHHHHhCCcchhhCCHHHHHHH-HHhheEEEecCCCCEEEeCCCCCCeEEEEEeCEEEEEcCCCcE-EEecCCCccC
Confidence 34455555553 444444322111 2233455678 9999999999999999999999999974 444 7799999999
Q ss_pred Hhhhh---hhcccc-cccCCCcccccCCchhhhhhhhhhhhhccC
Q 001057 603 AADIA---AKTSSA-GSLTPRSPLLTPRTSQIELLVNGHRTITEL 643 (1170)
Q Consensus 603 ELAL~---pRAATv-~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~ 643 (1170)
|++++ ||.+++ .|.++|.+|.+++ +.|+.++..
T Consensus 89 ~~~~~~~~~~~~~~~~a~~~~~~~~i~~--------~~~~~l~~~ 125 (134)
T 2d93_A 89 ITPTLDKQYMHGIVRTKVDDCQFVCIAQ--------QDYWRILNH 125 (134)
T ss_dssp CCSSSCCEECCSEEEESSSSEEEEEEEH--------HHHHHHSSC
T ss_pred hhHhcCCCcceeEEEEEecceEEEEEeH--------HHHHHHHHH
Confidence 99998 898899 9999999999999 888887764
|
| >2qcs_B CAMP-dependent protein kinase type I-alpha regula subunit, CAMP-dependent protein kinase, alpha-catalytic SU; cyclic adenosine monophosphate; HET: SEP TPO ANP TAM; 2.20A {Bos taurus} PDB: 1rl3_A* 1rgs_A* 1ne6_A* 1ne4_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=1.3e-08 Score=108.83 Aligned_cols=84 Identities=8% Similarity=-0.047 Sum_probs=73.9
Q ss_pred cccccCCCcccccccccCCCCCcceeecCCcEEEEEc---C---ccccccCCCCCchHhhhh---hhcccccccCCCccc
Q 001057 552 HDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED---L---NVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPL 622 (1170)
Q Consensus 552 ~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~---~---~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw 622 (1170)
........++|..|++|||.++.+|+|.+|.|.++.. | ..+..+++|+.|||.+++ ||.+||.|.++|.+|
T Consensus 178 ~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~~~~~~~~~~l~~G~~fGe~~ll~~~~~~~tv~a~~~~~~~ 257 (291)
T 2qcs_B 178 DALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPKAATVVARGPLKCV 257 (291)
T ss_dssp HHCEEEEECTTCEEECTTSCCCEEEEEEEEEEEEEEECSTTSCEEEEEEECTTCEECSGGGTCCCCCSSEEEEEEEEEEE
T ss_pred hhcEEEEECCCCEEEeCCccCCEEEEEEeCEEEEEEecCCCCccEEEEEeCCCCEecHHHHcCCCCcceEEEECCcEEEE
Confidence 3445667899999999999999999999999999852 3 358899999999999999 999999999999999
Q ss_pred ccCCchhhhhhhhhhhhhccC
Q 001057 623 LTPRTSQIELLVNGHRTITEL 643 (1170)
Q Consensus 623 ~ldR~~~~~~~~~tfr~Il~~ 643 (1170)
.|+| +.|..++..
T Consensus 258 ~i~~--------~~f~~~l~~ 270 (291)
T 2qcs_B 258 KLDR--------PRFERVLGP 270 (291)
T ss_dssp EEEH--------HHHHHHHCC
T ss_pred EEcH--------HHHHHHhcc
Confidence 9999 777777654
|
| >1wgp_A Probable cyclic nucleotide-gated ION channel 6; cyclic nucleotide monophosphate, CNMP, CNMP-binding, structural genomics; NMR {Arabidopsis thaliana} SCOP: b.82.3.2 | Back alignment and structure |
|---|
Probab=98.49 E-value=3.6e-08 Score=93.65 Aligned_cols=79 Identities=8% Similarity=-0.057 Sum_probs=67.1
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEE--cCcc--cc--ccCCCCCchHhhh---h---h------hcccccccC
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE--DLNV--LP--EISCDKNPTAADI---A---A------KTSSAGSLT 617 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~--~~~~--v~--~~~~g~sFGELAL---~---p------RAATv~A~t 617 (1170)
...+++|..|++|||.++.+|+|.+|.|.++. +|+. +. .+.+|+.|||+++ + | |++||.|.+
T Consensus 31 ~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~g~~~~~~~~~l~~G~~fGe~~l~~~~~~~~~~~~~~~~~~~~A~~ 110 (137)
T 1wgp_A 31 PCLFTEKSYLVREGDPVNEMLFIIRGRLESVTTDGGRSGFYNRSLLKEGDFCGDELLTWALDPKSGSNLPSSTRTVKALT 110 (137)
T ss_dssp CCCBCTTEEEECTTSBCSEEEEEEECCCEEECCSSCSSSSSCEEECCTTCBSSTHHHHHHHCSSCCSSSCBCSSEEEESS
T ss_pred EEEeCCCCEEEeCCCCCCeEEEEEeeEEEEEEcCCCcceeeeeeeecCCCEecHHHHHHHhccccccccccceeEEEEeE
Confidence 46689999999999999999999999999874 3543 45 8999999999996 4 4 479999999
Q ss_pred CCcccccCCchhhhhhhhhhhhhcc
Q 001057 618 PRSPLLTPRTSQIELLVNGHRTITE 642 (1170)
Q Consensus 618 ~~~lw~ldR~~~~~~~~~tfr~Il~ 642 (1170)
+|.+|.|++ +.|+.++.
T Consensus 111 ~~~~~~i~~--------~~~~~l~~ 127 (137)
T 1wgp_A 111 EVEAFALIA--------DELKFVAS 127 (137)
T ss_dssp CBEEEEEEH--------HHHHHHHH
T ss_pred EEEEEEECH--------HHHHHHHH
Confidence 999999999 67766553
|
| >3d0s_A Transcriptional regulatory protein; CAMP receptor protein (CRP), dimer, inactive(APO, unliganded allostery, DNA binding, cyclic AMP; 2.00A {Mycobacterium tuberculosis} PDB: 3i54_A* 3i59_A* 3mzh_A* 3h3u_A* 3r6s_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=7e-08 Score=99.50 Aligned_cols=100 Identities=15% Similarity=0.069 Sum_probs=81.1
Q ss_pred HhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---h
Q 001057 537 ILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---A 608 (1170)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---p 608 (1170)
+|..++++..... ........++||..|.+|||.++.+|+|.+|.|.++. +|+ .+..+.+|+.|||.+++ |
T Consensus 13 ~f~~l~~~~~~~l-~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~g~~~~~~~~~~G~~~G~~~~~~~~~ 91 (227)
T 3d0s_A 13 IFQGVEPSAIAAL-TKQLQPVDFPRGHTVFAEGEPGDRLYIIISGKVKIGRRAPDGRENLLTIMGPSDMFGELSIFDPGP 91 (227)
T ss_dssp TTSSCCSSTTHHH-HTTSCEEEECTTCEEECTTCCCCEEEEEEESCEEEEEECTTSCEEEEEEECTTCEESCHHHHSCSC
T ss_pred hhcCCCHHHHHHH-HhhCeEEEeCCCCEEEcCCCcCCEEEEEEeeEEEEEEECCCCcEEEEEEecCCCEEeeHHHcCCCC
Confidence 3455555433222 2334567889999999999999999999999999996 464 47799999999999998 9
Q ss_pred hcccccccCCCcccccCCchhhhhhhhhhhhhccCCC
Q 001057 609 KTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQN 645 (1170)
Q Consensus 609 RAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~ 645 (1170)
+.+||.|.++|.+|.+++ +.|..++....
T Consensus 92 ~~~~~~A~~~~~v~~i~~--------~~~~~l~~~~p 120 (227)
T 3d0s_A 92 RTSSATTITEVRAVSMDR--------DALRSWIADRP 120 (227)
T ss_dssp CSSEEEESSCEEEEEEEH--------HHHHHTTSSCH
T ss_pred ceeEEEEcccEEEEEEeH--------HHHHHHHHHCh
Confidence 999999999999999999 88888876553
|
| >4ev0_A Transcription regulator, CRP family; CAMP binding, winged helix-turn-helix motif, DNA binding, transcription activator; HET: CMP; 2.40A {Thermus thermophilus} | Back alignment and structure |
|---|
Probab=98.39 E-value=8.2e-08 Score=97.86 Aligned_cols=82 Identities=10% Similarity=0.011 Sum_probs=73.3
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---hhcccccccCCCcccccCC
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR 626 (1170)
.....+||..|.+|||.++.+|+|.+|.|.++. +|+ .+..+++|+.|||.+++ |+.+||.|.++|.+|.+++
T Consensus 23 ~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~g~~~~~~~~~~g~~~G~~~~~~~~~~~~~~~a~~~~~v~~i~~ 102 (216)
T 4ev0_A 23 QRRLYPQGKPIFYQGDLGQALYLVASGKVRLFRTHLGGQERTLALLGPGELFGEMSLLDEGERSASAVAVEDTELLALFR 102 (216)
T ss_dssp EEEEECTTCEEECTTCBCCEEEEEEESCEEEEEECSSSCEEEEEEECTTCEECHHHHHHCCBCSSEEEESSSEEEEEEEH
T ss_pred eEEEeCCCCEEEeCCCCCCEEEEEEeCEEEEEEECCCCCEEEEEEecCCCEEeehhhcCCCCcceEEEEcCCEEEEEEcH
Confidence 446689999999999999999999999999995 565 57899999999999988 9999999999999999999
Q ss_pred chhhhhhhhhhhhhccCC
Q 001057 627 TSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 627 ~~~~~~~~~tfr~Il~~~ 644 (1170)
+.|..++...
T Consensus 103 --------~~~~~l~~~~ 112 (216)
T 4ev0_A 103 --------EDYLALIRRL 112 (216)
T ss_dssp --------HHHHHHHHHC
T ss_pred --------HHHHHHHHHC
Confidence 8888777644
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3.3e-06 Score=92.55 Aligned_cols=133 Identities=17% Similarity=0.246 Sum_probs=91.6
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC---cEEEEEeeee-cccceEEEEe
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP---FVVRFFYSFT-CRENLYLVME 838 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HP---NIVrL~~~Fq-d~~~LyLVME 838 (1170)
++.++.|....||+. |..+++|+... ......+..|..+|..+.+. .|.+++.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 445788999999987 45688887432 23456788999999998742 2455555553 4456789999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL----------------------------------------- 877 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~----------------------------------------- 877 (1170)
|++|.+|....- ..++......++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999988876321 1234444444555555555555532
Q ss_pred -------------------CeeeccCCCCcEEeCC---CCc-EEEEecCCccc
Q 001057 878 -------------------NVIHRDLKPDNLLIGQ---DGH-IKLTDFGLSKV 907 (1170)
Q Consensus 878 -------------------GIIHRDIKPENILLd~---dG~-VKLsDFGLAk~ 907 (1170)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3599999999999987 455 48999998875
|
| >1o5l_A Transcriptional regulator, CRP family; TM1171, structural GE JCSG, PSI, protein structure initiative, joint center for S genomics; 2.30A {Thermotoga maritima} SCOP: b.82.3.2 | Back alignment and structure |
|---|
Probab=98.37 E-value=8.5e-08 Score=98.71 Aligned_cols=101 Identities=10% Similarity=-0.100 Sum_probs=77.0
Q ss_pred HHHhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh--
Q 001057 535 EKILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA-- 607 (1170)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~-- 607 (1170)
.++|++|.|...... ........++||..|.+||+..+++|+|.+|.|.++. +|+ .+..+++|+.|||.+++
T Consensus 4 ~~~~~~~~~~~~~~l-~~~~~~~~~~~g~~i~~~G~~~~~~y~v~~G~v~~~~~~~~G~~~~~~~~~~G~~~G~~~~~~~ 82 (213)
T 1o5l_A 4 DKIHHHHHHMDLKKL-LPCGKVIVFRKGEIVKHQDDPIEDVLILLEGTLKTEHVSENGKTLEIDEIKPVQIIASGFIFSS 82 (213)
T ss_dssp ---------CCGGGG-GGGSEEEEECTTCEEECTTCBCCEEEEEEESCEEEEEECTTSCEEEEEEECSSEESSGGGTTSS
T ss_pred cccchhhccCCHHHH-hcccEEEEECCCCEEEcCCCccceEEEEEeeEEEEEEECCCCCEEEEEEecCCCEeeeHHHhcC
Confidence 367777777554333 3445567789999999999999999999999999985 564 47789999999999986
Q ss_pred --hhcccccccCCCcccccCCchhhhhhhhhhhhhccCC
Q 001057 608 --AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 608 --pRAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~ 644 (1170)
|+.++|.|.++|.+|.+++ +.|..++...
T Consensus 83 ~~~~~~~~~A~~~~~v~~i~~--------~~~~~l~~~~ 113 (213)
T 1o5l_A 83 EPRFPVNVVAGENSKILSIPK--------EVFLDLLMKD 113 (213)
T ss_dssp SCBCSSEEEESSSEEEEEEEH--------HHHHHHHHHC
T ss_pred CCCceEEEEEccceEEEEEeH--------HHHHHHHHHC
Confidence 7899999999999999999 8888876543
|
| >3dkw_A DNR protein; CRP-FNR, HTH, beta barrel, dimerization helix, homodimer, transcription regulator; 3.60A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=98.36 E-value=1.3e-07 Score=97.07 Aligned_cols=91 Identities=11% Similarity=-0.024 Sum_probs=77.7
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---h-hcccccccCCCcccccC
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---A-KTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---p-RAATv~A~t~~~lw~ld 625 (1170)
....++||..|.+|||.++++|+|.+|.|.++. +|+ .+..+++|+.|||.+++ | +.+||.|.++|.+|.++
T Consensus 33 ~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~G~~~~~~~~~~g~~~G~~~~~~~~~~~~~~~~a~~~~~v~~i~ 112 (227)
T 3dkw_A 33 DLVNLDKGAYVFRQGEPAHAFYYLISGCVKIYRLTPEGQEKILEVTNERNTFAEAMMFMDTPNYVATAQAVVPSQLFRFS 112 (227)
T ss_dssp EEEECCTTEEEECTTSBCCEEEEEEESCEECCBCCGGGCCBCCCEECTTEEESCTTTTTTCSBCSSCEEESSCCEEEEEE
T ss_pred EEEEECCCCEEEcCCCccceEEEEEeCEEEEEEECCCCCEEEEEEcCCCCEeeeHHhcCCCCCCceEEEEcCcEEEEEEe
Confidence 456789999999999999999999999999986 343 57789999999999987 7 99999999999999999
Q ss_pred CchhhhhhhhhhhhhccCCCHHHHHHHH
Q 001057 626 RTSQIELLVNGHRTITELQNPQQIKKLL 653 (1170)
Q Consensus 626 R~~~~~~~~~tfr~Il~~~~~~kr~~y~ 653 (1170)
+ +.|..++.....=.+..+.
T Consensus 113 ~--------~~~~~l~~~~p~~~~~~~~ 132 (227)
T 3dkw_A 113 N--------KAYLRQLQDNTPLALALLA 132 (227)
T ss_dssp S--------HHHHHHHSSCTHHHHHHHH
T ss_pred H--------HHHHHHHHHCHHHHHHHHH
Confidence 9 8999988776544433333
|
| >3e97_A Transcriptional regulator, CRP/FNR family; YP_604437.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE; 1.86A {Deinococcus geothermalis dsm 11300} | Back alignment and structure |
|---|
Probab=98.35 E-value=8.8e-08 Score=99.02 Aligned_cols=83 Identities=16% Similarity=0.096 Sum_probs=72.4
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---hhcccccccCCCcccccCC
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR 626 (1170)
....++||..|.+|||.++.+|+|.+|.|.++. +|+ .+..+.+|+.|||.+++ |+.+||.|.++|.+|.+++
T Consensus 30 ~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~g~~~~~~~~~~g~~~G~~~~~~~~~~~~~~~a~~~~~v~~i~~ 109 (231)
T 3e97_A 30 TERNFQPDELVVEQDAEGEALHLVTTGVVRVSRVSLGGRERVLGDIYAPGVVGETAVLAHQERSASVRALTPVRTLMLHR 109 (231)
T ss_dssp EEEEECTTCBCCCTTCTTTCEEEECSSEEEEEEECC--CEEEEEEEESSEEESTTTTTCCCCCCEEEEESSCEEEEEECH
T ss_pred EEEEECCCCEEEeCCCCCCeEEEEEecEEEEEEECCCCceEEEEecCCCCEEeeHHHhCCCCceEEEEECCcEEEEEEeH
Confidence 456789999999999999999999999999986 453 47899999999999998 9999999999999999999
Q ss_pred chhhhhhhhhhhhhccCCC
Q 001057 627 TSQIELLVNGHRTITELQN 645 (1170)
Q Consensus 627 ~~~~~~~~~tfr~Il~~~~ 645 (1170)
+.|..++..+.
T Consensus 110 --------~~~~~l~~~~p 120 (231)
T 3e97_A 110 --------EHFELILRRHP 120 (231)
T ss_dssp --------HHHHHHHHHCH
T ss_pred --------HHHHHHHHHCH
Confidence 77877775443
|
| >3iwz_A CAP-like, catabolite activation-like protein; XCC, pathogenicity, CRP, CLP, C-DI-GMP receptor, quorum SENS binding, transcription; 2.30A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=98.32 E-value=1.6e-07 Score=96.55 Aligned_cols=82 Identities=10% Similarity=-0.030 Sum_probs=73.2
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh----hhcccccccCCCcccccC
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA----AKTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~----pRAATv~A~t~~~lw~ld 625 (1170)
.....+||..|.+|||.++.+|+|.+|.|.++. +|+ .+..+.+|+.|||.+++ |+.++|.|.++|.+|.++
T Consensus 35 ~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~G~~~~~~~~~~g~~~G~~~~~~~~~~~~~~~~a~~~~~v~~i~ 114 (230)
T 3iwz_A 35 HRRRYPTRTDVFRPGDPAGTLYYVISGSVSIIAEEDDDRELVLGYFGSGEFVGEMGLFIESDTREVILRTRTQCELAEIS 114 (230)
T ss_dssp EEEEECTTCEEECTTSBCCEEEEEEESCEEEEEECTTSCEEEEEEECTTCEESCGGGTSCCSBCCSEEEESSCEEEEEEE
T ss_pred eEEEeCCCCEEECCCCCCCeEEEEEeeEEEEEEECCCCCEEEEEEecCCCEEEehhhhcCCCCceeEEEEcCcEEEEEEe
Confidence 345679999999999999999999999999996 454 47889999999999987 789999999999999999
Q ss_pred CchhhhhhhhhhhhhccCC
Q 001057 626 RTSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 626 R~~~~~~~~~tfr~Il~~~ 644 (1170)
+ ..|..++...
T Consensus 115 ~--------~~~~~l~~~~ 125 (230)
T 3iwz_A 115 Y--------ERLQQLFQTS 125 (230)
T ss_dssp H--------HHHHHHHHTT
T ss_pred H--------HHHHHHHHHh
Confidence 9 8888888765
|
| >1zyb_A Transcription regulator, CRP family; NP_813211.1, structural genomics, joint center for structura genomics, JCSG; 2.15A {Bacteroides thetaiotaomicron} SCOP: a.4.5.4 b.82.3.2 | Back alignment and structure |
|---|
Probab=98.31 E-value=1.4e-07 Score=98.29 Aligned_cols=82 Identities=7% Similarity=-0.098 Sum_probs=72.3
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---h-hcccccccCCCcccccC
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---A-KTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---p-RAATv~A~t~~~lw~ld 625 (1170)
....++||..|.+|||.++.+|+|.+|.|.++. +|+ .+..+++|+.|||.+++ | +.+||.|.++|.+|.++
T Consensus 44 ~~~~~~~ge~i~~~G~~~~~~y~i~~G~v~~~~~~~~G~~~~l~~~~~G~~fG~~~~~~~~~~~~~~~~A~~~~~v~~i~ 123 (232)
T 1zyb_A 44 HFIKHKAGETIIKSGNPCTQLCFLLKGEISIVTNAKENIYTVIEQIEAPYLIEPQSLFGMNTNYASSYVAHTEVHTVCIS 123 (232)
T ss_dssp EEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECGGGSCEEEEEEESSEEECGGGGSSSCCBCSSEEEESSCEEEEEEE
T ss_pred EEEEECCCCEEECCCCcccEEEEEEeeEEEEEEECCCCCEEEEEEccCCCeeeehHHhCCCCCCceEEEEccceEEEEEE
Confidence 345689999999999999999999999999986 454 46789999999999998 6 99999999999999999
Q ss_pred CchhhhhhhhhhhhhccCC
Q 001057 626 RTSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 626 R~~~~~~~~~tfr~Il~~~ 644 (1170)
+ +.|..++...
T Consensus 124 ~--------~~~~~l~~~~ 134 (232)
T 1zyb_A 124 K--------AFVLSDLFRY 134 (232)
T ss_dssp H--------HHHHHTGGGS
T ss_pred H--------HHHHHHhccC
Confidence 9 8888877654
|
| >3fx3_A Cyclic nucleotide-binding protein; helix_TURN_helix, CAMP regulatory protein, structural genomi 2, protein structure initiative; 2.20A {Ruegeria pomeroyi} PDB: 3h3z_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=1.3e-07 Score=98.05 Aligned_cols=83 Identities=16% Similarity=0.038 Sum_probs=73.5
Q ss_pred cccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---hhcccccccCCCcccccC
Q 001057 554 DLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 554 ~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ld 625 (1170)
.....++||..|.+||+.++.+|+|.+|.|.++. +|+ .+..+++|+.|||.+++ |+.+||.|.++|.+|.++
T Consensus 34 ~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~G~~~~~~~~~~G~~~G~~~~~~~~~~~~~~~a~~~~~v~~i~ 113 (237)
T 3fx3_A 34 AVWRSYDRGETLFLQEEKAQAIHVVIDGWVKLFRMTPTGSEAVVSVFTRGESFGEAVALRNTPYPVSAEAVTPCEVMHIP 113 (237)
T ss_dssp CEEEEECTTCEEECTTSCCCEEEEEEESEEEEEEECTTSCEEEEEEEETTEEECHHHHHHTCCCSSEEEESSSEEEEEEE
T ss_pred CEEEEECCCCEEEcCCCccceEEEEEeeEEEEEEECCCCCEEEEEEeCCCCEechHHHhcCCCCCceEEECCceEEEEEc
Confidence 3456789999999999999999999999999996 454 57889999999999998 999999999999999999
Q ss_pred CchhhhhhhhhhhhhccCC
Q 001057 626 RTSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 626 R~~~~~~~~~tfr~Il~~~ 644 (1170)
+ ..|..++...
T Consensus 114 ~--------~~~~~l~~~~ 124 (237)
T 3fx3_A 114 S--------PVFVSLMRRD 124 (237)
T ss_dssp H--------HHHHHHHHHC
T ss_pred H--------HHHHHHHHHC
Confidence 9 7887777543
|
| >3b02_A Transcriptional regulator, CRP family; structural genomics, riken structural genomics/proteomics in RSGI; 1.92A {Thermus thermophilus} PDB: 2zdb_A | Back alignment and structure |
|---|
Probab=98.30 E-value=2.2e-07 Score=94.08 Aligned_cols=68 Identities=12% Similarity=-0.004 Sum_probs=62.8
Q ss_pred CCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---hhcccccccCCCcccccCC
Q 001057 558 MSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 558 ~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR 626 (1170)
.++||..|.+|||.++.+|+|.+|.|.++. +|+ .+..+.+|+.||| +++ |+.+||.|.++|.+|.+++
T Consensus 3 ~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~g~~~~~~~~~~G~~~Ge-~~~~~~~~~~~~~A~~~~~v~~i~~ 78 (195)
T 3b02_A 3 RFARKETIYLRGEEARTLYRLEEGLVRVVELLPDGRLITLRHVLPGDYFGE-EALEGKAYRYTAEAMTEAVVQGLEP 78 (195)
T ss_dssp EECTTCEEECTTSBCCCEEEEEESCEEEEEECTTSCEEEEEEECTTCEECG-GGGTCSBCSSEEEESSSEEEEEECG
T ss_pred EcCCCCEEECCCCCCCeEEEEEeCEEEEEEECCCCCEEEEEEecCCCEech-hhhCCCCceeEEEECCcEEEEEEcH
Confidence 468999999999999999999999999986 454 4789999999999 988 9999999999999999999
|
| >3dn7_A Cyclic nucleotide binding regulatory protein; structural genomics, APC88869, cyclic nucleotide binding REG protein, PSI-2; 1.80A {Cytophaga hutchinsonii} | Back alignment and structure |
|---|
Probab=98.28 E-value=1.8e-07 Score=94.10 Aligned_cols=84 Identities=7% Similarity=-0.171 Sum_probs=73.0
Q ss_pred cccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHh-hhh---hhcccccccCCCccccc
Q 001057 554 DLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAA-DIA---AKTSSAGSLTPRSPLLT 624 (1170)
Q Consensus 554 ~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGEL-AL~---pRAATv~A~t~~~lw~l 624 (1170)
.....++||..|.+|||..+++|+|.+|.|.++. +|+ .+..+.+|+.|||+ +++ |+.++|.|.++|.+|.+
T Consensus 30 ~~~~~~~~g~~l~~~G~~~~~~y~i~~G~v~~~~~~~~G~e~~~~~~~~g~~~ge~~~~~~~~~~~~~~~a~~~~~v~~i 109 (194)
T 3dn7_A 30 FQLKKVRKKETLLKTGEICRINYFVVKGCLRLFFIDEKGIEQTTQFAIENWWLSDYMAFQKQQPADFYIQSVENCELLSI 109 (194)
T ss_dssp CEEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECTTSCEEEEEEEETTCEECCHHHHHHTCBCSSEEEESSCEEEEEE
T ss_pred CEEEEEcCCCEEECCCCeeeEEEEeecCeEEEEEECCCCCEEEEEEccCCcEEeehHHHhcCCCCceEEEEECCEEEEEE
Confidence 3456789999999999999999999999999985 564 46789999999988 555 89999999999999999
Q ss_pred CCchhhhhhhhhhhhhccCCC
Q 001057 625 PRTSQIELLVNGHRTITELQN 645 (1170)
Q Consensus 625 dR~~~~~~~~~tfr~Il~~~~ 645 (1170)
++ +.|..++....
T Consensus 110 ~~--------~~~~~l~~~~p 122 (194)
T 3dn7_A 110 TY--------TEQENLFERIP 122 (194)
T ss_dssp EH--------HHHHHHHHHCT
T ss_pred eH--------HHHHHHHHhCH
Confidence 99 88888876543
|
| >2gau_A Transcriptional regulator, CRP/FNR family; structural genomics, porphyromona gingivalis, PSI, protein structure initiative; 1.90A {Porphyromonas gingivalis} SCOP: a.4.5.4 b.82.3.2 | Back alignment and structure |
|---|
Probab=98.27 E-value=2.1e-07 Score=96.32 Aligned_cols=82 Identities=7% Similarity=-0.061 Sum_probs=71.0
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---hhcccccccCCCcccccCC
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR 626 (1170)
....++||..|.+|||..+.+|+|.+|.|.++. +|+ .+..+.+|+.|||.+++ |+.+||.|.+++.+|.+++
T Consensus 34 ~~~~~~~g~~i~~~g~~~~~~y~v~~G~v~~~~~~~~g~~~~~~~~~~G~~~G~~~~~~~~~~~~~~~A~~~~~v~~i~~ 113 (232)
T 2gau_A 34 QPFPCKKASTVFSEGDIPNNLFYLYEGKIKILREGVYGRFHISRIVKPGQFFGMRPYFAEETCSSTAIAVENSKVLAIPV 113 (232)
T ss_dssp EEEEECTTCEEECTTCCCCEEEEEEESCEEEEC-----CCCEEEEECTTCEESHHHHHHTSCCSSEEEESSCEEEEEEEH
T ss_pred eEEEECCCCEEEeCCCCCCeEEEEEeCEEEEEEECCCCCEEEEEEeCCCCEeeeehhhCCCCcceEEEEecceEEEEEEH
Confidence 345689999999999999999999999999984 454 47899999999999988 9999999999999999999
Q ss_pred chhhhhhhhhhhhhccCC
Q 001057 627 TSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 627 ~~~~~~~~~tfr~Il~~~ 644 (1170)
+.|..++...
T Consensus 114 --------~~~~~l~~~~ 123 (232)
T 2gau_A 114 --------EAIEALLKGN 123 (232)
T ss_dssp --------HHHHHHHHHC
T ss_pred --------HHHHHHHHHC
Confidence 7777776543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=1e-05 Score=85.46 Aligned_cols=132 Identities=18% Similarity=0.212 Sum_probs=92.0
Q ss_pred eccCCCe-EEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEEEEeeccCC
Q 001057 766 ISQGAFG-RVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLVMEYLNGG 843 (1170)
Q Consensus 766 LG~GgFG-tVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyLVMEY~~GG 843 (1170)
+..|..| .||.......+..+.+|+-... ....+.+|..+|..+. +--+.+++.++.+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 4445444 6998877767778899975532 3456778999998775 223667778888888899999999998
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q 001057 844 DLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL---------------------------------------------- 877 (1170)
Q Consensus 844 SL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~---------------------------------------------- 877 (1170)
++.+..... ......+..++...|.-||+.
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 877654321 111223344444444444421
Q ss_pred ------------CeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 878 ------------NVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 878 ------------GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
.++|+|+.|.|||++.++.+-|+||+.|..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 278999999999999877778999999874
|
| >3ryp_A Catabolite gene activator; CAMP receptor protein (CRP), allostery, DNA binding cyclic A transcription regulator; HET: CMP; 1.60A {Escherichia coli} PDB: 2cgp_A* 3hif_A 1g6n_A* 3ryr_A* 1i5z_A* 1j59_A* 1lb2_A* 1run_A* 1zrc_A* 1zrd_A* 1zre_A* 1zrf_A* 2gzw_A* 2wc2_A 3iyd_G* 3n4m_A* 3qop_A* 3rdi_A* 3rou_A* 3rpq_A* ... | Back alignment and structure |
|---|
Probab=98.26 E-value=2e-07 Score=94.50 Aligned_cols=83 Identities=11% Similarity=0.023 Sum_probs=73.3
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh----hhcccccccCCCcccccC
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA----AKTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~----pRAATv~A~t~~~lw~ld 625 (1170)
....++||..|.+||+.++++|+|.+|.|.++. +|+ .+..+.+|+.|||.+++ |+.+||.|.++|.+|.++
T Consensus 20 ~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~g~~~~~~~~~~g~~~G~~~~~~~~~~~~~~~~a~~~~~v~~i~ 99 (210)
T 3ryp_A 20 HIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEIS 99 (210)
T ss_dssp EEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECTTCCEEEEEEEETTCEESCTTTTSTTCBCSSEEEESSCEEEEEEE
T ss_pred EEEEeCCCCEEECCCCCCCeEEEEEeCEEEEEEECCCCCEEEEEEcCCCCEeeeHHHhcCCCCceEEEEECCcEEEEEEc
Confidence 345689999999999999999999999999985 454 47789999999999988 689999999999999999
Q ss_pred CchhhhhhhhhhhhhccCCC
Q 001057 626 RTSQIELLVNGHRTITELQN 645 (1170)
Q Consensus 626 R~~~~~~~~~tfr~Il~~~~ 645 (1170)
+ ..|..++....
T Consensus 100 ~--------~~~~~l~~~~p 111 (210)
T 3ryp_A 100 Y--------KKFRQLIQVNP 111 (210)
T ss_dssp H--------HHHHHHHHHCT
T ss_pred H--------HHHHHHHHHCh
Confidence 9 88888876554
|
| >3kcc_A Catabolite gene activator; helix-turn-helix, CAMP, CAMP-binding, DNA-binding nucleotide-binding, transcription, transcription regulation; HET: CMP; 1.66A {Escherichia coli} | Back alignment and structure |
|---|
Probab=98.23 E-value=2.6e-07 Score=98.37 Aligned_cols=83 Identities=11% Similarity=0.023 Sum_probs=73.3
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh----hhcccccccCCCcccccC
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA----AKTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~----pRAATv~A~t~~~lw~ld 625 (1170)
.....+||..|++||+.++.+|+|.+|.|.++. +|+ .+..+.+|+.|||.+++ |+.+||.|.++|.+|.++
T Consensus 70 ~~~~~~~ge~i~~~G~~~~~~y~I~~G~v~~~~~~~~G~e~~~~~~~~G~~~Ge~~~~~~~~~~~~~~~A~~~~~l~~i~ 149 (260)
T 3kcc_A 70 HIHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEIS 149 (260)
T ss_dssp EEEEECTTCEEECTTCBCCEEEEEEECEEEEEEECTTCCEEEEEEEETTCEESCTTTTSTTCBCCSEEEESSCEEEEEEE
T ss_pred EEEEECCCCEEECCCCcCCeEEEEEeCEEEEEEECCCCCEEEEEEcCCCCEEeehHHhCCCCCCceEEEECCCeEEEEEc
Confidence 345679999999999999999999999999995 454 47889999999999988 689999999999999999
Q ss_pred CchhhhhhhhhhhhhccCCC
Q 001057 626 RTSQIELLVNGHRTITELQN 645 (1170)
Q Consensus 626 R~~~~~~~~~tfr~Il~~~~ 645 (1170)
+ +.|..++....
T Consensus 150 ~--------~~~~~l~~~~p 161 (260)
T 3kcc_A 150 Y--------KKFRQLIQVNP 161 (260)
T ss_dssp H--------HHHHHHHHHCT
T ss_pred H--------HHHHHHHHHCH
Confidence 9 88888876554
|
| >3dv8_A Transcriptional regulator, CRP/FNR family; cyclic nucleotide-binding domain, structural genomics, joint for structural genomics; 2.55A {Eubacterium rectale atcc 33656} | Back alignment and structure |
|---|
Probab=98.15 E-value=5.5e-07 Score=92.01 Aligned_cols=82 Identities=7% Similarity=-0.111 Sum_probs=72.1
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCC--chHhhhh---hhcccccccCCCccccc
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKN--PTAADIA---AKTSSAGSLTPRSPLLT 624 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~s--FGELAL~---pRAATv~A~t~~~lw~l 624 (1170)
.....+||..|.+|||..+++|+|.+|.|.++. +|+ .+..+.+|+. |||.+++ |+.++|.|.++|.+|.+
T Consensus 27 ~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~G~~~~~~~~~~G~~~~~g~~~~~~~~~~~~~~~a~~~~~~~~i 106 (220)
T 3dv8_A 27 ITQHVKKGTIIHNGNMDCTGLLLVKSGQLRTYILSDEGREITLYRLFDMDMCLLSASCIMRSIQFEVTIEAEKDTDLWII 106 (220)
T ss_dssp EEEEECTTCEEEEGGGCCCEEEEEEESCEEEEEECTTSCEEEEEEECTTCEESGGGGGGCTTCCCCCEEEESSCEEEEEE
T ss_pred ceEEeCCCCEEECCCCCcceEEEEEeceEEEEEECCCCCEEEEEecCCCCeeehhHHHHhCCCCCceEEEEeeeeEEEEE
Confidence 346689999999999999999999999999996 454 4678899999 8999988 99999999999999999
Q ss_pred CCchhhhhhhhhhhhhccCC
Q 001057 625 PRTSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 625 dR~~~~~~~~~tfr~Il~~~ 644 (1170)
++ +.|..++..+
T Consensus 107 ~~--------~~~~~l~~~~ 118 (220)
T 3dv8_A 107 PA--------EIYKGIMKDS 118 (220)
T ss_dssp EH--------HHHHHHHHHC
T ss_pred EH--------HHHHHHHHHC
Confidence 99 7887777544
|
| >2oz6_A Virulence factor regulator; winged helix, helix-turn-helix, transcription factor, CAMP-B proteins, CAMP receptor protein; HET: CMP; 2.80A {Pseudomonas aeruginosa} SCOP: a.4.5.4 b.82.3.2 | Back alignment and structure |
|---|
Probab=98.15 E-value=3.9e-07 Score=92.25 Aligned_cols=81 Identities=4% Similarity=-0.043 Sum_probs=70.5
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh-------hhcccccccCCCcccc
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA-------AKTSSAGSLTPRSPLL 623 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~-------pRAATv~A~t~~~lw~ 623 (1170)
...++||..|.+|||.++.+|+|.+|.|.++. +|+ .+..+++|+.|||.+++ |+.+||.|.++|.+|.
T Consensus 15 ~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~~G~~~~~~~~~~g~~~G~~~~~~~~~~~~~~~~~~~A~~~~~v~~ 94 (207)
T 2oz6_A 15 RRRYTAKSTIIYAGDRCETLFFIIKGSVTILIEDDDGREMIIGYLNSGDFFGELGLFEKEGSEQERSAWVRAKVECEVAE 94 (207)
T ss_dssp EEEECTTCEEECTTSBCCEEEEEEESEEEEEEECTTSCEEEEEEEETTCEESCTTTCC-----CBCCSEEEESSCEEEEE
T ss_pred eEEECCCCEEEcCCCCCCeEEEEEeCEEEEEEECCCCCEEEEEEcCCCCCcccHHHhcCCCCCCCcceEEEECCcEEEEE
Confidence 35679999999999999999999999999985 454 47789999999999887 3789999999999999
Q ss_pred cCCchhhhhhhhhhhhhccCC
Q 001057 624 TPRTSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 624 ldR~~~~~~~~~tfr~Il~~~ 644 (1170)
+++ +.|..++..+
T Consensus 95 i~~--------~~~~~l~~~~ 107 (207)
T 2oz6_A 95 ISY--------AKFRELSQQD 107 (207)
T ss_dssp EEH--------HHHHHHHHHC
T ss_pred ECH--------HHHHHHHHHC
Confidence 999 7777766543
|
| >2fmy_A COOA, carbon monoxide oxidation system transcription RE COOA-1; DNA transcription regulator, DNA binding protein; HET: HEM; 2.20A {Carboxydothermus hydrogenoformans} PDB: 2hkx_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=5.9e-07 Score=92.31 Aligned_cols=97 Identities=9% Similarity=0.011 Sum_probs=77.9
Q ss_pred HhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEE--cCc--cccccCCCCCchHhhhhhhccc
Q 001057 537 ILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE--DLN--VLPEISCDKNPTAADIAAKTSS 612 (1170)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~--~~~--~v~~~~~g~sFGELAL~pRAAT 612 (1170)
+|..++++..... ........++||..|.+|||.++.+|+|.+|.|.++. +|+ .+..+++|+.||| |+.+|
T Consensus 11 ~f~~l~~~~~~~l-~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~G~~~~~~~~~~G~~~G~----~~~~~ 85 (220)
T 2fmy_A 11 LLEVLNSEEYSGV-LKEFREQRYSKKAILYTPNTERNLVFLVKSGRVRVYLAYEDKEFTLAILEAGDIFCT----HTRAF 85 (220)
T ss_dssp HHHHTTSGGGTTT-GGGSEEEEECTTCEEECTTCSSCEEEEEEESEEEEEEECSSCEEEEEEEETTCEEES----CSSSE
T ss_pred hhhcCCHHHHHHH-HHhhheeEeCCCCEEECCCCCCCeEEEEEecEEEEEECCCCCEEEEEEcCCCCEeCC----ccceE
Confidence 4555555444332 2334566789999999999999999999999999974 454 4779999999999 99999
Q ss_pred ccccCCCcccccCCchhhhhhhhhhhhhccCCCH
Q 001057 613 AGSLTPRSPLLTPRTSQIELLVNGHRTITELQNP 646 (1170)
Q Consensus 613 v~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~ 646 (1170)
|.|.++|.+|.+++ ..|..++.....
T Consensus 86 ~~A~~~~~v~~i~~--------~~~~~l~~~~p~ 111 (220)
T 2fmy_A 86 IQAMEDTTILYTDI--------RNFQNIVVEFPA 111 (220)
T ss_dssp EEESSSEEEEEEEH--------HHHHHHHHHCTH
T ss_pred EEEcCcEEEEEEeH--------HHHHHHHHHCHH
Confidence 99999999999999 778777765443
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=7.7e-06 Score=92.04 Aligned_cols=80 Identities=25% Similarity=0.271 Sum_probs=50.1
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEeecccc-ccH---HHHHHHHHHHHHHHhcCC--C-cEEEEEeeeecccceE
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM-IRK---NAVESILAERNILISVRN--P-FVVRFFYSFTCRENLY 834 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i-~~~---~~ve~~l~EieILskL~H--P-NIVrL~~~Fqd~~~Ly 834 (1170)
.++.||.|.++.||++....+++.|++|....... ... .....+..|..+|..+.. | .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35689999999999997766678899997653211 000 112356778888887642 3 34455543 345678
Q ss_pred EEEeeccCC
Q 001057 835 LVMEYLNGG 843 (1170)
Q Consensus 835 LVMEY~~GG 843 (1170)
+||||+.|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3la7_A Global nitrogen regulator; activator, DNA-binding, transcription, transcription regulation; HET: BOG; 1.90A {Anabaena} PDB: 3la2_A* 3la3_A* 2xko_A* 2xgx_A* 2xhk_A* 2xkp_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.1e-06 Score=92.46 Aligned_cols=82 Identities=7% Similarity=-0.072 Sum_probs=71.3
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---h--hcccccccCCCcccccC
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---A--KTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---p--RAATv~A~t~~~lw~ld 625 (1170)
-..++||..|.+||+..+.+|+|.+|.|.++. +|+ .+..+.+|+.||+.+++ | |.++|.|.++|.+|.++
T Consensus 45 ~~~~~~ge~i~~~G~~~~~ly~v~~G~v~~~~~~~~G~~~~l~~~~~g~~~G~~~~~~~~~~~~~~~~~A~~~~~v~~i~ 124 (243)
T 3la7_A 45 VETFERNKTIFFPGDPAERVYFLLKGAVKLSRVYEAGEEITVALLRENSVFGVLSLLTGNKSDRFYHAVAFTPVELLSAP 124 (243)
T ss_dssp EEEECTTCEEECTTSBCCEEEEEEESCEEEEEECTTCCEEEEEEECTTCEESCHHHHSSCCSBCCEEEEESSSEEEEEEE
T ss_pred eEEECCCCEEEcCCCCCceEEEEEeCEEEEEEECCCCCEEEEEEecCCCEEcchHHhCCCCCcceEEEEEccceEEEEEc
Confidence 34579999999999999999999999999986 454 47789999999999988 3 66899999999999999
Q ss_pred CchhhhhhhhhhhhhccCCC
Q 001057 626 RTSQIELLVNGHRTITELQN 645 (1170)
Q Consensus 626 R~~~~~~~~~tfr~Il~~~~ 645 (1170)
+ +.|+.++....
T Consensus 125 ~--------~~~~~l~~~~p 136 (243)
T 3la7_A 125 I--------EQVEQALKENP 136 (243)
T ss_dssp H--------HHHHHHHTTCH
T ss_pred H--------HHHHHHHHHCH
Confidence 9 88888776543
|
| >3beh_A MLL3241 protein; transmembrane protein, membrane protein; HET: LDA; 3.10A {Mesorhizobium loti} PDB: 2zd9_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=4.6e-07 Score=101.31 Aligned_cols=83 Identities=10% Similarity=-0.029 Sum_probs=0.0
Q ss_pred ccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCchh
Q 001057 553 DDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQ 629 (1170)
Q Consensus 553 ~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~ 629 (1170)
.......++|..+.+|||.++.+|+|.+|.+.++..+ ...+++|+.|||.+++ ||.+||.|.++|.+|.++|
T Consensus 250 ~~~~~~~~~ge~I~~~G~~~~~ly~I~~G~v~v~~~~--~~~l~~G~~fGe~~~l~~~~~~~~~~A~~~~~l~~i~~--- 324 (355)
T 3beh_A 250 ALRARTVPAGAVICRIGEPGDRMFFVVEGSVSVATPN--PVELGPGAFFGEMALISGEPRSATVSAATTVSLLSLHS--- 324 (355)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred hceEEEECCCCEEEeCCCcCceEEEEEeeEEEEEECC--eeEECCCCEEeehHHhCCCCcceEEEECccEEEEEEeH---
Confidence 3456778999999999999999999999999999876 4689999999999998 9999999999999999999
Q ss_pred hhhhhhhhhhhccCCC
Q 001057 630 IELLVNGHRTITELQN 645 (1170)
Q Consensus 630 ~~~~~~tfr~Il~~~~ 645 (1170)
+.|+.++....
T Consensus 325 -----~~f~~ll~~~p 335 (355)
T 3beh_A 325 -----ADFQMLCSSSP 335 (355)
T ss_dssp ----------------
T ss_pred -----HHHHHHHHHCH
Confidence 88888776543
|
| >3cf6_E RAP guanine nucleotide exchange factor (GEF) 4; EPAC, rapgef4, CAMP, SP-camps, GEF, gunanine nucleotide exchange factor, G-protein, GTP-binding, nucleotide-binding; HET: SP1; 2.20A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.07 E-value=9.7e-07 Score=108.19 Aligned_cols=79 Identities=10% Similarity=-0.045 Sum_probs=71.1
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEEcCc-cccccCCCCCchHhhhh---hhcccccccC-CCcccccCCchhh
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLN-VLPEISCDKNPTAADIA---AKTSSAGSLT-PRSPLLTPRTSQI 630 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~-~v~~~~~g~sFGELAL~---pRAATv~A~t-~~~lw~ldR~~~~ 630 (1170)
...++||..|++|||.++.+|+|.+|.|.++..|+ .+..+.+|+.|||++++ ||.+||.|.+ +|.+|.++|
T Consensus 58 ~~~~~kGe~I~~eGd~~~~lyiIlsG~V~v~~~g~~il~~l~~Gd~fGe~al~~~~~~~~tv~A~edd~~ll~I~~---- 133 (694)
T 3cf6_E 58 ESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYGKGVVCTLHEGDDFGKLALVNDAPRAASIVLREDNCHFLRVDK---- 133 (694)
T ss_dssp EEECSTTCEEECTTSBCCEEEEEEESEEEEEETTTEEEEEEETTCEECHHHHHHTCBCSSEEEECSSSEEEEEEEH----
T ss_pred EEEECCCCEEECCCCcCCeEEEEEEEEEEEEEeCCEEEEEeCCCCEeehHHHhCCCCceEEEEEeeCceEEEEEeH----
Confidence 45789999999999999999999999999999886 68899999999999998 9999999999 599999999
Q ss_pred hhhhhhhhhhcc
Q 001057 631 ELLVNGHRTITE 642 (1170)
Q Consensus 631 ~~~~~tfr~Il~ 642 (1170)
..|+.++.
T Consensus 134 ----~~f~~ll~ 141 (694)
T 3cf6_E 134 ----EDFNRILR 141 (694)
T ss_dssp ----HHHHHHTT
T ss_pred ----HHHHHHHH
Confidence 55555554
|
| >1ft9_A Carbon monoxide oxidation system transcription regulator; heme sensor, catabolite gene activator protein; HET: HEM; 2.60A {Rhodospirillum rubrum} SCOP: a.4.5.4 b.82.3.1 | Back alignment and structure |
|---|
Probab=97.93 E-value=2.2e-06 Score=88.34 Aligned_cols=95 Identities=6% Similarity=-0.142 Sum_probs=75.6
Q ss_pred hcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEE--cCc--cccccCCCCCchHhhhhhhcccc
Q 001057 538 LDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE--DLN--VLPEISCDKNPTAADIAAKTSSA 613 (1170)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~--~~~--~v~~~~~g~sFGELAL~pRAATv 613 (1170)
|..+++...... ........++||..|.+|||.++.+|+|.+|.|.++. +|+ .+..+++|+.|| .|+.+||
T Consensus 8 f~~l~~~~~~~l-~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~~~~~~~G~~~~~~~~~~G~~fG----~~~~~~~ 82 (222)
T 1ft9_A 8 ANVLLSPDGETF-FRGFRSKIHAKGSLVCTGEGDENGVFVVVDGRLRVYLVGEEREISLFYLTSGDMFC----MHSGCLV 82 (222)
T ss_dssp HHHHTSTTTTTT-TTTCEEEEECTTCEEECTTCCCCCEEEEEESEEEEEEEETTEEEEEEEEETTCEEE----SCSSCEE
T ss_pred hhcCCHHHHHHH-HhhCcEEEECCCCEEECCCCCCCeEEEEEecEEEEEECCCCCEEEEEEcCCCCEec----CCCCEEE
Confidence 444445443332 2334567789999999999999999999999999973 454 477999999999 7999999
Q ss_pred cccCCCcccccCCchhhhhhhhhhhhhccCCC
Q 001057 614 GSLTPRSPLLTPRTSQIELLVNGHRTITELQN 645 (1170)
Q Consensus 614 ~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~ 645 (1170)
.|.++|.+|.+++ ..|..++....
T Consensus 83 ~A~~~~~v~~i~~--------~~~~~l~~~~p 106 (222)
T 1ft9_A 83 EATERTEVRFADI--------RTFEQKLQTCP 106 (222)
T ss_dssp EESSCEEEEEECH--------HHHHHHHHHCG
T ss_pred EEccceEEEEEeH--------HHHHHHHHHCh
Confidence 9999999999999 77777765443
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.88 E-value=8.7e-05 Score=80.24 Aligned_cols=137 Identities=15% Similarity=0.151 Sum_probs=77.7
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-----CCcEEEEE-e--eeecccce
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-----NPFVVRFF-Y--SFTCRENL 833 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-----HPNIVrL~-~--~Fqd~~~L 833 (1170)
-++.|+.|..+.||++... +| .+++|+.... . ..+..|..++..+. .|.++... + +....+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD-SG-AVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET-TE-EEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC-CC-CEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 3456777789999998753 33 5889988652 1 22233444444432 34444311 0 11345668
Q ss_pred EEEEeeccCCChH--------------HHHHhc-CCC--C-----------HH--------H------------------
Q 001057 834 YLVMEYLNGGDLY--------------SLLRNL-GCL--D-----------ED--------M------------------ 859 (1170)
Q Consensus 834 yLVMEY~~GGSL~--------------dlLk~~-~~L--S-----------Ee--------~------------------ 859 (1170)
|+||+|++|.++. ..++.. ..+ + .. .
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986542 111111 111 1 00 0
Q ss_pred -----HHHHHHHHHHHHHHHHh-------------CCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 860 -----ARVYIAELVLALEYLHS-------------LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 860 -----ar~IaaQIL~ALeYLHs-------------~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
...+..++..++.+|+. ..++|+|+++.|||++.++.+.|+||+.|..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11112234445666652 5799999999999998888999999998864
|
| >3e6c_C CPRK, cyclic nucleotide-binding protein; CPRK, halorespiration; HET: DNA 3C4; 1.80A {Desulfitobacterium hafniense} SCOP: a.4.5.4 b.82.3.2 PDB: 3e6b_A* 3e5u_C* 3e6d_A 3e5x_A* 3e5q_A 2h6b_A* 2h6c_A | Back alignment and structure |
|---|
Probab=97.84 E-value=4.7e-06 Score=87.61 Aligned_cols=84 Identities=11% Similarity=-0.048 Sum_probs=70.9
Q ss_pred cccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh-hhcccccccCCCcccccCCc
Q 001057 554 DLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA-AKTSSAGSLTPRSPLLTPRT 627 (1170)
Q Consensus 554 ~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~-pRAATv~A~t~~~lw~ldR~ 627 (1170)
.....++||..|.+||+.++++|+|.+|.|.++. +|+ .+..+.+|+.||| .+. .+.+||.|.++|.+|.+++
T Consensus 32 ~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v~~~~~~~~G~~~~~~~~~~G~~~G~-~l~~~~~~~~~A~~~~~v~~i~~- 109 (250)
T 3e6c_C 32 GLIRDFAKGSAVIMPGEEITSMIFLVEGKIKLDIIFEDGSEKLLYYAGGNSLIGK-LYPTGNNIYATAMEPTRTCWFSE- 109 (250)
T ss_dssp SEEEEECTTCEEECTTCCCCSEEEEEESCEEEEEECTTSCEEEEEEECTTCEECC-CSCCSCCEEEEESSSEEEEEECH-
T ss_pred CeEEEECCCCEEECCCCCCCeEEEEEeeEEEEEEECCCCCEEEEEEecCCCEEee-ecCCCCceEEEEcccEEEEEEcH-
Confidence 3456689999999999999999999999999986 454 4778999999999 333 6889999999999999999
Q ss_pred hhhhhhhhhhhhhccCCCH
Q 001057 628 SQIELLVNGHRTITELQNP 646 (1170)
Q Consensus 628 ~~~~~~~~tfr~Il~~~~~ 646 (1170)
..|..++.....
T Consensus 110 -------~~~~~l~~~~p~ 121 (250)
T 3e6c_C 110 -------KSLRTVFRTDED 121 (250)
T ss_dssp -------HHHHHHHHHCTH
T ss_pred -------HHHHHHHHHCHH
Confidence 888887765443
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.79 E-value=5.5e-05 Score=83.48 Aligned_cols=87 Identities=14% Similarity=0.124 Sum_probs=54.4
Q ss_pred eEEEEEe-ccCCCeEEEEeeec--C----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC---CcEEEEEeeeec
Q 001057 760 FEIIKPI-SQGAFGRVFLARKR--A----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRN---PFVVRFFYSFTC 829 (1170)
Q Consensus 760 Yevlk~L-G~GgFGtVyLArdk--~----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H---PNIVrL~~~Fqd 829 (1170)
...++.| +.|....+|++... . ++..+++|+..............+.+|..+|..+.. -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 88999999988653 0 156788997654320000001345677777776642 346667766655
Q ss_pred c---cceEEEEeeccCCChH
Q 001057 830 R---ENLYLVMEYLNGGDLY 846 (1170)
Q Consensus 830 ~---~~LyLVMEY~~GGSL~ 846 (1170)
. +..|+||||++|..|.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999886653
|
| >2zcw_A TTHA1359, transcriptional regulator, FNR/CRP family; stationary phase, DNA-binding, transcription regulation; 1.50A {Thermus thermophilus} | Back alignment and structure |
|---|
Probab=97.78 E-value=8e-06 Score=82.96 Aligned_cols=69 Identities=7% Similarity=-0.174 Sum_probs=62.2
Q ss_pred cCCCcccccccccCCCC--CcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---hhcccccccCCCcccccC
Q 001057 556 NLMSPKQNSLSRQGSKE--MLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~G--d~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ld 625 (1170)
...++||..|.+|||.. +++|+|.+|.|.++. +|+ .+..+.+|+.||+ +++ |+.+++.|.++|.+|.+
T Consensus 7 ~~~~~~g~~i~~~g~~~~~~~~y~v~~G~v~~~~~~~~G~~~~~~~~~~g~~~G~-~~l~~~~~~~~~~A~~~~~v~~i- 84 (202)
T 2zcw_A 7 TVSFKAGDVILYPGVPGPRDRAYRVLEGLVRLEAVDEEGNALTLRLVRPGGFFGE-EALFGQERIYFAEAATDVRLEPL- 84 (202)
T ss_dssp CEEECTTCEEECSBSCCTTCCCEEEEESCEEEEEECTTSCEEEEEEECTTCEECT-HHHHTCCBCSEEEESSCEEEEEC-
T ss_pred EEEECCCCEEECCCCCCCCCeEEEEEeCEEEEEEECCCCcEEEEEEecCCCEeee-hhcCCCCcceEEEEcccEEEEEE-
Confidence 45679999999999999 999999999999985 564 4778999999999 766 99999999999999999
Q ss_pred C
Q 001057 626 R 626 (1170)
Q Consensus 626 R 626 (1170)
+
T Consensus 85 ~ 85 (202)
T 2zcw_A 85 P 85 (202)
T ss_dssp C
T ss_pred h
Confidence 8
|
| >2bgc_A PRFA; bacterial infection, human pathogen, transcriptional regulat transcription; HET: PR3; 2.3A {Listeria monocytogenes} SCOP: a.4.5.4 b.82.3.3 PDB: 2beo_A* 1omi_A | Back alignment and structure |
|---|
Probab=97.72 E-value=4.5e-06 Score=87.28 Aligned_cols=80 Identities=6% Similarity=-0.106 Sum_probs=65.4
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh---hh--ccccccc-CCCccccc
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA---AK--TSSAGSL-TPRSPLLT 624 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~---pR--AATv~A~-t~~~lw~l 624 (1170)
...++||..|.+|||.++++|+|.+|.|.++. +|+ .+..+ +|+.|||.+++ ++ ..++.|+ ++|.+|.+
T Consensus 20 ~~~~~~ge~i~~~G~~~~~~y~I~~G~v~~~~~~~~G~e~~~~~~-~G~~~Ge~~~~~~~~~~~~~~~~a~~~~~~v~~i 98 (238)
T 2bgc_A 20 PKQFHKKELIFNQWDPQEYCIFLYDGITKLTSISENGTIMNLQYY-KGAFVIMSGFIDTETSVGYYNLEVISEQATAYVI 98 (238)
T ss_dssp CEEEETTCEEECTTCCCCEEEEEEESEEEEEEECTTSCEEEEEEE-ESSEEEESBCTTTCCBSCCCEEEECSSEEEEEEE
T ss_pred EEEECCCCEEEeCCCCCceEEEEEecEEEEEEECCCCCEEEEEEc-CCCEecchhhhcCCCcCcceeEEEEEcceEEEEE
Confidence 35678999999999999999999999999986 454 35566 89999999988 43 5666666 49999999
Q ss_pred CCchhhhhhhhhhhhhccCC
Q 001057 625 PRTSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 625 dR~~~~~~~~~tfr~Il~~~ 644 (1170)
++ ..|..++...
T Consensus 99 ~~--------~~~~~l~~~~ 110 (238)
T 2bgc_A 99 KI--------NELKELLSKN 110 (238)
T ss_dssp EH--------HHHHHHHHHC
T ss_pred eH--------HHHHHHHHHC
Confidence 99 7777776543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00038 Score=79.31 Aligned_cols=32 Identities=25% Similarity=0.391 Sum_probs=28.4
Q ss_pred HhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 875 Hs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
+...++|+|++|.|||++.++ ++|+||+.|..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 456799999999999998877 99999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0017 Score=72.41 Aligned_cols=76 Identities=14% Similarity=0.146 Sum_probs=58.5
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC---CCcEEEEEeeeecccceEEEEe
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR---NPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~---HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
-++.|+.|....+|++.. ++..|++|+.... ....+..|...|..|. ...+++++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 356789999999999874 4677889986542 2456778888888774 3567788877777788999999
Q ss_pred eccCCCh
Q 001057 839 YLNGGDL 845 (1170)
Q Consensus 839 Y~~GGSL 845 (1170)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0011 Score=71.77 Aligned_cols=132 Identities=15% Similarity=0.100 Sum_probs=72.6
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE-EEEEeeeecccceEEEEeec-
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV-VRFFYSFTCRENLYLVMEYL- 840 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNI-VrL~~~Fqd~~~LyLVMEY~- 840 (1170)
++.|+.|....+|++ ..|.+|+...... ......+|..++..+...++ .++++.+ .+.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 678999999999998 3478898754210 00112356666665542122 4555443 33457899999
Q ss_pred cCCChHHH---------------H---HhcC-CCC-----HHHHHHHHHH--------------HHHHHHHHH-------
Q 001057 841 NGGDLYSL---------------L---RNLG-CLD-----EDMARVYIAE--------------LVLALEYLH------- 875 (1170)
Q Consensus 841 ~GGSL~dl---------------L---k~~~-~LS-----Ee~ar~IaaQ--------------IL~ALeYLH------- 875 (1170)
+|.+|... + +... .+. ...+..+... +...+..|.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66544210 1 1111 010 1111111111 111111111
Q ss_pred -hCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 876 -SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 876 -s~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
...++|+|+.|.||| ..++.+.|+||..|..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 123899999999999 5667889999998874
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0015 Score=70.83 Aligned_cols=141 Identities=18% Similarity=0.137 Sum_probs=78.1
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc--EEEEEee------eeccc
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF--VVRFFYS------FTCRE 831 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN--IVrL~~~------Fqd~~ 831 (1170)
..-++.|+.|....||++... +| .+++|+..... ..+.+..|..++..+...+ +.+++.. ....+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g 96 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG 96 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence 445677888999999998753 34 57899876521 1123445666666554211 2333311 11234
Q ss_pred ceEEEEeeccCCChHH--------------HHHhc-CCC--------CHHHHHH---------------HHHHHHHHHHH
Q 001057 832 NLYLVMEYLNGGDLYS--------------LLRNL-GCL--------DEDMARV---------------YIAELVLALEY 873 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~d--------------lLk~~-~~L--------SEe~ar~---------------IaaQIL~ALeY 873 (1170)
..++||+|++|..+.. .++.. ..+ ....... +...+...+.+
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 5789999998865311 01111 011 1000000 00113344555
Q ss_pred HHh-------CCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 874 LHS-------LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 874 LHs-------~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
++. .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 552 3699999999999998776668999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0029 Score=68.73 Aligned_cols=136 Identities=16% Similarity=0.206 Sum_probs=76.3
Q ss_pred EEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCC--cEEEEEee-----eecccceEEE
Q 001057 764 KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP--FVVRFFYS-----FTCRENLYLV 836 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HP--NIVrL~~~-----Fqd~~~LyLV 836 (1170)
..|+ |....||++.. .+|+.+++|+...... ....+..|..++..+... .+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 3466 88889998764 3466788998763211 123455677777666421 23444432 1123456789
Q ss_pred EeeccCCChH-----H------H---HHh----cC-----CCCHHHH----H------------------HHHHHHHHHH
Q 001057 837 MEYLNGGDLY-----S------L---LRN----LG-----CLDEDMA----R------------------VYIAELVLAL 871 (1170)
Q Consensus 837 MEY~~GGSL~-----d------l---Lk~----~~-----~LSEe~a----r------------------~IaaQIL~AL 871 (1170)
|+|++|..+. . . ++. .. .++.... + ..+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875431 0 1 111 00 1111110 0 0111222222
Q ss_pred HHH----HhCCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 872 EYL----HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 872 eYL----Hs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
.-+ +...++|+|+++.|||++ + .+.|+||+.|..
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 222 234589999999999998 4 899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0038 Score=72.03 Aligned_cols=75 Identities=19% Similarity=0.242 Sum_probs=49.5
Q ss_pred EEEEeccCCCeEEEEeeecC-------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeecccce
Q 001057 762 IIKPISQGAFGRVFLARKRA-------TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF-VVRFFYSFTCRENL 833 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~-------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN-IVrL~~~Fqd~~~L 833 (1170)
-++.|+.|-...||++.... .+..|.+|+..... . ...+..|..++..+...+ ..++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678888899999998643 35789999874321 1 134457888888775323 3566666543
Q ss_pred EEEEeeccCCCh
Q 001057 834 YLVMEYLNGGDL 845 (1170)
Q Consensus 834 yLVMEY~~GGSL 845 (1170)
.+||||++|.+|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999987443
|
| >3idb_B CAMP-dependent protein kinase type II-beta regulatory subunit, CAMP-dependent protein kinase catalytic subunit alpha; PKA, SPR, affinity; HET: TPO SEP ANP; 1.62A {Rattus norvegicus} PDB: 3idc_B* | Back alignment and structure |
|---|
Probab=96.66 E-value=0.00035 Score=68.32 Aligned_cols=83 Identities=18% Similarity=0.207 Sum_probs=67.0
Q ss_pred hcccccccCCCcccccCCchhhhhhhhhhhhhccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------
Q 001057 609 KTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------ 682 (1170)
Q Consensus 609 RAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------ 682 (1170)
|.+||.| .+..+|..++ ..|+.+++..+..++.++.++|+.+++|..|++.++..|+..++...|
T Consensus 2 rr~~v~a-e~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~~~~f~~l~~~~l~~l~~~~~~~~~~~g~~i 72 (161)
T 3idb_B 2 RRASVCA-EAYNPDEEED--------DAESRIIHPKTDDQRNRLQEACKDILLFKNLDPEQMSQVLDAMFEKLVKEGEHV 72 (161)
T ss_dssp CCCCEEC-CCCCTTC----------------CCCCCCHHHHHHHHHHHTTCHHHHTSCHHHHHHHHHHCEEEEECTTCEE
T ss_pred CceeEEe-ccCCccchhc--------ccCCcccCCCCHHHHHHHHHHHhCCHhhhcCCHHHHHHHHHhcceeEeCCCCEE
Confidence 6677755 5578899999 899999999999999999999999999999999999999999988777
Q ss_pred HHhccccCcEEeeeehhh
Q 001057 683 IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 683 IiqgekgD~FyI~~~G~R 700 (1170)
+.+|+.++.+|++..|..
T Consensus 73 ~~~G~~~~~~y~i~~G~v 90 (161)
T 3idb_B 73 IDQGDDGDNFYVIDRGTF 90 (161)
T ss_dssp ECTTSCCCEEEEEEESEE
T ss_pred EeCCCCCcEEEEEEeCEE
Confidence 566799999999999984
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0041 Score=68.07 Aligned_cols=31 Identities=29% Similarity=0.519 Sum_probs=27.5
Q ss_pred CCeeeccCCCCcEEeCCC----CcEEEEecCCccc
Q 001057 877 LNVIHRDLKPDNLLIGQD----GHIKLTDFGLSKV 907 (1170)
Q Consensus 877 ~GIIHRDIKPENILLd~d----G~VKLsDFGLAk~ 907 (1170)
..++|+|+.+.|||++.+ +.+.|+||+.|..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6899999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0043 Score=69.14 Aligned_cols=75 Identities=15% Similarity=0.186 Sum_probs=42.8
Q ss_pred EEEeccCCCeEEEEeeecC--------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeecccce
Q 001057 763 IKPISQGAFGRVFLARKRA--------TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF-VVRFFYSFTCRENL 833 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~--------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN-IVrL~~~Fqd~~~L 833 (1170)
++.|+.|....||++.... .+..|.+|+...... .......|..++..+...+ +.++++.+. -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN----G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC----C
Confidence 4567888888999987643 136888998754211 1111246777777664222 345665442 2
Q ss_pred EEEEeeccCCCh
Q 001057 834 YLVMEYLNGGDL 845 (1170)
Q Consensus 834 yLVMEY~~GGSL 845 (1170)
++||||++|.+|
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.29 E-value=0.006 Score=69.76 Aligned_cols=136 Identities=15% Similarity=0.220 Sum_probs=79.8
Q ss_pred EEeccCCCeEEEEeeecC-------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEE
Q 001057 764 KPISQGAFGRVFLARKRA-------TGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk~-------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyL 835 (1170)
+.|..|-...+|++.... +++.|.+|+..... .....+.+|..+++.+. +....++++.+.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 346667777788877532 35788999863311 12344568888887775 3223566766654 28
Q ss_pred EEeeccCCChH--------------HHHH---hcC-----CCC--HHHHHHHHHHHHH-------------------HHH
Q 001057 836 VMEYLNGGDLY--------------SLLR---NLG-----CLD--EDMARVYIAELVL-------------------ALE 872 (1170)
Q Consensus 836 VMEY~~GGSL~--------------dlLk---~~~-----~LS--Ee~ar~IaaQIL~-------------------ALe 872 (1170)
||||++|.+|. ..|. ... ... ..++..+..++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999885542 1111 110 111 3455555544422 233
Q ss_pred HHH----h----CCeeeccCCCCcEEeCCC----CcEEEEecCCccc
Q 001057 873 YLH----S----LNVIHRDLKPDNLLIGQD----GHIKLTDFGLSKV 907 (1170)
Q Consensus 873 YLH----s----~GIIHRDIKPENILLd~d----G~VKLsDFGLAk~ 907 (1170)
.|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 332 2 248999999999999876 7899999999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=95.95 E-value=0.076 Score=57.00 Aligned_cols=79 Identities=14% Similarity=0.029 Sum_probs=54.2
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC---CcEEEEEeeeecccceEE
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN---PFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H---PNIVrL~~~Fqd~~~LyL 835 (1170)
...-+..+|.|..+.||++.. .+|+.|.+|+....... ....+..|...|+.|.- -.+++++.+ +.-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceE
Confidence 456678899999999999975 57889999986543211 12346779998888742 234455543 23478
Q ss_pred EEeeccCCCh
Q 001057 836 VMEYLNGGDL 845 (1170)
Q Consensus 836 VMEY~~GGSL 845 (1170)
||||+.++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.89 E-value=0.026 Score=66.00 Aligned_cols=76 Identities=14% Similarity=0.193 Sum_probs=48.2
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE-EEEEeeeecccceEEEEeec
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV-VRFFYSFTCRENLYLVMEYL 840 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNI-VrL~~~Fqd~~~LyLVMEY~ 840 (1170)
-++.|+.|-...+|++.....+..|.+|+...... ..+ ...+|..+|..|...++ .++++.|.. .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII-NREREKKISCILYNKNIAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS-CHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc-CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence 35678889999999998754457888998754210 000 11478888888864444 567776632 2599999
Q ss_pred cCCCh
Q 001057 841 NGGDL 845 (1170)
Q Consensus 841 ~GGSL 845 (1170)
+|.+|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.81 E-value=0.056 Score=60.04 Aligned_cols=31 Identities=23% Similarity=0.485 Sum_probs=27.9
Q ss_pred CCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 877 ~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3589999999999999888899999998875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.77 E-value=0.048 Score=58.73 Aligned_cols=121 Identities=23% Similarity=0.229 Sum_probs=80.3
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH-HhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCC
Q 001057 843 GDLYSLLRNL-GCLDEDMARVYIAELVLALEYL-HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920 (1170)
Q Consensus 843 GSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYL-Hs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~s 920 (1170)
-+|.++|... .+|+|++++.++.|.+.+|.-+ +...-..+=+-|..|+|..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 3789999765 6899999999999999998776 222222334457899999999888663 2110
Q ss_pred CCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q 001057 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDN 999 (1170)
Q Consensus 921 l~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qk 999 (1170)
.....+.|||... ...+.+.=|||||+++|.-|- |-+
T Consensus 98 ----------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~------------- 135 (229)
T 2yle_A 98 ----------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK------------- 135 (229)
T ss_dssp -------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC-------------
T ss_pred ----------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC-------------
Confidence 0112345666552 344677889999999998873 211
Q ss_pred HhccCCCCCCCCccCCHHHHHHHHHhccC
Q 001057 1000 IMNRDIPWPNIPEEMSVEACDLIDKLLTE 1028 (1170)
Q Consensus 1000 Il~~~l~fP~ip~~lS~eakDLIkkLLq~ 1028 (1170)
++.+..+|+.+..||..|..-
T Consensus 136 --------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 136 --------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------TTEEECCCHHHHHHHHHHTTC
T ss_pred --------cccchhhCHHHHHHHHHHHhc
Confidence 122357999999999999865
|
| >3pna_A CAMP-dependent protein kinase type I-alpha regula subunit; beta-barrel, CAMP-binding, catalytic subunit, transferase; HET: CMP; 1.50A {Bos taurus} PDB: 3fhi_B* 3iia_A 3plq_A* 1u7e_B* 3pvb_B* | Back alignment and structure |
|---|
Probab=93.30 E-value=0.022 Score=55.09 Aligned_cols=66 Identities=14% Similarity=0.130 Sum_probs=58.0
Q ss_pred hhhhhhccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 635 NGHRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 635 ~tfr~Il~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
..|..+++..+..++.++.++|+.+++|..|++.++..++..++...| +.+|+.++.+|++..|..
T Consensus 19 ~~~~~~~~~k~~~~~~~~~~~l~~~~~f~~l~~~~~~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~i~~G~v 90 (154)
T 3pna_A 19 ASYVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAMFPVSFIAGETVIQQGDEGDNFYVIDQGEM 90 (154)
T ss_dssp ---CCCCCCCCHHHHHHHHHHHHHCGGGTTCCHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEESCE
T ss_pred cccccccCCCCHHHHHHHHHHHHhChhhhhCCHHHHHHHHHhceEEEECCCCEEEeCCCCCCeEEEEEecEE
Confidence 679999999999999999999999999999999999999999887777 566799999999999983
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.25 E-value=0.12 Score=60.01 Aligned_cols=76 Identities=13% Similarity=0.149 Sum_probs=46.2
Q ss_pred EEEEeccCCCeEEEEeeecC-------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccce
Q 001057 762 IIKPISQGAFGRVFLARKRA-------TGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~-------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~L 833 (1170)
-++.|..|-...+|++.... .+..|.+++..... . ..-...+|..++..+. +.-..++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~-~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---G-KFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---c-hhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 34567778888899887652 15789999865421 0 0111246777776664 222345555443 2
Q ss_pred EEEEeeccCCCh
Q 001057 834 YLVMEYLNGGDL 845 (1170)
Q Consensus 834 yLVMEY~~GGSL 845 (1170)
++||||++|.+|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.39 E-value=1.5 Score=49.75 Aligned_cols=29 Identities=28% Similarity=0.485 Sum_probs=25.4
Q ss_pred eeeccCCCCcEEe------CCCCcEEEEecCCccc
Q 001057 879 VIHRDLKPDNLLI------GQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 879 IIHRDIKPENILL------d~dG~VKLsDFGLAk~ 907 (1170)
++|+|+.+.|||+ +.++.+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999999875
|
| >3ocp_A PRKG1 protein; serine/threonine kinase, TF2I and IRAG, transferase; HET: CMP; 2.49A {Homo sapiens} PDB: 3od0_A* 3ogj_A* | Back alignment and structure |
|---|
Probab=87.56 E-value=0.15 Score=48.07 Aligned_cols=57 Identities=12% Similarity=0.241 Sum_probs=50.2
Q ss_pred CCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 644 QNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 644 ~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
.+..++.++.++|++++++..|++.++..++..++...| +.+|+..+.+|++..|..
T Consensus 13 k~~~~~~~~~~~l~~~~~f~~l~~~~~~~l~~~~~~~~~~~g~~i~~~g~~~~~~y~i~~G~v 75 (139)
T 3ocp_A 13 KSPQSKDLIKEAILDNDFMKNLELSQIQEIVDCMYPVEYGKDSCIIKEGDVGSLVYVMEDGKV 75 (139)
T ss_dssp CCHHHHHHHHHHHHHCTTTTTSCHHHHHHHHHHCEEEEECSSCEEECTTSCCCEEEEEEECCE
T ss_pred CCHHHHHHHHHHHhcCHhhhcCCHHHHHHHHHhcEEEecCCCCEEEeCCCcCCEEEEEEeCEE
Confidence 356788889999999999999999999999999877777 566799999999999983
|
| >3gyd_A CNMP-BD protein, cyclic nucleotide-binding domain; nucleotide binding protein, structural genomics; HET: MSE CMP; 1.79A {Methylobacillus flagellatus KT} | Back alignment and structure |
|---|
Probab=80.33 E-value=0.21 Score=50.34 Aligned_cols=61 Identities=10% Similarity=0.126 Sum_probs=52.1
Q ss_pred hccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 640 ITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 640 Il~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
|....+..+...+.++|++++++..|++.++..++..++...| +.+|+.++.+|++..|..
T Consensus 25 i~~~~~~~~~~~~~~~L~~~~~f~~l~~~~l~~l~~~~~~~~~~~ge~i~~~G~~~~~ly~I~~G~v 91 (187)
T 3gyd_A 25 VHLGGADKYFEEILEIVNKIKLFGDFSNEEVRYLCSYMQCYAAPRDCQLLTEGDPGDYLLLILTGEV 91 (187)
T ss_dssp EEEEEGGGGHHHHHHHHTTCCSSCCCCHHHHHHHHTTCEEEEECTTCEEECTTSCCCEEEEEEEEEE
T ss_pred hccCccHHHHHHHHHHHhcCHhhhcCCHHHHHHHHHhcEEEEeCCCCEEEcCCCCCCeEEEEEeCEE
Confidence 3445566778889999999999999999999999988887777 566799999999999983
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1170 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-91 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-85 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-85 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-82 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-82 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-79 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-78 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-78 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-77 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-77 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-76 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-74 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-74 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-74 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-73 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-73 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-72 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-69 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-69 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-66 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-63 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-63 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-63 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-62 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-60 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-60 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-59 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-58 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-58 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-57 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-56 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-56 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-55 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-50 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-50 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-44 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-20 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 292 bits (748), Expect = 5e-91
Identities = 108/316 (34%), Positives = 173/316 (54%), Gaps = 34/316 (10%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
+ EDF+ K + +G+F V LAR+ AT +AIK+L+K +I++N V + ER+++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
+ +PF V+ +++F E LY + Y G+L +R +G DE R Y AE+V ALEY
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LH +IHRDLKP+N+L+ +D HI++TDFG +KV S
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK-------------------- 163
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993
Q + +S GT Y++PE+L ++D W++G I+++L+ G+PPF A
Sbjct: 164 --------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT---GAREVKQHPFFKN 1050
IF I+ + + PE+ +A DL++KLL + +RLG G +K HPFF++
Sbjct: 216 YLIFQKIIKLE---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 272
Query: 1051 INWDTLARQKAMFIPA 1066
+ W+ L +Q + A
Sbjct: 273 VTWENLHQQTPPKLTA 288
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 277 bits (709), Expect = 3e-85
Identities = 121/323 (37%), Positives = 185/323 (57%), Gaps = 39/323 (12%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNIL-ISV 815
IEDF + K + +G+FG+VFLA + T FAIK LKK ++ + VE + E+ +L ++
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
+PF+ F +F +ENL+ VMEYLNGGDL +++ D A Y AE++L L++LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S +++RDLK DN+L+ +DGHIK+ DFG+ K ++
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---------------------- 158
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
+ ++ GTPDY+APEILLG + + DWWS G++L+E+LIG PF+ + ++
Sbjct: 159 --------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055
+F +I + P P + EA DL+ KL P +RLG G +++QHP F+ INW+
Sbjct: 211 LFHSIRMDN---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFREINWEE 265
Query: 1056 LARQK--AMFIPAAES-LDTSYF 1075
L R++ F P +S D S F
Sbjct: 266 LERKEIDPPFRPKVKSPFDCSNF 288
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (702), Expect = 7e-85
Identities = 100/294 (34%), Positives = 149/294 (50%), Gaps = 38/294 (12%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
++EDFEI +P+ +G FG V+LAR++ + + A+KVL KA + + + E I +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
R+P ++R + F +YL++EY G +Y L+ L DE YI EL AL Y H
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S VIHRD+KP+NLL+G G +K+ DFG S
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA--------------------------- 156
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
++ ++ GT DYL PE++ G H D WS+G++ +E L+G PPF A T Q+
Sbjct: 157 -----PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ I + P+ ++ A DLI +LL NP QR REV +HP+
Sbjct: 212 TYKRISRVE---FTFPDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWIT 259
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 268 bits (687), Expect = 4e-82
Identities = 118/348 (33%), Positives = 191/348 (54%), Gaps = 43/348 (12%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
S++DF+I++ + G+FGRV L R R G +A+KVLKK ++R VE ER +L V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
+PF++R + +F + ++++M+Y+ GG+L+SLLR +A+ Y AE+ LALEYLH
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S ++I+RDLKP+N+L+ ++GHIK+TDFG +K
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAK----------------------------- 152
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
+++ GTPDY+APE++ + + DWWS GI+++E+L G PF +
Sbjct: 153 ----YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT--GAREVKQHPFFKNINW 1053
++ I+N ++ P + + DL+ +L+T + QRLG G +VK HP+FK + W
Sbjct: 209 TYEKILNAELR---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVW 265
Query: 1054 DTLARQKAM--FIPAAES--LDTSYFVSRYVWNPEDENVQGGSDFDDL 1097
+ L + + P + DTS F +Y + VQG + DL
Sbjct: 266 EKLLSRNIETPYEPPIQQGQGDTSQF-DKYPEEDINYGVQGEDPYADL 312
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 269 bits (688), Expect = 5e-82
Identities = 117/327 (35%), Positives = 186/327 (56%), Gaps = 38/327 (11%)
Query: 754 RTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
+ ++ DF+ +K + +G FG+V L R++ATG +A+K+L+K +I K+ V + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
+ R+PF+ Y+F + L VMEY NGG+L+ L E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
LHS +V++RD+K +NL++ +DGHIK+TDFGL K
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--------------------------- 153
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993
+ + GTP+YLAPE+L +G DWW +G++++E++ G PF +
Sbjct: 154 ---EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 994 QQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNI 1051
+++F+ I+ +I + P +S EA L+ LL ++P QRLG + A+EV +H FF +I
Sbjct: 211 ERLFELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
Query: 1052 NWDTLARQKAM--FIPAAES-LDTSYF 1075
NW + ++K + F P S +DT YF
Sbjct: 268 NWQDVVQKKLLPPFKPQVTSEVDTRYF 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (662), Expect = 2e-79
Identities = 73/294 (24%), Positives = 140/294 (47%), Gaps = 34/294 (11%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+ED+++++ + +GA+G V LA R T + A+K++ + + E+I E I +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS 876
+ VV+F+ YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+ + HRD+KP+NLL+ + ++K++DFGL+ V ++ + L
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL------------------- 162
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
+ + GT Y+APE+L H D WS GI+L +L G P++ +
Sbjct: 163 ---------NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ + N +++ L+ K+L ENP R+ ++K+ ++
Sbjct: 214 QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 264
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 260 bits (666), Expect = 1e-78
Identities = 101/334 (30%), Positives = 168/334 (50%), Gaps = 46/334 (13%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN---IL 812
++ DF + + I +G FG V+ RK TG ++A+K L K + K L ER ++
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALE 872
+ PF+V Y+F + L +++ +NGGDL+ L G E R Y AE++L LE
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
++H+ V++RDLKP N+L+ + GH++++D GL+
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD------------------------- 156
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLIGIPPFNAK 991
+++ H+ GT Y+APE+L G+ + ++ADW+S+G +LF+LL G PF
Sbjct: 157 -------FSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209
Query: 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFK 1049
+ + +P+ S E L++ LL + +RLG GA+EVK+ PFF+
Sbjct: 210 KTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
Query: 1050 NINWDTLARQK--AMFIP------AAESLDTSYF 1075
+++W + QK IP AA++ D F
Sbjct: 270 SLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSF 303
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (659), Expect = 1e-78
Identities = 87/308 (28%), Positives = 141/308 (45%), Gaps = 43/308 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ +EII + GAFG+V+ A+ + T L A KV+ + +E + E +IL S +
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 68
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHS 876
P +V+ +F NL++++E+ GG + +++ L L E +V + + AL YLH
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+IHRDLK N+L DG IKL DFG+S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAK----------------------------- 159
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGM-----GHGATADWWSVGIILFELLIGIPPFNAK 991
TR +++ S GTP ++APE+++ + AD WS+GI L E+ PP +
Sbjct: 160 -NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218
Query: 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051
P ++ I + P P S D + K L +N R ++ QHPF +
Sbjct: 219 NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVT-V 274
Query: 1052 NWDTLARQ 1059
+ + R+
Sbjct: 275 DSNKPIRE 282
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (648), Expect = 5e-77
Identities = 97/318 (30%), Positives = 153/318 (48%), Gaps = 46/318 (14%)
Query: 735 DEDTVRSLRT--SPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLK 792
DE+ + LR+ S +P + + + I QGA G V+ A ATG AI+ +
Sbjct: 2 DEEILEKLRSIVSVGDP-------KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN 54
Query: 793 KADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL 852
+K E I+ E ++ +NP +V + S+ + L++VMEYL GG L ++
Sbjct: 55 LQQQPKK---ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE- 110
Query: 853 GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912
C+DE E + ALE+LHS VIHRD+K DN+L+G DG +KLTDFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA------ 164
Query: 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWW 972
+T EQ ++ ++ GTP ++APE++ +G D W
Sbjct: 165 ------------------------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 973 SVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQ 1032
S+GI+ E++ G PP+ + P + I P PE++S D +++ L + +
Sbjct: 201 SLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEK 260
Query: 1033 RLGATGAREVKQHPFFKN 1050
R A+E+ QH F K
Sbjct: 261 RG---SAKELLQHQFLKI 275
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 255 bits (652), Expect = 8e-77
Identities = 122/362 (33%), Positives = 199/362 (54%), Gaps = 46/362 (12%)
Query: 719 EKLDSSNAMTEEESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLAR 778
+K ++ E + ED ++ T S++ ++ F+ IK + G+FGRV L +
Sbjct: 7 KKGSEQESVKEFLAKAKEDFLKKWETP-----SQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 779 KRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838
+ +G+ +A+K+L K +++ +E L E+ IL +V PF+V+ +SF NLY+VME
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121
Query: 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIK 898
Y+ GG+++S LR +G E AR Y A++VL EYLHSL++I+RDLKP+NLLI Q G+I+
Sbjct: 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181
Query: 899 LTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPE 958
+TDFG +K R + + ++ GTP+ LAPE
Sbjct: 182 VTDFGFAK---------------------------------RVKGRTWTLCGTPEALAPE 208
Query: 959 ILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEA 1018
I+L G+ DWW++G++++E+ G PPF A P QI++ I++ + + P S +
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF---PSHFSSDL 265
Query: 1019 CDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQK--AMFIPAAES-LDTS 1073
DL+ LL + +R G G ++K H +F +W + ++K A FIP + DTS
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS 325
Query: 1074 YF 1075
F
Sbjct: 326 NF 327
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 7e-76
Identities = 82/301 (27%), Positives = 141/301 (46%), Gaps = 47/301 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
ED+E++ I G++GR R+++ G + K L M + +++E N+L +++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKH 62
Query: 818 PFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNL----GCLDEDMARVYIAELVLAL 871
P +VR++ R N LY+VMEY GGDL S++ LDE+ + +L LAL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 872 EYLHSLN-----VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+ H + V+HRDLKP N+ + ++KL DFGL+++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI------------------- 163
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
L + + GTP Y++PE + M + +D WS+G +L+EL +P
Sbjct: 164 -----------LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212
Query: 987 PFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046
PF A + +++ I + IP S E ++I ++L R E+ ++P
Sbjct: 213 PFTAFSQKELAGKIREGK--FRRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILENP 267
Query: 1047 F 1047
Sbjct: 268 L 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 246 bits (629), Expect = 1e-74
Identities = 81/306 (26%), Positives = 131/306 (42%), Gaps = 48/306 (15%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR------KNAVESILAERNI 811
E++E + + +G V + T +A+K++ + E+ L E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 812 LISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLA 870
L V P +++ ++ +LV + + G+L+ L L E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 871 LEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVND 930
+ LH LN++HRDLKP+N+L+ D +IKLTDFG S
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------------------------ 158
Query: 931 ELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM------GHGATADWWSVGIILFELLIG 984
+ V GTP YLAPEI+ G+G D WS G+I++ LL G
Sbjct: 159 -------QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
Query: 985 IPPFNAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043
PPF + + IM+ + + + ++ S DL+ + L P +R A E
Sbjct: 212 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEAL 268
Query: 1044 QHPFFK 1049
HPFF+
Sbjct: 269 AHPFFQ 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 249 bits (636), Expect = 1e-74
Identities = 78/329 (23%), Positives = 141/329 (42%), Gaps = 43/329 (13%)
Query: 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI 811
K ++ ++I + + GAFG V +RATG+ FA K + K E++ E
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK---ETVRKEIQT 76
Query: 812 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLA 870
+ +R+P +V +F + ++ E+++GG+L+ + + ED A Y+ ++
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 871 LEYLHSLNVIHRDLKPDNLLIG--QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
L ++H N +H DLKP+N++ + +KL DFGL+
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---------------------- 174
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988
++ GT ++ APE+ G G D WSVG++ + LL G+ PF
Sbjct: 175 ---------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPF 225
Query: 989 NAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
+ + N+ + D + +S + D I KLL +P R+ + +HP+
Sbjct: 226 GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQALEHPW 282
Query: 1048 FKNINWDTLARQ--KAMFIPAAESLDTSY 1074
N Q + + +S+ T Y
Sbjct: 283 LTPGNAPGRDSQIPSSRYTKIRDSIKTKY 311
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 248 bits (635), Expect = 2e-74
Identities = 70/327 (21%), Positives = 142/327 (43%), Gaps = 43/327 (13%)
Query: 736 EDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKAD 795
ED + P+ K + + ++I++ + GAFG V ++ATG +F K +
Sbjct: 9 EDIWKKYVPQPVEV--KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY 66
Query: 796 MIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC- 854
+ K ++ E +I+ + +P ++ +F + + L++E+L+GG+L+ +
Sbjct: 67 PLDK---YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 123
Query: 855 LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLI--GQDGHIKLTDFGLSKVGLIHS 912
+ E Y+ + L+++H +++H D+KP+N++ + +K+ DFGL+
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK----- 178
Query: 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWW 972
T ++ APEI+ G D W
Sbjct: 179 --------------------------LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMW 212
Query: 973 SVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPV 1031
++G++ + LL G+ PF + + N+ D + + +S EA D I LL + P
Sbjct: 213 AIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPR 272
Query: 1032 QRLGATGAREVKQHPFFKNINWDTLAR 1058
+RL + +HP+ K + + +R
Sbjct: 273 KRL---TVHDALEHPWLKGDHSNLTSR 296
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (628), Expect = 7e-74
Identities = 79/339 (23%), Positives = 136/339 (40%), Gaps = 79/339 (23%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+DFE I + G G VF + +G + A K++ I+ I+ E +L +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P++V F+ +F + + ME+++GG L +L+ G + E + ++ L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 878 N-VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+ ++HRD+KP N+L+ G IKL DFG+S
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG------------------------------ 153
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF---NAKTP 993
+S GT Y++PE L G + +D WS+G+ L E+ +G P +AK
Sbjct: 154 --QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211
Query: 994 QQIFDNIMNRDI-------------------------------------PWPNIPEE-MS 1015
+ +F + D P P +P S
Sbjct: 212 ELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 271
Query: 1016 VEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054
+E D ++K L +NP +R +++ H F K + +
Sbjct: 272 LEFQDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAE 307
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (625), Expect = 2e-73
Identities = 126/342 (36%), Positives = 189/342 (55%), Gaps = 42/342 (12%)
Query: 740 RSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARK---RATGDLFAIKVLKKADM 796
LRT+ + ++ IE+FE++K + GA+G+VFL RK TG L+A+KVLKKA +
Sbjct: 7 HELRTANLTG-HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI 65
Query: 797 IRK-NAVESILAERNILISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC 854
++K E ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L
Sbjct: 66 VQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER 125
Query: 855 LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914
E ++Y+ E+VLALE+LH L +I+RD+K +N+L+ +GH+ LTDFGLSK + T+
Sbjct: 126 FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
Query: 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM--GHGATADWW 972
+ GT +Y+AP+I+ G GH DWW
Sbjct: 186 RA-----------------------------YDFCGTIEYMAPDIVRGGDSGHDKAVDWW 216
Query: 973 SVGIILFELLIGIPPFNAKTPQQIFDNIMNRDIPW-PNIPEEMSVEACDLIDKLLTENPV 1031
S+G++++ELL G PF + I R + P P+EMS A DLI +LL ++P
Sbjct: 217 SLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPK 276
Query: 1032 QRLGAT--GAREVKQHPFFKNINWDTLARQK--AMFIPAAES 1069
+RLG A E+K+H FF+ INWD LA +K A F P
Sbjct: 277 KRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRD 318
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 244 bits (623), Expect = 2e-73
Identities = 72/296 (24%), Positives = 114/296 (38%), Gaps = 41/296 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ F ++ I G+FG V+ AR ++ AIK + + + I+ E L +R+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P +++ + +LVMEY G L + L E + L YLHS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
N+IHRD+K N+L+ + G +KL DFG + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI------------------------------ 164
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMGHG---ATADWWSVGIILFELLIGIPPFNAKTPQ 994
+S GTP ++APE++L M G D WS+GI EL PP
Sbjct: 165 ----MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220
Query: 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+I + P S + +D L + P R + + +H F
Sbjct: 221 SALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVLR 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 240 bits (614), Expect = 4e-72
Identities = 81/300 (27%), Positives = 140/300 (46%), Gaps = 40/300 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ ++ + GAF V LA + T L AIK + K + + S+ E +L +++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
P +V + +LYL+M+ ++GG+L+ + G E A I +++ A++YLH L
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 878 NVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
++HRDLKP+NLL +D I ++DFGLSK
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---------------------------- 158
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994
+ + GTP Y+APE+L + D WS+G+I + LL G PPF +
Sbjct: 159 ---MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 215
Query: 995 QIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINW 1053
++F+ I+ + + + +++S A D I L+ ++P +R + QHP+
Sbjct: 216 KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGDTA 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (600), Expect = 4e-70
Identities = 79/333 (23%), Positives = 145/333 (43%), Gaps = 49/333 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E + I + + +G FG V + ++ + K +K + + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC-LDEDMARVYIAELVLALEYLHS 876
++ SF E L ++ E+++G D++ + L+E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 877 LNVIHRDLKPDNLLIGQD--GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
N+ H D++P+N++ IK+ +FG ++
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---------------------------- 152
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994
+ + P+Y APE+ D WS+G +++ LL GI PF A+T Q
Sbjct: 153 ---QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209
Query: 995 QIFDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK---- 1049
QI +NIMN + + +E+S+EA D +D+LL + R+ A E QHP+ K
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQKIE 266
Query: 1050 NINWD---TLARQKAMFIPAAESLDTSYFVSRY 1079
++ TL ++ + L+ +R
Sbjct: 267 RVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARI 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-69
Identities = 58/297 (19%), Positives = 123/297 (41%), Gaps = 44/297 (14%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+ I +G+F V+ T A L+ + K+ + E +L +++P
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPN 69
Query: 820 VVRFFYSFTC----RENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
+VRF+ S+ ++ + LV E + G L + L+ + + R + +++ L++LH
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 876 SLN--VIHRDLKPDNLLI-GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
+ +IHRDLK DN+ I G G +K+ D GL+ +
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL------------------------- 164
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992
+ +V GTP+++APE+ + + D ++ G+ + E+ P++
Sbjct: 165 -------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216
Query: 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049
+ + + + E ++I+ + +N +R +++ H FF+
Sbjct: 217 NAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 3e-69
Identities = 78/314 (24%), Positives = 143/314 (45%), Gaps = 43/314 (13%)
Query: 756 SIED-FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKN---AVESILAERNI 811
+++D ++ + + G F V R+++TG +A K +KK + E I E +I
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 812 LISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLAL 871
L +++P V+ + + ++ L++E + GG+L+ L L E+ A ++ +++ +
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDG----HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
YLHSL + H DLKP+N+++ IK+ DFGL+
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-------------------- 166
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPP 987
+ ++ GTP+++APEI+ G AD WS+G+I + LL G P
Sbjct: 167 -----------IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
Query: 988 FNAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHP 1046
F T Q+ N+ + + + S A D I +LL ++P +R+ ++ QHP
Sbjct: 216 FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHP 272
Query: 1047 FFKNINWDTLARQK 1060
+ K +
Sbjct: 273 WIKPKDTQQALSSA 286
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 221 bits (564), Expect = 8e-66
Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 34/292 (11%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ +E+ + + G V LAR A+KVL+ + E ++ +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 818 PFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
P +V + + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
H +IHRD+KP N++I +K+ DFG+++
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIAR--------------------------- 159
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993
Q +V GT YL+PE G A +D +S+G +L+E+L G PPF +P
Sbjct: 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 219
Query: 994 QQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044
+ + D P+ E +S + ++ K L +NP R A E++
Sbjct: 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMRA 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-63
Identities = 61/302 (20%), Positives = 115/302 (38%), Gaps = 38/302 (12%)
Query: 756 SIEDFEIIKPISQGAFGRVFLA--RKRATGDLFAIKVLKKADMIRKNAVESILAERNILI 813
++ED K + G FG V + + A+K+LK + + +LAE N++
Sbjct: 9 TLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQ 63
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
+ NP++VR E+ LVME G L L+ + + + ++ + ++Y
Sbjct: 64 QLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
L N +HRDL N+L+ + K++DFGLSK
Sbjct: 123 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSK--------------------------- 155
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKT 992
+ + + APE + + +D WS G++++E G P+
Sbjct: 156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 215
Query: 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052
++ + + P E DL++ T + R G ++ ++ +N
Sbjct: 216 GSEVTAMLEKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
Query: 1053 WD 1054
Sbjct: 274 EG 275
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-63
Identities = 86/315 (27%), Positives = 137/315 (43%), Gaps = 58/315 (18%)
Query: 752 KDRTSIEDFEII-KPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERN 810
K I+D+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 56
Query: 811 ILISV-RNPFVVRFFYSF----TCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVY 863
+ + P +VR + R+ L +VME L+GG+L+S +++ G E A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 864 IAELVLALEYLHSLNVIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPS 920
+ + A++YLHS+N+ HRD+KP+NLL + +KLTDFG +K
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------------- 162
Query: 921 LGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFE 980
T + TP Y+APE+L + + D WS+G+I++
Sbjct: 163 -----------------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI 205
Query: 981 LLIGIPPFNAKTPQQIFDNIMNR----DIPWPN-IPEEMSVEACDLIDKLLTENPVQRLG 1035
LL G PPF + I + R +PN E+S E LI LL P QR+
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM- 264
Query: 1036 ATGAREVKQHPFFKN 1050
E HP+
Sbjct: 265 --TITEFMNHPWIMQ 277
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 9e-63
Identities = 77/318 (24%), Positives = 120/318 (37%), Gaps = 61/318 (19%)
Query: 761 EIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKN--AVESILAERNILISVRNP 818
E + + +G F V+ AR + T + AIK +K + L E +L + +P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN 878
++ +F + N+ LV +++ + N L + Y+ + LEYLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 879 VIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPL 938
++HRDLKP+NLL+ ++G +KL DFGL+K
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKS------------------------------F 150
Query: 939 TREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997
R T Y APE+L G +G D W+VG IL ELL+ +P +
Sbjct: 151 GSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 210
Query: 998 DNIMN-------------------------RDIPWPNIPEEMSVEACDLIDKLLTENPVQ 1032
I IP +I + DLI L NP
Sbjct: 211 TRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCA 270
Query: 1033 RLGATGAREVKQHPFFKN 1050
R+ A + + +F N
Sbjct: 271 RI---TATQALKMKYFSN 285
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 3e-62
Identities = 54/295 (18%), Positives = 114/295 (38%), Gaps = 43/295 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ + I G+FG V+ + A+K+L +++ E +L R+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNV-TAPTPQQLQAFKNEVGVLRKTRH 63
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHS 876
++ F ++ L +V ++ G LY L + + + ++YLH+
Sbjct: 64 VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
++IHRDLK +N+ + +D +K+ DFGL+ V S
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS---------------------- 160
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHG---ATADWWSVGIILFELLIGIPPFNAKTP 993
Q ++G+ ++APE++ +D ++ GI+L+EL+ G P++
Sbjct: 161 ------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214
Query: 994 QQIFDNIMNRDIPWPN---IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
+ ++ R P+ + L+ + L + +R ++
Sbjct: 215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP---LFPQILAS 266
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 7e-62
Identities = 66/301 (21%), Positives = 125/301 (41%), Gaps = 52/301 (17%)
Query: 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVES---ILAERNIL--I 813
+++ + G FG V+ + + AIK ++K + + + + E +L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 814 SVRNPFVVRFFYSFTCRENLYLVMEYLNGG-DLYSLLRNLGCLDEDMARVYIAELVLALE 872
S V+R F ++ L++E DL+ + G L E++AR + +++ A+
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 873 YLHSLNVIHRDLKPDNLLIGQD-GHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
+ H+ V+HRD+K +N+LI + G +KL DFG +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL------------------------ 160
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNA 990
+ GT Y PE + HG +A WS+GI+L++++ G PF
Sbjct: 161 --------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+ I+ + + + +S E LI L P R E++ HP+ ++
Sbjct: 213 D------EEIIRGQVFF---RQRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQD 260
Query: 1051 I 1051
+
Sbjct: 261 V 261
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 208 bits (530), Expect = 4e-61
Identities = 75/319 (23%), Positives = 135/319 (42%), Gaps = 62/319 (19%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E + ++ I +G +G V+ A+ G+ FA+K ++ + + + + E +IL +++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
+V+ + ++ L LV E+L+ L G L+ A+ ++ +L+ + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
V+HRDLKP NLLI ++G +K+ DFGL++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARA------------------------------ 149
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAKTPQQI 996
R+ T Y AP++L+G + T D WSVG I E++ G P F +
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ 209
Query: 997 FDNIMN--------------------------RDIPWPNIPEEMSVEACDLIDKLLTENP 1030
I +PW + + + DL+ K+L +P
Sbjct: 210 LMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
Query: 1031 VQRLGATGAREVKQHPFFK 1049
QR+ A++ +H +FK
Sbjct: 270 NQRI---TAKQALEHAYFK 285
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 2e-60
Identities = 65/302 (21%), Positives = 105/302 (34%), Gaps = 40/302 (13%)
Query: 752 KDRTSIEDFEIIKPISQGAFGRVFLARKRATGD--LFAIKVLKKADMIRKNAVESILAER 809
+D I D E+ G FG V R AIKVLK+ K E ++ E
Sbjct: 7 RDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREA 60
Query: 810 NILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELV 868
I+ + NP++VR L LVME GG L+ L + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
+ ++YL N +HRDL N+L+ + K++DFGLSK
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK---------------------- 157
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPP 987
+ + + APE + + +D WS G+ ++E L G P
Sbjct: 158 -----ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 212
Query: 988 FNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
+ ++ I P E E L+ R + + +
Sbjct: 213 YKKMKGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
Query: 1048 FK 1049
+
Sbjct: 271 YS 272
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 3e-60
Identities = 78/333 (23%), Positives = 120/333 (36%), Gaps = 68/333 (20%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
+ +E + I QG FG VF AR R TG A+K + + ++ + L E IL +
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLL 66
Query: 816 RNPFVVRFFYSFT--------CRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAEL 867
++ VV C+ ++YLV ++ L L + + L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 868 VLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFL 927
+ L Y+H ++HRD+K N+LI +DG +KL DFGL++ +
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ------------ 174
Query: 928 VNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIP 986
+ + T Y PE+LLG +G D W G I+ E+ P
Sbjct: 175 --------------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
Query: 987 PFNAKTPQQIFDNIMN-----------------------------RDIPWPNIPEEMSVE 1017
T Q I R +
Sbjct: 221 IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPY 280
Query: 1018 ACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
A DLIDKLL +P QR+ + + H FF +
Sbjct: 281 ALDLIDKLLVLDPAQRI---DSDDALNHDFFWS 310
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 9e-60
Identities = 77/324 (23%), Positives = 134/324 (41%), Gaps = 62/324 (19%)
Query: 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR 816
+E+F+ ++ I +G +G V+ AR + TG++ A+K ++ D + + + E ++L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELN 59
Query: 817 NPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL-LRNLGCLDEDMARVYIAELVLALEYLH 875
+P +V+ LYLV E+L+ + L + + + Y+ +L+ L + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
S V+HRDLKP NLLI +G IKL DFGL++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARA---------------------------- 151
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATA-DWWSVGIILFELLIGIPPFNAKTPQ 994
R T Y APEILLG + +TA D WS+G I E++ F +
Sbjct: 152 --FGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 995 QIFDNIMN--------------------------RDIPWPNIPEEMSVEACDLIDKLLTE 1028
I + + + + L+ ++L
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY 269
Query: 1029 NPVQRLGATGAREVKQHPFFKNIN 1052
+P +R+ A+ HPFF+++
Sbjct: 270 DPNKRI---SAKAALAHPFFQDVT 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 2e-59
Identities = 61/294 (20%), Positives = 118/294 (40%), Gaps = 49/294 (16%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
++++ ++++ I +G FG V L R G+ A+K +K ++ LAE +++ +
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 57
Query: 816 RNPFVVRFF-YSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAELVLALE 872
R+ +V+ + LY+V EY+ G L LR+ G L D + ++ A+E
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
YL N +HRDL N+L+ +D K++DFGL+K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------------------------ 153
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAK 991
+ + + APE L +D WS GI+L+E+ G P+
Sbjct: 154 ---------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204
Query: 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
+ + + + P+ +++ + R ++++
Sbjct: 205 PLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 8e-59
Identities = 81/331 (24%), Positives = 129/331 (38%), Gaps = 67/331 (20%)
Query: 756 SIEDFEIIKPISQGAFGRVFLAR-KRATGDLFAIKVLKKADMIRKNAVESI--LAERNIL 812
+ + +E + I +GA+G+VF AR + G A+K ++ + +I +A L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 813 ISVRNPFVVRFFYSFTCREN-----LYLVMEYLNGGDL-YSLLRNLGCLDEDMARVYIAE 866
+ +P VVR F T L LV E+++ Y + + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
L+ L++LHS V+HRDLKP N+L+ G IKL DFGL++
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-------------------- 164
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP 986
+ Q SV T Y APE+LL + D WSVG I E+ P
Sbjct: 165 -----------IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213
Query: 987 PFNAKTPQQIFDNIMN------------------------RDIPWPNIPEEMSVEACDLI 1022
F + I++ P ++ DL+
Sbjct: 214 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 273
Query: 1023 DKLLTENPVQRLGATGAREVKQHPFFKNINW 1053
K LT NP +R+ A HP+F+++
Sbjct: 274 LKCLTFNPAKRI---SAYSALSHPYFQDLER 301
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 3e-58
Identities = 59/291 (20%), Positives = 102/291 (35%), Gaps = 34/291 (11%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNIL 812
+D +++ + G+FG V A A+K LK + + A++ + E N +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLAL 871
S+ + ++R + + +V E G L L ++ G Y ++ +
Sbjct: 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
YL S IHRDL NLL+ +K+ DFGL +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR------------------------- 159
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNA 990
P + + APE L +D W G+ L+E+ G P+
Sbjct: 160 --ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041
QI I P PE+ + +++ + P R R+
Sbjct: 218 LNGSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-58
Identities = 82/325 (25%), Positives = 130/325 (40%), Gaps = 68/325 (20%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF 819
+ + I +GA+G V A AIK + + + + L E IL+ R+
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHEN 67
Query: 820 VVRFF-----YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYL 874
++ + +++YLV + G DLY LL+ L D ++ +++ L+Y+
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKT-QHLSNDHICYFLYQILRGLKYI 125
Query: 875 HSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKD 934
HS NV+HRDLKP NLL+ +K+ DFGL++V
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA-------------------------- 159
Query: 935 QPPLTREQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLIGIPPFNAKTP 993
P T Y APEI+L G+ + D WSVG IL E+L P F K
Sbjct: 160 -DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218
Query: 994 QQIFDNIMN----------------------------RDIPWPNIPEEMSVEACDLIDKL 1025
++I+ +PW + +A DL+DK+
Sbjct: 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 278
Query: 1026 LTENPVQRLGATGAREVKQHPFFKN 1050
LT NP +R+ + HP+ +
Sbjct: 279 LTFNPHKRI---EVEQALAHPYLEQ 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (501), Expect = 5e-57
Identities = 55/313 (17%), Positives = 105/313 (33%), Gaps = 44/313 (14%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNP- 818
+ + + I G+FG ++L A G+ AIK+ K + E I ++
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQGGV 63
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN 878
+ + + +VME L + +++ +EY+HS N
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 879 VIHRDLKPDNLLI---GQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
IHRD+KPDN L+ + + + DFGL+K T
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ-------------------- 163
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995
R+ ++ GT Y + LG+ D S+G +L +G P+
Sbjct: 164 ---HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220
Query: 996 IFDNI-----MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
P + + E ++ + + + R++ ++ F +
Sbjct: 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
Query: 1051 -------INWDTL 1056
+W+ L
Sbjct: 281 GFSYDYVFDWNML 293
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 8e-57
Identities = 81/376 (21%), Positives = 126/376 (33%), Gaps = 78/376 (20%)
Query: 739 VRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR 798
V ++ +P DR + K I G+FG V+ A+ +G+L AIK + + +
Sbjct: 3 VTTVVATPGQG--PDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK 60
Query: 799 KNAVESILAERNILISVRNPFVVRFFYSFTC------RENLYLVMEYLNGGDLYSLLRNL 852
E I+ + + +VR Y F L LV++Y+
Sbjct: 61 NR-------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS 113
Query: 853 ---GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSKVG 908
L ++Y+ +L +L Y+HS + HRD+KP NLL+ D +KL DFG +K
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ- 172
Query: 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT 968
L R + + I + ++
Sbjct: 173 -----------------------------LVRGEPNVSYICSRYYRAPELIFGATDYTSS 203
Query: 969 ADWWSVGIILFELLIGIPPFNAKTPQQIFDNIMN-------------------------R 1003
D WS G +L ELL+G P F + I+ +
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 263
Query: 1004 DIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAM 1062
PW + EA L +LL P RL E H FF + +
Sbjct: 264 AHPWTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNVKLPNGR 320
Query: 1063 FIPAAESLDTSYFVSR 1078
PA + T S
Sbjct: 321 DTPALFNFTTQELSSN 336
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (498), Expect = 1e-56
Identities = 63/306 (20%), Positives = 118/306 (38%), Gaps = 62/306 (20%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRA-----TGDLFAIKVLKKADMIRKNAVESILAERNIL 812
+ E ++ I +GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 70
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG------------------- 853
NP +V+ + + L+ EY+ GDL LR++
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 854 -----CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908
L ++ + YL +HRDL N L+G++ +K+ DFGLS+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-- 188
Query: 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT 968
I+S D + + A ++ PE + +
Sbjct: 189 NIYSAD--------------------------YYKADGNDAIPIRWMPPESIFYNRYTTE 222
Query: 969 ADWWSVGIILFELL-IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLT 1027
+D W+ G++L+E+ G+ P+ +++ + + +I PE +E +L+ +
Sbjct: 223 SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWS 280
Query: 1028 ENPVQR 1033
+ P R
Sbjct: 281 KLPADR 286
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-56
Identities = 65/293 (22%), Positives = 116/293 (39%), Gaps = 40/293 (13%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E ++++ + G FG V++ A+K LK+ M ++ LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQH 67
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLH 875
+VR Y+ +E +Y++ EY+ G L L+ L + A++ + ++
Sbjct: 68 QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
N IHRDL+ N+L+ K+ DFGL++ L+ D
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLAR--------------------LIEDN---- 162
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQ 994
E + + APE + +D WS GI+L E++ G P+ T
Sbjct: 163 -----EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047
++ N+ P+ E L+ E P R R V + F
Sbjct: 218 EVIQNLERG--YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-56
Identities = 56/290 (19%), Positives = 114/290 (39%), Gaps = 41/290 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+D +K + G FG V + R AIK++K+ M + E +++++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSH 58
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHS 876
+V+ + T + ++++ EY+ G L + LR + ++ A+EYL S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
+HRDL N L+ G +K++DFGLS+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY----------------------------- 149
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQQ 995
L E + PE+L+ + +D W+ G++++E+ +G P+ T +
Sbjct: 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
++I + P S + ++ E +R + + +
Sbjct: 210 TAEHIAQGLRLY--RPHLASEKVYTIMYSCWHEKADERP---TFKILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 5e-56
Identities = 56/290 (19%), Positives = 116/290 (40%), Gaps = 41/290 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ ++ I G FG V L D AIK +++ M ++ + E +++ + +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED----FIEEAEVMMKLSH 59
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVL-ALEYLHS 876
P +V+ + + + LV E++ G L LR L + + V + YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQP 936
VIHRDL N L+G++ IK++DFG+++ F+++D+
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTR-------------------FVLDDQYT--- 157
Query: 937 PLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQQ 995
+ +PE+ + + +D WS G++++E+ G P+ ++ +
Sbjct: 158 -------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
Query: 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
+ ++I + P S +++ E P R + +
Sbjct: 211 VVEDISTGFRLY--KPRLASTHVYQIMNHCWKERPEDRP---AFSRLLRQ 255
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 5e-56
Identities = 82/351 (23%), Positives = 140/351 (39%), Gaps = 74/351 (21%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ ++P+ GA+G V A TG AIK L + + + E +L +R+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 818 PFVVRFFYSFTCRE------NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLAL 871
V+ FT E + YLVM ++ G DL L+++ L ED + + +++ L
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGL 134
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
Y+H+ +IHRDLKP NL + +D +K+ DFGL++
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR------------------------- 169
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNA 990
+ + T Y APE++L M + T D WSVG I+ E++ G F
Sbjct: 170 --------QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221
Query: 991 KTPQQIFDNIMN----------------------------RDIPWPNIPEEMSVEACDLI 1022
IM + +I S A +L+
Sbjct: 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281
Query: 1023 DKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQKAMFIPAAESLDTS 1073
+K+L + QR+ A E HP+F++++ Q + + + +D +
Sbjct: 282 EKMLVLDAEQRV---TAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 1e-55
Identities = 79/321 (24%), Positives = 128/321 (39%), Gaps = 62/321 (19%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ +E ++ I +G +G VF A+ R T ++ A+K ++ D + S L E +L +++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSL 877
+VR + L LV E+ + G LD ++ + ++ +L+ L + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 878 NVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPP 937
NV+HRDLKP NLLI ++G +KL +FGL++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARA------------------------------ 150
Query: 938 LTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIG-IPPFNAKTPQQ 995
R + T Y P++L G + + D WS G I EL P F
Sbjct: 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
Query: 996 IFDNIMN--------------------------RDIPWPNIPEEMSVEACDLIDKLLTEN 1029
I N+ +++ DL+ LL N
Sbjct: 211 QLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN 270
Query: 1030 PVQRLGATGAREVKQHPFFKN 1050
PVQR+ A E QHP+F +
Sbjct: 271 PVQRI---SAEEALQHPYFSD 288
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 6e-55
Identities = 71/307 (23%), Positives = 121/307 (39%), Gaps = 47/307 (15%)
Query: 751 SKDRTSI--EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAE 808
+KD I E + + QG FG V++ T AIK LK M E+ L E
Sbjct: 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQE 62
Query: 809 RNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--LDEDMARVYIAE 866
++ +R+ +V+ Y+ E +Y+V EY++ G L L+ L A+
Sbjct: 63 AQVMKKLRHEKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 867 LVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGF 926
+ + Y+ +N +HRDL+ N+L+G++ K+ DFGL++
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR-------------------- 161
Query: 927 LVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GI 985
L+ D E + + APE L +D WS GI+L EL G
Sbjct: 162 LIEDN---------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 212
Query: 986 PPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ- 1044
P+ +++ D + P E DL+ + + P +R ++
Sbjct: 213 VPYPGMVNREVLDQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERP---TFEYLQAF 267
Query: 1045 -HPFFKN 1050
+F +
Sbjct: 268 LEDYFTS 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-55
Identities = 59/318 (18%), Positives = 116/318 (36%), Gaps = 64/318 (20%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDL-----FAIKVLKKADMIRKNAVESILAERNIL 812
E+ E K + GAFG+V A A+K+LK+ + E++++E ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMM 94
Query: 813 ISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN-------------------- 851
+ + +V + T +YL+ EY GDL + LR+
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 852 ---LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908
L L + + ++ +E+L + +HRDL N+L+ +K+ DFGL++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT 968
+ S + + ++APE L +
Sbjct: 215 MSDSN----------------------------YVVRGNARLPVKWMAPESLFEGIYTIK 246
Query: 969 ADWWSVGIILFELL-IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLT 1027
+D WS GI+L+E+ +G+ P+ F ++ + P + E ++
Sbjct: 247 SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK-MDQPFYATEEIYIIMQSCWA 305
Query: 1028 ENPVQRLGATGAREVKQH 1045
+ +R +
Sbjct: 306 FDSRKRP---SFPNLTSF 320
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 8e-55
Identities = 61/308 (19%), Positives = 111/308 (36%), Gaps = 54/308 (17%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
D + I +G FG+V AR + G + + + K+ E +L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 816 RN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----------------LGCLDED 858
+ P ++ + R LYL +EY G+L LR L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 859 MARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918
+ A++ ++YL IHRDL N+L+G++ K+ DFGLS+ ++
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK----- 182
Query: 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978
K ++A E L + +D WS G++L
Sbjct: 183 --------------------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216
Query: 979 FELL-IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGAT 1037
+E++ +G P+ T ++++ + P E DL+ + E P +R
Sbjct: 217 WEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERP--- 271
Query: 1038 GAREVKQH 1045
++
Sbjct: 272 SFAQILVS 279
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 191 bits (485), Expect = 2e-54
Identities = 68/339 (20%), Positives = 127/339 (37%), Gaps = 83/339 (24%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISV 815
+ +D+++++ + +G + VF A + +K+LK + I E IL ++
Sbjct: 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENL 86
Query: 816 R-NPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALE 872
R P ++ + LV E++N D L + L + R Y+ E++ AL+
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL---TDYDIRFYMYEILKALD 143
Query: 873 YLHSLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
Y HS+ ++HRD+KP N++I + ++L D+GL++
Sbjct: 144 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE------------------------- 178
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPF-N 989
++ + + + PE+L+ + + D WS+G +L ++ PF +
Sbjct: 179 ------FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
Query: 990 AKTPQQIFDNIMN----------------------------------RDIPWPNIPEEMS 1015
I +S
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
Query: 1016 VEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054
EA D +DKLL + RL A RE +HP+F + D
Sbjct: 293 PEALDFLDKLLRYDHQSRLTA---REAMEHPYFYTVVKD 328
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (481), Expect = 3e-54
Identities = 62/283 (21%), Positives = 107/283 (37%), Gaps = 34/283 (12%)
Query: 756 SIEDFEIIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNIL 812
I +I + I G FG V + G AIK LK + L+E +I+
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIM 81
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR-NLGCLDEDMARVYIAELVLAL 871
+P V+ T + ++ E++ G L S LR N G + + +
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 872 EYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDE 931
+YL +N +HRDL N+L+ + K++DFGLS+ ++D +LG
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG--------- 192
Query: 932 LKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNA 990
+ APE + + +D WS GI+++E++ G P+
Sbjct: 193 ----------------GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
T Q + + I P + L+ ++ R
Sbjct: 237 MTNQDVINAIEQD--YRLPPPMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-53
Identities = 62/333 (18%), Positives = 114/333 (34%), Gaps = 37/333 (11%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKA--DMIRKNAVESILAERNILISV 815
+F+ IK + GAFG V+ G+ I V K + A + IL E ++ SV
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 816 RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH 875
NP V R + G L + + + + ++ + YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
++HRDL N+L+ H+K+TDFGL+K+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---------------------- 166
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL-IGIPPFNAKTPQ 994
+ ++A E +L + +D WS G+ ++EL+ G P++
Sbjct: 167 ------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220
Query: 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054
+I + + P +++ ++ K + R RE+ +
Sbjct: 221 EISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRP---KFRELIIEFSKMARDPQ 275
Query: 1055 TLARQKAMFIPAAESLDTSYFVSRYVWNPEDEN 1087
+ S S F + + ED +
Sbjct: 276 RYLVIQGDERMHLPSPTDSNFYRALM-DEEDMD 307
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 185 bits (469), Expect = 8e-53
Identities = 49/307 (15%), Positives = 98/307 (31%), Gaps = 40/307 (13%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-P 818
+++ + I +G+FG +F AIK + ++ + E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 819 FVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN 878
+ +Y + LV++ L L + +++ ++ +H +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 879 VIHRDLKPDNLLIG-----QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
+++RD+KPDN LIG I + DFG+ K T
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ------------------ 163
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIG---IPPFNA 990
R+K +++GT Y++ LG D ++G + L G A
Sbjct: 164 -----HIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218
Query: 991 KTPQQIFDNIMNRDIPWP--NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048
T +Q ++ I + P + E + + +
Sbjct: 219 ATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
Query: 1049 K-NINWD 1054
+ N D
Sbjct: 279 RLNTTED 285
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 8e-53
Identities = 64/293 (21%), Positives = 108/293 (36%), Gaps = 42/293 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILIS 814
E E+ + I +G FG V + + AIK K + E L E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQ 64
Query: 815 VRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL-RNLGCLDEDMARVYIAELVLALEY 873
+P +V+ T ++++ME G+L S L LD +Y +L AL Y
Sbjct: 65 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 874 LHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELK 933
L S +HRD+ N+L+ + +KL DFGLS+ +
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-------------------- 163
Query: 934 DQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKT 992
+ ++APE + + +D W G+ ++E+L+ G+ PF
Sbjct: 164 ---------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 214
Query: 993 PQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045
+ I N + +P L+ K +P +R E+K
Sbjct: 215 NNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (457), Expect = 3e-51
Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 43/301 (14%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
D + + G +G V+ + A+K LK+ M VE L E ++ +++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 72
Query: 818 PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLL--RNLGCLDEDMARVYIAELVLALEYLH 875
P +V+ T Y++ E++ G+L L N + + ++ A+EYL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 876 SLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQ 935
N IHRDL N L+G++ +K+ DFGLS+ + D
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-------------------LMTGDT---- 169
Query: 936 PPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQ 994
+ APE L +D W+ G++L+E+ G+ P+
Sbjct: 170 ------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223
Query: 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWD 1054
Q++ ++ +D PE + +L+ NP R E+ Q F+ + +
Sbjct: 224 QVY-ELLEKDYR-MERPEGCPEKVYELMRACWQWNPSDRP---SFAEIHQ--AFETMFQE 276
Query: 1055 T 1055
+
Sbjct: 277 S 277
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-50
Identities = 62/314 (19%), Positives = 117/314 (37%), Gaps = 51/314 (16%)
Query: 758 EDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
E + + + QG+FG V+ K AIK + +A +R+ L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVM 77
Query: 813 ISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRN----------LGCLDEDMARV 862
VVR + + ++ME + GDL S LR+ L
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 863 YIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLG 922
E+ + YL++ +HRDL N ++ +D +K+ DFG+++ I+ TD
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETD-------- 187
Query: 923 SGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELL 982
R+ +++PE L +D WS G++L+E+
Sbjct: 188 ------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 983 IGI-PPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041
P+ + +Q+ +M + + P+ +L+ NP R
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
Query: 1042 V---KQHPFFKNIN 1052
+ P F+ ++
Sbjct: 288 SIKEEMEPGFREVS 301
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 3e-50
Identities = 69/341 (20%), Positives = 129/341 (37%), Gaps = 83/341 (24%)
Query: 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS 814
T ++ ++ +KPI GA G V A AIK L + + + E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 815 VRNPFVVRFFYSFTCR------ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELV 868
V + ++ FT + +++YLVME ++ + LD + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQML 129
Query: 869 LALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLV 928
+++LHS +IHRDLKP N+++ D +K+ DFGL++
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---------------------- 167
Query: 929 NDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPF 988
T Y APE++LGMG+ D WSVG I+ E++ F
Sbjct: 168 ---------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218
Query: 989 NAKTPQQIFDNIMN---------------------------RDIPWPNI----------- 1010
+ ++ ++ + +P +
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278
Query: 1011 -PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
+ + +A DL+ K+L +P +R+ + QHP+
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 316
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 4e-50
Identities = 63/301 (20%), Positives = 109/301 (36%), Gaps = 56/301 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNAVESILAERNIL 812
K + GAFG+V A K A+K+LK + + + E++++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVL 80
Query: 813 ISVRN-PFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLR------------------NLG 853
+ N +V + T ++ EY GDL + LR +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 854 CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913
LD + + ++ + +L S N IHRDL N+L+ K+ DFGL++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR------- 193
Query: 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWS 973
K + ++APE + + +D WS
Sbjct: 194 ---------------------DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 232
Query: 974 VGIILFELL-IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQ 1032
GI L+EL +G P+ F ++ PE E D++ +P++
Sbjct: 233 YGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 1033 R 1033
R
Sbjct: 292 R 292
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (448), Expect = 2e-49
Identities = 76/329 (23%), Positives = 129/329 (39%), Gaps = 72/329 (21%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
E ++ + P+ GA+G V A TG A+K L + +A + E +L +++
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLKHMKH 76
Query: 818 PFVVRFFYSFT-----CRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALE 872
V+ FT N ++ +L G DL ++++ L +D + I +++ L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 135
Query: 873 YLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDEL 932
Y+HS ++IHRDLKP NL + +D +K+ DFGL++
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------------------- 169
Query: 933 KDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAK 991
+ T Y APEI+L H T D WSVG I+ ELL G F
Sbjct: 170 -------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222
Query: 992 TPQQIFDNIMN----------------------------RDIPWPNIPEEMSVEACDLID 1023
I+ + + N+ + A DL++
Sbjct: 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 282
Query: 1024 KLLTENPVQRLGATGAREVKQHPFFKNIN 1052
K+L + +R+ A + H +F +
Sbjct: 283 KMLVLDSDKRI---TAAQALAHAYFAQYH 308
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 1e-48
Identities = 60/301 (19%), Positives = 117/301 (38%), Gaps = 57/301 (18%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGD-------LFAIKVLKKADMIRKNAVESILAERN 810
+ + KP+ +GAFG+V LA A+K+LK D K+ + +++E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKD-LSDLISEME 70
Query: 811 ILISV-RNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGC--------------- 854
++ + ++ ++ + T LY+++EY + G+L L+
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 855 -LDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913
L ++ +EYL S IHRDL N+L+ +D +K+ DFGL++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------- 183
Query: 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWS 973
++ + ++APE L + +D WS
Sbjct: 184 ---------------------DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222
Query: 974 VGIILFELL-IGIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQ 1032
G++L+E+ +G P+ +++F + + P + E ++ P Q
Sbjct: 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQ 280
Query: 1033 R 1033
R
Sbjct: 281 R 281
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-47
Identities = 64/323 (19%), Positives = 121/323 (37%), Gaps = 60/323 (18%)
Query: 749 PCSKDRTSI--EDFEIIKPISQGAFGRVFLAR-----KRATGDLFAIKVLKKADMIRKNA 801
P + + ++ KP+ +GAFG+V A K AT A+K+LK+ +
Sbjct: 2 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSE 59
Query: 802 VESILAERNILISVRNPFVVRFFYSFTCREN--LYLVMEYLNGGDLYSLLRN-------- 851
++++E ILI + + V + L +++E+ G+L + LR+
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 852 --------LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFG 903
L + Y ++ +E+L S IHRDL N+L+ + +K+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 904 LSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM 963
L++ + D + +K ++APE +
Sbjct: 180 LAR-------------------DIYKDP---------DYVRKGDARLPLKWMAPETIFDR 211
Query: 964 GHGATADWWSVGIILFELLIGI-PPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLI 1022
+ +D WS G++L+E+ P+ + F + P+ + E +
Sbjct: 212 VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTM 270
Query: 1023 DKLLTENPVQRLGATGAREVKQH 1045
P QR E+ +H
Sbjct: 271 LDCWHGEPSQRP---TFSELVEH 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 58/296 (19%), Positives = 107/296 (36%), Gaps = 45/296 (15%)
Query: 744 TSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLARKRATGD----LFAIKVLKKADMIRK 799
T+ I+P K I G FG V+ + + AIK LK +
Sbjct: 1 TTEIHP--------SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--E 50
Query: 800 NAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSL-LRNLGCLDED 858
L E I+ + ++R + + + ++ EY+ G L G
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL 110
Query: 859 MARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918
+ + ++YL ++N +HRDL N+L+ + K++DFGLS+V
Sbjct: 111 QLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV----------- 159
Query: 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIIL 978
L+D P T + APE + + +D WS GI++
Sbjct: 160 -------------LEDDPEAT---YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVM 203
Query: 979 FELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQR 1033
+E++ G P+ + ++ I + P + L+ + + +R
Sbjct: 204 WEVMTYGERPYWELSNHEVMKAINDG--FRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-46
Identities = 59/322 (18%), Positives = 115/322 (35%), Gaps = 45/322 (13%)
Query: 730 EESSMDEDTVRSLRTSPINPCSKDRTSIEDFEIIKPISQGAFGRVFLAR---KRATGDLF 786
+ S+++ + V++++ I P + E+I +G FG V+
Sbjct: 5 DLSALNPELVQAVQHVVIGP---SSLIVHFNEVI---GRGHFGCVYHGTLLDNDGKKIHC 58
Query: 787 AIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFF-YSFTCRENLYLVMEYLNGGDL 845
A+K L + I + V L E I+ +P V+ + +V+ Y+ GDL
Sbjct: 59 AVKSLNRITDIGE--VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 116
Query: 846 YSLLRNLGCLDEDMARVYIA-ELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGL 904
+ +RN + ++ +++L S +HRDL N ++ + +K+ DFGL
Sbjct: 117 RNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGL 176
Query: 905 SKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG 964
++ ++ + K ++A E L
Sbjct: 177 AR--DMYDKE------------------------FDSVHNKTGAKLPVKWMALESLQTQK 210
Query: 965 HGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLID 1023
+D WS G++L+EL+ G PP+ I ++ PE +++
Sbjct: 211 FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDPLYEVML 268
Query: 1024 KLLTENPVQRLGATGAREVKQH 1045
K R E+
Sbjct: 269 KCWHPKAEMRP---SFSELVSR 287
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 7e-44
Identities = 56/324 (17%), Positives = 106/324 (32%), Gaps = 73/324 (22%)
Query: 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN 817
+ + I +G FG V+ + G+ A+K+ R+ AE + +R+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 818 PFVVRFFYSFTCREN----LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEY 873
++ F + L+LV +Y G L+ L E M ++ + L +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-STASGLAH 115
Query: 874 LHS--------LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
LH + HRDLK N+L+ ++G + D GL+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------------------- 156
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGAT------ADWWSVGIILF 979
+ + GT Y+APE+L + AD +++G++ +
Sbjct: 157 -------RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209
Query: 980 ELLIGIPPFNAKTPQQ-------------------IFDNIMNRDIPWPNIPEEMSVEACD 1020
E+ Q + + + +IP E
Sbjct: 210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 269
Query: 1021 LIDKLLTENPVQRLGATGAREVKQ 1044
++ + N RL A +K+
Sbjct: 270 IMRECWYANGAARL---TALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 5e-38
Identities = 56/350 (16%), Positives = 116/350 (33%), Gaps = 90/350 (25%)
Query: 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNI-------L 812
+ +++ + G F V+LA+ A+K+++ + + A + I + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 813 ISVRNPFVVRFFYSFT--CRENLYLVMEYLNGG---DLYSLLRNLGCLDEDMARVYIAEL 867
S+ +++ F +++VM + G + + +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 868 VLALEYL-HSLNVIHRDLKPDNLLIGQDGHI-KLTDFGLSKVGLIHSTDDLSAPSLGSGG 925
+L L+Y+ +IH D+KP+N+L+ L ++ +G D+
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---------- 184
Query: 926 FLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985
+ T +Y +PE+LLG G AD WS ++FEL+ G
Sbjct: 185 ------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
Query: 986 PPFNAKTPQQIFDNI------------------------------------MNRDIPWP- 1008
F + +++ WP
Sbjct: 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPL 286
Query: 1009 --------NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050
++ + E D + +L +P +R A + HP+ K+
Sbjct: 287 EDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKD 333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 6e-20
Identities = 25/161 (15%), Positives = 51/161 (31%), Gaps = 28/161 (17%)
Query: 761 EIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADM---------------IRKNAVESI 805
I K + +G VF +K K A+ S
Sbjct: 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 806 LAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIA 865
E L ++ V + + ++ME ++ +LY + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRVENPDEVLD 110
Query: 866 ELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSK 906
++ + + ++H DL N+L+ + I + DF S
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1170 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1ne6a1 | 136 | Regulatory subunit of Protein kinase A {Cow (Bos t | 99.4 | |
| d1cx4a1 | 136 | Regulatory subunit of Protein kinase A {Rat (Rattu | 99.34 | |
| d1o7fa3 | 124 | Regulatory domain of Epac2, domains 1 and 3 {Mouse | 98.97 | |
| d1q3ea_ | 193 | HCN pacemaker channel {Mouse (Mus musculus) [TaxId | 98.89 | |
| d1wgpa_ | 137 | Probable cyclic nucleotide-gated ion channel 6 {Th | 98.84 | |
| d1o7fa2 | 155 | Regulatory domain of Epac2, domains 1 and 3 {Mouse | 98.77 | |
| d1ne6a2 | 132 | Regulatory subunit of Protein kinase A {Cow (Bos t | 98.76 | |
| d1cx4a2 | 147 | Regulatory subunit of Protein kinase A {Rat (Rattu | 98.75 | |
| d1vp6a_ | 133 | Putative ion channel CnbD {Mesorhizobium loti [Tax | 98.66 | |
| d1i5za2 | 132 | Catabolite gene activator protein, N-terminal doma | 98.58 | |
| d3e5ua2 | 139 | Chlorophenol reduction protein CprK {Desulfitobact | 98.49 | |
| d2gaua2 | 142 | Transcriptional regulator PG0396, N-terminal domai | 98.46 | |
| d2oz6a2 | 134 | Cyclic AMP receptor-like protein Vfr {Pseudomonas | 98.43 | |
| d1zyba2 | 147 | Probable transcription regulator BT4300, N-termina | 98.37 | |
| d2zcwa2 | 112 | Transcriptional regulator TTHA1359, N-terminal dom | 98.33 | |
| d1o5la1 | 129 | CRP-like transcriptional regulator TM1171, N-termi | 98.31 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.12 | |
| d1ft9a2 | 132 | CO-sensing protein CooA, N-terminal domain {Rhodos | 97.71 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.69 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.51 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.3 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.06 | |
| d1ne6a2 | 132 | Regulatory subunit of Protein kinase A {Cow (Bos t | 94.84 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.83 | |
| d1cx4a1 | 136 | Regulatory subunit of Protein kinase A {Rat (Rattu | 93.8 | |
| d1cx4a2 | 147 | Regulatory subunit of Protein kinase A {Rat (Rattu | 93.3 | |
| d1ne6a1 | 136 | Regulatory subunit of Protein kinase A {Cow (Bos t | 89.52 | |
| d1wgpa_ | 137 | Probable cyclic nucleotide-gated ion channel 6 {Th | 89.37 | |
| d1o7fa3 | 124 | Regulatory domain of Epac2, domains 1 and 3 {Mouse | 89.3 | |
| d1vp6a_ | 133 | Putative ion channel CnbD {Mesorhizobium loti [Tax | 85.37 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-62 Score=547.59 Aligned_cols=293 Identities=40% Similarity=0.778 Sum_probs=266.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+++++|++++.||+|+||+||+|+++.+|+.||||++.+.........+++.+|+.+|+.++|||||+++++|++.+.+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 56789999999999999999999999999999999999876555566788999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||||+||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~----- 156 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI----- 156 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC-----
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccc-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.........+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 157 -------------------------~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~ 211 (337)
T d1o6la_ 157 -------------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211 (337)
T ss_dssp -------------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred -------------------------cCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH
Confidence 1112334678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES- 1069 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s- 1069 (1170)
++++.+..+.+.+| ..+|+++++||.+||++||.+|++. .++.|+++||||++++|+.+..+ .||++|...+
T Consensus 212 ~~~~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~ 288 (337)
T d1o6la_ 212 RLFELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSE 288 (337)
T ss_dssp HHHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSST
T ss_pred HHHHHHhcCCCCCC---ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCCCh
Confidence 99999999888766 6899999999999999999999973 35899999999999999998776 6889998766
Q ss_pred CCCCccccccc
Q 001057 1070 LDTSYFVSRYV 1080 (1170)
Q Consensus 1070 lDts~F~s~~~ 1080 (1170)
.++++|+..+.
T Consensus 289 ~~~~~f~~~~~ 299 (337)
T d1o6la_ 289 VDTRYFDDEFT 299 (337)
T ss_dssp TCCTTSCHHHH
T ss_pred hhhhhcCchhh
Confidence 78888877554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-61 Score=523.47 Aligned_cols=279 Identities=38% Similarity=0.715 Sum_probs=250.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||+++++|.+.+.+||
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 44789999999999999999999999999999999987665555667789999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~---- 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE---- 161 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccC----
Confidence 9999999999999999899999999999999999999999999999999999999999999999999999853100
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.......+.+||+.|||||++.+..|+.++|||||||+||||++|.+||.+.+..+
T Consensus 162 ------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~ 217 (288)
T d1uu3a_ 162 ------------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 217 (288)
T ss_dssp --------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH
Confidence 11123345789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhh---HHHHHcCCCCCCCChhhhhhccCCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATG---AREVKQHPFFKNINWDTLARQKAMFIP 1065 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~---AeEILqHPfF~~idwe~L~~~~ppfiP 1065 (1170)
++++|.+..+.+| ..+++++++||.+||+.||.+|||+.+ ...+++||||++++|+.|..+.||.+|
T Consensus 218 ~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 218 IFQKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHHHHTTCCCCC---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHHHcCCCCCC---ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 9999998887765 689999999999999999999999654 356899999999999999988887665
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.3e-60 Score=522.21 Aligned_cols=286 Identities=39% Similarity=0.775 Sum_probs=253.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
++++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 46789999999999999999999999999999999987655555567889999999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||||.||+|..++.....+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~------ 155 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------ 155 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS------
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEec------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+
T Consensus 156 ---------------------------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 208 (316)
T d1fota_ 156 ---------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208 (316)
T ss_dssp ---------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ---------------------------cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH
Confidence 11235789999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC--
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-- 1069 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-- 1069 (1170)
++.+|.++...+| ..+++++++||.+||++||.+|++. .+++++|+||||++++|+.+..+ .+|++|....
T Consensus 209 ~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~ 285 (316)
T d1fota_ 209 TYEKILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQ 285 (316)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC----
T ss_pred HHHHHHcCCCCCC---CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcCCCc
Confidence 9999999887665 6799999999999999999999852 35899999999999999998765 6788887544
Q ss_pred CCCCcccc
Q 001057 1070 LDTSYFVS 1077 (1170)
Q Consensus 1070 lDts~F~s 1077 (1170)
.|+++|+.
T Consensus 286 ~d~~~f~~ 293 (316)
T d1fota_ 286 GDTSQFDK 293 (316)
T ss_dssp --------
T ss_pred chhhhcCC
Confidence 56677653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-59 Score=524.05 Aligned_cols=287 Identities=40% Similarity=0.790 Sum_probs=260.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 44689999999999999999999999999999999998766555556778999999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~----- 192 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----- 192 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc-----
Confidence 999999999999999998899999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 193 ----------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 244 (350)
T d1rdqe_ 193 ----------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244 (350)
T ss_dssp ----------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ----------------------------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH
Confidence 1123568999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCC--hhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLG--ATGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES- 1069 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpS--a~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s- 1069 (1170)
.++..|......+| ..+++++.+||.+||++||.+|+. ...++++++||||++++|+.+..+ .+||+|...+
T Consensus 245 ~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~ 321 (350)
T d1rdqe_ 245 QIYEKIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGP 321 (350)
T ss_dssp HHHHHHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCST
T ss_pred HHHHHHhcCCCCCC---ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCCCCCc
Confidence 99999998887665 689999999999999999999973 135899999999999999998876 6789998765
Q ss_pred CCCCcccc
Q 001057 1070 LDTSYFVS 1077 (1170)
Q Consensus 1070 lDts~F~s 1077 (1170)
.|+++|+.
T Consensus 322 ~d~s~~~~ 329 (350)
T d1rdqe_ 322 GDTSNFDD 329 (350)
T ss_dssp TCCTTSCC
T ss_pred chhhhcCC
Confidence 67777764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-59 Score=500.72 Aligned_cols=258 Identities=39% Similarity=0.689 Sum_probs=237.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 45789999999999999999999999999999999998766555556678899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----- 157 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 157 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC-----
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC-----
Confidence 999999999999999988899999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQ 994 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ 994 (1170)
.......+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..
T Consensus 158 ---------------------------~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 210 (263)
T d2j4za1 158 ---------------------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210 (263)
T ss_dssp ---------------------------CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred ---------------------------CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH
Confidence 01123468999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
+++..+.+..+.+| ..+|+++++||.+||++||.+||| +.|+|+||||+.
T Consensus 211 ~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~t---~~eil~hp~~~~ 260 (263)
T d2j4za1 211 ETYKRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTCHHHHH
T ss_pred HHHHHHHcCCCCCC---ccCCHHHHHHHHHHccCCHhHCcC---HHHHHcCcCcCC
Confidence 99999998887665 679999999999999999999999 889999999963
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-59 Score=513.51 Aligned_cols=288 Identities=41% Similarity=0.789 Sum_probs=242.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHH-hcCCCcEEEEEeeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILI-SVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILs-kL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+..|..++. .++|||||+++++|.+.+.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 468999999999999999999999999999999998765544555667778888775 6899999999999999999999
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||||+||+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~------ 154 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------ 154 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC------
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcc------
Confidence 99999999999999998999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+
T Consensus 155 ------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~ 210 (320)
T d1xjda_ 155 ------------------------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210 (320)
T ss_dssp ------------------------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ------------------------cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 01112234689999999999999999999999999999999999999999999999
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhhc--cCCCCCCCCC-CCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLARQ--KAMFIPAAES-LDT 1072 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~~--~ppfiP~~~s-lDt 1072 (1170)
++..|..+.+.+| ..+|+++++||.+||++||.+||++. .++++||||++++|+.+..+ .||++|...+ .|+
T Consensus 211 ~~~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~s~~--~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~ 285 (320)
T d1xjda_ 211 LFHSIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDC 285 (320)
T ss_dssp HHHHHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC------------
T ss_pred HHHHHHcCCCCCC---ccCCHHHHHHHHHhcccCCCCCcCHH--HHHHhCchhccCCHHHHHhcCCCCCCCCCCCCccch
Confidence 9999998877655 68999999999999999999999932 36899999999999988765 6788888776 777
Q ss_pred Ccccccc
Q 001057 1073 SYFVSRY 1079 (1170)
Q Consensus 1073 s~F~s~~ 1079 (1170)
++|+..+
T Consensus 286 ~~f~~~~ 292 (320)
T d1xjda_ 286 SNFDKEF 292 (320)
T ss_dssp -------
T ss_pred hhcChHh
Confidence 8887654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.2e-58 Score=514.94 Aligned_cols=279 Identities=34% Similarity=0.643 Sum_probs=237.7
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHH---HHHHHhcCCCcEEEEEeeeecccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAE---RNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~E---ieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
++++|+++++||+|+||+||+|+++.+|+.||||++.+...........+.+| +.+++.++|||||+++++|.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 57899999999999999999999999999999999987654333333344444 666677789999999999999999
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|||||||+||+|.++|.+...+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~--- 158 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--- 158 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS---
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC---
Confidence 99999999999999999998999999999999999999999999999999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.......+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+.
T Consensus 159 -----------------------------~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 159 -----------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp -----------------------------SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred -----------------------------CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 012235689999999999974 56899999999999999999999999876
Q ss_pred CHH---HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc--cCCCC
Q 001057 992 TPQ---QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ--KAMFI 1064 (1170)
Q Consensus 992 ~~~---ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~--~ppfi 1064 (1170)
+.. .+...+...... .+..+|+++++||.+||++||.+||+. ..|+|+++||||++++|..+..+ .||++
T Consensus 210 ~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~ 286 (364)
T d1omwa3 210 KTKDKHEIDRMTLTMAVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 286 (364)
T ss_dssp CSSCHHHHHHHSSSCCCC---CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred CHHHHHHHHHhcccCCCC---CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcC
Confidence 543 344444444443 346899999999999999999999994 35899999999999999998776 67888
Q ss_pred CCCCC
Q 001057 1065 PAAES 1069 (1170)
Q Consensus 1065 P~~~s 1069 (1170)
|....
T Consensus 287 p~~~~ 291 (364)
T d1omwa3 287 PPRGE 291 (364)
T ss_dssp CCCC-
T ss_pred CCCCC
Confidence 86554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=491.23 Aligned_cols=260 Identities=28% Similarity=0.505 Sum_probs=221.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|++++|||||+++++|.+.+.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 5689999999999999999999999999999999976542 23346788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~----- 156 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN----- 156 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET-----
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC-----
Confidence 999999999999988888999999999999999999999999999999999999999999999999999853100
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.......+.+||+.|||||++.+..+ +.++|||||||++|||++|++||.+.+...
T Consensus 157 -----------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 213 (271)
T d1nvra_ 157 -----------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 213 (271)
T ss_dssp -----------------------TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS
T ss_pred -----------------------CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH
Confidence 11123346789999999999998776 578999999999999999999998765433
Q ss_pred -HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 996 -IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 996 -i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
.+..+.. ..........+++++++||.+||+.||.+||| +.|+|+||||+.
T Consensus 214 ~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~ 265 (271)
T d1nvra_ 214 QEYSDWKE-KKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHT-TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTC
T ss_pred HHHHHHhc-CCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCc
Confidence 3333333 32233334678999999999999999999999 889999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=485.49 Aligned_cols=268 Identities=29% Similarity=0.489 Sum_probs=233.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH---HHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK---NAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~---~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++|||||+++++|.+.+++
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3579999999999999999999999999999999987543222 2357889999999999999999999999999999
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC----cEEEEecCCccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG----HIKLTDFGLSKVGL 909 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG----~VKLsDFGLAk~~~ 909 (1170)
|||||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999888999999999999999999999999999999999999998776 59999999998531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.
T Consensus 169 -------------------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 169 -------------------------------FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp -------------------------------TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -------------------------------CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 0112345689999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhhhhh
Q 001057 990 AKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDTLAR 1058 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~L~~ 1058 (1170)
+.+..+++..|......++. .+..+|.++++||.+||+.||.+||+ +.|+|+||||+..+|.....
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~~~~l~ 284 (293)
T d1jksa_ 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQALS 284 (293)
T ss_dssp CSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTCC--------
T ss_pred CCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCChhHhhc
Confidence 99999999999988776552 23578999999999999999999999 88999999999998876443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=489.50 Aligned_cols=256 Identities=35% Similarity=0.580 Sum_probs=228.8
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|.+.+++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4799999999999999999999999999999999865432 2467899999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCC
Q 001057 838 EYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLS 917 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~ 917 (1170)
|||+||+|.+++.+ +.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~-------- 167 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-------- 167 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeec--------
Confidence 99999999998875 579999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHH
Q 001057 918 APSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTPQQIF 997 (1170)
Q Consensus 918 a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~ 997 (1170)
.........+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 168 ----------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 225 (293)
T d1yhwa1 168 ----------------------PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225 (293)
T ss_dssp ----------------------STTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred ----------------------cccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH
Confidence 0111234568999999999999999999999999999999999999999999988877
Q ss_pred HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 998 DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 998 qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
..+.....+....+..+++++++||.+||+.||.+||+ +.|+|+||||+.
T Consensus 226 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~Hp~~~~ 275 (293)
T d1yhwa1 226 YLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHTTCGGGGG
T ss_pred HHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCC
Confidence 77776554434456789999999999999999999999 889999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-56 Score=490.35 Aligned_cols=259 Identities=31% Similarity=0.562 Sum_probs=218.1
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++|||||+++++|.+.+.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35699999999999999999999999999999999876432 2345688999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC---CCCcEEEEecCCccccccccC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG---QDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd---~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||+. .+|.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~---- 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---- 161 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc----
Confidence 99999999999999988999999999999999999999999999999999999995 57899999999997521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 162 ---------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 162 ---------------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp --------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---------------------------CCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 11123456899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCC-CCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 994 QQIFDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP-~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
.+++..|......++ ..+..+|+++++||.+||++||.+||| +.|+++||||++.
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~ 270 (307)
T d1a06a_ 215 AKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT---CEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTTSS
T ss_pred HHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCCC
Confidence 999999998876654 234579999999999999999999999 8899999999853
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=485.44 Aligned_cols=258 Identities=33% Similarity=0.539 Sum_probs=230.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 837 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVM 837 (1170)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|++++|||||+++++|.+.+.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46999999999999999999999999999999997643 234567889999999999999999999999999999999
Q ss_pred eeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||+||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+...
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~------- 161 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT------- 161 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECH-------
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccC-------
Confidence 999999999998654 569999999999999999999999999999999999999999999999999997521
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-----cCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-----GMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-----g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.......+.+||+.|||||++. +..|+.++|||||||++|||++|.+||.+.
T Consensus 162 -----------------------~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~ 218 (288)
T d2jfla1 162 -----------------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218 (288)
T ss_dssp -----------------------HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -----------------------CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC
Confidence 1122334678999999999995 456889999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+..+++..+.....+....+..+|+++++||.+||+.||.+||| +.|+|+||||+.-
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~ell~hp~~~~~ 275 (288)
T d2jfla1 219 NPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT---TSQLLQHPFVTVD 275 (288)
T ss_dssp CGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSGGGCCC
T ss_pred CHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCC
Confidence 99999999988776555556789999999999999999999999 8899999999853
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=494.58 Aligned_cols=262 Identities=29% Similarity=0.523 Sum_probs=223.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|+.++|||||+++++|.+.+++|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34678999999999999999999999999999999997643 3344578899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 835 LVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
||||||.||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|++||+|||+|+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~---- 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 156 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccC----
Confidence 999999999999999988899999999999999999999997 599999999999999999999999999998521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+.
T Consensus 157 ----------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 157 ----------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp ----------------------------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ----------------------------CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 1223467999999999999999999999999999999999999999987654
Q ss_pred HHHHH------------------------------------------HHhccCCCCCCCC-ccCCHHHHHHHHHhccCCC
Q 001057 994 QQIFD------------------------------------------NIMNRDIPWPNIP-EEMSVEACDLIDKLLTENP 1030 (1170)
Q Consensus 994 ~ei~q------------------------------------------kIl~~~l~fP~ip-~~lS~eakDLIkkLLq~DP 1030 (1170)
.+... .+... ..|..+ ..+|.++++||.+||+.||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~dli~~~L~~dP 286 (322)
T d1s9ja_ 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE--PPPKLPSGVFSLEFQDFVNKCLIKNP 286 (322)
T ss_dssp THHHHHC------------------------------CCCCHHHHHHHHHTS--CCCCCCBTTBCHHHHHHHHHHTCSST
T ss_pred HHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhcc--CCccCccccCCHHHHHHHHHHcCCCh
Confidence 32211 11110 111122 2468999999999999999
Q ss_pred CCCCChhhHHHHHcCCCCCCCChhh
Q 001057 1031 VQRLGATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 1031 skRpSa~~AeEILqHPfF~~idwe~ 1055 (1170)
.+||| |+|+|+||||++.+|+.
T Consensus 287 ~~R~t---a~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 287 AERAD---LKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp TTSCC---HHHHHTSHHHHHHHHSC
T ss_pred hHCcC---HHHHhhCHhhCcCCccc
Confidence 99999 88999999998766543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-55 Score=491.25 Aligned_cols=264 Identities=27% Similarity=0.495 Sum_probs=235.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|+.+|++++|||||+++++|.+.+++|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34679999999999999999999999999999999997653 344577899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC--CCcEEEEecCCccccccc
Q 001057 835 LVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ--DGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~--dG~VKLsDFGLAk~~~~~ 911 (1170)
||||||+||+|.+++.+ .+.+++..++.|+.||+.||+|||++|||||||||+||||+. +|.+||+|||+|+...
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~-- 177 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 177 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC--
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc--
Confidence 99999999999999954 467999999999999999999999999999999999999964 5789999999998531
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
......+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.
T Consensus 178 -----------------------------~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 178 -----------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp -----------------------------TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------------------------cccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 011234568999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCChhh
Q 001057 992 TPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNINWDT 1055 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~idwe~ 1055 (1170)
+..+++..|......++. ....+|+++++||.+||+.||.+||| +.|+|+||||+..+|..
T Consensus 229 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 229 NDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPG 290 (350)
T ss_dssp SHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC---HHHHHHSTTTSCTTCCS
T ss_pred CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCCCCC
Confidence 999999999988776553 22468999999999999999999999 88999999999876643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=476.57 Aligned_cols=256 Identities=31% Similarity=0.574 Sum_probs=219.1
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec--ccceE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC--RENLY 834 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd--~~~Ly 834 (1170)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++++|||||+++++|.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4689999999999999999999999999999999987654 34556789999999999999999999999865 45689
Q ss_pred EEEeeccCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----eeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 835 LVMEYLNGGDLYSLLRN----LGCLDEDMARVYIAELVLALEYLHSLN-----VIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~----~~~LSEe~ar~IaaQIL~ALeYLHs~G-----IIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
||||||+||+|.+++.+ .+.+++..++.++.||+.||+|||++| ||||||||+||||+.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 357999999999999999999999876 999999999999999999999999999
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
+... .......+.+||+.|||||++.+..|+.++|||||||++|||++|.
T Consensus 162 ~~~~------------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~ 211 (269)
T d2java1 162 RILN------------------------------HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 211 (269)
T ss_dssp HHC-----------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred eecc------------------------------cCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCC
Confidence 8531 1112234578999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 986 PPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 986 pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
+||.+.+..+++..|.++... .++..+|+++.+||.+||+.||.+||+ +.|+++|||+
T Consensus 212 ~Pf~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li~~~L~~dp~~Rps---~~ell~hp~i 269 (269)
T d2java1 212 PPFTAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLI 269 (269)
T ss_dssp CSCCCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTC
T ss_pred CCCCCCCHHHHHHHHHcCCCC--CCCcccCHHHHHHHHHHcCCChhHCcC---HHHHHhCCcC
Confidence 999999999999999887654 445789999999999999999999999 8899999995
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-55 Score=483.41 Aligned_cols=254 Identities=28% Similarity=0.411 Sum_probs=230.1
Q ss_pred CeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEe
Q 001057 759 DFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVME 838 (1170)
Q Consensus 759 dYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVME 838 (1170)
.|+.++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|++++|||||+++++|.+.+.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999988766666777889999999999999999999999999999999999
Q ss_pred eccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCC
Q 001057 839 YLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSA 918 (1170)
Q Consensus 839 Y~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a 918 (1170)
||.||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------- 166 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC---------
Confidence 99999998888877889999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc---CCCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 919 PSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG---MGHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 919 ~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g---~~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+
T Consensus 167 -------------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~ 221 (309)
T d1u5ra_ 167 -------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221 (309)
T ss_dssp -------------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred -------------------------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH
Confidence 1134679999999999975 358899999999999999999999999999888
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
.+..+.....+.+ .+..+|+++++||.+||+.||.+||| +.|+|+||||..
T Consensus 222 ~~~~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 222 ALYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLR 272 (309)
T ss_dssp HHHHHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHS
T ss_pred HHHHHHhCCCCCC-CCCCCCHHHHHHHHHHCcCChhHCcC---HHHHHhCHHhcC
Confidence 8888887665433 23578999999999999999999999 889999999964
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-55 Score=470.96 Aligned_cols=252 Identities=24% Similarity=0.455 Sum_probs=219.4
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec----ccceEE
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC----RENLYL 835 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd----~~~LyL 835 (1170)
|++.++||+|+||+||+|+++.+++.||+|++..... .....+.+.+|+++|++++|||||+++++|.+ ...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4778899999999999999999999999999987543 34556789999999999999999999999875 356899
Q ss_pred EEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCCCcEEeC-CCCcEEEEecCCcccccccc
Q 001057 836 VMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLN--VIHRDLKPDNLLIG-QDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~G--IIHRDIKPENILLd-~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++| ||||||||+||||+ .++.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc---
Confidence 9999999999999999889999999999999999999999999 99999999999996 57899999999997420
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCC-
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAK- 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~- 991 (1170)
.....+.+||+.|||||++.+ .|+.++|||||||++|||++|.+||.+.
T Consensus 167 -----------------------------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 167 -----------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp -----------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred -----------------------------CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 112235689999999999875 6999999999999999999999999765
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
+...+++.+..+..+ +..+...++++++||.+||++||.+||| +.|+|+||||+
T Consensus 217 ~~~~~~~~i~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~ell~Hp~fk 270 (270)
T d1t4ha_ 217 NAAQIYRRVTSGVKP-ASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQ 270 (270)
T ss_dssp SHHHHHHHHTTTCCC-GGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC
T ss_pred cHHHHHHHHHcCCCC-cccCccCCHHHHHHHHHHccCCHhHCcC---HHHHhCCcccC
Confidence 455666666654432 3344678999999999999999999999 88999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.1e-55 Score=486.87 Aligned_cols=259 Identities=25% Similarity=0.469 Sum_probs=232.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+|+.+|+.++|||||+++++|.+.+++||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999987542 334678899999999999999999999999999999
Q ss_pred EEeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC--CCCcEEEEecCCcccccccc
Q 001057 836 VMEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG--QDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd--~dG~VKLsDFGLAk~~~~~~ 912 (1170)
|||||+||+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+||||+ .+|.+||+|||+|+...
T Consensus 104 vmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~--- 180 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--- 180 (352)
T ss_dssp EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC---
T ss_pred EEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC---
Confidence 999999999999886654 699999999999999999999999999999999999998 57899999999998531
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
......+.+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+
T Consensus 181 ----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 181 ----------------------------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp ----------------------------TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred ----------------------------CCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 0112345689999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 993 PQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
..+++..|......++. ....+|+++++||.+||++||.+||| +.|+|+||||++.
T Consensus 233 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~Hp~~~~~ 289 (352)
T d1koba_ 233 DLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSC
T ss_pred HHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCCC
Confidence 99999999988877653 34579999999999999999999999 8899999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.5e-54 Score=464.23 Aligned_cols=261 Identities=31% Similarity=0.517 Sum_probs=232.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeecccccc------HHHHHHHHHHHHHHHhcC-CCcEEEEEeeeec
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIR------KNAVESILAERNILISVR-NPFVVRFFYSFTC 829 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~------~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd 829 (1170)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|++++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999998754322 234457889999999997 9999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccc
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~ 909 (1170)
.+++|||||||+||+|.++|...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999998531
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc------CCCCcchhhhHHHHHHHHHHh
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG------MGHGATADWWSVGIILFELLI 983 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g------~~ys~ksDIWSLGVILYELLT 983 (1170)
........+||+.|+|||++.+ ..|+.++||||+||++|||++
T Consensus 162 -------------------------------~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~ 210 (277)
T d1phka_ 162 -------------------------------PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210 (277)
T ss_dssp -------------------------------TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred -------------------------------CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc
Confidence 0112234689999999999974 346889999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhccCCCCCC-CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 984 GIPPFNAKTPQQIFDNIMNRDIPWPN-IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 984 G~pPF~g~~~~ei~qkIl~~~l~fP~-ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
|.+||.+.+..++++.|..+...++. ....+|+++++||.+||++||.+||+ ++|+|+||||+..
T Consensus 211 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s---~~eil~h~~~~~~ 276 (277)
T d1phka_ 211 GSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQY 276 (277)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCTT
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHHHHh
Confidence 99999999999999999988766543 23479999999999999999999999 8899999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-54 Score=472.40 Aligned_cols=256 Identities=29% Similarity=0.497 Sum_probs=229.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+|+.+|..++|||||+++++|.+.+++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999998653 2335678999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCC--CcEEEEecCCccccccccC
Q 001057 837 MEYLNGGDLYSLLRNLG-CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQD--GHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~-~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~d--G~VKLsDFGLAk~~~~~~~ 913 (1170)
||||+||+|.+++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~---- 155 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---- 155 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC----
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc----
Confidence 99999999999998765 69999999999999999999999999999999999999854 489999999997521
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+.
T Consensus 156 ---------------------------~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 156 ---------------------------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp ---------------------------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ---------------------------cCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH
Confidence 11123456899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 994 QQIFDNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 994 ~ei~qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
.+++..|.+..+.++.. ...+|+++++||.+||++||.+||+ +.|+|+||||++
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~ 263 (321)
T d1tkia_ 209 QQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHS
T ss_pred HHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhcc
Confidence 99999999988776521 2368999999999999999999999 889999999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=465.18 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=215.4
Q ss_pred EEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccH--HHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEee
Q 001057 762 IIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRK--NAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEY 839 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~--~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY 839 (1170)
.+++||+|+||+||+|+++.+|+.||||++++...... .....+.+|+.+|+.++|||||+++++|.+.+++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 57899999999999999999999999999876543221 2235688999999999999999999999999999999999
Q ss_pred ccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCC
Q 001057 840 LNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAP 919 (1170)
Q Consensus 840 ~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~ 919 (1170)
+.|+++..++.....+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~---------- 151 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG---------- 151 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT----------
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccC----------
Confidence 9988887777767789999999999999999999999999999999999999999999999999997421
Q ss_pred CCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 001057 920 SLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQIFD 998 (1170)
Q Consensus 920 sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~ei~q 998 (1170)
.......+.+||+.|||||++.+. .|+.++|||||||++|||++|.+||.+.+..+++.
T Consensus 152 --------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~ 211 (299)
T d1ua2a_ 152 --------------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT 211 (299)
T ss_dssp --------------------SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred --------------------CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH
Confidence 011123456899999999999754 58999999999999999999999999999988887
Q ss_pred HHhccCC-----C---------------CCCC-----CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCC
Q 001057 999 NIMNRDI-----P---------------WPNI-----PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNI 1051 (1170)
Q Consensus 999 kIl~~~l-----~---------------fP~i-----p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~i 1051 (1170)
+|..... . ++.. ...+++++++||.+||+.||.+||| |.|+|+||||++.
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s---a~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 212 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYFSNR 286 (299)
T ss_dssp HHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGGTSS
T ss_pred HHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC---HHHHhCCHhhCCC
Confidence 7754210 0 0111 1356899999999999999999999 8899999999865
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-53 Score=467.91 Aligned_cols=284 Identities=42% Similarity=0.802 Sum_probs=240.6
Q ss_pred CCCCCCeEEEEEeccCCCeEEEEeee---cCCCCEEEEEEeeccccc-cHHHHHHHHHHHHHHHhcCC-CcEEEEEeeee
Q 001057 754 RTSIEDFEIIKPISQGAFGRVFLARK---RATGDLFAIKVLKKADMI-RKNAVESILAERNILISVRN-PFVVRFFYSFT 828 (1170)
Q Consensus 754 ~i~iedYevlk~LG~GgFGtVyLArd---k~TGe~VAIKvLkKs~i~-~~~~ve~~l~EieILskL~H-PNIVrL~~~Fq 828 (1170)
.+.+++|++++.||+|+||+||+|++ +.+|+.||||++.+.... .....+.+.+|+.+|++++| |||++++++|.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 35678999999999999999999987 457999999999765432 22334668899999999976 89999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
+...+|+||||+.||+|.+++...+.+++..++.+++||+.||.|||++||+||||||+||||+.+|.+||+|||+|+..
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999753
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC--CCCcchhhhHHHHHHHHHHhCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM--GHGATADWWSVGIILFELLIGIP 986 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~--~ys~ksDIWSLGVILYELLTG~p 986 (1170)
.. .......+..||+.|+|||++.+. .++.++|||||||+||+|++|..
T Consensus 180 ~~-----------------------------~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~ 230 (322)
T d1vzoa_ 180 VA-----------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230 (322)
T ss_dssp CG-----------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSC
T ss_pred cc-----------------------------cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCC
Confidence 10 112233467899999999999865 46789999999999999999999
Q ss_pred CCCCCCHHHHH----HHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCCh--hhHHHHHcCCCCCCCChhhhhhc-
Q 001057 987 PFNAKTPQQIF----DNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGA--TGAREVKQHPFFKNINWDTLARQ- 1059 (1170)
Q Consensus 987 PF~g~~~~ei~----qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa--~~AeEILqHPfF~~idwe~L~~~- 1059 (1170)
||.+.+..+.. ........+ ++..+++++.+||.+||++||.+||+. .+|+|+|+||||++++|+.+..+
T Consensus 231 PF~~~~~~~~~~~i~~~~~~~~~~---~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~ 307 (322)
T d1vzoa_ 231 PFTVDGEKNSQAEISRRILKSEPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 307 (322)
T ss_dssp TTSCTTSCCCHHHHHHHHHHCCCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred CCCCCCHHHHHHHHHHhcccCCCC---CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCC
Confidence 99876544433 333334443 346899999999999999999999974 35999999999999999999887
Q ss_pred -cCCCCCCCCC
Q 001057 1060 -KAMFIPAAES 1069 (1170)
Q Consensus 1060 -~ppfiP~~~s 1069 (1170)
.+|++|...+
T Consensus 308 ~~~p~~p~~~~ 318 (322)
T d1vzoa_ 308 VPAPFKPVIRD 318 (322)
T ss_dssp SCCSCCCCCCC
T ss_pred CCcCCCCCCCC
Confidence 6788887654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=452.89 Aligned_cols=263 Identities=31% Similarity=0.457 Sum_probs=217.3
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCC-CCEEEEEEeeccccccHHHHHHHHHHHHHHHhc---CCCcEEEEEeeeec--
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRAT-GDLFAIKVLKKADMIRKNAVESILAERNILISV---RNPFVVRFFYSFTC-- 829 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~T-Ge~VAIKvLkKs~i~~~~~ve~~l~EieILskL---~HPNIVrL~~~Fqd-- 829 (1170)
..++|++++.||+|+||+||+|++..+ ++.||||++...... ......+.+|+.+|+.+ +|||||+++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 347899999999999999999999765 678999998764322 22223455777776655 79999999999853
Q ss_pred ---ccceEEEEeeccCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCc
Q 001057 830 ---RENLYLVMEYLNGGDLYSLLRN-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLS 905 (1170)
Q Consensus 830 ---~~~LyLVMEY~~GGSL~dlLk~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLA 905 (1170)
..++|++|||+.++.+...... ...+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3578999999988776555443 356999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCC
Q 001057 906 KVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 906 k~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
+... ........+||+.|||||++.+..|+.++|||||||++|||++|.
T Consensus 164 ~~~~-------------------------------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~ 212 (305)
T d1blxa_ 164 RIYS-------------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212 (305)
T ss_dssp CCCC-------------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred hhhc-------------------------------ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCC
Confidence 7421 112334678999999999999999999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhccC------------------------CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 986 PPFNAKTPQQIFDNIMNRD------------------------IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 986 pPF~g~~~~ei~qkIl~~~------------------------l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+||.+.+..+++..|.... .+.+.....+++++++||.+||++||.+||| |.|
T Consensus 213 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s---a~e 289 (305)
T d1blxa_ 213 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYS 289 (305)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHH
T ss_pred CCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC---HHH
Confidence 9999999888887775310 0011123468999999999999999999999 889
Q ss_pred HHcCCCCCCCCh
Q 001057 1042 VKQHPFFKNINW 1053 (1170)
Q Consensus 1042 ILqHPfF~~idw 1053 (1170)
+|+||||+++++
T Consensus 290 ~L~Hpff~~i~~ 301 (305)
T d1blxa_ 290 ALSHPYFQDLER 301 (305)
T ss_dssp HHTSGGGTTCCC
T ss_pred HhcChhhcCchh
Confidence 999999998864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-53 Score=453.26 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=217.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHH---HHHHHHHHHHHHHhcC--CCcEEEEEeeeeccc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKN---AVESILAERNILISVR--NPFVVRFFYSFTCRE 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~---~ve~~l~EieILskL~--HPNIVrL~~~Fqd~~ 831 (1170)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+....... ....+.+|+.+|++++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 36899999999999999999999999999999999865432211 1234668999999987 899999999999999
Q ss_pred ceEEEEeeccC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-CCcEEEEecCCccccc
Q 001057 832 NLYLVMEYLNG-GDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-DGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 832 ~LyLVMEY~~G-GSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-dG~VKLsDFGLAk~~~ 909 (1170)
.+|+||||+.+ +++.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 688899988889999999999999999999999999999999999999985 4799999999997521
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCC-CcchhhhHHHHHHHHHHhCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGH-GATADWWSVGIILFELLIGIPPF 988 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~y-s~ksDIWSLGVILYELLTG~pPF 988 (1170)
.....+.+||+.|||||++.+..+ +.++|||||||++|||++|.+||
T Consensus 163 --------------------------------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf 210 (273)
T d1xwsa_ 163 --------------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210 (273)
T ss_dssp --------------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred --------------------------------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCC
Confidence 012235689999999999987765 67799999999999999999999
Q ss_pred CCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 989 NAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 989 ~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
.+. ..+......++ ..+|+++++||.+||+.||.+||| ++|+|+||||+++.
T Consensus 211 ~~~------~~i~~~~~~~~---~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 211 EHD------EEIIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVL 262 (273)
T ss_dssp CSH------HHHHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCC
T ss_pred CCc------hHHhhcccCCC---CCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCCCC
Confidence 763 23555565554 689999999999999999999999 88999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=452.61 Aligned_cols=261 Identities=30% Similarity=0.528 Sum_probs=217.0
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|++++.||+|+||+||+|+++.+|+.||||+++... ......+.+.+|+++|++++|||||+++++|.+.+++|||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 468999999999999999999999999999999997543 2233456788999999999999999999999999999999
Q ss_pred EeeccCCChHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 837 MEYLNGGDLYSLLR-N-LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 837 MEY~~GGSL~dlLk-~-~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|||+.+ ++..++. . ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~----- 153 (298)
T d1gz8a_ 80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG----- 153 (298)
T ss_dssp EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC-----
T ss_pred EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceecc-----
Confidence 999965 4554443 3 3569999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CCcchhhhHHHHHHHHHHhCCCCCCCCCH
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAKTP 993 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLGVILYELLTG~pPF~g~~~ 993 (1170)
.........+||+.|+|||++.... ++.++|||||||++|+|++|++||.+.+.
T Consensus 154 -------------------------~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~ 208 (298)
T d1gz8a_ 154 -------------------------VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208 (298)
T ss_dssp -------------------------CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred -------------------------CCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH
Confidence 0112234568999999999988766 47899999999999999999999999988
Q ss_pred HHHHHHHhccCC-----C-------------CCC--------CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCC
Q 001057 994 QQIFDNIMNRDI-----P-------------WPN--------IPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPF 1047 (1170)
Q Consensus 994 ~ei~qkIl~~~l-----~-------------fP~--------ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPf 1047 (1170)
.+.+..+..... . ++. ....++.++++||.+||+.||.+||| |.|+|+|||
T Consensus 209 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t---~~ell~H~f 285 (298)
T d1gz8a_ 209 IDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS---AKAALAHPF 285 (298)
T ss_dssp HHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGG
T ss_pred HHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhCCHh
Confidence 777766543110 0 000 01256889999999999999999999 889999999
Q ss_pred CCCCC
Q 001057 1048 FKNIN 1052 (1170)
Q Consensus 1048 F~~id 1052 (1170)
|+++.
T Consensus 286 f~~~~ 290 (298)
T d1gz8a_ 286 FQDVT 290 (298)
T ss_dssp GTTCC
T ss_pred hccCC
Confidence 99873
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-53 Score=467.70 Aligned_cols=254 Identities=32% Similarity=0.531 Sum_probs=214.0
Q ss_pred CCCCCeEEEE-EeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHh-cCCCcEEEEEeeeec---
Q 001057 755 TSIEDFEIIK-PISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILIS-VRNPFVVRFFYSFTC--- 829 (1170)
Q Consensus 755 i~iedYevlk-~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILsk-L~HPNIVrL~~~Fqd--- 829 (1170)
..+++|+++. +||+|+||+||+|+++.+|+.||||++++. ..+.+|+.++.+ ++|||||+++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3467899986 599999999999999999999999998753 346679988765 589999999999976
Q ss_pred -ccceEEEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---CCcEEEEecC
Q 001057 830 -RENLYLVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ---DGHIKLTDFG 903 (1170)
Q Consensus 830 -~~~LyLVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~---dG~VKLsDFG 903 (1170)
..++|||||||+||+|.++|.+. ..|++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46799999999999999999875 36999999999999999999999999999999999999985 5679999999
Q ss_pred CccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh
Q 001057 904 LSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI 983 (1170)
Q Consensus 904 LAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT 983 (1170)
+|+... ........+||+.|||||++.+..|+.++|||||||+||+|++
T Consensus 160 ~a~~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~llt 208 (335)
T d2ozaa1 160 FAKETT-------------------------------SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208 (335)
T ss_dssp TCEECC-------------------------------CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTT
T ss_pred eeeecc-------------------------------CCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhh
Confidence 998531 0112235689999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHH----HHHhccCCCCCCC-CccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 984 GIPPFNAKTPQQIF----DNIMNRDIPWPNI-PEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 984 G~pPF~g~~~~ei~----qkIl~~~l~fP~i-p~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
|.+||.+.+..... ..+......+|.. ...+|+++++||.+||++||.+||+ +.|+++||||.+
T Consensus 209 g~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 277 (335)
T d2ozaa1 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 277 (335)
T ss_dssp SSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHhhC
Confidence 99999887654443 3444455555422 1368999999999999999999999 889999999964
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.7e-51 Score=441.86 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=216.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----c
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE----N 832 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~----~ 832 (1170)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998876666677788999999999999999999999998754 3
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|||||||.||+|..++...+.+++..++.++.||+.||+|||++|||||||||+||||+.++.++|+|||+++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~- 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS- 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc-
Confidence 8999999999999999999899999999999999999999999999999999999999999999999999998753100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
........+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 165 --------------------------~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 165 --------------------------GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp ----------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --------------------------cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC
Confidence 011123346789999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhccCCCCC-CCCccCCHHHHHHHHHhccCCCCCCCC
Q 001057 993 PQQIFDNIMNRDIPWP-NIPEEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 993 ~~ei~qkIl~~~l~fP-~ip~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
..+++.++.......+ .....+|+++.+||.+||++||.+||+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~ 262 (277)
T d1o6ya_ 219 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262 (277)
T ss_dssp HHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS
T ss_pred HHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh
Confidence 9888888877665443 234578999999999999999999995
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.7e-52 Score=445.16 Aligned_cols=259 Identities=29% Similarity=0.503 Sum_probs=218.9
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|+++++||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.+|++++|||||+++++|.+.+.+|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 468999999999999999999985 789999999976532 333457889999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||+.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~------- 151 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG------- 151 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC-------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecc-------
Confidence 9999888777777777889999999999999999999999999999999999999999999999999997531
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCCCCHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNAKTPQQ 995 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g~~~~e 995 (1170)
..........||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+
T Consensus 152 -----------------------~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~ 208 (286)
T d1ob3a_ 152 -----------------------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208 (286)
T ss_dssp -----------------------C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------cCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH
Confidence 011123345799999999999865 46899999999999999999999999988887
Q ss_pred HHHHHhccC--------------------------CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 996 IFDNIMNRD--------------------------IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 996 i~qkIl~~~--------------------------l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
++.++.... .+++.....++++++|||.+||+.||.+||| |.|+|+||||+
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s---~~ell~Hp~f~ 285 (286)
T d1ob3a_ 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFK 285 (286)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGG
T ss_pred HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccC
Confidence 777664310 0011123467899999999999999999999 88999999997
Q ss_pred C
Q 001057 1050 N 1050 (1170)
Q Consensus 1050 ~ 1050 (1170)
+
T Consensus 286 ~ 286 (286)
T d1ob3a_ 286 E 286 (286)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-51 Score=448.96 Aligned_cols=258 Identities=31% Similarity=0.483 Sum_probs=214.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc-----
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE----- 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~----- 831 (1170)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 468999999999999999999999999999999997653 34556778999999999999999999999998765
Q ss_pred -ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 -NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 -~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
++||||||| |++|..+++. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~- 172 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD- 172 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence 579999999 6677776654 679999999999999999999999999999999999999999999999999998521
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.
T Consensus 173 --------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 173 --------------------------------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp --------------------------------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred --------------------------------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 112356799999999999874 56899999999999999999999999
Q ss_pred CCCHHHHHHHHhcc----------------------------CCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHH
Q 001057 990 AKTPQQIFDNIMNR----------------------------DIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGARE 1041 (1170)
Q Consensus 990 g~~~~ei~qkIl~~----------------------------~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeE 1041 (1170)
+.+....+..+... ...++.....+++++++||.+||+.||.+||| |.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~e 297 (346)
T d1cm8a_ 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGE 297 (346)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHH
T ss_pred CCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC---HHH
Confidence 98876665544321 11122233567999999999999999999999 889
Q ss_pred HHcCCCCCCCCh
Q 001057 1042 VKQHPFFKNINW 1053 (1170)
Q Consensus 1042 ILqHPfF~~idw 1053 (1170)
+|+||||+++.+
T Consensus 298 iL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 298 ALAHPYFESLHD 309 (346)
T ss_dssp HHHSGGGTTTC-
T ss_pred HhcChhhCcCCC
Confidence 999999998753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=440.81 Aligned_cols=256 Identities=23% Similarity=0.345 Sum_probs=217.4
Q ss_pred EEeccCCCeEEEEeeec--CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEEEeecc
Q 001057 764 KPISQGAFGRVFLARKR--ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVMEYLN 841 (1170)
Q Consensus 764 k~LG~GgFGtVyLArdk--~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLVMEY~~ 841 (1170)
++||+|+||+||+|.+. .+++.||||+++... ......+.+.+|+.+|++++|||||++++++.+ +.+|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 47999999999999864 456799999987543 334556789999999999999999999999865 56799999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCCCCCCC
Q 001057 842 GGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSL 921 (1170)
Q Consensus 842 GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl 921 (1170)
+|+|.+++.....+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~---------- 160 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD---------- 160 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT----------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccc----------
Confidence 9999999999889999999999999999999999999999999999999999999999999999853100
Q ss_pred CCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 001057 922 GSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNI 1000 (1170)
Q Consensus 922 ~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkI 1000 (1170)
...........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..++...|
T Consensus 161 -----------------~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i 223 (277)
T d1xbba_ 161 -----------------ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223 (277)
T ss_dssp -----------------CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred -----------------ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH
Confidence 011112234579999999999999999999999999999999997 99999999999988888
Q ss_pred hccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCC
Q 001057 1001 MNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKN 1050 (1170)
Q Consensus 1001 l~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~ 1050 (1170)
..+.. +..|..++.++.+||.+||+.||.+||++.++.+.|+|+|++-
T Consensus 224 ~~~~~--~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 224 EKGER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp HTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HcCCC--CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 77543 2345789999999999999999999999888888889988753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=430.34 Aligned_cols=261 Identities=30% Similarity=0.481 Sum_probs=223.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+++|+++++||+|+||+||+|+++.+|+.||||+++... ........+.+|+.+|+.++|||||+++++|.+...+++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 368999999999999999999999999999999997654 3445678899999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|+|+.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+...
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~------- 152 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFG------- 152 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC-------
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhccc-------
Confidence 9999999999999988899999999999999999999999999999999999999999999999999998531
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CCcchhhhHHHHHHHHHHhCCCCC-CCCCHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPF-NAKTPQ 994 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLGVILYELLTG~pPF-~g~~~~ 994 (1170)
..........+++.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+..
T Consensus 153 -----------------------~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~ 209 (292)
T d1unla_ 153 -----------------------IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp -----------------------SCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH
T ss_pred -----------------------CCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH
Confidence 0011222346788999999998765 689999999999999999999885 566666
Q ss_pred HHHHHHhccC--------------------------CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCC
Q 001057 995 QIFDNIMNRD--------------------------IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFF 1048 (1170)
Q Consensus 995 ei~qkIl~~~--------------------------l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF 1048 (1170)
+.+..+.... .........+++.+.+||.+||++||.+||| |+|+|+||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s---a~e~L~Hp~f 286 (292)
T d1unla_ 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYF 286 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGG
T ss_pred HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC---HHHHhcChhh
Confidence 6666654210 0111123467899999999999999999999 8899999999
Q ss_pred CCC
Q 001057 1049 KNI 1051 (1170)
Q Consensus 1049 ~~i 1051 (1170)
+++
T Consensus 287 ~~~ 289 (292)
T d1unla_ 287 SDF 289 (292)
T ss_dssp SSC
T ss_pred cCC
Confidence 875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=440.47 Aligned_cols=264 Identities=29% Similarity=0.406 Sum_probs=215.8
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-------
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC------- 829 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd------- 829 (1170)
+++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 6899999999999999999999999999999999876543 23345678899999999999999999998855
Q ss_pred -ccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccc
Q 001057 830 -RENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVG 908 (1170)
Q Consensus 830 -~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~ 908 (1170)
..++|+||||+.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999988776666666678999999999999999999999999999999999999999999999999999753
Q ss_pred ccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCC
Q 001057 909 LIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPP 987 (1170)
Q Consensus 909 ~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pP 987 (1170)
.... ........+.+||+.|+|||++.+. .|+.++|||||||++|||++|++|
T Consensus 168 ~~~~--------------------------~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~p 221 (318)
T d3blha1 168 SLAK--------------------------NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221 (318)
T ss_dssp CC-------------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccc--------------------------ccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCC
Confidence 1000 0111223456899999999999865 689999999999999999999999
Q ss_pred CCCCCHHHHHHHHhccCCCCCC-----C---------------C---------ccCCHHHHHHHHHhccCCCCCCCChhh
Q 001057 988 FNAKTPQQIFDNIMNRDIPWPN-----I---------------P---------EEMSVEACDLIDKLLTENPVQRLGATG 1038 (1170)
Q Consensus 988 F~g~~~~ei~qkIl~~~l~fP~-----i---------------p---------~~lS~eakDLIkkLLq~DPskRpSa~~ 1038 (1170)
|.+.+.......+......++. . + ...+++++|||.+||++||.+|||
T Consensus 222 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s--- 298 (318)
T d3blha1 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID--- 298 (318)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC---
T ss_pred CCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC---
Confidence 9998888777666542111110 0 0 013778899999999999999999
Q ss_pred HHHHHcCCCCCC
Q 001057 1039 AREVKQHPFFKN 1050 (1170)
Q Consensus 1039 AeEILqHPfF~~ 1050 (1170)
|.|+|+||||+.
T Consensus 299 a~elL~Hpff~~ 310 (318)
T d3blha1 299 SDDALNHDFFWS 310 (318)
T ss_dssp HHHHHHSGGGSS
T ss_pred HHHHHcChhhcc
Confidence 889999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=438.50 Aligned_cols=262 Identities=24% Similarity=0.327 Sum_probs=224.5
Q ss_pred CCCCeEEEEE-eccCCCeEEEEeeecC--CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 756 SIEDFEIIKP-ISQGAFGRVFLARKRA--TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 756 ~iedYevlk~-LG~GgFGtVyLArdk~--TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..++|.+... ||+|+||+||+|.++. ++..||||++++.. .....+.+.+|+.+|.+++|||||++++++.+ +.
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~ 82 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 82 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence 3457888884 9999999999998754 45589999987643 34566789999999999999999999999875 56
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+|||||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 89999999999999998654 57999999999999999999999999999999999999999999999999999863100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
. .........+||+.|||||++.+..|+.++|||||||++|||+| |.+||.+
T Consensus 163 ~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 163 D---------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp S---------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred c---------------------------cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC
Confidence 0 01112234579999999999999999999999999999999998 9999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
.+..+++..|..+.. +..|..+++++.+||.+||+.||.+||++.++.+.|+|+|++
T Consensus 216 ~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 216 MKGPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCTHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 988888888887653 244578999999999999999999999988899999998873
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=445.03 Aligned_cols=256 Identities=22% Similarity=0.363 Sum_probs=214.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCC-----EEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGD-----LFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTC 829 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe-----~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd 829 (1170)
..++|++.++||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|.++ +|||||+++++|.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 44789999999999999999999876554 69999886542 234456788999999998 89999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCC
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNL-----------------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKP 886 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~-----------------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKP 886 (1170)
.+.+|||||||+||+|.++|... ..+++..++.|+.||+.||.|||++|||||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 99999999999999999999754 2489999999999999999999999999999999
Q ss_pred CcEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCC
Q 001057 887 DNLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHG 966 (1170)
Q Consensus 887 ENILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys 966 (1170)
+|||++.++++||+|||+|+..... .......+.+||+.|||||++.+..|+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~----------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~ 244 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSD----------------------------SNYVVRGNARLPVKWMAPESLFEGIYT 244 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGC----------------------------TTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred hccccccCCeEEEeeccccccccCC----------------------------CceeeeccccCCCccCChHHHcCCCCC
Confidence 9999999999999999999853100 001122356789999999999999999
Q ss_pred cchhhhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 967 ATADWWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 967 ~ksDIWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.++|||||||+||||++ |.+||.+.+..+.+..++.....+ ..|..+++++++||.+||+.||.+||| +.||++|
T Consensus 245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt---~~ei~~~ 320 (325)
T d1rjba_ 245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPS---FPNLTSF 320 (325)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCCCcCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 99999999999999997 899999887766666666655443 345789999999999999999999999 5566554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-50 Score=438.54 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=215.8
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++.+.||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 455789999999999999999999999999999999876432 2457899999999999999999999999999999
Q ss_pred EEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
||||||++|+|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~-- 167 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-- 167 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS--
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC--
Confidence 999999999999999764 5689999999999999999999999999999999999999999999999999985210
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCC-CCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIP-PFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~p-PF~g~ 991 (1170)
..........||+.|||||++.+..|+.++|||||||++|||++|.. ||.+.
T Consensus 168 ---------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~ 220 (287)
T d1opja_ 168 ---------------------------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220 (287)
T ss_dssp ---------------------------SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ---------------------------CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc
Confidence 00111233468999999999999999999999999999999999654 55666
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
+...+++.+..+. . +..+..+++++.+||.+||+.||.+||++.++.+.|
T Consensus 221 ~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L 270 (287)
T d1opja_ 221 DLSQVYELLEKDY-R-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270 (287)
T ss_dssp CHHHHHHHHHTTC-C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hHHHHHHHHhcCC-C-CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 7777766665442 2 234578999999999999999999999955444433
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.9e-50 Score=439.76 Aligned_cols=256 Identities=27% Similarity=0.453 Sum_probs=211.5
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeec--ccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTC--REN 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd--~~~ 832 (1170)
..++|+++++||+|+||+||+|+++.+|+.||||++++.. .+.+.+|+.+|..+. ||||++++++|.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3468999999999999999999999999999999987542 356789999999995 9999999999974 456
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-cEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-~VKLsDFGLAk~~~~~ 911 (1170)
+|+|||||.+++|..+. +.+++..++.+++||+.||+|||++|||||||||+||||+.++ .+||+|||+|+...
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~-- 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-- 181 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC--
T ss_pred eeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceecc--
Confidence 99999999999997764 4699999999999999999999999999999999999998765 69999999997521
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC-CCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM-GHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~-~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
........+||+.|+|||++.+. .|+.++|||||||++|+|++|..||..
T Consensus 182 -----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 182 -----------------------------PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp -----------------------------TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred -----------------------------CCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 01123456799999999998875 479999999999999999999999976
Q ss_pred CC-HHHHHHHHhc-------------cCC---------------------CCCCCCccCCHHHHHHHHHhccCCCCCCCC
Q 001057 991 KT-PQQIFDNIMN-------------RDI---------------------PWPNIPEEMSVEACDLIDKLLTENPVQRLG 1035 (1170)
Q Consensus 991 ~~-~~ei~qkIl~-------------~~l---------------------~fP~ip~~lS~eakDLIkkLLq~DPskRpS 1035 (1170)
.. .......+.. ... ........++++++|||.+||++||.+|||
T Consensus 233 ~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t 312 (328)
T d3bqca1 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312 (328)
T ss_dssp CSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC
Confidence 54 2222222210 000 000112357899999999999999999999
Q ss_pred hhhHHHHHcCCCCCCCChh
Q 001057 1036 ATGAREVKQHPFFKNINWD 1054 (1170)
Q Consensus 1036 a~~AeEILqHPfF~~idwe 1054 (1170)
|+|+|+||||+++.|+
T Consensus 313 ---a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 313 ---AREAMEHPYFYTVVKD 328 (328)
T ss_dssp ---HHHHHTSGGGTTSCCC
T ss_pred ---HHHHhcCcccCCCCCC
Confidence 8899999999999885
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.4e-50 Score=435.53 Aligned_cols=256 Identities=23% Similarity=0.314 Sum_probs=208.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCC---EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGD---LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe---~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
+..++|++.+.||+|+||+||+|+++.+++ .||||.+.... .....+.+.+|+.+|++++|||||++++++.+.+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 445789999999999999999999987765 68899876543 3455678999999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
.+|||||||+||+|.+++... +.+++..+..++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999999988774 5699999999999999999999999999999999999999999999999999985310
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~ 989 (1170)
... ...........||+.|||||++.+..|+.++|||||||+||||+| |.+||.
T Consensus 181 ~~~-------------------------~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~ 235 (299)
T d1jpaa_ 181 DTS-------------------------DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW 235 (299)
T ss_dssp ----------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCC-------------------------cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCC
Confidence 000 000111223468999999999999999999999999999999998 899999
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
+.+..+++..+..+... ..+..++.++.+||.+||+.||.+||++.++
T Consensus 236 ~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei 283 (299)
T d1jpaa_ 236 DMTNQDVINAIEQDYRL--PPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283 (299)
T ss_dssp TCCHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCHHHHHHHHHcCCCC--CCCccchHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 99999998888765432 2356899999999999999999999995544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=426.93 Aligned_cols=250 Identities=22% Similarity=0.400 Sum_probs=209.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|++++.||+|+||+||+|+++ +++.||||++.+.... .+.+.+|+.+|.+++|||||++++++.+.+.+|||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 468999999999999999999986 5678999999764322 35688999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+|+....
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~----- 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----- 153 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC-----
Confidence 9999999999998765 5689999999999999999999999999999999999999999999999999985310
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ 994 (1170)
..........||+.|||||++.+..|+.++|||||||++|||+| |.+||...+..
T Consensus 154 ------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~ 209 (263)
T d1sm2a_ 154 ------------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 209 (263)
T ss_dssp -----------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH
T ss_pred ------------------------CCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH
Confidence 00112234579999999999999999999999999999999998 68888888888
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
++++.+..+... ..|..+++++.+||.+||+.||.+||+ +.++++|
T Consensus 210 ~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~~p~~Rps---~~~il~~ 255 (263)
T d1sm2a_ 210 EVVEDISTGFRL--YKPRLASTHVYQIMNHCWKERPEDRPA---FSRLLRQ 255 (263)
T ss_dssp HHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHhcCCC--CCccccCHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 888888776433 235678999999999999999999999 6666665
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=443.12 Aligned_cols=254 Identities=30% Similarity=0.463 Sum_probs=210.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec------c
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC------R 830 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd------~ 830 (1170)
.-+|+.+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+.+|++++|||||+++++|.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 34799999999999999999999999999999999765422 2369999999999999999999854 3
Q ss_pred cceEEEEeeccCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC-cEEEEecCCcc
Q 001057 831 ENLYLVMEYLNGGDLYSLL---RNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG-HIKLTDFGLSK 906 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlL---k~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG-~VKLsDFGLAk 906 (1170)
.++|||||||+++.+..+. .....+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 3589999999765433332 3345799999999999999999999999999999999999999876 89999999997
Q ss_pred ccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhc-CCCCcchhhhHHHHHHHHHHhCC
Q 001057 907 VGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLG-MGHGATADWWSVGIILFELLIGI 985 (1170)
Q Consensus 907 ~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g-~~ys~ksDIWSLGVILYELLTG~ 985 (1170)
... ......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.
T Consensus 172 ~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~ 220 (350)
T d1q5ka_ 172 QLV-------------------------------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220 (350)
T ss_dssp ECC-------------------------------TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTS
T ss_pred hcc-------------------------------CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCC
Confidence 531 0112235689999999999876 46899999999999999999999
Q ss_pred CCCCCCCHHHHHHHHhcc-----------------CCCCCC---------CCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 986 PPFNAKTPQQIFDNIMNR-----------------DIPWPN---------IPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 986 pPF~g~~~~ei~qkIl~~-----------------~l~fP~---------ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
+||.+.+..+++..|... ...++. ....+++++.+||.+||++||.+||| |
T Consensus 221 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a 297 (350)
T d1q5ka_ 221 PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---P 297 (350)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC---H
T ss_pred CCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC---H
Confidence 999998887777666431 111111 12357899999999999999999999 8
Q ss_pred HHHHcCCCCCCC
Q 001057 1040 REVKQHPFFKNI 1051 (1170)
Q Consensus 1040 eEILqHPfF~~i 1051 (1170)
.|+|+||||+++
T Consensus 298 ~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 298 LEACAHSFFDEL 309 (350)
T ss_dssp HHHHTSGGGGGG
T ss_pred HHHhcCHhhccc
Confidence 899999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=433.26 Aligned_cols=254 Identities=21% Similarity=0.319 Sum_probs=207.8
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEE
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyL 835 (1170)
..++|++.+.||+|+||+||+|+.+ ..||||+++.... .....+.+.+|+.+|.+++|||||++++++. .+.+||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~l 80 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAI 80 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEE
Confidence 4568999999999999999999754 3599999876543 3456788999999999999999999998764 567899
Q ss_pred EEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCC
Q 001057 836 VMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTD 914 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~ 914 (1170)
|||||+||+|.+++... ..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+.....
T Consensus 81 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~--- 157 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW--- 157 (276)
T ss_dssp EEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred EEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc---
Confidence 99999999999999765 56999999999999999999999999999999999999999999999999999753100
Q ss_pred CCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC---CCCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 915 DLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM---GHGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 915 d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~---~ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.......+.+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.
T Consensus 158 -------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 158 -------------------------SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp ---------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -------------------------CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCC
Confidence 011123456899999999999753 4889999999999999999999999987
Q ss_pred CHHHHHHHHhccCCCC---CCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 992 TPQQIFDNIMNRDIPW---PNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~f---P~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+....+..+....... +..+..+++++.+||.+||+.||.+||+ +.+|++|
T Consensus 213 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~~il~~ 266 (276)
T d1uwha_ 213 NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL---FPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred ChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 7655544444333322 2345678999999999999999999999 5566654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=429.97 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=215.3
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++++.||+|+||+||+|+++ ++..||||++..... ..+.+.+|+.+|.+++|||||++++++.+ +.+|
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 34478999999999999999999975 578899999976432 23568999999999999999999997754 6789
Q ss_pred EEEeeccCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRNL--GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~~--~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
||||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~-- 161 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-- 161 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccC--
Confidence 999999999999987543 3699999999999999999999999999999999999999999999999999985310
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
..........||+.|||||++.+..|+.++|||||||++|||+| |.+||...
T Consensus 162 ---------------------------~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 162 ---------------------------NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp ---------------------------SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ---------------------------CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 01112234679999999999999899999999999999999999 56777788
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
+..++++.+..+... ..|..+++++.+||.+||+.||.+|||+.++.+.| |+||.
T Consensus 215 ~~~~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L-~~~ft 269 (272)
T d1qpca_ 215 TNPEVIQNLERGYRM--VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL-EDFFT 269 (272)
T ss_dssp CHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH-HHHHH
T ss_pred CHHHHHHHHHhcCCC--CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHh-hhhhh
Confidence 888888888765432 34578999999999999999999999944443333 55664
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=439.10 Aligned_cols=261 Identities=30% Similarity=0.479 Sum_probs=212.7
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc----ce
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE----NL 833 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~----~L 833 (1170)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+++|+.+|+.++|||||++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 47999999999999999999999999999999997643 3455678899999999999999999999987653 23
Q ss_pred EEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccC
Q 001057 834 YLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHST 913 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~ 913 (1170)
+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+......
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~- 163 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH- 163 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG-
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC-
Confidence 444556679999999976 469999999999999999999999999999999999999999999999999998531000
Q ss_pred CCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHh-cCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 914 DDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILL-GMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 914 ~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~-g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
.........+||+.|+|||++. +..|+.++||||+||++|+|++|.+||.+.+
T Consensus 164 --------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 164 --------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp --------------------------CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred --------------------------ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 0111234568999999999985 4567999999999999999999999999888
Q ss_pred HHHHHHHHhccC----------------------------CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 993 PQQIFDNIMNRD----------------------------IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 993 ~~ei~qkIl~~~----------------------------l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
...+...+.... .++......+++++++||.+||++||.+||+ |.|+|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---a~e~L~ 294 (345)
T d1pmea_ 218 YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALA 294 (345)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHT
T ss_pred HHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC---HHHHhc
Confidence 766555443210 0111112367889999999999999999999 889999
Q ss_pred CCCCCCC
Q 001057 1045 HPFFKNI 1051 (1170)
Q Consensus 1045 HPfF~~i 1051 (1170)
||||+..
T Consensus 295 hpf~~~~ 301 (345)
T d1pmea_ 295 HPYLEQY 301 (345)
T ss_dssp SGGGTTT
T ss_pred CHhhccC
Confidence 9999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=437.26 Aligned_cols=256 Identities=29% Similarity=0.421 Sum_probs=215.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecc-----cc
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCR-----EN 832 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~-----~~ 832 (1170)
++|+++++||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+.+|+.++|||||+++++|... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 68999999999999999999999999999999998653 3444567789999999999999999999998643 23
Q ss_pred eEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
.++||+|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~---- 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT---- 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC----
T ss_pred eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc----
Confidence 4666777889999999865 57999999999999999999999999999999999999999999999999998742
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC-CCcchhhhHHHHHHHHHHhCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG-HGATADWWSVGIILFELLIGIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~-ys~ksDIWSLGVILYELLTG~pPF~g~ 991 (1170)
.....+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.
T Consensus 172 -----------------------------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 172 -----------------------------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp -----------------------------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----------------------------CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 11224567999999999987764 688999999999999999999999999
Q ss_pred CHHHHHHHHhccCCCC-----------------------CC-----CCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 992 TPQQIFDNIMNRDIPW-----------------------PN-----IPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~f-----------------------P~-----ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
+.......|....... +. ....+++++++||.+||+.||.+||| |.|+|
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~elL 299 (348)
T d2gfsa1 223 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQAL 299 (348)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred CHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC---HHHHh
Confidence 8887777765422111 10 11357899999999999999999999 88999
Q ss_pred cCCCCCCC
Q 001057 1044 QHPFFKNI 1051 (1170)
Q Consensus 1044 qHPfF~~i 1051 (1170)
+||||++.
T Consensus 300 ~Hp~f~~~ 307 (348)
T d2gfsa1 300 AHAYFAQY 307 (348)
T ss_dssp TSGGGTTT
T ss_pred cCHhhCCC
Confidence 99999875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=437.58 Aligned_cols=262 Identities=26% Similarity=0.424 Sum_probs=210.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec------c
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC------R 830 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd------~ 830 (1170)
.++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||+++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4689999999999999999999999999999999987543 45566788999999999999999999999964 3
Q ss_pred cceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 831 ENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 831 ~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
.++|+|||||.+ +|...+. ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~- 170 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 170 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc-
Confidence 678999999965 4555553 469999999999999999999999999999999999999999999999999987521
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNA 990 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g 990 (1170)
........+||+.|+|||++.+..++.++||||+||++|+|++|++||.+
T Consensus 171 ------------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~ 220 (355)
T d2b1pa1 171 ------------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_dssp ----------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ------------------------------cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCC
Confidence 11223456799999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHhccC----------------------CCCCCC-----------------CccCCHHHHHHHHHhccCCCC
Q 001057 991 KTPQQIFDNIMNRD----------------------IPWPNI-----------------PEEMSVEACDLIDKLLTENPV 1031 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~----------------------l~fP~i-----------------p~~lS~eakDLIkkLLq~DPs 1031 (1170)
.+...+..++.... ...... ....++++.+||.+||+.||+
T Consensus 221 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~ 300 (355)
T d2b1pa1 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred CCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence 88777666554211 111000 012477899999999999999
Q ss_pred CCCChhhHHHHHcCCCCCCCChhhh
Q 001057 1032 QRLGATGAREVKQHPFFKNINWDTL 1056 (1170)
Q Consensus 1032 kRpSa~~AeEILqHPfF~~idwe~L 1056 (1170)
+||| |+|+|+||||+..-+...
T Consensus 301 ~R~t---a~elL~Hpw~~~~~~~~~ 322 (355)
T d2b1pa1 301 KRIS---VDDALQHPYINVWYDPAE 322 (355)
T ss_dssp TSCC---HHHHHTSTTTGGGCCHHH
T ss_pred HCcC---HHHHhcCcccCCCCCccc
Confidence 9999 889999999997544333
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=421.12 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=219.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceEEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~LyLV 836 (1170)
.++|+++++||+|+||+||+|+++ +++.||||++++.... .+.+++|+.++.+++|||||+++++|.+.+.+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 468999999999999999999985 7889999999875432 35688999999999999999999999999999999
Q ss_pred EeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCC
Q 001057 837 MEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDD 915 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d 915 (1170)
|||+.+|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~----- 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----- 152 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS-----
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC-----
Confidence 9999999999997654 5799999999999999999999999999999999999999999999999999975310
Q ss_pred CCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCCCHH
Q 001057 916 LSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAKTPQ 994 (1170)
Q Consensus 916 ~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~~~~ 994 (1170)
..........||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 153 ------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 153 ------------------------DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp ------------------------SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred ------------------------CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 00011223579999999999999999999999999999999998 89999999999
Q ss_pred HHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 995 QIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 995 ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
++...|..+... ..|..+++++.+||.+||+.||.+||+ +.++++|
T Consensus 209 ~~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~ 254 (258)
T d1k2pa_ 209 ETAEHIAQGLRL--YRPHLASEKVYTIMYSCWHEKADERPT---FKILLSN 254 (258)
T ss_dssp HHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHhCCCC--CCcccccHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 999988875432 345789999999999999999999999 6777776
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=421.29 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=208.1
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCC---CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccce
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATG---DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENL 833 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TG---e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~L 833 (1170)
.++|++.+.||+|+||+||+|++..++ ..||||.++.. ......+.+.+|+.+|++++|||||+++++|. .+.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 468999999999999999999986543 56889887643 24455678999999999999999999999986 4679
Q ss_pred EEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
||||||+++|+|..++... +.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~-- 160 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-- 160 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC--
Confidence 9999999999999987654 5699999999999999999999999999999999999999999999999999985310
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 161 ---------------------------~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 161 ---------------------------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp -------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ---------------------------CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence 00112234568999999999999999999999999999999998 89999999
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+..+++..+.++... ..+..+|+++.+||.+||+.||.+||+ +.||++|
T Consensus 214 ~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ei~~~ 262 (273)
T d1mp8a_ 214 KNNDVIGRIENGERL--PMPPNCPPTLYSLMTKCWAYDPSRRPR---FTELKAQ 262 (273)
T ss_dssp CGGGHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 999999998876532 345789999999999999999999999 5566655
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=417.58 Aligned_cols=253 Identities=21% Similarity=0.299 Sum_probs=208.1
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecCCC----CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRATG----DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~TG----e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
..+.|+..++||+|+||+||+|..+.++ ..||||++.... .......+++|+.+|.+++|||||++++++.+.+
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 3467999999999999999999987655 479999986543 3445567899999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccc
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLI 910 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~ 910 (1170)
.+|+|||||.+|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999999988755 5799999999999999999999999999999999999999999999999999985310
Q ss_pred ccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCC
Q 001057 911 HSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFN 989 (1170)
Q Consensus 911 ~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~ 989 (1170)
.. ..........||+.|||||++.+..|+.++|||||||++|||++ |.+||.
T Consensus 163 ~~---------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 163 DP---------------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp --------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CC---------------------------ccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 00 00112234568999999999999999999999999999999998 566677
Q ss_pred CCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhH
Q 001057 990 AKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGA 1039 (1170)
Q Consensus 990 g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~A 1039 (1170)
+.+..++++.+..+.. +..+..++.++.+||.+||+.||.+||++.++
T Consensus 216 ~~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ei 263 (283)
T d1mqba_ 216 ELSNHEVMKAINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRPKFADI 263 (283)
T ss_dssp TCCHHHHHHHHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred cCCHHHHHHHHhccCC--CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHH
Confidence 7788888887776543 23457899999999999999999999995544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=419.85 Aligned_cols=259 Identities=23% Similarity=0.347 Sum_probs=210.4
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecC-CC--CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRA-TG--DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~-TG--e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
..++|++++.||+|+||+||+|+... ++ ..||||++.+.........+.+.+|+.+|++++|||||++|++|.+ +.
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PP 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cc
Confidence 45789999999999999999998653 33 3789999987666566677889999999999999999999999975 57
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
+|+|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 89999999999999887654 56999999999999999999999999999999999999999999999999999853100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
. ..........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+
T Consensus 165 ~---------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 165 D---------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp C---------------------------CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred C---------------------------CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0 11112334568889999999999999999999999999999998 8999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
.+..+++..+......++ .+..++.++.+||.+||..||.+||++.++.++|
T Consensus 218 ~~~~~~~~~i~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 218 LNGSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp CCHHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHhCCCCCC-CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999999999987765443 4578999999999999999999999966665554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=419.29 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=212.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccceE
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLY 834 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~Ly 834 (1170)
+..++|++.+.||+|+||+||+|+++.+ ..||||++..... ..+.+.+|+.+|.+++|||||++++++.+ +.+|
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~ 87 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 87 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence 4457899999999999999999998755 5699999976542 23578999999999999999999999865 5689
Q ss_pred EEEeeccCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCcccccccc
Q 001057 835 LVMEYLNGGDLYSLLRN--LGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 835 LVMEY~~GGSL~dlLk~--~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~ 912 (1170)
+|||||.+|+|..++.. .+.+++.++..++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+....
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~-- 165 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-- 165 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccC--
Confidence 99999999999988864 35799999999999999999999999999999999999999999999999999975210
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNAK 991 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g~ 991 (1170)
..........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.
T Consensus 166 ---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 166 ---------------------------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp -------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ---------------------------CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence 00112234579999999999999999999999999999999999 56667778
Q ss_pred CHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc--CCCCCCC
Q 001057 992 TPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ--HPFFKNI 1051 (1170)
Q Consensus 992 ~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq--HPfF~~i 1051 (1170)
...+++..+..+.. +..+..++.++++||.+||+.||++||+ +.+|++ |+||...
T Consensus 219 ~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps---~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 219 VNREVLDQVERGYR--MPCPPECPESLHDLMCQCWRKEPEERPT---FEYLQAFLEDYFTST 275 (285)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHhcCC--CCCCcccCHHHHHHHHHHcccCHhHCcC---HHHHHHHHhhhhcCC
Confidence 88888888776532 2345789999999999999999999999 555555 6788754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-48 Score=423.47 Aligned_cols=253 Identities=24% Similarity=0.360 Sum_probs=209.5
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCC----EEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeecccc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGD----LFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCREN 832 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe----~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~~ 832 (1170)
.++|+++++||+|+||+||+|++..+|+ .||+|.+.... .....+.+.+|+.+|++++|||||++++++.+. .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3579999999999999999999988887 57777765432 233457899999999999999999999999864 5
Q ss_pred eEEEEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 833 LYLVMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 833 LyLVMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
.+++|||+.+|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.....
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 77889999999999988764 57999999999999999999999999999999999999999999999999999863100
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
..........||+.|||||++.+..|+.++|||||||++|||+| |.+||.+
T Consensus 165 ----------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 165 ----------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp ----------------------------CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ----------------------------cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 00111234568999999999999999999999999999999998 8999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
.+..++...+..+... ..+..+++++.+||.+||+.||.+||+ +.++++|
T Consensus 217 ~~~~~~~~~i~~~~~~--~~p~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 266 (317)
T d1xkka_ 217 IPASEISSILEKGERL--PQPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 266 (317)
T ss_dssp SCGGGHHHHHHHTCCC--CCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CCHHHHHHHHHcCCCC--CCCcccCHHHHHHHHHhCCCChhhCcC---HHHHHHH
Confidence 9888888877765532 345789999999999999999999999 6677777
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=418.74 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=201.9
Q ss_pred CCCCeEEEEEeccCCCeEEEEeeecC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeec
Q 001057 756 SIEDFEIIKPISQGAFGRVFLARKRA-----TGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTC 829 (1170)
Q Consensus 756 ~iedYevlk~LG~GgFGtVyLArdk~-----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd 829 (1170)
..++|+++++||+|+||+||+|++.. +++.||||+++... .....+.+.+|..++.++ +|+|||.+++++..
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 34689999999999999999999754 45789999987543 334456777888888776 68999999988765
Q ss_pred c-cceEEEEeeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeC
Q 001057 830 R-ENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIG 892 (1170)
Q Consensus 830 ~-~~LyLVMEY~~GGSL~dlLk~~----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd 892 (1170)
. ..+|+|||||++|+|.+++... ..+++..+..|+.||+.||+|||++|||||||||+||||+
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 168 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC
Confidence 4 5699999999999999999653 2489999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhh
Q 001057 893 QDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWW 972 (1170)
Q Consensus 893 ~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIW 972 (1170)
.++++||+|||+|+..... .........+||+.|||||++.+..|+.++|||
T Consensus 169 ~~~~~Kl~DFGla~~~~~~----------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 220 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKD----------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220 (299)
T ss_dssp GGGCEEECC------CCSC----------------------------TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred CCCcEEEccCcchhhcccc----------------------------ccccccCceeeCccccchhHhhcCCCCccccee
Confidence 9999999999999853100 001123356799999999999999999999999
Q ss_pred HHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 973 SVGIILFELLIG-IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 973 SLGVILYELLTG-~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
||||++|||++| .+||.+.+..+.+..+...... +..+..+++++.+||.+||+.||.+||+ +.|+++|
T Consensus 221 S~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~eil~~ 290 (299)
T d1ywna1 221 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 290 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 999999999986 6788877655555444433322 2456789999999999999999999999 6666665
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-48 Score=418.27 Aligned_cols=256 Identities=23% Similarity=0.406 Sum_probs=220.2
Q ss_pred CCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeeccc
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd~~ 831 (1170)
.++|++++.||+|+||+||+|+.+ .+++.||||++.... .....+.+.+|+.+|+.++||||+++++++....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 468999999999999999999875 356899999987543 3455678999999999999999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCC
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLG------------------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPD 887 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~------------------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPE 887 (1170)
.+++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++|||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999996432 3889999999999999999999999999999999
Q ss_pred cEEeCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCc
Q 001057 888 NLLIGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGA 967 (1170)
Q Consensus 888 NILLd~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ 967 (1170)
||||+.++.+||+|||+|+..... .......+.+||+.|||||++.+..|+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSA----------------------------DYYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGG----------------------------GCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred ceEECCCCcEEEccchhheeccCC----------------------------ccccccCCCCcCcCcCCHHHHccCCCCh
Confidence 999999999999999999853100 0111233567999999999999999999
Q ss_pred chhhhHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 968 TADWWSVGIILFELLIG-IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 968 ksDIWSLGVILYELLTG-~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
++|||||||++|||++| .+||.+.+..++...+..+.. +..+..+++++.+||.+||+.||.+||++.++.+.|+
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~--~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 99999999999999998 578999999999999887764 3556789999999999999999999999666655443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=419.70 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=214.9
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCE--EEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeeeccc
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDL--FAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFTCRE 831 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~--VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fqd~~ 831 (1170)
+..++|++.++||+|+||+||+|+++.+|.. ||||.+... ......+.+.+|+.+|.++ +|||||+++++|.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4568999999999999999999999988875 666766543 2334556799999999998 7999999999999999
Q ss_pred ceEEEEeeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCC
Q 001057 832 NLYLVMEYLNGGDLYSLLRNL----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDG 895 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG 895 (1170)
.+||||||++||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999754 4699999999999999999999999999999999999999999
Q ss_pred cEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHH
Q 001057 896 HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVG 975 (1170)
Q Consensus 896 ~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLG 975 (1170)
.+||+|||+|+... .........||+.|+|||.+.+..|+.++||||||
T Consensus 165 ~~kl~DfG~a~~~~-------------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfG 213 (309)
T d1fvra_ 165 VAKIADFGLSRGQE-------------------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 213 (309)
T ss_dssp CEEECCTTCEESSC-------------------------------EECCC----CCTTTCCHHHHHHCEECHHHHHHHHH
T ss_pred ceEEcccccccccc-------------------------------ccccccceecCCcccchHHhccCCCCccceeehhH
Confidence 99999999997521 01112345699999999999999999999999999
Q ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 976 IILFELLIG-IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 976 VILYELLTG-~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
|++|||++| .+||.+.+..+++..+..+.. +..+..+++++++||.+||+.||++||+ +.++++|
T Consensus 214 vil~ell~~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 279 (309)
T d1fvra_ 214 VLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILVS 279 (309)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC--CCCCccCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 999999996 568999999999999887543 2345789999999999999999999999 6677766
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=411.47 Aligned_cols=244 Identities=25% Similarity=0.460 Sum_probs=206.4
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-ccce
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC-RENL 833 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd-~~~L 833 (1170)
+..++|++++.||+|+||.||+|+.+ |..||||++++.. ..+.+.+|+.+|++++|||||++++++.+ .+.+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 45678999999999999999999974 7789999997643 34678899999999999999999998854 5679
Q ss_pred EEEEeeccCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccc
Q 001057 834 YLVMEYLNGGDLYSLLRNLG--CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIH 911 (1170)
Q Consensus 834 yLVMEY~~GGSL~dlLk~~~--~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~ 911 (1170)
||||||+++|+|.++|...+ .+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++...
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~-- 154 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-- 154 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC--
Confidence 99999999999999997543 59999999999999999999999999999999999999999999999999997421
Q ss_pred cCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHh-CCCCCCC
Q 001057 912 STDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLI-GIPPFNA 990 (1170)
Q Consensus 912 ~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLT-G~pPF~g 990 (1170)
.......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+
T Consensus 155 -------------------------------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 155 -------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp --------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred -------------------------------CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 11223468899999999999999999999999999999998 8999999
Q ss_pred CCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHH
Q 001057 991 KTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAR 1040 (1170)
Q Consensus 991 ~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~Ae 1040 (1170)
.+..+++..|.++.. +.++..+++++.+||.+||..||.+||++.++.
T Consensus 204 ~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~ 251 (262)
T d1byga_ 204 IPLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251 (262)
T ss_dssp SCGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCHHHHHHHHHcCCC--CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 999999999876543 245678999999999999999999999954443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=411.78 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=214.2
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecCCC-------CEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRATG-------DLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYS 826 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~TG-------e~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~ 826 (1170)
+..++|++++.||+|+||.||+|++..++ ..||||++.+.. .......+.+|..++.++ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 45578999999999999999999976554 479999987643 344567788899999888 79999999999
Q ss_pred eecccceEEEEeeccCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEE
Q 001057 827 FTCRENLYLVMEYLNGGDLYSLLRNL----------------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLL 890 (1170)
Q Consensus 827 Fqd~~~LyLVMEY~~GGSL~dlLk~~----------------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENIL 890 (1170)
|.+++.+|+|||||.+|+|.++|... ..+++..+..++.||+.||+|||++|||||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 99999999999999999999999754 24899999999999999999999999999999999999
Q ss_pred eCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchh
Q 001057 891 IGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATAD 970 (1170)
Q Consensus 891 Ld~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksD 970 (1170)
++.++.+||+|||+++..... .........+||+.|+|||++.+..|+.++|
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~----------------------------~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D 219 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHI----------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGC----------------------------CTTCCCTTSCCGGGGSCHHHHHHCCCCHHHH
T ss_pred ecCCCCeEeccchhhcccccc----------------------------ccccccccCCCChhhhhhhHhcCCCCCchhh
Confidence 999999999999999853100 0111234567899999999999999999999
Q ss_pred hhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 971 WWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 971 IWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
||||||++|||++ |.+||.+.+..++++.+..+.. +..+..+++++.+||.+||+.||.+||++.++.+.|
T Consensus 220 iwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 220 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCC--CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 9999999999998 7999999999998888876532 245678999999999999999999999955444433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=410.26 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=224.5
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeecC-----CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKRA-----TGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC 829 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk~-----TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd 829 (1170)
+..++|++.+.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.++++++|||||++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 345789999999999999999998753 45789999987643 34556788999999999999999999999999
Q ss_pred ccceEEEEeeccCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEE
Q 001057 830 RENLYLVMEYLNGGDLYSLLRNL----------GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKL 899 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL~dlLk~~----------~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKL 899 (1170)
.+.+|+|||||.+|+|.+++... ..++...+..++.|++.||.|||+++|+||||||+||||+.++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 99999999999999999998643 24688999999999999999999999999999999999999999999
Q ss_pred EecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHH
Q 001057 900 TDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILF 979 (1170)
Q Consensus 900 sDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILY 979 (1170)
+|||+|+..... .........+||+.|+|||++.+..++.++|||||||++|
T Consensus 175 ~DFGla~~~~~~----------------------------~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 175 GDFGMTRDIYET----------------------------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp CCTTCCCGGGGG----------------------------GCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred eecccceeccCC----------------------------cceeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence 999999853100 0111233457899999999999999999999999999999
Q ss_pred HHHhC-CCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc---CCCCCCC
Q 001057 980 ELLIG-IPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ---HPFFKNI 1051 (1170)
Q Consensus 980 ELLTG-~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq---HPfF~~i 1051 (1170)
||++| .+||.+.+..+++..+.++.. +..+..+++.+.+||.+||+.||.+||++.++.+.|+ +|+|+++
T Consensus 227 El~t~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~ 300 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300 (308)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhCCC--CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCC
Confidence 99998 689999999999999887654 3456789999999999999999999999554444333 6666543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=408.75 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=217.6
Q ss_pred CCCCCeEEEEEeccCCCeEEEEeeec-----CCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhc-CCCcEEEEEeeee
Q 001057 755 TSIEDFEIIKPISQGAFGRVFLARKR-----ATGDLFAIKVLKKADMIRKNAVESILAERNILISV-RNPFVVRFFYSFT 828 (1170)
Q Consensus 755 i~iedYevlk~LG~GgFGtVyLArdk-----~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL-~HPNIVrL~~~Fq 828 (1170)
+..++|++.+.||+|+||.||+|+.. .+++.||||++++.. .......+.+|+.++..+ +|||||++++++.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 44578999999999999999999853 567899999997653 344566889999999999 6999999999999
Q ss_pred cccceEEEEeeccCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEE
Q 001057 829 CRENLYLVMEYLNGGDLYSLLRNLG------------------CLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLL 890 (1170)
Q Consensus 829 d~~~LyLVMEY~~GGSL~dlLk~~~------------------~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENIL 890 (1170)
+.+.+|||||||++|+|.+++.... .+++..+..|+.||+.||+|||++|||||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999997543 5899999999999999999999999999999999999
Q ss_pred eCCCCcEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchh
Q 001057 891 IGQDGHIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATAD 970 (1170)
Q Consensus 891 Ld~dG~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksD 970 (1170)
++.++.+||+|||+++..... .........+||+.|+|||++.+..++.++|
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 229 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKND----------------------------SNYVVKGNARLPVKWMAPESIFNCVYTFESD 229 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSC----------------------------TTSEECSSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred ccccCcccccccchheeccCC----------------------------CcceEeeecccChHHcCHHHhcCCCCCCccc
Confidence 999999999999999853100 0111223468999999999999999999999
Q ss_pred hhHHHHHHHHHHh-CCCCCCCCCHHHHHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHH
Q 001057 971 WWSVGIILFELLI-GIPPFNAKTPQQIFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVK 1043 (1170)
Q Consensus 971 IWSLGVILYELLT-G~pPF~g~~~~ei~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEIL 1043 (1170)
||||||++|||++ |.+||.+.+..+.+..++...... ..+..++.++.+||.+||+.||.+||++.++.++|
T Consensus 230 IwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRM-LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9999999999998 777788877767666666555432 34567899999999999999999999955554433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-46 Score=405.74 Aligned_cols=263 Identities=21% Similarity=0.304 Sum_probs=207.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCc-EEEEEeeeecccceEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPF-VVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPN-IVrL~~~Fqd~~~LyLV 836 (1170)
++|++++.||+|+||+||+|++..+|+.||||++...... ..+..|+++++.++|+| |+.+++++.+.+..|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 4799999999999999999999999999999998764321 34678999999998765 55666777888889999
Q ss_pred EeeccCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC---CCcEEEEecCCcccccccc
Q 001057 837 MEYLNGGDLYSLLR-NLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ---DGHIKLTDFGLSKVGLIHS 912 (1170)
Q Consensus 837 MEY~~GGSL~dlLk-~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~---dG~VKLsDFGLAk~~~~~~ 912 (1170)
|||+ +++|...+. ..+.+++..+..++.|++.||+|||++|||||||||+|||++. +..+||+|||+|+......
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9999 556666654 4567999999999999999999999999999999999999864 4579999999998632100
Q ss_pred CCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCCCCC
Q 001057 913 TDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFNAKT 992 (1170)
Q Consensus 913 ~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~g~~ 992 (1170)
. ..........+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+..
T Consensus 161 ~-----------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 161 T-----------------------HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp T-----------------------CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred c-----------------------ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccc
Confidence 0 00011123346789999999999999999999999999999999999999998766
Q ss_pred HHHHHHHHh---ccC--CCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCC
Q 001057 993 PQQIFDNIM---NRD--IPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFK 1049 (1170)
Q Consensus 993 ~~ei~qkIl---~~~--l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~ 1049 (1170)
.......+. ... .+.+.....+|+++.+||.+||+.||.+||++..+.++|+|+|.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 544333221 111 111222357899999999999999999999988888999987653
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-44 Score=391.78 Aligned_cols=259 Identities=19% Similarity=0.246 Sum_probs=210.3
Q ss_pred CCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC-CcEEEEEeeeecccceEE
Q 001057 757 IEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN-PFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 757 iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H-PNIVrL~~~Fqd~~~LyL 835 (1170)
-++|++++.||+|+||+||+|++..+|+.||||++.+... ...+.+|++++..+.| +||+.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4689999999999999999999999999999999865432 2346788899999976 899999999999999999
Q ss_pred EEeeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCC-----CCcEEEEecCCccccc
Q 001057 836 VMEYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQ-----DGHIKLTDFGLSKVGL 909 (1170)
Q Consensus 836 VMEY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~-----dG~VKLsDFGLAk~~~ 909 (1170)
||||+ |++|.+++... ..++...+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999998765 46999999999999999999999999999999999999974 5789999999998642
Q ss_pred cccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC
Q 001057 910 IHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN 989 (1170)
Q Consensus 910 ~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~ 989 (1170)
..... .........+.+||+.|||||++.+..++.++|||||||++|||++|..||.
T Consensus 158 ~~~~~-----------------------~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 158 DPVTK-----------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp CTTTC-----------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cCccc-----------------------cceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 11000 0011123446789999999999999999999999999999999999999998
Q ss_pred CCC---HHHHHHHHhccCC--CCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHc
Q 001057 990 AKT---PQQIFDNIMNRDI--PWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQ 1044 (1170)
Q Consensus 990 g~~---~~ei~qkIl~~~l--~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILq 1044 (1170)
+.. ....+..+..... +.+.+...+|+++.+|+..|+..+|.+||+...+.+++.
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp SCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred CccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 643 3344444433221 112233568899999999999999999999665655543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-44 Score=393.98 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=203.3
Q ss_pred EEEEeccCCCeEEEEeeecCCC---CEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcEEEEEeeeec-ccceEEEE
Q 001057 762 IIKPISQGAFGRVFLARKRATG---DLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTC-RENLYLVM 837 (1170)
Q Consensus 762 vlk~LG~GgFGtVyLArdk~TG---e~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNIVrL~~~Fqd-~~~LyLVM 837 (1170)
.-++||+|+||+||+|++..++ ..||||++++. ......+.+.+|+++|.+++|||||++++++.. +..+|+||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3578999999999999986543 36999998753 345667889999999999999999999998765 56799999
Q ss_pred eeccCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCCccccccccCCCC
Q 001057 838 EYLNGGDLYSLLRNL-GCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGLSKVGLIHSTDDL 916 (1170)
Q Consensus 838 EY~~GGSL~dlLk~~-~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGLAk~~~~~~~~d~ 916 (1170)
|||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||||+.++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~--- 185 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--- 185 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC---
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccc---
Confidence 999999999998865 4577888999999999999999999999999999999999999999999999985310000
Q ss_pred CCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCCCCcchhhhHHHHHHHHHHhCCCCCC-CCCHHH
Q 001057 917 SAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMGHGATADWWSVGIILFELLIGIPPFN-AKTPQQ 995 (1170)
Q Consensus 917 ~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~ys~ksDIWSLGVILYELLTG~pPF~-g~~~~e 995 (1170)
..........||+.|+|||++.+..++.++|||||||++|||++|..||. ..+..+
T Consensus 186 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~ 242 (311)
T d1r0pa_ 186 -----------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242 (311)
T ss_dssp -----------------------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------
T ss_pred -----------------------ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH
Confidence 00111234578999999999999999999999999999999999766665 445556
Q ss_pred HHHHHhccCCCCCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcC
Q 001057 996 IFDNIMNRDIPWPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQH 1045 (1170)
Q Consensus 996 i~qkIl~~~l~fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqH 1045 (1170)
+...+..+.. +..|..+++++.+||.+||+.||.+||+ +.||++|
T Consensus 243 ~~~~i~~g~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs---~~ei~~~ 287 (311)
T d1r0pa_ 243 ITVYLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPS---FSELVSR 287 (311)
T ss_dssp CHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHcCCC--CCCcccCcHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 6667766543 3456789999999999999999999999 6666665
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-43 Score=387.42 Aligned_cols=265 Identities=23% Similarity=0.398 Sum_probs=201.6
Q ss_pred CCCCCCCC-CCCCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC----------
Q 001057 748 NPCSKDRT-SIEDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR---------- 816 (1170)
Q Consensus 748 ~p~~~~~i-~iedYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~---------- 816 (1170)
+|...+.. ..++|+++++||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++
T Consensus 2 ~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~ 77 (362)
T d1q8ya_ 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSM 77 (362)
T ss_dssp CCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHH
T ss_pred CCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhc
Confidence 44444443 3457999999999999999999999999999999998653 33456778888888775
Q ss_pred -CCcEEEEEeeeecc--cceEEEEeeccCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCCCcE
Q 001057 817 -NPFVVRFFYSFTCR--ENLYLVMEYLNGGDLYSLL---RNLGCLDEDMARVYIAELVLALEYLHS-LNVIHRDLKPDNL 889 (1170)
Q Consensus 817 -HPNIVrL~~~Fqd~--~~LyLVMEY~~GGSL~dlL---k~~~~LSEe~ar~IaaQIL~ALeYLHs-~GIIHRDIKPENI 889 (1170)
|+|||++++++... ...+++|+++..+...... .....+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NI 157 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 157 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGE
T ss_pred CcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHe
Confidence 57899998887653 4566777776555433332 233579999999999999999999998 8999999999999
Q ss_pred EeCCCC------cEEEEecCCccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcC
Q 001057 890 LIGQDG------HIKLTDFGLSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGM 963 (1170)
Q Consensus 890 LLd~dG------~VKLsDFGLAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~ 963 (1170)
||+.++ .++|+|||.|.... ......+||+.|+|||++.+.
T Consensus 158 ll~~~~~~~~~~~~kl~dfg~s~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 158 LMEIVDSPENLIQIKIADLGNACWYD---------------------------------EHYTNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETT---------------------------------BCCCSCCSCGGGCCHHHHHTC
T ss_pred eeeccCcccccceeeEeecccccccc---------------------------------cccccccccccccChhhcccc
Confidence 998765 39999999987421 122356799999999999999
Q ss_pred CCCcchhhhHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc--c------------------------CCC-----
Q 001057 964 GHGATADWWSVGIILFELLIGIPPFNAKTPQ------QIFDNIMN--R------------------------DIP----- 1006 (1170)
Q Consensus 964 ~ys~ksDIWSLGVILYELLTG~pPF~g~~~~------ei~qkIl~--~------------------------~l~----- 1006 (1170)
.|+.++|||||||++++|++|+.||...... .....+.. + .+.
T Consensus 205 ~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (362)
T d1q8ya_ 205 PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284 (362)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBC
T ss_pred CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCC
Confidence 9999999999999999999999999754321 11111100 0 000
Q ss_pred --------CCCCCccCCHHHHHHHHHhccCCCCCCCChhhHHHHHcCCCCCCCC
Q 001057 1007 --------WPNIPEEMSVEACDLIDKLLTENPVQRLGATGAREVKQHPFFKNIN 1052 (1170)
Q Consensus 1007 --------fP~ip~~lS~eakDLIkkLLq~DPskRpSa~~AeEILqHPfF~~id 1052 (1170)
........+++++|||.+||++||.+||| |+|+|+||||++..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt---a~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 285 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDTL 335 (362)
T ss_dssp CHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTCT
T ss_pred chhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccCCCC
Confidence 00112345788999999999999999999 88999999999664
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=384.02 Aligned_cols=246 Identities=21% Similarity=0.322 Sum_probs=189.3
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHH--HHHHHHhcCCCcEEEEEeeeeccc----
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILA--ERNILISVRNPFVVRFFYSFTCRE---- 831 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~--EieILskL~HPNIVrL~~~Fqd~~---- 831 (1170)
.+|.+.+.||+|+||+||+|+. +|+.||||++.... ...... |+..+..++|||||++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 5799999999999999999986 58999999986532 123334 444556789999999999987654
Q ss_pred ceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCeeeccCCCCcEEeCCCCcEEEEecC
Q 001057 832 NLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHS--------LNVIHRDLKPDNLLIGQDGHIKLTDFG 903 (1170)
Q Consensus 832 ~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs--------~GIIHRDIKPENILLd~dG~VKLsDFG 903 (1170)
.+|||||||.+|+|.++|++. .+++.....++.|++.||.|||+ +|||||||||+||||+.+|.+||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 589999999999999999875 68999999999999999999996 599999999999999999999999999
Q ss_pred CccccccccCCCCCCCCCCCCCccccccccCCCCCcccccccccccCCCCCCchHHHhcCC------CCcchhhhHHHHH
Q 001057 904 LSKVGLIHSTDDLSAPSLGSGGFLVNDELKDQPPLTREQRQKHSVAGTPDYLAPEILLGMG------HGATADWWSVGII 977 (1170)
Q Consensus 904 LAk~~~~~~~~d~~a~sl~s~~~l~~~~l~~~~~lt~~~~~~~s~vGTp~YmAPEVL~g~~------ys~ksDIWSLGVI 977 (1170)
+|+...... ..........+||+.|||||++.+.. ++.++|||||||+
T Consensus 154 l~~~~~~~~--------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvv 207 (303)
T d1vjya_ 154 LAVRHDSAT--------------------------DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207 (303)
T ss_dssp TCEEEETTT--------------------------TEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred ccccccCCC--------------------------cceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHH
Confidence 998631000 00111233568999999999997653 5678999999999
Q ss_pred HHHHHhCCCCCCCC---------------CHHHHHHHHhccCCCCCCCCcc-----CCHHHHHHHHHhccCCCCCCCChh
Q 001057 978 LFELLIGIPPFNAK---------------TPQQIFDNIMNRDIPWPNIPEE-----MSVEACDLIDKLLTENPVQRLGAT 1037 (1170)
Q Consensus 978 LYELLTG~pPF~g~---------------~~~ei~qkIl~~~l~fP~ip~~-----lS~eakDLIkkLLq~DPskRpSa~ 1037 (1170)
||||++|.+||... ....+...+..... .|.++.. ....+.+|+.+||+.||.+||++.
T Consensus 208 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 286 (303)
T d1vjya_ 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286 (303)
T ss_dssp HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC-CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH
T ss_pred HHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhcccc-CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHH
Confidence 99999999887431 22333333333332 2333222 234588999999999999999954
Q ss_pred hH
Q 001057 1038 GA 1039 (1170)
Q Consensus 1038 ~A 1039 (1170)
++
T Consensus 287 ei 288 (303)
T d1vjya_ 287 RI 288 (303)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=8.1e-24 Score=214.16 Aligned_cols=135 Identities=19% Similarity=0.179 Sum_probs=107.5
Q ss_pred eEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccc---------------cHHHHHHHHHHHHHHHhcCCCcEEEEE
Q 001057 760 FEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMI---------------RKNAVESILAERNILISVRNPFVVRFF 824 (1170)
Q Consensus 760 Yevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~---------------~~~~ve~~l~EieILskL~HPNIVrL~ 824 (1170)
|.+.++||+|+||+||+|++. +|+.||||+++..... ..........|...|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999985 7899999987532110 011223456788999999999999887
Q ss_pred eeeecccceEEEEeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCCCcEEeCCCCcEEEEecCC
Q 001057 825 YSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLHSLNVIHRDLKPDNLLIGQDGHIKLTDFGL 904 (1170)
Q Consensus 825 ~~Fqd~~~LyLVMEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLHs~GIIHRDIKPENILLd~dG~VKLsDFGL 904 (1170)
++. ..++||||+.+..+.. ++...+..++.|++.||.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred Eec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 653 2379999998765432 4556677899999999999999999999999999999865 589999999
Q ss_pred ccc
Q 001057 905 SKV 907 (1170)
Q Consensus 905 Ak~ 907 (1170)
|+.
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred ccc
Confidence 974
|
| >d1ne6a1 b.82.3.2 (A:109-244) Regulatory subunit of Protein kinase A {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.40 E-value=2.1e-14 Score=138.53 Aligned_cols=119 Identities=11% Similarity=0.021 Sum_probs=103.2
Q ss_pred HHHHHHHHHHHHH--hcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCch
Q 001057 525 ERLERVAETLEKI--LDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPT 602 (1170)
Q Consensus 525 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFG 602 (1170)
+++..++++|++. |.+.++... ..-........+|+|..|.+|||.++.+|+|.+|.+.++.++..+.++++|+.||
T Consensus 13 ~~~~~l~~~l~~~~lF~~l~~~~l-~~l~~~~~~~~~~~ge~I~~~gd~~~~~yiI~~G~v~v~~~~~~~~~l~~G~~fG 91 (136)
T d1ne6a1 13 KTMAALAKAIEKNVLFSHLDDNER-SDIFDAMFPVSFIAGETVIQQGDEGDNFYVIDQGEMDVYVNNEWATSVGEGGSFG 91 (136)
T ss_dssp HHHHHHHHHHHHCGGGTSCCHHHH-HHHHHHCEEEEECTTCEEECTTSCCCEEEEEEESCEEEEETTEEEEEECTTCEEC
T ss_pred HHHHHHHHHHhCCHhhhhCCHHHH-HHHhcceEEEEECCCCEEEeCCCCcceeeeecCCceeeeccccccceeccccccc
Confidence 5677778888874 444433211 1115566778899999999999999999999999999999999999999999999
Q ss_pred Hhhhh---hhcccccccCCCcccccCCchhhhhhhhhhhhhccCCCHHHHHHH
Q 001057 603 AADIA---AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKL 652 (1170)
Q Consensus 603 ELAL~---pRAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~~kr~~y 652 (1170)
|++++ ||++||.|.++|.+|.|+| +.|+.+++.+...+|+||
T Consensus 92 e~~ll~~~~~~~tv~a~~~~~l~~i~~--------~~f~~ll~~~~~~~r~~y 136 (136)
T d1ne6a1 92 ELALIYGTPRAATVKAKTNVKLWGIDR--------DSYRRILMGSTLRKRKMY 136 (136)
T ss_dssp CHHHHHCCCCCSEEEESSCEEEEEEEH--------HHHHHHTHHHHHHHHHHH
T ss_pred cHHHcCCCcceEEEEEccCEEEEEEEH--------HHHHHHHhhCHHHHHhhC
Confidence 99999 9999999999999999999 999999999999999998
|
| >d1cx4a1 b.82.3.2 (A:130-265) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.34 E-value=5.7e-14 Score=134.32 Aligned_cols=120 Identities=11% Similarity=0.103 Sum_probs=103.2
Q ss_pred hHHHHHHHHHHHH--HhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEEcC----ccccccCC
Q 001057 524 NERLERVAETLEK--ILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL----NVLPEISC 597 (1170)
Q Consensus 524 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~----~~v~~~~~ 597 (1170)
+|.+.++.+.|.+ +|.+.++..+. .-+.......+++|..|++|||.++.+|+|.+|.|.++.+. ..+..+++
T Consensus 8 ~~~~~~l~~~l~~~~~F~~l~~~~~~-~l~~~~~~~~~~~g~~I~~~G~~~~~~y~I~~G~v~v~~~~~~~~~~~~~l~~ 86 (136)
T d1cx4a1 8 DDQRNRLQEACKDILLFKNLDPEQMS-QVLDAMFEKLVKEGEHVIDQGDDGDNFYVIDRGTFDIYVKCDGVGRCVGNYDN 86 (136)
T ss_dssp HHHHHHHHHHHTTCGGGTTCCHHHHH-HHHHHCEEEEECTTCEEECTTSCCCEEEEEEECEEEEEEEETTEEEEEEEEES
T ss_pred HHHHHHHHHHHhCCHhhhcCCHHHHH-HHhcceEEEEECCCCEEEECCCcchhhhhhhhheeEEeeccccceeeeeccCC
Confidence 6677777777776 45666654332 22666777889999999999999999999999999998753 45788999
Q ss_pred CCCchHhhhh---hhcccccccCCCcccccCCchhhhhhhhhhhhhccCCCHHHHHHH
Q 001057 598 DKNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIKKL 652 (1170)
Q Consensus 598 g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~~kr~~y 652 (1170)
|+.|||++++ ||.+||+|.++|.+|.|+| ++|++|++.+..++|+||
T Consensus 87 g~~fg~~~l~~~~~~~~s~~a~~~~~~~~i~~--------~~f~~ll~~~~~~~r~~y 136 (136)
T d1cx4a1 87 RGSFGELALMYNTPRAATITATSPGALWGLDR--------VTFRRIIVKNNAKKRKMY 136 (136)
T ss_dssp SCEECHHHHHHCCCCCSEEEESSCEEEEEEEH--------HHHHHHHHHHHHHHHHHH
T ss_pred ccccchHHHhCCCcceEEEEECCCEEEEEEeH--------HHHHHHHHhCHHHHHhcC
Confidence 9999999998 9999999999999999999 999999999999999998
|
| >d1o7fa3 b.82.3.2 (A:322-445) Regulatory domain of Epac2, domains 1 and 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory domain of Epac2, domains 1 and 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.97 E-value=3.1e-11 Score=113.41 Aligned_cols=107 Identities=12% Similarity=-0.020 Sum_probs=83.1
Q ss_pred HHHHHHHHHH--HhcccCCCccCcccccccccCC-CcccccccccCCCCCcceeecCCcEEEEEcCc-cccccCCCCCch
Q 001057 527 LERVAETLEK--ILDSWSPKKHTKKRTHDDLNLM-SPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLN-VLPEISCDKNPT 602 (1170)
Q Consensus 527 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~-~v~~~~~g~sFG 602 (1170)
++.+.+.|.+ +|..|++...... .....-.. .++|..|++|||.++.+|||-+|.|.++.++. .+..+++|..||
T Consensus 5 ~~~i~~~L~~~~~F~~l~~~~l~~l-~~~~~~~~~~~~ge~I~~~gd~~~~lyii~~G~v~~~~~~~~~~~~~~~G~~fG 83 (124)
T d1o7fa3 5 LEIIYDELLHIKALSHLSTTVKREL-AGVLIFESHAKGGTVLFNQGEEGTSWYIILKGSVNVVIYGKGVVCTLHEGDDFG 83 (124)
T ss_dssp HHHHHHHHTTCGGGTTSCHHHHHHH-HHHCEEEEECSTTCEEECTTSCCCEEEEEEESEEEEEETTTEEEEEEETTCEEC
T ss_pred HHHHHHHHhCCHhhhcCCHHHHHHH-HhhCeEEEEcCCCCEEEECCCcCceEEEEEcceEEEEEeeeeecccccCCcchh
Confidence 4456666654 4566665433221 22233233 45699999999999999999999999998765 477899999999
Q ss_pred Hhhhh---hhcccccccCC-CcccccCCchhhhhhhhhhhhhcc
Q 001057 603 AADIA---AKTSSAGSLTP-RSPLLTPRTSQIELLVNGHRTITE 642 (1170)
Q Consensus 603 ELAL~---pRAATv~A~t~-~~lw~ldR~~~~~~~~~tfr~Il~ 642 (1170)
|.+++ ||.+||+|+++ |.+|.|+| ..|++|+.
T Consensus 84 e~~ll~~~~r~~t~~a~~~~~~l~~i~~--------~~f~~il~ 119 (124)
T d1o7fa3 84 KLALVNDAPRAASIVLREDNCHFLRVDK--------EDFNRILR 119 (124)
T ss_dssp GGGGTCCSCCSSEEEESSSSEEEEEEEH--------HHHHHHHH
T ss_pred hhHhhCCCceeeEEEEEeCcEEEEEEcH--------HHHHHHHh
Confidence 99999 99999999996 89999999 88988874
|
| >d1q3ea_ b.82.3.2 (A:) HCN pacemaker channel {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: HCN pacemaker channel species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.89 E-value=1.4e-10 Score=116.44 Aligned_cols=87 Identities=10% Similarity=-0.104 Sum_probs=78.1
Q ss_pred ccccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCc
Q 001057 551 THDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRT 627 (1170)
Q Consensus 551 ~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~ 627 (1170)
+........++|..|++|||.++.+|+|.+|.|+|+.+++.+.++++|+.|||++++ ||.+||+|.++|.+|.|+|
T Consensus 88 ~~~~~~~~~~~g~~I~~~g~~~~~ly~i~~G~v~v~~~~~~~~~l~~G~~fGe~~~~~~~~~~~~~~a~~~~~l~~l~~- 166 (193)
T d1q3ea_ 88 LTKLKFEVFQPGDYIIREGTIGKKMYFIQHGVVSVLTKGNKEMKLSDGSYFGEICLLTRGRRTASVRADTYCRLYSLSV- 166 (193)
T ss_dssp HTTCEEEEECTTCEEECTTSBCCEEEEEEECCEEEEC-CCCEEEECTTCEECHHHHHHCSBCSSEEEESSCEEEEEEEH-
T ss_pred HHHHHHHhhccCceecccCCCCcceeEeeeeeEEeecCCcceeeeccceeeeeeeccCCCcccccceecCceEEEEEeH-
Confidence 444555677999999999999999999999999999999999999999999999999 9999999999999999999
Q ss_pred hhhhhhhhhhhhhccCCC
Q 001057 628 SQIELLVNGHRTITELQN 645 (1170)
Q Consensus 628 ~~~~~~~~tfr~Il~~~~ 645 (1170)
+.|..|+...-
T Consensus 167 -------~~f~~ll~~~p 177 (193)
T d1q3ea_ 167 -------DNFNEVLEEYP 177 (193)
T ss_dssp -------HHHHHHHHHSG
T ss_pred -------HHHHHHHHHCH
Confidence 88888876543
|
| >d1wgpa_ b.82.3.2 (A:) Probable cyclic nucleotide-gated ion channel 6 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Probable cyclic nucleotide-gated ion channel 6 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.84 E-value=4.2e-10 Score=108.05 Aligned_cols=73 Identities=8% Similarity=-0.115 Sum_probs=64.0
Q ss_pred cccCCCcccccccccCCCCCcceeecCCcEEEEEcC------ccccccCCCCCchHhhhh------------hhcccccc
Q 001057 554 DLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL------NVLPEISCDKNPTAADIA------------AKTSSAGS 615 (1170)
Q Consensus 554 ~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~------~~v~~~~~g~sFGELAL~------------pRAATv~A 615 (1170)
......++|..|++|||.++.+|+|.+|.|.++... ..+..+++|..|||++|+ +|+|||+|
T Consensus 29 ~~~~~~~~ge~I~~~Gd~~~~ly~i~~G~v~~~~~~~~~~~~~~~~~l~~G~~fGE~~ll~~~~~~~~~~~~~r~~tv~a 108 (137)
T d1wgpa_ 29 LKPCLFTEKSYLVREGDPVNEMLFIIRGRLESVTTDGGRSGFYNRSLLKEGDFCGDELLTWALDPKSGSNLPSSTRTVKA 108 (137)
T ss_dssp CBCCCBCTTEEEECTTSBCSEEEEEEECCCEEECCSSCSSSSSCEEECCTTCBSSTHHHHHHHCSSCCSSSCBCSSEEEE
T ss_pred cEEEEECCCCEEEecccccceeehhccCceEEEEecCCCceeeeeeeccCCcEEcchhHhccCCCcccccccccCcEEEE
Confidence 445678999999999999999999999999988532 235678999999999996 58899999
Q ss_pred cCCCcccccCC
Q 001057 616 LTPRSPLLTPR 626 (1170)
Q Consensus 616 ~t~~~lw~ldR 626 (1170)
.|+|.+|.|+|
T Consensus 109 ~t~~~l~~L~~ 119 (137)
T d1wgpa_ 109 LTEVEAFALIA 119 (137)
T ss_dssp SSCBEEEEEEH
T ss_pred eeeEEEEEEEH
Confidence 99999999999
|
| >d1o7fa2 b.82.3.2 (A:13-167) Regulatory domain of Epac2, domains 1 and 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory domain of Epac2, domains 1 and 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.77 E-value=6.1e-10 Score=108.46 Aligned_cols=79 Identities=10% Similarity=-0.072 Sum_probs=70.1
Q ss_pred cccCCCcccccccccCCCCCcceeecCCcEEEEEcC-------ccccccCCCCCchHhhhh---hhcccccccCCCcccc
Q 001057 554 DLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL-------NVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLL 623 (1170)
Q Consensus 554 ~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~-------~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ 623 (1170)
..-..+++|..|++|||.++.+|||.+|.|.|++.. ..+.++++|..||| +++ ||++||.|.|++.+|.
T Consensus 47 ~~~~~~~~ge~I~~~gd~~~~~y~I~~G~v~v~~~~~~~~~~~~~v~~l~~g~~fGe-~~l~~~~~~~tv~a~~~~~l~~ 125 (155)
T d1o7fa2 47 GYYENLEKGITLFRQGDIGTNWYAVLAGSLDVKVSETSSHQDAVTICTLGIGTAFGE-SILDNTPRHATIVTRESSELLR 125 (155)
T ss_dssp CEEEEECTTCEEECTTSBCCEEEEEEESCEEEEECSSSCGGGCEEEEEECTTCEECG-GGGGTCBCSSEEEESSSEEEEE
T ss_pred cEEEEECCCCEEEeCCCcceeeEEEeccchheeeecccccccccccccccccccchh-hhhcCCCceEEEEECCCEEEEE
Confidence 344568999999999999999999999999998642 34788999999999 666 9999999999999999
Q ss_pred cCCchhhhhhhhhhhhhc
Q 001057 624 TPRTSQIELLVNGHRTIT 641 (1170)
Q Consensus 624 ldR~~~~~~~~~tfr~Il 641 (1170)
|+| ..|+.|+
T Consensus 126 i~~--------~~f~~il 135 (155)
T d1o7fa2 126 IEQ--------EDFKALW 135 (155)
T ss_dssp EEH--------HHHHHHH
T ss_pred EeH--------HHHHHHH
Confidence 999 8898886
|
| >d1ne6a2 b.82.3.2 (A:245-376) Regulatory subunit of Protein kinase A {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Cow (Bos taurus) [TaxId: 9913]
Probab=98.76 E-value=2.5e-10 Score=107.84 Aligned_cols=83 Identities=7% Similarity=-0.036 Sum_probs=73.5
Q ss_pred ccccCCCcccccccccCCCCCcceeecCCcEEEEEcC---c---cccccCCCCCchHhhhh---hhcccccccCCCcccc
Q 001057 553 DDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL---N---VLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLL 623 (1170)
Q Consensus 553 ~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~---~---~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ 623 (1170)
.......++|..|++|||.++.+|||-+|.|.++..+ . .+..+++|..||+.+++ ||++||.|.+++.+|.
T Consensus 24 ~~~~~~~~~g~~I~~~Gd~~~~~yii~~G~v~~~~~~~~~~~~~~~~~~~~g~~fG~~~~~~~~~~~~t~~a~~~~~~~~ 103 (132)
T d1ne6a2 24 ALEPVQFEDGQKIVVQGEPGDEFFIILEGSAAVLQRRSENEEFVEVGRLGPSDYFGEIALLMNRPRAATVVARGPLKCVK 103 (132)
T ss_dssp HCEEEEECTTCEEECTTSCCCEEEEEEECCEEEEEESSSSCCEEEEEEECTTCEECHHHHHHTSSCSSEEEESSCEEEEE
T ss_pred hCEEEEECCCCEEEEcCCcchHHHHHHhhhheeeccCCccccchhhhhccccceeeEeeecCCCceeEEEEEcccEEEEE
Confidence 3445667899999999999999999999999998743 2 47789999999999999 9999999999999999
Q ss_pred cCCchhhhhhhhhhhhhccC
Q 001057 624 TPRTSQIELLVNGHRTITEL 643 (1170)
Q Consensus 624 ldR~~~~~~~~~tfr~Il~~ 643 (1170)
|++ ..|.+++..
T Consensus 104 i~~--------~~~~~ll~~ 115 (132)
T d1ne6a2 104 LDR--------PRFERVLGP 115 (132)
T ss_dssp EEH--------HHHHHHTGG
T ss_pred EEH--------HHHHHHHHH
Confidence 999 888888864
|
| >d1cx4a2 b.82.3.2 (A:266-412) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.75 E-value=6.1e-10 Score=106.69 Aligned_cols=85 Identities=6% Similarity=-0.067 Sum_probs=75.2
Q ss_pred cccccCCCcccccccccCCCCCcceeecCCcEEEEEcC-----------ccccccCCCCCchHhhhh---hhcccccccC
Q 001057 552 HDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL-----------NVLPEISCDKNPTAADIA---AKTSSAGSLT 617 (1170)
Q Consensus 552 ~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~-----------~~v~~~~~g~sFGELAL~---pRAATv~A~t 617 (1170)
.......+++|..|++|||.++.+|||-+|.|.++... ..+..+++|..|||.+++ ||++||.|.+
T Consensus 23 ~~~~~~~~~~ge~i~~~G~~~~~~y~i~~G~v~v~~~~~~~~~~~~~~~~~i~~~~~g~~fGe~~~~~~~~~~~t~~a~~ 102 (147)
T d1cx4a2 23 DVIGTKVYNDGEQIIAQGDSADSFFIVESGEVRITMKRKGKSDIEENGAVEIARCLRGQYFGELALVTNKPRAASAHAIG 102 (147)
T ss_dssp HHCEEEEECTTCEEECTTCCCCEEEEEEEEEEEEEEEC--------CCEEEEEEECTTCEESCHHHHHTCCCSSEEEEEE
T ss_pred HhCEEEEECCCCEEEeCCCCCceeEEEecceEEEEEecCCCccccccceeeeeeccCCcEeeehhhcCCCCceEEEEECC
Confidence 34455678999999999999999999999999998543 247889999999999999 9999999999
Q ss_pred CCcccccCCchhhhhhhhhhhhhccCC
Q 001057 618 PRSPLLTPRTSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 618 ~~~lw~ldR~~~~~~~~~tfr~Il~~~ 644 (1170)
+|.+|.|+| +.|+.++...
T Consensus 103 ~~~~~~i~~--------~~f~~ll~~~ 121 (147)
T d1cx4a2 103 TVKCLAMDV--------QAFERLLGPC 121 (147)
T ss_dssp EEEEEEEEH--------HHHHHHCGGG
T ss_pred CEEEEEEEH--------HHHHHHHHHC
Confidence 999999999 9999998653
|
| >d1vp6a_ b.82.3.2 (A:) Putative ion channel CnbD {Mesorhizobium loti [TaxId: 381]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Putative ion channel CnbD species: Mesorhizobium loti [TaxId: 381]
Probab=98.66 E-value=2.3e-09 Score=101.64 Aligned_cols=92 Identities=9% Similarity=-0.075 Sum_probs=77.6
Q ss_pred ccccCCCcccccccccCCCCCcceeecCCcEEEEEcCccccccCCCCCchHhhhh---hhcccccccCCCcccccCCchh
Q 001057 553 DDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDLNVLPEISCDKNPTAADIA---AKTSSAGSLTPRSPLLTPRTSQ 629 (1170)
Q Consensus 553 ~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~~~v~~~~~g~sFGELAL~---pRAATv~A~t~~~lw~ldR~~~ 629 (1170)
...-...++|..|++||+..+.+|+|.+|.|.++..+. .++++|..|||++++ |+.+||.|.++|.+|.+++
T Consensus 33 ~~~~~~~~~g~~i~~~G~~~~~~y~I~~G~v~v~~~~~--~~l~~G~~~G~~~~l~~~~~~~~~~a~~~~~i~~i~~--- 107 (133)
T d1vp6a_ 33 ALRARTVPAGAVICRIGEPGDRMFFVVEGSVSVATPNP--VELGPGAFFGEMALISGEPRSATVSAATTVSLLSLHS--- 107 (133)
T ss_dssp HCEEEEECTTCEEECTTSCCCEEEEEEESCEEECSSSC--EEECTTCEECHHHHHHCCCCSSCEEESSSEEEEEEEH---
T ss_pred hCEEEEECCCCEEEeCCCCCccceeeeccccEEEEeee--eeeccCcccccccccCCCcccceEEECCCEEEEEEeH---
Confidence 34456789999999999999999999999999987653 368999999999999 9999999999999999999
Q ss_pred hhhhhhhhhhhccCCCHHHHHHHHH
Q 001057 630 IELLVNGHRTITELQNPQQIKKLLD 654 (1170)
Q Consensus 630 ~~~~~~tfr~Il~~~~~~kr~~y~~ 654 (1170)
..|+.+++.+..=++.....
T Consensus 108 -----~~~~~l~~~~p~~~~~~~~~ 127 (133)
T d1vp6a_ 108 -----ADFQMLCSSSPEIAEIFRKT 127 (133)
T ss_dssp -----HHHHHHHHHCHHHHHHHHHH
T ss_pred -----HHHHHHHHhCHHHHHHHHHH
Confidence 89998887654444443333
|
| >d1i5za2 b.82.3.2 (A:6-137) Catabolite gene activator protein, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Catabolite gene activator protein, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=98.58 E-value=6.3e-09 Score=97.18 Aligned_cols=92 Identities=10% Similarity=0.013 Sum_probs=77.1
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEEc---Cc--cccccCCCCCchHhhhh----hhcccccccCCCcccccCC
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED---LN--VLPEISCDKNPTAADIA----AKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~---~~--~v~~~~~g~sFGELAL~----pRAATv~A~t~~~lw~ldR 626 (1170)
....+||+.|++|||..+.+|+|.+|.|.++.. |+ .+..+.+|+.||+++++ |+.+|+.|.++|.+|.+++
T Consensus 15 ~~~~~~g~~i~~~g~~~~~iy~i~~G~v~~~~~~~~g~e~~l~~~~~G~~~G~~~~~~~~~~~~~~~~a~~~~~v~~i~~ 94 (132)
T d1i5za2 15 IHKYPSKSTLIHQGEKAETLYYIVKGSVAVLIKDEEGKEMILSYLNQGDFIGELGLFEEGQERSAWVRAKTACEVAEISY 94 (132)
T ss_dssp EEEECTTCEEECTTSBCCEEEEEEECCEEEEEECTTCCEEEEEEECTTCEESCTTTTSSSCBCCSEEEESSCEEEEEEEH
T ss_pred EEEECcCCEEEcCCCCCCEEEEEEEccceeeeccccchhhhhhhhCcccccchHHHhcCCccceEEEEEccceEEEEEcH
Confidence 356899999999999999999999999998853 32 47789999999998887 7899999999999999999
Q ss_pred chhhhhhhhhhhhhccCCCHHHHHHHHHH
Q 001057 627 TSQIELLVNGHRTITELQNPQQIKKLLDV 655 (1170)
Q Consensus 627 ~~~~~~~~~tfr~Il~~~~~~kr~~y~~f 655 (1170)
..|.+++.....-...++..+
T Consensus 95 --------~~~~~~~~~~~~~~~~~~~~l 115 (132)
T d1i5za2 95 --------KKFRQLIQVNPDILMRLSAQM 115 (132)
T ss_dssp --------HHHHHHHHHCTHHHHHHHHHH
T ss_pred --------HHHHHHHhhCHHHHHHHHHHH
Confidence 999998876654444444433
|
| >d3e5ua2 b.82.3.2 (A:9-147) Chlorophenol reduction protein CprK {Desulfitobacterium hafniense [TaxId: 49338]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Chlorophenol reduction protein CprK species: Desulfitobacterium hafniense [TaxId: 49338]
Probab=98.49 E-value=1.1e-08 Score=97.44 Aligned_cols=102 Identities=11% Similarity=-0.038 Sum_probs=88.0
Q ss_pred ccccccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhhhhcccccccCCCcccccC
Q 001057 551 THDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIAAKTSSAGSLTPRSPLLTP 625 (1170)
Q Consensus 551 ~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~pRAATv~A~t~~~lw~ld 625 (1170)
+..-.-...+||..+++|||..+.+|+|-+|.+.++. +|+ .+..+++|+-|||+.+.|+.+++.|.+++.+|.++
T Consensus 21 ~~~~~~~~y~kg~~i~~~g~~~~~~y~v~~G~v~~~~~~~~g~~~~l~~~~~g~~~g~~~~~~~~~~~~a~~~~~v~~i~ 100 (139)
T d3e5ua2 21 TQMGLIRDFAKGSAVIMPGEEITSMIFLVEGKIKLDIIFEDGSEKLLYYAGGNSLIGKLYPTGNNIYATAMEPTRTCWFS 100 (139)
T ss_dssp GGGSEEEEECTTCEEECTTCCCCSEEEEEESEEEEEEECTTSCEEEEEEEETTCEECCCSCCSCEEEEEESSCEEEEEEC
T ss_pred HHhCEEEEECCCCEEEeCCCCCCEEEEEEeccceEEEeeccccccceeeccccceeehhhhhcccccccccccceEEEee
Confidence 3444455679999999999999999999999999886 443 46789999999999988999999999999999999
Q ss_pred CchhhhhhhhhhhhhccCCCHHHHHHHHHHhhccc
Q 001057 626 RTSQIELLVNGHRTITELQNPQQIKKLLDVSRSIA 660 (1170)
Q Consensus 626 R~~~~~~~~~tfr~Il~~~~~~kr~~y~~fl~~V~ 660 (1170)
+ +.|+.++..+..=.+..+..+.+++.
T Consensus 101 ~--------~~f~~l~~~~p~l~~~il~~~~~r~~ 127 (139)
T d3e5ua2 101 E--------KSLRTVFRTDEDMIFEIFKNYLTKVA 127 (139)
T ss_dssp H--------HHHHHHHHHCTHHHHHHHHHHHHHHH
T ss_pred H--------HHHHHHHhcCHHHHHHHHHHHHHHHH
Confidence 9 99999999888777777777777654
|
| >d2gaua2 b.82.3.2 (A:10-151) Transcriptional regulator PG0396, N-terminal domain {Porphyromonas gingivalis [TaxId: 837]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Transcriptional regulator PG0396, N-terminal domain species: Porphyromonas gingivalis [TaxId: 837]
Probab=98.46 E-value=6.8e-09 Score=98.86 Aligned_cols=108 Identities=6% Similarity=-0.044 Sum_probs=84.5
Q ss_pred HHHHhcccCCCccCcccccccccCCCcccccccccCCCCCcceeecCCcEEEEEc---Cc--cccccCCCCCchHhhhh-
Q 001057 534 LEKILDSWSPKKHTKKRTHDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED---LN--VLPEISCDKNPTAADIA- 607 (1170)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~---~~--~v~~~~~g~sFGELAL~- 607 (1170)
+..||..|++.....- .+.......|||..+++||+..+++|+|.+|.+.++.. |+ .+..+++|+.||+.+++
T Consensus 5 ~~elf~~l~~~~~~~l-~~~~~~~~~~~g~~l~~~g~~~~~ly~v~~G~v~~~~~~~~g~~~~~~~~~~G~~~G~~~~~~ 83 (142)
T d2gaua2 5 LRDVWSLLNEEERELL-DKEIQPFPCKKASTVFSEGDIPNNLFYLYEGKIKILREGVYGRFHISRIVKPGQFFGMRPYFA 83 (142)
T ss_dssp SHHHHTTCCHHHHHHH-HHHCEEEEECTTCEEECTTCCCCEEEEEEESCEEEEC-----CCCEEEEECTTCEESHHHHHH
T ss_pred HHHHHccCCHHHHHHH-HhcCEEEEECCCCEEEeCCCccceEEEEEecceeeEeeccccceeeeecccccchhhhhhhhc
Confidence 3456666666433222 33344577899999999999999999999999999963 43 35679999999999988
Q ss_pred --hhcccccccCCCcccccCCchhhhhhhhhhhhhccCCCHHHHH
Q 001057 608 --AKTSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQNPQQIK 650 (1170)
Q Consensus 608 --pRAATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~~~kr~ 650 (1170)
|+.++|.|.+++.+|.+++ +.|++++.....-.+.
T Consensus 84 ~~~~~~~~~a~~~s~v~~i~~--------~~~~~l~~~~~~~~~~ 120 (142)
T d2gaua2 84 EETCSSTAIAVENSKVLAIPV--------EAIEALLKGNTSFCRY 120 (142)
T ss_dssp TSCCSSEEEESSCEEEEEEEH--------HHHHHHHHHCHHHHHH
T ss_pred cCCceeEEEecCCEEEEEEeH--------HHHHHHHHHCHHHHHH
Confidence 9999999999999999999 8998888766543333
|
| >d2oz6a2 b.82.3.2 (A:9-142) Cyclic AMP receptor-like protein Vfr {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Cyclic AMP receptor-like protein Vfr species: Pseudomonas aeruginosa [TaxId: 287]
Probab=98.43 E-value=1.7e-08 Score=95.21 Aligned_cols=82 Identities=4% Similarity=-0.050 Sum_probs=72.4
Q ss_pred ccCCCcccccccccCCCCCcceeecCCcEEEEE---cCc--cccccCCCCCchHhhhh-------hhcccccccCCCccc
Q 001057 555 LNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIE---DLN--VLPEISCDKNPTAADIA-------AKTSSAGSLTPRSPL 622 (1170)
Q Consensus 555 ~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~---~~~--~v~~~~~g~sFGELAL~-------pRAATv~A~t~~~lw 622 (1170)
..+..|+|..|++|||..+.+|+|-+|.|.++. +|+ .+..+++|+.|||++++ ||++||.|.++|.+|
T Consensus 13 ~~~~~~~g~~i~~~g~~~~~~y~i~~G~v~v~~~~~~g~~~~~~~~~~g~~~G~~~~~~~~~~~~~~~~~~~a~~~~~vl 92 (134)
T d2oz6a2 13 HRRRYTAKSTIIYAGDRCETLFFIIKGSVTILIEDDDGREMIIGYLNSGDFFGELGLFEKEGSEQERSAWVRAKVECEVA 92 (134)
T ss_dssp EEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECTTSCEEEEEEEETTCEESCTTTCC-----CBCCSEEEESSCEEEE
T ss_pred EEEEECCCCEEEeCCCcCCEEEEEEEcccceeeeecccccceeeeccCCCccchHHHhcCccccccceeEEEECCCEEEE
Confidence 346689999999999999999999999999985 343 47789999999999887 799999999999999
Q ss_pred ccCCchhhhhhhhhhhhhccCC
Q 001057 623 LTPRTSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 623 ~ldR~~~~~~~~~tfr~Il~~~ 644 (1170)
.+++ ..|..++..+
T Consensus 93 ~i~~--------~~~~~~~~~~ 106 (134)
T d2oz6a2 93 EISY--------AKFRELSQQD 106 (134)
T ss_dssp EEEH--------HHHHHHHHHC
T ss_pred EEeH--------HHHHHHHHHC
Confidence 9999 8888888654
|
| >d1zyba2 b.82.3.2 (A:1-147) Probable transcription regulator BT4300, N-terminal domain {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Probable transcription regulator BT4300, N-terminal domain species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=98.37 E-value=1.9e-08 Score=96.18 Aligned_cols=101 Identities=7% Similarity=-0.054 Sum_probs=79.2
Q ss_pred HhcccCCCccCccccc-ccccCCCcccccccccCCCCCcceeecCCcEEEEEcC---c--cccccCCCCCchHhhhh---
Q 001057 537 ILDSWSPKKHTKKRTH-DDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL---N--VLPEISCDKNPTAADIA--- 607 (1170)
Q Consensus 537 ~~~~~~~~~~~~~~~~-~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~---~--~v~~~~~g~sFGELAL~--- 607 (1170)
+|.+|++.+....--+ ...-...++|..|++|||..+.+|+|-+|.|.++... + .+..+++|..|||++++
T Consensus 13 lF~~l~~~~~~~ll~~~~~~~~~~~~g~~i~~~g~~~~~iy~i~~G~v~v~~~~~~g~~~~~~~~~~g~~fGe~~~~~~~ 92 (147)
T d1zyba2 13 LFQGLCHEDFTSILDKVKLHFIKHKAGETIIKSGNPCTQLCFLLKGEISIVTNAKENIYTVIEQIEAPYLIEPQSLFGMN 92 (147)
T ss_dssp GGTTCCHHHHHHHHHTSCCEEEEECTTCEEECTTSBCCEEEEEEESEEEEEEECGGGSCEEEEEEESSEEECGGGGSSSC
T ss_pred ccccCCHHHHHHHHhhCceEEEEECCCCEEEeccCCccEEEEEecceEEEEEEcCCCCEEEEEEcCCCCEeccchhhccc
Confidence 4666666443322111 1123457999999999999999999999999999643 3 48899999999999997
Q ss_pred hh-cccccccCCCcccccCCchhhhhhhhhhhhhccCCC
Q 001057 608 AK-TSSAGSLTPRSPLLTPRTSQIELLVNGHRTITELQN 645 (1170)
Q Consensus 608 pR-AATv~A~t~~~lw~ldR~~~~~~~~~tfr~Il~~~~ 645 (1170)
++ ++||.|.++|.+..+++ ..|..++....
T Consensus 93 ~~~~~~v~a~~~~~vl~i~~--------~~~~~~~~~~p 123 (147)
T d1zyba2 93 TNYASSYVAHTEVHTVCISK--------AFVLSDLFRYD 123 (147)
T ss_dssp CBCSSEEEESSCEEEEEEEH--------HHHHHTGGGSH
T ss_pred ccccceeeecceeeeeehhH--------HHHHHHHHHCH
Confidence 55 79999999999999999 88888876554
|
| >d1o5la1 b.82.3.2 (A:1-129) CRP-like transcriptional regulator TM1171, N-terminal domain {Thermotoga maritima [TaxId: 2336]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: CRP-like transcriptional regulator TM1171, N-terminal domain species: Thermotoga maritima [TaxId: 2336]
Probab=98.31 E-value=6.3e-08 Score=89.87 Aligned_cols=81 Identities=9% Similarity=-0.121 Sum_probs=70.0
Q ss_pred cCCCcccccccccCCCCCcceeecCCcEEEEEc---C--ccccccCCCCCchHhhhh---hh-cccccccCCCcccccCC
Q 001057 556 NLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIED---L--NVLPEISCDKNPTAADIA---AK-TSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 556 ~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~---~--~~v~~~~~g~sFGELAL~---pR-AATv~A~t~~~lw~ldR 626 (1170)
-...+||..|++|||..+++|+|-+|.+.++.. | ..+..+++|..||+.+++ || .+|+.|.++|.+|.+++
T Consensus 12 ~~~~~kg~~l~~~g~~~~~~y~i~~G~v~~~~~~~~g~~~~~~~~~~g~~~g~~~~~~~~~~~~~~~~a~~~~~vl~i~~ 91 (129)
T d1o5la1 12 VIVFRKGEIVKHQDDPIEDVLILLEGTLKTEHVSENGKTLEIDEIKPVQIIASGFIFSSEPRFPVNVVAGENSKILSIPK 91 (129)
T ss_dssp EEEECTTCEEECTTCBCCEEEEEEESCEEEEEECTTSCEEEEEEECSSEESSGGGTTSSSCBCSSEEEESSSEEEEEEEH
T ss_pred EEEECCCCEEEECCCcCcEEEEEeccccEEEEeecccccchhhhcccccccchHHHhccCCCccEEEEeecccEEEEEcH
Confidence 346799999999999999999999999998753 3 247789999999999988 65 58999999999999999
Q ss_pred chhhhhhhhhhhhhccCC
Q 001057 627 TSQIELLVNGHRTITELQ 644 (1170)
Q Consensus 627 ~~~~~~~~~tfr~Il~~~ 644 (1170)
+.|+.++..+
T Consensus 92 --------~~~~~~~~~~ 101 (129)
T d1o5la1 92 --------EVFLDLLMKD 101 (129)
T ss_dssp --------HHHHHHHHHC
T ss_pred --------HHHHHHHHhC
Confidence 8888877654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.12 E-value=4.8e-06 Score=85.04 Aligned_cols=140 Identities=13% Similarity=0.111 Sum_probs=89.5
Q ss_pred CCeEEEEEeccCCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeecccceEEE
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTCRENLYLV 836 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd~~~LyLV 836 (1170)
+.|+..+..+-++.+.||++. .++..+.+|+...... .....+.+|..+|..+. +--+.+++.++.+.+..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 567877776656667999875 4566678887654321 12234567888877664 33356677777778889999
Q ss_pred EeeccCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 001057 837 MEYLNGGDLYSLLRNLGCLDEDMARVYIAELVLALEYLH----------------------------------------- 875 (1170)
Q Consensus 837 MEY~~GGSL~dlLk~~~~LSEe~ar~IaaQIL~ALeYLH----------------------------------------- 875 (1170)
|++++|.++........ . ...++.++...|..||
T Consensus 89 ~~~l~G~~~~~~~~~~~--~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ--S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTCS--C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccccc--c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 99999877754332110 0 1111222222222222
Q ss_pred ------------hC------CeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 876 ------------SL------NVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 876 ------------s~------GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
+. .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 21 279999999999998766667999998874
|
| >d1ft9a2 b.82.3.1 (A:2-133) CO-sensing protein CooA, N-terminal domain {Rhodospirillum rubrum [TaxId: 1085]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: CO-sensing protein CooA, N-terminal domain domain: CO-sensing protein CooA, N-terminal domain species: Rhodospirillum rubrum [TaxId: 1085]
Probab=97.71 E-value=3.5e-06 Score=79.31 Aligned_cols=91 Identities=7% Similarity=-0.164 Sum_probs=74.2
Q ss_pred ccccccCCCcccccccccCCCCCcceeecCCcEEEEEcC--c--cccccCCCCCchHhhhhhhcccccccCCCcccccCC
Q 001057 551 THDDLNLMSPKQNSLSRQGSKEMLDHVPDDDNAFVIEDL--N--VLPEISCDKNPTAADIAAKTSSAGSLTPRSPLLTPR 626 (1170)
Q Consensus 551 ~~~~~~~~~~k~~~~~~QGd~Gd~fYVie~G~~~v~~~~--~--~v~~~~~g~sFGELAL~pRAATv~A~t~~~lw~ldR 626 (1170)
.+...-+..+||+.|.+||+..+.+|+|-+|.+.+++.+ + .+..+++|..||| ++.++|.|+++|.++.++|
T Consensus 19 ~~~~~~~~~~kG~~i~~~g~~~~~ly~v~~G~v~~~~~~~g~e~~l~~~~~g~~f~~----~~~~~v~A~~~s~v~~i~~ 94 (132)
T d1ft9a2 19 FRGFRSKIHAKGSLVCTGEGDENGVFVVVDGRLRVYLVGEEREISLFYLTSGDMFCM----HSGCLVEATERTEVRFADI 94 (132)
T ss_dssp TTTCEEEEECTTCEEECTTCCCCCEEEEEESEEEEEEEETTEEEEEEEEETTCEEES----CSSCEEEESSCEEEEEECH
T ss_pred HHhCEEEEecCCcEEECCCCCCCEEEEEEeCeEeeeccccccceeeccccccccccc----cccccceeccceeeeeehH
Confidence 444566788999999999999999999999999998643 2 4778999999997 4689999999999999999
Q ss_pred chhhhhhhhhhhhhccCCCHHHHHHHH
Q 001057 627 TSQIELLVNGHRTITELQNPQQIKKLL 653 (1170)
Q Consensus 627 ~~~~~~~~~tfr~Il~~~~~~kr~~y~ 653 (1170)
+.|+..+.....=.+.++.
T Consensus 95 --------~~~~~ll~~~p~~~~~l~~ 113 (132)
T d1ft9a2 95 --------RTFEQKLQTCPSMAWGLIA 113 (132)
T ss_dssp --------HHHHHHHHHCGGGHHHHHH
T ss_pred --------HHHHHHHHHHHHHHHHHHH
Confidence 8888888765543333333
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.69 E-value=4.3e-05 Score=84.34 Aligned_cols=81 Identities=23% Similarity=0.257 Sum_probs=49.0
Q ss_pred EEEeccCCCeEEEEeeecCCCCEEEEEEeecc-cccc---HHHHHHHHHHHHHHHhcC-C--CcEEEEEeeeecccceEE
Q 001057 763 IKPISQGAFGRVFLARKRATGDLFAIKVLKKA-DMIR---KNAVESILAERNILISVR-N--PFVVRFFYSFTCRENLYL 835 (1170)
Q Consensus 763 lk~LG~GgFGtVyLArdk~TGe~VAIKvLkKs-~i~~---~~~ve~~l~EieILskL~-H--PNIVrL~~~Fqd~~~LyL 835 (1170)
.+.||.|....||++.+..+++.|.+|.-... .... .....+...|...|..+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 55799999999999998778889999964321 0000 011234556777776553 2 345666643 4456689
Q ss_pred EEeeccCCCh
Q 001057 836 VMEYLNGGDL 845 (1170)
Q Consensus 836 VMEY~~GGSL 845 (1170)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.51 E-value=0.00015 Score=73.29 Aligned_cols=136 Identities=17% Similarity=0.128 Sum_probs=81.4
Q ss_pred EeccCC-CeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCC--CcEEEEEeeeecccceEEEEeecc
Q 001057 765 PISQGA-FGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRN--PFVVRFFYSFTCRENLYLVMEYLN 841 (1170)
Q Consensus 765 ~LG~Gg-FGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~H--PNIVrL~~~Fqd~~~LyLVMEY~~ 841 (1170)
.+..|. -+.||++.. ..+..+.+|....... ..+..|...|+.+.. -.+.+++.+..+.+..++||+|++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 344444 468998875 4566688897654321 235667777766543 235677777788888999999998
Q ss_pred CCChHH--------------HHHhcCC-------CC--HHHH-----HHHH---------------HHHHHHHHHHHhC-
Q 001057 842 GGDLYS--------------LLRNLGC-------LD--EDMA-----RVYI---------------AELVLALEYLHSL- 877 (1170)
Q Consensus 842 GGSL~d--------------lLk~~~~-------LS--Ee~a-----r~Ia---------------aQIL~ALeYLHs~- 877 (1170)
|.++.. .+.+... +. .... ..+. ......+..+...
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 865522 1111110 00 0000 0000 0012223334332
Q ss_pred ------CeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 878 ------NVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 878 ------GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
.++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999998776678999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.30 E-value=0.0027 Score=67.56 Aligned_cols=70 Identities=16% Similarity=0.208 Sum_probs=42.2
Q ss_pred CCCeEEEEeeecCCCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcCCCcE--EEEE-----eeeecccceEEEEeecc
Q 001057 769 GAFGRVFLARKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFV--VRFF-----YSFTCRENLYLVMEYLN 841 (1170)
Q Consensus 769 GgFGtVyLArdk~TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~HPNI--VrL~-----~~Fqd~~~LyLVMEY~~ 841 (1170)
+.--.||++.. .+|..|++|+...... ..+.+..|...|..|....| +... ..+...+..+.|++++.
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 33468999986 4688899999765321 23456677777776642211 1111 12233456788999987
Q ss_pred CC
Q 001057 842 GG 843 (1170)
Q Consensus 842 GG 843 (1170)
|.
T Consensus 108 G~ 109 (325)
T d1zyla1 108 GR 109 (325)
T ss_dssp CE
T ss_pred Cc
Confidence 63
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.06 E-value=0.006 Score=66.43 Aligned_cols=78 Identities=19% Similarity=0.282 Sum_probs=51.0
Q ss_pred CCeEEEEEeccCCCeEEEEeeecC-------CCCEEEEEEeeccccccHHHHHHHHHHHHHHHhcC-CCcEEEEEeeeec
Q 001057 758 EDFEIIKPISQGAFGRVFLARKRA-------TGDLFAIKVLKKADMIRKNAVESILAERNILISVR-NPFVVRFFYSFTC 829 (1170)
Q Consensus 758 edYevlk~LG~GgFGtVyLArdk~-------TGe~VAIKvLkKs~i~~~~~ve~~l~EieILskL~-HPNIVrL~~~Fqd 829 (1170)
+++++ +.|+.|-.-.+|++.... ..+.|.+++...... . ....+|..+++.+. +.-..+++++|.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~----~-idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET----E-SHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC----H-HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcch----h-hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 34444 568888888999987643 346788887653321 1 23457888888775 4334577777654
Q ss_pred ccceEEEEeeccCCCh
Q 001057 830 RENLYLVMEYLNGGDL 845 (1170)
Q Consensus 830 ~~~LyLVMEY~~GGSL 845 (1170)
.+||||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 589999987544
|
| >d1ne6a2 b.82.3.2 (A:245-376) Regulatory subunit of Protein kinase A {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Cow (Bos taurus) [TaxId: 9913]
Probab=94.84 E-value=0.0017 Score=59.93 Aligned_cols=48 Identities=17% Similarity=0.252 Sum_probs=44.4
Q ss_pred HHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 653 LDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 653 ~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
++||++||+|++|++.++..|+++++...| +.+|++++.+|++..|+.
T Consensus 1 ~~~L~~i~~f~~L~~~~~~~l~~~~~~~~~~~g~~I~~~Gd~~~~~yii~~G~v 54 (132)
T d1ne6a2 1 EEFLSKVSILESLDKWERLTVADALEPVQFEDGQKIVVQGEPGDEFFIILEGSA 54 (132)
T ss_dssp HHHHHTSGGGGGSCHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEECCE
T ss_pred ChhHhCCHhhhCCCHHHHHHHHHhCEEEEECCCCEEEEcCCcchHHHHHHhhhh
Confidence 589999999999999999999999999888 566799999999999984
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.83 E-value=0.064 Score=55.58 Aligned_cols=31 Identities=35% Similarity=0.360 Sum_probs=27.7
Q ss_pred CCeeeccCCCCcEEeCCCCcEEEEecCCccc
Q 001057 877 LNVIHRDLKPDNLLIGQDGHIKLTDFGLSKV 907 (1170)
Q Consensus 877 ~GIIHRDIKPENILLd~dG~VKLsDFGLAk~ 907 (1170)
.|+||+|+.+.|||++.+...-|.||+.|..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999999864
|
| >d1cx4a1 b.82.3.2 (A:130-265) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=93.80 E-value=0.008 Score=55.66 Aligned_cols=60 Identities=20% Similarity=0.225 Sum_probs=53.2
Q ss_pred ccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 641 TELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 641 l~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
+--.+..++..+.++|+++++|++|++.++..|+++++...| +.+|+.++.+|++..|..
T Consensus 3 ~~~kt~~~~~~l~~~l~~~~~F~~l~~~~~~~l~~~~~~~~~~~g~~I~~~G~~~~~~y~I~~G~v 68 (136)
T d1cx4a1 3 IHPKTDDQRNRLQEACKDILLFKNLDPEQMSQVLDAMFEKLVKEGEHVIDQGDDGDNFYVIDRGTF 68 (136)
T ss_dssp CCCCCHHHHHHHHHHHTTCGGGTTCCHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEECEE
T ss_pred cccCCHHHHHHHHHHHhCCHhhhcCCHHHHHHHhcceEEEEECCCCEEEECCCcchhhhhhhhhee
Confidence 334567888889999999999999999999999999999888 566799999999999974
|
| >d1cx4a2 b.82.3.2 (A:266-412) Regulatory subunit of Protein kinase A {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=93.30 E-value=0.0061 Score=56.92 Aligned_cols=48 Identities=17% Similarity=0.243 Sum_probs=44.0
Q ss_pred HHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 653 LDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 653 ~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
++||+++|+|++|++.++.+|++.++...| +.+|+.++.+|++..|+.
T Consensus 1 e~~l~~~p~f~~l~~~~l~~l~~~~~~~~~~~ge~i~~~G~~~~~~y~i~~G~v 54 (147)
T d1cx4a2 1 ESFIESLPFLKSLEVSERLKVVDVIGTKVYNDGEQIIAQGDSADSFFIVESGEV 54 (147)
T ss_dssp HHHHHTCGGGTTSCHHHHHHHHHHCEEEEECTTCEEECTTCCCCEEEEEEEEEE
T ss_pred ChhHhcCHhhcCCCHHHHHHHHHhCEEEEECCCCEEEeCCCCCceeEEEecceE
Confidence 589999999999999999999999998887 566799999999999983
|
| >d1ne6a1 b.82.3.2 (A:109-244) Regulatory subunit of Protein kinase A {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory subunit of Protein kinase A species: Cow (Bos taurus) [TaxId: 9913]
Probab=89.52 E-value=0.044 Score=50.96 Aligned_cols=63 Identities=14% Similarity=0.144 Sum_probs=53.9
Q ss_pred hhhhccCCCHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehh
Q 001057 637 HRTITELQNPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGR 699 (1170)
Q Consensus 637 fr~Il~~~~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~ 699 (1170)
|-+-++.-+.+....+..+|++.++|++|++.++..|++.+....| +.+|+.++.+|++..|+
T Consensus 3 ~~~~~~~~~~~~~~~l~~~l~~~~lF~~l~~~~l~~l~~~~~~~~~~~ge~I~~~gd~~~~~yiI~~G~ 71 (136)
T d1ne6a1 3 YVRKVIPKDYKTMAALAKAIEKNVLFSHLDDNERSDIFDAMFPVSFIAGETVIQQGDEGDNFYVIDQGE 71 (136)
T ss_dssp CCCCCCCCCHHHHHHHHHHHHHCGGGTSCCHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEESC
T ss_pred cccccCCCCHHHHHHHHHHHhCCHhhhhCCHHHHHHHhcceEEEEECCCCEEEeCCCCcceeeeecCCc
Confidence 3444555667777788899999999999999999999999998888 56679999999999997
|
| >d1wgpa_ b.82.3.2 (A:) Probable cyclic nucleotide-gated ion channel 6 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Probable cyclic nucleotide-gated ion channel 6 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=89.37 E-value=0.026 Score=52.65 Aligned_cols=46 Identities=17% Similarity=0.286 Sum_probs=42.3
Q ss_pred HhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 655 VSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 655 fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
+|++||+|++|++..+..|+..++...| +.+|+.++.+|++..|+.
T Consensus 7 ~l~~vp~F~~l~~~~l~~l~~~~~~~~~~~ge~I~~~Gd~~~~ly~i~~G~v 58 (137)
T d1wgpa_ 7 GVRRVPLFENMDERLLDAICERLKPCLFTEKSYLVREGDPVNEMLFIIRGRL 58 (137)
T ss_dssp SCSSCSGGGSCCHHHHHHHHHHCBCCCBCTTEEEECTTSBCSEEEEEEECCC
T ss_pred HHHCCHhHhCCCHHHHHHHHHhcEEEEECCCCEEEecccccceeehhccCce
Confidence 6899999999999999999999999888 566799999999999973
|
| >d1o7fa3 b.82.3.2 (A:322-445) Regulatory domain of Epac2, domains 1 and 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Regulatory domain of Epac2, domains 1 and 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=89.30 E-value=0.046 Score=49.58 Aligned_cols=55 Identities=9% Similarity=0.038 Sum_probs=47.4
Q ss_pred CHHHHHHHHHHhhccccCCCCCHHHHHHHHHHHHHHHH-------HHhccccCcEEeeeehh
Q 001057 645 NPQQIKKLLDVSRSIASVNDCDYNSLEHMLDRLEELKY-------IIQDRKVDALFVETFGR 699 (1170)
Q Consensus 645 ~~~kr~~y~~fl~~V~~l~~l~~~el~klADaLe~~~f-------IiqgekgD~FyI~~~G~ 699 (1170)
|.+-++.+.++|+++++|+.|++..+.+|++.+....| +.+|++++.+|++..|.
T Consensus 1 t~~d~~~i~~~L~~~~~F~~l~~~~l~~l~~~~~~~~~~~~ge~I~~~gd~~~~lyii~~G~ 62 (124)
T d1o7fa3 1 TVDDLEIIYDELLHIKALSHLSTTVKRELAGVLIFESHAKGGTVLFNQGEEGTSWYIILKGS 62 (124)
T ss_dssp CHHHHHHHHHHHTTCGGGTTSCHHHHHHHHHHCEEEEECSTTCEEECTTSCCCEEEEEEESE
T ss_pred CHHHHHHHHHHHhCCHhhhcCCHHHHHHHHhhCeEEEEcCCCCEEEECCCcCceEEEEEcce
Confidence 34567789999999999999999999999999876444 45679999999999997
|
| >d1vp6a_ b.82.3.2 (A:) Putative ion channel CnbD {Mesorhizobium loti [TaxId: 381]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: Double-stranded beta-helix superfamily: cAMP-binding domain-like family: cAMP-binding domain domain: Putative ion channel CnbD species: Mesorhizobium loti [TaxId: 381]
Probab=85.37 E-value=0.058 Score=49.50 Aligned_cols=49 Identities=10% Similarity=0.045 Sum_probs=44.3
Q ss_pred HHHHhhccccCCCCCHHHHHHHHHHHHHHHH------HHhccccCcEEeeeehhh
Q 001057 652 LLDVSRSIASVNDCDYNSLEHMLDRLEELKY------IIQDRKVDALFVETFGRR 700 (1170)
Q Consensus 652 y~~fl~~V~~l~~l~~~el~klADaLe~~~f------IiqgekgD~FyI~~~G~R 700 (1170)
.-++|++||+|+.|++.++..|++.++...| +.+|+..+.+|++..|..
T Consensus 9 ~~~~l~~~p~F~~l~~~~l~~l~~~~~~~~~~~g~~i~~~G~~~~~~y~I~~G~v 63 (133)
T d1vp6a_ 9 NWQLVAAVPLFQKLGPAVLVEIVRALRARTVPAGAVICRIGEPGDRMFFVVEGSV 63 (133)
T ss_dssp HHHHHTTCGGGGGCCHHHHHHHHHHCEEEEECTTCEEECTTSCCCEEEEEEESCE
T ss_pred HHHHHHCCCccccCCHHHHHHHHHhCEEEEECCCCEEEeCCCCCccceeeecccc
Confidence 4489999999999999999999999988888 677799999999999973
|